NA	CHEMICAL	GENE-Y	9	1	Oncogenic gene expression is associated with derangement of the chemical/gene pathway and chemical-reversible alterations of mitochondrial dynamics and respiration .	T13	T27	22410778
NA	CHEMICAL	GENE-N	9	9	Oncogenic gene expression is associated with derangement of the chemical/gene pathway and chemical-reversible alterations of mitochondrial dynamics and respiration .	T13	T28	22410778
NA	CHEMICAL	GENE-Y	12	1	Oncogenic gene expression is associated with derangement of the chemical/gene pathway and chemical-reversible alterations of mitochondrial dynamics and respiration .	T14	T27	22410778
NA	CHEMICAL	GENE-N	12	9	Oncogenic gene expression is associated with derangement of the chemical/gene pathway and chemical-reversible alterations of mitochondrial dynamics and respiration .	T14	T28	22410778
NA	CHEMICAL	GENE-Y	23	9	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T6	T19	22410778
NA	CHEMICAL	GENE-N	23	40	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T6	T20	22410778
NA	CHEMICAL	GENE-N	23	17	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T6	T21	22410778
NA	CHEMICAL	GENE-N	23	57	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T6	T22	22410778
NA	CHEMICAL	GENE-Y	31	9	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T7	T19	22410778
NA	CHEMICAL	GENE-N	31	40	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T7	T20	22410778
NA	CHEMICAL	GENE-N	31	17	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T7	T21	22410778
NA	CHEMICAL	GENE-N	31	57	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T7	T22	22410778
NA	CHEMICAL	GENE-N	53	40	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T8	T20	22410778
NA	CHEMICAL	GENE-N	53	17	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T8	T21	22410778
NA	CHEMICAL	GENE-N	53	57	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T8	T22	22410778
NA	CHEMICAL	GENE-N	57	40	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T9	T20	22410778
NA	CHEMICAL	GENE-N	57	17	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T9	T21	22410778
NA	CHEMICAL	GENE-N	57	57	In previous papers , it has been shown that gene transformed mouse cells are much more sensitive as compared with normal cells to chemical withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of gene . Recent observations suggest that transformed cells have a derangement in the chemical/chemical-dependent protein kinase ( chemical/gene ) pathway , which is known to regulate several mitochondrial functions .	T9	T22	22410778
NA	CHEMICAL	GENE-N	6	6	Herein , the derangement of the chemical/gene pathway and its impact on transformation-linked changes of mitochondrial functions is investigated .	T10	T23	22410778
CPR:3	CHEMICAL	GENE-N	8	3	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T11	T24	22410778
NA	CHEMICAL	GENE-Y	8	12	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T11	T25	22410778
CPR:3	CHEMICAL	GENE-N	8	22	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T11	T26	22410778
NA	CHEMICAL	GENE-N	18	3	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T12	T24	22410778
CPR:4	CHEMICAL	GENE-Y	18	12	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T12	T25	22410778
NA	CHEMICAL	GENE-N	18	22	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T12	T26	22410778
NA	CHEMICAL	GENE-N	8	3	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T1	T24	22410778
NA	CHEMICAL	GENE-Y	8	12	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T1	T25	22410778
NA	CHEMICAL	GENE-N	8	22	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T1	T26	22410778
NA	CHEMICAL	GENE-N	3	3	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T2	T24	22410778
NA	CHEMICAL	GENE-Y	3	12	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T2	T25	22410778
NA	CHEMICAL	GENE-N	3	22	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T2	T26	22410778
NA	CHEMICAL	GENE-N	38	3	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T3	T24	22410778
NA	CHEMICAL	GENE-Y	38	12	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T3	T25	22410778
NA	CHEMICAL	GENE-N	38	22	Exogenous stimulation of gene activity , achieved by chemical treatment , protected gene-transformed cells from apoptosis induced by chemical deprivation , enhanced gene activity , intracellular chemical ( chemical ) levels , mitochondrial fusion and decreased intracellular reactive chemical species ( ROS ) levels .	T3	T26	22410778
CPR:6	CHEMICAL	GENE-N	6	11	injection of a subthreshold dose of chemical , a use-dependent chemical receptor antagonist , reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice .	T3	T10	17146052
NA	CHEMICAL	GENE-N	2	11	injection of a subthreshold dose of chemical , a use-dependent chemical receptor antagonist , reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice .	T4	T10	17146052
CPR:3	CHEMICAL	GENE-Y	1	8	The chemical analog chemical attenuates kainate-induced seizures via gene activation : comparison with the effects of chemical .	T34	T42	15723099
CPR:3	CHEMICAL	GENE-Y	3	8	The chemical analog chemical attenuates kainate-induced seizures via gene activation : comparison with the effects of chemical .	T33	T42	15723099
NA	CHEMICAL	GENE-Y	16	8	The chemical analog chemical attenuates kainate-induced seizures via gene activation : comparison with the effects of chemical .	T32	T42	15723099
NA	CHEMICAL	GENE-Y	0	7	chemical and chemical are high-affinity ligands at gene .	T4	T37	15723099
NA	CHEMICAL	GENE-Y	2	7	chemical and chemical are high-affinity ligands at gene .	T9	T37	15723099
CPR:4	CHEMICAL	GENE-Y	0	8	chemical pre-treatment also attenuated the chemical-induced increases in gene/gene expression , gene DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	T25	T38	15723099
CPR:4	CHEMICAL	GENE-Y	0	8	chemical pre-treatment also attenuated the chemical-induced increases in gene/gene expression , gene DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	T25	T39	15723099
CPR:4	CHEMICAL	GENE-Y	0	11	chemical pre-treatment also attenuated the chemical-induced increases in gene/gene expression , gene DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	T25	T40	15723099
CPR:3	CHEMICAL	GENE-Y	5	8	chemical pre-treatment also attenuated the chemical-induced increases in gene/gene expression , gene DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	T26	T38	15723099
CPR:3	CHEMICAL	GENE-Y	5	8	chemical pre-treatment also attenuated the chemical-induced increases in gene/gene expression , gene DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	T26	T39	15723099
CPR:3	CHEMICAL	GENE-Y	5	11	chemical pre-treatment also attenuated the chemical-induced increases in gene/gene expression , gene DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	T26	T40	15723099
NA	CHEMICAL	GENE-Y	4	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T30	T41	15723099
NA	CHEMICAL	GENE-Y	4	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T30	T35	15723099
NA	CHEMICAL	GENE-Y	4	38	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T30	T36	15723099
NA	CHEMICAL	GENE-Y	5	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T31	T41	15723099
NA	CHEMICAL	GENE-Y	5	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T31	T35	15723099
NA	CHEMICAL	GENE-Y	5	38	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T31	T36	15723099
CPR:6	CHEMICAL	GENE-Y	15	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T1	T41	15723099
NA	CHEMICAL	GENE-Y	15	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T1	T35	15723099
NA	CHEMICAL	GENE-Y	15	38	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T1	T36	15723099
NA	CHEMICAL	GENE-Y	5	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T2	T41	15723099
NA	CHEMICAL	GENE-Y	5	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T2	T35	15723099
NA	CHEMICAL	GENE-Y	5	38	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T2	T36	15723099
NA	CHEMICAL	GENE-Y	4	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T3	T41	15723099
NA	CHEMICAL	GENE-Y	4	5	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T3	T35	15723099
NA	CHEMICAL	GENE-Y	4	38	The anticonvulsant action of chemical or chemical was significantly counteracted by a selective gene antagonist chemical , suggesting that the anticonvulsant action of chemical or chemical is , at least in part , related to gene-activated modulation of gene transcription factors .	T3	T36	15723099
NA	CHEMICAL	GENE-Y	38	40	Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age-matched healthy premenopausal women with regard to body weight , body mass index , waist and hip circumferences , waist to hip ratio , fasting plasma chemical , gene levels , gene resistance measured by homeostasis model assessment ( HOMA ) -gene resistance index , beta cell function measured by HOMA-β index , gene and gene levels .	T2	T13	23529671
NA	CHEMICAL	GENE-Y	38	43	Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age-matched healthy premenopausal women with regard to body weight , body mass index , waist and hip circumferences , waist to hip ratio , fasting plasma chemical , gene levels , gene resistance measured by homeostasis model assessment ( HOMA ) -gene resistance index , beta cell function measured by HOMA-β index , gene and gene levels .	T2	T14	23529671
NA	CHEMICAL	GENE-Y	38	53	Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age-matched healthy premenopausal women with regard to body weight , body mass index , waist and hip circumferences , waist to hip ratio , fasting plasma chemical , gene levels , gene resistance measured by homeostasis model assessment ( HOMA ) -gene resistance index , beta cell function measured by HOMA-β index , gene and gene levels .	T2	T15	23529671
NA	CHEMICAL	GENE-Y	38	65	Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age-matched healthy premenopausal women with regard to body weight , body mass index , waist and hip circumferences , waist to hip ratio , fasting plasma chemical , gene levels , gene resistance measured by homeostasis model assessment ( HOMA ) -gene resistance index , beta cell function measured by HOMA-β index , gene and gene levels .	T2	T16	23529671
NA	CHEMICAL	GENE-Y	38	67	Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age-matched healthy premenopausal women with regard to body weight , body mass index , waist and hip circumferences , waist to hip ratio , fasting plasma chemical , gene levels , gene resistance measured by homeostasis model assessment ( HOMA ) -gene resistance index , beta cell function measured by HOMA-β index , gene and gene levels .	T2	T17	23529671
NA	CHEMICAL	GENE-Y	11	2	There was a positive correlation between gene levels and fasting plasma chemical in hyperprolactinemic women .	T1	T3	23529671
NA	CHEMICAL	GENE-Y	3	0	gene sensitizes to chemical by modulating gene and gene/gene signal pathway in FRO anaplastic thyroid carcinoma cells .	T13	T43	22918703
NA	CHEMICAL	GENE-Y	3	6	gene sensitizes to chemical by modulating gene and gene/gene signal pathway in FRO anaplastic thyroid carcinoma cells .	T13	T44	22918703
NA	CHEMICAL	GENE-N	3	8	gene sensitizes to chemical by modulating gene and gene/gene signal pathway in FRO anaplastic thyroid carcinoma cells .	T13	T45	22918703
NA	CHEMICAL	GENE-N	3	8	gene sensitizes to chemical by modulating gene and gene/gene signal pathway in FRO anaplastic thyroid carcinoma cells .	T13	T46	22918703
NA	CHEMICAL	GENE-Y	10	15	In the present study , we evaluated the effects of chemical on cell survival , gene , and gene/gene signal pathway in FRO anaplastic thyroid carcinoma ( ATC ) cells .	T5	T31	22918703
NA	CHEMICAL	GENE-N	10	18	In the present study , we evaluated the effects of chemical on cell survival , gene , and gene/gene signal pathway in FRO anaplastic thyroid carcinoma ( ATC ) cells .	T5	T32	22918703
NA	CHEMICAL	GENE-N	10	18	In the present study , we evaluated the effects of chemical on cell survival , gene , and gene/gene signal pathway in FRO anaplastic thyroid carcinoma ( ATC ) cells .	T5	T33	22918703
NA	CHEMICAL	GENE-Y	14	7	Moreover , we investigated the roles of gene in cell survival under condition of chemical treatment in FRO ATC cells .	T6	T34	22918703
NA	CHEMICAL	GENE-Y	1	7	After chemical treatment , cell viability , gene , and gene protein levels were not changed .	T7	T35	22918703
NA	CHEMICAL	GENE-Y	1	10	After chemical treatment , cell viability , gene , and gene protein levels were not changed .	T7	T36	22918703
NA	CHEMICAL	GENE-Y	1	15	In chemical-treated situation , cell viability was not different before and after administration of either gene siRNA or chemical whereas it was lessened after co-administration of gene siRNA and chemical .	T9	T41	22918703
NA	CHEMICAL	GENE-Y	1	26	In chemical-treated situation , cell viability was not different before and after administration of either gene siRNA or chemical whereas it was lessened after co-administration of gene siRNA and chemical .	T9	T42	22918703
NA	CHEMICAL	GENE-Y	18	15	In chemical-treated situation , cell viability was not different before and after administration of either gene siRNA or chemical whereas it was lessened after co-administration of gene siRNA and chemical .	T10	T41	22918703
NA	CHEMICAL	GENE-Y	18	26	In chemical-treated situation , cell viability was not different before and after administration of either gene siRNA or chemical whereas it was lessened after co-administration of gene siRNA and chemical .	T10	T42	22918703
NA	CHEMICAL	GENE-Y	29	15	In chemical-treated situation , cell viability was not different before and after administration of either gene siRNA or chemical whereas it was lessened after co-administration of gene siRNA and chemical .	T11	T41	22918703
NA	CHEMICAL	GENE-Y	29	26	In chemical-treated situation , cell viability was not different before and after administration of either gene siRNA or chemical whereas it was lessened after co-administration of gene siRNA and chemical .	T11	T42	22918703
NA	CHEMICAL	GENE-Y	2	11	Compared to chemical treatment alone , cell viability was reduced with gene plasmid but it was unchanged with gene siRNA .	T12	T14	22918703
NA	CHEMICAL	GENE-Y	2	18	Compared to chemical treatment alone , cell viability was reduced with gene plasmid but it was unchanged with gene siRNA .	T12	T15	22918703
NA	CHEMICAL	GENE-Y	1	1	While gene plasmid transfection diminished gene and chemical-Akt protein levels , gene siRNA transfection did not alter the protein levels .	T2	T20	22918703
NA	CHEMICAL	GENE-Y	1	5	While gene plasmid transfection diminished gene and chemical-Akt protein levels , gene siRNA transfection did not alter the protein levels .	T2	T21	22918703
NA	CHEMICAL	GENE-Y	1	11	While gene plasmid transfection diminished gene and chemical-Akt protein levels , gene siRNA transfection did not alter the protein levels .	T2	T23	22918703
NA	CHEMICAL	GENE-Y	14	7	In conclusion , these results suggest that gene may sensitize FRO ATC cells to chemical thereby inhibiting cell survival by modulating gene and gene/gene signal pathway .	T3	T24	22918703
NA	CHEMICAL	GENE-Y	14	21	In conclusion , these results suggest that gene may sensitize FRO ATC cells to chemical thereby inhibiting cell survival by modulating gene and gene/gene signal pathway .	T3	T25	22918703
NA	CHEMICAL	GENE-N	14	23	In conclusion , these results suggest that gene may sensitize FRO ATC cells to chemical thereby inhibiting cell survival by modulating gene and gene/gene signal pathway .	T3	T26	22918703
NA	CHEMICAL	GENE-N	14	23	In conclusion , these results suggest that gene may sensitize FRO ATC cells to chemical thereby inhibiting cell survival by modulating gene and gene/gene signal pathway .	T3	T27	22918703
CPR:4	CHEMICAL	GENE-Y	0	14	chemical prevents chemical liver injury in rats through suppression of Kupffer cell sensitization and gene production .	T21	T31	12105857
NA	CHEMICAL	GENE-Y	2	14	chemical prevents chemical liver injury in rats through suppression of Kupffer cell sensitization and gene production .	T22	T31	12105857
NA	CHEMICAL	GENE-Y	25	19	BACKGROUND & AIMS : Sensitization of Kupffer cells ( KCs ) to lipopolysaccharide ( LPS ) and overproduction of gene are critical for progression of chemical liver injury .	T10	T23	12105857
CPR:4	CHEMICAL	GENE-Y	0	6	chemical has been shown to suppress gene production from macrophages .	T12	T28	12105857
NA	CHEMICAL	GENE-Y	7	24	KCs were isolated after 4 weeks of chemical treatment and intracellular chemical ( [ chemical ] i ) was measured using fura-2 , whereas gene was evaluated by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay .	T17	T29	12105857
NA	CHEMICAL	GENE-Y	11	24	KCs were isolated after 4 weeks of chemical treatment and intracellular chemical ( [ chemical ] i ) was measured using fura-2 , whereas gene was evaluated by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay .	T18	T29	12105857
NA	CHEMICAL	GENE-Y	14	24	KCs were isolated after 4 weeks of chemical treatment and intracellular chemical ( [ chemical ] i ) was measured using fura-2 , whereas gene was evaluated by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay .	T19	T29	12105857
CPR:4	CHEMICAL	GENE-Y	2	8	Furthermore , chemical abolished the LPS-induced increase in gene expression and [ chemical ] i elevation in KCs .	T5	T24	12105857
NA	CHEMICAL	GENE-Y	12	8	Furthermore , chemical abolished the LPS-induced increase in gene expression and [ chemical ] i elevation in KCs .	T6	T24	12105857
CPR:4	CHEMICAL	GENE-Y	2	6	Moreover , chemical reduced the LPS-induced gene production by KCs by decreasing gene messenger RNA .	T9	T25	12105857
CPR:4	CHEMICAL	GENE-Y	2	12	Moreover , chemical reduced the LPS-induced gene production by KCs by decreasing gene messenger RNA .	T9	T26	12105857
CPR:5	CHEMICAL	GENE-Y	5	10	Reactive Metabolite Trapping Studies on chemical-based Inverse Agonists of the gene .	T24	T26	23610086
CPR:5	CHEMICAL	GENE-Y	11	8	The current study examined the bioactivation potential of gene inverse agonists , chemical ( 1 ) and chemical ( 2 ) , containing a fused chemical motif in the core structure .	T21	T25	23610086
CPR:5	CHEMICAL	GENE-Y	11	8	The current study examined the bioactivation potential of gene inverse agonists , chemical ( 1 ) and chemical ( 2 ) , containing a fused chemical motif in the core structure .	T11	T25	23610086
CPR:5	CHEMICAL	GENE-Y	11	8	The current study examined the bioactivation potential of gene inverse agonists , chemical ( 1 ) and chemical ( 2 ) , containing a fused chemical motif in the core structure .	T12	T25	23610086
CPR:4	CHEMICAL	GENE-Y	5	2	Inhibition of gene/gene activation with chemical blocks migration and invasion of MDA-MB-231 cells .	T11	T40	23064031
CPR:4	CHEMICAL	GENE-Y	5	2	Inhibition of gene/gene activation with chemical blocks migration and invasion of MDA-MB-231 cells .	T11	T41	23064031
NA	CHEMICAL	GENE-Y	15	2	We use gene as a metastatic inducer of MDA-MB-231 cells to investigate the effect of chemical on cell migration and invasion .	T5	T22	23064031
CPR:4	CHEMICAL	GENE-Y	0	2	chemical suppressed gene-mediated protein levels of gene and gene , and reduced gene expression and activity , concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity .	T6	T23	23064031
CPR:4	CHEMICAL	GENE-Y	0	6	chemical suppressed gene-mediated protein levels of gene and gene , and reduced gene expression and activity , concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity .	T6	T24	23064031
CPR:4	CHEMICAL	GENE-Y	0	8	chemical suppressed gene-mediated protein levels of gene and gene , and reduced gene expression and activity , concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity .	T6	T25	23064031
CPR:4	CHEMICAL	GENE-Y	0	12	chemical suppressed gene-mediated protein levels of gene and gene , and reduced gene expression and activity , concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity .	T6	T26	23064031
CPR:4	CHEMICAL	GENE-Y	0	2	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T7	T27	23064031
CPR:4	CHEMICAL	GENE-Y	0	5	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T7	T28	23064031
CPR:4	CHEMICAL	GENE-Y	0	7	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T7	T29	23064031
CPR:4	CHEMICAL	GENE-N	0	11	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T7	T30	23064031
CPR:4	CHEMICAL	GENE-N	0	13	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T7	T31	23064031
CPR:4	CHEMICAL	GENE-N	0	15	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T7	T32	23064031
NA	CHEMICAL	GENE-Y	10	2	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T8	T27	23064031
NA	CHEMICAL	GENE-Y	10	5	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T8	T28	23064031
NA	CHEMICAL	GENE-Y	10	7	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T8	T29	23064031
NA	CHEMICAL	GENE-N	10	11	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T8	T30	23064031
NA	CHEMICAL	GENE-N	10	13	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T8	T31	23064031
NA	CHEMICAL	GENE-N	10	15	chemical abrogated gene-induced phosphorylation of gene ( gene ) and chemical 3-kinase ( gene ) /gene .	T8	T32	23064031
CPR:4	CHEMICAL	GENE-N	5	2	The specific gene inhibitor , chemical , blocked significantly gene-induced cell migration and invasion .	T9	T33	23064031
CPR:4	CHEMICAL	GENE-Y	5	9	The specific gene inhibitor , chemical , blocked significantly gene-induced cell migration and invasion .	T9	T34	23064031
CPR:4	CHEMICAL	GENE-Y	5	3	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T35	23064031
CPR:4	CHEMICAL	GENE-Y	5	7	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T36	23064031
CPR:4	CHEMICAL	GENE-Y	5	8	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T37	23064031
CPR:4	CHEMICAL	GENE-N	5	22	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T38	23064031
CPR:4	CHEMICAL	GENE-N	5	22	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T39	23064031
CPR:4	CHEMICAL	GENE-N	5	26	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T12	23064031
CPR:4	CHEMICAL	GENE-N	5	26	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T13	23064031
CPR:4	CHEMICAL	GENE-Y	5	31	Furthermore , the gene inhibitor chemical inhibited gene-induced gene expression , cell migration and invasion , as well as the activation of gene/gene , suggesting that gene/gene activation occur downstream of gene activation .	T10	T14	23064031
CPR:4	CHEMICAL	GENE-Y	4	7	These findings suggest that chemical inhibited the gene-induced invasion and migration of MDA-MB-231 cells via gene-dependent gene/gene signaling , leading to the down-regulation of gene expression .	T2	T15	23064031
CPR:4	CHEMICAL	GENE-Y	4	15	These findings suggest that chemical inhibited the gene-induced invasion and migration of MDA-MB-231 cells via gene-dependent gene/gene signaling , leading to the down-regulation of gene expression .	T2	T16	23064031
CPR:4	CHEMICAL	GENE-N	4	16	These findings suggest that chemical inhibited the gene-induced invasion and migration of MDA-MB-231 cells via gene-dependent gene/gene signaling , leading to the down-regulation of gene expression .	T2	T17	23064031
CPR:4	CHEMICAL	GENE-N	4	16	These findings suggest that chemical inhibited the gene-induced invasion and migration of MDA-MB-231 cells via gene-dependent gene/gene signaling , leading to the down-regulation of gene expression .	T2	T18	23064031
CPR:4	CHEMICAL	GENE-Y	4	24	These findings suggest that chemical inhibited the gene-induced invasion and migration of MDA-MB-231 cells via gene-dependent gene/gene signaling , leading to the down-regulation of gene expression .	T2	T19	23064031
NA	CHEMICAL	GENE-N	6	2	These include gene , gene , chemical-dehydrogenases , gene , gene and gene .	T6	T21	19962254
NA	CHEMICAL	GENE-Y	6	4	These include gene , gene , chemical-dehydrogenases , gene , gene and gene .	T6	T22	19962254
NA	CHEMICAL	GENE-N	6	8	These include gene , gene , chemical-dehydrogenases , gene , gene and gene .	T6	T24	19962254
NA	CHEMICAL	GENE-N	6	10	These include gene , gene , chemical-dehydrogenases , gene , gene and gene .	T6	T25	19962254
NA	CHEMICAL	GENE-N	6	12	These include gene , gene , chemical-dehydrogenases , gene , gene and gene .	T6	T26	19962254
CPR:4	CHEMICAL	GENE-N	7	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T7	T27	19962254
CPR:4	CHEMICAL	GENE-Y	7	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T7	T28	19962254
CPR:4	CHEMICAL	GENE-N	9	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T8	T27	19962254
CPR:4	CHEMICAL	GENE-Y	9	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T8	T28	19962254
CPR:4	CHEMICAL	GENE-N	14	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T9	T27	19962254
CPR:4	CHEMICAL	GENE-Y	14	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T9	T28	19962254
CPR:4	CHEMICAL	GENE-N	16	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T10	T27	19962254
CPR:4	CHEMICAL	GENE-Y	16	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T10	T28	19962254
CPR:4	CHEMICAL	GENE-N	18	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T11	T27	19962254
CPR:4	CHEMICAL	GENE-Y	18	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T11	T28	19962254
CPR:4	CHEMICAL	GENE-N	2	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T12	T27	19962254
CPR:4	CHEMICAL	GENE-Y	2	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T12	T28	19962254
CPR:9	CHEMICAL	GENE-N	26	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T13	T27	19962254
CPR:9	CHEMICAL	GENE-Y	26	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T13	T28	19962254
NA	CHEMICAL	GENE-N	34	32	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T14	T27	19962254
NA	CHEMICAL	GENE-Y	34	36	As discussed in this review , various chemical including chemical and its 20alpha-dihydro-derivative , chemical , chemical , chemical and chemical can reduce intratissular levels of chemical in breast cancer by blocking gene and chemical-dehydrogenase type 1 activities .	T14	T28	19962254
NA	CHEMICAL	GENE-Y	11	12	A possible correlation has been postulated between breast cell proliferation and chemical sulfotransferase activity .	T15	T29	19962254
CPR:4	CHEMICAL	GENE-Y	2	10	Structure-based design , synthesis and evaluation of novel chemical derivatives as gene inhibitors and potential for cancer polypharmacology .	T2	T9	23279865
CPR:4	CHEMICAL	GENE-Y	3	10	A series of chemical derivatives were synthesized and evaluated for gene inhibition , gene expression and suppression of cancer cell growth in vitro .	T1	T8	23279865
NA	CHEMICAL	GENE-Y	3	13	A series of chemical derivatives were synthesized and evaluated for gene inhibition , gene expression and suppression of cancer cell growth in vitro .	T1	T3	23279865
NA	CHEMICAL	GENE-N	11	9	Synergistic enhancement of cancer therapy using a combination of gene targeted chemical copolymer-drug conjugates and gold nanorod induced hyperthermia .	T17	T33	23602864
NA	CHEMICAL	GENE-N	9	17	In this study , tumor hyperthermia was utilized as a means to increase the active delivery of gene ( gene ) targeted chemical ( chemical ) copolymer-drug conjugates .	T7	T23	23602864
NA	CHEMICAL	GENE-N	9	19	In this study , tumor hyperthermia was utilized as a means to increase the active delivery of gene ( gene ) targeted chemical ( chemical ) copolymer-drug conjugates .	T7	T24	23602864
NA	CHEMICAL	GENE-N	24	17	In this study , tumor hyperthermia was utilized as a means to increase the active delivery of gene ( gene ) targeted chemical ( chemical ) copolymer-drug conjugates .	T8	T23	23602864
NA	CHEMICAL	GENE-N	24	19	In this study , tumor hyperthermia was utilized as a means to increase the active delivery of gene ( gene ) targeted chemical ( chemical ) copolymer-drug conjugates .	T8	T24	23602864
NA	CHEMICAL	GENE-N	12	8	Following hyperthermia , induced expression of cell surface gene ( gene ) chemical regulated protein 78kDa ( gene ) was utilized for targeted drug therapy .	T9	T25	23602864
NA	CHEMICAL	GENE-N	12	10	Following hyperthermia , induced expression of cell surface gene ( gene ) chemical regulated protein 78kDa ( gene ) was utilized for targeted drug therapy .	T9	T26	23602864
NA	CHEMICAL	GENE-Y	12	15	Following hyperthermia , induced expression of cell surface gene ( gene ) chemical regulated protein 78kDa ( gene ) was utilized for targeted drug therapy .	T9	T27	23602864
NA	CHEMICAL	GENE-Y	12	17	Following hyperthermia , induced expression of cell surface gene ( gene ) chemical regulated protein 78kDa ( gene ) was utilized for targeted drug therapy .	T9	T28	23602864
NA	CHEMICAL	GENE-Y	5	19	Conjugates bearing the anticancer agents chemical ( chemical ) , chemical ( chemical ) , or chemical and the gene targeting peptide WDLAWMFRLPVG were synthesized and characterized .	T10	T29	23602864
NA	CHEMICAL	GENE-Y	7	19	Conjugates bearing the anticancer agents chemical ( chemical ) , chemical ( chemical ) , or chemical and the gene targeting peptide WDLAWMFRLPVG were synthesized and characterized .	T11	T29	23602864
NA	CHEMICAL	GENE-Y	10	19	Conjugates bearing the anticancer agents chemical ( chemical ) , chemical ( chemical ) , or chemical and the gene targeting peptide WDLAWMFRLPVG were synthesized and characterized .	T12	T29	23602864
NA	CHEMICAL	GENE-Y	12	19	Conjugates bearing the anticancer agents chemical ( chemical ) , chemical ( chemical ) , or chemical and the gene targeting peptide WDLAWMFRLPVG were synthesized and characterized .	T13	T29	23602864
NA	CHEMICAL	GENE-Y	16	19	Conjugates bearing the anticancer agents chemical ( chemical ) , chemical ( chemical ) , or chemical and the gene targeting peptide WDLAWMFRLPVG were synthesized and characterized .	T14	T29	23602864
NA	CHEMICAL	GENE-N	2	0	gene targeted chemical and chemical conjugates demonstrated active binding comparable to native targeting peptide .	T15	T32	23602864
NA	CHEMICAL	GENE-N	4	0	gene targeted chemical and chemical conjugates demonstrated active binding comparable to native targeting peptide .	T16	T32	23602864
NA	CHEMICAL	GENE-N	0	0	gene targeted chemical conjugates exhibited high potency against DU145 cells with an IC50 of 2.4nM .	T1	T18	23602864
NA	CHEMICAL	GENE-N	2	0	gene targeted chemical and chemical conjugates demonstrated synergistic effects in combination with hyperthermia with combination index values of 0.65 and 0.45 respectively .	T2	T19	23602864
NA	CHEMICAL	GENE-N	4	0	gene targeted chemical and chemical conjugates demonstrated synergistic effects in combination with hyperthermia with combination index values of 0.65 and 0.45 respectively .	T3	T19	23602864
NA	CHEMICAL	GENE-N	7	5	Based on these results , gene targeted chemical conjugates were selected for in vivo evaluation .	T4	T20	23602864
NA	CHEMICAL	GENE-N	28	26	In DU145 tumor bearing mice , a single treatment of tumor hyperthermia , induced via gold nanorod mediated plasmonic photothermal therapy , and intravenous administration of gene targeted chemical copolymer-chemical at 10mg/kg resulted in maintained tumor regression for a period of 30days .	T5	T21	23602864
NA	CHEMICAL	GENE-N	6	26	In DU145 tumor bearing mice , a single treatment of tumor hyperthermia , induced via gold nanorod mediated plasmonic photothermal therapy , and intravenous administration of gene targeted chemical copolymer-chemical at 10mg/kg resulted in maintained tumor regression for a period of 30days .	T6	T21	23602864
NA	CHEMICAL	GENE-N	2	3	Stimulation of chemical receptors modulates Jurkat T cell growth and adhesion to gene .	T12	T21	17662248
NA	CHEMICAL	GENE-Y	2	12	Stimulation of chemical receptors modulates Jurkat T cell growth and adhesion to gene .	T12	T22	17662248
NA	CHEMICAL	GENE-N	15	6	The aims of this study were to investigate the expression and the functional roles of chemical ( chemical ) receptors in leukemic Jurkat T cells .	T11	T19	17662248
NA	CHEMICAL	GENE-N	15	6	The aims of this study were to investigate the expression and the functional roles of chemical ( chemical ) receptors in leukemic Jurkat T cells .	T1	T19	17662248
NA	CHEMICAL	GENE-Y	18	12	RT-PCR and immunofluorescence/confocal microscopy analysis showed that Jurkat T cells express the gene and gene subunits of the chemical receptors .	T2	T13	17662248
NA	CHEMICAL	GENE-Y	18	14	RT-PCR and immunofluorescence/confocal microscopy analysis showed that Jurkat T cells express the gene and gene subunits of the chemical receptors .	T2	T14	17662248
NA	CHEMICAL	GENE-N	18	19	RT-PCR and immunofluorescence/confocal microscopy analysis showed that Jurkat T cells express the gene and gene subunits of the chemical receptors .	T2	T15	17662248
CPR:6	CHEMICAL	GENE-N	6	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T3	T16	17662248
CPR:6	CHEMICAL	GENE-N	8	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T4	T16	17662248
CPR:6	CHEMICAL	GENE-N	11	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T5	T16	17662248
CPR:6	CHEMICAL	GENE-N	13	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T6	T16	17662248
NA	CHEMICAL	GENE-N	18	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T7	T16	17662248
NA	CHEMICAL	GENE-N	35	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T8	T16	17662248
NA	CHEMICAL	GENE-Y	35	61	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T8	T17	17662248
NA	CHEMICAL	GENE-N	41	4	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T9	T16	17662248
NA	CHEMICAL	GENE-Y	41	61	Exposure of Jurkat cells to either chemical [ chemical ] or chemical ( chemical ) , two selective chemical receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas chemical ( 1 microM ) and chemical ( 10 microM ) significantly increased ( 137.2+/-22.0 % ; P < 0.01 ) Jurkat T cell adhesion to gene .	T9	T17	17662248
NA	CHEMICAL	GENE-N	9	6	Quantitative analysis of the interaction of gene with chemicals and chemical receptor coactivator 1 using surface plasmon resonance biosensor systems : a case study of the Baikal seal ( Pusa sibirica ) and the mouse .	T9	T39	23015691
NA	CHEMICAL	GENE-N	9	13	Quantitative analysis of the interaction of gene with chemicals and chemical receptor coactivator 1 using surface plasmon resonance biosensor systems : a case study of the Baikal seal ( Pusa sibirica ) and the mouse .	T9	T40	23015691
NA	CHEMICAL	GENE-N	10	6	Quantitative analysis of the interaction of gene with chemicals and chemical receptor coactivator 1 using surface plasmon resonance biosensor systems : a case study of the Baikal seal ( Pusa sibirica ) and the mouse .	T10	T39	23015691
NA	CHEMICAL	GENE-N	10	13	Quantitative analysis of the interaction of gene with chemicals and chemical receptor coactivator 1 using surface plasmon resonance biosensor systems : a case study of the Baikal seal ( Pusa sibirica ) and the mouse .	T10	T40	23015691
NA	CHEMICAL	GENE-Y	8	1	The gene ( gene ) not only displays a high basal transcriptional activity but also acts as a ligand-dependent transcriptional factor .	T6	T27	23015691
NA	CHEMICAL	GENE-Y	8	3	The gene ( gene ) not only displays a high basal transcriptional activity but also acts as a ligand-dependent transcriptional factor .	T6	T25	23015691
NA	CHEMICAL	GENE-N	38	13	The objectives of this study are to establish a high-throughput tool to screen gene ligands and to clarify how gene proteins from the Baikal seal ( gene ) and the mouse ( gene ) interact with chemicals and chemical receptor coactivator 1 ( gene ) .	T7	T26	23015691
NA	CHEMICAL	GENE-N	38	19	The objectives of this study are to establish a high-throughput tool to screen gene ligands and to clarify how gene proteins from the Baikal seal ( gene ) and the mouse ( gene ) interact with chemicals and chemical receptor coactivator 1 ( gene ) .	T7	T28	23015691
NA	CHEMICAL	GENE-Y	38	26	The objectives of this study are to establish a high-throughput tool to screen gene ligands and to clarify how gene proteins from the Baikal seal ( gene ) and the mouse ( gene ) interact with chemicals and chemical receptor coactivator 1 ( gene ) .	T7	T29	23015691
NA	CHEMICAL	GENE-Y	38	32	The objectives of this study are to establish a high-throughput tool to screen gene ligands and to clarify how gene proteins from the Baikal seal ( gene ) and the mouse ( gene ) interact with chemicals and chemical receptor coactivator 1 ( gene ) .	T7	T30	23015691
NA	CHEMICAL	GENE-N	38	41	The objectives of this study are to establish a high-throughput tool to screen gene ligands and to clarify how gene proteins from the Baikal seal ( gene ) and the mouse ( gene ) interact with chemicals and chemical receptor coactivator 1 ( gene ) .	T7	T31	23015691
NA	CHEMICAL	GENE-N	38	41	The objectives of this study are to establish a high-throughput tool to screen gene ligands and to clarify how gene proteins from the Baikal seal ( gene ) and the mouse ( gene ) interact with chemicals and chemical receptor coactivator 1 ( gene ) .	T7	T32	23015691
NA	CHEMICAL	GENE-N	0	19	chemical and chemical , chemical , chemical , chemical , and chemical showed compound-specific but similar affinities for both gene .	T8	T11	23015691
NA	CHEMICAL	GENE-N	1	19	chemical and chemical , chemical , chemical , chemical , and chemical showed compound-specific but similar affinities for both gene .	T1	T11	23015691
NA	CHEMICAL	GENE-N	4	19	chemical and chemical , chemical , chemical , chemical , and chemical showed compound-specific but similar affinities for both gene .	T2	T11	23015691
NA	CHEMICAL	GENE-N	6	19	chemical and chemical , chemical , chemical , chemical , and chemical showed compound-specific but similar affinities for both gene .	T3	T11	23015691
NA	CHEMICAL	GENE-N	8	19	chemical and chemical , chemical , chemical , chemical , and chemical showed compound-specific but similar affinities for both gene .	T4	T11	23015691
NA	CHEMICAL	GENE-N	11	19	chemical and chemical , chemical , chemical , chemical , and chemical showed compound-specific but similar affinities for both gene .	T5	T11	23015691
NA	CHEMICAL	GENE-Y	10	5	Efficacy and safety of the gene/gene concentrate , haemate-P/humate-P : chemical cofactor unit dosing in patients with von Willebrand disease .	T2	T9	11858481
NA	CHEMICAL	GENE-Y	10	5	Efficacy and safety of the gene/gene concentrate , haemate-P/humate-P : chemical cofactor unit dosing in patients with von Willebrand disease .	T2	T10	11858481
NA	CHEMICAL	GENE-Y	5	21	The present study was initiated to evaluate the safety and efficacy of Haemate-P ( Humate-P in North America ) ( anti-hemophilic gene/gene complex [ human ] dried , pasteurized ) dosed in chemical cofactor units ( VWF : RCo ) in the treatment of von Willebrand disease ( VWD ) patients in Canada .	T1	T3	11858481
NA	CHEMICAL	GENE-Y	5	21	The present study was initiated to evaluate the safety and efficacy of Haemate-P ( Humate-P in North America ) ( anti-hemophilic gene/gene complex [ human ] dried , pasteurized ) dosed in chemical cofactor units ( VWF : RCo ) in the treatment of von Willebrand disease ( VWD ) patients in Canada .	T1	T4	11858481
NA	CHEMICAL	GENE-Y	0	1	chemical synthase : a critical target in cancer therapy ?	T22	T32	15353299
NA	CHEMICAL	GENE-Y	0	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T12	T30	15353299
NA	CHEMICAL	GENE-Y	0	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T12	T31	15353299
NA	CHEMICAL	GENE-Y	8	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T13	T30	15353299
NA	CHEMICAL	GENE-Y	8	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T13	T31	15353299
NA	CHEMICAL	GENE-Y	14	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T14	T30	15353299
NA	CHEMICAL	GENE-Y	14	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T14	T31	15353299
NA	CHEMICAL	GENE-Y	20	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T15	T30	15353299
NA	CHEMICAL	GENE-Y	20	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T15	T31	15353299
NA	CHEMICAL	GENE-Y	20	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T16	T30	15353299
NA	CHEMICAL	GENE-Y	20	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T16	T31	15353299
NA	CHEMICAL	GENE-Y	22	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T17	T30	15353299
NA	CHEMICAL	GENE-Y	22	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T17	T31	15353299
NA	CHEMICAL	GENE-Y	8	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T18	T30	15353299
NA	CHEMICAL	GENE-Y	8	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T18	T31	15353299
NA	CHEMICAL	GENE-Y	8	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T19	T30	15353299
NA	CHEMICAL	GENE-Y	8	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T19	T31	15353299
NA	CHEMICAL	GENE-Y	31	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T20	T30	15353299
NA	CHEMICAL	GENE-Y	31	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T20	T31	15353299
CPR:9	CHEMICAL	GENE-Y	8	1	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T21	T30	15353299
CPR:9	CHEMICAL	GENE-Y	8	3	chemical synthase ( gene ) continues to be a critical target for chemical ( chemical ) and its prodrugs , chemical/chemical ( chemical ) , chemical ( chemical ) , and chemical , primarily because this enzyme is essential for the synthesis of chemical , a precursor for DNA synthesis .	T21	T31	15353299
NA	CHEMICAL	GENE-Y	1	26	While chemical antimetabolites have other sites of action , antifolates chemical ( chemical , chemical ) and chemical ( chemical ) are more specific and potent gene inhibitors .	T1	T23	15353299
CPR:4	CHEMICAL	GENE-Y	10	26	While chemical antimetabolites have other sites of action , antifolates chemical ( chemical , chemical ) and chemical ( chemical ) are more specific and potent gene inhibitors .	T2	T23	15353299
CPR:4	CHEMICAL	GENE-Y	12	26	While chemical antimetabolites have other sites of action , antifolates chemical ( chemical , chemical ) and chemical ( chemical ) are more specific and potent gene inhibitors .	T3	T23	15353299
CPR:4	CHEMICAL	GENE-Y	14	26	While chemical antimetabolites have other sites of action , antifolates chemical ( chemical , chemical ) and chemical ( chemical ) are more specific and potent gene inhibitors .	T4	T23	15353299
CPR:4	CHEMICAL	GENE-Y	17	26	While chemical antimetabolites have other sites of action , antifolates chemical ( chemical , chemical ) and chemical ( chemical ) are more specific and potent gene inhibitors .	T5	T23	15353299
CPR:4	CHEMICAL	GENE-Y	19	26	While chemical antimetabolites have other sites of action , antifolates chemical ( chemical , chemical ) and chemical ( chemical ) are more specific and potent gene inhibitors .	T6	T23	15353299
NA	CHEMICAL	GENE-Y	4	19	The availability of the chemical prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that chemical phosphorylase , the activating enzyme for chemical , is expressed at a higher level in tumor tissue compared with normal tissue counterparts .	T9	T27	15353299
NA	CHEMICAL	GENE-Y	18	19	The availability of the chemical prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that chemical phosphorylase , the activating enzyme for chemical , is expressed at a higher level in tumor tissue compared with normal tissue counterparts .	T10	T27	15353299
CPR:9	CHEMICAL	GENE-Y	25	19	The availability of the chemical prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that chemical phosphorylase , the activating enzyme for chemical , is expressed at a higher level in tumor tissue compared with normal tissue counterparts .	T11	T27	15353299
NA	CHEMICAL	GENE-Y	5	2	Characterization of gene and phospholipid-chemical chemical peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro chemical exposure .	T30	T60	23384997
NA	CHEMICAL	GENE-N	5	6	Characterization of gene and phospholipid-chemical chemical peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro chemical exposure .	T30	T61	23384997
NA	CHEMICAL	GENE-Y	4	2	Characterization of gene and phospholipid-chemical chemical peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro chemical exposure .	T31	T60	23384997
NA	CHEMICAL	GENE-N	4	6	Characterization of gene and phospholipid-chemical chemical peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro chemical exposure .	T31	T61	23384997
NA	CHEMICAL	GENE-Y	21	2	Characterization of gene and phospholipid-chemical chemical peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro chemical exposure .	T29	T60	23384997
NA	CHEMICAL	GENE-N	21	6	Characterization of gene and phospholipid-chemical chemical peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro chemical exposure .	T29	T61	23384997
NA	CHEMICAL	GENE-N	0	1	chemical peroxidase ( gene ) is the largest and the most studied gene family .	T25	T49	23384997
NA	CHEMICAL	GENE-N	0	3	chemical peroxidase ( gene ) is the largest and the most studied gene family .	T25	T50	23384997
NA	CHEMICAL	GENE-N	0	12	chemical peroxidase ( gene ) is the largest and the most studied gene family .	T25	T51	23384997
NA	CHEMICAL	GENE-Y	9	0	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T26	T52	23384997
NA	CHEMICAL	GENE-Y	9	2	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T26	T53	23384997
NA	CHEMICAL	GENE-Y	9	4	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T26	T54	23384997
NA	CHEMICAL	GENE-N	9	10	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T26	T55	23384997
NA	CHEMICAL	GENE-N	9	12	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T26	T56	23384997
NA	CHEMICAL	GENE-N	9	14	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T26	T57	23384997
NA	CHEMICAL	GENE-Y	8	0	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T27	T52	23384997
NA	CHEMICAL	GENE-Y	8	2	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T27	T53	23384997
NA	CHEMICAL	GENE-Y	8	4	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T27	T54	23384997
NA	CHEMICAL	GENE-N	8	10	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T27	T55	23384997
NA	CHEMICAL	GENE-N	8	12	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T27	T56	23384997
NA	CHEMICAL	GENE-N	8	14	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T27	T57	23384997
NA	CHEMICAL	GENE-Y	24	0	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T28	T52	23384997
NA	CHEMICAL	GENE-Y	24	2	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T28	T53	23384997
NA	CHEMICAL	GENE-Y	24	4	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T28	T54	23384997
NA	CHEMICAL	GENE-N	24	10	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T28	T55	23384997
NA	CHEMICAL	GENE-N	24	12	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T28	T56	23384997
NA	CHEMICAL	GENE-N	24	14	gene ( gene , gene ) and phospholipid chemical chemical peroxidase ( gene , gene ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .	T28	T57	23384997
NA	CHEMICAL	GENE-N	34	2	Transcripts of gene genes were more highly expressed in most tissues examined in vivo ( except blood , head kidney and spleen ) , whereas those of the gene genes were more responsive to chemical exposure in vitro , especially to the organic form .	T18	T41	23384997
NA	CHEMICAL	GENE-Y	34	28	Transcripts of gene genes were more highly expressed in most tissues examined in vivo ( except blood , head kidney and spleen ) , whereas those of the gene genes were more responsive to chemical exposure in vitro , especially to the organic form .	T18	T42	23384997
NA	CHEMICAL	GENE-Y	8	2	Interestingly , gene was the most sensitive to chemical availability in non stressful conditions , whereas gene and gene were highly induced by exposure to chemical levels that had some toxic effects on the cells .	T19	T43	23384997
NA	CHEMICAL	GENE-Y	8	16	Interestingly , gene was the most sensitive to chemical availability in non stressful conditions , whereas gene and gene were highly induced by exposure to chemical levels that had some toxic effects on the cells .	T19	T44	23384997
NA	CHEMICAL	GENE-Y	8	18	Interestingly , gene was the most sensitive to chemical availability in non stressful conditions , whereas gene and gene were highly induced by exposure to chemical levels that had some toxic effects on the cells .	T19	T45	23384997
NA	CHEMICAL	GENE-Y	25	2	Interestingly , gene was the most sensitive to chemical availability in non stressful conditions , whereas gene and gene were highly induced by exposure to chemical levels that had some toxic effects on the cells .	T20	T43	23384997
CPR:3	CHEMICAL	GENE-Y	25	16	Interestingly , gene was the most sensitive to chemical availability in non stressful conditions , whereas gene and gene were highly induced by exposure to chemical levels that had some toxic effects on the cells .	T20	T44	23384997
CPR:3	CHEMICAL	GENE-Y	25	18	Interestingly , gene was the most sensitive to chemical availability in non stressful conditions , whereas gene and gene were highly induced by exposure to chemical levels that had some toxic effects on the cells .	T20	T45	23384997
NA	CHEMICAL	GENE-N	7	8	Redundancy and specificity in the regulation of chemical cyclase and other effectors .	T28	T59	12297509
NA	CHEMICAL	GENE-N	4	16	Platelet agonists such as chemical and epinephrine suppress chemical-stimulated chemical formation by activating receptors coupled to gene family members , four of which are present in platelets .	T13	T48	12297509
NA	CHEMICAL	GENE-N	8	16	Platelet agonists such as chemical and epinephrine suppress chemical-stimulated chemical formation by activating receptors coupled to gene family members , four of which are present in platelets .	T19	T48	12297509
NA	CHEMICAL	GENE-N	9	16	Platelet agonists such as chemical and epinephrine suppress chemical-stimulated chemical formation by activating receptors coupled to gene family members , four of which are present in platelets .	T20	T48	12297509
NA	CHEMICAL	GENE-N	15	9	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T21	T49	12297509
NA	CHEMICAL	GENE-N	15	23	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T21	T50	12297509
NA	CHEMICAL	GENE-N	15	30	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T21	T51	12297509
NA	CHEMICAL	GENE-N	15	52	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T21	T52	12297509
NA	CHEMICAL	GENE-Y	15	7	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T21	T53	12297509
NA	CHEMICAL	GENE-N	29	9	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T22	T49	12297509
NA	CHEMICAL	GENE-N	29	23	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T22	T50	12297509
NA	CHEMICAL	GENE-N	29	30	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T22	T51	12297509
NA	CHEMICAL	GENE-N	29	52	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T22	T52	12297509
NA	CHEMICAL	GENE-Y	29	7	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T22	T53	12297509
NA	CHEMICAL	GENE-Y	29	69	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T22	T54	12297509
NA	CHEMICAL	GENE-N	66	30	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T23	T51	12297509
NA	CHEMICAL	GENE-N	66	52	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T23	T52	12297509
NA	CHEMICAL	GENE-Y	66	69	To address questions about the specificity of receptor : gene coupling , the regulation of chemical formation in vivo and the contribution of gene-mediated pathways that do not involve chemical cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed gene family members and compared the results with platelets from mice that lacked the chemical receptor , gene .	T23	T54	12297509
NA	CHEMICAL	GENE-Y	14	6	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T25	T55	12297509
NA	CHEMICAL	GENE-Y	14	8	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T25	T56	12297509
NA	CHEMICAL	GENE-N	14	31	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T25	T57	12297509
NA	CHEMICAL	GENE-Y	11	6	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T26	T55	12297509
NA	CHEMICAL	GENE-Y	11	8	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T26	T56	12297509
NA	CHEMICAL	GENE-N	11	31	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T26	T57	12297509
NA	CHEMICAL	GENE-Y	30	6	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T27	T55	12297509
NA	CHEMICAL	GENE-Y	30	8	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T27	T56	12297509
NA	CHEMICAL	GENE-N	30	31	As reported previously , loss of gene or gene inhibited aggregation in response to chemical and chemical , respectively , producing defects that could not be reversed by adding an chemical cyclase inhibitor .	T27	T57	12297509
NA	CHEMICAL	GENE-Y	3	3	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T3	T33	12297509
NA	CHEMICAL	GENE-Y	3	5	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T3	T34	12297509
NA	CHEMICAL	GENE-N	3	17	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T3	T35	12297509
NA	CHEMICAL	GENE-Y	3	21	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T3	T36	12297509
NA	CHEMICAL	GENE-Y	12	3	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T4	T33	12297509
NA	CHEMICAL	GENE-Y	12	5	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T4	T34	12297509
NA	CHEMICAL	GENE-N	12	17	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T4	T35	12297509
NA	CHEMICAL	GENE-Y	12	21	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T4	T36	12297509
NA	CHEMICAL	GENE-Y	15	3	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T5	T33	12297509
NA	CHEMICAL	GENE-Y	15	5	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T5	T34	12297509
NA	CHEMICAL	GENE-N	15	17	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T5	T35	12297509
NA	CHEMICAL	GENE-Y	15	21	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T5	T36	12297509
NA	CHEMICAL	GENE-Y	16	3	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T6	T33	12297509
NA	CHEMICAL	GENE-Y	16	5	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T6	T34	12297509
NA	CHEMICAL	GENE-N	16	17	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T6	T35	12297509
NA	CHEMICAL	GENE-Y	16	21	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T6	T36	12297509
NA	CHEMICAL	GENE-Y	29	3	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T7	T33	12297509
NA	CHEMICAL	GENE-Y	29	5	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T7	T34	12297509
NA	CHEMICAL	GENE-N	29	17	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T7	T35	12297509
NA	CHEMICAL	GENE-Y	29	21	Loss of either gene or gene impaired the ability of chemical and chemical to inhibit chemical-stimulated chemical cyclase activity and caused a 40 % -50 % rise in basal chemical levels , whereas loss of gene did not .	T7	T36	12297509
NA	CHEMICAL	GENE-Y	8	4	Conversely , deletion of gene abolished responses to chemical and caused chemical levels to fall by 30 % , effects that did not translate into enhanced responsiveness to agonists ex vivo .	T8	T37	12297509
NA	CHEMICAL	GENE-Y	11	4	Conversely , deletion of gene abolished responses to chemical and caused chemical levels to fall by 30 % , effects that did not translate into enhanced responsiveness to agonists ex vivo .	T9	T37	12297509
NA	CHEMICAL	GENE-N	8	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T38	12297509
NA	CHEMICAL	GENE-N	8	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T39	12297509
NA	CHEMICAL	GENE-Y	8	22	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T40	12297509
NA	CHEMICAL	GENE-N	8	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T41	12297509
NA	CHEMICAL	GENE-Y	8	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T42	12297509
NA	CHEMICAL	GENE-Y	8	6	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T43	12297509
NA	CHEMICAL	GENE-N	8	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T44	12297509
NA	CHEMICAL	GENE-N	8	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T10	T45	12297509
NA	CHEMICAL	GENE-N	10	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T38	12297509
NA	CHEMICAL	GENE-N	10	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T39	12297509
NA	CHEMICAL	GENE-Y	10	22	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T40	12297509
NA	CHEMICAL	GENE-N	10	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T41	12297509
NA	CHEMICAL	GENE-Y	10	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T42	12297509
NA	CHEMICAL	GENE-Y	10	6	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T43	12297509
NA	CHEMICAL	GENE-N	10	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T44	12297509
NA	CHEMICAL	GENE-N	10	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T11	T45	12297509
NA	CHEMICAL	GENE-N	35	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T38	12297509
NA	CHEMICAL	GENE-N	35	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T39	12297509
NA	CHEMICAL	GENE-Y	35	22	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T40	12297509
NA	CHEMICAL	GENE-N	35	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T41	12297509
NA	CHEMICAL	GENE-Y	35	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T42	12297509
NA	CHEMICAL	GENE-Y	35	6	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T43	12297509
NA	CHEMICAL	GENE-N	35	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T44	12297509
NA	CHEMICAL	GENE-N	35	7	From these results we conclude that 1 ) chemical levels in circulating platelets reflect ongoing signaling through gene , gene , and gene , but not gene ; 2 ) platelet chemical gene ) and chemical ( gene ) receptors display strong preferences among gene family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to gene .	T12	T45	12297509
NA	CHEMICAL	GENE-N	15	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T36	17203585
NA	CHEMICAL	GENE-N	15	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T37	17203585
NA	CHEMICAL	GENE-N	15	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T38	17203585
NA	CHEMICAL	GENE-Y	15	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T39	17203585
NA	CHEMICAL	GENE-Y	15	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T40	17203585
NA	CHEMICAL	GENE-Y	15	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T41	17203585
NA	CHEMICAL	GENE-Y	15	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T42	17203585
NA	CHEMICAL	GENE-Y	15	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T43	17203585
NA	CHEMICAL	GENE-Y	15	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T44	17203585
NA	CHEMICAL	GENE-Y	15	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T45	17203585
NA	CHEMICAL	GENE-Y	15	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T17	T46	17203585
NA	CHEMICAL	GENE-N	17	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T36	17203585
NA	CHEMICAL	GENE-N	17	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T37	17203585
NA	CHEMICAL	GENE-N	17	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T38	17203585
NA	CHEMICAL	GENE-Y	17	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T39	17203585
NA	CHEMICAL	GENE-Y	17	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T40	17203585
NA	CHEMICAL	GENE-Y	17	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T41	17203585
NA	CHEMICAL	GENE-Y	17	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T42	17203585
NA	CHEMICAL	GENE-Y	17	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T43	17203585
NA	CHEMICAL	GENE-Y	17	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T44	17203585
NA	CHEMICAL	GENE-Y	17	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T45	17203585
NA	CHEMICAL	GENE-Y	17	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T18	T46	17203585
NA	CHEMICAL	GENE-N	26	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T36	17203585
NA	CHEMICAL	GENE-N	26	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T37	17203585
NA	CHEMICAL	GENE-N	26	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T38	17203585
NA	CHEMICAL	GENE-Y	26	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T39	17203585
NA	CHEMICAL	GENE-Y	26	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T40	17203585
NA	CHEMICAL	GENE-Y	26	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T41	17203585
NA	CHEMICAL	GENE-Y	26	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T42	17203585
NA	CHEMICAL	GENE-Y	26	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T43	17203585
NA	CHEMICAL	GENE-Y	26	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T44	17203585
NA	CHEMICAL	GENE-Y	26	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T45	17203585
NA	CHEMICAL	GENE-Y	26	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T46	17203585
NA	CHEMICAL	GENE-N	26	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T47	17203585
NA	CHEMICAL	GENE-N	26	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T19	T48	17203585
NA	CHEMICAL	GENE-N	28	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T36	17203585
NA	CHEMICAL	GENE-N	28	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T37	17203585
NA	CHEMICAL	GENE-N	28	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T38	17203585
NA	CHEMICAL	GENE-Y	28	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T39	17203585
NA	CHEMICAL	GENE-Y	28	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T40	17203585
NA	CHEMICAL	GENE-Y	28	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T41	17203585
NA	CHEMICAL	GENE-Y	28	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T42	17203585
NA	CHEMICAL	GENE-Y	28	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T43	17203585
NA	CHEMICAL	GENE-Y	28	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T44	17203585
NA	CHEMICAL	GENE-Y	28	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T45	17203585
NA	CHEMICAL	GENE-Y	28	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T46	17203585
NA	CHEMICAL	GENE-N	28	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T47	17203585
NA	CHEMICAL	GENE-N	28	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T20	T48	17203585
NA	CHEMICAL	GENE-N	36	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T36	17203585
NA	CHEMICAL	GENE-N	36	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T37	17203585
NA	CHEMICAL	GENE-N	36	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T38	17203585
NA	CHEMICAL	GENE-Y	36	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T39	17203585
NA	CHEMICAL	GENE-Y	36	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T40	17203585
NA	CHEMICAL	GENE-Y	36	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T41	17203585
NA	CHEMICAL	GENE-Y	36	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T42	17203585
NA	CHEMICAL	GENE-Y	36	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T43	17203585
NA	CHEMICAL	GENE-Y	36	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T44	17203585
NA	CHEMICAL	GENE-Y	36	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T45	17203585
NA	CHEMICAL	GENE-Y	36	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T46	17203585
NA	CHEMICAL	GENE-N	36	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T47	17203585
NA	CHEMICAL	GENE-N	36	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T48	17203585
NA	CHEMICAL	GENE-N	36	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T49	17203585
NA	CHEMICAL	GENE-N	36	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T21	T50	17203585
NA	CHEMICAL	GENE-N	38	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T36	17203585
NA	CHEMICAL	GENE-N	38	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T37	17203585
NA	CHEMICAL	GENE-N	38	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T38	17203585
NA	CHEMICAL	GENE-Y	38	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T39	17203585
NA	CHEMICAL	GENE-Y	38	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T40	17203585
NA	CHEMICAL	GENE-Y	38	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T41	17203585
NA	CHEMICAL	GENE-Y	38	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T42	17203585
NA	CHEMICAL	GENE-Y	38	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T43	17203585
NA	CHEMICAL	GENE-Y	38	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T44	17203585
NA	CHEMICAL	GENE-Y	38	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T45	17203585
NA	CHEMICAL	GENE-Y	38	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T46	17203585
NA	CHEMICAL	GENE-N	38	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T47	17203585
NA	CHEMICAL	GENE-N	38	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T48	17203585
NA	CHEMICAL	GENE-N	38	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T49	17203585
NA	CHEMICAL	GENE-N	38	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T22	T50	17203585
NA	CHEMICAL	GENE-N	46	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T36	17203585
NA	CHEMICAL	GENE-N	46	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T37	17203585
NA	CHEMICAL	GENE-N	46	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T38	17203585
NA	CHEMICAL	GENE-Y	46	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T39	17203585
NA	CHEMICAL	GENE-Y	46	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T40	17203585
NA	CHEMICAL	GENE-Y	46	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T41	17203585
NA	CHEMICAL	GENE-Y	46	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T42	17203585
NA	CHEMICAL	GENE-Y	46	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T43	17203585
NA	CHEMICAL	GENE-Y	46	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T44	17203585
NA	CHEMICAL	GENE-Y	46	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T45	17203585
NA	CHEMICAL	GENE-Y	46	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T46	17203585
NA	CHEMICAL	GENE-N	46	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T47	17203585
NA	CHEMICAL	GENE-N	46	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T48	17203585
NA	CHEMICAL	GENE-N	46	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T49	17203585
NA	CHEMICAL	GENE-N	46	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T23	T50	17203585
NA	CHEMICAL	GENE-N	48	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T37	17203585
NA	CHEMICAL	GENE-N	48	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T38	17203585
NA	CHEMICAL	GENE-Y	48	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T39	17203585
NA	CHEMICAL	GENE-Y	48	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T40	17203585
NA	CHEMICAL	GENE-Y	48	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T41	17203585
NA	CHEMICAL	GENE-Y	48	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T42	17203585
NA	CHEMICAL	GENE-Y	48	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T43	17203585
NA	CHEMICAL	GENE-Y	48	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T44	17203585
NA	CHEMICAL	GENE-Y	48	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T45	17203585
NA	CHEMICAL	GENE-Y	48	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T46	17203585
NA	CHEMICAL	GENE-N	48	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T47	17203585
NA	CHEMICAL	GENE-N	48	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T48	17203585
NA	CHEMICAL	GENE-N	48	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T49	17203585
NA	CHEMICAL	GENE-N	48	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T24	T50	17203585
NA	CHEMICAL	GENE-Y	56	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T39	17203585
NA	CHEMICAL	GENE-Y	56	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T40	17203585
NA	CHEMICAL	GENE-Y	56	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T41	17203585
NA	CHEMICAL	GENE-Y	56	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T42	17203585
NA	CHEMICAL	GENE-Y	56	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T43	17203585
NA	CHEMICAL	GENE-Y	56	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T44	17203585
NA	CHEMICAL	GENE-Y	56	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T45	17203585
NA	CHEMICAL	GENE-Y	56	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T46	17203585
NA	CHEMICAL	GENE-N	56	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T47	17203585
NA	CHEMICAL	GENE-N	56	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T48	17203585
NA	CHEMICAL	GENE-N	56	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T49	17203585
NA	CHEMICAL	GENE-N	56	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T25	T50	17203585
NA	CHEMICAL	GENE-Y	58	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T39	17203585
NA	CHEMICAL	GENE-Y	58	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T40	17203585
NA	CHEMICAL	GENE-Y	58	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T41	17203585
NA	CHEMICAL	GENE-Y	58	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T42	17203585
NA	CHEMICAL	GENE-Y	58	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T43	17203585
NA	CHEMICAL	GENE-Y	58	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T44	17203585
NA	CHEMICAL	GENE-Y	58	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T45	17203585
NA	CHEMICAL	GENE-Y	58	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T46	17203585
NA	CHEMICAL	GENE-N	58	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T47	17203585
NA	CHEMICAL	GENE-N	58	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T48	17203585
NA	CHEMICAL	GENE-N	58	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T49	17203585
NA	CHEMICAL	GENE-N	58	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T26	T50	17203585
NA	CHEMICAL	GENE-Y	66	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T41	17203585
NA	CHEMICAL	GENE-Y	66	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T42	17203585
NA	CHEMICAL	GENE-Y	66	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T43	17203585
NA	CHEMICAL	GENE-Y	66	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T44	17203585
NA	CHEMICAL	GENE-Y	66	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T45	17203585
NA	CHEMICAL	GENE-Y	66	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T46	17203585
NA	CHEMICAL	GENE-N	66	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T47	17203585
NA	CHEMICAL	GENE-N	66	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T48	17203585
NA	CHEMICAL	GENE-N	66	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T49	17203585
NA	CHEMICAL	GENE-N	66	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T50	17203585
NA	CHEMICAL	GENE-N	66	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T29	17203585
NA	CHEMICAL	GENE-N	66	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T27	T30	17203585
NA	CHEMICAL	GENE-Y	68	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T41	17203585
NA	CHEMICAL	GENE-Y	68	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T42	17203585
NA	CHEMICAL	GENE-Y	68	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T43	17203585
NA	CHEMICAL	GENE-Y	68	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T44	17203585
NA	CHEMICAL	GENE-Y	68	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T45	17203585
NA	CHEMICAL	GENE-Y	68	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T46	17203585
NA	CHEMICAL	GENE-N	68	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T47	17203585
NA	CHEMICAL	GENE-N	68	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T48	17203585
NA	CHEMICAL	GENE-N	68	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T49	17203585
NA	CHEMICAL	GENE-N	68	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T50	17203585
NA	CHEMICAL	GENE-N	68	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T29	17203585
NA	CHEMICAL	GENE-N	68	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T28	T30	17203585
NA	CHEMICAL	GENE-N	15	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T36	17203585
NA	CHEMICAL	GENE-N	15	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T37	17203585
NA	CHEMICAL	GENE-N	15	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T38	17203585
NA	CHEMICAL	GENE-Y	15	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T39	17203585
NA	CHEMICAL	GENE-Y	15	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T40	17203585
NA	CHEMICAL	GENE-Y	15	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T41	17203585
NA	CHEMICAL	GENE-Y	15	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T42	17203585
NA	CHEMICAL	GENE-Y	15	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T43	17203585
NA	CHEMICAL	GENE-Y	15	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T44	17203585
NA	CHEMICAL	GENE-Y	15	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T45	17203585
NA	CHEMICAL	GENE-Y	15	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T1	T46	17203585
NA	CHEMICAL	GENE-N	28	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T36	17203585
NA	CHEMICAL	GENE-N	28	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T37	17203585
NA	CHEMICAL	GENE-N	28	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T38	17203585
NA	CHEMICAL	GENE-Y	28	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T39	17203585
NA	CHEMICAL	GENE-Y	28	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T40	17203585
NA	CHEMICAL	GENE-Y	28	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T41	17203585
NA	CHEMICAL	GENE-Y	28	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T42	17203585
NA	CHEMICAL	GENE-Y	28	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T43	17203585
NA	CHEMICAL	GENE-Y	28	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T44	17203585
NA	CHEMICAL	GENE-Y	28	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T45	17203585
NA	CHEMICAL	GENE-Y	28	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T46	17203585
NA	CHEMICAL	GENE-N	28	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T47	17203585
NA	CHEMICAL	GENE-N	28	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T2	T48	17203585
NA	CHEMICAL	GENE-N	7	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T36	17203585
NA	CHEMICAL	GENE-N	7	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T37	17203585
NA	CHEMICAL	GENE-N	7	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T38	17203585
NA	CHEMICAL	GENE-Y	7	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T39	17203585
NA	CHEMICAL	GENE-Y	7	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T40	17203585
NA	CHEMICAL	GENE-Y	7	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T41	17203585
NA	CHEMICAL	GENE-Y	7	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T42	17203585
NA	CHEMICAL	GENE-Y	7	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T43	17203585
NA	CHEMICAL	GENE-Y	7	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T3	T44	17203585
NA	CHEMICAL	GENE-N	22	7	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T36	17203585
NA	CHEMICAL	GENE-N	22	9	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T37	17203585
NA	CHEMICAL	GENE-N	22	11	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T38	17203585
NA	CHEMICAL	GENE-Y	22	20	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T39	17203585
NA	CHEMICAL	GENE-Y	22	22	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T40	17203585
NA	CHEMICAL	GENE-Y	22	31	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T41	17203585
NA	CHEMICAL	GENE-Y	22	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T42	17203585
NA	CHEMICAL	GENE-Y	22	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T43	17203585
NA	CHEMICAL	GENE-Y	22	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T44	17203585
NA	CHEMICAL	GENE-Y	22	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T45	17203585
NA	CHEMICAL	GENE-Y	22	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T46	17203585
NA	CHEMICAL	GENE-N	22	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T4	T47	17203585
NA	CHEMICAL	GENE-Y	73	33	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T42	17203585
NA	CHEMICAL	GENE-Y	73	41	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T43	17203585
NA	CHEMICAL	GENE-Y	73	43	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T44	17203585
NA	CHEMICAL	GENE-Y	73	51	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T45	17203585
NA	CHEMICAL	GENE-Y	73	53	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T46	17203585
NA	CHEMICAL	GENE-N	73	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T47	17203585
NA	CHEMICAL	GENE-N	73	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T48	17203585
NA	CHEMICAL	GENE-N	73	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T49	17203585
NA	CHEMICAL	GENE-N	73	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T50	17203585
NA	CHEMICAL	GENE-N	73	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T29	17203585
NA	CHEMICAL	GENE-N	73	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T5	T30	17203585
NA	CHEMICAL	GENE-N	96	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T47	17203585
NA	CHEMICAL	GENE-N	96	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T48	17203585
NA	CHEMICAL	GENE-N	96	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T49	17203585
NA	CHEMICAL	GENE-N	96	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T50	17203585
NA	CHEMICAL	GENE-N	96	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T29	17203585
NA	CHEMICAL	GENE-N	96	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T30	17203585
NA	CHEMICAL	GENE-Y	96	117	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T31	17203585
NA	CHEMICAL	GENE-Y	96	119	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T6	T32	17203585
NA	CHEMICAL	GENE-N	99	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T47	17203585
NA	CHEMICAL	GENE-N	99	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T48	17203585
NA	CHEMICAL	GENE-N	99	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T49	17203585
NA	CHEMICAL	GENE-N	99	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T50	17203585
NA	CHEMICAL	GENE-N	99	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T29	17203585
NA	CHEMICAL	GENE-N	99	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T30	17203585
NA	CHEMICAL	GENE-Y	99	117	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T31	17203585
NA	CHEMICAL	GENE-Y	99	119	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T7	T32	17203585
NA	CHEMICAL	GENE-N	101	61	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T47	17203585
NA	CHEMICAL	GENE-N	101	63	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T48	17203585
NA	CHEMICAL	GENE-N	101	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T49	17203585
NA	CHEMICAL	GENE-N	101	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T50	17203585
NA	CHEMICAL	GENE-N	101	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T29	17203585
NA	CHEMICAL	GENE-N	101	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T30	17203585
NA	CHEMICAL	GENE-Y	101	117	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T31	17203585
NA	CHEMICAL	GENE-Y	101	119	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T8	T32	17203585
NA	CHEMICAL	GENE-N	110	71	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T9	T49	17203585
NA	CHEMICAL	GENE-N	110	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T9	T50	17203585
NA	CHEMICAL	GENE-N	110	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T9	T29	17203585
NA	CHEMICAL	GENE-N	110	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T9	T30	17203585
NA	CHEMICAL	GENE-Y	110	117	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T9	T31	17203585
NA	CHEMICAL	GENE-Y	110	119	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T9	T32	17203585
NA	CHEMICAL	GENE-N	112	73	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T10	T50	17203585
NA	CHEMICAL	GENE-N	112	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T10	T29	17203585
NA	CHEMICAL	GENE-N	112	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T10	T30	17203585
NA	CHEMICAL	GENE-Y	112	117	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T10	T31	17203585
NA	CHEMICAL	GENE-Y	112	119	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T10	T32	17203585
NA	CHEMICAL	GENE-N	121	104	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T11	T29	17203585
NA	CHEMICAL	GENE-N	121	106	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T11	T30	17203585
NA	CHEMICAL	GENE-Y	121	117	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T11	T31	17203585
NA	CHEMICAL	GENE-Y	121	119	The expression of glycans was examined by gene-histochemistry using gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for terminal chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for chemical ( chemical ) ; gene ( gene ) for terminal chemical with/ without chemical ( chemical wo chemical ) ; succynilated WGA ( sWGA ) for terminal chemical without chemical ( terminal chemical without chemical ) ; gene ( gene ) for terminal chemical ( chemical terminal ) ; and gene ( gene ) chemical .	T11	T32	17203585
NA	CHEMICAL	GENE-N	16	17	OBJECTIVE : The purpose of this study was to delineate the role of structural abnormalities and chemical channel dysfunction in the Brugada sign .	T2	T6	20022821
NA	CHEMICAL	GENE-Y	11	18	METHODS : Activation and repolarization characteristics of the explanted heart of a patient with a loss-of-function mutation in gene ( gene ) and dilated cardiomyopathy were determined after induction of right-sided ST-segment elevation by chemical .	T3	T7	20022821
NA	CHEMICAL	GENE-N	11	20	METHODS : Activation and repolarization characteristics of the explanted heart of a patient with a loss-of-function mutation in gene ( gene ) and dilated cardiomyopathy were determined after induction of right-sided ST-segment elevation by chemical .	T3	T8	20022821
NA	CHEMICAL	GENE-N	8	9	In addition , right ventricular structural discontinuities and chemical channel dysfunction were simulated in a computer model encompassing the heart and thorax .	T4	T9	20022821
NA	CHEMICAL	GENE-N	3	4	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T25	T36	11292635
NA	CHEMICAL	GENE-Y	3	5	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T25	T37	11292635
NA	CHEMICAL	GENE-N	3	4	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T26	T36	11292635
NA	CHEMICAL	GENE-Y	3	5	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T26	T37	11292635
NA	CHEMICAL	GENE-N	3	4	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T27	T36	11292635
NA	CHEMICAL	GENE-Y	3	5	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T27	T37	11292635
CPR:9	CHEMICAL	GENE-N	7	4	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T28	T36	11292635
CPR:9	CHEMICAL	GENE-Y	7	5	Contribution of the chemical-chemical-chemical cotransporter gene to chemical secretion in rat OMCD .	T28	T37	11292635
NA	CHEMICAL	GENE-N	10	11	In rat kidney the `` secretory '' isoform of the chemical-chemical-chemical cotransporter ( gene ) localizes to the basolateral membrane of the alpha-intercalated cell .	T10	T33	11292635
NA	CHEMICAL	GENE-Y	10	13	In rat kidney the `` secretory '' isoform of the chemical-chemical-chemical cotransporter ( gene ) localizes to the basolateral membrane of the alpha-intercalated cell .	T10	T34	11292635
NA	CHEMICAL	GENE-N	10	11	In rat kidney the `` secretory '' isoform of the chemical-chemical-chemical cotransporter ( gene ) localizes to the basolateral membrane of the alpha-intercalated cell .	T12	T33	11292635
NA	CHEMICAL	GENE-Y	10	13	In rat kidney the `` secretory '' isoform of the chemical-chemical-chemical cotransporter ( gene ) localizes to the basolateral membrane of the alpha-intercalated cell .	T12	T34	11292635
NA	CHEMICAL	GENE-N	10	11	In rat kidney the `` secretory '' isoform of the chemical-chemical-chemical cotransporter ( gene ) localizes to the basolateral membrane of the alpha-intercalated cell .	T13	T33	11292635
NA	CHEMICAL	GENE-Y	10	13	In rat kidney the `` secretory '' isoform of the chemical-chemical-chemical cotransporter ( gene ) localizes to the basolateral membrane of the alpha-intercalated cell .	T13	T34	11292635
NA	CHEMICAL	GENE-Y	18	38	The purpose of this study was to determine whether rat outer medullary collecting duct ( OMCD ) secretes chemical and whether transepithelial chemical transport occurs , in part , through chemical uptake across the basolateral membrane mediated by gene in series with chemical efflux across the apical membrane .	T6	T32	11292635
NA	CHEMICAL	GENE-Y	22	38	The purpose of this study was to determine whether rat outer medullary collecting duct ( OMCD ) secretes chemical and whether transepithelial chemical transport occurs , in part , through chemical uptake across the basolateral membrane mediated by gene in series with chemical efflux across the apical membrane .	T7	T32	11292635
CPR:9	CHEMICAL	GENE-Y	30	38	The purpose of this study was to determine whether rat outer medullary collecting duct ( OMCD ) secretes chemical and whether transepithelial chemical transport occurs , in part , through chemical uptake across the basolateral membrane mediated by gene in series with chemical efflux across the apical membrane .	T8	T32	11292635
CPR:9	CHEMICAL	GENE-Y	42	38	The purpose of this study was to determine whether rat outer medullary collecting duct ( OMCD ) secretes chemical and whether transepithelial chemical transport occurs , in part , through chemical uptake across the basolateral membrane mediated by gene in series with chemical efflux across the apical membrane .	T9	T32	11292635
NA	CHEMICAL	GENE-Y	0	20	chemical-sensitive chemical secretion was dependent on extracellular chemical and either chemical or chemical , consistent with the ion dependency of gene-mediated chemical transport .	T19	T35	11292635
NA	CHEMICAL	GENE-Y	1	20	chemical-sensitive chemical secretion was dependent on extracellular chemical and either chemical or chemical , consistent with the ion dependency of gene-mediated chemical transport .	T20	T35	11292635
NA	CHEMICAL	GENE-Y	7	20	chemical-sensitive chemical secretion was dependent on extracellular chemical and either chemical or chemical , consistent with the ion dependency of gene-mediated chemical transport .	T21	T35	11292635
NA	CHEMICAL	GENE-Y	10	20	chemical-sensitive chemical secretion was dependent on extracellular chemical and either chemical or chemical , consistent with the ion dependency of gene-mediated chemical transport .	T22	T35	11292635
NA	CHEMICAL	GENE-Y	12	20	chemical-sensitive chemical secretion was dependent on extracellular chemical and either chemical or chemical , consistent with the ion dependency of gene-mediated chemical transport .	T23	T35	11292635
CPR:9	CHEMICAL	GENE-Y	21	20	chemical-sensitive chemical secretion was dependent on extracellular chemical and either chemical or chemical , consistent with the ion dependency of gene-mediated chemical transport .	T24	T35	11292635
NA	CHEMICAL	GENE-Y	6	15	In conclusion , OMCD tubules from chemical-treated rats secrete chemical into the luminal fluid through gene-mediated chemical uptake across the basolateral membrane in series with chemical efflux across the apical membrane .	T1	T29	11292635
CPR:9	CHEMICAL	GENE-Y	9	15	In conclusion , OMCD tubules from chemical-treated rats secrete chemical into the luminal fluid through gene-mediated chemical uptake across the basolateral membrane in series with chemical efflux across the apical membrane .	T2	T29	11292635
CPR:9	CHEMICAL	GENE-Y	16	15	In conclusion , OMCD tubules from chemical-treated rats secrete chemical into the luminal fluid through gene-mediated chemical uptake across the basolateral membrane in series with chemical efflux across the apical membrane .	T3	T29	11292635
CPR:9	CHEMICAL	GENE-Y	25	15	In conclusion , OMCD tubules from chemical-treated rats secrete chemical into the luminal fluid through gene-mediated chemical uptake across the basolateral membrane in series with chemical efflux across the apical membrane .	T4	T29	11292635
CPR:9	CHEMICAL	GENE-Y	5	4	The physiological role of gene-mediated chemical uptake remains to be determined .	T5	T30	11292635
NA	CHEMICAL	GENE-Y	6	6	The key difference in structure of gene and gene is replacement of chemical with chemical at position 560 .	T1	T15	17853709
NA	CHEMICAL	GENE-Y	6	3	The key difference in structure of gene and gene is replacement of chemical with chemical at position 560 .	T1	T16	17853709
NA	CHEMICAL	GENE-Y	14	6	The key difference in structure of gene and gene is replacement of chemical with chemical at position 560 .	T2	T15	17853709
NA	CHEMICAL	GENE-Y	14	3	The key difference in structure of gene and gene is replacement of chemical with chemical at position 560 .	T2	T16	17853709
CPR:3	CHEMICAL	GENE-N	9	11	Maqui berry ( Aristotelia chilensis ) and the constituent chemical inhibit gene cell death induced by visible light .	T15	T19	23561088
NA	CHEMICAL	GENE-N	0	10	chemical inhibits myofibroblast differentiation in nasal polyp-derived fibroblasts via the gene pathway .	T7	T28	22422627
NA	CHEMICAL	GENE-Y	4	9	NPDFs were pre-treated with chemical prior to induction by gene .	T3	T14	22422627
CPR:4	CHEMICAL	GENE-Y	4	1	In gene-induced NPDFs , chemical significantly inhibited the expression of gene and gene mRNA and reduced gene and gene protein levels .	T5	T22	22422627
CPR:4	CHEMICAL	GENE-Y	4	10	In gene-induced NPDFs , chemical significantly inhibited the expression of gene and gene mRNA and reduced gene and gene protein levels .	T5	T23	22422627
CPR:4	CHEMICAL	GENE-N	4	12	In gene-induced NPDFs , chemical significantly inhibited the expression of gene and gene mRNA and reduced gene and gene protein levels .	T5	T24	22422627
CPR:4	CHEMICAL	GENE-Y	4	16	In gene-induced NPDFs , chemical significantly inhibited the expression of gene and gene mRNA and reduced gene and gene protein levels .	T5	T25	22422627
CPR:4	CHEMICAL	GENE-N	4	18	In gene-induced NPDFs , chemical significantly inhibited the expression of gene and gene mRNA and reduced gene and gene protein levels .	T5	T26	22422627
CPR:4	CHEMICAL	GENE-N	0	6	chemical only suppressed the expression of gene among the evaluated signaling molecules .	T6	T27	22422627
CPR:4	CHEMICAL	GENE-N	0	6	chemical ( a specific inhibitor of gene gene ) markedly suppressed the increased expression of gene and gene in gene-induced NPDFs .	T1	T8	22422627
CPR:4	CHEMICAL	GENE-N	0	2	chemical ( a specific inhibitor of gene gene ) markedly suppressed the increased expression of gene and gene in gene-induced NPDFs .	T1	T9	22422627
CPR:4	CHEMICAL	GENE-N	0	15	chemical ( a specific inhibitor of gene gene ) markedly suppressed the increased expression of gene and gene in gene-induced NPDFs .	T1	T10	22422627
CPR:4	CHEMICAL	GENE-Y	0	17	chemical ( a specific inhibitor of gene gene ) markedly suppressed the increased expression of gene and gene in gene-induced NPDFs .	T1	T11	22422627
CPR:4	CHEMICAL	GENE-Y	0	19	chemical ( a specific inhibitor of gene gene ) markedly suppressed the increased expression of gene and gene in gene-induced NPDFs .	T1	T12	22422627
NA	CHEMICAL	GENE-Y	23	42	CSF production in wildtype mice was ( in microl/min ) 0.37 +/- 0.04 microl/min ( control ) , 0.16 +/- 0.03 microl/min ( chemical-treated ) and 1.14 +/- 0.15 microl/min ( chemical-treated ) , and reduced by up to 25 % in gene null mice .	T1	T9	14753499
NA	CHEMICAL	GENE-Y	2	42	CSF production in wildtype mice was ( in microl/min ) 0.37 +/- 0.04 microl/min ( control ) , 0.16 +/- 0.03 microl/min ( chemical-treated ) and 1.14 +/- 0.15 microl/min ( chemical-treated ) , and reduced by up to 25 % in gene null mice .	T2	T9	14753499
NA	CHEMICAL	GENE-Y	0	5	chemical and chemical bind to gene ( gene ) and inhibit its gene activity in human fibroblasts .	T12	T25	11689471
NA	CHEMICAL	GENE-Y	0	7	chemical and chemical bind to gene ( gene ) and inhibit its gene activity in human fibroblasts .	T12	T26	11689471
CPR:4	CHEMICAL	GENE-N	0	12	chemical and chemical bind to gene ( gene ) and inhibit its gene activity in human fibroblasts .	T12	T27	11689471
NA	CHEMICAL	GENE-Y	2	5	chemical and chemical bind to gene ( gene ) and inhibit its gene activity in human fibroblasts .	T13	T25	11689471
NA	CHEMICAL	GENE-Y	2	7	chemical and chemical bind to gene ( gene ) and inhibit its gene activity in human fibroblasts .	T13	T26	11689471
CPR:4	CHEMICAL	GENE-N	2	12	chemical and chemical bind to gene ( gene ) and inhibit its gene activity in human fibroblasts .	T13	T27	11689471
NA	CHEMICAL	GENE-Y	4	12	The Kd values of chemical binding to crude extract and to recombinant gene were 45.2 and 54.6 microM , respectively .	T8	T19	11689471
NA	CHEMICAL	GENE-Y	14	0	gene is a gene containing a polypeptide binding site recognizing specific gene and an chemical binding site .	T9	T20	11689471
NA	CHEMICAL	GENE-N	14	3	gene is a gene containing a polypeptide binding site recognizing specific gene and an chemical binding site .	T9	T21	11689471
NA	CHEMICAL	GENE-N	14	11	gene is a gene containing a polypeptide binding site recognizing specific gene and an chemical binding site .	T9	T22	11689471
NA	CHEMICAL	GENE-N	14	8	gene is a gene containing a polypeptide binding site recognizing specific gene and an chemical binding site .	T9	T23	11689471
CPR:4	CHEMICAL	GENE-N	0	2	chemical inhibited gene activity stimulated by this specific heptapeptide but did not block chemical binding or induce gene expression .	T11	T24	11689471
NA	CHEMICAL	GENE-Y	0	17	chemical inhibited gene activity stimulated by this specific heptapeptide but did not block chemical binding or induce gene expression .	T11	T14	11689471
NA	CHEMICAL	GENE-N	2	2	chemical inhibited gene activity stimulated by this specific heptapeptide but did not block chemical binding or induce gene expression .	T2	T24	11689471
NA	CHEMICAL	GENE-Y	2	17	chemical inhibited gene activity stimulated by this specific heptapeptide but did not block chemical binding or induce gene expression .	T2	T14	11689471
NA	CHEMICAL	GENE-Y	10	1	The gene Regulates Vascular Smooth Muscle Cell Proliferation via Controlling chemical-dependent Signaling .	T12	T42	23609438
NA	CHEMICAL	GENE-Y	1	1	The gene contributes to a variety of cell activation processes in pathologies such as inflammation , carcinogenesis and vascular remodeling .	T3	T31	23609438
NA	CHEMICAL	GENE-Y	4	1	The gene contributes to a variety of cell activation processes in pathologies such as inflammation , carcinogenesis and vascular remodeling .	T4	T31	23609438
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T5	T29	23609438
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T5	T30	23609438
NA	CHEMICAL	GENE-Y	1	33	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T5	T32	23609438
NA	CHEMICAL	GENE-N	1	22	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T5	T33	23609438
NA	CHEMICAL	GENE-Y	1	35	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T5	T36	23609438
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T6	T29	23609438
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T6	T30	23609438
NA	CHEMICAL	GENE-Y	1	33	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T6	T32	23609438
NA	CHEMICAL	GENE-N	1	22	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T6	T33	23609438
NA	CHEMICAL	GENE-Y	1	35	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T6	T36	23609438
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T7	T29	23609438
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T7	T30	23609438
NA	CHEMICAL	GENE-Y	1	33	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T7	T32	23609438
NA	CHEMICAL	GENE-N	1	22	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T7	T33	23609438
NA	CHEMICAL	GENE-Y	1	35	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T7	T36	23609438
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T8	T29	23609438
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T8	T30	23609438
NA	CHEMICAL	GENE-Y	1	33	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T8	T32	23609438
NA	CHEMICAL	GENE-N	1	22	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T8	T33	23609438
NA	CHEMICAL	GENE-Y	1	35	gene ( gene ) -induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular chemical concentration ( [ chemical ] i ) and was enhanced by elevating [ chemical ] i. gene blockade or knockdown inhibited proliferation by suppressing the rise in [ chemical ] i and attenuating the expression of gene ( gene ) , gene and gene ( gene ) .	T8	T36	23609438
NA	CHEMICAL	GENE-Y	8	11	This anti-proliferative effect was abolished by elevating [ chemical ] i. gene overexpression induced VSMC proliferation , and potentiated gene-induced proliferation , by inducing gene phosphorylation , gene and gene .	T10	T38	23609438
NA	CHEMICAL	GENE-N	8	19	This anti-proliferative effect was abolished by elevating [ chemical ] i. gene overexpression induced VSMC proliferation , and potentiated gene-induced proliferation , by inducing gene phosphorylation , gene and gene .	T10	T39	23609438
NA	CHEMICAL	GENE-N	8	24	This anti-proliferative effect was abolished by elevating [ chemical ] i. gene overexpression induced VSMC proliferation , and potentiated gene-induced proliferation , by inducing gene phosphorylation , gene and gene .	T10	T40	23609438
NA	CHEMICAL	GENE-Y	8	27	This anti-proliferative effect was abolished by elevating [ chemical ] i. gene overexpression induced VSMC proliferation , and potentiated gene-induced proliferation , by inducing gene phosphorylation , gene and gene .	T10	T41	23609438
NA	CHEMICAL	GENE-Y	8	29	This anti-proliferative effect was abolished by elevating [ chemical ] i. gene overexpression induced VSMC proliferation , and potentiated gene-induced proliferation , by inducing gene phosphorylation , gene and gene .	T10	T14	23609438
NA	CHEMICAL	GENE-Y	3	3	Pharmacological stimulation of gene unexpectedly suppressed proliferation by inhibiting the rise in [ chemical ] i and abolishing the expression and activity of gene and gene .	T1	T15	23609438
NA	CHEMICAL	GENE-Y	3	23	Pharmacological stimulation of gene unexpectedly suppressed proliferation by inhibiting the rise in [ chemical ] i and abolishing the expression and activity of gene and gene .	T1	T16	23609438
NA	CHEMICAL	GENE-Y	3	25	Pharmacological stimulation of gene unexpectedly suppressed proliferation by inhibiting the rise in [ chemical ] i and abolishing the expression and activity of gene and gene .	T1	T17	23609438
CPR:4	CHEMICAL	GENE-N	0	5	chemical is an inhibitor of gene which is able to block the absorption of 30 % of ingested fat .	T5	T14	15382615
NA	CHEMICAL	GENE-Y	8	8	Results of renal biopsy prompted us to undertake a biochemical and molecular biological evaluation of the patient for suspected chemical phosphoribosyltransferase ( gene ) deficiency .	T8	T17	17126311
NA	CHEMICAL	GENE-Y	8	22	Results of renal biopsy prompted us to undertake a biochemical and molecular biological evaluation of the patient for suspected chemical phosphoribosyltransferase ( gene ) deficiency .	T8	T18	17126311
NA	CHEMICAL	GENE-Y	14	10	Analysis of the patient family showed that heterozygotes for this gene gene mutation , in spite of a 69 % lower gene enzymatic activity than that of healthy subjects , had no detectable chemical concentrations in both serum and urine .	T2	T13	17126311
NA	CHEMICAL	GENE-Y	14	21	Analysis of the patient family showed that heterozygotes for this gene gene mutation , in spite of a 69 % lower gene enzymatic activity than that of healthy subjects , had no detectable chemical concentrations in both serum and urine .	T2	T14	17126311
NA	CHEMICAL	GENE-Y	25	6	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T38	8930173
NA	CHEMICAL	GENE-Y	25	8	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T41	8930173
NA	CHEMICAL	GENE-N	25	27	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T31	8930173
NA	CHEMICAL	GENE-N	25	34	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T33	8930173
NA	CHEMICAL	GENE-Y	25	38	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T34	8930173
NA	CHEMICAL	GENE-Y	25	40	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T35	8930173
NA	CHEMICAL	GENE-Y	25	42	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T12	T36	8930173
NA	CHEMICAL	GENE-Y	17	6	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T38	8930173
NA	CHEMICAL	GENE-Y	17	8	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T41	8930173
NA	CHEMICAL	GENE-N	17	27	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T31	8930173
NA	CHEMICAL	GENE-N	17	34	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T33	8930173
NA	CHEMICAL	GENE-Y	17	38	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T34	8930173
NA	CHEMICAL	GENE-Y	17	40	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T35	8930173
NA	CHEMICAL	GENE-Y	17	42	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T2	T36	8930173
NA	CHEMICAL	GENE-Y	31	6	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T38	8930173
NA	CHEMICAL	GENE-Y	31	8	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T41	8930173
NA	CHEMICAL	GENE-N	31	27	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T31	8930173
NA	CHEMICAL	GENE-N	31	34	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T33	8930173
NA	CHEMICAL	GENE-Y	31	38	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T34	8930173
NA	CHEMICAL	GENE-Y	31	40	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T35	8930173
NA	CHEMICAL	GENE-Y	31	42	To identify selective compounds for nonadrenergic gene ( gene ) , the affinities of 22 ligands for chemical binding have been compared at human platelet I1-chemical binding sites ( analyzed under chemical mask of gene ) and at gene , gene and gene stably expressed on transfected Chinese hamster ovary cells .	T8	T36	8930173
NA	CHEMICAL	GENE-Y	0	8	chemical , an endogenous neurotransmitter candidate for the gene , was identified as the most selective agent for a subcomponent of platelet gene .	T13	T39	8930173
NA	CHEMICAL	GENE-N	0	22	chemical , an endogenous neurotransmitter candidate for the gene , was identified as the most selective agent for a subcomponent of platelet gene .	T13	T40	8930173
NA	CHEMICAL	GENE-Y	18	8	chemical , an endogenous neurotransmitter candidate for the gene , was identified as the most selective agent for a subcomponent of platelet gene .	T14	T39	8930173
NA	CHEMICAL	GENE-N	18	22	chemical , an endogenous neurotransmitter candidate for the gene , was identified as the most selective agent for a subcomponent of platelet gene .	T14	T40	8930173
NA	CHEMICAL	GENE-N	3	11	The affinity of chemical at the high affinity component of platelet gene was 1400-fold selective over gene , 5000-fold selective over gene and 800-fold selective over gene .	T15	T42	8930173
NA	CHEMICAL	GENE-Y	3	16	The affinity of chemical at the high affinity component of platelet gene was 1400-fold selective over gene , 5000-fold selective over gene and 800-fold selective over gene .	T15	T43	8930173
NA	CHEMICAL	GENE-Y	3	21	The affinity of chemical at the high affinity component of platelet gene was 1400-fold selective over gene , 5000-fold selective over gene and 800-fold selective over gene .	T15	T44	8930173
NA	CHEMICAL	GENE-Y	3	26	The affinity of chemical at the high affinity component of platelet gene was 1400-fold selective over gene , 5000-fold selective over gene and 800-fold selective over gene .	T15	T45	8930173
NA	CHEMICAL	GENE-N	0	14	chemical and chemical also displayed selectivities for a high affinity component of the platelet gene over gene .	T16	T19	8930173
NA	CHEMICAL	GENE-N	0	7	chemical and chemical also displayed selectivities for a high affinity component of the platelet gene over gene .	T16	T20	8930173
NA	CHEMICAL	GENE-N	2	14	chemical and chemical also displayed selectivities for a high affinity component of the platelet gene over gene .	T17	T19	8930173
NA	CHEMICAL	GENE-N	2	7	chemical and chemical also displayed selectivities for a high affinity component of the platelet gene over gene .	T17	T20	8930173
NA	CHEMICAL	GENE-Y	0	13	chemical was the most selective compound for the high affinity state of the gene , displaying 7- , 23- and 9-fold higher affinity than gene , gene and platelet gene , respectively .	T1	T21	8930173
NA	CHEMICAL	GENE-Y	0	24	chemical was the most selective compound for the high affinity state of the gene , displaying 7- , 23- and 9-fold higher affinity than gene , gene and platelet gene , respectively .	T1	T22	8930173
NA	CHEMICAL	GENE-Y	0	26	chemical was the most selective compound for the high affinity state of the gene , displaying 7- , 23- and 9-fold higher affinity than gene , gene and platelet gene , respectively .	T1	T23	8930173
NA	CHEMICAL	GENE-N	0	29	chemical was the most selective compound for the high affinity state of the gene , displaying 7- , 23- and 9-fold higher affinity than gene , gene and platelet gene , respectively .	T1	T24	8930173
NA	CHEMICAL	GENE-Y	0	16	chemical displayed , respectively , 18- and 31-fold selectivity for the high affinity state of the gene as compared to gene- or gene , and was > 100,000- fold selective over platelet gene .	T4	T26	8930173
NA	CHEMICAL	GENE-Y	0	20	chemical displayed , respectively , 18- and 31-fold selectivity for the high affinity state of the gene as compared to gene- or gene , and was > 100,000- fold selective over platelet gene .	T4	T27	8930173
NA	CHEMICAL	GENE-Y	0	19	chemical displayed , respectively , 18- and 31-fold selectivity for the high affinity state of the gene as compared to gene- or gene , and was > 100,000- fold selective over platelet gene .	T4	T28	8930173
NA	CHEMICAL	GENE-N	0	32	chemical displayed , respectively , 18- and 31-fold selectivity for the high affinity state of the gene as compared to gene- or gene , and was > 100,000- fold selective over platelet gene .	T4	T29	8930173
NA	CHEMICAL	GENE-N	2	9	Mechanistically , gene is recruited to DSBs via the chemical-terminal chemical-SQ/TQ domain of gene , and DSBs generated by ionizing radiation or during CSR are hyperresected in the absence of gene .	T1	T13	23333305
NA	CHEMICAL	GENE-Y	2	11	Mechanistically , gene is recruited to DSBs via the chemical-terminal chemical-SQ/TQ domain of gene , and DSBs generated by ionizing radiation or during CSR are hyperresected in the absence of gene .	T1	T14	23333305
NA	CHEMICAL	GENE-Y	2	28	Mechanistically , gene is recruited to DSBs via the chemical-terminal chemical-SQ/TQ domain of gene , and DSBs generated by ionizing radiation or during CSR are hyperresected in the absence of gene .	T1	T15	23333305
NA	CHEMICAL	GENE-Y	19	4	Transgenic expression of the gene ( gene ) in the duodenum of gene-null mice attenuates the age-dependent decline in chemical absorption .	T9	T36	17207992
NA	CHEMICAL	GENE-Y	19	6	Transgenic expression of the gene ( gene ) in the duodenum of gene-null mice attenuates the age-dependent decline in chemical absorption .	T9	T37	17207992
NA	CHEMICAL	GENE-Y	19	12	Transgenic expression of the gene ( gene ) in the duodenum of gene-null mice attenuates the age-dependent decline in chemical absorption .	T9	T38	17207992
NA	CHEMICAL	GENE-Y	14	3	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T5	T18	17207992
NA	CHEMICAL	GENE-Y	14	22	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T5	T19	17207992
NA	CHEMICAL	GENE-Y	14	28	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T5	T20	17207992
NA	CHEMICAL	GENE-N	14	35	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T5	T21	17207992
NA	CHEMICAL	GENE-Y	14	37	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T5	T22	17207992
NA	CHEMICAL	GENE-Y	14	37	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T5	T23	17207992
NA	CHEMICAL	GENE-Y	6	3	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T7	T18	17207992
NA	CHEMICAL	GENE-Y	6	22	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T7	T19	17207992
NA	CHEMICAL	GENE-Y	6	28	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T7	T20	17207992
NA	CHEMICAL	GENE-N	6	35	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T7	T21	17207992
NA	CHEMICAL	GENE-Y	6	37	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T7	T22	17207992
NA	CHEMICAL	GENE-Y	6	37	To determine if gene 's actions in the proximal small intestine can sufficiently restore chemical homeostasis , we generated transgenic mice expressing gene exclusively in the duodenum of gene-null mice by using the chemical deaminase enhancer ( gene+/gene-null ) .	T7	T23	17207992
NA	CHEMICAL	GENE-Y	8	16	However , when 90-day-old rachitic mice were fed a rescue diet , serum chemical improved in gene+/gene-null mice , but not in gene-null mice .	T8	T32	17207992
NA	CHEMICAL	GENE-Y	8	16	However , when 90-day-old rachitic mice were fed a rescue diet , serum chemical improved in gene+/gene-null mice , but not in gene-null mice .	T8	T33	17207992
NA	CHEMICAL	GENE-Y	8	22	However , when 90-day-old rachitic mice were fed a rescue diet , serum chemical improved in gene+/gene-null mice , but not in gene-null mice .	T8	T34	17207992
NA	CHEMICAL	GENE-Y	18	4	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T2	T35	17207992
NA	CHEMICAL	GENE-Y	18	11	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T2	T11	17207992
NA	CHEMICAL	GENE-Y	18	11	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T2	T12	17207992
NA	CHEMICAL	GENE-Y	18	22	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T2	T13	17207992
NA	CHEMICAL	GENE-Y	4	4	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T3	T35	17207992
NA	CHEMICAL	GENE-Y	4	11	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T3	T11	17207992
NA	CHEMICAL	GENE-Y	4	11	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T3	T12	17207992
NA	CHEMICAL	GENE-Y	4	22	In conclusion , transgenic gene in the proximal small intestine of gene+/gene-null mice was transcriptionally active and regulated chemical absorption , but gene actions elsewhere in the intestine are probably necessary to support adequate chemical homeostasis .	T3	T13	17207992
NA	CHEMICAL	GENE-Y	15	11	Previously , we and others have shown that mutations in the gene gene encoding an chemical-binding cassette ( ABC ) transporter underlie the skin disease HI .	T2	T4	16902423
NA	CHEMICAL	GENE-N	15	14	Previously , we and others have shown that mutations in the gene gene encoding an chemical-binding cassette ( ABC ) transporter underlie the skin disease HI .	T2	T5	16902423
NA	CHEMICAL	GENE-N	5	3	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T11	T26	10907719
NA	CHEMICAL	GENE-Y	5	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T11	T25	10907719
CPR:6	CHEMICAL	GENE-N	3	3	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T2	T26	10907719
NA	CHEMICAL	GENE-Y	3	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T2	T25	10907719
NA	CHEMICAL	GENE-N	21	3	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T6	T26	10907719
CPR:6	CHEMICAL	GENE-Y	21	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T6	T25	10907719
NA	CHEMICAL	GENE-N	23	3	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T9	T26	10907719
NA	CHEMICAL	GENE-Y	23	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T9	T25	10907719
NA	CHEMICAL	GENE-N	42	3	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T10	T26	10907719
NA	CHEMICAL	GENE-Y	42	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T10	T25	10907719
NA	CHEMICAL	GENE-N	23	3	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T12	T26	10907719
NA	CHEMICAL	GENE-Y	23	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T12	T25	10907719
NA	CHEMICAL	GENE-Y	47	26	UNLABELLED : Apparent gene occupancy in mouse cerebral cortex , hippocampus , and striatum by chemical , an antagonist , and chemical , a relatively selective gene antagonist , was estimated with competitive binding studies using two different radioligands : chemical ( chemical ) and chemical ( chemical ) .	T13	T25	10907719
NA	CHEMICAL	GENE-N	19	3	Both radioligands labeled gene in these brain regions , and the relative regional distributions of the specific binding of chemical in vivo paralleled the distribution of gene .	T14	T27	10907719
NA	CHEMICAL	GENE-N	19	26	Both radioligands labeled gene in these brain regions , and the relative regional distributions of the specific binding of chemical in vivo paralleled the distribution of gene .	T14	T28	10907719
NA	CHEMICAL	GENE-N	8	5	A similar discrepancy in sensitivity to competitors between chemical and chemical was also observed when chemical was used as a competitor , indicating that binding to different subtypes of the gene could not account for the observed differences in sensitivity to competition .	T18	T29	10907719
NA	CHEMICAL	GENE-N	10	5	A similar discrepancy in sensitivity to competitors between chemical and chemical was also observed when chemical was used as a competitor , indicating that binding to different subtypes of the gene could not account for the observed differences in sensitivity to competition .	T19	T29	10907719
NA	CHEMICAL	GENE-N	15	5	A similar discrepancy in sensitivity to competitors between chemical and chemical was also observed when chemical was used as a competitor , indicating that binding to different subtypes of the gene could not account for the observed differences in sensitivity to competition .	T20	T29	10907719
NA	CHEMICAL	GENE-N	10	22	This finding , together with the more favorable accumulation of chemical in cerebral cortex , hippocampus , and striatum , leads us to conclude that chemical , or its positron emitting counterpart , should be the more favorable radiotracer for the estimation of gene occupancy by cholinergic drugs in the brain .	T4	T23	10907719
NA	CHEMICAL	GENE-N	25	22	This finding , together with the more favorable accumulation of chemical in cerebral cortex , hippocampus , and striatum , leads us to conclude that chemical , or its positron emitting counterpart , should be the more favorable radiotracer for the estimation of gene occupancy by cholinergic drugs in the brain .	T5	T23	10907719
CPR:3	CHEMICAL	GENE-N	2	27	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T2	T24	23562365
CPR:3	CHEMICAL	GENE-Y	2	33	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T2	T25	23562365
CPR:3	CHEMICAL	GENE-Y	2	39	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T2	T26	23562365
CPR:4	CHEMICAL	GENE-Y	2	45	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T2	T27	23562365
CPR:3	CHEMICAL	GENE-N	4	27	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T3	T24	23562365
CPR:3	CHEMICAL	GENE-Y	4	33	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T3	T25	23562365
CPR:3	CHEMICAL	GENE-Y	4	39	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T3	T26	23562365
CPR:4	CHEMICAL	GENE-Y	4	45	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T3	T27	23562365
NA	CHEMICAL	GENE-N	29	27	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T5	T24	23562365
NA	CHEMICAL	GENE-Y	29	33	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T5	T25	23562365
NA	CHEMICAL	GENE-Y	29	39	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T5	T26	23562365
NA	CHEMICAL	GENE-Y	29	45	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T5	T27	23562365
NA	CHEMICAL	GENE-N	35	27	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T6	T24	23562365
NA	CHEMICAL	GENE-Y	35	33	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T6	T25	23562365
NA	CHEMICAL	GENE-Y	35	39	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T6	T26	23562365
NA	CHEMICAL	GENE-Y	35	45	Treatment with chemical or chemical resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase , which was further supported by observations of increased phosphorylation of gene at chemical10 , phosphorylation of gene at chemical15 , expression of gene , and decreased expression of gene .	T6	T27	23562365
NA	CHEMICAL	GENE-Y	10	1	The gene is the binding site for the antiepileptic drug chemical .	T13	T26	15210974
NA	CHEMICAL	GENE-Y	13	6	Here , we show that the gene is the brain binding site of chemical ( chemical ) , a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy .	T10	T17	15210974
NA	CHEMICAL	GENE-Y	15	6	Here , we show that the gene is the brain binding site of chemical ( chemical ) , a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy .	T12	T17	15210974
NA	CHEMICAL	GENE-Y	15	9	Brain membranes and purified synaptic vesicles from mice lacking gene do not bind a tritiated chemical derivative , indicating that gene is necessary for chemical binding .	T5	T18	15210974
NA	CHEMICAL	GENE-Y	15	20	Brain membranes and purified synaptic vesicles from mice lacking gene do not bind a tritiated chemical derivative , indicating that gene is necessary for chemical binding .	T5	T19	15210974
NA	CHEMICAL	GENE-Y	24	9	Brain membranes and purified synaptic vesicles from mice lacking gene do not bind a tritiated chemical derivative , indicating that gene is necessary for chemical binding .	T6	T18	15210974
NA	CHEMICAL	GENE-Y	24	20	Brain membranes and purified synaptic vesicles from mice lacking gene do not bind a tritiated chemical derivative , indicating that gene is necessary for chemical binding .	T6	T19	15210974
NA	CHEMICAL	GENE-Y	0	6	chemical and related compounds bind to gene expressed in fibroblasts , indicating that gene is sufficient for chemical binding .	T7	T20	15210974
NA	CHEMICAL	GENE-Y	0	13	chemical and related compounds bind to gene expressed in fibroblasts , indicating that gene is sufficient for chemical binding .	T7	T21	15210974
NA	CHEMICAL	GENE-Y	17	6	chemical and related compounds bind to gene expressed in fibroblasts , indicating that gene is sufficient for chemical binding .	T8	T20	15210974
NA	CHEMICAL	GENE-Y	17	13	chemical and related compounds bind to gene expressed in fibroblasts , indicating that gene is sufficient for chemical binding .	T8	T21	15210974
NA	CHEMICAL	GENE-Y	16	19	Furthermore , there is a high degree of correlation between binding affinities of a series of chemical derivatives to gene in fibroblasts and to the chemical-binding site in brain .	T9	T24	15210974
NA	CHEMICAL	GENE-Y	25	19	Furthermore , there is a high degree of correlation between binding affinities of a series of chemical derivatives to gene in fibroblasts and to the chemical-binding site in brain .	T11	T24	15210974
NA	CHEMICAL	GENE-Y	5	5	These experimental results suggest that gene is the binding site of chemical in the brain and that chemical acts by modulating the function of gene , supporting previous indications that chemical possesses a mechanism of action distinct from that of other antiepileptic drugs .	T1	T14	15210974
NA	CHEMICAL	GENE-Y	5	24	These experimental results suggest that gene is the binding site of chemical in the brain and that chemical acts by modulating the function of gene , supporting previous indications that chemical possesses a mechanism of action distinct from that of other antiepileptic drugs .	T1	T15	15210974
NA	CHEMICAL	GENE-Y	17	5	These experimental results suggest that gene is the binding site of chemical in the brain and that chemical acts by modulating the function of gene , supporting previous indications that chemical possesses a mechanism of action distinct from that of other antiepileptic drugs .	T2	T14	15210974
NA	CHEMICAL	GENE-Y	17	24	These experimental results suggest that gene is the binding site of chemical in the brain and that chemical acts by modulating the function of gene , supporting previous indications that chemical possesses a mechanism of action distinct from that of other antiepileptic drugs .	T2	T15	15210974
NA	CHEMICAL	GENE-Y	30	5	These experimental results suggest that gene is the binding site of chemical in the brain and that chemical acts by modulating the function of gene , supporting previous indications that chemical possesses a mechanism of action distinct from that of other antiepileptic drugs .	T3	T14	15210974
NA	CHEMICAL	GENE-Y	30	24	These experimental results suggest that gene is the binding site of chemical in the brain and that chemical acts by modulating the function of gene , supporting previous indications that chemical possesses a mechanism of action distinct from that of other antiepileptic drugs .	T3	T15	15210974
NA	CHEMICAL	GENE-Y	0	0	gene-induced platelet aggregation was independent of chemical formation and chemical secretion but enhanced by feedback stimulation through these pathways .	T2	T21	17510465
NA	CHEMICAL	GENE-Y	9	0	gene-induced platelet aggregation was independent of chemical formation and chemical secretion but enhanced by feedback stimulation through these pathways .	T3	T21	17510465
NA	CHEMICAL	GENE-Y	3	15	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T4	T22	17510465
NA	CHEMICAL	GENE-Y	3	13	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T4	T23	17510465
NA	CHEMICAL	GENE-Y	3	22	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T4	T24	17510465
NA	CHEMICAL	GENE-Y	5	15	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T5	T22	17510465
NA	CHEMICAL	GENE-Y	5	13	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T5	T23	17510465
NA	CHEMICAL	GENE-Y	5	22	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T5	T24	17510465
NA	CHEMICAL	GENE-Y	9	15	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T6	T22	17510465
NA	CHEMICAL	GENE-Y	9	13	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T6	T23	17510465
NA	CHEMICAL	GENE-Y	9	22	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T6	T24	17510465
NA	CHEMICAL	GENE-Y	11	15	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T7	T22	17510465
NA	CHEMICAL	GENE-Y	11	13	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T7	T23	17510465
NA	CHEMICAL	GENE-Y	11	22	Treatments that raised chemical ( chemical ) , sequestered chemical ( chemical ) or prevented gene-platelet interaction ( sRAGE , gene [ gene ] ) induced almost complete inhibition .	T7	T24	17510465
NA	CHEMICAL	GENE-N	16	5	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T8	T25	17510465
CPR:4	CHEMICAL	GENE-N	16	11	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T8	T26	17510465
CPR:4	CHEMICAL	GENE-N	16	13	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T8	T27	17510465
NA	CHEMICAL	GENE-N	16	19	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T8	T28	17510465
NA	CHEMICAL	GENE-N	16	25	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T8	T29	17510465
NA	CHEMICAL	GENE-N	16	27	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T8	T30	17510465
NA	CHEMICAL	GENE-N	21	5	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T9	T25	17510465
NA	CHEMICAL	GENE-N	21	11	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T9	T26	17510465
NA	CHEMICAL	GENE-N	21	13	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T9	T27	17510465
CPR:4	CHEMICAL	GENE-N	21	19	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T9	T28	17510465
NA	CHEMICAL	GENE-N	21	25	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T9	T29	17510465
NA	CHEMICAL	GENE-N	21	27	Modulation of the function of gene ( CD36-/- mice ) , gene ( gene ) ( chemical ) , gene ( chemical ) , and gene ( gene , 6D1 antibody ) induced approximately 50 % inhibition .	T9	T30	17510465
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a potent suppressor of lymphoma growth by inhibition of the gene : a new action for an old drug .	T18	T25	11587223
CPR:4	CHEMICAL	GENE-Y	0	6	chemical was fortuitously found to be a novel , potent inhibitor of the gene .	T12	T23	11587223
CPR:9	CHEMICAL	GENE-Y	9	11	It showed high rat lymphoma growth-inhibitory and lytic activity in vitro ( IC50 = 0.16 mM ) , based specifically on inhibition of gene -- mediated chemical uptake , in contrast to its colonic metabolites , chemical and chemical .	T13	T24	11587223
CPR:4	CHEMICAL	GENE-Y	9	11	It showed high rat lymphoma growth-inhibitory and lytic activity in vitro ( IC50 = 0.16 mM ) , based specifically on inhibition of gene -- mediated chemical uptake , in contrast to its colonic metabolites , chemical and chemical .	T14	T24	11587223
CPR:4	CHEMICAL	GENE-Y	38	11	It showed high rat lymphoma growth-inhibitory and lytic activity in vitro ( IC50 = 0.16 mM ) , based specifically on inhibition of gene -- mediated chemical uptake , in contrast to its colonic metabolites , chemical and chemical .	T15	T24	11587223
NA	CHEMICAL	GENE-N	9	16	Advances in antihypertensive combination therapy : benefits of low-dose chemical diuretics in conjunction with chemical , a gene inhibitor .	T16	T26	11588409
CPR:4	CHEMICAL	GENE-N	14	16	Advances in antihypertensive combination therapy : benefits of low-dose chemical diuretics in conjunction with chemical , a gene inhibitor .	T15	T26	11588409
NA	CHEMICAL	GENE-Y	13	24	The preferred initial agents for the treatment of high blood pressure are low-dose chemical diuretics , beta blockers , chemical antagonists , and chemical-converting enzyme ( gene ) inhibitors .	T12	T17	11588409
NA	CHEMICAL	GENE-Y	13	26	The preferred initial agents for the treatment of high blood pressure are low-dose chemical diuretics , beta blockers , chemical antagonists , and chemical-converting enzyme ( gene ) inhibitors .	T12	T18	11588409
NA	CHEMICAL	GENE-Y	19	24	The preferred initial agents for the treatment of high blood pressure are low-dose chemical diuretics , beta blockers , chemical antagonists , and chemical-converting enzyme ( gene ) inhibitors .	T2	T17	11588409
NA	CHEMICAL	GENE-Y	19	26	The preferred initial agents for the treatment of high blood pressure are low-dose chemical diuretics , beta blockers , chemical antagonists , and chemical-converting enzyme ( gene ) inhibitors .	T2	T18	11588409
NA	CHEMICAL	GENE-Y	23	24	The preferred initial agents for the treatment of high blood pressure are low-dose chemical diuretics , beta blockers , chemical antagonists , and chemical-converting enzyme ( gene ) inhibitors .	T8	T17	11588409
NA	CHEMICAL	GENE-Y	23	26	The preferred initial agents for the treatment of high blood pressure are low-dose chemical diuretics , beta blockers , chemical antagonists , and chemical-converting enzyme ( gene ) inhibitors .	T8	T18	11588409
CPR:4	CHEMICAL	GENE-N	0	4	chemical , the prototypical gene inhibitor , inhibits not only gene but also gene .	T9	T20	11588409
CPR:4	CHEMICAL	GENE-Y	0	10	chemical , the prototypical gene inhibitor , inhibits not only gene but also gene .	T9	T21	11588409
CPR:4	CHEMICAL	GENE-Y	0	13	chemical , the prototypical gene inhibitor , inhibits not only gene but also gene .	T9	T22	11588409
CPR:4	CHEMICAL	GENE-Y	5	2	Like conventional gene inhibitors , chemical causes extracellular volume reduction and vasodilatation ; moreover , it increases levels of gene and gene .	T10	T23	11588409
CPR:3	CHEMICAL	GENE-N	5	19	Like conventional gene inhibitors , chemical causes extracellular volume reduction and vasodilatation ; moreover , it increases levels of gene and gene .	T10	T24	11588409
CPR:3	CHEMICAL	GENE-Y	5	21	Like conventional gene inhibitors , chemical causes extracellular volume reduction and vasodilatation ; moreover , it increases levels of gene and gene .	T10	T25	11588409
NA	CHEMICAL	GENE-Y	0	2	chemical , a selective gene , and its active metabolite chemical may inhibit apoptosis and inflammation after cerebral ischemia .	T2	T22	17194886
NA	CHEMICAL	GENE-Y	2	2	chemical , a selective gene , and its active metabolite chemical may inhibit apoptosis and inflammation after cerebral ischemia .	T8	T22	17194886
NA	CHEMICAL	GENE-Y	0	18	chemical ( 30 mg/kg ) or chemical treatment ( 30 mg/kg ) did not reduce the levels of gene or gene immunostaining .	T1	T17	17194886
NA	CHEMICAL	GENE-Y	0	20	chemical ( 30 mg/kg ) or chemical treatment ( 30 mg/kg ) did not reduce the levels of gene or gene immunostaining .	T1	T18	17194886
NA	CHEMICAL	GENE-Y	6	18	chemical ( 30 mg/kg ) or chemical treatment ( 30 mg/kg ) did not reduce the levels of gene or gene immunostaining .	T3	T17	17194886
NA	CHEMICAL	GENE-Y	6	20	chemical ( 30 mg/kg ) or chemical treatment ( 30 mg/kg ) did not reduce the levels of gene or gene immunostaining .	T3	T18	17194886
CPR:4	CHEMICAL	GENE-Y	0	12	chemical ( 30 mg/kg ) also significantly decreased the protein levels of gene but not gene or gene in the cortex ipsilateral to the middle cerebral artery occlusion .	T4	T19	17194886
NA	CHEMICAL	GENE-N	0	15	chemical ( 30 mg/kg ) also significantly decreased the protein levels of gene but not gene or gene in the cortex ipsilateral to the middle cerebral artery occlusion .	T4	T20	17194886
NA	CHEMICAL	GENE-Y	0	16	chemical ( 30 mg/kg ) also significantly decreased the protein levels of gene but not gene or gene in the cortex ipsilateral to the middle cerebral artery occlusion .	T4	T21	17194886
NA	CHEMICAL	GENE-Y	12	11	Changes in gene expression associated with loss of function of the gene chemical dehydrogenase in mouse embryonic fibroblasts .	T10	T20	15805545
NA	CHEMICAL	GENE-N	12	13	Changes in gene expression associated with loss of function of the gene chemical dehydrogenase in mouse embryonic fibroblasts .	T10	T21	15805545
NA	CHEMICAL	GENE-Y	24	26	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T5	T16	15805545
NA	CHEMICAL	GENE-Y	24	28	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T5	T17	15805545
NA	CHEMICAL	GENE-N	24	31	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T5	T18	15805545
NA	CHEMICAL	GENE-Y	25	26	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T6	T16	15805545
NA	CHEMICAL	GENE-Y	25	28	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T6	T17	15805545
NA	CHEMICAL	GENE-N	25	31	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T6	T18	15805545
NA	CHEMICAL	GENE-Y	32	26	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T7	T16	15805545
NA	CHEMICAL	GENE-Y	32	28	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T7	T17	15805545
NA	CHEMICAL	GENE-N	32	31	One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X-linked gene chemical chemical dehydrogenase-like ( gene ) encoding a chemical dehydrogenase .	T7	T18	15805545
NA	CHEMICAL	GENE-Y	23	35	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T1	T11	15805545
NA	CHEMICAL	GENE-Y	23	37	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T1	T12	15805545
NA	CHEMICAL	GENE-N	23	20	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T1	T13	15805545
NA	CHEMICAL	GENE-Y	23	49	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T1	T14	15805545
NA	CHEMICAL	GENE-Y	23	51	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T1	T15	15805545
NA	CHEMICAL	GENE-Y	30	35	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T2	T11	15805545
NA	CHEMICAL	GENE-Y	30	37	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T2	T12	15805545
NA	CHEMICAL	GENE-N	30	20	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T2	T13	15805545
NA	CHEMICAL	GENE-Y	30	49	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T2	T14	15805545
NA	CHEMICAL	GENE-Y	30	51	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T2	T15	15805545
NA	CHEMICAL	GENE-Y	43	35	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T3	T11	15805545
NA	CHEMICAL	GENE-Y	43	37	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T3	T12	15805545
NA	CHEMICAL	GENE-N	43	20	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T3	T13	15805545
NA	CHEMICAL	GENE-Y	43	49	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T3	T14	15805545
NA	CHEMICAL	GENE-Y	43	51	Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in chemical biosynthesis , 7 are involved in chemical synthesis , 3 ( gene , gene , and gene ) encode chemical-regulatory proteins , and 2 ( gene and gene ) are lipid transporters .	T3	T15	15805545
NA	CHEMICAL	GENE-Y	2	1	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T4	23416007
NA	CHEMICAL	GENE-Y	2	5	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T7	23416007
NA	CHEMICAL	GENE-Y	2	17	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T8	23416007
NA	CHEMICAL	GENE-Y	2	21	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T9	23416007
NA	CHEMICAL	GENE-Y	2	2	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T11	23416007
NA	CHEMICAL	GENE-Y	2	37	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T12	23416007
NA	CHEMICAL	GENE-Y	2	37	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T13	23416007
NA	CHEMICAL	GENE-N	2	39	While gene in hypoxia translocates to the nucleus where it transcribes the target genes including gene ( gene ) mRNA , gene is degraded under normoxia , which involves its chemical hydroxylation and subsequent binding to the gene-gene-gene ( gene ) complex .	T1	T14	23416007
CPR:4	CHEMICAL	GENE-N	1	5	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T12	T29	23349208
NA	CHEMICAL	GENE-Y	1	25	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T12	T30	23349208
NA	CHEMICAL	GENE-Y	1	36	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T12	T31	23349208
CPR:4	CHEMICAL	GENE-N	4	5	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T13	T29	23349208
NA	CHEMICAL	GENE-Y	4	25	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T13	T30	23349208
NA	CHEMICAL	GENE-Y	4	36	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T13	T31	23349208
CPR:4	CHEMICAL	GENE-N	11	5	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T14	T29	23349208
NA	CHEMICAL	GENE-Y	11	25	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T14	T30	23349208
NA	CHEMICAL	GENE-Y	11	36	Both chemical , but chemical to a lesser extent compared with chemical , selectively and dose-dependently reduced the percentage of gene-expressing Th cells in a gene-dependent fashion , whereas the expression of the cell surface marker gene was unaltered on activated T cells .	T14	T31	23349208
CPR:3	CHEMICAL	GENE-Y	4	8	In monocytes , both chemical and chemical increased gene without affecting gene and gene .	T16	T32	23349208
NA	CHEMICAL	GENE-Y	4	11	In monocytes , both chemical and chemical increased gene without affecting gene and gene .	T16	T33	23349208
NA	CHEMICAL	GENE-Y	4	13	In monocytes , both chemical and chemical increased gene without affecting gene and gene .	T16	T34	23349208
CPR:3	CHEMICAL	GENE-Y	6	8	In monocytes , both chemical and chemical increased gene without affecting gene and gene .	T17	T32	23349208
NA	CHEMICAL	GENE-Y	6	11	In monocytes , both chemical and chemical increased gene without affecting gene and gene .	T17	T33	23349208
NA	CHEMICAL	GENE-Y	6	13	In monocytes , both chemical and chemical increased gene without affecting gene and gene .	T17	T34	23349208
CPR:3	CHEMICAL	GENE-N	6	16	Further investigation demonstrated that 8k reduced chemical-induced activation of mitochondrial apoptosis by inhibiting the expression of gene and elevating the expression of gene .	T3	T8	23403085
CPR:4	CHEMICAL	GENE-N	6	22	Further investigation demonstrated that 8k reduced chemical-induced activation of mitochondrial apoptosis by inhibiting the expression of gene and elevating the expression of gene .	T3	T9	23403085
CPR:3	CHEMICAL	GENE-Y	0	8	chemical crystals stimulate monocytes and macrophages to release gene through the gene component of the inflammasome .	T1	T9	17352828
NA	CHEMICAL	GENE-Y	0	11	chemical crystals stimulate monocytes and macrophages to release gene through the gene component of the inflammasome .	T1	T11	17352828
NA	CHEMICAL	GENE-N	9	3	The effectiveness of gene inhibition was first evaluated in a mouse model of chemical crystal-induced inflammation .	T2	T6	17352828
NA	CHEMICAL	GENE-Y	5	6	Dominant expression of mRNA for chemical synthase in leptomeninges , choroid plexus , and oligodendrocytes of the adult rat brain .	T7	T13	8415655
NA	CHEMICAL	GENE-Y	0	2	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T1	T9	8415655
NA	CHEMICAL	GENE-Y	0	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T1	T10	8415655
NA	CHEMICAL	GENE-Y	0	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T1	T12	8415655
NA	CHEMICAL	GENE-Y	0	10	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T1	T8	8415655
NA	CHEMICAL	GENE-Y	1	2	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T3	T9	8415655
NA	CHEMICAL	GENE-Y	1	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T3	T10	8415655
NA	CHEMICAL	GENE-Y	1	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T3	T12	8415655
NA	CHEMICAL	GENE-Y	1	10	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T3	T8	8415655
NA	CHEMICAL	GENE-Y	4	2	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T4	T9	8415655
NA	CHEMICAL	GENE-Y	4	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T4	T10	8415655
NA	CHEMICAL	GENE-Y	4	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T4	T12	8415655
NA	CHEMICAL	GENE-Y	4	10	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T4	T8	8415655
NA	CHEMICAL	GENE-Y	7	2	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T6	T9	8415655
NA	CHEMICAL	GENE-Y	7	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T6	T10	8415655
NA	CHEMICAL	GENE-Y	7	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T6	T12	8415655
NA	CHEMICAL	GENE-Y	7	10	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T6	T8	8415655
CPR:9	CHEMICAL	GENE-Y	19	2	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T2	T9	8415655
CPR:9	CHEMICAL	GENE-Y	19	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T2	T10	8415655
CPR:9	CHEMICAL	GENE-Y	19	5	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T2	T12	8415655
CPR:9	CHEMICAL	GENE-Y	19	10	chemical-independent chemical synthase [ chemical D-isomerase ; chemical D-isomerase , gene ] is an enzyme responsible for biosynthesis of chemical in the central nervous system .	T2	T8	8415655
NA	CHEMICAL	GENE-N	2	7	Interactions of chemical and chemical at chemical receptors : patch clamp recordings in cultured neurones and area CA1 in hippocampal slices .	T45	T54	8882618
NA	CHEMICAL	GENE-N	4	7	Interactions of chemical and chemical at chemical receptors : patch clamp recordings in cultured neurones and area CA1 in hippocampal slices .	T46	T54	8882618
NA	CHEMICAL	GENE-N	6	7	Interactions of chemical and chemical at chemical receptors : patch clamp recordings in cultured neurones and area CA1 in hippocampal slices .	T47	T54	8882618
NA	CHEMICAL	GENE-N	3	8	In conclusion , chemical and the chemical seem to bind to different sites on chemical receptors but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site .	T26	T52	8882618
NA	CHEMICAL	GENE-N	2	8	In conclusion , chemical and the chemical seem to bind to different sites on chemical receptors but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site .	T27	T52	8882618
NA	CHEMICAL	GENE-N	14	8	In conclusion , chemical and the chemical seem to bind to different sites on chemical receptors but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site .	T28	T52	8882618
NA	CHEMICAL	GENE-Y	6	0	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T14	T48	23053666
NA	CHEMICAL	GENE-Y	6	2	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T14	T50	23053666
NA	CHEMICAL	GENE-N	6	16	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T14	T51	23053666
NA	CHEMICAL	GENE-Y	6	17	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T14	T49	23053666
NA	CHEMICAL	GENE-Y	12	0	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T15	T48	23053666
NA	CHEMICAL	GENE-Y	12	2	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T15	T50	23053666
NA	CHEMICAL	GENE-N	12	16	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T15	T51	23053666
NA	CHEMICAL	GENE-Y	12	17	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T15	T49	23053666
NA	CHEMICAL	GENE-Y	14	0	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T13	T48	23053666
NA	CHEMICAL	GENE-Y	14	2	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T13	T50	23053666
NA	CHEMICAL	GENE-N	14	16	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T13	T51	23053666
NA	CHEMICAL	GENE-Y	14	17	gene and gene regulate sensitivity to chemical by controlling expression of the chemical and chemical influx transporter gene .	T13	T49	23053666
NA	CHEMICAL	GENE-Y	15	9	We found that knockdown of the expression of either gene or gene produced marked changes in the phenotype of ovarian cancer cells , including an increase in resistance to chemical ( cDDP ) .	T8	T30	23053666
NA	CHEMICAL	GENE-Y	15	11	We found that knockdown of the expression of either gene or gene produced marked changes in the phenotype of ovarian cancer cells , including an increase in resistance to chemical ( cDDP ) .	T8	T31	23053666
NA	CHEMICAL	GENE-Y	4	16	The net accumulation of chemical ( chemical ) and the chemical-DNA adduct levels were reduced in geneKD and geneKD cells .	T9	T44	23053666
NA	CHEMICAL	GENE-Y	4	18	The net accumulation of chemical ( chemical ) and the chemical-DNA adduct levels were reduced in geneKD and geneKD cells .	T9	T45	23053666
NA	CHEMICAL	GENE-Y	6	16	The net accumulation of chemical ( chemical ) and the chemical-DNA adduct levels were reduced in geneKD and geneKD cells .	T10	T44	23053666
NA	CHEMICAL	GENE-Y	6	18	The net accumulation of chemical ( chemical ) and the chemical-DNA adduct levels were reduced in geneKD and geneKD cells .	T10	T45	23053666
NA	CHEMICAL	GENE-Y	10	16	The net accumulation of chemical ( chemical ) and the chemical-DNA adduct levels were reduced in geneKD and geneKD cells .	T11	T44	23053666
NA	CHEMICAL	GENE-Y	10	18	The net accumulation of chemical ( chemical ) and the chemical-DNA adduct levels were reduced in geneKD and geneKD cells .	T11	T45	23053666
NA	CHEMICAL	GENE-N	5	7	The endogenous mRNA levels of chemical influx transporter gene were found to be significantly reduced in the knockdown cells , and exogenous expression of gene restored their sensitivity to cDDP .	T12	T46	23053666
NA	CHEMICAL	GENE-Y	5	8	The endogenous mRNA levels of chemical influx transporter gene were found to be significantly reduced in the knockdown cells , and exogenous expression of gene restored their sensitivity to cDDP .	T12	T47	23053666
NA	CHEMICAL	GENE-Y	5	24	The endogenous mRNA levels of chemical influx transporter gene were found to be significantly reduced in the knockdown cells , and exogenous expression of gene restored their sensitivity to cDDP .	T12	T17	23053666
NA	CHEMICAL	GENE-Y	1	17	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T1	T22	23053666
NA	CHEMICAL	GENE-Y	1	19	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T1	T23	23053666
NA	CHEMICAL	GENE-Y	3	17	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T2	T22	23053666
NA	CHEMICAL	GENE-Y	3	19	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T2	T23	23053666
NA	CHEMICAL	GENE-Y	7	17	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T3	T22	23053666
NA	CHEMICAL	GENE-Y	7	19	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T3	T23	23053666
NA	CHEMICAL	GENE-Y	11	17	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T4	T22	23053666
NA	CHEMICAL	GENE-Y	11	19	Baseline chemical ( chemical ) level , chemical uptake , and chemical cytotoxicity were also reduced in geneKD and geneKD cells .	T4	T23	23053666
NA	CHEMICAL	GENE-Y	0	1	chemical-dependent gene activity was also markedly reduced in both types of gene knockdown cells when incubated with the substrate chemical .	T5	T24	23053666
NA	CHEMICAL	GENE-N	0	11	chemical-dependent gene activity was also markedly reduced in both types of gene knockdown cells when incubated with the substrate chemical .	T5	T25	23053666
CPR:9	CHEMICAL	GENE-Y	19	1	chemical-dependent gene activity was also markedly reduced in both types of gene knockdown cells when incubated with the substrate chemical .	T6	T24	23053666
NA	CHEMICAL	GENE-N	19	11	chemical-dependent gene activity was also markedly reduced in both types of gene knockdown cells when incubated with the substrate chemical .	T6	T25	23053666
NA	CHEMICAL	GENE-Y	3	9	Intracerebroventricular administration of chemical ( 5 micrograms/rat ) , a gene analogue , induced barrel rotation in rats .	T5	T17	2087492
NA	CHEMICAL	GENE-Y	9	9	Intracerebroventricular administration of chemical ( 5 micrograms/rat ) , a gene analogue , induced barrel rotation in rats .	T11	T17	2087492
CPR:4	CHEMICAL	GENE-Y	4	18	The suppressive effect of chemical on barrel rotation could be partially countered by chemical , a selective peripheral gene gene antagonist .	T6	T15	2087492
CPR:4	CHEMICAL	GENE-Y	4	19	The suppressive effect of chemical on barrel rotation could be partially countered by chemical , a selective peripheral gene gene antagonist .	T6	T16	2087492
CPR:6	CHEMICAL	GENE-Y	13	18	The suppressive effect of chemical on barrel rotation could be partially countered by chemical , a selective peripheral gene gene antagonist .	T7	T15	2087492
CPR:6	CHEMICAL	GENE-Y	13	19	The suppressive effect of chemical on barrel rotation could be partially countered by chemical , a selective peripheral gene gene antagonist .	T7	T16	2087492
NA	CHEMICAL	GENE-N	0	6	chemical as a surrogate of chemical to monitor gene activation .	T20	T33	16965760
NA	CHEMICAL	GENE-N	2	6	chemical as a surrogate of chemical to monitor gene activation .	T21	T33	16965760
NA	CHEMICAL	GENE-N	0	0	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T2	T22	16965760
NA	CHEMICAL	GENE-N	0	2	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T2	T26	16965760
NA	CHEMICAL	GENE-N	0	5	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T2	T27	16965760
NA	CHEMICAL	GENE-N	0	7	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T2	T30	16965760
NA	CHEMICAL	GENE-N	0	23	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T2	T25	16965760
NA	CHEMICAL	GENE-N	18	0	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T5	T22	16965760
NA	CHEMICAL	GENE-N	18	2	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T5	T26	16965760
NA	CHEMICAL	GENE-N	18	5	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T5	T27	16965760
NA	CHEMICAL	GENE-N	18	7	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T5	T30	16965760
CPR:9	CHEMICAL	GENE-N	18	23	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T5	T25	16965760
NA	CHEMICAL	GENE-N	20	0	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T7	T22	16965760
NA	CHEMICAL	GENE-N	20	2	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T7	T26	16965760
NA	CHEMICAL	GENE-N	20	5	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T7	T27	16965760
NA	CHEMICAL	GENE-N	20	7	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T7	T30	16965760
CPR:9	CHEMICAL	GENE-N	20	23	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T7	T25	16965760
NA	CHEMICAL	GENE-N	23	0	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T8	T22	16965760
NA	CHEMICAL	GENE-N	23	2	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T8	T26	16965760
NA	CHEMICAL	GENE-N	23	5	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T8	T27	16965760
NA	CHEMICAL	GENE-N	23	7	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T8	T30	16965760
CPR:9	CHEMICAL	GENE-N	23	23	gene ( gene ) -coupled gene ( gene ) activities traditionally are assessed by measuring chemical triggered by chemical ( chemical ) , a gene hydrolysis product , or by measuring the production of chemical using cumbersome radioactive assays .	T8	T25	16965760
NA	CHEMICAL	GENE-N	4	12	The short lifetime of chemical makes this detection very challenging in measuring gene responses .	T11	T28	16965760
CPR:3	CHEMICAL	GENE-N	7	16	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T14	T29	16965760
CPR:4	CHEMICAL	GENE-N	7	15	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T14	T31	16965760
CPR:3	CHEMICAL	GENE-N	9	16	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T15	T29	16965760
CPR:4	CHEMICAL	GENE-N	9	15	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T15	T31	16965760
NA	CHEMICAL	GENE-N	13	16	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T16	T29	16965760
CPR:9	CHEMICAL	GENE-N	13	15	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T16	T31	16965760
NA	CHEMICAL	GENE-N	27	16	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T17	T29	16965760
CPR:9	CHEMICAL	GENE-N	27	15	It has been known for decades that chemical ( chemical ) leads to chemical accumulation on gene activation by inhibiting gene , the final enzyme of the chemical metabolic cascade .	T17	T31	16965760
NA	CHEMICAL	GENE-N	4	15	We show here that chemical can be used as a surrogate of chemical to monitor gene activation .	T18	T32	16965760
NA	CHEMICAL	GENE-N	12	15	We show here that chemical can be used as a surrogate of chemical to monitor gene activation .	T19	T32	16965760
NA	CHEMICAL	GENE-N	7	23	It has the advantage over the traditional chemical assay of allowing the measurement of inverse agonist activity as well as the analysis of gene activity in any nontransfected primary cultures .	T1	T24	16965760
NA	CHEMICAL	GENE-Y	13	2	Alleles of gene ( gene ) with elevated slippage rates were identified among chemical-sensitive mutants and were also isolated using a slippage-dependent reporter gene .	T1	T4	23223234
NA	CHEMICAL	GENE-Y	13	4	Alleles of gene ( gene ) with elevated slippage rates were identified among chemical-sensitive mutants and were also isolated using a slippage-dependent reporter gene .	T1	T5	23223234
CPR:4	CHEMICAL	GENE-Y	0	2	chemical suppressed gene-dependent chemical hepatotoxicity via depleting heme pool and releasing chemical .	T23	T41	23583009
NA	CHEMICAL	GENE-Y	3	2	chemical suppressed gene-dependent chemical hepatotoxicity via depleting heme pool and releasing chemical .	T24	T41	23583009
NA	CHEMICAL	GENE-Y	11	2	chemical suppressed gene-dependent chemical hepatotoxicity via depleting heme pool and releasing chemical .	T25	T41	23583009
NA	CHEMICAL	GENE-Y	2	12	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T8	T38	23583009
NA	CHEMICAL	GENE-Y	2	14	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T8	T28	23583009
NA	CHEMICAL	GENE-Y	6	12	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T13	T38	23583009
NA	CHEMICAL	GENE-Y	6	14	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T13	T28	23583009
NA	CHEMICAL	GENE-Y	11	12	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T21	T38	23583009
NA	CHEMICAL	GENE-Y	11	14	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T21	T28	23583009
NA	CHEMICAL	GENE-Y	18	12	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T6	T38	23583009
NA	CHEMICAL	GENE-Y	18	14	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T6	T28	23583009
NA	CHEMICAL	GENE-Y	20	12	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T7	T38	23583009
NA	CHEMICAL	GENE-Y	20	14	Naturally occuring chemical protects hepatocytes from chemical-induced oxidative stress , and chemical oxygenase-1 ( gene ) induction and chemical ( chemical ) metabolite may be implicated in the beneficial effect .	T7	T28	23583009
CPR:4	CHEMICAL	GENE-Y	7	9	However , the precise mechanism by which chemical counteracts gene-mediated chemical hepatotoxicity through gene system is still remained unclear .	T9	T31	23583009
NA	CHEMICAL	GENE-Y	7	13	However , the precise mechanism by which chemical counteracts gene-mediated chemical hepatotoxicity through gene system is still remained unclear .	T9	T32	23583009
NA	CHEMICAL	GENE-Y	10	9	However , the precise mechanism by which chemical counteracts gene-mediated chemical hepatotoxicity through gene system is still remained unclear .	T10	T31	23583009
NA	CHEMICAL	GENE-Y	10	13	However , the precise mechanism by which chemical counteracts gene-mediated chemical hepatotoxicity through gene system is still remained unclear .	T10	T32	23583009
CPR:3	CHEMICAL	GENE-Y	5	7	Our data showed that chronic chemical over-activated gene but suppressed gene with concurrent hepatic oxidative damage , which was partially normalized by chemical ( 100mg/kg.bw . ) .	T12	T33	23583009
CPR:4	CHEMICAL	GENE-Y	5	10	Our data showed that chronic chemical over-activated gene but suppressed gene with concurrent hepatic oxidative damage , which was partially normalized by chemical ( 100mg/kg.bw . ) .	T12	T34	23583009
NA	CHEMICAL	GENE-Y	22	7	Our data showed that chronic chemical over-activated gene but suppressed gene with concurrent hepatic oxidative damage , which was partially normalized by chemical ( 100mg/kg.bw . ) .	T14	T33	23583009
NA	CHEMICAL	GENE-Y	22	10	Our data showed that chronic chemical over-activated gene but suppressed gene with concurrent hepatic oxidative damage , which was partially normalized by chemical ( 100mg/kg.bw . ) .	T14	T34	23583009
CPR:3	CHEMICAL	GENE-Y	0	5	chemical ( 100μM ) induced gene and depleted heme pool when incubated to human hepatocytes .	T15	T35	23583009
CPR:3	CHEMICAL	GENE-Y	0	4	chemical-stimulated ( 100mM ) gene upregulation was suppressed by chemical but further enhanced by gene inhibition with resultant chemical accumulation .	T16	T36	23583009
CPR:4	CHEMICAL	GENE-Y	0	14	chemical-stimulated ( 100mM ) gene upregulation was suppressed by chemical but further enhanced by gene inhibition with resultant chemical accumulation .	T16	T37	23583009
CPR:4	CHEMICAL	GENE-Y	9	4	chemical-stimulated ( 100mM ) gene upregulation was suppressed by chemical but further enhanced by gene inhibition with resultant chemical accumulation .	T17	T36	23583009
NA	CHEMICAL	GENE-Y	9	14	chemical-stimulated ( 100mM ) gene upregulation was suppressed by chemical but further enhanced by gene inhibition with resultant chemical accumulation .	T17	T37	23583009
NA	CHEMICAL	GENE-Y	18	4	chemical-stimulated ( 100mM ) gene upregulation was suppressed by chemical but further enhanced by gene inhibition with resultant chemical accumulation .	T18	T36	23583009
CPR:9	CHEMICAL	GENE-Y	18	14	chemical-stimulated ( 100mM ) gene upregulation was suppressed by chemical but further enhanced by gene inhibition with resultant chemical accumulation .	T18	T37	23583009
CPR:4	CHEMICAL	GENE-Y	0	9	chemical scavenging blocked the suppression of chemical only on gene activity .	T19	T39	23583009
NA	CHEMICAL	GENE-Y	6	9	chemical scavenging blocked the suppression of chemical only on gene activity .	T20	T39	23583009
CPR:4	CHEMICAL	GENE-Y	0	4	chemical donor dose-dependently inactivated gene of chemical-incubated microsome , which was mimicked by gene substrate but abolished by chemical scavenger .	T22	T40	23583009
NA	CHEMICAL	GENE-Y	0	13	chemical donor dose-dependently inactivated gene of chemical-incubated microsome , which was mimicked by gene substrate but abolished by chemical scavenger .	T22	T26	23583009
CPR:3	CHEMICAL	GENE-Y	6	4	chemical donor dose-dependently inactivated gene of chemical-incubated microsome , which was mimicked by gene substrate but abolished by chemical scavenger .	T1	T40	23583009
NA	CHEMICAL	GENE-Y	6	13	chemical donor dose-dependently inactivated gene of chemical-incubated microsome , which was mimicked by gene substrate but abolished by chemical scavenger .	T1	T26	23583009
CPR:4	CHEMICAL	GENE-Y	0	4	chemical donor dose-dependently inactivated gene of chemical-incubated microsome , which was mimicked by gene substrate but abolished by chemical scavenger .	T2	T40	23583009
NA	CHEMICAL	GENE-Y	0	13	chemical donor dose-dependently inactivated gene of chemical-incubated microsome , which was mimicked by gene substrate but abolished by chemical scavenger .	T2	T26	23583009
NA	CHEMICAL	GENE-Y	3	2	Thus , gene-mediated chemical hepatotoxicity was alleviated by chemical through gene induction .	T3	T27	23583009
NA	CHEMICAL	GENE-Y	3	10	Thus , gene-mediated chemical hepatotoxicity was alleviated by chemical through gene induction .	T3	T29	23583009
NA	CHEMICAL	GENE-Y	8	2	Thus , gene-mediated chemical hepatotoxicity was alleviated by chemical through gene induction .	T4	T27	23583009
CPR:3	CHEMICAL	GENE-Y	8	10	Thus , gene-mediated chemical hepatotoxicity was alleviated by chemical through gene induction .	T4	T29	23583009
NA	CHEMICAL	GENE-N	5	6	Severe impairment of salivation in chemical/chemical/chemical cotransporter ( gene ) -deficient mice .	T25	T42	10831596
NA	CHEMICAL	GENE-Y	5	8	Severe impairment of salivation in chemical/chemical/chemical cotransporter ( gene ) -deficient mice .	T25	T43	10831596
NA	CHEMICAL	GENE-N	5	6	Severe impairment of salivation in chemical/chemical/chemical cotransporter ( gene ) -deficient mice .	T26	T42	10831596
NA	CHEMICAL	GENE-Y	5	8	Severe impairment of salivation in chemical/chemical/chemical cotransporter ( gene ) -deficient mice .	T26	T43	10831596
NA	CHEMICAL	GENE-N	5	6	Severe impairment of salivation in chemical/chemical/chemical cotransporter ( gene ) -deficient mice .	T27	T42	10831596
NA	CHEMICAL	GENE-Y	5	8	Severe impairment of salivation in chemical/chemical/chemical cotransporter ( gene ) -deficient mice .	T27	T43	10831596
NA	CHEMICAL	GENE-Y	27	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T11	T34	10831596
NA	CHEMICAL	GENE-Y	27	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T11	T35	10831596
NA	CHEMICAL	GENE-N	27	28	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T11	T36	10831596
NA	CHEMICAL	GENE-Y	27	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T12	T34	10831596
NA	CHEMICAL	GENE-Y	27	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T12	T35	10831596
NA	CHEMICAL	GENE-N	27	28	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T12	T36	10831596
NA	CHEMICAL	GENE-Y	27	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T13	T34	10831596
NA	CHEMICAL	GENE-Y	27	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T13	T35	10831596
NA	CHEMICAL	GENE-N	27	28	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T13	T36	10831596
NA	CHEMICAL	GENE-Y	31	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T14	T34	10831596
NA	CHEMICAL	GENE-Y	31	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T14	T35	10831596
NA	CHEMICAL	GENE-N	31	28	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T14	T36	10831596
NA	CHEMICAL	GENE-Y	31	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T15	T34	10831596
NA	CHEMICAL	GENE-Y	31	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T15	T35	10831596
NA	CHEMICAL	GENE-N	31	28	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T15	T36	10831596
NA	CHEMICAL	GENE-Y	31	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T16	T34	10831596
NA	CHEMICAL	GENE-Y	31	30	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T16	T35	10831596
NA	CHEMICAL	GENE-N	31	28	To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of chemical/chemical/chemical cotransporter isoform 1 ( gene ) , the gene encoding the salivary chemical/chemical/chemical cotransporter .	T16	T36	10831596
NA	CHEMICAL	GENE-Y	3	21	Consistent with defective chemical uptake , a loss of chemical-sensitive chemical influx was observed in parotid acinar cells from mice lacking gene .	T20	T40	10831596
NA	CHEMICAL	GENE-Y	6	21	Consistent with defective chemical uptake , a loss of chemical-sensitive chemical influx was observed in parotid acinar cells from mice lacking gene .	T21	T40	10831596
NA	CHEMICAL	GENE-Y	10	21	Consistent with defective chemical uptake , a loss of chemical-sensitive chemical influx was observed in parotid acinar cells from mice lacking gene .	T22	T40	10831596
NA	CHEMICAL	GENE-N	0	2	chemical/ chemical exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking gene is associated with anion exchanger-dependent chemical uptake .	T23	T41	10831596
NA	CHEMICAL	GENE-Y	0	23	chemical/ chemical exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking gene is associated with anion exchanger-dependent chemical uptake .	T23	T28	10831596
NA	CHEMICAL	GENE-N	1	2	chemical/ chemical exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking gene is associated with anion exchanger-dependent chemical uptake .	T24	T41	10831596
NA	CHEMICAL	GENE-Y	1	23	chemical/ chemical exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking gene is associated with anion exchanger-dependent chemical uptake .	T24	T28	10831596
NA	CHEMICAL	GENE-N	0	2	chemical/ chemical exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking gene is associated with anion exchanger-dependent chemical uptake .	T2	T41	10831596
NA	CHEMICAL	GENE-Y	0	23	chemical/ chemical exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking gene is associated with anion exchanger-dependent chemical uptake .	T2	T28	10831596
NA	CHEMICAL	GENE-N	5	7	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T3	T29	10831596
NA	CHEMICAL	GENE-N	5	8	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T3	T30	10831596
NA	CHEMICAL	GENE-N	5	14	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T3	T31	10831596
NA	CHEMICAL	GENE-N	6	7	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T4	T29	10831596
NA	CHEMICAL	GENE-N	6	8	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T4	T30	10831596
NA	CHEMICAL	GENE-N	6	14	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T4	T31	10831596
NA	CHEMICAL	GENE-N	21	7	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T5	T29	10831596
NA	CHEMICAL	GENE-N	21	8	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T5	T30	10831596
NA	CHEMICAL	GENE-N	21	14	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T5	T31	10831596
NA	CHEMICAL	GENE-N	21	7	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T6	T29	10831596
NA	CHEMICAL	GENE-N	21	8	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T6	T30	10831596
NA	CHEMICAL	GENE-N	21	14	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T6	T31	10831596
NA	CHEMICAL	GENE-N	21	7	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T7	T29	10831596
NA	CHEMICAL	GENE-N	21	8	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T7	T30	10831596
NA	CHEMICAL	GENE-N	21	14	Indeed , expression of the chemical/ chemical exchanger gene was enhanced suggesting that this transporter compensates for the loss of functional chemical/chemical/chemical cotransporter .	T7	T31	10831596
NA	CHEMICAL	GENE-Y	10	14	Furthermore , the ability of the parotid gland to conserve chemical was abolished in gene-deficient mice .	T8	T32	10831596
NA	CHEMICAL	GENE-Y	0	16	chemical stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via gene-dependent gene/gene and gene/gene activation .	T16	T27	23639192
CPR:3	CHEMICAL	GENE-N	0	17	chemical stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via gene-dependent gene/gene and gene/gene activation .	T16	T28	23639192
CPR:3	CHEMICAL	GENE-N	0	17	chemical stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via gene-dependent gene/gene and gene/gene activation .	T16	T29	23639192
CPR:3	CHEMICAL	GENE-N	0	19	chemical stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via gene-dependent gene/gene and gene/gene activation .	T16	T30	23639192
CPR:3	CHEMICAL	GENE-N	0	19	chemical stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via gene-dependent gene/gene and gene/gene activation .	T16	T31	23639192
NA	CHEMICAL	GENE-Y	4	21	Here we show that chemical increases proliferation and differentiation and opposes chemical-induced apoptosis in human osteoblastic MG-63 cells containing two chemical receptor ( gene ) isoforms .	T9	T23	23639192
NA	CHEMICAL	GENE-Y	4	23	Here we show that chemical increases proliferation and differentiation and opposes chemical-induced apoptosis in human osteoblastic MG-63 cells containing two chemical receptor ( gene ) isoforms .	T9	T24	23639192
NA	CHEMICAL	GENE-Y	11	21	Here we show that chemical increases proliferation and differentiation and opposes chemical-induced apoptosis in human osteoblastic MG-63 cells containing two chemical receptor ( gene ) isoforms .	T10	T23	23639192
NA	CHEMICAL	GENE-Y	11	23	Here we show that chemical increases proliferation and differentiation and opposes chemical-induced apoptosis in human osteoblastic MG-63 cells containing two chemical receptor ( gene ) isoforms .	T10	T24	23639192
NA	CHEMICAL	GENE-Y	20	21	Here we show that chemical increases proliferation and differentiation and opposes chemical-induced apoptosis in human osteoblastic MG-63 cells containing two chemical receptor ( gene ) isoforms .	T11	T23	23639192
NA	CHEMICAL	GENE-Y	20	23	Here we show that chemical increases proliferation and differentiation and opposes chemical-induced apoptosis in human osteoblastic MG-63 cells containing two chemical receptor ( gene ) isoforms .	T11	T24	23639192
NA	CHEMICAL	GENE-Y	0	17	chemical promotes proliferation by altering cell cycle distribution whereas chemical-mediated survival may be associated with up-regulation of gene expression .	T12	T25	23639192
CPR:3	CHEMICAL	GENE-Y	9	17	chemical promotes proliferation by altering cell cycle distribution whereas chemical-mediated survival may be associated with up-regulation of gene expression .	T13	T25	23639192
CPR:6	CHEMICAL	GENE-Y	5	3	Treatment with the gene antagonist chemical abolishes the above actions of chemical on osteoblast-derived cells .	T14	T26	23639192
NA	CHEMICAL	GENE-Y	11	3	Treatment with the gene antagonist chemical abolishes the above actions of chemical on osteoblast-derived cells .	T15	T26	23639192
NA	CHEMICAL	GENE-Y	14	25	Using small interfering double-stranded RNA technology , we further demonstrate that the effects of chemical on proliferation , differentiation and survival are mediated by both gene and gene .	T2	T17	23639192
NA	CHEMICAL	GENE-Y	14	27	Using small interfering double-stranded RNA technology , we further demonstrate that the effects of chemical on proliferation , differentiation and survival are mediated by both gene and gene .	T2	T18	23639192
CPR:3	CHEMICAL	GENE-N	6	14	Moreover , we also demonstrate that chemical functions at least partially through activation of gene/gene and gene/gene signaling .	T3	T19	23639192
CPR:3	CHEMICAL	GENE-N	6	14	Moreover , we also demonstrate that chemical functions at least partially through activation of gene/gene and gene/gene signaling .	T3	T20	23639192
CPR:3	CHEMICAL	GENE-N	6	16	Moreover , we also demonstrate that chemical functions at least partially through activation of gene/gene and gene/gene signaling .	T3	T21	23639192
CPR:3	CHEMICAL	GENE-N	6	16	Moreover , we also demonstrate that chemical functions at least partially through activation of gene/gene and gene/gene signaling .	T3	T22	23639192
CPR:4	CHEMICAL	GENE-N	2	3	High-affinity blockade of gene by chemical analogues .	T20	T31	18574460
NA	CHEMICAL	GENE-N	8	16	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T10	T25	18574460
NA	CHEMICAL	GENE-Y	8	17	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T10	T26	18574460
NA	CHEMICAL	GENE-N	8	32	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T10	T27	18574460
NA	CHEMICAL	GENE-Y	8	17	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T10	T28	18574460
NA	CHEMICAL	GENE-N	31	16	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T11	T25	18574460
NA	CHEMICAL	GENE-Y	31	17	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T11	T26	18574460
NA	CHEMICAL	GENE-N	31	32	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T11	T27	18574460
NA	CHEMICAL	GENE-Y	31	17	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T11	T28	18574460
NA	CHEMICAL	GENE-N	8	16	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T12	T25	18574460
NA	CHEMICAL	GENE-Y	8	17	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T12	T26	18574460
NA	CHEMICAL	GENE-N	8	32	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T12	T27	18574460
NA	CHEMICAL	GENE-Y	8	17	EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of chemical on gene ( gene ) and the effect of one compound ( chemical ) on neuronal chemical channels ( gene ) heterologously expressed in human embryonic kidney cell line 293 .	T12	T28	18574460
NA	CHEMICAL	GENE-Y	7	2	The IC ( 50 ) for block of resting channels at -150 mV was 2.3 , 3.9 and 11.3 microM in gene , respectively , and 29.2 microM for chemical in gene .	T18	T29	18574460
CPR:4	CHEMICAL	GENE-Y	7	2	The IC ( 50 ) for block of resting channels at -150 mV was 2.3 , 3.9 and 11.3 microM in gene , respectively , and 29.2 microM for chemical in gene .	T18	T30	18574460
CPR:4	CHEMICAL	GENE-Y	17	23	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T1	T21	18574460
NA	CHEMICAL	GENE-Y	17	31	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T1	T22	18574460
CPR:4	CHEMICAL	GENE-Y	19	23	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T2	T21	18574460
NA	CHEMICAL	GENE-Y	19	31	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T2	T22	18574460
CPR:4	CHEMICAL	GENE-Y	21	23	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T3	T21	18574460
NA	CHEMICAL	GENE-Y	21	31	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T3	T22	18574460
NA	CHEMICAL	GENE-Y	29	23	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T4	T21	18574460
CPR:4	CHEMICAL	GENE-Y	29	31	Estimated affinities for the fast-inactivated channel state were 81 nM , 312 nM and 227 nM for chemical , chemical and chemical in gene , and 450 nM for chemical in gene .	T4	T22	18574460
CPR:4	CHEMICAL	GENE-N	4	7	CONCLUSIONS AND IMPLICATIONS : chemical analogues constitute a novel class of chemical channel-blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug chemical .	T5	T23	18574460
NA	CHEMICAL	GENE-N	11	7	CONCLUSIONS AND IMPLICATIONS : chemical analogues constitute a novel class of chemical channel-blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug chemical .	T6	T23	18574460
NA	CHEMICAL	GENE-N	7	7	CONCLUSIONS AND IMPLICATIONS : chemical analogues constitute a novel class of chemical channel-blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug chemical .	T7	T23	18574460
NA	CHEMICAL	GENE-Y	28	0	gene is expressed in differentiating osteoclast-like cells and the gene mutation selectively impairs the gene-gene interaction in co-immunoprecipitations , which molecular modelling indicates results from effects on critical chemical bonds required to stabilise the gene-gene complex .	T1	T4	23117207
NA	CHEMICAL	GENE-N	28	9	gene is expressed in differentiating osteoclast-like cells and the gene mutation selectively impairs the gene-gene interaction in co-immunoprecipitations , which molecular modelling indicates results from effects on critical chemical bonds required to stabilise the gene-gene complex .	T1	T5	23117207
NA	CHEMICAL	GENE-Y	28	14	gene is expressed in differentiating osteoclast-like cells and the gene mutation selectively impairs the gene-gene interaction in co-immunoprecipitations , which molecular modelling indicates results from effects on critical chemical bonds required to stabilise the gene-gene complex .	T1	T6	23117207
NA	CHEMICAL	GENE-Y	28	14	gene is expressed in differentiating osteoclast-like cells and the gene mutation selectively impairs the gene-gene interaction in co-immunoprecipitations , which molecular modelling indicates results from effects on critical chemical bonds required to stabilise the gene-gene complex .	T1	T7	23117207
NA	CHEMICAL	GENE-N	28	34	gene is expressed in differentiating osteoclast-like cells and the gene mutation selectively impairs the gene-gene interaction in co-immunoprecipitations , which molecular modelling indicates results from effects on critical chemical bonds required to stabilise the gene-gene complex .	T1	T8	23117207
NA	CHEMICAL	GENE-Y	28	34	gene is expressed in differentiating osteoclast-like cells and the gene mutation selectively impairs the gene-gene interaction in co-immunoprecipitations , which molecular modelling indicates results from effects on critical chemical bonds required to stabilise the gene-gene complex .	T1	T9	23117207
CPR:9	CHEMICAL	GENE-Y	0	8	chemical is actively eliminated from neuronal cells by gene .	T13	T37	23600914
CPR:9	CHEMICAL	GENE-Y	1	6	High chemical turnover catalyzed by chemical 24-hydroxylase is essential for neural functions , especially learning .	T9	T21	23600914
NA	CHEMICAL	GENE-Y	5	6	High chemical turnover catalyzed by chemical 24-hydroxylase is essential for neural functions , especially learning .	T6	T21	23600914
CPR:9	CHEMICAL	GENE-Y	1	8	Because chemical ( chemical ) , produced by gene , induces apoptosis of neuronal cells , it is vital to eliminate it rapidly from cells .	T3	T20	23600914
CPR:9	CHEMICAL	GENE-Y	3	8	Because chemical ( chemical ) , produced by gene , induces apoptosis of neuronal cells , it is vital to eliminate it rapidly from cells .	T4	T20	23600914
NA	CHEMICAL	GENE-N	14	8	Here , using differentiated SH-SY5Y neuron-like cells as a model , we examined whether chemical is actively eliminated via gene induced by its accumulation .	T5	T22	23600914
CPR:3	CHEMICAL	GENE-Y	9	3	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T7	T23	23600914
CPR:3	CHEMICAL	GENE-Y	9	5	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T7	T24	23600914
NA	CHEMICAL	GENE-N	9	23	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T7	T25	23600914
NA	CHEMICAL	GENE-N	9	24	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T7	T26	23600914
NA	CHEMICAL	GENE-N	9	24	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T7	T27	23600914
CPR:3	CHEMICAL	GENE-Y	14	3	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T8	T23	23600914
CPR:3	CHEMICAL	GENE-Y	14	5	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T8	T24	23600914
NA	CHEMICAL	GENE-N	14	23	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T8	T25	23600914
NA	CHEMICAL	GENE-N	14	24	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T8	T26	23600914
NA	CHEMICAL	GENE-N	14	24	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T8	T27	23600914
CPR:3	CHEMICAL	GENE-Y	16	3	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T10	T23	23600914
CPR:3	CHEMICAL	GENE-Y	16	5	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T10	T24	23600914
NA	CHEMICAL	GENE-N	16	23	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T10	T25	23600914
NA	CHEMICAL	GENE-N	16	24	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T10	T26	23600914
NA	CHEMICAL	GENE-N	16	24	The expression of gene and gene was induced by chemical , as well as chemical and chemical , which are ligands of the gene gene/gene .	T10	T27	23600914
NA	CHEMICAL	GENE-Y	10	4	When the expression of gene and gene was induced , chemical efflux was stimulated in the presence of gene ( gene ) , whereas gene was not an efficient acceptor .	T11	T28	23600914
NA	CHEMICAL	GENE-Y	10	6	When the expression of gene and gene was induced , chemical efflux was stimulated in the presence of gene ( gene ) , whereas gene was not an efficient acceptor .	T11	T29	23600914
NA	CHEMICAL	GENE-N	10	14	When the expression of gene and gene was induced , chemical efflux was stimulated in the presence of gene ( gene ) , whereas gene was not an efficient acceptor .	T11	T30	23600914
NA	CHEMICAL	GENE-N	10	20	When the expression of gene and gene was induced , chemical efflux was stimulated in the presence of gene ( gene ) , whereas gene was not an efficient acceptor .	T11	T31	23600914
NA	CHEMICAL	GENE-Y	10	24	When the expression of gene and gene was induced , chemical efflux was stimulated in the presence of gene ( gene ) , whereas gene was not an efficient acceptor .	T11	T32	23600914
CPR:9	CHEMICAL	GENE-Y	21	14	To confirm the role of each transporter , we analyzed HEK293 cells stably expressing gene or gene ; we clearly observed chemical efflux in the presence of gene , whereas efflux in the presence of gene was marginal .	T12	T35	23600914
CPR:9	CHEMICAL	GENE-Y	21	16	To confirm the role of each transporter , we analyzed HEK293 cells stably expressing gene or gene ; we clearly observed chemical efflux in the presence of gene , whereas efflux in the presence of gene was marginal .	T12	T36	23600914
NA	CHEMICAL	GENE-N	21	27	To confirm the role of each transporter , we analyzed HEK293 cells stably expressing gene or gene ; we clearly observed chemical efflux in the presence of gene , whereas efflux in the presence of gene was marginal .	T12	T14	23600914
NA	CHEMICAL	GENE-Y	21	35	To confirm the role of each transporter , we analyzed HEK293 cells stably expressing gene or gene ; we clearly observed chemical efflux in the presence of gene , whereas efflux in the presence of gene was marginal .	T12	T15	23600914
NA	CHEMICAL	GENE-N	9	9	Furthermore , the treatment of primary cerebral neurons with gene/gene ligands suppressed the toxicity of chemical .	T1	T16	23600914
NA	CHEMICAL	GENE-N	9	9	Furthermore , the treatment of primary cerebral neurons with gene/gene ligands suppressed the toxicity of chemical .	T1	T17	23600914
NA	CHEMICAL	GENE-Y	14	15	Additionally , more specific mechanisms exist where xenobiotics act as ligands , including the chemical receptor , gene and the gene family of transcription factors .	T1	T2	22926699
NA	CHEMICAL	GENE-Y	14	8	Additionally , more specific mechanisms exist where xenobiotics act as ligands , including the chemical receptor , gene and the gene family of transcription factors .	T1	T3	22926699
NA	CHEMICAL	GENE-N	14	15	Additionally , more specific mechanisms exist where xenobiotics act as ligands , including the chemical receptor , gene and the gene family of transcription factors .	T1	T4	22926699
NA	CHEMICAL	GENE-Y	9	11	Coming full circle : contributions of central and peripheral chemical actions to energy balance .	T7	T12	23270805
NA	CHEMICAL	GENE-Y	2	9	The neuropeptide chemical has emerged as an important chemical in the regulation of energy balance .	T1	T8	23270805
NA	CHEMICAL	GENE-Y	6	9	The neuropeptide chemical has emerged as an important chemical in the regulation of energy balance .	T4	T8	23270805
NA	CHEMICAL	GENE-Y	3	19	Systemic administration of chemical recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating gene contributes to energy regulation .	T3	T9	23270805
NA	CHEMICAL	GENE-Y	3	19	Systemic administration of chemical recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating gene contributes to energy regulation .	T3	T10	23270805
NA	CHEMICAL	GENE-Y	19	19	Systemic administration of chemical recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating gene contributes to energy regulation .	T5	T9	23270805
NA	CHEMICAL	GENE-Y	19	19	Systemic administration of chemical recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating gene contributes to energy regulation .	T5	T10	23270805
NA	CHEMICAL	GENE-Y	6	7	Repeated Low Dose Administration of the chemical Lipase Inhibitor chemical Retains gene Receptor Mediated Antinociceptive and Gastroprotective Effects .	T17	T29	23412396
NA	CHEMICAL	GENE-Y	6	11	Repeated Low Dose Administration of the chemical Lipase Inhibitor chemical Retains gene Receptor Mediated Antinociceptive and Gastroprotective Effects .	T17	T30	23412396
CPR:4	CHEMICAL	GENE-Y	9	7	Repeated Low Dose Administration of the chemical Lipase Inhibitor chemical Retains gene Receptor Mediated Antinociceptive and Gastroprotective Effects .	T18	T29	23412396
NA	CHEMICAL	GENE-Y	9	11	Repeated Low Dose Administration of the chemical Lipase Inhibitor chemical Retains gene Receptor Mediated Antinociceptive and Gastroprotective Effects .	T18	T30	23412396
NA	CHEMICAL	GENE-Y	1	2	The chemical lipase ( gene ) inhibitor chemical produces antinociceptive and anti-inflammatory effects .	T10	T26	23412396
NA	CHEMICAL	GENE-Y	1	4	The chemical lipase ( gene ) inhibitor chemical produces antinociceptive and anti-inflammatory effects .	T10	T23	23412396
CPR:4	CHEMICAL	GENE-Y	7	2	The chemical lipase ( gene ) inhibitor chemical produces antinociceptive and anti-inflammatory effects .	T11	T26	23412396
CPR:4	CHEMICAL	GENE-Y	7	4	The chemical lipase ( gene ) inhibitor chemical produces antinociceptive and anti-inflammatory effects .	T11	T23	23412396
NA	CHEMICAL	GENE-N	7	19	However , repeated administration of high dose chemical ( 40 mg/kg ) causes dependence , antinociceptive tolerance , cross-tolerance to the pharmacological effects of gene agonists , and gene receptor downregulation and desensitization .	T7	T22	23412396
NA	CHEMICAL	GENE-Y	7	8	However , repeated administration of high dose chemical ( 40 mg/kg ) causes dependence , antinociceptive tolerance , cross-tolerance to the pharmacological effects of gene agonists , and gene receptor downregulation and desensitization .	T7	T24	23412396
CPR:4	CHEMICAL	GENE-Y	7	8	Mice given daily injections of high dose chemical ( ≥16 mg/kg ) for six days displayed decreased gene receptor density and function in brain , as assessed in chemical binding and chemical-stimulated [ chemical ] GTPγS binding assays , respectively .	T13	T28	23412396
NA	CHEMICAL	GENE-Y	8	8	Mice given daily injections of high dose chemical ( ≥16 mg/kg ) for six days displayed decreased gene receptor density and function in brain , as assessed in chemical binding and chemical-stimulated [ chemical ] GTPγS binding assays , respectively .	T14	T28	23412396
NA	CHEMICAL	GENE-Y	24	8	Mice given daily injections of high dose chemical ( ≥16 mg/kg ) for six days displayed decreased gene receptor density and function in brain , as assessed in chemical binding and chemical-stimulated [ chemical ] GTPγS binding assays , respectively .	T15	T28	23412396
NA	CHEMICAL	GENE-Y	8	8	Mice given daily injections of high dose chemical ( ≥16 mg/kg ) for six days displayed decreased gene receptor density and function in brain , as assessed in chemical binding and chemical-stimulated [ chemical ] GTPγS binding assays , respectively .	T16	T28	23412396
NA	CHEMICAL	GENE-Y	4	4	In contrast , normal gene receptor expression and function were maintained following repeated administration of low dose chemical ( ≤8 mg/kg ) .	T1	T19	23412396
NA	CHEMICAL	GENE-N	5	0	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T5	T14	23333897
NA	CHEMICAL	GENE-N	5	24	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T5	T16	23333897
NA	CHEMICAL	GENE-N	5	32	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T5	T7	23333897
NA	CHEMICAL	GENE-N	5	33	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T5	T8	23333897
NA	CHEMICAL	GENE-N	5	0	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T6	T14	23333897
NA	CHEMICAL	GENE-N	5	24	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T6	T16	23333897
NA	CHEMICAL	GENE-N	5	32	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T6	T7	23333897
NA	CHEMICAL	GENE-N	5	33	gene polymerization was measured by chemical-chemical staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( gene induction ) , and pull-down assays ( gene gene ) .	T6	T8	23333897
NA	CHEMICAL	GENE-N	19	19	RESULTS : In contrast to immune stimulatory sequence ISS 1018 , BCG DNA spontaneously formed nanoparticulate structures and induced gene polymerization as did synthetic chemical nanoparticles .	T1	T10	23333897
NA	CHEMICAL	GENE-Y	2	11	Co-incubation with chemical nanoparticles amplified the responsiveness of macrophages toward the gene ligand ISS 1018 .	T2	T12	23333897
NA	CHEMICAL	GENE-Y	3	4	Activation of cytoprotective chemical synthase-1 by chemical as a possible explanation for its hair growth-stimulating effect .	T11	T21	9008235
CPR:3	CHEMICAL	GENE-Y	6	4	Activation of cytoprotective chemical synthase-1 by chemical as a possible explanation for its hair growth-stimulating effect .	T12	T21	9008235
NA	CHEMICAL	GENE-Y	11	13	These NSAIDs are well-known inhibitors of both the cytoprotective isoform of chemical endoperoxide synthase-1 ( gene ) and of the inducible form ( gene ) .	T5	T13	9008235
NA	CHEMICAL	GENE-Y	11	15	These NSAIDs are well-known inhibitors of both the cytoprotective isoform of chemical endoperoxide synthase-1 ( gene ) and of the inducible form ( gene ) .	T5	T14	9008235
NA	CHEMICAL	GENE-Y	11	23	These NSAIDs are well-known inhibitors of both the cytoprotective isoform of chemical endoperoxide synthase-1 ( gene ) and of the inducible form ( gene ) .	T5	T15	9008235
CPR:3	CHEMICAL	GENE-Y	13	6	We thus speculated that activation of gene might be a mechanism by which chemical ( chemical ) stimulates hair growth in vivo .	T6	T19	9008235
CPR:3	CHEMICAL	GENE-Y	9	6	We thus speculated that activation of gene might be a mechanism by which chemical ( chemical ) stimulates hair growth in vivo .	T7	T19	9008235
CPR:3	CHEMICAL	GENE-Y	4	11	We demonstrate here that chemical is a potent activator of purified gene ( AC50 = 80 microM ) , as assayed by chemical consumption and PGE2 production .	T8	T20	9008235
NA	CHEMICAL	GENE-Y	22	11	We demonstrate here that chemical is a potent activator of purified gene ( AC50 = 80 microM ) , as assayed by chemical consumption and PGE2 production .	T9	T20	9008235
NA	CHEMICAL	GENE-Y	11	3	Full-length cDNAs of gene ( gene ) were cloned by screening a human placental cDNA library , which encode a 243 amino acid protein , identical to gene ( gene ) as confirmed by protein sequence analysis .	T2	T15	15664409
NA	CHEMICAL	GENE-Y	11	5	Full-length cDNAs of gene ( gene ) were cloned by screening a human placental cDNA library , which encode a 243 amino acid protein , identical to gene ( gene ) as confirmed by protein sequence analysis .	T2	T18	15664409
NA	CHEMICAL	GENE-Y	11	11	Full-length cDNAs of gene ( gene ) were cloned by screening a human placental cDNA library , which encode a 243 amino acid protein , identical to gene ( gene ) as confirmed by protein sequence analysis .	T2	T11	15664409
NA	CHEMICAL	GENE-Y	11	29	Full-length cDNAs of gene ( gene ) were cloned by screening a human placental cDNA library , which encode a 243 amino acid protein , identical to gene ( gene ) as confirmed by protein sequence analysis .	T2	T14	15664409
CPR:9	CHEMICAL	GENE-Y	1	15	As chemical metabolism deficiencies have been seen in placental infarcts previously , these indicate that gene/gene may have a role in placental diseases .	T3	T19	15664409
CPR:9	CHEMICAL	GENE-Y	1	15	As chemical metabolism deficiencies have been seen in placental infarcts previously , these indicate that gene/gene may have a role in placental diseases .	T3	T20	15664409
NA	CHEMICAL	GENE-Y	17	1	The gene ( gene ) gene polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant chemical-based chemotherapy .	T2	T16	23567490
NA	CHEMICAL	GENE-Y	17	3	The gene ( gene ) gene polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant chemical-based chemotherapy .	T2	T14	23567490
NA	CHEMICAL	GENE-N	17	5	The gene ( gene ) gene polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant chemical-based chemotherapy .	T2	T15	23567490
NA	CHEMICAL	GENE-Y	3	8	Patients treated with chemical-based chemotherapy , carrying the gene gene genotype had significantly decreased time-to-tumor recurrence ( TTR ) in univariate analysis and multivariate analysis ( hazard ratio ( HR ) 2.47 ; 95 % confidence interval ( CI ) 1.16-5.29 ; P=0.019 ) .	T1	T6	23567490
NA	CHEMICAL	GENE-N	3	9	Patients treated with chemical-based chemotherapy , carrying the gene gene genotype had significantly decreased time-to-tumor recurrence ( TTR ) in univariate analysis and multivariate analysis ( hazard ratio ( HR ) 2.47 ; 95 % confidence interval ( CI ) 1.16-5.29 ; P=0.019 ) .	T1	T7	23567490
CPR:6	CHEMICAL	GENE-N	2	29	Within the chemical scaffold , either electronic or steric perturbations to the central chemical ring led to a loss of selective M ( 1 ) allosteric agonism and afforded pan-gene antagonism , which was demonstrated to be mediated via the orthosteric site .	T1	T6	23200253
CPR:6	CHEMICAL	GENE-N	13	29	Within the chemical scaffold , either electronic or steric perturbations to the central chemical ring led to a loss of selective M ( 1 ) allosteric agonism and afforded pan-gene antagonism , which was demonstrated to be mediated via the orthosteric site .	T2	T6	23200253
CPR:6	CHEMICAL	GENE-N	7	31	Additional SAR around a related M ( 1 ) allosteric agonist family ( chemical ) identified similar , subtle 'molecular switches ' that modulated modes of pharmacology from allosteric agonism to pan-gene orthosteric antagonism .	T3	T7	23200253
NA	CHEMICAL	GENE-N	0	12	chemical ( chemical ) is cotranslationally inserted into protein in response to gene codons and is the 21st chemical in the genetic code .	T1	T34	17194211
NA	CHEMICAL	GENE-N	2	12	chemical ( chemical ) is cotranslationally inserted into protein in response to gene codons and is the 21st chemical in the genetic code .	T5	T34	17194211
NA	CHEMICAL	GENE-N	18	12	chemical ( chemical ) is cotranslationally inserted into protein in response to gene codons and is the 21st chemical in the genetic code .	T4	T34	17194211
NA	CHEMICAL	GENE-Y	12	10	Herein , comparative genomics and experimental analyses revealed that the gene ( chemicalS ) is the previously identified chemical-containing protein known as the gene .	T7	T25	17194211
NA	CHEMICAL	GENE-Y	12	23	Herein , comparative genomics and experimental analyses revealed that the gene ( chemicalS ) is the previously identified chemical-containing protein known as the gene .	T7	T27	17194211
NA	CHEMICAL	GENE-Y	18	10	Herein , comparative genomics and experimental analyses revealed that the gene ( chemicalS ) is the previously identified chemical-containing protein known as the gene .	T8	T25	17194211
NA	CHEMICAL	GENE-Y	18	23	Herein , comparative genomics and experimental analyses revealed that the gene ( chemicalS ) is the previously identified chemical-containing protein known as the gene .	T8	T27	17194211
CPR:9	CHEMICAL	GENE-Y	2	0	gene required chemical and chemical-tRNA ( [ Ser ] Sec ) as substrates to generate chemical-tRNA ( [ Ser ] Sec ) .	T9	T28	17194211
CPR:9	CHEMICAL	GENE-Y	4	0	gene required chemical and chemical-tRNA ( [ Ser ] Sec ) as substrates to generate chemical-tRNA ( [ Ser ] Sec ) .	T10	T28	17194211
CPR:9	CHEMICAL	GENE-Y	15	0	gene required chemical and chemical-tRNA ( [ Ser ] Sec ) as substrates to generate chemical-tRNA ( [ Ser ] Sec ) .	T11	T28	17194211
NA	CHEMICAL	GENE-Y	26	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T12	T29	17194211
NA	CHEMICAL	GENE-Y	26	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T12	T30	17194211
NA	CHEMICAL	GENE-Y	26	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T12	T31	17194211
NA	CHEMICAL	GENE-N	26	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T12	T32	17194211
NA	CHEMICAL	GENE-Y	26	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T12	T33	17194211
NA	CHEMICAL	GENE-Y	14	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T13	T29	17194211
NA	CHEMICAL	GENE-Y	14	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T13	T30	17194211
NA	CHEMICAL	GENE-Y	14	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T13	T31	17194211
NA	CHEMICAL	GENE-N	14	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T13	T32	17194211
NA	CHEMICAL	GENE-Y	14	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T13	T33	17194211
NA	CHEMICAL	GENE-Y	16	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T14	T29	17194211
NA	CHEMICAL	GENE-Y	16	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T14	T30	17194211
NA	CHEMICAL	GENE-Y	16	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T14	T31	17194211
NA	CHEMICAL	GENE-N	16	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T14	T32	17194211
NA	CHEMICAL	GENE-Y	16	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T14	T33	17194211
NA	CHEMICAL	GENE-Y	19	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T15	T29	17194211
NA	CHEMICAL	GENE-Y	19	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T15	T30	17194211
NA	CHEMICAL	GENE-Y	19	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T15	T31	17194211
NA	CHEMICAL	GENE-N	19	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T15	T32	17194211
NA	CHEMICAL	GENE-Y	19	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T15	T33	17194211
NA	CHEMICAL	GENE-Y	29	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T16	T29	17194211
NA	CHEMICAL	GENE-Y	29	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T16	T30	17194211
NA	CHEMICAL	GENE-Y	29	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T16	T31	17194211
NA	CHEMICAL	GENE-N	29	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T16	T32	17194211
NA	CHEMICAL	GENE-Y	29	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T16	T33	17194211
NA	CHEMICAL	GENE-Y	32	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T17	T29	17194211
NA	CHEMICAL	GENE-Y	32	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T17	T30	17194211
NA	CHEMICAL	GENE-Y	32	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T17	T31	17194211
NA	CHEMICAL	GENE-N	32	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T17	T32	17194211
NA	CHEMICAL	GENE-Y	32	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T17	T33	17194211
NA	CHEMICAL	GENE-Y	41	6	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T18	T29	17194211
NA	CHEMICAL	GENE-Y	41	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T18	T30	17194211
NA	CHEMICAL	GENE-Y	41	39	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T18	T31	17194211
NA	CHEMICAL	GENE-N	41	10	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T18	T32	17194211
NA	CHEMICAL	GENE-Y	41	37	Moreover , it was found that gene was synthesized on the tRNA scaffold from chemical , chemical , and chemical using tRNA ( [ Ser ] chemical ) , chemical-tRNA synthetase , chemical-tRNA ( [ Ser ] Sec ) kinase , chemical synthetase , and gene .	T18	T33	17194211
NA	CHEMICAL	GENE-Y	5	16	By identifying the pathway of chemical biosynthesis in mammals , this study not only functionally characterized gene but also assigned the function of the chemical-tRNA ( [ Ser ] Sec ) kinase .	T19	T35	17194211
NA	CHEMICAL	GENE-Y	5	7	By identifying the pathway of chemical biosynthesis in mammals , this study not only functionally characterized gene but also assigned the function of the chemical-tRNA ( [ Ser ] Sec ) kinase .	T19	T36	17194211
NA	CHEMICAL	GENE-Y	24	16	By identifying the pathway of chemical biosynthesis in mammals , this study not only functionally characterized gene but also assigned the function of the chemical-tRNA ( [ Ser ] Sec ) kinase .	T20	T35	17194211
NA	CHEMICAL	GENE-Y	24	7	By identifying the pathway of chemical biosynthesis in mammals , this study not only functionally characterized gene but also assigned the function of the chemical-tRNA ( [ Ser ] Sec ) kinase .	T20	T36	17194211
NA	CHEMICAL	GENE-Y	6	8	In addition , we found that chemical synthetase 2 could synthesize chemical in vitro but chemical synthetase 1 could not .	T21	T37	17194211
NA	CHEMICAL	GENE-Y	6	17	In addition , we found that chemical synthetase 2 could synthesize chemical in vitro but chemical synthetase 1 could not .	T21	T23	17194211
CPR:9	CHEMICAL	GENE-Y	6	8	In addition , we found that chemical synthetase 2 could synthesize chemical in vitro but chemical synthetase 1 could not .	T2	T37	17194211
NA	CHEMICAL	GENE-Y	6	17	In addition , we found that chemical synthetase 2 could synthesize chemical in vitro but chemical synthetase 1 could not .	T2	T23	17194211
NA	CHEMICAL	GENE-Y	15	8	In addition , we found that chemical synthetase 2 could synthesize chemical in vitro but chemical synthetase 1 could not .	T3	T37	17194211
NA	CHEMICAL	GENE-Y	15	17	In addition , we found that chemical synthetase 2 could synthesize chemical in vitro but chemical synthetase 1 could not .	T3	T23	17194211
NA	CHEMICAL	GENE-N	0	1	chemical receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to chemical .	T18	T41	8793745
NA	CHEMICAL	GENE-N	12	1	chemical receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to chemical .	T19	T41	8793745
NA	CHEMICAL	GENE-N	5	6	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T11	T40	8793745
NA	CHEMICAL	GENE-N	5	18	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T11	T33	8793745
NA	CHEMICAL	GENE-N	17	6	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T16	T40	8793745
NA	CHEMICAL	GENE-N	17	18	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T16	T33	8793745
NA	CHEMICAL	GENE-N	9	6	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T3	T40	8793745
NA	CHEMICAL	GENE-N	9	18	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T3	T33	8793745
NA	CHEMICAL	GENE-N	21	6	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T10	T40	8793745
NA	CHEMICAL	GENE-N	21	18	The kinetics of onset of chemical gene desensitization by chemical , and the extent of attenuation of chemical receptor desensitization by chemical , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons .	T10	T33	8793745
NA	CHEMICAL	GENE-N	19	20	The amplitudes of these components varied widely between cells , suggesting the existence of at least three populations of chemical receptor subtypes , the relative density of which varied from cell to cell .	T15	T39	8793745
NA	CHEMICAL	GENE-N	6	5	The complex patterns of sensitivity to chemical seen in hippocampal neurons could be reconstituted by assembly of recombinant chemical receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the gene and gene subunits .	T17	T20	8793745
NA	CHEMICAL	GENE-Y	6	39	The complex patterns of sensitivity to chemical seen in hippocampal neurons could be reconstituted by assembly of recombinant chemical receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the gene and gene subunits .	T17	T21	8793745
NA	CHEMICAL	GENE-Y	6	41	The complex patterns of sensitivity to chemical seen in hippocampal neurons could be reconstituted by assembly of recombinant chemical receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the gene and gene subunits .	T17	T22	8793745
NA	CHEMICAL	GENE-N	6	5	The complex patterns of sensitivity to chemical seen in hippocampal neurons could be reconstituted by assembly of recombinant chemical receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the gene and gene subunits .	T1	T20	8793745
NA	CHEMICAL	GENE-Y	6	39	The complex patterns of sensitivity to chemical seen in hippocampal neurons could be reconstituted by assembly of recombinant chemical receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the gene and gene subunits .	T1	T21	8793745
NA	CHEMICAL	GENE-Y	6	41	The complex patterns of sensitivity to chemical seen in hippocampal neurons could be reconstituted by assembly of recombinant chemical receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the gene and gene subunits .	T1	T22	8793745
NA	CHEMICAL	GENE-N	4	8	Recovery from modulation by chemical was slower for gene and gene than for gene and gene .	T2	T23	8793745
NA	CHEMICAL	GENE-N	4	10	Recovery from modulation by chemical was slower for gene and gene than for gene and gene .	T2	T24	8793745
NA	CHEMICAL	GENE-N	4	13	Recovery from modulation by chemical was slower for gene and gene than for gene and gene .	T2	T25	8793745
NA	CHEMICAL	GENE-N	4	15	Recovery from modulation by chemical was slower for gene and gene than for gene and gene .	T2	T26	8793745
NA	CHEMICAL	GENE-Y	20	9	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T4	T27	8793745
NA	CHEMICAL	GENE-Y	20	15	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T4	T28	8793745
NA	CHEMICAL	GENE-N	20	21	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T4	T29	8793745
NA	CHEMICAL	GENE-N	20	35	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T4	T30	8793745
NA	CHEMICAL	GENE-N	20	37	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T4	T31	8793745
NA	CHEMICAL	GENE-Y	20	48	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T4	T32	8793745
NA	CHEMICAL	GENE-Y	26	9	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T5	T27	8793745
NA	CHEMICAL	GENE-Y	26	15	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T5	T28	8793745
NA	CHEMICAL	GENE-N	26	21	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T5	T29	8793745
NA	CHEMICAL	GENE-N	26	35	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T5	T30	8793745
NA	CHEMICAL	GENE-N	26	37	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T5	T31	8793745
NA	CHEMICAL	GENE-Y	26	48	Coexpression of the flip and flop splice variants of gene , in the absence of gene , revealed that heteromeric chemical receptors with intermediate sensitivity to chemical , similar to responses observed for the combinations gene or gene , could be generated independently of the presence of the gene subunit .	T5	T32	8793745
NA	CHEMICAL	GENE-N	6	11	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T7	T34	8793745
NA	CHEMICAL	GENE-N	6	15	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T7	T35	8793745
NA	CHEMICAL	GENE-Y	6	20	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T7	T36	8793745
NA	CHEMICAL	GENE-Y	6	22	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T7	T37	8793745
NA	CHEMICAL	GENE-N	32	11	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T8	T34	8793745
NA	CHEMICAL	GENE-N	32	15	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T8	T35	8793745
NA	CHEMICAL	GENE-Y	32	20	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T8	T36	8793745
NA	CHEMICAL	GENE-Y	32	22	However , recovery from modulation by chemical was twofold slower for gene than for homomeric gene , indicating that the gene and gene subunits are not functionally equivalent in controlling sensitivity to chemical .	T8	T37	8793745
NA	CHEMICAL	GENE-N	2	11	There is a growing appreciation that the chemical ( chemical ) -gene ( gene ) signaling pathway is organized to form transduction units that function to deliver specific messages .	T5	T19	17088426
NA	CHEMICAL	GENE-N	2	13	There is a growing appreciation that the chemical ( chemical ) -gene ( gene ) signaling pathway is organized to form transduction units that function to deliver specific messages .	T5	T21	17088426
NA	CHEMICAL	GENE-N	9	11	There is a growing appreciation that the chemical ( chemical ) -gene ( gene ) signaling pathway is organized to form transduction units that function to deliver specific messages .	T9	T19	17088426
NA	CHEMICAL	GENE-N	9	13	There is a growing appreciation that the chemical ( chemical ) -gene ( gene ) signaling pathway is organized to form transduction units that function to deliver specific messages .	T9	T21	17088426
CPR:3	CHEMICAL	GENE-N	18	8	Such organization results in the local activation of gene subsets through the generation of confined intracellular gradients of chemical , but the mechanisms responsible for limiting the diffusion of chemical largely remain to be clarified .	T3	T14	17088426
NA	CHEMICAL	GENE-N	29	8	Such organization results in the local activation of gene subsets through the generation of confined intracellular gradients of chemical , but the mechanisms responsible for limiting the diffusion of chemical largely remain to be clarified .	T4	T14	17088426
NA	CHEMICAL	GENE-N	27	7	By using pharmacological and genetic manipulation of gene ( gene ) , we demonstrate that compartmentalized gene and gene are responsible for selectively modulating the concentration of chemical in individual subcellular compartments .	T10	T15	17088426
NA	CHEMICAL	GENE-N	27	9	By using pharmacological and genetic manipulation of gene ( gene ) , we demonstrate that compartmentalized gene and gene are responsible for selectively modulating the concentration of chemical in individual subcellular compartments .	T10	T16	17088426
CPR:9	CHEMICAL	GENE-Y	27	16	By using pharmacological and genetic manipulation of gene ( gene ) , we demonstrate that compartmentalized gene and gene are responsible for selectively modulating the concentration of chemical in individual subcellular compartments .	T10	T17	17088426
CPR:9	CHEMICAL	GENE-Y	27	18	By using pharmacological and genetic manipulation of gene ( gene ) , we demonstrate that compartmentalized gene and gene are responsible for selectively modulating the concentration of chemical in individual subcellular compartments .	T10	T18	17088426
CPR:3	CHEMICAL	GENE-Y	0	5	chemical induce the expression of gene via gene activation in human keratinocyte HaCaT cells .	T26	T43	17459764
CPR:3	CHEMICAL	GENE-Y	0	7	chemical induce the expression of gene via gene activation in human keratinocyte HaCaT cells .	T26	T44	17459764
NA	CHEMICAL	GENE-Y	8	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T6	T31	17459764
NA	CHEMICAL	GENE-Y	8	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T6	T32	17459764
NA	CHEMICAL	GENE-Y	10	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T7	T31	17459764
NA	CHEMICAL	GENE-Y	10	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T7	T32	17459764
NA	CHEMICAL	GENE-Y	13	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T8	T31	17459764
NA	CHEMICAL	GENE-Y	13	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T8	T32	17459764
NA	CHEMICAL	GENE-Y	12	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T9	T31	17459764
NA	CHEMICAL	GENE-Y	12	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T9	T32	17459764
NA	CHEMICAL	GENE-Y	17	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T10	T31	17459764
NA	CHEMICAL	GENE-Y	17	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T10	T32	17459764
NA	CHEMICAL	GENE-Y	20	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T11	T31	17459764
NA	CHEMICAL	GENE-Y	20	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T11	T32	17459764
NA	CHEMICAL	GENE-Y	12	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T12	T31	17459764
NA	CHEMICAL	GENE-Y	12	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T12	T32	17459764
NA	CHEMICAL	GENE-Y	12	12	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T13	T31	17459764
NA	CHEMICAL	GENE-Y	12	32	We examined in HaCaT keratinocyte cell line whether chemical ( chemical ) a chemical , chemical ( chemical ) a chemical , and chemical a chemical , modulate expression of gene ( gene ) , an enzyme pivotal to skin inflammation and reparation .	T13	T32	17459764
NA	CHEMICAL	GENE-Y	8	12	We demonstrate that only treatment of HaCaT with chemical and chemical or a gene ligand ( chemical ) , induced gene expression ( protein and mRNA ) .	T14	T33	17459764
CPR:3	CHEMICAL	GENE-Y	8	20	We demonstrate that only treatment of HaCaT with chemical and chemical or a gene ligand ( chemical ) , induced gene expression ( protein and mRNA ) .	T14	T34	17459764
NA	CHEMICAL	GENE-Y	10	12	We demonstrate that only treatment of HaCaT with chemical and chemical or a gene ligand ( chemical ) , induced gene expression ( protein and mRNA ) .	T15	T33	17459764
CPR:3	CHEMICAL	GENE-Y	10	20	We demonstrate that only treatment of HaCaT with chemical and chemical or a gene ligand ( chemical ) , induced gene expression ( protein and mRNA ) .	T15	T34	17459764
NA	CHEMICAL	GENE-Y	12	12	We demonstrate that only treatment of HaCaT with chemical and chemical or a gene ligand ( chemical ) , induced gene expression ( protein and mRNA ) .	T16	T33	17459764
CPR:3	CHEMICAL	GENE-Y	12	20	We demonstrate that only treatment of HaCaT with chemical and chemical or a gene ligand ( chemical ) , induced gene expression ( protein and mRNA ) .	T16	T34	17459764
CPR:3	CHEMICAL	GENE-N	9	3	Moreover stimulation of gene activity was increased by those chemical or chemical .	T17	T35	17459764
CPR:3	CHEMICAL	GENE-N	11	3	Moreover stimulation of gene activity was increased by those chemical or chemical .	T18	T35	17459764
CPR:6	CHEMICAL	GENE-Y	4	8	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T19	T36	17459764
NA	CHEMICAL	GENE-Y	4	13	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T19	T37	17459764
NA	CHEMICAL	GENE-N	4	19	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T19	T38	17459764
NA	CHEMICAL	GENE-Y	4	27	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T19	T39	17459764
NA	CHEMICAL	GENE-Y	4	31	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T19	T40	17459764
CPR:6	CHEMICAL	GENE-Y	6	8	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T20	T36	17459764
NA	CHEMICAL	GENE-Y	6	13	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T20	T37	17459764
NA	CHEMICAL	GENE-N	6	19	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T20	T38	17459764
NA	CHEMICAL	GENE-Y	6	27	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T20	T39	17459764
NA	CHEMICAL	GENE-Y	6	31	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T20	T40	17459764
NA	CHEMICAL	GENE-Y	22	8	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T21	T36	17459764
NA	CHEMICAL	GENE-Y	22	13	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T21	T37	17459764
NA	CHEMICAL	GENE-N	22	19	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T21	T38	17459764
NA	CHEMICAL	GENE-Y	22	27	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T21	T39	17459764
NA	CHEMICAL	GENE-Y	22	31	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T21	T40	17459764
NA	CHEMICAL	GENE-Y	24	8	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T22	T36	17459764
NA	CHEMICAL	GENE-Y	24	13	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T22	T37	17459764
NA	CHEMICAL	GENE-N	24	19	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T22	T38	17459764
NA	CHEMICAL	GENE-Y	24	27	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T22	T39	17459764
NA	CHEMICAL	GENE-Y	24	31	The inhibitory effects of chemical and chemical ( gene antagonists ) , on gene expression and on stimulation of gene activity by chemical and chemical suggest that gene is implicated in gene induction .	T22	T40	17459764
CPR:4	CHEMICAL	GENE-Y	5	2	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T23	T41	17459764
CPR:4	CHEMICAL	GENE-Y	5	11	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T23	T42	17459764
NA	CHEMICAL	GENE-N	5	25	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T23	T27	17459764
NA	CHEMICAL	GENE-Y	8	2	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T24	T41	17459764
NA	CHEMICAL	GENE-Y	8	11	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T24	T42	17459764
NA	CHEMICAL	GENE-N	8	25	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T24	T27	17459764
NA	CHEMICAL	GENE-Y	17	2	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T25	T41	17459764
NA	CHEMICAL	GENE-Y	17	11	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T25	T42	17459764
NA	CHEMICAL	GENE-N	17	25	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T25	T27	17459764
NA	CHEMICAL	GENE-Y	5	2	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T2	T41	17459764
NA	CHEMICAL	GENE-Y	5	11	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T2	T42	17459764
CPR:3	CHEMICAL	GENE-N	5	25	Finally , gene inhibitor methyl chemical blocked the chemical effects on gene induction , promoter activity and chemical mobilization suggesting involvement of chemical metabolites in gene activation .	T2	T27	17459764
CPR:3	CHEMICAL	GENE-Y	4	6	These findings demonstrate that chemical increased gene activity is necessary for the gene induction in HaCaT human keratinocyte cells .	T3	T28	17459764
CPR:3	CHEMICAL	GENE-Y	4	12	These findings demonstrate that chemical increased gene activity is necessary for the gene induction in HaCaT human keratinocyte cells .	T3	T29	17459764
NA	CHEMICAL	GENE-Y	9	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T6	T27	23333834
NA	CHEMICAL	GENE-Y	9	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T7	T27	23333834
NA	CHEMICAL	GENE-Y	11	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T8	T27	23333834
NA	CHEMICAL	GENE-Y	11	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T9	T27	23333834
NA	CHEMICAL	GENE-Y	14	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T10	T27	23333834
NA	CHEMICAL	GENE-Y	14	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T11	T27	23333834
NA	CHEMICAL	GENE-Y	23	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T12	T27	23333834
NA	CHEMICAL	GENE-Y	23	20	Out of the three putative sites ( i.e. , chemical70-chemical78 , chemical82-chemical96 , and chemical113-chemical122 ) available on OPG for gene binding , chemical113-chemical122 was used as a template for peptide synthesis .	T13	T27	23333834
NA	CHEMICAL	GENE-Y	2	29	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T1	T15	23333834
NA	CHEMICAL	GENE-Y	2	29	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T1	T16	23333834
CPR:4	CHEMICAL	GENE-Y	2	33	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T1	T17	23333834
CPR:4	CHEMICAL	GENE-Y	2	35	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T1	T19	23333834
NA	CHEMICAL	GENE-Y	12	29	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T2	T15	23333834
NA	CHEMICAL	GENE-Y	12	29	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T2	T16	23333834
CPR:4	CHEMICAL	GENE-Y	12	33	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T2	T17	23333834
CPR:4	CHEMICAL	GENE-Y	12	35	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T2	T19	23333834
NA	CHEMICAL	GENE-Y	15	29	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T3	T15	23333834
NA	CHEMICAL	GENE-Y	15	29	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T3	T16	23333834
CPR:4	CHEMICAL	GENE-Y	15	33	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T3	T17	23333834
CPR:4	CHEMICAL	GENE-Y	15	35	The peptide chemical ( YLEIEFSLKHR ) , obtained by direct substitution of chemical with a chemical residue in the template sequence , significantly ( p < 0.05 ) inhibited gene-gene binding , and gene induced gene activity and formation of multinucleated osteoclasts without any cytotoxicity .	T3	T19	23333834
NA	CHEMICAL	GENE-Y	4	14	Published literature on the chemical-chemical ( chemical ) pathway for penile erection and on gene inhibition using sildenafil as the model for pharmacologic gene inhibition are assessed .	T3	T17	12414329
NA	CHEMICAL	GENE-Y	4	23	Published literature on the chemical-chemical ( chemical ) pathway for penile erection and on gene inhibition using sildenafil as the model for pharmacologic gene inhibition are assessed .	T3	T18	12414329
NA	CHEMICAL	GENE-Y	2	14	Published literature on the chemical-chemical ( chemical ) pathway for penile erection and on gene inhibition using sildenafil as the model for pharmacologic gene inhibition are assessed .	T5	T17	12414329
NA	CHEMICAL	GENE-Y	2	23	Published literature on the chemical-chemical ( chemical ) pathway for penile erection and on gene inhibition using sildenafil as the model for pharmacologic gene inhibition are assessed .	T5	T18	12414329
NA	CHEMICAL	GENE-Y	6	14	Published literature on the chemical-chemical ( chemical ) pathway for penile erection and on gene inhibition using sildenafil as the model for pharmacologic gene inhibition are assessed .	T6	T17	12414329
NA	CHEMICAL	GENE-Y	6	23	Published literature on the chemical-chemical ( chemical ) pathway for penile erection and on gene inhibition using sildenafil as the model for pharmacologic gene inhibition are assessed .	T6	T18	12414329
CPR:9	CHEMICAL	GENE-Y	11	0	gene is the predominant gene in the corpus cavernosum , and chemical is its primary substrate .	T7	T19	12414329
CPR:9	CHEMICAL	GENE-N	11	4	gene is the predominant gene in the corpus cavernosum , and chemical is its primary substrate .	T7	T20	12414329
NA	CHEMICAL	GENE-Y	9	19	Therefore , in men with ED , elevation of chemical in corpus cavernosal tissue via selective inhibition of chemical-specific gene is a means of improving erectile function at minimal risk of adverse events .	T8	T22	12414329
CPR:4	CHEMICAL	GENE-Y	18	19	Therefore , in men with ED , elevation of chemical in corpus cavernosal tissue via selective inhibition of chemical-specific gene is a means of improving erectile function at minimal risk of adverse events .	T9	T22	12414329
CPR:4	CHEMICAL	GENE-Y	11	18	This approach is validated by the clinical efficacy and safety of chemical , the pioneering drug for selective gene inhibitor therapy for ED .	T10	T23	12414329
CPR:4	CHEMICAL	GENE-Y	0	5	chemical exhibits inhibitory potency against gene and a 10-fold lower dose-related inhibitory potency against rod outer segment gene , the predominant gene in the phototransduction cascade in rods .	T11	T25	12414329
CPR:4	CHEMICAL	GENE-N	0	17	chemical exhibits inhibitory potency against gene and a 10-fold lower dose-related inhibitory potency against rod outer segment gene , the predominant gene in the phototransduction cascade in rods .	T11	T26	12414329
CPR:4	CHEMICAL	GENE-N	0	21	chemical exhibits inhibitory potency against gene and a 10-fold lower dose-related inhibitory potency against rod outer segment gene , the predominant gene in the phototransduction cascade in rods .	T11	T12	12414329
CPR:4	CHEMICAL	GENE-N	2	11	As free chemical plasma concentrations approach concentrations sufficient to inhibit retinal gene , usually at higher therapeutic doses , transient , reversible visual adverse events can occur , albeit infrequently .	T2	T15	12414329
CPR:5	CHEMICAL	GENE-Y	3	7	Agonistic activity of chemical on activation of gene/gene pathway in the rat uterus during the estrous cycle .	T14	T27	23583603
CPR:3	CHEMICAL	GENE-N	3	7	Agonistic activity of chemical on activation of gene/gene pathway in the rat uterus during the estrous cycle .	T14	T28	23583603
NA	CHEMICAL	GENE-N	5	15	We examined the ability of chemical ( chemical ) to block uterine cell proliferation via gene/gene pathway in the uterus of the rat during the estrous cycle .	T6	T24	23583603
NA	CHEMICAL	GENE-N	5	15	We examined the ability of chemical ( chemical ) to block uterine cell proliferation via gene/gene pathway in the uterus of the rat during the estrous cycle .	T6	T15	23583603
NA	CHEMICAL	GENE-N	7	15	We examined the ability of chemical ( chemical ) to block uterine cell proliferation via gene/gene pathway in the uterus of the rat during the estrous cycle .	T9	T24	23583603
NA	CHEMICAL	GENE-N	7	15	We examined the ability of chemical ( chemical ) to block uterine cell proliferation via gene/gene pathway in the uterus of the rat during the estrous cycle .	T9	T15	23583603
CPR:4	CHEMICAL	GENE-Y	1	5	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T10	T18	23583603
CPR:4	CHEMICAL	GENE-Y	1	19	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T10	T19	23583603
NA	CHEMICAL	GENE-Y	1	9	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T10	T20	23583603
NA	CHEMICAL	GENE-Y	1	31	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T10	T21	23583603
NA	CHEMICAL	GENE-Y	1	41	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T10	T22	23583603
NA	CHEMICAL	GENE-Y	15	5	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T11	T18	23583603
NA	CHEMICAL	GENE-Y	15	19	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T11	T19	23583603
NA	CHEMICAL	GENE-Y	15	9	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T11	T20	23583603
NA	CHEMICAL	GENE-Y	15	31	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T11	T21	23583603
NA	CHEMICAL	GENE-Y	15	41	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T11	T22	23583603
NA	CHEMICAL	GENE-Y	9	5	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T12	T18	23583603
NA	CHEMICAL	GENE-Y	9	19	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T12	T19	23583603
NA	CHEMICAL	GENE-Y	9	9	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T12	T20	23583603
NA	CHEMICAL	GENE-Y	9	31	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T12	T21	23583603
NA	CHEMICAL	GENE-Y	9	41	Both chemical treatments , induced a significant decrease ( p < 0.01 ) in uterine chemical receptor alpha ( gene ) content , had no effect on uterine chemical receptor ( gene ) protein expression and caused marked nuclear localization of gene , in both luminal and glandular uterine epithelium , as compared to vehicle-treated animals .	T12	T22	23583603
CPR:3	CHEMICAL	GENE-N	5	8	Furthermore , we detected that chemical treatment induced gene ( gene ) Ser 9 phosphorylation , which correlates with gene nuclear localization .	T13	T23	23583603
CPR:3	CHEMICAL	GENE-Y	5	10	Furthermore , we detected that chemical treatment induced gene ( gene ) Ser 9 phosphorylation , which correlates with gene nuclear localization .	T13	T25	23583603
NA	CHEMICAL	GENE-Y	5	19	Furthermore , we detected that chemical treatment induced gene ( gene ) Ser 9 phosphorylation , which correlates with gene nuclear localization .	T13	T26	23583603
CPR:4	CHEMICAL	GENE-N	6	34	We observed that the administration of chemical at 08:00h on proestrus day produced a 15 % inhibition of luminal epithelial cell proliferation , reduced uterine wet weight by 21 % and caused reduction of gene phosphorylation at chemical 473 as compared to vehicle-treated animals , whereas chemical treatment at 00:00h on estrus day had no effect on these parameters .	T1	T16	23583603
NA	CHEMICAL	GENE-N	37	34	We observed that the administration of chemical at 08:00h on proestrus day produced a 15 % inhibition of luminal epithelial cell proliferation , reduced uterine wet weight by 21 % and caused reduction of gene phosphorylation at chemical 473 as compared to vehicle-treated animals , whereas chemical treatment at 00:00h on estrus day had no effect on these parameters .	T2	T16	23583603
NA	CHEMICAL	GENE-N	46	34	We observed that the administration of chemical at 08:00h on proestrus day produced a 15 % inhibition of luminal epithelial cell proliferation , reduced uterine wet weight by 21 % and caused reduction of gene phosphorylation at chemical 473 as compared to vehicle-treated animals , whereas chemical treatment at 00:00h on estrus day had no effect on these parameters .	T3	T16	23583603
NA	CHEMICAL	GENE-Y	1	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T19	T28	8797532
NA	CHEMICAL	GENE-Y	1	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T19	T29	8797532
NA	CHEMICAL	GENE-Y	3	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T16	T28	8797532
NA	CHEMICAL	GENE-Y	3	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T16	T29	8797532
NA	CHEMICAL	GENE-Y	8	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T17	T28	8797532
NA	CHEMICAL	GENE-Y	8	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T17	T29	8797532
NA	CHEMICAL	GENE-Y	8	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T18	T28	8797532
NA	CHEMICAL	GENE-Y	8	4	Striatal chemical , chemical transporter , and gene in chronic chemical users .	T18	T29	8797532
NA	CHEMICAL	GENE-Y	4	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T3	T20	8797532
NA	CHEMICAL	GENE-Y	4	21	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T3	T21	8797532
NA	CHEMICAL	GENE-Y	4	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T3	T22	8797532
NA	CHEMICAL	GENE-Y	4	27	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T3	T23	8797532
NA	CHEMICAL	GENE-Y	10	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T4	T20	8797532
NA	CHEMICAL	GENE-Y	10	21	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T4	T21	8797532
NA	CHEMICAL	GENE-Y	10	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T4	T22	8797532
NA	CHEMICAL	GENE-Y	10	27	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T4	T23	8797532
NA	CHEMICAL	GENE-Y	18	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T5	T20	8797532
NA	CHEMICAL	GENE-Y	18	21	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T5	T21	8797532
NA	CHEMICAL	GENE-Y	18	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T5	T22	8797532
NA	CHEMICAL	GENE-Y	18	27	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T5	T23	8797532
NA	CHEMICAL	GENE-Y	29	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T7	T20	8797532
NA	CHEMICAL	GENE-Y	29	21	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T7	T21	8797532
NA	CHEMICAL	GENE-Y	29	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T7	T22	8797532
NA	CHEMICAL	GENE-Y	29	27	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T7	T23	8797532
NA	CHEMICAL	GENE-Y	29	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T8	T20	8797532
NA	CHEMICAL	GENE-Y	29	21	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T8	T21	8797532
NA	CHEMICAL	GENE-Y	29	19	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T8	T22	8797532
NA	CHEMICAL	GENE-Y	29	27	We measured levels of chemical , as well as two chemical nerve terminal indices , namely , the chemical transporter ( gene ) and the gene ( gene ) in autopsied brain of 12 chronic chemical users .	T8	T23	8797532
NA	CHEMICAL	GENE-Y	19	1	Striatal gene protein ( -25 to -46 % ) and gene ( -17 to -22 % ) were reduced , whereas gene determined by chemical binding was normal .	T12	T24	8797532
NA	CHEMICAL	GENE-Y	19	10	Striatal gene protein ( -25 to -46 % ) and gene ( -17 to -22 % ) were reduced , whereas gene determined by chemical binding was normal .	T12	T25	8797532
NA	CHEMICAL	GENE-Y	19	21	Striatal gene protein ( -25 to -46 % ) and gene ( -17 to -22 % ) were reduced , whereas gene determined by chemical binding was normal .	T12	T26	8797532
CPR:4	CHEMICAL	GENE-Y	22	1	Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of chemical decreased chemical-induced maximal relaxation ( E ( max ) ) of chemical-contracted preparations in a concentration dependent fashion , indicating desensitization of the gene .	T2	T20	16324695
CPR:5	CHEMICAL	GENE-Y	24	1	Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of chemical decreased chemical-induced maximal relaxation ( E ( max ) ) of chemical-contracted preparations in a concentration dependent fashion , indicating desensitization of the gene .	T7	T20	16324695
NA	CHEMICAL	GENE-Y	34	1	Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of chemical decreased chemical-induced maximal relaxation ( E ( max ) ) of chemical-contracted preparations in a concentration dependent fashion , indicating desensitization of the gene .	T8	T20	16324695
CPR:3	CHEMICAL	GENE-N	2	6	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T9	T21	16324695
CPR:3	CHEMICAL	GENE-N	2	8	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T9	T22	16324695
CPR:3	CHEMICAL	GENE-N	2	30	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T9	T23	16324695
CPR:4	CHEMICAL	GENE-Y	2	7	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T9	T24	16324695
CPR:3	CHEMICAL	GENE-N	13	6	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T10	T21	16324695
CPR:3	CHEMICAL	GENE-N	13	8	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T10	T22	16324695
CPR:3	CHEMICAL	GENE-N	13	30	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T10	T23	16324695
CPR:4	CHEMICAL	GENE-Y	13	7	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T10	T24	16324695
NA	CHEMICAL	GENE-N	16	6	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T11	T21	16324695
NA	CHEMICAL	GENE-N	16	8	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T11	T22	16324695
NA	CHEMICAL	GENE-N	16	30	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T11	T23	16324695
CPR:5	CHEMICAL	GENE-Y	16	7	Preincubation with 1 microM of the gene ( gene ) activator chemical ( chemical ) caused a small but significant decrease in chemical-induced E ( max ) , indicating activated gene-mediated heterologous gene desensitization .	T11	T24	16324695
NA	CHEMICAL	GENE-N	29	6	To investigate the capacity of activated gene to regulate homologous desensitization , we incubated the smooth muscle strips with the combination of both 1 microM PMA and 1 microM chemical .	T12	T25	16324695
CPR:4	CHEMICAL	GENE-N	4	4	Moreover , the specific gene-inhibitor chemical ( chemical ) markedly increased the potency and E ( max ) of chemical for all conditions used , including control conditions , and the synergistic effects of chemical and chemical were completely prevented .	T1	T16	16324695
CPR:4	CHEMICAL	GENE-N	7	4	Moreover , the specific gene-inhibitor chemical ( chemical ) markedly increased the potency and E ( max ) of chemical for all conditions used , including control conditions , and the synergistic effects of chemical and chemical were completely prevented .	T3	T16	16324695
NA	CHEMICAL	GENE-N	19	4	Moreover , the specific gene-inhibitor chemical ( chemical ) markedly increased the potency and E ( max ) of chemical for all conditions used , including control conditions , and the synergistic effects of chemical and chemical were completely prevented .	T4	T16	16324695
NA	CHEMICAL	GENE-N	34	4	Moreover , the specific gene-inhibitor chemical ( chemical ) markedly increased the potency and E ( max ) of chemical for all conditions used , including control conditions , and the synergistic effects of chemical and chemical were completely prevented .	T5	T16	16324695
NA	CHEMICAL	GENE-N	36	4	Moreover , the specific gene-inhibitor chemical ( chemical ) markedly increased the potency and E ( max ) of chemical for all conditions used , including control conditions , and the synergistic effects of chemical and chemical were completely prevented .	T6	T16	16324695
NA	CHEMICAL	GENE-N	3	2	Tethered dimers as chemical synthetase inhibitors with antibacterial activity .	T6	T11	12852767
NA	CHEMICAL	GENE-N	3	4	Effective inhibitors of chemical synthetase also inhibited the growth of Gram-positive ( but not Gram-negative ) bacteria , including antibiotic-resistant strains .	T2	T8	12852767
NA	CHEMICAL	GENE-Y	10	12	Drug-protein interactions : isolation and characterization of covalent adducts of chemical and gene .	T12	T22	3994963
NA	CHEMICAL	GENE-Y	0	6	chemical , an alpha-adrenergic antagonist containing a chemical group , labels gene in the presence of chemical .	T1	T21	3994963
NA	CHEMICAL	GENE-Y	6	6	chemical , an alpha-adrenergic antagonist containing a chemical group , labels gene in the presence of chemical .	T7	T21	3994963
NA	CHEMICAL	GENE-Y	6	6	chemical , an alpha-adrenergic antagonist containing a chemical group , labels gene in the presence of chemical .	T2	T21	3994963
NA	CHEMICAL	GENE-Y	4	2	Adducts of gene and chemical were separated by high-performance liquid chromatography into four major fractions : two containing 0.6 and 1.2 mol of drug per mol of protein and two different fractions each containing 2.0 mol/mol .	T4	T16	3994963
NA	CHEMICAL	GENE-N	8	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T5	T17	3994963
NA	CHEMICAL	GENE-Y	8	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T5	T18	3994963
NA	CHEMICAL	GENE-Y	8	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T5	T19	3994963
NA	CHEMICAL	GENE-N	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T6	T17	3994963
NA	CHEMICAL	GENE-Y	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T6	T18	3994963
NA	CHEMICAL	GENE-Y	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T6	T19	3994963
NA	CHEMICAL	GENE-N	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T8	T17	3994963
NA	CHEMICAL	GENE-Y	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T8	T18	3994963
NA	CHEMICAL	GENE-Y	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T8	T19	3994963
NA	CHEMICAL	GENE-N	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T9	T17	3994963
NA	CHEMICAL	GENE-Y	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T9	T18	3994963
NA	CHEMICAL	GENE-Y	3	3	Each adduct had a reduced ability to activate chemical phosphodiesterase and gene , and the chemical binding capacities of the chemical-gene adducts were diminished to the extent of chemical incorporation into each adduct .	T9	T19	3994963
NA	CHEMICAL	GENE-Y	7	8	Isolation and characterization of labeled peptides from chemical-modified gene indicated that peptides encompassing residues 38-75 , 107-126 , and 127-148 contained chemical label .	T10	T20	3994963
NA	CHEMICAL	GENE-Y	21	8	Isolation and characterization of labeled peptides from chemical-modified gene indicated that peptides encompassing residues 38-75 , 107-126 , and 127-148 contained chemical label .	T11	T20	3994963
CPR:9	CHEMICAL	GENE-N	2	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T20	T54	12167474
NA	CHEMICAL	GENE-N	6	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T21	T54	12167474
CPR:9	CHEMICAL	GENE-N	9	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T22	T54	12167474
CPR:9	CHEMICAL	GENE-N	11	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T23	T54	12167474
CPR:9	CHEMICAL	GENE-N	15	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T24	T54	12167474
CPR:9	CHEMICAL	GENE-N	18	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T25	T54	12167474
CPR:9	CHEMICAL	GENE-N	20	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T26	T54	12167474
CPR:9	CHEMICAL	GENE-N	25	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T28	T54	12167474
NA	CHEMICAL	GENE-N	30	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T29	T54	12167474
NA	CHEMICAL	GENE-N	33	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T30	T54	12167474
NA	CHEMICAL	GENE-N	33	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T31	T54	12167474
NA	CHEMICAL	GENE-N	42	7	Most halogenated chemical are metabolized by chemical gene to chemical , chemical , and an chemical ( with chemical ) or an chemical ( with chemical ) that may eliminate chemical to give a chemical , which reacts with chemical groups of chemical residues in proteins .	T32	T54	12167474
NA	CHEMICAL	GENE-N	2	10	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T34	T37	12167474
NA	CHEMICAL	GENE-Y	2	14	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T34	T38	12167474
NA	CHEMICAL	GENE-Y	2	16	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T34	T39	12167474
NA	CHEMICAL	GENE-Y	2	20	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T34	T40	12167474
NA	CHEMICAL	GENE-Y	2	3	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T34	T41	12167474
NA	CHEMICAL	GENE-N	4	10	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T35	T37	12167474
NA	CHEMICAL	GENE-Y	4	14	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T35	T38	12167474
NA	CHEMICAL	GENE-Y	4	16	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T35	T39	12167474
NA	CHEMICAL	GENE-Y	4	20	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T35	T40	12167474
NA	CHEMICAL	GENE-Y	4	3	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T35	T41	12167474
NA	CHEMICAL	GENE-N	9	10	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T1	T37	12167474
NA	CHEMICAL	GENE-Y	9	14	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T1	T38	12167474
NA	CHEMICAL	GENE-Y	9	16	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T1	T39	12167474
NA	CHEMICAL	GENE-Y	9	20	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T1	T40	12167474
NA	CHEMICAL	GENE-Y	9	3	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T1	T41	12167474
NA	CHEMICAL	GENE-N	2	10	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T3	T37	12167474
NA	CHEMICAL	GENE-Y	2	14	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T3	T38	12167474
NA	CHEMICAL	GENE-Y	2	16	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T3	T39	12167474
NA	CHEMICAL	GENE-Y	2	20	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T3	T40	12167474
NA	CHEMICAL	GENE-Y	2	3	Nine mammalian chemical ( chemical ) -containing enzymes catalyze chemical gene reactions , including gene ( gene ) , and gene ( gene ) .	T3	T41	12167474
NA	CHEMICAL	GENE-N	3	4	Most of the chemical gene are syncatalytically inactivated .	T5	T42	12167474
NA	CHEMICAL	GENE-N	3	7	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T7	T43	12167474
NA	CHEMICAL	GENE-N	3	9	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T7	T44	12167474
NA	CHEMICAL	GENE-N	3	11	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T7	T45	12167474
NA	CHEMICAL	GENE-N	3	19	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T7	T46	12167474
NA	CHEMICAL	GENE-N	3	21	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T7	T47	12167474
NA	CHEMICAL	GENE-N	5	7	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T8	T43	12167474
NA	CHEMICAL	GENE-N	5	9	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T8	T44	12167474
NA	CHEMICAL	GENE-N	5	11	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T8	T45	12167474
NA	CHEMICAL	GENE-N	5	19	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T8	T46	12167474
NA	CHEMICAL	GENE-N	5	21	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T8	T47	12167474
NA	CHEMICAL	GENE-N	17	7	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T9	T43	12167474
NA	CHEMICAL	GENE-N	17	9	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T9	T44	12167474
NA	CHEMICAL	GENE-N	17	11	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T9	T45	12167474
NA	CHEMICAL	GENE-N	17	19	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T9	T46	12167474
NA	CHEMICAL	GENE-N	17	21	Interestingly , the chemical- and chemical dehydrogenase complexes ( gene and gene ) , but not the chemical dehydrogenase complex ( gene ) , are susceptible to inactivation .	T9	T47	12167474
NA	CHEMICAL	GENE-Y	0	2	chemical AT1 receptor antagonist chemical and the defence reaction in the anaesthetised rat .	T5	T13	12719755
CPR:6	CHEMICAL	GENE-Y	4	2	chemical AT1 receptor antagonist chemical and the defence reaction in the anaesthetised rat .	T6	T13	12719755
NA	CHEMICAL	GENE-Y	0	5	chemical acting on chemical AT1 receptors at the central nervous system appears to have an important role in these modulatory processes .	T1	T8	12719755
NA	CHEMICAL	GENE-Y	3	5	chemical acting on chemical AT1 receptors at the central nervous system appears to have an important role in these modulatory processes .	T2	T8	12719755
CPR:4	CHEMICAL	GENE-Y	26	5	We investigated the effect of gene blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent chemical .	T4	T10	12719755
CPR:4	CHEMICAL	GENE-Y	0	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T3	T13	23386029
CPR:4	CHEMICAL	GENE-Y	0	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T3	T14	23386029
NA	CHEMICAL	GENE-Y	10	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T4	T13	23386029
NA	CHEMICAL	GENE-Y	10	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T4	T14	23386029
NA	CHEMICAL	GENE-Y	12	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T5	T13	23386029
NA	CHEMICAL	GENE-Y	12	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T5	T14	23386029
NA	CHEMICAL	GENE-Y	15	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T6	T13	23386029
NA	CHEMICAL	GENE-Y	15	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T6	T14	23386029
NA	CHEMICAL	GENE-Y	17	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T7	T13	23386029
NA	CHEMICAL	GENE-Y	17	2	chemical ( 1 ) reduced the pro-inflammatory factor such as chemical ( chemical ) , chemical ( chemical ) and gene ( gene ) .	T7	T14	23386029
CPR:5	CHEMICAL	GENE-Y	3	8	The atypical antidepressant chemical exhibits agonist activity at gene .	T24	T43	22708686
CPR:5	CHEMICAL	GENE-N	4	11	We previously reported that chemical antidepressants act as agonists at distinct gene .	T11	T36	22708686
NA	CHEMICAL	GENE-N	10	15	Here , we investigated the effect of the atypical antidepressant chemical at cloned and native gene .	T14	T37	22708686
NA	CHEMICAL	GENE-N	5	13	EXPERIMENTAL APPROACH : Effects of chemical were examined in CHO cells transfected with gene , C6 glioma cells and rat brain membranes by the use of radioligand binding and functional assays including the stimulation of chemical binding and gene phosphorylation .	T15	T38	22708686
NA	CHEMICAL	GENE-N	5	38	EXPERIMENTAL APPROACH : Effects of chemical were examined in CHO cells transfected with gene , C6 glioma cells and rat brain membranes by the use of radioligand binding and functional assays including the stimulation of chemical binding and gene phosphorylation .	T15	T39	22708686
NA	CHEMICAL	GENE-N	35	13	EXPERIMENTAL APPROACH : Effects of chemical were examined in CHO cells transfected with gene , C6 glioma cells and rat brain membranes by the use of radioligand binding and functional assays including the stimulation of chemical binding and gene phosphorylation .	T16	T38	22708686
NA	CHEMICAL	GENE-N	35	38	EXPERIMENTAL APPROACH : Effects of chemical were examined in CHO cells transfected with gene , C6 glioma cells and rat brain membranes by the use of radioligand binding and functional assays including the stimulation of chemical binding and gene phosphorylation .	T16	T39	22708686
NA	CHEMICAL	GENE-N	3	11	KEY RESULTS : chemical displayed 12- and 18-fold higher affinity for gene respectively .	T17	T40	22708686
NA	CHEMICAL	GENE-Y	1	7	In chemical assays , chemical selectively activated gene .	T18	T41	22708686
CPR:3	CHEMICAL	GENE-Y	4	7	In chemical assays , chemical selectively activated gene .	T19	T41	22708686
CPR:6	CHEMICAL	GENE-Y	10	8	The agonist activity was antagonized by the selective gene blocker chemical ( chemical ) .	T20	T42	22708686
CPR:6	CHEMICAL	GENE-Y	12	8	The agonist activity was antagonized by the selective gene blocker chemical ( chemical ) .	T21	T42	22708686
CPR:5	CHEMICAL	GENE-Y	1	6	The chemical analogue chemical also displayed gene agonist activity .	T22	T25	22708686
CPR:5	CHEMICAL	GENE-Y	3	6	The chemical analogue chemical also displayed gene agonist activity .	T23	T25	22708686
NA	CHEMICAL	GENE-N	0	4	chemical and chemical increased gene phosphorylation in CHO cells expressing gene and C6 cells , and these effects were antagonized by chemical .	T1	T26	22708686
NA	CHEMICAL	GENE-Y	0	10	chemical and chemical increased gene phosphorylation in CHO cells expressing gene and C6 cells , and these effects were antagonized by chemical .	T1	T27	22708686
NA	CHEMICAL	GENE-N	2	4	chemical and chemical increased gene phosphorylation in CHO cells expressing gene and C6 cells , and these effects were antagonized by chemical .	T2	T26	22708686
NA	CHEMICAL	GENE-Y	2	10	chemical and chemical increased gene phosphorylation in CHO cells expressing gene and C6 cells , and these effects were antagonized by chemical .	T2	T27	22708686
NA	CHEMICAL	GENE-N	21	4	chemical and chemical increased gene phosphorylation in CHO cells expressing gene and C6 cells , and these effects were antagonized by chemical .	T3	T26	22708686
NA	CHEMICAL	GENE-Y	21	10	chemical and chemical increased gene phosphorylation in CHO cells expressing gene and C6 cells , and these effects were antagonized by chemical .	T3	T27	22708686
NA	CHEMICAL	GENE-Y	7	39	Fluorescence of the reporter dye is turned on by rapid removal of the chemical quencher , an event that immediately occurs only after highly selective , two-electron reduction of the sterically and conformationally restricted chemical substrate by the cancer-associated gene ( gene ) .	T5	T6	23198810
NA	CHEMICAL	GENE-Y	7	41	Fluorescence of the reporter dye is turned on by rapid removal of the chemical quencher , an event that immediately occurs only after highly selective , two-electron reduction of the sterically and conformationally restricted chemical substrate by the cancer-associated gene ( gene ) .	T5	T7	23198810
CPR:9	CHEMICAL	GENE-Y	7	39	Fluorescence of the reporter dye is turned on by rapid removal of the chemical quencher , an event that immediately occurs only after highly selective , two-electron reduction of the sterically and conformationally restricted chemical substrate by the cancer-associated gene ( gene ) .	T1	T6	23198810
CPR:9	CHEMICAL	GENE-Y	7	41	Fluorescence of the reporter dye is turned on by rapid removal of the chemical quencher , an event that immediately occurs only after highly selective , two-electron reduction of the sterically and conformationally restricted chemical substrate by the cancer-associated gene ( gene ) .	T1	T7	23198810
NA	CHEMICAL	GENE-Y	7	39	Fluorescence of the reporter dye is turned on by rapid removal of the chemical quencher , an event that immediately occurs only after highly selective , two-electron reduction of the sterically and conformationally restricted chemical substrate by the cancer-associated gene ( gene ) .	T2	T6	23198810
NA	CHEMICAL	GENE-Y	7	41	Fluorescence of the reporter dye is turned on by rapid removal of the chemical quencher , an event that immediately occurs only after highly selective , two-electron reduction of the sterically and conformationally restricted chemical substrate by the cancer-associated gene ( gene ) .	T2	T7	23198810
NA	CHEMICAL	GENE-Y	0	5	chemical and chemical inhibit endothelin gene by an allosteric type of mechanism .	T17	T37	10727528
NA	CHEMICAL	GENE-Y	2	5	chemical and chemical inhibit endothelin gene by an allosteric type of mechanism .	T18	T37	10727528
NA	CHEMICAL	GENE-N	4	17	This study shows that chemical and chemical , its major blood metabolite , reverse contractile actions of gene ( gene ) in isolated rat aorta and human mammary arteries .	T4	T23	10727528
NA	CHEMICAL	GENE-N	4	19	This study shows that chemical and chemical , its major blood metabolite , reverse contractile actions of gene ( gene ) in isolated rat aorta and human mammary arteries .	T4	T24	10727528
NA	CHEMICAL	GENE-N	6	17	This study shows that chemical and chemical , its major blood metabolite , reverse contractile actions of gene ( gene ) in isolated rat aorta and human mammary arteries .	T5	T23	10727528
NA	CHEMICAL	GENE-N	6	19	This study shows that chemical and chemical , its major blood metabolite , reverse contractile actions of gene ( gene ) in isolated rat aorta and human mammary arteries .	T5	T24	10727528
NA	CHEMICAL	GENE-Y	5	9	They also prevent the intracellular chemical mobilizing action of gene in cultured endothelial cells but not those of gene or UTP .	T6	T25	10727528
NA	CHEMICAL	GENE-Y	5	18	They also prevent the intracellular chemical mobilizing action of gene in cultured endothelial cells but not those of gene or UTP .	T6	T26	10727528
CPR:4	CHEMICAL	GENE-Y	7	5	Inhibition of the actions of gene by chemical is apparently competitive .	T7	T27	10727528
NA	CHEMICAL	GENE-Y	0	2	chemical inhibit chemical-gene binding to recombinant gene .	T8	T28	10727528
NA	CHEMICAL	GENE-Y	0	4	chemical inhibit chemical-gene binding to recombinant gene .	T8	T29	10727528
NA	CHEMICAL	GENE-Y	2	2	chemical inhibit chemical-gene binding to recombinant gene .	T9	T28	10727528
NA	CHEMICAL	GENE-Y	2	4	chemical inhibit chemical-gene binding to recombinant gene .	T9	T29	10727528
NA	CHEMICAL	GENE-Y	0	4	chemical promotes dissociation of chemical-gene gene complexes both in the absence and the presence of unlabeled gene .	T10	T30	10727528
NA	CHEMICAL	GENE-Y	0	5	chemical promotes dissociation of chemical-gene gene complexes both in the absence and the presence of unlabeled gene .	T10	T31	10727528
NA	CHEMICAL	GENE-Y	0	16	chemical promotes dissociation of chemical-gene gene complexes both in the absence and the presence of unlabeled gene .	T10	T32	10727528
NA	CHEMICAL	GENE-Y	4	4	chemical promotes dissociation of chemical-gene gene complexes both in the absence and the presence of unlabeled gene .	T11	T30	10727528
NA	CHEMICAL	GENE-Y	4	5	chemical promotes dissociation of chemical-gene gene complexes both in the absence and the presence of unlabeled gene .	T11	T31	10727528
NA	CHEMICAL	GENE-Y	4	16	chemical promotes dissociation of chemical-gene gene complexes both in the absence and the presence of unlabeled gene .	T11	T32	10727528
NA	CHEMICAL	GENE-Y	10	10	It has no influence on the rate of association of chemical-gene to gene .	T12	T33	10727528
NA	CHEMICAL	GENE-Y	10	11	It has no influence on the rate of association of chemical-gene to gene .	T12	T34	10727528
NA	CHEMICAL	GENE-Y	0	6	chemical do not promote dissociation of chemical-gene gene complexes .	T13	T35	10727528
NA	CHEMICAL	GENE-Y	0	7	chemical do not promote dissociation of chemical-gene gene complexes .	T13	T36	10727528
NA	CHEMICAL	GENE-Y	6	6	chemical do not promote dissociation of chemical-gene gene complexes .	T14	T35	10727528
NA	CHEMICAL	GENE-Y	6	7	chemical do not promote dissociation of chemical-gene gene complexes .	T14	T36	10727528
NA	CHEMICAL	GENE-Y	4	9	It is concluded that chemical are allosteric inhibitors of gene .	T2	T19	10727528
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene-induced reactive chemical species accumulation and myofibroblast differentiation via enhanced gene-gene signaling .	T24	T53	23284002
CPR:3	CHEMICAL	GENE-Y	0	12	chemical inhibits gene-induced reactive chemical species accumulation and myofibroblast differentiation via enhanced gene-gene signaling .	T24	T51	23284002
CPR:3	CHEMICAL	GENE-N	0	12	chemical inhibits gene-induced reactive chemical species accumulation and myofibroblast differentiation via enhanced gene-gene signaling .	T24	T52	23284002
NA	CHEMICAL	GENE-Y	4	2	chemical inhibits gene-induced reactive chemical species accumulation and myofibroblast differentiation via enhanced gene-gene signaling .	T25	T53	23284002
NA	CHEMICAL	GENE-Y	4	12	chemical inhibits gene-induced reactive chemical species accumulation and myofibroblast differentiation via enhanced gene-gene signaling .	T25	T51	23284002
NA	CHEMICAL	GENE-N	4	12	chemical inhibits gene-induced reactive chemical species accumulation and myofibroblast differentiation via enhanced gene-gene signaling .	T25	T52	23284002
NA	CHEMICAL	GENE-Y	10	19	The present study aimed at investigating the role of reactive chemical species ( ROS ) scavenging by chemical on gene ( gene-induced myofibroblast differentiation of corneal fibroblasts in vitro .	T8	T34	23284002
NA	CHEMICAL	GENE-Y	10	14	The present study aimed at investigating the role of reactive chemical species ( ROS ) scavenging by chemical on gene ( gene-induced myofibroblast differentiation of corneal fibroblasts in vitro .	T8	T35	23284002
NA	CHEMICAL	GENE-Y	17	19	The present study aimed at investigating the role of reactive chemical species ( ROS ) scavenging by chemical on gene ( gene-induced myofibroblast differentiation of corneal fibroblasts in vitro .	T12	T34	23284002
NA	CHEMICAL	GENE-Y	17	14	The present study aimed at investigating the role of reactive chemical species ( ROS ) scavenging by chemical on gene ( gene-induced myofibroblast differentiation of corneal fibroblasts in vitro .	T12	T35	23284002
NA	CHEMICAL	GENE-Y	12	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T13	T36	23284002
NA	CHEMICAL	GENE-N	12	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T13	T37	23284002
NA	CHEMICAL	GENE-Y	12	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T13	T38	23284002
NA	CHEMICAL	GENE-N	12	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T13	T39	23284002
NA	CHEMICAL	GENE-Y	12	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T13	T40	23284002
NA	CHEMICAL	GENE-N	12	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T13	T41	23284002
NA	CHEMICAL	GENE-Y	15	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T14	T36	23284002
NA	CHEMICAL	GENE-N	15	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T14	T37	23284002
NA	CHEMICAL	GENE-Y	15	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T14	T38	23284002
NA	CHEMICAL	GENE-N	15	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T14	T39	23284002
NA	CHEMICAL	GENE-Y	15	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T14	T40	23284002
NA	CHEMICAL	GENE-N	15	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T14	T41	23284002
NA	CHEMICAL	GENE-Y	18	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T15	T36	23284002
CPR:4	CHEMICAL	GENE-N	18	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T15	T37	23284002
NA	CHEMICAL	GENE-Y	18	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T15	T38	23284002
NA	CHEMICAL	GENE-N	18	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T15	T39	23284002
NA	CHEMICAL	GENE-Y	18	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T15	T40	23284002
NA	CHEMICAL	GENE-N	18	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T15	T41	23284002
NA	CHEMICAL	GENE-Y	20	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T16	T36	23284002
CPR:4	CHEMICAL	GENE-N	20	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T16	T37	23284002
NA	CHEMICAL	GENE-Y	20	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T16	T38	23284002
NA	CHEMICAL	GENE-N	20	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T16	T39	23284002
NA	CHEMICAL	GENE-Y	20	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T16	T40	23284002
NA	CHEMICAL	GENE-N	20	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T16	T41	23284002
NA	CHEMICAL	GENE-Y	8	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T17	T36	23284002
NA	CHEMICAL	GENE-N	8	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T17	T37	23284002
NA	CHEMICAL	GENE-Y	8	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T17	T38	23284002
NA	CHEMICAL	GENE-N	8	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T17	T39	23284002
NA	CHEMICAL	GENE-Y	8	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T17	T40	23284002
NA	CHEMICAL	GENE-N	8	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T17	T41	23284002
NA	CHEMICAL	GENE-Y	27	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T18	T36	23284002
NA	CHEMICAL	GENE-N	27	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T18	T37	23284002
NA	CHEMICAL	GENE-Y	27	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T18	T38	23284002
NA	CHEMICAL	GENE-N	27	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T18	T39	23284002
NA	CHEMICAL	GENE-Y	27	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T18	T40	23284002
NA	CHEMICAL	GENE-N	27	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T18	T41	23284002
NA	CHEMICAL	GENE-Y	36	7	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T19	T36	23284002
NA	CHEMICAL	GENE-N	36	16	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T19	T37	23284002
CPR:3	CHEMICAL	GENE-Y	36	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T19	T38	23284002
CPR:3	CHEMICAL	GENE-N	36	31	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T19	T39	23284002
CPR:3	CHEMICAL	GENE-Y	36	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T19	T40	23284002
CPR:3	CHEMICAL	GENE-N	36	33	Human immortalized corneal fibroblasts were treated with gene in the presence of chemical , the chemical oxidase inhibitor chemical ( chemical ) , the antioxidant chemical ( chemical ) , the gene-gene ( gene-gene ) activator chemical , or small interfering RNA .	T19	T41	23284002
NA	CHEMICAL	GENE-Y	2	20	ROS , chemical , intracellular chemical ( chemical ) level , cellular total antioxidant capacity , and the activation of gene-gene signaling were determined with various assays .	T20	T46	23284002
NA	CHEMICAL	GENE-N	2	20	ROS , chemical , intracellular chemical ( chemical ) level , cellular total antioxidant capacity , and the activation of gene-gene signaling were determined with various assays .	T20	T47	23284002
NA	CHEMICAL	GENE-Y	5	20	ROS , chemical , intracellular chemical ( chemical ) level , cellular total antioxidant capacity , and the activation of gene-gene signaling were determined with various assays .	T21	T46	23284002
NA	CHEMICAL	GENE-N	5	20	ROS , chemical , intracellular chemical ( chemical ) level , cellular total antioxidant capacity , and the activation of gene-gene signaling were determined with various assays .	T21	T47	23284002
NA	CHEMICAL	GENE-Y	7	20	ROS , chemical , intracellular chemical ( chemical ) level , cellular total antioxidant capacity , and the activation of gene-gene signaling were determined with various assays .	T22	T46	23284002
NA	CHEMICAL	GENE-N	7	20	ROS , chemical , intracellular chemical ( chemical ) level , cellular total antioxidant capacity , and the activation of gene-gene signaling were determined with various assays .	T22	T47	23284002
NA	CHEMICAL	GENE-Y	2	5	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T23	T48	23284002
NA	CHEMICAL	GENE-N	2	5	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T23	T49	23284002
CPR:4	CHEMICAL	GENE-Y	2	13	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T23	T50	23284002
NA	CHEMICAL	GENE-Y	2	5	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T2	T48	23284002
NA	CHEMICAL	GENE-N	2	5	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T2	T49	23284002
NA	CHEMICAL	GENE-Y	2	13	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T2	T50	23284002
NA	CHEMICAL	GENE-Y	23	5	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T3	T48	23284002
NA	CHEMICAL	GENE-N	23	5	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T3	T49	23284002
NA	CHEMICAL	GENE-Y	23	13	Treatment with chemical and the gene-gene activator resulted in increased inhibition of the gene-induced myofibroblast differentiation as compared with treatment with chemical or chemical .	T3	T50	23284002
CPR:4	CHEMICAL	GENE-Y	2	12	Furthermore , chemical also decreased cellular ROS and chemical accumulation induced by gene , whereas it elevated intracellular chemical level and cellular total antioxidant capacity .	T4	T26	23284002
NA	CHEMICAL	GENE-Y	8	12	Furthermore , chemical also decreased cellular ROS and chemical accumulation induced by gene , whereas it elevated intracellular chemical level and cellular total antioxidant capacity .	T5	T26	23284002
NA	CHEMICAL	GENE-Y	18	12	Furthermore , chemical also decreased cellular ROS and chemical accumulation induced by gene , whereas it elevated intracellular chemical level and cellular total antioxidant capacity .	T6	T26	23284002
NA	CHEMICAL	GENE-Y	3	5	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T7	T27	23284002
CPR:3	CHEMICAL	GENE-Y	3	13	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T7	T28	23284002
CPR:3	CHEMICAL	GENE-N	3	13	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T7	T29	23284002
NA	CHEMICAL	GENE-Y	3	19	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T7	T30	23284002
NA	CHEMICAL	GENE-Y	28	5	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T9	T27	23284002
NA	CHEMICAL	GENE-Y	28	13	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T9	T28	23284002
NA	CHEMICAL	GENE-N	28	13	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T9	T29	23284002
NA	CHEMICAL	GENE-Y	28	19	In addition , chemical induced gene nuclear translocation and up-regulated the expression of gene-gene downstream antioxidant genes , whereas gene knockdown by RNA interference blocked the inhibition of chemical on myofibroblast differentiation .	T9	T30	23284002
NA	CHEMICAL	GENE-Y	10	10	Our results showed that bone remodeling was significantly decreased in gene ( -/- ) and gene ( -/- ) mice and in animals treated with chemical-RANTES ( an antagonist of gene and gene ) .	T2	T24	23059626
NA	CHEMICAL	GENE-Y	10	15	Our results showed that bone remodeling was significantly decreased in gene ( -/- ) and gene ( -/- ) mice and in animals treated with chemical-RANTES ( an antagonist of gene and gene ) .	T2	T25	23059626
CPR:6	CHEMICAL	GENE-Y	10	30	Our results showed that bone remodeling was significantly decreased in gene ( -/- ) and gene ( -/- ) mice and in animals treated with chemical-RANTES ( an antagonist of gene and gene ) .	T2	T26	23059626
CPR:6	CHEMICAL	GENE-Y	10	32	Our results showed that bone remodeling was significantly decreased in gene ( -/- ) and gene ( -/- ) mice and in animals treated with chemical-RANTES ( an antagonist of gene and gene ) .	T2	T27	23059626
CPR:4	CHEMICAL	GENE-Y	10	3	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T28	23059626
CPR:4	CHEMICAL	GENE-Y	10	5	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T29	23059626
CPR:4	CHEMICAL	GENE-Y	10	10	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T30	23059626
CPR:4	CHEMICAL	GENE-Y	10	12	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T31	23059626
CPR:4	CHEMICAL	GENE-Y	10	14	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T32	23059626
CPR:4	CHEMICAL	GENE-Y	10	17	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T33	23059626
CPR:4	CHEMICAL	GENE-Y	10	17	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T34	23059626
CPR:4	CHEMICAL	GENE-Y	10	19	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T35	23059626
NA	CHEMICAL	GENE-Y	10	28	mRNA levels of gene ( gene ) , its ligand gene , gene ( gene ) and gene/gene ( gene ) ratio were diminished in the periodontium of gene ( -/- ) mice and in the group treated with chemical-RANTES .	T3	T37	23059626
CPR:4	CHEMICAL	GENE-Y	0	7	chemical-RANTES treatment also reduced the levels of gene and gene ( gene ) .	T4	T5	23059626
CPR:4	CHEMICAL	GENE-Y	0	9	chemical-RANTES treatment also reduced the levels of gene and gene ( gene ) .	T4	T6	23059626
CPR:4	CHEMICAL	GENE-Y	0	11	chemical-RANTES treatment also reduced the levels of gene and gene ( gene ) .	T4	T8	23059626
CPR:4	CHEMICAL	GENE-Y	8	6	The expression of the osteoblast markers gene ( gene ) and gene was decreased , while gene ( gene ) was augmented in gene ( -/- ) and chemical-RANTES-treated mice .	T1	T9	23059626
CPR:4	CHEMICAL	GENE-Y	8	8	The expression of the osteoblast markers gene ( gene ) and gene was decreased , while gene ( gene ) was augmented in gene ( -/- ) and chemical-RANTES-treated mice .	T1	T10	23059626
CPR:4	CHEMICAL	GENE-Y	8	11	The expression of the osteoblast markers gene ( gene ) and gene was decreased , while gene ( gene ) was augmented in gene ( -/- ) and chemical-RANTES-treated mice .	T1	T11	23059626
CPR:3	CHEMICAL	GENE-Y	8	16	The expression of the osteoblast markers gene ( gene ) and gene was decreased , while gene ( gene ) was augmented in gene ( -/- ) and chemical-RANTES-treated mice .	T1	T12	23059626
CPR:3	CHEMICAL	GENE-Y	8	18	The expression of the osteoblast markers gene ( gene ) and gene was decreased , while gene ( gene ) was augmented in gene ( -/- ) and chemical-RANTES-treated mice .	T1	T13	23059626
NA	CHEMICAL	GENE-Y	8	23	The expression of the osteoblast markers gene ( gene ) and gene was decreased , while gene ( gene ) was augmented in gene ( -/- ) and chemical-RANTES-treated mice .	T1	T14	23059626
NA	CHEMICAL	GENE-Y	6	6	To investigate the mechanism of hypergeneaemia in rats with acute liver failure induced by the administration of chemical ( chemical ) , we focused on the role of gene ( gene ) in islet insulin synthesis .	T2	T13	17097861
NA	CHEMICAL	GENE-Y	6	30	To investigate the mechanism of hypergeneaemia in rats with acute liver failure induced by the administration of chemical ( chemical ) , we focused on the role of gene ( gene ) in islet insulin synthesis .	T2	T14	17097861
NA	CHEMICAL	GENE-N	6	5	To investigate the mechanism of hypergeneaemia in rats with acute liver failure induced by the administration of chemical ( chemical ) , we focused on the role of gene ( gene ) in islet insulin synthesis .	T2	T15	17097861
NA	CHEMICAL	GENE-Y	19	6	To investigate the mechanism of hypergeneaemia in rats with acute liver failure induced by the administration of chemical ( chemical ) , we focused on the role of gene ( gene ) in islet insulin synthesis .	T3	T13	17097861
NA	CHEMICAL	GENE-Y	19	30	To investigate the mechanism of hypergeneaemia in rats with acute liver failure induced by the administration of chemical ( chemical ) , we focused on the role of gene ( gene ) in islet insulin synthesis .	T3	T14	17097861
NA	CHEMICAL	GENE-N	19	5	To investigate the mechanism of hypergeneaemia in rats with acute liver failure induced by the administration of chemical ( chemical ) , we focused on the role of gene ( gene ) in islet insulin synthesis .	T3	T15	17097861
CPR:3	CHEMICAL	GENE-N	5	6	In the present study , chemical-stimulated gene secretion was significantly increased in chemical-treated rats compared to controls .	T4	T24	17097861
CPR:3	CHEMICAL	GENE-N	12	6	In the present study , chemical-stimulated gene secretion was significantly increased in chemical-treated rats compared to controls .	T5	T24	17097861
CPR:3	CHEMICAL	GENE-Y	17	4	Levels of mRNA encoding gene , gene , and gene were increased in the pancreatic islets of chemical-treated rats .	T6	T25	17097861
CPR:3	CHEMICAL	GENE-Y	17	6	Levels of mRNA encoding gene , gene , and gene were increased in the pancreatic islets of chemical-treated rats .	T6	T26	17097861
NA	CHEMICAL	GENE-N	17	9	Levels of mRNA encoding gene , gene , and gene were increased in the pancreatic islets of chemical-treated rats .	T6	T27	17097861
NA	CHEMICAL	GENE-N	10	14	This mRNA level elevation was not prevented by pretreatment with chemical . When the gene in gene mRNA was incubated with the islet cytosolic fraction , the RNA-protein complex level was increased in the cytosolic fraction obtained from chemical-treated rats compared to the level in control rats .	T7	T28	17097861
NA	CHEMICAL	GENE-Y	10	16	This mRNA level elevation was not prevented by pretreatment with chemical . When the gene in gene mRNA was incubated with the islet cytosolic fraction , the RNA-protein complex level was increased in the cytosolic fraction obtained from chemical-treated rats compared to the level in control rats .	T7	T29	17097861
CPR:3	CHEMICAL	GENE-N	38	14	This mRNA level elevation was not prevented by pretreatment with chemical . When the gene in gene mRNA was incubated with the islet cytosolic fraction , the RNA-protein complex level was increased in the cytosolic fraction obtained from chemical-treated rats compared to the level in control rats .	T8	T28	17097861
CPR:3	CHEMICAL	GENE-Y	38	16	This mRNA level elevation was not prevented by pretreatment with chemical . When the gene in gene mRNA was incubated with the islet cytosolic fraction , the RNA-protein complex level was increased in the cytosolic fraction obtained from chemical-treated rats compared to the level in control rats .	T8	T29	17097861
CPR:3	CHEMICAL	GENE-Y	9	14	The cytosolic fraction obtained from pancreatic islets obtained from chemical-treated rats had an increased gene level compared to the levels obtained from the pancreatic islets of control rats .	T1	T9	17097861
CPR:4	CHEMICAL	GENE-Y	6	3	Effects of the gene/gene gene inhibitor chemical on gene- and gene-overexpressing breast cancer cell line proliferation , radiosensitization , and resistance .	T11	T40	14751502
CPR:4	CHEMICAL	GENE-Y	6	3	Effects of the gene/gene gene inhibitor chemical on gene- and gene-overexpressing breast cancer cell line proliferation , radiosensitization , and resistance .	T11	T41	14751502
CPR:4	CHEMICAL	GENE-N	6	4	Effects of the gene/gene gene inhibitor chemical on gene- and gene-overexpressing breast cancer cell line proliferation , radiosensitization , and resistance .	T11	T42	14751502
NA	CHEMICAL	GENE-Y	6	8	Effects of the gene/gene gene inhibitor chemical on gene- and gene-overexpressing breast cancer cell line proliferation , radiosensitization , and resistance .	T11	T43	14751502
NA	CHEMICAL	GENE-Y	6	10	Effects of the gene/gene gene inhibitor chemical on gene- and gene-overexpressing breast cancer cell line proliferation , radiosensitization , and resistance .	T11	T44	14751502
NA	CHEMICAL	GENE-Y	31	9	To gauge the potential clinical utility of targeting both gene and gene to control growth and radiosensitize human breast cancers , we examined the effect of a dual gene/gene inhibitor , chemical , on the proliferation and radiation response of either gene- or gene-overexpressing human breast cancer cell lines .	T7	T24	14751502
NA	CHEMICAL	GENE-Y	31	11	To gauge the potential clinical utility of targeting both gene and gene to control growth and radiosensitize human breast cancers , we examined the effect of a dual gene/gene inhibitor , chemical , on the proliferation and radiation response of either gene- or gene-overexpressing human breast cancer cell lines .	T7	T27	14751502
CPR:4	CHEMICAL	GENE-Y	31	28	To gauge the potential clinical utility of targeting both gene and gene to control growth and radiosensitize human breast cancers , we examined the effect of a dual gene/gene inhibitor , chemical , on the proliferation and radiation response of either gene- or gene-overexpressing human breast cancer cell lines .	T7	T28	14751502
CPR:4	CHEMICAL	GENE-Y	31	28	To gauge the potential clinical utility of targeting both gene and gene to control growth and radiosensitize human breast cancers , we examined the effect of a dual gene/gene inhibitor , chemical , on the proliferation and radiation response of either gene- or gene-overexpressing human breast cancer cell lines .	T7	T29	14751502
NA	CHEMICAL	GENE-Y	31	41	To gauge the potential clinical utility of targeting both gene and gene to control growth and radiosensitize human breast cancers , we examined the effect of a dual gene/gene inhibitor , chemical , on the proliferation and radiation response of either gene- or gene-overexpressing human breast cancer cell lines .	T7	T30	14751502
NA	CHEMICAL	GENE-Y	31	43	To gauge the potential clinical utility of targeting both gene and gene to control growth and radiosensitize human breast cancers , we examined the effect of a dual gene/gene inhibitor , chemical , on the proliferation and radiation response of either gene- or gene-overexpressing human breast cancer cell lines .	T7	T31	14751502
NA	CHEMICAL	GENE-Y	32	13	METHODS AND MATERIALS : Primary human breast cancer cell lines that endogenously overexpress gene or gene and luminal mammary epithelial H16N2 cells stably transfected with gene were evaluated for the effect of chemical on inhibition of ligand-induced or gene phosphorylation , proliferation , radiosensitization , and inhibition of downstream signaling .	T8	T32	14751502
NA	CHEMICAL	GENE-Y	32	15	METHODS AND MATERIALS : Primary human breast cancer cell lines that endogenously overexpress gene or gene and luminal mammary epithelial H16N2 cells stably transfected with gene were evaluated for the effect of chemical on inhibition of ligand-induced or gene phosphorylation , proliferation , radiosensitization , and inhibition of downstream signaling .	T8	T33	14751502
NA	CHEMICAL	GENE-Y	32	25	METHODS AND MATERIALS : Primary human breast cancer cell lines that endogenously overexpress gene or gene and luminal mammary epithelial H16N2 cells stably transfected with gene were evaluated for the effect of chemical on inhibition of ligand-induced or gene phosphorylation , proliferation , radiosensitization , and inhibition of downstream signaling .	T8	T34	14751502
NA	CHEMICAL	GENE-N	32	14	METHODS AND MATERIALS : Primary human breast cancer cell lines that endogenously overexpress gene or gene and luminal mammary epithelial H16N2 cells stably transfected with gene were evaluated for the effect of chemical on inhibition of ligand-induced or gene phosphorylation , proliferation , radiosensitization , and inhibition of downstream signaling .	T8	T36	14751502
CPR:4	CHEMICAL	GENE-Y	2	7	RESULTS : chemical inhibited constitutive and/or ligand-induced gene or gene chemical phosphorylation of all five cell lines , which correlated with the antiproliferative response in all but one cell line .	T9	T38	14751502
CPR:4	CHEMICAL	GENE-Y	2	9	RESULTS : chemical inhibited constitutive and/or ligand-induced gene or gene chemical phosphorylation of all five cell lines , which correlated with the antiproliferative response in all but one cell line .	T9	T39	14751502
NA	CHEMICAL	GENE-Y	10	7	RESULTS : chemical inhibited constitutive and/or ligand-induced gene or gene chemical phosphorylation of all five cell lines , which correlated with the antiproliferative response in all but one cell line .	T10	T38	14751502
NA	CHEMICAL	GENE-Y	10	9	RESULTS : chemical inhibited constitutive and/or ligand-induced gene or gene chemical phosphorylation of all five cell lines , which correlated with the antiproliferative response in all but one cell line .	T10	T39	14751502
NA	CHEMICAL	GENE-Y	0	2	chemical radiosensitized gene-overexpressing cell lines , but gene-overexpressing cells were unable to form colonies after brief exposure to chemical even in the absence of radiation , and thus could not be evaluated for radiosensitization .	T1	T12	14751502
NA	CHEMICAL	GENE-Y	0	7	chemical radiosensitized gene-overexpressing cell lines , but gene-overexpressing cells were unable to form colonies after brief exposure to chemical even in the absence of radiation , and thus could not be evaluated for radiosensitization .	T1	T13	14751502
NA	CHEMICAL	GENE-Y	18	2	chemical radiosensitized gene-overexpressing cell lines , but gene-overexpressing cells were unable to form colonies after brief exposure to chemical even in the absence of radiation , and thus could not be evaluated for radiosensitization .	T2	T12	14751502
NA	CHEMICAL	GENE-Y	18	7	chemical radiosensitized gene-overexpressing cell lines , but gene-overexpressing cells were unable to form colonies after brief exposure to chemical even in the absence of radiation , and thus could not be evaluated for radiosensitization .	T2	T13	14751502
NA	CHEMICAL	GENE-N	12	16	Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of chemical to inhibit downstream gene and gene activation , despite inhibition of gene phosphorylation .	T4	T14	14751502
NA	CHEMICAL	GENE-N	12	18	Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of chemical to inhibit downstream gene and gene activation , despite inhibition of gene phosphorylation .	T4	T15	14751502
CPR:4	CHEMICAL	GENE-Y	12	24	Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of chemical to inhibit downstream gene and gene activation , despite inhibition of gene phosphorylation .	T4	T16	14751502
CPR:4	CHEMICAL	GENE-Y	2	9	CONCLUSION : chemical potently inhibits receptor phosphorylation in either gene- or gene-overexpressing cell lines and has both antiproliferative and radiosensitizing effects .	T5	T20	14751502
CPR:4	CHEMICAL	GENE-Y	2	11	CONCLUSION : chemical potently inhibits receptor phosphorylation in either gene- or gene-overexpressing cell lines and has both antiproliferative and radiosensitizing effects .	T5	T21	14751502
NA	CHEMICAL	GENE-N	2	21	Resistance to chemical was not due to a lack of receptor inhibition , but rather with a lack of inhibition of gene and gene , suggesting that measurement of inhibition of crucial signaling pathways may better predict response than inhibition of receptor phosphorylation .	T6	T22	14751502
NA	CHEMICAL	GENE-N	2	23	Resistance to chemical was not due to a lack of receptor inhibition , but rather with a lack of inhibition of gene and gene , suggesting that measurement of inhibition of crucial signaling pathways may better predict response than inhibition of receptor phosphorylation .	T6	T23	14751502
NA	CHEMICAL	GENE-N	34	11	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T10	T19	11695255
CPR:4	CHEMICAL	GENE-Y	34	31	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T10	T20	11695255
NA	CHEMICAL	GENE-Y	34	41	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T10	T21	11695255
NA	CHEMICAL	GENE-Y	34	41	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T10	T22	11695255
NA	CHEMICAL	GENE-N	29	11	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T11	T19	11695255
NA	CHEMICAL	GENE-Y	29	31	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T11	T20	11695255
CPR:4	CHEMICAL	GENE-Y	29	41	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T11	T21	11695255
CPR:4	CHEMICAL	GENE-Y	29	41	A series of studies is reviewed that assesses the relationship between gene released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective gene inhibitor ( chemical ) in comparison to a dual gene/gene inhibitor ( chemical ) .	T11	T22	11695255
CPR:9	CHEMICAL	GENE-Y	20	28	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T12	T23	11695255
CPR:9	CHEMICAL	GENE-Y	20	30	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T12	T24	11695255
NA	CHEMICAL	GENE-Y	20	39	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T12	T25	11695255
CPR:9	CHEMICAL	GENE-Y	22	28	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T13	T23	11695255
CPR:9	CHEMICAL	GENE-Y	22	30	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T13	T24	11695255
NA	CHEMICAL	GENE-Y	22	39	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T13	T25	11695255
NA	CHEMICAL	GENE-Y	33	28	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T14	T23	11695255
NA	CHEMICAL	GENE-Y	33	30	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T14	T24	11695255
NA	CHEMICAL	GENE-Y	33	39	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of chemical ( chemical ; a product of both gene and gene ) and chemical ( as a biomarker for gene activity ) with parallel assessments of pain .	T14	T25	11695255
CPR:9	CHEMICAL	GENE-Y	4	13	The time course of chemical production was consistent with early release due to gene activity followed by increased production 2-3 hours after surgery , consistent with gene expression .	T15	T26	11695255
CPR:9	CHEMICAL	GENE-Y	4	26	The time course of chemical production was consistent with early release due to gene activity followed by increased production 2-3 hours after surgery , consistent with gene expression .	T15	T27	11695255
CPR:4	CHEMICAL	GENE-Y	0	12	chemical selectively suppressed chemical but not chemical at time points consistent with gene activity , while producing analgesia .	T6	T16	11695255
CPR:9	CHEMICAL	GENE-Y	3	12	chemical selectively suppressed chemical but not chemical at time points consistent with gene activity , while producing analgesia .	T7	T16	11695255
NA	CHEMICAL	GENE-Y	6	12	chemical selectively suppressed chemical but not chemical at time points consistent with gene activity , while producing analgesia .	T8	T16	11695255
NA	CHEMICAL	GENE-N	13	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T7	T13	11369259
NA	CHEMICAL	GENE-N	13	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T7	T15	11369259
NA	CHEMICAL	GENE-N	13	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T7	T16	11369259
NA	CHEMICAL	GENE-N	18	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T10	T13	11369259
NA	CHEMICAL	GENE-Y	18	55	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T10	T14	11369259
NA	CHEMICAL	GENE-N	18	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T10	T15	11369259
NA	CHEMICAL	GENE-N	18	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T10	T16	11369259
NA	CHEMICAL	GENE-N	23	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T11	T13	11369259
NA	CHEMICAL	GENE-Y	23	55	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T11	T14	11369259
NA	CHEMICAL	GENE-N	23	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T11	T15	11369259
NA	CHEMICAL	GENE-N	23	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T11	T16	11369259
NA	CHEMICAL	GENE-N	28	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T12	T13	11369259
NA	CHEMICAL	GENE-Y	28	55	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T12	T14	11369259
NA	CHEMICAL	GENE-N	28	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T12	T15	11369259
NA	CHEMICAL	GENE-N	28	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T12	T16	11369259
NA	CHEMICAL	GENE-N	18	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T1	T13	11369259
NA	CHEMICAL	GENE-Y	18	55	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T1	T14	11369259
NA	CHEMICAL	GENE-N	18	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T1	T15	11369259
NA	CHEMICAL	GENE-N	18	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T1	T16	11369259
NA	CHEMICAL	GENE-N	39	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T2	T13	11369259
NA	CHEMICAL	GENE-Y	39	55	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T2	T14	11369259
NA	CHEMICAL	GENE-N	39	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T2	T15	11369259
NA	CHEMICAL	GENE-N	39	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T2	T16	11369259
NA	CHEMICAL	GENE-N	8	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T3	T13	11369259
NA	CHEMICAL	GENE-N	75	44	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T4	T13	11369259
NA	CHEMICAL	GENE-Y	75	55	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T4	T14	11369259
NA	CHEMICAL	GENE-N	75	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T4	T15	11369259
NA	CHEMICAL	GENE-N	75	50	Recent studies have indicated that the basic residues chemical ( 93 ) , chemical ( 96 ) , chemical ( 125 ) , chemical ( 165 ) , chemical ( 169 ) , chemical ( 236 ) , and chemical ( 240 ) ( gene numbering ) constitute an exosite in the catalytic domain of gene that can effectively bind heparin only if the acidic chemical-terminal Gla domain of the gene was neutralized by physiological levels of chemical .	T4	T16	11369259
NA	CHEMICAL	GENE-Y	2	2	Binding of a full-length heparin chain to this site of gene in the presence of chemical makes a significant contribution to acceleration of the gene inhibition by gene through a ternary complex bridging or template mechanism .	T5	T17	11369259
NA	CHEMICAL	GENE-N	2	2	Binding of a full-length heparin chain to this site of gene in the presence of chemical makes a significant contribution to acceleration of the gene inhibition by gene through a ternary complex bridging or template mechanism .	T5	T18	11369259
NA	CHEMICAL	GENE-Y	2	2	Binding of a full-length heparin chain to this site of gene in the presence of chemical makes a significant contribution to acceleration of the gene inhibition by gene through a ternary complex bridging or template mechanism .	T5	T19	11369259
NA	CHEMICAL	GENE-Y	10	21	Moreover , certain basic residues of this site , particularly chemical ( 165 ) and chemical ( 169 ) , play a key role in gene and/or gene recognition by gene in the prothrombinase complex .	T8	T20	11369259
NA	CHEMICAL	GENE-Y	10	24	Moreover , certain basic residues of this site , particularly chemical ( 165 ) and chemical ( 169 ) , play a key role in gene and/or gene recognition by gene in the prothrombinase complex .	T8	T21	11369259
NA	CHEMICAL	GENE-Y	10	21	Moreover , certain basic residues of this site , particularly chemical ( 165 ) and chemical ( 169 ) , play a key role in gene and/or gene recognition by gene in the prothrombinase complex .	T8	T22	11369259
NA	CHEMICAL	GENE-Y	15	21	Moreover , certain basic residues of this site , particularly chemical ( 165 ) and chemical ( 169 ) , play a key role in gene and/or gene recognition by gene in the prothrombinase complex .	T9	T20	11369259
NA	CHEMICAL	GENE-Y	15	24	Moreover , certain basic residues of this site , particularly chemical ( 165 ) and chemical ( 169 ) , play a key role in gene and/or gene recognition by gene in the prothrombinase complex .	T9	T21	11369259
NA	CHEMICAL	GENE-Y	15	21	Moreover , certain basic residues of this site , particularly chemical ( 165 ) and chemical ( 169 ) , play a key role in gene and/or gene recognition by gene in the prothrombinase complex .	T9	T22	11369259
CPR:4	CHEMICAL	GENE-N	0	2	chemical-chemical : a novel chemical/gene inhibitor combination .	T47	T62	23371303
CPR:4	CHEMICAL	GENE-N	0	2	chemical-chemical : a novel chemical/gene inhibitor combination .	T48	T62	23371303
NA	CHEMICAL	GENE-N	2	2	chemical-chemical : a novel chemical/gene inhibitor combination .	T49	T62	23371303
CPR:4	CHEMICAL	GENE-N	0	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T1	T60	23371303
NA	CHEMICAL	GENE-N	0	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T1	T50	23371303
CPR:4	CHEMICAL	GENE-N	0	22	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T1	T51	23371303
CPR:4	CHEMICAL	GENE-N	3	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T14	T60	23371303
NA	CHEMICAL	GENE-N	3	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T14	T50	23371303
CPR:4	CHEMICAL	GENE-N	3	22	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T14	T51	23371303
CPR:4	CHEMICAL	GENE-N	5	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T30	T60	23371303
NA	CHEMICAL	GENE-N	5	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T30	T50	23371303
CPR:4	CHEMICAL	GENE-N	5	22	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T30	T51	23371303
NA	CHEMICAL	GENE-N	8	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T42	T60	23371303
NA	CHEMICAL	GENE-N	8	8	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T42	T50	23371303
NA	CHEMICAL	GENE-N	8	22	chemical ( formerly chemical , chemical ) is a synthetic non-chemical , gene inhibitor that inhibits the activities of gene and some gene enzymes .	T42	T51	23371303
NA	CHEMICAL	GENE-N	2	2	Although not a chemical , the chemical structure of chemical closely resembles portions of the chemical bicyclic ring system , and chemical has been shown to bond covalently to gene .	T38	T59	23371303
NA	CHEMICAL	GENE-N	2	2	Although not a chemical , the chemical structure of chemical closely resembles portions of the chemical bicyclic ring system , and chemical has been shown to bond covalently to gene .	T39	T59	23371303
NA	CHEMICAL	GENE-N	15	2	Although not a chemical , the chemical structure of chemical closely resembles portions of the chemical bicyclic ring system , and chemical has been shown to bond covalently to gene .	T40	T59	23371303
NA	CHEMICAL	GENE-N	2	2	Although not a chemical , the chemical structure of chemical closely resembles portions of the chemical bicyclic ring system , and chemical has been shown to bond covalently to gene .	T41	T59	23371303
CPR:4	CHEMICAL	GENE-N	3	32	The addition of chemical greatly ( 4-1024-fold minimum inhibitory concentration [ MIC ] reduction ) improves the activity of chemical versus most species of Enterobacteriaceae depending on the presence or absence of gene enzyme ( s ) .	T44	T61	23371303
CPR:4	CHEMICAL	GENE-N	19	32	The addition of chemical greatly ( 4-1024-fold minimum inhibitory concentration [ MIC ] reduction ) improves the activity of chemical versus most species of Enterobacteriaceae depending on the presence or absence of gene enzyme ( s ) .	T45	T61	23371303
CPR:4	CHEMICAL	GENE-N	4	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T12	T52	23371303
CPR:4	CHEMICAL	GENE-N	4	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T13	T52	23371303
NA	CHEMICAL	GENE-N	17	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T15	T52	23371303
NA	CHEMICAL	GENE-N	25	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T16	T52	23371303
NA	CHEMICAL	GENE-N	25	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T17	T52	23371303
NA	CHEMICAL	GENE-N	31	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T18	T52	23371303
NA	CHEMICAL	GENE-N	33	9	Pharmacodynamic data suggest that chemical-chemical is rapidly bactericidal versus gene-producing Gram-negative bacilli that are not inhibited by chemical alone.Clinical trials to date have reported that chemical-chemical is as effective as standard chemical therapy in complicated intra-abdominal infection and complicated urinary tract infection , including infection caused by chemical-resistant Gram-negative isolates .	T19	T52	23371303
NA	CHEMICAL	GENE-N	0	34	chemical-chemical appears to be well tolerated in healthy subjects and hospitalized patients , with few serious drug-related treatment-emergent adverse events reported to date.In conclusion , chemical serves to broaden the spectrum of chemical versus gene-producing Gram-negative bacilli .	T23	T53	23371303
NA	CHEMICAL	GENE-N	0	34	chemical-chemical appears to be well tolerated in healthy subjects and hospitalized patients , with few serious drug-related treatment-emergent adverse events reported to date.In conclusion , chemical serves to broaden the spectrum of chemical versus gene-producing Gram-negative bacilli .	T24	T53	23371303
CPR:4	CHEMICAL	GENE-N	25	34	chemical-chemical appears to be well tolerated in healthy subjects and hospitalized patients , with few serious drug-related treatment-emergent adverse events reported to date.In conclusion , chemical serves to broaden the spectrum of chemical versus gene-producing Gram-negative bacilli .	T26	T53	23371303
CPR:4	CHEMICAL	GENE-N	32	34	chemical-chemical appears to be well tolerated in healthy subjects and hospitalized patients , with few serious drug-related treatment-emergent adverse events reported to date.In conclusion , chemical serves to broaden the spectrum of chemical versus gene-producing Gram-negative bacilli .	T27	T53	23371303
NA	CHEMICAL	GENE-N	4	18	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T31	T54	23371303
NA	CHEMICAL	GENE-N	4	20	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T31	T55	23371303
NA	CHEMICAL	GENE-N	4	23	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T31	T56	23371303
NA	CHEMICAL	GENE-N	4	25	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T31	T57	23371303
NA	CHEMICAL	GENE-N	4	28	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T31	T58	23371303
NA	CHEMICAL	GENE-N	4	18	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T32	T54	23371303
NA	CHEMICAL	GENE-N	4	20	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T32	T55	23371303
NA	CHEMICAL	GENE-N	4	23	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T32	T56	23371303
NA	CHEMICAL	GENE-N	4	25	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T32	T57	23371303
NA	CHEMICAL	GENE-N	4	28	Potential future roles for chemical-chemical include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing gene ( gene ) , gene ( gene ) and/or gene .	T32	T58	23371303
CPR:9	CHEMICAL	GENE-Y	7	13	The test procedure was verified with respect to intestinal chemical hydrolysis by demonstrating a linear relationship between chemical/chemical excretion and log jejunal mucosal gene activity by in vitro assay ( R2 = 0.95 ) in a further group of subjects .	T1	T17	3089818
CPR:9	CHEMICAL	GENE-Y	7	13	The test procedure was verified with respect to intestinal chemical hydrolysis by demonstrating a linear relationship between chemical/chemical excretion and log jejunal mucosal gene activity by in vitro assay ( R2 = 0.95 ) in a further group of subjects .	T2	T17	3089818
CPR:9	CHEMICAL	GENE-Y	13	13	The test procedure was verified with respect to intestinal chemical hydrolysis by demonstrating a linear relationship between chemical/chemical excretion and log jejunal mucosal gene activity by in vitro assay ( R2 = 0.95 ) in a further group of subjects .	T3	T17	3089818
NA	CHEMICAL	GENE-N	20	17	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T5	T29	11513839
NA	CHEMICAL	GENE-Y	20	43	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T5	T32	11513839
NA	CHEMICAL	GENE-Y	20	45	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T5	T33	11513839
NA	CHEMICAL	GENE-Y	20	47	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T5	T34	11513839
NA	CHEMICAL	GENE-N	22	17	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T7	T29	11513839
NA	CHEMICAL	GENE-Y	22	43	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T7	T32	11513839
NA	CHEMICAL	GENE-Y	22	45	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T7	T33	11513839
NA	CHEMICAL	GENE-Y	22	47	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T7	T34	11513839
NA	CHEMICAL	GENE-N	24	17	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T10	T29	11513839
NA	CHEMICAL	GENE-Y	24	43	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T10	T32	11513839
NA	CHEMICAL	GENE-Y	24	45	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T10	T33	11513839
NA	CHEMICAL	GENE-Y	24	47	In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the gene receptor agonists chemical , chemical and chemical in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at gene , gene and gene receptors .	T10	T34	11513839
NA	CHEMICAL	GENE-N	7	15	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T11	T35	11513839
NA	CHEMICAL	GENE-N	7	27	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T11	T36	11513839
NA	CHEMICAL	GENE-N	14	15	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T12	T35	11513839
NA	CHEMICAL	GENE-N	14	27	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T12	T36	11513839
NA	CHEMICAL	GENE-N	26	15	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T13	T35	11513839
NA	CHEMICAL	GENE-N	26	27	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T13	T36	11513839
NA	CHEMICAL	GENE-N	26	15	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T14	T35	11513839
NA	CHEMICAL	GENE-N	26	27	In vitro studies showed that all three chemical are high affinity , full agonists at gene receptors , but that chemical is functionally less potent as a gene agonist than chemical and chemical .	T14	T36	11513839
NA	CHEMICAL	GENE-N	3	29	The observation that chemical and chemical produce almost identical central serotonergic effects , after intracerebral as well as after systemic administration , is in agreement with their comparable functional gene receptor agonist potencies and their free levels in cortical dialysates after 3.2 mg/kg i.v .	T3	T30	11513839
NA	CHEMICAL	GENE-N	5	29	The observation that chemical and chemical produce almost identical central serotonergic effects , after intracerebral as well as after systemic administration , is in agreement with their comparable functional gene receptor agonist potencies and their free levels in cortical dialysates after 3.2 mg/kg i.v .	T4	T30	11513839
NA	CHEMICAL	GENE-Y	1	33	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T7	T30	7599160
NA	CHEMICAL	GENE-N	1	23	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T7	T31	7599160
NA	CHEMICAL	GENE-N	1	37	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T7	T32	7599160
NA	CHEMICAL	GENE-Y	10	33	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T8	T30	7599160
NA	CHEMICAL	GENE-N	10	23	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T8	T31	7599160
NA	CHEMICAL	GENE-N	10	37	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T8	T32	7599160
NA	CHEMICAL	GENE-Y	23	33	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T9	T30	7599160
NA	CHEMICAL	GENE-N	23	23	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T9	T31	7599160
NA	CHEMICAL	GENE-N	23	37	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T9	T32	7599160
NA	CHEMICAL	GENE-Y	29	33	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T10	T30	7599160
NA	CHEMICAL	GENE-N	29	23	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T10	T31	7599160
NA	CHEMICAL	GENE-N	29	37	Extracellular chemical ( protein bound and free ) and intracellular chemical ( protein bound and free ) were determined after culturing L-1210 cells in the presence of chemical ( chemical ) bound to gene ( gene , gene ) .	T10	T32	7599160
NA	CHEMICAL	GENE-Y	2	6	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T24	T33	7599160
NA	CHEMICAL	GENE-Y	2	8	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T24	T34	7599160
NA	CHEMICAL	GENE-Y	2	12	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T24	T35	7599160
NA	CHEMICAL	GENE-Y	2	14	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T24	T36	7599160
NA	CHEMICAL	GENE-Y	5	6	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T25	T33	7599160
NA	CHEMICAL	GENE-Y	5	8	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T25	T34	7599160
NA	CHEMICAL	GENE-Y	5	12	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T25	T35	7599160
NA	CHEMICAL	GENE-Y	5	14	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T25	T36	7599160
NA	CHEMICAL	GENE-Y	11	6	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T26	T33	7599160
NA	CHEMICAL	GENE-Y	11	8	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T26	T34	7599160
NA	CHEMICAL	GENE-Y	11	12	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T26	T35	7599160
NA	CHEMICAL	GENE-Y	11	14	Intracellular protein-bound chemical fractionated with chemical synthase ( gene ) and chemical mutase ( gene ) activity .	T26	T36	7599160
NA	CHEMICAL	GENE-N	11	13	The data also showed significant decrease in the levels of serum chemical , gene and gene and significant increase in the level of serum gene in chemical-intoxicated rats .	T4	T33	23282999
NA	CHEMICAL	GENE-N	11	15	The data also showed significant decrease in the levels of serum chemical , gene and gene and significant increase in the level of serum gene in chemical-intoxicated rats .	T4	T34	23282999
NA	CHEMICAL	GENE-Y	11	6	The data also showed significant decrease in the levels of serum chemical , gene and gene and significant increase in the level of serum gene in chemical-intoxicated rats .	T4	T35	23282999
NA	CHEMICAL	GENE-N	26	13	The data also showed significant decrease in the levels of serum chemical , gene and gene and significant increase in the level of serum gene in chemical-intoxicated rats .	T6	T33	23282999
NA	CHEMICAL	GENE-N	26	15	The data also showed significant decrease in the levels of serum chemical , gene and gene and significant increase in the level of serum gene in chemical-intoxicated rats .	T6	T34	23282999
NA	CHEMICAL	GENE-Y	26	6	The data also showed significant decrease in the levels of serum chemical , gene and gene and significant increase in the level of serum gene in chemical-intoxicated rats .	T6	T35	23282999
NA	CHEMICAL	GENE-N	14	25	By contrast , the editing of some sites is completely lost or significantly reduced in other non-green tissues ; for instance , the editing of gene , gene , and gene is completely lost in roots and in chemical-treated seedlings .	T5	T21	23645360
NA	CHEMICAL	GENE-N	14	27	By contrast , the editing of some sites is completely lost or significantly reduced in other non-green tissues ; for instance , the editing of gene , gene , and gene is completely lost in roots and in chemical-treated seedlings .	T5	T22	23645360
NA	CHEMICAL	GENE-N	14	30	By contrast , the editing of some sites is completely lost or significantly reduced in other non-green tissues ; for instance , the editing of gene , gene , and gene is completely lost in roots and in chemical-treated seedlings .	T5	T23	23645360
NA	CHEMICAL	GENE-N	12	3	The editing of gene is also completely lost in albino mutants and chemical-treated seedlings .	T1	T6	23645360
NA	CHEMICAL	GENE-N	14	7	In addition , the expression of nucleus-encoded gene dependent transcripts is specifically induced by chemical , and the splicing of gene transcripts is significantly reduced in the albino mutants and inhibitor-treated seedlings .	T2	T13	23645360
NA	CHEMICAL	GENE-N	14	20	In addition , the expression of nucleus-encoded gene dependent transcripts is specifically induced by chemical , and the splicing of gene transcripts is significantly reduced in the albino mutants and inhibitor-treated seedlings .	T2	T14	23645360
CPR:5	CHEMICAL	GENE-Y	0	3	chemical , a gene agonist , induces gene in cytotoxic T lymphocytes in vitro .	T8	T20	15072849
CPR:3	CHEMICAL	GENE-Y	0	7	chemical , a gene agonist , induces gene in cytotoxic T lymphocytes in vitro .	T8	T21	15072849
CPR:3	CHEMICAL	GENE-Y	0	8	chemical ( chemical ) , an activator of gene ( gene ) , induces by several routes a profound anti-viral and anti-tumor effect in vivo .	T1	T11	15072849
CPR:3	CHEMICAL	GENE-Y	0	10	chemical ( chemical ) , an activator of gene ( gene ) , induces by several routes a profound anti-viral and anti-tumor effect in vivo .	T1	T15	15072849
CPR:3	CHEMICAL	GENE-Y	2	8	chemical ( chemical ) , an activator of gene ( gene ) , induces by several routes a profound anti-viral and anti-tumor effect in vivo .	T4	T11	15072849
CPR:3	CHEMICAL	GENE-Y	2	10	chemical ( chemical ) , an activator of gene ( gene ) , induces by several routes a profound anti-viral and anti-tumor effect in vivo .	T4	T15	15072849
NA	CHEMICAL	GENE-Y	11	14	This functional synergism prompted our current experiments addressing the question whether chemical may influence gene-release and/or induce gene in CTLs in vitro .	T5	T12	15072849
NA	CHEMICAL	GENE-Y	11	17	This functional synergism prompted our current experiments addressing the question whether chemical may influence gene-release and/or induce gene in CTLs in vitro .	T5	T13	15072849
CPR:3	CHEMICAL	GENE-Y	9	15	In peripheral lymphocytes of healthy and diseased subjects , chemical induced a significant increase of gene ( + ) CTLs within 12h in all experiments performed .	T6	T14	15072849
CPR:3	CHEMICAL	GENE-Y	58	5	This effect was most pronounced in CTLs of patients suffering from atopic dermatitis , a model disorder for subnormal gene expression : as compared to gene ( + ) CTLs detected at time point zero ( 100 % ) , up to 270 % of gene ( + ) CTLs were induced by 2.5 microg/ml [ corrected ] chemical .	T7	T18	15072849
NA	CHEMICAL	GENE-Y	13	0	gene release from peripheral blood CTLs after PMA/ionomycin-stimulation was not influenced significantly by chemical .	T2	T19	15072849
NA	CHEMICAL	GENE-N	11	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T11	20624420
NA	CHEMICAL	GENE-Y	11	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T12	20624420
NA	CHEMICAL	GENE-Y	11	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T13	20624420
NA	CHEMICAL	GENE-Y	11	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T14	20624420
NA	CHEMICAL	GENE-Y	11	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T15	20624420
NA	CHEMICAL	GENE-Y	11	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T16	20624420
NA	CHEMICAL	GENE-Y	11	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T17	20624420
NA	CHEMICAL	GENE-N	11	16	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T18	20624420
NA	CHEMICAL	GENE-N	11	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T1	T23	20624420
NA	CHEMICAL	GENE-N	13	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T11	20624420
NA	CHEMICAL	GENE-Y	13	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T12	20624420
NA	CHEMICAL	GENE-Y	13	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T13	20624420
NA	CHEMICAL	GENE-Y	13	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T14	20624420
NA	CHEMICAL	GENE-Y	13	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T15	20624420
NA	CHEMICAL	GENE-Y	13	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T16	20624420
NA	CHEMICAL	GENE-Y	13	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T17	20624420
NA	CHEMICAL	GENE-N	13	16	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T18	20624420
NA	CHEMICAL	GENE-Y	13	53	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T19	20624420
NA	CHEMICAL	GENE-N	13	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T2	T23	20624420
NA	CHEMICAL	GENE-N	13	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T11	20624420
NA	CHEMICAL	GENE-Y	13	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T12	20624420
NA	CHEMICAL	GENE-Y	13	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T13	20624420
NA	CHEMICAL	GENE-Y	13	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T14	20624420
NA	CHEMICAL	GENE-Y	13	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T15	20624420
NA	CHEMICAL	GENE-Y	13	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T16	20624420
NA	CHEMICAL	GENE-Y	13	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T17	20624420
NA	CHEMICAL	GENE-N	13	16	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T18	20624420
NA	CHEMICAL	GENE-Y	13	53	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T19	20624420
NA	CHEMICAL	GENE-N	13	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T3	T23	20624420
NA	CHEMICAL	GENE-N	34	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T11	20624420
NA	CHEMICAL	GENE-Y	34	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T12	20624420
NA	CHEMICAL	GENE-Y	34	20	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T13	20624420
NA	CHEMICAL	GENE-Y	34	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T14	20624420
NA	CHEMICAL	GENE-Y	34	28	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T15	20624420
NA	CHEMICAL	GENE-Y	34	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T16	20624420
NA	CHEMICAL	GENE-Y	34	42	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T17	20624420
NA	CHEMICAL	GENE-N	34	16	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T18	20624420
NA	CHEMICAL	GENE-Y	34	53	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T19	20624420
NA	CHEMICAL	GENE-N	34	55	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T20	20624420
NA	CHEMICAL	GENE-Y	34	64	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T21	20624420
NA	CHEMICAL	GENE-Y	34	64	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T22	20624420
NA	CHEMICAL	GENE-N	34	12	Results from microinfusion studies show that anticonvulsant efficacy is obtained by chemical ( A ) modulators or cholinergic antagonists ( gene-gene ) in AT , cholinergic antagonists ( gene-gene ) in MS , combined chemicalrgic ( chemical ) and cholinergic antagonist ( gene-gene ) , chemical antagonist , or modulators of gene ( gene , gene ) in PRC , and cholinergic antagonist ( gene-gene ) or gene agonist in PPC .	T4	T23	20624420
CPR:4	CHEMICAL	GENE-Y	4	0	A molecular mechanism for chemical-mediated gene inhibition in neurons .	T12	T35	20089905
CPR:4	CHEMICAL	GENE-N	0	2	chemical is a nonsteroidal anti-inflammatory drug widely used to relieve pain and inflammation in many disorders via inhibition of gene .	T1	T17	20089905
CPR:4	CHEMICAL	GENE-Y	6	11	Recently , we have demonstrated that chemical inhibits intracellular signaling of gene and promotes significant axonal growth and functional recovery following spinal cord lesions in rodents .	T7	T24	20089905
CPR:4	CHEMICAL	GENE-Y	7	11	In addition , another study suggests that chemical reduces generation of gene peptide via inactivation of gene signaling , although it may also regulate gene formation by direct inhibition of the gene .	T8	T25	20089905
CPR:4	CHEMICAL	GENE-Y	7	16	In addition , another study suggests that chemical reduces generation of gene peptide via inactivation of gene signaling , although it may also regulate gene formation by direct inhibition of the gene .	T8	T26	20089905
CPR:3	CHEMICAL	GENE-Y	7	24	In addition , another study suggests that chemical reduces generation of gene peptide via inactivation of gene signaling , although it may also regulate gene formation by direct inhibition of the gene .	T8	T27	20089905
CPR:4	CHEMICAL	GENE-N	7	31	In addition , another study suggests that chemical reduces generation of gene peptide via inactivation of gene signaling , although it may also regulate gene formation by direct inhibition of the gene .	T8	T28	20089905
CPR:4	CHEMICAL	GENE-Y	5	8	The molecular mechanisms by which chemical inhibits the gene signal in neurons , however , remain unclear .	T9	T29	20089905
NA	CHEMICAL	GENE-Y	16	8	Here , we report that the transcription factor gene ( gene ) is essential for coupling chemical to gene inhibition and subsequent neurite growth promotion in neurons .	T10	T30	20089905
NA	CHEMICAL	GENE-Y	16	10	Here , we report that the transcription factor gene ( gene ) is essential for coupling chemical to gene inhibition and subsequent neurite growth promotion in neurons .	T10	T31	20089905
CPR:4	CHEMICAL	GENE-Y	16	18	Here , we report that the transcription factor gene ( gene ) is essential for coupling chemical to gene inhibition and subsequent neurite growth promotion in neurons .	T10	T32	20089905
CPR:3	CHEMICAL	GENE-Y	0	2	chemical activates gene in neuron-like PC12 and B104 cells .	T11	T33	20089905
NA	CHEMICAL	GENE-Y	1	2	Activation of gene with traditional agonists mimics the gene-inhibiting properties of chemical in PC12 cells and , like chemical , promotes neurite elongation in primary cultured neurons exposed to axonal growth inhibitors .	T2	T34	20089905
CPR:4	CHEMICAL	GENE-Y	1	8	Activation of gene with traditional agonists mimics the gene-inhibiting properties of chemical in PC12 cells and , like chemical , promotes neurite elongation in primary cultured neurons exposed to axonal growth inhibitors .	T2	T13	20089905
NA	CHEMICAL	GENE-Y	1	2	Activation of gene with traditional agonists mimics the gene-inhibiting properties of chemical in PC12 cells and , like chemical , promotes neurite elongation in primary cultured neurons exposed to axonal growth inhibitors .	T3	T34	20089905
NA	CHEMICAL	GENE-Y	1	8	Activation of gene with traditional agonists mimics the gene-inhibiting properties of chemical in PC12 cells and , like chemical , promotes neurite elongation in primary cultured neurons exposed to axonal growth inhibitors .	T3	T13	20089905
NA	CHEMICAL	GENE-Y	4	7	Moreover , the effect of chemical on gene activity and neurite growth in neuronal cultures is prevented by selective gene inhibition .	T4	T18	20089905
NA	CHEMICAL	GENE-Y	4	19	Moreover , the effect of chemical on gene activity and neurite growth in neuronal cultures is prevented by selective gene inhibition .	T4	T19	20089905
NA	CHEMICAL	GENE-Y	14	4	These findings support that gene plays an essential role in mediating the gene-inhibiting effect of chemical .	T5	T20	20089905
CPR:4	CHEMICAL	GENE-Y	14	12	These findings support that gene plays an essential role in mediating the gene-inhibiting effect of chemical .	T5	T21	20089905
NA	CHEMICAL	GENE-N	0	1	chemical transporter and chemical channel mechanisms in the rapid pressor response to chemical .	T41	T49	9476974
NA	CHEMICAL	GENE-N	0	4	chemical transporter and chemical channel mechanisms in the rapid pressor response to chemical .	T41	T50	9476974
NA	CHEMICAL	GENE-N	3	1	chemical transporter and chemical channel mechanisms in the rapid pressor response to chemical .	T42	T49	9476974
NA	CHEMICAL	GENE-N	3	4	chemical transporter and chemical channel mechanisms in the rapid pressor response to chemical .	T42	T50	9476974
NA	CHEMICAL	GENE-N	6	1	chemical transporter and chemical channel mechanisms in the rapid pressor response to chemical .	T43	T49	9476974
NA	CHEMICAL	GENE-N	6	4	chemical transporter and chemical channel mechanisms in the rapid pressor response to chemical .	T43	T50	9476974
NA	CHEMICAL	GENE-N	0	26	chemical ( 0.03-3 mg/kg ) produced dose-dependent , rapid , and brief increases in blood pressure ( BP ) in conscious rats pretreated with the chemical receptor antagonist , chemical .	T14	T46	9476974
NA	CHEMICAL	GENE-N	13	26	chemical ( 0.03-3 mg/kg ) produced dose-dependent , rapid , and brief increases in blood pressure ( BP ) in conscious rats pretreated with the chemical receptor antagonist , chemical .	T10	T46	9476974
CPR:6	CHEMICAL	GENE-N	29	26	chemical ( 0.03-3 mg/kg ) produced dose-dependent , rapid , and brief increases in blood pressure ( BP ) in conscious rats pretreated with the chemical receptor antagonist , chemical .	T13	T46	9476974
NA	CHEMICAL	GENE-N	0	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T15	T47	9476974
NA	CHEMICAL	GENE-N	6	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T16	T47	9476974
NA	CHEMICAL	GENE-N	8	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T17	T47	9476974
NA	CHEMICAL	GENE-N	10	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T18	T47	9476974
NA	CHEMICAL	GENE-N	12	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T19	T47	9476974
NA	CHEMICAL	GENE-N	14	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T20	T47	9476974
NA	CHEMICAL	GENE-N	7	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T21	T47	9476974
NA	CHEMICAL	GENE-N	18	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T22	T47	9476974
NA	CHEMICAL	GENE-N	21	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T23	T47	9476974
NA	CHEMICAL	GENE-N	37	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T24	T47	9476974
CPR:4	CHEMICAL	GENE-N	41	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T25	T47	9476974
CPR:4	CHEMICAL	GENE-N	43	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T26	T47	9476974
CPR:4	CHEMICAL	GENE-N	45	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T27	T47	9476974
CPR:4	CHEMICAL	GENE-N	47	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T28	T47	9476974
CPR:4	CHEMICAL	GENE-N	49	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T29	T47	9476974
CPR:4	CHEMICAL	GENE-N	52	38	chemical uptake inhibitors structurally analogous to chemical ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse chemical transporter selectivities ( chemical , chemical , chemical , chemical , chemical , and chemical ) either did not produce a rapid pressor response or produced only a small pressor response .	T30	T47	9476974
NA	CHEMICAL	GENE-N	5	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T31	T48	9476974
CPR:4	CHEMICAL	GENE-N	8	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T32	T48	9476974
CPR:4	CHEMICAL	GENE-N	10	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T33	T48	9476974
CPR:4	CHEMICAL	GENE-N	12	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T34	T48	9476974
CPR:4	CHEMICAL	GENE-N	14	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T35	T48	9476974
CPR:4	CHEMICAL	GENE-N	16	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T36	T48	9476974
CPR:4	CHEMICAL	GENE-N	18	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T37	T48	9476974
CPR:4	CHEMICAL	GENE-N	21	6	At nonconvulsant doses , the chemical channel blockers chemical , chemical , chemical , chemical , chemical , chemical , and chemical produced a small pressor response or no increase in BP .	T38	T48	9476974
NA	CHEMICAL	GENE-N	8	12	The present data suggest that the inhibition of chemical , chemical , or chemical transporter functions , either alone or in combination , does not mediate the rapid pressor response to chemical .	T4	T44	9476974
NA	CHEMICAL	GENE-N	10	12	The present data suggest that the inhibition of chemical , chemical , or chemical transporter functions , either alone or in combination , does not mediate the rapid pressor response to chemical .	T5	T44	9476974
NA	CHEMICAL	GENE-N	13	12	The present data suggest that the inhibition of chemical , chemical , or chemical transporter functions , either alone or in combination , does not mediate the rapid pressor response to chemical .	T6	T44	9476974
NA	CHEMICAL	GENE-N	20	12	The present data suggest that the inhibition of chemical , chemical , or chemical transporter functions , either alone or in combination , does not mediate the rapid pressor response to chemical .	T7	T44	9476974
NA	CHEMICAL	GENE-Y	8	9	From these results , it is proposed that chemical hydroxylase activity determines chemical concentrations by regulating chemical availability .	T21	T26	6621777
NA	CHEMICAL	GENE-Y	12	9	From these results , it is proposed that chemical hydroxylase activity determines chemical concentrations by regulating chemical availability .	T22	T26	6621777
CPR:9	CHEMICAL	GENE-Y	16	9	From these results , it is proposed that chemical hydroxylase activity determines chemical concentrations by regulating chemical availability .	T23	T26	6621777
NA	CHEMICAL	GENE-Y	7	2	Development of gene inhibitors : effect of chemical substituents on gene transcriptional activity under hypoxia .	T5	T15	23267767
NA	CHEMICAL	GENE-N	7	10	Development of gene inhibitors : effect of chemical substituents on gene transcriptional activity under hypoxia .	T5	T14	23267767
NA	CHEMICAL	GENE-N	4	15	A series of substituted chemical were synthesized and evaluated for their ability to inhibit hypoxia-induced gene transcriptional activity using a cell-based reporter assay in HeLa cells expressing the gene-dependent firefly luciferase reporter construct ( gene-Luc ) and constitutively expressing CMV-driven Renilla luciferase reporter , and their ability to inhibit cell growth ( GI ( 50 ) ) using the chemical assay .	T1	T6	23267767
NA	CHEMICAL	GENE-N	4	28	A series of substituted chemical were synthesized and evaluated for their ability to inhibit hypoxia-induced gene transcriptional activity using a cell-based reporter assay in HeLa cells expressing the gene-dependent firefly luciferase reporter construct ( gene-Luc ) and constitutively expressing CMV-driven Renilla luciferase reporter , and their ability to inhibit cell growth ( GI ( 50 ) ) using the chemical assay .	T1	T7	23267767
NA	CHEMICAL	GENE-N	4	34	A series of substituted chemical were synthesized and evaluated for their ability to inhibit hypoxia-induced gene transcriptional activity using a cell-based reporter assay in HeLa cells expressing the gene-dependent firefly luciferase reporter construct ( gene-Luc ) and constitutively expressing CMV-driven Renilla luciferase reporter , and their ability to inhibit cell growth ( GI ( 50 ) ) using the chemical assay .	T1	T8	23267767
NA	CHEMICAL	GENE-N	59	28	A series of substituted chemical were synthesized and evaluated for their ability to inhibit hypoxia-induced gene transcriptional activity using a cell-based reporter assay in HeLa cells expressing the gene-dependent firefly luciferase reporter construct ( gene-Luc ) and constitutively expressing CMV-driven Renilla luciferase reporter , and their ability to inhibit cell growth ( GI ( 50 ) ) using the chemical assay .	T2	T7	23267767
NA	CHEMICAL	GENE-N	59	34	A series of substituted chemical were synthesized and evaluated for their ability to inhibit hypoxia-induced gene transcriptional activity using a cell-based reporter assay in HeLa cells expressing the gene-dependent firefly luciferase reporter construct ( gene-Luc ) and constitutively expressing CMV-driven Renilla luciferase reporter , and their ability to inhibit cell growth ( GI ( 50 ) ) using the chemical assay .	T2	T8	23267767
NA	CHEMICAL	GENE-Y	0	18	chemical-induced contraction in the rat coronary artery : possible involvement of the endothelium , reactive chemical species and gene metabolites .	T26	T39	11811354
NA	CHEMICAL	GENE-Y	15	18	chemical-induced contraction in the rat coronary artery : possible involvement of the endothelium , reactive chemical species and gene metabolites .	T27	T39	11811354
NA	CHEMICAL	GENE-N	0	4	chemical radical scavengers , gene and gene , significantly attenuated the contraction .	T14	T31	11811354
NA	CHEMICAL	GENE-Y	0	6	chemical radical scavengers , gene and gene , significantly attenuated the contraction .	T14	T32	11811354
CPR:4	CHEMICAL	GENE-Y	6	0	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T15	T33	11811354
CPR:4	CHEMICAL	GENE-Y	6	2	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T15	T34	11811354
NA	CHEMICAL	GENE-Y	6	17	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T15	T35	11811354
NA	CHEMICAL	GENE-Y	6	24	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T15	T36	11811354
CPR:4	CHEMICAL	GENE-Y	8	0	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T16	T33	11811354
CPR:4	CHEMICAL	GENE-Y	8	2	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T16	T34	11811354
NA	CHEMICAL	GENE-Y	8	17	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T16	T35	11811354
NA	CHEMICAL	GENE-Y	8	24	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T16	T36	11811354
CPR:4	CHEMICAL	GENE-Y	10	0	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T17	T33	11811354
CPR:4	CHEMICAL	GENE-Y	10	2	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T17	T34	11811354
NA	CHEMICAL	GENE-Y	10	17	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T17	T35	11811354
NA	CHEMICAL	GENE-Y	10	24	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T17	T36	11811354
NA	CHEMICAL	GENE-Y	14	0	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T18	T33	11811354
NA	CHEMICAL	GENE-Y	14	2	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T18	T34	11811354
NA	CHEMICAL	GENE-Y	14	17	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T18	T35	11811354
NA	CHEMICAL	GENE-Y	14	24	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T18	T36	11811354
NA	CHEMICAL	GENE-Y	31	0	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T19	T33	11811354
NA	CHEMICAL	GENE-Y	31	2	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T19	T34	11811354
CPR:4	CHEMICAL	GENE-Y	31	17	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T19	T35	11811354
CPR:4	CHEMICAL	GENE-Y	31	24	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T19	T36	11811354
NA	CHEMICAL	GENE-Y	33	0	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T20	T33	11811354
NA	CHEMICAL	GENE-Y	33	2	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T20	T34	11811354
CPR:4	CHEMICAL	GENE-Y	33	17	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T20	T35	11811354
CPR:4	CHEMICAL	GENE-Y	33	24	gene ( gene ) inhibitors ( chemical , chemical and chemical ) attenuated the chemical-induced contraction in a concentration-dependent manner , and gene ( gene ) inhibitors at high concentrations ( chemical and chemical ) slightly attenuated the contraction .	T20	T36	11811354
NA	CHEMICAL	GENE-Y	0	2	A chemical synthetase inhibitor ( chemical ) attenuated the contraction to a small extent only at high concentrations .	T22	T37	11811354
CPR:4	CHEMICAL	GENE-Y	5	2	A chemical synthetase inhibitor ( chemical ) attenuated the contraction to a small extent only at high concentrations .	T23	T37	11811354
NA	CHEMICAL	GENE-Y	0	2	A chemical receptor antagonist ( chemical ) attenuated the contraction in a concentration-dependent manner .	T24	T38	11811354
CPR:6	CHEMICAL	GENE-Y	5	2	A chemical receptor antagonist ( chemical ) attenuated the contraction in a concentration-dependent manner .	T25	T38	11811354
CPR:6	CHEMICAL	GENE-N	1	1	A gene antagonist ( chemical ) attenuated the contraction in part and an gene antagonist ( chemical ) nearly abolished the contraction .	T2	T28	11811354
NA	CHEMICAL	GENE-N	1	13	A gene antagonist ( chemical ) attenuated the contraction in part and an gene antagonist ( chemical ) nearly abolished the contraction .	T2	T29	11811354
NA	CHEMICAL	GENE-N	9	1	A gene antagonist ( chemical ) attenuated the contraction in part and an gene antagonist ( chemical ) nearly abolished the contraction .	T3	T28	11811354
CPR:6	CHEMICAL	GENE-N	9	13	A gene antagonist ( chemical ) attenuated the contraction in part and an gene antagonist ( chemical ) nearly abolished the contraction .	T3	T29	11811354
NA	CHEMICAL	GENE-Y	12	36	From these results , it was suggested that the contraction induced by chemical in the rat coronary artery in the presence of chemical and chemical is endothelium dependent , and involves reactive chemical species and endothelial gene metabolites of chemical .	T5	T30	11811354
NA	CHEMICAL	GENE-Y	22	36	From these results , it was suggested that the contraction induced by chemical in the rat coronary artery in the presence of chemical and chemical is endothelium dependent , and involves reactive chemical species and endothelial gene metabolites of chemical .	T7	T30	11811354
NA	CHEMICAL	GENE-Y	24	36	From these results , it was suggested that the contraction induced by chemical in the rat coronary artery in the presence of chemical and chemical is endothelium dependent , and involves reactive chemical species and endothelial gene metabolites of chemical .	T8	T30	11811354
NA	CHEMICAL	GENE-Y	32	36	From these results , it was suggested that the contraction induced by chemical in the rat coronary artery in the presence of chemical and chemical is endothelium dependent , and involves reactive chemical species and endothelial gene metabolites of chemical .	T9	T30	11811354
NA	CHEMICAL	GENE-Y	39	36	From these results , it was suggested that the contraction induced by chemical in the rat coronary artery in the presence of chemical and chemical is endothelium dependent , and involves reactive chemical species and endothelial gene metabolites of chemical .	T10	T30	11811354
NA	CHEMICAL	GENE-N	2	3	Demonstration of chemical receptors on human platelets by flow cytometry .	T9	T19	6701456
NA	CHEMICAL	GENE-Y	3	0	gene conjugated with chemical ( gene-HIS ) has been used for the demonstration of chemical receptors on human platelets .	T7	T10	6701456
NA	CHEMICAL	GENE-Y	3	5	gene conjugated with chemical ( gene-HIS ) has been used for the demonstration of chemical receptors on human platelets .	T7	T18	6701456
NA	CHEMICAL	GENE-N	3	15	gene conjugated with chemical ( gene-HIS ) has been used for the demonstration of chemical receptors on human platelets .	T7	T11	6701456
NA	CHEMICAL	GENE-Y	0	0	gene conjugated with chemical ( gene-HIS ) has been used for the demonstration of chemical receptors on human platelets .	T1	T10	6701456
NA	CHEMICAL	GENE-Y	0	5	gene conjugated with chemical ( gene-HIS ) has been used for the demonstration of chemical receptors on human platelets .	T1	T18	6701456
NA	CHEMICAL	GENE-N	0	15	gene conjugated with chemical ( gene-HIS ) has been used for the demonstration of chemical receptors on human platelets .	T1	T11	6701456
NA	CHEMICAL	GENE-Y	14	3	The binding of gene-HIS was inhibited on 35-79 % of the platelets by the chemical H1 receptor antagonists chemical and chemical .	T2	T12	6701456
NA	CHEMICAL	GENE-Y	14	16	The binding of gene-HIS was inhibited on 35-79 % of the platelets by the chemical H1 receptor antagonists chemical and chemical .	T2	T13	6701456
CPR:4	CHEMICAL	GENE-Y	18	3	The binding of gene-HIS was inhibited on 35-79 % of the platelets by the chemical H1 receptor antagonists chemical and chemical .	T3	T12	6701456
CPR:6	CHEMICAL	GENE-Y	18	16	The binding of gene-HIS was inhibited on 35-79 % of the platelets by the chemical H1 receptor antagonists chemical and chemical .	T3	T13	6701456
CPR:4	CHEMICAL	GENE-Y	20	3	The binding of gene-HIS was inhibited on 35-79 % of the platelets by the chemical H1 receptor antagonists chemical and chemical .	T4	T12	6701456
CPR:6	CHEMICAL	GENE-Y	20	16	The binding of gene-HIS was inhibited on 35-79 % of the platelets by the chemical H1 receptor antagonists chemical and chemical .	T4	T13	6701456
NA	CHEMICAL	GENE-Y	1	3	The chemical H2 receptor antagonist chemical blocked the gene-HIS binding on 14-37 % of the platelets .	T5	T14	6701456
NA	CHEMICAL	GENE-Y	1	8	The chemical H2 receptor antagonist chemical blocked the gene-HIS binding on 14-37 % of the platelets .	T5	T15	6701456
CPR:6	CHEMICAL	GENE-Y	5	3	The chemical H2 receptor antagonist chemical blocked the gene-HIS binding on 14-37 % of the platelets .	T6	T14	6701456
CPR:4	CHEMICAL	GENE-Y	5	8	The chemical H2 receptor antagonist chemical blocked the gene-HIS binding on 14-37 % of the platelets .	T6	T15	6701456
NA	CHEMICAL	GENE-Y	3	4	Clinical assessment of chemical transporter blockade through biochemical and pharmacological profiles .	T28	T36	15184278
NA	CHEMICAL	GENE-Y	16	20	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T3	T29	15184278
NA	CHEMICAL	GENE-Y	16	22	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T3	T30	15184278
NA	CHEMICAL	GENE-Y	16	29	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T3	T34	15184278
NA	CHEMICAL	GENE-Y	18	20	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T10	T29	15184278
NA	CHEMICAL	GENE-Y	18	22	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T10	T30	15184278
NA	CHEMICAL	GENE-Y	18	29	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T10	T34	15184278
NA	CHEMICAL	GENE-Y	36	20	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T17	T29	15184278
NA	CHEMICAL	GENE-Y	36	22	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T17	T30	15184278
CPR:6	CHEMICAL	GENE-Y	36	29	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T17	T34	15184278
NA	CHEMICAL	GENE-Y	31	20	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T18	T29	15184278
NA	CHEMICAL	GENE-Y	31	22	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T18	T30	15184278
CPR:6	CHEMICAL	GENE-Y	31	29	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T18	T34	15184278
NA	CHEMICAL	GENE-Y	44	20	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T19	T29	15184278
NA	CHEMICAL	GENE-Y	44	22	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T19	T30	15184278
CPR:9	CHEMICAL	GENE-Y	44	29	BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral chemical ( chemical ) transporter ( gene ) function , we chronically antagonized gene by a range of doses of chemical [ chemical ] , which blocks the chemical reuptake process .	T19	T34	15184278
NA	CHEMICAL	GENE-Y	2	14	Plasma from chemical-treated subjects ( ex vivo effect ) dose-dependently decreased radioligand binding to gene ( maximum inhibition was 60 % ) ( P=0.02 ) .	T21	T35	15184278
NA	CHEMICAL	GENE-Y	19	9	CONCLUSIONS : These findings suggest that the degree of gene blockade can be assessed with the plasma or urine chemical/chemical ratio and the pressor effect of tyramine .	T13	T31	15184278
NA	CHEMICAL	GENE-Y	19	9	CONCLUSIONS : These findings suggest that the degree of gene blockade can be assessed with the plasma or urine chemical/chemical ratio and the pressor effect of tyramine .	T14	T31	15184278
NA	CHEMICAL	GENE-Y	1	18	In a genome-wide meta-analysis of a population-based discovery cohort ( n = 33 533 ) , rs838133 in gene ( 19q13.33 ) , rs197273 near gene ( gene ) ( 2p24.2 ) , and rs10163409 in gene ( 16q12.2 ) were among the top associations ( P < 10 ( -5 ) ) for percentage of total caloric intake from protein and chemical .	T2	T3	23372041
NA	CHEMICAL	GENE-Y	1	1	In a genome-wide meta-analysis of a population-based discovery cohort ( n = 33 533 ) , rs838133 in gene ( 19q13.33 ) , rs197273 near gene ( gene ) ( 2p24.2 ) , and rs10163409 in gene ( 16q12.2 ) were among the top associations ( P < 10 ( -5 ) ) for percentage of total caloric intake from protein and chemical .	T2	T4	23372041
NA	CHEMICAL	GENE-Y	1	27	In a genome-wide meta-analysis of a population-based discovery cohort ( n = 33 533 ) , rs838133 in gene ( 19q13.33 ) , rs197273 near gene ( gene ) ( 2p24.2 ) , and rs10163409 in gene ( 16q12.2 ) were among the top associations ( P < 10 ( -5 ) ) for percentage of total caloric intake from protein and chemical .	T2	T5	23372041
NA	CHEMICAL	GENE-Y	1	36	In a genome-wide meta-analysis of a population-based discovery cohort ( n = 33 533 ) , rs838133 in gene ( 19q13.33 ) , rs197273 near gene ( gene ) ( 2p24.2 ) , and rs10163409 in gene ( 16q12.2 ) were among the top associations ( P < 10 ( -5 ) ) for percentage of total caloric intake from protein and chemical .	T2	T6	23372041
CPR:9	CHEMICAL	GENE-Y	9	12	Once formed , the molecule can be converted to chemical by chemical-chemical aminotransferase ( gene ) .	T5	T31	16970975
CPR:9	CHEMICAL	GENE-Y	9	14	Once formed , the molecule can be converted to chemical by chemical-chemical aminotransferase ( gene ) .	T5	T32	16970975
NA	CHEMICAL	GENE-Y	11	12	Once formed , the molecule can be converted to chemical by chemical-chemical aminotransferase ( gene ) .	T6	T31	16970975
NA	CHEMICAL	GENE-Y	11	14	Once formed , the molecule can be converted to chemical by chemical-chemical aminotransferase ( gene ) .	T6	T32	16970975
NA	CHEMICAL	GENE-Y	11	12	Once formed , the molecule can be converted to chemical by chemical-chemical aminotransferase ( gene ) .	T7	T31	16970975
NA	CHEMICAL	GENE-Y	11	14	Once formed , the molecule can be converted to chemical by chemical-chemical aminotransferase ( gene ) .	T7	T32	16970975
NA	CHEMICAL	GENE-Y	5	3	In defects of gene , chemical is transformed to chemical , resulting in high levels of chemical in the body .	T9	T33	16970975
NA	CHEMICAL	GENE-Y	9	3	In defects of gene , chemical is transformed to chemical , resulting in high levels of chemical in the body .	T10	T33	16970975
NA	CHEMICAL	GENE-Y	16	3	In defects of gene , chemical is transformed to chemical , resulting in high levels of chemical in the body .	T11	T33	16970975
NA	CHEMICAL	GENE-N	8	0	gene subtypes mediating the regulation and modulation of chemical sensitization in rabbit thoracic aorta .	T33	T40	7875228
NA	CHEMICAL	GENE-Y	4	31	In beta-escin-skinned strips of chemical-pretreated smooth muscle , the enhancement of chemical contraction produced by chemical was significantly decreased , whereas the amplitude was the same as that produced by chemical or chemical ; this enhancement was inhibited by the selective gene antagonist chemical ( 100 nM ) .	T18	T39	7875228
NA	CHEMICAL	GENE-Y	11	31	In beta-escin-skinned strips of chemical-pretreated smooth muscle , the enhancement of chemical contraction produced by chemical was significantly decreased , whereas the amplitude was the same as that produced by chemical or chemical ; this enhancement was inhibited by the selective gene antagonist chemical ( 100 nM ) .	T19	T39	7875228
NA	CHEMICAL	GENE-Y	15	31	In beta-escin-skinned strips of chemical-pretreated smooth muscle , the enhancement of chemical contraction produced by chemical was significantly decreased , whereas the amplitude was the same as that produced by chemical or chemical ; this enhancement was inhibited by the selective gene antagonist chemical ( 100 nM ) .	T21	T39	7875228
NA	CHEMICAL	GENE-Y	30	31	In beta-escin-skinned strips of chemical-pretreated smooth muscle , the enhancement of chemical contraction produced by chemical was significantly decreased , whereas the amplitude was the same as that produced by chemical or chemical ; this enhancement was inhibited by the selective gene antagonist chemical ( 100 nM ) .	T22	T39	7875228
NA	CHEMICAL	GENE-Y	32	31	In beta-escin-skinned strips of chemical-pretreated smooth muscle , the enhancement of chemical contraction produced by chemical was significantly decreased , whereas the amplitude was the same as that produced by chemical or chemical ; this enhancement was inhibited by the selective gene antagonist chemical ( 100 nM ) .	T23	T39	7875228
CPR:6	CHEMICAL	GENE-Y	43	31	In beta-escin-skinned strips of chemical-pretreated smooth muscle , the enhancement of chemical contraction produced by chemical was significantly decreased , whereas the amplitude was the same as that produced by chemical or chemical ; this enhancement was inhibited by the selective gene antagonist chemical ( 100 nM ) .	T24	T39	7875228
CPR:3	CHEMICAL	GENE-N	8	5	Furthermore , the phosphorylation of gene produced by chemical was greater than that produced by chemical .	T6	T34	7875228
CPR:3	CHEMICAL	GENE-N	15	5	Furthermore , the phosphorylation of gene produced by chemical was greater than that produced by chemical .	T7	T34	7875228
NA	CHEMICAL	GENE-Y	14	3	When the cloned gene was transfected into COS 1 cells , gene stimulated intracellular chemical accumulation with an EC50 of 0.1 nM , whereas gene was > 250-fold less potent ( EC50 27.6 nM ) .	T1	T3	9231703
NA	CHEMICAL	GENE-N	14	11	When the cloned gene was transfected into COS 1 cells , gene stimulated intracellular chemical accumulation with an EC50 of 0.1 nM , whereas gene was > 250-fold less potent ( EC50 27.6 nM ) .	T1	T5	9231703
NA	CHEMICAL	GENE-Y	14	24	When the cloned gene was transfected into COS 1 cells , gene stimulated intracellular chemical accumulation with an EC50 of 0.1 nM , whereas gene was > 250-fold less potent ( EC50 27.6 nM ) .	T1	T6	9231703
NA	CHEMICAL	GENE-Y	10	4	Stimulation of the transfected gene by salmon calcitonin also resulted in chemical hydrolysis with an EC50 of 2.5 nM .	T2	T10	9231703
CPR:4	CHEMICAL	GENE-Y	3	5	Preclinical pharmacology of chemical : a novel selective inhibitor of gene .	T17	T33	15655513
CPR:4	CHEMICAL	GENE-Y	7	9	This manuscript presents the preclinical profile of chemical , a novel gene ( gene ) selective inhibitor .	T10	T30	15655513
CPR:4	CHEMICAL	GENE-Y	7	13	This manuscript presents the preclinical profile of chemical , a novel gene ( gene ) selective inhibitor .	T10	T32	15655513
CPR:4	CHEMICAL	GENE-Y	0	3	chemical inhibited purified gene and gene with K ( i ) values of 3 and 0.06 microM , respectively .	T4	T20	15655513
CPR:4	CHEMICAL	GENE-Y	0	5	chemical inhibited purified gene and gene with K ( i ) values of 3 and 0.06 microM , respectively .	T4	T21	15655513
CPR:4	CHEMICAL	GENE-Y	4	15	In cellular assays , chemical had an IC ( 50 ) of 0.14 microM in gene-expressing dermal fibroblasts , but caused no inhibition of gene at concentrations up to 30 microM ( HEK 293 cells transfected with gene ) .	T8	T22	15655513
NA	CHEMICAL	GENE-Y	4	24	In cellular assays , chemical had an IC ( 50 ) of 0.14 microM in gene-expressing dermal fibroblasts , but caused no inhibition of gene at concentrations up to 30 microM ( HEK 293 cells transfected with gene ) .	T8	T23	15655513
NA	CHEMICAL	GENE-N	4	37	In cellular assays , chemical had an IC ( 50 ) of 0.14 microM in gene-expressing dermal fibroblasts , but caused no inhibition of gene at concentrations up to 30 microM ( HEK 293 cells transfected with gene ) .	T8	T24	15655513
CPR:4	CHEMICAL	GENE-Y	1	18	In a human whole blood assay , IC ( 50 ) values for chemical were 0.13 microM for gene and 67 microM for gene ( gene/gene selectivity ratio 515 ) .	T9	T25	15655513
CPR:4	CHEMICAL	GENE-Y	1	23	In a human whole blood assay , IC ( 50 ) values for chemical were 0.13 microM for gene and 67 microM for gene ( gene/gene selectivity ratio 515 ) .	T9	T26	15655513
CPR:4	CHEMICAL	GENE-Y	1	25	In a human whole blood assay , IC ( 50 ) values for chemical were 0.13 microM for gene and 67 microM for gene ( gene/gene selectivity ratio 515 ) .	T9	T27	15655513
CPR:4	CHEMICAL	GENE-Y	1	25	In a human whole blood assay , IC ( 50 ) values for chemical were 0.13 microM for gene and 67 microM for gene ( gene/gene selectivity ratio 515 ) .	T9	T28	15655513
CPR:4	CHEMICAL	GENE-Y	3	5	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T12	T29	15655513
NA	CHEMICAL	GENE-Y	3	26	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T12	T31	15655513
CPR:9	CHEMICAL	GENE-Y	6	5	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T13	T29	15655513
NA	CHEMICAL	GENE-Y	6	26	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T13	T31	15655513
CPR:9	CHEMICAL	GENE-Y	7	5	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T14	T29	15655513
NA	CHEMICAL	GENE-Y	7	26	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T14	T31	15655513
NA	CHEMICAL	GENE-Y	7	5	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T15	T29	15655513
CPR:9	CHEMICAL	GENE-Y	7	26	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T15	T31	15655513
NA	CHEMICAL	GENE-Y	7	5	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T16	T29	15655513
CPR:9	CHEMICAL	GENE-Y	7	26	Ex vivo , chemical inhibited gene-derived chemical ( chemical ) generation with an ID ( 50 ) of 33 mg kg ( -1 ) , whereas gene-derived production of chemical ( chemical ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( -1 ) .	T16	T31	15655513
CPR:4	CHEMICAL	GENE-Y	10	6	However , consistent with its low gene inhibitory activity , chemical at a dose of 100 mg kg ( -1 ) orally caused no ulcers and was significantly less ulcerogenic than chemical ( P < 0.05 ) .	T3	T18	15655513
CPR:4	CHEMICAL	GENE-Y	12	6	However , consistent with its low gene inhibitory activity , chemical at a dose of 100 mg kg ( -1 ) orally caused no ulcers and was significantly less ulcerogenic than chemical ( P < 0.05 ) .	T5	T18	15655513
NA	CHEMICAL	GENE-N	2	4	Binding of chemical to gene may be involved in its inhibition of gene production .	T7	T14	8755512
CPR:4	CHEMICAL	GENE-Y	2	12	Binding of chemical to gene may be involved in its inhibition of gene production .	T7	T15	8755512
CPR:4	CHEMICAL	GENE-Y	4	13	The immunomodulatory activity of chemical has been ascribed to the selective inhibition of gene from monocytes .	T2	T10	8755512
CPR:4	CHEMICAL	GENE-N	7	4	Crystallographic analysis of the gene with bound chemical inhibitors at 2.0 A resolution .	T18	T23	9843368
NA	CHEMICAL	GENE-N	1	2	The chemical hydroxylases represent a superfamily of structurally and functionally closely related enzymes , one of those functions being reversible inhibition by chemical derivatives .	T10	T22	9843368
CPR:4	CHEMICAL	GENE-N	4	2	The chemical hydroxylases represent a superfamily of structurally and functionally closely related enzymes , one of those functions being reversible inhibition by chemical derivatives .	T6	T22	9843368
NA	CHEMICAL	GENE-Y	32	16	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T8	T20	9843368
NA	CHEMICAL	GENE-Y	32	18	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T8	T21	9843368
CPR:4	CHEMICAL	GENE-Y	27	16	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T9	T20	9843368
CPR:4	CHEMICAL	GENE-Y	27	18	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T9	T21	9843368
NA	CHEMICAL	GENE-Y	31	16	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T11	T20	9843368
NA	CHEMICAL	GENE-Y	31	18	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T11	T21	9843368
NA	CHEMICAL	GENE-Y	46	16	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T12	T20	9843368
NA	CHEMICAL	GENE-Y	46	18	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T12	T21	9843368
NA	CHEMICAL	GENE-Y	55	16	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T13	T20	9843368
NA	CHEMICAL	GENE-Y	55	18	Here we present the crystal structure of the dimeric catalytic domain ( residues 117-424 ) of gene ( gene ) , cocrystallized with various potent and well-known chemical inhibitors and refined at a resolution of 2.0 A . The chemical bind by bidentate coordination to each chemical in both subunits of the dimer through the chemical groups , forming a blue-green colored ligand-to-metal charge-transfer complex .	T13	T21	9843368
CPR:4	CHEMICAL	GENE-Y	0	7	chemical prevents cardiac hypertrophy and overexpression of gene and gene in pressure-overloaded rat heart .	T11	T44	15942707
CPR:4	CHEMICAL	GENE-Y	0	9	chemical prevents cardiac hypertrophy and overexpression of gene and gene in pressure-overloaded rat heart .	T11	T45	15942707
NA	CHEMICAL	GENE-Y	5	9	To evaluate the effect of chemical on both myocardial gene expression and cardiac hypertrophy , infra-renal aortic banding was performed for 4 weeks in adult Sprague-Dawley rats to induce cardiac hypertrophy .	T9	T42	15942707
NA	CHEMICAL	GENE-Y	2	12	Treatment with chemical , chemical , or chemical did not significantly affect gene and gene proteins expression in the banding groups .	T3	T20	15942707
NA	CHEMICAL	GENE-Y	2	14	Treatment with chemical , chemical , or chemical did not significantly affect gene and gene proteins expression in the banding groups .	T3	T21	15942707
NA	CHEMICAL	GENE-Y	4	12	Treatment with chemical , chemical , or chemical did not significantly affect gene and gene proteins expression in the banding groups .	T4	T20	15942707
NA	CHEMICAL	GENE-Y	4	14	Treatment with chemical , chemical , or chemical did not significantly affect gene and gene proteins expression in the banding groups .	T4	T21	15942707
NA	CHEMICAL	GENE-Y	7	12	Treatment with chemical , chemical , or chemical did not significantly affect gene and gene proteins expression in the banding groups .	T5	T20	15942707
NA	CHEMICAL	GENE-Y	7	14	Treatment with chemical , chemical , or chemical did not significantly affect gene and gene proteins expression in the banding groups .	T5	T21	15942707
CPR:4	CHEMICAL	GENE-Y	2	9	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T6	T26	15942707
CPR:4	CHEMICAL	GENE-Y	2	11	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T6	T27	15942707
CPR:4	CHEMICAL	GENE-Y	2	13	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T6	T28	15942707
CPR:3	CHEMICAL	GENE-Y	2	16	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T6	T29	15942707
CPR:4	CHEMICAL	GENE-Y	21	4	Increased immunohistochemical labeling of gene , gene , and gene in the ventricular myocardium was observed in the banding group and chemical again normalized the labeling .	T7	T30	15942707
CPR:4	CHEMICAL	GENE-Y	21	6	Increased immunohistochemical labeling of gene , gene , and gene in the ventricular myocardium was observed in the banding group and chemical again normalized the labeling .	T7	T31	15942707
CPR:4	CHEMICAL	GENE-Y	21	9	Increased immunohistochemical labeling of gene , gene , and gene in the ventricular myocardium was observed in the banding group and chemical again normalized the labeling .	T7	T32	15942707
NA	CHEMICAL	GENE-Y	0	0	gene negatively regulates gene signalling by forming a ternary complex with gene and gene .	T3	T37	17128263
NA	CHEMICAL	GENE-Y	0	3	gene negatively regulates gene signalling by forming a ternary complex with gene and gene .	T3	T40	17128263
NA	CHEMICAL	GENE-Y	0	7	gene negatively regulates gene signalling by forming a ternary complex with gene and gene .	T3	T38	17128263
NA	CHEMICAL	GENE-Y	0	7	gene negatively regulates gene signalling by forming a ternary complex with gene and gene .	T3	T39	17128263
NA	CHEMICAL	GENE-Y	5	5	Here , we demonstrate that gene ( gene ) modulates the action of gene-mediated signalling by interacting with chemical kinase Jak2 ( gene ) in a gene-dependent manner .	T1	T15	17128263
NA	CHEMICAL	GENE-Y	5	7	Here , we demonstrate that gene ( gene ) modulates the action of gene-mediated signalling by interacting with chemical kinase Jak2 ( gene ) in a gene-dependent manner .	T1	T16	17128263
NA	CHEMICAL	GENE-Y	5	13	Here , we demonstrate that gene ( gene ) modulates the action of gene-mediated signalling by interacting with chemical kinase Jak2 ( gene ) in a gene-dependent manner .	T1	T17	17128263
NA	CHEMICAL	GENE-Y	5	20	Here , we demonstrate that gene ( gene ) modulates the action of gene-mediated signalling by interacting with chemical kinase Jak2 ( gene ) in a gene-dependent manner .	T1	T18	17128263
NA	CHEMICAL	GENE-Y	5	22	Here , we demonstrate that gene ( gene ) modulates the action of gene-mediated signalling by interacting with chemical kinase Jak2 ( gene ) in a gene-dependent manner .	T1	T20	17128263
NA	CHEMICAL	GENE-Y	5	26	Here , we demonstrate that gene ( gene ) modulates the action of gene-mediated signalling by interacting with chemical kinase Jak2 ( gene ) in a gene-dependent manner .	T1	T21	17128263
NA	CHEMICAL	GENE-Y	24	2	Interestingly , gene physically linked gene and gene ( gene ) by binding to both using different domains , and this process was implicated in the modulation of gene signalling through gene .	T2	T33	17128263
NA	CHEMICAL	GENE-Y	24	5	Interestingly , gene physically linked gene and gene ( gene ) by binding to both using different domains , and this process was implicated in the modulation of gene signalling through gene .	T2	T34	17128263
NA	CHEMICAL	GENE-N	24	7	Interestingly , gene physically linked gene and gene ( gene ) by binding to both using different domains , and this process was implicated in the modulation of gene signalling through gene .	T2	T35	17128263
NA	CHEMICAL	GENE-N	24	9	Interestingly , gene physically linked gene and gene ( gene ) by binding to both using different domains , and this process was implicated in the modulation of gene signalling through gene .	T2	T36	17128263
NA	CHEMICAL	GENE-N	24	13	Interestingly , gene physically linked gene and gene ( gene ) by binding to both using different domains , and this process was implicated in the modulation of gene signalling through gene .	T2	T5	17128263
NA	CHEMICAL	GENE-Y	24	31	Interestingly , gene physically linked gene and gene ( gene ) by binding to both using different domains , and this process was implicated in the modulation of gene signalling through gene .	T2	T6	17128263
NA	CHEMICAL	GENE-Y	1	2	In chemical hydratase deficiency ( mutations in gene ) , it derives from chemical degradation .	T2	T15	23355087
NA	CHEMICAL	GENE-Y	1	7	In chemical hydratase deficiency ( mutations in gene ) , it derives from chemical degradation .	T2	T28	23355087
NA	CHEMICAL	GENE-Y	6	2	In chemical hydratase deficiency ( mutations in gene ) , it derives from chemical degradation .	T5	T15	23355087
NA	CHEMICAL	GENE-Y	6	7	In chemical hydratase deficiency ( mutations in gene ) , it derives from chemical degradation .	T5	T28	23355087
NA	CHEMICAL	GENE-Y	0	0	gene responded only to chemical .	T1	T13	23535288
NA	CHEMICAL	GENE-N	2	17	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T10	T31	23541982
NA	CHEMICAL	GENE-N	2	19	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T10	T33	23541982
NA	CHEMICAL	GENE-Y	2	30	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T10	T36	23541982
NA	CHEMICAL	GENE-N	7	17	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T15	T31	23541982
NA	CHEMICAL	GENE-N	7	19	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T15	T33	23541982
NA	CHEMICAL	GENE-Y	7	30	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T15	T36	23541982
NA	CHEMICAL	GENE-N	9	17	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T19	T31	23541982
NA	CHEMICAL	GENE-N	9	19	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T19	T33	23541982
NA	CHEMICAL	GENE-Y	9	30	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T19	T36	23541982
NA	CHEMICAL	GENE-N	11	17	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T2	T31	23541982
NA	CHEMICAL	GENE-N	11	19	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T2	T33	23541982
NA	CHEMICAL	GENE-Y	11	30	The neurospecific chemical 24-hydroxylase converts excess brain chemical into chemical ( chemical ) which , via the gene ( gene ) , can increase the expression and synthesis of astrocyte gene .	T2	T36	23541982
CPR:4	CHEMICAL	GENE-Y	0	3	chemical also increases gene ( gene ) deposition and gene pathology .	T1	T22	23541982
CPR:4	CHEMICAL	GENE-Y	0	5	chemical also increases gene ( gene ) deposition and gene pathology .	T1	T23	23541982
CPR:4	CHEMICAL	GENE-Y	0	9	chemical also increases gene ( gene ) deposition and gene pathology .	T1	T24	23541982
NA	CHEMICAL	GENE-Y	2	0	gene , chemical , gene and gene were correlated in Alzheimer disease ( AD ) samples .	T3	T25	23541982
NA	CHEMICAL	GENE-Y	2	4	gene , chemical , gene and gene were correlated in Alzheimer disease ( AD ) samples .	T3	T26	23541982
NA	CHEMICAL	GENE-Y	2	6	gene , chemical , gene and gene were correlated in Alzheimer disease ( AD ) samples .	T3	T27	23541982
CPR:3	CHEMICAL	GENE-Y	2	8	Excess of chemical converted into chemical may up-regulate gene synthesis which is a scavenger for gene and gene .	T4	T28	23541982
NA	CHEMICAL	GENE-Y	2	15	Excess of chemical converted into chemical may up-regulate gene synthesis which is a scavenger for gene and gene .	T4	T29	23541982
NA	CHEMICAL	GENE-Y	2	12	Excess of chemical converted into chemical may up-regulate gene synthesis which is a scavenger for gene and gene .	T4	T30	23541982
CPR:3	CHEMICAL	GENE-Y	5	8	Excess of chemical converted into chemical may up-regulate gene synthesis which is a scavenger for gene and gene .	T5	T28	23541982
NA	CHEMICAL	GENE-Y	5	15	Excess of chemical converted into chemical may up-regulate gene synthesis which is a scavenger for gene and gene .	T5	T29	23541982
NA	CHEMICAL	GENE-Y	5	12	Excess of chemical converted into chemical may up-regulate gene synthesis which is a scavenger for gene and gene .	T5	T30	23541982
NA	CHEMICAL	GENE-Y	19	28	In AD this protective mechanism seems to be inefficient , probably due to the presence of high concentrations of chemical , microvascular dysfunction and the decreased efficiency of gene as lipid transporter and gene scavenger .	T6	T32	23541982
NA	CHEMICAL	GENE-Y	19	33	In AD this protective mechanism seems to be inefficient , probably due to the presence of high concentrations of chemical , microvascular dysfunction and the decreased efficiency of gene as lipid transporter and gene scavenger .	T6	T34	23541982
NA	CHEMICAL	GENE-Y	3	20	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T5	T27	23619606
NA	CHEMICAL	GENE-Y	3	23	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T5	T28	23619606
NA	CHEMICAL	GENE-Y	3	25	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T5	T29	23619606
NA	CHEMICAL	GENE-Y	3	28	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T5	T30	23619606
NA	CHEMICAL	GENE-Y	3	30	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T5	T31	23619606
NA	CHEMICAL	GENE-Y	49	20	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T12	T27	23619606
NA	CHEMICAL	GENE-Y	49	23	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T12	T28	23619606
NA	CHEMICAL	GENE-Y	49	25	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T12	T29	23619606
NA	CHEMICAL	GENE-Y	49	28	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T12	T30	23619606
NA	CHEMICAL	GENE-Y	49	30	To identify the chemical ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv/129 wild-type ( gene ) , gene-null ( gene-null ) and gene ( gene ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % chemical .	T12	T31	23619606
NA	CHEMICAL	GENE-Y	4	17	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T15	T32	23619606
NA	CHEMICAL	GENE-Y	4	21	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T15	T33	23619606
NA	CHEMICAL	GENE-Y	4	23	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T15	T34	23619606
NA	CHEMICAL	GENE-Y	6	17	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T16	T32	23619606
NA	CHEMICAL	GENE-Y	6	21	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T16	T33	23619606
NA	CHEMICAL	GENE-Y	6	23	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T16	T34	23619606
NA	CHEMICAL	GENE-Y	8	17	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T18	T32	23619606
NA	CHEMICAL	GENE-Y	8	21	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T18	T33	23619606
NA	CHEMICAL	GENE-Y	8	23	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T18	T34	23619606
NA	CHEMICAL	GENE-Y	10	17	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T19	T32	23619606
NA	CHEMICAL	GENE-Y	10	21	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T19	T33	23619606
NA	CHEMICAL	GENE-Y	10	23	The plasma levels of chemical , chemical , chemical and chemical were higher in the pregnant control gene mice than in gene-null and gene mice .	T19	T34	23619606
NA	CHEMICAL	GENE-Y	0	13	chemical exposure significantly decreased the levels of these four FAs only in pregnant gene mice .	T20	T35	23619606
NA	CHEMICAL	GENE-N	2	8	However , chemical exposure did not clearly influence gene nor gene expressions in the liver of all maternal mice .	T7	T23	23619606
NA	CHEMICAL	GENE-N	2	10	However , chemical exposure did not clearly influence gene nor gene expressions in the liver of all maternal mice .	T7	T24	23619606
NA	CHEMICAL	GENE-N	0	4	chemical deficiency impairs the gene-effector system and leads to chemical phosphatase overactivation and cell death in the rat hippocampus .	T22	T38	22902329
NA	CHEMICAL	GENE-N	0	10	chemical deficiency impairs the gene-effector system and leads to chemical phosphatase overactivation and cell death in the rat hippocampus .	T22	T39	22902329
NA	CHEMICAL	GENE-N	9	4	chemical deficiency impairs the gene-effector system and leads to chemical phosphatase overactivation and cell death in the rat hippocampus .	T23	T38	22902329
NA	CHEMICAL	GENE-N	9	10	chemical deficiency impairs the gene-effector system and leads to chemical phosphatase overactivation and cell death in the rat hippocampus .	T23	T39	22902329
CPR:3	CHEMICAL	GENE-N	18	9	We previously demonstrated that the somatostatinergic system , implicated in neuronal survival control , can be modulated by chemical in the rat dentate gyrus , increasing chemical response element binding protein phosphorylation .	T12	T33	22902329
NA	CHEMICAL	GENE-N	26	9	We previously demonstrated that the somatostatinergic system , implicated in neuronal survival control , can be modulated by chemical in the rat dentate gyrus , increasing chemical response element binding protein phosphorylation .	T13	T33	22902329
NA	CHEMICAL	GENE-Y	10	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T14	T34	22902329
NA	CHEMICAL	GENE-Y	10	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T14	T35	22902329
NA	CHEMICAL	GENE-Y	16	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T15	T34	22902329
NA	CHEMICAL	GENE-Y	16	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T15	T35	22902329
NA	CHEMICAL	GENE-Y	2	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T16	T34	22902329
NA	CHEMICAL	GENE-Y	2	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T16	T35	22902329
NA	CHEMICAL	GENE-Y	35	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T17	T34	22902329
NA	CHEMICAL	GENE-Y	35	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T17	T35	22902329
NA	CHEMICAL	GENE-Y	2	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T18	T34	22902329
NA	CHEMICAL	GENE-Y	2	2	To gain a better understanding of the molecular actions of chemical and examine the link among chemical , chemical and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of chemical on the gene signaling pathway and neuronal survival in the rat hippocampus .	T18	T35	22902329
NA	CHEMICAL	GENE-Y	2	2	No changes in chemical expression were detected in chemical-deficient rats .	T19	T36	22902329
NA	CHEMICAL	GENE-Y	2	2	No changes in chemical expression were detected in chemical-deficient rats .	T20	T36	22902329
NA	CHEMICAL	GENE-N	6	12	These rats , however , showed a significant increase in the chemical receptor density and dissociation constant , which correlated with a significant increase in the protein levels of genes .	T21	T37	22902329
NA	CHEMICAL	GENE-N	6	12	These rats , however , showed a significant increase in the chemical receptor density and dissociation constant , which correlated with a significant increase in the protein levels of genes .	T21	T24	22902329
NA	CHEMICAL	GENE-N	6	12	These rats , however , showed a significant increase in the chemical receptor density and dissociation constant , which correlated with a significant increase in the protein levels of genes .	T2	T37	22902329
NA	CHEMICAL	GENE-N	6	12	These rats , however , showed a significant increase in the chemical receptor density and dissociation constant , which correlated with a significant increase in the protein levels of genes .	T2	T24	22902329
NA	CHEMICAL	GENE-N	2	10	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T3	T25	22902329
NA	CHEMICAL	GENE-N	2	20	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T3	T26	22902329
NA	CHEMICAL	GENE-N	2	23	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T3	T27	22902329
NA	CHEMICAL	GENE-N	9	10	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T4	T25	22902329
NA	CHEMICAL	GENE-N	9	20	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T4	T26	22902329
NA	CHEMICAL	GENE-N	9	23	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T4	T27	22902329
NA	CHEMICAL	GENE-N	16	10	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T5	T25	22902329
NA	CHEMICAL	GENE-N	16	20	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T5	T26	22902329
NA	CHEMICAL	GENE-N	16	23	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T5	T27	22902329
NA	CHEMICAL	GENE-N	19	10	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T6	T25	22902329
NA	CHEMICAL	GENE-N	19	20	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T6	T26	22902329
NA	CHEMICAL	GENE-N	19	23	Nevertheless , chemical deficiency impaired the ability of the chemical receptors to couple to the effectors chemical cyclase and chemical phosphatase by diminishing gene functionality .	T6	T27	22902329
NA	CHEMICAL	GENE-N	2	7	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T7	T28	22902329
NA	CHEMICAL	GENE-Y	2	10	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T7	T29	22902329
NA	CHEMICAL	GENE-Y	2	16	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T7	T30	22902329
NA	CHEMICAL	GENE-N	2	13	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T7	T31	22902329
NA	CHEMICAL	GENE-N	6	7	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T8	T28	22902329
NA	CHEMICAL	GENE-Y	6	10	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T8	T29	22902329
NA	CHEMICAL	GENE-Y	6	16	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T8	T30	22902329
NA	CHEMICAL	GENE-N	6	13	Furthermore , chemical deficiency significantly increased chemical phosphatase activity and gene expression , as well as gene activation , and decreased gene phosphorylation .	T8	T31	22902329
CPR:4	CHEMICAL	GENE-N	0	6	chemical induces apoptosis through suppression of gene signaling pathway in HL-60 cells .	T11	T20	23111283
CPR:4	CHEMICAL	GENE-Y	5	8	Western blot analysis indicated that chemical inhibits the gene/gene/gene pathway .	T10	T17	23111283
CPR:4	CHEMICAL	GENE-Y	5	8	Western blot analysis indicated that chemical inhibits the gene/gene/gene pathway .	T10	T18	23111283
CPR:4	CHEMICAL	GENE-N	5	8	Western blot analysis indicated that chemical inhibits the gene/gene/gene pathway .	T10	T19	23111283
CPR:5	CHEMICAL	GENE-N	17	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T3	T33	14730417
CPR:5	CHEMICAL	GENE-N	19	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T4	T33	14730417
CPR:5	CHEMICAL	GENE-N	21	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T5	T33	14730417
CPR:5	CHEMICAL	GENE-N	23	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T6	T33	14730417
CPR:5	CHEMICAL	GENE-N	25	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T7	T33	14730417
CPR:5	CHEMICAL	GENE-N	27	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T8	T33	14730417
CPR:5	CHEMICAL	GENE-N	29	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T9	T33	14730417
CPR:5	CHEMICAL	GENE-N	31	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T10	T33	14730417
CPR:5	CHEMICAL	GENE-N	33	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T11	T33	14730417
CPR:6	CHEMICAL	GENE-N	38	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T12	T33	14730417
CPR:6	CHEMICAL	GENE-N	40	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T13	T33	14730417
CPR:6	CHEMICAL	GENE-N	42	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T14	T33	14730417
CPR:6	CHEMICAL	GENE-N	9	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T15	T33	14730417
CPR:6	CHEMICAL	GENE-N	46	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T16	T33	14730417
CPR:6	CHEMICAL	GENE-N	48	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T17	T33	14730417
CPR:6	CHEMICAL	GENE-N	50	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T18	T33	14730417
CPR:6	CHEMICAL	GENE-N	52	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T19	T33	14730417
CPR:6	CHEMICAL	GENE-N	54	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T20	T33	14730417
CPR:6	CHEMICAL	GENE-N	56	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T21	T33	14730417
CPR:6	CHEMICAL	GENE-N	58	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T22	T33	14730417
CPR:6	CHEMICAL	GENE-N	60	9	The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) and antagonists ( chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical ) at all three subtypes of gene in an identical cellular background .	T23	T33	14730417
NA	CHEMICAL	GENE-N	5	5	Furthermore , we analyzed the gene-mediated chemical cyclase activity in isolated membranes from these cell lines .	T2	T24	14730417
NA	CHEMICAL	GENE-N	5	7	Furthermore , we analyzed the gene-mediated chemical cyclase activity in isolated membranes from these cell lines .	T2	T25	14730417
NA	CHEMICAL	GENE-Y	4	1	Adenovirus-delivered gene treatment for chemical-induced acute lung injury .	T10	T24	23614728
NA	CHEMICAL	GENE-Y	15	20	Objective : In this study , the histopathological changes of the lungs after exposure to chemical and the effect of gene treatment were examined .	T6	T20	23614728
NA	CHEMICAL	GENE-Y	5	13	The lung injury induced by chemical was markedly reduced after the injection of Ad/gene .	T1	T12	23614728
NA	CHEMICAL	GENE-Y	18	3	The increase of gene and gene and decrease of gene in the serum and bronchoalveolar lavage fluid of chemical-exposed animals were abolished by the administration of Ad/gene .	T2	T13	23614728
NA	CHEMICAL	GENE-Y	18	5	The increase of gene and gene and decrease of gene in the serum and bronchoalveolar lavage fluid of chemical-exposed animals were abolished by the administration of Ad/gene .	T2	T14	23614728
NA	CHEMICAL	GENE-Y	18	9	The increase of gene and gene and decrease of gene in the serum and bronchoalveolar lavage fluid of chemical-exposed animals were abolished by the administration of Ad/gene .	T2	T15	23614728
NA	CHEMICAL	GENE-Y	18	26	The increase of gene and gene and decrease of gene in the serum and bronchoalveolar lavage fluid of chemical-exposed animals were abolished by the administration of Ad/gene .	T2	T17	23614728
NA	CHEMICAL	GENE-Y	10	4	Discussion and conclusions : gene has the beneficial effects on chemical-induced lung injury .	T3	T18	23614728
NA	CHEMICAL	GENE-Y	6	8	Molecular mechanism regulating 24-hour rhythm of chemical d3 receptor expression in mouse ventral striatum .	T6	T35	23429911
NA	CHEMICAL	GENE-Y	1	3	The chemical D3 receptor ( gene ) in the ventral striatum is thought to influence motivation and motor functions .	T3	T21	23429911
NA	CHEMICAL	GENE-Y	1	2	The chemical D3 receptor ( gene ) in the ventral striatum is thought to influence motivation and motor functions .	T3	T19	23429911
NA	CHEMICAL	GENE-Y	8	3	The transcription of gene was enhanced by the chemical-related gene α ( gene ) , and its activation was inhibited by the orphan receptor gene , an endogenous antagonist of gene .	T4	T22	23429911
NA	CHEMICAL	GENE-Y	8	10	The transcription of gene was enhanced by the chemical-related gene α ( gene ) , and its activation was inhibited by the orphan receptor gene , an endogenous antagonist of gene .	T4	T23	23429911
NA	CHEMICAL	GENE-Y	8	10	The transcription of gene was enhanced by the chemical-related gene α ( gene ) , and its activation was inhibited by the orphan receptor gene , an endogenous antagonist of gene .	T4	T24	23429911
NA	CHEMICAL	GENE-N	8	9	The transcription of gene was enhanced by the chemical-related gene α ( gene ) , and its activation was inhibited by the orphan receptor gene , an endogenous antagonist of gene .	T4	T25	23429911
NA	CHEMICAL	GENE-Y	8	10	The transcription of gene was enhanced by the chemical-related gene α ( gene ) , and its activation was inhibited by the orphan receptor gene , an endogenous antagonist of gene .	T4	T26	23429911
NA	CHEMICAL	GENE-Y	8	10	The transcription of gene was enhanced by the chemical-related gene α ( gene ) , and its activation was inhibited by the orphan receptor gene , an endogenous antagonist of gene .	T4	T27	23429911
NA	CHEMICAL	GENE-Y	3	9	The serum or chemical-induced oscillation in the expression of gene in cells was abrogated by the downregulation or overexpression of gene , suggesting that gene functions as a regulator of gene oscillations in the cellular autonomous clock .	T5	T28	23429911
NA	CHEMICAL	GENE-Y	3	20	The serum or chemical-induced oscillation in the expression of gene in cells was abrogated by the downregulation or overexpression of gene , suggesting that gene functions as a regulator of gene oscillations in the cellular autonomous clock .	T5	T29	23429911
NA	CHEMICAL	GENE-Y	3	24	The serum or chemical-induced oscillation in the expression of gene in cells was abrogated by the downregulation or overexpression of gene , suggesting that gene functions as a regulator of gene oscillations in the cellular autonomous clock .	T5	T30	23429911
NA	CHEMICAL	GENE-Y	3	30	The serum or chemical-induced oscillation in the expression of gene in cells was abrogated by the downregulation or overexpression of gene , suggesting that gene functions as a regulator of gene oscillations in the cellular autonomous clock .	T5	T31	23429911
CPR:5	CHEMICAL	GENE-Y	1	6	Moreover , the effects of the gene agonist chemical ( chemical ) -induced locomotor hypoactivity were significantly increased when gene proteins were abundant .	T1	T8	23429911
CPR:5	CHEMICAL	GENE-Y	1	19	Moreover , the effects of the gene agonist chemical ( chemical ) -induced locomotor hypoactivity were significantly increased when gene proteins were abundant .	T1	T9	23429911
CPR:5	CHEMICAL	GENE-Y	10	6	Moreover , the effects of the gene agonist chemical ( chemical ) -induced locomotor hypoactivity were significantly increased when gene proteins were abundant .	T2	T8	23429911
CPR:5	CHEMICAL	GENE-Y	10	19	Moreover , the effects of the gene agonist chemical ( chemical ) -induced locomotor hypoactivity were significantly increased when gene proteins were abundant .	T2	T9	23429911
CPR:9	CHEMICAL	GENE-N	5	4	The catalytic competence of gene in the synthesis of chemical from chemical in the brain : an in vitro study .	T18	T35	23098818
CPR:9	CHEMICAL	GENE-N	5	4	The catalytic competence of gene in the synthesis of chemical from chemical in the brain : an in vitro study .	T19	T35	23098818
NA	CHEMICAL	GENE-N	17	8	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T8	T25	23098818
NA	CHEMICAL	GENE-N	17	10	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T8	T26	23098818
NA	CHEMICAL	GENE-N	19	8	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T9	T25	23098818
NA	CHEMICAL	GENE-N	19	10	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T9	T26	23098818
NA	CHEMICAL	GENE-N	6	8	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T10	T25	23098818
NA	CHEMICAL	GENE-N	6	10	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T10	T26	23098818
NA	CHEMICAL	GENE-N	6	8	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T11	T25	23098818
NA	CHEMICAL	GENE-N	6	10	The aim of present study was to identify gene ( gene ) isoforms which can catalyze the chemical-demethylation of chemical to chemical , and to find out whether that alternative pathway of chemical synthesis may take place in the brain .	T11	T26	23098818
NA	CHEMICAL	GENE-N	0	2	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T13	T32	23098818
CPR:9	CHEMICAL	GENE-N	0	6	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T13	T33	23098818
CPR:9	CHEMICAL	GENE-Y	0	28	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T13	T34	23098818
NA	CHEMICAL	GENE-N	12	2	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T14	T32	23098818
CPR:9	CHEMICAL	GENE-N	12	6	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T14	T33	23098818
CPR:9	CHEMICAL	GENE-Y	12	28	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T14	T34	23098818
NA	CHEMICAL	GENE-N	12	2	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T15	T32	23098818
CPR:9	CHEMICAL	GENE-N	12	6	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T15	T33	23098818
CPR:9	CHEMICAL	GENE-Y	12	28	chemicalf the gene isoforms studied , gene isoforms were the most efficient in catalyzing the O-demethylation of chemical to chemical , but they were less effective than the gene .	T15	T34	23098818
CPR:4	CHEMICAL	GENE-N	9	7	The reaction was inhibited by the specific gene inhibitors chemical and chemical .	T1	T20	23098818
CPR:4	CHEMICAL	GENE-N	7	7	The reaction was inhibited by the specific gene inhibitors chemical and chemical .	T2	T20	23098818
CPR:9	CHEMICAL	GENE-Y	8	6	Human liver microsomes of the wild-type gene metabolized chemical to chemical more effectively than did the defective gene*4*4 ones .	T3	T21	23098818
CPR:9	CHEMICAL	GENE-Y	8	17	Human liver microsomes of the wild-type gene metabolized chemical to chemical more effectively than did the defective gene*4*4 ones .	T3	T22	23098818
CPR:9	CHEMICAL	GENE-Y	9	6	Human liver microsomes of the wild-type gene metabolized chemical to chemical more effectively than did the defective gene*4*4 ones .	T4	T21	23098818
CPR:9	CHEMICAL	GENE-Y	9	17	Human liver microsomes of the wild-type gene metabolized chemical to chemical more effectively than did the defective gene*4*4 ones .	T4	T22	23098818
NA	CHEMICAL	GENE-Y	8	0	gene genotypes and haplotypes modify the responses to chemical in patients with erectile dysfunction .	T8	T16	22064666
NA	CHEMICAL	GENE-Y	7	5	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T1	T9	22064666
NA	CHEMICAL	GENE-Y	7	7	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T1	T10	22064666
NA	CHEMICAL	GENE-Y	7	22	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T1	T12	22064666
CPR:9	CHEMICAL	GENE-Y	13	5	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T3	T9	22064666
CPR:9	CHEMICAL	GENE-Y	13	7	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T3	T10	22064666
NA	CHEMICAL	GENE-Y	13	22	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T3	T12	22064666
NA	CHEMICAL	GENE-Y	30	5	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T4	T9	22064666
NA	CHEMICAL	GENE-Y	30	7	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T4	T10	22064666
NA	CHEMICAL	GENE-Y	30	22	Although genetic polymorphisms in the gene ( gene ) gene may impair endogenous chemical formation , there is little information about how gene polymorphisms and haplotypes affect the responses to chemical .	T4	T12	22064666
CPR:5	CHEMICAL	GENE-Y	4	8	Synthesis and evaluation of chemical derivatives as potent gene agonists with high water solubility .	T7	T10	23265901
CPR:5	CHEMICAL	GENE-Y	4	16	The introduction of the chemical group resulted in not only improved water solubility but also enhanced gene agonistic activity .	T4	T8	23265901
CPR:4	CHEMICAL	GENE-Y	0	3	chemical directly inhibits gene activity in continuous ambulatory peritoneal dialysis therapy .	T9	T21	20184869
NA	CHEMICAL	GENE-Y	3	5	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T1	T12	20184869
NA	CHEMICAL	GENE-Y	3	7	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T1	T13	20184869
NA	CHEMICAL	GENE-Y	3	14	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T1	T14	20184869
NA	CHEMICAL	GENE-Y	3	30	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T1	T15	20184869
CPR:4	CHEMICAL	GENE-Y	11	5	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T2	T12	20184869
CPR:4	CHEMICAL	GENE-Y	11	7	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T2	T13	20184869
NA	CHEMICAL	GENE-Y	11	14	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T2	T14	20184869
NA	CHEMICAL	GENE-Y	11	30	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T2	T15	20184869
NA	CHEMICAL	GENE-Y	30	5	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T3	T12	20184869
NA	CHEMICAL	GENE-Y	30	7	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T3	T13	20184869
NA	CHEMICAL	GENE-Y	30	14	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T3	T14	20184869
NA	CHEMICAL	GENE-Y	30	30	We determined whether an chemical-converting enzyme ( gene ) inhibitor , chemical , inhibits gene activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the gene-chemical complex .	T3	T15	20184869
CPR:4	CHEMICAL	GENE-Y	6	8	METHODS : The inhibitory effect of chemical on gene activity was measured in peritoneal effluents from 17 patients on CAPD .	T4	T16	20184869
NA	CHEMICAL	GENE-Y	4	4	Molecular models of the gene-chemical complex were simulated by 1000 iterations of random docking and energy minimization .	T5	T17	20184869
CPR:4	CHEMICAL	GENE-Y	2	5	RESULTS : chemical directly inhibited gene activity in peritoneal effluents from patients on CAPD ( IC50 ; 48 micromol/l ) , and that chemical binding to the gene active site could be formed in each complex model without molecular distortion .	T6	T18	20184869
NA	CHEMICAL	GENE-Y	2	27	RESULTS : chemical directly inhibited gene activity in peritoneal effluents from patients on CAPD ( IC50 ; 48 micromol/l ) , and that chemical binding to the gene active site could be formed in each complex model without molecular distortion .	T6	T19	20184869
NA	CHEMICAL	GENE-Y	23	5	RESULTS : chemical directly inhibited gene activity in peritoneal effluents from patients on CAPD ( IC50 ; 48 micromol/l ) , and that chemical binding to the gene active site could be formed in each complex model without molecular distortion .	T7	T18	20184869
NA	CHEMICAL	GENE-Y	23	27	RESULTS : chemical directly inhibited gene activity in peritoneal effluents from patients on CAPD ( IC50 ; 48 micromol/l ) , and that chemical binding to the gene active site could be formed in each complex model without molecular distortion .	T7	T19	20184869
NA	CHEMICAL	GENE-N	2	8	Evaluation of chemical H1- , H2- , and H3-receptor ligands at the gene : identification of 4-methylchemical as the first potent and selective gene agonist .	T11	T32	15947036
NA	CHEMICAL	GENE-Y	2	12	Evaluation of chemical H1- , H2- , and H3-receptor ligands at the gene : identification of 4-methylchemical as the first potent and selective gene agonist .	T11	T34	15947036
NA	CHEMICAL	GENE-Y	2	23	Evaluation of chemical H1- , H2- , and H3-receptor ligands at the gene : identification of 4-methylchemical as the first potent and selective gene agonist .	T11	T33	15947036
NA	CHEMICAL	GENE-N	16	8	Evaluation of chemical H1- , H2- , and H3-receptor ligands at the gene : identification of 4-methylchemical as the first potent and selective gene agonist .	T12	T32	15947036
NA	CHEMICAL	GENE-Y	16	12	Evaluation of chemical H1- , H2- , and H3-receptor ligands at the gene : identification of 4-methylchemical as the first potent and selective gene agonist .	T12	T34	15947036
NA	CHEMICAL	GENE-Y	16	23	Evaluation of chemical H1- , H2- , and H3-receptor ligands at the gene : identification of 4-methylchemical as the first potent and selective gene agonist .	T12	T33	15947036
NA	CHEMICAL	GENE-Y	1	6	The chemical H ( 4 ) receptor ( gene ) is involved in the chemotaxis of leukocytes and mast cells to sites of inflammation and is suggested to be a potential drug target for asthma and allergy .	T5	T23	15947036
NA	CHEMICAL	GENE-Y	1	2	The chemical H ( 4 ) receptor ( gene ) is involved in the chemotaxis of leukocytes and mast cells to sites of inflammation and is suggested to be a potential drug target for asthma and allergy .	T5	T18	15947036
NA	CHEMICAL	GENE-Y	22	5	Almost all of the tested gene and gene antagonists , including several important therapeutics , displaced less than 30 % of specific chemical binding to the gene at concentrations up to 10 microM .	T6	T21	15947036
NA	CHEMICAL	GENE-Y	22	7	Almost all of the tested gene and gene antagonists , including several important therapeutics , displaced less than 30 % of specific chemical binding to the gene at concentrations up to 10 microM .	T6	T22	15947036
NA	CHEMICAL	GENE-Y	22	26	Almost all of the tested gene and gene antagonists , including several important therapeutics , displaced less than 30 % of specific chemical binding to the gene at concentrations up to 10 microM .	T6	T24	15947036
NA	CHEMICAL	GENE-Y	7	4	Most of the tested gene agonists and chemical-based gene ligands show micromolar-to-nanomolar range gene affinity , and these ligands exert different intrinsic gene activities , ranging from full agonists to inverse agonists .	T7	T25	15947036
NA	CHEMICAL	GENE-Y	7	8	Most of the tested gene agonists and chemical-based gene ligands show micromolar-to-nanomolar range gene affinity , and these ligands exert different intrinsic gene activities , ranging from full agonists to inverse agonists .	T7	T26	15947036
NA	CHEMICAL	GENE-Y	7	13	Most of the tested gene agonists and chemical-based gene ligands show micromolar-to-nanomolar range gene affinity , and these ligands exert different intrinsic gene activities , ranging from full agonists to inverse agonists .	T7	T27	15947036
CPR:5	CHEMICAL	GENE-Y	7	22	Most of the tested gene agonists and chemical-based gene ligands show micromolar-to-nanomolar range gene affinity , and these ligands exert different intrinsic gene activities , ranging from full agonists to inverse agonists .	T7	T28	15947036
NA	CHEMICAL	GENE-Y	4	8	Interestingly , we identified chemical as a high-affinity gene ligand ( K ( i ) = 50 nM ) that has a > 100-fold selectivity for the gene over the other chemical receptor subtypes .	T8	T29	15947036
NA	CHEMICAL	GENE-Y	4	10	Interestingly , we identified chemical as a high-affinity gene ligand ( K ( i ) = 50 nM ) that has a > 100-fold selectivity for the gene over the other chemical receptor subtypes .	T8	T30	15947036
NA	CHEMICAL	GENE-N	4	32	Interestingly , we identified chemical as a high-affinity gene ligand ( K ( i ) = 50 nM ) that has a > 100-fold selectivity for the gene over the other chemical receptor subtypes .	T8	T31	15947036
NA	CHEMICAL	GENE-Y	6	8	Interestingly , we identified chemical as a high-affinity gene ligand ( K ( i ) = 50 nM ) that has a > 100-fold selectivity for the gene over the other chemical receptor subtypes .	T9	T29	15947036
NA	CHEMICAL	GENE-Y	6	10	Interestingly , we identified chemical as a high-affinity gene ligand ( K ( i ) = 50 nM ) that has a > 100-fold selectivity for the gene over the other chemical receptor subtypes .	T9	T30	15947036
NA	CHEMICAL	GENE-N	6	32	Interestingly , we identified chemical as a high-affinity gene ligand ( K ( i ) = 50 nM ) that has a > 100-fold selectivity for the gene over the other chemical receptor subtypes .	T9	T31	15947036
CPR:3	CHEMICAL	GENE-Y	2	6	Moreover , chemical potently activated the gene ( pEC ( 50 ) = 7.4 +/- 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective gene antagonist chemical [ chemical ] ( pA ( 2 ) = 7.8 ) .	T1	T13	15947036
NA	CHEMICAL	GENE-Y	2	7	Moreover , chemical potently activated the gene ( pEC ( 50 ) = 7.4 +/- 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective gene antagonist chemical [ chemical ] ( pA ( 2 ) = 7.8 ) .	T1	T14	15947036
NA	CHEMICAL	GENE-Y	19	6	Moreover , chemical potently activated the gene ( pEC ( 50 ) = 7.4 +/- 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective gene antagonist chemical [ chemical ] ( pA ( 2 ) = 7.8 ) .	T2	T13	15947036
CPR:6	CHEMICAL	GENE-Y	19	7	Moreover , chemical potently activated the gene ( pEC ( 50 ) = 7.4 +/- 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective gene antagonist chemical [ chemical ] ( pA ( 2 ) = 7.8 ) .	T2	T14	15947036
NA	CHEMICAL	GENE-Y	7	6	Moreover , chemical potently activated the gene ( pEC ( 50 ) = 7.4 +/- 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective gene antagonist chemical [ chemical ] ( pA ( 2 ) = 7.8 ) .	T3	T13	15947036
CPR:6	CHEMICAL	GENE-Y	7	7	Moreover , chemical potently activated the gene ( pEC ( 50 ) = 7.4 +/- 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective gene antagonist chemical [ chemical ] ( pA ( 2 ) = 7.8 ) .	T3	T14	15947036
CPR:9	CHEMICAL	GENE-N	8	16	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T4	T27	16207494
CPR:9	CHEMICAL	GENE-N	8	18	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T4	T10	16207494
CPR:9	CHEMICAL	GENE-N	8	22	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T4	T13	16207494
CPR:9	CHEMICAL	GENE-N	8	24	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T4	T14	16207494
CPR:9	CHEMICAL	GENE-N	10	16	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T5	T27	16207494
CPR:9	CHEMICAL	GENE-N	10	18	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T5	T10	16207494
CPR:9	CHEMICAL	GENE-N	10	22	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T5	T13	16207494
CPR:9	CHEMICAL	GENE-N	10	24	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T5	T14	16207494
NA	CHEMICAL	GENE-N	15	16	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T6	T27	16207494
NA	CHEMICAL	GENE-N	15	18	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T6	T10	16207494
NA	CHEMICAL	GENE-N	15	22	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T6	T13	16207494
NA	CHEMICAL	GENE-N	15	24	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T6	T14	16207494
NA	CHEMICAL	GENE-N	18	16	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T1	T27	16207494
NA	CHEMICAL	GENE-N	18	18	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T1	T10	16207494
NA	CHEMICAL	GENE-N	18	22	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T1	T13	16207494
NA	CHEMICAL	GENE-N	18	24	In the present study , age-related changes of chemical ( chemical ) synthesizing enzymes , chemical kinase ( gene ) and chemical oxidase ( gene ) , their protein contents and activities were examined in the gerbil hippocampus proper .	T1	T14	16207494
NA	CHEMICAL	GENE-N	8	8	It was concluded that the presence of the gene in these isoforms is not relevant for the formation of the gene/gene complex in the absence of chemical , that is the interaction of gene with inactive gene .	T1	T17	17570336
NA	CHEMICAL	GENE-N	8	9	It was concluded that the presence of the gene in these isoforms is not relevant for the formation of the gene/gene complex in the absence of chemical , that is the interaction of gene with inactive gene .	T1	T18	17570336
NA	CHEMICAL	GENE-Y	8	9	It was concluded that the presence of the gene in these isoforms is not relevant for the formation of the gene/gene complex in the absence of chemical , that is the interaction of gene with inactive gene .	T1	T19	17570336
NA	CHEMICAL	GENE-Y	8	9	It was concluded that the presence of the gene in these isoforms is not relevant for the formation of the gene/gene complex in the absence of chemical , that is the interaction of gene with inactive gene .	T1	T3	17570336
NA	CHEMICAL	GENE-N	8	9	It was concluded that the presence of the gene in these isoforms is not relevant for the formation of the gene/gene complex in the absence of chemical , that is the interaction of gene with inactive gene .	T1	T4	17570336
NA	CHEMICAL	GENE-Y	21	8	In this study we report the effects of gene on learning and memory in intact rats pretreated with the anabolic androgenic chemical chemical .	T3	T9	23092877
NA	CHEMICAL	GENE-Y	9	8	In this study we report the effects of gene on learning and memory in intact rats pretreated with the anabolic androgenic chemical chemical .	T4	T9	23092877
NA	CHEMICAL	GENE-Y	4	24	Male Wistar rats received chemical ( 15 mg/kg ) or peanut oil every third day for 3 weeks and were subsequently treated with recombinant gene ( 1.0 IU/kg ) or saline for 10 consecutive days .	T5	T13	23092877
NA	CHEMICAL	GENE-Y	12	3	In addition , gene was demonstrated to increase the body weight gain and was able to attenuate the reduced body weight seen in chemical-treated animals .	T6	T24	23092877
NA	CHEMICAL	GENE-Y	7	28	In general , the rats treated with chemical alone did not exhibit any pronounced alteration in memory compared with controls in the MWM , and in many cases gene did not induce any alteration .	T1	T8	23092877
NA	CHEMICAL	GENE-Y	3	6	Molecular recognition of chemical tRNA by gene from hyperthermophilic archaeon , Aeropyrum pernix K1 .	T6	T10	17150756
NA	CHEMICAL	GENE-Y	6	2	To investigate the recognition sites of chemical tRNA for gene from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined chemicalation activities by using overexpressed gene and various chemical tRNA transcripts that were prepared by in vitro transcription system .	T4	T9	17150756
NA	CHEMICAL	GENE-Y	6	2	To investigate the recognition sites of chemical tRNA for gene from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined chemicalation activities by using overexpressed gene and various chemical tRNA transcripts that were prepared by in vitro transcription system .	T4	T7	17150756
NA	CHEMICAL	GENE-Y	22	2	To investigate the recognition sites of chemical tRNA for gene from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined chemicalation activities by using overexpressed gene and various chemical tRNA transcripts that were prepared by in vitro transcription system .	T1	T9	17150756
NA	CHEMICAL	GENE-Y	22	2	To investigate the recognition sites of chemical tRNA for gene from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined chemicalation activities by using overexpressed gene and various chemical tRNA transcripts that were prepared by in vitro transcription system .	T1	T7	17150756
NA	CHEMICAL	GENE-Y	30	2	To investigate the recognition sites of chemical tRNA for gene from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined chemicalation activities by using overexpressed gene and various chemical tRNA transcripts that were prepared by in vitro transcription system .	T2	T9	17150756
NA	CHEMICAL	GENE-Y	30	2	To investigate the recognition sites of chemical tRNA for gene from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined chemicalation activities by using overexpressed gene and various chemical tRNA transcripts that were prepared by in vitro transcription system .	T2	T7	17150756
NA	CHEMICAL	GENE-Y	2	0	gene antagonists as aquaretic agents for the treatment of hyponatremia .	T13	T20	16843091
NA	CHEMICAL	GENE-Y	2	2	It is a state of relative water excess due to stimulated chemical ( chemical ) and fluid intake greater than obligatory losses .	T8	T15	16843091
NA	CHEMICAL	GENE-Y	13	2	It is a state of relative water excess due to stimulated chemical ( chemical ) and fluid intake greater than obligatory losses .	T10	T15	16843091
NA	CHEMICAL	GENE-Y	8	19	In this respect , pharmacologic research has yielded a number of compounds exhibiting antagonistic qualities at the chemical V2 receptor .	T11	T18	16843091
CPR:6	CHEMICAL	GENE-N	6	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T1	T14	16843091
CPR:6	CHEMICAL	GENE-N	17	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T2	T14	16843091
CPR:6	CHEMICAL	GENE-N	20	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T3	T14	16843091
CPR:6	CHEMICAL	GENE-N	22	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T4	T14	16843091
CPR:6	CHEMICAL	GENE-N	25	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T5	T14	16843091
CPR:6	CHEMICAL	GENE-N	27	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T6	T14	16843091
CPR:6	CHEMICAL	GENE-N	31	6	However , several promising nonpeptide , gene antagonists have been described ; these agents are chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , and chemical .	T7	T14	16843091
NA	CHEMICAL	GENE-N	9	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T103	9313928
NA	CHEMICAL	GENE-Y	9	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T107	9313928
NA	CHEMICAL	GENE-Y	9	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T75	9313928
NA	CHEMICAL	GENE-Y	9	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T80	9313928
NA	CHEMICAL	GENE-Y	9	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T87	9313928
NA	CHEMICAL	GENE-Y	9	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T91	9313928
NA	CHEMICAL	GENE-Y	9	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T92	9313928
NA	CHEMICAL	GENE-Y	9	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T95	9313928
NA	CHEMICAL	GENE-Y	9	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T101	9313928
NA	CHEMICAL	GENE-N	9	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T51	T102	9313928
NA	CHEMICAL	GENE-N	11	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T103	9313928
NA	CHEMICAL	GENE-Y	11	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T107	9313928
NA	CHEMICAL	GENE-Y	11	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T75	9313928
NA	CHEMICAL	GENE-Y	11	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T80	9313928
NA	CHEMICAL	GENE-Y	11	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T87	9313928
NA	CHEMICAL	GENE-Y	11	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T91	9313928
NA	CHEMICAL	GENE-Y	11	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T92	9313928
NA	CHEMICAL	GENE-Y	11	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T95	9313928
NA	CHEMICAL	GENE-Y	11	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T101	9313928
NA	CHEMICAL	GENE-N	11	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T67	T102	9313928
NA	CHEMICAL	GENE-N	6	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T103	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T107	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T75	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T80	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T87	9313928
NA	CHEMICAL	GENE-Y	6	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T91	9313928
NA	CHEMICAL	GENE-Y	6	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T92	9313928
NA	CHEMICAL	GENE-Y	6	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T95	9313928
NA	CHEMICAL	GENE-Y	6	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T101	9313928
NA	CHEMICAL	GENE-N	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T1	T102	9313928
NA	CHEMICAL	GENE-N	6	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T103	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T107	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T75	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T80	9313928
NA	CHEMICAL	GENE-Y	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T87	9313928
NA	CHEMICAL	GENE-Y	6	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T91	9313928
NA	CHEMICAL	GENE-Y	6	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T92	9313928
NA	CHEMICAL	GENE-Y	6	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T95	9313928
NA	CHEMICAL	GENE-Y	6	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T101	9313928
NA	CHEMICAL	GENE-N	6	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T10	T102	9313928
NA	CHEMICAL	GENE-N	23	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T103	9313928
NA	CHEMICAL	GENE-Y	23	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T107	9313928
NA	CHEMICAL	GENE-Y	23	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T75	9313928
NA	CHEMICAL	GENE-Y	23	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T80	9313928
NA	CHEMICAL	GENE-Y	23	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T87	9313928
NA	CHEMICAL	GENE-Y	23	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T91	9313928
NA	CHEMICAL	GENE-Y	23	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T92	9313928
NA	CHEMICAL	GENE-Y	23	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T95	9313928
NA	CHEMICAL	GENE-Y	23	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T101	9313928
NA	CHEMICAL	GENE-N	23	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T13	T102	9313928
NA	CHEMICAL	GENE-N	25	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T103	9313928
NA	CHEMICAL	GENE-Y	25	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T107	9313928
NA	CHEMICAL	GENE-Y	25	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T75	9313928
NA	CHEMICAL	GENE-Y	25	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T80	9313928
NA	CHEMICAL	GENE-Y	25	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T87	9313928
NA	CHEMICAL	GENE-Y	25	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T91	9313928
NA	CHEMICAL	GENE-Y	25	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T92	9313928
NA	CHEMICAL	GENE-Y	25	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T95	9313928
NA	CHEMICAL	GENE-Y	25	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T101	9313928
NA	CHEMICAL	GENE-N	25	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T18	T102	9313928
NA	CHEMICAL	GENE-N	30	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T103	9313928
NA	CHEMICAL	GENE-Y	30	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T107	9313928
NA	CHEMICAL	GENE-Y	30	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T75	9313928
NA	CHEMICAL	GENE-Y	30	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T80	9313928
NA	CHEMICAL	GENE-Y	30	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T87	9313928
NA	CHEMICAL	GENE-Y	30	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T91	9313928
NA	CHEMICAL	GENE-Y	30	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T92	9313928
NA	CHEMICAL	GENE-Y	30	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T95	9313928
NA	CHEMICAL	GENE-Y	30	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T101	9313928
NA	CHEMICAL	GENE-N	30	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T23	T102	9313928
NA	CHEMICAL	GENE-N	32	6	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T103	9313928
NA	CHEMICAL	GENE-Y	32	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T107	9313928
NA	CHEMICAL	GENE-Y	32	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T75	9313928
NA	CHEMICAL	GENE-Y	32	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T80	9313928
NA	CHEMICAL	GENE-Y	32	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T87	9313928
NA	CHEMICAL	GENE-Y	32	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T91	9313928
NA	CHEMICAL	GENE-Y	32	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T92	9313928
NA	CHEMICAL	GENE-Y	32	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T95	9313928
NA	CHEMICAL	GENE-Y	32	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T101	9313928
NA	CHEMICAL	GENE-N	32	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T30	T102	9313928
NA	CHEMICAL	GENE-Y	47	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T107	9313928
NA	CHEMICAL	GENE-Y	47	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T75	9313928
NA	CHEMICAL	GENE-Y	47	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T80	9313928
NA	CHEMICAL	GENE-Y	47	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T87	9313928
NA	CHEMICAL	GENE-Y	47	37	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T91	9313928
NA	CHEMICAL	GENE-Y	47	39	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T92	9313928
NA	CHEMICAL	GENE-Y	47	41	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T95	9313928
NA	CHEMICAL	GENE-Y	47	43	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T101	9313928
NA	CHEMICAL	GENE-N	47	13	Eight types and subtypes of the gene , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor , the chemical ( chemical ) receptor and the gene , gene , gene and gene subtypes of the chemical receptor , were stably expressed in Chinese hamster ovary cells .	T45	T102	9313928
NA	CHEMICAL	GENE-Y	30	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T48	T104	9313928
NA	CHEMICAL	GENE-Y	30	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T48	T105	9313928
NA	CHEMICAL	GENE-Y	30	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T48	T106	9313928
NA	CHEMICAL	GENE-Y	30	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T48	T110	9313928
NA	CHEMICAL	GENE-Y	38	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T49	T104	9313928
NA	CHEMICAL	GENE-Y	38	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T49	T105	9313928
NA	CHEMICAL	GENE-Y	38	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T49	T106	9313928
NA	CHEMICAL	GENE-Y	38	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T49	T110	9313928
NA	CHEMICAL	GENE-Y	5	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T50	T104	9313928
NA	CHEMICAL	GENE-Y	5	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T50	T105	9313928
NA	CHEMICAL	GENE-Y	5	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T50	T106	9313928
NA	CHEMICAL	GENE-Y	24	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T52	T104	9313928
NA	CHEMICAL	GENE-Y	24	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T52	T105	9313928
NA	CHEMICAL	GENE-Y	24	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T52	T106	9313928
NA	CHEMICAL	GENE-Y	24	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T52	T110	9313928
NA	CHEMICAL	GENE-Y	26	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T53	T104	9313928
NA	CHEMICAL	GENE-Y	26	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T53	T105	9313928
NA	CHEMICAL	GENE-Y	26	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T53	T106	9313928
NA	CHEMICAL	GENE-Y	26	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T53	T110	9313928
NA	CHEMICAL	GENE-Y	28	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T54	T104	9313928
NA	CHEMICAL	GENE-Y	28	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T54	T105	9313928
NA	CHEMICAL	GENE-Y	28	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T54	T106	9313928
NA	CHEMICAL	GENE-Y	28	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T54	T110	9313928
NA	CHEMICAL	GENE-Y	32	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T56	T104	9313928
NA	CHEMICAL	GENE-Y	32	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T56	T105	9313928
NA	CHEMICAL	GENE-Y	32	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T56	T106	9313928
NA	CHEMICAL	GENE-Y	32	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T56	T110	9313928
NA	CHEMICAL	GENE-Y	34	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T57	T104	9313928
NA	CHEMICAL	GENE-Y	34	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T57	T105	9313928
NA	CHEMICAL	GENE-Y	34	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T57	T106	9313928
NA	CHEMICAL	GENE-Y	34	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T57	T110	9313928
NA	CHEMICAL	GENE-Y	36	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T58	T104	9313928
NA	CHEMICAL	GENE-Y	36	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T58	T105	9313928
NA	CHEMICAL	GENE-Y	36	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T58	T106	9313928
NA	CHEMICAL	GENE-Y	36	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T58	T110	9313928
NA	CHEMICAL	GENE-Y	41	1	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T60	T104	9313928
NA	CHEMICAL	GENE-Y	41	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T60	T105	9313928
NA	CHEMICAL	GENE-Y	41	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T60	T106	9313928
NA	CHEMICAL	GENE-Y	41	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T60	T110	9313928
NA	CHEMICAL	GENE-Y	43	3	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T61	T105	9313928
NA	CHEMICAL	GENE-Y	43	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T61	T106	9313928
NA	CHEMICAL	GENE-Y	43	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T61	T110	9313928
NA	CHEMICAL	GENE-Y	45	6	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T62	T106	9313928
NA	CHEMICAL	GENE-Y	45	47	The gene , gene and chemical receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as chemical , chemical and chemical for chemical , chemical , chemical and chemical for chemical , and chemical , chemical and chemical for gene .	T62	T110	9313928
NA	CHEMICAL	GENE-Y	1	2	The chemical receptor bound chemical alpha and chemical with Ki values of 3-4 nM .	T64	T111	9313928
NA	CHEMICAL	GENE-Y	4	2	The chemical receptor bound chemical alpha and chemical with Ki values of 3-4 nM .	T65	T111	9313928
NA	CHEMICAL	GENE-Y	7	2	The chemical receptor bound chemical alpha and chemical with Ki values of 3-4 nM .	T66	T111	9313928
NA	CHEMICAL	GENE-Y	4	1	The gene receptor bound chemical , chemical and chemical in addition to chemical and chemical , with Ki values of 14-36 nM .	T2	T112	9313928
NA	CHEMICAL	GENE-Y	6	1	The gene receptor bound chemical , chemical and chemical in addition to chemical and chemical , with Ki values of 14-36 nM .	T3	T112	9313928
NA	CHEMICAL	GENE-Y	8	1	The gene receptor bound chemical , chemical and chemical in addition to chemical and chemical , with Ki values of 14-36 nM .	T4	T112	9313928
NA	CHEMICAL	GENE-Y	12	1	The gene receptor bound chemical , chemical and chemical in addition to chemical and chemical , with Ki values of 14-36 nM .	T5	T112	9313928
NA	CHEMICAL	GENE-Y	14	1	The gene receptor bound chemical , chemical and chemical in addition to chemical and chemical , with Ki values of 14-36 nM .	T6	T112	9313928
NA	CHEMICAL	GENE-Y	0	4	chemical and two putative gene antagonists , chemical and chemical , did not show any significant binding to this receptor .	T7	T76	9313928
CPR:6	CHEMICAL	GENE-Y	7	4	chemical and two putative gene antagonists , chemical and chemical , did not show any significant binding to this receptor .	T8	T76	9313928
CPR:6	CHEMICAL	GENE-Y	9	4	chemical and two putative gene antagonists , chemical and chemical , did not show any significant binding to this receptor .	T9	T76	9313928
CPR:5	CHEMICAL	GENE-Y	0	4	chemical , a putative gene agonist , and chemical , a putative gene/gene agonist , also bound to this receptor with Ki values of 120 nM .	T11	T77	9313928
NA	CHEMICAL	GENE-Y	0	12	chemical , a putative gene agonist , and chemical , a putative gene/gene agonist , also bound to this receptor with Ki values of 120 nM .	T11	T78	9313928
NA	CHEMICAL	GENE-Y	0	12	chemical , a putative gene agonist , and chemical , a putative gene/gene agonist , also bound to this receptor with Ki values of 120 nM .	T11	T79	9313928
NA	CHEMICAL	GENE-Y	8	4	chemical , a putative gene agonist , and chemical , a putative gene/gene agonist , also bound to this receptor with Ki values of 120 nM .	T12	T77	9313928
CPR:5	CHEMICAL	GENE-Y	8	12	chemical , a putative gene agonist , and chemical , a putative gene/gene agonist , also bound to this receptor with Ki values of 120 nM .	T12	T78	9313928
CPR:5	CHEMICAL	GENE-Y	8	12	chemical , a putative gene agonist , and chemical , a putative gene/gene agonist , also bound to this receptor with Ki values of 120 nM .	T12	T79	9313928
NA	CHEMICAL	GENE-Y	6	15	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T19	T83	9313928
NA	CHEMICAL	GENE-Y	6	21	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T19	T84	9313928
NA	CHEMICAL	GENE-Y	6	31	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T19	T85	9313928
NA	CHEMICAL	GENE-Y	6	36	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T19	T86	9313928
NA	CHEMICAL	GENE-Y	8	15	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T20	T83	9313928
NA	CHEMICAL	GENE-Y	8	21	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T20	T84	9313928
NA	CHEMICAL	GENE-Y	8	31	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T20	T85	9313928
NA	CHEMICAL	GENE-Y	8	36	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T20	T86	9313928
NA	CHEMICAL	GENE-Y	10	15	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T21	T83	9313928
NA	CHEMICAL	GENE-Y	10	21	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T21	T84	9313928
NA	CHEMICAL	GENE-Y	10	31	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T21	T85	9313928
NA	CHEMICAL	GENE-Y	10	36	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T21	T86	9313928
NA	CHEMICAL	GENE-Y	26	15	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T22	T83	9313928
NA	CHEMICAL	GENE-Y	26	21	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T22	T84	9313928
NA	CHEMICAL	GENE-Y	26	31	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T22	T85	9313928
NA	CHEMICAL	GENE-Y	26	36	The two receptors were discriminated by chemical , chemical and chemical that bound to the gene receptor but not to the gene receptor , and by chemical that bound to the gene but not to the gene receptor .	T22	T86	9313928
NA	CHEMICAL	GENE-Y	11	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T24	T88	9313928
NA	CHEMICAL	GENE-Y	13	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T25	T88	9313928
NA	CHEMICAL	GENE-Y	15	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T26	T88	9313928
NA	CHEMICAL	GENE-Y	17	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T27	T88	9313928
NA	CHEMICAL	GENE-Y	8	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T28	T88	9313928
NA	CHEMICAL	GENE-Y	21	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T29	T88	9313928
NA	CHEMICAL	GENE-Y	26	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T31	T88	9313928
NA	CHEMICAL	GENE-Y	28	1	The gene receptor showed the broadest binding profile , and bound chemical , chemical , chemical , chemical , chemical and chemical , in addition to chemical and chemical , with Ki values of 0.6-3.7 nM .	T32	T88	9313928
NA	CHEMICAL	GENE-Y	37	4	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T33	T89	9313928
NA	CHEMICAL	GENE-Y	37	39	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T33	T90	9313928
NA	CHEMICAL	GENE-Y	37	21	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T33	T94	9313928
NA	CHEMICAL	GENE-Y	7	4	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T34	T89	9313928
NA	CHEMICAL	GENE-Y	7	39	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T34	T90	9313928
NA	CHEMICAL	GENE-Y	7	21	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T34	T94	9313928
NA	CHEMICAL	GENE-Y	9	4	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T35	T89	9313928
NA	CHEMICAL	GENE-Y	9	39	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T35	T90	9313928
NA	CHEMICAL	GENE-Y	9	21	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T35	T94	9313928
NA	CHEMICAL	GENE-Y	11	4	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T36	T89	9313928
NA	CHEMICAL	GENE-Y	11	39	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T36	T90	9313928
NA	CHEMICAL	GENE-Y	11	21	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T36	T94	9313928
NA	CHEMICAL	GENE-Y	15	4	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T37	T89	9313928
NA	CHEMICAL	GENE-Y	15	39	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T37	T90	9313928
NA	CHEMICAL	GENE-Y	15	21	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T37	T94	9313928
NA	CHEMICAL	GENE-Y	18	4	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T38	T89	9313928
NA	CHEMICAL	GENE-Y	18	39	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T38	T90	9313928
NA	CHEMICAL	GENE-Y	18	21	In addition , three gene ligands , chemical , chemical and chemical , and one chemical ligand , chemical , bound to this receptor with Ki values comparable to the Ki values of these compounds for the chemical and gene receptors , respectively .	T38	T94	9313928
CPR:4	CHEMICAL	GENE-Y	0	4	chemical is a selective gene inhibitor which has little or no effect on the gene isoenzyme at doses up to 1000 mg/day .	T1	T40	11398914
NA	CHEMICAL	GENE-Y	0	14	chemical is a selective gene inhibitor which has little or no effect on the gene isoenzyme at doses up to 1000 mg/day .	T1	T41	11398914
CPR:4	CHEMICAL	GENE-Y	0	5	chemical has greater selectivity for gene than chemical , chemical , chemical and chemical .	T6	T39	11398914
NA	CHEMICAL	GENE-Y	7	5	chemical has greater selectivity for gene than chemical , chemical , chemical and chemical .	T17	T39	11398914
NA	CHEMICAL	GENE-Y	9	5	chemical has greater selectivity for gene than chemical , chemical , chemical and chemical .	T19	T39	11398914
NA	CHEMICAL	GENE-Y	11	5	chemical has greater selectivity for gene than chemical , chemical , chemical and chemical .	T20	T39	11398914
NA	CHEMICAL	GENE-Y	13	5	chemical has greater selectivity for gene than chemical , chemical , chemical and chemical .	T22	T39	11398914
CPR:3	CHEMICAL	GENE-Y	2	2	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T13	23443810
NA	CHEMICAL	GENE-Y	2	8	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T14	23443810
NA	CHEMICAL	GENE-Y	2	15	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T15	23443810
NA	CHEMICAL	GENE-N	2	17	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T16	23443810
NA	CHEMICAL	GENE-N	2	19	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T17	23443810
NA	CHEMICAL	GENE-Y	2	23	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T18	23443810
NA	CHEMICAL	GENE-Y	2	25	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T19	23443810
NA	CHEMICAL	GENE-Y	2	39	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T1	T20	23443810
CPR:4	CHEMICAL	GENE-Y	32	2	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T13	23443810
NA	CHEMICAL	GENE-Y	32	8	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T14	23443810
NA	CHEMICAL	GENE-Y	32	15	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T15	23443810
NA	CHEMICAL	GENE-N	32	17	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T16	23443810
NA	CHEMICAL	GENE-N	32	19	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T17	23443810
NA	CHEMICAL	GENE-Y	32	23	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T18	23443810
NA	CHEMICAL	GENE-Y	32	25	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T19	23443810
NA	CHEMICAL	GENE-Y	32	39	Interestingly , gene expression positively correlated with urine gene chemical ratio ( ACR ) , gene , gene ( gene ) , and gene ( gene ) ; while negatively correlated with chemical clearance ratio ( Ccr ) and gene protein .	T2	T20	23443810
NA	CHEMICAL	GENE-N	20	8	PURPOSE : The purpose of this review is to summarize current knowledge of detailed biochemical evidence for the role of chemical type A receptors ( gene ) in the mechanisms of general anesthesia .	T4	T12	21194017
NA	CHEMICAL	GENE-N	20	22	PURPOSE : The purpose of this review is to summarize current knowledge of detailed biochemical evidence for the role of chemical type A receptors ( gene ) in the mechanisms of general anesthesia .	T4	T14	21194017
NA	CHEMICAL	GENE-N	30	12	PRINCIPAL FINDINGS : With the knowledge that all general anesthetics positively modulate gene-mediated inhibitory transmission , site-directed mutagenesis comparing sequences of gene subunits of varying sensitivity led to identification of chemical residues in the transmembrane domain that are critical for the drug actions in vitro .	T8	T16	21194017
NA	CHEMICAL	GENE-N	30	21	PRINCIPAL FINDINGS : With the knowledge that all general anesthetics positively modulate gene-mediated inhibitory transmission , site-directed mutagenesis comparing sequences of gene subunits of varying sensitivity led to identification of chemical residues in the transmembrane domain that are critical for the drug actions in vitro .	T8	T17	21194017
NA	CHEMICAL	GENE-N	1	23	Using a photo incorporable analogue of the general anesthetic , chemical , we identified two transmembrane chemical that were affinity labelled in purified gene . Homology protein structural modelling positions these two residues , alphaM1-11 ' and betaM3-4 ' , close to each other in a single type of gene at the gene .	T9	T18	21194017
NA	CHEMICAL	GENE-N	1	1	Using a photo incorporable analogue of the general anesthetic , chemical , we identified two transmembrane chemical that were affinity labelled in purified gene . Homology protein structural modelling positions these two residues , alphaM1-11 ' and betaM3-4 ' , close to each other in a single type of gene at the gene .	T9	T20	21194017
NA	CHEMICAL	GENE-N	1	23	Using a photo incorporable analogue of the general anesthetic , chemical , we identified two transmembrane chemical that were affinity labelled in purified gene . Homology protein structural modelling positions these two residues , alphaM1-11 ' and betaM3-4 ' , close to each other in a single type of gene at the gene .	T10	T18	21194017
NA	CHEMICAL	GENE-N	1	1	Using a photo incorporable analogue of the general anesthetic , chemical , we identified two transmembrane chemical that were affinity labelled in purified gene . Homology protein structural modelling positions these two residues , alphaM1-11 ' and betaM3-4 ' , close to each other in a single type of gene at the gene .	T10	T20	21194017
NA	CHEMICAL	GENE-N	1	23	Using a photo incorporable analogue of the general anesthetic , chemical , we identified two transmembrane chemical that were affinity labelled in purified gene . Homology protein structural modelling positions these two residues , alphaM1-11 ' and betaM3-4 ' , close to each other in a single type of gene at the gene .	T11	T18	21194017
NA	CHEMICAL	GENE-N	1	1	Using a photo incorporable analogue of the general anesthetic , chemical , we identified two transmembrane chemical that were affinity labelled in purified gene . Homology protein structural modelling positions these two residues , alphaM1-11 ' and betaM3-4 ' , close to each other in a single type of gene at the gene .	T11	T20	21194017
CPR:3	CHEMICAL	GENE-Y	3	8	Osteoblasts survive the chemical treatment by activation of gene-mediated pathway .	T7	T35	23337567
CPR:3	CHEMICAL	GENE-Y	5	7	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T9	23337567
CPR:3	CHEMICAL	GENE-Y	5	9	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T10	23337567
CPR:3	CHEMICAL	GENE-Y	5	11	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T11	23337567
CPR:3	CHEMICAL	GENE-Y	5	13	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T12	23337567
CPR:3	CHEMICAL	GENE-Y	5	16	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T13	23337567
CPR:3	CHEMICAL	GENE-Y	5	18	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T14	23337567
CPR:3	CHEMICAL	GENE-Y	5	18	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T15	23337567
CPR:3	CHEMICAL	GENE-Y	5	24	Additionally , these effects of chemical on γ-gene , gene , gene , gene , and gene ( gene/gene ) were reduced by an gene inhibitor .	T2	T16	23337567
NA	CHEMICAL	GENE-N	9	6	The available X-ray structures contain only gene gene which in addition differ in orientation ( anti vs syn ) of the chemical .	T9	T35	23534440
NA	CHEMICAL	GENE-N	9	7	The available X-ray structures contain only gene gene which in addition differ in orientation ( anti vs syn ) of the chemical .	T9	T36	23534440
NA	CHEMICAL	GENE-N	6	0	gene is unusual due to its 11-chemical bulge .	T3	T16	23534440
NA	CHEMICAL	GENE-N	10	14	The simulations indicate that the long bulge is a stalk-specific eight-chemical insertion into consensual gene only subtly modifying its structural dynamics .	T4	T17	23534440
NA	CHEMICAL	GENE-N	11	21	Still , even bsc0χOL3 is unable to fully stabilize an essential chemical-edge chemical-bond between the bulge and non-canonical stem of the gene .	T5	T23	23534440
NA	CHEMICAL	GENE-N	12	21	Still , even bsc0χOL3 is unable to fully stabilize an essential chemical-edge chemical-bond between the bulge and non-canonical stem of the gene .	T6	T23	23534440
NA	CHEMICAL	GENE-Y	8	10	In our previous study , we identified the chemical receptor alpha ( gene ) as a relevant enhancer of gene-induced signal transduction leading to transactivation of gene ( gene ) .	T1	T10	23412922
NA	CHEMICAL	GENE-Y	8	12	In our previous study , we identified the chemical receptor alpha ( gene ) as a relevant enhancer of gene-induced signal transduction leading to transactivation of gene ( gene ) .	T1	T11	23412922
NA	CHEMICAL	GENE-Y	8	19	In our previous study , we identified the chemical receptor alpha ( gene ) as a relevant enhancer of gene-induced signal transduction leading to transactivation of gene ( gene ) .	T1	T12	23412922
NA	CHEMICAL	GENE-Y	8	26	In our previous study , we identified the chemical receptor alpha ( gene ) as a relevant enhancer of gene-induced signal transduction leading to transactivation of gene ( gene ) .	T1	T13	23412922
NA	CHEMICAL	GENE-Y	8	15	In our previous study , we identified the chemical receptor alpha ( gene ) as a relevant enhancer of gene-induced signal transduction leading to transactivation of gene ( gene ) .	T1	T14	23412922
CPR:3	CHEMICAL	GENE-Y	0	3	chemical-stimulated processing of gene is mediated via gene ( gene and accompanied by enhanced migration in MCF-7 breast cancer cells .	T14	T40	23624423
NA	CHEMICAL	GENE-Y	0	7	chemical-stimulated processing of gene is mediated via gene ( gene and accompanied by enhanced migration in MCF-7 breast cancer cells .	T14	T41	23624423
NA	CHEMICAL	GENE-Y	0	9	chemical-stimulated processing of gene is mediated via gene ( gene and accompanied by enhanced migration in MCF-7 breast cancer cells .	T14	T39	23624423
CPR:3	CHEMICAL	GENE-Y	0	10	chemical ( E2 ) has been recently shown to induce gene processing in breast cancer cells .	T2	T28	23624423
NA	CHEMICAL	GENE-Y	6	12	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T7	T30	23624423
NA	CHEMICAL	GENE-Y	6	29	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T7	T31	23624423
NA	CHEMICAL	GENE-Y	6	33	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T7	T32	23624423
NA	CHEMICAL	GENE-N	6	33	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T7	T33	23624423
NA	CHEMICAL	GENE-Y	18	12	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T8	T30	23624423
NA	CHEMICAL	GENE-Y	18	29	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T8	T31	23624423
NA	CHEMICAL	GENE-Y	18	33	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T8	T32	23624423
NA	CHEMICAL	GENE-N	18	33	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T8	T33	23624423
NA	CHEMICAL	GENE-Y	18	12	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T9	T30	23624423
NA	CHEMICAL	GENE-Y	18	29	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T9	T31	23624423
NA	CHEMICAL	GENE-Y	18	33	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T9	T32	23624423
NA	CHEMICAL	GENE-N	18	33	We therefore addressed possible effects of chemical on the generation of cleaved gene and its signal mechanism ( s ) in chemical-responsive MCF-7 breast cancer cells that express both gene and chemical receptor α ( gene ) .	T9	T33	23624423
NA	CHEMICAL	GENE-Y	0	15	chemical ( chemical , chemical 's active form ) failed to prevent E2-induced proteolysis of gene and migration , but rather triggered gene cleavage coincident with augmented migration .	T10	T34	23624423
NA	CHEMICAL	GENE-Y	0	22	chemical ( chemical , chemical 's active form ) failed to prevent E2-induced proteolysis of gene and migration , but rather triggered gene cleavage coincident with augmented migration .	T10	T35	23624423
NA	CHEMICAL	GENE-Y	2	15	chemical ( chemical , chemical 's active form ) failed to prevent E2-induced proteolysis of gene and migration , but rather triggered gene cleavage coincident with augmented migration .	T11	T34	23624423
NA	CHEMICAL	GENE-Y	2	22	chemical ( chemical , chemical 's active form ) failed to prevent E2-induced proteolysis of gene and migration , but rather triggered gene cleavage coincident with augmented migration .	T11	T35	23624423
NA	CHEMICAL	GENE-Y	4	15	chemical ( chemical , chemical 's active form ) failed to prevent E2-induced proteolysis of gene and migration , but rather triggered gene cleavage coincident with augmented migration .	T12	T34	23624423
NA	CHEMICAL	GENE-Y	4	22	chemical ( chemical , chemical 's active form ) failed to prevent E2-induced proteolysis of gene and migration , but rather triggered gene cleavage coincident with augmented migration .	T12	T35	23624423
NA	CHEMICAL	GENE-Y	0	1	chemical-induced gene truncation also occurred in SK-BR-3 cells that express gene and lack gene , but not in MDA-MB-231 cells that express neither gene nor gene .	T13	T36	23624423
NA	CHEMICAL	GENE-Y	0	10	chemical-induced gene truncation also occurred in SK-BR-3 cells that express gene and lack gene , but not in MDA-MB-231 cells that express neither gene nor gene .	T13	T37	23624423
NA	CHEMICAL	GENE-Y	0	13	chemical-induced gene truncation also occurred in SK-BR-3 cells that express gene and lack gene , but not in MDA-MB-231 cells that express neither gene nor gene .	T13	T38	23624423
NA	CHEMICAL	GENE-Y	0	23	chemical-induced gene truncation also occurred in SK-BR-3 cells that express gene and lack gene , but not in MDA-MB-231 cells that express neither gene nor gene .	T13	T15	23624423
NA	CHEMICAL	GENE-Y	0	25	chemical-induced gene truncation also occurred in SK-BR-3 cells that express gene and lack gene , but not in MDA-MB-231 cells that express neither gene nor gene .	T13	T16	23624423
NA	CHEMICAL	GENE-Y	2	5	Furthermore , chemical-stimulated cleavage of gene and migration were tremendously attenuated by G15 , a gene antagonist , or siRNA against gene .	T1	T19	23624423
NA	CHEMICAL	GENE-Y	2	15	Furthermore , chemical-stimulated cleavage of gene and migration were tremendously attenuated by G15 , a gene antagonist , or siRNA against gene .	T1	T20	23624423
NA	CHEMICAL	GENE-Y	2	21	Furthermore , chemical-stimulated cleavage of gene and migration were tremendously attenuated by G15 , a gene antagonist , or siRNA against gene .	T1	T21	23624423
NA	CHEMICAL	GENE-Y	10	5	In addition , inhibitors for gene or gene remarkably suppressed chemical-induced truncation of gene , suggesting involvement of gene signaling .	T3	T22	23624423
NA	CHEMICAL	GENE-N	10	7	In addition , inhibitors for gene or gene remarkably suppressed chemical-induced truncation of gene , suggesting involvement of gene signaling .	T3	T23	23624423
NA	CHEMICAL	GENE-Y	10	13	In addition , inhibitors for gene or gene remarkably suppressed chemical-induced truncation of gene , suggesting involvement of gene signaling .	T3	T24	23624423
NA	CHEMICAL	GENE-Y	10	18	In addition , inhibitors for gene or gene remarkably suppressed chemical-induced truncation of gene , suggesting involvement of gene signaling .	T3	T25	23624423
CPR:6	CHEMICAL	GENE-Y	0	2	chemical : a gene antagonist with unique additional actions .	T7	T14	2888789
CPR:6	CHEMICAL	GENE-Y	2	4	UNLABELLED : chemical is a gene antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension .	T3	T10	2888789
NA	CHEMICAL	GENE-N	19	9	Evidence has been obtained in man for interaction with gene in the brain ; and in the peripheral circulation chemical does not , as do other beta blockers , increase peripheral vascular resistance , but reduces it .	T4	T8	2888789
NA	CHEMICAL	GENE-Y	1	6	Effect of isolated chemical supplementation on gene-dependent chemical efflux potential in postmenopausal women .	T19	T33	17224860
NA	CHEMICAL	GENE-Y	7	6	Effect of isolated chemical supplementation on gene-dependent chemical efflux potential in postmenopausal women .	T20	T33	17224860
NA	CHEMICAL	GENE-Y	3	25	We studied in a clinical trial whether isolated chemical treatment in postmenopausal women could affect reverse chemical transport as evaluated by chemical-binding cassette A1- ( gene ) , dependent chemical efflux from macrophages .	T7	T29	17224860
NA	CHEMICAL	GENE-Y	16	25	We studied in a clinical trial whether isolated chemical treatment in postmenopausal women could affect reverse chemical transport as evaluated by chemical-binding cassette A1- ( gene ) , dependent chemical efflux from macrophages .	T13	T29	17224860
NA	CHEMICAL	GENE-Y	3	25	We studied in a clinical trial whether isolated chemical treatment in postmenopausal women could affect reverse chemical transport as evaluated by chemical-binding cassette A1- ( gene ) , dependent chemical efflux from macrophages .	T14	T29	17224860
CPR:9	CHEMICAL	GENE-Y	29	25	We studied in a clinical trial whether isolated chemical treatment in postmenopausal women could affect reverse chemical transport as evaluated by chemical-binding cassette A1- ( gene ) , dependent chemical efflux from macrophages .	T15	T29	17224860
NA	CHEMICAL	GENE-Y	0	8	chemical-labeled J774 macrophage cells , with and without gene up-regulation , were incubated with the samples , and gene-dependent chemical efflux and serum lipid and gene levels were assessed .	T17	T31	17224860
NA	CHEMICAL	GENE-Y	0	18	chemical-labeled J774 macrophage cells , with and without gene up-regulation , were incubated with the samples , and gene-dependent chemical efflux and serum lipid and gene levels were assessed .	T17	T32	17224860
NA	CHEMICAL	GENE-N	0	25	chemical-labeled J774 macrophage cells , with and without gene up-regulation , were incubated with the samples , and gene-dependent chemical efflux and serum lipid and gene levels were assessed .	T17	T21	17224860
NA	CHEMICAL	GENE-Y	19	8	chemical-labeled J774 macrophage cells , with and without gene up-regulation , were incubated with the samples , and gene-dependent chemical efflux and serum lipid and gene levels were assessed .	T18	T31	17224860
CPR:9	CHEMICAL	GENE-Y	19	18	chemical-labeled J774 macrophage cells , with and without gene up-regulation , were incubated with the samples , and gene-dependent chemical efflux and serum lipid and gene levels were assessed .	T18	T32	17224860
NA	CHEMICAL	GENE-N	19	25	chemical-labeled J774 macrophage cells , with and without gene up-regulation , were incubated with the samples , and gene-dependent chemical efflux and serum lipid and gene levels were assessed .	T18	T21	17224860
NA	CHEMICAL	GENE-Y	2	7	Thus , chemical supplementation did not affect gene-dependent chemical efflux to serum .	T4	T22	17224860
CPR:9	CHEMICAL	GENE-Y	8	7	Thus , chemical supplementation did not affect gene-dependent chemical efflux to serum .	T5	T22	17224860
CPR:3	CHEMICAL	GENE-N	3	13	However , as a novel finding , chemical treatment increased a subclass of gene , the gene levels by 18 % without affecting any other serum lipid concentrations .	T6	T23	17224860
CPR:3	CHEMICAL	GENE-N	3	16	However , as a novel finding , chemical treatment increased a subclass of gene , the gene levels by 18 % without affecting any other serum lipid concentrations .	T6	T24	17224860
CPR:9	CHEMICAL	GENE-Y	1	0	gene-facilitated chemical efflux and lipid parameters did not differ between chemical-producing and non-chemical-producing women .	T8	T25	17224860
NA	CHEMICAL	GENE-Y	10	0	gene-facilitated chemical efflux and lipid parameters did not differ between chemical-producing and non-chemical-producing women .	T9	T25	17224860
NA	CHEMICAL	GENE-Y	12	0	gene-facilitated chemical efflux and lipid parameters did not differ between chemical-producing and non-chemical-producing women .	T10	T25	17224860
CPR:4	CHEMICAL	GENE-Y	2	11	Discovery of chemical ( chemical ) : a potent and selective gene inhibitor as a topical drug for alopecia .	T7	T16	23449197
CPR:4	CHEMICAL	GENE-Y	4	11	Discovery of chemical ( chemical ) : a potent and selective gene inhibitor as a topical drug for alopecia .	T8	T16	23449197
CPR:4	CHEMICAL	GENE-Y	0	10	chemical 11 ( chemical ) was synthesized and evaluated as gene ( also known as gene or gene ) inhibitor .	T1	T9	23449197
CPR:4	CHEMICAL	GENE-Y	0	15	chemical 11 ( chemical ) was synthesized and evaluated as gene ( also known as gene or gene ) inhibitor .	T1	T10	23449197
CPR:4	CHEMICAL	GENE-Y	0	17	chemical 11 ( chemical ) was synthesized and evaluated as gene ( also known as gene or gene ) inhibitor .	T1	T11	23449197
CPR:4	CHEMICAL	GENE-Y	3	10	chemical 11 ( chemical ) was synthesized and evaluated as gene ( also known as gene or gene ) inhibitor .	T6	T9	23449197
CPR:4	CHEMICAL	GENE-Y	3	15	chemical 11 ( chemical ) was synthesized and evaluated as gene ( also known as gene or gene ) inhibitor .	T6	T10	23449197
CPR:4	CHEMICAL	GENE-Y	3	17	chemical 11 ( chemical ) was synthesized and evaluated as gene ( also known as gene or gene ) inhibitor .	T6	T11	23449197
NA	CHEMICAL	GENE-Y	0	8	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T10	T28	23270704
NA	CHEMICAL	GENE-N	0	10	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T10	T29	23270704
CPR:4	CHEMICAL	GENE-Y	0	21	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T10	T27	23270704
NA	CHEMICAL	GENE-Y	2	8	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T11	T28	23270704
CPR:9	CHEMICAL	GENE-N	2	10	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T11	T29	23270704
CPR:4	CHEMICAL	GENE-Y	2	21	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T11	T27	23270704
NA	CHEMICAL	GENE-Y	13	8	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T12	T28	23270704
NA	CHEMICAL	GENE-N	13	10	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T12	T29	23270704
NA	CHEMICAL	GENE-Y	13	21	chemical and chemical alleviate intermittent hypoxia induced abnormal gene and gene and low chemical by suppressing endoplasmic reticulum stress and activated gene in rat testes .	T12	T27	23270704
NA	CHEMICAL	GENE-N	12	13	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T8	T24	23270704
NA	CHEMICAL	GENE-N	12	15	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T8	T26	23270704
NA	CHEMICAL	GENE-N	12	27	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T8	T13	23270704
NA	CHEMICAL	GENE-N	20	13	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T1	T24	23270704
NA	CHEMICAL	GENE-N	20	15	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T1	T26	23270704
CPR:4	CHEMICAL	GENE-N	20	27	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T1	T13	23270704
NA	CHEMICAL	GENE-N	15	13	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T2	T24	23270704
NA	CHEMICAL	GENE-N	15	15	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T2	T26	23270704
CPR:4	CHEMICAL	GENE-N	15	27	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T2	T13	23270704
NA	CHEMICAL	GENE-N	7	13	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T3	T24	23270704
NA	CHEMICAL	GENE-N	7	15	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T3	T26	23270704
NA	CHEMICAL	GENE-N	7	27	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T3	T13	23270704
NA	CHEMICAL	GENE-N	34	13	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T4	T24	23270704
NA	CHEMICAL	GENE-N	34	15	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T4	T26	23270704
NA	CHEMICAL	GENE-N	34	27	We hypothesized that hypoxia induced testicular damage is mediated by an activated chemical oxidase ( gene ) , therefore , chemical ( chemical ) an inhibitor of gene and chemical ( RS ) , a chemical influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .	T4	T13	23270704
NA	CHEMICAL	GENE-N	5	8	Hypoxic rats displayed lower serum chemical and higher gene and gene .	T7	T14	23270704
NA	CHEMICAL	GENE-N	5	10	Hypoxic rats displayed lower serum chemical and higher gene and gene .	T7	T15	23270704
NA	CHEMICAL	GENE-Y	2	12	They include chemical antagonists , dopaminergic agonists , chemical , chemical , gene analogs and chemical .	T4	T20	17504182
NA	CHEMICAL	GENE-Y	8	12	They include chemical antagonists , dopaminergic agonists , chemical , chemical , gene analogs and chemical .	T5	T20	17504182
NA	CHEMICAL	GENE-Y	10	12	They include chemical antagonists , dopaminergic agonists , chemical , chemical , gene analogs and chemical .	T6	T20	17504182
NA	CHEMICAL	GENE-Y	15	12	They include chemical antagonists , dopaminergic agonists , chemical , chemical , gene analogs and chemical .	T7	T20	17504182
CPR:4	CHEMICAL	GENE-Y	0	2	chemical blocks gene activation without modifying chemical synthesis .	T2	T14	17504182
NA	CHEMICAL	GENE-Y	6	2	chemical blocks gene activation without modifying chemical synthesis .	T3	T14	17504182
NA	CHEMICAL	GENE-Y	8	2	Encapsulation of gene and gene receptor ligands into chemical nanoparticles potentiates their immune properties .	T6	T24	23352911
NA	CHEMICAL	GENE-Y	8	4	Encapsulation of gene and gene receptor ligands into chemical nanoparticles potentiates their immune properties .	T6	T25	23352911
NA	CHEMICAL	GENE-N	24	4	As activation of intracytoplasmic gene is able to induce proinflammatory molecules , the added value of encapsulation of gene and gene receptor ligands into chemical ( chemical ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .	T3	T20	23352911
NA	CHEMICAL	GENE-Y	24	18	As activation of intracytoplasmic gene is able to induce proinflammatory molecules , the added value of encapsulation of gene and gene receptor ligands into chemical ( chemical ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .	T3	T21	23352911
NA	CHEMICAL	GENE-Y	24	20	As activation of intracytoplasmic gene is able to induce proinflammatory molecules , the added value of encapsulation of gene and gene receptor ligands into chemical ( chemical ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .	T3	T22	23352911
NA	CHEMICAL	GENE-N	26	4	As activation of intracytoplasmic gene is able to induce proinflammatory molecules , the added value of encapsulation of gene and gene receptor ligands into chemical ( chemical ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .	T4	T20	23352911
NA	CHEMICAL	GENE-Y	26	18	As activation of intracytoplasmic gene is able to induce proinflammatory molecules , the added value of encapsulation of gene and gene receptor ligands into chemical ( chemical ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .	T4	T21	23352911
NA	CHEMICAL	GENE-Y	26	20	As activation of intracytoplasmic gene is able to induce proinflammatory molecules , the added value of encapsulation of gene and gene receptor ligands into chemical ( chemical ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .	T4	T22	23352911
NA	CHEMICAL	GENE-N	4	0	gene ligands encapsulated into chemical NPs were efficiently taken up by DCs and subsequently induced a strong up-regulation of maturation markers and the enhancement of proinflammatory gene secretion by DCs .	T5	T23	23352911
NA	CHEMICAL	GENE-N	4	26	gene ligands encapsulated into chemical NPs were efficiently taken up by DCs and subsequently induced a strong up-regulation of maturation markers and the enhancement of proinflammatory gene secretion by DCs .	T5	T7	23352911
NA	CHEMICAL	GENE-N	7	5	Furthermore , co-injection of encapsulated gene-ligands with chemical particles carrying gene HIV-1 antigen allowed a 100 fold increase in antibody responses in comparison to Alum .	T1	T8	23352911
NA	CHEMICAL	GENE-N	7	10	Furthermore , co-injection of encapsulated gene-ligands with chemical particles carrying gene HIV-1 antigen allowed a 100 fold increase in antibody responses in comparison to Alum .	T1	T9	23352911
NA	CHEMICAL	GENE-Y	1	2	The chemical decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells .	T20	T31	11106255
NA	CHEMICAL	GENE-N	4	5	In studying kinetics of chemical hydroxylase and chemical decarboxylase ( gene ) in human carcinoid hepatic metastases and adjacent normal liver ( J . A. Gilbert et al , Biochem .	T4	T21	11106255
NA	CHEMICAL	GENE-Y	4	8	In studying kinetics of chemical hydroxylase and chemical decarboxylase ( gene ) in human carcinoid hepatic metastases and adjacent normal liver ( J . A. Gilbert et al , Biochem .	T4	T23	11106255
NA	CHEMICAL	GENE-Y	4	10	In studying kinetics of chemical hydroxylase and chemical decarboxylase ( gene ) in human carcinoid hepatic metastases and adjacent normal liver ( J . A. Gilbert et al , Biochem .	T4	T26	11106255
NA	CHEMICAL	GENE-N	7	5	In studying kinetics of chemical hydroxylase and chemical decarboxylase ( gene ) in human carcinoid hepatic metastases and adjacent normal liver ( J . A. Gilbert et al , Biochem .	T5	T21	11106255
NA	CHEMICAL	GENE-Y	7	8	In studying kinetics of chemical hydroxylase and chemical decarboxylase ( gene ) in human carcinoid hepatic metastases and adjacent normal liver ( J . A. Gilbert et al , Biochem .	T5	T23	11106255
NA	CHEMICAL	GENE-Y	7	10	In studying kinetics of chemical hydroxylase and chemical decarboxylase ( gene ) in human carcinoid hepatic metastases and adjacent normal liver ( J . A. Gilbert et al , Biochem .	T5	T26	11106255
NA	CHEMICAL	GENE-Y	15	8	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T11	T29	11106255
CPR:4	CHEMICAL	GENE-Y	15	13	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T11	T30	11106255
NA	CHEMICAL	GENE-Y	17	8	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T12	T29	11106255
CPR:4	CHEMICAL	GENE-Y	17	13	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T12	T30	11106255
NA	CHEMICAL	GENE-Y	4	8	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T13	T29	11106255
CPR:4	CHEMICAL	GENE-Y	4	13	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T13	T30	11106255
NA	CHEMICAL	GENE-Y	22	8	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T14	T29	11106255
CPR:4	CHEMICAL	GENE-Y	22	13	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T14	T30	11106255
NA	CHEMICAL	GENE-Y	26	8	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T15	T29	11106255
CPR:4	CHEMICAL	GENE-Y	26	13	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T15	T30	11106255
NA	CHEMICAL	GENE-Y	28	8	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T16	T29	11106255
CPR:4	CHEMICAL	GENE-Y	28	13	To assess the feasibility of targeting these high gene levels for chemotherapy , gene inhibitors chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) were incubated ( 72 h ) with NCI-H727 human lung carcinoid cells .	T16	T30	11106255
NA	CHEMICAL	GENE-Y	26	18	For lung tumor lines ( carcinoid , two SCLC , and one large cell lung carcinoma ) , gene activity was correlated with the potency of chemical-induced cytotoxicity .	T6	T24	11106255
NA	CHEMICAL	GENE-Y	9	14	However , carcinoid cell death was not solely attributable to complete inhibition of either gene activity or the chemical synthetic pathway .	T7	T25	11106255
NA	CHEMICAL	GENE-Y	11	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T8	T17	23645248
NA	CHEMICAL	GENE-Y	11	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T8	T18	23645248
NA	CHEMICAL	GENE-Y	11	42	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T8	T19	23645248
NA	CHEMICAL	GENE-Y	11	44	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T8	T20	23645248
NA	CHEMICAL	GENE-Y	11	47	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T8	T21	23645248
NA	CHEMICAL	GENE-Y	20	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T9	T17	23645248
NA	CHEMICAL	GENE-Y	20	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T9	T18	23645248
NA	CHEMICAL	GENE-Y	20	42	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T9	T19	23645248
NA	CHEMICAL	GENE-Y	20	44	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T9	T20	23645248
NA	CHEMICAL	GENE-Y	20	47	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T9	T21	23645248
NA	CHEMICAL	GENE-Y	26	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T10	T17	23645248
NA	CHEMICAL	GENE-Y	26	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T10	T18	23645248
NA	CHEMICAL	GENE-Y	26	42	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T10	T19	23645248
NA	CHEMICAL	GENE-Y	26	44	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T10	T20	23645248
NA	CHEMICAL	GENE-Y	26	47	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T10	T21	23645248
NA	CHEMICAL	GENE-Y	46	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T11	T17	23645248
NA	CHEMICAL	GENE-Y	46	12	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T11	T18	23645248
NA	CHEMICAL	GENE-Y	46	42	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T11	T19	23645248
NA	CHEMICAL	GENE-Y	46	44	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T11	T20	23645248
NA	CHEMICAL	GENE-Y	46	47	In thyroid stem/progenitor cells derived from nodular goitres the ability of chemical to induce thyrosphere formation , the expression of chemical receptors and the effect of chemical on growth , expression of marker of stem cells and thyroid differentiation ( gene , gene , gene , chemical symporter expression ) were analysed .	T11	T21	23645248
NA	CHEMICAL	GENE-N	6	10	Thyroid stem and progenitor cells expressed chemical receptor alpha and beta with an 8 time higher expression level of chemical receptor alpha mRNA compared to differentiated thyrocytes .	T13	T22	23645248
NA	CHEMICAL	GENE-N	6	8	Thyroid stem and progenitor cells expressed chemical receptor alpha and beta with an 8 time higher expression level of chemical receptor alpha mRNA compared to differentiated thyrocytes .	T13	T23	23645248
NA	CHEMICAL	GENE-N	19	10	Thyroid stem and progenitor cells expressed chemical receptor alpha and beta with an 8 time higher expression level of chemical receptor alpha mRNA compared to differentiated thyrocytes .	T14	T22	23645248
NA	CHEMICAL	GENE-N	19	8	Thyroid stem and progenitor cells expressed chemical receptor alpha and beta with an 8 time higher expression level of chemical receptor alpha mRNA compared to differentiated thyrocytes .	T14	T23	23645248
NA	CHEMICAL	GENE-Y	15	16	In contrast , TSH-induced differentiation of progenitor cells , in particular the expression of the chemical symporter , was significantly inhibited by chemical.In conclusion , chemical stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells .	T2	T16	23645248
CPR:4	CHEMICAL	GENE-Y	22	16	In contrast , TSH-induced differentiation of progenitor cells , in particular the expression of the chemical symporter , was significantly inhibited by chemical.In conclusion , chemical stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells .	T3	T16	23645248
NA	CHEMICAL	GENE-Y	25	16	In contrast , TSH-induced differentiation of progenitor cells , in particular the expression of the chemical symporter , was significantly inhibited by chemical.In conclusion , chemical stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells .	T4	T16	23645248
NA	CHEMICAL	GENE-N	3	4	Non-selective inhibition of chemical oxidase ( gene ) enzymes ( ie , isoforms A and B ) in the brain are associated with clinically significant antidepressant effects .	T5	T14	19300583
NA	CHEMICAL	GENE-N	3	6	Non-selective inhibition of chemical oxidase ( gene ) enzymes ( ie , isoforms A and B ) in the brain are associated with clinically significant antidepressant effects .	T5	T16	19300583
CPR:4	CHEMICAL	GENE-N	13	7	Currently , the use of orally administered gene inhibitor antidepressants ( eg , chemical , chemical ) is limited by the risk of chemical-provoked events ( eg , acute hypertension and headache , also known as the `` cheese reaction '' ) when combined with dietary chemical .	T6	T15	19300583
CPR:4	CHEMICAL	GENE-N	15	7	Currently , the use of orally administered gene inhibitor antidepressants ( eg , chemical , chemical ) is limited by the risk of chemical-provoked events ( eg , acute hypertension and headache , also known as the `` cheese reaction '' ) when combined with dietary chemical .	T7	T15	19300583
NA	CHEMICAL	GENE-N	23	7	Currently , the use of orally administered gene inhibitor antidepressants ( eg , chemical , chemical ) is limited by the risk of chemical-provoked events ( eg , acute hypertension and headache , also known as the `` cheese reaction '' ) when combined with dietary chemical .	T8	T15	19300583
NA	CHEMICAL	GENE-N	46	7	Currently , the use of orally administered gene inhibitor antidepressants ( eg , chemical , chemical ) is limited by the risk of chemical-provoked events ( eg , acute hypertension and headache , also known as the `` cheese reaction '' ) when combined with dietary chemical .	T9	T15	19300583
NA	CHEMICAL	GENE-Y	26	26	Delivery of chemical transdermally ( EMSAM ( ( R ) ) ) bypasses hepatic first pass metabolism , thereby avoiding significant inhibition of gastrointestinal and hepatic gene activity ( ie , reduced risk of chemical-provoked events ) while still providing sufficient levels of selegiline in the brain to produce an antidepressant effect .	T1	T12	19300583
NA	CHEMICAL	GENE-Y	2	26	Delivery of chemical transdermally ( EMSAM ( ( R ) ) ) bypasses hepatic first pass metabolism , thereby avoiding significant inhibition of gastrointestinal and hepatic gene activity ( ie , reduced risk of chemical-provoked events ) while still providing sufficient levels of selegiline in the brain to produce an antidepressant effect .	T2	T12	19300583
NA	CHEMICAL	GENE-Y	12	2	Involvement of gene and the gene cytoskeleton in the antitumorigenic action of chemical .	T17	T35	23353701
NA	CHEMICAL	GENE-N	12	5	Involvement of gene and the gene cytoskeleton in the antitumorigenic action of chemical .	T17	T36	23353701
CPR:4	CHEMICAL	GENE-Y	2	15	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T8	T31	23353701
CPR:4	CHEMICAL	GENE-Y	2	17	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T8	T32	23353701
CPR:4	CHEMICAL	GENE-Y	4	15	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T9	T31	23353701
CPR:4	CHEMICAL	GENE-Y	4	17	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T9	T32	23353701
NA	CHEMICAL	GENE-Y	11	15	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T10	T31	23353701
NA	CHEMICAL	GENE-Y	11	17	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T10	T32	23353701
NA	CHEMICAL	GENE-Y	13	15	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T11	T31	23353701
NA	CHEMICAL	GENE-Y	13	17	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T11	T32	23353701
CPR:9	CHEMICAL	GENE-Y	24	15	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T13	T31	23353701
CPR:9	CHEMICAL	GENE-Y	24	17	Treatment with chemical ( chemical ) , an inhibitor of transmethylation-suppressive chemical ( chemical ) hydrolase ( gene ) , enhanced the level of chemical and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner .	T13	T32	23353701
CPR:4	CHEMICAL	GENE-Y	8	18	Through immunoblotting analysis , it was found that chemical was capable of indirectly diminishing the phosphorylation of oncogenic gene and its gene activity .	T15	T33	23353701
CPR:4	CHEMICAL	GENE-N	8	21	Through immunoblotting analysis , it was found that chemical was capable of indirectly diminishing the phosphorylation of oncogenic gene and its gene activity .	T15	T34	23353701
CPR:4	CHEMICAL	GENE-N	2	4	Interestingly , chemical disrupted gene cytoskeleton structures , leading to morphological changes , and suppressed the formation of a signaling complex composed of gene and gene/gene , which is linked to various tumorigenic responses .	T1	T18	23353701
CPR:4	CHEMICAL	GENE-Y	2	23	Interestingly , chemical disrupted gene cytoskeleton structures , leading to morphological changes , and suppressed the formation of a signaling complex composed of gene and gene/gene , which is linked to various tumorigenic responses .	T1	T19	23353701
CPR:4	CHEMICAL	GENE-N	2	25	Interestingly , chemical disrupted gene cytoskeleton structures , leading to morphological changes , and suppressed the formation of a signaling complex composed of gene and gene/gene , which is linked to various tumorigenic responses .	T1	T20	23353701
CPR:4	CHEMICAL	GENE-N	2	25	Interestingly , chemical disrupted gene cytoskeleton structures , leading to morphological changes , and suppressed the formation of a signaling complex composed of gene and gene/gene , which is linked to various tumorigenic responses .	T1	T21	23353701
NA	CHEMICAL	GENE-Y	10	14	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T2	T22	23353701
CPR:4	CHEMICAL	GENE-Y	10	38	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T2	T23	23353701
NA	CHEMICAL	GENE-N	10	31	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T2	T24	23353701
NA	CHEMICAL	GENE-N	10	31	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T2	T25	23353701
CPR:4	CHEMICAL	GENE-Y	24	14	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T3	T22	23353701
NA	CHEMICAL	GENE-Y	24	38	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T3	T23	23353701
NA	CHEMICAL	GENE-N	24	31	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T3	T24	23353701
NA	CHEMICAL	GENE-N	24	31	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T3	T25	23353701
NA	CHEMICAL	GENE-Y	24	56	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T3	T26	23353701
CPR:4	CHEMICAL	GENE-Y	26	14	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T4	T22	23353701
NA	CHEMICAL	GENE-Y	26	38	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T4	T23	23353701
NA	CHEMICAL	GENE-N	26	31	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T4	T24	23353701
NA	CHEMICAL	GENE-N	26	31	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T4	T25	23353701
NA	CHEMICAL	GENE-Y	26	56	In agreement with these data , the exogenous treatment of chemical or inhibition of gene by specific siRNA or another type of inhibitor , chemical ( chemical ) , similarly resulted in antitumorigenic responses , suppressive activity on gene , the alteration of gene cytoskeleton , and a change of the colocalization pattern between gene and gene .	T4	T26	23353701
NA	CHEMICAL	GENE-Y	7	23	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T12	T25	17544870
NA	CHEMICAL	GENE-Y	7	11	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T12	T26	17544870
NA	CHEMICAL	GENE-Y	7	28	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T12	T18	17544870
NA	CHEMICAL	GENE-Y	7	34	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T12	T19	17544870
NA	CHEMICAL	GENE-Y	7	23	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T13	T25	17544870
NA	CHEMICAL	GENE-Y	7	11	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T13	T26	17544870
NA	CHEMICAL	GENE-Y	7	28	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T13	T18	17544870
NA	CHEMICAL	GENE-Y	7	34	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T13	T19	17544870
NA	CHEMICAL	GENE-Y	7	23	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T14	T25	17544870
NA	CHEMICAL	GENE-Y	7	11	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T14	T26	17544870
NA	CHEMICAL	GENE-Y	7	28	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T14	T18	17544870
NA	CHEMICAL	GENE-Y	7	34	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T14	T19	17544870
NA	CHEMICAL	GENE-Y	8	23	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T15	T25	17544870
NA	CHEMICAL	GENE-Y	8	11	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T15	T26	17544870
NA	CHEMICAL	GENE-Y	8	28	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T15	T18	17544870
NA	CHEMICAL	GENE-Y	8	34	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T15	T19	17544870
NA	CHEMICAL	GENE-Y	18	23	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T16	T25	17544870
NA	CHEMICAL	GENE-Y	18	11	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T16	T26	17544870
NA	CHEMICAL	GENE-Y	18	28	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T16	T18	17544870
NA	CHEMICAL	GENE-Y	18	34	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T16	T19	17544870
NA	CHEMICAL	GENE-Y	7	23	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T1	T25	17544870
NA	CHEMICAL	GENE-Y	7	11	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T1	T26	17544870
NA	CHEMICAL	GENE-Y	7	28	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T1	T18	17544870
NA	CHEMICAL	GENE-Y	7	34	The influence of candidate gene polymorphisms involved in chemical and chemical or receptor function ( chemical chemical-methyltransferase , chemical binding protein beta polypeptide 3 , gene , and gene [ homo sapiens ] [ gene ] ) on weight loss and gastric functions was evaluated .	T1	T19	17544870
CPR:3	CHEMICAL	GENE-Y	1	30	The chemical group showed significant retardation in gastric emptying of solids ( P = .03 ) , reduced maximum tolerated volume ( P = .03 ) , and increased postprandial gene compared with the placebo group .	T4	T20	17544870
NA	CHEMICAL	GENE-Y	15	7	The LS/SS genotype of the promoter for gene was associated with enhanced weight loss with chemical .	T7	T21	17544870
CPR:3	CHEMICAL	GENE-Y	5	14	CONCLUSIONS : Weight reduction with chemical is associated with altered gastric functions and increased gene and is significantly associated with gene genotype .	T8	T22	17544870
NA	CHEMICAL	GENE-Y	5	20	CONCLUSIONS : Weight reduction with chemical is associated with altered gastric functions and increased gene and is significantly associated with gene genotype .	T8	T23	17544870
CPR:4	CHEMICAL	GENE-Y	7	4	Enhancement of radiosensitivity by gene inhibitor , chemical and chemical , in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction .	T19	T22	17016621
CPR:4	CHEMICAL	GENE-Y	9	4	Enhancement of radiosensitivity by gene inhibitor , chemical and chemical , in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction .	T20	T22	17016621
CPR:4	CHEMICAL	GENE-Y	2	13	Similar to chemical and chemical , chemical and chemical ( chemical ) are gene inhibitors .	T3	T21	17016621
CPR:4	CHEMICAL	GENE-Y	4	13	Similar to chemical and chemical , chemical and chemical ( chemical ) are gene inhibitors .	T4	T21	17016621
CPR:4	CHEMICAL	GENE-Y	6	13	Similar to chemical and chemical , chemical and chemical ( chemical ) are gene inhibitors .	T5	T21	17016621
CPR:4	CHEMICAL	GENE-Y	1	13	Similar to chemical and chemical , chemical and chemical ( chemical ) are gene inhibitors .	T6	T21	17016621
CPR:4	CHEMICAL	GENE-Y	10	13	Similar to chemical and chemical , chemical and chemical ( chemical ) are gene inhibitors .	T7	T21	17016621
CPR:3	CHEMICAL	GENE-Y	16	7	The rate limiting enzyme of beta-oxidation ( gene ) was significantly over-expressed in the liver with chemical treatment .	T10	T14	23585332
CPR:9	CHEMICAL	GENE-Y	3	22	Reuptake of extracellular chemical ( chemical ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the chemical transporter ( gene , uptake 1 ) .	T17	T28	12181285
CPR:9	CHEMICAL	GENE-Y	3	24	Reuptake of extracellular chemical ( chemical ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the chemical transporter ( gene , uptake 1 ) .	T17	T31	12181285
CPR:9	CHEMICAL	GENE-Y	5	22	Reuptake of extracellular chemical ( chemical ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the chemical transporter ( gene , uptake 1 ) .	T18	T28	12181285
CPR:9	CHEMICAL	GENE-Y	5	24	Reuptake of extracellular chemical ( chemical ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the chemical transporter ( gene , uptake 1 ) .	T18	T31	12181285
NA	CHEMICAL	GENE-Y	21	22	Reuptake of extracellular chemical ( chemical ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the chemical transporter ( gene , uptake 1 ) .	T3	T28	12181285
NA	CHEMICAL	GENE-Y	21	24	Reuptake of extracellular chemical ( chemical ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the chemical transporter ( gene , uptake 1 ) .	T3	T31	12181285
NA	CHEMICAL	GENE-Y	14	4	Making use of the gene as a powerful , neurone-specific transporter system , we loadedchemical ( chemical ) into cultured rat SCG neurones .	T19	T46	12181285
NA	CHEMICAL	GENE-Y	16	4	Making use of the gene as a powerful , neurone-specific transporter system , we loadedchemical ( chemical ) into cultured rat SCG neurones .	T20	T46	12181285
NA	CHEMICAL	GENE-Y	10	25	The ensuing radioactive outflow from these cultures was enhanced by chemical and chemical , but reduced ( in the presence of chemical ) by the gene inhibitors cyanine 863 , chemical and chemical .	T21	T47	12181285
NA	CHEMICAL	GENE-Y	12	25	The ensuing radioactive outflow from these cultures was enhanced by chemical and chemical , but reduced ( in the presence of chemical ) by the gene inhibitors cyanine 863 , chemical and chemical .	T22	T47	12181285
NA	CHEMICAL	GENE-Y	17	25	The ensuing radioactive outflow from these cultures was enhanced by chemical and chemical , but reduced ( in the presence of chemical ) by the gene inhibitors cyanine 863 , chemical and chemical .	T23	T47	12181285
CPR:4	CHEMICAL	GENE-Y	30	25	The ensuing radioactive outflow from these cultures was enhanced by chemical and chemical , but reduced ( in the presence of chemical ) by the gene inhibitors cyanine 863 , chemical and chemical .	T24	T47	12181285
CPR:4	CHEMICAL	GENE-Y	32	25	The ensuing radioactive outflow from these cultures was enhanced by chemical and chemical , but reduced ( in the presence of chemical ) by the gene inhibitors cyanine 863 , chemical and chemical .	T25	T47	12181285
NA	CHEMICAL	GENE-N	31	42	Two observations suggest that a depletion of storage vesicles by cyanine 863 accounts for the latter phenomenon : first , the primary radioactive product isolated from supernatants of cultures loaded with chemical was the metabolite chemical ; and second , inhibition of gene significantly reduced the radioactive outflow in response to cyanine 863 .	T1	T27	12181285
NA	CHEMICAL	GENE-N	35	42	Two observations suggest that a depletion of storage vesicles by cyanine 863 accounts for the latter phenomenon : first , the primary radioactive product isolated from supernatants of cultures loaded with chemical was the metabolite chemical ; and second , inhibition of gene significantly reduced the radioactive outflow in response to cyanine 863 .	T2	T27	12181285
CPR:9	CHEMICAL	GENE-N	3	19	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T4	T29	12181285
CPR:9	CHEMICAL	GENE-N	3	20	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T4	T30	12181285
CPR:9	CHEMICAL	GENE-N	8	19	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T5	T29	12181285
CPR:9	CHEMICAL	GENE-N	8	20	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T5	T30	12181285
CPR:9	CHEMICAL	GENE-N	10	19	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T6	T29	12181285
CPR:9	CHEMICAL	GENE-N	10	20	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T6	T30	12181285
CPR:9	CHEMICAL	GENE-N	12	19	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T7	T29	12181285
CPR:9	CHEMICAL	GENE-N	12	20	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T7	T30	12181285
CPR:9	CHEMICAL	GENE-N	14	19	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T8	T29	12181285
CPR:9	CHEMICAL	GENE-N	14	20	The outflow of chemical was significantly enhanced by chemical , chemical , chemical and chemical as potential substrates for gene-related gene .	T8	T30	12181285
NA	CHEMICAL	GENE-Y	2	26	However , chemical at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of chemical , indicating the gene and not an gene as their primary site of action .	T9	T32	12181285
NA	CHEMICAL	GENE-N	2	30	However , chemical at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of chemical , indicating the gene and not an gene as their primary site of action .	T9	T33	12181285
CPR:9	CHEMICAL	GENE-Y	22	26	However , chemical at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of chemical , indicating the gene and not an gene as their primary site of action .	T10	T32	12181285
NA	CHEMICAL	GENE-N	22	30	However , chemical at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of chemical , indicating the gene and not an gene as their primary site of action .	T10	T33	12181285
NA	CHEMICAL	GENE-Y	3	9	No trans-stimulation of chemical outflow was observed by the gene and gene substrate carnitine at 100 microM .	T14	T34	12181285
NA	CHEMICAL	GENE-Y	3	11	No trans-stimulation of chemical outflow was observed by the gene and gene substrate carnitine at 100 microM .	T14	T35	12181285
CPR:9	CHEMICAL	GENE-N	8	4	Our observations indicate an gene-mediated transmembrane transport of chemical .	T15	T36	12181285
NA	CHEMICAL	GENE-Y	3	7	Aripiprazole acts as a selective chemical D2 receptor partial agonist .	T11	T16	17501690
NA	CHEMICAL	GENE-N	9	19	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T2	T12	17501690
NA	CHEMICAL	GENE-Y	9	11	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T2	T13	17501690
NA	CHEMICAL	GENE-N	32	19	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T3	T12	17501690
NA	CHEMICAL	GENE-Y	32	11	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T3	T13	17501690
NA	CHEMICAL	GENE-N	34	19	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T4	T12	17501690
NA	CHEMICAL	GENE-Y	34	11	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T4	T13	17501690
NA	CHEMICAL	GENE-N	15	19	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T5	T12	17501690
NA	CHEMICAL	GENE-Y	15	11	It has been claimed that partial agonism of the chemical D ( 2 ) and chemical ( 1A ) receptors and antagonism of the gene receptor contribute to the clinical profile of chemical , a so-called chemical- and 5-HT stabiliser .	T5	T13	17501690
CPR:4	CHEMICAL	GENE-Y	0	3	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T15	22641218
CPR:4	CHEMICAL	GENE-Y	0	16	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T16	22641218
CPR:4	CHEMICAL	GENE-Y	0	19	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T17	22641218
CPR:4	CHEMICAL	GENE-Y	0	21	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T18	22641218
CPR:4	CHEMICAL	GENE-Y	0	27	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T19	22641218
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T20	22641218
NA	CHEMICAL	GENE-Y	0	31	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T21	22641218
CPR:4	CHEMICAL	GENE-N	0	34	chemical , a gene inhibitor and anti-inflammatory compound used in traditional Chinese medicine , also decreased gene-induced phosphorylation of gene and gene , and suppressed basal , gene- and gene ( gene ) -induced gene reporter gene activity .	T1	T22	22641218
CPR:3	CHEMICAL	GENE-Y	0	12	chemical also inhibited cell proliferation , while increasing sub-G0 DNA fragmentation and gene markers of apoptosis .	T2	T24	22641218
NA	CHEMICAL	GENE-Y	0	2	chemical and gene for septic shock .	T3	T6	18954704
NA	CHEMICAL	GENE-Y	15	17	This article summarizes the current knowledge on the benefit/risk profile from the use of low-dose chemical and gene in treating septic shock .	T2	T4	18954704
CPR:4	CHEMICAL	GENE-Y	4	10	Synthesis of derivatives of chemical and their inhibitory activities against gene ( gene ) .	T2	T7	23353736
CPR:4	CHEMICAL	GENE-Y	4	12	Synthesis of derivatives of chemical and their inhibitory activities against gene ( gene ) .	T2	T6	23353736
CPR:4	CHEMICAL	GENE-Y	10	3	A series of gene inhibitors have been identified based upon a chemical scaffold using structure-based drug design methods .	T1	T3	23353736
NA	CHEMICAL	GENE-N	10	0	gene ( gene ) is an gene belonging to the chemical-binding cassette transporter superfamily expressed in several organs .	T10	T16	23220037
NA	CHEMICAL	GENE-N	10	2	gene ( gene ) is an gene belonging to the chemical-binding cassette transporter superfamily expressed in several organs .	T10	T20	23220037
NA	CHEMICAL	GENE-N	10	6	gene ( gene ) is an gene belonging to the chemical-binding cassette transporter superfamily expressed in several organs .	T10	T22	23220037
NA	CHEMICAL	GENE-N	10	5	gene ( gene ) is an gene belonging to the chemical-binding cassette transporter superfamily expressed in several organs .	T10	T25	23220037
CPR:9	CHEMICAL	GENE-N	2	8	The herbicide chemical ( PQ ) is a gene substrate responsible for thousands of fatal intoxications worldwide that still lacks an effective antidote .	T7	T23	23220037
CPR:3	CHEMICAL	GENE-N	18	25	The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether chemical ( chemical ) , a known gene inducer , could efficiently protect Caco-2 cells against PQ cytotoxicity , 6 h after the incubation with the herbicide , reflecting a real-life intoxication scenario .	T8	T24	23220037
CPR:3	CHEMICAL	GENE-N	20	25	The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether chemical ( chemical ) , a known gene inducer , could efficiently protect Caco-2 cells against PQ cytotoxicity , 6 h after the incubation with the herbicide , reflecting a real-life intoxication scenario .	T9	T24	23220037
NA	CHEMICAL	GENE-Y	6	3	Cooperative effects for gene differ between chemical and its metabolites .	T12	T19	23327532
NA	CHEMICAL	GENE-Y	3	11	We hypothesized that chemical metabolites have lower affinity than chemical toward gene and limited ability to induce cooperative effects during metabolism .	T4	T16	23327532
NA	CHEMICAL	GENE-Y	9	11	We hypothesized that chemical metabolites have lower affinity than chemical toward gene and limited ability to induce cooperative effects during metabolism .	T5	T16	23327532
NA	CHEMICAL	GENE-Y	14	23	To test the hypothesis , we determined the potency and mechanism of inhibition for chemical and its metabolites toward oxidation of chemical using gene Supersomes® and human liver microsomes .	T6	T17	23327532
NA	CHEMICAL	GENE-Y	21	23	To test the hypothesis , we determined the potency and mechanism of inhibition for chemical and its metabolites toward oxidation of chemical using gene Supersomes® and human liver microsomes .	T7	T17	23327532
NA	CHEMICAL	GENE-Y	0	7	chemical and chemical possessed similar affinity for gene .	T9	T18	23327532
NA	CHEMICAL	GENE-Y	2	7	chemical and chemical possessed similar affinity for gene .	T10	T18	23327532
NA	CHEMICAL	GENE-Y	0	4	chemical-dependent lysosomal enlargement in gene-deficient cells involves gene transcription factor and gene ( gene ) transporter .	T18	T41	23368743
NA	CHEMICAL	GENE-Y	0	7	chemical-dependent lysosomal enlargement in gene-deficient cells involves gene transcription factor and gene ( gene ) transporter .	T18	T42	23368743
NA	CHEMICAL	GENE-Y	0	11	chemical-dependent lysosomal enlargement in gene-deficient cells involves gene transcription factor and gene ( gene ) transporter .	T18	T39	23368743
NA	CHEMICAL	GENE-Y	0	13	chemical-dependent lysosomal enlargement in gene-deficient cells involves gene transcription factor and gene ( gene ) transporter .	T18	T40	23368743
CPR:9	CHEMICAL	GENE-N	1	6	Cellular chemical is controlled by chemical-chelating proteins and by chemical transporters .	T4	T28	23368743
CPR:9	CHEMICAL	GENE-N	1	10	Cellular chemical is controlled by chemical-chelating proteins and by chemical transporters .	T4	T29	23368743
NA	CHEMICAL	GENE-N	5	6	Cellular chemical is controlled by chemical-chelating proteins and by chemical transporters .	T8	T28	23368743
NA	CHEMICAL	GENE-N	5	10	Cellular chemical is controlled by chemical-chelating proteins and by chemical transporters .	T8	T29	23368743
NA	CHEMICAL	GENE-N	9	6	Cellular chemical is controlled by chemical-chelating proteins and by chemical transporters .	T9	T28	23368743
NA	CHEMICAL	GENE-N	9	10	Cellular chemical is controlled by chemical-chelating proteins and by chemical transporters .	T9	T29	23368743
NA	CHEMICAL	GENE-N	4	9	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T10	T30	23368743
CPR:9	CHEMICAL	GENE-Y	4	10	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T10	T31	23368743
CPR:9	CHEMICAL	GENE-Y	4	12	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T10	T32	23368743
NA	CHEMICAL	GENE-Y	4	26	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T10	T33	23368743
NA	CHEMICAL	GENE-Y	4	32	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T10	T34	23368743
NA	CHEMICAL	GENE-N	20	9	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T11	T30	23368743
NA	CHEMICAL	GENE-Y	20	10	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T11	T31	23368743
NA	CHEMICAL	GENE-Y	20	12	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T11	T32	23368743
NA	CHEMICAL	GENE-Y	20	26	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T11	T33	23368743
NA	CHEMICAL	GENE-Y	20	32	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T11	T34	23368743
NA	CHEMICAL	GENE-N	22	9	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T12	T30	23368743
NA	CHEMICAL	GENE-Y	22	10	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T12	T31	23368743
NA	CHEMICAL	GENE-Y	22	12	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T12	T32	23368743
NA	CHEMICAL	GENE-Y	22	26	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T12	T33	23368743
CPR:9	CHEMICAL	GENE-Y	22	32	The recent identification of chemical permeability of the lysosomal gene gene ( gene ) , and the evidence of abnormal chemical levels in cells deficient in gene , suggested a role for gene in chemical transport .	T12	T34	23368743
NA	CHEMICAL	GENE-Y	34	17	In agreement with the previously published data , an acute siRNA ( small interfering RNA ) -driven gene KD ( knockdown ) leads to the build-up of large cytoplasmic vesicles positive for LysoTracker™ and chemical staining , when cells are exposed to high concentrations of chemical .	T13	T35	23368743
NA	CHEMICAL	GENE-Y	45	17	In agreement with the previously published data , an acute siRNA ( small interfering RNA ) -driven gene KD ( knockdown ) leads to the build-up of large cytoplasmic vesicles positive for LysoTracker™ and chemical staining , when cells are exposed to high concentrations of chemical .	T14	T35	23368743
NA	CHEMICAL	GENE-Y	7	10	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T15	T36	23368743
NA	CHEMICAL	GENE-N	7	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T15	T37	23368743
NA	CHEMICAL	GENE-Y	7	24	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T15	T38	23368743
NA	CHEMICAL	GENE-Y	7	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T15	T19	23368743
NA	CHEMICAL	GENE-Y	7	32	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T15	T20	23368743
NA	CHEMICAL	GENE-Y	9	10	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T16	T36	23368743
NA	CHEMICAL	GENE-N	9	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T16	T37	23368743
NA	CHEMICAL	GENE-Y	9	24	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T16	T38	23368743
NA	CHEMICAL	GENE-Y	9	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T16	T19	23368743
NA	CHEMICAL	GENE-Y	9	32	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T16	T20	23368743
NA	CHEMICAL	GENE-Y	9	10	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T17	T36	23368743
NA	CHEMICAL	GENE-N	9	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T17	T37	23368743
NA	CHEMICAL	GENE-Y	9	24	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T17	T38	23368743
NA	CHEMICAL	GENE-Y	9	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T17	T19	23368743
NA	CHEMICAL	GENE-Y	9	32	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T17	T20	23368743
NA	CHEMICAL	GENE-Y	9	10	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T2	T36	23368743
NA	CHEMICAL	GENE-N	9	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T2	T37	23368743
NA	CHEMICAL	GENE-Y	9	24	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T2	T38	23368743
NA	CHEMICAL	GENE-Y	9	13	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T2	T19	23368743
NA	CHEMICAL	GENE-Y	9	32	We now show that lysosomal enlargement and chemical build-up in gene-KD cells exposed to chemical are ameliorated by KD of the chemical-sensitive transcription factor gene ( gene ) or the chemical transporter ZnT4 .	T2	T20	23368743
NA	CHEMICAL	GENE-Y	9	0	gene KD is associated with a build-up of cytoplasmic chemical and with enhanced transcriptional response of mRNA for gene ( gene ) .	T3	T21	23368743
NA	CHEMICAL	GENE-Y	9	5	gene KD is associated with a build-up of cytoplasmic chemical and with enhanced transcriptional response of mRNA for gene ( gene ) .	T3	T22	23368743
NA	CHEMICAL	GENE-Y	9	5	gene KD is associated with a build-up of cytoplasmic chemical and with enhanced transcriptional response of mRNA for gene ( gene ) .	T3	T23	23368743
NA	CHEMICAL	GENE-Y	12	0	gene KD did not suppress lysosomal secretion , but it did delay chemical leak from the lysosomes into the cytoplasm .	T5	T24	23368743
CPR:9	CHEMICAL	GENE-Y	7	6	These results underscore a role for gene in chemical metabolism .	T6	T25	23368743
NA	CHEMICAL	GENE-Y	3	13	A series of chemical analogs were designed and the interaction between chemical and gene studied by the docking method to improve the biological activity and reduce the gastrointestinal side effects of chemical .	T1	T14	19952416
NA	CHEMICAL	GENE-Y	11	13	A series of chemical analogs were designed and the interaction between chemical and gene studied by the docking method to improve the biological activity and reduce the gastrointestinal side effects of chemical .	T11	T14	19952416
NA	CHEMICAL	GENE-Y	31	13	A series of chemical analogs were designed and the interaction between chemical and gene studied by the docking method to improve the biological activity and reduce the gastrointestinal side effects of chemical .	T2	T14	19952416
NA	CHEMICAL	GENE-N	9	11	In terms of the mechanisms , we found that chemical chemical hydrolase ( gene ) which degrades chemical , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age-dependent differences .	T12	T18	23597506
NA	CHEMICAL	GENE-N	9	13	In terms of the mechanisms , we found that chemical chemical hydrolase ( gene ) which degrades chemical , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age-dependent differences .	T12	T15	23597506
NA	CHEMICAL	GENE-N	10	11	In terms of the mechanisms , we found that chemical chemical hydrolase ( gene ) which degrades chemical , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age-dependent differences .	T13	T18	23597506
NA	CHEMICAL	GENE-N	10	13	In terms of the mechanisms , we found that chemical chemical hydrolase ( gene ) which degrades chemical , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age-dependent differences .	T13	T15	23597506
CPR:9	CHEMICAL	GENE-N	9	11	In terms of the mechanisms , we found that chemical chemical hydrolase ( gene ) which degrades chemical , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age-dependent differences .	T1	T18	23597506
CPR:9	CHEMICAL	GENE-N	9	13	In terms of the mechanisms , we found that chemical chemical hydrolase ( gene ) which degrades chemical , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age-dependent differences .	T1	T15	23597506
CPR:9	CHEMICAL	GENE-Y	8	11	However , enzymes contributing to oxidative metabolism of chemical , namely gene and gene , were increased in the brain of aged mice , possibly enhancing the oxidative breakdown of chemical .	T2	T16	23597506
CPR:9	CHEMICAL	GENE-N	8	13	However , enzymes contributing to oxidative metabolism of chemical , namely gene and gene , were increased in the brain of aged mice , possibly enhancing the oxidative breakdown of chemical .	T2	T17	23597506
CPR:9	CHEMICAL	GENE-Y	12	11	However , enzymes contributing to oxidative metabolism of chemical , namely gene and gene , were increased in the brain of aged mice , possibly enhancing the oxidative breakdown of chemical .	T3	T16	23597506
CPR:9	CHEMICAL	GENE-N	12	13	However , enzymes contributing to oxidative metabolism of chemical , namely gene and gene , were increased in the brain of aged mice , possibly enhancing the oxidative breakdown of chemical .	T3	T17	23597506
NA	CHEMICAL	GENE-N	1	1	At a pre-receptor level , glucocorticoid action is modulated by chemical dehydrogenases ( gene ) .	T2	T14	16980198
NA	CHEMICAL	GENE-N	1	1	At a pre-receptor level , glucocorticoid action is modulated by chemical dehydrogenases ( gene ) .	T2	T15	16980198
CPR:9	CHEMICAL	GENE-Y	2	0	gene activates chemical to chemical to facilitate gene ( gene ) -mediated action .	T3	T16	16980198
NA	CHEMICAL	GENE-Y	2	3	gene activates chemical to chemical to facilitate gene ( gene ) -mediated action .	T3	T17	16980198
NA	CHEMICAL	GENE-Y	2	9	gene activates chemical to chemical to facilitate gene ( gene ) -mediated action .	T3	T18	16980198
CPR:9	CHEMICAL	GENE-Y	4	0	gene activates chemical to chemical to facilitate gene ( gene ) -mediated action .	T4	T16	16980198
NA	CHEMICAL	GENE-Y	4	3	gene activates chemical to chemical to facilitate gene ( gene ) -mediated action .	T4	T17	16980198
NA	CHEMICAL	GENE-Y	4	9	gene activates chemical to chemical to facilitate gene ( gene ) -mediated action .	T4	T18	16980198
NA	CHEMICAL	GENE-Y	5	3	By contrast , gene plays a pivotal role in chemical target tissues where it catalyses the opposite reaction ( i.e .	T5	T19	16980198
NA	CHEMICAL	GENE-Y	2	3	inactivation of chemical to chemical ) to prevent activation of the gene ( gene ) by chemical .	T6	T20	16980198
NA	CHEMICAL	GENE-Y	2	13	inactivation of chemical to chemical ) to prevent activation of the gene ( gene ) by chemical .	T6	T21	16980198
NA	CHEMICAL	GENE-Y	4	3	inactivation of chemical to chemical ) to prevent activation of the gene ( gene ) by chemical .	T7	T20	16980198
NA	CHEMICAL	GENE-Y	4	13	inactivation of chemical to chemical ) to prevent activation of the gene ( gene ) by chemical .	T7	T21	16980198
CPR:3	CHEMICAL	GENE-Y	16	3	inactivation of chemical to chemical ) to prevent activation of the gene ( gene ) by chemical .	T8	T20	16980198
CPR:3	CHEMICAL	GENE-Y	16	13	inactivation of chemical to chemical ) to prevent activation of the gene ( gene ) by chemical .	T8	T21	16980198
NA	CHEMICAL	GENE-Y	25	3	Mutations in the gene gene cause a rare form of inherited hypertension , the syndrome of apparent mineralocorticoid excess ( AME ) , in which chemical activates the gene resulting in severe hypertension and hypokalemia .	T9	T22	16980198
CPR:3	CHEMICAL	GENE-Y	25	28	Mutations in the gene gene cause a rare form of inherited hypertension , the syndrome of apparent mineralocorticoid excess ( AME ) , in which chemical activates the gene resulting in severe hypertension and hypokalemia .	T9	T23	16980198
CPR:4	CHEMICAL	GENE-Y	10	5	Ingestion of competitive inhibitors of gene such as liquorice and chemical result in a similar but milder clinical phenotype .	T11	T24	16980198
NA	CHEMICAL	GENE-Y	0	6	chemical dimers exhibiting selectivity for the gene subtype .	T8	T23	12438517
CPR:6	CHEMICAL	GENE-N	0	2	chemical is a potent and selective gene antagonist .	T1	T17	12438517
NA	CHEMICAL	GENE-Y	4	14	Initial studies showed that chemical was about 4- and 15-fold more selective for the gene in comparison with the gene , respectively .	T4	T15	12438517
NA	CHEMICAL	GENE-N	4	19	Initial studies showed that chemical was about 4- and 15-fold more selective for the gene in comparison with the gene , respectively .	T4	T16	12438517
NA	CHEMICAL	GENE-N	11	4	To improve on this gene subtype selectivity , a series of chemical dimers ( varying from n = 2 to 24 spacer atoms ) were prepared and evaluated for receptor binding on gene subtypes expressed in Chinese hamster ovary cells .	T5	T18	12438517
NA	CHEMICAL	GENE-N	11	8	To improve on this gene subtype selectivity , a series of chemical dimers ( varying from n = 2 to 24 spacer atoms ) were prepared and evaluated for receptor binding on gene subtypes expressed in Chinese hamster ovary cells .	T5	T19	12438517
NA	CHEMICAL	GENE-N	13	7	Each dimeric analog showed higher affinities for gene versus the gene ; and chemical dimers with spacers of n = 2 , 3 , 4 , 18 , and 24 exhibited selectivity for the gene .	T6	T20	12438517
NA	CHEMICAL	GENE-Y	13	10	Each dimeric analog showed higher affinities for gene versus the gene ; and chemical dimers with spacers of n = 2 , 3 , 4 , 18 , and 24 exhibited selectivity for the gene .	T6	T21	12438517
NA	CHEMICAL	GENE-Y	13	18	Each dimeric analog showed higher affinities for gene versus the gene ; and chemical dimers with spacers of n = 2 , 3 , 4 , 18 , and 24 exhibited selectivity for the gene .	T6	T22	12438517
NA	CHEMICAL	GENE-Y	20	4	respectively ) for the gene in receptor binding and in functional studies ( 42- and 29-fold , respectively ) measuring chemical changes using a cell-based luciferase reporter gene assay .	T2	T9	12438517
NA	CHEMICAL	GENE-N	6	7	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T6	T13	18034539
NA	CHEMICAL	GENE-N	6	12	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T6	T14	18034539
NA	CHEMICAL	GENE-N	6	28	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T6	T15	18034539
NA	CHEMICAL	GENE-N	6	42	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T6	T16	18034539
NA	CHEMICAL	GENE-Y	6	46	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T6	T17	18034539
NA	CHEMICAL	GENE-N	9	7	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T7	T13	18034539
NA	CHEMICAL	GENE-N	9	12	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T7	T14	18034539
NA	CHEMICAL	GENE-N	9	28	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T7	T15	18034539
NA	CHEMICAL	GENE-N	9	42	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T7	T16	18034539
NA	CHEMICAL	GENE-Y	9	46	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T7	T17	18034539
NA	CHEMICAL	GENE-N	21	7	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T8	T13	18034539
NA	CHEMICAL	GENE-N	21	12	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T8	T14	18034539
NA	CHEMICAL	GENE-N	21	28	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T8	T15	18034539
NA	CHEMICAL	GENE-N	21	42	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T8	T16	18034539
NA	CHEMICAL	GENE-Y	21	46	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T8	T17	18034539
NA	CHEMICAL	GENE-N	36	7	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T9	T13	18034539
NA	CHEMICAL	GENE-N	36	12	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T9	T14	18034539
NA	CHEMICAL	GENE-N	36	28	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T9	T15	18034539
NA	CHEMICAL	GENE-N	36	42	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T9	T16	18034539
CPR:3	CHEMICAL	GENE-Y	36	46	One is that the binding of chemical to nuclear chemical receptors ( gene ) does not match their therapeutic efficacy : chemical activates the three receptor subtypes , gene , without measurable receptor binding , whereas chemical preferentially binds to and activates gene in preference to gene .	T9	T17	18034539
NA	CHEMICAL	GENE-Y	3	4	Crystal structure of chemical kinase in complex with chemical and derivatives .	T24	T38	15985434
NA	CHEMICAL	GENE-Y	5	4	Crystal structure of chemical kinase in complex with chemical and derivatives .	T25	T38	15985434
NA	CHEMICAL	GENE-Y	0	1	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T1	T26	15985434
NA	CHEMICAL	GENE-Y	0	3	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T1	T30	15985434
CPR:9	CHEMICAL	GENE-Y	9	1	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T15	T26	15985434
CPR:9	CHEMICAL	GENE-Y	9	3	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T15	T30	15985434
CPR:9	CHEMICAL	GENE-Y	11	1	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T16	T26	15985434
CPR:9	CHEMICAL	GENE-Y	11	3	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T16	T30	15985434
CPR:9	CHEMICAL	GENE-Y	14	1	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T20	T26	15985434
CPR:9	CHEMICAL	GENE-Y	14	3	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T20	T30	15985434
NA	CHEMICAL	GENE-Y	19	1	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T4	T26	15985434
NA	CHEMICAL	GENE-Y	19	3	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T4	T30	15985434
NA	CHEMICAL	GENE-Y	21	1	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T6	T26	15985434
NA	CHEMICAL	GENE-Y	21	3	chemical kinase ( gene ) catalyzes the phosphorylation of chemical , chemical , and chemical in the presence of chemical and chemical .	T6	T30	15985434
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( chemical , chemical ) is a relatively selective inhibitor of gene ( gene ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .	T11	T31	15985434
CPR:4	CHEMICAL	GENE-N	0	14	chemical ( chemical , chemical ) is a relatively selective inhibitor of gene ( gene ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .	T11	T32	15985434
CPR:4	CHEMICAL	GENE-N	2	7	chemical ( chemical , chemical ) is a relatively selective inhibitor of gene ( gene ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .	T12	T31	15985434
CPR:4	CHEMICAL	GENE-N	2	14	chemical ( chemical , chemical ) is a relatively selective inhibitor of gene ( gene ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .	T12	T32	15985434
CPR:4	CHEMICAL	GENE-N	4	7	chemical ( chemical , chemical ) is a relatively selective inhibitor of gene ( gene ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .	T13	T31	15985434
CPR:4	CHEMICAL	GENE-N	4	14	chemical ( chemical , chemical ) is a relatively selective inhibitor of gene ( gene ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .	T13	T32	15985434
NA	CHEMICAL	GENE-Y	6	10	Affinity chromatography investigations have shown that chemical also interacts with gene .	T14	T33	15985434
NA	CHEMICAL	GENE-Y	12	11	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T17	T34	15985434
NA	CHEMICAL	GENE-Y	12	31	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T17	T35	15985434
NA	CHEMICAL	GENE-N	12	35	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T17	T36	15985434
NA	CHEMICAL	GENE-Y	12	11	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T18	T34	15985434
NA	CHEMICAL	GENE-Y	12	31	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T18	T35	15985434
NA	CHEMICAL	GENE-N	12	35	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T18	T36	15985434
NA	CHEMICAL	GENE-Y	12	11	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T19	T34	15985434
NA	CHEMICAL	GENE-Y	12	31	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T19	T35	15985434
NA	CHEMICAL	GENE-N	12	35	To understand this interaction , we determined the crystal structure of gene in complex with chemical , chemical , and chemical , the two latter derivatives being designed to bind to gene but not to gene .	T19	T36	15985434
NA	CHEMICAL	GENE-Y	6	14	Structural analysis revealed that these three chemical bind similarly in the chemical-binding site of gene rather than in the anticipated chemical-binding site .	T21	T37	15985434
NA	CHEMICAL	GENE-Y	11	14	Structural analysis revealed that these three chemical bind similarly in the chemical-binding site of gene rather than in the anticipated chemical-binding site .	T22	T37	15985434
NA	CHEMICAL	GENE-Y	20	14	Structural analysis revealed that these three chemical bind similarly in the chemical-binding site of gene rather than in the anticipated chemical-binding site .	T23	T37	15985434
NA	CHEMICAL	GENE-Y	12	10	This work provides detailed structural information on the interactions between gene and chemical and analogs .	T5	T27	15985434
CPR:5	CHEMICAL	GENE-Y	8	4	Full agonists to the gene , such as chemical , have been associated with a series of undesired side effects , such as weight gain , fluid retention , cardiac hypertrophy , and hepatotoxicity .	T3	T4	23432662
NA	CHEMICAL	GENE-Y	12	2	Nevertheless , gene is involved in the expression of genes that control chemical and lipid metabolism and is an important target for drugs against type 2 diabetes , dyslipidemia , atherosclerosis , and cardiovascular disease .	T2	T5	23432662
NA	CHEMICAL	GENE-Y	6	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T31	23567861
NA	CHEMICAL	GENE-N	6	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T32	23567861
NA	CHEMICAL	GENE-N	6	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T33	23567861
NA	CHEMICAL	GENE-Y	6	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T34	23567861
NA	CHEMICAL	GENE-Y	6	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T35	23567861
NA	CHEMICAL	GENE-Y	6	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T36	23567861
NA	CHEMICAL	GENE-N	6	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T37	23567861
NA	CHEMICAL	GENE-N	6	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T38	23567861
NA	CHEMICAL	GENE-N	6	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T4	T39	23567861
NA	CHEMICAL	GENE-Y	20	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T31	23567861
NA	CHEMICAL	GENE-N	20	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T32	23567861
NA	CHEMICAL	GENE-N	20	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T33	23567861
NA	CHEMICAL	GENE-Y	20	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T34	23567861
NA	CHEMICAL	GENE-Y	20	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T35	23567861
NA	CHEMICAL	GENE-Y	20	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T36	23567861
NA	CHEMICAL	GENE-N	20	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T37	23567861
NA	CHEMICAL	GENE-N	20	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T38	23567861
NA	CHEMICAL	GENE-N	20	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T39	23567861
NA	CHEMICAL	GENE-Y	20	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T5	T40	23567861
NA	CHEMICAL	GENE-Y	23	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T31	23567861
NA	CHEMICAL	GENE-N	23	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T32	23567861
NA	CHEMICAL	GENE-N	23	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T33	23567861
NA	CHEMICAL	GENE-Y	23	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T34	23567861
NA	CHEMICAL	GENE-Y	23	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T35	23567861
NA	CHEMICAL	GENE-Y	23	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T36	23567861
NA	CHEMICAL	GENE-N	23	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T37	23567861
NA	CHEMICAL	GENE-N	23	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T38	23567861
NA	CHEMICAL	GENE-N	23	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T39	23567861
NA	CHEMICAL	GENE-Y	23	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T6	T40	23567861
NA	CHEMICAL	GENE-Y	26	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T31	23567861
NA	CHEMICAL	GENE-N	26	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T32	23567861
NA	CHEMICAL	GENE-N	26	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T33	23567861
NA	CHEMICAL	GENE-Y	26	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T34	23567861
NA	CHEMICAL	GENE-Y	26	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T35	23567861
NA	CHEMICAL	GENE-Y	26	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T36	23567861
NA	CHEMICAL	GENE-N	26	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T37	23567861
NA	CHEMICAL	GENE-N	26	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T38	23567861
NA	CHEMICAL	GENE-N	26	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T39	23567861
NA	CHEMICAL	GENE-Y	26	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T7	T40	23567861
NA	CHEMICAL	GENE-Y	29	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T31	23567861
NA	CHEMICAL	GENE-N	29	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T32	23567861
NA	CHEMICAL	GENE-N	29	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T33	23567861
NA	CHEMICAL	GENE-Y	29	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T34	23567861
NA	CHEMICAL	GENE-Y	29	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T35	23567861
NA	CHEMICAL	GENE-Y	29	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T36	23567861
NA	CHEMICAL	GENE-N	29	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T37	23567861
NA	CHEMICAL	GENE-N	29	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T38	23567861
NA	CHEMICAL	GENE-N	29	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T39	23567861
NA	CHEMICAL	GENE-Y	29	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T8	T40	23567861
NA	CHEMICAL	GENE-Y	33	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T31	23567861
NA	CHEMICAL	GENE-N	33	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T32	23567861
NA	CHEMICAL	GENE-N	33	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T33	23567861
NA	CHEMICAL	GENE-Y	33	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T34	23567861
NA	CHEMICAL	GENE-Y	33	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T35	23567861
NA	CHEMICAL	GENE-Y	33	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T36	23567861
NA	CHEMICAL	GENE-N	33	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T37	23567861
NA	CHEMICAL	GENE-N	33	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T38	23567861
NA	CHEMICAL	GENE-N	33	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T39	23567861
NA	CHEMICAL	GENE-Y	33	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T10	T40	23567861
NA	CHEMICAL	GENE-Y	34	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T31	23567861
NA	CHEMICAL	GENE-N	34	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T32	23567861
NA	CHEMICAL	GENE-N	34	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T33	23567861
NA	CHEMICAL	GENE-Y	34	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T34	23567861
NA	CHEMICAL	GENE-Y	34	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T35	23567861
NA	CHEMICAL	GENE-Y	34	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T36	23567861
NA	CHEMICAL	GENE-N	34	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T37	23567861
NA	CHEMICAL	GENE-N	34	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T38	23567861
NA	CHEMICAL	GENE-N	34	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T39	23567861
NA	CHEMICAL	GENE-Y	34	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T11	T40	23567861
NA	CHEMICAL	GENE-Y	37	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T31	23567861
NA	CHEMICAL	GENE-N	37	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T32	23567861
NA	CHEMICAL	GENE-N	37	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T33	23567861
NA	CHEMICAL	GENE-Y	37	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T34	23567861
NA	CHEMICAL	GENE-Y	37	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T35	23567861
NA	CHEMICAL	GENE-Y	37	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T36	23567861
NA	CHEMICAL	GENE-N	37	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T37	23567861
NA	CHEMICAL	GENE-N	37	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T38	23567861
NA	CHEMICAL	GENE-N	37	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T39	23567861
NA	CHEMICAL	GENE-Y	37	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T12	T40	23567861
NA	CHEMICAL	GENE-Y	44	8	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T31	23567861
NA	CHEMICAL	GENE-N	44	10	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T32	23567861
NA	CHEMICAL	GENE-N	44	12	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T33	23567861
NA	CHEMICAL	GENE-Y	44	14	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T34	23567861
NA	CHEMICAL	GENE-Y	44	16	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T35	23567861
NA	CHEMICAL	GENE-Y	44	18	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T36	23567861
NA	CHEMICAL	GENE-N	44	28	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T37	23567861
NA	CHEMICAL	GENE-N	44	32	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T38	23567861
NA	CHEMICAL	GENE-N	44	33	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T39	23567861
NA	CHEMICAL	GENE-Y	44	49	The results showed that levels of chemical , gene , gene , gene , gene , gene , gene , chemical , total chemical , non-esterified chemical , gene chemical , very gene chemical/gene chemical , reactive chemical species ( ROS ) , and chemical-reactive substance ( TBARS ) in serum were down-regulated , while gene was augmented by GS treatment .	T13	T40	23567861
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T2	T4	23220641
NA	CHEMICAL	GENE-Y	1	2	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T2	T7	23220641
NA	CHEMICAL	GENE-N	1	6	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T2	T8	23220641
NA	CHEMICAL	GENE-N	1	8	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T2	T10	23220641
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T3	T4	23220641
NA	CHEMICAL	GENE-Y	1	2	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T3	T7	23220641
NA	CHEMICAL	GENE-N	1	6	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T3	T8	23220641
NA	CHEMICAL	GENE-N	1	8	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T3	T10	23220641
NA	CHEMICAL	GENE-Y	15	0	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T1	T4	23220641
NA	CHEMICAL	GENE-Y	15	2	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T1	T7	23220641
NA	CHEMICAL	GENE-N	15	6	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T1	T8	23220641
NA	CHEMICAL	GENE-N	15	8	gene ( gene ) enzymes or gene are a family of chemical-dependent protein chemical ( chemical ) deacetylases .	T1	T10	23220641
NA	CHEMICAL	GENE-N	7	5	Binding of antipsychotic drugs at gene : chemical is selective for the gene .	T15	T26	7691623
NA	CHEMICAL	GENE-Y	7	12	Binding of antipsychotic drugs at gene : chemical is selective for the gene .	T15	T25	7691623
NA	CHEMICAL	GENE-N	6	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T6	T19	7691623
NA	CHEMICAL	GENE-N	8	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T9	T19	7691623
NA	CHEMICAL	GENE-N	10	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T12	T19	7691623
NA	CHEMICAL	GENE-N	12	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T13	T19	7691623
NA	CHEMICAL	GENE-N	14	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T14	T19	7691623
NA	CHEMICAL	GENE-N	16	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T2	T19	7691623
NA	CHEMICAL	GENE-N	18	26	The binding of the antipsychotic drugs chemical , chemical , chemical , chemical , chemical , chemical and chemical was studied at the subtypes of the gene .	T4	T19	7691623
NA	CHEMICAL	GENE-Y	4	16	Saturation experiments showed that chemical labelled a single population of binding sites in the spleen ( gene ) and hippocampus ( gene and gene ) ( dissociation constants ( KD ) : 0.26 nM and 0.14 nM respectively ) .	T5	T20	7691623
NA	CHEMICAL	GENE-Y	4	21	Saturation experiments showed that chemical labelled a single population of binding sites in the spleen ( gene ) and hippocampus ( gene and gene ) ( dissociation constants ( KD ) : 0.26 nM and 0.14 nM respectively ) .	T5	T21	7691623
NA	CHEMICAL	GENE-Y	4	23	Saturation experiments showed that chemical labelled a single population of binding sites in the spleen ( gene ) and hippocampus ( gene and gene ) ( dissociation constants ( KD ) : 0.26 nM and 0.14 nM respectively ) .	T5	T22	7691623
NA	CHEMICAL	GENE-N	4	12	With the exception of chemical , all the antipsychotic drugs tested failed to show selectivity for either of the gene subtypes .	T1	T16	7691623
CPR:5	CHEMICAL	GENE-Y	5	8	Evaluation of drug interactions of chemical ( a gene agonist ) with statins : from in vitro data to clinical study design .	T19	T39	23256625
CPR:5	CHEMICAL	GENE-Y	8	12	This work investigated the drug interaction potential of chemical , a novel gene agonist , with the gene inhibitors chemical and chemical .	T14	T37	23256625
NA	CHEMICAL	GENE-Y	8	10	This work investigated the drug interaction potential of chemical , a novel gene agonist , with the gene inhibitors chemical and chemical .	T14	T22	23256625
NA	CHEMICAL	GENE-Y	10	12	This work investigated the drug interaction potential of chemical , a novel gene agonist , with the gene inhibitors chemical and chemical .	T6	T37	23256625
CPR:4	CHEMICAL	GENE-Y	10	10	This work investigated the drug interaction potential of chemical , a novel gene agonist , with the gene inhibitors chemical and chemical .	T6	T22	23256625
NA	CHEMICAL	GENE-Y	10	12	This work investigated the drug interaction potential of chemical , a novel gene agonist , with the gene inhibitors chemical and chemical .	T8	T37	23256625
CPR:4	CHEMICAL	GENE-Y	10	10	This work investigated the drug interaction potential of chemical , a novel gene agonist , with the gene inhibitors chemical and chemical .	T8	T22	23256625
CPR:4	CHEMICAL	GENE-N	12	7	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T9	T24	23256625
CPR:4	CHEMICAL	GENE-N	12	9	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T9	T25	23256625
NA	CHEMICAL	GENE-N	24	7	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T10	T24	23256625
NA	CHEMICAL	GENE-N	24	9	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T10	T25	23256625
NA	CHEMICAL	GENE-N	15	7	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T11	T24	23256625
NA	CHEMICAL	GENE-N	15	9	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T11	T25	23256625
NA	CHEMICAL	GENE-N	15	7	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T12	T24	23256625
NA	CHEMICAL	GENE-N	15	9	In vitro experiments assessed the inhibition of gene and gene enzymes by chemical , and a clinical drug interaction study investigated the effect of chemical ( 300 mg BID ) on the pharmacokinetic profile of chemical ( 40 mg single dose ) and chemical ( 10 mg single dose ) .	T12	T25	23256625
CPR:4	CHEMICAL	GENE-N	3	15	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T26	23256625
CPR:4	CHEMICAL	GENE-Y	3	17	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T27	23256625
CPR:4	CHEMICAL	GENE-Y	3	19	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T28	23256625
CPR:4	CHEMICAL	GENE-Y	3	21	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T29	23256625
CPR:4	CHEMICAL	GENE-Y	3	23	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T30	23256625
CPR:4	CHEMICAL	GENE-Y	3	25	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T31	23256625
CPR:4	CHEMICAL	GENE-N	3	28	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T32	23256625
CPR:4	CHEMICAL	GENE-Y	3	30	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T33	23256625
CPR:4	CHEMICAL	GENE-Y	3	33	In vitro , chemical demonstrated little/weak inhibition ( IC50 values > 30 μM ) towards gene ( gene , gene , gene , gene , gene ) , gene , gene , or gene .	T13	T34	23256625
CPR:4	CHEMICAL	GENE-Y	2	4	However , chemical inhibited gene and gene , which are transporters involved in statin disposition .	T15	T35	23256625
CPR:4	CHEMICAL	GENE-Y	2	6	However , chemical inhibited gene and gene , which are transporters involved in statin disposition .	T15	T36	23256625
CPR:4	CHEMICAL	GENE-Y	54	65	In the clinical study , small increases in the AUC ( 0-inf ) of chemical [ mean ratio ( 90 % CI ) of 1.34 ( 1.22 , 1.48 ) ] and chemical [ mean ratio ( 90 % CI ) of 1.39 ( 1.30 , 1.49 ) ] were observed when co-administered with chemical , which is consistent with an inhibitory effect on intestinal gene and gene .	T18	T38	23256625
CPR:4	CHEMICAL	GENE-Y	54	67	In the clinical study , small increases in the AUC ( 0-inf ) of chemical [ mean ratio ( 90 % CI ) of 1.34 ( 1.22 , 1.48 ) ] and chemical [ mean ratio ( 90 % CI ) of 1.39 ( 1.30 , 1.49 ) ] were observed when co-administered with chemical , which is consistent with an inhibitory effect on intestinal gene and gene .	T18	T20	23256625
NA	CHEMICAL	GENE-Y	3	7	In contrast , chemical did not inhibit gene based on the lack of changes in chemical acid exposure [ mean AUC ( 0-inf ) ratio ( 90 % CI ) of 1.05 ( 0.91 , 1.21 ) ] .	T1	T21	23256625
NA	CHEMICAL	GENE-Y	7	7	In contrast , chemical did not inhibit gene based on the lack of changes in chemical acid exposure [ mean AUC ( 0-inf ) ratio ( 90 % CI ) of 1.05 ( 0.91 , 1.21 ) ] .	T2	T21	23256625
NA	CHEMICAL	GENE-Y	0	1	chemical receptor binding and uterotonic activity of chemical and its metabolites following enzymatic degradation .	T36	T48	9760035
NA	CHEMICAL	GENE-Y	7	1	chemical receptor binding and uterotonic activity of chemical and its metabolites following enzymatic degradation .	T37	T48	9760035
NA	CHEMICAL	GENE-Y	1	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T24	T43	9760035
NA	CHEMICAL	GENE-Y	1	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T24	T44	9760035
NA	CHEMICAL	GENE-Y	3	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T25	T43	9760035
NA	CHEMICAL	GENE-Y	3	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T25	T44	9760035
NA	CHEMICAL	GENE-Y	7	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T26	T43	9760035
NA	CHEMICAL	GENE-Y	7	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T26	T44	9760035
NA	CHEMICAL	GENE-Y	13	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T27	T43	9760035
NA	CHEMICAL	GENE-Y	13	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T27	T44	9760035
NA	CHEMICAL	GENE-Y	13	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T28	T43	9760035
NA	CHEMICAL	GENE-Y	13	13	Both chemical , chemical metabolite I and chemical metabolite II displayed binding affinities to the myometrial chemical receptor of a similar magnitude as chemical .	T28	T44	9760035
NA	CHEMICAL	GENE-Y	0	3	chemical was found to have agonistic properties on isolated myometrial strips and it was found to exert this effect through generation of chemical , as is the case for chemical .	T29	T46	9760035
NA	CHEMICAL	GENE-Y	22	3	chemical was found to have agonistic properties on isolated myometrial strips and it was found to exert this effect through generation of chemical , as is the case for chemical .	T30	T46	9760035
NA	CHEMICAL	GENE-Y	3	3	chemical was found to have agonistic properties on isolated myometrial strips and it was found to exert this effect through generation of chemical , as is the case for chemical .	T31	T46	9760035
NA	CHEMICAL	GENE-Y	6	22	However , maximal contractile effect of chemical was approximately 50 % lower than that of chemical ( 2.70 +/- 0.12 g compared to 5.22 +/- 0.26 g ) and EC50 was approximately ten times higher ( 48.0 +/- 8.20 nM compared to 5.62 +/- 1.22 nM ) .	T32	T47	9760035
NA	CHEMICAL	GENE-Y	15	22	However , maximal contractile effect of chemical was approximately 50 % lower than that of chemical ( 2.70 +/- 0.12 g compared to 5.22 +/- 0.26 g ) and EC50 was approximately ten times higher ( 48.0 +/- 8.20 nM compared to 5.62 +/- 1.22 nM ) .	T34	T47	9760035
NA	CHEMICAL	GENE-Y	8	7	All three compounds displayed antagonistic properties against gene in vitro , with chemical being the strongest inhibitor ( pA2 = 8.21 ) and chemical metabolite II ( pA2 = 8.01 ) being stronger than chemical metabolite I ( pA2 = 7.81 ) .	T2	T38	9760035
CPR:4	CHEMICAL	GENE-Y	7	7	All three compounds displayed antagonistic properties against gene in vitro , with chemical being the strongest inhibitor ( pA2 = 8.21 ) and chemical metabolite II ( pA2 = 8.01 ) being stronger than chemical metabolite I ( pA2 = 7.81 ) .	T3	T38	9760035
CPR:4	CHEMICAL	GENE-Y	8	7	All three compounds displayed antagonistic properties against gene in vitro , with chemical being the strongest inhibitor ( pA2 = 8.21 ) and chemical metabolite II ( pA2 = 8.01 ) being stronger than chemical metabolite I ( pA2 = 7.81 ) .	T4	T38	9760035
CPR:4	CHEMICAL	GENE-Y	8	7	All three compounds displayed antagonistic properties against gene in vitro , with chemical being the strongest inhibitor ( pA2 = 8.21 ) and chemical metabolite II ( pA2 = 8.01 ) being stronger than chemical metabolite I ( pA2 = 7.81 ) .	T5	T38	9760035
CPR:6	CHEMICAL	GENE-Y	4	9	These results indicate that chemical is a partial agonist/antagonist to the chemical receptor while the two metabolites chemical metabolite I and chemical metabolite II are pure antagonists .	T6	T39	9760035
NA	CHEMICAL	GENE-Y	9	9	These results indicate that chemical is a partial agonist/antagonist to the chemical receptor while the two metabolites chemical metabolite I and chemical metabolite II are pure antagonists .	T7	T39	9760035
CPR:6	CHEMICAL	GENE-Y	6	9	These results indicate that chemical is a partial agonist/antagonist to the chemical receptor while the two metabolites chemical metabolite I and chemical metabolite II are pure antagonists .	T8	T39	9760035
CPR:6	CHEMICAL	GENE-Y	6	9	These results indicate that chemical is a partial agonist/antagonist to the chemical receptor while the two metabolites chemical metabolite I and chemical metabolite II are pure antagonists .	T9	T39	9760035
NA	CHEMICAL	GENE-N	7	4	All three analogues bound to the myometrial chemical V1 receptor , albeit with much lower affinities than to the chemical receptor .	T10	T40	9760035
NA	CHEMICAL	GENE-Y	7	4	All three analogues bound to the myometrial chemical V1 receptor , albeit with much lower affinities than to the chemical receptor .	T10	T41	9760035
NA	CHEMICAL	GENE-N	4	4	All three analogues bound to the myometrial chemical V1 receptor , albeit with much lower affinities than to the chemical receptor .	T11	T40	9760035
NA	CHEMICAL	GENE-Y	4	4	All three analogues bound to the myometrial chemical V1 receptor , albeit with much lower affinities than to the chemical receptor .	T11	T41	9760035
NA	CHEMICAL	GENE-N	0	1	chemical channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts .	T10	T16	10662748
NA	CHEMICAL	GENE-N	20	21	The present study examined arrhythmic risk in patients with overt and concealed forms of the disease and the effectiveness of chemical channel blockers to unmask the syndrome and , thus , identify patients at risk .	T3	T13	10662748
NA	CHEMICAL	GENE-Y	8	45	METHODS AND RESULTS : The effect of intravenous chemical ( 1 mg/kg ) , chemical ( 10 mg/kg ) , or chemical ( 2 mg/kg ) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG ( group A ) , 11 members of 3 families in whom a gene mutation was associated with the syndrome and 8 members in whom it was not ( group B ) , and 53 control subjects ( group C ) .	T4	T15	10662748
NA	CHEMICAL	GENE-Y	14	45	METHODS AND RESULTS : The effect of intravenous chemical ( 1 mg/kg ) , chemical ( 10 mg/kg ) , or chemical ( 2 mg/kg ) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG ( group A ) , 11 members of 3 families in whom a gene mutation was associated with the syndrome and 8 members in whom it was not ( group B ) , and 53 control subjects ( group C ) .	T5	T15	10662748
NA	CHEMICAL	GENE-Y	21	45	METHODS AND RESULTS : The effect of intravenous chemical ( 1 mg/kg ) , chemical ( 10 mg/kg ) , or chemical ( 2 mg/kg ) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG ( group A ) , 11 members of 3 families in whom a gene mutation was associated with the syndrome and 8 members in whom it was not ( group B ) , and 53 control subjects ( group C ) .	T6	T15	10662748
NA	CHEMICAL	GENE-Y	3	5	Role of extracellular chemical and gene in gene secretion induced by hyposmolarity , gene , and high chemical in GH4C1 cells .	T14	T24	2120879
NA	CHEMICAL	GENE-Y	3	6	Role of extracellular chemical and gene in gene secretion induced by hyposmolarity , gene , and high chemical in GH4C1 cells .	T14	T25	2120879
NA	CHEMICAL	GENE-Y	3	13	Role of extracellular chemical and gene in gene secretion induced by hyposmolarity , gene , and high chemical in GH4C1 cells .	T14	T26	2120879
NA	CHEMICAL	GENE-Y	17	5	Role of extracellular chemical and gene in gene secretion induced by hyposmolarity , gene , and high chemical in GH4C1 cells .	T13	T24	2120879
NA	CHEMICAL	GENE-Y	17	6	Role of extracellular chemical and gene in gene secretion induced by hyposmolarity , gene , and high chemical in GH4C1 cells .	T13	T25	2120879
NA	CHEMICAL	GENE-Y	17	13	Role of extracellular chemical and gene in gene secretion induced by hyposmolarity , gene , and high chemical in GH4C1 cells .	T13	T26	2120879
NA	CHEMICAL	GENE-Y	9	9	The mechanism by which 30 % medium hyposmolarity induces gene secretion by GH4C1 cells was compared with that induced by 100 nmol/l gene or 30 mmol/l chemical .	T2	T21	2120879
NA	CHEMICAL	GENE-Y	9	22	The mechanism by which 30 % medium hyposmolarity induces gene secretion by GH4C1 cells was compared with that induced by 100 nmol/l gene or 30 mmol/l chemical .	T2	T16	2120879
NA	CHEMICAL	GENE-N	2	6	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T3	T17	2120879
NA	CHEMICAL	GENE-Y	2	14	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T3	T18	2120879
NA	CHEMICAL	GENE-N	5	6	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T4	T17	2120879
NA	CHEMICAL	GENE-Y	5	14	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T4	T18	2120879
CPR:4	CHEMICAL	GENE-N	10	6	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T5	T17	2120879
NA	CHEMICAL	GENE-Y	10	14	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T5	T18	2120879
NA	CHEMICAL	GENE-N	19	6	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T6	T17	2120879
CPR:4	CHEMICAL	GENE-Y	19	14	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T6	T18	2120879
NA	CHEMICAL	GENE-N	12	6	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T7	T17	2120879
CPR:4	CHEMICAL	GENE-Y	12	14	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T7	T18	2120879
NA	CHEMICAL	GENE-N	27	6	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T8	T17	2120879
CPR:4	CHEMICAL	GENE-Y	27	14	Removing medium chemical , blocking chemical channels with 50 mumol/l chemical , or inhibiting gene activation with 20 mumol/l chemical , 10 mumol/l chemical or 10 mumol/l chemical almost completely blocked hyposmolarity-induced secretion .	T8	T18	2120879
NA	CHEMICAL	GENE-Y	5	12	The smooth muscle relaxant , chemical , which is believed relatively specific in inhibiting the chemical-gene interaction , depressed hyposmolarity-induced gene secretion in a dose-dependent manner ( r = -0.991 , p less than 0.01 ) .	T9	T19	2120879
CPR:4	CHEMICAL	GENE-Y	5	20	The smooth muscle relaxant , chemical , which is believed relatively specific in inhibiting the chemical-gene interaction , depressed hyposmolarity-induced gene secretion in a dose-dependent manner ( r = -0.991 , p less than 0.01 ) .	T9	T20	2120879
NA	CHEMICAL	GENE-Y	15	12	The smooth muscle relaxant , chemical , which is believed relatively specific in inhibiting the chemical-gene interaction , depressed hyposmolarity-induced gene secretion in a dose-dependent manner ( r = -0.991 , p less than 0.01 ) .	T10	T19	2120879
NA	CHEMICAL	GENE-Y	15	20	The smooth muscle relaxant , chemical , which is believed relatively specific in inhibiting the chemical-gene interaction , depressed hyposmolarity-induced gene secretion in a dose-dependent manner ( r = -0.991 , p less than 0.01 ) .	T10	T20	2120879
NA	CHEMICAL	GENE-Y	8	17	The above drugs also blocked or decreased high chemical-induced secretion , but had much less effect on gene-induced secretion .	T11	T22	2120879
NA	CHEMICAL	GENE-Y	9	3	Secretion induced by gene , hyposmolarity , or high chemical was optimal at pH 7.3-7.65 and was significantly depressed at pH 6.0 or 8.0 , indicating that release of hormone induced by all 3 stimuli is due to an active cell process requiring a physiologic extracellular pH and is not produced by nonspecific cell toxicity .	T12	T23	2120879
NA	CHEMICAL	GENE-N	4	1	The gene of the chemical ( 1 ) receptor have not yet been conclusively resolved , and bear limited sequence identity to known structures .	T4	T15	23434648
NA	CHEMICAL	GENE-Y	4	5	The gene of the chemical ( 1 ) receptor have not yet been conclusively resolved , and bear limited sequence identity to known structures .	T4	T16	23434648
NA	CHEMICAL	GENE-Y	14	15	This study involved development of a peptide to characterize the intrinsic structure of the chemical ( 1 ) gene second gene .	T5	T17	23434648
NA	CHEMICAL	GENE-N	14	18	This study involved development of a peptide to characterize the intrinsic structure of the chemical ( 1 ) gene second gene .	T5	T18	23434648
NA	CHEMICAL	GENE-N	14	20	This study involved development of a peptide to characterize the intrinsic structure of the chemical ( 1 ) gene second gene .	T5	T19	23434648
NA	CHEMICAL	GENE-N	21	11	The loop was embedded between two helices that assemble into a gene , which served as a receptor-mimetic folding constraint ( chemical ( 1 ) -CC-gene peptide ) .	T6	T20	23434648
NA	CHEMICAL	GENE-Y	21	20	The loop was embedded between two helices that assemble into a gene , which served as a receptor-mimetic folding constraint ( chemical ( 1 ) -CC-gene peptide ) .	T6	T21	23434648
NA	CHEMICAL	GENE-N	21	25	The loop was embedded between two helices that assemble into a gene , which served as a receptor-mimetic folding constraint ( chemical ( 1 ) -CC-gene peptide ) .	T6	T22	23434648
NA	CHEMICAL	GENE-N	12	4	In contrast , the gene sequence showed well-defined structure only near its chemical-terminal residues .	T1	T25	23434648
NA	CHEMICAL	GENE-Y	11	12	The NMR ensemble was combined with a computational model of the chemical ( 1 ) receptor that had previously been validated .	T2	T8	23434648
NA	CHEMICAL	GENE-N	9	12	Many stimuli cause HSC to activate , lose their chemical and produce gene .	T2	T18	16253547
NA	CHEMICAL	GENE-N	4	29	We also determine if chemical : ( 1 ) reverse HSC activation ; ( 2 ) maintain/restore HSC intracellular chemical levels ; ( 3 ) maintain expression of HSC gene ( gene ) in HSC that are becoming activated or are chronically activated .	T7	T19	16253547
NA	CHEMICAL	GENE-N	4	31	We also determine if chemical : ( 1 ) reverse HSC activation ; ( 2 ) maintain/restore HSC intracellular chemical levels ; ( 3 ) maintain expression of HSC gene ( gene ) in HSC that are becoming activated or are chronically activated .	T7	T20	16253547
NA	CHEMICAL	GENE-N	19	29	We also determine if chemical : ( 1 ) reverse HSC activation ; ( 2 ) maintain/restore HSC intracellular chemical levels ; ( 3 ) maintain expression of HSC gene ( gene ) in HSC that are becoming activated or are chronically activated .	T8	T19	16253547
NA	CHEMICAL	GENE-N	19	31	We also determine if chemical : ( 1 ) reverse HSC activation ; ( 2 ) maintain/restore HSC intracellular chemical levels ; ( 3 ) maintain expression of HSC gene ( gene ) in HSC that are becoming activated or are chronically activated .	T8	T20	16253547
NA	CHEMICAL	GENE-Y	12	3	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T13	T21	16253547
NA	CHEMICAL	GENE-Y	12	5	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T13	T22	16253547
NA	CHEMICAL	GENE-Y	12	7	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T13	T23	16253547
NA	CHEMICAL	GENE-N	12	10	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T13	T24	16253547
CPR:4	CHEMICAL	GENE-Y	23	3	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T14	T21	16253547
CPR:4	CHEMICAL	GENE-Y	23	5	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T14	T22	16253547
CPR:4	CHEMICAL	GENE-Y	23	7	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T14	T23	16253547
CPR:4	CHEMICAL	GENE-N	23	10	mRNA levels for gene , gene and gene , the gene for chemical , decreased during activation of freshly isolated HSC even with chemical supplementation .	T14	T24	16253547
NA	CHEMICAL	GENE-Y	4	0	gene , gene and gene mRNA and gene protein was undetectable in chronically activated HSC and remained absent after chemical supplementation .	T1	T25	16253547
NA	CHEMICAL	GENE-Y	4	2	gene , gene and gene mRNA and gene protein was undetectable in chronically activated HSC and remained absent after chemical supplementation .	T1	T26	16253547
NA	CHEMICAL	GENE-Y	4	4	gene , gene and gene mRNA and gene protein was undetectable in chronically activated HSC and remained absent after chemical supplementation .	T1	T16	16253547
NA	CHEMICAL	GENE-N	4	7	gene , gene and gene mRNA and gene protein was undetectable in chronically activated HSC and remained absent after chemical supplementation .	T1	T17	16253547
NA	CHEMICAL	GENE-Y	14	4	Impaired expression of the gene gene in skeletal muscle during lactation : fibrates and chemical reverse lactation-induced downregulation of the gene gene .	T12	T36	10909982
CPR:3	CHEMICAL	GENE-Y	14	6	Impaired expression of the gene gene in skeletal muscle during lactation : fibrates and chemical reverse lactation-induced downregulation of the gene gene .	T12	T35	10909982
NA	CHEMICAL	GENE-Y	14	2	Changes in gene mRNA occur in parallel with modifications in the levels of free chemical , which are reduced in lactation and are upregulated due to weaning or fasting .	T10	T31	10909982
NA	CHEMICAL	GENE-Y	6	15	Conversely , when mice are fed a high-fat diet after parturition , the downregulation of gene mRNA and gene protein levels due to lactation is partially reversed , as is the reduction in serum free chemical levels .	T11	T33	10909982
NA	CHEMICAL	GENE-Y	6	18	Conversely , when mice are fed a high-fat diet after parturition , the downregulation of gene mRNA and gene protein levels due to lactation is partially reversed , as is the reduction in serum free chemical levels .	T11	T34	10909982
CPR:3	CHEMICAL	GENE-N	5	15	Treatment of lactating mice with a single injection of chemical , an activator of the gene ( gene ) , raises gene mRNA in skeletal muscle to levels similar to those in virgin mice .	T1	T13	10909982
CPR:3	CHEMICAL	GENE-N	5	17	Treatment of lactating mice with a single injection of chemical , an activator of the gene ( gene ) , raises gene mRNA in skeletal muscle to levels similar to those in virgin mice .	T1	T14	10909982
CPR:3	CHEMICAL	GENE-Y	5	21	Treatment of lactating mice with a single injection of chemical , an activator of the gene ( gene ) , raises gene mRNA in skeletal muscle to levels similar to those in virgin mice .	T1	T15	10909982
NA	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T2	T16	10909982
CPR:3	CHEMICAL	GENE-Y	0	19	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T2	T17	10909982
NA	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T2	T19	10909982
NA	CHEMICAL	GENE-Y	0	34	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T2	T20	10909982
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T3	T16	10909982
CPR:3	CHEMICAL	GENE-Y	2	19	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T3	T17	10909982
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T3	T19	10909982
NA	CHEMICAL	GENE-Y	2	34	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T3	T20	10909982
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T4	T16	10909982
NA	CHEMICAL	GENE-Y	5	19	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T4	T17	10909982
CPR:3	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T4	T19	10909982
CPR:3	CHEMICAL	GENE-Y	5	34	chemical ( chemical ) , a specific ligand of the gene subtype , causes the most dramatic increase in gene mRNA , whereas chemical , a specific activator of gene , also significantly increases gene mRNA abundance in skeletal muscle of lactating mice .	T4	T20	10909982
NA	CHEMICAL	GENE-Y	6	13	However , in virgin mice , chemical and chemical do not significantly affect gene mRNA expression , whereas chemical is at least as effective as it is in lactating dams .	T5	T21	10909982
NA	CHEMICAL	GENE-Y	1	13	However , in virgin mice , chemical and chemical do not significantly affect gene mRNA expression , whereas chemical is at least as effective as it is in lactating dams .	T6	T21	10909982
NA	CHEMICAL	GENE-Y	18	13	However , in virgin mice , chemical and chemical do not significantly affect gene mRNA expression , whereas chemical is at least as effective as it is in lactating dams .	T7	T21	10909982
NA	CHEMICAL	GENE-Y	21	5	It is proposed that the gene gene is regulated in skeletal muscle during lactation in response to changes in circulating free chemical by mechanisms involving activation of gene .	T8	T22	10909982
CPR:3	CHEMICAL	GENE-N	21	27	It is proposed that the gene gene is regulated in skeletal muscle during lactation in response to changes in circulating free chemical by mechanisms involving activation of gene .	T8	T25	10909982
NA	CHEMICAL	GENE-Y	7	10	Design , Synthesis and Biological Evaluation of chemical Derivatives as gene Ligands with Potential for Treatment of chemical Abuse .	T11	T19	23631463
NA	CHEMICAL	GENE-Y	17	10	Design , Synthesis and Biological Evaluation of chemical Derivatives as gene Ligands with Potential for Treatment of chemical Abuse .	T10	T19	23631463
NA	CHEMICAL	GENE-Y	6	7	Attenuation of increased endocannabinoid signaling with a gene neutral antagonist might offer a new therapeutic direction for treatment of chemical abuse .	T2	T16	23631463
CPR:6	CHEMICAL	GENE-Y	5	22	We have recently reported that a mono-hydroxylated metabolite of the synthetic chemical cannabinoid chemical ( 3 ) exhibits neutral antagonist activity at gene and thus may serve as a promising lead for the development of novel chemical abuse therapies .	T3	T13	23631463
CPR:6	CHEMICAL	GENE-Y	13	22	We have recently reported that a mono-hydroxylated metabolite of the synthetic chemical cannabinoid chemical ( 3 ) exhibits neutral antagonist activity at gene and thus may serve as a promising lead for the development of novel chemical abuse therapies .	T4	T13	23631463
NA	CHEMICAL	GENE-Y	5	22	We have recently reported that a mono-hydroxylated metabolite of the synthetic chemical cannabinoid chemical ( 3 ) exhibits neutral antagonist activity at gene and thus may serve as a promising lead for the development of novel chemical abuse therapies .	T5	T13	23631463
CPR:6	CHEMICAL	GENE-Y	12	20	In the current study , we show that systematic modification of an chemical scaffold identifies two new compounds with dual gene antagonist/gene agonist activity .	T6	T14	23631463
CPR:5	CHEMICAL	GENE-Y	12	21	In the current study , we show that systematic modification of an chemical scaffold identifies two new compounds with dual gene antagonist/gene agonist activity .	T6	T15	23631463
NA	CHEMICAL	GENE-N	14	3	Similar to the gene antagonist/inverse agonist rimonabant , analogues 27 and 30 decrease oral chemical self-administration , without affecting total fluid intake and block the development of chemical-conditioned place preference .	T7	T17	23631463
NA	CHEMICAL	GENE-N	27	3	Similar to the gene antagonist/inverse agonist rimonabant , analogues 27 and 30 decrease oral chemical self-administration , without affecting total fluid intake and block the development of chemical-conditioned place preference .	T8	T17	23631463
NA	CHEMICAL	GENE-N	2	0	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T20	T37	20589617
NA	CHEMICAL	GENE-Y	2	5	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T20	T38	20589617
NA	CHEMICAL	GENE-N	10	0	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T21	T37	20589617
NA	CHEMICAL	GENE-Y	10	5	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T21	T38	20589617
NA	CHEMICAL	GENE-N	12	0	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T22	T37	20589617
NA	CHEMICAL	GENE-Y	12	5	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T22	T38	20589617
NA	CHEMICAL	GENE-N	15	0	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T19	T37	20589617
NA	CHEMICAL	GENE-Y	15	5	gene polymorphism of the chemical reductase gene does not affect chemical , chemical , and chemical serum levels in Turkish children with neural tube defects .	T19	T38	20589617
NA	CHEMICAL	GENE-N	11	9	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T16	T31	20589617
NA	CHEMICAL	GENE-Y	11	14	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T16	T34	20589617
NA	CHEMICAL	GENE-Y	11	16	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T16	T23	20589617
NA	CHEMICAL	GENE-Y	11	24	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T16	T28	20589617
NA	CHEMICAL	GENE-N	28	9	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T5	T31	20589617
NA	CHEMICAL	GENE-Y	28	14	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T5	T34	20589617
NA	CHEMICAL	GENE-Y	28	16	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T5	T23	20589617
NA	CHEMICAL	GENE-Y	28	24	Association between neural tube defects ( NTDs ) and gene polymorphism of the chemical reductase ( gene ) gene was suspected , because the gene gene codes for a key enzyme in chemical metabolism .	T5	T28	20589617
NA	CHEMICAL	GENE-N	2	13	We examined chemical , chemical and chemical serum concentrations and polymorphism of the gene gene gene in Turkish children with neural tube defects .	T10	T29	20589617
NA	CHEMICAL	GENE-Y	2	14	We examined chemical , chemical and chemical serum concentrations and polymorphism of the gene gene gene in Turkish children with neural tube defects .	T10	T30	20589617
NA	CHEMICAL	GENE-N	4	13	We examined chemical , chemical and chemical serum concentrations and polymorphism of the gene gene gene in Turkish children with neural tube defects .	T11	T29	20589617
NA	CHEMICAL	GENE-Y	4	14	We examined chemical , chemical and chemical serum concentrations and polymorphism of the gene gene gene in Turkish children with neural tube defects .	T11	T30	20589617
NA	CHEMICAL	GENE-N	6	13	We examined chemical , chemical and chemical serum concentrations and polymorphism of the gene gene gene in Turkish children with neural tube defects .	T12	T29	20589617
NA	CHEMICAL	GENE-Y	6	14	We examined chemical , chemical and chemical serum concentrations and polymorphism of the gene gene gene in Turkish children with neural tube defects .	T12	T30	20589617
NA	CHEMICAL	GENE-Y	3	24	The levels of chemical , chemical and chemical serum concentrations in NTDs were evaluated and compared , along with information concerning alleles of the gene gene .	T13	T35	20589617
NA	CHEMICAL	GENE-Y	5	24	The levels of chemical , chemical and chemical serum concentrations in NTDs were evaluated and compared , along with information concerning alleles of the gene gene .	T14	T35	20589617
NA	CHEMICAL	GENE-Y	7	24	The levels of chemical , chemical and chemical serum concentrations in NTDs were evaluated and compared , along with information concerning alleles of the gene gene .	T15	T35	20589617
NA	CHEMICAL	GENE-N	3	3	We concluded that gene gene gene polymorphism does not affect chemical , chemical and chemical metabolism in Turkish children with NTDs .	T2	T24	20589617
NA	CHEMICAL	GENE-Y	3	4	We concluded that gene gene gene polymorphism does not affect chemical , chemical and chemical metabolism in Turkish children with NTDs .	T2	T25	20589617
NA	CHEMICAL	GENE-N	12	3	We concluded that gene gene gene polymorphism does not affect chemical , chemical and chemical metabolism in Turkish children with NTDs .	T3	T24	20589617
NA	CHEMICAL	GENE-Y	12	4	We concluded that gene gene gene polymorphism does not affect chemical , chemical and chemical metabolism in Turkish children with NTDs .	T3	T25	20589617
NA	CHEMICAL	GENE-N	14	3	We concluded that gene gene gene polymorphism does not affect chemical , chemical and chemical metabolism in Turkish children with NTDs .	T4	T24	20589617
NA	CHEMICAL	GENE-Y	14	4	We concluded that gene gene gene polymorphism does not affect chemical , chemical and chemical metabolism in Turkish children with NTDs .	T4	T25	20589617
NA	CHEMICAL	GENE-Y	7	5	The preventive effect of uncarboxylated gene against chemical-induced endothelial apoptosis through the activation of chemical 3-kinase/gene signaling pathway : gene and endothelial apoptosis .	T12	T43	23639572
NA	CHEMICAL	GENE-N	7	15	The preventive effect of uncarboxylated gene against chemical-induced endothelial apoptosis through the activation of chemical 3-kinase/gene signaling pathway : gene and endothelial apoptosis .	T12	T41	23639572
NA	CHEMICAL	GENE-Y	7	19	The preventive effect of uncarboxylated gene against chemical-induced endothelial apoptosis through the activation of chemical 3-kinase/gene signaling pathway : gene and endothelial apoptosis .	T12	T42	23639572
NA	CHEMICAL	GENE-Y	14	5	The preventive effect of uncarboxylated gene against chemical-induced endothelial apoptosis through the activation of chemical 3-kinase/gene signaling pathway : gene and endothelial apoptosis .	T11	T43	23639572
NA	CHEMICAL	GENE-N	14	15	The preventive effect of uncarboxylated gene against chemical-induced endothelial apoptosis through the activation of chemical 3-kinase/gene signaling pathway : gene and endothelial apoptosis .	T11	T41	23639572
NA	CHEMICAL	GENE-Y	14	19	The preventive effect of uncarboxylated gene against chemical-induced endothelial apoptosis through the activation of chemical 3-kinase/gene signaling pathway : gene and endothelial apoptosis .	T11	T42	23639572
NA	CHEMICAL	GENE-Y	9	7	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T6	T30	23639572
NA	CHEMICAL	GENE-Y	9	21	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T6	T32	23639572
NA	CHEMICAL	GENE-N	9	7	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T6	T33	23639572
NA	CHEMICAL	GENE-Y	9	27	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T6	T34	23639572
NA	CHEMICAL	GENE-Y	7	7	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T7	T30	23639572
NA	CHEMICAL	GENE-Y	7	21	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T7	T32	23639572
NA	CHEMICAL	GENE-N	7	7	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T7	T33	23639572
NA	CHEMICAL	GENE-Y	7	27	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T7	T34	23639572
NA	CHEMICAL	GENE-Y	24	7	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T8	T30	23639572
NA	CHEMICAL	GENE-Y	24	21	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T8	T32	23639572
NA	CHEMICAL	GENE-N	24	7	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T8	T33	23639572
NA	CHEMICAL	GENE-Y	24	27	Apoptosis was evaluated using various methods including a terminal chemical transferase-mediated chemical nick-end labeling analysis kit and Western blotting for cleaved gene , cleaved chemical polymerase and gene .	T8	T34	23639572
NA	CHEMICAL	GENE-N	15	3	The phosphorylations of gene and gene ( gene ) as well as the level of chemical were measured to confirm the effect of gene on gene signaling pathway .	T10	T35	23639572
NA	CHEMICAL	GENE-Y	15	5	The phosphorylations of gene and gene ( gene ) as well as the level of chemical were measured to confirm the effect of gene on gene signaling pathway .	T10	T36	23639572
NA	CHEMICAL	GENE-Y	15	7	The phosphorylations of gene and gene ( gene ) as well as the level of chemical were measured to confirm the effect of gene on gene signaling pathway .	T10	T37	23639572
NA	CHEMICAL	GENE-Y	15	23	The phosphorylations of gene and gene ( gene ) as well as the level of chemical were measured to confirm the effect of gene on gene signaling pathway .	T10	T38	23639572
NA	CHEMICAL	GENE-Y	15	25	The phosphorylations of gene and gene ( gene ) as well as the level of chemical were measured to confirm the effect of gene on gene signaling pathway .	T10	T39	23639572
NA	CHEMICAL	GENE-Y	4	4	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T1	T13	23639572
NA	CHEMICAL	GENE-Y	4	11	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T1	T14	23639572
NA	CHEMICAL	GENE-N	4	11	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T1	T15	23639572
NA	CHEMICAL	GENE-N	4	11	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T1	T16	23639572
NA	CHEMICAL	GENE-Y	11	4	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T2	T13	23639572
NA	CHEMICAL	GENE-Y	11	11	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T2	T14	23639572
CPR:4	CHEMICAL	GENE-N	11	11	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T2	T15	23639572
CPR:4	CHEMICAL	GENE-N	11	11	RESULTS : Pretreatment of gene ( 30ng/ml ) prevented LA-induced apoptosis in gene-stimulated endothelial cells ; effects were abolished by pretreatment with the chemical 3-kinase ( gene ) inhibitor , chemical .	T2	T16	23639572
NA	CHEMICAL	GENE-Y	19	2	Treatment of gene ( ranged from 0.3 to 30ng/ml ) significantly increased the phosphorylation of gene and gene and chemical secretion from endothelial cells in a gene dependent manner .	T3	T17	23639572
NA	CHEMICAL	GENE-N	19	15	Treatment of gene ( ranged from 0.3 to 30ng/ml ) significantly increased the phosphorylation of gene and gene and chemical secretion from endothelial cells in a gene dependent manner .	T3	T18	23639572
NA	CHEMICAL	GENE-Y	19	17	Treatment of gene ( ranged from 0.3 to 30ng/ml ) significantly increased the phosphorylation of gene and gene and chemical secretion from endothelial cells in a gene dependent manner .	T3	T19	23639572
NA	CHEMICAL	GENE-N	19	24	Treatment of gene ( ranged from 0.3 to 30ng/ml ) significantly increased the phosphorylation of gene and gene and chemical secretion from endothelial cells in a gene dependent manner .	T3	T20	23639572
CPR:9	CHEMICAL	GENE-Y	5	9	Measurement of Transport Activities of chemical in chemical Export Pump and gene Using LC-MS/MS .	T10	T15	23470629
CPR:9	CHEMICAL	GENE-N	5	6	Measurement of Transport Activities of chemical in chemical Export Pump and gene Using LC-MS/MS .	T10	T16	23470629
NA	CHEMICAL	GENE-Y	7	9	Measurement of Transport Activities of chemical in chemical Export Pump and gene Using LC-MS/MS .	T11	T15	23470629
NA	CHEMICAL	GENE-N	7	6	Measurement of Transport Activities of chemical in chemical Export Pump and gene Using LC-MS/MS .	T11	T16	23470629
NA	CHEMICAL	GENE-N	23	15	The analytical method was applied to measurements of transport activities in membrane vesicles obtained from gene- , and gene-expressing Sf9 cells for conjugated chemical .	T5	T12	23470629
CPR:9	CHEMICAL	GENE-Y	23	18	The analytical method was applied to measurements of transport activities in membrane vesicles obtained from gene- , and gene-expressing Sf9 cells for conjugated chemical .	T5	T13	23470629
NA	CHEMICAL	GENE-N	4	4	Identification and characterization of a novel chemical-containing chemical oxidase of mammalian cell origin .	T29	T47	12141946
NA	CHEMICAL	GENE-N	7	4	Identification and characterization of a novel chemical-containing chemical oxidase of mammalian cell origin .	T30	T47	12141946
CPR:9	CHEMICAL	GENE-Y	4	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T15	T44	12141946
CPR:9	CHEMICAL	GENE-Y	4	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T15	T33	12141946
NA	CHEMICAL	GENE-Y	4	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T15	T38	12141946
NA	CHEMICAL	GENE-Y	4	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T15	T39	12141946
CPR:9	CHEMICAL	GENE-Y	6	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T17	T44	12141946
CPR:9	CHEMICAL	GENE-Y	6	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T17	T33	12141946
NA	CHEMICAL	GENE-Y	6	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T17	T38	12141946
NA	CHEMICAL	GENE-Y	6	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T17	T39	12141946
NA	CHEMICAL	GENE-Y	11	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T23	T44	12141946
NA	CHEMICAL	GENE-Y	11	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T23	T33	12141946
NA	CHEMICAL	GENE-Y	11	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T23	T38	12141946
NA	CHEMICAL	GENE-Y	11	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T23	T39	12141946
NA	CHEMICAL	GENE-Y	11	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T25	T44	12141946
NA	CHEMICAL	GENE-Y	11	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T25	T33	12141946
NA	CHEMICAL	GENE-Y	11	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T25	T38	12141946
NA	CHEMICAL	GENE-Y	11	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T25	T39	12141946
NA	CHEMICAL	GENE-Y	1	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T26	T44	12141946
NA	CHEMICAL	GENE-Y	1	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T26	T33	12141946
NA	CHEMICAL	GENE-Y	1	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T26	T38	12141946
NA	CHEMICAL	GENE-Y	1	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T26	T39	12141946
NA	CHEMICAL	GENE-Y	24	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T9	T44	12141946
NA	CHEMICAL	GENE-Y	24	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T9	T33	12141946
NA	CHEMICAL	GENE-Y	24	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T9	T38	12141946
NA	CHEMICAL	GENE-Y	24	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T9	T39	12141946
NA	CHEMICAL	GENE-Y	31	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T13	T44	12141946
NA	CHEMICAL	GENE-Y	31	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T13	T33	12141946
CPR:9	CHEMICAL	GENE-Y	31	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T13	T38	12141946
CPR:9	CHEMICAL	GENE-Y	31	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T13	T39	12141946
NA	CHEMICAL	GENE-Y	33	12	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T14	T44	12141946
NA	CHEMICAL	GENE-Y	33	18	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T14	T33	12141946
CPR:9	CHEMICAL	GENE-Y	33	25	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T14	T38	12141946
CPR:9	CHEMICAL	GENE-Y	33	27	During chemical catabolism , chemical and chemical are first acetylated by chemical/chemical chemical ( 1 ) -acetyltransferase ( gene ) and subsequently oxidized by chemical oxidase ( gene ) to produce chemical and chemical , respectively .	T14	T39	12141946
NA	CHEMICAL	GENE-Y	7	5	In attempting to clone the gene involved in this back-conversion pathway , we encountered an gene that preferentially cleaves chemical in the absence of prior acetylation by gene .	T16	T40	12141946
NA	CHEMICAL	GENE-N	7	15	In attempting to clone the gene involved in this back-conversion pathway , we encountered an gene that preferentially cleaves chemical in the absence of prior acetylation by gene .	T16	T41	12141946
CPR:9	CHEMICAL	GENE-Y	7	27	In attempting to clone the gene involved in this back-conversion pathway , we encountered an gene that preferentially cleaves chemical in the absence of prior acetylation by gene .	T16	T42	12141946
NA	CHEMICAL	GENE-Y	25	0	A BLAST search using gene sequences identified homologous mammalian cDNAs derived from human hepatoma and mouse mammary carcinoma : the encoded proteins differed by 20 chemical .	T18	T43	12141946
NA	CHEMICAL	GENE-N	16	5	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T27	T45	12141946
CPR:9	CHEMICAL	GENE-N	16	13	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T27	T46	12141946
NA	CHEMICAL	GENE-Y	16	32	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T27	T31	12141946
NA	CHEMICAL	GENE-N	18	5	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T28	T45	12141946
CPR:9	CHEMICAL	GENE-N	18	13	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T28	T46	12141946
NA	CHEMICAL	GENE-Y	18	32	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T28	T31	12141946
NA	CHEMICAL	GENE-N	26	5	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T1	T45	12141946
NA	CHEMICAL	GENE-N	26	13	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T1	T46	12141946
NA	CHEMICAL	GENE-Y	26	32	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T1	T31	12141946
NA	CHEMICAL	GENE-N	16	5	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T2	T45	12141946
NA	CHEMICAL	GENE-N	16	13	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T2	T46	12141946
NA	CHEMICAL	GENE-Y	16	32	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T2	T31	12141946
NA	CHEMICAL	GENE-N	32	5	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T3	T45	12141946
NA	CHEMICAL	GENE-N	32	13	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T3	T46	12141946
CPR:9	CHEMICAL	GENE-Y	32	32	Substrate specificity using lysates of gene-transfected HEK-293 cells revealed that the newly identified gene strongly favoured chemical over chemical and that it failed to act on chemical , chemical or the preferred gene substrate , chemical .	T3	T31	12141946
CPR:4	CHEMICAL	GENE-Y	3	1	The gene inhibitor , chemical , only partially blocked oxidation of chemical while a previously reported gene substrate , chemical , potently inhibited the reaction .	T4	T32	12141946
NA	CHEMICAL	GENE-Y	3	16	The gene inhibitor , chemical , only partially blocked oxidation of chemical while a previously reported gene substrate , chemical , potently inhibited the reaction .	T4	T34	12141946
NA	CHEMICAL	GENE-Y	11	1	The gene inhibitor , chemical , only partially blocked oxidation of chemical while a previously reported gene substrate , chemical , potently inhibited the reaction .	T5	T32	12141946
NA	CHEMICAL	GENE-Y	11	16	The gene inhibitor , chemical , only partially blocked oxidation of chemical while a previously reported gene substrate , chemical , potently inhibited the reaction .	T5	T34	12141946
NA	CHEMICAL	GENE-Y	13	1	The gene inhibitor , chemical , only partially blocked oxidation of chemical while a previously reported gene substrate , chemical , potently inhibited the reaction .	T6	T32	12141946
CPR:9	CHEMICAL	GENE-Y	13	16	The gene inhibitor , chemical , only partially blocked oxidation of chemical while a previously reported gene substrate , chemical , potently inhibited the reaction .	T6	T34	12141946
NA	CHEMICAL	GENE-N	24	9	Overall , the data indicate that the enzyme represents a novel gene which , on the basis of substrate specificity , we have designated chemical oxidase in order to distinguish it from the gene involved in chemical back-conversion .	T7	T35	12141946
NA	CHEMICAL	GENE-N	24	9	Overall , the data indicate that the enzyme represents a novel gene which , on the basis of substrate specificity , we have designated chemical oxidase in order to distinguish it from the gene involved in chemical back-conversion .	T7	T36	12141946
NA	CHEMICAL	GENE-N	24	33	Overall , the data indicate that the enzyme represents a novel gene which , on the basis of substrate specificity , we have designated chemical oxidase in order to distinguish it from the gene involved in chemical back-conversion .	T7	T37	12141946
NA	CHEMICAL	GENE-N	9	9	Overall , the data indicate that the enzyme represents a novel gene which , on the basis of substrate specificity , we have designated chemical oxidase in order to distinguish it from the gene involved in chemical back-conversion .	T8	T35	12141946
NA	CHEMICAL	GENE-N	9	9	Overall , the data indicate that the enzyme represents a novel gene which , on the basis of substrate specificity , we have designated chemical oxidase in order to distinguish it from the gene involved in chemical back-conversion .	T8	T36	12141946
NA	CHEMICAL	GENE-N	9	33	Overall , the data indicate that the enzyme represents a novel gene which , on the basis of substrate specificity , we have designated chemical oxidase in order to distinguish it from the gene involved in chemical back-conversion .	T8	T37	12141946
NA	CHEMICAL	GENE-Y	0	1	chemical transporter polymorphisms and measures of impulsivity , aggression , and sensation seeking among African-American chemical-dependent individuals .	T9	T21	12057823
NA	CHEMICAL	GENE-Y	15	1	chemical transporter polymorphisms and measures of impulsivity , aggression , and sensation seeking among African-American chemical-dependent individuals .	T10	T21	12057823
NA	CHEMICAL	GENE-Y	9	10	Considerable evidence indicates that serotonergic mechanisms , particularly the chemical transporter ( gene ) , may mediate central effects of chemical and may also be involved in impulsive and aggressive behavior .	T8	T18	12057823
NA	CHEMICAL	GENE-Y	9	12	Considerable evidence indicates that serotonergic mechanisms , particularly the chemical transporter ( gene ) , may mediate central effects of chemical and may also be involved in impulsive and aggressive behavior .	T8	T11	12057823
NA	CHEMICAL	GENE-Y	20	10	Considerable evidence indicates that serotonergic mechanisms , particularly the chemical transporter ( gene ) , may mediate central effects of chemical and may also be involved in impulsive and aggressive behavior .	T4	T18	12057823
NA	CHEMICAL	GENE-Y	20	12	Considerable evidence indicates that serotonergic mechanisms , particularly the chemical transporter ( gene ) , may mediate central effects of chemical and may also be involved in impulsive and aggressive behavior .	T4	T11	12057823
NA	CHEMICAL	GENE-Y	4	6	We investigated whether polymorphisms in the gene gene were related to traits of impulsivity , sensation seeking , and aggression among chemical abusers .	T5	T13	12057823
NA	CHEMICAL	GENE-Y	18	4	Two polymorphisms of the gene gene were examined involving the 5 ' promoter ( gene ) region and a 17 base pair gene ( gene ) marker among chemical patients .	T7	T14	12057823
NA	CHEMICAL	GENE-N	18	10	Two polymorphisms of the gene gene were examined involving the 5 ' promoter ( gene ) region and a 17 base pair gene ( gene ) marker among chemical patients .	T7	T15	12057823
NA	CHEMICAL	GENE-N	18	17	Two polymorphisms of the gene gene were examined involving the 5 ' promoter ( gene ) region and a 17 base pair gene ( gene ) marker among chemical patients .	T7	T16	12057823
NA	CHEMICAL	GENE-N	18	24	Two polymorphisms of the gene gene were examined involving the 5 ' promoter ( gene ) region and a 17 base pair gene ( gene ) marker among chemical patients .	T7	T17	12057823
CPR:4	CHEMICAL	GENE-Y	0	3	chemical inhibition of gene .	T23	T42	9310349
CPR:4	CHEMICAL	GENE-Y	4	6	Here we report that chemical is a potent inhibitor of the gene ( gene ) .	T11	T32	9310349
CPR:4	CHEMICAL	GENE-Y	4	13	Here we report that chemical is a potent inhibitor of the gene ( gene ) .	T11	T33	9310349
NA	CHEMICAL	GENE-Y	9	14	Two substrates were employed in this study : fluorescein chemical and the phosphotyrosyl peptide gene-pY527 .	T13	T34	9310349
CPR:4	CHEMICAL	GENE-Y	4	11	With either substrate , chemical was a slow binding inhibitor of gene .	T14	T35	9310349
CPR:4	CHEMICAL	GENE-Y	3	13	Among the other chemical studied , chemical was more potent and selective for gene .	T15	T36	9310349
CPR:4	CHEMICAL	GENE-Y	6	13	Among the other chemical studied , chemical was more potent and selective for gene .	T16	T36	9310349
CPR:9	CHEMICAL	GENE-Y	4	6	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T17	T37	9310349
CPR:9	CHEMICAL	GENE-Y	4	8	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T17	T38	9310349
NA	CHEMICAL	GENE-Y	4	23	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T17	T39	9310349
NA	CHEMICAL	GENE-Y	12	6	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T19	T37	9310349
NA	CHEMICAL	GENE-Y	12	8	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T19	T38	9310349
NA	CHEMICAL	GENE-Y	12	23	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T19	T39	9310349
NA	CHEMICAL	GENE-Y	41	6	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T20	T37	9310349
NA	CHEMICAL	GENE-Y	41	8	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T20	T38	9310349
CPR:4	CHEMICAL	GENE-Y	41	23	The hydrolysis of fluorescein chemical by gene and gene was sensitive to chemical , with IC50 values of less than 1 microM ; gene , however , under the same conditions , was inhibited by only 50 % with 141 microM chemical .	T20	T39	9310349
NA	CHEMICAL	GENE-Y	7	4	Similarly , with the gene-pY527 substrate , chemical inhibition was also gene dependent .	T21	T40	9310349
NA	CHEMICAL	GENE-N	7	11	Similarly , with the gene-pY527 substrate , chemical inhibition was also gene dependent .	T21	T41	9310349
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibited gene with an IC50 value of 23 microM , gene with an IC50 value of 2 microM , and did not inhibit gene at concentrations up to 1 mM .	T22	T25	9310349
CPR:4	CHEMICAL	GENE-Y	0	11	chemical inhibited gene with an IC50 value of 23 microM , gene with an IC50 value of 2 microM , and did not inhibit gene at concentrations up to 1 mM .	T22	T26	9310349
NA	CHEMICAL	GENE-Y	0	24	chemical inhibited gene with an IC50 value of 23 microM , gene with an IC50 value of 2 microM , and did not inhibit gene at concentrations up to 1 mM .	T22	T27	9310349
CPR:4	CHEMICAL	GENE-N	1	6	The chemical inhibition of these three gene and two substrates is consistent with the formation of a ternary complex comprised of enzyme , substrate , and inhibitor .	T2	T28	9310349
CPR:4	CHEMICAL	GENE-N	3	0	gene inhibition by chemical or chemical was diminished by the metal chelating agent chemical , or by the reducing agent chemical , suggesting that a metal ion and the oxidation of a chemical residue are required for full inhibition .	T3	T29	9310349
CPR:4	CHEMICAL	GENE-N	5	0	gene inhibition by chemical or chemical was diminished by the metal chelating agent chemical , or by the reducing agent chemical , suggesting that a metal ion and the oxidation of a chemical residue are required for full inhibition .	T4	T29	9310349
NA	CHEMICAL	GENE-N	13	0	gene inhibition by chemical or chemical was diminished by the metal chelating agent chemical , or by the reducing agent chemical , suggesting that a metal ion and the oxidation of a chemical residue are required for full inhibition .	T6	T29	9310349
NA	CHEMICAL	GENE-N	20	0	gene inhibition by chemical or chemical was diminished by the metal chelating agent chemical , or by the reducing agent chemical , suggesting that a metal ion and the oxidation of a chemical residue are required for full inhibition .	T7	T29	9310349
NA	CHEMICAL	GENE-N	32	0	gene inhibition by chemical or chemical was diminished by the metal chelating agent chemical , or by the reducing agent chemical , suggesting that a metal ion and the oxidation of a chemical residue are required for full inhibition .	T8	T29	9310349
NA	CHEMICAL	GENE-N	4	11	After pretreatment with single chemical , cells were stimulated with pro-inflammatory gene ( gene , gene , gene ) .	T3	T9	23561115
NA	CHEMICAL	GENE-Y	4	13	After pretreatment with single chemical , cells were stimulated with pro-inflammatory gene ( gene , gene , gene ) .	T3	T10	23561115
NA	CHEMICAL	GENE-Y	4	15	After pretreatment with single chemical , cells were stimulated with pro-inflammatory gene ( gene , gene , gene ) .	T3	T11	23561115
NA	CHEMICAL	GENE-Y	4	17	After pretreatment with single chemical , cells were stimulated with pro-inflammatory gene ( gene , gene , gene ) .	T3	T12	23561115
NA	CHEMICAL	GENE-Y	5	15	One of these compounds is chemical ( chemical ) , which ameliorates the phenotype of gene transgenic mice associated with decreased protein aggregation and phosphorylation , improved neuronal integrity and reduced neuroinflammation .	T8	T25	23296837
NA	CHEMICAL	GENE-Y	7	15	One of these compounds is chemical ( chemical ) , which ameliorates the phenotype of gene transgenic mice associated with decreased protein aggregation and phosphorylation , improved neuronal integrity and reduced neuroinflammation .	T9	T25	23296837
NA	CHEMICAL	GENE-Y	1	6	Reductions in striatal chemical and chemical hydroxylase content were also less pronounced with chemical treatment .	T14	T26	23296837
NA	CHEMICAL	GENE-Y	1	6	Reductions in striatal chemical and chemical hydroxylase content were also less pronounced with chemical treatment .	T15	T26	23296837
CPR:3	CHEMICAL	GENE-Y	13	6	Reductions in striatal chemical and chemical hydroxylase content were also less pronounced with chemical treatment .	T16	T26	23296837
NA	CHEMICAL	GENE-N	4	15	The neuroinflammatory response to chemical was markedly attenuated , and indices of oxidative stress and gene activation were significantly prevented with chemical .	T17	T27	23296837
CPR:4	CHEMICAL	GENE-N	21	15	The neuroinflammatory response to chemical was markedly attenuated , and indices of oxidative stress and gene activation were significantly prevented with chemical .	T18	T27	23296837
CPR:4	CHEMICAL	GENE-N	7	18	In cultured primary microglia and astrocytes , chemical had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced gene activation , gene induction , and chemical production .	T1	T20	23296837
CPR:4	CHEMICAL	GENE-Y	7	21	In cultured primary microglia and astrocytes , chemical had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced gene activation , gene induction , and chemical production .	T1	T21	23296837
NA	CHEMICAL	GENE-N	18	18	In cultured primary microglia and astrocytes , chemical had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced gene activation , gene induction , and chemical production .	T2	T20	23296837
NA	CHEMICAL	GENE-Y	18	21	In cultured primary microglia and astrocytes , chemical had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced gene activation , gene induction , and chemical production .	T2	T21	23296837
CPR:4	CHEMICAL	GENE-N	6	9	Additionally , in SH-SY5Y cells , chemical-induced demethylation of gene ( gene ) , the master regulator of the cellular phosphoregulatory network , and cytotoxicity were ameliorated by chemical .	T4	T22	23296837
CPR:4	CHEMICAL	GENE-N	6	11	Additionally , in SH-SY5Y cells , chemical-induced demethylation of gene ( gene ) , the master regulator of the cellular phosphoregulatory network , and cytotoxicity were ameliorated by chemical .	T4	T23	23296837
CPR:3	CHEMICAL	GENE-N	28	9	Additionally , in SH-SY5Y cells , chemical-induced demethylation of gene ( gene ) , the master regulator of the cellular phosphoregulatory network , and cytotoxicity were ameliorated by chemical .	T5	T22	23296837
CPR:3	CHEMICAL	GENE-N	28	11	Additionally , in SH-SY5Y cells , chemical-induced demethylation of gene ( gene ) , the master regulator of the cellular phosphoregulatory network , and cytotoxicity were ameliorated by chemical .	T5	T23	23296837
NA	CHEMICAL	GENE-Y	6	4	Defective processing of the gene in chemical-induced mouse colon tumors .	T5	T45	12720300
NA	CHEMICAL	GENE-Y	8	8	To determine the expression and activation status of gene in chemically induced tumors , 6-wk-old A/J mice were injected intraperitoneally with either chemical ( chemical ) ( 10 mg/kg body weight , once a week for 6 wk ) or normal saline solution , and colon tumors were isolated 24 wk following the last injection .	T3	T38	12720300
NA	CHEMICAL	GENE-Y	24	8	To determine the expression and activation status of gene in chemically induced tumors , 6-wk-old A/J mice were injected intraperitoneally with either chemical ( chemical ) ( 10 mg/kg body weight , once a week for 6 wk ) or normal saline solution , and colon tumors were isolated 24 wk following the last injection .	T4	T38	12720300
NA	CHEMICAL	GENE-N	6	1	With a fluorogenic peptide substrate for chemical proteases , a deficiency in gene activity was found in the tumors .	T1	T11	12720300
NA	CHEMICAL	GENE-Y	6	1	With a fluorogenic peptide substrate for chemical proteases , a deficiency in gene activity was found in the tumors .	T1	T12	12720300
NA	CHEMICAL	GENE-Y	9	9	To gain further insight into the functionality of the gene pathway , cDNA microarrays were performed and the expression levels of a panel of 21 gene-specific target genes were determined in chemical-induced tumors that overexpress the ligand .	T2	T25	12720300
NA	CHEMICAL	GENE-Y	9	21	To gain further insight into the functionality of the gene pathway , cDNA microarrays were performed and the expression levels of a panel of 21 gene-specific target genes were determined in chemical-induced tumors that overexpress the ligand .	T2	T26	12720300
CPR:4	CHEMICAL	GENE-Y	9	3	Postoperative concentrations of gene were decreased significantly in the chemical group ( P < 0.001 ) .	T3	T10	10673876
NA	CHEMICAL	GENE-Y	0	1	chemical synthase expression in resectable and unresectable pancreatic cancer : role as predictive or prognostic marker ?	T4	T15	16538493
NA	CHEMICAL	GENE-Y	4	5	BACKGROUND AND AIMS : chemical synthase ( gene ) is an important enzyme for DNA synthesis and the target for chemical ( chemical ) .	T3	T11	16538493
NA	CHEMICAL	GENE-Y	4	7	BACKGROUND AND AIMS : chemical synthase ( gene ) is an important enzyme for DNA synthesis and the target for chemical ( chemical ) .	T3	T14	16538493
NA	CHEMICAL	GENE-Y	7	5	BACKGROUND AND AIMS : chemical synthase ( gene ) is an important enzyme for DNA synthesis and the target for chemical ( chemical ) .	T1	T11	16538493
NA	CHEMICAL	GENE-Y	7	7	BACKGROUND AND AIMS : chemical synthase ( gene ) is an important enzyme for DNA synthesis and the target for chemical ( chemical ) .	T1	T14	16538493
NA	CHEMICAL	GENE-Y	22	5	BACKGROUND AND AIMS : chemical synthase ( gene ) is an important enzyme for DNA synthesis and the target for chemical ( chemical ) .	T2	T11	16538493
NA	CHEMICAL	GENE-Y	22	7	BACKGROUND AND AIMS : chemical synthase ( gene ) is an important enzyme for DNA synthesis and the target for chemical ( chemical ) .	T2	T14	16538493
CPR:3	CHEMICAL	GENE-Y	11	17	Administration of low , but not high , doses of oral chemical in DSS-treated mice resulted in a significant decrease in disease severity , histologic damage scores , as well as colonic level of gene .	T15	T17	23115221
NA	CHEMICAL	GENE-N	24	13	Therefore , we studied whether GLT had potential for inhibition or induction of gene ( gene ) and an influence on the action of chemical .	T7	T14	22566187
NA	CHEMICAL	GENE-N	24	15	Therefore , we studied whether GLT had potential for inhibition or induction of gene ( gene ) and an influence on the action of chemical .	T7	T15	22566187
CPR:4	CHEMICAL	GENE-N	1	15	These chemical , but not GvEx , showed a certain level of inhibition of human-cDNA-expressed gene .	T12	T16	22566187
NA	CHEMICAL	GENE-N	1	14	In a comparison of GLT and grapefruit juice , GLT showed weaker inhibition of gene activities and of chemical 1'-hydroxylation than grapefruit juice .	T13	T17	22566187
CPR:3	CHEMICAL	GENE-Y	1	8	Fungicide chemical and environmental pollutant chemical induce the gene transporter in bovine mammary epithelial cells by the chemical receptor signaling pathway .	T18	T42	23081912
NA	CHEMICAL	GENE-Y	1	18	Fungicide chemical and environmental pollutant chemical induce the gene transporter in bovine mammary epithelial cells by the chemical receptor signaling pathway .	T18	T41	23081912
CPR:3	CHEMICAL	GENE-Y	5	8	Fungicide chemical and environmental pollutant chemical induce the gene transporter in bovine mammary epithelial cells by the chemical receptor signaling pathway .	T20	T42	23081912
NA	CHEMICAL	GENE-Y	5	18	Fungicide chemical and environmental pollutant chemical induce the gene transporter in bovine mammary epithelial cells by the chemical receptor signaling pathway .	T20	T41	23081912
NA	CHEMICAL	GENE-Y	17	8	Fungicide chemical and environmental pollutant chemical induce the gene transporter in bovine mammary epithelial cells by the chemical receptor signaling pathway .	T19	T42	23081912
NA	CHEMICAL	GENE-Y	17	18	Fungicide chemical and environmental pollutant chemical induce the gene transporter in bovine mammary epithelial cells by the chemical receptor signaling pathway .	T19	T41	23081912
NA	CHEMICAL	GENE-Y	8	9	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T9	T29	23081912
NA	CHEMICAL	GENE-Y	8	11	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T9	T30	23081912
NA	CHEMICAL	GENE-N	8	19	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T9	T31	23081912
NA	CHEMICAL	GENE-N	8	22	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T9	T32	23081912
NA	CHEMICAL	GENE-N	8	32	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T9	T33	23081912
NA	CHEMICAL	GENE-Y	8	33	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T9	T34	23081912
NA	CHEMICAL	GENE-Y	17	9	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T10	T29	23081912
NA	CHEMICAL	GENE-Y	17	11	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T10	T30	23081912
NA	CHEMICAL	GENE-N	17	19	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T10	T31	23081912
NA	CHEMICAL	GENE-N	17	22	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T10	T32	23081912
NA	CHEMICAL	GENE-N	17	32	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T10	T33	23081912
NA	CHEMICAL	GENE-Y	17	33	Using computer analysis , we recently identified nuclear chemical receptor ( gene ) binding sites termed `` chemical response elements '' ( gene ) in the 5'-untranslated region ( 5'-UTR ) of gene gene ( Accession No .	T10	T34	23081912
CPR:5	CHEMICAL	GENE-Y	13	10	As these regulatory motifs mediate regulation of target genes by gene agonists including chemical and chemical , we have systematically investigated the effect of both contaminants on functional gene transport activity in primary bovine mammary epithelial cells .	T11	T36	23081912
NA	CHEMICAL	GENE-Y	13	28	As these regulatory motifs mediate regulation of target genes by gene agonists including chemical and chemical , we have systematically investigated the effect of both contaminants on functional gene transport activity in primary bovine mammary epithelial cells .	T11	T37	23081912
CPR:5	CHEMICAL	GENE-Y	15	10	As these regulatory motifs mediate regulation of target genes by gene agonists including chemical and chemical , we have systematically investigated the effect of both contaminants on functional gene transport activity in primary bovine mammary epithelial cells .	T12	T36	23081912
NA	CHEMICAL	GENE-Y	15	28	As these regulatory motifs mediate regulation of target genes by gene agonists including chemical and chemical , we have systematically investigated the effect of both contaminants on functional gene transport activity in primary bovine mammary epithelial cells .	T12	T37	23081912
NA	CHEMICAL	GENE-Y	0	4	chemical or chemical doubled gene-mediated chemical secretion .	T14	T38	23081912
NA	CHEMICAL	GENE-Y	1	4	chemical or chemical doubled gene-mediated chemical secretion .	T15	T38	23081912
CPR:9	CHEMICAL	GENE-Y	5	4	chemical or chemical doubled gene-mediated chemical secretion .	T16	T38	23081912
CPR:4	CHEMICAL	GENE-Y	10	8	This effect was almost completely reversed by specific gene inhibitor chemical .	T17	T39	23081912
CPR:6	CHEMICAL	GENE-Y	7	7	Receptor binding was significantly reduced by specific gene antagonist chemical .	T2	T23	23081912
CPR:3	CHEMICAL	GENE-Y	4	2	Induction of gene by chemical and chemical resulted in a time- and dose-dependent increase of gene gene expression and transporter protein levels .	T3	T24	23081912
CPR:3	CHEMICAL	GENE-Y	4	15	Induction of gene by chemical and chemical resulted in a time- and dose-dependent increase of gene gene expression and transporter protein levels .	T3	T25	23081912
CPR:3	CHEMICAL	GENE-Y	6	2	Induction of gene by chemical and chemical resulted in a time- and dose-dependent increase of gene gene expression and transporter protein levels .	T4	T24	23081912
CPR:3	CHEMICAL	GENE-Y	6	15	Induction of gene by chemical and chemical resulted in a time- and dose-dependent increase of gene gene expression and transporter protein levels .	T4	T25	23081912
NA	CHEMICAL	GENE-Y	12	7	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T3	T13	11212269
NA	CHEMICAL	GENE-Y	12	14	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T3	T14	11212269
NA	CHEMICAL	GENE-Y	12	38	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T3	T15	11212269
NA	CHEMICAL	GENE-Y	10	7	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T4	T13	11212269
NA	CHEMICAL	GENE-Y	10	14	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T4	T14	11212269
CPR:4	CHEMICAL	GENE-Y	10	38	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T4	T15	11212269
NA	CHEMICAL	GENE-Y	4	7	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T5	T13	11212269
NA	CHEMICAL	GENE-Y	4	14	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T5	T14	11212269
NA	CHEMICAL	GENE-Y	4	38	We report here that a human degradation-resistant gene analogue , h [ chemical ] -gene significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of gene inhibitor chemical or the antimetabolite chemical .	T5	T15	11212269
NA	CHEMICAL	GENE-Y	2	4	h [ chemical ] -gene significantly improved survival and reduced weight loss but did not impair chemotherapy effectiveness in tumor-bearing mice treated with cyclical irinotecan .	T6	T16	11212269
NA	CHEMICAL	GENE-Y	4	6	Furthermore , h [ chemical ] -gene reduced chemotherapy-induced apoptosis , decreased activation of gene , and inhibited gene cleavage in heterologous cells transfected with the gene .	T1	T7	11212269
NA	CHEMICAL	GENE-N	4	14	Furthermore , h [ chemical ] -gene reduced chemotherapy-induced apoptosis , decreased activation of gene , and inhibited gene cleavage in heterologous cells transfected with the gene .	T1	T8	11212269
CPR:4	CHEMICAL	GENE-N	4	18	Furthermore , h [ chemical ] -gene reduced chemotherapy-induced apoptosis , decreased activation of gene , and inhibited gene cleavage in heterologous cells transfected with the gene .	T1	T9	11212269
NA	CHEMICAL	GENE-Y	4	26	Furthermore , h [ chemical ] -gene reduced chemotherapy-induced apoptosis , decreased activation of gene , and inhibited gene cleavage in heterologous cells transfected with the gene .	T1	T10	11212269
NA	CHEMICAL	GENE-N	5	5	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T11	T38	16213084
NA	CHEMICAL	GENE-N	5	16	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T11	T39	16213084
NA	CHEMICAL	GENE-N	5	35	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T11	T40	16213084
NA	CHEMICAL	GENE-N	5	5	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T12	T38	16213084
NA	CHEMICAL	GENE-N	5	16	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T12	T39	16213084
NA	CHEMICAL	GENE-N	5	35	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T12	T40	16213084
CPR:4	CHEMICAL	GENE-N	5	5	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T14	T38	16213084
CPR:4	CHEMICAL	GENE-N	5	16	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T14	T39	16213084
NA	CHEMICAL	GENE-N	5	35	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T14	T40	16213084
NA	CHEMICAL	GENE-N	5	5	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T15	T38	16213084
NA	CHEMICAL	GENE-N	5	16	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T15	T39	16213084
CPR:9	CHEMICAL	GENE-N	5	35	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T15	T40	16213084
NA	CHEMICAL	GENE-N	15	5	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T16	T38	16213084
NA	CHEMICAL	GENE-N	15	16	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T16	T39	16213084
NA	CHEMICAL	GENE-N	15	35	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T16	T40	16213084
NA	CHEMICAL	GENE-N	5	5	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T18	T38	16213084
NA	CHEMICAL	GENE-N	5	16	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T18	T39	16213084
NA	CHEMICAL	GENE-N	5	35	This process was reduced by a protonophore , chemical , and a typical chemical transporter ( gene ) inhibitor , chemical , suggesting that chemical uptake by rat astrocytes is mediated by chemical-coupled chemical transport system .	T18	T40	16213084
NA	CHEMICAL	GENE-Y	1	26	Because chemical reduced to 67 % of the chemical uptake even at 10mM , it is unlikely that chemical uptake in rat astrocytes is mediated by gene and/or gene .	T1	T33	16213084
NA	CHEMICAL	GENE-Y	1	28	Because chemical reduced to 67 % of the chemical uptake even at 10mM , it is unlikely that chemical uptake in rat astrocytes is mediated by gene and/or gene .	T1	T34	16213084
NA	CHEMICAL	GENE-Y	8	26	Because chemical reduced to 67 % of the chemical uptake even at 10mM , it is unlikely that chemical uptake in rat astrocytes is mediated by gene and/or gene .	T2	T33	16213084
NA	CHEMICAL	GENE-Y	8	28	Because chemical reduced to 67 % of the chemical uptake even at 10mM , it is unlikely that chemical uptake in rat astrocytes is mediated by gene and/or gene .	T2	T34	16213084
CPR:9	CHEMICAL	GENE-Y	11	26	Because chemical reduced to 67 % of the chemical uptake even at 10mM , it is unlikely that chemical uptake in rat astrocytes is mediated by gene and/or gene .	T3	T33	16213084
CPR:9	CHEMICAL	GENE-Y	11	28	Because chemical reduced to 67 % of the chemical uptake even at 10mM , it is unlikely that chemical uptake in rat astrocytes is mediated by gene and/or gene .	T3	T34	16213084
NA	CHEMICAL	GENE-N	0	6	chemical alters expression of endometrial chemical receptors and their cofactors in new users of chemical .	T13	T39	17094978
NA	CHEMICAL	GENE-N	5	6	chemical alters expression of endometrial chemical receptors and their cofactors in new users of chemical .	T15	T39	17094978
NA	CHEMICAL	GENE-N	14	6	chemical alters expression of endometrial chemical receptors and their cofactors in new users of chemical .	T14	T39	17094978
NA	CHEMICAL	GENE-N	13	14	OBJECTIVE : To evaluate the effect of mifepristone on the expression of endometrial chemical receptors and their co-factors in depot chemical ( DMPA ) users .	T9	T35	17094978
NA	CHEMICAL	GENE-N	20	14	OBJECTIVE : To evaluate the effect of mifepristone on the expression of endometrial chemical receptors and their co-factors in depot chemical ( DMPA ) users .	T2	T35	17094978
NA	CHEMICAL	GENE-N	10	15	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T28	17094978
NA	CHEMICAL	GENE-Y	10	13	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T29	17094978
NA	CHEMICAL	GENE-Y	10	15	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T30	17094978
NA	CHEMICAL	GENE-N	10	26	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T31	17094978
NA	CHEMICAL	GENE-N	10	24	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T32	17094978
NA	CHEMICAL	GENE-Y	10	26	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T33	17094978
NA	CHEMICAL	GENE-N	10	11	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T6	T34	17094978
NA	CHEMICAL	GENE-N	22	15	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T28	17094978
NA	CHEMICAL	GENE-Y	22	13	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T29	17094978
NA	CHEMICAL	GENE-Y	22	15	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T30	17094978
NA	CHEMICAL	GENE-N	22	26	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T31	17094978
NA	CHEMICAL	GENE-N	22	24	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T32	17094978
NA	CHEMICAL	GENE-Y	22	26	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T33	17094978
NA	CHEMICAL	GENE-N	22	11	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T7	T34	17094978
NA	CHEMICAL	GENE-N	14	15	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T28	17094978
NA	CHEMICAL	GENE-Y	14	13	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T29	17094978
NA	CHEMICAL	GENE-Y	14	15	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T30	17094978
NA	CHEMICAL	GENE-N	14	26	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T31	17094978
NA	CHEMICAL	GENE-N	14	24	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T32	17094978
NA	CHEMICAL	GENE-Y	14	26	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T33	17094978
NA	CHEMICAL	GENE-N	14	11	MAIN OUTCOME MEASURE ( S ) : The expression of chemical receptor subtypes alpha and beta ( gene and gene ) , chemical receptors A and B ( gene and gene ) , and chemical receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry , respectively .	T8	T34	17094978
NA	CHEMICAL	GENE-Y	0	3	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T10	T36	17094978
NA	CHEMICAL	GENE-Y	0	3	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T10	T37	17094978
NA	CHEMICAL	GENE-N	0	1	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T10	T38	17094978
NA	CHEMICAL	GENE-Y	11	3	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T11	T36	17094978
NA	CHEMICAL	GENE-Y	11	3	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T11	T37	17094978
NA	CHEMICAL	GENE-N	11	1	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T11	T38	17094978
NA	CHEMICAL	GENE-Y	13	3	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T12	T36	17094978
NA	CHEMICAL	GENE-Y	13	3	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T12	T37	17094978
NA	CHEMICAL	GENE-N	13	1	chemical receptor coactivator 1 ( gene ) , silencing mediator for chemical and chemical receptors , and cell proliferation were evaluated by immunohistochemistry .	T12	T38	17094978
CPR:3	CHEMICAL	GENE-Y	9	9	RESULT ( S ) : The expression of endometrial gene , gene , gene , and gene was increased significantly after 1 week of chemical , but the increase was no longer seen after 10 weeks .	T1	T16	17094978
CPR:3	CHEMICAL	GENE-N	9	11	RESULT ( S ) : The expression of endometrial gene , gene , gene , and gene was increased significantly after 1 week of chemical , but the increase was no longer seen after 10 weeks .	T1	T17	17094978
CPR:3	CHEMICAL	GENE-Y	9	13	RESULT ( S ) : The expression of endometrial gene , gene , gene , and gene was increased significantly after 1 week of chemical , but the increase was no longer seen after 10 weeks .	T1	T18	17094978
CPR:3	CHEMICAL	GENE-Y	9	2	RESULT ( S ) : The expression of endometrial gene , gene , gene , and gene was increased significantly after 1 week of chemical , but the increase was no longer seen after 10 weeks .	T1	T19	17094978
CPR:3	CHEMICAL	GENE-Y	8	19	CONCLUSION ( S ) : Short-term exposure of chemical in new starters of DMPA increases the expression of endometrial gene , gene , gene , and gene and promotes cell proliferation .	T3	T24	17094978
CPR:3	CHEMICAL	GENE-N	8	21	CONCLUSION ( S ) : Short-term exposure of chemical in new starters of DMPA increases the expression of endometrial gene , gene , gene , and gene and promotes cell proliferation .	T3	T25	17094978
CPR:3	CHEMICAL	GENE-Y	8	23	CONCLUSION ( S ) : Short-term exposure of chemical in new starters of DMPA increases the expression of endometrial gene , gene , gene , and gene and promotes cell proliferation .	T3	T26	17094978
CPR:3	CHEMICAL	GENE-Y	8	2	CONCLUSION ( S ) : Short-term exposure of chemical in new starters of DMPA increases the expression of endometrial gene , gene , gene , and gene and promotes cell proliferation .	T3	T27	17094978
NA	CHEMICAL	GENE-N	5	12	The broad-spectrum anti-emetic activity of chemical , a novel chemical D2 , D3 and gene antagonist .	T30	T40	11350861
CPR:6	CHEMICAL	GENE-Y	5	14	The broad-spectrum anti-emetic activity of chemical , a novel chemical D2 , D3 and gene antagonist .	T30	T41	11350861
NA	CHEMICAL	GENE-N	7	12	The broad-spectrum anti-emetic activity of chemical , a novel chemical D2 , D3 and gene antagonist .	T31	T40	11350861
NA	CHEMICAL	GENE-Y	7	14	The broad-spectrum anti-emetic activity of chemical , a novel chemical D2 , D3 and gene antagonist .	T31	T41	11350861
NA	CHEMICAL	GENE-N	6	18	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T15	T34	11350861
NA	CHEMICAL	GENE-Y	6	24	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T15	T35	11350861
NA	CHEMICAL	GENE-N	8	18	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T16	T34	11350861
NA	CHEMICAL	GENE-Y	8	24	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T16	T35	11350861
NA	CHEMICAL	GENE-N	11	18	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T11	T34	11350861
NA	CHEMICAL	GENE-Y	11	24	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T11	T35	11350861
NA	CHEMICAL	GENE-N	11	18	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T12	T34	11350861
NA	CHEMICAL	GENE-Y	11	24	The anti-emetic and pharmacological profile of chemical ( chemical ) , a novel and potent chemical D2 , D3 and chemical-3 ( 5-HT3 ) receptors ligand , was investigated in the present study .	T12	T35	11350861
CPR:6	CHEMICAL	GENE-Y	5	18	In guinea-pig isolated colon , chemical produced a rightward shift of the concentration-response curves of chemical , a gene agonist ( pA2 value of 7.04 ) .	T13	T36	11350861
CPR:5	CHEMICAL	GENE-Y	15	18	In guinea-pig isolated colon , chemical produced a rightward shift of the concentration-response curves of chemical , a gene agonist ( pA2 value of 7.04 ) .	T14	T36	11350861
CPR:6	CHEMICAL	GENE-Y	6	1	Other gene antagonists also produced such a shift in the following antagonistic-potency order : chemical > chemical=chemical > > chemical .	T17	T37	11350861
CPR:6	CHEMICAL	GENE-Y	6	1	Other gene antagonists also produced such a shift in the following antagonistic-potency order : chemical > chemical=chemical > > chemical .	T18	T37	11350861
CPR:6	CHEMICAL	GENE-Y	16	1	Other gene antagonists also produced such a shift in the following antagonistic-potency order : chemical > chemical=chemical > > chemical .	T19	T37	11350861
CPR:6	CHEMICAL	GENE-Y	6	1	Other gene antagonists also produced such a shift in the following antagonistic-potency order : chemical > chemical=chemical > > chemical .	T20	T37	11350861
NA	CHEMICAL	GENE-Y	6	8	potently inhibited hypothermia induced by the chemical D3 receptor agonist ; chemical ( chemical ) ( 0.3 mg kg ( -1 ) s.c. ) .	T22	T38	11350861
CPR:5	CHEMICAL	GENE-Y	11	8	potently inhibited hypothermia induced by the chemical D3 receptor agonist ; chemical ( chemical ) ( 0.3 mg kg ( -1 ) s.c. ) .	T23	T38	11350861
CPR:5	CHEMICAL	GENE-Y	12	8	potently inhibited hypothermia induced by the chemical D3 receptor agonist ; chemical ( chemical ) ( 0.3 mg kg ( -1 ) s.c. ) .	T24	T38	11350861
NA	CHEMICAL	GENE-Y	0	10	chemical and chemical , which have affinity for chemical D3 receptor , also inhibited chemical-induced hypothermia .	T25	T39	11350861
NA	CHEMICAL	GENE-Y	2	10	chemical and chemical , which have affinity for chemical D3 receptor , also inhibited chemical-induced hypothermia .	T26	T39	11350861
NA	CHEMICAL	GENE-Y	8	10	chemical and chemical , which have affinity for chemical D3 receptor , also inhibited chemical-induced hypothermia .	T27	T39	11350861
NA	CHEMICAL	GENE-Y	14	10	chemical and chemical , which have affinity for chemical D3 receptor , also inhibited chemical-induced hypothermia .	T28	T39	11350861
NA	CHEMICAL	GENE-Y	4	6	Multiple enzyme inhibitions by chemical H3 receptor antagonists as potential procognitive agents .	T10	T18	16599255
NA	CHEMICAL	GENE-Y	3	5	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T2	T12	16599255
NA	CHEMICAL	GENE-N	3	21	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T2	T11	16599255
NA	CHEMICAL	GENE-Y	3	17	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T2	T13	16599255
NA	CHEMICAL	GENE-Y	14	5	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T9	T12	16599255
CPR:9	CHEMICAL	GENE-N	14	21	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T9	T11	16599255
NA	CHEMICAL	GENE-Y	14	17	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T9	T13	16599255
NA	CHEMICAL	GENE-Y	0	5	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T1	T12	16599255
NA	CHEMICAL	GENE-N	0	21	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T1	T11	16599255
NA	CHEMICAL	GENE-Y	0	17	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T1	T13	16599255
NA	CHEMICAL	GENE-Y	17	5	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T3	T12	16599255
NA	CHEMICAL	GENE-N	17	21	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T3	T11	16599255
CPR:4	CHEMICAL	GENE-Y	17	17	chemicalovel highly affine chemical H3 receptor ligands with additional inhibitory effects on the main chemical metabolizing enzyme in the brain , gene , chemically show structural elements of the gene inhibitor chemical .	T3	T13	16599255
NA	CHEMICAL	GENE-Y	8	0	gene antagonism , inhibition of metabolisation of neuronal chemical as well as inhibition of hydrolysis of chemical are each one believed to improve reduced cognitive functions , which is useful for symptomatic treatment of Alzheimer 's disease .	T4	T14	16599255
NA	CHEMICAL	GENE-Y	16	0	gene antagonism , inhibition of metabolisation of neuronal chemical as well as inhibition of hydrolysis of chemical are each one believed to improve reduced cognitive functions , which is useful for symptomatic treatment of Alzheimer 's disease .	T5	T14	16599255
CPR:9	CHEMICAL	GENE-Y	6	6	Some of the new compounds proved in a slightly modified colorimetric Ellmann 's assay to be potent inhibitors of gene and of gene which is another catalytic enzyme hydrolysing chemical .	T6	T15	16599255
CPR:9	CHEMICAL	GENE-Y	6	6	Some of the new compounds proved in a slightly modified colorimetric Ellmann 's assay to be potent inhibitors of gene and of gene which is another catalytic enzyme hydrolysing chemical .	T6	T16	16599255
NA	CHEMICAL	GENE-N	11	12	We found that this interaction is highly specific , requires the chemical-UBP domain of gene , and is disrupted by the inactivating gene mutation within gene .	T1	T15	23382074
NA	CHEMICAL	GENE-Y	11	14	We found that this interaction is highly specific , requires the chemical-UBP domain of gene , and is disrupted by the inactivating gene mutation within gene .	T1	T17	23382074
NA	CHEMICAL	GENE-N	11	22	We found that this interaction is highly specific , requires the chemical-UBP domain of gene , and is disrupted by the inactivating gene mutation within gene .	T1	T18	23382074
NA	CHEMICAL	GENE-Y	11	25	We found that this interaction is highly specific , requires the chemical-UBP domain of gene , and is disrupted by the inactivating gene mutation within gene .	T1	T19	23382074
NA	CHEMICAL	GENE-Y	5	5	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T2	T20	23382074
NA	CHEMICAL	GENE-N	5	16	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T2	T22	23382074
NA	CHEMICAL	GENE-N	5	33	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T2	T23	23382074
NA	CHEMICAL	GENE-N	5	37	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T2	T24	23382074
NA	CHEMICAL	GENE-Y	18	5	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T3	T20	23382074
NA	CHEMICAL	GENE-N	18	16	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T3	T22	23382074
NA	CHEMICAL	GENE-N	18	33	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T3	T23	23382074
NA	CHEMICAL	GENE-N	18	37	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T3	T24	23382074
NA	CHEMICAL	GENE-Y	24	5	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T4	T20	23382074
NA	CHEMICAL	GENE-N	24	16	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T4	T22	23382074
NA	CHEMICAL	GENE-N	24	33	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T4	T23	23382074
NA	CHEMICAL	GENE-N	24	37	Moreover , we show that gene is acetylated on multiple chemical residues and that alteration of a single chemical ( K129 ) within the chemical-UBP domain is sufficient to alter interaction of the gene with the core gene complex .	T4	T24	23382074
NA	CHEMICAL	GENE-Y	2	3	Determination of chemical dimethylaminohydrolase activity in the kidney .	T15	T25	17653133
NA	CHEMICAL	GENE-Y	0	1	chemical dimethylaminohydrolase ( gene ) metabolizes asymmetric chemical to generate chemical and is present in large quantities in the kidney .	T1	T16	17653133
NA	CHEMICAL	GENE-Y	0	3	chemical dimethylaminohydrolase ( gene ) metabolizes asymmetric chemical to generate chemical and is present in large quantities in the kidney .	T1	T20	17653133
CPR:9	CHEMICAL	GENE-Y	7	1	chemical dimethylaminohydrolase ( gene ) metabolizes asymmetric chemical to generate chemical and is present in large quantities in the kidney .	T8	T16	17653133
CPR:9	CHEMICAL	GENE-Y	7	3	chemical dimethylaminohydrolase ( gene ) metabolizes asymmetric chemical to generate chemical and is present in large quantities in the kidney .	T8	T20	17653133
CPR:9	CHEMICAL	GENE-Y	10	1	chemical dimethylaminohydrolase ( gene ) metabolizes asymmetric chemical to generate chemical and is present in large quantities in the kidney .	T14	T16	17653133
CPR:9	CHEMICAL	GENE-Y	10	3	chemical dimethylaminohydrolase ( gene ) metabolizes asymmetric chemical to generate chemical and is present in large quantities in the kidney .	T14	T20	17653133
CPR:9	CHEMICAL	GENE-Y	14	13	We present a new study that optimizes the Prescott-Jones colorimetric assay to measure gene-dependent chemical generation in kidney homogenates .	T2	T18	17653133
CPR:9	CHEMICAL	GENE-N	6	8	We found that the removal of chemical with gene is necessary since chemical also produces a positive reaction .	T3	T19	17653133
NA	CHEMICAL	GENE-N	12	8	We found that the removal of chemical with gene is necessary since chemical also produces a positive reaction .	T4	T19	17653133
NA	CHEMICAL	GENE-N	2	10	Deproteinization with chemical was found to be optimal and that gene inhibitors were not necessary .	T5	T21	17653133
NA	CHEMICAL	GENE-N	2	0	gene or chemical synthase isoenzymes were not found to influence chemical production .	T7	T22	17653133
NA	CHEMICAL	GENE-N	2	3	gene or chemical synthase isoenzymes were not found to influence chemical production .	T7	T23	17653133
NA	CHEMICAL	GENE-N	10	0	gene or chemical synthase isoenzymes were not found to influence chemical production .	T9	T22	17653133
NA	CHEMICAL	GENE-N	10	3	gene or chemical synthase isoenzymes were not found to influence chemical production .	T9	T23	17653133
CPR:9	CHEMICAL	GENE-Y	2	7	Our optimized chemical production assay to measure gene activity correlated closely with the direct measure of the rate of asymmetric chemical consumption .	T10	T24	17653133
CPR:9	CHEMICAL	GENE-Y	20	7	Our optimized chemical production assay to measure gene activity correlated closely with the direct measure of the rate of asymmetric chemical consumption .	T11	T24	17653133
CPR:9	CHEMICAL	GENE-Y	7	3	Selective inhibition of gene spares renal function and chemical synthesis in cirrhotic rats with ascites .	T10	T18	10220509
CPR:4	CHEMICAL	GENE-Y	12	9	The current study evaluates the effects of a selective gene inhibitor ( chemical ) on renal function in cirrhotic rats with ascites .	T3	T12	10220509
NA	CHEMICAL	GENE-Y	4	20	RESULTS : Administration of chemical to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective gene/gene inhibitor , chemical , resulted in a marked reduction in urine volume , urinary excretion of chemical , and glomerular filtration rate and in a significant impairment in renal water metabolism .	T8	T16	10220509
NA	CHEMICAL	GENE-Y	4	20	RESULTS : Administration of chemical to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective gene/gene inhibitor , chemical , resulted in a marked reduction in urine volume , urinary excretion of chemical , and glomerular filtration rate and in a significant impairment in renal water metabolism .	T8	T17	10220509
CPR:4	CHEMICAL	GENE-Y	5	20	RESULTS : Administration of chemical to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective gene/gene inhibitor , chemical , resulted in a marked reduction in urine volume , urinary excretion of chemical , and glomerular filtration rate and in a significant impairment in renal water metabolism .	T9	T16	10220509
CPR:4	CHEMICAL	GENE-Y	5	20	RESULTS : Administration of chemical to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective gene/gene inhibitor , chemical , resulted in a marked reduction in urine volume , urinary excretion of chemical , and glomerular filtration rate and in a significant impairment in renal water metabolism .	T9	T17	10220509
CPR:9	CHEMICAL	GENE-Y	20	20	RESULTS : Administration of chemical to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective gene/gene inhibitor , chemical , resulted in a marked reduction in urine volume , urinary excretion of chemical , and glomerular filtration rate and in a significant impairment in renal water metabolism .	T1	T16	10220509
CPR:9	CHEMICAL	GENE-Y	20	20	RESULTS : Administration of chemical to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective gene/gene inhibitor , chemical , resulted in a marked reduction in urine volume , urinary excretion of chemical , and glomerular filtration rate and in a significant impairment in renal water metabolism .	T1	T17	10220509
NA	CHEMICAL	GENE-Y	4	19	The contrasting activity of chemical versus chemical and chemical anticancer complexes : control of cell selectivity , cross-resistance , gene dependence , and apoptosis pathway .	T15	T21	23368735
NA	CHEMICAL	GENE-Y	6	19	The contrasting activity of chemical versus chemical and chemical anticancer complexes : control of cell selectivity , cross-resistance , gene dependence , and apoptosis pathway .	T16	T21	23368735
NA	CHEMICAL	GENE-Y	8	19	The contrasting activity of chemical versus chemical and chemical anticancer complexes : control of cell selectivity , cross-resistance , gene dependence , and apoptosis pathway .	T17	T21	23368735
NA	CHEMICAL	GENE-Y	1	6	The chemical complexes retain potency in gene mutant colon cells .	T11	T18	23368735
NA	CHEMICAL	GENE-N	18	4	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T5	T11	23354728
NA	CHEMICAL	GENE-N	18	7	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T5	T12	23354728
NA	CHEMICAL	GENE-Y	18	21	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T5	T13	23354728
NA	CHEMICAL	GENE-N	18	24	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T5	T7	23354728
NA	CHEMICAL	GENE-Y	18	30	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T5	T8	23354728
NA	CHEMICAL	GENE-Y	18	10	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T5	T9	23354728
NA	CHEMICAL	GENE-N	19	4	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T6	T11	23354728
NA	CHEMICAL	GENE-N	19	7	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T6	T12	23354728
NA	CHEMICAL	GENE-Y	19	21	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T6	T13	23354728
NA	CHEMICAL	GENE-N	19	24	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T6	T7	23354728
NA	CHEMICAL	GENE-Y	19	30	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T6	T8	23354728
NA	CHEMICAL	GENE-Y	19	10	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T6	T9	23354728
NA	CHEMICAL	GENE-N	4	4	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T1	T11	23354728
NA	CHEMICAL	GENE-N	4	7	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T1	T12	23354728
NA	CHEMICAL	GENE-Y	4	21	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T1	T13	23354728
NA	CHEMICAL	GENE-N	4	24	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T1	T7	23354728
NA	CHEMICAL	GENE-Y	4	30	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T1	T8	23354728
NA	CHEMICAL	GENE-Y	4	10	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T1	T9	23354728
NA	CHEMICAL	GENE-N	27	4	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T2	T11	23354728
NA	CHEMICAL	GENE-N	27	7	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T2	T12	23354728
NA	CHEMICAL	GENE-Y	27	21	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T2	T13	23354728
NA	CHEMICAL	GENE-N	27	24	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T2	T7	23354728
NA	CHEMICAL	GENE-Y	27	30	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T2	T8	23354728
NA	CHEMICAL	GENE-Y	27	10	These agents include newer gene-based therapies and gene agonists , as well as new therapeutic classes such as chemical-coupled chemical cotransporter 2 inhibitors , gene agonists , chemical dehydrogenase type 1 inhibitors , gene activators , and several others that may enter clinical use over the next decade .	T2	T9	23354728
NA	CHEMICAL	GENE-N	7	17	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T1	T8	3320565
NA	CHEMICAL	GENE-N	7	33	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T1	T9	3320565
NA	CHEMICAL	GENE-N	7	17	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T2	T8	3320565
NA	CHEMICAL	GENE-N	7	33	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T2	T9	3320565
NA	CHEMICAL	GENE-N	22	17	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T3	T8	3320565
NA	CHEMICAL	GENE-N	22	33	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T3	T9	3320565
NA	CHEMICAL	GENE-N	7	17	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T4	T8	3320565
NA	CHEMICAL	GENE-N	7	33	The following was demonstrated in the rat and confirmed in man : interaction of chemical with the gene , antichemical activity against chemical ( in particular against the early transient rise induced by gene analogs ) and adrenal chemical .	T4	T9	3320565
NA	CHEMICAL	GENE-Y	0	2	chemical CB1 receptors in the paraventricular nucleus and central control of penile erection : immunocytochemistry , autoradiography and behavioral studies .	T15	T30	17507169
CPR:6	CHEMICAL	GENE-Y	1	11	[ chemical ] ( chemical ) , a selective chemical CB1 receptor antagonist , injected into the paraventricular nucleus of the hypothalamus ( PVN ) of male rats , induces penile erection .	T6	T16	17507169
CPR:6	CHEMICAL	GENE-Y	4	11	[ chemical ] ( chemical ) , a selective chemical CB1 receptor antagonist , injected into the paraventricular nucleus of the hypothalamus ( PVN ) of male rats , induces penile erection .	T13	T16	17507169
NA	CHEMICAL	GENE-Y	4	11	[ chemical ] ( chemical ) , a selective chemical CB1 receptor antagonist , injected into the paraventricular nucleus of the hypothalamus ( PVN ) of male rats , induces penile erection .	T1	T16	17507169
NA	CHEMICAL	GENE-Y	9	7	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T20	17507169
NA	CHEMICAL	GENE-N	9	10	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T21	17507169
NA	CHEMICAL	GENE-N	9	12	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T22	17507169
NA	CHEMICAL	GENE-Y	9	14	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T23	17507169
NA	CHEMICAL	GENE-Y	9	16	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T24	17507169
NA	CHEMICAL	GENE-Y	9	20	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T25	17507169
NA	CHEMICAL	GENE-Y	9	22	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T26	17507169
NA	CHEMICAL	GENE-Y	9	25	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T27	17507169
NA	CHEMICAL	GENE-Y	9	31	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T9	T28	17507169
NA	CHEMICAL	GENE-Y	19	7	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T20	17507169
NA	CHEMICAL	GENE-N	19	10	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T21	17507169
NA	CHEMICAL	GENE-N	19	12	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T22	17507169
NA	CHEMICAL	GENE-Y	19	14	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T23	17507169
NA	CHEMICAL	GENE-Y	19	16	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T24	17507169
NA	CHEMICAL	GENE-Y	19	20	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T25	17507169
NA	CHEMICAL	GENE-Y	19	22	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T26	17507169
NA	CHEMICAL	GENE-Y	19	25	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T27	17507169
NA	CHEMICAL	GENE-Y	19	31	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T11	T28	17507169
NA	CHEMICAL	GENE-Y	32	7	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T20	17507169
NA	CHEMICAL	GENE-N	32	10	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T21	17507169
NA	CHEMICAL	GENE-N	32	12	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T22	17507169
NA	CHEMICAL	GENE-Y	32	14	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T23	17507169
NA	CHEMICAL	GENE-Y	32	16	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T24	17507169
NA	CHEMICAL	GENE-Y	32	20	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T25	17507169
NA	CHEMICAL	GENE-Y	32	22	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T26	17507169
NA	CHEMICAL	GENE-Y	32	25	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T27	17507169
NA	CHEMICAL	GENE-Y	32	31	Double immunofluorescence studies with selective antibodies against gene , chemical transporters ( gene ( gene and gene ) , chemical decarboxylase-67 ( gene ) and gene itself , have shown that gene in the PVN are located mainly in GABAergic terminals and fibers surrounding chemicalergic cell bodies .	T12	T28	17507169
NA	CHEMICAL	GENE-Y	1	11	As chemicalergic synapses in the PVN impinge directly on oxytocinergic neurons or on excitatory glutamatergic synapses , which also impinge on oxytocinergic neurons , these results suggest that the blockade of gene decreases GABA release in the PVN , increasing in turn glutamatergic neurotransmission to activate oxytocinergic neurons mediating penile erection .	T14	T29	17507169
NA	CHEMICAL	GENE-Y	41	6	The present findings confirm that PVN gene , localized mainly in GABAergic synapses that control in an inhibitory fashion excitatory synapses , exert an inhibitory control on penile erection , demonstrating for the first time that chronic blockade of gene by chemical increases the density of these receptors in the PVN .	T5	T18	17507169
CPR:4	CHEMICAL	GENE-Y	41	39	The present findings confirm that PVN gene , localized mainly in GABAergic synapses that control in an inhibitory fashion excitatory synapses , exert an inhibitory control on penile erection , demonstrating for the first time that chronic blockade of gene by chemical increases the density of these receptors in the PVN .	T5	T19	17507169
NA	CHEMICAL	GENE-Y	2	3	ARF represses chemical receptor transactivation in prostate cancer .	T9	T45	23449888
NA	CHEMICAL	GENE-Y	0	1	chemical receptor ( gene ) signaling is essential for prostate cancer ( PCa ) development in humans .	T1	T10	23449888
NA	CHEMICAL	GENE-Y	0	3	chemical receptor ( gene ) signaling is essential for prostate cancer ( PCa ) development in humans .	T1	T27	23449888
NA	CHEMICAL	GENE-Y	11	6	Here , we provide evidence that gene physically interacts with gene and functions as an gene corespressor in both an chemical-dependent and chemical-independent manner .	T6	T31	23449888
NA	CHEMICAL	GENE-Y	11	10	Here , we provide evidence that gene physically interacts with gene and functions as an gene corespressor in both an chemical-dependent and chemical-independent manner .	T6	T32	23449888
NA	CHEMICAL	GENE-Y	11	15	Here , we provide evidence that gene physically interacts with gene and functions as an gene corespressor in both an chemical-dependent and chemical-independent manner .	T6	T33	23449888
NA	CHEMICAL	GENE-Y	11	6	Here , we provide evidence that gene physically interacts with gene and functions as an gene corespressor in both an chemical-dependent and chemical-independent manner .	T7	T31	23449888
NA	CHEMICAL	GENE-Y	11	10	Here , we provide evidence that gene physically interacts with gene and functions as an gene corespressor in both an chemical-dependent and chemical-independent manner .	T7	T32	23449888
NA	CHEMICAL	GENE-Y	11	15	Here , we provide evidence that gene physically interacts with gene and functions as an gene corespressor in both an chemical-dependent and chemical-independent manner .	T7	T33	23449888
NA	CHEMICAL	GENE-Y	11	2	Overexpression of gene in PCa cells significantly attenuates the activities of chemical response region ( gene ) -gene .	T8	T38	23449888
NA	CHEMICAL	GENE-N	11	13	Overexpression of gene in PCa cells significantly attenuates the activities of chemical response region ( gene ) -gene .	T8	T39	23449888
NA	CHEMICAL	GENE-N	11	15	Overexpression of gene in PCa cells significantly attenuates the activities of chemical response region ( gene ) -gene .	T8	T40	23449888
NA	CHEMICAL	GENE-N	11	17	Overexpression of gene in PCa cells significantly attenuates the activities of chemical response region ( gene ) -gene .	T8	T41	23449888
NA	CHEMICAL	GENE-Y	5	17	Furthermore , we demonstrated that gene binds to both the chemical-terminal domain and the ligand-binding domain of gene , and the gene of gene is required for the interaction of gene and gene proteins .	T2	T16	23449888
NA	CHEMICAL	GENE-N	5	21	Furthermore , we demonstrated that gene binds to both the chemical-terminal domain and the ligand-binding domain of gene , and the gene of gene is required for the interaction of gene and gene proteins .	T2	T17	23449888
NA	CHEMICAL	GENE-Y	5	23	Furthermore , we demonstrated that gene binds to both the chemical-terminal domain and the ligand-binding domain of gene , and the gene of gene is required for the interaction of gene and gene proteins .	T2	T18	23449888
NA	CHEMICAL	GENE-Y	5	30	Furthermore , we demonstrated that gene binds to both the chemical-terminal domain and the ligand-binding domain of gene , and the gene of gene is required for the interaction of gene and gene proteins .	T2	T19	23449888
NA	CHEMICAL	GENE-Y	5	32	Furthermore , we demonstrated that gene binds to both the chemical-terminal domain and the ligand-binding domain of gene , and the gene of gene is required for the interaction of gene and gene proteins .	T2	T20	23449888
NA	CHEMICAL	GENE-Y	3	13	gene perturbs the chemical-induced interaction between the chemical terminus and chemical terminus of gene .	T3	T22	23449888
NA	CHEMICAL	GENE-Y	0	13	gene perturbs the chemical-induced interaction between the chemical terminus and chemical terminus of gene .	T4	T22	23449888
NA	CHEMICAL	GENE-Y	10	13	gene perturbs the chemical-induced interaction between the chemical terminus and chemical terminus of gene .	T5	T22	23449888
CPR:9	CHEMICAL	GENE-N	7	3	This aminophospholipid `` gene '' selectively transports chemical to the cytosolic leaflet of the bilayer and is sensitive to chemical , chemical , and modification by chemical reagents .	T24	T43	16618126
NA	CHEMICAL	GENE-N	19	3	This aminophospholipid `` gene '' selectively transports chemical to the cytosolic leaflet of the bilayer and is sensitive to chemical , chemical , and modification by chemical reagents .	T28	T43	16618126
NA	CHEMICAL	GENE-N	21	3	This aminophospholipid `` gene '' selectively transports chemical to the cytosolic leaflet of the bilayer and is sensitive to chemical , chemical , and modification by chemical reagents .	T29	T43	16618126
NA	CHEMICAL	GENE-N	26	3	This aminophospholipid `` gene '' selectively transports chemical to the cytosolic leaflet of the bilayer and is sensitive to chemical , chemical , and modification by chemical reagents .	T30	T43	16618126
NA	CHEMICAL	GENE-Y	2	0	A candidate chemical flippase ATP8A1 ( gene ) , originally isolated from bovine secretory vesicles , is a member of this subfamily based on sequence homology to the founding member of the subfamily , the gene , which has been linked to ribosomal assembly , the formation of Golgi-coated vesicles , and the maintenance of PS asymmetry .	T32	T52	16618126
NA	CHEMICAL	GENE-Y	2	6	A candidate chemical flippase ATP8A1 ( gene ) , originally isolated from bovine secretory vesicles , is a member of this subfamily based on sequence homology to the founding member of the subfamily , the gene , which has been linked to ribosomal assembly , the formation of Golgi-coated vesicles , and the maintenance of PS asymmetry .	T32	T53	16618126
NA	CHEMICAL	GENE-Y	2	35	A candidate chemical flippase ATP8A1 ( gene ) , originally isolated from bovine secretory vesicles , is a member of this subfamily based on sequence homology to the founding member of the subfamily , the gene , which has been linked to ribosomal assembly , the formation of Golgi-coated vesicles , and the maintenance of PS asymmetry .	T32	T54	16618126
NA	CHEMICAL	GENE-Y	10	3	To determine if gene has biochemical characteristics consistent with a chemical flippase , a murine homologue of this enzyme was expressed in insect cells and purified .	T34	T55	16618126
NA	CHEMICAL	GENE-N	10	9	To determine if gene has biochemical characteristics consistent with a chemical flippase , a murine homologue of this enzyme was expressed in insect cells and purified .	T34	T56	16618126
NA	CHEMICAL	GENE-Y	5	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T1	T35	16618126
NA	CHEMICAL	GENE-Y	14	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T2	T35	16618126
NA	CHEMICAL	GENE-Y	2	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T3	T35	16618126
CPR:3	CHEMICAL	GENE-Y	23	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T4	T35	16618126
CPR:3	CHEMICAL	GENE-Y	5	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T5	T35	16618126
CPR:3	CHEMICAL	GENE-Y	27	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T6	T35	16618126
CPR:3	CHEMICAL	GENE-Y	35	2	The purified gene is inactive in detergent micelles or in micelles containing chemical , chemical , or chemical , is minimally activated by chemical or chemical ( chemical ) , and is maximally activated by chemical .	T7	T35	16618126
NA	CHEMICAL	GENE-N	16	3	Similar to the gene , gene is activated only by the naturally occurring chemical isomer of chemical and not the chemical stereoisomer .	T9	T36	16618126
NA	CHEMICAL	GENE-Y	16	5	Similar to the gene , gene is activated only by the naturally occurring chemical isomer of chemical and not the chemical stereoisomer .	T9	T37	16618126
CPR:3	CHEMICAL	GENE-N	4	3	Similar to the gene , gene is activated only by the naturally occurring chemical isomer of chemical and not the chemical stereoisomer .	T10	T36	16618126
CPR:3	CHEMICAL	GENE-Y	4	5	Similar to the gene , gene is activated only by the naturally occurring chemical isomer of chemical and not the chemical stereoisomer .	T10	T37	16618126
NA	CHEMICAL	GENE-N	4	3	Similar to the gene , gene is activated only by the naturally occurring chemical isomer of chemical and not the chemical stereoisomer .	T11	T36	16618126
NA	CHEMICAL	GENE-Y	4	5	Similar to the gene , gene is activated only by the naturally occurring chemical isomer of chemical and not the chemical stereoisomer .	T11	T37	16618126
NA	CHEMICAL	GENE-N	4	14	Most modifications of the chemical headgroup structure decrease recognition by the plasma membrane chemical flippase .	T13	T40	16618126
NA	CHEMICAL	GENE-N	13	14	Most modifications of the chemical headgroup structure decrease recognition by the plasma membrane chemical flippase .	T14	T40	16618126
CPR:4	CHEMICAL	GENE-Y	10	2	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T15	T41	16618126
NA	CHEMICAL	GENE-Y	10	32	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T15	T42	16618126
CPR:4	CHEMICAL	GENE-Y	12	2	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T16	T41	16618126
NA	CHEMICAL	GENE-Y	12	32	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T16	T42	16618126
CPR:4	CHEMICAL	GENE-Y	14	2	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T17	T41	16618126
NA	CHEMICAL	GENE-Y	14	32	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T17	T42	16618126
CPR:4	CHEMICAL	GENE-Y	17	2	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T18	T41	16618126
NA	CHEMICAL	GENE-Y	17	32	Activation of gene is also reduced by these modifications ; chemical , chemical , chemical , and chemical , which are not transported by the plasma membrane flippase , do not activate gene .	T18	T42	16618126
CPR:3	CHEMICAL	GENE-Y	4	14	Weakly translocated lipids ( chemical , chemical , and chemical ) are also weak gene activators .	T19	T44	16618126
CPR:3	CHEMICAL	GENE-Y	6	14	Weakly translocated lipids ( chemical , chemical , and chemical ) are also weak gene activators .	T20	T44	16618126
CPR:3	CHEMICAL	GENE-Y	9	14	Weakly translocated lipids ( chemical , chemical , and chemical ) are also weak gene activators .	T21	T44	16618126
CPR:9	CHEMICAL	GENE-N	2	11	However , chemical , which is transported by the plasma membrane gene at a rate equivalent to chemical , is incapable of activating gene activity .	T22	T45	16618126
NA	CHEMICAL	GENE-Y	2	13	However , chemical , which is transported by the plasma membrane gene at a rate equivalent to chemical , is incapable of activating gene activity .	T22	T46	16618126
NA	CHEMICAL	GENE-N	17	11	However , chemical , which is transported by the plasma membrane gene at a rate equivalent to chemical , is incapable of activating gene activity .	T23	T45	16618126
NA	CHEMICAL	GENE-Y	17	13	However , chemical , which is transported by the plasma membrane gene at a rate equivalent to chemical , is incapable of activating gene activity .	T23	T46	16618126
CPR:4	CHEMICAL	GENE-N	5	3	Pharmacological inhibition of gene with chemical abrogated the gene-induced phosphorylation of gene , gene and its downstream effector , gene .	T2	T15	23261705
CPR:4	CHEMICAL	GENE-Y	5	8	Pharmacological inhibition of gene with chemical abrogated the gene-induced phosphorylation of gene , gene and its downstream effector , gene .	T2	T16	23261705
CPR:4	CHEMICAL	GENE-Y	5	11	Pharmacological inhibition of gene with chemical abrogated the gene-induced phosphorylation of gene , gene and its downstream effector , gene .	T2	T17	23261705
CPR:4	CHEMICAL	GENE-Y	5	13	Pharmacological inhibition of gene with chemical abrogated the gene-induced phosphorylation of gene , gene and its downstream effector , gene .	T2	T18	23261705
CPR:4	CHEMICAL	GENE-Y	5	19	Pharmacological inhibition of gene with chemical abrogated the gene-induced phosphorylation of gene , gene and its downstream effector , gene .	T2	T19	23261705
CPR:4	CHEMICAL	GENE-Y	20	2	Furthermore , gene-stimulated T-I cell proliferation and the expression of gene gene , gene and gene were also blocked by chemical .	T1	T24	23261705
CPR:4	CHEMICAL	GENE-N	20	10	Furthermore , gene-stimulated T-I cell proliferation and the expression of gene gene , gene and gene were also blocked by chemical .	T1	T25	23261705
CPR:4	CHEMICAL	GENE-Y	20	11	Furthermore , gene-stimulated T-I cell proliferation and the expression of gene gene , gene and gene were also blocked by chemical .	T1	T26	23261705
CPR:4	CHEMICAL	GENE-Y	20	13	Furthermore , gene-stimulated T-I cell proliferation and the expression of gene gene , gene and gene were also blocked by chemical .	T1	T27	23261705
CPR:4	CHEMICAL	GENE-Y	20	15	Furthermore , gene-stimulated T-I cell proliferation and the expression of gene gene , gene and gene were also blocked by chemical .	T1	T4	23261705
NA	CHEMICAL	GENE-N	9	4	Here , we identified gene ( gene ) as a chemical-binding protein .	T3	T8	20223979
NA	CHEMICAL	GENE-N	9	6	Here , we identified gene ( gene ) as a chemical-binding protein .	T3	T9	20223979
NA	CHEMICAL	GENE-N	9	11	Here , we identified gene ( gene ) as a chemical-binding protein .	T3	T10	20223979
NA	CHEMICAL	GENE-N	0	8	chemical initiates its teratogenic effects by binding to gene and inhibiting the associated gene activity .	T4	T18	20223979
CPR:4	CHEMICAL	GENE-N	0	13	chemical initiates its teratogenic effects by binding to gene and inhibiting the associated gene activity .	T4	T19	20223979
CPR:9	CHEMICAL	GENE-N	18	11	To evaluate to what extent the regional differences in expression of gene and gene affect the absorption of a dual substrate , we investigated the transport of chemical across different small intestinal segments ( duodenum , proximal jejunum and ileum ) .	T6	T19	23395914
CPR:9	CHEMICAL	GENE-N	18	13	To evaluate to what extent the regional differences in expression of gene and gene affect the absorption of a dual substrate , we investigated the transport of chemical across different small intestinal segments ( duodenum , proximal jejunum and ileum ) .	T6	T20	23395914
CPR:9	CHEMICAL	GENE-N	8	3	The involvement of gene in the absorption of chemical was clearly shown by coperfusion of chemical with the gene inhibitor chemical .	T10	T21	23395914
NA	CHEMICAL	GENE-N	8	18	The involvement of gene in the absorption of chemical was clearly shown by coperfusion of chemical with the gene inhibitor chemical .	T10	T22	23395914
NA	CHEMICAL	GENE-N	15	3	The involvement of gene in the absorption of chemical was clearly shown by coperfusion of chemical with the gene inhibitor chemical .	T11	T21	23395914
NA	CHEMICAL	GENE-N	15	18	The involvement of gene in the absorption of chemical was clearly shown by coperfusion of chemical with the gene inhibitor chemical .	T11	T22	23395914
NA	CHEMICAL	GENE-N	20	3	The involvement of gene in the absorption of chemical was clearly shown by coperfusion of chemical with the gene inhibitor chemical .	T12	T21	23395914
CPR:4	CHEMICAL	GENE-N	20	18	The involvement of gene in the absorption of chemical was clearly shown by coperfusion of chemical with the gene inhibitor chemical .	T12	T22	23395914
CPR:9	CHEMICAL	GENE-N	2	2	Involvement of gene mediated metabolism in the absorption of chemical could not be demonstrated in this rat model .	T1	T16	23395914
NA	CHEMICAL	GENE-N	15	15	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T4	T11	23643725
NA	CHEMICAL	GENE-N	15	22	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T4	T12	23643725
NA	CHEMICAL	GENE-N	15	15	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T4	T13	23643725
NA	CHEMICAL	GENE-N	15	37	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T4	T14	23643725
NA	CHEMICAL	GENE-N	15	15	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T4	T15	23643725
NA	CHEMICAL	GENE-N	15	43	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T4	T16	23643725
NA	CHEMICAL	GENE-N	15	15	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T5	T11	23643725
NA	CHEMICAL	GENE-N	15	22	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T5	T12	23643725
NA	CHEMICAL	GENE-N	15	15	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T5	T13	23643725
NA	CHEMICAL	GENE-N	15	37	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T5	T14	23643725
NA	CHEMICAL	GENE-N	15	15	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T5	T15	23643725
NA	CHEMICAL	GENE-N	15	43	Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in chemical peroxidase ( gene ) activity during the exponential growth and a more important role of gene ( gene ) and chemical reductase ( gene ) activities during the slow growth phase .	T5	T16	23643725
CPR:3	CHEMICAL	GENE-N	26	30	In addition , during acute exposure tests performed at the end of the chronic exposure , biofilms chronically exposed to 75 and 150μgL ( -1 ) chemical showed a higher gene activity than controls .	T1	T9	23643725
NA	CHEMICAL	GENE-N	2	11	It has a particular selectivity profile for the known nuclear chemical receptors with low affinity for gene and no transactivating potential for gene .	T2	T15	8142113
NA	CHEMICAL	GENE-Y	2	2	It has a particular selectivity profile for the known nuclear chemical receptors with low affinity for gene and no transactivating potential for gene .	T2	T16	8142113
NA	CHEMICAL	GENE-Y	2	2	It has a particular selectivity profile for the known nuclear chemical receptors with low affinity for gene and no transactivating potential for gene .	T2	T17	8142113
NA	CHEMICAL	GENE-N	2	13	Furthermore , chemical does not bind to members of the cellular chemical binding protein family .	T5	T18	8142113
NA	CHEMICAL	GENE-N	11	13	Furthermore , chemical does not bind to members of the cellular chemical binding protein family .	T6	T18	8142113
NA	CHEMICAL	GENE-N	6	8	To map supercoiling , we used chemical as a DNA structure probe to show that the human genome is organized into gene .	T1	T2	23416946
CPR:9	CHEMICAL	GENE-Y	2	0	gene produces chemical that inhibit apoptosis and stimulate angiogenesis and invasiveness .	T6	T25	11078056
NA	CHEMICAL	GENE-Y	4	1	Selective gene inhibitors reduce chemical synthesis , restore apoptosis , and inhibit cancer cell proliferation .	T7	T27	11078056
CPR:4	CHEMICAL	GENE-Y	3	23	In contrast , chemical-like nonselective NSAIDs such as chemical and chemical inhibit not only the enzymatic action of the highly inducible , proinflammatory gene but the constitutively expressed , cytoprotective gene as well .	T8	T29	11078056
CPR:4	CHEMICAL	GENE-Y	3	30	In contrast , chemical-like nonselective NSAIDs such as chemical and chemical inhibit not only the enzymatic action of the highly inducible , proinflammatory gene but the constitutively expressed , cytoprotective gene as well .	T8	T30	11078056
CPR:4	CHEMICAL	GENE-Y	8	23	In contrast , chemical-like nonselective NSAIDs such as chemical and chemical inhibit not only the enzymatic action of the highly inducible , proinflammatory gene but the constitutively expressed , cytoprotective gene as well .	T9	T29	11078056
CPR:4	CHEMICAL	GENE-Y	8	30	In contrast , chemical-like nonselective NSAIDs such as chemical and chemical inhibit not only the enzymatic action of the highly inducible , proinflammatory gene but the constitutively expressed , cytoprotective gene as well .	T9	T30	11078056
CPR:4	CHEMICAL	GENE-Y	10	23	In contrast , chemical-like nonselective NSAIDs such as chemical and chemical inhibit not only the enzymatic action of the highly inducible , proinflammatory gene but the constitutively expressed , cytoprotective gene as well .	T10	T29	11078056
CPR:4	CHEMICAL	GENE-Y	10	30	In contrast , chemical-like nonselective NSAIDs such as chemical and chemical inhibit not only the enzymatic action of the highly inducible , proinflammatory gene but the constitutively expressed , cytoprotective gene as well .	T10	T30	11078056
CPR:4	CHEMICAL	GENE-Y	6	1	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T11	T33	11078056
CPR:4	CHEMICAL	GENE-Y	6	29	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T11	T14	11078056
NA	CHEMICAL	GENE-Y	6	32	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T11	T15	11078056
CPR:4	CHEMICAL	GENE-Y	8	1	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T12	T33	11078056
CPR:4	CHEMICAL	GENE-Y	8	29	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T12	T14	11078056
NA	CHEMICAL	GENE-Y	8	32	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T12	T15	11078056
CPR:4	CHEMICAL	GENE-Y	10	1	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T13	T33	11078056
CPR:4	CHEMICAL	GENE-Y	10	29	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T13	T14	11078056
NA	CHEMICAL	GENE-Y	10	32	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T13	T15	11078056
CPR:4	CHEMICAL	GENE-Y	6	1	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T1	T33	11078056
CPR:4	CHEMICAL	GENE-Y	6	29	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T1	T14	11078056
NA	CHEMICAL	GENE-Y	6	32	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T1	T15	11078056
CPR:4	CHEMICAL	GENE-Y	16	1	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T2	T33	11078056
CPR:4	CHEMICAL	GENE-Y	16	29	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T2	T14	11078056
NA	CHEMICAL	GENE-Y	16	32	Selective gene inhibitors , such as chemical , chemical ( chemical ) , and chemical ( chemical ) , are NSAIDs that have been modified chemically to preferentially inhibit gene but not gene .	T2	T15	11078056
CPR:4	CHEMICAL	GENE-Y	3	19	For instance , chemical inhibits the growth of cultured colon cancer cells ( HCA-7 and Moser-S ) that express gene but has no effect on HCT-116 tumor cells that do not express gene .	T3	T16	11078056
NA	CHEMICAL	GENE-Y	3	32	For instance , chemical inhibits the growth of cultured colon cancer cells ( HCA-7 and Moser-S ) that express gene but has no effect on HCT-116 tumor cells that do not express gene .	T3	T17	11078056
NA	CHEMICAL	GENE-Y	0	4	chemical induces apoptosis in gene expressing LNCaP prostate cancer cells and , surprisingly , in colon cancer S/KS cells that does not express gene .	T4	T18	11078056
NA	CHEMICAL	GENE-Y	0	23	chemical induces apoptosis in gene expressing LNCaP prostate cancer cells and , surprisingly , in colon cancer S/KS cells that does not express gene .	T4	T19	11078056
CPR:4	CHEMICAL	GENE-Y	6	16	This effect may due to induction of apoptosis through uncoupling of oxidative phosphorylation and down-regulation of gene , as has been demonstrated for some nonselective NSAIDs , for instance , chemical .	T5	T21	11078056
NA	CHEMICAL	GENE-N	2	0	gene modulates chemical sensitivity of the chemical EP3 receptor .	T16	T31	23087260
NA	CHEMICAL	GENE-Y	2	8	gene modulates chemical sensitivity of the chemical EP3 receptor .	T16	T32	23087260
NA	CHEMICAL	GENE-N	6	0	gene modulates chemical sensitivity of the chemical EP3 receptor .	T17	T31	23087260
NA	CHEMICAL	GENE-Y	6	8	gene modulates chemical sensitivity of the chemical EP3 receptor .	T17	T32	23087260
NA	CHEMICAL	GENE-N	7	4	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T8	T22	23087260
NA	CHEMICAL	GENE-Y	7	16	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T8	T27	23087260
NA	CHEMICAL	GENE-N	8	4	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T11	T22	23087260
NA	CHEMICAL	GENE-Y	8	16	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T11	T27	23087260
NA	CHEMICAL	GENE-N	11	4	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T14	T22	23087260
NA	CHEMICAL	GENE-Y	11	16	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T14	T27	23087260
NA	CHEMICAL	GENE-N	8	4	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T4	T22	23087260
NA	CHEMICAL	GENE-Y	8	16	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T4	T27	23087260
NA	CHEMICAL	GENE-N	31	4	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T5	T22	23087260
NA	CHEMICAL	GENE-Y	31	16	Unlike the majority of gene , the chemical ( chemical ) chemical 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of chemical ( chemical ) .	T5	T27	23087260
NA	CHEMICAL	GENE-N	22	11	Seven point mutations were introduced into the conserved motif in the gene ( gene ) of gene , resulting in acquisition of chemical-sensitive agonist binding .	T7	T23	23087260
NA	CHEMICAL	GENE-N	22	13	Seven point mutations were introduced into the conserved motif in the gene ( gene ) of gene , resulting in acquisition of chemical-sensitive agonist binding .	T7	T24	23087260
NA	CHEMICAL	GENE-Y	22	16	Seven point mutations were introduced into the conserved motif in the gene ( gene ) of gene , resulting in acquisition of chemical-sensitive agonist binding .	T7	T25	23087260
NA	CHEMICAL	GENE-N	21	15	Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the gene receptor , conditions where high chemical levels are present ; however , high affinity binding chemical was observed in broken cell preparations washed free of chemical .	T9	T28	23087260
NA	CHEMICAL	GENE-N	31	15	Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the gene receptor , conditions where high chemical levels are present ; however , high affinity binding chemical was observed in broken cell preparations washed free of chemical .	T10	T28	23087260
NA	CHEMICAL	GENE-N	41	15	Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the gene receptor , conditions where high chemical levels are present ; however , high affinity binding chemical was observed in broken cell preparations washed free of chemical .	T12	T28	23087260
NA	CHEMICAL	GENE-N	1	4	The chemical binding of gene in broken cell membrane fractions was inhibited by addition of chemical ( IC ( 50 ) 21 ± 1.8 nM ) .	T13	T29	23087260
NA	CHEMICAL	GENE-N	15	4	The chemical binding of gene in broken cell membrane fractions was inhibited by addition of chemical ( IC ( 50 ) 21 ± 1.8 nM ) .	T15	T29	23087260
NA	CHEMICAL	GENE-N	4	4	Moreover , mutation of gene can alter this coupled equilibrium from chemical-insensitive agonist binding to more conventional chemical-sensitive binding .	T1	T19	23087260
NA	CHEMICAL	GENE-N	17	4	Moreover , mutation of gene can alter this coupled equilibrium from chemical-insensitive agonist binding to more conventional chemical-sensitive binding .	T2	T19	23087260
NA	CHEMICAL	GENE-Y	2	0	gene is a transmembrane glycoprotein that mediates chemical-dependent interactions between adjacent epithelial cells .	T1	T4	23572389
NA	CHEMICAL	GENE-Y	2	9	Protection of chemical against AGEs-induced endothelial dysfunction through inhibiting gene/gene pathway activation in human umbilical vein endothelial cells .	T11	T32	23528363
NA	CHEMICAL	GENE-N	2	9	Protection of chemical against AGEs-induced endothelial dysfunction through inhibiting gene/gene pathway activation in human umbilical vein endothelial cells .	T11	T31	23528363
NA	CHEMICAL	GENE-N	1	2	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T8	T29	23528363
NA	CHEMICAL	GENE-N	1	4	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T8	T30	23528363
NA	CHEMICAL	GENE-N	8	2	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T9	T29	23528363
NA	CHEMICAL	GENE-N	8	4	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T9	T30	23528363
NA	CHEMICAL	GENE-N	10	2	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T10	T29	23528363
NA	CHEMICAL	GENE-N	10	4	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T10	T30	23528363
NA	CHEMICAL	GENE-N	10	2	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T1	T29	23528363
NA	CHEMICAL	GENE-N	10	4	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T1	T30	23528363
NA	CHEMICAL	GENE-N	33	2	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T2	T29	23528363
NA	CHEMICAL	GENE-N	33	4	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T2	T30	23528363
NA	CHEMICAL	GENE-N	4	2	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T3	T29	23528363
NA	CHEMICAL	GENE-N	4	4	The chemical dismutase ( gene ) activity and chemical ( chemical ) level in cell supernatant were detected by kits while the intracellular reactive chemical species ( ROS ) generation was determined by chemical ( chemical ) kit .	T3	T30	23528363
NA	CHEMICAL	GENE-N	12	5	GA significantly increased antioxidant enzyme gene activity and decreased peroxide degradation product chemical level in a dose-dependent manner .	T4	T19	23528363
NA	CHEMICAL	GENE-Y	13	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T10	T46	2922761
NA	CHEMICAL	GENE-Y	22	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T20	T46	2922761
NA	CHEMICAL	GENE-Y	24	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T21	T46	2922761
NA	CHEMICAL	GENE-Y	27	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T22	T46	2922761
NA	CHEMICAL	GENE-Y	29	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T23	T46	2922761
NA	CHEMICAL	GENE-Y	23	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T24	T46	2922761
NA	CHEMICAL	GENE-Y	35	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T25	T46	2922761
NA	CHEMICAL	GENE-Y	48	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T26	T46	2922761
NA	CHEMICAL	GENE-Y	42	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T27	T46	2922761
NA	CHEMICAL	GENE-Y	63	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T28	T46	2922761
NA	CHEMICAL	GENE-Y	42	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T30	T46	2922761
NA	CHEMICAL	GENE-Y	37	37	Some of these effects are known to be influenced by dietary levels of chemical . We therefore compared the toxic effects of chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) in male Sprague-Dawley rats maintained on diets containing different levels of chemical . Animals were fed either an NIH-07 diet supplemented with chemical ( 3.1 ppm chemical ) , an NIH-07 diet not supplemented with chemical , or an AIN-076 purified diet devoid of chemical . The chemical had no effect on gene times of animals fed the supplemented diet .	T32	T46	2922761
NA	CHEMICAL	GENE-Y	1	14	When chemical was omitted from the diet , however , chemical-dosed animals had elevated gene times .	T33	T47	2922761
CPR:3	CHEMICAL	GENE-Y	10	14	When chemical was omitted from the diet , however , chemical-dosed animals had elevated gene times .	T34	T47	2922761
NA	CHEMICAL	GENE-Y	0	5	chemical-dosed animals showed no change in gene times .	T35	T48	2922761
CPR:3	CHEMICAL	GENE-Y	3	11	In the high-dose chemical group , there was a twofold increase in gene times but only after prolonged dosing .	T36	T39	2922761
NA	CHEMICAL	GENE-Y	2	11	For all chemical-dosed groups maintained on the purified diet , changes in gene times occured as early as 1 week .	T4	T40	2922761
CPR:3	CHEMICAL	GENE-Y	5	15	The order of effect was chemical greater than chemical greater than chemical , with increases in gene times correlating with increases in hemorrhagic deaths .	T5	T41	2922761
CPR:3	CHEMICAL	GENE-Y	8	15	The order of effect was chemical greater than chemical greater than chemical , with increases in gene times correlating with increases in hemorrhagic deaths .	T6	T41	2922761
CPR:3	CHEMICAL	GENE-Y	11	15	The order of effect was chemical greater than chemical greater than chemical , with increases in gene times correlating with increases in hemorrhagic deaths .	T7	T41	2922761
CPR:4	CHEMICAL	GENE-Y	0	9	chemical and chemical , but not chemical , caused a dose-dependent reduction in plasma gene , an effect that correlated with chemical-induced bone effects .	T11	T42	2922761
CPR:4	CHEMICAL	GENE-Y	2	9	chemical and chemical , but not chemical , caused a dose-dependent reduction in plasma gene , an effect that correlated with chemical-induced bone effects .	T12	T42	2922761
CPR:4	CHEMICAL	GENE-Y	6	9	chemical and chemical , but not chemical , caused a dose-dependent reduction in plasma gene , an effect that correlated with chemical-induced bone effects .	T13	T42	2922761
NA	CHEMICAL	GENE-Y	12	9	chemical and chemical , but not chemical , caused a dose-dependent reduction in plasma gene , an effect that correlated with chemical-induced bone effects .	T14	T42	2922761
CPR:3	CHEMICAL	GENE-N	11	4	In contrast , serum gene was elevated in animals dosed with chemical or chemical but not in those dose with chemical .	T15	T43	2922761
CPR:3	CHEMICAL	GENE-N	13	4	In contrast , serum gene was elevated in animals dosed with chemical or chemical but not in those dose with chemical .	T16	T43	2922761
NA	CHEMICAL	GENE-N	20	4	In contrast , serum gene was elevated in animals dosed with chemical or chemical but not in those dose with chemical .	T17	T43	2922761
CPR:4	CHEMICAL	GENE-Y	5	11	The persistent membrane retention of chemical causes lasting inhibition of chemical transporter function .	T17	T24	15002740
NA	CHEMICAL	GENE-Y	10	11	The persistent membrane retention of chemical causes lasting inhibition of chemical transporter function .	T18	T24	15002740
NA	CHEMICAL	GENE-Y	9	16	The present study examined the potential membrane retention of chemical ( chemical ) following exposures of 293-gene cells to chemical , and its effect on chemical uptake .	T9	T20	15002740
NA	CHEMICAL	GENE-Y	11	16	The present study examined the potential membrane retention of chemical ( chemical ) following exposures of 293-gene cells to chemical , and its effect on chemical uptake .	T12	T20	15002740
NA	CHEMICAL	GENE-Y	11	16	The present study examined the potential membrane retention of chemical ( chemical ) following exposures of 293-gene cells to chemical , and its effect on chemical uptake .	T1	T20	15002740
NA	CHEMICAL	GENE-Y	16	16	The present study examined the potential membrane retention of chemical ( chemical ) following exposures of 293-gene cells to chemical , and its effect on chemical uptake .	T2	T20	15002740
NA	CHEMICAL	GENE-Y	0	10	chemical trapped in membranes was displaceable by the structurally unrelated gene inhibitor , chemical , in a concentration-dependent manner , implying interaction of retained chemical with the gene .	T7	T21	15002740
NA	CHEMICAL	GENE-Y	0	27	chemical trapped in membranes was displaceable by the structurally unrelated gene inhibitor , chemical , in a concentration-dependent manner , implying interaction of retained chemical with the gene .	T7	T22	15002740
CPR:4	CHEMICAL	GENE-Y	2	10	chemical trapped in membranes was displaceable by the structurally unrelated gene inhibitor , chemical , in a concentration-dependent manner , implying interaction of retained chemical with the gene .	T8	T21	15002740
NA	CHEMICAL	GENE-Y	2	27	chemical trapped in membranes was displaceable by the structurally unrelated gene inhibitor , chemical , in a concentration-dependent manner , implying interaction of retained chemical with the gene .	T8	T22	15002740
NA	CHEMICAL	GENE-Y	24	10	chemical trapped in membranes was displaceable by the structurally unrelated gene inhibitor , chemical , in a concentration-dependent manner , implying interaction of retained chemical with the gene .	T10	T21	15002740
NA	CHEMICAL	GENE-Y	24	27	chemical trapped in membranes was displaceable by the structurally unrelated gene inhibitor , chemical , in a concentration-dependent manner , implying interaction of retained chemical with the gene .	T10	T22	15002740
NA	CHEMICAL	GENE-Y	4	21	The results demonstrate that chemical and chemical are persistently retained in cell membranes , at least partly in association with the gene .	T13	T23	15002740
NA	CHEMICAL	GENE-Y	6	21	The results demonstrate that chemical and chemical are persistently retained in cell membranes , at least partly in association with the gene .	T14	T23	15002740
NA	CHEMICAL	GENE-N	1	9	Oligomeric chemical- ( POG- ) peptides , wherein the gene is supported by chemical-terminal capping , exhibit chemical precipitation properties ( O , chemical = chemical ) .	T3	T17	23363425
NA	CHEMICAL	GENE-N	13	9	Oligomeric chemical- ( POG- ) peptides , wherein the gene is supported by chemical-terminal capping , exhibit chemical precipitation properties ( O , chemical = chemical ) .	T10	T17	23363425
NA	CHEMICAL	GENE-N	17	9	Oligomeric chemical- ( POG- ) peptides , wherein the gene is supported by chemical-terminal capping , exhibit chemical precipitation properties ( O , chemical = chemical ) .	T4	T17	23363425
NA	CHEMICAL	GENE-N	23	9	Oligomeric chemical- ( POG- ) peptides , wherein the gene is supported by chemical-terminal capping , exhibit chemical precipitation properties ( O , chemical = chemical ) .	T5	T17	23363425
NA	CHEMICAL	GENE-N	2	9	Oligomeric chemical- ( POG- ) peptides , wherein the gene is supported by chemical-terminal capping , exhibit chemical precipitation properties ( O , chemical = chemical ) .	T6	T17	23363425
NA	CHEMICAL	GENE-N	3	13	As quantified by a molybdate assay , the length of the covalently tethered gene ( number of POG units ) determines the amount of amorphous chemical obtained from chemical solution .	T7	T15	23363425
NA	CHEMICAL	GENE-N	3	13	As quantified by a molybdate assay , the length of the covalently tethered gene ( number of POG units ) determines the amount of amorphous chemical obtained from chemical solution .	T8	T15	23363425
NA	CHEMICAL	GENE-N	13	8	Although lacking charged side chains , the synthetic gene precipitate large quantities of chemical resulting in micrometer-sized spheres of varying surface morphologies as analyzed by scanning electron microscopy .	T9	T16	23363425
NA	CHEMICAL	GENE-N	2	6	Expression and chemical-binding properties of brain gene isoforms .	T9	T40	19029287
NA	CHEMICAL	GENE-N	1	1	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T2	T24	19029287
NA	CHEMICAL	GENE-N	1	3	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T2	T21	19029287
NA	CHEMICAL	GENE-Y	1	2	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T2	T25	19029287
NA	CHEMICAL	GENE-Y	1	2	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T2	T28	19029287
NA	CHEMICAL	GENE-N	11	1	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T8	T24	19029287
NA	CHEMICAL	GENE-N	11	3	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T8	T21	19029287
NA	CHEMICAL	GENE-Y	11	2	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T8	T25	19029287
NA	CHEMICAL	GENE-Y	11	2	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T8	T28	19029287
NA	CHEMICAL	GENE-N	13	1	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T1	T24	19029287
NA	CHEMICAL	GENE-N	13	3	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T1	T21	19029287
NA	CHEMICAL	GENE-Y	13	2	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T1	T25	19029287
NA	CHEMICAL	GENE-Y	13	2	The gene ( gene ) isoforms gene and gene display similar chemical ( chemical ) binding properties and are both expressed in mammalian brain .	T1	T28	19029287
NA	CHEMICAL	GENE-Y	13	7	It is also unknown to what extent gene and gene contribute to L-type-specific chemical binding activity in brain .	T6	T22	19029287
NA	CHEMICAL	GENE-Y	13	9	It is also unknown to what extent gene and gene contribute to L-type-specific chemical binding activity in brain .	T6	T23	19029287
NA	CHEMICAL	GENE-Y	0	3	chemical binding to geneDHP ( -/- ) and gene-DM brains was reduced to 15.1 and 4.4 % of wild type , respectively , indicating that gene accounts for 10.7 % of brain gene .	T7	T34	19029287
NA	CHEMICAL	GENE-N	0	4	chemical binding to geneDHP ( -/- ) and gene-DM brains was reduced to 15.1 and 4.4 % of wild type , respectively , indicating that gene accounts for 10.7 % of brain gene .	T7	T35	19029287
NA	CHEMICAL	GENE-Y	0	4	chemical binding to geneDHP ( -/- ) and gene-DM brains was reduced to 15.1 and 4.4 % of wild type , respectively , indicating that gene accounts for 10.7 % of brain gene .	T7	T36	19029287
NA	CHEMICAL	GENE-N	0	32	chemical binding to geneDHP ( -/- ) and gene-DM brains was reduced to 15.1 and 4.4 % of wild type , respectively , indicating that gene accounts for 10.7 % of brain gene .	T7	T37	19029287
NA	CHEMICAL	GENE-Y	2	5	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T3	T13	19029287
NA	CHEMICAL	GENE-Y	2	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T3	T14	19029287
NA	CHEMICAL	GENE-Y	2	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T3	T15	19029287
NA	CHEMICAL	GENE-Y	2	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T3	T16	19029287
NA	CHEMICAL	GENE-Y	31	5	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T4	T13	19029287
NA	CHEMICAL	GENE-Y	31	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T4	T14	19029287
NA	CHEMICAL	GENE-Y	31	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T4	T15	19029287
NA	CHEMICAL	GENE-Y	31	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T4	T16	19029287
NA	CHEMICAL	GENE-Y	33	5	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T5	T13	19029287
NA	CHEMICAL	GENE-Y	33	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T5	T14	19029287
NA	CHEMICAL	GENE-Y	33	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T5	T15	19029287
NA	CHEMICAL	GENE-Y	33	6	Inhibition of chemical binding to geneDHP ( -/- ) ( predominantly gene ) and wild-type ( predominantly gene ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of chemical and chemical for the gene binding pocket , a finding further confirmed with heterologously expressed channels .	T5	T16	19029287
NA	CHEMICAL	GENE-Y	2	3	Purification of chemical hydroxylase from rat liver .	T14	T18	10709635
NA	CHEMICAL	GENE-Y	0	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T1	T15	10709635
CPR:9	CHEMICAL	GENE-Y	6	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T10	T15	10709635
CPR:9	CHEMICAL	GENE-Y	6	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T12	T15	10709635
CPR:9	CHEMICAL	GENE-Y	6	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T2	T15	10709635
NA	CHEMICAL	GENE-Y	21	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T3	T15	10709635
NA	CHEMICAL	GENE-Y	17	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T4	T15	10709635
NA	CHEMICAL	GENE-Y	17	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T5	T15	10709635
NA	CHEMICAL	GENE-Y	27	1	chemical hydroxylase catalyse the last step in chemical biosynthesis , the formation of chemical from chemical , a reaction dependent on chemical , chemical , chemical and chemical .	T6	T15	10709635
NA	CHEMICAL	GENE-Y	11	12	Initial attempts to purify the protein from rat liver showed that chemical hydroxylase is unstable .	T7	T16	10709635
NA	CHEMICAL	GENE-Y	14	15	We , therefore , determined the influence of various compounds on the stability of chemical hydroxylase at different storage temperatures .	T8	T17	10709635
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T22	T26	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T22	T27	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T22	T28	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T22	T30	2347042
NA	CHEMICAL	GENE-Y	23	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T23	T26	2347042
NA	CHEMICAL	GENE-Y	23	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T23	T27	2347042
NA	CHEMICAL	GENE-Y	23	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T23	T28	2347042
NA	CHEMICAL	GENE-Y	23	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T23	T30	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T1	T26	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T1	T27	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T1	T28	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T1	T30	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T2	T26	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T2	T27	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T2	T28	2347042
NA	CHEMICAL	GENE-Y	21	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T2	T30	2347042
NA	CHEMICAL	GENE-Y	56	88	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T3	T29	2347042
NA	CHEMICAL	GENE-Y	60	88	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T4	T29	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T5	T26	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T5	T27	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T5	T28	2347042
NA	CHEMICAL	GENE-Y	24	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T5	T30	2347042
NA	CHEMICAL	GENE-Y	2	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T7	T26	2347042
NA	CHEMICAL	GENE-Y	2	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T7	T27	2347042
NA	CHEMICAL	GENE-Y	2	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T7	T28	2347042
NA	CHEMICAL	GENE-Y	2	2	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T7	T30	2347042
NA	CHEMICAL	GENE-Y	90	88	At 6 h after injection of the compound ( 400 mg/kg ) into rats bearing hepatoma 3924A , the pools of chemical and chemical in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of chemical-requiring enzymes of chemical biosynthesis , gene , chemical synthase , and chemical synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of chemical biosynthetic enzymes , chemical synthase II and chemical synthase .	T8	T29	2347042
CPR:6	CHEMICAL	GENE-Y	0	10	chemical : a selective chemical type 1 ( AT1 ) receptor antagonist for the treatment of heart failure .	T17	T27	15991937
NA	CHEMICAL	GENE-Y	4	10	chemical : a selective chemical type 1 ( AT1 ) receptor antagonist for the treatment of heart failure .	T18	T27	15991937
CPR:6	CHEMICAL	GENE-Y	0	27	chemical ( chemical ) is the prototype of a new class of potent and selective chemical ( chemical ) type 1 ( AT ( 1 ) ) receptor antagonists with the largest published preclinical and clinical data base .	T1	T25	15991937
CPR:6	CHEMICAL	GENE-Y	2	27	chemical ( chemical ) is the prototype of a new class of potent and selective chemical ( chemical ) type 1 ( AT ( 1 ) ) receptor antagonists with the largest published preclinical and clinical data base .	T2	T25	15991937
NA	CHEMICAL	GENE-Y	15	27	chemical ( chemical ) is the prototype of a new class of potent and selective chemical ( chemical ) type 1 ( AT ( 1 ) ) receptor antagonists with the largest published preclinical and clinical data base .	T15	T25	15991937
NA	CHEMICAL	GENE-Y	17	27	chemical ( chemical ) is the prototype of a new class of potent and selective chemical ( chemical ) type 1 ( AT ( 1 ) ) receptor antagonists with the largest published preclinical and clinical data base .	T16	T25	15991937
NA	CHEMICAL	GENE-Y	4	10	Since all of the chemical antagonists are selective for the gene , these drugs should exhibit similar cardiovascular effects .	T12	T22	15991937
NA	CHEMICAL	GENE-Y	0	11	chemical ( parent compound ) , has moderate affinity for the gene ( competitive inhibition ) .	T13	T24	15991937
CPR:4	CHEMICAL	GENE-Y	0	18	chemical is well-absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite ( designated E3174 ) with an affinity 20- to 30-times greater for the gene ( non-competitive inhibition ) .	T14	T26	15991937
CPR:4	CHEMICAL	GENE-Y	12	2	Clinical experience in heart failure is growing , and recent data suggest an improved survival with chemical versus chemical , a drug from the chemical-converting-enzyme inhibitor class with proven benefit in this population .	T3	T19	15991937
CPR:4	CHEMICAL	GENE-Y	18	2	Clinical experience in heart failure is growing , and recent data suggest an improved survival with chemical versus chemical , a drug from the chemical-converting-enzyme inhibitor class with proven benefit in this population .	T4	T19	15991937
NA	CHEMICAL	GENE-Y	2	2	Clinical experience in heart failure is growing , and recent data suggest an improved survival with chemical versus chemical , a drug from the chemical-converting-enzyme inhibitor class with proven benefit in this population .	T5	T19	15991937
CPR:4	CHEMICAL	GENE-Y	14	14	Blood pressure was increased in rats exposed to IH , and treatment with the gene inhibitor chemical [ chemical ] ( 33 mg/day ) lowered blood pressure in IH but not sham group rats .	T1	T10	23093023
CPR:4	CHEMICAL	GENE-Y	4	14	Blood pressure was increased in rats exposed to IH , and treatment with the gene inhibitor chemical [ chemical ] ( 33 mg/day ) lowered blood pressure in IH but not sham group rats .	T2	T10	23093023
CPR:5	CHEMICAL	GENE-Y	10	22	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T17	T32	9211565
CPR:5	CHEMICAL	GENE-N	10	24	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T17	T33	9211565
CPR:6	CHEMICAL	GENE-N	10	27	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T17	T34	9211565
CPR:5	CHEMICAL	GENE-Y	12	22	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T21	T32	9211565
CPR:5	CHEMICAL	GENE-N	12	24	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T21	T33	9211565
CPR:6	CHEMICAL	GENE-N	12	27	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T21	T34	9211565
CPR:5	CHEMICAL	GENE-Y	10	22	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T1	T32	9211565
CPR:5	CHEMICAL	GENE-N	10	24	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T1	T33	9211565
CPR:6	CHEMICAL	GENE-N	10	27	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T1	T34	9211565
NA	CHEMICAL	GENE-Y	15	22	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T5	T32	9211565
NA	CHEMICAL	GENE-N	15	24	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T5	T33	9211565
NA	CHEMICAL	GENE-N	15	27	This study was designed to determine the gastroprotective properties of chemical ( chemical ) , a novel prokinetic chemical derivative agonist of gene and gene receptors and gene antagonist , on mucosal injury produced by 50 % ( v/v ) chemical .	T5	T34	9211565
NA	CHEMICAL	GENE-N	6	20	On the contrary , pretreatment with chemical worsened chemical-induced erosions , however , did not affect gastric mucus secretion , gene content or chemical levels , although the non-protein chemical fraction was significantly decreased .	T20	T35	9211565
NA	CHEMICAL	GENE-N	8	20	On the contrary , pretreatment with chemical worsened chemical-induced erosions , however , did not affect gastric mucus secretion , gene content or chemical levels , although the non-protein chemical fraction was significantly decreased .	T22	T35	9211565
NA	CHEMICAL	GENE-N	23	20	On the contrary , pretreatment with chemical worsened chemical-induced erosions , however , did not affect gastric mucus secretion , gene content or chemical levels , although the non-protein chemical fraction was significantly decreased .	T23	T35	9211565
NA	CHEMICAL	GENE-N	29	20	On the contrary , pretreatment with chemical worsened chemical-induced erosions , however , did not affect gastric mucus secretion , gene content or chemical levels , although the non-protein chemical fraction was significantly decreased .	T24	T35	9211565
NA	CHEMICAL	GENE-N	0	12	chemical is highly bound to plasma proteins and has minimal interaction with gene .	T7	T13	23527529
NA	CHEMICAL	GENE-N	0	8	chemical is not a potent reversible inhibitor of gene ( chemical ) .	T8	T14	23527529
NA	CHEMICAL	GENE-N	10	8	chemical is not a potent reversible inhibitor of gene ( chemical ) .	T9	T14	23527529
NA	CHEMICAL	GENE-N	0	6	chemical is a moderate inhibitor of gene ( chemical ) with KI values of 19 , 16 and 4.5 µM , respectively .	T10	T15	23527529
NA	CHEMICAL	GENE-N	0	6	chemical is a moderate inhibitor of gene ( chemical ) with KI values of 19 , 16 and 4.5 µM , respectively .	T1	T15	23527529
CPR:9	CHEMICAL	GENE-N	0	14	chemical is both a substrate and inhibitor ( IC50 = 1.9 µM ) of gene .	T2	T12	23527529
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( chemical , chemical ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting gene ( gene ) .	T1	T30	15975002
CPR:4	CHEMICAL	GENE-Y	0	20	chemical ( chemical , chemical ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting gene ( gene ) .	T1	T31	15975002
CPR:4	CHEMICAL	GENE-Y	2	18	chemical ( chemical , chemical ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting gene ( gene ) .	T4	T30	15975002
CPR:4	CHEMICAL	GENE-Y	2	20	chemical ( chemical , chemical ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting gene ( gene ) .	T4	T31	15975002
CPR:4	CHEMICAL	GENE-Y	4	18	chemical ( chemical , chemical ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting gene ( gene ) .	T13	T30	15975002
CPR:4	CHEMICAL	GENE-Y	4	20	chemical ( chemical , chemical ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting gene ( gene ) .	T13	T31	15975002
CPR:4	CHEMICAL	GENE-Y	6	15	Early-onset diarrhea is observed immediately after chemical infusion and probably due to the inhibition of gene activity , which can be eliminated by administration of chemical .	T16	T32	15975002
CPR:3	CHEMICAL	GENE-Y	25	15	Early-onset diarrhea is observed immediately after chemical infusion and probably due to the inhibition of gene activity , which can be eliminated by administration of chemical .	T17	T32	15975002
NA	CHEMICAL	GENE-Y	10	26	Late-onset diarrhea appears to be associated with intestinal exposure to chemical ( chemical ) , the major active metabolite of chemical , which may bind to gene and induce apoptosis of intestinal epithelia , leading to the disturbance in the absorptive and secretory functions of mucosa .	T18	T22	15975002
NA	CHEMICAL	GENE-Y	3	26	Late-onset diarrhea appears to be associated with intestinal exposure to chemical ( chemical ) , the major active metabolite of chemical , which may bind to gene and induce apoptosis of intestinal epithelia , leading to the disturbance in the absorptive and secretory functions of mucosa .	T19	T22	15975002
NA	CHEMICAL	GENE-Y	20	26	Late-onset diarrhea appears to be associated with intestinal exposure to chemical ( chemical ) , the major active metabolite of chemical , which may bind to gene and induce apoptosis of intestinal epithelia , leading to the disturbance in the absorptive and secretory functions of mucosa .	T20	T22	15975002
CPR:3	CHEMICAL	GENE-N	0	10	chemical and chemical may also stimulate the production of pro-inflammatory gene and chemical ( chemical ) , thus inducing the secretion of chemical and chemical .	T2	T23	15975002
CPR:3	CHEMICAL	GENE-N	2	10	chemical and chemical may also stimulate the production of pro-inflammatory gene and chemical ( chemical ) , thus inducing the secretion of chemical and chemical .	T3	T23	15975002
NA	CHEMICAL	GENE-N	1	10	chemical and chemical may also stimulate the production of pro-inflammatory gene and chemical ( chemical ) , thus inducing the secretion of chemical and chemical .	T5	T23	15975002
NA	CHEMICAL	GENE-N	14	10	chemical and chemical may also stimulate the production of pro-inflammatory gene and chemical ( chemical ) , thus inducing the secretion of chemical and chemical .	T6	T23	15975002
NA	CHEMICAL	GENE-N	13	10	chemical and chemical may also stimulate the production of pro-inflammatory gene and chemical ( chemical ) , thus inducing the secretion of chemical and chemical .	T7	T23	15975002
NA	CHEMICAL	GENE-N	13	10	chemical and chemical may also stimulate the production of pro-inflammatory gene and chemical ( chemical ) , thus inducing the secretion of chemical and chemical .	T8	T23	15975002
NA	CHEMICAL	GENE-N	36	12	These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , gene ( gene ) inhibitors , gene ( gene ) inhibitors , gene ( gene ) inhibitors , or blockers of biliary excretion of chemical .	T10	T24	15975002
NA	CHEMICAL	GENE-N	36	14	These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , gene ( gene ) inhibitors , gene ( gene ) inhibitors , gene ( gene ) inhibitors , or blockers of biliary excretion of chemical .	T10	T25	15975002
NA	CHEMICAL	GENE-Y	36	18	These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , gene ( gene ) inhibitors , gene ( gene ) inhibitors , gene ( gene ) inhibitors , or blockers of biliary excretion of chemical .	T10	T26	15975002
NA	CHEMICAL	GENE-Y	36	20	These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , gene ( gene ) inhibitors , gene ( gene ) inhibitors , gene ( gene ) inhibitors , or blockers of biliary excretion of chemical .	T10	T27	15975002
NA	CHEMICAL	GENE-Y	36	24	These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , gene ( gene ) inhibitors , gene ( gene ) inhibitors , gene ( gene ) inhibitors , or blockers of biliary excretion of chemical .	T10	T28	15975002
NA	CHEMICAL	GENE-Y	36	26	These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , gene ( gene ) inhibitors , gene ( gene ) inhibitors , gene ( gene ) inhibitors , or blockers of biliary excretion of chemical .	T10	T29	15975002
NA	CHEMICAL	GENE-Y	7	4	Beta 2- but not gene are involved in chemical enhancement of aggressive behavior in long-term isolated mice .	T10	T18	7816863
NA	CHEMICAL	GENE-N	8	4	The effects of several gene antagonists on the chemical-induced increase in aggressive behavior in long-term isolated mice were examined .	T6	T13	7816863
CPR:6	CHEMICAL	GENE-N	3	9	Intraperitoneal administration of chemical ( 2.5-10 mg/kg ) , a nonselective gene antagonist , dose dependently attenuated the chemical-induced enhancement of aggressive behavior without significantly affecting the basal aggressive responses .	T4	T14	7816863
NA	CHEMICAL	GENE-N	9	9	Intraperitoneal administration of chemical ( 2.5-10 mg/kg ) , a nonselective gene antagonist , dose dependently attenuated the chemical-induced enhancement of aggressive behavior without significantly affecting the basal aggressive responses .	T5	T14	7816863
CPR:6	CHEMICAL	GENE-Y	0	8	chemical ( 1.25-5 mg/kg , IP ) , a selective gene antagonist , also blocked the desipramine-induced enhancement of aggressive behavior in a dose-dependent manner , whereas chemical ( 5-20 mg/kg , IP ) , a selective gene antagonist , did not affect it .	T7	T15	7816863
NA	CHEMICAL	GENE-Y	0	8	chemical ( 1.25-5 mg/kg , IP ) , a selective gene antagonist , also blocked the desipramine-induced enhancement of aggressive behavior in a dose-dependent manner , whereas chemical ( 5-20 mg/kg , IP ) , a selective gene antagonist , did not affect it .	T7	T16	7816863
NA	CHEMICAL	GENE-Y	8	8	chemical ( 1.25-5 mg/kg , IP ) , a selective gene antagonist , also blocked the desipramine-induced enhancement of aggressive behavior in a dose-dependent manner , whereas chemical ( 5-20 mg/kg , IP ) , a selective gene antagonist , did not affect it .	T8	T15	7816863
CPR:6	CHEMICAL	GENE-Y	8	8	chemical ( 1.25-5 mg/kg , IP ) , a selective gene antagonist , also blocked the desipramine-induced enhancement of aggressive behavior in a dose-dependent manner , whereas chemical ( 5-20 mg/kg , IP ) , a selective gene antagonist , did not affect it .	T8	T16	7816863
CPR:5	CHEMICAL	GENE-Y	2	10	Moreover , chemical ( 0.1-0.5 mg/kg , IP ) , a lipophilic gene agonist , significantly increased the duration of basal aggressive behavior .	T9	T17	7816863
CPR:4	CHEMICAL	GENE-Y	4	2	The selective gene inhibitor chemical ( chemical ) inhibits B cell signaling and function in vitro and in vivo and augments the activity of chemical in chronic lymphocytic leukemia .	T10	T27	23220742
CPR:4	CHEMICAL	GENE-Y	6	2	The selective gene inhibitor chemical ( chemical ) inhibits B cell signaling and function in vitro and in vivo and augments the activity of chemical in chronic lymphocytic leukemia .	T11	T27	23220742
NA	CHEMICAL	GENE-Y	14	2	The selective gene inhibitor chemical ( chemical ) inhibits B cell signaling and function in vitro and in vivo and augments the activity of chemical in chronic lymphocytic leukemia .	T9	T27	23220742
CPR:4	CHEMICAL	GENE-Y	0	19	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T2	T18	23220742
CPR:4	CHEMICAL	GENE-Y	0	22	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T2	T19	23220742
CPR:4	CHEMICAL	GENE-Y	0	32	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T2	T20	23220742
NA	CHEMICAL	GENE-N	0	4	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T2	T22	23220742
CPR:4	CHEMICAL	GENE-Y	5	19	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T3	T18	23220742
CPR:4	CHEMICAL	GENE-Y	5	22	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T3	T19	23220742
CPR:4	CHEMICAL	GENE-Y	5	32	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T3	T20	23220742
NA	CHEMICAL	GENE-N	5	4	chemical ( also known as chemical ) is a novel , highly selective , and orally bioavailable small molecule gene inhibitor ( gene IC ( 50 ) = 1 nM ) with anti-gene activity that is at least 80-fold greater than its affinity for other gene .	T3	T22	23220742
CPR:4	CHEMICAL	GENE-Y	0	3	chemical successfully inhibited gene-mediated gene signaling and decreased cell viability in NHL and CLL .	T6	T23	23220742
CPR:4	CHEMICAL	GENE-N	0	4	chemical successfully inhibited gene-mediated gene signaling and decreased cell viability in NHL and CLL .	T6	T24	23220742
NA	CHEMICAL	GENE-Y	0	3	chemical binding to gene transfected membranes : a potential high throughput preclinical screen .	T16	T19	11698075
NA	CHEMICAL	GENE-Y	3	21	The pharmacological characteristics of chemical binding were examined in membranes prepared from human embryonic kidney ( HEK293 ) cells stably expressing gene .	T8	T17	11698075
NA	CHEMICAL	GENE-Y	21	21	The pharmacological characteristics of chemical binding were examined in membranes prepared from human embryonic kidney ( HEK293 ) cells stably expressing gene .	T1	T17	11698075
NA	CHEMICAL	GENE-Y	22	2	More robust gene secretion and microparticle generation with gene-AP was attributable to stronger and more sustained phosphorylation of myosin light chain at chemical 19 and chemical 18 .	T1	T27	23307185
NA	CHEMICAL	GENE-Y	22	8	More robust gene secretion and microparticle generation with gene-AP was attributable to stronger and more sustained phosphorylation of myosin light chain at chemical 19 and chemical 18 .	T1	T29	23307185
NA	CHEMICAL	GENE-Y	2	2	More robust gene secretion and microparticle generation with gene-AP was attributable to stronger and more sustained phosphorylation of myosin light chain at chemical 19 and chemical 18 .	T2	T27	23307185
NA	CHEMICAL	GENE-Y	2	8	More robust gene secretion and microparticle generation with gene-AP was attributable to stronger and more sustained phosphorylation of myosin light chain at chemical 19 and chemical 18 .	T2	T29	23307185
NA	CHEMICAL	GENE-N	5	9	The main molecular target of chemical antifungals is the gene protein gene/gene .	T4	T35	16964330
NA	CHEMICAL	GENE-N	5	11	The main molecular target of chemical antifungals is the gene protein gene/gene .	T4	T36	16964330
NA	CHEMICAL	GENE-N	5	11	The main molecular target of chemical antifungals is the gene protein gene/gene .	T4	T37	16964330
NA	CHEMICAL	GENE-N	1	22	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T5	T38	16964330
NA	CHEMICAL	GENE-N	1	24	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T5	T39	16964330
NA	CHEMICAL	GENE-N	1	27	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T5	T40	16964330
NA	CHEMICAL	GENE-N	1	6	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T5	T41	16964330
NA	CHEMICAL	GENE-N	5	22	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T6	T38	16964330
NA	CHEMICAL	GENE-N	5	24	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T6	T39	16964330
NA	CHEMICAL	GENE-N	5	27	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T6	T40	16964330
NA	CHEMICAL	GENE-N	5	6	The chemical , of which chemical is the sole representative in human therapy , affect two targets in the ergosterol pathway : gene ( gene ) and gene ( gene ) .	T6	T41	16964330
CPR:4	CHEMICAL	GENE-N	1	14	The chemical group are protein synthesis inhibitors that work by blocking the function of gene .	T7	T42	16964330
CPR:9	CHEMICAL	GENE-Y	5	4	DNA damage is accepted as a consequence of chemical deprivation induced by chemotherapeutic inhibitors of chemical synthase ( gene ) , but the types of damage and signaling responses remain incompletely understood .	T13	T19	18773878
CPR:9	CHEMICAL	GENE-Y	5	18	DNA damage is accepted as a consequence of chemical deprivation induced by chemotherapeutic inhibitors of chemical synthase ( gene ) , but the types of damage and signaling responses remain incompletely understood .	T13	T22	18773878
NA	CHEMICAL	GENE-Y	5	4	DNA damage is accepted as a consequence of chemical deprivation induced by chemotherapeutic inhibitors of chemical synthase ( gene ) , but the types of damage and signaling responses remain incompletely understood .	T2	T19	18773878
NA	CHEMICAL	GENE-Y	5	18	DNA damage is accepted as a consequence of chemical deprivation induced by chemotherapeutic inhibitors of chemical synthase ( gene ) , but the types of damage and signaling responses remain incompletely understood .	T2	T22	18773878
NA	CHEMICAL	GENE-Y	5	1	When gene , which is a central component of HR , was depleted by siRNA cells were sensitized to chemical ( chemical ) , which specifically inhibits gene .	T15	T28	18773878
NA	CHEMICAL	GENE-Y	5	27	When gene , which is a central component of HR , was depleted by siRNA cells were sensitized to chemical ( chemical ) , which specifically inhibits gene .	T15	T29	18773878
NA	CHEMICAL	GENE-Y	21	1	When gene , which is a central component of HR , was depleted by siRNA cells were sensitized to chemical ( chemical ) , which specifically inhibits gene .	T16	T28	18773878
CPR:4	CHEMICAL	GENE-Y	21	27	When gene , which is a central component of HR , was depleted by siRNA cells were sensitized to chemical ( chemical ) , which specifically inhibits gene .	T16	T29	18773878
NA	CHEMICAL	GENE-Y	15	15	To our knowledge , this is the first demonstration in mammalian cells that depletion of gene causes sensitivity to chemical deprivation .	T1	T18	18773878
NA	CHEMICAL	GENE-N	22	2	Phosphorylation of gene ( gene subunit ) and formation of damage-induced foci were strikingly evident following IC ( 50 ) doses of chemical .	T4	T20	18773878
NA	CHEMICAL	GENE-Y	22	4	Phosphorylation of gene ( gene subunit ) and formation of damage-induced foci were strikingly evident following IC ( 50 ) doses of chemical .	T4	T21	18773878
CPR:3	CHEMICAL	GENE-Y	0	6	chemical treatment also induced foci of gene , gene , gene , and gene , although the extent of co-localization with gene foci varied .	T7	T23	18773878
CPR:3	CHEMICAL	GENE-Y	0	8	chemical treatment also induced foci of gene , gene , gene , and gene , although the extent of co-localization with gene foci varied .	T7	T24	18773878
CPR:3	CHEMICAL	GENE-Y	0	10	chemical treatment also induced foci of gene , gene , gene , and gene , although the extent of co-localization with gene foci varied .	T7	T25	18773878
CPR:3	CHEMICAL	GENE-Y	0	13	chemical treatment also induced foci of gene , gene , gene , and gene , although the extent of co-localization with gene foci varied .	T7	T26	18773878
NA	CHEMICAL	GENE-Y	0	21	chemical treatment also induced foci of gene , gene , gene , and gene , although the extent of co-localization with gene foci varied .	T7	T27	18773878
NA	CHEMICAL	GENE-Y	39	14	Since pathologies are often related to inflammation , an inflammatory HUVEC culture condition with gene stimulation has been introduced and suggested to be widely applied for studying nanocarriers , since cellular uptake in this assay was clearly increased for chemical contents ⩾20mol. % .	T1	T9	23429231
CPR:4	CHEMICAL	GENE-Y	8	6	Structural basis of inhibition of the gene by chemical .	T9	T16	17355872
NA	CHEMICAL	GENE-Y	2	9	We identified chemical as a compound that binds to gene and showed that it inhibits gene activity with an IC ( 50 ) value of 22 microM .	T2	T12	17355872
CPR:4	CHEMICAL	GENE-Y	2	3	We identified chemical as a compound that binds to gene and showed that it inhibits gene activity with an IC ( 50 ) value of 22 microM .	T2	T13	17355872
NA	CHEMICAL	GENE-Y	20	9	We identified chemical as a compound that binds to gene and showed that it inhibits gene activity with an IC ( 50 ) value of 22 microM .	T3	T12	17355872
NA	CHEMICAL	GENE-Y	20	3	We identified chemical as a compound that binds to gene and showed that it inhibits gene activity with an IC ( 50 ) value of 22 microM .	T3	T13	17355872
NA	CHEMICAL	GENE-Y	24	18	To provide insights into how sirtuin function is altered by inhibitors , we determined two crystal structures of gene , one in complex with chemical-ribose , the other bound to chemical .	T4	T14	17355872
NA	CHEMICAL	GENE-Y	21	18	To provide insights into how sirtuin function is altered by inhibitors , we determined two crystal structures of gene , one in complex with chemical-ribose , the other bound to chemical .	T5	T14	17355872
NA	CHEMICAL	GENE-N	14	5	As the RTH mutant , gene , was new , the optimum dose of chemical was unclear .	T6	T28	20615127
NA	CHEMICAL	GENE-N	14	22	SUMMARY : The patient was a newborn female having severe hypothyroidism with a free chemical level of 0.36 ng/dL and a serum gene level of 177 microU/mL .	T7	T33	20615127
NA	CHEMICAL	GENE-N	2	15	Supplementation with chemical at a dose of > 350 microg/day did not normalize the serum gene level ; however , the patient showed normal growth and intelligence at 14 years of age .	T8	T34	20615127
NA	CHEMICAL	GENE-N	2	10	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T1	T15	20615127
NA	CHEMICAL	GENE-Y	2	12	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T1	T16	20615127
NA	CHEMICAL	GENE-N	3	10	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T2	T15	20615127
NA	CHEMICAL	GENE-Y	3	12	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T2	T16	20615127
NA	CHEMICAL	GENE-N	25	10	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T3	T15	20615127
NA	CHEMICAL	GENE-Y	25	12	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T3	T16	20615127
NA	CHEMICAL	GENE-N	17	10	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T4	T15	20615127
NA	CHEMICAL	GENE-Y	17	12	However , a chemical-chemical-transferase pull-down assay showed reduced binding of gene with gene in the absence of chemical and impaired release in the presence of chemical .	T4	T16	20615127
CPR:4	CHEMICAL	GENE-N	3	5	Comprehensive review of chemical , a second-generation chemical oxidase inhibitor , for the treatment of Parkinson 's disease .	T26	T36	18035186
NA	CHEMICAL	GENE-N	5	5	Comprehensive review of chemical , a second-generation chemical oxidase inhibitor , for the treatment of Parkinson 's disease .	T27	T36	18035186
NA	CHEMICAL	GENE-N	4	5	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T16	T29	18035186
NA	CHEMICAL	GENE-N	4	7	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T16	T32	18035186
NA	CHEMICAL	GENE-Y	4	14	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T16	T34	18035186
NA	CHEMICAL	GENE-Y	4	16	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T16	T35	18035186
NA	CHEMICAL	GENE-N	29	5	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T8	T29	18035186
NA	CHEMICAL	GENE-N	29	7	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T8	T32	18035186
NA	CHEMICAL	GENE-Y	29	14	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T8	T34	18035186
NA	CHEMICAL	GENE-Y	29	16	BACKGROUND : Inhibitors of chemical oxidase ( gene ) with selectivity and specificity for gene ( gene ) prolong the duration of action of both endogenously and exogenously derived chemical .	T8	T35	18035186
CPR:4	CHEMICAL	GENE-Y	0	15	chemical [ chemical ] is a second-generation chemical pharmacophore that selectively and irreversibly inhibits brain gene and is specifically designed for the treatment of Parkinson 's disease ( PD ) .	T9	T31	18035186
CPR:4	CHEMICAL	GENE-Y	2	15	chemical [ chemical ] is a second-generation chemical pharmacophore that selectively and irreversibly inhibits brain gene and is specifically designed for the treatment of Parkinson 's disease ( PD ) .	T10	T31	18035186
CPR:4	CHEMICAL	GENE-Y	5	15	chemical [ chemical ] is a second-generation chemical pharmacophore that selectively and irreversibly inhibits brain gene and is specifically designed for the treatment of Parkinson 's disease ( PD ) .	T14	T31	18035186
NA	CHEMICAL	GENE-N	4	5	The search terms were chemical oxidase , neuroprotection , Parkinson disease , chemical , chemical , and chemical .	T22	T33	18035186
NA	CHEMICAL	GENE-N	12	5	The search terms were chemical oxidase , neuroprotection , Parkinson disease , chemical , chemical , and chemical .	T23	T33	18035186
NA	CHEMICAL	GENE-N	14	5	The search terms were chemical oxidase , neuroprotection , Parkinson disease , chemical , chemical , and chemical .	T24	T33	18035186
NA	CHEMICAL	GENE-N	17	5	The search terms were chemical oxidase , neuroprotection , Parkinson disease , chemical , chemical , and chemical .	T25	T33	18035186
CPR:4	CHEMICAL	GENE-Y	11	39	Based on the results from those studies , we concluded that chemical PO QD , at the therapeutic dosage range of 0.5 to 1 rag/d , is effective and well tolerated and completely , selectively , and specifically inhibited gene .	T2	T28	18035186
NA	CHEMICAL	GENE-Y	4	17	In experimental models , chemical has been found to have neuroprotective properties that may be independent of gene inhibition .	T19	T30	18035186
CPR:4	CHEMICAL	GENE-Y	0	2	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T2	T8	22931533
CPR:4	CHEMICAL	GENE-Y	0	8	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T2	T9	22931533
NA	CHEMICAL	GENE-N	0	16	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T2	T10	22931533
NA	CHEMICAL	GENE-N	0	18	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T2	T11	22931533
NA	CHEMICAL	GENE-Y	2	2	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T3	T8	22931533
NA	CHEMICAL	GENE-Y	2	8	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T3	T9	22931533
NA	CHEMICAL	GENE-N	2	16	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T3	T10	22931533
NA	CHEMICAL	GENE-N	2	18	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T3	T11	22931533
NA	CHEMICAL	GENE-Y	2	2	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T4	T8	22931533
NA	CHEMICAL	GENE-Y	2	8	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T4	T9	22931533
NA	CHEMICAL	GENE-N	2	16	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T4	T10	22931533
NA	CHEMICAL	GENE-N	2	18	chemical is a reversible , competitive gene ( gene ) inhibitor and allosteric potentiating ligand of gene ( gene-APL ) that shares many common structural elements with chemical-based opioids .	T4	T11	22931533
CPR:4	CHEMICAL	GENE-N	0	5	chemical inhibits chemical production and gene via gene expression in RAW264.7 macrophages stimulated with lipopolysaccharide .	T36	T68	16781459
NA	CHEMICAL	GENE-Y	0	7	chemical inhibits chemical production and gene via gene expression in RAW264.7 macrophages stimulated with lipopolysaccharide .	T36	T69	16781459
NA	CHEMICAL	GENE-N	2	5	chemical inhibits chemical production and gene via gene expression in RAW264.7 macrophages stimulated with lipopolysaccharide .	T37	T68	16781459
NA	CHEMICAL	GENE-Y	2	7	chemical inhibits chemical production and gene via gene expression in RAW264.7 macrophages stimulated with lipopolysaccharide .	T37	T69	16781459
CPR:9	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T1	T67	16781459
CPR:9	CHEMICAL	GENE-Y	0	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T1	T42	16781459
CPR:9	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T1	T46	16781459
CPR:9	CHEMICAL	GENE-Y	0	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T1	T50	16781459
CPR:9	CHEMICAL	GENE-Y	1	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T16	T67	16781459
CPR:9	CHEMICAL	GENE-Y	1	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T16	T42	16781459
CPR:9	CHEMICAL	GENE-Y	1	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T16	T46	16781459
CPR:9	CHEMICAL	GENE-Y	1	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T16	T50	16781459
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T33	T67	16781459
NA	CHEMICAL	GENE-Y	5	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T33	T42	16781459
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T33	T46	16781459
NA	CHEMICAL	GENE-Y	5	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T33	T50	16781459
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T5	T67	16781459
NA	CHEMICAL	GENE-Y	5	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T5	T42	16781459
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T5	T46	16781459
NA	CHEMICAL	GENE-Y	5	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T5	T50	16781459
CPR:9	CHEMICAL	GENE-Y	26	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T10	T67	16781459
CPR:9	CHEMICAL	GENE-Y	26	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T10	T42	16781459
CPR:9	CHEMICAL	GENE-Y	26	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T10	T46	16781459
CPR:9	CHEMICAL	GENE-Y	26	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T10	T50	16781459
CPR:9	CHEMICAL	GENE-Y	28	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T15	T67	16781459
CPR:9	CHEMICAL	GENE-Y	28	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T15	T42	16781459
CPR:9	CHEMICAL	GENE-Y	28	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T15	T46	16781459
CPR:9	CHEMICAL	GENE-Y	28	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T15	T50	16781459
NA	CHEMICAL	GENE-Y	41	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T20	T67	16781459
NA	CHEMICAL	GENE-Y	41	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T20	T42	16781459
NA	CHEMICAL	GENE-Y	41	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T20	T46	16781459
NA	CHEMICAL	GENE-Y	41	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T20	T50	16781459
NA	CHEMICAL	GENE-Y	43	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T21	T67	16781459
NA	CHEMICAL	GENE-Y	43	17	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T21	T42	16781459
NA	CHEMICAL	GENE-Y	43	5	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T21	T46	16781459
NA	CHEMICAL	GENE-Y	43	23	chemical ( chemical ) , a regulatory gaseous molecule that is endogenously synthesized by chemical gamma-lyase ( gene ) and/or chemical beta-synthase ( gene ) from chemical ( chemical ) metabolism , is a putative vasodilator , and its role in chemical ( chemical ) production is unexplored .	T21	T50	16781459
CPR:4	CHEMICAL	GENE-Y	9	17	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T22	T58	16781459
NA	CHEMICAL	GENE-N	9	23	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T22	T60	16781459
NA	CHEMICAL	GENE-Y	9	25	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T22	T61	16781459
CPR:9	CHEMICAL	GENE-Y	14	17	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T23	T58	16781459
NA	CHEMICAL	GENE-N	14	23	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T23	T60	16781459
NA	CHEMICAL	GENE-Y	14	25	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T23	T61	16781459
NA	CHEMICAL	GENE-Y	19	17	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T24	T58	16781459
NA	CHEMICAL	GENE-N	19	23	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T24	T60	16781459
NA	CHEMICAL	GENE-Y	19	25	Here , we show that at noncytotoxic concentrations , chemical was able to inhibit chemical production and gene ( ichemicalS ) expression via gene ( gene ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .	T24	T61	16781459
CPR:3	CHEMICAL	GENE-Y	1	19	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T25	T62	16781459
CPR:3	CHEMICAL	GENE-N	1	12	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T25	T63	16781459
CPR:3	CHEMICAL	GENE-N	1	28	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T25	T64	16781459
NA	CHEMICAL	GENE-Y	7	19	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T26	T62	16781459
NA	CHEMICAL	GENE-N	7	12	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T26	T63	16781459
NA	CHEMICAL	GENE-N	7	28	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T26	T64	16781459
NA	CHEMICAL	GENE-Y	10	19	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T27	T62	16781459
NA	CHEMICAL	GENE-N	10	12	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T27	T63	16781459
NA	CHEMICAL	GENE-N	10	28	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T27	T64	16781459
NA	CHEMICAL	GENE-Y	13	19	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T28	T62	16781459
NA	CHEMICAL	GENE-N	13	12	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T28	T63	16781459
NA	CHEMICAL	GENE-N	13	28	Both chemical solution prepared by bubbling pure chemical gas and chemical , a chemical donor , dose dependently induced gene expression through the activation of the gene ( gene ) .	T28	T64	16781459
CPR:4	CHEMICAL	GENE-Y	2	8	Pretreatment with chemical or chemical significantly inhibited LPS-induced gene expression and chemical production .	T29	T65	16781459
CPR:4	CHEMICAL	GENE-Y	4	8	Pretreatment with chemical or chemical significantly inhibited LPS-induced gene expression and chemical production .	T30	T65	16781459
CPR:9	CHEMICAL	GENE-Y	11	8	Pretreatment with chemical or chemical significantly inhibited LPS-induced gene expression and chemical production .	T31	T65	16781459
NA	CHEMICAL	GENE-Y	2	10	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T32	T66	16781459
NA	CHEMICAL	GENE-Y	2	31	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T32	T38	16781459
NA	CHEMICAL	GENE-Y	2	38	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T32	T39	16781459
CPR:9	CHEMICAL	GENE-Y	19	10	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T34	T66	16781459
NA	CHEMICAL	GENE-Y	19	31	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T34	T38	16781459
NA	CHEMICAL	GENE-Y	19	38	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T34	T39	16781459
NA	CHEMICAL	GENE-Y	24	10	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T35	T66	16781459
NA	CHEMICAL	GENE-Y	24	31	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T35	T38	16781459
NA	CHEMICAL	GENE-Y	24	38	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T35	T39	16781459
NA	CHEMICAL	GENE-Y	4	10	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T2	T66	16781459
CPR:4	CHEMICAL	GENE-Y	4	31	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T2	T38	16781459
NA	CHEMICAL	GENE-Y	4	38	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T2	T39	16781459
NA	CHEMICAL	GENE-Y	2	10	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T3	T66	16781459
NA	CHEMICAL	GENE-Y	2	31	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T3	T38	16781459
CPR:4	CHEMICAL	GENE-Y	2	38	Moreover , chemical production in LPS-stimulated macrophages that are expressing gene mRNA was significantly reduced by the addition of chemical , a substrate for chemical , but enhanced by the selective gene inhibitor chemical but not by the gene inhibitor chemical .	T3	T39	16781459
NA	CHEMICAL	GENE-Y	4	4	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T40	16781459
NA	CHEMICAL	GENE-Y	4	8	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T41	16781459
NA	CHEMICAL	GENE-Y	4	18	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T43	16781459
NA	CHEMICAL	GENE-Y	4	21	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T44	16781459
CPR:4	CHEMICAL	GENE-Y	4	35	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T45	16781459
NA	CHEMICAL	GENE-Y	4	41	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T47	16781459
NA	CHEMICAL	GENE-N	4	25	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T4	T48	16781459
NA	CHEMICAL	GENE-Y	38	4	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T40	16781459
NA	CHEMICAL	GENE-Y	38	8	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T41	16781459
NA	CHEMICAL	GENE-Y	38	18	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T43	16781459
NA	CHEMICAL	GENE-Y	38	21	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T44	16781459
CPR:9	CHEMICAL	GENE-Y	38	35	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T45	16781459
NA	CHEMICAL	GENE-Y	38	41	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T47	16781459
NA	CHEMICAL	GENE-N	38	25	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T48	16781459
NA	CHEMICAL	GENE-N	38	76	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T6	T49	16781459
NA	CHEMICAL	GENE-Y	25	4	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T40	16781459
NA	CHEMICAL	GENE-Y	25	8	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T41	16781459
NA	CHEMICAL	GENE-Y	25	18	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T43	16781459
NA	CHEMICAL	GENE-Y	25	21	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T44	16781459
NA	CHEMICAL	GENE-Y	25	35	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T45	16781459
NA	CHEMICAL	GENE-Y	25	41	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T47	16781459
NA	CHEMICAL	GENE-N	25	25	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T7	T48	16781459
NA	CHEMICAL	GENE-Y	25	4	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T40	16781459
NA	CHEMICAL	GENE-Y	25	8	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T41	16781459
NA	CHEMICAL	GENE-Y	25	18	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T43	16781459
NA	CHEMICAL	GENE-Y	25	21	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T44	16781459
NA	CHEMICAL	GENE-Y	25	35	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T45	16781459
NA	CHEMICAL	GENE-Y	25	41	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T47	16781459
CPR:4	CHEMICAL	GENE-N	25	25	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T8	T48	16781459
NA	CHEMICAL	GENE-Y	25	4	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T40	16781459
NA	CHEMICAL	GENE-Y	25	8	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T41	16781459
NA	CHEMICAL	GENE-Y	25	18	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T43	16781459
NA	CHEMICAL	GENE-Y	25	21	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T44	16781459
NA	CHEMICAL	GENE-Y	25	35	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T45	16781459
NA	CHEMICAL	GENE-Y	25	41	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T47	16781459
NA	CHEMICAL	GENE-N	25	25	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T48	16781459
CPR:4	CHEMICAL	GENE-N	25	76	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T9	T49	16781459
NA	CHEMICAL	GENE-Y	34	4	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T40	16781459
NA	CHEMICAL	GENE-Y	34	8	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T41	16781459
NA	CHEMICAL	GENE-Y	34	18	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T43	16781459
NA	CHEMICAL	GENE-Y	34	21	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T44	16781459
NA	CHEMICAL	GENE-Y	34	35	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T45	16781459
NA	CHEMICAL	GENE-Y	34	41	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T47	16781459
NA	CHEMICAL	GENE-N	34	25	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T48	16781459
CPR:9	CHEMICAL	GENE-Y	34	108	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T11	T53	16781459
NA	CHEMICAL	GENE-N	101	76	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T12	T49	16781459
NA	CHEMICAL	GENE-Y	101	85	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T12	T51	16781459
NA	CHEMICAL	GENE-Y	101	93	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T12	T52	16781459
CPR:9	CHEMICAL	GENE-Y	101	108	While either blockage of gene activity by the gene inhibitor , tin protoporphyrin IX , or down-regulation of gene expression by gene small interfering RNA ( siRNA ) reversed the inhibitory effects of chemical on gene expression and chemical production , gene overexpression produced the same inhibitory effects of chemical . In addition , LPS-induced nuclear factor gene activation was diminished in RAW264.7 macrophages preincubated with chemical . Interestingly , the inhibitory effect of chemical on gene activation was reversed by the transient transfection with gene siRNA , but was mimicked by either gene gene transfection or treatment with chemical ( chemical ) , an end product of gene .	T12	T53	16781459
CPR:4	CHEMICAL	GENE-Y	0	8	chemical treatment also inhibited LPS-induced chemical production and gene expression via its inactivation of gene .	T13	T54	16781459
CPR:4	CHEMICAL	GENE-N	0	14	chemical treatment also inhibited LPS-induced chemical production and gene expression via its inactivation of gene .	T13	T55	16781459
CPR:9	CHEMICAL	GENE-Y	5	8	chemical treatment also inhibited LPS-induced chemical production and gene expression via its inactivation of gene .	T14	T54	16781459
NA	CHEMICAL	GENE-N	5	14	chemical treatment also inhibited LPS-induced chemical production and gene expression via its inactivation of gene .	T14	T55	16781459
NA	CHEMICAL	GENE-Y	3	4	The structures of chemical kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue .	T28	T37	9336833
NA	CHEMICAL	GENE-Y	13	1	chemical kinase from Herpes simplex virus type 1 ( gene ) was crystallized in an chemical-terminally truncated but fully active form .	T1	T29	9336833
NA	CHEMICAL	GENE-Y	13	9	chemical kinase from Herpes simplex virus type 1 ( gene ) was crystallized in an chemical-terminally truncated but fully active form .	T1	T35	9336833
NA	CHEMICAL	GENE-Y	0	1	chemical kinase from Herpes simplex virus type 1 ( gene ) was crystallized in an chemical-terminally truncated but fully active form .	T25	T29	9336833
NA	CHEMICAL	GENE-Y	0	9	chemical kinase from Herpes simplex virus type 1 ( gene ) was crystallized in an chemical-terminally truncated but fully active form .	T25	T35	9336833
NA	CHEMICAL	GENE-Y	6	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T5	T32	9336833
NA	CHEMICAL	GENE-Y	9	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T6	T32	9336833
NA	CHEMICAL	GENE-Y	7	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T7	T32	9336833
NA	CHEMICAL	GENE-Y	13	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T8	T32	9336833
NA	CHEMICAL	GENE-Y	16	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T9	T32	9336833
NA	CHEMICAL	GENE-Y	18	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T10	T32	9336833
NA	CHEMICAL	GENE-Y	7	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T11	T32	9336833
NA	CHEMICAL	GENE-Y	24	3	The structures of gene complexed with chemical at the chemical-site and chemical ( chemical ) , chemical ( chemical ) , or chemical ( chemical ) at the substrate-site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .	T12	T32	9336833
NA	CHEMICAL	GENE-Y	5	0	gene catalyzes the phosphorylation of chemical resulting in an chemical , and the phosphorylation of chemical giving rise to an chemical .	T14	T33	9336833
NA	CHEMICAL	GENE-Y	9	0	gene catalyzes the phosphorylation of chemical resulting in an chemical , and the phosphorylation of chemical giving rise to an chemical .	T15	T33	9336833
NA	CHEMICAL	GENE-Y	15	0	gene catalyzes the phosphorylation of chemical resulting in an chemical , and the phosphorylation of chemical giving rise to an chemical .	T16	T33	9336833
NA	CHEMICAL	GENE-Y	8	0	gene catalyzes the phosphorylation of chemical resulting in an chemical , and the phosphorylation of chemical giving rise to an chemical .	T17	T33	9336833
NA	CHEMICAL	GENE-N	10	10	The existence of multiple affinity states for the opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells has been demonstrated by competition binding studies with chemical and chemical ( chemical ) .	T9	T28	2982865
NA	CHEMICAL	GENE-N	10	10	The existence of multiple affinity states for the opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells has been demonstrated by competition binding studies with chemical and chemical ( chemical ) .	T14	T28	2982865
NA	CHEMICAL	GENE-N	29	10	The existence of multiple affinity states for the opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells has been demonstrated by competition binding studies with chemical and chemical ( chemical ) .	T17	T28	2982865
CPR:4	CHEMICAL	GENE-N	8	18	However , in the presence of 100 mM chemical , which is required for opiate inhibition of chemical cyclase activity , analysis of competition binding data revealed three sites : the first , consisting of 17.5 % of total receptor population has a Kd = 0.38 +/- 0.18 nM ; the second , 50.6 % of the population , has a Kd = 6.8 +/- 2.2 nM ; and the third , 31.9 % of the population , has a Kd of 410 +/- 110 nM .	T22	T29	2982865
NA	CHEMICAL	GENE-N	17	18	However , in the presence of 100 mM chemical , which is required for opiate inhibition of chemical cyclase activity , analysis of competition binding data revealed three sites : the first , consisting of 17.5 % of total receptor population has a Kd = 0.38 +/- 0.18 nM ; the second , 50.6 % of the population , has a Kd = 6.8 +/- 2.2 nM ; and the third , 31.9 % of the population , has a Kd of 410 +/- 110 nM .	T23	T29	2982865
NA	CHEMICAL	GENE-N	18	5	These multiple affinity states of receptor in the hybrid cells are agonist-specific , and the percentage of total gene in high affinity state is relatively constant in various concentrations of chemical .	T2	T26	2982865
NA	CHEMICAL	GENE-N	17	4	Multiple affinity states of gene can be demonstrated further by Scatchard analysis of saturation binding studies with chemical .	T3	T27	2982865
CPR:4	CHEMICAL	GENE-Y	0	7	chemical modulates intercellular adhesion through inhibition of gene .	T15	T29	23146664
NA	CHEMICAL	GENE-N	11	13	Filtering and analysis of data identified three oncogenic pathways interfered by chemical : gene/gene pathway , cell adhesion and gene/gene signaling .	T10	T24	23146664
NA	CHEMICAL	GENE-N	11	13	Filtering and analysis of data identified three oncogenic pathways interfered by chemical : gene/gene pathway , cell adhesion and gene/gene signaling .	T10	T25	23146664
NA	CHEMICAL	GENE-Y	11	19	Filtering and analysis of data identified three oncogenic pathways interfered by chemical : gene/gene pathway , cell adhesion and gene/gene signaling .	T10	T26	23146664
NA	CHEMICAL	GENE-N	11	19	Filtering and analysis of data identified three oncogenic pathways interfered by chemical : gene/gene pathway , cell adhesion and gene/gene signaling .	T10	T27	23146664
NA	CHEMICAL	GENE-Y	7	0	gene emerged as a consensus target of chemical , orchestrating these pathways .	T11	T28	23146664
CPR:3	CHEMICAL	GENE-Y	2	10	Moreover , chemical treatment restored membranous expression of adhesion molecules gene and gene .	T14	T16	23146664
CPR:3	CHEMICAL	GENE-Y	2	12	Moreover , chemical treatment restored membranous expression of adhesion molecules gene and gene .	T14	T17	23146664
CPR:4	CHEMICAL	GENE-Y	11	0	gene expression was elevated in APC ( min ) polyps and chemical treatment reduced its expression .	T3	T20	23146664
NA	CHEMICAL	GENE-Y	7	16	Our data demonstrates novel pharmacological mechanism of chemical in modulation of cell adhesion and role of gene in APC ( min ) polyposis .	T4	T21	23146664
CPR:4	CHEMICAL	GENE-Y	8	5	We propose that inhibition of gene expression by chemical can impede with neoplastic progression in colorectal carcinogenesis .	T5	T22	23146664
NA	CHEMICAL	GENE-N	8	3	Disruption of the gene also affected growth in a gene-defective strain background where mismatch repair is essential , particularly in the presence of the DNA damaging agent chemical ( chemical ) .	T1	T8	23261051
NA	CHEMICAL	GENE-N	8	8	Disruption of the gene also affected growth in a gene-defective strain background where mismatch repair is essential , particularly in the presence of the DNA damaging agent chemical ( chemical ) .	T1	T9	23261051
NA	CHEMICAL	GENE-N	29	3	Disruption of the gene also affected growth in a gene-defective strain background where mismatch repair is essential , particularly in the presence of the DNA damaging agent chemical ( chemical ) .	T2	T8	23261051
NA	CHEMICAL	GENE-N	29	8	Disruption of the gene also affected growth in a gene-defective strain background where mismatch repair is essential , particularly in the presence of the DNA damaging agent chemical ( chemical ) .	T2	T9	23261051
NA	CHEMICAL	GENE-Y	15	6	Promoter replacements conferring constitutive expression of gene revealed that the transcriptional induction in response to chemical is required to maintain induced levels of gene .	T3	T10	23261051
NA	CHEMICAL	GENE-Y	15	23	Promoter replacements conferring constitutive expression of gene revealed that the transcriptional induction in response to chemical is required to maintain induced levels of gene .	T3	T11	23261051
NA	CHEMICAL	GENE-Y	18	20	Gitelman 's variant of Bartter 's syndrome , inherited hypokalemic alkalosis , is caused by mutation in the chemical-sensitive chemical co-transporter ( gene ) .	T1	T7	11456284
NA	CHEMICAL	GENE-Y	18	22	Gitelman 's variant of Bartter 's syndrome , inherited hypokalemic alkalosis , is caused by mutation in the chemical-sensitive chemical co-transporter ( gene ) .	T1	T8	11456284
NA	CHEMICAL	GENE-Y	19	20	Gitelman 's variant of Bartter 's syndrome , inherited hypokalemic alkalosis , is caused by mutation in the chemical-sensitive chemical co-transporter ( gene ) .	T2	T7	11456284
NA	CHEMICAL	GENE-Y	19	22	Gitelman 's variant of Bartter 's syndrome , inherited hypokalemic alkalosis , is caused by mutation in the chemical-sensitive chemical co-transporter ( gene ) .	T2	T8	11456284
NA	CHEMICAL	GENE-N	6	1	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T1	T28	23275442
NA	CHEMICAL	GENE-Y	6	1	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T1	T29	23275442
NA	CHEMICAL	GENE-Y	6	11	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T1	T30	23275442
NA	CHEMICAL	GENE-Y	6	30	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T1	T31	23275442
NA	CHEMICAL	GENE-N	1	1	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T2	T28	23275442
NA	CHEMICAL	GENE-Y	1	1	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T2	T29	23275442
NA	CHEMICAL	GENE-Y	1	11	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T2	T30	23275442
NA	CHEMICAL	GENE-Y	1	30	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T2	T31	23275442
NA	CHEMICAL	GENE-N	11	1	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T3	T28	23275442
NA	CHEMICAL	GENE-Y	11	1	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T3	T29	23275442
NA	CHEMICAL	GENE-Y	11	11	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T3	T30	23275442
NA	CHEMICAL	GENE-Y	11	30	The gene/gene interaction occurred on the chemical and chemical termini of gene ; a single internal deletion from chemical 455 to 466 ( Δ455-466 ) was found to significantly reduce gene protein stability .	T3	T31	23275442
NA	CHEMICAL	GENE-Y	1	1	The gene ( gene ) is a chemical channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death .	T2	T22	23061466
NA	CHEMICAL	GENE-Y	1	3	The gene ( gene ) is a chemical channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death .	T2	T21	23061466
NA	CHEMICAL	GENE-N	1	6	The gene ( gene ) is a chemical channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death .	T2	T23	23061466
NA	CHEMICAL	GENE-Y	7	1	The gene ( gene ) is a chemical channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death .	T5	T22	23061466
NA	CHEMICAL	GENE-Y	7	3	The gene ( gene ) is a chemical channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death .	T5	T21	23061466
NA	CHEMICAL	GENE-N	7	6	The gene ( gene ) is a chemical channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death .	T5	T23	23061466
CPR:4	CHEMICAL	GENE-Y	1	28	The chemical ( natural products ) such as chemical , chemical , chemical and chemical carry the common molecular structure of chemical that possessed positive ionotropic effect and gene blocking activity .	T6	T25	23061466
CPR:4	CHEMICAL	GENE-Y	8	28	The chemical ( natural products ) such as chemical , chemical , chemical and chemical carry the common molecular structure of chemical that possessed positive ionotropic effect and gene blocking activity .	T7	T25	23061466
CPR:4	CHEMICAL	GENE-Y	10	28	The chemical ( natural products ) such as chemical , chemical , chemical and chemical carry the common molecular structure of chemical that possessed positive ionotropic effect and gene blocking activity .	T8	T25	23061466
CPR:4	CHEMICAL	GENE-Y	12	28	The chemical ( natural products ) such as chemical , chemical , chemical and chemical carry the common molecular structure of chemical that possessed positive ionotropic effect and gene blocking activity .	T9	T25	23061466
CPR:4	CHEMICAL	GENE-Y	14	28	The chemical ( natural products ) such as chemical , chemical , chemical and chemical carry the common molecular structure of chemical that possessed positive ionotropic effect and gene blocking activity .	T10	T25	23061466
CPR:4	CHEMICAL	GENE-Y	21	28	The chemical ( natural products ) such as chemical , chemical , chemical and chemical carry the common molecular structure of chemical that possessed positive ionotropic effect and gene blocking activity .	T11	T25	23061466
NA	CHEMICAL	GENE-Y	16	2	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T15	23097088
NA	CHEMICAL	GENE-Y	16	8	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T16	23097088
NA	CHEMICAL	GENE-Y	16	10	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T17	23097088
NA	CHEMICAL	GENE-Y	16	12	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T18	23097088
NA	CHEMICAL	GENE-Y	16	14	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T19	23097088
NA	CHEMICAL	GENE-Y	16	16	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T20	23097088
NA	CHEMICAL	GENE-Y	16	18	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T22	23097088
NA	CHEMICAL	GENE-N	16	21	Interestingly , gene was found to associate with gene , gene , gene , gene , gene , gene , and gene .	T2	T23	23097088
CPR:3	CHEMICAL	GENE-Y	1	4	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T3	T24	23097088
NA	CHEMICAL	GENE-Y	1	24	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T3	T5	23097088
NA	CHEMICAL	GENE-Y	1	38	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T3	T6	23097088
NA	CHEMICAL	GENE-N	1	32	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T3	T7	23097088
NA	CHEMICAL	GENE-N	1	32	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T3	T9	23097088
NA	CHEMICAL	GENE-Y	42	4	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T1	T24	23097088
NA	CHEMICAL	GENE-Y	42	24	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T1	T5	23097088
NA	CHEMICAL	GENE-Y	42	38	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T1	T6	23097088
CPR:4	CHEMICAL	GENE-N	42	32	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T1	T7	23097088
NA	CHEMICAL	GENE-Y	42	52	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T1	T8	23097088
NA	CHEMICAL	GENE-N	42	32	Following chemical treatment , gene was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for gene by 6-16 h. Interestingly , there was a loss in the binding of gene to gene during chemical-induced germ cell loss , suggesting that a loss of gene-gene interactions might have facilitated junction restructuring .	T1	T9	23097088
CPR:4	CHEMICAL	GENE-N	1	4	Oral chemical ( as a representative of the chemical family ) inhibited diabetes-induced increase in gene DNA-binding affinity in electrophoretic mobility shift assay and transcription factor array in nuclear extract isolated from whole retina .	T1	T16	17259377
CPR:4	CHEMICAL	GENE-N	4	4	Oral chemical ( as a representative of the chemical family ) inhibited diabetes-induced increase in gene DNA-binding affinity in electrophoretic mobility shift assay and transcription factor array in nuclear extract isolated from whole retina .	T2	T16	17259377
CPR:4	CHEMICAL	GENE-Y	2	8	All three chemical inhibited the diabetes-induced translocation of gene ( a subunit of gene ) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature , as well as of gene and gene into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections .	T3	T17	17259377
CPR:4	CHEMICAL	GENE-N	2	10	All three chemical inhibited the diabetes-induced translocation of gene ( a subunit of gene ) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature , as well as of gene and gene into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections .	T3	T18	17259377
CPR:4	CHEMICAL	GENE-Y	2	32	All three chemical inhibited the diabetes-induced translocation of gene ( a subunit of gene ) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature , as well as of gene and gene into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections .	T3	T19	17259377
CPR:4	CHEMICAL	GENE-Y	2	34	All three chemical inhibited the diabetes-induced translocation of gene ( a subunit of gene ) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature , as well as of gene and gene into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections .	T3	T20	17259377
CPR:4	CHEMICAL	GENE-N	0	4	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T4	T21	17259377
CPR:4	CHEMICAL	GENE-Y	0	30	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T4	T22	17259377
CPR:4	CHEMICAL	GENE-Y	0	3	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T4	T23	17259377
CPR:4	CHEMICAL	GENE-Y	0	3	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T4	T24	17259377
CPR:4	CHEMICAL	GENE-N	4	4	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T5	T21	17259377
NA	CHEMICAL	GENE-Y	4	30	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T5	T22	17259377
NA	CHEMICAL	GENE-Y	4	3	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T5	T23	17259377
NA	CHEMICAL	GENE-Y	4	3	chemical ( also as a representative of the chemical ) inhibited the diabetes-induced upregulation of several inflammatory gene products , which are regulated by gene , including vascular cell adhesion molecule , gene , gene , and gene in whole-retinal lysate .	T5	T24	17259377
NA	CHEMICAL	GENE-Y	8	13	We have previously isolated from human hemofiltrate an chemical-terminally truncated form of the gene ( gene ) , and characterized gene as a strong agonist of gene , gene , and to a lower extent gene .	T1	T26	11544332
NA	CHEMICAL	GENE-Y	8	15	We have previously isolated from human hemofiltrate an chemical-terminally truncated form of the gene ( gene ) , and characterized gene as a strong agonist of gene , gene , and to a lower extent gene .	T1	T5	11544332
NA	CHEMICAL	GENE-Y	8	20	We have previously isolated from human hemofiltrate an chemical-terminally truncated form of the gene ( gene ) , and characterized gene as a strong agonist of gene , gene , and to a lower extent gene .	T1	T7	11544332
NA	CHEMICAL	GENE-Y	8	26	We have previously isolated from human hemofiltrate an chemical-terminally truncated form of the gene ( gene ) , and characterized gene as a strong agonist of gene , gene , and to a lower extent gene .	T1	T8	11544332
NA	CHEMICAL	GENE-Y	8	28	We have previously isolated from human hemofiltrate an chemical-terminally truncated form of the gene ( gene ) , and characterized gene as a strong agonist of gene , gene , and to a lower extent gene .	T1	T9	11544332
NA	CHEMICAL	GENE-Y	8	35	We have previously isolated from human hemofiltrate an chemical-terminally truncated form of the gene ( gene ) , and characterized gene as a strong agonist of gene , gene , and to a lower extent gene .	T1	T10	11544332
NA	CHEMICAL	GENE-N	1	18	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T5	T30	15985706
NA	CHEMICAL	GENE-Y	1	23	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T5	T31	15985706
NA	CHEMICAL	GENE-N	1	24	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T5	T32	15985706
NA	CHEMICAL	GENE-N	1	38	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T5	T33	15985706
CPR:4	CHEMICAL	GENE-N	27	18	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T6	T30	15985706
CPR:4	CHEMICAL	GENE-Y	27	23	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T6	T31	15985706
CPR:4	CHEMICAL	GENE-N	27	24	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T6	T32	15985706
NA	CHEMICAL	GENE-N	27	38	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T6	T33	15985706
CPR:4	CHEMICAL	GENE-N	32	18	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T7	T30	15985706
NA	CHEMICAL	GENE-Y	32	23	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T7	T31	15985706
NA	CHEMICAL	GENE-N	32	24	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T7	T32	15985706
CPR:4	CHEMICAL	GENE-N	32	38	Using chemical-labeled gastric mucosal cells , we show that stimulatory effect of beta-adrenergic agonist , isoproterenol , on gene secretion was inhibited by gene gene inhibitor , chemical , as well as chemical , a specific inhibitor of gene .	T7	T33	15985706
NA	CHEMICAL	GENE-N	16	7	Both inhibitors , moreover , blunted the gene secretory responses to beta-adrenergic agonist-generated second messenger , chemical as well as chemical cyclase activator , chemical .	T8	T34	15985706
CPR:9	CHEMICAL	GENE-N	16	17	Both inhibitors , moreover , blunted the gene secretory responses to beta-adrenergic agonist-generated second messenger , chemical as well as chemical cyclase activator , chemical .	T8	T36	15985706
NA	CHEMICAL	GENE-N	20	7	Both inhibitors , moreover , blunted the gene secretory responses to beta-adrenergic agonist-generated second messenger , chemical as well as chemical cyclase activator , chemical .	T9	T34	15985706
NA	CHEMICAL	GENE-N	20	17	Both inhibitors , moreover , blunted the gene secretory responses to beta-adrenergic agonist-generated second messenger , chemical as well as chemical cyclase activator , chemical .	T9	T36	15985706
CPR:4	CHEMICAL	GENE-N	24	7	Both inhibitors , moreover , blunted the gene secretory responses to beta-adrenergic agonist-generated second messenger , chemical as well as chemical cyclase activator , chemical .	T10	T34	15985706
CPR:3	CHEMICAL	GENE-N	24	17	Both inhibitors , moreover , blunted the gene secretory responses to beta-adrenergic agonist-generated second messenger , chemical as well as chemical cyclase activator , chemical .	T10	T36	15985706
NA	CHEMICAL	GENE-N	5	1	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T11	T37	15985706
NA	CHEMICAL	GENE-N	5	14	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T11	T38	15985706
NA	CHEMICAL	GENE-Y	5	20	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T11	T39	15985706
NA	CHEMICAL	GENE-Y	5	24	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T11	T14	15985706
NA	CHEMICAL	GENE-N	5	30	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T11	T15	15985706
CPR:4	CHEMICAL	GENE-N	12	1	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T12	T37	15985706
CPR:4	CHEMICAL	GENE-N	12	14	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T12	T38	15985706
CPR:4	CHEMICAL	GENE-Y	12	20	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T12	T39	15985706
CPR:3	CHEMICAL	GENE-Y	12	24	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T12	T14	15985706
NA	CHEMICAL	GENE-N	12	30	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T12	T15	15985706
NA	CHEMICAL	GENE-N	18	1	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T13	T37	15985706
NA	CHEMICAL	GENE-N	18	14	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T13	T38	15985706
NA	CHEMICAL	GENE-Y	18	20	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T13	T39	15985706
NA	CHEMICAL	GENE-Y	18	24	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T13	T14	15985706
NA	CHEMICAL	GENE-N	18	30	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T13	T15	15985706
NA	CHEMICAL	GENE-N	5	1	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T1	T37	15985706
NA	CHEMICAL	GENE-N	5	14	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T1	T38	15985706
NA	CHEMICAL	GENE-Y	5	20	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T1	T39	15985706
NA	CHEMICAL	GENE-Y	5	24	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T1	T14	15985706
CPR:4	CHEMICAL	GENE-N	5	30	The gene secretory responses to chemical , furthermore , were inhibited by chemical , a selective inhibitor of chemical kinase gene responsible for ligand-independent gene autophosphorylation , but not by gene inhibitor , chemical .	T1	T15	15985706
CPR:4	CHEMICAL	GENE-N	17	3	The inhibition of gene , moreover , did not cause attenuation in gene secretion in response to chemical and chemical .	T2	T17	15985706
NA	CHEMICAL	GENE-N	17	11	The inhibition of gene , moreover , did not cause attenuation in gene secretion in response to chemical and chemical .	T2	T18	15985706
CPR:4	CHEMICAL	GENE-N	11	3	The inhibition of gene , moreover , did not cause attenuation in gene secretion in response to chemical and chemical .	T3	T17	15985706
NA	CHEMICAL	GENE-N	11	11	The inhibition of gene , moreover , did not cause attenuation in gene secretion in response to chemical and chemical .	T3	T18	15985706
NA	CHEMICAL	GENE-N	20	21	Volatile anesthetics at concentrations that are used in clinical practice to induce anesthesia selectively inhibit activity of the plasma membrane chemical-transport ATPase ( Kosk-Kosicka , D. , and Roszczynska , G .	T3	T15	7499320
CPR:3	CHEMICAL	GENE-Y	5	11	Regulation of sexual reproduction by chemical involves the activation of chemical receptors ( gene ) in the hypothalamus .	T7	T26	23296142
CPR:3	CHEMICAL	GENE-Y	5	13	Regulation of sexual reproduction by chemical involves the activation of chemical receptors ( gene ) in the hypothalamus .	T7	T30	23296142
NA	CHEMICAL	GENE-Y	10	11	Regulation of sexual reproduction by chemical involves the activation of chemical receptors ( gene ) in the hypothalamus .	T8	T26	23296142
NA	CHEMICAL	GENE-Y	10	13	Regulation of sexual reproduction by chemical involves the activation of chemical receptors ( gene ) in the hypothalamus .	T8	T30	23296142
CPR:3	CHEMICAL	GENE-Y	12	22	Using surface biotinylation , we observed that treatment of N-38 neurons with chemical or with a membrane impermeant chemical elevated plasma membrane gene protein levels , indicating that membrane signaling increased receptor insertion into the cell membrane .	T9	T11	23296142
CPR:3	CHEMICAL	GENE-Y	15	22	Using surface biotinylation , we observed that treatment of N-38 neurons with chemical or with a membrane impermeant chemical elevated plasma membrane gene protein levels , indicating that membrane signaling increased receptor insertion into the cell membrane .	T1	T11	23296142
CPR:4	CHEMICAL	GENE-Y	9	2	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T2	T12	23296142
CPR:6	CHEMICAL	GENE-Y	9	7	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T2	T13	23296142
NA	CHEMICAL	GENE-N	9	13	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T2	T14	23296142
NA	CHEMICAL	GENE-N	9	15	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T2	T15	23296142
CPR:4	CHEMICAL	GENE-Y	19	2	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T3	T12	23296142
NA	CHEMICAL	GENE-Y	19	7	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T3	T13	23296142
CPR:4	CHEMICAL	GENE-N	19	13	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T3	T14	23296142
CPR:4	CHEMICAL	GENE-N	19	15	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T3	T15	23296142
CPR:4	CHEMICAL	GENE-Y	21	2	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T4	T12	23296142
NA	CHEMICAL	GENE-Y	21	7	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T4	T13	23296142
CPR:4	CHEMICAL	GENE-N	21	13	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T4	T14	23296142
CPR:4	CHEMICAL	GENE-N	21	15	Insertion of gene was blocked by the gene antagonist chemical or with the gene ( gene ) pathway inhibitor chemical ( chemical ) .	T4	T15	23296142
NA	CHEMICAL	GENE-Y	6	9	Downstream membrane-initiated signaling was confirmed by chemical activation of gene ( gene ) and the release of intracellular calcium .	T5	T16	23296142
NA	CHEMICAL	GENE-Y	6	11	Downstream membrane-initiated signaling was confirmed by chemical activation of gene ( gene ) and the release of intracellular calcium .	T5	T17	23296142
NA	CHEMICAL	GENE-Y	0	8	chemical makes multiple adducts on free chemical , but does not form an adduct on chemical 438 of gene .	T27	T34	22898212
NA	CHEMICAL	GENE-Y	6	8	chemical makes multiple adducts on free chemical , but does not form an adduct on chemical 438 of gene .	T29	T34	22898212
NA	CHEMICAL	GENE-Y	15	8	chemical makes multiple adducts on free chemical , but does not form an adduct on chemical 438 of gene .	T28	T34	22898212
CPR:4	CHEMICAL	GENE-Y	0	3	chemical irreversibly inhibits gene ( gene ) in human plasma by forming adducts on the active site chemical ( chemical-198 ) .	T6	T30	22898212
CPR:4	CHEMICAL	GENE-Y	0	5	chemical irreversibly inhibits gene ( gene ) in human plasma by forming adducts on the active site chemical ( chemical-198 ) .	T6	T31	22898212
NA	CHEMICAL	GENE-Y	7	3	chemical irreversibly inhibits gene ( gene ) in human plasma by forming adducts on the active site chemical ( chemical-198 ) .	T8	T30	22898212
NA	CHEMICAL	GENE-Y	7	5	chemical irreversibly inhibits gene ( gene ) in human plasma by forming adducts on the active site chemical ( chemical-198 ) .	T8	T31	22898212
NA	CHEMICAL	GENE-Y	19	3	chemical irreversibly inhibits gene ( gene ) in human plasma by forming adducts on the active site chemical ( chemical-198 ) .	T9	T30	22898212
NA	CHEMICAL	GENE-Y	19	5	chemical irreversibly inhibits gene ( gene ) in human plasma by forming adducts on the active site chemical ( chemical-198 ) .	T9	T31	22898212
NA	CHEMICAL	GENE-Y	6	1	Inhibited gene undergoes aging to release chemical and chemical .	T10	T32	22898212
NA	CHEMICAL	GENE-Y	8	1	Inhibited gene undergoes aging to release chemical and chemical .	T11	T32	22898212
CPR:4	CHEMICAL	GENE-Y	4	5	Mass spectral analysis of chemical-inhibited gene digested with chemical-C showed an chemical adduct ( +106amu ) on chemical 499 , a residue far from the active site , but not on chemical-438 .	T16	T33	22898212
NA	CHEMICAL	GENE-Y	8	5	Mass spectral analysis of chemical-inhibited gene digested with chemical-C showed an chemical adduct ( +106amu ) on chemical 499 , a residue far from the active site , but not on chemical-438 .	T17	T33	22898212
NA	CHEMICAL	GENE-Y	11	5	Mass spectral analysis of chemical-inhibited gene digested with chemical-C showed an chemical adduct ( +106amu ) on chemical 499 , a residue far from the active site , but not on chemical-438 .	T18	T33	22898212
NA	CHEMICAL	GENE-Y	17	5	Mass spectral analysis of chemical-inhibited gene digested with chemical-C showed an chemical adduct ( +106amu ) on chemical 499 , a residue far from the active site , but not on chemical-438 .	T19	T33	22898212
NA	CHEMICAL	GENE-Y	31	5	Mass spectral analysis of chemical-inhibited gene digested with chemical-C showed an chemical adduct ( +106amu ) on chemical 499 , a residue far from the active site , but not on chemical-438 .	T20	T33	22898212
CPR:3	CHEMICAL	GENE-Y	0	9	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T9	T24	23512787
CPR:3	CHEMICAL	GENE-Y	0	11	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T9	T25	23512787
CPR:3	CHEMICAL	GENE-N	0	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T9	T26	23512787
CPR:3	CHEMICAL	GENE-N	0	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T9	T27	23512787
NA	CHEMICAL	GENE-Y	3	9	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T10	T24	23512787
NA	CHEMICAL	GENE-Y	3	11	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T10	T25	23512787
NA	CHEMICAL	GENE-N	3	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T10	T26	23512787
NA	CHEMICAL	GENE-N	3	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T10	T27	23512787
NA	CHEMICAL	GENE-Y	5	9	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T11	T24	23512787
NA	CHEMICAL	GENE-Y	5	11	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T11	T25	23512787
NA	CHEMICAL	GENE-N	5	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T11	T26	23512787
NA	CHEMICAL	GENE-N	5	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T11	T27	23512787
NA	CHEMICAL	GENE-Y	22	9	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T12	T24	23512787
NA	CHEMICAL	GENE-Y	22	11	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T12	T25	23512787
NA	CHEMICAL	GENE-N	22	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T12	T26	23512787
NA	CHEMICAL	GENE-N	22	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T12	T27	23512787
NA	CHEMICAL	GENE-Y	28	9	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T13	T24	23512787
NA	CHEMICAL	GENE-Y	28	11	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T13	T25	23512787
NA	CHEMICAL	GENE-N	28	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T13	T26	23512787
NA	CHEMICAL	GENE-N	28	15	chemical administration enhanced chemical ( chemical ) activity , gene ( gene ) expression and gene/gene pathway activation , which might ameliorate chemical injection-induced progressive elevation of reactive chemical species ( ROS ) formation in mice .	T13	T27	23512787
NA	CHEMICAL	GENE-Y	8	11	In addition to the effect on ROS , chemical ameliorated chemical-reduced gene ( gene ) expression .	T14	T28	23512787
CPR:4	CHEMICAL	GENE-Y	8	13	In addition to the effect on ROS , chemical ameliorated chemical-reduced gene ( gene ) expression .	T14	T29	23512787
CPR:4	CHEMICAL	GENE-Y	10	11	In addition to the effect on ROS , chemical ameliorated chemical-reduced gene ( gene ) expression .	T15	T28	23512787
CPR:4	CHEMICAL	GENE-Y	10	13	In addition to the effect on ROS , chemical ameliorated chemical-reduced gene ( gene ) expression .	T15	T29	23512787
NA	CHEMICAL	GENE-Y	0	2	chemical has a high affinity and selectivity for chemical transporters , but little or no affinity for various gene .	T5	T59	19445548
NA	CHEMICAL	GENE-N	0	13	chemical has a high affinity and selectivity for chemical transporters , but little or no affinity for various gene .	T5	T60	19445548
NA	CHEMICAL	GENE-Y	8	2	chemical has a high affinity and selectivity for chemical transporters , but little or no affinity for various gene .	T7	T59	19445548
NA	CHEMICAL	GENE-N	8	13	chemical has a high affinity and selectivity for chemical transporters , but little or no affinity for various gene .	T7	T60	19445548
CPR:9	CHEMICAL	GENE-Y	13	12	It undergoes extensive biotransformation , which is affected by poor metabolism by gene in a small percentage of the population ; these patients have greater exposure to and slower elimination of chemical than extensive metabolizers .	T17	T61	19445548
CPR:4	CHEMICAL	GENE-Y	5	0	gene inhibitors , such as chemical , are associated with changes in chemical pharmacokinetics similar to those observed among poor gene metabolizers .	T19	T62	19445548
NA	CHEMICAL	GENE-Y	5	20	gene inhibitors , such as chemical , are associated with changes in chemical pharmacokinetics similar to those observed among poor gene metabolizers .	T19	T63	19445548
NA	CHEMICAL	GENE-Y	11	0	gene inhibitors , such as chemical , are associated with changes in chemical pharmacokinetics similar to those observed among poor gene metabolizers .	T20	T62	19445548
CPR:9	CHEMICAL	GENE-Y	11	20	gene inhibitors , such as chemical , are associated with changes in chemical pharmacokinetics similar to those observed among poor gene metabolizers .	T20	T63	19445548
CPR:9	CHEMICAL	GENE-Y	0	6	chemical appeared better tolerated among extensive gene metabolizers than among poor metabolizers .	T41	T64	19445548
CPR:4	CHEMICAL	GENE-Y	0	6	chemical : a unique class of gene inhibitors .	T3	T12	23468189
NA	CHEMICAL	GENE-Y	1	7	Based on our previously published work on gene antagonists , we have synthesized a series of chemical that inhibit the gene/gene interaction .	T1	T5	23468189
CPR:4	CHEMICAL	GENE-Y	1	20	Based on our previously published work on gene antagonists , we have synthesized a series of chemical that inhibit the gene/gene interaction .	T1	T6	23468189
CPR:4	CHEMICAL	GENE-Y	1	20	Based on our previously published work on gene antagonists , we have synthesized a series of chemical that inhibit the gene/gene interaction .	T1	T7	23468189
NA	CHEMICAL	GENE-Y	28	20	In the current study , we have used insulinoma ( RIN ) and AtT-20ins cell lines engineered for overexpression of gene or gene to investigate the role of chemical transporter isoforms in mediating chemical cytotoxicity .	T7	T18	7926307
NA	CHEMICAL	GENE-Y	28	22	In the current study , we have used insulinoma ( RIN ) and AtT-20ins cell lines engineered for overexpression of gene or gene to investigate the role of chemical transporter isoforms in mediating chemical cytotoxicity .	T7	T19	7926307
NA	CHEMICAL	GENE-N	28	21	In the current study , we have used insulinoma ( RIN ) and AtT-20ins cell lines engineered for overexpression of gene or gene to investigate the role of chemical transporter isoforms in mediating chemical cytotoxicity .	T7	T20	7926307
NA	CHEMICAL	GENE-Y	33	20	In the current study , we have used insulinoma ( RIN ) and AtT-20ins cell lines engineered for overexpression of gene or gene to investigate the role of chemical transporter isoforms in mediating chemical cytotoxicity .	T8	T18	7926307
NA	CHEMICAL	GENE-Y	33	22	In the current study , we have used insulinoma ( RIN ) and AtT-20ins cell lines engineered for overexpression of gene or gene to investigate the role of chemical transporter isoforms in mediating chemical cytotoxicity .	T8	T19	7926307
NA	CHEMICAL	GENE-N	33	21	In the current study , we have used insulinoma ( RIN ) and AtT-20ins cell lines engineered for overexpression of gene or gene to investigate the role of chemical transporter isoforms in mediating chemical cytotoxicity .	T8	T20	7926307
NA	CHEMICAL	GENE-Y	5	16	The in vivo effects of chemical were evaluated by implantation of RIN cells expressing or lacking gene into athymic nude rats .	T9	T21	7926307
CPR:9	CHEMICAL	GENE-Y	33	11	The drug had a potent cytotoxic effect on RIN cells expressing gene , but had no effect on cells lacking gene expression , as indicated by histological analysis and measurement of the blood chemical levels of treated animals .	T10	T22	7926307
NA	CHEMICAL	GENE-Y	33	20	The drug had a potent cytotoxic effect on RIN cells expressing gene , but had no effect on cells lacking gene expression , as indicated by histological analysis and measurement of the blood chemical levels of treated animals .	T10	T23	7926307
NA	CHEMICAL	GENE-Y	5	7	The preferential cytotoxic effect of chemical on gene-expressing cell lines was confirmed by in vitro analysis of gene-expressing and untransfected RIN cells , as well as gene- and gene-overexpressing AtT-20ins cells .	T11	T24	7926307
NA	CHEMICAL	GENE-Y	5	17	The preferential cytotoxic effect of chemical on gene-expressing cell lines was confirmed by in vitro analysis of gene-expressing and untransfected RIN cells , as well as gene- and gene-overexpressing AtT-20ins cells .	T11	T25	7926307
NA	CHEMICAL	GENE-Y	5	26	The preferential cytotoxic effect of chemical on gene-expressing cell lines was confirmed by in vitro analysis of gene-expressing and untransfected RIN cells , as well as gene- and gene-overexpressing AtT-20ins cells .	T11	T12	7926307
NA	CHEMICAL	GENE-Y	5	28	The preferential cytotoxic effect of chemical on gene-expressing cell lines was confirmed by in vitro analysis of gene-expressing and untransfected RIN cells , as well as gene- and gene-overexpressing AtT-20ins cells .	T11	T13	7926307
CPR:9	CHEMICAL	GENE-Y	6	6	Consistent with these data , only gene-expressing RIN or AtT-20ins cells transported chemical efficiently .	T1	T14	7926307
NA	CHEMICAL	GENE-Y	3	4	Drug-drug interactions between chemical reductase inhibitors ( statins ) and antiviral gene inhibitors .	T23	T39	23703578
NA	CHEMICAL	GENE-N	3	11	Drug-drug interactions between chemical reductase inhibitors ( statins ) and antiviral gene inhibitors .	T23	T40	23703578
NA	CHEMICAL	GENE-Y	1	2	The chemical reductase inhibitors are a class of drugs also known as statins .	T19	T35	23703578
CPR:9	CHEMICAL	GENE-N	10	18	Drug-drug interactions are dependent on statins ' pharmacokinetic profile : chemical , chemical and chemical are metabolized through gene , while the metabolism of the other statins is independent of this gene .	T20	T36	23703578
NA	CHEMICAL	GENE-N	10	31	Drug-drug interactions are dependent on statins ' pharmacokinetic profile : chemical , chemical and chemical are metabolized through gene , while the metabolism of the other statins is independent of this gene .	T20	T37	23703578
CPR:9	CHEMICAL	GENE-N	12	18	Drug-drug interactions are dependent on statins ' pharmacokinetic profile : chemical , chemical and chemical are metabolized through gene , while the metabolism of the other statins is independent of this gene .	T21	T36	23703578
NA	CHEMICAL	GENE-N	12	31	Drug-drug interactions are dependent on statins ' pharmacokinetic profile : chemical , chemical and chemical are metabolized through gene , while the metabolism of the other statins is independent of this gene .	T21	T37	23703578
CPR:9	CHEMICAL	GENE-N	14	18	Drug-drug interactions are dependent on statins ' pharmacokinetic profile : chemical , chemical and chemical are metabolized through gene , while the metabolism of the other statins is independent of this gene .	T22	T36	23703578
NA	CHEMICAL	GENE-N	14	31	Drug-drug interactions are dependent on statins ' pharmacokinetic profile : chemical , chemical and chemical are metabolized through gene , while the metabolism of the other statins is independent of this gene .	T22	T37	23703578
NA	CHEMICAL	GENE-N	4	16	All HIV PIs except chemical are coadministered with a low dose of chemical , a potent gene inhibitor to improve their pharmacokinetic properties .	T1	T26	23703578
CPR:4	CHEMICAL	GENE-N	8	16	All HIV PIs except chemical are coadministered with a low dose of chemical , a potent gene inhibitor to improve their pharmacokinetic properties .	T2	T26	23703578
CPR:4	CHEMICAL	GENE-N	2	14	The HCV-PIs chemical and chemical are both , to different extents , inhibitors of gene .	T3	T28	23703578
CPR:4	CHEMICAL	GENE-N	4	14	The HCV-PIs chemical and chemical are both , to different extents , inhibitors of gene .	T4	T28	23703578
CPR:9	CHEMICAL	GENE-N	0	5	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T5	T29	23703578
NA	CHEMICAL	GENE-N	0	15	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T5	T30	23703578
CPR:9	CHEMICAL	GENE-N	2	5	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T6	T29	23703578
NA	CHEMICAL	GENE-N	2	15	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T6	T30	23703578
NA	CHEMICAL	GENE-N	19	5	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T7	T29	23703578
CPR:4	CHEMICAL	GENE-N	19	15	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T7	T30	23703578
NA	CHEMICAL	GENE-N	21	5	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T8	T29	23703578
CPR:4	CHEMICAL	GENE-N	21	15	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T8	T30	23703578
NA	CHEMICAL	GENE-N	33	5	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T9	T29	23703578
CPR:4	CHEMICAL	GENE-N	33	15	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T9	T30	23703578
NA	CHEMICAL	GENE-N	35	5	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T10	T29	23703578
CPR:4	CHEMICAL	GENE-N	35	15	chemical and chemical metabolized through gene have the highest potency for drug-drug interaction with potent gene inhibitors such as chemical- or chemical-boosted HIV-PI or the hepatitis C virus ( HCV ) PI , chemical or chemical , and therefore their coadministration is contraindicated .	T10	T30	23703578
CPR:9	CHEMICAL	GENE-N	0	4	chemical is also a gene substrate , but less potent drug-drug interactions have been reported with gene inhibitors .	T11	T31	23703578
NA	CHEMICAL	GENE-N	0	16	chemical is also a gene substrate , but less potent drug-drug interactions have been reported with gene inhibitors .	T11	T32	23703578
NA	CHEMICAL	GENE-N	3	11	The negatively charged chemical has been found previously to be a gene ( gene ) -dependent microtubule inhibitor [ Wallin M , Deinum J and Friden B , FEBS Lett 179 : 289-293 , 1985 ] .	T11	T30	1908244
NA	CHEMICAL	GENE-N	3	13	The negatively charged chemical has been found previously to be a gene ( gene ) -dependent microtubule inhibitor [ Wallin M , Deinum J and Friden B , FEBS Lett 179 : 289-293 , 1985 ] .	T11	T31	1908244
NA	CHEMICAL	GENE-Y	7	9	In the present study the binding of chemical to gene and gene was investigated .	T13	T32	1908244
NA	CHEMICAL	GENE-Y	7	11	In the present study the binding of chemical to gene and gene was investigated .	T13	T33	1908244
NA	CHEMICAL	GENE-N	13	2	Both these gene were found to have two to three binding sites for chemical which is compatible with the reported number of basic chemical repeats of these gene , considered to be the ultimate gene binding domains .	T14	T34	1908244
NA	CHEMICAL	GENE-N	13	27	Both these gene were found to have two to three binding sites for chemical which is compatible with the reported number of basic chemical repeats of these gene , considered to be the ultimate gene binding domains .	T14	T35	1908244
NA	CHEMICAL	GENE-N	13	34	Both these gene were found to have two to three binding sites for chemical which is compatible with the reported number of basic chemical repeats of these gene , considered to be the ultimate gene binding domains .	T14	T36	1908244
NA	CHEMICAL	GENE-N	23	2	Both these gene were found to have two to three binding sites for chemical which is compatible with the reported number of basic chemical repeats of these gene , considered to be the ultimate gene binding domains .	T15	T34	1908244
NA	CHEMICAL	GENE-N	23	27	Both these gene were found to have two to three binding sites for chemical which is compatible with the reported number of basic chemical repeats of these gene , considered to be the ultimate gene binding domains .	T15	T35	1908244
NA	CHEMICAL	GENE-N	23	34	Both these gene were found to have two to three binding sites for chemical which is compatible with the reported number of basic chemical repeats of these gene , considered to be the ultimate gene binding domains .	T15	T36	1908244
NA	CHEMICAL	GENE-N	6	8	The Kd for the binding of chemical to gene was estimated to be 20 microM at 4 degrees , and for the binding of tau , 200 microM .	T16	T37	1908244
NA	CHEMICAL	GENE-N	4	16	Two new negatively charged chemical derivatives , chemical and chemical , were found to be similar gene-dependent microtubule inhibitors .	T2	T20	1908244
NA	CHEMICAL	GENE-N	7	16	Two new negatively charged chemical derivatives , chemical and chemical , were found to be similar gene-dependent microtubule inhibitors .	T3	T20	1908244
NA	CHEMICAL	GENE-N	9	16	Two new negatively charged chemical derivatives , chemical and chemical , were found to be similar gene-dependent microtubule inhibitors .	T4	T20	1908244
NA	CHEMICAL	GENE-N	5	0	A positively charged derivative , chemical , did not inhibit microtubule assembly or alter the composition of the coassembled gene .	T8	T21	1908244
NA	CHEMICAL	GENE-N	2	6	The uncharged chemical bound to both gene and gene , but no effects were seen on microtubule assembly , the composition of coassembled gene or the microtubule morphology .	T9	T22	1908244
NA	CHEMICAL	GENE-N	2	8	The uncharged chemical bound to both gene and gene , but no effects were seen on microtubule assembly , the composition of coassembled gene or the microtubule morphology .	T9	T23	1908244
NA	CHEMICAL	GENE-N	2	23	The uncharged chemical bound to both gene and gene , but no effects were seen on microtubule assembly , the composition of coassembled gene or the microtubule morphology .	T9	T24	1908244
NA	CHEMICAL	GENE-N	7	11	Our results suggest that only negatively charged chemical derivatives have a gene-dependent microtubule inhibitory effect .	T10	T25	1908244
NA	CHEMICAL	GENE-N	6	3	The regulation of gene synthesis by chemical plays an essential role in the neuroendocrine control of reproduction .	T6	T28	23211523
NA	CHEMICAL	GENE-Y	10	5	For example , involvement of gene in LHβ induction by chemical has been discovered .	T4	T31	23211523
NA	CHEMICAL	GENE-Y	0	2	gene caused a sustained increase in nuclear gene levels , which was significantly reduced by gene ( JchemicalK ) inhibition .	T7	T36	23211523
NA	CHEMICAL	GENE-N	0	2	gene caused a sustained increase in nuclear gene levels , which was significantly reduced by gene ( JchemicalK ) inhibition .	T7	T38	23211523
NA	CHEMICAL	GENE-N	0	17	gene caused a sustained increase in nuclear gene levels , which was significantly reduced by gene ( JchemicalK ) inhibition .	T7	T39	23211523
NA	CHEMICAL	GENE-N	5	5	However , none of the gene in that region were required for promoter activation by chemical .	T1	T11	23211523
NA	CHEMICAL	GENE-Y	4	4	Furthermore , knockdown of gene significantly attenuated gene-induced gene expression .	T2	T23	23211523
NA	CHEMICAL	GENE-Y	4	7	Furthermore , knockdown of gene significantly attenuated gene-induced gene expression .	T2	T24	23211523
CPR:3	CHEMICAL	GENE-Y	4	8	Furthermore , knockdown of gene significantly attenuated gene-induced gene expression .	T2	T25	23211523
CPR:4	CHEMICAL	GENE-Y	0	21	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T1	T11	15946589
CPR:4	CHEMICAL	GENE-Y	0	23	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T1	T12	15946589
CPR:4	CHEMICAL	GENE-Y	0	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T1	T13	15946589
CPR:4	CHEMICAL	GENE-Y	0	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T1	T14	15946589
CPR:4	CHEMICAL	GENE-Y	0	27	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T1	T15	15946589
CPR:4	CHEMICAL	GENE-Y	0	3	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T1	T16	15946589
CPR:4	CHEMICAL	GENE-Y	2	21	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T2	T11	15946589
CPR:4	CHEMICAL	GENE-Y	2	23	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T2	T12	15946589
CPR:4	CHEMICAL	GENE-Y	2	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T2	T13	15946589
CPR:4	CHEMICAL	GENE-Y	2	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T2	T14	15946589
CPR:4	CHEMICAL	GENE-Y	2	27	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T2	T15	15946589
CPR:4	CHEMICAL	GENE-Y	2	3	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T2	T16	15946589
CPR:4	CHEMICAL	GENE-Y	4	21	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T3	T11	15946589
CPR:4	CHEMICAL	GENE-Y	4	23	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T3	T12	15946589
CPR:4	CHEMICAL	GENE-Y	4	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T3	T13	15946589
CPR:4	CHEMICAL	GENE-Y	4	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T3	T14	15946589
CPR:4	CHEMICAL	GENE-Y	4	27	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T3	T15	15946589
CPR:4	CHEMICAL	GENE-Y	4	3	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T3	T16	15946589
CPR:4	CHEMICAL	GENE-Y	6	21	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T4	T11	15946589
CPR:4	CHEMICAL	GENE-Y	6	23	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T4	T12	15946589
CPR:4	CHEMICAL	GENE-Y	6	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T4	T13	15946589
CPR:4	CHEMICAL	GENE-Y	6	25	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T4	T14	15946589
CPR:4	CHEMICAL	GENE-Y	6	27	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T4	T15	15946589
CPR:4	CHEMICAL	GENE-Y	6	3	chemical ( chemical , chemical , chemical ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of gene , gene , gene-gene , gene , and gene represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .	T4	T16	15946589
NA	CHEMICAL	GENE-N	4	6	The reported mechanism of chemical resistance in GISTs involves missense mutation in the gene of gene including gene , gene , and gene .	T6	T17	15946589
NA	CHEMICAL	GENE-N	4	15	The reported mechanism of chemical resistance in GISTs involves missense mutation in the gene of gene including gene , gene , and gene .	T6	T18	15946589
NA	CHEMICAL	GENE-N	4	17	The reported mechanism of chemical resistance in GISTs involves missense mutation in the gene of gene including gene , gene , and gene .	T6	T19	15946589
NA	CHEMICAL	GENE-N	4	19	The reported mechanism of chemical resistance in GISTs involves missense mutation in the gene of gene including gene , gene , and gene .	T6	T20	15946589
NA	CHEMICAL	GENE-N	4	22	The reported mechanism of chemical resistance in GISTs involves missense mutation in the gene of gene including gene , gene , and gene .	T6	T21	15946589
CPR:4	CHEMICAL	GENE-Y	2	4	Discovery of chemical based gene inhibitors .	T2	T19	23232060
CPR:4	CHEMICAL	GENE-Y	6	6	A series of compounds based on a chemical scaffold that are potent and selective inhibitors of gene ( gene ) activity are described .	T1	T3	23232060
CPR:4	CHEMICAL	GENE-Y	6	18	A series of compounds based on a chemical scaffold that are potent and selective inhibitors of gene ( gene ) activity are described .	T1	T4	23232060
NA	CHEMICAL	GENE-N	11	2	Induction of gene , transporters , and drug metabolizing enzymes by chemical .	T11	T42	23439660
NA	CHEMICAL	GENE-N	2	7	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T24	23439660
NA	CHEMICAL	GENE-N	2	9	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T25	23439660
NA	CHEMICAL	GENE-Y	2	13	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T26	23439660
NA	CHEMICAL	GENE-Y	2	15	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T27	23439660
NA	CHEMICAL	GENE-Y	2	18	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T28	23439660
NA	CHEMICAL	GENE-Y	2	20	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T29	23439660
NA	CHEMICAL	GENE-Y	2	25	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T30	23439660
NA	CHEMICAL	GENE-Y	2	27	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T8	T31	23439660
NA	CHEMICAL	GENE-N	24	7	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T24	23439660
NA	CHEMICAL	GENE-N	24	9	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T25	23439660
NA	CHEMICAL	GENE-Y	24	13	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T26	23439660
NA	CHEMICAL	GENE-Y	24	15	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T27	23439660
NA	CHEMICAL	GENE-Y	24	18	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T28	23439660
NA	CHEMICAL	GENE-Y	24	20	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T29	23439660
NA	CHEMICAL	GENE-Y	24	25	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T30	23439660
NA	CHEMICAL	GENE-Y	24	27	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T31	23439660
NA	CHEMICAL	GENE-N	24	45	Many transporters and DMEs are regulated by gene [ gene ; e.g. , gene ( gene ) , gene ( gene ) , and chemical receptor ( gene ) ] ; however , there is a paucity of information regarding the influence of opioids on gene .	T9	T32	23439660
NA	CHEMICAL	GENE-N	11	27	The objective of this study was to determine the influence of chemical administration ( 15 mg/kg intraperitoneally twice daily for 8 days ) on liver expression of gene , transporters , and DMEs in rats .	T10	T33	23439660
NA	CHEMICAL	GENE-Y	23	23	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T1	T15	23439660
NA	CHEMICAL	GENE-Y	23	25	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T1	T16	23439660
NA	CHEMICAL	GENE-Y	23	28	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T1	T17	23439660
NA	CHEMICAL	GENE-Y	27	23	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T2	T15	23439660
NA	CHEMICAL	GENE-Y	27	25	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T2	T16	23439660
NA	CHEMICAL	GENE-Y	27	28	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T2	T17	23439660
NA	CHEMICAL	GENE-Y	27	23	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T3	T15	23439660
NA	CHEMICAL	GENE-Y	27	25	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T3	T16	23439660
NA	CHEMICAL	GENE-Y	27	28	Therefore , a series of transactivation/translocation assays were conducted to determine whether the observed changes of transporters/DMEs are mediated by direct activation of gene , gene , or gene by chemical or its major metabolites ( chemical and chemical ) .	T3	T17	23439660
NA	CHEMICAL	GENE-Y	1	6	Neither chemical nor its metabolites activated gene , gene , or gene .	T4	T18	23439660
NA	CHEMICAL	GENE-Y	1	8	Neither chemical nor its metabolites activated gene , gene , or gene .	T4	T19	23439660
NA	CHEMICAL	GENE-Y	1	11	Neither chemical nor its metabolites activated gene , gene , or gene .	T4	T20	23439660
NA	CHEMICAL	GENE-Y	7	16	Cell proliferation and apoptosis rate were measured in HDMVEC by chemical ( chemical ) incorporation and gene and gene activity , respectively .	T17	T24	23371451
NA	CHEMICAL	GENE-Y	7	18	Cell proliferation and apoptosis rate were measured in HDMVEC by chemical ( chemical ) incorporation and gene and gene activity , respectively .	T17	T25	23371451
NA	CHEMICAL	GENE-Y	12	16	Cell proliferation and apoptosis rate were measured in HDMVEC by chemical ( chemical ) incorporation and gene and gene activity , respectively .	T18	T24	23371451
NA	CHEMICAL	GENE-Y	12	18	Cell proliferation and apoptosis rate were measured in HDMVEC by chemical ( chemical ) incorporation and gene and gene activity , respectively .	T18	T25	23371451
CPR:4	CHEMICAL	GENE-Y	10	2	Effects of gene ( gene ) and gene inhibitor ( chemical ) on acid-induced lung injury in rats .	T9	T22	16245075
CPR:4	CHEMICAL	GENE-Y	10	4	Effects of gene ( gene ) and gene inhibitor ( chemical ) on acid-induced lung injury in rats .	T9	T23	16245075
CPR:4	CHEMICAL	GENE-Y	10	7	Effects of gene ( gene ) and gene inhibitor ( chemical ) on acid-induced lung injury in rats .	T9	T24	16245075
NA	CHEMICAL	GENE-Y	28	9	We examined the effects of the high dose of gene ( gene ) , which is capable of increasing peripheral neutrophils , and a specific gene inhibitor ( chemical ) on acid lung injury in rats .	T3	T12	16245075
NA	CHEMICAL	GENE-Y	28	11	We examined the effects of the high dose of gene ( gene ) , which is capable of increasing peripheral neutrophils , and a specific gene inhibitor ( chemical ) on acid lung injury in rats .	T3	T13	16245075
CPR:4	CHEMICAL	GENE-Y	28	23	We examined the effects of the high dose of gene ( gene ) , which is capable of increasing peripheral neutrophils , and a specific gene inhibitor ( chemical ) on acid lung injury in rats .	T3	T14	16245075
NA	CHEMICAL	GENE-Y	3	6	Thirty minutes before chemical instillation , gene ( 150 microg kg ( -1 ) ) was injected subcutaneously or chemical ( 10 mg kg ( -1 ) h ( -1 ) ) was infused continuously into the right jugular vein .	T6	T15	16245075
NA	CHEMICAL	GENE-Y	19	6	Thirty minutes before chemical instillation , gene ( 150 microg kg ( -1 ) ) was injected subcutaneously or chemical ( 10 mg kg ( -1 ) h ( -1 ) ) was infused continuously into the right jugular vein .	T7	T15	16245075
NA	CHEMICAL	GENE-Y	1	3	Both chemical and gene attenuated the parameters increased by acid-induced lung injury in rats .	T2	T10	16245075
NA	CHEMICAL	GENE-N	0	1	chemical oxidase importance in vivo in xenobiotic metabolism : chemical nitroreduction in mice .	T21	T45	23462233
NA	CHEMICAL	GENE-N	9	1	chemical oxidase importance in vivo in xenobiotic metabolism : chemical nitroreduction in mice .	T22	T45	23462233
NA	CHEMICAL	GENE-N	0	1	chemical oxidase ( gene ) metabolizes many xenobiotics in vitro , but its importance in vivo is usually unknown relative to gene ( gene ) and other detoxification systems .	T1	T23	23462233
NA	CHEMICAL	GENE-N	0	3	chemical oxidase ( gene ) metabolizes many xenobiotics in vitro , but its importance in vivo is usually unknown relative to gene ( gene ) and other detoxification systems .	T1	T34	23462233
NA	CHEMICAL	GENE-N	0	21	chemical oxidase ( gene ) metabolizes many xenobiotics in vitro , but its importance in vivo is usually unknown relative to gene ( gene ) and other detoxification systems .	T1	T26	23462233
NA	CHEMICAL	GENE-N	0	23	chemical oxidase ( gene ) metabolizes many xenobiotics in vitro , but its importance in vivo is usually unknown relative to gene ( gene ) and other detoxification systems .	T1	T29	23462233
CPR:9	CHEMICAL	GENE-N	7	15	Currently , the most important insecticides are chemical , which are metabolized in vitro by gene on reduction of the chemical group and by gene via oxidation reactions .	T13	T35	23462233
CPR:9	CHEMICAL	GENE-N	7	24	Currently , the most important insecticides are chemical , which are metabolized in vitro by gene on reduction of the chemical group and by gene via oxidation reactions .	T13	T36	23462233
CPR:9	CHEMICAL	GENE-N	12	15	Currently , the most important insecticides are chemical , which are metabolized in vitro by gene on reduction of the chemical group and by gene via oxidation reactions .	T14	T35	23462233
NA	CHEMICAL	GENE-N	12	24	Currently , the most important insecticides are chemical , which are metabolized in vitro by gene on reduction of the chemical group and by gene via oxidation reactions .	T14	T36	23462233
CPR:4	CHEMICAL	GENE-N	10	6	The procedure was to reduce liver gene activity by providing chemical or chemical in the drinking water or to use the gene-deficient DBA/2 mouse strain .	T15	T39	23462233
NA	CHEMICAL	GENE-N	10	21	The procedure was to reduce liver gene activity by providing chemical or chemical in the drinking water or to use the gene-deficient DBA/2 mouse strain .	T15	T40	23462233
CPR:4	CHEMICAL	GENE-N	12	6	The procedure was to reduce liver gene activity by providing chemical or chemical in the drinking water or to use the gene-deficient DBA/2 mouse strain .	T16	T39	23462233
NA	CHEMICAL	GENE-N	12	21	The procedure was to reduce liver gene activity by providing chemical or chemical in the drinking water or to use the gene-deficient DBA/2 mouse strain .	T16	T40	23462233
CPR:4	CHEMICAL	GENE-N	9	1	Liver gene activity was reduced by 45 % with chemical and 61 % with chemical and 81 % in gene-deficient mice relative to controls .	T17	T42	23462233
NA	CHEMICAL	GENE-N	9	19	Liver gene activity was reduced by 45 % with chemical and 61 % with chemical and 81 % in gene-deficient mice relative to controls .	T17	T43	23462233
CPR:4	CHEMICAL	GENE-N	14	1	Liver gene activity was reduced by 45 % with chemical and 61 % with chemical and 81 % in gene-deficient mice relative to controls .	T18	T42	23462233
NA	CHEMICAL	GENE-N	14	19	Liver gene activity was reduced by 45 % with chemical and 61 % with chemical and 81 % in gene-deficient mice relative to controls .	T18	T43	23462233
NA	CHEMICAL	GENE-N	9	16	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T19	T44	23462233
NA	CHEMICAL	GENE-N	9	26	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T19	T24	23462233
NA	CHEMICAL	GENE-N	9	46	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T19	T25	23462233
NA	CHEMICAL	GENE-N	11	16	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T20	T44	23462233
NA	CHEMICAL	GENE-N	11	26	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T20	T24	23462233
NA	CHEMICAL	GENE-N	11	46	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T20	T25	23462233
NA	CHEMICAL	GENE-N	11	16	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T2	T44	23462233
CPR:9	CHEMICAL	GENE-N	11	26	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T2	T24	23462233
NA	CHEMICAL	GENE-N	11	46	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T2	T25	23462233
NA	CHEMICAL	GENE-N	35	16	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T3	T44	23462233
CPR:4	CHEMICAL	GENE-N	35	26	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T3	T24	23462233
NA	CHEMICAL	GENE-N	35	46	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T3	T25	23462233
NA	CHEMICAL	GENE-N	16	16	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T4	T44	23462233
CPR:4	CHEMICAL	GENE-N	16	26	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T4	T24	23462233
NA	CHEMICAL	GENE-N	16	46	When mice were treated ip with the major neonicotinoid chemical ( chemical ) , metabolism by gene oxidation reactions was not appreciably affected , whereas the gene-generated chemical metabolite was decreased by 30 % with chemical and 56 % with chemical and 86 % in the gene-deficient mice .	T4	T25	23462233
NA	CHEMICAL	GENE-N	2	28	The other chemical nitroreduction metabolite , desnitro-chemical , was decreased by 55 % , 65 % , and 81 % with chemical , chemical , and in the gene-deficient mice , respectively .	T5	T27	23462233
NA	CHEMICAL	GENE-N	6	28	The other chemical nitroreduction metabolite , desnitro-chemical , was decreased by 55 % , 65 % , and 81 % with chemical , chemical , and in the gene-deficient mice , respectively .	T6	T27	23462233
NA	CHEMICAL	GENE-N	21	28	The other chemical nitroreduction metabolite , desnitro-chemical , was decreased by 55 % , 65 % , and 81 % with chemical , chemical , and in the gene-deficient mice , respectively .	T7	T27	23462233
NA	CHEMICAL	GENE-N	23	28	The other chemical nitroreduction metabolite , desnitro-chemical , was decreased by 55 % , 65 % , and 81 % with chemical , chemical , and in the gene-deficient mice , respectively .	T8	T27	23462233
CPR:9	CHEMICAL	GENE-N	24	4	Thus , decreasing liver gene activity by three quite different procedures gave a corresponding decrease for in vivo reductive metabolites in the liver of chemical-treated mice .	T9	T28	23462233
CPR:9	CHEMICAL	GENE-N	4	1	Possible gene involvement in chemical metabolism in insects was evaluated using gene-expressing and gene-deficient Drosophila , but no differences were found in chemical nitroreduction or sensitivity between the two strains .	T10	T30	23462233
CPR:9	CHEMICAL	GENE-N	4	11	Possible gene involvement in chemical metabolism in insects was evaluated using gene-expressing and gene-deficient Drosophila , but no differences were found in chemical nitroreduction or sensitivity between the two strains .	T10	T31	23462233
NA	CHEMICAL	GENE-N	4	13	Possible gene involvement in chemical metabolism in insects was evaluated using gene-expressing and gene-deficient Drosophila , but no differences were found in chemical nitroreduction or sensitivity between the two strains .	T10	T32	23462233
NA	CHEMICAL	GENE-N	22	1	Possible gene involvement in chemical metabolism in insects was evaluated using gene-expressing and gene-deficient Drosophila , but no differences were found in chemical nitroreduction or sensitivity between the two strains .	T11	T30	23462233
NA	CHEMICAL	GENE-N	22	11	Possible gene involvement in chemical metabolism in insects was evaluated using gene-expressing and gene-deficient Drosophila , but no differences were found in chemical nitroreduction or sensitivity between the two strains .	T11	T31	23462233
NA	CHEMICAL	GENE-N	22	13	Possible gene involvement in chemical metabolism in insects was evaluated using gene-expressing and gene-deficient Drosophila , but no differences were found in chemical nitroreduction or sensitivity between the two strains .	T11	T32	23462233
NA	CHEMICAL	GENE-Y	0	16	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T7	T24	11922402
NA	CHEMICAL	GENE-Y	0	21	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T7	T25	11922402
NA	CHEMICAL	GENE-Y	2	16	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T8	T24	11922402
NA	CHEMICAL	GENE-Y	2	21	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T8	T25	11922402
NA	CHEMICAL	GENE-Y	5	16	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T9	T24	11922402
NA	CHEMICAL	GENE-Y	5	21	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T9	T25	11922402
NA	CHEMICAL	GENE-Y	8	16	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T10	T24	11922402
NA	CHEMICAL	GENE-Y	8	21	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T10	T25	11922402
NA	CHEMICAL	GENE-Y	13	16	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T11	T24	11922402
NA	CHEMICAL	GENE-Y	13	21	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T11	T25	11922402
NA	CHEMICAL	GENE-Y	18	16	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T12	T24	11922402
NA	CHEMICAL	GENE-Y	18	21	chemical ( chemical ) ( chemical ) and chemical are competitive inhibitors of chemical by binding to the chemical receptor ( gene ) .	T12	T25	11922402
NA	CHEMICAL	GENE-Y	0	19	chemical and chemical are the most potent pure antiestrogens and chemical has the highest affinity of all antiestrogens to gene .	T2	T23	11922402
NA	CHEMICAL	GENE-Y	2	19	chemical and chemical are the most potent pure antiestrogens and chemical has the highest affinity of all antiestrogens to gene .	T3	T23	11922402
NA	CHEMICAL	GENE-Y	10	19	chemical and chemical are the most potent pure antiestrogens and chemical has the highest affinity of all antiestrogens to gene .	T4	T23	11922402
NA	CHEMICAL	GENE-N	20	8	Female precocious puberty may require hyperactivity of both gene axes because of the `` two-cell ' arrangement required for ovarian chemical production .	T1	T31	9039330
NA	CHEMICAL	GENE-Y	30	15	Our results revealed an important role of base excision repair ( BER ) as the gene , gene , gene and gene mutants showed pronounced sensitivity to essential oil and chemical .	T7	T13	23523831
NA	CHEMICAL	GENE-Y	30	17	Our results revealed an important role of base excision repair ( BER ) as the gene , gene , gene and gene mutants showed pronounced sensitivity to essential oil and chemical .	T7	T14	23523831
NA	CHEMICAL	GENE-Y	30	19	Our results revealed an important role of base excision repair ( BER ) as the gene , gene , gene and gene mutants showed pronounced sensitivity to essential oil and chemical .	T7	T15	23523831
NA	CHEMICAL	GENE-Y	30	21	Our results revealed an important role of base excision repair ( BER ) as the gene , gene , gene and gene mutants showed pronounced sensitivity to essential oil and chemical .	T7	T16	23523831
NA	CHEMICAL	GENE-Y	4	5	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T8	T17	23523831
NA	CHEMICAL	GENE-Y	4	8	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T8	T18	23523831
NA	CHEMICAL	GENE-Y	18	5	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T9	T17	23523831
NA	CHEMICAL	GENE-Y	18	8	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T9	T18	23523831
NA	CHEMICAL	GENE-Y	25	5	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T10	T17	23523831
NA	CHEMICAL	GENE-Y	25	8	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T10	T18	23523831
NA	CHEMICAL	GENE-Y	8	5	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T1	T17	23523831
NA	CHEMICAL	GENE-Y	8	8	In the absence of chemical dismutase ( in geneΔ mutant strain ) sensitivity to the essential oil and chemical increased indicating that this oil and chemical are generating reactive chemical species ( ROS ) .	T1	T18	23523831
NA	CHEMICAL	GENE-Y	6	10	The ROS production was confirmed by chemical probing assay in gene-deficient strains .	T2	T12	23523831
CPR:3	CHEMICAL	GENE-N	0	14	chemical , a chemical ( chemical ) ylated peptide-based erythropoiesis-stimulating agent , stimulates the gene dimer that governs erythropoiesis .	T1	T10	23318685
CPR:3	CHEMICAL	GENE-N	3	14	chemical , a chemical ( chemical ) ylated peptide-based erythropoiesis-stimulating agent , stimulates the gene dimer that governs erythropoiesis .	T2	T10	23318685
CPR:3	CHEMICAL	GENE-N	5	14	chemical , a chemical ( chemical ) ylated peptide-based erythropoiesis-stimulating agent , stimulates the gene dimer that governs erythropoiesis .	T5	T10	23318685
NA	CHEMICAL	GENE-N	45	8	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T25	17632107
NA	CHEMICAL	GENE-N	45	10	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T14	17632107
NA	CHEMICAL	GENE-Y	45	13	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T16	17632107
NA	CHEMICAL	GENE-Y	45	15	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T17	17632107
NA	CHEMICAL	GENE-Y	45	17	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T19	17632107
NA	CHEMICAL	GENE-Y	45	20	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T21	17632107
NA	CHEMICAL	GENE-N	45	49	Structural and functional properties were investigated for four gene ( gene ) , gene , gene , gene , and gene , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the chemical oxidase PPAR response element .	T9	T22	17632107
NA	CHEMICAL	GENE-N	2	0	gene showed a high similarity in the primary structure to other vertebrate counterparts , gene contained additional sequences of 21 and 28 chemical , respectively , as in the case of other teleost fish species when compared with African clawed frog counterparts .	T10	T23	17632107
NA	CHEMICAL	GENE-N	2	2	gene showed a high similarity in the primary structure to other vertebrate counterparts , gene contained additional sequences of 21 and 28 chemical , respectively , as in the case of other teleost fish species when compared with African clawed frog counterparts .	T10	T24	17632107
CPR:3	CHEMICAL	GENE-Y	12	5	The transcriptional activity of torafugu gene was enhanced 4.5- and 11.5-fold by chemical and chemical ( chemical ) each at 10 microM , respectively , whereas that of gene , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	T11	T26	17632107
CPR:3	CHEMICAL	GENE-Y	12	28	The transcriptional activity of torafugu gene was enhanced 4.5- and 11.5-fold by chemical and chemical ( chemical ) each at 10 microM , respectively , whereas that of gene , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	T11	T27	17632107
CPR:3	CHEMICAL	GENE-Y	14	5	The transcriptional activity of torafugu gene was enhanced 4.5- and 11.5-fold by chemical and chemical ( chemical ) each at 10 microM , respectively , whereas that of gene , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	T12	T26	17632107
CPR:3	CHEMICAL	GENE-Y	14	28	The transcriptional activity of torafugu gene was enhanced 4.5- and 11.5-fold by chemical and chemical ( chemical ) each at 10 microM , respectively , whereas that of gene , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	T12	T27	17632107
CPR:3	CHEMICAL	GENE-Y	16	5	The transcriptional activity of torafugu gene was enhanced 4.5- and 11.5-fold by chemical and chemical ( chemical ) each at 10 microM , respectively , whereas that of gene , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	T13	T26	17632107
CPR:3	CHEMICAL	GENE-Y	16	28	The transcriptional activity of torafugu gene was enhanced 4.5- and 11.5-fold by chemical and chemical ( chemical ) each at 10 microM , respectively , whereas that of gene , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	T13	T27	17632107
NA	CHEMICAL	GENE-N	12	4	The activities of torafugu gene were also enhanced 5.6- and 6.3-fold by chemical at 1 microM , respectively , but not by chemical at this concentration .	T1	T28	17632107
NA	CHEMICAL	GENE-N	4	4	The activities of torafugu gene were also enhanced 5.6- and 6.3-fold by chemical at 1 microM , respectively , but not by chemical at this concentration .	T2	T28	17632107
CPR:3	CHEMICAL	GENE-N	14	7	Furthermore , the activities of the two gene were enhanced 4.3- and 7.6-fold by chemical , 4.4- and 5.2-fold by chemical , and 6.7- and 8.0-fold by chemical each at 50 microM , respectively .	T3	T15	17632107
CPR:3	CHEMICAL	GENE-N	20	7	Furthermore , the activities of the two gene were enhanced 4.3- and 7.6-fold by chemical , 4.4- and 5.2-fold by chemical , and 6.7- and 8.0-fold by chemical each at 50 microM , respectively .	T4	T15	17632107
CPR:3	CHEMICAL	GENE-N	27	7	Furthermore , the activities of the two gene were enhanced 4.3- and 7.6-fold by chemical , 4.4- and 5.2-fold by chemical , and 6.7- and 8.0-fold by chemical each at 50 microM , respectively .	T5	T15	17632107
NA	CHEMICAL	GENE-N	13	8	On the other hand , the activities of gene were not changed by chemical , chemical , chemical , nor PUFAs .	T6	T18	17632107
NA	CHEMICAL	GENE-N	15	8	On the other hand , the activities of gene were not changed by chemical , chemical , chemical , nor PUFAs .	T7	T18	17632107
NA	CHEMICAL	GENE-N	17	8	On the other hand , the activities of gene were not changed by chemical , chemical , chemical , nor PUFAs .	T8	T18	17632107
NA	CHEMICAL	GENE-Y	5	0	gene is required for vesicular chemical /chemical -antiport activity .	T21	T29	23607712
NA	CHEMICAL	GENE-Y	6	0	gene is required for vesicular chemical /chemical -antiport activity .	T22	T29	23607712
NA	CHEMICAL	GENE-Y	2	0	gene , a vesicular protein interacting with membranes upon low-affinity chemical -binding , plays a major role in excitation-release coupling , by synchronizing chemical entry with fast neurotransmitter release .	T8	T26	23607712
NA	CHEMICAL	GENE-Y	2	0	gene , a vesicular protein interacting with membranes upon low-affinity chemical -binding , plays a major role in excitation-release coupling , by synchronizing chemical entry with fast neurotransmitter release .	T9	T26	23607712
NA	CHEMICAL	GENE-Y	13	5	Here , we report that gene is necessary for expression of the vesicular chemical /chemical -antiport .	T10	T27	23607712
NA	CHEMICAL	GENE-Y	14	5	Here , we report that gene is necessary for expression of the vesicular chemical /chemical -antiport .	T11	T27	23607712
NA	CHEMICAL	GENE-Y	8	15	The results were congruent and highly significant : chemical /chemical -antiport activity is detectable only in acidic organelles expressing functional gene .	T19	T28	23607712
NA	CHEMICAL	GENE-Y	9	15	The results were congruent and highly significant : chemical /chemical -antiport activity is detectable only in acidic organelles expressing functional gene .	T20	T28	23607712
NA	CHEMICAL	GENE-Y	20	3	In contrast , gene-deficient cells - and cells where transgenically encoded gene was acutely photo-inactivated - were devoid of any chemical /chemical -antiport activity .	T1	T23	23607712
NA	CHEMICAL	GENE-Y	20	5	In contrast , gene-deficient cells - and cells where transgenically encoded gene was acutely photo-inactivated - were devoid of any chemical /chemical -antiport activity .	T1	T24	23607712
NA	CHEMICAL	GENE-Y	3	3	In contrast , gene-deficient cells - and cells where transgenically encoded gene was acutely photo-inactivated - were devoid of any chemical /chemical -antiport activity .	T2	T23	23607712
NA	CHEMICAL	GENE-Y	3	5	In contrast , gene-deficient cells - and cells where transgenically encoded gene was acutely photo-inactivated - were devoid of any chemical /chemical -antiport activity .	T2	T24	23607712
CPR:6	CHEMICAL	GENE-N	2	13	Iontophoresis of chemical , whose serotonergic actions include antagonism and partial agonism at gene receptors , also increased chemical and decreased firing ( n=4 ) .	T8	T22	10682715
NA	CHEMICAL	GENE-N	18	13	Iontophoresis of chemical , whose serotonergic actions include antagonism and partial agonism at gene receptors , also increased chemical and decreased firing ( n=4 ) .	T9	T22	10682715
CPR:6	CHEMICAL	GENE-N	0	4	chemical ( intravenous , 1 mg/kg ) , whose serotonergic actions include gene and gene antagonism , typically raised chemical levels ( four of five cells ) and always blocked inhibition by chemical ( n = 3 ) .	T10	T23	10682715
CPR:6	CHEMICAL	GENE-N	0	14	chemical ( intravenous , 1 mg/kg ) , whose serotonergic actions include gene and gene antagonism , typically raised chemical levels ( four of five cells ) and always blocked inhibition by chemical ( n = 3 ) .	T10	T24	10682715
NA	CHEMICAL	GENE-N	19	4	chemical ( intravenous , 1 mg/kg ) , whose serotonergic actions include gene and gene antagonism , typically raised chemical levels ( four of five cells ) and always blocked inhibition by chemical ( n = 3 ) .	T11	T23	10682715
NA	CHEMICAL	GENE-N	19	14	chemical ( intravenous , 1 mg/kg ) , whose serotonergic actions include gene and gene antagonism , typically raised chemical levels ( four of five cells ) and always blocked inhibition by chemical ( n = 3 ) .	T11	T24	10682715
NA	CHEMICAL	GENE-N	32	4	chemical ( intravenous , 1 mg/kg ) , whose serotonergic actions include gene and gene antagonism , typically raised chemical levels ( four of five cells ) and always blocked inhibition by chemical ( n = 3 ) .	T12	T23	10682715
NA	CHEMICAL	GENE-N	32	14	chemical ( intravenous , 1 mg/kg ) , whose serotonergic actions include gene and gene antagonism , typically raised chemical levels ( four of five cells ) and always blocked inhibition by chemical ( n = 3 ) .	T12	T24	10682715
NA	CHEMICAL	GENE-Y	7	18	There has been much recent interest in chemical ( chemical ) signaling through one of its receptors , gene , in fibrotic diseases , but the mechanisms by which chemical-gene signaling promotes pathological fibrosis remain to be fully elucidated .	T4	T8	23322166
NA	CHEMICAL	GENE-Y	7	29	There has been much recent interest in chemical ( chemical ) signaling through one of its receptors , gene , in fibrotic diseases , but the mechanisms by which chemical-gene signaling promotes pathological fibrosis remain to be fully elucidated .	T4	T16	23322166
NA	CHEMICAL	GENE-Y	9	18	There has been much recent interest in chemical ( chemical ) signaling through one of its receptors , gene , in fibrotic diseases , but the mechanisms by which chemical-gene signaling promotes pathological fibrosis remain to be fully elucidated .	T5	T8	23322166
NA	CHEMICAL	GENE-Y	9	29	There has been much recent interest in chemical ( chemical ) signaling through one of its receptors , gene , in fibrotic diseases , but the mechanisms by which chemical-gene signaling promotes pathological fibrosis remain to be fully elucidated .	T5	T16	23322166
NA	CHEMICAL	GENE-Y	29	18	There has been much recent interest in chemical ( chemical ) signaling through one of its receptors , gene , in fibrotic diseases , but the mechanisms by which chemical-gene signaling promotes pathological fibrosis remain to be fully elucidated .	T2	T8	23322166
NA	CHEMICAL	GENE-Y	29	29	There has been much recent interest in chemical ( chemical ) signaling through one of its receptors , gene , in fibrotic diseases , but the mechanisms by which chemical-gene signaling promotes pathological fibrosis remain to be fully elucidated .	T2	T16	23322166
NA	CHEMICAL	GENE-Y	12	14	Using a mouse peritoneal fibrosis model , we demonstrate central roles for chemical and gene in fibroblast proliferation .	T3	T17	23322166
NA	CHEMICAL	GENE-Y	12	2	Fasting serum gene , gene , gene , gene , gene , chemical , as well as body fat composition were analyzed during thyrotoxicosis in 40 hyperthyroid patients ( 50.5 ± 15.2 years old , 22 females , 31 with Graves disease , and 9 with toxic nodular goiter ) .	T2	T12	23572405
NA	CHEMICAL	GENE-Y	12	4	Fasting serum gene , gene , gene , gene , gene , chemical , as well as body fat composition were analyzed during thyrotoxicosis in 40 hyperthyroid patients ( 50.5 ± 15.2 years old , 22 females , 31 with Graves disease , and 9 with toxic nodular goiter ) .	T2	T13	23572405
NA	CHEMICAL	GENE-Y	12	6	Fasting serum gene , gene , gene , gene , gene , chemical , as well as body fat composition were analyzed during thyrotoxicosis in 40 hyperthyroid patients ( 50.5 ± 15.2 years old , 22 females , 31 with Graves disease , and 9 with toxic nodular goiter ) .	T2	T14	23572405
NA	CHEMICAL	GENE-Y	12	8	Fasting serum gene , gene , gene , gene , gene , chemical , as well as body fat composition were analyzed during thyrotoxicosis in 40 hyperthyroid patients ( 50.5 ± 15.2 years old , 22 females , 31 with Graves disease , and 9 with toxic nodular goiter ) .	T2	T15	23572405
NA	CHEMICAL	GENE-Y	12	10	Fasting serum gene , gene , gene , gene , gene , chemical , as well as body fat composition were analyzed during thyrotoxicosis in 40 hyperthyroid patients ( 50.5 ± 15.2 years old , 22 females , 31 with Graves disease , and 9 with toxic nodular goiter ) .	T2	T16	23572405
CPR:4	CHEMICAL	GENE-Y	16	23	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T4	T8	23465614
CPR:4	CHEMICAL	GENE-Y	16	25	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T4	T9	23465614
CPR:4	CHEMICAL	GENE-Y	16	27	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T4	T10	23465614
CPR:4	CHEMICAL	GENE-Y	16	29	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T4	T11	23465614
NA	CHEMICAL	GENE-Y	16	43	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T4	T12	23465614
NA	CHEMICAL	GENE-Y	40	23	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T6	T8	23465614
NA	CHEMICAL	GENE-Y	40	25	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T6	T9	23465614
NA	CHEMICAL	GENE-Y	40	27	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T6	T10	23465614
NA	CHEMICAL	GENE-Y	40	29	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T6	T11	23465614
CPR:5	CHEMICAL	GENE-Y	40	43	Of the compounds active in the present assay system , the most potent compound 7 , chemical , significantly suppressed the induction of gene ( gene and gene ( gene ) protein expression , and inhibited adipocyte differentiation induced by chemical , a gene agonist .	T6	T12	23465614
CPR:4	CHEMICAL	GENE-Y	6	12	Fragment-based drug design and identification of chemical , a novel orally bioavailable gene inhibitor for cancer therapy .	T3	T10	23416191
CPR:4	CHEMICAL	GENE-N	6	12	The most potent compound 5 ( chemical ) has demonstrated to inhibit gene activity , downregulate phosphorylation of gene , increase the expression of cleaved gene , inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values .	T1	T5	23416191
CPR:4	CHEMICAL	GENE-Y	6	18	The most potent compound 5 ( chemical ) has demonstrated to inhibit gene activity , downregulate phosphorylation of gene , increase the expression of cleaved gene , inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values .	T1	T6	23416191
CPR:3	CHEMICAL	GENE-Y	6	25	The most potent compound 5 ( chemical ) has demonstrated to inhibit gene activity , downregulate phosphorylation of gene , increase the expression of cleaved gene , inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values .	T1	T7	23416191
CPR:5	CHEMICAL	GENE-Y	2	6	CONTEXT : chemical is a novel gene and gene selective agonist recently approved for insomnia treatment .	T11	T13	17015817
CPR:5	CHEMICAL	GENE-Y	2	8	CONTEXT : chemical is a novel gene and gene selective agonist recently approved for insomnia treatment .	T11	T14	17015817
CPR:3	CHEMICAL	GENE-Y	0	5	chemical binding and activation of gene in GH4ZR7 cells .	T26	T37	7665369
NA	CHEMICAL	GENE-Y	6	5	chemical binding and activation of gene in GH4ZR7 cells .	T27	T37	7665369
NA	CHEMICAL	GENE-Y	0	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T1	T34	7665369
NA	CHEMICAL	GENE-Y	0	12	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T1	T28	7665369
NA	CHEMICAL	GENE-Y	0	14	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T1	T30	7665369
NA	CHEMICAL	GENE-Y	0	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T1	T31	7665369
NA	CHEMICAL	GENE-Y	19	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T12	T34	7665369
NA	CHEMICAL	GENE-Y	19	12	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T12	T28	7665369
NA	CHEMICAL	GENE-Y	19	14	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T12	T30	7665369
NA	CHEMICAL	GENE-Y	19	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T12	T31	7665369
NA	CHEMICAL	GENE-Y	9	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T21	T34	7665369
CPR:4	CHEMICAL	GENE-Y	9	12	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T21	T28	7665369
CPR:4	CHEMICAL	GENE-Y	9	14	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T21	T30	7665369
NA	CHEMICAL	GENE-Y	9	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T21	T31	7665369
NA	CHEMICAL	GENE-Y	17	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T5	T34	7665369
CPR:9	CHEMICAL	GENE-Y	17	12	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T5	T28	7665369
CPR:9	CHEMICAL	GENE-Y	17	14	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T5	T30	7665369
NA	CHEMICAL	GENE-Y	17	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T5	T31	7665369
NA	CHEMICAL	GENE-Y	19	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T6	T34	7665369
NA	CHEMICAL	GENE-Y	19	12	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T6	T28	7665369
NA	CHEMICAL	GENE-Y	19	14	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T6	T30	7665369
NA	CHEMICAL	GENE-Y	19	5	chemical inhibition of radioligand binding to the gene and chemical inhibition of gene ( gene ) -stimulated chemical production in GH4ZR7 cells , stably transfected with a rat D2 chemical receptor , were evaluated .	T6	T31	7665369
NA	CHEMICAL	GENE-Y	0	7	chemical inhibition of the binding of the gene-specific radioligand , chemical , exhibited a KI ( inhibition constant ) of 6.9 +/- 2.6 nM , whereas chemical was much less potent ( 370 +/- 160 nM ) .	T7	T32	7665369
NA	CHEMICAL	GENE-Y	10	7	chemical inhibition of the binding of the gene-specific radioligand , chemical , exhibited a KI ( inhibition constant ) of 6.9 +/- 2.6 nM , whereas chemical was much less potent ( 370 +/- 160 nM ) .	T8	T32	7665369
NA	CHEMICAL	GENE-Y	13	7	chemical inhibition of the binding of the gene-specific radioligand , chemical , exhibited a KI ( inhibition constant ) of 6.9 +/- 2.6 nM , whereas chemical was much less potent ( 370 +/- 160 nM ) .	T9	T32	7665369
CPR:4	CHEMICAL	GENE-Y	0	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T10	T33	7665369
CPR:9	CHEMICAL	GENE-Y	7	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T11	T33	7665369
CPR:4	CHEMICAL	GENE-Y	4	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T13	T33	7665369
CPR:4	CHEMICAL	GENE-Y	4	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T14	T33	7665369
CPR:4	CHEMICAL	GENE-Y	4	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T15	T33	7665369
CPR:4	CHEMICAL	GENE-Y	4	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T16	T33	7665369
CPR:4	CHEMICAL	GENE-Y	4	6	chemical were also effective in inhibiting gene-stimulated chemical production , with EC50 values for chemical , chemical , chemical , chemical , and chemical of 8 +/- 2 , 47 +/- 2 , 28 +/- 2 , 2 +/- 1 , and 8 +/- 1 nM , respectively .	T17	T33	7665369
NA	CHEMICAL	GENE-N	2	11	Inhibition of chemical production by chemical was blocked by the chemical receptor antagonist , chemical ( IC50 , 300 +/- 150 nM ) .	T18	T35	7665369
NA	CHEMICAL	GENE-N	5	11	Inhibition of chemical production by chemical was blocked by the chemical receptor antagonist , chemical ( IC50 , 300 +/- 150 nM ) .	T19	T35	7665369
NA	CHEMICAL	GENE-N	10	11	Inhibition of chemical production by chemical was blocked by the chemical receptor antagonist , chemical ( IC50 , 300 +/- 150 nM ) .	T20	T35	7665369
CPR:6	CHEMICAL	GENE-N	14	11	Inhibition of chemical production by chemical was blocked by the chemical receptor antagonist , chemical ( IC50 , 300 +/- 150 nM ) .	T22	T35	7665369
NA	CHEMICAL	GENE-Y	8	11	Our results indicate that ergot compounds , especially chemical , bind to gene and elicit second messenger responses similar to that of chemical .	T23	T36	7665369
NA	CHEMICAL	GENE-Y	22	11	Our results indicate that ergot compounds , especially chemical , bind to gene and elicit second messenger responses similar to that of chemical .	T24	T36	7665369
CPR:4	CHEMICAL	GENE-Y	0	2	chemical derivatives as gene inhibitors .	T11	T17	11141093
NA	CHEMICAL	GENE-Y	1	20	In a search for less flexible analogues of chemical ( 1 ) , a chemical chemical endowed with an interesting gene affinity profile , we discovered compound 2 , in which the terminal chemical groups of 1 have been incorporated into a chemical system .	T5	T12	11141093
NA	CHEMICAL	GENE-Y	1	20	In a search for less flexible analogues of chemical ( 1 ) , a chemical chemical endowed with an interesting gene affinity profile , we discovered compound 2 , in which the terminal chemical groups of 1 have been incorporated into a chemical system .	T9	T12	11141093
NA	CHEMICAL	GENE-Y	1	20	In a search for less flexible analogues of chemical ( 1 ) , a chemical chemical endowed with an interesting gene affinity profile , we discovered compound 2 , in which the terminal chemical groups of 1 have been incorporated into a chemical system .	T10	T12	11141093
NA	CHEMICAL	GENE-Y	15	20	In a search for less flexible analogues of chemical ( 1 ) , a chemical chemical endowed with an interesting gene affinity profile , we discovered compound 2 , in which the terminal chemical groups of 1 have been incorporated into a chemical system .	T1	T12	11141093
NA	CHEMICAL	GENE-Y	42	20	In a search for less flexible analogues of chemical ( 1 ) , a chemical chemical endowed with an interesting gene affinity profile , we discovered compound 2 , in which the terminal chemical groups of 1 have been incorporated into a chemical system .	T2	T12	11141093
CPR:4	CHEMICAL	GENE-Y	10	5	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T3	T13	11141093
NA	CHEMICAL	GENE-Y	10	39	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T3	T14	11141093
NA	CHEMICAL	GENE-Y	10	41	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T3	T15	11141093
CPR:4	CHEMICAL	GENE-Y	16	5	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T4	T13	11141093
NA	CHEMICAL	GENE-Y	16	39	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T4	T14	11141093
NA	CHEMICAL	GENE-Y	16	41	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T4	T15	11141093
NA	CHEMICAL	GENE-Y	26	5	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T6	T13	11141093
NA	CHEMICAL	GENE-Y	26	39	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T6	T14	11141093
NA	CHEMICAL	GENE-Y	26	41	Since this compound retains good gene inhibitory activity and its chemical moiety is reminiscent of the chemical ( 3 ) , we have designed and synthesized chemical 4-6 , and their biological evaluation has been assessed in vitro against gene and gene .	T6	T15	11141093
NA	CHEMICAL	GENE-N	0	1	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T13	T30	16719808
NA	CHEMICAL	GENE-N	0	10	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T13	T32	16719808
NA	CHEMICAL	GENE-N	0	15	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T13	T33	16719808
NA	CHEMICAL	GENE-N	0	17	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T13	T31	16719808
NA	CHEMICAL	GENE-N	9	1	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T16	T30	16719808
NA	CHEMICAL	GENE-N	9	10	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T16	T32	16719808
NA	CHEMICAL	GENE-N	9	15	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T16	T33	16719808
NA	CHEMICAL	GENE-N	9	17	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T16	T31	16719808
NA	CHEMICAL	GENE-N	23	1	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T15	T30	16719808
NA	CHEMICAL	GENE-N	23	10	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T15	T32	16719808
NA	CHEMICAL	GENE-N	23	15	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T15	T33	16719808
NA	CHEMICAL	GENE-N	23	17	chemical receptors are not alone : dynamic regulation of chemical receptor structure and function by gene and gene leads to disease-specific nuances of chemical-signalling .	T15	T31	16719808
NA	CHEMICAL	GENE-N	0	1	chemical receptors of the chemical ( chemical- ) subtype are tetrameric allosteric and gene .	T1	T17	16719808
NA	CHEMICAL	GENE-N	0	13	chemical receptors of the chemical ( chemical- ) subtype are tetrameric allosteric and gene .	T1	T28	16719808
NA	CHEMICAL	GENE-N	4	1	chemical receptors of the chemical ( chemical- ) subtype are tetrameric allosteric and gene .	T7	T17	16719808
NA	CHEMICAL	GENE-N	4	13	chemical receptors of the chemical ( chemical- ) subtype are tetrameric allosteric and gene .	T7	T28	16719808
NA	CHEMICAL	GENE-N	6	1	chemical receptors of the chemical ( chemical- ) subtype are tetrameric allosteric and gene .	T10	T17	16719808
NA	CHEMICAL	GENE-N	6	13	chemical receptors of the chemical ( chemical- ) subtype are tetrameric allosteric and gene .	T10	T28	16719808
NA	CHEMICAL	GENE-N	4	5	On the structural level chemical receptors have an enormous flexibility due to seven genes ( gene , gene and gene ) , alternative splicing , RNA-editing and extensive posttranslational modifications , like phosphorylation and glycosylation .	T9	T23	16719808
NA	CHEMICAL	GENE-Y	4	15	On the structural level chemical receptors have an enormous flexibility due to seven genes ( gene , gene and gene ) , alternative splicing , RNA-editing and extensive posttranslational modifications , like phosphorylation and glycosylation .	T9	T24	16719808
NA	CHEMICAL	GENE-N	4	17	On the structural level chemical receptors have an enormous flexibility due to seven genes ( gene , gene and gene ) , alternative splicing , RNA-editing and extensive posttranslational modifications , like phosphorylation and glycosylation .	T9	T25	16719808
NA	CHEMICAL	GENE-N	4	19	On the structural level chemical receptors have an enormous flexibility due to seven genes ( gene , gene and gene ) , alternative splicing , RNA-editing and extensive posttranslational modifications , like phosphorylation and glycosylation .	T9	T26	16719808
NA	CHEMICAL	GENE-N	0	1	chemical receptors are thought to be responsible for excitotoxicity and subsequent downstream events like neuroinflammation and apoptosis and thus have been implicated in many important human pathologies , ranging from amyotrophic lateral sclerosis , Alzheimer 's and Parkinson ' disease , depression , epilepsy , trauma and stroke to schizophrenia .	T11	T27	16719808
NA	CHEMICAL	GENE-N	4	25	This fundamental significance of chemical receptor-related excitotoxicity is discussed in the context of the developing clinical success of chemical , but moreover set into relation to various proteomic and genetic markers of said diseases .	T12	T29	16719808
NA	CHEMICAL	GENE-N	9	25	This fundamental significance of chemical receptor-related excitotoxicity is discussed in the context of the developing clinical success of chemical , but moreover set into relation to various proteomic and genetic markers of said diseases .	T2	T29	16719808
NA	CHEMICAL	GENE-Y	0	14	chemical residues at the N- and C-termini are essential for the folding of active gene polypeptide .	T3	T14	23044488
CPR:9	CHEMICAL	GENE-Y	2	0	gene ( gene ) is currently the most suitable bioscavenger for the prophylaxis of highly toxic chemical ( OP ) nerve agents .	T1	T4	23044488
CPR:9	CHEMICAL	GENE-Y	2	2	gene ( gene ) is currently the most suitable bioscavenger for the prophylaxis of highly toxic chemical ( OP ) nerve agents .	T1	T10	23044488
NA	CHEMICAL	GENE-Y	13	11	Studies have indicated that the three-dimensional structure and the domains of gene ( chemical pocket , lip of the active center gorge , and the anionic substrate-binding domain ) that are critical for the binding of substrate are also essential for the selectivity and binding of inhibitors including OPs .	T2	T12	23044488
NA	CHEMICAL	GENE-Y	13	5	Moreover , treatment of high-fat-diet-fed gene-knockout mice with a selective gene inhibitor , chemical , improved vascular function , and also attenuated obesity .	T1	T3	23378608
CPR:4	CHEMICAL	GENE-Y	13	8	Moreover , treatment of high-fat-diet-fed gene-knockout mice with a selective gene inhibitor , chemical , improved vascular function , and also attenuated obesity .	T1	T4	23378608
CPR:6	CHEMICAL	GENE-Y	0	10	chemical ( chemical , chemical ) is a novel antiallergic/chemical H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories .	T1	T20	12046981
CPR:6	CHEMICAL	GENE-Y	2	10	chemical ( chemical , chemical ) is a novel antiallergic/chemical H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories .	T10	T20	12046981
CPR:6	CHEMICAL	GENE-Y	4	10	chemical ( chemical , chemical ) is a novel antiallergic/chemical H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories .	T12	T20	12046981
NA	CHEMICAL	GENE-Y	6	10	chemical ( chemical , chemical ) is a novel antiallergic/chemical H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories .	T8	T20	12046981
CPR:6	CHEMICAL	GENE-Y	0	5	chemical is a selective chemical H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as chemical and chemical from human polymorphonuclear leukocytes and eosinophils .	T13	T21	12046981
NA	CHEMICAL	GENE-Y	1	5	chemical is a selective chemical H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as chemical and chemical from human polymorphonuclear leukocytes and eosinophils .	T14	T21	12046981
NA	CHEMICAL	GENE-Y	19	5	chemical is a selective chemical H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as chemical and chemical from human polymorphonuclear leukocytes and eosinophils .	T15	T21	12046981
NA	CHEMICAL	GENE-Y	2	5	chemical is a selective chemical H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as chemical and chemical from human polymorphonuclear leukocytes and eosinophils .	T16	T21	12046981
NA	CHEMICAL	GENE-Y	0	18	chemical exerted no significant effects on action potential duration in isolated guinea pig ventricular myocytes , myocardium and gene .	T18	T22	12046981
CPR:6	CHEMICAL	GENE-Y	8	5	In vitro metabolism of the gene receptor antagonist chemical .	T10	T25	23030680
NA	CHEMICAL	GENE-N	3	18	The metabolism of chemical has been examined in vitro using hepatic microsomes from human and recombinant heterologously expressed gene ( gene ) .	T2	T16	23030680
NA	CHEMICAL	GENE-N	3	20	The metabolism of chemical has been examined in vitro using hepatic microsomes from human and recombinant heterologously expressed gene ( gene ) .	T2	T17	23030680
NA	CHEMICAL	GENE-N	30	1	The gene data was normalized relative to the levels of each gene form in native human liver microsomes to better assess the contribution of each gene in the metabolism of chemical .	T9	T18	23030680
NA	CHEMICAL	GENE-N	30	11	The gene data was normalized relative to the levels of each gene form in native human liver microsomes to better assess the contribution of each gene in the metabolism of chemical .	T9	T19	23030680
CPR:9	CHEMICAL	GENE-N	30	25	The gene data was normalized relative to the levels of each gene form in native human liver microsomes to better assess the contribution of each gene in the metabolism of chemical .	T9	T20	23030680
NA	CHEMICAL	GENE-Y	0	0	gene has shown to be an essential component in gene catalyzed chemical formation and provides insights on the disconnect between human liver microsomes data and that of gene .	T1	T11	23030680
CPR:9	CHEMICAL	GENE-Y	0	9	gene has shown to be an essential component in gene catalyzed chemical formation and provides insights on the disconnect between human liver microsomes data and that of gene .	T1	T12	23030680
NA	CHEMICAL	GENE-N	0	27	gene has shown to be an essential component in gene catalyzed chemical formation and provides insights on the disconnect between human liver microsomes data and that of gene .	T1	T13	23030680
NA	CHEMICAL	GENE-N	8	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T13	T33	2450203
NA	CHEMICAL	GENE-N	8	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T13	T34	2450203
NA	CHEMICAL	GENE-N	10	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T14	T33	2450203
NA	CHEMICAL	GENE-N	10	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T14	T34	2450203
NA	CHEMICAL	GENE-N	12	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T16	T33	2450203
NA	CHEMICAL	GENE-N	12	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T16	T34	2450203
NA	CHEMICAL	GENE-N	14	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T17	T33	2450203
NA	CHEMICAL	GENE-N	14	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T17	T34	2450203
NA	CHEMICAL	GENE-N	16	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T18	T33	2450203
NA	CHEMICAL	GENE-N	16	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T18	T34	2450203
NA	CHEMICAL	GENE-N	28	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T19	T33	2450203
NA	CHEMICAL	GENE-N	28	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T19	T34	2450203
NA	CHEMICAL	GENE-N	36	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T20	T33	2450203
NA	CHEMICAL	GENE-N	36	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T20	T34	2450203
NA	CHEMICAL	GENE-N	39	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T21	T33	2450203
NA	CHEMICAL	GENE-N	39	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T21	T34	2450203
NA	CHEMICAL	GENE-N	48	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T23	T33	2450203
NA	CHEMICAL	GENE-N	48	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T23	T34	2450203
NA	CHEMICAL	GENE-N	54	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T24	T33	2450203
CPR:5	CHEMICAL	GENE-N	54	20	Limitation of SRF was produced by the anticonvulsant chemical ( chemical , chemical , chemical and chemical ) at low to mid nanomolar concentrations , by a convulsant chemical which does not bind to high affinity chemical receptors ( chemical ) at high nanomolar concentrations and by a chemical receptor weak partial agonist ( chemical ) at micromolar concentrations .	T24	T34	2450203
NA	CHEMICAL	GENE-N	5	11	The limitation of SRF by chemical was not prevented by inverse or partial agonists at the chemical receptor , including chemical and the chemical .	T26	T29	2450203
NA	CHEMICAL	GENE-N	16	11	The limitation of SRF by chemical was not prevented by inverse or partial agonists at the chemical receptor , including chemical and the chemical .	T1	T29	2450203
CPR:5	CHEMICAL	GENE-N	5	11	The limitation of SRF by chemical was not prevented by inverse or partial agonists at the chemical receptor , including chemical and the chemical .	T2	T29	2450203
CPR:5	CHEMICAL	GENE-N	23	11	The limitation of SRF by chemical was not prevented by inverse or partial agonists at the chemical receptor , including chemical and the chemical .	T3	T29	2450203
NA	CHEMICAL	GENE-N	12	19	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T5	T30	2450203
NA	CHEMICAL	GENE-N	12	18	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T5	T31	2450203
NA	CHEMICAL	GENE-N	12	39	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T5	T32	2450203
NA	CHEMICAL	GENE-N	16	19	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T6	T30	2450203
NA	CHEMICAL	GENE-N	16	18	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T6	T31	2450203
NA	CHEMICAL	GENE-N	16	39	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T6	T32	2450203
NA	CHEMICAL	GENE-N	38	19	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T7	T30	2450203
NA	CHEMICAL	GENE-N	38	18	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T7	T31	2450203
NA	CHEMICAL	GENE-N	38	39	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T7	T32	2450203
NA	CHEMICAL	GENE-N	26	19	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T8	T30	2450203
NA	CHEMICAL	GENE-N	26	18	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T8	T31	2450203
NA	CHEMICAL	GENE-N	26	39	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T8	T32	2450203
NA	CHEMICAL	GENE-N	31	19	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T9	T30	2450203
NA	CHEMICAL	GENE-N	31	18	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T9	T31	2450203
CPR:3	CHEMICAL	GENE-N	31	39	These findings suggest that limitation of SRF was produced by binding of chemical , but not chemical , to gene and not to high affinity central chemical receptors , and that chemical limit SRF by slowing recovery of chemical channels from inactivation .	T9	T32	2450203
NA	CHEMICAL	GENE-Y	2	10	Pharmacogenomics of chemical metabolism : functional analysis of genetic variants in chemical deaminase and chemical kinase .	T23	T47	23230131
NA	CHEMICAL	GENE-Y	2	10	Pharmacogenomics of chemical metabolism : functional analysis of genetic variants in chemical deaminase and chemical kinase .	T23	T46	23230131
NA	CHEMICAL	GENE-Y	10	10	Pharmacogenomics of chemical metabolism : functional analysis of genetic variants in chemical deaminase and chemical kinase .	T24	T47	23230131
NA	CHEMICAL	GENE-Y	10	10	Pharmacogenomics of chemical metabolism : functional analysis of genetic variants in chemical deaminase and chemical kinase .	T24	T46	23230131
NA	CHEMICAL	GENE-Y	10	10	Pharmacogenomics of chemical metabolism : functional analysis of genetic variants in chemical deaminase and chemical kinase .	T22	T47	23230131
NA	CHEMICAL	GENE-Y	10	10	Pharmacogenomics of chemical metabolism : functional analysis of genetic variants in chemical deaminase and chemical kinase .	T22	T46	23230131
CPR:9	CHEMICAL	GENE-Y	0	10	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T1	T40	23230131
CPR:9	CHEMICAL	GENE-Y	0	12	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T1	T43	23230131
CPR:9	CHEMICAL	GENE-Y	0	16	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T1	T45	23230131
CPR:9	CHEMICAL	GENE-Y	0	18	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T1	T27	23230131
CPR:9	CHEMICAL	GENE-Y	2	10	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T5	T40	23230131
CPR:9	CHEMICAL	GENE-Y	2	12	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T5	T43	23230131
CPR:9	CHEMICAL	GENE-Y	2	16	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T5	T45	23230131
CPR:9	CHEMICAL	GENE-Y	2	18	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T5	T27	23230131
CPR:9	CHEMICAL	GENE-Y	3	10	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T8	T40	23230131
CPR:9	CHEMICAL	GENE-Y	3	12	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T8	T43	23230131
CPR:9	CHEMICAL	GENE-Y	3	16	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T8	T45	23230131
CPR:9	CHEMICAL	GENE-Y	3	18	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T8	T27	23230131
NA	CHEMICAL	GENE-Y	9	10	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T16	T40	23230131
NA	CHEMICAL	GENE-Y	9	12	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T16	T43	23230131
NA	CHEMICAL	GENE-Y	9	16	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T16	T45	23230131
NA	CHEMICAL	GENE-Y	9	18	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T16	T27	23230131
NA	CHEMICAL	GENE-Y	15	10	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T20	T40	23230131
NA	CHEMICAL	GENE-Y	15	12	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T20	T43	23230131
NA	CHEMICAL	GENE-Y	15	16	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T20	T45	23230131
NA	CHEMICAL	GENE-Y	15	18	chemical ( chemical , chemical ) is metabolized by chemical deaminase ( gene ) and chemical kinase ( gene ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .	T20	T27	23230131
CPR:9	CHEMICAL	GENE-Y	23	5	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T32	23230131
CPR:9	CHEMICAL	GENE-N	23	7	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T33	23230131
CPR:9	CHEMICAL	GENE-N	23	9	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T34	23230131
CPR:9	CHEMICAL	GENE-Y	23	12	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T35	23230131
CPR:9	CHEMICAL	GENE-N	23	14	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T36	23230131
CPR:9	CHEMICAL	GENE-N	23	16	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T37	23230131
CPR:9	CHEMICAL	GENE-N	23	19	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T9	T38	23230131
CPR:9	CHEMICAL	GENE-Y	39	5	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T32	23230131
CPR:9	CHEMICAL	GENE-N	39	7	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T33	23230131
CPR:9	CHEMICAL	GENE-N	39	9	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T34	23230131
CPR:9	CHEMICAL	GENE-Y	39	12	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T35	23230131
CPR:9	CHEMICAL	GENE-N	39	14	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T36	23230131
CPR:9	CHEMICAL	GENE-N	39	16	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T37	23230131
CPR:9	CHEMICAL	GENE-N	39	19	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T10	T38	23230131
CPR:9	CHEMICAL	GENE-Y	42	5	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T32	23230131
CPR:9	CHEMICAL	GENE-N	42	7	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T33	23230131
CPR:9	CHEMICAL	GENE-N	42	9	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T34	23230131
CPR:9	CHEMICAL	GENE-Y	42	12	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T35	23230131
CPR:9	CHEMICAL	GENE-N	42	14	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T36	23230131
CPR:9	CHEMICAL	GENE-N	42	16	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T37	23230131
CPR:9	CHEMICAL	GENE-N	42	19	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T11	T38	23230131
CPR:9	CHEMICAL	GENE-Y	15	5	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T32	23230131
CPR:9	CHEMICAL	GENE-N	15	7	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T33	23230131
CPR:9	CHEMICAL	GENE-N	15	9	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T34	23230131
CPR:9	CHEMICAL	GENE-Y	15	12	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T35	23230131
CPR:9	CHEMICAL	GENE-N	15	14	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T36	23230131
CPR:9	CHEMICAL	GENE-N	15	16	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T37	23230131
CPR:9	CHEMICAL	GENE-N	15	19	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T12	T38	23230131
CPR:9	CHEMICAL	GENE-Y	49	5	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T13	T32	23230131
NA	CHEMICAL	GENE-N	49	9	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T13	T34	23230131
NA	CHEMICAL	GENE-Y	49	12	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T13	T35	23230131
NA	CHEMICAL	GENE-N	49	14	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T13	T36	23230131
NA	CHEMICAL	GENE-N	49	16	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T13	T37	23230131
NA	CHEMICAL	GENE-N	49	19	Wild-type enzymes and variants of gene ( gene and gene ) and gene ( gene , gene , and gene ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for chemical ( chemical ) , chemical , and its metabolite chemical ( chemical ) as substrates .	T13	T38	23230131
CPR:9	CHEMICAL	GENE-Y	16	2	All three gene proteins showed similar K ( m ) and V ( max ) for chemical and chemical deamination , except for gene70Thr , which had a 2.5-fold lower K ( m ) and 6-fold lower V ( max ) for chemical deamination .	T14	T39	23230131
NA	CHEMICAL	GENE-Y	16	23	All three gene proteins showed similar K ( m ) and V ( max ) for chemical and chemical deamination , except for gene70Thr , which had a 2.5-fold lower K ( m ) and 6-fold lower V ( max ) for chemical deamination .	T14	T41	23230131
CPR:9	CHEMICAL	GENE-Y	18	2	All three gene proteins showed similar K ( m ) and V ( max ) for chemical and chemical deamination , except for gene70Thr , which had a 2.5-fold lower K ( m ) and 6-fold lower V ( max ) for chemical deamination .	T15	T39	23230131
NA	CHEMICAL	GENE-Y	18	23	All three gene proteins showed similar K ( m ) and V ( max ) for chemical and chemical deamination , except for gene70Thr , which had a 2.5-fold lower K ( m ) and 6-fold lower V ( max ) for chemical deamination .	T15	T41	23230131
NA	CHEMICAL	GENE-Y	27	2	All three gene proteins showed similar K ( m ) and V ( max ) for chemical and chemical deamination , except for gene70Thr , which had a 2.5-fold lower K ( m ) and 6-fold lower V ( max ) for chemical deamination .	T17	T39	23230131
CPR:9	CHEMICAL	GENE-Y	27	23	All three gene proteins showed similar K ( m ) and V ( max ) for chemical and chemical deamination , except for gene70Thr , which had a 2.5-fold lower K ( m ) and 6-fold lower V ( max ) for chemical deamination .	T17	T41	23230131
CPR:9	CHEMICAL	GENE-Y	9	2	All four gene proteins yielded comparable metabolic activity for chemical and chemical monophosphorylation , except for gene24Val , which demonstrated an approximately 2-fold increase ( P < 0.05 ) in the intrinsic clearance of chemical monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .	T18	T42	23230131
NA	CHEMICAL	GENE-Y	9	16	All four gene proteins yielded comparable metabolic activity for chemical and chemical monophosphorylation , except for gene24Val , which demonstrated an approximately 2-fold increase ( P < 0.05 ) in the intrinsic clearance of chemical monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .	T18	T44	23230131
CPR:9	CHEMICAL	GENE-Y	11	2	All four gene proteins yielded comparable metabolic activity for chemical and chemical monophosphorylation , except for gene24Val , which demonstrated an approximately 2-fold increase ( P < 0.05 ) in the intrinsic clearance of chemical monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .	T19	T42	23230131
NA	CHEMICAL	GENE-Y	11	16	All four gene proteins yielded comparable metabolic activity for chemical and chemical monophosphorylation , except for gene24Val , which demonstrated an approximately 2-fold increase ( P < 0.05 ) in the intrinsic clearance of chemical monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .	T19	T44	23230131
NA	CHEMICAL	GENE-Y	34	2	All four gene proteins yielded comparable metabolic activity for chemical and chemical monophosphorylation , except for gene24Val , which demonstrated an approximately 2-fold increase ( P < 0.05 ) in the intrinsic clearance of chemical monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .	T21	T42	23230131
CPR:9	CHEMICAL	GENE-Y	34	16	All four gene proteins yielded comparable metabolic activity for chemical and chemical monophosphorylation , except for gene24Val , which demonstrated an approximately 2-fold increase ( P < 0.05 ) in the intrinsic clearance of chemical monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .	T21	T44	23230131
NA	CHEMICAL	GENE-Y	0	0	gene did not significantly contribute to chemical monophosphorylation .	T2	T25	23230131
CPR:9	CHEMICAL	GENE-N	13	4	In conclusion , the gene substitution does not significantly modulate gene activity toward chemical , and therefore would not contribute to interindividual variability in response to chemical .	T3	T26	23230131
CPR:9	CHEMICAL	GENE-Y	13	10	In conclusion , the gene substitution does not significantly modulate gene activity toward chemical , and therefore would not contribute to interindividual variability in response to chemical .	T3	T28	23230131
NA	CHEMICAL	GENE-N	23	4	In conclusion , the gene substitution does not significantly modulate gene activity toward chemical , and therefore would not contribute to interindividual variability in response to chemical .	T4	T26	23230131
NA	CHEMICAL	GENE-Y	23	10	In conclusion , the gene substitution does not significantly modulate gene activity toward chemical , and therefore would not contribute to interindividual variability in response to chemical .	T4	T28	23230131
CPR:9	CHEMICAL	GENE-Y	9	7	The higher in vitro catalytic efficiency of gene24Val toward chemical monophosphorylation may be relevant to chemical clinical response .	T6	T29	23230131
CPR:9	CHEMICAL	GENE-Y	15	7	The higher in vitro catalytic efficiency of gene24Val toward chemical monophosphorylation may be relevant to chemical clinical response .	T7	T29	23230131
NA	CHEMICAL	GENE-Y	0	5	chemicalyan fluorescent protein was fused to the C terminus of the gene , and a specific binding sequence for the small fluorescent compound chemical arsenical hairpin binder , FlAsH , was inserted into the third intracellular loop ; the latter site was labeled in intact cells by incubation with FlAsH .	T7	T13	20083608
NA	CHEMICAL	GENE-Y	23	5	chemicalyan fluorescent protein was fused to the C terminus of the gene , and a specific binding sequence for the small fluorescent compound chemical arsenical hairpin binder , FlAsH , was inserted into the third intracellular loop ; the latter site was labeled in intact cells by incubation with FlAsH .	T8	T13	20083608
NA	CHEMICAL	GENE-Y	4	11	Exploring the effect of chemical-substitution in chemical on the interaction with gene : discovery of a potential clinical candidate for treatment of chemical abuse .	T9	T12	23527317
NA	CHEMICAL	GENE-Y	6	11	Exploring the effect of chemical-substitution in chemical on the interaction with gene : discovery of a potential clinical candidate for treatment of chemical abuse .	T10	T12	23527317
NA	CHEMICAL	GENE-Y	5	11	Exploring the effect of chemical-substitution in chemical on the interaction with gene : discovery of a potential clinical candidate for treatment of chemical abuse .	T8	T12	23527317
NA	CHEMICAL	GENE-N	3	17	A series of chemical-substituted chemical analogues was synthesized and evaluated for their chemical binding affinity at the gene and for their inhibition of vesicular chemical uptake .	T1	T11	23527317
NA	CHEMICAL	GENE-N	4	17	A series of chemical-substituted chemical analogues was synthesized and evaluated for their chemical binding affinity at the gene and for their inhibition of vesicular chemical uptake .	T5	T11	23527317
NA	CHEMICAL	GENE-N	12	17	A series of chemical-substituted chemical analogues was synthesized and evaluated for their chemical binding affinity at the gene and for their inhibition of vesicular chemical uptake .	T7	T11	23527317
CPR:9	CHEMICAL	GENE-N	24	17	A series of chemical-substituted chemical analogues was synthesized and evaluated for their chemical binding affinity at the gene and for their inhibition of vesicular chemical uptake .	T3	T11	23527317
NA	CHEMICAL	GENE-N	0	1	chemical oxidase activities in brown adipose tissue of the rat : identification of chemical-sensitive ( chemical-resistant ) activity at the fat cell membrane .	T11	T27	6150080
NA	CHEMICAL	GENE-N	13	1	chemical oxidase activities in brown adipose tissue of the rat : identification of chemical-sensitive ( chemical-resistant ) activity at the fat cell membrane .	T13	T27	6150080
NA	CHEMICAL	GENE-N	3	1	chemical oxidase activities in brown adipose tissue of the rat : identification of chemical-sensitive ( chemical-resistant ) activity at the fat cell membrane .	T12	T27	6150080
NA	CHEMICAL	GENE-N	0	1	chemical oxidase activity , previously described in homogenates of brown adipose tissue of the rat , has now been investigated in preparations of isolated fat cells .	T1	T14	6150080
NA	CHEMICAL	GENE-Y	9	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T7	T19	6150080
NA	CHEMICAL	GENE-N	9	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T7	T20	6150080
NA	CHEMICAL	GENE-Y	9	10	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T7	T21	6150080
NA	CHEMICAL	GENE-Y	9	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T7	T22	6150080
NA	CHEMICAL	GENE-Y	18	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T8	T19	6150080
NA	CHEMICAL	GENE-N	18	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T8	T20	6150080
NA	CHEMICAL	GENE-Y	18	10	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T8	T21	6150080
NA	CHEMICAL	GENE-Y	18	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T8	T22	6150080
NA	CHEMICAL	GENE-Y	19	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T9	T19	6150080
NA	CHEMICAL	GENE-N	19	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T9	T20	6150080
NA	CHEMICAL	GENE-Y	19	10	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T9	T21	6150080
NA	CHEMICAL	GENE-Y	19	11	It was found that the specific activities of both chemical oxidase A ( gene ) and of the chemical-sensitive chemical-resistant amine oxidase ( gene ) were higher in isolated fat cells than in the original whole tissue .	T9	T22	6150080
CPR:3	CHEMICAL	GENE-Y	11	21	In plasma membranes prepared from these isolated brown fat cells by chemical extraction there was a similar enrichment of activity of gene and of the plasma membrane marker enzyme , gene . However in preparations of cell membranes made by binding the cells to polycation-coated beads , enrichment of gene activity was much greater than that of gene .	T10	T23	6150080
NA	CHEMICAL	GENE-N	11	30	In plasma membranes prepared from these isolated brown fat cells by chemical extraction there was a similar enrichment of activity of gene and of the plasma membrane marker enzyme , gene . However in preparations of cell membranes made by binding the cells to polycation-coated beads , enrichment of gene activity was much greater than that of gene .	T10	T24	6150080
NA	CHEMICAL	GENE-N	11	49	In plasma membranes prepared from these isolated brown fat cells by chemical extraction there was a similar enrichment of activity of gene and of the plasma membrane marker enzyme , gene . However in preparations of cell membranes made by binding the cells to polycation-coated beads , enrichment of gene activity was much greater than that of gene .	T10	T25	6150080
CPR:9	CHEMICAL	GENE-N	6	11	Positive staining of mitochondria was achieved in the presence of the gene substrate , chemical .	T2	T15	6150080
CPR:9	CHEMICAL	GENE-Y	16	13	Staining around the edges of the brown fat cells was observed with the gene substrates , chemical and chemical .	T3	T16	6150080
CPR:9	CHEMICAL	GENE-Y	18	13	Staining around the edges of the brown fat cells was observed with the gene substrates , chemical and chemical .	T4	T16	6150080
CPR:4	CHEMICAL	GENE-Y	17	14	Staining was largely absent when substrate was omitted or after pretreatment with the irreversible gene inhibitor , chemical and the slowly reversible inhibitor , chemical .	T5	T17	6150080
CPR:4	CHEMICAL	GENE-Y	24	14	Staining was largely absent when substrate was omitted or after pretreatment with the irreversible gene inhibitor , chemical and the slowly reversible inhibitor , chemical .	T6	T17	6150080
CPR:9	CHEMICAL	GENE-N	1	12	The chemical required for potentiation of skeletal muscle contraction is released via gene hemichannels .	T21	T38	23583931
CPR:3	CHEMICAL	GENE-N	8	13	During repetitive stimulation of skeletal muscle , extracellular chemical levels raise , activating gene , increasing chemical influx , and enhancing contractile force , a response called potentiation .	T15	T37	23583931
NA	CHEMICAL	GENE-N	16	13	During repetitive stimulation of skeletal muscle , extracellular chemical levels raise , activating gene , increasing chemical influx , and enhancing contractile force , a response called potentiation .	T2	T37	23583931
NA	CHEMICAL	GENE-Y	3	9	We found that chemical appears to be released through gene hemichannels ( gene HCs ) .	T9	T29	23583931
NA	CHEMICAL	GENE-Y	3	12	We found that chemical appears to be released through gene hemichannels ( gene HCs ) .	T9	T30	23583931
NA	CHEMICAL	GENE-Y	13	7	Immunocytochemical analyses and function were consistent with gene localization to T-tubules intercalated with chemical and chemical receptors in slow ( soleus ) and fast ( extensor digitorum longus , EDL ) muscles .	T10	T31	23583931
NA	CHEMICAL	GENE-N	13	9	Immunocytochemical analyses and function were consistent with gene localization to T-tubules intercalated with chemical and chemical receptors in slow ( soleus ) and fast ( extensor digitorum longus , EDL ) muscles .	T10	T32	23583931
NA	CHEMICAL	GENE-Y	15	7	Immunocytochemical analyses and function were consistent with gene localization to T-tubules intercalated with chemical and chemical receptors in slow ( soleus ) and fast ( extensor digitorum longus , EDL ) muscles .	T11	T31	23583931
NA	CHEMICAL	GENE-N	15	9	Immunocytochemical analyses and function were consistent with gene localization to T-tubules intercalated with chemical and chemical receptors in slow ( soleus ) and fast ( extensor digitorum longus , EDL ) muscles .	T11	T32	23583931
CPR:9	CHEMICAL	GENE-N	3	12	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T16	T33	23583931
CPR:9	CHEMICAL	GENE-Y	3	27	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T16	T34	23583931
CPR:9	CHEMICAL	GENE-N	10	12	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T17	T33	23583931
CPR:9	CHEMICAL	GENE-Y	10	27	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T17	T34	23583931
NA	CHEMICAL	GENE-N	14	12	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T18	T33	23583931
NA	CHEMICAL	GENE-Y	14	27	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T18	T34	23583931
NA	CHEMICAL	GENE-N	24	12	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T19	T33	23583931
NA	CHEMICAL	GENE-Y	24	27	Consistent with two chemical uptake pathways , induced uptake of chemical , a fluorescent chemical derivative , was decreased by inhibition of HCs or chemical transporter ( gene ) , and blocked by dual blockade .	T19	T34	23583931
NA	CHEMICAL	GENE-Y	0	22	chemical release , chemical uptake , and potentiation induced by repetitive electrical stimulation were blocked by HC blockers and did not occur in muscles of gene knockout mice .	T20	T22	23583931
NA	CHEMICAL	GENE-Y	3	22	chemical release , chemical uptake , and potentiation induced by repetitive electrical stimulation were blocked by HC blockers and did not occur in muscles of gene knockout mice .	T1	T22	23583931
NA	CHEMICAL	GENE-Y	21	3	MRS2179 , a gene blocker , prevented potentiation in EDL , but not soleus muscles , suggesting that in fast muscles chemical activates gene but not gene .	T3	T23	23583931
CPR:3	CHEMICAL	GENE-Y	21	23	MRS2179 , a gene blocker , prevented potentiation in EDL , but not soleus muscles , suggesting that in fast muscles chemical activates gene but not gene .	T3	T24	23583931
NA	CHEMICAL	GENE-N	21	26	MRS2179 , a gene blocker , prevented potentiation in EDL , but not soleus muscles , suggesting that in fast muscles chemical activates gene but not gene .	T3	T25	23583931
NA	CHEMICAL	GENE-Y	2	7	Phosphorylation on chemical and chemical residues of gene was increased during potentiation , possibly mediating HC opening .	T4	T26	23583931
NA	CHEMICAL	GENE-Y	4	7	Phosphorylation on chemical and chemical residues of gene was increased during potentiation , possibly mediating HC opening .	T5	T26	23583931
CPR:9	CHEMICAL	GENE-Y	10	2	Opening of gene HCs during repetitive activation allows efflux of chemical , influx of chemical and possibly chemical too , which are required for potentiation of contraction .	T6	T27	23583931
CPR:9	CHEMICAL	GENE-Y	14	2	Opening of gene HCs during repetitive activation allows efflux of chemical , influx of chemical and possibly chemical too , which are required for potentiation of contraction .	T7	T27	23583931
CPR:9	CHEMICAL	GENE-Y	17	2	Opening of gene HCs during repetitive activation allows efflux of chemical , influx of chemical and possibly chemical too , which are required for potentiation of contraction .	T8	T27	23583931
CPR:3	CHEMICAL	GENE-Y	13	1	Porcine gene and gene are both activated by a selective gene ligand , chemical .	T6	T34	18439678
CPR:3	CHEMICAL	GENE-Y	13	3	Porcine gene and gene are both activated by a selective gene ligand , chemical .	T6	T32	18439678
NA	CHEMICAL	GENE-Y	13	10	Porcine gene and gene are both activated by a selective gene ligand , chemical .	T6	T33	18439678
NA	CHEMICAL	GENE-N	1	3	Both gene and gene proteins were expressed in cell lines and were chemical-glycosylated .	T2	T21	18439678
CPR:3	CHEMICAL	GENE-Y	1	11	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T3	T28	18439678
CPR:3	CHEMICAL	GENE-Y	1	13	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T3	T29	18439678
CPR:3	CHEMICAL	GENE-Y	1	16	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T3	T30	18439678
NA	CHEMICAL	GENE-Y	1	20	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T3	T31	18439678
CPR:3	CHEMICAL	GENE-Y	4	11	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T4	T28	18439678
CPR:3	CHEMICAL	GENE-Y	4	13	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T4	T29	18439678
CPR:3	CHEMICAL	GENE-Y	4	16	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T4	T30	18439678
NA	CHEMICAL	GENE-Y	4	20	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T4	T31	18439678
CPR:3	CHEMICAL	GENE-Y	6	11	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T5	T28	18439678
CPR:3	CHEMICAL	GENE-Y	6	13	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T5	T29	18439678
CPR:3	CHEMICAL	GENE-Y	6	16	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T5	T30	18439678
NA	CHEMICAL	GENE-Y	6	20	Two chemical molecules , chemical and chemical , markedly activated both gene and gene whereas only gene , but not gene , was activated by the ligands .	T5	T31	18439678
NA	CHEMICAL	GENE-N	2	3	Amelioration of chemical-induced gene resistance in C2C12 muscle cells by rooibos ( Aspalathus linearis ) .	T27	T43	23639187
NA	CHEMICAL	GENE-Y	3	16	Increased levels of chemical ( chemical ) , specifically chemical such as chemical are associated with gene resistance of muscle , fat and liver .	T15	T28	23639187
NA	CHEMICAL	GENE-Y	5	16	Increased levels of chemical ( chemical ) , specifically chemical such as chemical are associated with gene resistance of muscle , fat and liver .	T19	T28	23639187
NA	CHEMICAL	GENE-Y	9	16	Increased levels of chemical ( chemical ) , specifically chemical such as chemical are associated with gene resistance of muscle , fat and liver .	T21	T28	23639187
NA	CHEMICAL	GENE-Y	12	16	Increased levels of chemical ( chemical ) , specifically chemical such as chemical are associated with gene resistance of muscle , fat and liver .	T25	T28	23639187
NA	CHEMICAL	GENE-N	8	16	Rooibos ( Aspalathus linearis ) and its unique chemical , chemical , shown to reduce hyperglycemia in diabetic rats , could play a role in preventing or ameliorating the development of gene resistance .	T18	T41	23639187
NA	CHEMICAL	GENE-N	10	16	Rooibos ( Aspalathus linearis ) and its unique chemical , chemical , shown to reduce hyperglycemia in diabetic rats , could play a role in preventing or ameliorating the development of gene resistance .	T20	T41	23639187
NA	CHEMICAL	GENE-Y	1	7	At a mechanistic level both extracts down-regulated gene activation , which is associated with chemical-induced gene resistance .	T11	T29	23639187
NA	CHEMICAL	GENE-N	1	15	At a mechanistic level both extracts down-regulated gene activation , which is associated with chemical-induced gene resistance .	T11	T30	23639187
NA	CHEMICAL	GENE-N	4	5	Protein levels of the chemical transporter ( gene ) involved in chemical transport via these two pathways were also increased .	T12	T35	23639187
NA	CHEMICAL	GENE-Y	4	7	Protein levels of the chemical transporter ( gene ) involved in chemical transport via these two pathways were also increased .	T12	T36	23639187
CPR:9	CHEMICAL	GENE-N	11	5	Protein levels of the chemical transporter ( gene ) involved in chemical transport via these two pathways were also increased .	T13	T35	23639187
CPR:9	CHEMICAL	GENE-Y	11	7	Protein levels of the chemical transporter ( gene ) involved in chemical transport via these two pathways were also increased .	T13	T36	23639187
NA	CHEMICAL	GENE-N	10	1	This in vitro study therefore confirms that rooibos can ameliorate chemical-induced gene resistance in C2C12 skeletal muscle cells .	T14	T37	23639187
NA	CHEMICAL	GENE-Y	5	6	A novel membrane sensor for chemical H1-receptor antagonist `` chemical '' .	T12	T14	15352500
CPR:6	CHEMICAL	GENE-Y	9	6	A novel membrane sensor for chemical H1-receptor antagonist `` chemical '' .	T13	T14	15352500
NA	CHEMICAL	GENE-Y	2	5	Effect of chemical on serum gene levels .	T11	T19	16418149
NA	CHEMICAL	GENE-Y	2	0	gene is a 167 chemical protein encoded by the obesity gene that is synthesized in adipose tissue and interacts with receptors in the hypothalamus linked to the regulation of appetite and metabolism .	T4	T12	16418149
NA	CHEMICAL	GENE-Y	0	13	chemical is a chemical chemical that increases appetite through its antiserotonergic effect on gene receptors in the brain .	T5	T15	16418149
NA	CHEMICAL	GENE-Y	3	13	chemical is a chemical chemical that increases appetite through its antiserotonergic effect on gene receptors in the brain .	T6	T15	16418149
NA	CHEMICAL	GENE-Y	1	13	chemical is a chemical chemical that increases appetite through its antiserotonergic effect on gene receptors in the brain .	T7	T15	16418149
NA	CHEMICAL	GENE-Y	4	2	Although both gene and chemical are effective in controlling appetite , their interaction has not been addressed in clinical studies .	T8	T16	16418149
CPR:3	CHEMICAL	GENE-Y	33	33	The mean body weight at baseline ( 52.59 kg ) did not differ significantly from that at 1 week after treatment ( 52.84 kg ; P > .05 ) , but the mean gene level after 1 week of treatment with chemical ( 3.14 ng/mL ) was 14.2 % higher than that at baseline ( 2.75 ng/mL ; P < .05 ) .	T1	T13	16418149
CPR:4	CHEMICAL	GENE-N	5	2	Suppression of gene activity by chemical is mediated by direct inhibition of gene .	T19	T49	11054378
NA	CHEMICAL	GENE-N	5	12	Suppression of gene activity by chemical is mediated by direct inhibition of gene .	T19	T50	11054378
NA	CHEMICAL	GENE-N	13	20	Various drugs used in the treatment of IBD , such as glucocorticoids , chemical , and chemical , interfere with gene/gene signaling .	T11	T32	11054378
NA	CHEMICAL	GENE-Y	13	20	Various drugs used in the treatment of IBD , such as glucocorticoids , chemical , and chemical , interfere with gene/gene signaling .	T11	T33	11054378
NA	CHEMICAL	GENE-N	3	20	Various drugs used in the treatment of IBD , such as glucocorticoids , chemical , and chemical , interfere with gene/gene signaling .	T12	T32	11054378
NA	CHEMICAL	GENE-Y	3	20	Various drugs used in the treatment of IBD , such as glucocorticoids , chemical , and chemical , interfere with gene/gene signaling .	T12	T33	11054378
CPR:4	CHEMICAL	GENE-N	13	15	The aim of this study was to define the molecular mechanism by which chemical inhibits gene activation .	T13	T35	11054378
NA	CHEMICAL	GENE-N	5	10	METHODS : The effects of chemical and its moieties on gene signaling were evaluated using electromobility shift , transfection , and immune complex kinase assays .	T14	T37	11054378
NA	CHEMICAL	GENE-N	4	6	The direct effect of chemical on gene ( gene ) activity was investigated using purified recombinant gene proteins .	T15	T38	11054378
NA	CHEMICAL	GENE-N	4	8	The direct effect of chemical on gene ( gene ) activity was investigated using purified recombinant gene proteins .	T15	T39	11054378
NA	CHEMICAL	GENE-N	4	16	The direct effect of chemical on gene ( gene ) activity was investigated using purified recombinant gene proteins .	T15	T40	11054378
CPR:3	CHEMICAL	GENE-N	8	2	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T41	11054378
CPR:3	CHEMICAL	GENE-Y	8	2	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T42	11054378
NA	CHEMICAL	GENE-Y	8	6	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T43	11054378
NA	CHEMICAL	GENE-Y	8	13	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T44	11054378
NA	CHEMICAL	GENE-Y	8	15	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T45	11054378
NA	CHEMICAL	GENE-Y	8	17	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T46	11054378
NA	CHEMICAL	GENE-Y	8	22	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T47	11054378
NA	CHEMICAL	GENE-Y	8	24	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T16	T48	11054378
CPR:4	CHEMICAL	GENE-N	31	2	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T41	11054378
CPR:4	CHEMICAL	GENE-Y	31	2	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T42	11054378
NA	CHEMICAL	GENE-Y	31	6	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T43	11054378
CPR:4	CHEMICAL	GENE-Y	31	13	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T44	11054378
CPR:4	CHEMICAL	GENE-Y	31	15	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T45	11054378
CPR:4	CHEMICAL	GENE-Y	31	17	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T46	11054378
CPR:4	CHEMICAL	GENE-Y	31	22	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T47	11054378
CPR:4	CHEMICAL	GENE-Y	31	24	RESULTS : gene/gene activity induced by gene , chemical , or overexpression of gene , gene , gene , or constitutively active gene and gene mutants was inhibited dose dependently by chemical .	T17	T48	11054378
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibited gene-induced activation of endogenous gene in Jurkat T cells and SW620 colon cells , as well as the catalytic activity of purified gene and gene in vitro .	T18	T20	11054378
CPR:4	CHEMICAL	GENE-N	0	6	chemical inhibited gene-induced activation of endogenous gene in Jurkat T cells and SW620 colon cells , as well as the catalytic activity of purified gene and gene in vitro .	T18	T21	11054378
CPR:4	CHEMICAL	GENE-Y	0	24	chemical inhibited gene-induced activation of endogenous gene in Jurkat T cells and SW620 colon cells , as well as the catalytic activity of purified gene and gene in vitro .	T18	T22	11054378
CPR:4	CHEMICAL	GENE-Y	0	26	chemical inhibited gene-induced activation of endogenous gene in Jurkat T cells and SW620 colon cells , as well as the catalytic activity of purified gene and gene in vitro .	T18	T23	11054378
NA	CHEMICAL	GENE-Y	2	4	Activation of gene , gene , and gene was unaffected by chemical .	T5	T25	11054378
NA	CHEMICAL	GENE-N	2	7	Activation of gene , gene , and gene was unaffected by chemical .	T5	T26	11054378
NA	CHEMICAL	GENE-Y	11	4	Activation of gene , gene , and gene was unaffected by chemical .	T6	T25	11054378
NA	CHEMICAL	GENE-N	11	7	Activation of gene , gene , and gene was unaffected by chemical .	T6	T26	11054378
NA	CHEMICAL	GENE-N	10	6	The decrease in substrate phosphorylation by gene is associated with a decrease in autophosphorylation of gene and can be antagonized by excess chemical .	T7	T27	11054378
CPR:4	CHEMICAL	GENE-N	10	15	The decrease in substrate phosphorylation by gene is associated with a decrease in autophosphorylation of gene and can be antagonized by excess chemical .	T7	T28	11054378
NA	CHEMICAL	GENE-N	5	7	CONCLUSIONS : These data identify chemical as a direct inhibitor of gene by antagonizing chemical binding .	T8	T29	11054378
NA	CHEMICAL	GENE-N	7	7	CONCLUSIONS : These data identify chemical as a direct inhibitor of gene by antagonizing chemical binding .	T9	T29	11054378
CPR:9	CHEMICAL	GENE-N	17	13	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T19	23607523
CPR:9	CHEMICAL	GENE-N	17	4	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T20	23607523
CPR:9	CHEMICAL	GENE-N	17	7	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T21	23607523
CPR:9	CHEMICAL	GENE-N	17	9	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T22	23607523
CPR:9	CHEMICAL	GENE-N	17	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T23	23607523
CPR:9	CHEMICAL	GENE-N	17	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T24	23607523
CPR:9	CHEMICAL	GENE-N	17	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T4	T25	23607523
NA	CHEMICAL	GENE-N	36	13	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T19	23607523
NA	CHEMICAL	GENE-N	36	4	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T20	23607523
NA	CHEMICAL	GENE-N	36	7	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T21	23607523
NA	CHEMICAL	GENE-N	36	9	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T22	23607523
NA	CHEMICAL	GENE-N	36	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T23	23607523
NA	CHEMICAL	GENE-N	36	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T24	23607523
NA	CHEMICAL	GENE-N	36	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T6	T25	23607523
NA	CHEMICAL	GENE-N	2	13	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T19	23607523
NA	CHEMICAL	GENE-N	2	4	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T20	23607523
NA	CHEMICAL	GENE-N	2	7	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T21	23607523
NA	CHEMICAL	GENE-N	2	9	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T22	23607523
NA	CHEMICAL	GENE-N	2	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T23	23607523
NA	CHEMICAL	GENE-N	2	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T24	23607523
NA	CHEMICAL	GENE-N	2	21	This includes gene ( gene ) and gene ( gene ) required for the formation of the chemical core unit , as well as a suite of tailoring enzymes ( e.g. , four gene , an chemical-methyltransferase , and an chemical-glycosyltransferase ) necessary for further modifications of the core structure .	T7	T25	23607523
NA	CHEMICAL	GENE-N	1	5	The chemical-glycosyltransferase is predicted to transfer either chemical or a pseudosugar ( chemical ) to the aglycone .	T8	T26	23607523
NA	CHEMICAL	GENE-N	7	5	The chemical-glycosyltransferase is predicted to transfer either chemical or a pseudosugar ( chemical ) to the aglycone .	T9	T26	23607523
NA	CHEMICAL	GENE-N	4	5	The chemical-glycosyltransferase is predicted to transfer either chemical or a pseudosugar ( chemical ) to the aglycone .	T10	T26	23607523
NA	CHEMICAL	GENE-Y	6	3	Distinct role of gene in mediating chemical generation downstream of both gene and gene in platelets .	T15	T43	23640884
NA	CHEMICAL	GENE-N	6	11	Distinct role of gene in mediating chemical generation downstream of both gene and gene in platelets .	T15	T44	23640884
NA	CHEMICAL	GENE-Y	6	13	Distinct role of gene in mediating chemical generation downstream of both gene and gene in platelets .	T15	T45	23640884
NA	CHEMICAL	GENE-Y	0	3	chemical-rich chemical kinase 2 ( gene ) is activated by various agonists in platelets .	T1	T16	23640884
NA	CHEMICAL	GENE-Y	0	3	chemical-rich chemical kinase 2 ( gene ) is activated by various agonists in platelets .	T1	T28	23640884
NA	CHEMICAL	GENE-Y	1	3	chemical-rich chemical kinase 2 ( gene ) is activated by various agonists in platelets .	T4	T16	23640884
NA	CHEMICAL	GENE-Y	1	3	chemical-rich chemical kinase 2 ( gene ) is activated by various agonists in platelets .	T4	T28	23640884
NA	CHEMICAL	GENE-Y	10	19	We found that platelet aggregation and secretion in response to chemical and AYPGKF were diminished in the presence of gene inhibitors or in gene-deficient platelets , suggesting that gene plays a positive regulatory role in platelet functional responses .	T6	T29	23640884
NA	CHEMICAL	GENE-Y	10	23	We found that platelet aggregation and secretion in response to chemical and AYPGKF were diminished in the presence of gene inhibitors or in gene-deficient platelets , suggesting that gene plays a positive regulatory role in platelet functional responses .	T6	T30	23640884
NA	CHEMICAL	GENE-Y	10	28	We found that platelet aggregation and secretion in response to chemical and AYPGKF were diminished in the presence of gene inhibitors or in gene-deficient platelets , suggesting that gene plays a positive regulatory role in platelet functional responses .	T6	T31	23640884
NA	CHEMICAL	GENE-Y	5	9	It has been shown that chemical- , but not gene- , induced chemical ( chemical ) generation depends on gene signaling .	T7	T32	23640884
NA	CHEMICAL	GENE-N	5	19	It has been shown that chemical- , but not gene- , induced chemical ( chemical ) generation depends on gene signaling .	T7	T33	23640884
NA	CHEMICAL	GENE-Y	12	9	It has been shown that chemical- , but not gene- , induced chemical ( chemical ) generation depends on gene signaling .	T8	T32	23640884
NA	CHEMICAL	GENE-N	12	19	It has been shown that chemical- , but not gene- , induced chemical ( chemical ) generation depends on gene signaling .	T8	T33	23640884
NA	CHEMICAL	GENE-Y	14	9	It has been shown that chemical- , but not gene- , induced chemical ( chemical ) generation depends on gene signaling .	T9	T32	23640884
NA	CHEMICAL	GENE-N	14	19	It has been shown that chemical- , but not gene- , induced chemical ( chemical ) generation depends on gene signaling .	T9	T33	23640884
NA	CHEMICAL	GENE-Y	1	3	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T10	T34	23640884
NA	CHEMICAL	GENE-N	1	5	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T10	T35	23640884
NA	CHEMICAL	GENE-N	1	9	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T10	T36	23640884
NA	CHEMICAL	GENE-N	1	14	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T10	T37	23640884
NA	CHEMICAL	GENE-Y	17	3	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T11	T34	23640884
NA	CHEMICAL	GENE-N	17	5	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T11	T35	23640884
NA	CHEMICAL	GENE-N	17	9	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T11	T36	23640884
NA	CHEMICAL	GENE-N	17	14	Unlike chemical , gene activates gene pathways , and gene pathways can substitute for gene signaling for chemical generation .	T11	T37	23640884
NA	CHEMICAL	GENE-Y	16	3	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T12	T38	23640884
NA	CHEMICAL	GENE-N	16	9	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T12	T39	23640884
NA	CHEMICAL	GENE-N	16	11	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T12	T40	23640884
NA	CHEMICAL	GENE-Y	16	25	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T12	T41	23640884
NA	CHEMICAL	GENE-Y	19	3	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T13	T38	23640884
NA	CHEMICAL	GENE-N	19	9	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T13	T39	23640884
NA	CHEMICAL	GENE-N	19	11	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T13	T40	23640884
NA	CHEMICAL	GENE-Y	19	25	We found that gene was activated downstream of both gene and gene-mediated pathways , and both chemical- and AYPGKF-induced chemical generation was significantly diminished in gene-deficient platelets .	T13	T41	23640884
NA	CHEMICAL	GENE-N	3	9	In addition , chemical generation induced by co-stimulation of gene and gene pathways , which is dependent on gene signaling , was inhibited by blocking gene .	T14	T42	23640884
NA	CHEMICAL	GENE-Y	3	11	In addition , chemical generation induced by co-stimulation of gene and gene pathways , which is dependent on gene signaling , was inhibited by blocking gene .	T14	T17	23640884
NA	CHEMICAL	GENE-N	3	18	In addition , chemical generation induced by co-stimulation of gene and gene pathways , which is dependent on gene signaling , was inhibited by blocking gene .	T14	T18	23640884
NA	CHEMICAL	GENE-Y	3	25	In addition , chemical generation induced by co-stimulation of gene and gene pathways , which is dependent on gene signaling , was inhibited by blocking gene .	T14	T19	23640884
NA	CHEMICAL	GENE-Y	4	8	Furthermore , inhibition of chemical-induced chemical generation by gene antagonist was not rescued by co-stimulation of gene pathways in the presence of gene inhibitor .	T2	T20	23640884
NA	CHEMICAL	GENE-N	4	16	Furthermore , inhibition of chemical-induced chemical generation by gene antagonist was not rescued by co-stimulation of gene pathways in the presence of gene inhibitor .	T2	T21	23640884
NA	CHEMICAL	GENE-Y	4	22	Furthermore , inhibition of chemical-induced chemical generation by gene antagonist was not rescued by co-stimulation of gene pathways in the presence of gene inhibitor .	T2	T22	23640884
NA	CHEMICAL	GENE-Y	5	8	Furthermore , inhibition of chemical-induced chemical generation by gene antagonist was not rescued by co-stimulation of gene pathways in the presence of gene inhibitor .	T3	T20	23640884
NA	CHEMICAL	GENE-N	5	16	Furthermore , inhibition of chemical-induced chemical generation by gene antagonist was not rescued by co-stimulation of gene pathways in the presence of gene inhibitor .	T3	T21	23640884
NA	CHEMICAL	GENE-Y	5	22	Furthermore , inhibition of chemical-induced chemical generation by gene antagonist was not rescued by co-stimulation of gene pathways in the presence of gene inhibitor .	T3	T22	23640884
NA	CHEMICAL	GENE-Y	3	7	Characterization of the chemical adduct of substrate-bound gene by electron paramagnetic resonance : electronic structure of the active site and mechanistic implications .	T44	T58	17602574
NA	CHEMICAL	GENE-Y	15	0	gene ( gene ) is a non-heme chemical metalloenzyme that catalyzes the first committed step in oxidative chemical catabolism .	T1	T46	17602574
NA	CHEMICAL	GENE-Y	15	2	gene ( gene ) is a non-heme chemical metalloenzyme that catalyzes the first committed step in oxidative chemical catabolism .	T1	T54	17602574
NA	CHEMICAL	GENE-Y	7	0	gene ( gene ) is a non-heme chemical metalloenzyme that catalyzes the first committed step in oxidative chemical catabolism .	T32	T46	17602574
NA	CHEMICAL	GENE-Y	7	2	gene ( gene ) is a non-heme chemical metalloenzyme that catalyzes the first committed step in oxidative chemical catabolism .	T32	T54	17602574
CPR:9	CHEMICAL	GENE-Y	2	0	gene ( gene ) is a non-heme chemical metalloenzyme that catalyzes the first committed step in oxidative chemical catabolism .	T5	T46	17602574
CPR:9	CHEMICAL	GENE-Y	2	2	gene ( gene ) is a non-heme chemical metalloenzyme that catalyzes the first committed step in oxidative chemical catabolism .	T5	T54	17602574
NA	CHEMICAL	GENE-Y	9	5	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T22	T48	17602574
NA	CHEMICAL	GENE-N	9	33	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T22	T53	17602574
NA	CHEMICAL	GENE-Y	18	5	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T27	T48	17602574
NA	CHEMICAL	GENE-N	18	33	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T27	T53	17602574
NA	CHEMICAL	GENE-Y	7	5	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T28	T48	17602574
NA	CHEMICAL	GENE-N	7	33	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T28	T53	17602574
NA	CHEMICAL	GENE-Y	29	5	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T29	T48	17602574
NA	CHEMICAL	GENE-N	29	33	The active site coordination of gene comprises a mononuclear chemical ligated by the Nepsilon atoms of three protein-derived chemical , thus representing a new variant on the chemical ( chemical ) facial triad motif .	T29	T53	17602574
NA	CHEMICAL	GENE-Y	10	4	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T33	T55	17602574
NA	CHEMICAL	GENE-N	10	30	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T33	T56	17602574
NA	CHEMICAL	GENE-Y	13	4	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T34	T55	17602574
NA	CHEMICAL	GENE-N	13	30	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T34	T56	17602574
NA	CHEMICAL	GENE-Y	17	4	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T35	T55	17602574
NA	CHEMICAL	GENE-N	17	30	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T35	T56	17602574
NA	CHEMICAL	GENE-Y	25	4	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T36	T55	17602574
NA	CHEMICAL	GENE-N	25	30	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T36	T56	17602574
NA	CHEMICAL	GENE-Y	29	4	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T37	T55	17602574
NA	CHEMICAL	GENE-N	29	30	In these experiments , gene exhibits an ordered binding of chemical prior to chemical ( and presumably chemical ) similar to that observed for the chemical class of non-heme chemical enzymes .	T37	T56	17602574
NA	CHEMICAL	GENE-Y	10	3	Moreover , the gene active site is essentially unreactive toward chemical in the absence of substrate , suggesting an obligate ordered binding of chemical prior to chemical .	T38	T57	17602574
NA	CHEMICAL	GENE-Y	11	3	Moreover , the gene active site is essentially unreactive toward chemical in the absence of substrate , suggesting an obligate ordered binding of chemical prior to chemical .	T39	T57	17602574
NA	CHEMICAL	GENE-Y	26	3	Moreover , the gene active site is essentially unreactive toward chemical in the absence of substrate , suggesting an obligate ordered binding of chemical prior to chemical .	T40	T57	17602574
NA	CHEMICAL	GENE-Y	5	7	However , upon addition of chemical to gene in the presence of substrate chemical , a low-spin { chemical } 7 ( S = 1/2 ) signal that accounts for approximately 85 % of the chemical within the enzyme develops .	T2	T47	17602574
CPR:9	CHEMICAL	GENE-Y	8	7	However , upon addition of chemical to gene in the presence of substrate chemical , a low-spin { chemical } 7 ( S = 1/2 ) signal that accounts for approximately 85 % of the chemical within the enzyme develops .	T3	T47	17602574
NA	CHEMICAL	GENE-Y	7	7	However , upon addition of chemical to gene in the presence of substrate chemical , a low-spin { chemical } 7 ( S = 1/2 ) signal that accounts for approximately 85 % of the chemical within the enzyme develops .	T4	T47	17602574
NA	CHEMICAL	GENE-Y	35	7	However , upon addition of chemical to gene in the presence of substrate chemical , a low-spin { chemical } 7 ( S = 1/2 ) signal that accounts for approximately 85 % of the chemical within the enzyme develops .	T6	T47	17602574
NA	CHEMICAL	GENE-Y	3	18	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T16	T49	17602574
NA	CHEMICAL	GENE-Y	3	38	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T16	T50	17602574
NA	CHEMICAL	GENE-Y	17	18	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T17	T49	17602574
NA	CHEMICAL	GENE-Y	17	38	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T17	T50	17602574
NA	CHEMICAL	GENE-Y	22	18	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T18	T49	17602574
NA	CHEMICAL	GENE-Y	22	38	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T18	T50	17602574
NA	CHEMICAL	GENE-Y	27	18	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T19	T49	17602574
NA	CHEMICAL	GENE-Y	27	38	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T19	T50	17602574
NA	CHEMICAL	GENE-Y	34	18	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T20	T49	17602574
NA	CHEMICAL	GENE-Y	34	38	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T20	T50	17602574
NA	CHEMICAL	GENE-Y	37	18	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T21	T49	17602574
NA	CHEMICAL	GENE-Y	37	38	The unusual { chemical } 7 ( S = 1/2 ) electronic configuration adopted by the substrate-bound chemical gene ( termed { ES-chemical } 7 ) is a result of the chemical coordination of chemical in the chemical-bound gene active site .	T21	T50	17602574
NA	CHEMICAL	GENE-Y	6	22	The DFT-predicted geometric parameters for { ES-chemical } 7 are in good agreement with the crystallographically determined substrate-bound active site configuration of gene and are consistent with known chemical model complexes .	T23	T51	17602574
NA	CHEMICAL	GENE-Y	28	22	The DFT-predicted geometric parameters for { ES-chemical } 7 are in good agreement with the crystallographically determined substrate-bound active site configuration of gene and are consistent with known chemical model complexes .	T24	T51	17602574
NA	CHEMICAL	GENE-Y	2	30	The effects of abciximab ( 1-10 microg/ml ) , chemical ( 3-30 nM ) , or chemical ( 0.3-3 microg/ml ) on basal and chemical ( 3 microM ) -induced gene externalization were measured in n=62 healthy blood donors and n=177 patients with stable coronary artery disease .	T2	T17	12165285
NA	CHEMICAL	GENE-Y	16	30	The effects of abciximab ( 1-10 microg/ml ) , chemical ( 3-30 nM ) , or chemical ( 0.3-3 microg/ml ) on basal and chemical ( 3 microM ) -induced gene externalization were measured in n=62 healthy blood donors and n=177 patients with stable coronary artery disease .	T3	T17	12165285
NA	CHEMICAL	GENE-Y	24	30	The effects of abciximab ( 1-10 microg/ml ) , chemical ( 3-30 nM ) , or chemical ( 0.3-3 microg/ml ) on basal and chemical ( 3 microM ) -induced gene externalization were measured in n=62 healthy blood donors and n=177 patients with stable coronary artery disease .	T4	T17	12165285
NA	CHEMICAL	GENE-N	19	12	Although a significant platelet hyperreactivity was observed in the patients , the gene genotype did not influence basal or chemical-induced gene expression .	T5	T22	12165285
CPR:3	CHEMICAL	GENE-Y	19	20	Although a significant platelet hyperreactivity was observed in the patients , the gene genotype did not influence basal or chemical-induced gene expression .	T5	T23	12165285
NA	CHEMICAL	GENE-Y	6	7	A moderate ( twofold ) stimulation of gene expression by abciximab but not by chemical or chemical was observed in one patient .	T6	T24	12165285
NA	CHEMICAL	GENE-Y	16	7	A moderate ( twofold ) stimulation of gene expression by abciximab but not by chemical or chemical was observed in one patient .	T7	T24	12165285
NA	CHEMICAL	GENE-N	29	9	In no other subject any activation of platelets by gene inhibitors was observed and there were no statistically significant differences between gene genotypes with respect to the effects of gene inhibitors on basal or chemical-stimulated gene expression .	T1	T8	12165285
NA	CHEMICAL	GENE-N	29	21	In no other subject any activation of platelets by gene inhibitors was observed and there were no statistically significant differences between gene genotypes with respect to the effects of gene inhibitors on basal or chemical-stimulated gene expression .	T1	T9	12165285
NA	CHEMICAL	GENE-N	29	29	In no other subject any activation of platelets by gene inhibitors was observed and there were no statistically significant differences between gene genotypes with respect to the effects of gene inhibitors on basal or chemical-stimulated gene expression .	T1	T10	12165285
CPR:3	CHEMICAL	GENE-Y	29	35	In no other subject any activation of platelets by gene inhibitors was observed and there were no statistically significant differences between gene genotypes with respect to the effects of gene inhibitors on basal or chemical-stimulated gene expression .	T1	T11	12165285
NA	CHEMICAL	GENE-Y	9	15	EA ( 15mg/kgb.w. , p.o.×14days ) treatment modulated enhanced chemical level , lipid peroxidation , gene activity , chemical production and protein chemical formation in lungs of rats exposed to toxic anticancer drugs .	T5	T14	23603381
NA	CHEMICAL	GENE-Y	18	15	EA ( 15mg/kgb.w. , p.o.×14days ) treatment modulated enhanced chemical level , lipid peroxidation , gene activity , chemical production and protein chemical formation in lungs of rats exposed to toxic anticancer drugs .	T7	T14	23603381
NA	CHEMICAL	GENE-Y	22	15	EA ( 15mg/kgb.w. , p.o.×14days ) treatment modulated enhanced chemical level , lipid peroxidation , gene activity , chemical production and protein chemical formation in lungs of rats exposed to toxic anticancer drugs .	T8	T14	23603381
NA	CHEMICAL	GENE-N	0	10	chemical A ( 1 ) and A ( 2A ) receptors are expressed in the basal ganglia , a group of structures involved in various aspects of motor control .	T2	T12	15095008
NA	CHEMICAL	GENE-Y	6	11	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T6	T13	15095008
NA	CHEMICAL	GENE-Y	6	16	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T6	T14	15095008
NA	CHEMICAL	GENE-Y	6	7	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T6	T15	15095008
NA	CHEMICAL	GENE-Y	16	11	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T7	T13	15095008
NA	CHEMICAL	GENE-Y	16	16	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T7	T14	15095008
NA	CHEMICAL	GENE-Y	16	7	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T7	T15	15095008
NA	CHEMICAL	GENE-Y	7	11	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T8	T13	15095008
NA	CHEMICAL	GENE-Y	7	16	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T8	T14	15095008
NA	CHEMICAL	GENE-Y	7	7	These cells express high levels of chemical A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the chemical- and chemical-regulated 32-kDa phosphoprotein gene .	T8	T15	15095008
NA	CHEMICAL	GENE-N	3	4	RATIONALE : The chemical 1 ( B/D ) ( gene ) receptor has shown potential as a target for decreasing aggression .	T8	T21	20407761
NA	CHEMICAL	GENE-N	3	4	RATIONALE : The chemical 1 ( B/D ) ( gene ) receptor has shown potential as a target for decreasing aggression .	T8	T22	20407761
NA	CHEMICAL	GENE-N	20	1	The gene agonist zolmitriptan 's ability to reduce aggressive behavior in humans and its interaction with the well-known aggression-enhancing drug chemical were examined .	T11	T20	20407761
CPR:4	CHEMICAL	GENE-N	0	5	chemical is an oral chemical kinase inhibitor ( TKI ) , which silences the protein product of the gene fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing gene .	T4	T15	22594847
CPR:4	CHEMICAL	GENE-Y	0	18	chemical is an oral chemical kinase inhibitor ( TKI ) , which silences the protein product of the gene fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing gene .	T4	T16	22594847
NA	CHEMICAL	GENE-Y	0	33	chemical is an oral chemical kinase inhibitor ( TKI ) , which silences the protein product of the gene fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing gene .	T4	T17	22594847
NA	CHEMICAL	GENE-N	4	5	chemical is an oral chemical kinase inhibitor ( TKI ) , which silences the protein product of the gene fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing gene .	T5	T15	22594847
NA	CHEMICAL	GENE-Y	4	18	chemical is an oral chemical kinase inhibitor ( TKI ) , which silences the protein product of the gene fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing gene .	T5	T16	22594847
NA	CHEMICAL	GENE-Y	4	33	chemical is an oral chemical kinase inhibitor ( TKI ) , which silences the protein product of the gene fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing gene .	T5	T17	22594847
NA	CHEMICAL	GENE-Y	4	24	Emerging data suggest that chemical may also have activity in other subsets of lung cancer , including tumors demonstrating amplification or mutation of the gene oncogene , or translocation of the gene oncogene .	T6	T18	22594847
NA	CHEMICAL	GENE-Y	4	31	Emerging data suggest that chemical may also have activity in other subsets of lung cancer , including tumors demonstrating amplification or mutation of the gene oncogene , or translocation of the gene oncogene .	T6	T19	22594847
CPR:9	CHEMICAL	GENE-Y	3	1	Increased gene-mediated cationic chemical transport functionally compensates in gene knockout cell lines .	T9	T30	9614060
NA	CHEMICAL	GENE-Y	3	8	Increased gene-mediated cationic chemical transport functionally compensates in gene knockout cell lines .	T9	T31	9614060
CPR:9	CHEMICAL	GENE-N	3	8	The majority of chemical transport is mediated by gene , although several other carriers have been kinetically defined .	T4	T16	9614060
CPR:9	CHEMICAL	GENE-N	2	0	gene cationic chemical transport is mediated by proteins encoded by a family of genes , gene , gene , and gene .	T5	T17	9614060
CPR:9	CHEMICAL	GENE-Y	2	10	gene cationic chemical transport is mediated by proteins encoded by a family of genes , gene , gene , and gene .	T5	T18	9614060
CPR:9	CHEMICAL	GENE-Y	2	10	gene cationic chemical transport is mediated by proteins encoded by a family of genes , gene , gene , and gene .	T5	T19	9614060
CPR:9	CHEMICAL	GENE-Y	2	10	gene cationic chemical transport is mediated by proteins encoded by a family of genes , gene , gene , and gene .	T5	T20	9614060
NA	CHEMICAL	GENE-Y	2	12	High affinity chemical transport was investigated in embryonic fibroblast cells derived from gene knockout mice that lack functional gene .	T6	T21	9614060
NA	CHEMICAL	GENE-Y	2	18	High affinity chemical transport was investigated in embryonic fibroblast cells derived from gene knockout mice that lack functional gene .	T6	T22	9614060
NA	CHEMICAL	GENE-Y	6	13	However , the apparent affinity for chemical transport was 2.4 times lower in gene ( -/- ) cells when compared with wild type cells , a property characteristic of gene-mediated transport .	T8	T23	9614060
CPR:9	CHEMICAL	GENE-Y	6	25	However , the apparent affinity for chemical transport was 2.4 times lower in gene ( -/- ) cells when compared with wild type cells , a property characteristic of gene-mediated transport .	T8	T24	9614060
CPR:4	CHEMICAL	GENE-N	0	2	chemical has a direct inhibitory effect on the chemical-sensitive chemical channel .	T23	T48	20188727
NA	CHEMICAL	GENE-N	8	2	chemical has a direct inhibitory effect on the chemical-sensitive chemical channel .	T24	T48	20188727
NA	CHEMICAL	GENE-N	2	2	chemical has a direct inhibitory effect on the chemical-sensitive chemical channel .	T25	T48	20188727
NA	CHEMICAL	GENE-N	1	27	The chemical , chemical and chemical , are used in the treatment of type II diabetes mellitus , as well as being routinely used in studies investigating gene activity .	T18	T33	20188727
NA	CHEMICAL	GENE-N	3	27	The chemical , chemical and chemical , are used in the treatment of type II diabetes mellitus , as well as being routinely used in studies investigating gene activity .	T9	T33	20188727
NA	CHEMICAL	GENE-N	5	27	The chemical , chemical and chemical , are used in the treatment of type II diabetes mellitus , as well as being routinely used in studies investigating gene activity .	T15	T33	20188727
NA	CHEMICAL	GENE-N	6	19	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T10	T34	20188727
NA	CHEMICAL	GENE-N	6	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T10	T35	20188727
NA	CHEMICAL	GENE-N	6	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T10	T36	20188727
NA	CHEMICAL	GENE-N	17	19	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T11	T34	20188727
NA	CHEMICAL	GENE-N	17	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T11	T35	20188727
NA	CHEMICAL	GENE-N	17	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T11	T36	20188727
NA	CHEMICAL	GENE-N	18	19	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T12	T34	20188727
NA	CHEMICAL	GENE-N	18	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T12	T35	20188727
NA	CHEMICAL	GENE-N	18	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T12	T36	20188727
NA	CHEMICAL	GENE-N	21	19	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T13	T34	20188727
NA	CHEMICAL	GENE-N	21	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T13	T35	20188727
NA	CHEMICAL	GENE-N	21	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T13	T36	20188727
NA	CHEMICAL	GENE-N	23	19	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T14	T34	20188727
NA	CHEMICAL	GENE-N	23	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T14	T35	20188727
NA	CHEMICAL	GENE-N	23	20	We used the patch-clamp technique and chemical flux assays to determine the role of these drugs in chemical-sensitive chemical channel ( chemical ( chemical ) ) regulation in cell lines expressing the cloned components of gene and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .	T14	T36	20188727
CPR:4	CHEMICAL	GENE-N	0	11	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T37	20188727
CPR:4	CHEMICAL	GENE-Y	0	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T38	20188727
CPR:4	CHEMICAL	GENE-Y	0	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T39	20188727
CPR:4	CHEMICAL	GENE-Y	0	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T40	20188727
CPR:4	CHEMICAL	GENE-Y	0	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T41	20188727
CPR:4	CHEMICAL	GENE-Y	0	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T42	20188727
CPR:4	CHEMICAL	GENE-Y	0	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T19	T43	20188727
NA	CHEMICAL	GENE-N	3	11	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T37	20188727
NA	CHEMICAL	GENE-Y	3	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T38	20188727
NA	CHEMICAL	GENE-Y	3	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T39	20188727
NA	CHEMICAL	GENE-Y	3	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T40	20188727
NA	CHEMICAL	GENE-Y	3	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T41	20188727
NA	CHEMICAL	GENE-Y	3	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T42	20188727
NA	CHEMICAL	GENE-Y	3	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T20	T43	20188727
NA	CHEMICAL	GENE-N	10	11	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T37	20188727
NA	CHEMICAL	GENE-Y	10	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T38	20188727
NA	CHEMICAL	GENE-Y	10	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T39	20188727
NA	CHEMICAL	GENE-Y	10	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T40	20188727
NA	CHEMICAL	GENE-Y	10	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T41	20188727
NA	CHEMICAL	GENE-Y	10	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T42	20188727
NA	CHEMICAL	GENE-Y	10	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T21	T43	20188727
NA	CHEMICAL	GENE-N	12	11	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T37	20188727
NA	CHEMICAL	GENE-Y	12	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T38	20188727
NA	CHEMICAL	GENE-Y	12	28	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T39	20188727
NA	CHEMICAL	GENE-Y	12	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T40	20188727
NA	CHEMICAL	GENE-Y	12	30	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T41	20188727
NA	CHEMICAL	GENE-Y	12	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T42	20188727
NA	CHEMICAL	GENE-Y	12	36	chemical but not chemical inhibits a number of variants of chemical ( chemical ) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( gene/gene and gene/gene ) and pancreatic beta-cells ( gene/gene ) .	T22	T43	20188727
NA	CHEMICAL	GENE-N	14	15	The extent and rate of inhibition are similar to that seen with the known chemical ( chemical ) blocker chemical .	T1	T26	20188727
NA	CHEMICAL	GENE-N	16	15	The extent and rate of inhibition are similar to that seen with the known chemical ( chemical ) blocker chemical .	T2	T26	20188727
CPR:4	CHEMICAL	GENE-N	19	15	The extent and rate of inhibition are similar to that seen with the known chemical ( chemical ) blocker chemical .	T3	T26	20188727
CPR:4	CHEMICAL	GENE-Y	2	9	Additionally , chemical inhibited the current elicited through the gene ( functional without gene ) channel with an IC50 of 1.78 mM .	T4	T27	20188727
NA	CHEMICAL	GENE-Y	2	13	Additionally , chemical inhibited the current elicited through the gene ( functional without gene ) channel with an IC50 of 1.78 mM .	T4	T28	20188727
CPR:4	CHEMICAL	GENE-Y	0	6	chemical reduced the open probability of gene/gene channels by approximately 90 % in inside-out patches .	T5	T29	20188727
CPR:4	CHEMICAL	GENE-Y	0	6	chemical reduced the open probability of gene/gene channels by approximately 90 % in inside-out patches .	T5	T30	20188727
NA	CHEMICAL	GENE-N	4	10	These findings suggest that chemical interacts directly with the pore-forming gene subunit however the chemical receptor is able to significantly modulate the affinity .	T6	T31	20188727
NA	CHEMICAL	GENE-Y	4	15	These findings suggest that chemical interacts directly with the pore-forming gene subunit however the chemical receptor is able to significantly modulate the affinity .	T6	T32	20188727
NA	CHEMICAL	GENE-N	14	10	These findings suggest that chemical interacts directly with the pore-forming gene subunit however the chemical receptor is able to significantly modulate the affinity .	T7	T31	20188727
NA	CHEMICAL	GENE-Y	14	15	These findings suggest that chemical interacts directly with the pore-forming gene subunit however the chemical receptor is able to significantly modulate the affinity .	T7	T32	20188727
NA	CHEMICAL	GENE-Y	6	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T9	T20	23340897
NA	CHEMICAL	GENE-Y	6	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T9	T21	23340897
NA	CHEMICAL	GENE-Y	8	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T11	T20	23340897
NA	CHEMICAL	GENE-Y	8	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T11	T21	23340897
NA	CHEMICAL	GENE-Y	17	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T2	T20	23340897
NA	CHEMICAL	GENE-Y	17	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T2	T21	23340897
NA	CHEMICAL	GENE-Y	2	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T7	T20	23340897
NA	CHEMICAL	GENE-Y	2	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T7	T21	23340897
NA	CHEMICAL	GENE-Y	2	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T8	T20	23340897
NA	CHEMICAL	GENE-Y	2	38	OBJECTIVETo 1 ) determine if plasma chemical ( chemical ) concentrations differ among obese youth with normal chemical tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between chemical and in vivo gene sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma chemical concentrations were examined in banked specimens in 9- to 20-year-old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired chemical tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo gene sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m ( 2 ) , respectively .	T8	T21	23340897
NA	CHEMICAL	GENE-Y	7	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T1	T16	23340897
NA	CHEMICAL	GENE-Y	7	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T1	T17	23340897
NA	CHEMICAL	GENE-Y	7	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T1	T18	23340897
NA	CHEMICAL	GENE-Y	7	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T1	T19	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T3	T16	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T3	T17	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T3	T18	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T3	T19	23340897
NA	CHEMICAL	GENE-Y	48	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T4	T16	23340897
NA	CHEMICAL	GENE-Y	48	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T4	T17	23340897
NA	CHEMICAL	GENE-Y	48	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T4	T18	23340897
NA	CHEMICAL	GENE-Y	48	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T4	T19	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T5	T16	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T5	T17	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T5	T18	23340897
NA	CHEMICAL	GENE-Y	20	9	Furthermore , there was no association between chemical and in vivo gene sensitivity or β-cell function relative to gene sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma chemical concentrations across the chemical tolerance groups , and 2 ) no relationship between chemical and in vivo gene sensitivity and β-cell function relative to gene sensitivity in any of the groups .	T5	T19	23340897
NA	CHEMICAL	GENE-N	5	10	Moreover , the active permethylated chemical aglycon derivatives examined exhibit gene VRE antimicrobial activity at levels that approach ( typically within 2-fold ) their activity against sensitive bacteria .	T13	T17	23617725
NA	CHEMICAL	GENE-Y	5	18	Isolation and function of the chemical transporter gene ( gene ) from rabbit and discrimination between transport via PAT1 and gene in renal brush-border membrane vesicles .	T19	T33	16373326
NA	CHEMICAL	GENE-Y	5	9	Isolation and function of the chemical transporter gene ( gene ) from rabbit and discrimination between transport via PAT1 and gene in renal brush-border membrane vesicles .	T19	T34	16373326
NA	CHEMICAL	GENE-Y	5	7	Isolation and function of the chemical transporter gene ( gene ) from rabbit and discrimination between transport via PAT1 and gene in renal brush-border membrane vesicles .	T19	T31	16373326
NA	CHEMICAL	GENE-N	5	20	Isolation and function of the chemical transporter gene ( gene ) from rabbit and discrimination between transport via PAT1 and gene in renal brush-border membrane vesicles .	T19	T32	16373326
NA	CHEMICAL	GENE-Y	13	17	The purpose of this investigation was to determine whether this pH-dependent uptake represents chemical/chemical cotransport via a gene-like transport system .	T9	T24	16373326
NA	CHEMICAL	GENE-Y	13	17	The purpose of this investigation was to determine whether this pH-dependent uptake represents chemical/chemical cotransport via a gene-like transport system .	T10	T24	16373326
NA	CHEMICAL	GENE-Y	23	1	The gene cDNA was isolated ( 2296bp including both 5 ' and 3 ' untranslated regions and gene and the gene codes for a protein of 475 chemical ( 92 % identity to gene ) .	T11	T25	16373326
NA	CHEMICAL	GENE-N	23	17	The gene cDNA was isolated ( 2296bp including both 5 ' and 3 ' untranslated regions and gene and the gene codes for a protein of 475 chemical ( 92 % identity to gene ) .	T11	T26	16373326
NA	CHEMICAL	GENE-N	23	20	The gene cDNA was isolated ( 2296bp including both 5 ' and 3 ' untranslated regions and gene and the gene codes for a protein of 475 chemical ( 92 % identity to gene ) .	T11	T27	16373326
NA	CHEMICAL	GENE-Y	23	33	The gene cDNA was isolated ( 2296bp including both 5 ' and 3 ' untranslated regions and gene and the gene codes for a protein of 475 chemical ( 92 % identity to gene ) .	T11	T28	16373326
NA	CHEMICAL	GENE-Y	4	9	When expressed heterologously in a mammalian cell line , gene mediates pH-dependent , chemical-independent uptake of chemical , chemical , chemical and chemical .	T12	T30	16373326
CPR:9	CHEMICAL	GENE-Y	3	9	When expressed heterologously in a mammalian cell line , gene mediates pH-dependent , chemical-independent uptake of chemical , chemical , chemical and chemical .	T13	T30	16373326
CPR:9	CHEMICAL	GENE-Y	3	9	When expressed heterologously in a mammalian cell line , gene mediates pH-dependent , chemical-independent uptake of chemical , chemical , chemical and chemical .	T14	T30	16373326
CPR:9	CHEMICAL	GENE-Y	3	9	When expressed heterologously in a mammalian cell line , gene mediates pH-dependent , chemical-independent uptake of chemical , chemical , chemical and chemical .	T15	T30	16373326
CPR:9	CHEMICAL	GENE-Y	4	9	When expressed heterologously in a mammalian cell line , gene mediates pH-dependent , chemical-independent uptake of chemical , chemical , chemical and chemical .	T16	T30	16373326
NA	CHEMICAL	GENE-Y	4	10	In the presence of chemical and under conditions in which gene transport function was suppressed , a second chemical uptake system was detected that exhibited functional characteristics similar to those of the gene .	T3	T20	16373326
NA	CHEMICAL	GENE-N	4	20	In the presence of chemical and under conditions in which gene transport function was suppressed , a second chemical uptake system was detected that exhibited functional characteristics similar to those of the gene .	T3	T21	16373326
CPR:9	CHEMICAL	GENE-Y	8	10	In the presence of chemical and under conditions in which gene transport function was suppressed , a second chemical uptake system was detected that exhibited functional characteristics similar to those of the gene .	T4	T20	16373326
NA	CHEMICAL	GENE-N	8	20	In the presence of chemical and under conditions in which gene transport function was suppressed , a second chemical uptake system was detected that exhibited functional characteristics similar to those of the gene .	T4	T21	16373326
NA	CHEMICAL	GENE-Y	13	0	gene Deficiency Impairs Secretory Vesicle Biogenesis and Leads to Growth Retardation and Decreased chemical Tolerance .	T2	T32	23630454
CPR:4	CHEMICAL	GENE-N	9	13	Fragment-based design , synthesis , and biological evaluation of chemical derivatives as novel gene inhibitors .	T4	T9	23314054
CPR:4	CHEMICAL	GENE-Y	4	9	We have previously reported a nanomolar inhibitor of antiapoptotic gene protein , chemical ( S1 ) .	T3	T7	23314054
NA	CHEMICAL	GENE-N	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T15	T20	23369343
NA	CHEMICAL	GENE-N	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T15	T21	23369343
NA	CHEMICAL	GENE-N	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T15	T22	23369343
NA	CHEMICAL	GENE-Y	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T15	T19	23369343
NA	CHEMICAL	GENE-N	29	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T16	T20	23369343
NA	CHEMICAL	GENE-N	29	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T16	T21	23369343
NA	CHEMICAL	GENE-N	29	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T16	T22	23369343
NA	CHEMICAL	GENE-Y	29	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T16	T19	23369343
NA	CHEMICAL	GENE-N	31	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T17	T20	23369343
NA	CHEMICAL	GENE-N	31	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T17	T21	23369343
NA	CHEMICAL	GENE-N	31	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T17	T22	23369343
NA	CHEMICAL	GENE-Y	31	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T17	T19	23369343
NA	CHEMICAL	GENE-N	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T1	T20	23369343
NA	CHEMICAL	GENE-N	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T1	T21	23369343
NA	CHEMICAL	GENE-N	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T1	T22	23369343
NA	CHEMICAL	GENE-Y	5	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T1	T19	23369343
NA	CHEMICAL	GENE-N	25	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T2	T20	23369343
NA	CHEMICAL	GENE-N	25	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T2	T21	23369343
NA	CHEMICAL	GENE-N	25	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T2	T22	23369343
NA	CHEMICAL	GENE-Y	25	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T2	T19	23369343
NA	CHEMICAL	GENE-N	42	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T3	T20	23369343
NA	CHEMICAL	GENE-N	42	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T3	T21	23369343
NA	CHEMICAL	GENE-N	42	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T3	T22	23369343
NA	CHEMICAL	GENE-Y	42	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T3	T19	23369343
NA	CHEMICAL	GENE-N	46	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T4	T20	23369343
NA	CHEMICAL	GENE-N	46	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T4	T21	23369343
NA	CHEMICAL	GENE-N	46	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T4	T22	23369343
NA	CHEMICAL	GENE-Y	46	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T4	T19	23369343
NA	CHEMICAL	GENE-N	53	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T5	T20	23369343
NA	CHEMICAL	GENE-N	53	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T5	T21	23369343
NA	CHEMICAL	GENE-N	53	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T5	T22	23369343
NA	CHEMICAL	GENE-Y	53	23	Similarly , intraperitoneal administration of chemical ( 100mg/kg BW ) and sandalwood oil ( 1g/kg BW ) for two weeks modulated parameters such as serum gene , gene , chemical , chemical dismutase , gene , free chemical , protein chemical , chemical , liver lipid chemical contents , and antioxidant capacity in chemical mediated oxidative stress induced mice .	T5	T19	23369343
NA	CHEMICAL	GENE-N	0	5	A novel mutation of the gene gene in a patient with non-inherited chemical-responsive sideroblastic anemia .	T7	T13	10577279
NA	CHEMICAL	GENE-N	7	5	A novel mutation of the gene gene in a patient with non-inherited chemical-responsive sideroblastic anemia .	T6	T13	10577279
NA	CHEMICAL	GENE-N	7	0	A novel missense mutation , gene , in exon 5 of the gene gene ( gene ) was identified in a Japanese male with chemical-responsive sideroblastic anemia .	T5	T10	10577279
NA	CHEMICAL	GENE-Y	7	12	A novel missense mutation , gene , in exon 5 of the gene gene ( gene ) was identified in a Japanese male with chemical-responsive sideroblastic anemia .	T5	T11	10577279
NA	CHEMICAL	GENE-Y	7	0	A novel missense mutation , gene , in exon 5 of the gene gene ( gene ) was identified in a Japanese male with chemical-responsive sideroblastic anemia .	T5	T8	10577279
NA	CHEMICAL	GENE-N	5	0	A novel missense mutation , gene , in exon 5 of the gene gene ( gene ) was identified in a Japanese male with chemical-responsive sideroblastic anemia .	T1	T10	10577279
NA	CHEMICAL	GENE-Y	5	12	A novel missense mutation , gene , in exon 5 of the gene gene ( gene ) was identified in a Japanese male with chemical-responsive sideroblastic anemia .	T1	T11	10577279
NA	CHEMICAL	GENE-Y	5	0	A novel missense mutation , gene , in exon 5 of the gene gene ( gene ) was identified in a Japanese male with chemical-responsive sideroblastic anemia .	T1	T8	10577279
NA	CHEMICAL	GENE-Y	4	5	Activity of the mutant chemical synthase protein expressed in vitro was 15.1 % compared with the normal control , but was increased up to 34.5 % by the addition of chemical , consistent with the clinical response of the patient to chemical treatment .	T2	T9	10577279
CPR:3	CHEMICAL	GENE-Y	30	5	Activity of the mutant chemical synthase protein expressed in vitro was 15.1 % compared with the normal control , but was increased up to 34.5 % by the addition of chemical , consistent with the clinical response of the patient to chemical treatment .	T3	T9	10577279
NA	CHEMICAL	GENE-Y	8	5	Activity of the mutant chemical synthase protein expressed in vitro was 15.1 % compared with the normal control , but was increased up to 34.5 % by the addition of chemical , consistent with the clinical response of the patient to chemical treatment .	T4	T9	10577279
NA	CHEMICAL	GENE-N	10	20	Therefore , electrophysiological responses and changes in levels of intracellular chemical in mouse cholinergic LDT neurons following application of specific gene agonists and antagonists were examined .	T23	T38	22381584
CPR:5	CHEMICAL	GENE-Y	7	4	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T24	T39	22381584
NA	CHEMICAL	GENE-N	7	11	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T24	T40	22381584
NA	CHEMICAL	GENE-N	7	12	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T24	T41	22381584
NA	CHEMICAL	GENE-Y	17	4	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T25	T39	22381584
CPR:5	CHEMICAL	GENE-N	17	11	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T25	T40	22381584
NA	CHEMICAL	GENE-N	17	12	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T25	T41	22381584
NA	CHEMICAL	GENE-Y	24	4	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T26	T39	22381584
NA	CHEMICAL	GENE-N	24	11	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T26	T40	22381584
NA	CHEMICAL	GENE-N	24	12	Unexpectedly , both the genespecific agonist , chemical , and the gene ( gene ) agonist , chemical ( LY ) , induced a chemical-insensitive outward current/hyperpolarization .	T26	T41	22381584
CPR:6	CHEMICAL	GENE-N	10	8	Both outward currents were significantly reduced by the gene antagonist chemical and the chemical-induced current was blocked by the specific gene antagonist chemical .	T1	T28	22381584
NA	CHEMICAL	GENE-Y	10	20	Both outward currents were significantly reduced by the gene antagonist chemical and the chemical-induced current was blocked by the specific gene antagonist chemical .	T1	T29	22381584
NA	CHEMICAL	GENE-N	8	8	Both outward currents were significantly reduced by the gene antagonist chemical and the chemical-induced current was blocked by the specific gene antagonist chemical .	T2	T28	22381584
NA	CHEMICAL	GENE-Y	8	20	Both outward currents were significantly reduced by the gene antagonist chemical and the chemical-induced current was blocked by the specific gene antagonist chemical .	T2	T29	22381584
NA	CHEMICAL	GENE-N	22	8	Both outward currents were significantly reduced by the gene antagonist chemical and the chemical-induced current was blocked by the specific gene antagonist chemical .	T3	T28	22381584
CPR:6	CHEMICAL	GENE-Y	22	20	Both outward currents were significantly reduced by the gene antagonist chemical and the chemical-induced current was blocked by the specific gene antagonist chemical .	T3	T29	22381584
NA	CHEMICAL	GENE-N	3	8	The large-conductance , chemical-dependent chemical ( BK ) channel blocker , iberiotoxin , attenuated chemical actions .	T12	T30	22381584
NA	CHEMICAL	GENE-N	4	8	The large-conductance , chemical-dependent chemical ( BK ) channel blocker , iberiotoxin , attenuated chemical actions .	T13	T30	22381584
NA	CHEMICAL	GENE-N	14	8	The large-conductance , chemical-dependent chemical ( BK ) channel blocker , iberiotoxin , attenuated chemical actions .	T14	T30	22381584
NA	CHEMICAL	GENE-N	2	12	Effects of chemicalrgic input would be , thus , expected not only to be excitation via stimulation of gene and gene , but also inhibition via actions at gene and gene on these neurons .	T16	T33	22381584
NA	CHEMICAL	GENE-Y	2	20	Effects of chemicalrgic input would be , thus , expected not only to be excitation via stimulation of gene and gene , but also inhibition via actions at gene and gene on these neurons .	T16	T34	22381584
NA	CHEMICAL	GENE-Y	2	28	Effects of chemicalrgic input would be , thus , expected not only to be excitation via stimulation of gene and gene , but also inhibition via actions at gene and gene on these neurons .	T16	T35	22381584
NA	CHEMICAL	GENE-N	2	30	Effects of chemicalrgic input would be , thus , expected not only to be excitation via stimulation of gene and gene , but also inhibition via actions at gene and gene on these neurons .	T16	T36	22381584
NA	CHEMICAL	GENE-Y	3	4	Synthesis of novel chemical receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity .	T5	T18	23448346
NA	CHEMICAL	GENE-Y	0	1	chemical receptor ( gene ) antagonists are valuable in the treatment of gene-positive human breast cancer .	T1	T6	23448346
NA	CHEMICAL	GENE-N	0	3	chemical receptor ( gene ) antagonists are valuable in the treatment of gene-positive human breast cancer .	T1	T7	23448346
NA	CHEMICAL	GENE-Y	0	12	chemical receptor ( gene ) antagonists are valuable in the treatment of gene-positive human breast cancer .	T1	T12	23448346
NA	CHEMICAL	GENE-Y	12	30	In this study , we designed and synthesized nine new derivatives of chemical ( E2 ) with a bulky side chain attached to its C-7α position , and determined their gene antagonistic activity using in vitro bioassays .	T2	T8	23448346
NA	CHEMICAL	GENE-Y	32	14	Computational docking analysis was conducted to model the interaction of these antagonists with the gene and showed that they could tightly bind to the gene in a manner similar to that of chemical , a pure gene antagonist .	T3	T13	23448346
NA	CHEMICAL	GENE-N	32	24	Computational docking analysis was conducted to model the interaction of these antagonists with the gene and showed that they could tightly bind to the gene in a manner similar to that of chemical , a pure gene antagonist .	T3	T14	23448346
CPR:6	CHEMICAL	GENE-Y	32	36	Computational docking analysis was conducted to model the interaction of these antagonists with the gene and showed that they could tightly bind to the gene in a manner similar to that of chemical , a pure gene antagonist .	T3	T15	23448346
CPR:4	CHEMICAL	GENE-N	0	1	chemical as Novel chemical Binding Group for Selective gene Inhibition .	T8	T19	23547652
CPR:4	CHEMICAL	GENE-N	3	1	chemical as Novel chemical Binding Group for Selective gene Inhibition .	T9	T19	23547652
CPR:4	CHEMICAL	GENE-N	7	5	Small molecules bearing hydroxamic acid as the chemical binding group ( ZBG ) have been the most effective gene inhibitors ( genei ) to date .	T5	T10	23547652
CPR:4	CHEMICAL	GENE-N	7	21	Small molecules bearing hydroxamic acid as the chemical binding group ( ZBG ) have been the most effective gene inhibitors ( genei ) to date .	T5	T11	23547652
CPR:4	CHEMICAL	GENE-N	3	15	We have identified chemical ( chemical ) as a novel ZBG that is compatible with gene inhibition .	T2	T12	23547652
CPR:4	CHEMICAL	GENE-N	5	15	We have identified chemical ( chemical ) as a novel ZBG that is compatible with gene inhibition .	T3	T12	23547652
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene and gene with an IC50 of 681 and 3675 nM , respectively .	T4	T13	23547652
CPR:4	CHEMICAL	GENE-Y	0	4	chemical inhibits gene and gene with an IC50 of 681 and 3675 nM , respectively .	T4	T14	23547652
NA	CHEMICAL	GENE-Y	2	7	Remarkably , chemical gives no inhibition of gene .	T6	T15	23547652
NA	CHEMICAL	GENE-N	0	6	chemical and chemical sites on the gene and their allosteric interaction .	T21	T29	11551210
NA	CHEMICAL	GENE-N	2	6	chemical and chemical sites on the gene and their allosteric interaction .	T22	T29	11551210
CPR:4	CHEMICAL	GENE-N	0	15	chemical are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral gene ( gene ) by binding to one or more specific sites on the gene .	T1	T24	11551210
NA	CHEMICAL	GENE-N	0	17	chemical are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral gene ( gene ) by binding to one or more specific sites on the gene .	T1	T25	11551210
NA	CHEMICAL	GENE-N	0	29	chemical are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral gene ( gene ) by binding to one or more specific sites on the gene .	T1	T26	11551210
CPR:4	CHEMICAL	GENE-N	0	12	chemical are naturally occurring , uncharged noncompetitive inhibitors of peripheral and neuronal gene , which have no demonstrable general anesthetic activity in vivo .	T9	T27	11551210
NA	CHEMICAL	GENE-N	4	35	In this study , chemical ( chemical ) , an analogue of the cationic noncompetitive inhibitor chemical ( chemical ) , was used to characterize the chemical and chemical sites on the desensitized Torpedo californica gene and to investigate if these sites interact .	T10	T28	11551210
NA	CHEMICAL	GENE-N	6	35	In this study , chemical ( chemical ) , an analogue of the cationic noncompetitive inhibitor chemical ( chemical ) , was used to characterize the chemical and chemical sites on the desensitized Torpedo californica gene and to investigate if these sites interact .	T11	T28	11551210
NA	CHEMICAL	GENE-N	16	35	In this study , chemical ( chemical ) , an analogue of the cationic noncompetitive inhibitor chemical ( chemical ) , was used to characterize the chemical and chemical sites on the desensitized Torpedo californica gene and to investigate if these sites interact .	T12	T28	11551210
NA	CHEMICAL	GENE-N	18	35	In this study , chemical ( chemical ) , an analogue of the cationic noncompetitive inhibitor chemical ( chemical ) , was used to characterize the chemical and chemical sites on the desensitized Torpedo californica gene and to investigate if these sites interact .	T13	T28	11551210
NA	CHEMICAL	GENE-N	9	35	In this study , chemical ( chemical ) , an analogue of the cationic noncompetitive inhibitor chemical ( chemical ) , was used to characterize the chemical and chemical sites on the desensitized Torpedo californica gene and to investigate if these sites interact .	T14	T28	11551210
NA	CHEMICAL	GENE-N	9	35	In this study , chemical ( chemical ) , an analogue of the cationic noncompetitive inhibitor chemical ( chemical ) , was used to characterize the chemical and chemical sites on the desensitized Torpedo californica gene and to investigate if these sites interact .	T15	T28	11551210
NA	CHEMICAL	GENE-Y	5	12	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T25	23439872
NA	CHEMICAL	GENE-Y	5	14	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T26	23439872
NA	CHEMICAL	GENE-Y	5	19	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T28	23439872
NA	CHEMICAL	GENE-Y	5	23	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T29	23439872
NA	CHEMICAL	GENE-Y	5	25	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T30	23439872
NA	CHEMICAL	GENE-Y	5	28	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T31	23439872
NA	CHEMICAL	GENE-Y	5	30	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T32	23439872
NA	CHEMICAL	GENE-Y	5	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T33	23439872
NA	CHEMICAL	GENE-Y	5	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T11	T34	23439872
NA	CHEMICAL	GENE-Y	10	12	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T25	23439872
NA	CHEMICAL	GENE-Y	10	14	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T26	23439872
NA	CHEMICAL	GENE-Y	10	19	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T28	23439872
NA	CHEMICAL	GENE-Y	10	23	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T29	23439872
NA	CHEMICAL	GENE-Y	10	25	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T30	23439872
NA	CHEMICAL	GENE-Y	10	28	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T31	23439872
NA	CHEMICAL	GENE-Y	10	30	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T32	23439872
NA	CHEMICAL	GENE-Y	10	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T33	23439872
NA	CHEMICAL	GENE-Y	10	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T12	T34	23439872
NA	CHEMICAL	GENE-Y	17	12	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T25	23439872
NA	CHEMICAL	GENE-Y	17	14	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T26	23439872
NA	CHEMICAL	GENE-Y	17	19	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T28	23439872
NA	CHEMICAL	GENE-Y	17	23	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T29	23439872
NA	CHEMICAL	GENE-Y	17	25	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T30	23439872
NA	CHEMICAL	GENE-Y	17	28	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T31	23439872
NA	CHEMICAL	GENE-Y	17	30	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T32	23439872
NA	CHEMICAL	GENE-Y	17	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T33	23439872
NA	CHEMICAL	GENE-Y	17	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T13	T34	23439872
NA	CHEMICAL	GENE-Y	2	12	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T25	23439872
NA	CHEMICAL	GENE-Y	2	14	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T26	23439872
NA	CHEMICAL	GENE-Y	2	19	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T28	23439872
NA	CHEMICAL	GENE-Y	2	23	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T29	23439872
NA	CHEMICAL	GENE-Y	2	25	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T30	23439872
NA	CHEMICAL	GENE-Y	2	28	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T31	23439872
NA	CHEMICAL	GENE-Y	2	30	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T32	23439872
NA	CHEMICAL	GENE-Y	2	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T33	23439872
NA	CHEMICAL	GENE-Y	2	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T14	T34	23439872
NA	CHEMICAL	GENE-Y	11	12	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T25	23439872
NA	CHEMICAL	GENE-Y	11	14	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T26	23439872
NA	CHEMICAL	GENE-Y	11	19	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T28	23439872
NA	CHEMICAL	GENE-Y	11	23	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T29	23439872
NA	CHEMICAL	GENE-Y	11	25	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T30	23439872
NA	CHEMICAL	GENE-Y	11	28	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T31	23439872
NA	CHEMICAL	GENE-Y	11	30	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T32	23439872
NA	CHEMICAL	GENE-Y	11	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T33	23439872
NA	CHEMICAL	GENE-Y	11	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T15	T34	23439872
NA	CHEMICAL	GENE-Y	2	12	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T25	23439872
NA	CHEMICAL	GENE-Y	2	14	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T26	23439872
NA	CHEMICAL	GENE-Y	2	19	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T28	23439872
NA	CHEMICAL	GENE-Y	2	23	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T29	23439872
NA	CHEMICAL	GENE-Y	2	25	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T30	23439872
NA	CHEMICAL	GENE-Y	2	28	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T31	23439872
NA	CHEMICAL	GENE-Y	2	30	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T32	23439872
NA	CHEMICAL	GENE-Y	2	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T33	23439872
NA	CHEMICAL	GENE-Y	2	36	Strain-dependent down-regulation of several key one-chemical metabolism genes , including chemical chemicaltransferase 1α ( gene ) , chemical-β-synthase ( gene ) , chemical reductase ( gene ) , gene ( gene ) , and chemical dehydrogenase 1 ( gene ) , was observed .	T16	T34	23439872
NA	CHEMICAL	GENE-Y	8	2	Induction of gene and activation of gene in chemical-treated squamous carcinoma cells .	T13	T50	15887238
CPR:3	CHEMICAL	GENE-Y	8	6	Induction of gene and activation of gene in chemical-treated squamous carcinoma cells .	T13	T51	15887238
CPR:4	CHEMICAL	GENE-N	0	2	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T1	T35	15887238
CPR:4	CHEMICAL	GENE-Y	0	8	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T1	T38	15887238
CPR:4	CHEMICAL	GENE-Y	0	10	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T1	T40	15887238
CPR:4	CHEMICAL	GENE-Y	0	12	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T1	T15	15887238
CPR:4	CHEMICAL	GENE-Y	0	16	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T1	T18	15887238
CPR:4	CHEMICAL	GENE-N	0	2	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T1	T20	15887238
NA	CHEMICAL	GENE-N	3	2	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T7	T35	15887238
NA	CHEMICAL	GENE-Y	3	8	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T7	T38	15887238
NA	CHEMICAL	GENE-Y	3	10	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T7	T40	15887238
NA	CHEMICAL	GENE-Y	3	12	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T7	T15	15887238
NA	CHEMICAL	GENE-Y	3	16	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T7	T18	15887238
NA	CHEMICAL	GENE-N	3	2	chemical is a chemical kinase inhibitor of the gene , gene ( gene ) , and gene gene .	T7	T20	15887238
CPR:3	CHEMICAL	GENE-Y	13	21	Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of chemical-induced changes in cell morphology and growth similar to changes associated with gene ( gene ) activation .	T9	T36	15887238
CPR:3	CHEMICAL	GENE-Y	13	27	Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of chemical-induced changes in cell morphology and growth similar to changes associated with gene ( gene ) activation .	T9	T37	15887238
NA	CHEMICAL	GENE-Y	0	6	chemical-induced changes were blocked with the gene antagonist cetuximab , which suggested direct involvement of gene in this process .	T10	T39	15887238
CPR:3	CHEMICAL	GENE-Y	0	15	chemical-induced changes were blocked with the gene antagonist cetuximab , which suggested direct involvement of gene in this process .	T10	T41	15887238
CPR:3	CHEMICAL	GENE-Y	7	11	Western blot analysis of cells incubated with chemical demonstrated activation of gene and downstream signaling that was reduced by inhibition of gene ( gene ) and gene , but not gene/gene .	T11	T42	15887238
NA	CHEMICAL	GENE-Y	7	21	Western blot analysis of cells incubated with chemical demonstrated activation of gene and downstream signaling that was reduced by inhibition of gene ( gene ) and gene , but not gene/gene .	T11	T43	15887238
NA	CHEMICAL	GENE-Y	7	23	Western blot analysis of cells incubated with chemical demonstrated activation of gene and downstream signaling that was reduced by inhibition of gene ( gene ) and gene , but not gene/gene .	T11	T44	15887238
NA	CHEMICAL	GENE-Y	7	26	Western blot analysis of cells incubated with chemical demonstrated activation of gene and downstream signaling that was reduced by inhibition of gene ( gene ) and gene , but not gene/gene .	T11	T45	15887238
NA	CHEMICAL	GENE-Y	7	30	Western blot analysis of cells incubated with chemical demonstrated activation of gene and downstream signaling that was reduced by inhibition of gene ( gene ) and gene , but not gene/gene .	T11	T46	15887238
NA	CHEMICAL	GENE-Y	7	30	Western blot analysis of cells incubated with chemical demonstrated activation of gene and downstream signaling that was reduced by inhibition of gene ( gene ) and gene , but not gene/gene .	T11	T47	15887238
NA	CHEMICAL	GENE-N	1	1	An in vitro gene assay showed that chemical did not directly affect gene gene activity , suggesting involvement of gene-activating molecules .	T12	T48	15887238
NA	CHEMICAL	GENE-Y	1	12	An in vitro gene assay showed that chemical did not directly affect gene gene activity , suggesting involvement of gene-activating molecules .	T12	T49	15887238
NA	CHEMICAL	GENE-N	1	1	An in vitro gene assay showed that chemical did not directly affect gene gene activity , suggesting involvement of gene-activating molecules .	T12	T14	15887238
NA	CHEMICAL	GENE-Y	1	19	An in vitro gene assay showed that chemical did not directly affect gene gene activity , suggesting involvement of gene-activating molecules .	T12	T16	15887238
NA	CHEMICAL	GENE-Y	12	5	Inhibitors and neutralizing antibodies against gene ( gene ) , and to a lesser extent gene , reduced chemical-mediated gene ( gene ) activation .	T2	T17	15887238
NA	CHEMICAL	GENE-Y	12	7	Inhibitors and neutralizing antibodies against gene ( gene ) , and to a lesser extent gene , reduced chemical-mediated gene ( gene ) activation .	T2	T19	15887238
NA	CHEMICAL	GENE-Y	12	11	Inhibitors and neutralizing antibodies against gene ( gene ) , and to a lesser extent gene , reduced chemical-mediated gene ( gene ) activation .	T2	T21	15887238
CPR:3	CHEMICAL	GENE-N	12	12	Inhibitors and neutralizing antibodies against gene ( gene ) , and to a lesser extent gene , reduced chemical-mediated gene ( gene ) activation .	T2	T22	15887238
CPR:3	CHEMICAL	GENE-N	12	21	Inhibitors and neutralizing antibodies against gene ( gene ) , and to a lesser extent gene , reduced chemical-mediated gene ( gene ) activation .	T2	T23	15887238
CPR:3	CHEMICAL	GENE-Y	0	7	chemical stimulated the rapid release of soluble gene and the subsequent induction of membrane-bound gene , which correlated with biphasic gene activation .	T3	T24	15887238
CPR:3	CHEMICAL	GENE-Y	0	14	chemical stimulated the rapid release of soluble gene and the subsequent induction of membrane-bound gene , which correlated with biphasic gene activation .	T3	T25	15887238
CPR:3	CHEMICAL	GENE-N	0	20	chemical stimulated the rapid release of soluble gene and the subsequent induction of membrane-bound gene , which correlated with biphasic gene activation .	T3	T27	15887238
NA	CHEMICAL	GENE-Y	6	8	Together , these results suggested that chemical affects gene activation and signaling pathways through rapid release and increased expression of endogenous gene-activating ligands .	T4	T29	15887238
CPR:3	CHEMICAL	GENE-Y	6	21	Together , these results suggested that chemical affects gene activation and signaling pathways through rapid release and increased expression of endogenous gene-activating ligands .	T4	T31	15887238
NA	CHEMICAL	GENE-N	5	7	Characteristics of the binding of chemical to gene .	T20	T38	3134891
NA	CHEMICAL	GENE-N	9	11	To determine the factors that influence the interaction between chemical and gene , the binding of chemical to gene was determined by equilibrium dialysis under a variety of experimental conditions .	T13	T34	3134891
NA	CHEMICAL	GENE-N	9	18	To determine the factors that influence the interaction between chemical and gene , the binding of chemical to gene was determined by equilibrium dialysis under a variety of experimental conditions .	T13	T24	3134891
NA	CHEMICAL	GENE-N	16	11	To determine the factors that influence the interaction between chemical and gene , the binding of chemical to gene was determined by equilibrium dialysis under a variety of experimental conditions .	T2	T34	3134891
NA	CHEMICAL	GENE-N	16	18	To determine the factors that influence the interaction between chemical and gene , the binding of chemical to gene was determined by equilibrium dialysis under a variety of experimental conditions .	T2	T24	3134891
NA	CHEMICAL	GENE-N	7	7	This interaction was found to be similar in some respects to the interaction between chemical and gene .	T9	T31	3134891
NA	CHEMICAL	GENE-N	11	17	It was saturable , with between 1 and 2 mol of chemical bound to 1 mol of gene .	T10	T32	3134891
NA	CHEMICAL	GENE-N	4	7	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T12	T33	3134891
NA	CHEMICAL	GENE-N	4	39	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T12	T35	3134891
NA	CHEMICAL	GENE-N	27	7	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T14	T33	3134891
NA	CHEMICAL	GENE-N	27	39	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T14	T35	3134891
NA	CHEMICAL	GENE-N	29	7	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T15	T33	3134891
NA	CHEMICAL	GENE-N	29	39	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T15	T35	3134891
NA	CHEMICAL	GENE-N	31	7	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T16	T33	3134891
NA	CHEMICAL	GENE-N	31	39	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T16	T35	3134891
NA	CHEMICAL	GENE-N	10	7	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T17	T33	3134891
NA	CHEMICAL	GENE-N	10	39	The site at which chemical bound to gene appears to be similar to that at which certain antipsychotic agents bind , since several of them , including chemical , chemical and chemical , prevented the binding of chemical to gene .	T17	T35	3134891
NA	CHEMICAL	GENE-N	2	2	However , in contrast to the reversible binding of most chemical to gene , chemical bound to gene irreversibly .	T18	T36	3134891
NA	CHEMICAL	GENE-N	2	2	However , in contrast to the reversible binding of most chemical to gene , chemical bound to gene irreversibly .	T18	T37	3134891
NA	CHEMICAL	GENE-N	2	2	However , in contrast to the reversible binding of most chemical to gene , chemical bound to gene irreversibly .	T19	T36	3134891
NA	CHEMICAL	GENE-N	2	2	However , in contrast to the reversible binding of most chemical to gene , chemical bound to gene irreversibly .	T19	T37	3134891
NA	CHEMICAL	GENE-N	3	5	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T1	T21	3134891
NA	CHEMICAL	GENE-N	3	12	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T1	T22	3134891
NA	CHEMICAL	GENE-N	3	9	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T1	T23	3134891
NA	CHEMICAL	GENE-N	9	5	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T3	T21	3134891
NA	CHEMICAL	GENE-N	9	12	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T3	T22	3134891
NA	CHEMICAL	GENE-N	9	9	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T3	T23	3134891
NA	CHEMICAL	GENE-N	9	5	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T4	T21	3134891
NA	CHEMICAL	GENE-N	9	12	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T4	T22	3134891
NA	CHEMICAL	GENE-N	9	9	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T4	T23	3134891
NA	CHEMICAL	GENE-N	9	5	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T5	T21	3134891
NA	CHEMICAL	GENE-N	9	12	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T5	T22	3134891
NA	CHEMICAL	GENE-N	9	9	The binding of chemical to gene was fairly selective in that other gene agents such as chemical , chemical and chemical failed to bind to gene when examined under the same experimental conditions .	T5	T23	3134891
NA	CHEMICAL	GENE-Y	5	14	We provide evidence that defective chemical catabolism promotes the development of fasting hypoglycemia in gene-/- mice by limiting gluconeogenic substrate availability .	T1	T14	17403374
NA	CHEMICAL	GENE-Y	11	0	gene-/- liver and skeletal muscle show markedly reduced mRNA expression of chemical-degrading enzymes .	T2	T15	17403374
NA	CHEMICAL	GENE-N	6	7	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T3	T16	17403374
NA	CHEMICAL	GENE-N	6	9	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T3	T17	17403374
NA	CHEMICAL	GENE-Y	6	30	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T3	T18	17403374
CPR:9	CHEMICAL	GENE-N	17	7	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T5	T16	17403374
CPR:9	CHEMICAL	GENE-N	17	9	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T5	T17	17403374
NA	CHEMICAL	GENE-Y	17	30	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T5	T18	17403374
CPR:9	CHEMICAL	GENE-N	18	7	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T6	T16	17403374
CPR:9	CHEMICAL	GENE-N	18	9	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T6	T17	17403374
NA	CHEMICAL	GENE-Y	18	30	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T6	T18	17403374
CPR:9	CHEMICAL	GENE-N	20	7	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T7	T16	17403374
CPR:9	CHEMICAL	GENE-N	20	9	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T7	T17	17403374
NA	CHEMICAL	GENE-Y	20	30	Furthermore , the enzymatic activity of chemical aminotransferase ( gene ) , which converts the critical gluconeogenic chemical chemical into chemical , is decreased ( approximately 50 % ) in gene-/- hepatocytes .	T7	T18	17403374
NA	CHEMICAL	GENE-Y	8	18	Consistent with this observation , intraperitoneal injection of chemical , but not chemical , rescues fasting hypoglycemia in gene-/- mice .	T8	T10	17403374
NA	CHEMICAL	GENE-Y	12	18	Consistent with this observation , intraperitoneal injection of chemical , but not chemical , rescues fasting hypoglycemia in gene-/- mice .	T9	T10	17403374
NA	CHEMICAL	GENE-Y	29	3	The complexity of gene regulation has made it difficult to determine whether these different roles require different thresholds of gene activity and whether the surge of activity as inhibitory chemical are removed at mitotic onset is essential for cell proliferation .	T2	T17	23525902
NA	CHEMICAL	GENE-N	29	19	The complexity of gene regulation has made it difficult to determine whether these different roles require different thresholds of gene activity and whether the surge of activity as inhibitory chemical are removed at mitotic onset is essential for cell proliferation .	T2	T18	23525902
NA	CHEMICAL	GENE-Y	16	7	We rescued cells lethally depleted of endogenous gene with an exogenous gene conferring sensitivity to one chemical analogue inhibitor ( chemical ) and resistance to another ( chemical ) .	T3	T19	23525902
NA	CHEMICAL	GENE-Y	16	11	We rescued cells lethally depleted of endogenous gene with an exogenous gene conferring sensitivity to one chemical analogue inhibitor ( chemical ) and resistance to another ( chemical ) .	T3	T20	23525902
NA	CHEMICAL	GENE-Y	20	7	We rescued cells lethally depleted of endogenous gene with an exogenous gene conferring sensitivity to one chemical analogue inhibitor ( chemical ) and resistance to another ( chemical ) .	T4	T19	23525902
NA	CHEMICAL	GENE-Y	20	11	We rescued cells lethally depleted of endogenous gene with an exogenous gene conferring sensitivity to one chemical analogue inhibitor ( chemical ) and resistance to another ( chemical ) .	T4	T20	23525902
NA	CHEMICAL	GENE-Y	27	7	We rescued cells lethally depleted of endogenous gene with an exogenous gene conferring sensitivity to one chemical analogue inhibitor ( chemical ) and resistance to another ( chemical ) .	T5	T19	23525902
NA	CHEMICAL	GENE-Y	27	11	We rescued cells lethally depleted of endogenous gene with an exogenous gene conferring sensitivity to one chemical analogue inhibitor ( chemical ) and resistance to another ( chemical ) .	T5	T20	23525902
NA	CHEMICAL	GENE-Y	2	22	At no chemical concentration was mitosis in rescued clones prevented without also inducing endoreduplication , suggesting that these two key roles for gene are not simply controlled by different gene activity thresholds .	T6	T8	23525902
NA	CHEMICAL	GENE-Y	2	29	At no chemical concentration was mitosis in rescued clones prevented without also inducing endoreduplication , suggesting that these two key roles for gene are not simply controlled by different gene activity thresholds .	T6	T9	23525902
NA	CHEMICAL	GENE-Y	3	7	We also rescued chemical-resistant clones using exogenous gene without inhibitory phosphorylation sites , indicating that the mitotic surge of gene activity is dispensable for cell proliferation .	T1	T10	23525902
NA	CHEMICAL	GENE-Y	3	19	We also rescued chemical-resistant clones using exogenous gene without inhibitory phosphorylation sites , indicating that the mitotic surge of gene activity is dispensable for cell proliferation .	T1	T11	23525902
CPR:6	CHEMICAL	GENE-N	14	16	The mechanism ( s ) responsible for arterial vasodilation observed following acute administration of chemical , a novel vasodilator/gene antagonist , has been investigated in rats .	T27	T34	1712335
CPR:4	CHEMICAL	GENE-Y	0	8	chemical ( 0.3 mg/kg , iv ) produced a significant inhibition of the gene mediated positive chronotropic response to chemical .	T23	T45	1712335
CPR:3	CHEMICAL	GENE-Y	19	8	chemical ( 0.3 mg/kg , iv ) produced a significant inhibition of the gene mediated positive chronotropic response to chemical .	T24	T45	1712335
CPR:4	CHEMICAL	GENE-Y	4	9	This same dose of chemical also inhibited , but to a lesser degree , the gene mediated vasodepressor response to chemical in pithed rats whose blood pressure was elevated by a constant intravenous infusion of gene .	T25	T46	1712335
NA	CHEMICAL	GENE-Y	4	35	This same dose of chemical also inhibited , but to a lesser degree , the gene mediated vasodepressor response to chemical in pithed rats whose blood pressure was elevated by a constant intravenous infusion of gene .	T25	T29	1712335
NA	CHEMICAL	GENE-Y	8	9	This same dose of chemical also inhibited , but to a lesser degree , the gene mediated vasodepressor response to chemical in pithed rats whose blood pressure was elevated by a constant intravenous infusion of gene .	T26	T46	1712335
NA	CHEMICAL	GENE-Y	8	35	This same dose of chemical also inhibited , but to a lesser degree , the gene mediated vasodepressor response to chemical in pithed rats whose blood pressure was elevated by a constant intravenous infusion of gene .	T26	T29	1712335
NA	CHEMICAL	GENE-N	2	5	Thus , chemical blocks both gene at antihypertensive doses , with modest selectivity being observed for the gene subtype .	T1	T30	1712335
CPR:4	CHEMICAL	GENE-Y	2	17	Thus , chemical blocks both gene at antihypertensive doses , with modest selectivity being observed for the gene subtype .	T1	T31	1712335
CPR:4	CHEMICAL	GENE-N	0	6	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T2	T32	1712335
NA	CHEMICAL	GENE-Y	0	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T2	T33	1712335
NA	CHEMICAL	GENE-N	0	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T2	T35	1712335
NA	CHEMICAL	GENE-N	6	6	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T3	T32	1712335
NA	CHEMICAL	GENE-Y	6	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T3	T33	1712335
NA	CHEMICAL	GENE-N	6	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T3	T35	1712335
NA	CHEMICAL	GENE-N	28	6	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T4	T32	1712335
NA	CHEMICAL	GENE-Y	28	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T4	T33	1712335
NA	CHEMICAL	GENE-N	28	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T4	T35	1712335
NA	CHEMICAL	GENE-N	32	6	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T5	T32	1712335
NA	CHEMICAL	GENE-Y	32	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T5	T33	1712335
CPR:6	CHEMICAL	GENE-N	32	10	chemical produced significant inhibition of the gene mediated pressor response to chemical in the pithed rat , but had no effect on the gene mediated pressor response to chemical , suggesting that chemical is also an gene antagonist at antihypertensive doses .	T5	T35	1712335
NA	CHEMICAL	GENE-Y	0	10	chemical had no effect on the pressor response elicited by gene , indicating a lack of nonspecific vasodilator activity .	T6	T36	1712335
NA	CHEMICAL	GENE-N	5	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T7	T37	1712335
NA	CHEMICAL	GENE-N	5	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T7	T38	1712335
NA	CHEMICAL	GENE-N	5	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T7	T39	1712335
CPR:3	CHEMICAL	GENE-N	9	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T8	T37	1712335
CPR:3	CHEMICAL	GENE-N	9	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T8	T38	1712335
NA	CHEMICAL	GENE-N	9	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T8	T39	1712335
NA	CHEMICAL	GENE-N	27	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T9	T37	1712335
NA	CHEMICAL	GENE-N	27	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T9	T38	1712335
NA	CHEMICAL	GENE-N	27	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T9	T39	1712335
NA	CHEMICAL	GENE-N	46	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T10	T37	1712335
CPR:9	CHEMICAL	GENE-N	46	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T10	T38	1712335
NA	CHEMICAL	GENE-N	46	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T10	T39	1712335
NA	CHEMICAL	GENE-N	33	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T11	T37	1712335
CPR:4	CHEMICAL	GENE-N	33	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T11	T38	1712335
NA	CHEMICAL	GENE-N	33	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T11	T39	1712335
NA	CHEMICAL	GENE-N	43	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T12	T37	1712335
NA	CHEMICAL	GENE-N	43	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T12	T38	1712335
CPR:6	CHEMICAL	GENE-N	43	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T12	T39	1712335
NA	CHEMICAL	GENE-N	46	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T13	T37	1712335
NA	CHEMICAL	GENE-N	46	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T13	T38	1712335
NA	CHEMICAL	GENE-N	46	6	The vasopressor response to the chemical channel activator , chemical , which is mediated through the opening of voltage dependent genes and the subsequent translocation of extracellular chemical , was significantly inhibited by chemical ( 1 mg/kg , iv ) , suggesting that chemical is also a chemical channel antagonist , consistent with our previous in vitro studies .	T13	T39	1712335
NA	CHEMICAL	GENE-N	10	25	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T14	T40	1712335
NA	CHEMICAL	GENE-N	10	39	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T14	T41	1712335
CPR:6	CHEMICAL	GENE-N	28	25	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T15	T40	1712335
NA	CHEMICAL	GENE-N	28	39	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T15	T41	1712335
NA	CHEMICAL	GENE-N	28	68	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T15	T42	1712335
NA	CHEMICAL	GENE-N	42	25	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T16	T40	1712335
CPR:6	CHEMICAL	GENE-N	42	39	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T16	T41	1712335
NA	CHEMICAL	GENE-N	42	68	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T16	T42	1712335
NA	CHEMICAL	GENE-N	60	25	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T17	T40	1712335
NA	CHEMICAL	GENE-N	60	39	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T17	T41	1712335
NA	CHEMICAL	GENE-N	60	68	In anesthetized spontaneously hypertensive rats , the antihypertensive activity of chemical was nearly abolished by combined pretreatment of the rats with high doses of the gene antagonist , chemical ( 1 mg/kg , iv ) , and the nonselective gene antagonist , chemical ( 3 mg/kg , iv ) , suggesting that the majority of the antihypertensive response produced by chemical may be accounted for by blockade of gene .	T17	T42	1712335
NA	CHEMICAL	GENE-N	3	5	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T4	T22	23293126
NA	CHEMICAL	GENE-N	3	7	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T4	T23	23293126
NA	CHEMICAL	GENE-N	3	11	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T4	T24	23293126
NA	CHEMICAL	GENE-N	3	13	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T4	T25	23293126
NA	CHEMICAL	GENE-N	10	5	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T5	T22	23293126
NA	CHEMICAL	GENE-N	10	7	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T5	T23	23293126
NA	CHEMICAL	GENE-N	10	11	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T5	T24	23293126
NA	CHEMICAL	GENE-N	10	13	Results revealed that chemical , gene ( gene ) and chemical peroxidase ( gene ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .	T5	T25	23293126
NA	CHEMICAL	GENE-N	0	2	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T6	T26	23293126
NA	CHEMICAL	GENE-N	0	9	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T6	T27	23293126
NA	CHEMICAL	GENE-N	0	11	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T6	T28	23293126
NA	CHEMICAL	GENE-N	0	15	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T6	T29	23293126
NA	CHEMICAL	GENE-N	0	17	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T6	T30	23293126
NA	CHEMICAL	GENE-N	14	2	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T7	T26	23293126
NA	CHEMICAL	GENE-N	14	9	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T7	T27	23293126
NA	CHEMICAL	GENE-N	14	11	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T7	T28	23293126
NA	CHEMICAL	GENE-N	14	15	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T7	T29	23293126
NA	CHEMICAL	GENE-N	14	17	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T7	T30	23293126
NA	CHEMICAL	GENE-N	21	2	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T8	T26	23293126
NA	CHEMICAL	GENE-N	21	9	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T8	T27	23293126
NA	CHEMICAL	GENE-N	21	11	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T8	T28	23293126
NA	CHEMICAL	GENE-N	21	15	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T8	T29	23293126
NA	CHEMICAL	GENE-N	21	17	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T8	T30	23293126
NA	CHEMICAL	GENE-N	23	2	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T9	T26	23293126
NA	CHEMICAL	GENE-N	23	9	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T9	T27	23293126
NA	CHEMICAL	GENE-N	23	11	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T9	T28	23293126
NA	CHEMICAL	GENE-N	23	15	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T9	T29	23293126
NA	CHEMICAL	GENE-N	23	17	chemical and gene were correlated with smoking index and gene ( gene ) , chemical dismutase ( gene ) enzyme and chemical ( chemical ) were inversely correlated with duration of pesticides ' exposure .	T9	T30	23293126
NA	CHEMICAL	GENE-N	5	3	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T10	T31	23293126
NA	CHEMICAL	GENE-N	5	10	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T10	T32	23293126
NA	CHEMICAL	GENE-N	14	3	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T11	T31	23293126
NA	CHEMICAL	GENE-N	14	10	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T11	T32	23293126
NA	CHEMICAL	GENE-N	16	3	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T12	T31	23293126
NA	CHEMICAL	GENE-N	16	10	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T12	T32	23293126
NA	CHEMICAL	GENE-N	20	3	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T13	T31	23293126
NA	CHEMICAL	GENE-N	20	10	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T13	T32	23293126
NA	CHEMICAL	GENE-N	25	3	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T14	T31	23293126
NA	CHEMICAL	GENE-N	25	10	In nonsmokers , gene and chemical were negatively correlated with gene and correlated with chemical ( chemical ) , and chemical was negatively correlated with chemical .	T14	T32	23293126
NA	CHEMICAL	GENE-N	5	0	gene was negatively correlated with chemical in all the sprayers , but was correlated with gene in smokers and with chemical in nonsmokers .	T15	T33	23293126
NA	CHEMICAL	GENE-N	5	15	gene was negatively correlated with chemical in all the sprayers , but was correlated with gene in smokers and with chemical in nonsmokers .	T15	T34	23293126
NA	CHEMICAL	GENE-N	20	0	gene was negatively correlated with chemical in all the sprayers , but was correlated with gene in smokers and with chemical in nonsmokers .	T16	T33	23293126
NA	CHEMICAL	GENE-N	20	15	gene was negatively correlated with chemical in all the sprayers , but was correlated with gene in smokers and with chemical in nonsmokers .	T16	T34	23293126
NA	CHEMICAL	GENE-N	15	3	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T17	T35	23293126
NA	CHEMICAL	GENE-N	15	8	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T17	T36	23293126
NA	CHEMICAL	GENE-N	15	10	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T17	T37	23293126
NA	CHEMICAL	GENE-N	15	19	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T17	T19	23293126
NA	CHEMICAL	GENE-N	17	3	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T18	T35	23293126
NA	CHEMICAL	GENE-N	17	8	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T18	T36	23293126
NA	CHEMICAL	GENE-N	17	10	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T18	T37	23293126
NA	CHEMICAL	GENE-N	17	19	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T18	T19	23293126
NA	CHEMICAL	GENE-N	15	3	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T1	T35	23293126
NA	CHEMICAL	GENE-N	15	8	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T1	T36	23293126
NA	CHEMICAL	GENE-N	15	10	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T1	T37	23293126
NA	CHEMICAL	GENE-N	15	19	In smokers , gene was negatively correlated with gene , gene was negatively correlated with chemical and chemical and gene were negatively correlated with chemical .	T1	T19	23293126
CPR:4	CHEMICAL	GENE-Y	4	7	Design and synthesis of chemical as potent gene-gene inhibitors .	T3	T11	23416003
CPR:4	CHEMICAL	GENE-Y	4	7	Design and synthesis of chemical as potent gene-gene inhibitors .	T3	T12	23416003
CPR:4	CHEMICAL	GENE-Y	0	7	chemical were designed and synthesized as potent gene-gene inhibitors .	T1	T9	23416003
CPR:4	CHEMICAL	GENE-Y	0	7	chemical were designed and synthesized as potent gene-gene inhibitors .	T1	T10	23416003
NA	CHEMICAL	GENE-Y	22	14	An X-ray crystal structure of optimized compound 9b bound in the active site of gene showed that the bicyclic scaffold provides 5 chemical bonding interactions in addition to projecting groups for interactions within the S1 , S2 and S3 pockets .	T2	T5	23416003
NA	CHEMICAL	GENE-N	3	4	Studies on an chemical gene antagonist chemical : asymmetric synthesis , neuroactivity , and structural characterization .	T13	T19	23432124
CPR:6	CHEMICAL	GENE-N	6	4	Studies on an chemical gene antagonist chemical : asymmetric synthesis , neuroactivity , and structural characterization .	T12	T19	23432124
NA	CHEMICAL	GENE-Y	0	8	chemical was crystallized with the ligand-binding domain of gene , and the structure revealed a complex containing chemical at the glutamate binding site .	T8	T18	23432124
NA	CHEMICAL	GENE-Y	17	8	chemical was crystallized with the ligand-binding domain of gene , and the structure revealed a complex containing chemical at the glutamate binding site .	T10	T18	23432124
CPR:4	CHEMICAL	GENE-Y	20	7	Inhibition of Th1/Th17 responses via suppression of gene and gene activation contributes to the amelioration of murine experimental colitis by a natural chemical glucoside chemical .	T9	T19	23261528
CPR:4	CHEMICAL	GENE-Y	20	9	Inhibition of Th1/Th17 responses via suppression of gene and gene activation contributes to the amelioration of murine experimental colitis by a natural chemical glucoside chemical .	T9	T20	23261528
CPR:4	CHEMICAL	GENE-Y	20	7	Inhibition of Th1/Th17 responses via suppression of gene and gene activation contributes to the amelioration of murine experimental colitis by a natural chemical glucoside chemical .	T10	T19	23261528
CPR:4	CHEMICAL	GENE-Y	20	9	Inhibition of Th1/Th17 responses via suppression of gene and gene activation contributes to the amelioration of murine experimental colitis by a natural chemical glucoside chemical .	T10	T20	23261528
CPR:4	CHEMICAL	GENE-N	4	18	Further study showed that chemical dose-dependently inhibited the proliferation and activation of T lymphocytes , and suppressed pro-inflammatory gene levels of activated T cells .	T8	T11	23261528
CPR:4	CHEMICAL	GENE-Y	2	8	Moreover , chemical treatment inhibited the phosphorylations of gene and gene in CD4 ( + ) T cells , which were the crucial transcription factors for Th1 and Th17 respectively .	T1	T12	23261528
CPR:4	CHEMICAL	GENE-Y	2	10	Moreover , chemical treatment inhibited the phosphorylations of gene and gene in CD4 ( + ) T cells , which were the crucial transcription factors for Th1 and Th17 respectively .	T1	T13	23261528
CPR:4	CHEMICAL	GENE-N	9	12	A review of the structural and functional features of chemical , an gene blocker .	T10	T17	16220064
NA	CHEMICAL	GENE-Y	3	15	Effective inhibition of chemical is provided by the latest class of antihypertensive medications , the gene receptor blockers ( ARBs ) .	T3	T14	16220064
NA	CHEMICAL	GENE-Y	11	8	Neonatal epileptic encephalopathy caused by mutations in the gene gene encoding chemical oxidase .	T10	T18	15772097
NA	CHEMICAL	GENE-Y	11	12	Neonatal epileptic encephalopathy caused by mutations in the gene gene encoding chemical oxidase .	T10	T19	15772097
NA	CHEMICAL	GENE-Y	9	10	Cerebrospinal fluid and urine analyses indicated reduced activity of chemical decarboxylase and other chemical-dependent enzymes .	T3	T11	15772097
NA	CHEMICAL	GENE-Y	13	10	Cerebrospinal fluid and urine analyses indicated reduced activity of chemical decarboxylase and other chemical-dependent enzymes .	T4	T11	15772097
NA	CHEMICAL	GENE-Y	6	17	Seizures ceased with the administration of chemical , having been resistant to treatment with pyridoxine , suggesting a defect of chemical oxidase ( gene ) .	T5	T12	15772097
NA	CHEMICAL	GENE-Y	6	23	Seizures ceased with the administration of chemical , having been resistant to treatment with pyridoxine , suggesting a defect of chemical oxidase ( gene ) .	T5	T13	15772097
NA	CHEMICAL	GENE-Y	17	17	Seizures ceased with the administration of chemical , having been resistant to treatment with pyridoxine , suggesting a defect of chemical oxidase ( gene ) .	T6	T12	15772097
NA	CHEMICAL	GENE-Y	17	23	Seizures ceased with the administration of chemical , having been resistant to treatment with pyridoxine , suggesting a defect of chemical oxidase ( gene ) .	T6	T13	15772097
NA	CHEMICAL	GENE-N	36	13	Expression studies in Chinese hamster ovary cells showed that the splice site ( IVS3-1gene ) and stop codon ( X262Q ) mutations were null activity mutations and that the missense mutation ( gene ) markedly reduced chemical oxidase activity .	T7	T15	15772097
NA	CHEMICAL	GENE-N	36	32	Expression studies in Chinese hamster ovary cells showed that the splice site ( IVS3-1gene ) and stop codon ( X262Q ) mutations were null activity mutations and that the missense mutation ( gene ) markedly reduced chemical oxidase activity .	T7	T16	15772097
NA	CHEMICAL	GENE-Y	36	37	Expression studies in Chinese hamster ovary cells showed that the splice site ( IVS3-1gene ) and stop codon ( X262Q ) mutations were null activity mutations and that the missense mutation ( gene ) markedly reduced chemical oxidase activity .	T7	T17	15772097
CPR:4	CHEMICAL	GENE-Y	2	4	Novel racemic chemical analogues as potent gene inhibitors .	T12	T14	23583510
NA	CHEMICAL	GENE-N	1	12	Phytoestrogen chemical protects against endothelial barrier dysfunction in vascular endothelial cells through gene-mediated suppression of gene signaling .	T17	T41	23254196
NA	CHEMICAL	GENE-Y	1	15	Phytoestrogen chemical protects against endothelial barrier dysfunction in vascular endothelial cells through gene-mediated suppression of gene signaling .	T17	T42	23254196
CPR:4	CHEMICAL	GENE-Y	5	16	Here , we report that chemical at physiologically relevant concentrations ( 0.1-10 μM ) significantly inhibited gene-induced increase in endothelial monolayer permeability .	T5	T26	23254196
CPR:4	CHEMICAL	GENE-Y	0	9	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T7	T27	23254196
CPR:4	CHEMICAL	GENE-Y	0	12	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T7	T28	23254196
CPR:4	CHEMICAL	GENE-N	0	15	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T7	T29	23254196
CPR:4	CHEMICAL	GENE-N	0	17	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T7	T30	23254196
NA	CHEMICAL	GENE-Y	20	9	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T8	T27	23254196
NA	CHEMICAL	GENE-Y	20	12	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T8	T28	23254196
NA	CHEMICAL	GENE-N	20	15	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T8	T29	23254196
NA	CHEMICAL	GENE-N	20	17	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T8	T30	23254196
NA	CHEMICAL	GENE-Y	24	9	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T9	T27	23254196
NA	CHEMICAL	GENE-Y	24	12	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T9	T28	23254196
NA	CHEMICAL	GENE-N	24	15	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T9	T29	23254196
NA	CHEMICAL	GENE-N	24	17	chemical also reduced the formation of stress fibers by gene and suppressed gene-induced phosphorylation of gene ( gene ) on chemical ( 19 ) /chemical ( 18 ) in endothelial cells ( ECs ) .	T9	T30	23254196
NA	CHEMICAL	GENE-Y	0	11	chemical had no effect on resting intracellular [ chemical ] or gene-induced increase in chemical mobilization .	T10	T31	23254196
NA	CHEMICAL	GENE-Y	8	11	chemical had no effect on resting intracellular [ chemical ] or gene-induced increase in chemical mobilization .	T11	T31	23254196
NA	CHEMICAL	GENE-Y	14	11	chemical had no effect on resting intracellular [ chemical ] or gene-induced increase in chemical mobilization .	T12	T31	23254196
NA	CHEMICAL	GENE-Y	7	5	Addition of the inhibitors of gene or chemical receptor did not alter the protective effect of chemical .	T14	T32	23254196
NA	CHEMICAL	GENE-Y	7	6	Addition of the inhibitors of gene or chemical receptor did not alter the protective effect of chemical .	T14	T33	23254196
NA	CHEMICAL	GENE-Y	16	5	Addition of the inhibitors of gene or chemical receptor did not alter the protective effect of chemical .	T15	T32	23254196
NA	CHEMICAL	GENE-Y	16	6	Addition of the inhibitors of gene or chemical receptor did not alter the protective effect of chemical .	T15	T33	23254196
NA	CHEMICAL	GENE-Y	7	0	gene inhibitor blocked the protective effect of chemical on endothelial permeability and also ablated gene-induced gene-phosphorylation in ECs .	T16	T38	23254196
NA	CHEMICAL	GENE-Y	7	14	gene inhibitor blocked the protective effect of chemical on endothelial permeability and also ablated gene-induced gene-phosphorylation in ECs .	T16	T39	23254196
NA	CHEMICAL	GENE-N	7	15	gene inhibitor blocked the protective effect of chemical on endothelial permeability and also ablated gene-induced gene-phosphorylation in ECs .	T16	T40	23254196
NA	CHEMICAL	GENE-N	2	2	Inhibition of gene significantly attenuated the effect of chemical on gene-induced EC permeability , gene phosphorylation , and gene membrane translocation in ECs .	T1	T18	23254196
NA	CHEMICAL	GENE-Y	2	10	Inhibition of gene significantly attenuated the effect of chemical on gene-induced EC permeability , gene phosphorylation , and gene membrane translocation in ECs .	T1	T19	23254196
NA	CHEMICAL	GENE-N	2	14	Inhibition of gene significantly attenuated the effect of chemical on gene-induced EC permeability , gene phosphorylation , and gene membrane translocation in ECs .	T1	T20	23254196
NA	CHEMICAL	GENE-Y	2	18	Inhibition of gene significantly attenuated the effect of chemical on gene-induced EC permeability , gene phosphorylation , and gene membrane translocation in ECs .	T1	T21	23254196
NA	CHEMICAL	GENE-Y	2	2	Furthermore , gene diminished chemical production in ECs , which were prevented by treatment with chemical .	T2	T22	23254196
CPR:4	CHEMICAL	GENE-Y	6	2	Furthermore , gene diminished chemical production in ECs , which were prevented by treatment with chemical .	T3	T22	23254196
NA	CHEMICAL	GENE-Y	9	4	Here we show that gene and gene cooperatively repress chemical receptor-dependent activity of gene-class endogenous retroviruses ( ERVs ) in liver .	T1	T3	23377542
NA	CHEMICAL	GENE-Y	9	6	Here we show that gene and gene cooperatively repress chemical receptor-dependent activity of gene-class endogenous retroviruses ( ERVs ) in liver .	T1	T4	23377542
NA	CHEMICAL	GENE-N	9	13	Here we show that gene and gene cooperatively repress chemical receptor-dependent activity of gene-class endogenous retroviruses ( ERVs ) in liver .	T1	T7	23377542
NA	CHEMICAL	GENE-N	8	6	Effect of chronic renal failure on gene and chemical synthetase expression .	T23	T37	16809898
NA	CHEMICAL	GENE-Y	8	9	Effect of chronic renal failure on gene and chemical synthetase expression .	T23	T38	16809898
CPR:9	CHEMICAL	GENE-Y	2	11	Sources of chemical include dietary proteins and endogenous synthesis by chemical synthetase and chemical lyase .	T3	T29	16809898
CPR:9	CHEMICAL	GENE-Y	2	14	Sources of chemical include dietary proteins and endogenous synthesis by chemical synthetase and chemical lyase .	T3	T30	16809898
NA	CHEMICAL	GENE-Y	10	11	Sources of chemical include dietary proteins and endogenous synthesis by chemical synthetase and chemical lyase .	T9	T29	16809898
NA	CHEMICAL	GENE-Y	10	14	Sources of chemical include dietary proteins and endogenous synthesis by chemical synthetase and chemical lyase .	T9	T30	16809898
NA	CHEMICAL	GENE-Y	13	11	Sources of chemical include dietary proteins and endogenous synthesis by chemical synthetase and chemical lyase .	T10	T29	16809898
NA	CHEMICAL	GENE-Y	13	14	Sources of chemical include dietary proteins and endogenous synthesis by chemical synthetase and chemical lyase .	T10	T30	16809898
CPR:9	CHEMICAL	GENE-Y	0	6	chemical is converted to chemical by gene in the liver and gene in the kidney .	T12	T31	16809898
CPR:9	CHEMICAL	GENE-Y	0	11	chemical is converted to chemical by gene in the liver and gene in the kidney .	T12	T32	16809898
CPR:9	CHEMICAL	GENE-Y	4	6	chemical is converted to chemical by gene in the liver and gene in the kidney .	T13	T31	16809898
CPR:9	CHEMICAL	GENE-Y	4	11	chemical is converted to chemical by gene in the liver and gene in the kidney .	T13	T32	16809898
CPR:9	CHEMICAL	GENE-N	6	7	We hypothesized that preservation of plasma chemical in CRF may be , partly , due to downregulation/inhibition of gene .	T19	T33	16809898
NA	CHEMICAL	GENE-Y	2	3	METHODS : chemical synthetase , gene protein abundance and activity were measured in the liver and kidneys of rats 6 weeks after 5/6 nephrectomy or sham operation .	T20	T34	16809898
NA	CHEMICAL	GENE-N	2	5	METHODS : chemical synthetase , gene protein abundance and activity were measured in the liver and kidneys of rats 6 weeks after 5/6 nephrectomy or sham operation .	T20	T35	16809898
NA	CHEMICAL	GENE-N	12	3	In addition , gene activity was measured in the presence of different chemical concentrations to simulate azotemia in vitro .	T1	T36	16809898
CPR:4	CHEMICAL	GENE-N	6	2	However , in vitro experiments simulating a uremic milieu revealed a marked concentration-dependent inhibition of gene activity by chemical in the tissue lysates .	T4	T26	16809898
NA	CHEMICAL	GENE-Y	2	7	CRF had no significant effect on chemical synthetase abundance in the kidney , liver , spleen or intestine .	T5	T27	16809898
CPR:4	CHEMICAL	GENE-N	19	13	CONCLUSIONS : Although CRF does not change the abundance or intrinsic properties of gene , the inherent rise in chemical concentration inhibits its enzymatic activity .	T6	T28	16809898
NA	CHEMICAL	GENE-Y	7	8	The role of extranuclear signaling actions of chemical receptor in mediating chemical regulation of gene expression and the cell cycle .	T10	T45	17138644
NA	CHEMICAL	GENE-Y	11	8	The role of extranuclear signaling actions of chemical receptor in mediating chemical regulation of gene expression and the cell cycle .	T11	T45	17138644
NA	CHEMICAL	GENE-Y	28	0	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T12	17138644
NA	CHEMICAL	GENE-Y	28	2	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T25	17138644
NA	CHEMICAL	GENE-N	28	5	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T36	17138644
NA	CHEMICAL	GENE-Y	28	13	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T39	17138644
NA	CHEMICAL	GENE-Y	28	19	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T17	17138644
NA	CHEMICAL	GENE-N	28	22	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T23	17138644
NA	CHEMICAL	GENE-N	28	24	gene ( gene ) contains a motif that interacts with the gene of gene and mediates rapid activation of gene and downstream gene ( gene ) without relying on the transcriptional activity of the receptor .	T6	T24	17138644
CPR:3	CHEMICAL	GENE-Y	0	3	chemical activation of gene/gene occurred outside the nucleus with the gene that was distributed between the cytoplasm and nucleus , but not with gene that was predominantly nuclear .	T5	T27	17138644
CPR:3	CHEMICAL	GENE-N	0	3	chemical activation of gene/gene occurred outside the nucleus with the gene that was distributed between the cytoplasm and nucleus , but not with gene that was predominantly nuclear .	T5	T28	17138644
NA	CHEMICAL	GENE-Y	0	10	chemical activation of gene/gene occurred outside the nucleus with the gene that was distributed between the cytoplasm and nucleus , but not with gene that was predominantly nuclear .	T5	T29	17138644
NA	CHEMICAL	GENE-Y	0	23	chemical activation of gene/gene occurred outside the nucleus with the gene that was distributed between the cytoplasm and nucleus , but not with gene that was predominantly nuclear .	T5	T30	17138644
NA	CHEMICAL	GENE-Y	13	6	Breast cancer cells stably expressing wild-type gene or gene with disrupting point mutations in the gene ( gene ) that do not affect the transcriptional activity of gene , were compared for effects of chemical on endogenous target gene expression and cell proliferation .	T7	T31	17138644
NA	CHEMICAL	GENE-Y	13	8	Breast cancer cells stably expressing wild-type gene or gene with disrupting point mutations in the gene ( gene ) that do not affect the transcriptional activity of gene , were compared for effects of chemical on endogenous target gene expression and cell proliferation .	T7	T32	17138644
NA	CHEMICAL	GENE-N	13	15	Breast cancer cells stably expressing wild-type gene or gene with disrupting point mutations in the gene ( gene ) that do not affect the transcriptional activity of gene , were compared for effects of chemical on endogenous target gene expression and cell proliferation .	T7	T33	17138644
NA	CHEMICAL	GENE-N	13	17	Breast cancer cells stably expressing wild-type gene or gene with disrupting point mutations in the gene ( gene ) that do not affect the transcriptional activity of gene , were compared for effects of chemical on endogenous target gene expression and cell proliferation .	T7	T34	17138644
NA	CHEMICAL	GENE-Y	13	27	Breast cancer cells stably expressing wild-type gene or gene with disrupting point mutations in the gene ( gene ) that do not affect the transcriptional activity of gene , were compared for effects of chemical on endogenous target gene expression and cell proliferation .	T7	T35	17138644
NA	CHEMICAL	GENE-Y	0	4	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T37	17138644
NA	CHEMICAL	GENE-N	0	12	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T38	17138644
CPR:3	CHEMICAL	GENE-Y	0	17	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T40	17138644
CPR:3	CHEMICAL	GENE-Y	0	21	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T41	17138644
CPR:3	CHEMICAL	GENE-N	0	21	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T42	17138644
NA	CHEMICAL	GENE-Y	0	28	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T43	17138644
NA	CHEMICAL	GENE-Y	0	9	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T44	17138644
NA	CHEMICAL	GENE-N	0	12	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T8	T13	17138644
NA	CHEMICAL	GENE-Y	10	4	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T37	17138644
NA	CHEMICAL	GENE-N	10	12	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T38	17138644
NA	CHEMICAL	GENE-Y	10	17	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T40	17138644
NA	CHEMICAL	GENE-Y	10	21	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T41	17138644
NA	CHEMICAL	GENE-N	10	21	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T42	17138644
NA	CHEMICAL	GENE-Y	10	28	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T43	17138644
NA	CHEMICAL	GENE-Y	10	9	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T44	17138644
NA	CHEMICAL	GENE-N	10	12	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T13	17138644
NA	CHEMICAL	GENE-Y	10	45	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T14	17138644
NA	CHEMICAL	GENE-Y	10	48	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T9	T15	17138644
NA	CHEMICAL	GENE-Y	16	4	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T37	17138644
NA	CHEMICAL	GENE-N	16	12	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T38	17138644
NA	CHEMICAL	GENE-Y	16	17	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T40	17138644
NA	CHEMICAL	GENE-Y	16	21	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T41	17138644
NA	CHEMICAL	GENE-N	16	21	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T42	17138644
NA	CHEMICAL	GENE-Y	16	28	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T43	17138644
NA	CHEMICAL	GENE-Y	16	9	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T44	17138644
NA	CHEMICAL	GENE-N	16	12	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T13	17138644
NA	CHEMICAL	GENE-Y	16	45	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T14	17138644
NA	CHEMICAL	GENE-Y	16	48	chemical induction of the gene gene , which lacks a chemical response element , was dependent on gene activation of the gene/gene pathway , whereas induction of the gene ( gene ) gene that contains a functional gene was unaffected by mutations that interfere with gene activation of gene .	T1	T15	17138644
NA	CHEMICAL	GENE-N	0	12	chemical induction of cell cycle progression was also abrogated in cells expressing gene , and no effect of chemical on gene expression and cell cycle was observed in the presence of gene .	T2	T16	17138644
NA	CHEMICAL	GENE-Y	0	20	chemical induction of cell cycle progression was also abrogated in cells expressing gene , and no effect of chemical on gene expression and cell cycle was observed in the presence of gene .	T2	T18	17138644
NA	CHEMICAL	GENE-Y	0	31	chemical induction of cell cycle progression was also abrogated in cells expressing gene , and no effect of chemical on gene expression and cell cycle was observed in the presence of gene .	T2	T19	17138644
NA	CHEMICAL	GENE-N	9	12	chemical induction of cell cycle progression was also abrogated in cells expressing gene , and no effect of chemical on gene expression and cell cycle was observed in the presence of gene .	T3	T16	17138644
NA	CHEMICAL	GENE-Y	9	20	chemical induction of cell cycle progression was also abrogated in cells expressing gene , and no effect of chemical on gene expression and cell cycle was observed in the presence of gene .	T3	T18	17138644
NA	CHEMICAL	GENE-Y	9	31	chemical induction of cell cycle progression was also abrogated in cells expressing gene , and no effect of chemical on gene expression and cell cycle was observed in the presence of gene .	T3	T19	17138644
NA	CHEMICAL	GENE-N	9	13	In this study we explore the mechanisms by which a double mutation ( gene/gene ) in gene ( gene ) associated with dilated cardiomyopathy reduces the chemical-activated maximal tension of cardiac muscle .	T1	T26	20371872
NA	CHEMICAL	GENE-N	9	13	In this study we explore the mechanisms by which a double mutation ( gene/gene ) in gene ( gene ) associated with dilated cardiomyopathy reduces the chemical-activated maximal tension of cardiac muscle .	T1	T27	20371872
NA	CHEMICAL	GENE-Y	9	16	In this study we explore the mechanisms by which a double mutation ( gene/gene ) in gene ( gene ) associated with dilated cardiomyopathy reduces the chemical-activated maximal tension of cardiac muscle .	T1	T31	20371872
NA	CHEMICAL	GENE-Y	9	18	In this study we explore the mechanisms by which a double mutation ( gene/gene ) in gene ( gene ) associated with dilated cardiomyopathy reduces the chemical-activated maximal tension of cardiac muscle .	T1	T4	20371872
NA	CHEMICAL	GENE-N	3	0	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T10	20371872
NA	CHEMICAL	GENE-N	3	2	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T11	20371872
NA	CHEMICAL	GENE-N	3	6	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T12	20371872
NA	CHEMICAL	GENE-N	3	10	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T13	20371872
NA	CHEMICAL	GENE-Y	3	20	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T14	20371872
NA	CHEMICAL	GENE-N	3	15	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T15	20371872
NA	CHEMICAL	GENE-N	3	13	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T16	20371872
NA	CHEMICAL	GENE-N	3	27	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T17	20371872
NA	CHEMICAL	GENE-N	3	13	gene or gene ) indicates that gene , but not gene , causes a reduction in the calcium affinity of gene in gene complex , gene ( gene ) , and the chemical sensitivity of contraction and gene in cardiac muscle preparations .	T2	T18	20371872
CPR:4	CHEMICAL	GENE-N	3	19	In rats , chemical and chemical were shown to interfere with hepatic organic anion uptake by inhibition of the gene gene and gene .	T3	T44	12085361
CPR:4	CHEMICAL	GENE-Y	3	20	In rats , chemical and chemical were shown to interfere with hepatic organic anion uptake by inhibition of the gene gene and gene .	T3	T45	12085361
CPR:4	CHEMICAL	GENE-Y	3	22	In rats , chemical and chemical were shown to interfere with hepatic organic anion uptake by inhibition of the gene gene and gene .	T3	T46	12085361
CPR:4	CHEMICAL	GENE-N	5	19	In rats , chemical and chemical were shown to interfere with hepatic organic anion uptake by inhibition of the gene gene and gene .	T6	T44	12085361
CPR:4	CHEMICAL	GENE-Y	5	20	In rats , chemical and chemical were shown to interfere with hepatic organic anion uptake by inhibition of the gene gene and gene .	T6	T45	12085361
CPR:4	CHEMICAL	GENE-Y	5	22	In rats , chemical and chemical were shown to interfere with hepatic organic anion uptake by inhibition of the gene gene and gene .	T6	T46	12085361
NA	CHEMICAL	GENE-N	7	12	Therefore , we investigated the effects of chemical and chemical on the gene of human liver and determined whether chemical is a substrate of 1 or several of these carriers .	T14	T47	12085361
NA	CHEMICAL	GENE-N	9	12	Therefore , we investigated the effects of chemical and chemical on the gene of human liver and determined whether chemical is a substrate of 1 or several of these carriers .	T16	T47	12085361
NA	CHEMICAL	GENE-N	19	12	Therefore , we investigated the effects of chemical and chemical on the gene of human liver and determined whether chemical is a substrate of 1 or several of these carriers .	T17	T47	12085361
CPR:4	CHEMICAL	GENE-Y	11	17	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T48	12085361
CPR:4	CHEMICAL	GENE-Y	11	19	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T49	12085361
CPR:4	CHEMICAL	GENE-Y	11	22	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T50	12085361
CPR:4	CHEMICAL	GENE-Y	11	25	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T51	12085361
CPR:4	CHEMICAL	GENE-Y	11	27	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T52	12085361
CPR:4	CHEMICAL	GENE-Y	11	30	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T53	12085361
CPR:4	CHEMICAL	GENE-Y	11	33	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T54	12085361
CPR:4	CHEMICAL	GENE-Y	11	35	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T55	12085361
CPR:4	CHEMICAL	GENE-Y	11	38	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T56	12085361
CPR:4	CHEMICAL	GENE-Y	11	42	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T57	12085361
CPR:4	CHEMICAL	GENE-Y	11	44	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T58	12085361
CPR:4	CHEMICAL	GENE-Y	11	47	In complementary RNA ( cRNA ) -injected Xenopus laevis oocytes , chemical ( 10 micromol/L ) cis-inhibited gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , gene ( gene ) ( gene ) , and gene ( gene ) ( gene ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .	T18	T59	12085361
CPR:4	CHEMICAL	GENE-Y	0	6	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T1	T29	12085361
CPR:4	CHEMICAL	GENE-Y	0	16	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T1	T30	12085361
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T1	T31	12085361
CPR:4	CHEMICAL	GENE-Y	0	21	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T1	T32	12085361
CPR:9	CHEMICAL	GENE-Y	6	6	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T2	T29	12085361
NA	CHEMICAL	GENE-Y	6	16	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T2	T30	12085361
NA	CHEMICAL	GENE-Y	6	18	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T2	T31	12085361
NA	CHEMICAL	GENE-Y	6	21	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T2	T32	12085361
NA	CHEMICAL	GENE-Y	22	6	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T4	T29	12085361
CPR:9	CHEMICAL	GENE-Y	22	16	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T4	T30	12085361
CPR:9	CHEMICAL	GENE-Y	22	18	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T4	T31	12085361
CPR:9	CHEMICAL	GENE-Y	22	21	chemical ( 10 micromol/L ) inhibited gene-mediated chemical uptake by 50 % , whereas inhibition of gene- , gene- , and gene-mediated chemical transport was below 15 % .	T4	T32	12085361
CPR:4	CHEMICAL	GENE-Y	2	4	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T5	T33	12085361
CPR:4	CHEMICAL	GENE-Y	2	6	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T5	T34	12085361
CPR:4	CHEMICAL	GENE-Y	2	8	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T5	T35	12085361
CPR:4	CHEMICAL	GENE-Y	2	10	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T5	T36	12085361
CPR:9	CHEMICAL	GENE-Y	11	4	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T7	T33	12085361
CPR:9	CHEMICAL	GENE-Y	11	6	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T7	T34	12085361
CPR:9	CHEMICAL	GENE-Y	11	8	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T7	T35	12085361
CPR:9	CHEMICAL	GENE-Y	11	10	100 micromol/L chemical inhibited gene- and gene- , gene- and gene-mediated chemical uptake by 66 % , 96 % , 25 % , and 49 % , respectively .	T7	T36	12085361
CPR:9	CHEMICAL	GENE-Y	3	8	Direct transport of chemical could be shown for gene ( apparent K ( m ) value 13 micromol/L ) and gene ( 2.3 micromol/L ) .	T8	T40	12085361
CPR:9	CHEMICAL	GENE-Y	3	20	Direct transport of chemical could be shown for gene ( apparent K ( m ) value 13 micromol/L ) and gene ( 2.3 micromol/L ) .	T8	T41	12085361
NA	CHEMICAL	GENE-N	7	12	In conclusion , these results show that chemical and chemical interact with gene-mediated substrate transport to different extents .	T10	T42	12085361
NA	CHEMICAL	GENE-N	9	12	In conclusion , these results show that chemical and chemical interact with gene-mediated substrate transport to different extents .	T11	T42	12085361
CPR:4	CHEMICAL	GENE-Y	5	12	Cloning , Characterization , and chemical and chemical Inhibition Studies of an gene from Trypanosoma cruzi , the Causative Agent of Chagas Disease .	T7	T15	23391336
CPR:4	CHEMICAL	GENE-Y	7	12	Cloning , Characterization , and chemical and chemical Inhibition Studies of an gene from Trypanosoma cruzi , the Causative Agent of Chagas Disease .	T8	T15	23391336
CPR:9	CHEMICAL	GENE-Y	2	3	The enzyme ( gene ) has a very high catalytic activity for the chemical hydration reaction , being similar kinetically to the human ( h ) isoform gene , although it is devoid of the chemical64 proton shuttle .	T1	T9	23391336
CPR:9	CHEMICAL	GENE-Y	2	27	The enzyme ( gene ) has a very high catalytic activity for the chemical hydration reaction , being similar kinetically to the human ( h ) isoform gene , although it is devoid of the chemical64 proton shuttle .	T1	T12	23391336
NA	CHEMICAL	GENE-Y	31	3	The enzyme ( gene ) has a very high catalytic activity for the chemical hydration reaction , being similar kinetically to the human ( h ) isoform gene , although it is devoid of the chemical64 proton shuttle .	T2	T9	23391336
NA	CHEMICAL	GENE-Y	31	27	The enzyme ( gene ) has a very high catalytic activity for the chemical hydration reaction , being similar kinetically to the human ( h ) isoform gene , although it is devoid of the chemical64 proton shuttle .	T2	T12	23391336
CPR:4	CHEMICAL	GENE-Y	4	0	A large number of chemical and some chemical were investigated as gene inhibitors .	T3	T14	23391336
CPR:4	CHEMICAL	GENE-Y	7	0	A large number of chemical and some chemical were investigated as gene inhibitors .	T4	T14	23391336
NA	CHEMICAL	GENE-N	6	0	gene mediate the antinociceptive effect of chemical .	T25	T46	23562495
NA	CHEMICAL	GENE-N	2	36	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T16	T40	23562495
NA	CHEMICAL	GENE-N	2	38	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T16	T41	23562495
NA	CHEMICAL	GENE-Y	2	40	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T16	T42	23562495
NA	CHEMICAL	GENE-Y	2	42	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T16	T43	23562495
NA	CHEMICAL	GENE-N	17	36	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T18	T40	23562495
NA	CHEMICAL	GENE-N	17	38	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T18	T41	23562495
NA	CHEMICAL	GENE-Y	17	40	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T18	T42	23562495
NA	CHEMICAL	GENE-Y	17	42	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T18	T43	23562495
NA	CHEMICAL	GENE-Y	17	44	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T18	T44	23562495
NA	CHEMICAL	GENE-N	17	46	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T18	T45	23562495
NA	CHEMICAL	GENE-N	10	36	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T19	T40	23562495
NA	CHEMICAL	GENE-N	10	38	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T19	T41	23562495
NA	CHEMICAL	GENE-Y	10	40	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T19	T42	23562495
NA	CHEMICAL	GENE-Y	10	42	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T19	T43	23562495
NA	CHEMICAL	GENE-Y	10	44	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T19	T44	23562495
NA	CHEMICAL	GENE-N	10	46	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T19	T45	23562495
NA	CHEMICAL	GENE-N	29	36	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T20	T40	23562495
NA	CHEMICAL	GENE-N	29	38	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T20	T41	23562495
NA	CHEMICAL	GENE-Y	29	40	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T20	T42	23562495
NA	CHEMICAL	GENE-Y	29	42	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T20	T43	23562495
NA	CHEMICAL	GENE-Y	29	44	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T20	T44	23562495
NA	CHEMICAL	GENE-N	29	46	Methods The chemical-induced writhing test and the paw-licking test , in which paw licking was induced by chemical and chemical , were performed to evaluate the antinociceptive action of chemical and to determine the involvement of gene , gene , gene , gene , gene and gene in its antinociceptive mechanism .	T20	T45	23562495
NA	CHEMICAL	GENE-N	11	1	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T5	T26	23562495
NA	CHEMICAL	GENE-N	11	9	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T5	T27	23562495
NA	CHEMICAL	GENE-N	10	1	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T6	T26	23562495
NA	CHEMICAL	GENE-N	10	9	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T6	T27	23562495
NA	CHEMICAL	GENE-N	10	1	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T7	T26	23562495
NA	CHEMICAL	GENE-N	10	9	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T7	T27	23562495
NA	CHEMICAL	GENE-N	28	1	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T8	T26	23562495
NA	CHEMICAL	GENE-N	28	9	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T8	T27	23562495
NA	CHEMICAL	GENE-N	38	1	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T9	T26	23562495
NA	CHEMICAL	GENE-N	38	9	In an investigation into the participation of gene and gene in chemical 's antinociceptive mechanism , we used chemical ( 2.2μg/paw ) , chemical ( 10mmol/paw ) , chemical ( 1.2mmol/paw ) and acidified saline ( 2 % chemical , pH 1.98 ) .	T9	T27	23562495
NA	CHEMICAL	GENE-N	25	5	Finally , the involvement of gene and gene was also studied , and we showed that both play a role in the antinociceptive mechanism of chemical .	T10	T32	23562495
NA	CHEMICAL	GENE-N	25	7	Finally , the involvement of gene and gene was also studied , and we showed that both play a role in the antinociceptive mechanism of chemical .	T10	T33	23562495
CPR:3	CHEMICAL	GENE-Y	4	7	Various genes controlled by chemical , including gene , gene , gene , gene , gene , and gene , were dramatically over-expressed .	T22	T36	17350061
CPR:3	CHEMICAL	GENE-Y	4	9	Various genes controlled by chemical , including gene , gene , gene , gene , gene , and gene , were dramatically over-expressed .	T22	T37	17350061
CPR:3	CHEMICAL	GENE-Y	4	11	Various genes controlled by chemical , including gene , gene , gene , gene , gene , and gene , were dramatically over-expressed .	T22	T38	17350061
CPR:3	CHEMICAL	GENE-Y	4	13	Various genes controlled by chemical , including gene , gene , gene , gene , gene , and gene , were dramatically over-expressed .	T22	T39	17350061
CPR:3	CHEMICAL	GENE-Y	4	15	Various genes controlled by chemical , including gene , gene , gene , gene , gene , and gene , were dramatically over-expressed .	T22	T40	17350061
CPR:3	CHEMICAL	GENE-Y	4	18	Various genes controlled by chemical , including gene , gene , gene , gene , gene , and gene , were dramatically over-expressed .	T22	T41	17350061
CPR:3	CHEMICAL	GENE-Y	0	3	chemical-regulated genes including gene and gene were over-expressed , although gene was suppressed .	T24	T42	17350061
CPR:3	CHEMICAL	GENE-Y	0	5	chemical-regulated genes including gene and gene were over-expressed , although gene was suppressed .	T24	T28	17350061
CPR:4	CHEMICAL	GENE-Y	0	10	chemical-regulated genes including gene and gene were over-expressed , although gene was suppressed .	T24	T29	17350061
NA	CHEMICAL	GENE-Y	4	17	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T1	T30	17350061
NA	CHEMICAL	GENE-Y	4	19	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T1	T31	17350061
NA	CHEMICAL	GENE-Y	4	30	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T1	T32	17350061
NA	CHEMICAL	GENE-Y	16	17	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T2	T30	17350061
NA	CHEMICAL	GENE-Y	16	19	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T2	T31	17350061
NA	CHEMICAL	GENE-Y	16	30	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T2	T32	17350061
CPR:9	CHEMICAL	GENE-Y	23	17	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T4	T30	17350061
CPR:9	CHEMICAL	GENE-Y	23	19	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T4	T31	17350061
NA	CHEMICAL	GENE-Y	23	30	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T4	T32	17350061
NA	CHEMICAL	GENE-Y	34	17	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T5	T30	17350061
NA	CHEMICAL	GENE-Y	34	19	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T5	T31	17350061
CPR:9	CHEMICAL	GENE-Y	34	30	Several genes involved with chemical metabolism also showed remarkable expression changes , including increased expression of chemical dehydrogenase-7 ( gene ; involved in chemical production ) and decreased expression of gene ( involved in chemical production ) .	T5	T32	17350061
CPR:9	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T6	T33	17350061
CPR:9	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T6	T34	17350061
CPR:9	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T6	T35	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T7	T33	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T7	T34	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T7	T35	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T8	T33	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T8	T34	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T8	T35	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T9	T33	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T9	T34	17350061
NA	CHEMICAL	GENE-Y	6	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T9	T35	17350061
NA	CHEMICAL	GENE-Y	18	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T10	T33	17350061
NA	CHEMICAL	GENE-Y	18	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T10	T34	17350061
NA	CHEMICAL	GENE-Y	18	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T10	T35	17350061
NA	CHEMICAL	GENE-Y	19	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T11	T33	17350061
NA	CHEMICAL	GENE-Y	19	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T11	T34	17350061
NA	CHEMICAL	GENE-Y	19	11	The expression of key genes important in chemical metabolism , such as chemical adenosyltransferase-1a , chemical-chemical methyltransferase and chemical chemical-methyltransferase , were suppressed .	T11	T35	17350061
NA	CHEMICAL	GENE-Y	7	13	In vivo , cromolyn inhibited tumor growth in mice bearing tumor with endogenous gene ( BxPC-3 : control , mean = 1.6 x 10 ( 9 ) photons/s , versus cromolyn , mean = 4.4 x 10 ( 8 ) photons/s , difference = 1.2 x 10 ( 9 ) photons/s ; 95 % CI = 6.2 x 10 ( 8 ) to 1.6 x 10 ( 9 ) photons/s ; P < .001 , n = 5 ; MPanc-96 : control , mean = 1.1 x 10 ( 10 ) photons/s , versus cromolyn , mean = 4.8 x 10 ( 9 ) photons/s , difference = 6.2 x 10 ( 9 ) photons/s ; 95 % CI = 1.9 x 10 ( 9 ) to 1.0 x 10 ( 10 ) photons/s ; P = .009 , n = 5 ) and increased the effectiveness of chemical ( BxPC-3 : chemical , mean = 9.2 x 10 ( 8 ) photons/s , versus combination , mean = 1.8 x 10 ( 8 ) photons/s , difference = 7.4 x 10 ( 8 ) photons/s ; 95 % CI = 4.5 x 10 ( 8 ) to 1.0 x 10 ( 9 ) photons/s ; P < .001 ; MPanc-96 : chemical , mean = 4.1 x 10 ( 9 ) photons/s , versus combination , mean = 2.0 x 10 ( 9 ) photons/s , difference = 2.1 x 10 ( 9 ) photons/s ; 95 % CI = 4.4 x 10 ( 8 ) to 3.8 x 10 ( 9 ) photons/s ; P < .001 ) .	T2	T16	17179482
NA	CHEMICAL	GENE-Y	7	13	In vivo , cromolyn inhibited tumor growth in mice bearing tumor with endogenous gene ( BxPC-3 : control , mean = 1.6 x 10 ( 9 ) photons/s , versus cromolyn , mean = 4.4 x 10 ( 8 ) photons/s , difference = 1.2 x 10 ( 9 ) photons/s ; 95 % CI = 6.2 x 10 ( 8 ) to 1.6 x 10 ( 9 ) photons/s ; P < .001 , n = 5 ; MPanc-96 : control , mean = 1.1 x 10 ( 10 ) photons/s , versus cromolyn , mean = 4.8 x 10 ( 9 ) photons/s , difference = 6.2 x 10 ( 9 ) photons/s ; 95 % CI = 1.9 x 10 ( 9 ) to 1.0 x 10 ( 10 ) photons/s ; P = .009 , n = 5 ) and increased the effectiveness of chemical ( BxPC-3 : chemical , mean = 9.2 x 10 ( 8 ) photons/s , versus combination , mean = 1.8 x 10 ( 8 ) photons/s , difference = 7.4 x 10 ( 8 ) photons/s ; 95 % CI = 4.5 x 10 ( 8 ) to 1.0 x 10 ( 9 ) photons/s ; P < .001 ; MPanc-96 : chemical , mean = 4.1 x 10 ( 9 ) photons/s , versus combination , mean = 2.0 x 10 ( 9 ) photons/s , difference = 2.1 x 10 ( 9 ) photons/s ; 95 % CI = 4.4 x 10 ( 8 ) to 3.8 x 10 ( 9 ) photons/s ; P < .001 ) .	T3	T16	17179482
NA	CHEMICAL	GENE-Y	7	13	In vivo , cromolyn inhibited tumor growth in mice bearing tumor with endogenous gene ( BxPC-3 : control , mean = 1.6 x 10 ( 9 ) photons/s , versus cromolyn , mean = 4.4 x 10 ( 8 ) photons/s , difference = 1.2 x 10 ( 9 ) photons/s ; 95 % CI = 6.2 x 10 ( 8 ) to 1.6 x 10 ( 9 ) photons/s ; P < .001 , n = 5 ; MPanc-96 : control , mean = 1.1 x 10 ( 10 ) photons/s , versus cromolyn , mean = 4.8 x 10 ( 9 ) photons/s , difference = 6.2 x 10 ( 9 ) photons/s ; 95 % CI = 1.9 x 10 ( 9 ) to 1.0 x 10 ( 10 ) photons/s ; P = .009 , n = 5 ) and increased the effectiveness of chemical ( BxPC-3 : chemical , mean = 9.2 x 10 ( 8 ) photons/s , versus combination , mean = 1.8 x 10 ( 8 ) photons/s , difference = 7.4 x 10 ( 8 ) photons/s ; 95 % CI = 4.5 x 10 ( 8 ) to 1.0 x 10 ( 9 ) photons/s ; P < .001 ; MPanc-96 : chemical , mean = 4.1 x 10 ( 9 ) photons/s , versus combination , mean = 2.0 x 10 ( 9 ) photons/s , difference = 2.1 x 10 ( 9 ) photons/s ; 95 % CI = 4.4 x 10 ( 8 ) to 3.8 x 10 ( 9 ) photons/s ; P < .001 ) .	T4	T16	17179482
CPR:6	CHEMICAL	GENE-N	0	3	chemical is an gene antagonist ( ERA ) that was recently approved for treatment of pulmonary arterial hypertension ( PAH ) .	T1	T9	19920913
NA	CHEMICAL	GENE-Y	24	0	gene mediates the vasoconstrictor effect of gene on vascular smooth muscle , whereas gene is expressed primarily on vascular endothelial cells where it induces chemical synthesis and acts to clear gene from the circulation .	T3	T13	19920913
NA	CHEMICAL	GENE-N	24	6	gene mediates the vasoconstrictor effect of gene on vascular smooth muscle , whereas gene is expressed primarily on vascular endothelial cells where it induces chemical synthesis and acts to clear gene from the circulation .	T3	T14	19920913
NA	CHEMICAL	GENE-Y	24	13	gene mediates the vasoconstrictor effect of gene on vascular smooth muscle , whereas gene is expressed primarily on vascular endothelial cells where it induces chemical synthesis and acts to clear gene from the circulation .	T3	T15	19920913
NA	CHEMICAL	GENE-N	24	30	gene mediates the vasoconstrictor effect of gene on vascular smooth muscle , whereas gene is expressed primarily on vascular endothelial cells where it induces chemical synthesis and acts to clear gene from the circulation .	T3	T16	19920913
CPR:6	CHEMICAL	GENE-Y	0	4	chemical is the first gene selective ERA approved for use in the US .	T4	T17	19920913
NA	CHEMICAL	GENE-Y	3	3	The effect of a novel transition state inhibitor of chemical phosphorylase on chemical activity .	T20	T42	17041099
NA	CHEMICAL	GENE-Y	12	3	The effect of a novel transition state inhibitor of chemical phosphorylase on chemical activity .	T21	T42	17041099
NA	CHEMICAL	GENE-Y	2	2	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T14	T36	17041099
NA	CHEMICAL	GENE-Y	2	10	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T14	T39	17041099
NA	CHEMICAL	GENE-Y	2	2	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T14	T23	17041099
NA	CHEMICAL	GENE-Y	2	20	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T14	T29	17041099
NA	CHEMICAL	GENE-Y	17	2	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T2	T36	17041099
NA	CHEMICAL	GENE-Y	17	10	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T2	T39	17041099
NA	CHEMICAL	GENE-Y	17	2	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T2	T23	17041099
NA	CHEMICAL	GENE-Y	17	20	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T2	T29	17041099
NA	CHEMICAL	GENE-Y	26	2	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T8	T36	17041099
NA	CHEMICAL	GENE-Y	26	10	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T8	T39	17041099
NA	CHEMICAL	GENE-Y	26	2	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T8	T23	17041099
NA	CHEMICAL	GENE-Y	26	20	Pemetrexed is a new-generation antifolate inhibitor of chemical synthase ( gene ) and a weaker inhibitor of chemical transformylase ( gene ) required for de novo chemical synthesis .	T8	T29	17041099
NA	CHEMICAL	GENE-Y	0	1	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T9	T30	17041099
NA	CHEMICAL	GENE-Y	0	3	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T9	T31	17041099
NA	CHEMICAL	GENE-Y	6	1	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T10	T30	17041099
NA	CHEMICAL	GENE-Y	6	3	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T10	T31	17041099
CPR:9	CHEMICAL	GENE-Y	9	1	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T11	T30	17041099
CPR:9	CHEMICAL	GENE-Y	9	3	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T11	T31	17041099
CPR:9	CHEMICAL	GENE-Y	11	1	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T12	T30	17041099
CPR:9	CHEMICAL	GENE-Y	11	3	chemical phosphorylase ( gene ) salvages chemical by releasing chemical from chemical and is often deleted in mesothelioma .	T12	T31	17041099
NA	CHEMICAL	GENE-Y	9	7	The current study addresses the effect of gene on chemical activity using a highly potent transition state inhibitor of gene , MT-DADMe-Immucillin A ( ImmA ; K ( i ) = 86 pmol/L ) in the gene ( + ) NCI-H28 and gene ( - ) NCI-H2052 mesothelioma cell lines .	T13	T32	17041099
NA	CHEMICAL	GENE-Y	9	19	The current study addresses the effect of gene on chemical activity using a highly potent transition state inhibitor of gene , MT-DADMe-Immucillin A ( ImmA ; K ( i ) = 86 pmol/L ) in the gene ( + ) NCI-H28 and gene ( - ) NCI-H2052 mesothelioma cell lines .	T13	T33	17041099
NA	CHEMICAL	GENE-Y	9	22	The current study addresses the effect of gene on chemical activity using a highly potent transition state inhibitor of gene , MT-DADMe-Immucillin A ( ImmA ; K ( i ) = 86 pmol/L ) in the gene ( + ) NCI-H28 and gene ( - ) NCI-H2052 mesothelioma cell lines .	T13	T34	17041099
NA	CHEMICAL	GENE-Y	9	22	The current study addresses the effect of gene on chemical activity using a highly potent transition state inhibitor of gene , MT-DADMe-Immucillin A ( ImmA ; K ( i ) = 86 pmol/L ) in the gene ( + ) NCI-H28 and gene ( - ) NCI-H2052 mesothelioma cell lines .	T13	T35	17041099
NA	CHEMICAL	GENE-Y	13	6	Based on selective nucleoside protection , gene was found to be the primary chemical target in both cell lines with gene inhibition requiring 20- to 30-fold higher chemical concentrations .	T15	T37	17041099
NA	CHEMICAL	GENE-Y	13	20	Based on selective nucleoside protection , gene was found to be the primary chemical target in both cell lines with gene inhibition requiring 20- to 30-fold higher chemical concentrations .	T15	T38	17041099
NA	CHEMICAL	GENE-Y	27	6	Based on selective nucleoside protection , gene was found to be the primary chemical target in both cell lines with gene inhibition requiring 20- to 30-fold higher chemical concentrations .	T16	T37	17041099
CPR:4	CHEMICAL	GENE-Y	27	20	Based on selective nucleoside protection , gene was found to be the primary chemical target in both cell lines with gene inhibition requiring 20- to 30-fold higher chemical concentrations .	T16	T38	17041099
NA	CHEMICAL	GENE-Y	5	28	ImmA had no effect on chemical activity but , when chemical was added , the chemical IC ( 50 ) decreased by a factor of approximately 3 in gene ( + ) H28 cells with no effect in gene ( - ) H2052 cells .	T17	T40	17041099
NA	CHEMICAL	GENE-Y	5	38	ImmA had no effect on chemical activity but , when chemical was added , the chemical IC ( 50 ) decreased by a factor of approximately 3 in gene ( + ) H28 cells with no effect in gene ( - ) H2052 cells .	T17	T41	17041099
NA	CHEMICAL	GENE-Y	10	28	ImmA had no effect on chemical activity but , when chemical was added , the chemical IC ( 50 ) decreased by a factor of approximately 3 in gene ( + ) H28 cells with no effect in gene ( - ) H2052 cells .	T18	T40	17041099
NA	CHEMICAL	GENE-Y	10	38	ImmA had no effect on chemical activity but , when chemical was added , the chemical IC ( 50 ) decreased by a factor of approximately 3 in gene ( + ) H28 cells with no effect in gene ( - ) H2052 cells .	T18	T41	17041099
NA	CHEMICAL	GENE-Y	15	28	ImmA had no effect on chemical activity but , when chemical was added , the chemical IC ( 50 ) decreased by a factor of approximately 3 in gene ( + ) H28 cells with no effect in gene ( - ) H2052 cells .	T19	T40	17041099
NA	CHEMICAL	GENE-Y	15	38	ImmA had no effect on chemical activity but , when chemical was added , the chemical IC ( 50 ) decreased by a factor of approximately 3 in gene ( + ) H28 cells with no effect in gene ( - ) H2052 cells .	T19	T41	17041099
NA	CHEMICAL	GENE-Y	11	5	Conversely , the transfection of gene into H2052 cells increased the chemical IC ( 50 ) by nearly 3-fold but only in the presence of chemical ; this was reversed by ImmA .	T1	T22	17041099
NA	CHEMICAL	GENE-Y	21	5	Conversely , the transfection of gene into H2052 cells increased the chemical IC ( 50 ) by nearly 3-fold but only in the presence of chemical ; this was reversed by ImmA .	T3	T22	17041099
NA	CHEMICAL	GENE-Y	10	1	An gene-specific short interfering RNA produced a 2-fold decrease in chemical IC ( 50 ) in gene ( + ) HeLa cells in the presence of chemical .	T4	T24	17041099
NA	CHEMICAL	GENE-Y	10	16	An gene-specific short interfering RNA produced a 2-fold decrease in chemical IC ( 50 ) in gene ( + ) HeLa cells in the presence of chemical .	T4	T25	17041099
NA	CHEMICAL	GENE-Y	9	1	An gene-specific short interfering RNA produced a 2-fold decrease in chemical IC ( 50 ) in gene ( + ) HeLa cells in the presence of chemical .	T5	T24	17041099
NA	CHEMICAL	GENE-Y	9	16	An gene-specific short interfering RNA produced a 2-fold decrease in chemical IC ( 50 ) in gene ( + ) HeLa cells in the presence of chemical .	T5	T25	17041099
NA	CHEMICAL	GENE-Y	12	7	These data indicate that suppression of constitutive gene has no effect on chemical activity when the primary target is gene .	T6	T26	17041099
NA	CHEMICAL	GENE-Y	12	19	These data indicate that suppression of constitutive gene has no effect on chemical activity when the primary target is gene .	T6	T27	17041099
NA	CHEMICAL	GENE-N	7	3	Both microtubule and gene are required for gene-induced chemical uptake .	T1	T8	22996137
NA	CHEMICAL	GENE-Y	7	7	Both microtubule and gene are required for gene-induced chemical uptake .	T1	T12	22996137
NA	CHEMICAL	GENE-N	17	4	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T2	T14	22996137
NA	CHEMICAL	GENE-N	17	5	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T2	T15	22996137
NA	CHEMICAL	GENE-N	17	9	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T2	T16	22996137
NA	CHEMICAL	GENE-Y	17	20	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T2	T17	22996137
NA	CHEMICAL	GENE-Y	17	20	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T2	T18	22996137
NA	CHEMICAL	GENE-N	25	4	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T3	T14	22996137
NA	CHEMICAL	GENE-N	25	5	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T3	T15	22996137
NA	CHEMICAL	GENE-N	25	9	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T3	T16	22996137
CPR:9	CHEMICAL	GENE-Y	25	20	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T3	T17	22996137
CPR:9	CHEMICAL	GENE-Y	25	20	Disruption of microtubule prevented gene-induced gene remodeling and distal gene signal transduction , with reduction in surface chemical transporter isoform 4 ( gene ) and chemical uptake .	T3	T18	22996137
NA	CHEMICAL	GENE-N	13	3	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T19	22996137
NA	CHEMICAL	GENE-Y	13	6	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T20	22996137
NA	CHEMICAL	GENE-Y	13	16	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T21	22996137
NA	CHEMICAL	GENE-N	13	23	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T22	22996137
NA	CHEMICAL	GENE-N	13	24	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T23	22996137
NA	CHEMICAL	GENE-N	13	33	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T24	22996137
NA	CHEMICAL	GENE-Y	13	35	Though microtubule mediated gene remodeling through gene , reorganization of microtubule depended on chemical phosphorylation of gene , the mechanism is different from gene-induced gene remodeling , which relied on the activity of gene and gene .	T4	T25	22996137
NA	CHEMICAL	GENE-Y	5	5	Triple pharmacological blockade of the gene-gene-chemical system in nondiabetic CKD : an open-label crossover randomized controlled trial .	T10	T23	18423812
NA	CHEMICAL	GENE-Y	5	5	Triple pharmacological blockade of the gene-gene-chemical system in nondiabetic CKD : an open-label crossover randomized controlled trial .	T10	T24	18423812
NA	CHEMICAL	GENE-Y	5	5	BACKGROUND : Agents inhibiting the gene-gene-chemical ( RAAS ) system have an important role in slowing the progression of chronic kidney disease .	T6	T19	18423812
NA	CHEMICAL	GENE-Y	5	5	BACKGROUND : Agents inhibiting the gene-gene-chemical ( RAAS ) system have an important role in slowing the progression of chronic kidney disease .	T6	T20	18423812
NA	CHEMICAL	GENE-Y	9	10	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T2	T12	18423812
NA	CHEMICAL	GENE-Y	9	14	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T2	T15	18423812
NA	CHEMICAL	GENE-Y	9	16	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T2	T17	18423812
NA	CHEMICAL	GENE-Y	9	10	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T2	T18	18423812
NA	CHEMICAL	GENE-Y	9	44	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T2	T21	18423812
NA	CHEMICAL	GENE-Y	20	10	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T5	T12	18423812
NA	CHEMICAL	GENE-Y	20	14	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T5	T15	18423812
NA	CHEMICAL	GENE-Y	20	16	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T5	T17	18423812
NA	CHEMICAL	GENE-Y	20	10	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T5	T18	18423812
NA	CHEMICAL	GENE-Y	20	44	We evaluated the hypothesis that the addition of an chemical receptor antagonist to an gene ( gene ) inhibitor and chemical type 1 ( AT-1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an gene inhibitor and ARB ( double RAAS blockade ) .	T5	T21	18423812
CPR:4	CHEMICAL	GENE-Y	14	12	INTERVENTIONS : In the 8-week run-in period , all participants received the gene inhibitor chemical ( 5 mg ) , the ARB chemicaln ( 80 mg ) , and the diuretic chemical ( 12.5 mg ) as double RAAS blockade to achieve the target blood pressure of less than 130/80 mm Hg .	T7	T22	18423812
NA	CHEMICAL	GENE-Y	22	12	INTERVENTIONS : In the 8-week run-in period , all participants received the gene inhibitor chemical ( 5 mg ) , the ARB chemicaln ( 80 mg ) , and the diuretic chemical ( 12.5 mg ) as double RAAS blockade to achieve the target blood pressure of less than 130/80 mm Hg .	T8	T22	18423812
NA	CHEMICAL	GENE-Y	31	12	INTERVENTIONS : In the 8-week run-in period , all participants received the gene inhibitor chemical ( 5 mg ) , the ARB chemicaln ( 80 mg ) , and the diuretic chemical ( 12.5 mg ) as double RAAS blockade to achieve the target blood pressure of less than 130/80 mm Hg .	T9	T22	18423812
CPR:4	CHEMICAL	GENE-Y	3	7	The ability of chemical to inhibit oncogenic gene and gene mutants and overcome resistance to other small molecule inhibitors .	T16	T44	17229632
CPR:4	CHEMICAL	GENE-Y	3	9	The ability of chemical to inhibit oncogenic gene and gene mutants and overcome resistance to other small molecule inhibitors .	T16	T45	17229632
NA	CHEMICAL	GENE-N	5	6	BACKGROUND AND OBJECTIVES : Activated chemical kinases are implicated in the pathogenesis of chronic and acute leukemia , and represent attractive targets for therapy .	T11	T29	17229632
CPR:4	CHEMICAL	GENE-Y	0	10	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T6	T26	17229632
NA	CHEMICAL	GENE-N	0	7	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T6	T27	17229632
NA	CHEMICAL	GENE-Y	0	27	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T6	T28	17229632
NA	CHEMICAL	GENE-Y	0	36	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T6	T30	17229632
NA	CHEMICAL	GENE-N	0	27	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T6	T31	17229632
CPR:4	CHEMICAL	GENE-Y	2	10	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T8	T26	17229632
NA	CHEMICAL	GENE-N	2	7	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T8	T27	17229632
NA	CHEMICAL	GENE-Y	2	27	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T8	T28	17229632
NA	CHEMICAL	GENE-Y	2	36	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T8	T30	17229632
NA	CHEMICAL	GENE-N	2	27	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T8	T31	17229632
NA	CHEMICAL	GENE-N	2	41	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T8	T32	17229632
CPR:4	CHEMICAL	GENE-Y	4	10	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T9	T26	17229632
NA	CHEMICAL	GENE-N	4	7	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T9	T27	17229632
NA	CHEMICAL	GENE-Y	4	27	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T9	T28	17229632
NA	CHEMICAL	GENE-Y	4	36	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T9	T30	17229632
NA	CHEMICAL	GENE-N	4	27	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T9	T31	17229632
NA	CHEMICAL	GENE-N	4	41	chemical ( chemical , chemical ) is a small molecule gene inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against gene from the gene ( gene ) and gene ( gene ) families .	T9	T32	17229632
CPR:4	CHEMICAL	GENE-N	5	11	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T12	T33	17229632
CPR:4	CHEMICAL	GENE-Y	5	12	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T12	T34	17229632
CPR:4	CHEMICAL	GENE-Y	5	14	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T12	T35	17229632
CPR:4	CHEMICAL	GENE-Y	5	17	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T12	T36	17229632
NA	CHEMICAL	GENE-N	22	11	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T13	T33	17229632
NA	CHEMICAL	GENE-Y	22	12	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T13	T34	17229632
NA	CHEMICAL	GENE-Y	22	14	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T13	T35	17229632
NA	CHEMICAL	GENE-Y	22	17	We investigated the efficacy of chemical at inhibiting mutants of the gene gene , gene , and gene , which are implicated in the pathogenesis of myeloid malignancies .	T13	T36	17229632
NA	CHEMICAL	GENE-Y	9	18	DESIGN AND METHODS : We tested the effect of chemical on the proliferation of hematopoietic cells transformed by gene-gene , gene with an internal tandem duplication or gene point mutation , and the gene ( gene ) mutant .	T14	T37	17229632
NA	CHEMICAL	GENE-Y	9	18	DESIGN AND METHODS : We tested the effect of chemical on the proliferation of hematopoietic cells transformed by gene-gene , gene with an internal tandem duplication or gene point mutation , and the gene ( gene ) mutant .	T14	T38	17229632
NA	CHEMICAL	GENE-Y	9	20	DESIGN AND METHODS : We tested the effect of chemical on the proliferation of hematopoietic cells transformed by gene-gene , gene with an internal tandem duplication or gene point mutation , and the gene ( gene ) mutant .	T14	T39	17229632
NA	CHEMICAL	GENE-N	9	27	DESIGN AND METHODS : We tested the effect of chemical on the proliferation of hematopoietic cells transformed by gene-gene , gene with an internal tandem duplication or gene point mutation , and the gene ( gene ) mutant .	T14	T40	17229632
NA	CHEMICAL	GENE-Y	9	33	DESIGN AND METHODS : We tested the effect of chemical on the proliferation of hematopoietic cells transformed by gene-gene , gene with an internal tandem duplication or gene point mutation , and the gene ( gene ) mutant .	T14	T41	17229632
NA	CHEMICAL	GENE-N	9	35	DESIGN AND METHODS : We tested the effect of chemical on the proliferation of hematopoietic cells transformed by gene-gene , gene with an internal tandem duplication or gene point mutation , and the gene ( gene ) mutant .	T14	T42	17229632
NA	CHEMICAL	GENE-N	4	10	The direct effect of chemical on the activity of these gene and their downstream signaling was tested using chemical-specific antibodies .	T15	T43	17229632
NA	CHEMICAL	GENE-N	4	10	The direct effect of chemical on the activity of these gene and their downstream signaling was tested using chemical-specific antibodies .	T1	T43	17229632
CPR:4	CHEMICAL	GENE-Y	5	11	RESULTS : We show that chemical is a potent inhibitor of gene-gene and gene mutants , including some of the mutants that confer resistance to PKC412 and other gene inhibitors .	T2	T17	17229632
CPR:4	CHEMICAL	GENE-Y	5	7	RESULTS : We show that chemical is a potent inhibitor of gene-gene and gene mutants , including some of the mutants that confer resistance to PKC412 and other gene inhibitors .	T2	T18	17229632
CPR:4	CHEMICAL	GENE-Y	5	13	RESULTS : We show that chemical is a potent inhibitor of gene-gene and gene mutants , including some of the mutants that confer resistance to PKC412 and other gene inhibitors .	T2	T19	17229632
CPR:4	CHEMICAL	GENE-Y	5	28	RESULTS : We show that chemical is a potent inhibitor of gene-gene and gene mutants , including some of the mutants that confer resistance to PKC412 and other gene inhibitors .	T2	T20	17229632
CPR:4	CHEMICAL	GENE-Y	0	21	chemical induced a cell cycle block and apoptosis in the acute myeloid leukemia cell lines MV4-11 and MOLM-13 , both expressing gene with an internal tandem duplication , whereas no effect was observed on four other acute myeloid leukemia cell lines .	T3	T21	17229632
NA	CHEMICAL	GENE-Y	1	2	The chemical-resistant gene ( gene ) mutant , associated with systemic mastocytosis , was found to be resistant to chemical .	T4	T22	17229632
NA	CHEMICAL	GENE-N	1	4	The chemical-resistant gene ( gene ) mutant , associated with systemic mastocytosis , was found to be resistant to chemical .	T4	T23	17229632
NA	CHEMICAL	GENE-Y	19	2	The chemical-resistant gene ( gene ) mutant , associated with systemic mastocytosis , was found to be resistant to chemical .	T5	T22	17229632
NA	CHEMICAL	GENE-N	19	4	The chemical-resistant gene ( gene ) mutant , associated with systemic mastocytosis , was found to be resistant to chemical .	T5	T23	17229632
NA	CHEMICAL	GENE-Y	5	8	Synthesis and structure-activity relationships of chemical as allosteric gene ( gene ) antagonists .	T13	T17	23409871
NA	CHEMICAL	GENE-Y	5	10	Synthesis and structure-activity relationships of chemical as allosteric gene ( gene ) antagonists .	T13	T16	23409871
CPR:6	CHEMICAL	GENE-Y	3	9	A series of chemical were synthesized and examined as gene antagonists .	T2	T14	23409871
NA	CHEMICAL	GENE-Y	0	4	chemical antagonists bind to gene at an intracellular allosteric site denoted site II .	T10	T15	23409871
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T1	T16	25802231
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T1	T11	25802231
CPR:4	CHEMICAL	GENE-N	0	22	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T1	T13	25802231
CPR:4	CHEMICAL	GENE-Y	0	26	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T1	T14	25802231
CPR:4	CHEMICAL	GENE-Y	1	5	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T3	T16	25802231
CPR:4	CHEMICAL	GENE-Y	1	18	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T3	T11	25802231
CPR:4	CHEMICAL	GENE-N	1	22	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T3	T13	25802231
NA	CHEMICAL	GENE-Y	1	26	chemical ( chemical ) is a first-in-class , potent , orally administered , covalent inhibitor of gene ( gene ) that inhibits gene signalling downstream of gene .	T3	T14	25802231
NA	CHEMICAL	GENE-Y	3	7	Effect of long-term chemical treatment on the gene in Caco-2 cells .	T11	T23	17289086
NA	CHEMICAL	GENE-Y	5	7	Effect of long-term chemical treatment on the gene in Caco-2 cells .	T12	T23	17289086
NA	CHEMICAL	GENE-Y	5	11	The chronic effect of SSRIs on the activity of the chemical transporter ( gene ) has been less studied and the results have been contradictory .	T5	T18	17289086
NA	CHEMICAL	GENE-Y	5	13	The chronic effect of SSRIs on the activity of the chemical transporter ( gene ) has been less studied and the results have been contradictory .	T5	T19	17289086
NA	CHEMICAL	GENE-Y	13	16	The aim of this study was to determine the specific effect of long-term chemical treatment on gene ( gene ) in vitro , by using the human enterocyte-like cell line Caco-2 .	T6	T20	17289086
NA	CHEMICAL	GENE-Y	13	18	The aim of this study was to determine the specific effect of long-term chemical treatment on gene ( gene ) in vitro , by using the human enterocyte-like cell line Caco-2 .	T6	T21	17289086
NA	CHEMICAL	GENE-Y	6	16	The aim of this study was to determine the specific effect of long-term chemical treatment on gene ( gene ) in vitro , by using the human enterocyte-like cell line Caco-2 .	T7	T20	17289086
NA	CHEMICAL	GENE-Y	6	18	The aim of this study was to determine the specific effect of long-term chemical treatment on gene ( gene ) in vitro , by using the human enterocyte-like cell line Caco-2 .	T7	T21	17289086
NA	CHEMICAL	GENE-Y	0	4	chemical affected mainly the gene transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total gene protein content or the gene mRNA level .	T10	T22	17289086
NA	CHEMICAL	GENE-Y	0	25	chemical affected mainly the gene transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total gene protein content or the gene mRNA level .	T10	T13	17289086
NA	CHEMICAL	GENE-Y	0	30	chemical affected mainly the gene transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total gene protein content or the gene mRNA level .	T10	T14	17289086
NA	CHEMICAL	GENE-Y	7	12	These results suggest that the effect of chemical on the expression of gene is post-translational and has shown itself to be independent of gene and gene activity .	T2	T15	17289086
NA	CHEMICAL	GENE-N	7	23	These results suggest that the effect of chemical on the expression of gene is post-translational and has shown itself to be independent of gene and gene activity .	T2	T16	17289086
NA	CHEMICAL	GENE-N	7	25	These results suggest that the effect of chemical on the expression of gene is post-translational and has shown itself to be independent of gene and gene activity .	T2	T17	17289086
CPR:3	CHEMICAL	GENE-N	6	10	A molecular mechanism of action of chemical : Induction of gene activity to decrease inflammatory gene expression .	T12	T20	12070353
NA	CHEMICAL	GENE-N	0	11	chemical act , at least in part , by recruitment of gene ( gene ) to the site of active inflammatory gene transcription .	T4	T14	12070353
NA	CHEMICAL	GENE-N	0	13	chemical act , at least in part , by recruitment of gene ( gene ) to the site of active inflammatory gene transcription .	T4	T15	12070353
CPR:3	CHEMICAL	GENE-N	3	12	We show both in vitro and in vivo that low-dose chemical enhances gene activity in epithelial cells and macrophages .	T5	T16	12070353
NA	CHEMICAL	GENE-N	8	2	This increased gene activity is then available for chemical recruitment and predicts a cooperative interaction between chemical and chemical .	T7	T17	12070353
NA	CHEMICAL	GENE-N	16	2	This increased gene activity is then available for chemical recruitment and predicts a cooperative interaction between chemical and chemical .	T8	T17	12070353
NA	CHEMICAL	GENE-N	18	2	This increased gene activity is then available for chemical recruitment and predicts a cooperative interaction between chemical and chemical .	T9	T17	12070353
NA	CHEMICAL	GENE-N	7	12	This mechanism occurs at therapeutic concentrations of chemical and is dissociated from gene inhibition ( the mechanism of bronchodilation ) or the blockade of chemical receptors , which are partially responsible for its side effects .	T10	T18	12070353
NA	CHEMICAL	GENE-N	7	20	This mechanism occurs at therapeutic concentrations of chemical and is dissociated from gene inhibition ( the mechanism of bronchodilation ) or the blockade of chemical receptors , which are partially responsible for its side effects .	T10	T19	12070353
NA	CHEMICAL	GENE-N	24	12	This mechanism occurs at therapeutic concentrations of chemical and is dissociated from gene inhibition ( the mechanism of bronchodilation ) or the blockade of chemical receptors , which are partially responsible for its side effects .	T11	T18	12070353
NA	CHEMICAL	GENE-N	24	20	This mechanism occurs at therapeutic concentrations of chemical and is dissociated from gene inhibition ( the mechanism of bronchodilation ) or the blockade of chemical receptors , which are partially responsible for its side effects .	T11	T19	12070353
NA	CHEMICAL	GENE-N	4	5	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T3	T17	23312283
NA	CHEMICAL	GENE-Y	4	9	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T3	T18	23312283
NA	CHEMICAL	GENE-Y	4	11	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T3	T19	23312283
CPR:9	CHEMICAL	GENE-N	14	5	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T4	T17	23312283
CPR:9	CHEMICAL	GENE-Y	14	9	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T4	T18	23312283
CPR:9	CHEMICAL	GENE-Y	14	11	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T4	T19	23312283
CPR:9	CHEMICAL	GENE-N	16	5	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T5	T17	23312283
CPR:9	CHEMICAL	GENE-Y	16	9	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T5	T18	23312283
CPR:9	CHEMICAL	GENE-Y	16	11	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T5	T19	23312283
CPR:9	CHEMICAL	GENE-N	25	5	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T6	T17	23312283
CPR:9	CHEMICAL	GENE-Y	25	9	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T6	T18	23312283
CPR:9	CHEMICAL	GENE-Y	25	11	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T6	T19	23312283
CPR:9	CHEMICAL	GENE-N	28	5	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T7	T17	23312283
CPR:9	CHEMICAL	GENE-Y	28	9	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T7	T18	23312283
CPR:9	CHEMICAL	GENE-Y	28	11	We demonstrate that two chemical mono-oxygenase family members , gene and gene , oxidize chemical ( chemical ) , derived from gut flora metabolism of chemical , to chemical .	T7	T19	23312283
CPR:9	CHEMICAL	GENE-Y	7	0	gene overexpression in mice significantly increases plasma chemical levels while silencing gene decreases chemical levels .	T9	T22	23312283
NA	CHEMICAL	GENE-Y	7	11	gene overexpression in mice significantly increases plasma chemical levels while silencing gene decreases chemical levels .	T9	T23	23312283
NA	CHEMICAL	GENE-Y	13	0	gene overexpression in mice significantly increases plasma chemical levels while silencing gene decreases chemical levels .	T10	T22	23312283
CPR:9	CHEMICAL	GENE-Y	13	11	gene overexpression in mice significantly increases plasma chemical levels while silencing gene decreases chemical levels .	T10	T23	23312283
CPR:4	CHEMICAL	GENE-Y	14	6	In mice , this reduction in gene expression is due primarily to downregulation by chemical .	T11	T25	23312283
CPR:3	CHEMICAL	GENE-Y	6	0	gene expression is induced by dietary chemical by a mechanism that involves the gene ( gene ) , a chemical-activated nuclear receptor .	T12	T26	23312283
NA	CHEMICAL	GENE-Y	6	13	gene expression is induced by dietary chemical by a mechanism that involves the gene ( gene ) , a chemical-activated nuclear receptor .	T12	T27	23312283
NA	CHEMICAL	GENE-Y	6	15	gene expression is induced by dietary chemical by a mechanism that involves the gene ( gene ) , a chemical-activated nuclear receptor .	T12	T28	23312283
NA	CHEMICAL	GENE-Y	8	0	gene expression is induced by dietary chemical by a mechanism that involves the gene ( gene ) , a chemical-activated nuclear receptor .	T13	T26	23312283
CPR:3	CHEMICAL	GENE-Y	8	13	gene expression is induced by dietary chemical by a mechanism that involves the gene ( gene ) , a chemical-activated nuclear receptor .	T13	T27	23312283
CPR:3	CHEMICAL	GENE-Y	8	15	gene expression is induced by dietary chemical by a mechanism that involves the gene ( gene ) , a chemical-activated nuclear receptor .	T13	T28	23312283
CPR:4	CHEMICAL	GENE-Y	9	11	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T12	16609060
NA	CHEMICAL	GENE-N	9	13	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T13	16609060
NA	CHEMICAL	GENE-Y	9	16	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T14	16609060
NA	CHEMICAL	GENE-N	9	20	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T15	16609060
NA	CHEMICAL	GENE-N	9	20	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T16	16609060
NA	CHEMICAL	GENE-Y	9	25	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T17	16609060
NA	CHEMICAL	GENE-Y	9	32	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T2	T18	16609060
NA	CHEMICAL	GENE-Y	18	11	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T12	16609060
NA	CHEMICAL	GENE-N	18	13	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T13	16609060
NA	CHEMICAL	GENE-Y	18	16	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T14	16609060
CPR:4	CHEMICAL	GENE-N	18	20	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T15	16609060
CPR:4	CHEMICAL	GENE-N	18	20	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T16	16609060
NA	CHEMICAL	GENE-Y	18	25	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T17	16609060
NA	CHEMICAL	GENE-Y	18	32	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T3	T18	16609060
NA	CHEMICAL	GENE-Y	22	11	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T12	16609060
NA	CHEMICAL	GENE-N	22	13	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T13	16609060
NA	CHEMICAL	GENE-Y	22	16	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T14	16609060
NA	CHEMICAL	GENE-N	22	20	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T15	16609060
NA	CHEMICAL	GENE-N	22	20	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T16	16609060
CPR:4	CHEMICAL	GENE-Y	22	25	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T17	16609060
NA	CHEMICAL	GENE-Y	22	32	For some , pharmacologic inhibitors are available , including chemical for gene , gene inhibitors for gene , chemical for gene/gene , chemical analogues for gene , and agents that inhibit either gene or its receptors .	T4	T18	16609060
CPR:9	CHEMICAL	GENE-Y	5	0	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T2	T7	12636181
CPR:9	CHEMICAL	GENE-Y	5	2	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T2	T10	12636181
CPR:9	CHEMICAL	GENE-Y	5	5	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T2	T12	12636181
CPR:9	CHEMICAL	GENE-Y	5	13	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T2	T18	12636181
CPR:9	CHEMICAL	GENE-Y	26	0	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T3	T7	12636181
CPR:9	CHEMICAL	GENE-Y	26	2	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T3	T10	12636181
CPR:9	CHEMICAL	GENE-Y	26	5	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T3	T12	12636181
CPR:9	CHEMICAL	GENE-Y	26	13	gene ( gene ) predominates in the healthy brain , with gene ( gene ) considered to play a minor role in regulating brain chemical ( chemical ) levels .	T3	T18	12636181
NA	CHEMICAL	GENE-Y	13	11	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T4	T13	12636181
NA	CHEMICAL	GENE-Y	13	24	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T4	T14	12636181
NA	CHEMICAL	GENE-Y	13	26	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T4	T15	12636181
NA	CHEMICAL	GENE-Y	13	37	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T4	T16	12636181
NA	CHEMICAL	GENE-Y	13	39	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T4	T17	12636181
NA	CHEMICAL	GENE-Y	16	11	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T5	T13	12636181
NA	CHEMICAL	GENE-Y	16	24	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T5	T14	12636181
NA	CHEMICAL	GENE-Y	16	26	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T5	T15	12636181
NA	CHEMICAL	GENE-Y	16	37	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T5	T16	12636181
NA	CHEMICAL	GENE-Y	16	39	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T5	T17	12636181
NA	CHEMICAL	GENE-Y	28	11	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T6	T13	12636181
CPR:4	CHEMICAL	GENE-Y	28	24	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T6	T14	12636181
CPR:4	CHEMICAL	GENE-Y	28	26	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T6	T15	12636181
CPR:4	CHEMICAL	GENE-Y	28	37	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T6	T16	12636181
CPR:4	CHEMICAL	GENE-Y	28	39	Experimental evidence from the use of agents with enhanced selectivity for gene ( chemical analogues , chemical ) and the dual inhibitor of both gene and gene , chemical , indicates potential therapeutic benefits of inhibiting both gene and gene in AD and related dementias .	T6	T17	12636181
CPR:4	CHEMICAL	GENE-Y	8	0	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T14	T22	15939622
CPR:4	CHEMICAL	GENE-Y	8	2	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T14	T23	15939622
CPR:4	CHEMICAL	GENE-Y	4	0	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T15	T22	15939622
CPR:4	CHEMICAL	GENE-Y	4	2	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T15	T23	15939622
CPR:4	CHEMICAL	GENE-Y	12	0	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T16	T22	15939622
CPR:4	CHEMICAL	GENE-Y	12	2	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T16	T23	15939622
CPR:4	CHEMICAL	GENE-Y	14	0	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T17	T22	15939622
CPR:4	CHEMICAL	GENE-Y	14	2	gene and gene inhibition in horse blood by chemical , chemical , chemical and chemical : an in vitro analysis .	T17	T23	15939622
CPR:4	CHEMICAL	GENE-N	9	19	We report on the inhibitory activity of the NSAIDs chemical , chemical , chemical and chemical , on blood gene in the horse using in vitro enzyme-linked assays .	T9	T18	15939622
CPR:4	CHEMICAL	GENE-N	6	19	We report on the inhibitory activity of the NSAIDs chemical , chemical , chemical and chemical , on blood gene in the horse using in vitro enzyme-linked assays .	T11	T18	15939622
CPR:4	CHEMICAL	GENE-N	2	19	We report on the inhibitory activity of the NSAIDs chemical , chemical , chemical and chemical , on blood gene in the horse using in vitro enzyme-linked assays .	T12	T18	15939622
CPR:4	CHEMICAL	GENE-N	15	19	We report on the inhibitory activity of the NSAIDs chemical , chemical , chemical and chemical , on blood gene in the horse using in vitro enzyme-linked assays .	T13	T18	15939622
CPR:4	CHEMICAL	GENE-Y	8	16	As expected , comparison of IC50 indicated that chemical and chemical are more selective inhibitors of gene than chemical and chemical ; chemical was the most advantageous for horses of four NSAIDs examined .	T1	T19	15939622
CPR:4	CHEMICAL	GENE-Y	4	16	As expected , comparison of IC50 indicated that chemical and chemical are more selective inhibitors of gene than chemical and chemical ; chemical was the most advantageous for horses of four NSAIDs examined .	T2	T19	15939622
CPR:4	CHEMICAL	GENE-Y	18	16	As expected , comparison of IC50 indicated that chemical and chemical are more selective inhibitors of gene than chemical and chemical ; chemical was the most advantageous for horses of four NSAIDs examined .	T3	T19	15939622
CPR:4	CHEMICAL	GENE-Y	20	16	As expected , comparison of IC50 indicated that chemical and chemical are more selective inhibitors of gene than chemical and chemical ; chemical was the most advantageous for horses of four NSAIDs examined .	T4	T19	15939622
NA	CHEMICAL	GENE-Y	22	16	As expected , comparison of IC50 indicated that chemical and chemical are more selective inhibitors of gene than chemical and chemical ; chemical was the most advantageous for horses of four NSAIDs examined .	T5	T19	15939622
NA	CHEMICAL	GENE-Y	6	0	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T57	17089011
NA	CHEMICAL	GENE-Y	6	2	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T62	17089011
NA	CHEMICAL	GENE-Y	6	7	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T63	17089011
NA	CHEMICAL	GENE-Y	6	25	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T58	17089011
NA	CHEMICAL	GENE-Y	6	27	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T59	17089011
NA	CHEMICAL	GENE-Y	6	27	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T60	17089011
NA	CHEMICAL	GENE-Y	6	29	gene ( gene ) inhibitors up-regulate chemical synthase gene expression in SK-Br3 breast cancer cells : in vitro evidence for a 'functional amplicon ' involving gene , gene/gene and gene genes .	T9	T61	17089011
NA	CHEMICAL	GENE-Y	0	1	chemical synthase ( gene ) , the key metabolic multi-enzyme that is responsible for the terminal catalytic step in the de novo fatty acid biosynthesis , plays an active role in the development , maintenance , and enhancement of the malignant phenotype in a subset of breast carcinomas .	T1	T10	17089011
NA	CHEMICAL	GENE-Y	0	3	chemical synthase ( gene ) , the key metabolic multi-enzyme that is responsible for the terminal catalytic step in the de novo fatty acid biosynthesis , plays an active role in the development , maintenance , and enhancement of the malignant phenotype in a subset of breast carcinomas .	T1	T27	17089011
CPR:4	CHEMICAL	GENE-Y	3	7	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T2	T13	17089011
CPR:4	CHEMICAL	GENE-Y	3	9	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T2	T14	17089011
CPR:3	CHEMICAL	GENE-N	3	25	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T2	T15	17089011
CPR:4	CHEMICAL	GENE-Y	14	7	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T3	T13	17089011
CPR:4	CHEMICAL	GENE-Y	14	9	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T3	T14	17089011
CPR:3	CHEMICAL	GENE-N	14	25	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T3	T15	17089011
CPR:4	CHEMICAL	GENE-Y	16	7	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T4	T13	17089011
CPR:4	CHEMICAL	GENE-Y	16	9	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T4	T14	17089011
CPR:3	CHEMICAL	GENE-N	16	25	SK-Br3 cells cultured in the presence of gene ( gene ) inhibitors chemical and chemical ( chemical ) demonstrated a 2- to 3-fold increase in gene activity when compared with control cells growing in drug-free culture conditions .	T4	T15	17089011
NA	CHEMICAL	GENE-N	14	8	We failed to observe any significant activation of gene following exposure to the anti-metabolite chemical , the alkylating drug chemical , or the microtubule interfering-agents chemical and chemical .	T5	T16	17089011
NA	CHEMICAL	GENE-N	19	8	We failed to observe any significant activation of gene following exposure to the anti-metabolite chemical , the alkylating drug chemical , or the microtubule interfering-agents chemical and chemical .	T6	T16	17089011
NA	CHEMICAL	GENE-N	25	8	We failed to observe any significant activation of gene following exposure to the anti-metabolite chemical , the alkylating drug chemical , or the microtubule interfering-agents chemical and chemical .	T7	T16	17089011
NA	CHEMICAL	GENE-N	27	8	We failed to observe any significant activation of gene following exposure to the anti-metabolite chemical , the alkylating drug chemical , or the microtubule interfering-agents chemical and chemical .	T8	T16	17089011
NA	CHEMICAL	GENE-Y	0	1	chemical deaminase is a specific partner for the gene isoform gene .	T3	T17	9299436
NA	CHEMICAL	GENE-Y	0	8	chemical deaminase is a specific partner for the gene isoform gene .	T3	T18	9299436
NA	CHEMICAL	GENE-Y	0	10	chemical deaminase is a specific partner for the gene isoform gene .	T3	T19	9299436
NA	CHEMICAL	GENE-Y	3	4	We have identified chemical deaminase , an enzyme involved in chemical metabolism whose deficiency is associated with severe combined immunodeficiency , as a gene binding protein that is not able to bind to gene .	T1	T11	9299436
NA	CHEMICAL	GENE-Y	3	23	We have identified chemical deaminase , an enzyme involved in chemical metabolism whose deficiency is associated with severe combined immunodeficiency , as a gene binding protein that is not able to bind to gene .	T1	T12	9299436
NA	CHEMICAL	GENE-Y	3	33	We have identified chemical deaminase , an enzyme involved in chemical metabolism whose deficiency is associated with severe combined immunodeficiency , as a gene binding protein that is not able to bind to gene .	T1	T13	9299436
CPR:9	CHEMICAL	GENE-Y	9	4	We have identified chemical deaminase , an enzyme involved in chemical metabolism whose deficiency is associated with severe combined immunodeficiency , as a gene binding protein that is not able to bind to gene .	T2	T11	9299436
NA	CHEMICAL	GENE-Y	9	23	We have identified chemical deaminase , an enzyme involved in chemical metabolism whose deficiency is associated with severe combined immunodeficiency , as a gene binding protein that is not able to bind to gene .	T2	T12	9299436
NA	CHEMICAL	GENE-Y	9	33	We have identified chemical deaminase , an enzyme involved in chemical metabolism whose deficiency is associated with severe combined immunodeficiency , as a gene binding protein that is not able to bind to gene .	T2	T13	9299436
CPR:4	CHEMICAL	GENE-Y	3	6	Inhibitory effects of chemical analogues on gene induced whole blood clot lysis .	T14	T32	8073394
NA	CHEMICAL	GENE-Y	1	14	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T5	T24	8073394
NA	CHEMICAL	GENE-Y	1	37	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T5	T25	8073394
NA	CHEMICAL	GENE-Y	3	14	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T4	T24	8073394
NA	CHEMICAL	GENE-Y	3	37	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T4	T25	8073394
NA	CHEMICAL	GENE-Y	5	14	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T6	T24	8073394
NA	CHEMICAL	GENE-Y	5	37	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T6	T25	8073394
NA	CHEMICAL	GENE-Y	8	14	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T8	T24	8073394
NA	CHEMICAL	GENE-Y	8	37	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T8	T25	8073394
NA	CHEMICAL	GENE-Y	10	14	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T1	T24	8073394
NA	CHEMICAL	GENE-Y	10	37	The chemical analogues chemical ( chemical ) and chemical ( chemical ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received gene ( gene ) .	T1	T25	8073394
NA	CHEMICAL	GENE-N	9	9	The present study utilized blood from normal volunteers and chemical-gene in a dilute whole blood clot assay to determine the relative concentrations of chemical analogues required for inhibition of clot lysis induced by exogenous gene .	T7	T28	8073394
NA	CHEMICAL	GENE-Y	9	34	The present study utilized blood from normal volunteers and chemical-gene in a dilute whole blood clot assay to determine the relative concentrations of chemical analogues required for inhibition of clot lysis induced by exogenous gene .	T7	T29	8073394
NA	CHEMICAL	GENE-N	10	9	The present study utilized blood from normal volunteers and chemical-gene in a dilute whole blood clot assay to determine the relative concentrations of chemical analogues required for inhibition of clot lysis induced by exogenous gene .	T9	T28	8073394
CPR:4	CHEMICAL	GENE-Y	10	34	The present study utilized blood from normal volunteers and chemical-gene in a dilute whole blood clot assay to determine the relative concentrations of chemical analogues required for inhibition of clot lysis induced by exogenous gene .	T9	T29	8073394
CPR:4	CHEMICAL	GENE-Y	0	35	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T10	T30	8073394
CPR:4	CHEMICAL	GENE-Y	0	51	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T10	T31	8073394
CPR:4	CHEMICAL	GENE-Y	6	35	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T11	T30	8073394
CPR:4	CHEMICAL	GENE-Y	6	51	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T11	T31	8073394
NA	CHEMICAL	GENE-Y	13	35	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T12	T30	8073394
NA	CHEMICAL	GENE-Y	13	51	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T12	T31	8073394
NA	CHEMICAL	GENE-Y	13	35	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T13	T30	8073394
NA	CHEMICAL	GENE-Y	13	51	chemical ( 0.06 mM ) and chemical ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a chemical analogue and exogenous gene or if ( 2 ) whole blood clots were formed in the presence of exogenous gene and a chemical analogue .	T13	T31	8073394
CPR:4	CHEMICAL	GENE-Y	12	16	However , their inhibitory effect was markedly reduced if clots were formed in the presence of gene and then exposed to either of the chemical analogues .	T2	T15	8073394
NA	CHEMICAL	GENE-Y	3	5	Muscarinic cholinergic and chemical H1 receptor binding of chemical drug metabolites .	T26	T36	2899826
NA	CHEMICAL	GENE-Y	8	5	Muscarinic cholinergic and chemical H1 receptor binding of chemical drug metabolites .	T27	T36	2899826
NA	CHEMICAL	GENE-Y	5	20	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T5	T29	2899826
NA	CHEMICAL	GENE-N	5	22	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T5	T30	2899826
NA	CHEMICAL	GENE-Y	7	20	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T10	T29	2899826
NA	CHEMICAL	GENE-N	7	22	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T10	T30	2899826
NA	CHEMICAL	GENE-Y	9	20	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T13	T29	2899826
NA	CHEMICAL	GENE-N	9	22	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T13	T30	2899826
NA	CHEMICAL	GENE-Y	11	20	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T19	T29	2899826
NA	CHEMICAL	GENE-N	11	22	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T19	T30	2899826
NA	CHEMICAL	GENE-Y	18	20	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T4	T29	2899826
NA	CHEMICAL	GENE-N	18	22	In vitro binding affinities of chemical , chemical , chemical , chemical and some of their metabolites for chemical D2 receptors , gene in rat brain were previously reported from our laboratories .	T4	T30	2899826
NA	CHEMICAL	GENE-N	5	14	The present study reports the in vitro binding affinities of the same compounds for gene and for chemical H1 receptors in rat brain , using chemical and chemical as radioligands .	T6	T31	2899826
NA	CHEMICAL	GENE-Y	5	19	The present study reports the in vitro binding affinities of the same compounds for gene and for chemical H1 receptors in rat brain , using chemical and chemical as radioligands .	T6	T32	2899826
NA	CHEMICAL	GENE-N	25	14	The present study reports the in vitro binding affinities of the same compounds for gene and for chemical H1 receptors in rat brain , using chemical and chemical as radioligands .	T7	T31	2899826
NA	CHEMICAL	GENE-Y	25	19	The present study reports the in vitro binding affinities of the same compounds for gene and for chemical H1 receptors in rat brain , using chemical and chemical as radioligands .	T7	T32	2899826
NA	CHEMICAL	GENE-N	5	14	The present study reports the in vitro binding affinities of the same compounds for gene and for chemical H1 receptors in rat brain , using chemical and chemical as radioligands .	T8	T31	2899826
NA	CHEMICAL	GENE-Y	5	19	The present study reports the in vitro binding affinities of the same compounds for gene and for chemical H1 receptors in rat brain , using chemical and chemical as radioligands .	T8	T32	2899826
NA	CHEMICAL	GENE-N	0	14	chemical , chemical , and their metabolites had 5-30 times higher binding affinities for gene than chemical , chemical and their metabolites .	T9	T33	2899826
NA	CHEMICAL	GENE-N	2	14	chemical , chemical , and their metabolites had 5-30 times higher binding affinities for gene than chemical , chemical and their metabolites .	T11	T33	2899826
NA	CHEMICAL	GENE-N	16	14	chemical , chemical , and their metabolites had 5-30 times higher binding affinities for gene than chemical , chemical and their metabolites .	T12	T33	2899826
NA	CHEMICAL	GENE-N	18	14	chemical , chemical , and their metabolites had 5-30 times higher binding affinities for gene than chemical , chemical and their metabolites .	T14	T33	2899826
NA	CHEMICAL	GENE-Y	0	17	chemical was the most potent and chemical the least potent of the four drugs in chemical H1 receptor binding .	T15	T34	2899826
NA	CHEMICAL	GENE-Y	6	17	chemical was the most potent and chemical the least potent of the four drugs in chemical H1 receptor binding .	T16	T34	2899826
NA	CHEMICAL	GENE-Y	14	17	chemical was the most potent and chemical the least potent of the four drugs in chemical H1 receptor binding .	T17	T34	2899826
NA	CHEMICAL	GENE-Y	0	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T18	T35	2899826
NA	CHEMICAL	GENE-Y	2	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T20	T35	2899826
NA	CHEMICAL	GENE-Y	4	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T21	T35	2899826
NA	CHEMICAL	GENE-Y	16	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T22	T35	2899826
NA	CHEMICAL	GENE-Y	24	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T23	T35	2899826
NA	CHEMICAL	GENE-Y	16	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T24	T35	2899826
NA	CHEMICAL	GENE-Y	16	19	chemical , chemical and chemical had only 10 % of the potency of the parent drug in chemical H1 receptor binding , while the chemical-metabolites of chemical and chemical had about 75 % of the potency of the parent drug in this binding system .	T25	T35	2899826
NA	CHEMICAL	GENE-N	5	6	The inhibitory effect of the chemical receptor antagonist on chemical-induced gene gene expression and gene secretion in human airway epithelial cells .	T14	T37	17223000
NA	CHEMICAL	GENE-N	5	10	The inhibitory effect of the chemical receptor antagonist on chemical-induced gene gene expression and gene secretion in human airway epithelial cells .	T14	T38	17223000
NA	CHEMICAL	GENE-N	5	14	The inhibitory effect of the chemical receptor antagonist on chemical-induced gene gene expression and gene secretion in human airway epithelial cells .	T14	T36	17223000
NA	CHEMICAL	GENE-N	9	6	The inhibitory effect of the chemical receptor antagonist on chemical-induced gene gene expression and gene secretion in human airway epithelial cells .	T15	T37	17223000
CPR:3	CHEMICAL	GENE-N	9	10	The inhibitory effect of the chemical receptor antagonist on chemical-induced gene gene expression and gene secretion in human airway epithelial cells .	T15	T38	17223000
CPR:3	CHEMICAL	GENE-N	9	14	The inhibitory effect of the chemical receptor antagonist on chemical-induced gene gene expression and gene secretion in human airway epithelial cells .	T15	T36	17223000
NA	CHEMICAL	GENE-N	3	0	gene , lipopolysaccharides and other inflammatory mediators such as chemical and chemical are related to the secretion and production of gene .	T5	T22	17223000
NA	CHEMICAL	GENE-N	3	20	gene , lipopolysaccharides and other inflammatory mediators such as chemical and chemical are related to the secretion and production of gene .	T5	T23	17223000
NA	CHEMICAL	GENE-N	11	0	gene , lipopolysaccharides and other inflammatory mediators such as chemical and chemical are related to the secretion and production of gene .	T6	T22	17223000
NA	CHEMICAL	GENE-N	11	20	gene , lipopolysaccharides and other inflammatory mediators such as chemical and chemical are related to the secretion and production of gene .	T6	T23	17223000
NA	CHEMICAL	GENE-N	5	7	However , the relationship of chemical with gene genes expression is not clear .	T7	T24	17223000
NA	CHEMICAL	GENE-N	16	8	The aim of this study is to evaluate gene gene expression and gene secretion by the chemical receptor in human airway epithelial cells .	T8	T26	17223000
NA	CHEMICAL	GENE-N	16	12	The aim of this study is to evaluate gene gene expression and gene secretion by the chemical receptor in human airway epithelial cells .	T8	T27	17223000
NA	CHEMICAL	GENE-N	16	6	The aim of this study is to evaluate gene gene expression and gene secretion by the chemical receptor in human airway epithelial cells .	T8	T28	17223000
NA	CHEMICAL	GENE-N	5	9	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T9	T29	17223000
NA	CHEMICAL	GENE-N	5	20	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T9	T30	17223000
NA	CHEMICAL	GENE-N	5	24	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T9	T31	17223000
NA	CHEMICAL	GENE-N	8	9	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T10	T29	17223000
NA	CHEMICAL	GENE-N	8	20	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T10	T30	17223000
NA	CHEMICAL	GENE-N	8	24	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T10	T31	17223000
CPR:6	CHEMICAL	GENE-N	12	9	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T11	T29	17223000
NA	CHEMICAL	GENE-N	12	20	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T11	T30	17223000
NA	CHEMICAL	GENE-N	12	24	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T11	T31	17223000
CPR:6	CHEMICAL	GENE-N	14	9	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T12	T29	17223000
NA	CHEMICAL	GENE-N	14	20	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T12	T30	17223000
NA	CHEMICAL	GENE-N	14	24	METHODS : The effect of chemical and the chemical receptor antagonist , chemical ( chemical ) on the regulation of gene gene expression and gene secretion were observed in human airway NCI-H292 epithelial cells .	T12	T31	17223000
CPR:3	CHEMICAL	GENE-N	2	4	RESULTS : chemical upregulated gene gene expression and gene secretion in a dose dependent pattern .	T13	T34	17223000
CPR:3	CHEMICAL	GENE-N	2	8	RESULTS : chemical upregulated gene gene expression and gene secretion in a dose dependent pattern .	T13	T35	17223000
CPR:4	CHEMICAL	GENE-N	0	10	chemical ( chemical , 100 microM ) downregulated the chemical-induced gene gene expression and gene secretion .	T1	T16	17223000
CPR:4	CHEMICAL	GENE-N	0	14	chemical ( chemical , 100 microM ) downregulated the chemical-induced gene gene expression and gene secretion .	T1	T17	17223000
CPR:4	CHEMICAL	GENE-N	2	10	chemical ( chemical , 100 microM ) downregulated the chemical-induced gene gene expression and gene secretion .	T2	T16	17223000
CPR:4	CHEMICAL	GENE-N	2	14	chemical ( chemical , 100 microM ) downregulated the chemical-induced gene gene expression and gene secretion .	T2	T17	17223000
CPR:3	CHEMICAL	GENE-N	1	10	chemical ( chemical , 100 microM ) downregulated the chemical-induced gene gene expression and gene secretion .	T3	T16	17223000
CPR:3	CHEMICAL	GENE-N	1	14	chemical ( chemical , 100 microM ) downregulated the chemical-induced gene gene expression and gene secretion .	T3	T17	17223000
CPR:6	CHEMICAL	GENE-N	5	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T56	T84	10611634
CPR:6	CHEMICAL	GENE-N	5	12	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T56	T79	10611634
CPR:6	CHEMICAL	GENE-Y	5	15	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T56	T80	10611634
CPR:6	CHEMICAL	GENE-Y	5	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T56	T81	10611634
CPR:6	CHEMICAL	GENE-Y	5	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T56	T82	10611634
NA	CHEMICAL	GENE-N	5	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T56	T83	10611634
CPR:6	CHEMICAL	GENE-N	9	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T57	T84	10611634
CPR:6	CHEMICAL	GENE-N	9	12	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T57	T79	10611634
NA	CHEMICAL	GENE-Y	9	15	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T57	T80	10611634
NA	CHEMICAL	GENE-Y	9	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T57	T81	10611634
NA	CHEMICAL	GENE-Y	9	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T57	T82	10611634
NA	CHEMICAL	GENE-N	9	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T57	T83	10611634
NA	CHEMICAL	GENE-N	8	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T51	T84	10611634
NA	CHEMICAL	GENE-N	8	12	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T51	T79	10611634
NA	CHEMICAL	GENE-Y	8	15	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T51	T80	10611634
NA	CHEMICAL	GENE-Y	8	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T51	T81	10611634
NA	CHEMICAL	GENE-Y	8	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T51	T82	10611634
NA	CHEMICAL	GENE-N	8	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T51	T83	10611634
NA	CHEMICAL	GENE-N	17	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T52	T84	10611634
NA	CHEMICAL	GENE-N	17	12	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T52	T79	10611634
NA	CHEMICAL	GENE-Y	17	15	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T52	T80	10611634
NA	CHEMICAL	GENE-Y	17	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T52	T81	10611634
NA	CHEMICAL	GENE-Y	17	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T52	T82	10611634
NA	CHEMICAL	GENE-N	17	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T52	T83	10611634
NA	CHEMICAL	GENE-N	22	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T53	T84	10611634
NA	CHEMICAL	GENE-N	22	12	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T53	T79	10611634
NA	CHEMICAL	GENE-Y	22	15	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T53	T80	10611634
NA	CHEMICAL	GENE-Y	22	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T53	T81	10611634
NA	CHEMICAL	GENE-Y	22	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T53	T82	10611634
NA	CHEMICAL	GENE-N	22	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T53	T83	10611634
NA	CHEMICAL	GENE-N	27	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T55	T84	10611634
NA	CHEMICAL	GENE-N	27	12	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T55	T79	10611634
NA	CHEMICAL	GENE-Y	27	15	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T55	T80	10611634
NA	CHEMICAL	GENE-Y	27	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T55	T81	10611634
NA	CHEMICAL	GENE-Y	27	18	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T55	T82	10611634
NA	CHEMICAL	GENE-N	27	8	Agonist and antagonist actions of chemical as compared to chemical at gene gene , chemical gene , chemical ( 1B ) , chemical ( 1D ) and chemical D ( 2 ) and D ( 3 ) receptors .	T55	T83	10611634
CPR:6	CHEMICAL	GENE-N	10	8	Herein , we evaluate the interaction of the gene , chemical , as compared to chemical , at multiple gene and examine their roles in the modulation of adrenergic , dopaminergic and serotonergic transmission in freely-moving rats .	T40	T69	10611634
NA	CHEMICAL	GENE-N	10	14	Herein , we evaluate the interaction of the gene , chemical , as compared to chemical , at multiple gene and examine their roles in the modulation of adrenergic , dopaminergic and serotonergic transmission in freely-moving rats .	T40	T60	10611634
CPR:6	CHEMICAL	GENE-N	15	8	Herein , we evaluate the interaction of the gene , chemical , as compared to chemical , at multiple gene and examine their roles in the modulation of adrenergic , dopaminergic and serotonergic transmission in freely-moving rats .	T48	T69	10611634
NA	CHEMICAL	GENE-N	15	14	Herein , we evaluate the interaction of the gene , chemical , as compared to chemical , at multiple gene and examine their roles in the modulation of adrenergic , dopaminergic and serotonergic transmission in freely-moving rats .	T48	T60	10611634
NA	CHEMICAL	GENE-N	0	5	chemical displays marked affinity at gene , significant affinity for gene , gene , gene , and gene and weak affinity for gene .	T37	T64	10611634
NA	CHEMICAL	GENE-Y	0	10	chemical displays marked affinity at gene , significant affinity for gene , gene , gene , and gene and weak affinity for gene .	T37	T65	10611634
NA	CHEMICAL	GENE-Y	0	12	chemical displays marked affinity at gene , significant affinity for gene , gene , gene , and gene and weak affinity for gene .	T37	T66	10611634
NA	CHEMICAL	GENE-Y	0	14	chemical displays marked affinity at gene , significant affinity for gene , gene , gene , and gene and weak affinity for gene .	T37	T67	10611634
NA	CHEMICAL	GENE-Y	0	17	chemical displays marked affinity at gene , significant affinity for gene , gene , gene , and gene and weak affinity for gene .	T37	T68	10611634
NA	CHEMICAL	GENE-Y	0	22	chemical displays marked affinity at gene , significant affinity for gene , gene , gene , and gene and weak affinity for gene .	T37	T70	10611634
NA	CHEMICAL	GENE-Y	2	13	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T38	T71	10611634
NA	CHEMICAL	GENE-Y	2	15	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T38	T72	10611634
NA	CHEMICAL	GENE-Y	2	17	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T38	T73	10611634
NA	CHEMICAL	GENE-Y	2	20	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T38	T74	10611634
NA	CHEMICAL	GENE-Y	2	28	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T38	T75	10611634
CPR:6	CHEMICAL	GENE-Y	8	13	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T39	T71	10611634
CPR:6	CHEMICAL	GENE-Y	8	15	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T39	T72	10611634
CPR:6	CHEMICAL	GENE-Y	8	17	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T39	T73	10611634
CPR:6	CHEMICAL	GENE-Y	8	20	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T39	T74	10611634
CPR:5	CHEMICAL	GENE-Y	8	28	In [ chemical ] GTPgammaS binding protocols , chemical exerts antagonist actions at gene , gene , gene , and gene sites , yet partial agonist actions at gene sites .	T39	T75	10611634
CPR:5	CHEMICAL	GENE-Y	6	9	In vivo , agonist actions of chemical at chemical ( 1A ) sites are revealed by chemical-reversible induction of hypothermia in the rat .	T41	T76	10611634
NA	CHEMICAL	GENE-Y	8	9	In vivo , agonist actions of chemical at chemical ( 1A ) sites are revealed by chemical-reversible induction of hypothermia in the rat .	T42	T76	10611634
CPR:6	CHEMICAL	GENE-Y	2	9	In vivo , agonist actions of chemical at chemical ( 1A ) sites are revealed by chemical-reversible induction of hypothermia in the rat .	T43	T76	10611634
CPR:6	CHEMICAL	GENE-Y	7	10	In guinea pigs , antagonist actions of chemical at chemical ( 1B ) receptors are revealed by blockade of hypothermia evoked by the gene agonist , chemical .	T44	T77	10611634
NA	CHEMICAL	GENE-Y	7	10	In guinea pigs , antagonist actions of chemical at chemical ( 1B ) receptors are revealed by blockade of hypothermia evoked by the gene agonist , chemical .	T44	T78	10611634
NA	CHEMICAL	GENE-Y	9	10	In guinea pigs , antagonist actions of chemical at chemical ( 1B ) receptors are revealed by blockade of hypothermia evoked by the gene agonist , chemical .	T45	T77	10611634
NA	CHEMICAL	GENE-Y	9	10	In guinea pigs , antagonist actions of chemical at chemical ( 1B ) receptors are revealed by blockade of hypothermia evoked by the gene agonist , chemical .	T45	T78	10611634
NA	CHEMICAL	GENE-Y	3	10	In guinea pigs , antagonist actions of chemical at chemical ( 1B ) receptors are revealed by blockade of hypothermia evoked by the gene agonist , chemical .	T47	T77	10611634
CPR:5	CHEMICAL	GENE-Y	3	10	In guinea pigs , antagonist actions of chemical at chemical ( 1B ) receptors are revealed by blockade of hypothermia evoked by the gene agonist , chemical .	T47	T78	10611634
CPR:5	CHEMICAL	GENE-Y	3	13	In distinction to chemical , chemical shows only modest partial agonist actions at gene sites versus marked antagonist actions at gene .	T49	T58	10611634
CPR:6	CHEMICAL	GENE-N	3	20	In distinction to chemical , chemical shows only modest partial agonist actions at gene sites versus marked antagonist actions at gene .	T49	T59	10611634
CPR:5	CHEMICAL	GENE-Y	5	13	In distinction to chemical , chemical shows only modest partial agonist actions at gene sites versus marked antagonist actions at gene .	T50	T58	10611634
CPR:6	CHEMICAL	GENE-N	5	20	In distinction to chemical , chemical shows only modest partial agonist actions at gene sites versus marked antagonist actions at gene .	T50	T59	10611634
CPR:6	CHEMICAL	GENE-N	8	4	In conclusion , the gene antagonist properties of chemical increase chemical and chemical levels both alone and in association with fluoxetine .	T28	T61	10611634
NA	CHEMICAL	GENE-N	10	4	In conclusion , the gene antagonist properties of chemical increase chemical and chemical levels both alone and in association with fluoxetine .	T29	T61	10611634
NA	CHEMICAL	GENE-N	12	4	In conclusion , the gene antagonist properties of chemical increase chemical and chemical levels both alone and in association with fluoxetine .	T30	T61	10611634
CPR:4	CHEMICAL	GENE-Y	0	2	chemical : a novel anti-Parkinsonian chemical oxidase-B inhibitor with neuroprotective activity .	T13	T19	20600573
NA	CHEMICAL	GENE-Y	2	2	chemical : a novel anti-Parkinsonian chemical oxidase-B inhibitor with neuroprotective activity .	T14	T19	20600573
CPR:4	CHEMICAL	GENE-Y	0	1	chemical ( chemical ) is a novel , highly potent irreversible chemical oxidase ( MAO ) -B inhibitor , anti-Parkinsonian drug .	T1	T18	20600573
CPR:4	CHEMICAL	GENE-Y	1	1	chemical ( chemical ) is a novel , highly potent irreversible chemical oxidase ( MAO ) -B inhibitor , anti-Parkinsonian drug .	T3	T18	20600573
NA	CHEMICAL	GENE-Y	5	1	chemical ( chemical ) is a novel , highly potent irreversible chemical oxidase ( MAO ) -B inhibitor , anti-Parkinsonian drug .	T11	T18	20600573
CPR:4	CHEMICAL	GENE-Y	3	11	Its S-isomer , chemical is thousand times less potent as an gene inhibitor .	T6	T15	20600573
CPR:4	CHEMICAL	GENE-Y	10	32	However , both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models , indicating that the neuroprotective effect of chemical does not depend on inhibition of gene , but rather is associated with the chemical moiety , which promotes mitochondrial viability and stabilizes permeability transition by regulating gene family proteins .	T7	T16	20600573
NA	CHEMICAL	GENE-Y	40	32	However , both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models , indicating that the neuroprotective effect of chemical does not depend on inhibition of gene , but rather is associated with the chemical moiety , which promotes mitochondrial viability and stabilizes permeability transition by regulating gene family proteins .	T8	T16	20600573
CPR:3	CHEMICAL	GENE-Y	40	53	However , both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models , indicating that the neuroprotective effect of chemical does not depend on inhibition of gene , but rather is associated with the chemical moiety , which promotes mitochondrial viability and stabilizes permeability transition by regulating gene family proteins .	T8	T17	20600573
NA	CHEMICAL	GENE-Y	8	10	Single nucleotide polymorphisms ( SNPs ) in the chemical-chemical-methyltransferase ( gene ) gene have been related to cognitive function .	T1	T4	22992330
NA	CHEMICAL	GENE-Y	8	10	Single nucleotide polymorphisms ( SNPs ) in the chemical-chemical-methyltransferase ( gene ) gene have been related to cognitive function .	T2	T4	22992330
NA	CHEMICAL	GENE-N	1	20	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T3	T17	22991293
NA	CHEMICAL	GENE-Y	1	23	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T3	T20	22991293
NA	CHEMICAL	GENE-N	1	31	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T3	T25	22991293
NA	CHEMICAL	GENE-N	20	20	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T1	T17	22991293
NA	CHEMICAL	GENE-Y	20	23	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T1	T20	22991293
NA	CHEMICAL	GENE-N	20	31	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T1	T25	22991293
NA	CHEMICAL	GENE-N	7	20	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T2	T17	22991293
NA	CHEMICAL	GENE-Y	7	23	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T2	T20	22991293
NA	CHEMICAL	GENE-N	7	31	X-linked hypochemicalmia ( XLH/HYP ) -with renal chemical wasting , hypophosphatemia , osteomalacia , and tooth abscesses-is caused by mutations in the chemical-metallopeptidase gene gene ( phosphate-regulating gene with homologies to gene on the X chromosome ) .	T2	T25	22991293
NA	CHEMICAL	GENE-N	2	29	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T4	T28	22991293
NA	CHEMICAL	GENE-N	2	31	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T4	T29	22991293
NA	CHEMICAL	GENE-N	2	2	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T4	T31	22991293
NA	CHEMICAL	GENE-N	13	29	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T5	T28	22991293
NA	CHEMICAL	GENE-N	13	31	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T5	T29	22991293
NA	CHEMICAL	GENE-N	13	47	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T5	T30	22991293
NA	CHEMICAL	GENE-N	13	2	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T5	T31	22991293
NA	CHEMICAL	GENE-N	3	29	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T6	T28	22991293
NA	CHEMICAL	GENE-N	3	31	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T6	T29	22991293
NA	CHEMICAL	GENE-N	3	2	Inactivating mutations in gene lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization-inhibiting , gene ( gene ) -containing peptides , which are proteolytically derived from the mineral-binding matrix proteins of the gene family ( gene ) .	T6	T31	22991293
CPR:4	CHEMICAL	GENE-Y	0	3	chemical directly inhibits gene secretion through chemical-activated protein kinase in rat primary gastric cells .	T13	T32	23066988
NA	CHEMICAL	GENE-Y	0	8	chemical directly inhibits gene secretion through chemical-activated protein kinase in rat primary gastric cells .	T13	T33	23066988
NA	CHEMICAL	GENE-Y	6	3	chemical directly inhibits gene secretion through chemical-activated protein kinase in rat primary gastric cells .	T14	T32	23066988
NA	CHEMICAL	GENE-Y	6	8	chemical directly inhibits gene secretion through chemical-activated protein kinase in rat primary gastric cells .	T14	T33	23066988
CPR:4	CHEMICAL	GENE-N	0	11	chemical treatment is also associated with lower circulating levels of the gene gene .	T12	T16	23066988
CPR:4	CHEMICAL	GENE-Y	0	12	chemical treatment is also associated with lower circulating levels of the gene gene .	T12	T17	23066988
NA	CHEMICAL	GENE-Y	3	6	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T2	T18	23066988
NA	CHEMICAL	GENE-Y	3	21	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T2	T19	23066988
NA	CHEMICAL	GENE-Y	3	24	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T2	T20	23066988
NA	CHEMICAL	GENE-Y	3	32	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T2	T21	23066988
NA	CHEMICAL	GENE-Y	3	34	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T2	T22	23066988
NA	CHEMICAL	GENE-Y	16	6	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T4	T18	23066988
NA	CHEMICAL	GENE-Y	16	21	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T4	T19	23066988
NA	CHEMICAL	GENE-Y	16	24	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T4	T20	23066988
NA	CHEMICAL	GENE-Y	16	32	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T4	T21	23066988
NA	CHEMICAL	GENE-Y	16	34	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T4	T22	23066988
NA	CHEMICAL	GENE-Y	30	6	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T5	T18	23066988
NA	CHEMICAL	GENE-Y	30	21	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T5	T19	23066988
NA	CHEMICAL	GENE-Y	30	24	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T5	T20	23066988
NA	CHEMICAL	GENE-Y	30	32	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T5	T21	23066988
NA	CHEMICAL	GENE-Y	30	34	To test whether chemical directly affects gene cells , rat primary stomach cells were treated with chemical and the levels of gene secretion , gene gene expression and activation of chemical-activated protein kinase ( gene ) were examined .	T5	T22	23066988
CPR:4	CHEMICAL	GENE-Y	0	3	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T6	T23	23066988
CPR:4	CHEMICAL	GENE-Y	0	6	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T6	T24	23066988
NA	CHEMICAL	GENE-Y	0	19	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T6	T25	23066988
NA	CHEMICAL	GENE-Y	0	26	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T6	T26	23066988
NA	CHEMICAL	GENE-Y	0	34	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T6	T27	23066988
CPR:3	CHEMICAL	GENE-Y	21	3	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T7	T23	23066988
CPR:3	CHEMICAL	GENE-Y	21	6	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T7	T24	23066988
CPR:4	CHEMICAL	GENE-Y	21	19	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T7	T25	23066988
NA	CHEMICAL	GENE-Y	21	26	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T7	T26	23066988
NA	CHEMICAL	GENE-Y	21	34	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T7	T27	23066988
NA	CHEMICAL	GENE-Y	28	3	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T8	T23	23066988
NA	CHEMICAL	GENE-Y	28	6	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T8	T24	23066988
NA	CHEMICAL	GENE-Y	28	19	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T8	T25	23066988
CPR:3	CHEMICAL	GENE-Y	28	26	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T8	T26	23066988
NA	CHEMICAL	GENE-Y	28	34	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T8	T27	23066988
NA	CHEMICAL	GENE-Y	30	3	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T9	T23	23066988
NA	CHEMICAL	GENE-Y	30	6	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T9	T24	23066988
NA	CHEMICAL	GENE-Y	30	19	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T9	T25	23066988
CPR:3	CHEMICAL	GENE-Y	30	26	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T9	T26	23066988
CPR:4	CHEMICAL	GENE-Y	30	34	chemical significantly reduced gene secretion and gene mRNA production and both these effects were blocked by co-incubation with the gene inhibitor chemical . Furthermore , the gene activator chemical ( chemical ) significantly inhibited gene secretion .	T9	T27	23066988
CPR:3	CHEMICAL	GENE-Y	2	12	Finally , chemical treatment caused a significant increase in the level of gene .	T10	T30	23066988
CPR:4	CHEMICAL	GENE-Y	4	8	Our results show that chemical directly inhibits stomach gene production and secretion through gene .	T11	T31	23066988
NA	CHEMICAL	GENE-Y	4	13	Our results show that chemical directly inhibits stomach gene production and secretion through gene .	T11	T15	23066988
NA	CHEMICAL	GENE-Y	5	11	It is physiologically generated by chemical-γ-lyase , chemical-β-synthase , and chemical sulfurtransferase .	T3	T16	23297346
NA	CHEMICAL	GENE-Y	7	11	It is physiologically generated by chemical-γ-lyase , chemical-β-synthase , and chemical sulfurtransferase .	T4	T16	23297346
NA	CHEMICAL	GENE-Y	10	11	It is physiologically generated by chemical-γ-lyase , chemical-β-synthase , and chemical sulfurtransferase .	T6	T16	23297346
CPR:3	CHEMICAL	GENE-Y	4	15	Substantial evidence shows that chemical is involved in aging by inhibiting free-radical reactions , activating gene , and probably interacting with the age-related gene gene .	T8	T17	23297346
NA	CHEMICAL	GENE-Y	4	24	Substantial evidence shows that chemical is involved in aging by inhibiting free-radical reactions , activating gene , and probably interacting with the age-related gene gene .	T8	T18	23297346
CPR:4	CHEMICAL	GENE-Y	5	8	Monoclonal antibody 25B1 generated against chemical inhibited fetal gene has been extensively characterized with respect to its gene properties .	T5	T14	1692236
NA	CHEMICAL	GENE-Y	5	17	Monoclonal antibody 25B1 generated against chemical inhibited fetal gene has been extensively characterized with respect to its gene properties .	T5	T10	1692236
CPR:4	CHEMICAL	GENE-Y	8	8	Monoclonal antibody 25B1 appears to be directed against a conformational epitope located in close proximity to the catalytic center of the enzyme and was found to be most suitable for studying the stabilization of the active site of gene against denaturation by heat or chemical following phosphorylation by organophosphorus gene compounds .	T6	T12	1692236
NA	CHEMICAL	GENE-Y	8	8	Monoclonal antibody 25B1 appears to be directed against a conformational epitope located in close proximity to the catalytic center of the enzyme and was found to be most suitable for studying the stabilization of the active site of gene against denaturation by heat or chemical following phosphorylation by organophosphorus gene compounds .	T6	T13	1692236
CPR:9	CHEMICAL	GENE-N	13	8	A unique cytosolic activity related but distinct from gene catalyses metabolic activation of chemical . chemical ( chemical ) is a prototype bioreductive drug employed to treat a variety of cancers including head and neck cancer .	T17	T34	10755406
NA	CHEMICAL	GENE-N	13	8	A unique cytosolic activity related but distinct from gene catalyses metabolic activation of chemical . chemical ( chemical ) is a prototype bioreductive drug employed to treat a variety of cancers including head and neck cancer .	T1	T34	10755406
NA	CHEMICAL	GENE-N	17	8	A unique cytosolic activity related but distinct from gene catalyses metabolic activation of chemical . chemical ( chemical ) is a prototype bioreductive drug employed to treat a variety of cancers including head and neck cancer .	T2	T34	10755406
CPR:4	CHEMICAL	GENE-N	5	11	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T5	T28	10755406
CPR:4	CHEMICAL	GENE-N	5	13	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T5	T29	10755406
NA	CHEMICAL	GENE-N	8	11	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T8	T28	10755406
NA	CHEMICAL	GENE-N	8	13	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T8	T29	10755406
NA	CHEMICAL	GENE-N	10	11	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T9	T28	10755406
NA	CHEMICAL	GENE-N	10	13	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T9	T29	10755406
CPR:9	CHEMICAL	GENE-N	22	11	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T10	T28	10755406
CPR:9	CHEMICAL	GENE-N	22	13	Among the various enzymes , chemical inhibitable cytosolic chemical : chemical oxidoreductase1 ( gene ) was shown to catalyse bioreductive activation of chemical leading to cross-linking of the DNA and cytotoxicity .	T10	T29	10755406
CPR:9	CHEMICAL	GENE-N	10	5	However , the role of gene in metabolic activation of chemical has been disputed .	T11	T30	10755406
CPR:9	CHEMICAL	GENE-N	24	13	In this report , we present cellular and animal models to demonstrate that gene may play only a minor role in metabolic activation of chemical .	T12	T31	10755406
NA	CHEMICAL	GENE-N	7	21	We further demonstrate that bioreductive activation of chemical is catalysed by a unique cytosolic activity which is related but distinct from gene .	T13	T32	10755406
NA	CHEMICAL	GENE-N	20	9	The cytosolic fractions from liver and colon tissues of gene-/- mice showed similar amounts of DNA cross-linking upon exposure to chemical , as observed in gene+/+ mice .	T3	T22	10755406
NA	CHEMICAL	GENE-N	20	25	The cytosolic fractions from liver and colon tissues of gene-/- mice showed similar amounts of DNA cross-linking upon exposure to chemical , as observed in gene+/+ mice .	T3	T23	10755406
NA	CHEMICAL	GENE-N	6	16	The unique cytosolic activity that activated chemical in cytosolic fractions of liver and colon tissues of gene-/- mice was designated as cytosolic chemical reductase .	T4	T24	10755406
NA	CHEMICAL	GENE-N	6	20	The unique cytosolic activity that activated chemical in cytosolic fractions of liver and colon tissues of gene-/- mice was designated as cytosolic chemical reductase .	T4	T25	10755406
NA	CHEMICAL	GENE-N	22	16	The unique cytosolic activity that activated chemical in cytosolic fractions of liver and colon tissues of gene-/- mice was designated as cytosolic chemical reductase .	T6	T24	10755406
NA	CHEMICAL	GENE-N	22	20	The unique cytosolic activity that activated chemical in cytosolic fractions of liver and colon tissues of gene-/- mice was designated as cytosolic chemical reductase .	T6	T25	10755406
CPR:5	CHEMICAL	GENE-Y	12	8	In this study , the activity of the gene subtype-selective agonist , chemical , was investigated in a guinea pig model of chemical-induced cough .	T18	T26	10640321
NA	CHEMICAL	GENE-Y	17	8	In this study , the activity of the gene subtype-selective agonist , chemical , was investigated in a guinea pig model of chemical-induced cough .	T5	T26	10640321
CPR:5	CHEMICAL	GENE-Y	9	7	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T7	T23	10640321
NA	CHEMICAL	GENE-Y	9	12	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T7	T24	10640321
NA	CHEMICAL	GENE-Y	9	20	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T7	T25	10640321
NA	CHEMICAL	GENE-Y	14	7	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T8	T23	10640321
CPR:5	CHEMICAL	GENE-Y	14	12	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T8	T24	10640321
NA	CHEMICAL	GENE-Y	14	20	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T8	T25	10640321
NA	CHEMICAL	GENE-Y	16	7	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T9	T23	10640321
CPR:5	CHEMICAL	GENE-Y	16	12	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T9	T24	10640321
NA	CHEMICAL	GENE-Y	16	20	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T9	T25	10640321
NA	CHEMICAL	GENE-Y	22	7	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T10	T23	10640321
NA	CHEMICAL	GENE-Y	22	12	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T10	T24	10640321
CPR:5	CHEMICAL	GENE-Y	22	20	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T10	T25	10640321
NA	CHEMICAL	GENE-Y	28	7	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T11	T23	10640321
NA	CHEMICAL	GENE-Y	28	12	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T11	T24	10640321
NA	CHEMICAL	GENE-Y	28	20	Parenteral administration of selective agonists of the gene ( chemical ) , gene ( chemical and chemical ) , and gene ( chemical ) produced dose-related inhibition of chemical-induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	T11	T25	10640321
CPR:6	CHEMICAL	GENE-N	5	2	The nonselective gene antagonist , chemical ( 3 mg/kg , i.m .	T12	T27	10640321
CPR:5	CHEMICAL	GENE-N	7	8	) , attenuated the antitussive effects of chemical or chemical , indicating that the antitussive activity of both compounds is gene-mediated .	T13	T28	10640321
CPR:5	CHEMICAL	GENE-N	9	8	) , attenuated the antitussive effects of chemical or chemical , indicating that the antitussive activity of both compounds is gene-mediated .	T14	T28	10640321
CPR:6	CHEMICAL	GENE-Y	4	1	The gene antagonist , chemical ( 10 mg/kg , i.p .	T15	T29	10640321
CPR:6	CHEMICAL	GENE-Y	6	8	In contrast , combined pretreatment with chemical ( gene antagonist ; 20 mg/kg , s.c . )	T17	T30	10640321
CPR:6	CHEMICAL	GENE-Y	1	3	and chemical ( gene antagonist ; 20 mg/kg , s.c .	T19	T31	10640321
NA	CHEMICAL	GENE-N	23	10	) , at doses that inhibited the antitussive activity of gene agonists , respectively , was without effect on the antitussive response of chemical ( 20 mg/kg , i.p . ) .	T1	T20	10640321
CPR:6	CHEMICAL	GENE-N	1	1	The gene antagonist chemical ( 3 mg/kg , i.p . )	T2	T21	10640321
CPR:4	CHEMICAL	GENE-Y	0	7	chemical treatment decreases chemical binding and chemical transporter mRNA in SK-N-SHSY5Y cells .	T7	T19	10424850
NA	CHEMICAL	GENE-Y	3	7	chemical treatment decreases chemical binding and chemical transporter mRNA in SK-N-SHSY5Y cells .	T8	T19	10424850
NA	CHEMICAL	GENE-Y	6	7	chemical treatment decreases chemical binding and chemical transporter mRNA in SK-N-SHSY5Y cells .	T9	T19	10424850
CPR:4	CHEMICAL	GENE-Y	2	15	The antidepressant chemical has been shown to decrease synaptic membrane concentrations of the chemical re-uptake transporter ( gene ) in vivo and in vitro , on both an acute and a chronic basis .	T1	T18	10424850
CPR:4	CHEMICAL	GENE-Y	2	17	The antidepressant chemical has been shown to decrease synaptic membrane concentrations of the chemical re-uptake transporter ( gene ) in vivo and in vitro , on both an acute and a chronic basis .	T1	T10	10424850
NA	CHEMICAL	GENE-Y	13	15	The antidepressant chemical has been shown to decrease synaptic membrane concentrations of the chemical re-uptake transporter ( gene ) in vivo and in vitro , on both an acute and a chronic basis .	T6	T18	10424850
NA	CHEMICAL	GENE-Y	13	17	The antidepressant chemical has been shown to decrease synaptic membrane concentrations of the chemical re-uptake transporter ( gene ) in vivo and in vitro , on both an acute and a chronic basis .	T6	T10	10424850
NA	CHEMICAL	GENE-Y	11	27	In this study , we treated SK-N-SHSY5Y cells with 100 nM chemical for 24 or 72 h , and measured chemical binding ( as an estimate of gene ) and gene mRNA by quantitative reverse transcription polymerase chain reaction .	T2	T13	10424850
NA	CHEMICAL	GENE-Y	11	30	In this study , we treated SK-N-SHSY5Y cells with 100 nM chemical for 24 or 72 h , and measured chemical binding ( as an estimate of gene ) and gene mRNA by quantitative reverse transcription polymerase chain reaction .	T2	T14	10424850
NA	CHEMICAL	GENE-Y	20	27	In this study , we treated SK-N-SHSY5Y cells with 100 nM chemical for 24 or 72 h , and measured chemical binding ( as an estimate of gene ) and gene mRNA by quantitative reverse transcription polymerase chain reaction .	T3	T13	10424850
NA	CHEMICAL	GENE-Y	20	30	In this study , we treated SK-N-SHSY5Y cells with 100 nM chemical for 24 or 72 h , and measured chemical binding ( as an estimate of gene ) and gene mRNA by quantitative reverse transcription polymerase chain reaction .	T3	T14	10424850
NA	CHEMICAL	GENE-N	13	2	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T4	T16	23266732
NA	CHEMICAL	GENE-N	13	14	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T4	T17	23266732
NA	CHEMICAL	GENE-Y	13	48	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T4	T7	23266732
NA	CHEMICAL	GENE-Y	13	50	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T4	T8	23266732
NA	CHEMICAL	GENE-Y	13	1	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T4	T9	23266732
NA	CHEMICAL	GENE-N	13	2	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T5	T16	23266732
NA	CHEMICAL	GENE-N	13	14	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T5	T17	23266732
NA	CHEMICAL	GENE-Y	13	48	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T5	T7	23266732
NA	CHEMICAL	GENE-Y	13	50	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T5	T8	23266732
NA	CHEMICAL	GENE-Y	13	1	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T5	T9	23266732
NA	CHEMICAL	GENE-N	24	2	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T6	T16	23266732
NA	CHEMICAL	GENE-N	24	14	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T6	T17	23266732
NA	CHEMICAL	GENE-Y	24	48	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T6	T7	23266732
NA	CHEMICAL	GENE-Y	24	50	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T6	T8	23266732
NA	CHEMICAL	GENE-Y	24	1	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T6	T9	23266732
NA	CHEMICAL	GENE-N	12	2	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T1	T16	23266732
NA	CHEMICAL	GENE-N	12	14	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T1	T17	23266732
NA	CHEMICAL	GENE-Y	12	48	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T1	T7	23266732
NA	CHEMICAL	GENE-Y	12	50	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T1	T8	23266732
NA	CHEMICAL	GENE-Y	12	1	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T1	T9	23266732
NA	CHEMICAL	GENE-N	13	2	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T2	T16	23266732
NA	CHEMICAL	GENE-N	13	14	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T2	T17	23266732
NA	CHEMICAL	GENE-Y	13	48	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T2	T7	23266732
NA	CHEMICAL	GENE-Y	13	50	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T2	T8	23266732
NA	CHEMICAL	GENE-Y	13	1	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T2	T9	23266732
NA	CHEMICAL	GENE-N	1	2	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T3	T16	23266732
NA	CHEMICAL	GENE-N	1	14	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T3	T17	23266732
NA	CHEMICAL	GENE-Y	1	1	Compared to the HC group , aqueous Mate tea extract significantly reduced gene ( gene ) and chemical ( chemical ) levels and increased chemical ( chemical ) and chemical ( chemical ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased gene ( gene ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic gene ( gene ) and gene ( gene ) .	T3	T9	23266732
NA	CHEMICAL	GENE-N	0	1	chemical-binding proteins and role of chemical in causing bacterial cell death .	T34	T54	6311012
NA	CHEMICAL	GENE-N	5	1	chemical-binding proteins and role of chemical in causing bacterial cell death .	T35	T54	6311012
NA	CHEMICAL	GENE-N	5	1	These proteins have been designated chemical-binding proteins .	T14	T40	6311012
NA	CHEMICAL	GENE-N	11	34	They can be separated into distinct entities through the use of chemical gel electrophoresis and binding of radioactive chemical . Six major proteins have been defined in the Enterobacteriaceae , chemical-binding proteins 1 to 6 .	T22	T42	6311012
NA	CHEMICAL	GENE-N	18	34	They can be separated into distinct entities through the use of chemical gel electrophoresis and binding of radioactive chemical . Six major proteins have been defined in the Enterobacteriaceae , chemical-binding proteins 1 to 6 .	T23	T42	6311012
NA	CHEMICAL	GENE-N	26	34	They can be separated into distinct entities through the use of chemical gel electrophoresis and binding of radioactive chemical . Six major proteins have been defined in the Enterobacteriaceae , chemical-binding proteins 1 to 6 .	T24	T42	6311012
NA	CHEMICAL	GENE-N	12	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T25	T43	6311012
NA	CHEMICAL	GENE-N	12	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T25	T44	6311012
NA	CHEMICAL	GENE-N	12	22	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T25	T45	6311012
NA	CHEMICAL	GENE-N	12	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T25	T46	6311012
NA	CHEMICAL	GENE-N	12	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T25	T47	6311012
NA	CHEMICAL	GENE-N	26	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T26	T43	6311012
NA	CHEMICAL	GENE-N	26	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T26	T44	6311012
NA	CHEMICAL	GENE-N	26	22	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T26	T45	6311012
NA	CHEMICAL	GENE-N	26	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T26	T46	6311012
NA	CHEMICAL	GENE-N	26	14	Selection of mutants has shown that there are three essential proteins : chemical-binding protein 1 , which is divided into geneBs , a gene , and chemical-binding protein 1A , which acts as a replacement for gene .	T26	T47	6311012
NA	CHEMICAL	GENE-N	0	2	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T29	T48	6311012
NA	CHEMICAL	GENE-N	0	5	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T29	T49	6311012
NA	CHEMICAL	GENE-N	0	11	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T29	T50	6311012
NA	CHEMICAL	GENE-N	0	15	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T29	T51	6311012
NA	CHEMICAL	GENE-N	9	2	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T30	T48	6311012
NA	CHEMICAL	GENE-N	9	5	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T30	T49	6311012
NA	CHEMICAL	GENE-N	9	11	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T30	T50	6311012
NA	CHEMICAL	GENE-N	9	15	chemical-binding protein 2 is a gene-elongation initiating enzyme and chemical-binding protein 3 is a septal gene-synthesizing enzyme .	T30	T51	6311012
NA	CHEMICAL	GENE-N	0	7	chemical-binding proteins 4 , 5 , and 6 are not essential for bacterial survival .	T31	T52	6311012
NA	CHEMICAL	GENE-N	2	6	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T32	T53	6311012
NA	CHEMICAL	GENE-N	2	14	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T32	T36	6311012
NA	CHEMICAL	GENE-N	2	24	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T32	T37	6311012
NA	CHEMICAL	GENE-N	4	6	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T33	T53	6311012
NA	CHEMICAL	GENE-N	4	14	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T33	T36	6311012
NA	CHEMICAL	GENE-N	4	24	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T33	T37	6311012
NA	CHEMICAL	GENE-N	12	6	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T1	T53	6311012
NA	CHEMICAL	GENE-N	12	14	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T1	T36	6311012
NA	CHEMICAL	GENE-N	12	24	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T1	T37	6311012
NA	CHEMICAL	GENE-N	22	6	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T2	T53	6311012
NA	CHEMICAL	GENE-N	22	14	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T2	T36	6311012
NA	CHEMICAL	GENE-N	22	24	Binding of chemical to chemical-binding protein 1Bs produces lysis , binding to chemical-binding protein 2 produces round cells , and binding to chemical-binding protein 3 produces long filaments .	T2	T37	6311012
NA	CHEMICAL	GENE-N	0	11	chemical is a chemical derivative that binds specifically to chemical-binding protein 2 .	T3	T38	6311012
NA	CHEMICAL	GENE-N	2	11	chemical is a chemical derivative that binds specifically to chemical-binding protein 2 .	T4	T38	6311012
NA	CHEMICAL	GENE-N	9	11	chemical is a chemical derivative that binds specifically to chemical-binding protein 2 .	T5	T38	6311012
NA	CHEMICAL	GENE-N	7	4	The compound is more gene stable than chemical and has no major delay in entry into the periplasmic space as do some chemical .	T6	T39	6311012
NA	CHEMICAL	GENE-N	13	4	The compound is more gene stable than chemical and has no major delay in entry into the periplasmic space as do some chemical .	T7	T39	6311012
CPR:3	CHEMICAL	GENE-N	6	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T12	T41	6311012
CPR:3	CHEMICAL	GENE-N	10	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T13	T41	6311012
CPR:3	CHEMICAL	GENE-N	12	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T15	T41	6311012
CPR:3	CHEMICAL	GENE-N	20	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T16	T41	6311012
CPR:3	CHEMICAL	GENE-N	22	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T17	T41	6311012
CPR:3	CHEMICAL	GENE-N	14	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T18	T41	6311012
CPR:3	CHEMICAL	GENE-N	27	48	This agent acts synergistically with many chemical , such as chemical , chemical , and the like , and with chemical , chemical , chemical , or chemical to inhibit gram-negative bacilli , probably on the basis of binding to different proteins needed for the production of the gene of the bacterial cell wall .	T19	T41	6311012
NA	CHEMICAL	GENE-N	11	11	To test this hypothesis , constructs were evaluated consisting of an gene : gene ( gene ) attached to an gene .	T1	T13	23406497
NA	CHEMICAL	GENE-Y	11	13	To test this hypothesis , constructs were evaluated consisting of an gene : gene ( gene ) attached to an gene .	T1	T14	23406497
NA	CHEMICAL	GENE-Y	11	15	To test this hypothesis , constructs were evaluated consisting of an gene : gene ( gene ) attached to an gene .	T1	T3	23406497
NA	CHEMICAL	GENE-N	11	20	To test this hypothesis , constructs were evaluated consisting of an gene : gene ( gene ) attached to an gene .	T1	T4	23406497
NA	CHEMICAL	GENE-N	3	9	The effect of chemical deficiency on chemical : chemical aminotransferase isoenzymes in rat liver .	T17	T35	6703688
NA	CHEMICAL	GENE-N	6	9	The effect of chemical deficiency on chemical : chemical aminotransferase isoenzymes in rat liver .	T18	T35	6703688
NA	CHEMICAL	GENE-N	8	9	The effect of chemical deficiency on chemical : chemical aminotransferase isoenzymes in rat liver .	T19	T35	6703688
NA	CHEMICAL	GENE-N	0	3	chemical : chemical aminotransferase ( gene ) in the liver catalyzes most of the chemical transamination in mammalian tissues ( E. V. Rowsell , K. Snell , J . A. Carnie , and K. V. Rowsell ( 1972 ) Biochem .	T8	T25	6703688
NA	CHEMICAL	GENE-N	0	5	chemical : chemical aminotransferase ( gene ) in the liver catalyzes most of the chemical transamination in mammalian tissues ( E. V. Rowsell , K. Snell , J . A. Carnie , and K. V. Rowsell ( 1972 ) Biochem .	T8	T26	6703688
NA	CHEMICAL	GENE-N	2	3	chemical : chemical aminotransferase ( gene ) in the liver catalyzes most of the chemical transamination in mammalian tissues ( E. V. Rowsell , K. Snell , J . A. Carnie , and K. V. Rowsell ( 1972 ) Biochem .	T9	T25	6703688
NA	CHEMICAL	GENE-N	2	5	chemical : chemical aminotransferase ( gene ) in the liver catalyzes most of the chemical transamination in mammalian tissues ( E. V. Rowsell , K. Snell , J . A. Carnie , and K. V. Rowsell ( 1972 ) Biochem .	T9	T26	6703688
CPR:9	CHEMICAL	GENE-N	14	3	chemical : chemical aminotransferase ( gene ) in the liver catalyzes most of the chemical transamination in mammalian tissues ( E. V. Rowsell , K. Snell , J . A. Carnie , and K. V. Rowsell ( 1972 ) Biochem .	T11	T25	6703688
CPR:9	CHEMICAL	GENE-N	14	5	chemical : chemical aminotransferase ( gene ) in the liver catalyzes most of the chemical transamination in mammalian tissues ( E. V. Rowsell , K. Snell , J . A. Carnie , and K. V. Rowsell ( 1972 ) Biochem .	T11	T26	6703688
NA	CHEMICAL	GENE-N	3	7	The effects of chemical deficiency on hepatic gene isoenzymes , designated gene and gene , respectively , were examined with male rats ; gene is located both in the peroxisomes and in the mitochondria , and gene only in the mitochondria .	T12	T27	6703688
NA	CHEMICAL	GENE-Y	3	11	The effects of chemical deficiency on hepatic gene isoenzymes , designated gene and gene , respectively , were examined with male rats ; gene is located both in the peroxisomes and in the mitochondria , and gene only in the mitochondria .	T12	T28	6703688
NA	CHEMICAL	GENE-Y	3	13	The effects of chemical deficiency on hepatic gene isoenzymes , designated gene and gene , respectively , were examined with male rats ; gene is located both in the peroxisomes and in the mitochondria , and gene only in the mitochondria .	T12	T29	6703688
NA	CHEMICAL	GENE-Y	3	23	The effects of chemical deficiency on hepatic gene isoenzymes , designated gene and gene , respectively , were examined with male rats ; gene is located both in the peroxisomes and in the mitochondria , and gene only in the mitochondria .	T12	T30	6703688
NA	CHEMICAL	GENE-Y	3	36	The effects of chemical deficiency on hepatic gene isoenzymes , designated gene and gene , respectively , were examined with male rats ; gene is located both in the peroxisomes and in the mitochondria , and gene only in the mitochondria .	T12	T31	6703688
CPR:9	CHEMICAL	GENE-Y	10	8	The holo activity of combined peroxisomal and mitochondrial gene with a low Km for chemical rapidly decreased after a lag time of about 2 days during feeding of the chemical-deficient diet ( by 50 % in 5 days , by 86 % in 14 days ) .	T14	T32	6703688
NA	CHEMICAL	GENE-Y	29	8	The holo activity of combined peroxisomal and mitochondrial gene with a low Km for chemical rapidly decreased after a lag time of about 2 days during feeding of the chemical-deficient diet ( by 50 % in 5 days , by 86 % in 14 days ) .	T15	T32	6703688
CPR:9	CHEMICAL	GENE-Y	6	4	The holo activity of gene with a high Km for chemical decreased more slowly than gene ( by 33 % in 14 days , by 60 % in 28 days ) .	T16	T34	6703688
CPR:9	CHEMICAL	GENE-Y	6	15	The holo activity of gene with a high Km for chemical decreased more slowly than gene ( by 33 % in 14 days , by 60 % in 28 days ) .	T16	T20	6703688
NA	CHEMICAL	GENE-Y	3	12	Urinary excretion of chemical began to increase in 8-9 days , when gene remained intact but most of gene is depleted .	T1	T21	6703688
NA	CHEMICAL	GENE-Y	3	18	Urinary excretion of chemical began to increase in 8-9 days , when gene remained intact but most of gene is depleted .	T1	T22	6703688
NA	CHEMICAL	GENE-Y	5	26	When the defect in the chemical transamination in vivo in chemical deficiency is considered , these findings suggest that it is due to the deficiency of gene .	T2	T23	6703688
NA	CHEMICAL	GENE-Y	10	26	When the defect in the chemical transamination in vivo in chemical deficiency is considered , these findings suggest that it is due to the deficiency of gene .	T3	T23	6703688
CPR:9	CHEMICAL	GENE-N	2	15	In the in vitro model we observed high permeability of chemical and chemical with the gene-mediated efflux ratios of 0.53 and 0.06 , as well as medium permeability of chemical with 0.82 .	T6	T21	23353658
CPR:9	CHEMICAL	GENE-N	2	15	In the in vitro model we observed high permeability of chemical and chemical with the gene-mediated efflux ratios of 0.53 and 0.06 , as well as medium permeability of chemical with 0.82 .	T7	T21	23353658
CPR:9	CHEMICAL	GENE-N	2	15	In the in vitro model we observed high permeability of chemical and chemical with the gene-mediated efflux ratios of 0.53 and 0.06 , as well as medium permeability of chemical with 0.82 .	T8	T21	23353658
CPR:4	CHEMICAL	GENE-Y	0	2	chemical reduces gene expression and secretion in cultured human adipocytes .	T7	T21	10768100
NA	CHEMICAL	GENE-N	9	15	In this study , we investigated the effect of chemical , a ligand of the gene gene , on gene expression and secretion in human adipocytes .	T5	T13	10768100
NA	CHEMICAL	GENE-Y	9	11	In this study , we investigated the effect of chemical , a ligand of the gene gene , on gene expression and secretion in human adipocytes .	T5	T14	10768100
NA	CHEMICAL	GENE-Y	9	19	In this study , we investigated the effect of chemical , a ligand of the gene gene , on gene expression and secretion in human adipocytes .	T5	T15	10768100
CPR:4	CHEMICAL	GENE-Y	16	14	RESULTS : Exposure of in vitro differentiated subcutaneous adipocytes from young normal-weight females to 1 microgram/ml chemical for 72 h caused a reduction of both gene secretion ( by 29 +/- 5 % ; p < 0.01 ) and gene mRNA expression ( by 26 +/- 3 % ; p < 0.05 ) .	T6	T19	10768100
CPR:4	CHEMICAL	GENE-Y	16	14	RESULTS : Exposure of in vitro differentiated subcutaneous adipocytes from young normal-weight females to 1 microgram/ml chemical for 72 h caused a reduction of both gene secretion ( by 29 +/- 5 % ; p < 0.01 ) and gene mRNA expression ( by 26 +/- 3 % ; p < 0.05 ) .	T6	T20	10768100
CPR:4	CHEMICAL	GENE-Y	7	12	In cultures from severely obese subjects , chemical induced a decrease of gene antigen secretion from newly differentiated omental adipocytes by 49 +/- 8 % ( p < 0.01 ) and from subcutaneous adipocytes by 30 +/- 7 % ( p < 0.05 ) .	T1	T8	10768100
CPR:4	CHEMICAL	GENE-Y	12	18	Exposure of freshly isolated subcutaneous and omental adipocytes in suspension culture to chemical induced a similar reduction of gene concentration in the culture medium ( by 35 +/- 11 % , p < 0.05 , and 33 +/- 8 % , p < 0.05 compared with control , respectively ) .	T2	T10	10768100
CPR:4	CHEMICAL	GENE-Y	7	9	CONCLUSION/INTERPRETATION : This study provides evidence that chemical reduces gene production in human adipocytes , probably at the transcriptional level .	T3	T11	10768100
NA	CHEMICAL	GENE-N	3	10	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T21	T49	14733708
NA	CHEMICAL	GENE-Y	3	2	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T21	T47	14733708
NA	CHEMICAL	GENE-N	3	10	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T21	T48	14733708
NA	CHEMICAL	GENE-N	5	10	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T22	T49	14733708
NA	CHEMICAL	GENE-Y	5	2	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T22	T47	14733708
NA	CHEMICAL	GENE-N	5	10	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T22	T48	14733708
NA	CHEMICAL	GENE-N	9	10	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T23	T49	14733708
NA	CHEMICAL	GENE-Y	9	2	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T23	T47	14733708
NA	CHEMICAL	GENE-N	9	10	Ocular hypotensive gene chemical ( chemical ) analogs : chemical receptor subtype binding affinities and selectivities , and agonist potencies at FP and other genes in cultured cells .	T23	T48	14733708
NA	CHEMICAL	GENE-Y	0	7	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T8	T35	14733708
NA	CHEMICAL	GENE-Y	0	24	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T8	T36	14733708
NA	CHEMICAL	GENE-N	0	30	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T8	T37	14733708
NA	CHEMICAL	GENE-Y	0	38	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T8	T38	14733708
NA	CHEMICAL	GENE-Y	2	7	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T9	T35	14733708
NA	CHEMICAL	GENE-Y	2	24	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T9	T36	14733708
NA	CHEMICAL	GENE-N	2	30	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T9	T37	14733708
NA	CHEMICAL	GENE-Y	2	38	chemical ( chemical ) was the most gene-selective compound , exhibiting a high affinity ( Ki = 35 +/- 5 nM ) for the gene , and minimal affinity for gene ( Ki = 52,000 nM ) , gene ( Ki = 9540 nM ) , gene ( Ki = 3501 nM ) , gene ( Ki = 41,000 nM ) , gene ( Ki > 90,000 nM ) , and gene ( Ki = 121,000 nM ) receptors .	T9	T38	14733708
NA	CHEMICAL	GENE-Y	0	9	chemical was the most potent chemical analog tested in gene functional chemical turnover assays in the following cell types : human ciliary muscle ( EC50 = 1.4 nM ) , human trabecular meshwork ( EC50 = 3.6 nM ) , and mouse fibroblasts and rat aortic smooth muscle cells ( EC50 = 2.6 nM ) .	T14	T43	14733708
NA	CHEMICAL	GENE-Y	5	9	chemical was the most potent chemical analog tested in gene functional chemical turnover assays in the following cell types : human ciliary muscle ( EC50 = 1.4 nM ) , human trabecular meshwork ( EC50 = 3.6 nM ) , and mouse fibroblasts and rat aortic smooth muscle cells ( EC50 = 2.6 nM ) .	T15	T43	14733708
NA	CHEMICAL	GENE-Y	8	9	chemical was the most potent chemical analog tested in gene functional chemical turnover assays in the following cell types : human ciliary muscle ( EC50 = 1.4 nM ) , human trabecular meshwork ( EC50 = 3.6 nM ) , and mouse fibroblasts and rat aortic smooth muscle cells ( EC50 = 2.6 nM ) .	T16	T43	14733708
NA	CHEMICAL	GENE-Y	1	9	Although chemical exhibited a relatively high affinity for the gene ( Ki = 98 nM ) , it had significant functional activity at gene ( EC50 = 32-124 nM ) and gene ( EC50 = 119 nM ) receptors .	T19	T44	14733708
NA	CHEMICAL	GENE-Y	1	23	Although chemical exhibited a relatively high affinity for the gene ( Ki = 98 nM ) , it had significant functional activity at gene ( EC50 = 32-124 nM ) and gene ( EC50 = 119 nM ) receptors .	T19	T45	14733708
NA	CHEMICAL	GENE-Y	1	31	Although chemical exhibited a relatively high affinity for the gene ( Ki = 98 nM ) , it had significant functional activity at gene ( EC50 = 32-124 nM ) and gene ( EC50 = 119 nM ) receptors .	T19	T46	14733708
NA	CHEMICAL	GENE-Y	0	12	chemical was less selective , exhibiting a relatively high affinity for the gene ( Ki = 83 nM ) , gene ( Ki = 95 nM ) , and gene ( Ki = 387 nM ) receptors .	T1	T24	14733708
NA	CHEMICAL	GENE-Y	0	20	chemical was less selective , exhibiting a relatively high affinity for the gene ( Ki = 83 nM ) , gene ( Ki = 95 nM ) , and gene ( Ki = 387 nM ) receptors .	T1	T25	14733708
NA	CHEMICAL	GENE-Y	0	29	chemical was less selective , exhibiting a relatively high affinity for the gene ( Ki = 83 nM ) , gene ( Ki = 95 nM ) , and gene ( Ki = 387 nM ) receptors .	T1	T26	14733708
NA	CHEMICAL	GENE-N	0	6	chemical exhibited functional activity at the gene ( EC50 = 2.7 nM ) and gene ( EC50 = 2.8-3.8 nM in most cells ) receptors .	T2	T27	14733708
NA	CHEMICAL	GENE-Y	0	14	chemical exhibited functional activity at the gene ( EC50 = 2.7 nM ) and gene ( EC50 = 2.8-3.8 nM in most cells ) receptors .	T2	T28	14733708
NA	CHEMICAL	GENE-Y	0	9	chemical ( nonhydrolyzed amide ) also behaved as an gene agonist at the cloned gene ( EC50 = 681 nM ) , in h-TM ( EC50 = 3245 nM ) and other cell types .	T3	T29	14733708
NA	CHEMICAL	GENE-Y	0	14	chemical ( nonhydrolyzed amide ) also behaved as an gene agonist at the cloned gene ( EC50 = 681 nM ) , in h-TM ( EC50 = 3245 nM ) and other cell types .	T3	T30	14733708
NA	CHEMICAL	GENE-Y	0	12	chemical and chemical bound with low affinity ( Ki = 5.9 microM to > 22 microM ) to the gene , were not selective , but activated the gene .	T4	T31	14733708
NA	CHEMICAL	GENE-Y	0	12	chemical and chemical bound with low affinity ( Ki = 5.9 microM to > 22 microM ) to the gene , were not selective , but activated the gene .	T4	T32	14733708
NA	CHEMICAL	GENE-Y	2	12	chemical and chemical bound with low affinity ( Ki = 5.9 microM to > 22 microM ) to the gene , were not selective , but activated the gene .	T5	T31	14733708
NA	CHEMICAL	GENE-Y	2	12	chemical and chemical bound with low affinity ( Ki = 5.9 microM to > 22 microM ) to the gene , were not selective , but activated the gene .	T5	T32	14733708
NA	CHEMICAL	GENE-Y	2	18	Central effects of chemical and chemical : measurement of psychomotor performance , subjective sleepiness , and brain chemical H1-receptor occupancy using chemical positron emission tomography .	T23	T28	15286093
NA	CHEMICAL	GENE-Y	5	18	Central effects of chemical and chemical : measurement of psychomotor performance , subjective sleepiness , and brain chemical H1-receptor occupancy using chemical positron emission tomography .	T24	T28	15286093
NA	CHEMICAL	GENE-Y	17	18	Central effects of chemical and chemical : measurement of psychomotor performance , subjective sleepiness , and brain chemical H1-receptor occupancy using chemical positron emission tomography .	T21	T28	15286093
NA	CHEMICAL	GENE-Y	21	18	Central effects of chemical and chemical : measurement of psychomotor performance , subjective sleepiness , and brain chemical H1-receptor occupancy using chemical positron emission tomography .	T22	T28	15286093
NA	CHEMICAL	GENE-Y	0	1	chemical H1-receptor ( gene ) antagonists , or chemical , often induce sedative side effects when used for the treatment of allergic disorders .	T1	T25	15286093
NA	CHEMICAL	GENE-Y	0	3	chemical H1-receptor ( gene ) antagonists , or chemical , often induce sedative side effects when used for the treatment of allergic disorders .	T1	T26	15286093
CPR:6	CHEMICAL	GENE-Y	8	1	chemical H1-receptor ( gene ) antagonists , or chemical , often induce sedative side effects when used for the treatment of allergic disorders .	T15	T25	15286093
CPR:6	CHEMICAL	GENE-Y	8	3	chemical H1-receptor ( gene ) antagonists , or chemical , often induce sedative side effects when used for the treatment of allergic disorders .	T15	T26	15286093
NA	CHEMICAL	GENE-Y	53	54	This study compared the sedative profiles of the second-generation chemical , chemical and chemical , using 3 different criteria : subjective sleepiness evaluated by the Stanford Sleepiness Scale , objective psychomotor tests ( simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations ) , and measurement of chemical H1-receptor occupancy ( H1RO ) in the brain .	T16	T27	15286093
NA	CHEMICAL	GENE-N	0	1	chemical kinase blockers : new hope for successful cancer therapy .	T40	T56	19149483
NA	CHEMICAL	GENE-N	0	1	chemical kinases ( gene ) are attractive targets for cancer therapy , as quite often their abnormal signaling has been linked with tumor development and growth .	T1	T41	19149483
NA	CHEMICAL	GENE-N	0	3	chemical kinases ( gene ) are attractive targets for cancer therapy , as quite often their abnormal signaling has been linked with tumor development and growth .	T1	T50	19149483
NA	CHEMICAL	GENE-N	12	13	During the last few years , thorough analysis of the mechanism underlying chemical kinase 's activity led to novel cancer therapy using gene blockers .	T34	T51	19149483
NA	CHEMICAL	GENE-N	12	22	During the last few years , thorough analysis of the mechanism underlying chemical kinase 's activity led to novel cancer therapy using gene blockers .	T34	T52	19149483
CPR:4	CHEMICAL	GENE-N	8	5	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T35	T53	19149483
CPR:4	CHEMICAL	GENE-Y	8	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T35	T54	19149483
CPR:4	CHEMICAL	GENE-Y	8	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T35	T55	19149483
CPR:4	CHEMICAL	GENE-N	10	5	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T36	T53	19149483
CPR:4	CHEMICAL	GENE-Y	10	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T36	T54	19149483
CPR:4	CHEMICAL	GENE-Y	10	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T36	T55	19149483
CPR:4	CHEMICAL	GENE-N	12	5	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T37	T53	19149483
CPR:4	CHEMICAL	GENE-Y	12	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T37	T54	19149483
CPR:4	CHEMICAL	GENE-Y	12	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T37	T55	19149483
CPR:4	CHEMICAL	GENE-N	14	5	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T38	T53	19149483
CPR:4	CHEMICAL	GENE-Y	14	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T38	T54	19149483
CPR:4	CHEMICAL	GENE-Y	14	20	The most successful example of gene blockers is chemical ( chemical , chemical , chemical ) , the inhibitor of gene/gene oncoprotein , which has become a first-line therapy for chronic myelogenous leukemia .	T38	T55	19149483
CPR:4	CHEMICAL	GENE-Y	5	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T2	T42	19149483
CPR:4	CHEMICAL	GENE-N	5	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T2	T43	19149483
NA	CHEMICAL	GENE-N	5	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T2	T44	19149483
NA	CHEMICAL	GENE-N	5	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T2	T45	19149483
CPR:4	CHEMICAL	GENE-Y	11	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T3	T42	19149483
NA	CHEMICAL	GENE-N	11	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T3	T43	19149483
NA	CHEMICAL	GENE-N	11	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T3	T44	19149483
NA	CHEMICAL	GENE-N	11	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T3	T45	19149483
NA	CHEMICAL	GENE-Y	1	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T4	T42	19149483
NA	CHEMICAL	GENE-N	1	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T4	T43	19149483
CPR:4	CHEMICAL	GENE-N	1	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T4	T44	19149483
CPR:4	CHEMICAL	GENE-N	1	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T4	T45	19149483
NA	CHEMICAL	GENE-Y	20	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T5	T42	19149483
NA	CHEMICAL	GENE-N	20	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T5	T43	19149483
CPR:4	CHEMICAL	GENE-N	20	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T5	T44	19149483
CPR:4	CHEMICAL	GENE-N	20	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T5	T45	19149483
NA	CHEMICAL	GENE-Y	20	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T5	T46	19149483
NA	CHEMICAL	GENE-Y	5	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T6	T42	19149483
NA	CHEMICAL	GENE-N	5	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T6	T43	19149483
CPR:4	CHEMICAL	GENE-N	5	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T6	T44	19149483
CPR:4	CHEMICAL	GENE-N	5	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T6	T45	19149483
NA	CHEMICAL	GENE-Y	25	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T7	T42	19149483
NA	CHEMICAL	GENE-N	25	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T7	T43	19149483
CPR:4	CHEMICAL	GENE-N	25	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T7	T44	19149483
CPR:4	CHEMICAL	GENE-N	25	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T7	T45	19149483
NA	CHEMICAL	GENE-Y	25	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T7	T46	19149483
NA	CHEMICAL	GENE-Y	27	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T8	T42	19149483
NA	CHEMICAL	GENE-N	27	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T8	T43	19149483
CPR:4	CHEMICAL	GENE-N	27	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T8	T44	19149483
CPR:4	CHEMICAL	GENE-N	27	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T8	T45	19149483
NA	CHEMICAL	GENE-Y	27	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T8	T46	19149483
NA	CHEMICAL	GENE-Y	5	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T9	T42	19149483
NA	CHEMICAL	GENE-N	5	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T9	T43	19149483
CPR:4	CHEMICAL	GENE-N	5	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T9	T44	19149483
CPR:4	CHEMICAL	GENE-N	5	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T9	T45	19149483
NA	CHEMICAL	GENE-Y	32	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T10	T42	19149483
NA	CHEMICAL	GENE-N	32	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T10	T43	19149483
CPR:4	CHEMICAL	GENE-N	32	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T10	T44	19149483
CPR:4	CHEMICAL	GENE-N	32	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T10	T45	19149483
NA	CHEMICAL	GENE-Y	32	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T10	T46	19149483
NA	CHEMICAL	GENE-Y	34	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T11	T42	19149483
NA	CHEMICAL	GENE-N	34	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T11	T43	19149483
CPR:4	CHEMICAL	GENE-N	34	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T11	T44	19149483
CPR:4	CHEMICAL	GENE-N	34	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T11	T45	19149483
NA	CHEMICAL	GENE-Y	34	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T11	T46	19149483
NA	CHEMICAL	GENE-Y	41	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T12	T42	19149483
NA	CHEMICAL	GENE-N	41	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T12	T43	19149483
NA	CHEMICAL	GENE-N	41	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T12	T44	19149483
NA	CHEMICAL	GENE-N	41	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T12	T45	19149483
CPR:4	CHEMICAL	GENE-Y	41	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T12	T46	19149483
NA	CHEMICAL	GENE-Y	5	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T13	T42	19149483
NA	CHEMICAL	GENE-N	5	5	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T13	T43	19149483
NA	CHEMICAL	GENE-N	5	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T13	T44	19149483
NA	CHEMICAL	GENE-N	5	1	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T13	T45	19149483
CPR:4	CHEMICAL	GENE-Y	5	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T13	T46	19149483
NA	CHEMICAL	GENE-Y	46	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T14	T42	19149483
NA	CHEMICAL	GENE-N	46	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T14	T44	19149483
CPR:4	CHEMICAL	GENE-Y	46	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T14	T46	19149483
NA	CHEMICAL	GENE-Y	48	15	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T15	T42	19149483
NA	CHEMICAL	GENE-N	48	38	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T15	T44	19149483
CPR:4	CHEMICAL	GENE-Y	48	52	Others gene inhibitors used recently in cancer therapy include chemical ( chemical ) specific for gene gene , chemical ( chemical ) , chemical ( chemical , chemical ) and chemical ( chemical , chemical ) specific for gene kinase , chemical ( chemical ) and chemical ( chemical ) specific for gene kinase .	T15	T46	19149483
CPR:4	CHEMICAL	GENE-N	11	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T16	T47	19149483
CPR:4	CHEMICAL	GENE-N	17	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T17	T47	19149483
CPR:4	CHEMICAL	GENE-N	19	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T18	T47	19149483
CPR:4	CHEMICAL	GENE-N	21	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T19	T47	19149483
CPR:4	CHEMICAL	GENE-N	11	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T20	T47	19149483
CPR:4	CHEMICAL	GENE-N	26	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T21	T47	19149483
CPR:4	CHEMICAL	GENE-N	29	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T22	T47	19149483
CPR:4	CHEMICAL	GENE-N	31	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T23	T47	19149483
CPR:4	CHEMICAL	GENE-N	34	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T24	T47	19149483
CPR:4	CHEMICAL	GENE-N	36	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T25	T47	19149483
CPR:4	CHEMICAL	GENE-N	36	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T26	T47	19149483
CPR:4	CHEMICAL	GENE-N	39	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T27	T47	19149483
CPR:4	CHEMICAL	GENE-N	41	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T28	T47	19149483
CPR:4	CHEMICAL	GENE-N	43	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T29	T47	19149483
CPR:4	CHEMICAL	GENE-N	47	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T30	T47	19149483
CPR:4	CHEMICAL	GENE-N	49	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T31	T47	19149483
CPR:4	CHEMICAL	GENE-N	51	2	The following gene blockers for treatment of various human tumors are in clinical development : chemical ( chemical , chemical , chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical/chemical ) , chemical ( chemical , chemical ) , and chemical ( chemical , chemical ) .	T32	T47	19149483
CPR:4	CHEMICAL	GENE-Y	2	2	We developed a computational model of the hypothalamic-pituitary-gonadal ( HPG ) axis in female fathead minnows to predict dose-response and time-course ( DRTC ) behaviors for endocrine effects of the gene inhibitor , chemical ( chemical ) .	T1	T7	23475784
CPR:4	CHEMICAL	GENE-Y	35	2	We developed a computational model of the hypothalamic-pituitary-gonadal ( HPG ) axis in female fathead minnows to predict dose-response and time-course ( DRTC ) behaviors for endocrine effects of the gene inhibitor , chemical ( chemical ) .	T2	T7	23475784
NA	CHEMICAL	GENE-Y	7	14	For model development , we used plasma chemical ( E2 ) concentrations and ovarian gene mRNA data from two time-course experiments , each of which included both an exposure and a depuration phase , and plasma E2 data from a third 4-day study .	T3	T11	23475784
NA	CHEMICAL	GENE-Y	12	4	The model accurately predicted gene mRNA fold changes for controls and three chemical doses ( 0 , 0.5 , and 3 µg/l ) and plasma E2 dose response from the 4-day study .	T5	T12	23475784
NA	CHEMICAL	GENE-N	0	5	chemical discrimination and antagonism by gene neutral and inverse agonist antagonists .	T15	T27	23287700
NA	CHEMICAL	GENE-N	0	2	chemical receptor 1 ( gene ) inverse agonists ( e.g. , chemical ) have been reported to produce adverse effects including nausea , emesis , and anhedonia that limit their clinical applications .	T1	T16	23287700
NA	CHEMICAL	GENE-N	0	2	chemical receptor 1 ( gene ) inverse agonists ( e.g. , chemical ) have been reported to produce adverse effects including nausea , emesis , and anhedonia that limit their clinical applications .	T1	T19	23287700
CPR:5	CHEMICAL	GENE-N	11	2	chemical receptor 1 ( gene ) inverse agonists ( e.g. , chemical ) have been reported to produce adverse effects including nausea , emesis , and anhedonia that limit their clinical applications .	T9	T16	23287700
CPR:5	CHEMICAL	GENE-N	11	2	chemical receptor 1 ( gene ) inverse agonists ( e.g. , chemical ) have been reported to produce adverse effects including nausea , emesis , and anhedonia that limit their clinical applications .	T9	T19	23287700
CPR:5	CHEMICAL	GENE-N	9	6	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T7	T21	23287700
NA	CHEMICAL	GENE-N	9	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T7	T22	23287700
NA	CHEMICAL	GENE-N	9	24	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T7	T23	23287700
NA	CHEMICAL	GENE-N	9	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T7	T24	23287700
CPR:5	CHEMICAL	GENE-N	11	6	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T8	T21	23287700
NA	CHEMICAL	GENE-N	11	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T8	T22	23287700
NA	CHEMICAL	GENE-N	11	24	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T8	T23	23287700
NA	CHEMICAL	GENE-N	11	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T8	T24	23287700
NA	CHEMICAL	GENE-N	18	6	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T10	T21	23287700
CPR:6	CHEMICAL	GENE-N	18	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T10	T22	23287700
NA	CHEMICAL	GENE-N	18	24	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T10	T23	23287700
NA	CHEMICAL	GENE-N	18	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T10	T24	23287700
NA	CHEMICAL	GENE-N	41	6	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T11	T21	23287700
NA	CHEMICAL	GENE-N	41	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T11	T22	23287700
NA	CHEMICAL	GENE-N	41	24	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T11	T23	23287700
CPR:5	CHEMICAL	GENE-N	41	10	In the present studies , the gene inverse agonist chemical ( chemical ) and the gene neutral antagonist chemical were compared for their ability to modify gene-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel gene full agonist chemical .	T11	T24	23287700
CPR:3	CHEMICAL	GENE-N	3	8	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T12	T25	23287700
NA	CHEMICAL	GENE-N	3	25	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T12	T26	23287700
NA	CHEMICAL	GENE-N	6	8	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T13	T25	23287700
CPR:5	CHEMICAL	GENE-N	6	25	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T13	T26	23287700
NA	CHEMICAL	GENE-N	6	8	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T14	T25	23287700
CPR:5	CHEMICAL	GENE-N	6	25	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T14	T26	23287700
NA	CHEMICAL	GENE-N	8	8	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T2	T25	23287700
CPR:6	CHEMICAL	GENE-N	8	25	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T2	T26	23287700
NA	CHEMICAL	GENE-N	46	8	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T3	T25	23287700
CPR:5	CHEMICAL	GENE-N	46	25	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T3	T26	23287700
CPR:5	CHEMICAL	GENE-N	61	25	Results indicate that chemical serves as an effective gene discriminative stimulus , with an onset and time course of action comparable with that of the gene agonist chemical , and that the inverse agonist chemical and the neutral antagonist chemical produce dose-related rightward shifts in the chemical dose-effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of chemical .	T4	T26	23287700
NA	CHEMICAL	GENE-Y	5	16	Here , we report that a specific 29-chemical peptide derived from the intracellular domain fragment of gene interacts with and potentiates binding of gene to gene-expressing cells , leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced gene and gene signaling .	T1	T8	23471969
NA	CHEMICAL	GENE-Y	5	23	Here , we report that a specific 29-chemical peptide derived from the intracellular domain fragment of gene interacts with and potentiates binding of gene to gene-expressing cells , leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced gene and gene signaling .	T1	T10	23471969
NA	CHEMICAL	GENE-Y	5	25	Here , we report that a specific 29-chemical peptide derived from the intracellular domain fragment of gene interacts with and potentiates binding of gene to gene-expressing cells , leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced gene and gene signaling .	T1	T11	23471969
NA	CHEMICAL	GENE-N	5	41	Here , we report that a specific 29-chemical peptide derived from the intracellular domain fragment of gene interacts with and potentiates binding of gene to gene-expressing cells , leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced gene and gene signaling .	T1	T12	23471969
NA	CHEMICAL	GENE-N	5	43	Here , we report that a specific 29-chemical peptide derived from the intracellular domain fragment of gene interacts with and potentiates binding of gene to gene-expressing cells , leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced gene and gene signaling .	T1	T13	23471969
NA	CHEMICAL	GENE-Y	13	6	An endogenous intracellular domain fragment of gene ( gene ) containing these 29 chemical is produced by regulated proteolysis of the full-length receptor .	T2	T15	23471969
NA	CHEMICAL	GENE-N	13	7	An endogenous intracellular domain fragment of gene ( gene ) containing these 29 chemical is produced by regulated proteolysis of the full-length receptor .	T2	T16	23471969
NA	CHEMICAL	GENE-N	2	10	OBJECTIVE : chemical , a rapid- and short-acting insulinotropic chemical receptor ligand , exhibits hypoglycemic action unlike other chemical .	T1	T26	20025554
NA	CHEMICAL	GENE-N	4	10	OBJECTIVE : chemical , a rapid- and short-acting insulinotropic chemical receptor ligand , exhibits hypoglycemic action unlike other chemical .	T15	T26	20025554
NA	CHEMICAL	GENE-N	4	10	OBJECTIVE : chemical , a rapid- and short-acting insulinotropic chemical receptor ligand , exhibits hypoglycemic action unlike other chemical .	T6	T26	20025554
NA	CHEMICAL	GENE-Y	6	8	The efficacy of the combination of chemical and gene inhibitors for diabetic patients on hemodialysis ( HD ) has not been prospectively evaluated ; therefore , we evaluated the efficacy and safety of chemical in these patients .	T11	T25	20025554
NA	CHEMICAL	GENE-Y	33	8	The efficacy of the combination of chemical and gene inhibitors for diabetic patients on hemodialysis ( HD ) has not been prospectively evaluated ; therefore , we evaluated the efficacy and safety of chemical in these patients .	T12	T25	20025554
NA	CHEMICAL	GENE-Y	10	12	The efficacy of the treatment was determined by monitoring plasma chemical , gene ( gene ) , and gene ( gene ) levels and using homeostasis model assessment of gene resistance ( HOMA-IR ) .	T19	T27	20025554
NA	CHEMICAL	GENE-Y	10	13	The efficacy of the treatment was determined by monitoring plasma chemical , gene ( gene ) , and gene ( gene ) levels and using homeostasis model assessment of gene resistance ( HOMA-IR ) .	T19	T28	20025554
NA	CHEMICAL	GENE-Y	10	18	The efficacy of the treatment was determined by monitoring plasma chemical , gene ( gene ) , and gene ( gene ) levels and using homeostasis model assessment of gene resistance ( HOMA-IR ) .	T19	T29	20025554
NA	CHEMICAL	GENE-Y	10	20	The efficacy of the treatment was determined by monitoring plasma chemical , gene ( gene ) , and gene ( gene ) levels and using homeostasis model assessment of gene resistance ( HOMA-IR ) .	T19	T30	20025554
NA	CHEMICAL	GENE-Y	10	29	The efficacy of the treatment was determined by monitoring plasma chemical , gene ( gene ) , and gene ( gene ) levels and using homeostasis model assessment of gene resistance ( HOMA-IR ) .	T19	T22	20025554
CPR:4	CHEMICAL	GENE-Y	0	6	chemical reduced fasting plasma chemical and gene levels after 4 weeks and gene levels after 8 weeks .	T3	T23	20025554
CPR:4	CHEMICAL	GENE-Y	0	12	chemical reduced fasting plasma chemical and gene levels after 4 weeks and gene levels after 8 weeks .	T3	T24	20025554
NA	CHEMICAL	GENE-Y	4	6	chemical reduced fasting plasma chemical and gene levels after 4 weeks and gene levels after 8 weeks .	T4	T23	20025554
NA	CHEMICAL	GENE-Y	4	12	chemical reduced fasting plasma chemical and gene levels after 4 weeks and gene levels after 8 weeks .	T4	T24	20025554
CPR:4	CHEMICAL	GENE-Y	14	12	Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the gene inhibitor chemical in an advanced-aged diet-induced obesity mouse model .	T8	T18	23636640
CPR:4	CHEMICAL	GENE-Y	16	14	METHODS : After 1 month of HFD alone , the mice were given the gene inhibitor chemical for a further 11 months .	T4	T15	23636640
NA	CHEMICAL	GENE-Y	7	22	A low toxicity maintenance regime , using chemical and readily available drugs , for mantle cell lymphoma and other malignancies with excess gene levels .	T13	T20	12710892
CPR:4	CHEMICAL	GENE-Y	16	8	Agents which have recently been shown to block gene translation by regulating calcium levels are the chemical , chemical ( chemical ) , the antidiabetic chemical , and the antifungal agent , chemical .	T11	T19	12710892
CPR:4	CHEMICAL	GENE-Y	18	8	Agents which have recently been shown to block gene translation by regulating calcium levels are the chemical , chemical ( chemical ) , the antidiabetic chemical , and the antifungal agent , chemical .	T12	T19	12710892
CPR:4	CHEMICAL	GENE-Y	8	8	Agents which have recently been shown to block gene translation by regulating calcium levels are the chemical , chemical ( chemical ) , the antidiabetic chemical , and the antifungal agent , chemical .	T1	T19	12710892
CPR:4	CHEMICAL	GENE-Y	25	8	Agents which have recently been shown to block gene translation by regulating calcium levels are the chemical , chemical ( chemical ) , the antidiabetic chemical , and the antifungal agent , chemical .	T2	T19	12710892
CPR:4	CHEMICAL	GENE-Y	32	8	Agents which have recently been shown to block gene translation by regulating calcium levels are the chemical , chemical ( chemical ) , the antidiabetic chemical , and the antifungal agent , chemical .	T3	T19	12710892
NA	CHEMICAL	GENE-Y	15	22	Two types of agent which have been shown to inhibit angiogenesis are the teratogen , chemical , and the selective inhibitors of gene ( gene ) .	T4	T14	12710892
NA	CHEMICAL	GENE-Y	15	24	Two types of agent which have been shown to inhibit angiogenesis are the teratogen , chemical , and the selective inhibitors of gene ( gene ) .	T4	T15	12710892
NA	CHEMICAL	GENE-Y	5	21	Comparison of the novel antipsychotic chemical with chemical and chemical : inhibition of dorsal raphe cell firing and the role of gene activation .	T26	T41	10516958
NA	CHEMICAL	GENE-Y	7	21	Comparison of the novel antipsychotic chemical with chemical and chemical : inhibition of dorsal raphe cell firing and the role of gene activation .	T27	T41	10516958
NA	CHEMICAL	GENE-Y	9	21	Comparison of the novel antipsychotic chemical with chemical and chemical : inhibition of dorsal raphe cell firing and the role of gene activation .	T28	T41	10516958
NA	CHEMICAL	GENE-Y	0	11	chemical is a novel antipsychotic agent which binds with high affinity to gene ( Ki = 3.4 nM ) , in addition to gene , gene , and gene sites .	T1	T40	10516958
NA	CHEMICAL	GENE-Y	0	23	chemical is a novel antipsychotic agent which binds with high affinity to gene ( Ki = 3.4 nM ) , in addition to gene , gene , and gene sites .	T1	T30	10516958
NA	CHEMICAL	GENE-Y	0	25	chemical is a novel antipsychotic agent which binds with high affinity to gene ( Ki = 3.4 nM ) , in addition to gene , gene , and gene sites .	T1	T31	10516958
NA	CHEMICAL	GENE-Y	0	28	chemical is a novel antipsychotic agent which binds with high affinity to gene ( Ki = 3.4 nM ) , in addition to gene , gene , and gene sites .	T1	T32	10516958
CPR:5	CHEMICAL	GENE-Y	10	14	While it is an antagonist at these latter receptors , chemical behaves as a gene agonist in vitro in chemical cyclase measurements .	T14	T35	10516958
NA	CHEMICAL	GENE-N	10	12	While it is an antagonist at these latter receptors , chemical behaves as a gene agonist in vitro in chemical cyclase measurements .	T14	T36	10516958
NA	CHEMICAL	GENE-Y	5	14	While it is an antagonist at these latter receptors , chemical behaves as a gene agonist in vitro in chemical cyclase measurements .	T15	T35	10516958
NA	CHEMICAL	GENE-N	5	12	While it is an antagonist at these latter receptors , chemical behaves as a gene agonist in vitro in chemical cyclase measurements .	T15	T36	10516958
NA	CHEMICAL	GENE-Y	13	10	The goal of the present study was to examine the gene properties of chemical in vivo using as a marker of central gene activity the inhibition of firing of chemical-containing neurons in the dorsal raphe nucleus .	T16	T37	10516958
NA	CHEMICAL	GENE-Y	13	22	The goal of the present study was to examine the gene properties of chemical in vivo using as a marker of central gene activity the inhibition of firing of chemical-containing neurons in the dorsal raphe nucleus .	T16	T38	10516958
NA	CHEMICAL	GENE-Y	7	10	The goal of the present study was to examine the gene properties of chemical in vivo using as a marker of central gene activity the inhibition of firing of chemical-containing neurons in the dorsal raphe nucleus .	T17	T37	10516958
NA	CHEMICAL	GENE-Y	7	22	The goal of the present study was to examine the gene properties of chemical in vivo using as a marker of central gene activity the inhibition of firing of chemical-containing neurons in the dorsal raphe nucleus .	T17	T38	10516958
CPR:6	CHEMICAL	GENE-Y	5	3	Pretreatment with the gene antagonist chemical ( 10 micrograms/kg i.v . )	T21	T39	10516958
NA	CHEMICAL	GENE-N	6	6	Because all three agents also bind to gene , antagonists of which inhibit chemical neuronal firing , this aspect of their pharmacology was assessed with chemical ( chemical ) , a chemical re-uptake blocker previously shown to reverse the effects of alpha 1 antagonists on raphe unit activity .	T2	T29	10516958
NA	CHEMICAL	GENE-N	25	6	Because all three agents also bind to gene , antagonists of which inhibit chemical neuronal firing , this aspect of their pharmacology was assessed with chemical ( chemical ) , a chemical re-uptake blocker previously shown to reverse the effects of alpha 1 antagonists on raphe unit activity .	T3	T29	10516958
NA	CHEMICAL	GENE-N	27	6	Because all three agents also bind to gene , antagonists of which inhibit chemical neuronal firing , this aspect of their pharmacology was assessed with chemical ( chemical ) , a chemical re-uptake blocker previously shown to reverse the effects of alpha 1 antagonists on raphe unit activity .	T4	T29	10516958
NA	CHEMICAL	GENE-N	31	6	Because all three agents also bind to gene , antagonists of which inhibit chemical neuronal firing , this aspect of their pharmacology was assessed with chemical ( chemical ) , a chemical re-uptake blocker previously shown to reverse the effects of alpha 1 antagonists on raphe unit activity .	T5	T29	10516958
CPR:5	CHEMICAL	GENE-Y	3	11	These profiles suggest a mechanism of action for each agent , gene agonism for chemical and alpha 1 antagonism for chemical and chemical .	T10	T33	10516958
NA	CHEMICAL	GENE-Y	3	11	These profiles suggest a mechanism of action for each agent , gene agonism for chemical and alpha 1 antagonism for chemical and chemical .	T11	T33	10516958
NA	CHEMICAL	GENE-Y	3	11	These profiles suggest a mechanism of action for each agent , gene agonism for chemical and alpha 1 antagonism for chemical and chemical .	T12	T33	10516958
NA	CHEMICAL	GENE-Y	0	12	chemical replacement enhances chemical-stimulated locomotion in female C57BL/6 mice through chemical receptor alpha .	T17	T29	23608737
NA	CHEMICAL	GENE-Y	3	12	chemical replacement enhances chemical-stimulated locomotion in female C57BL/6 mice through chemical receptor alpha .	T18	T29	23608737
NA	CHEMICAL	GENE-Y	10	12	chemical replacement enhances chemical-stimulated locomotion in female C57BL/6 mice through chemical receptor alpha .	T19	T29	23608737
NA	CHEMICAL	GENE-Y	5	17	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T13	T24	23608737
NA	CHEMICAL	GENE-Y	5	22	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T13	T25	23608737
NA	CHEMICAL	GENE-Y	5	35	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T13	T26	23608737
NA	CHEMICAL	GENE-Y	5	37	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T13	T27	23608737
NA	CHEMICAL	GENE-Y	5	40	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T13	T28	23608737
NA	CHEMICAL	GENE-Y	5	42	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T13	T20	23608737
CPR:5	CHEMICAL	GENE-Y	19	17	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T15	T24	23608737
NA	CHEMICAL	GENE-Y	19	22	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T15	T25	23608737
NA	CHEMICAL	GENE-Y	19	35	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T15	T26	23608737
NA	CHEMICAL	GENE-Y	19	37	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T15	T27	23608737
NA	CHEMICAL	GENE-Y	19	40	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T15	T28	23608737
NA	CHEMICAL	GENE-Y	19	42	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T15	T20	23608737
NA	CHEMICAL	GENE-Y	24	17	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T16	T24	23608737
CPR:5	CHEMICAL	GENE-Y	24	22	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T16	T25	23608737
NA	CHEMICAL	GENE-Y	24	35	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T16	T26	23608737
NA	CHEMICAL	GENE-Y	24	37	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T16	T27	23608737
NA	CHEMICAL	GENE-Y	24	40	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T16	T28	23608737
NA	CHEMICAL	GENE-Y	24	42	To examine receptor mediation of chemical effects , Ovx mice replaced for 2 days with either the gene-selective agonist chemical or the gene-selective agonist chemical were compared to Sham mice , and mice lacking either gene ( geneKO ) or gene ( geneKO ) were compared to WT littermates .	T16	T20	23608737
NA	CHEMICAL	GENE-Y	10	0	geneKO mice displayed modestly attenuated behavioral responses to novelty and chemical compared to αWT littermates , but no behavioral differences were found between geneKO and βWT mice .	T6	T21	23608737
NA	CHEMICAL	GENE-Y	10	23	geneKO mice displayed modestly attenuated behavioral responses to novelty and chemical compared to αWT littermates , but no behavioral differences were found between geneKO and βWT mice .	T6	T22	23608737
CPR:4	CHEMICAL	GENE-Y	14	12	These compounds resulted from our efforts to merge the pharmacophores of selective gene inhibitor chemical with a mimic of the chemical ( gene ) sequence of gene to obtain designed multiple ligands with potential antithrombotic activity .	T1	T7	23644213
NA	CHEMICAL	GENE-N	14	22	These compounds resulted from our efforts to merge the pharmacophores of selective gene inhibitor chemical with a mimic of the chemical ( gene ) sequence of gene to obtain designed multiple ligands with potential antithrombotic activity .	T1	T9	23644213
NA	CHEMICAL	GENE-N	14	26	These compounds resulted from our efforts to merge the pharmacophores of selective gene inhibitor chemical with a mimic of the chemical ( gene ) sequence of gene to obtain designed multiple ligands with potential antithrombotic activity .	T1	T10	23644213
NA	CHEMICAL	GENE-Y	20	12	These compounds resulted from our efforts to merge the pharmacophores of selective gene inhibitor chemical with a mimic of the chemical ( gene ) sequence of gene to obtain designed multiple ligands with potential antithrombotic activity .	T2	T7	23644213
NA	CHEMICAL	GENE-N	20	22	These compounds resulted from our efforts to merge the pharmacophores of selective gene inhibitor chemical with a mimic of the chemical ( gene ) sequence of gene to obtain designed multiple ligands with potential antithrombotic activity .	T2	T9	23644213
NA	CHEMICAL	GENE-N	20	26	These compounds resulted from our efforts to merge the pharmacophores of selective gene inhibitor chemical with a mimic of the chemical ( gene ) sequence of gene to obtain designed multiple ligands with potential antithrombotic activity .	T2	T10	23644213
NA	CHEMICAL	GENE-Y	2	13	Green tea chemical leads to global improvement among Alzheimer 's disease-related phenotypes in gene/gene-gene Tg mice .	T5	T23	23333093
NA	CHEMICAL	GENE-Y	2	13	Green tea chemical leads to global improvement among Alzheimer 's disease-related phenotypes in gene/gene-gene Tg mice .	T5	T24	23333093
NA	CHEMICAL	GENE-N	2	13	Green tea chemical leads to global improvement among Alzheimer 's disease-related phenotypes in gene/gene-gene Tg mice .	T5	T22	23333093
NA	CHEMICAL	GENE-N	5	6	As expected , mutations of chemical kinase genes ( gene , gene , and gene ) were common in de novo AML , with a cumulative frequency of 30 % .	T2	T7	17494858
NA	CHEMICAL	GENE-Y	5	9	As expected , mutations of chemical kinase genes ( gene , gene , and gene ) were common in de novo AML , with a cumulative frequency of 30 % .	T2	T8	17494858
NA	CHEMICAL	GENE-Y	5	11	As expected , mutations of chemical kinase genes ( gene , gene , and gene ) were common in de novo AML , with a cumulative frequency of 30 % .	T2	T9	17494858
NA	CHEMICAL	GENE-Y	5	14	As expected , mutations of chemical kinase genes ( gene , gene , and gene ) were common in de novo AML , with a cumulative frequency of 30 % .	T2	T10	17494858
NA	CHEMICAL	GENE-Y	0	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T1	T14	9587031
NA	CHEMICAL	GENE-Y	0	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T1	T15	9587031
CPR:9	CHEMICAL	GENE-Y	4	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T2	T14	9587031
NA	CHEMICAL	GENE-Y	4	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T2	T15	9587031
NA	CHEMICAL	GENE-Y	8	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T3	T14	9587031
NA	CHEMICAL	GENE-Y	8	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T3	T15	9587031
NA	CHEMICAL	GENE-Y	21	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T4	T14	9587031
NA	CHEMICAL	GENE-Y	21	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T4	T15	9587031
NA	CHEMICAL	GENE-Y	8	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T5	T14	9587031
NA	CHEMICAL	GENE-Y	8	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T5	T15	9587031
NA	CHEMICAL	GENE-Y	8	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T6	T14	9587031
NA	CHEMICAL	GENE-Y	8	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T6	T15	9587031
NA	CHEMICAL	GENE-Y	8	1	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T7	T14	9587031
CPR:9	CHEMICAL	GENE-Y	8	28	chemical reductase deficiency impairs chemical synthesis , defects in cytosolic reduction of chemical ( CblC/D ) impair the synthesis of both chemical- and chemical and deficiencies of chemical synthase ( CblE/G ) are associated with defective chemical synthesis .	T7	T15	9587031
CPR:4	CHEMICAL	GENE-N	10	3	Inhibition of testicular gene from laboratory animals and man by chemical and its isomers .	T11	T20	3735252
CPR:4	CHEMICAL	GENE-Y	4	10	The inhibitory effect of chemical and chemical upon testicular cytosolic gene was measured in vitro .	T2	T12	3735252
CPR:4	CHEMICAL	GENE-Y	6	10	The inhibitory effect of chemical and chemical upon testicular cytosolic gene was measured in vitro .	T5	T12	3735252
CPR:4	CHEMICAL	GENE-N	0	6	chemical ( 0-100 mumol/l ) inhibited gene prepared from the testes of the mouse greater than rabbit greater than human greater than rat greater than hamster .	T1	T13	3735252
NA	CHEMICAL	GENE-N	14	0	gene activity measured in vitro in serum of men and hamsters was unaffected by chemical .	T3	T14	3735252
CPR:4	CHEMICAL	GENE-N	0	8	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T4	T15	3735252
NA	CHEMICAL	GENE-Y	0	19	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T4	T16	3735252
NA	CHEMICAL	GENE-Y	0	24	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T4	T17	3735252
NA	CHEMICAL	GENE-N	14	8	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T6	T15	3735252
CPR:4	CHEMICAL	GENE-Y	14	19	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T6	T16	3735252
NA	CHEMICAL	GENE-Y	14	24	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T6	T17	3735252
NA	CHEMICAL	GENE-N	11	8	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T7	T15	3735252
NA	CHEMICAL	GENE-Y	11	19	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T7	T16	3735252
CPR:9	CHEMICAL	GENE-Y	11	24	chemical and its isomers were non-competitive inhibitors of gene with respect to the coenzyme chemical , competitive inhibitors of gene and noncompetitive-competitive inhibitors of gene with respect to the substrate chemical .	T7	T17	3735252
NA	CHEMICAL	GENE-Y	9	4	Posttranslational modification of the gene ( gene ) by chemical ( chemical ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration , axon fasciculation , and synaptic plasticity .	T8	T21	23619613
NA	CHEMICAL	GENE-Y	9	6	Posttranslational modification of the gene ( gene ) by chemical ( chemical ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration , axon fasciculation , and synaptic plasticity .	T8	T24	23619613
NA	CHEMICAL	GENE-Y	11	4	Posttranslational modification of the gene ( gene ) by chemical ( chemical ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration , axon fasciculation , and synaptic plasticity .	T10	T21	23619613
NA	CHEMICAL	GENE-Y	11	6	Posttranslational modification of the gene ( gene ) by chemical ( chemical ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration , axon fasciculation , and synaptic plasticity .	T10	T24	23619613
NA	CHEMICAL	GENE-Y	4	8	Here , we describe a novel function of gene ( chemical-NCAM ) in innate immunity of the lung .	T4	T19	23619613
NA	CHEMICAL	GENE-Y	4	4	Here , we describe a novel function of gene ( chemical-NCAM ) in innate immunity of the lung .	T4	T20	23619613
NA	CHEMICAL	GENE-Y	8	16	In mature lung tissue of healthy donors , chemical was exclusively attached to the transmembrane isoform gene and located to intracellular compartments of epithelial cells .	T5	T22	23619613
NA	CHEMICAL	GENE-Y	11	17	In patients with chronic obstructive pulmonary disease , however , increased chemical levels and processing of the gene carrier were observed .	T6	T23	23619613
NA	CHEMICAL	GENE-Y	5	2	Processing of gene was reproduced in a mouse model by chemical administration leading to an activation of the inflammasome and secretion of gene .	T7	T25	23619613
CPR:3	CHEMICAL	GENE-Y	5	22	Processing of gene was reproduced in a mouse model by chemical administration leading to an activation of the inflammasome and secretion of gene .	T7	T26	23619613
NA	CHEMICAL	GENE-Y	3	8	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T9	T27	23619613
NA	CHEMICAL	GENE-Y	3	23	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T9	T11	23619613
NA	CHEMICAL	GENE-N	3	3	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T9	T12	23619613
NA	CHEMICAL	GENE-N	3	2	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T9	T13	23619613
NA	CHEMICAL	GENE-Y	3	3	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T9	T14	23619613
NA	CHEMICAL	GENE-Y	3	8	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T1	T27	23619613
NA	CHEMICAL	GENE-Y	3	23	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T1	T11	23619613
NA	CHEMICAL	GENE-N	3	3	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T1	T12	23619613
NA	CHEMICAL	GENE-N	3	2	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T1	T13	23619613
NA	CHEMICAL	GENE-Y	3	3	As shown in a cell culture model , chemical-gene was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by gene or lipopolysaccharide induced gene-mediated gene shedding , resulting in the secretion of soluble chemical-NCAM .	T1	T14	23619613
NA	CHEMICAL	GENE-Y	2	6	Interestingly , chemical chains of secreted gene neutralized the cytotoxic activity of extracellular gene as well as DNA/gene-network-containing `` neutrophil extracellular traps '' , which are formed during invasion of microorganisms .	T2	T15	23619613
NA	CHEMICAL	GENE-N	2	13	Interestingly , chemical chains of secreted gene neutralized the cytotoxic activity of extracellular gene as well as DNA/gene-network-containing `` neutrophil extracellular traps '' , which are formed during invasion of microorganisms .	T2	T16	23619613
NA	CHEMICAL	GENE-N	2	17	Interestingly , chemical chains of secreted gene neutralized the cytotoxic activity of extracellular gene as well as DNA/gene-network-containing `` neutrophil extracellular traps '' , which are formed during invasion of microorganisms .	T2	T17	23619613
NA	CHEMICAL	GENE-N	0	1	chemical receptor-alpha ( gene ) antagonists have been widely used for breast cancer therapy .	T1	T11	20512796
NA	CHEMICAL	GENE-N	0	3	chemical receptor-alpha ( gene ) antagonists have been widely used for breast cancer therapy .	T1	T22	20512796
CPR:6	CHEMICAL	GENE-N	4	16	Recent studies indicate that chemical initially acts as an antagonist , but later functions as an gene agonist , promoting tumor growth .	T8	T24	20512796
NA	CHEMICAL	GENE-N	7	1	The gene-targeting PROTACs are composed of an chemical on one end and a gene ( gene ) -derived synthetic pentapeptide on the other .	T9	T28	20512796
NA	CHEMICAL	GENE-N	7	12	The gene-targeting PROTACs are composed of an chemical on one end and a gene ( gene ) -derived synthetic pentapeptide on the other .	T9	T29	20512796
NA	CHEMICAL	GENE-N	7	12	The gene-targeting PROTACs are composed of an chemical on one end and a gene ( gene ) -derived synthetic pentapeptide on the other .	T9	T30	20512796
CPR:4	CHEMICAL	GENE-N	9	18	With the pentapeptide linked through the C7alpha position of chemical , the resulting PROTAC shows the most effective gene degradation and highest affinity for the chemical receptor .	T3	T18	20512796
NA	CHEMICAL	GENE-N	9	26	With the pentapeptide linked through the C7alpha position of chemical , the resulting PROTAC shows the most effective gene degradation and highest affinity for the chemical receptor .	T3	T19	20512796
NA	CHEMICAL	GENE-N	25	18	With the pentapeptide linked through the C7alpha position of chemical , the resulting PROTAC shows the most effective gene degradation and highest affinity for the chemical receptor .	T4	T18	20512796
NA	CHEMICAL	GENE-N	25	26	With the pentapeptide linked through the C7alpha position of chemical , the resulting PROTAC shows the most effective gene degradation and highest affinity for the chemical receptor .	T4	T19	20512796
CPR:4	CHEMICAL	GENE-Y	0	7	chemical , an chemical that reversibly inhibits gene and reduces intracellular substrate burden , is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option .	T4	T9	16247743
CPR:4	CHEMICAL	GENE-Y	3	7	chemical , an chemical that reversibly inhibits gene and reduces intracellular substrate burden , is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option .	T5	T9	16247743
CPR:6	CHEMICAL	GENE-Y	4	9	Practical asymmetric synthesis of chemical , a potent human gene antagonist , via a stereoselective Lewis acid-catalyzed trans acetalization reaction .	T9	T11	12227806
CPR:6	CHEMICAL	GENE-Y	6	17	A streamlined and high-yielding synthesis of chemical ( 1 ) , a potent chemical ( chemical ) receptor antagonist , is described .	T5	T10	12227806
NA	CHEMICAL	GENE-Y	13	17	A streamlined and high-yielding synthesis of chemical ( 1 ) , a potent chemical ( chemical ) receptor antagonist , is described .	T7	T10	12227806
NA	CHEMICAL	GENE-Y	15	17	A streamlined and high-yielding synthesis of chemical ( 1 ) , a potent chemical ( chemical ) receptor antagonist , is described .	T8	T10	12227806
NA	CHEMICAL	GENE-Y	2	1	The gene chemical kinase is important for gene-induced gene phosphorylation , colony formation in soft agar and tumor growth in vivo .	T6	T40	23589302
NA	CHEMICAL	GENE-N	2	3	The gene chemical kinase is important for gene-induced gene phosphorylation , colony formation in soft agar and tumor growth in vivo .	T6	T41	23589302
NA	CHEMICAL	GENE-Y	2	7	The gene chemical kinase is important for gene-induced gene phosphorylation , colony formation in soft agar and tumor growth in vivo .	T6	T39	23589302
NA	CHEMICAL	GENE-Y	2	8	The gene chemical kinase is important for gene-induced gene phosphorylation , colony formation in soft agar and tumor growth in vivo .	T6	T42	23589302
NA	CHEMICAL	GENE-Y	4	0	gene is a cytoplasmic chemical kinase that is activated in response to gene ( gene ) stimulation .	T1	T7	23589302
NA	CHEMICAL	GENE-N	4	2	gene is a cytoplasmic chemical kinase that is activated in response to gene ( gene ) stimulation .	T1	T15	23589302
NA	CHEMICAL	GENE-N	4	2	gene is a cytoplasmic chemical kinase that is activated in response to gene ( gene ) stimulation .	T1	T31	23589302
NA	CHEMICAL	GENE-N	4	14	gene is a cytoplasmic chemical kinase that is activated in response to gene ( gene ) stimulation .	T1	T8	23589302
NA	CHEMICAL	GENE-N	4	5	Multifunctional targets of dietary chemical in disease : a case for the gene network and energy metabolism .	T4	T14	23063595
NA	CHEMICAL	GENE-Y	7	1	The gene/gene pathway and the energy sensor chemical-activated protein kinase ( gene ) are attractive therapeutic targets as a part of preventive management of disease .	T2	T7	23063595
NA	CHEMICAL	GENE-Y	7	1	The gene/gene pathway and the energy sensor chemical-activated protein kinase ( gene ) are attractive therapeutic targets as a part of preventive management of disease .	T2	T8	23063595
NA	CHEMICAL	GENE-Y	7	9	The gene/gene pathway and the energy sensor chemical-activated protein kinase ( gene ) are attractive therapeutic targets as a part of preventive management of disease .	T2	T9	23063595
NA	CHEMICAL	GENE-Y	7	11	The gene/gene pathway and the energy sensor chemical-activated protein kinase ( gene ) are attractive therapeutic targets as a part of preventive management of disease .	T2	T10	23063595
CPR:4	CHEMICAL	GENE-N	3	6	Several effects of chemical are useful in this scenario , including a reduction in the activities of gene and modulation of cellular metabolism through gene inhibitors , gene activators , calorie-restriction mimetics or epigenetic regulators .	T3	T11	23063595
CPR:4	CHEMICAL	GENE-N	3	11	Several effects of chemical are useful in this scenario , including a reduction in the activities of gene and modulation of cellular metabolism through gene inhibitors , gene activators , calorie-restriction mimetics or epigenetic regulators .	T3	T12	23063595
CPR:3	CHEMICAL	GENE-Y	3	27	Several effects of chemical are useful in this scenario , including a reduction in the activities of gene and modulation of cellular metabolism through gene inhibitors , gene activators , calorie-restriction mimetics or epigenetic regulators .	T3	T13	23063595
NA	CHEMICAL	GENE-Y	8	9	Characterization of the substrate mimic bound to engineered chemical synthase in solution using high-resolution NMR spectroscopy and mutagenesis : implication of the molecular mechanism in biosynthesis of chemical .	T29	T42	18081314
NA	CHEMICAL	GENE-Y	10	9	Characterization of the substrate mimic bound to engineered chemical synthase in solution using high-resolution NMR spectroscopy and mutagenesis : implication of the molecular mechanism in biosynthesis of chemical .	T28	T42	18081314
NA	CHEMICAL	GENE-Y	13	10	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T25	T32	18081314
NA	CHEMICAL	GENE-Y	13	28	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T25	T36	18081314
NA	CHEMICAL	GENE-Y	17	10	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T1	T32	18081314
NA	CHEMICAL	GENE-Y	17	28	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T1	T36	18081314
NA	CHEMICAL	GENE-Y	10	10	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T3	T32	18081314
NA	CHEMICAL	GENE-Y	10	28	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T3	T36	18081314
NA	CHEMICAL	GENE-Y	24	10	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T5	T32	18081314
NA	CHEMICAL	GENE-Y	24	28	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( chemical ) mimic ( chemical ) to the engineered chemical ( chemical ) synthase ( gene ) in solution .	T5	T36	18081314
NA	CHEMICAL	GENE-Y	3	6	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T11	T38	18081314
NA	CHEMICAL	GENE-Y	3	42	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T11	T39	18081314
NA	CHEMICAL	GENE-Y	26	6	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T12	T38	18081314
NA	CHEMICAL	GENE-Y	26	42	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T12	T39	18081314
NA	CHEMICAL	GENE-Y	28	6	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T13	T38	18081314
NA	CHEMICAL	GENE-Y	28	42	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T13	T39	18081314
NA	CHEMICAL	GENE-Y	31	6	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T14	T38	18081314
NA	CHEMICAL	GENE-Y	31	42	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T14	T39	18081314
NA	CHEMICAL	GENE-Y	33	6	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T15	T38	18081314
NA	CHEMICAL	GENE-Y	33	42	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T15	T39	18081314
NA	CHEMICAL	GENE-Y	37	6	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T16	T38	18081314
NA	CHEMICAL	GENE-Y	37	42	The binding of chemical to the gene protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at chemical , chemical , and chemical of chemical were observed upon chemical binding to the engineered gene in a concentration-dependent manner .	T16	T39	18081314
NA	CHEMICAL	GENE-Y	10	9	The detailed conformational change and 3D structure of the gene-bound chemical were further demonstrated by 2D chemical NMR experiments using the transferred NOE technique .	T17	T40	18081314
NA	CHEMICAL	GENE-Y	16	9	The detailed conformational change and 3D structure of the gene-bound chemical were further demonstrated by 2D chemical NMR experiments using the transferred NOE technique .	T18	T40	18081314
NA	CHEMICAL	GENE-Y	5	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T19	T41	18081314
NA	CHEMICAL	GENE-Y	7	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T20	T41	18081314
NA	CHEMICAL	GENE-Y	9	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T21	T41	18081314
NA	CHEMICAL	GENE-Y	11	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T22	T41	18081314
NA	CHEMICAL	GENE-Y	14	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T23	T41	18081314
NA	CHEMICAL	GENE-Y	16	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T24	T41	18081314
NA	CHEMICAL	GENE-Y	49	24	The distances between the protons chemical and chemical , chemical and chemical , and chemical and chemical are shorter following their binding to the gene in solution-down to within 5 A . These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound chemical changed to a more compact conformation with an oval shape .	T26	T41	18081314
NA	CHEMICAL	GENE-Y	4	11	The bound conformation of chemical fits the crystal structure of the gene substrate binding pocket considerably better than that of the unbound chemical .	T27	T30	18081314
NA	CHEMICAL	GENE-Y	4	11	The bound conformation of chemical fits the crystal structure of the gene substrate binding pocket considerably better than that of the unbound chemical .	T2	T30	18081314
NA	CHEMICAL	GENE-Y	44	41	For example , Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function , which has been established by the docking studies using the NMR structure of the gene-bound form of chemical and the gene crystal structure .	T4	T33	18081314
NA	CHEMICAL	GENE-Y	44	47	For example , Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function , which has been established by the docking studies using the NMR structure of the gene-bound form of chemical and the gene crystal structure .	T4	T34	18081314
NA	CHEMICAL	GENE-Y	14	8	A combined pharmacological and genetic approach was undertaken to investigate the contribution of endogenous chemical to the motor actions of gene ( gene ) ligands .	T1	T28	23643745
NA	CHEMICAL	GENE-Y	14	8	A combined pharmacological and genetic approach was undertaken to investigate the contribution of endogenous chemical to the motor actions of gene ( gene ) ligands .	T1	T35	23643745
NA	CHEMICAL	GENE-N	5	5	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T40	23643745
NA	CHEMICAL	GENE-Y	5	12	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T41	23643745
NA	CHEMICAL	GENE-Y	5	14	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T42	23643745
CPR:6	CHEMICAL	GENE-Y	5	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T43	23643745
CPR:6	CHEMICAL	GENE-Y	5	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T44	23643745
NA	CHEMICAL	GENE-Y	5	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T45	23643745
NA	CHEMICAL	GENE-Y	5	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T46	23643745
NA	CHEMICAL	GENE-Y	5	33	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T47	23643745
NA	CHEMICAL	GENE-Y	5	37	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T4	T48	23643745
NA	CHEMICAL	GENE-N	28	5	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T40	23643745
NA	CHEMICAL	GENE-Y	28	12	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T41	23643745
NA	CHEMICAL	GENE-Y	28	14	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T42	23643745
NA	CHEMICAL	GENE-Y	28	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T43	23643745
NA	CHEMICAL	GENE-Y	28	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T44	23643745
CPR:6	CHEMICAL	GENE-Y	28	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T45	23643745
CPR:6	CHEMICAL	GENE-Y	28	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T46	23643745
NA	CHEMICAL	GENE-Y	28	33	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T47	23643745
NA	CHEMICAL	GENE-Y	28	37	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T5	T48	23643745
NA	CHEMICAL	GENE-N	30	5	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T40	23643745
NA	CHEMICAL	GENE-Y	30	12	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T41	23643745
NA	CHEMICAL	GENE-Y	30	14	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T42	23643745
NA	CHEMICAL	GENE-Y	30	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T43	23643745
NA	CHEMICAL	GENE-Y	30	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T44	23643745
CPR:6	CHEMICAL	GENE-Y	30	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T45	23643745
CPR:6	CHEMICAL	GENE-Y	30	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T46	23643745
NA	CHEMICAL	GENE-Y	30	33	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T47	23643745
NA	CHEMICAL	GENE-Y	30	37	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T6	T48	23643745
NA	CHEMICAL	GENE-N	35	5	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T40	23643745
NA	CHEMICAL	GENE-Y	35	12	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T41	23643745
NA	CHEMICAL	GENE-Y	35	14	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T42	23643745
NA	CHEMICAL	GENE-Y	35	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T43	23643745
NA	CHEMICAL	GENE-Y	35	21	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T44	23643745
NA	CHEMICAL	GENE-Y	35	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T45	23643745
NA	CHEMICAL	GENE-Y	35	26	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T46	23643745
CPR:6	CHEMICAL	GENE-Y	35	33	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T47	23643745
NA	CHEMICAL	GENE-Y	35	37	The involvement of the various gene subtypes in the motor effects of gene and gene antagonists was evaluated pharmacologically , using gene/gene ( chemical ) , gene/gene ( chemical , chemical ) and gene ( chemical ) receptor antagonists , and by using gene knockout mice .	T7	T48	23643745
NA	CHEMICAL	GENE-N	0	8	chemical also attenuated the hypolocomotion induced by the gene agonist chemical and chemical precursor chemical , whereas chemical ( and chemical ) worsened it .	T10	T51	23643745
NA	CHEMICAL	GENE-N	10	8	chemical also attenuated the hypolocomotion induced by the gene agonist chemical and chemical precursor chemical , whereas chemical ( and chemical ) worsened it .	T11	T51	23643745
NA	CHEMICAL	GENE-N	12	8	chemical also attenuated the hypolocomotion induced by the gene agonist chemical and chemical precursor chemical , whereas chemical ( and chemical ) worsened it .	T12	T51	23643745
NA	CHEMICAL	GENE-N	14	8	chemical also attenuated the hypolocomotion induced by the gene agonist chemical and chemical precursor chemical , whereas chemical ( and chemical ) worsened it .	T13	T51	23643745
NA	CHEMICAL	GENE-N	17	8	chemical also attenuated the hypolocomotion induced by the gene agonist chemical and chemical precursor chemical , whereas chemical ( and chemical ) worsened it .	T14	T51	23643745
NA	CHEMICAL	GENE-N	20	8	chemical also attenuated the hypolocomotion induced by the gene agonist chemical and chemical precursor chemical , whereas chemical ( and chemical ) worsened it .	T15	T51	23643745
NA	CHEMICAL	GENE-Y	4	4	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T20	23643745
NA	CHEMICAL	GENE-Y	4	6	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T21	23643745
NA	CHEMICAL	GENE-Y	4	11	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T22	23643745
NA	CHEMICAL	GENE-Y	4	16	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T23	23643745
NA	CHEMICAL	GENE-Y	4	26	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T24	23643745
NA	CHEMICAL	GENE-Y	4	35	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T25	23643745
NA	CHEMICAL	GENE-Y	4	42	Motor facilitation induced by gene and gene antagonists was lost in gene ( -/- ) and gene ( -/- ) mice whereas motor inhibition induced by gene antagonists ( and chemical ) was lost in gene ( -/- ) but preserved in gene ( -/- ) mice .	T2	T26	23643745
NA	CHEMICAL	GENE-Y	14	6	We demonstrate that motor actions of gene ligands rely on the modulation of endogenous chemical .	T3	T29	23643745
NA	CHEMICAL	GENE-N	13	6	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T9	T19	9204085
NA	CHEMICAL	GENE-N	13	6	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T9	T20	9204085
NA	CHEMICAL	GENE-N	13	23	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T9	T21	9204085
NA	CHEMICAL	GENE-N	15	6	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T10	T19	9204085
NA	CHEMICAL	GENE-N	15	6	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T10	T20	9204085
NA	CHEMICAL	GENE-N	15	23	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T10	T21	9204085
NA	CHEMICAL	GENE-N	20	6	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T11	T19	9204085
NA	CHEMICAL	GENE-N	20	6	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T11	T20	9204085
NA	CHEMICAL	GENE-N	20	23	Binding and transactivation assays were used to compare affinities and transcriptional activities of chemical and chemical for the gene , chemical receptors ( gene ) .	T11	T21	9204085
NA	CHEMICAL	GENE-N	4	21	The mitogenic effect of chemical on bone cells was inhibited by antichemicals ( chemical and chemical ) which compete for binding to the gene .	T14	T25	2521824
NA	CHEMICAL	GENE-N	13	21	The mitogenic effect of chemical on bone cells was inhibited by antichemicals ( chemical and chemical ) which compete for binding to the gene .	T15	T25	2521824
NA	CHEMICAL	GENE-N	15	21	The mitogenic effect of chemical on bone cells was inhibited by antichemicals ( chemical and chemical ) which compete for binding to the gene .	T16	T25	2521824
NA	CHEMICAL	GENE-N	11	21	The mitogenic effect of chemical on bone cells was inhibited by antichemicals ( chemical and chemical ) which compete for binding to the gene .	T17	T25	2521824
CPR:3	CHEMICAL	GENE-N	8	13	In addition to effects on cell proliferation , chemical increased the percentage of gene ( gene ) positive cells in all three bone cell systems tested , and this effect was inhibited by antiandrogens .	T1	T19	2521824
CPR:3	CHEMICAL	GENE-N	8	15	In addition to effects on cell proliferation , chemical increased the percentage of gene ( gene ) positive cells in all three bone cell systems tested , and this effect was inhibited by antiandrogens .	T1	T20	2521824
NA	CHEMICAL	GENE-N	2	0	gene in chemical metabolism .	T9	T16	23330546
CPR:3	CHEMICAL	GENE-N	0	6	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T1	T13	23330546
CPR:3	CHEMICAL	GENE-Y	0	10	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T1	T14	23330546
CPR:3	CHEMICAL	GENE-Y	0	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T1	T15	23330546
CPR:3	CHEMICAL	GENE-Y	0	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T1	T10	23330546
CPR:3	CHEMICAL	GENE-Y	0	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T1	T11	23330546
NA	CHEMICAL	GENE-N	12	6	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T8	T13	23330546
NA	CHEMICAL	GENE-Y	12	10	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T8	T14	23330546
NA	CHEMICAL	GENE-Y	12	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T8	T15	23330546
NA	CHEMICAL	GENE-Y	12	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T8	T10	23330546
NA	CHEMICAL	GENE-Y	12	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T8	T11	23330546
NA	CHEMICAL	GENE-N	18	6	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T2	T13	23330546
NA	CHEMICAL	GENE-Y	18	10	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T2	T14	23330546
NA	CHEMICAL	GENE-Y	18	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T2	T15	23330546
NA	CHEMICAL	GENE-Y	18	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T2	T10	23330546
NA	CHEMICAL	GENE-Y	18	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T2	T11	23330546
NA	CHEMICAL	GENE-N	19	6	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T3	T13	23330546
NA	CHEMICAL	GENE-Y	19	10	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T3	T14	23330546
NA	CHEMICAL	GENE-Y	19	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T3	T15	23330546
NA	CHEMICAL	GENE-Y	19	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T3	T10	23330546
NA	CHEMICAL	GENE-Y	19	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T3	T11	23330546
NA	CHEMICAL	GENE-N	33	6	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T4	T13	23330546
NA	CHEMICAL	GENE-Y	33	10	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T4	T14	23330546
NA	CHEMICAL	GENE-Y	33	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T4	T15	23330546
NA	CHEMICAL	GENE-Y	33	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T4	T10	23330546
NA	CHEMICAL	GENE-Y	33	14	chemical are signaling molecules that activate gene , such as gene , chemical X receptor , gene , and chemical receptor , and play a critical role in the regulation of lipid , chemical , energy , and drug metabolism .	T4	T11	23330546
NA	CHEMICAL	GENE-N	16	1	These gene regulate phase I oxidation , phase II conjugation , and phase III transport in chemical and drug metabolism in the digestive system .	T5	T12	23330546
NA	CHEMICAL	GENE-Y	12	0	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T2	T17	8666140
NA	CHEMICAL	GENE-N	12	3	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T2	T18	8666140
NA	CHEMICAL	GENE-Y	12	10	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T2	T19	8666140
NA	CHEMICAL	GENE-Y	12	12	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T2	T21	8666140
NA	CHEMICAL	GENE-Y	12	16	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T2	T22	8666140
NA	CHEMICAL	GENE-Y	33	0	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T3	T17	8666140
NA	CHEMICAL	GENE-N	33	3	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T3	T18	8666140
NA	CHEMICAL	GENE-Y	33	10	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T3	T19	8666140
NA	CHEMICAL	GENE-Y	33	12	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T3	T21	8666140
NA	CHEMICAL	GENE-Y	33	16	gene is a gene that initiates the sequential processing of gene to gene by cleaving the gene molecule on the chemical-terminal side of the dibasic peptide , Arg31-Arg32 , joining the B-chain and chemical-peptide .	T3	T22	8666140
CPR:3	CHEMICAL	GENE-Y	14	2	Expressions of gene and gene , but not gene , are coordinately regulated by chemical , consistent with the important role of gene in regulating gene processing .	T4	T25	8666140
CPR:3	CHEMICAL	GENE-Y	14	4	Expressions of gene and gene , but not gene , are coordinately regulated by chemical , consistent with the important role of gene in regulating gene processing .	T4	T26	8666140
NA	CHEMICAL	GENE-Y	14	8	Expressions of gene and gene , but not gene , are coordinately regulated by chemical , consistent with the important role of gene in regulating gene processing .	T4	T27	8666140
NA	CHEMICAL	GENE-Y	14	22	Expressions of gene and gene , but not gene , are coordinately regulated by chemical , consistent with the important role of gene in regulating gene processing .	T4	T28	8666140
NA	CHEMICAL	GENE-Y	14	23	Expressions of gene and gene , but not gene , are coordinately regulated by chemical , consistent with the important role of gene in regulating gene processing .	T4	T29	8666140
NA	CHEMICAL	GENE-Y	4	13	Single-strand conformational analysis and chemical sequencing of the entire coding region of the gene gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 ( gene ) and 14 ( gene ) , neither of which was associated with NIDDM in this population .	T1	T10	8666140
NA	CHEMICAL	GENE-N	4	28	Single-strand conformational analysis and chemical sequencing of the entire coding region of the gene gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 ( gene ) and 14 ( gene ) , neither of which was associated with NIDDM in this population .	T1	T11	8666140
NA	CHEMICAL	GENE-N	4	33	Single-strand conformational analysis and chemical sequencing of the entire coding region of the gene gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 ( gene ) and 14 ( gene ) , neither of which was associated with NIDDM in this population .	T1	T12	8666140
NA	CHEMICAL	GENE-N	0	14	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T12	T33	23391632
NA	CHEMICAL	GENE-N	0	27	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T12	T34	23391632
NA	CHEMICAL	GENE-N	12	14	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T14	T33	23391632
NA	CHEMICAL	GENE-N	12	27	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T14	T34	23391632
NA	CHEMICAL	GENE-N	9	14	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T15	T33	23391632
NA	CHEMICAL	GENE-N	9	27	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T15	T34	23391632
NA	CHEMICAL	GENE-N	23	14	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T16	T33	23391632
NA	CHEMICAL	GENE-N	23	27	chemical eliminated all Leydig cells in the control testis on day 4 post-chemical , as judged by undetectable serum chemical level and no chemical dehydrogenase positive ( gene ( pos ) ) cells in the interstitium .	T16	T34	23391632
NA	CHEMICAL	GENE-N	3	15	However , in chemical-treated groups , there were detectable serum chemical concentrations and some oval-shaped gene ( pos ) cells in the interstitium .	T17	T35	23391632
NA	CHEMICAL	GENE-N	10	15	However , in chemical-treated groups , there were detectable serum chemical concentrations and some oval-shaped gene ( pos ) cells in the interstitium .	T18	T35	23391632
NA	CHEMICAL	GENE-N	13	1	These gene ( pos ) cells were not stained by the antibody against chemical dehydrogenase 1 ( gene1 ) , a marker for Leydig cells at a more advanced stage .	T1	T36	23391632
NA	CHEMICAL	GENE-Y	13	15	These gene ( pos ) cells were not stained by the antibody against chemical dehydrogenase 1 ( gene1 ) , a marker for Leydig cells at a more advanced stage .	T1	T21	23391632
NA	CHEMICAL	GENE-Y	13	15	These gene ( pos ) cells were not stained by the antibody against chemical dehydrogenase 1 ( gene1 ) , a marker for Leydig cells at a more advanced stage .	T1	T22	23391632
NA	CHEMICAL	GENE-Y	24	7	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T23	23391632
NA	CHEMICAL	GENE-Y	24	9	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T24	23391632
NA	CHEMICAL	GENE-Y	24	11	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T25	23391632
NA	CHEMICAL	GENE-Y	24	17	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T26	23391632
NA	CHEMICAL	GENE-Y	24	19	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T27	23391632
NA	CHEMICAL	GENE-Y	24	21	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T28	23391632
NA	CHEMICAL	GENE-N	24	30	However , there were detectable concentrations of gene , gene and gene mRNAs but undetectable concentrations of gene , gene and gene in the chemical-treated testes , indicating that these gene ( pos ) cells were newly formed progenitor Leydig cells .	T3	T29	23391632
CPR:3	CHEMICAL	GENE-Y	24	4	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T4	T30	23391632
CPR:3	CHEMICAL	GENE-Y	24	6	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T4	T31	23391632
NA	CHEMICAL	GENE-Y	24	17	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T4	T32	23391632
NA	CHEMICAL	GENE-Y	30	4	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T5	T30	23391632
NA	CHEMICAL	GENE-Y	30	6	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T5	T31	23391632
NA	CHEMICAL	GENE-Y	30	17	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T5	T32	23391632
NA	CHEMICAL	GENE-Y	49	17	The mRNA level for gene ( gene , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post-chemical , but not in the chemical treated testes , suggesting that these gene positive stem cells were differentiated into progenitor Leydig cells in the chemical-treated testes .	T6	T32	23391632
NA	CHEMICAL	GENE-N	0	1	chemical receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo : correlation with gamma oscillations .	T15	T18	23022398
NA	CHEMICAL	GENE-N	9	10	Other groups received either an infusion of the selective chemical receptor antagonist ( chemical ; 10 nmol ; intra-mPFC ) or vehicle , 10 min prior to chemical preceding LFS600 , or prior to a supra-threshold LTD protocol ( 900 pulses , 1 Hz ; LFS900 ) .	T11	T17	23022398
CPR:6	CHEMICAL	GENE-N	13	10	Other groups received either an infusion of the selective chemical receptor antagonist ( chemical ; 10 nmol ; intra-mPFC ) or vehicle , 10 min prior to chemical preceding LFS600 , or prior to a supra-threshold LTD protocol ( 900 pulses , 1 Hz ; LFS900 ) .	T12	T17	23022398
NA	CHEMICAL	GENE-N	27	10	Other groups received either an infusion of the selective chemical receptor antagonist ( chemical ; 10 nmol ; intra-mPFC ) or vehicle , 10 min prior to chemical preceding LFS600 , or prior to a supra-threshold LTD protocol ( 900 pulses , 1 Hz ; LFS900 ) .	T13	T17	23022398
NA	CHEMICAL	GENE-N	5	6	Our data also indicate that chemical receptor pre-activation is essential to the muscarinic enhancement of mPFC synaptic depression , since chemical microinjection into the mPFC blocked the conversion of transient depression into long-lasting LTD produced by chemical .	T2	T16	23022398
CPR:4	CHEMICAL	GENE-N	20	6	Our data also indicate that chemical receptor pre-activation is essential to the muscarinic enhancement of mPFC synaptic depression , since chemical microinjection into the mPFC blocked the conversion of transient depression into long-lasting LTD produced by chemical .	T3	T16	23022398
NA	CHEMICAL	GENE-N	36	6	Our data also indicate that chemical receptor pre-activation is essential to the muscarinic enhancement of mPFC synaptic depression , since chemical microinjection into the mPFC blocked the conversion of transient depression into long-lasting LTD produced by chemical .	T4	T16	23022398
NA	CHEMICAL	GENE-Y	0	6	chemical restores cognitive deficits and improves gene and gene pathologies in a senescence-accelerated mouse model .	T8	T21	22824191
NA	CHEMICAL	GENE-Y	0	8	chemical restores cognitive deficits and improves gene and gene pathologies in a senescence-accelerated mouse model .	T8	T22	22824191
CPR:6	CHEMICAL	GENE-N	7	10	In the present study we tested whether chemical , a gene antagonist commonly used as antihypertensive drug , could ameliorate the cognitive impairments and increases in AD-related markers shown by the senescence-accelerated mouse prone-8 ( SAMP8 ) .	T6	T17	22824191
NA	CHEMICAL	GENE-Y	20	0	gene hyperphosphorylation ( PHF-1 epitope ) shown by SAMP8 mice at this age was also decreased in the hippocampus of chemical-treated mice , an effect probably related to a decrease in gene expression .	T2	T10	22824191
NA	CHEMICAL	GENE-Y	20	31	gene hyperphosphorylation ( PHF-1 epitope ) shown by SAMP8 mice at this age was also decreased in the hippocampus of chemical-treated mice , an effect probably related to a decrease in gene expression .	T2	T11	22824191
NA	CHEMICAL	GENE-N	2	5	Interestingly , chemical also phosphorylated gene in SAMP8 mice , which was associated with an increase of gene phosphorylation , contributing therefore to the reductions in gene hyperphosphorylation .	T3	T12	22824191
NA	CHEMICAL	GENE-Y	2	6	Interestingly , chemical also phosphorylated gene in SAMP8 mice , which was associated with an increase of gene phosphorylation , contributing therefore to the reductions in gene hyperphosphorylation .	T3	T13	22824191
NA	CHEMICAL	GENE-Y	2	26	Interestingly , chemical also phosphorylated gene in SAMP8 mice , which was associated with an increase of gene phosphorylation , contributing therefore to the reductions in gene hyperphosphorylation .	T3	T14	22824191
NA	CHEMICAL	GENE-Y	19	2	Synaptic pathology in SAMP8 mice , as shown by decreases in gene and gene , was also counteracted by chemical treatment .	T4	T15	22824191
NA	CHEMICAL	GENE-Y	19	13	Synaptic pathology in SAMP8 mice , as shown by decreases in gene and gene , was also counteracted by chemical treatment .	T4	T16	22824191
NA	CHEMICAL	GENE-Y	0	1	chemical ( chemical ) accumulates in tissues and fluids of patients with Smith-Lemli-Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding chemical-Δ ( 7 ) -reductase ( gene ) .	T1	T29	22718275
NA	CHEMICAL	GENE-Y	0	29	chemical ( chemical ) accumulates in tissues and fluids of patients with Smith-Lemli-Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding chemical-Δ ( 7 ) -reductase ( gene ) .	T1	T30	22718275
NA	CHEMICAL	GENE-Y	2	1	chemical ( chemical ) accumulates in tissues and fluids of patients with Smith-Lemli-Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding chemical-Δ ( 7 ) -reductase ( gene ) .	T11	T29	22718275
NA	CHEMICAL	GENE-Y	2	29	chemical ( chemical ) accumulates in tissues and fluids of patients with Smith-Lemli-Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding chemical-Δ ( 7 ) -reductase ( gene ) .	T11	T30	22718275
NA	CHEMICAL	GENE-Y	27	1	chemical ( chemical ) accumulates in tissues and fluids of patients with Smith-Lemli-Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding chemical-Δ ( 7 ) -reductase ( gene ) .	T10	T29	22718275
NA	CHEMICAL	GENE-Y	27	29	chemical ( chemical ) accumulates in tissues and fluids of patients with Smith-Lemli-Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding chemical-Δ ( 7 ) -reductase ( gene ) .	T10	T30	22718275
NA	CHEMICAL	GENE-Y	5	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T15	T31	22718275
NA	CHEMICAL	GENE-Y	33	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T16	T31	22718275
NA	CHEMICAL	GENE-Y	25	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T17	T31	22718275
NA	CHEMICAL	GENE-Y	37	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T18	T31	22718275
NA	CHEMICAL	GENE-Y	25	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T19	T31	22718275
NA	CHEMICAL	GENE-Y	43	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T20	T31	22718275
NA	CHEMICAL	GENE-Y	52	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T21	T31	22718275
NA	CHEMICAL	GENE-Y	25	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T22	T31	22718275
NA	CHEMICAL	GENE-Y	25	26	As the high oxidizability of chemical may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a gene-KO mouse model of SLOS , including chemical , chemical ( chemical ) , and chemical ( chemical ) that are formed from the oxidation of chemical , chemical and chemical , respectively .	T23	T31	22718275
NA	CHEMICAL	GENE-Y	6	31	In addition to a previously described chemical , chemical ( chemical ) , we provide evidence for the chemical structures of three new chemical in the brain and/or liver tissue of gene-KO mice , two of which were quantified .	T24	T32	22718275
NA	CHEMICAL	GENE-Y	7	31	In addition to a previously described chemical , chemical ( chemical ) , we provide evidence for the chemical structures of three new chemical in the brain and/or liver tissue of gene-KO mice , two of which were quantified .	T25	T32	22718275
NA	CHEMICAL	GENE-Y	10	31	In addition to a previously described chemical , chemical ( chemical ) , we provide evidence for the chemical structures of three new chemical in the brain and/or liver tissue of gene-KO mice , two of which were quantified .	T26	T32	22718275
NA	CHEMICAL	GENE-Y	23	31	In addition to a previously described chemical , chemical ( chemical ) , we provide evidence for the chemical structures of three new chemical in the brain and/or liver tissue of gene-KO mice , two of which were quantified .	T27	T32	22718275
NA	CHEMICAL	GENE-Y	5	17	We find that levels of chemical and chemical are also elevated in brain and/or liver tissues of gene-KO mice relative to matching WT mice .	T2	T28	22718275
NA	CHEMICAL	GENE-Y	7	17	We find that levels of chemical and chemical are also elevated in brain and/or liver tissues of gene-KO mice relative to matching WT mice .	T3	T28	22718275
NA	CHEMICAL	GENE-Y	18	18	In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for gene/chemical receptors ( gene/gene ) and gene ( gene ) , have been associated with poor prognosis and metastasis .	T12	T27	23562496
NA	CHEMICAL	GENE-Y	18	19	In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for gene/chemical receptors ( gene/gene ) and gene ( gene ) , have been associated with poor prognosis and metastasis .	T12	T28	23562496
NA	CHEMICAL	GENE-Y	18	21	In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for gene/chemical receptors ( gene/gene ) and gene ( gene ) , have been associated with poor prognosis and metastasis .	T12	T29	23562496
NA	CHEMICAL	GENE-Y	18	21	In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for gene/chemical receptors ( gene/gene ) and gene ( gene ) , have been associated with poor prognosis and metastasis .	T12	T30	23562496
NA	CHEMICAL	GENE-Y	18	24	In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for gene/chemical receptors ( gene/gene ) and gene ( gene ) , have been associated with poor prognosis and metastasis .	T12	T31	23562496
NA	CHEMICAL	GENE-Y	18	26	In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for gene/chemical receptors ( gene/gene ) and gene ( gene ) , have been associated with poor prognosis and metastasis .	T12	T32	23562496
CPR:4	CHEMICAL	GENE-Y	0	6	chemical and chemical induced apoptosis by gene downregulation .	T5	T25	23562496
CPR:4	CHEMICAL	GENE-Y	2	6	chemical and chemical induced apoptosis by gene downregulation .	T6	T25	23562496
CPR:4	CHEMICAL	GENE-Y	2	14	Importantly , chemical and chemical exerted more potent inhibitory effects on the proliferation , gene expression and invasive phenotype of MDA-MB-231 than chemical .	T7	T26	23562496
CPR:4	CHEMICAL	GENE-Y	4	14	Importantly , chemical and chemical exerted more potent inhibitory effects on the proliferation , gene expression and invasive phenotype of MDA-MB-231 than chemical .	T8	T26	23562496
NA	CHEMICAL	GENE-Y	10	14	Importantly , chemical and chemical exerted more potent inhibitory effects on the proliferation , gene expression and invasive phenotype of MDA-MB-231 than chemical .	T9	T26	23562496
CPR:5	CHEMICAL	GENE-Y	4	10	Safety and tolerability of chemical inhalation solution , a novel gene agonist : results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis .	T17	T22	15704203
CPR:5	CHEMICAL	GENE-Y	0	1	chemical ( chemical ) is a selective gene agonist that stimulates ciliary beat frequency and chemical secretion in normal and cystic fibrosis ( CF ) airway epithelia , and is being investigated as an inhaled treatment for CF .	T1	T20	15704203
CPR:5	CHEMICAL	GENE-Y	2	1	chemical ( chemical ) is a selective gene agonist that stimulates ciliary beat frequency and chemical secretion in normal and cystic fibrosis ( CF ) airway epithelia , and is being investigated as an inhaled treatment for CF .	T9	T20	15704203
NA	CHEMICAL	GENE-Y	1	1	chemical ( chemical ) is a selective gene agonist that stimulates ciliary beat frequency and chemical secretion in normal and cystic fibrosis ( CF ) airway epithelia , and is being investigated as an inhaled treatment for CF .	T2	T20	15704203
CPR:9	CHEMICAL	GENE-Y	1	8	The chemical secretory response is mediated via a non-gene pathway , and the driving force for chemical secretion is enhanced by the effect of gene activation to also inhibit epithelial chemical transport .	T10	T18	15704203
NA	CHEMICAL	GENE-Y	1	24	The chemical secretory response is mediated via a non-gene pathway , and the driving force for chemical secretion is enhanced by the effect of gene activation to also inhibit epithelial chemical transport .	T10	T19	15704203
NA	CHEMICAL	GENE-Y	16	8	The chemical secretory response is mediated via a non-gene pathway , and the driving force for chemical secretion is enhanced by the effect of gene activation to also inhibit epithelial chemical transport .	T12	T18	15704203
NA	CHEMICAL	GENE-Y	16	24	The chemical secretory response is mediated via a non-gene pathway , and the driving force for chemical secretion is enhanced by the effect of gene activation to also inhibit epithelial chemical transport .	T12	T19	15704203
NA	CHEMICAL	GENE-Y	7	8	The chemical secretory response is mediated via a non-gene pathway , and the driving force for chemical secretion is enhanced by the effect of gene activation to also inhibit epithelial chemical transport .	T13	T18	15704203
NA	CHEMICAL	GENE-Y	7	24	The chemical secretory response is mediated via a non-gene pathway , and the driving force for chemical secretion is enhanced by the effect of gene activation to also inhibit epithelial chemical transport .	T13	T19	15704203
CPR:5	CHEMICAL	GENE-Y	0	23	chemical is metabolically more stable and better tolerated , and may enhance mucociliary clearance for a longer period of time than previously investigated gene agonists .	T14	T21	15704203
NA	CHEMICAL	GENE-N	7	8	Characterization of binding sites of a new chemical receptor antagonist , chemical , in the rat brain .	T23	T33	9551716
CPR:6	CHEMICAL	GENE-N	11	8	Characterization of binding sites of a new chemical receptor antagonist , chemical , in the rat brain .	T24	T33	9551716
NA	CHEMICAL	GENE-N	19	20	The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of chemical receptors , chemical ( chemical ) , in the rat brain .	T8	T28	9551716
CPR:6	CHEMICAL	GENE-N	22	20	The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of chemical receptors , chemical ( chemical ) , in the rat brain .	T12	T28	9551716
CPR:6	CHEMICAL	GENE-N	24	20	The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of chemical receptors , chemical ( chemical ) , in the rat brain .	T14	T28	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T1	T25	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T1	T26	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T1	T27	9551716
CPR:6	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T2	T25	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T2	T26	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T2	T27	9551716
NA	CHEMICAL	GENE-Y	20	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T3	T25	9551716
NA	CHEMICAL	GENE-Y	20	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T3	T26	9551716
NA	CHEMICAL	GENE-Y	20	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T3	T27	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T4	T25	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T4	T26	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T4	T27	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T5	T25	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T5	T26	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T5	T27	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T6	T25	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T6	T26	9551716
NA	CHEMICAL	GENE-Y	4	7	Saturation and competition studies in the presence or absence of the chemical H1 receptor antagonist , chemical , revealed that chemical bound with similar affinities to both the chemical-insensitive chemical NT1 receptors ( 20 % of the total binding population ) and the recently cloned chemical-sensitive gene ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .	T6	T27	9551716
NA	CHEMICAL	GENE-N	8	0	A total of 68 chemicals including derivatives of chemical , chemical , chemical , chemical , chemical , and chemical were examined for their abilities to interact with gene .	T9	T40	23432429
NA	CHEMICAL	GENE-N	10	0	A total of 68 chemicals including derivatives of chemical , chemical , chemical , chemical , chemical , and chemical were examined for their abilities to interact with gene .	T17	T40	23432429
NA	CHEMICAL	GENE-N	12	0	A total of 68 chemicals including derivatives of chemical , chemical , chemical , chemical , chemical , and chemical were examined for their abilities to interact with gene .	T22	T40	23432429
NA	CHEMICAL	GENE-N	14	0	A total of 68 chemicals including derivatives of chemical , chemical , chemical , chemical , chemical , and chemical were examined for their abilities to interact with gene .	T27	T40	23432429
NA	CHEMICAL	GENE-N	16	0	A total of 68 chemicals including derivatives of chemical , chemical , chemical , chemical , chemical , and chemical were examined for their abilities to interact with gene .	T31	T40	23432429
NA	CHEMICAL	GENE-N	19	0	A total of 68 chemicals including derivatives of chemical , chemical , chemical , chemical , chemical , and chemical were examined for their abilities to interact with gene .	T6	T40	23432429
NA	CHEMICAL	GENE-Y	12	20	Fifty-one of these 68 chemicals induced stronger Type I binding spectra ( chemical low- to high-spin state shift ) with gene than those seen with gene , i.e. , the spectral binding intensities ( ΔAmax/Ks ratio ) determined with these chemicals were always higher for gene .	T7	T45	23432429
NA	CHEMICAL	GENE-N	12	25	Fifty-one of these 68 chemicals induced stronger Type I binding spectra ( chemical low- to high-spin state shift ) with gene than those seen with gene , i.e. , the spectral binding intensities ( ΔAmax/Ks ratio ) determined with these chemicals were always higher for gene .	T7	T46	23432429
NA	CHEMICAL	GENE-Y	12	45	Fifty-one of these 68 chemicals induced stronger Type I binding spectra ( chemical low- to high-spin state shift ) with gene than those seen with gene , i.e. , the spectral binding intensities ( ΔAmax/Ks ratio ) determined with these chemicals were always higher for gene .	T7	T47	23432429
NA	CHEMICAL	GENE-Y	3	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T8	T48	23432429
NA	CHEMICAL	GENE-Y	5	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T10	T48	23432429
NA	CHEMICAL	GENE-Y	2	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T11	T48	23432429
NA	CHEMICAL	GENE-Y	9	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T12	T48	23432429
NA	CHEMICAL	GENE-Y	11	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T13	T48	23432429
NA	CHEMICAL	GENE-Y	13	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T14	T48	23432429
NA	CHEMICAL	GENE-Y	15	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T15	T48	23432429
NA	CHEMICAL	GENE-Y	17	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T16	T48	23432429
NA	CHEMICAL	GENE-Y	2	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T18	T48	23432429
NA	CHEMICAL	GENE-Y	21	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T19	T48	23432429
NA	CHEMICAL	GENE-Y	23	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T20	T48	23432429
NA	CHEMICAL	GENE-Y	26	38	In addition , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical were found to induce a Type I spectral change only with gene .	T21	T48	23432429
CPR:9	CHEMICAL	GENE-Y	0	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T23	T49	23432429
CPR:4	CHEMICAL	GENE-Y	2	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T24	T49	23432429
CPR:4	CHEMICAL	GENE-Y	13	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T25	T49	23432429
CPR:4	CHEMICAL	GENE-Y	15	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T26	T49	23432429
CPR:4	CHEMICAL	GENE-Y	17	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T28	T49	23432429
CPR:4	CHEMICAL	GENE-Y	19	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T29	T49	23432429
CPR:4	CHEMICAL	GENE-Y	21	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T30	T49	23432429
CPR:4	CHEMICAL	GENE-Y	23	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T32	T49	23432429
CPR:4	CHEMICAL	GENE-Y	25	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T33	T49	23432429
CPR:4	CHEMICAL	GENE-Y	27	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T1	T49	23432429
CPR:4	CHEMICAL	GENE-Y	0	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T2	T49	23432429
CPR:4	CHEMICAL	GENE-Y	21	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T3	T49	23432429
CPR:4	CHEMICAL	GENE-Y	5	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T4	T49	23432429
CPR:4	CHEMICAL	GENE-Y	36	5	chemical 7-hydroxylation , catalyzed by gene , was strongly inhibited by chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical ; these chemicals induced Type I spectral changes with low Ks values .	T5	T49	23432429
NA	CHEMICAL	GENE-Y	3	4	Localization of an chemical dehydrogenase activity to the distal nephron .	T20	T35	1727721
NA	CHEMICAL	GENE-Y	1	2	An chemical dehydrogenase ( gene ) activity has been localized in the rat kidney by a histochemical technique which links chemical metabolism with the production of a color reaction .	T10	T27	1727721
NA	CHEMICAL	GENE-Y	1	4	An chemical dehydrogenase ( gene ) activity has been localized in the rat kidney by a histochemical technique which links chemical metabolism with the production of a color reaction .	T10	T28	1727721
NA	CHEMICAL	GENE-Y	20	2	An chemical dehydrogenase ( gene ) activity has been localized in the rat kidney by a histochemical technique which links chemical metabolism with the production of a color reaction .	T6	T27	1727721
NA	CHEMICAL	GENE-Y	20	4	An chemical dehydrogenase ( gene ) activity has been localized in the rat kidney by a histochemical technique which links chemical metabolism with the production of a color reaction .	T6	T28	1727721
NA	CHEMICAL	GENE-N	6	6	These results demonstrate the presence of a gene activity separate from the chemical ( chemical ) -dependent chemical dehydrogenase recently purified and cloned from rat liver .	T16	T29	1727721
NA	CHEMICAL	GENE-Y	6	6	These results demonstrate the presence of a gene activity separate from the chemical ( chemical ) -dependent chemical dehydrogenase recently purified and cloned from rat liver .	T16	T30	1727721
NA	CHEMICAL	GENE-N	14	6	These results demonstrate the presence of a gene activity separate from the chemical ( chemical ) -dependent chemical dehydrogenase recently purified and cloned from rat liver .	T17	T29	1727721
NA	CHEMICAL	GENE-Y	14	6	These results demonstrate the presence of a gene activity separate from the chemical ( chemical ) -dependent chemical dehydrogenase recently purified and cloned from rat liver .	T17	T30	1727721
NA	CHEMICAL	GENE-N	17	6	These results demonstrate the presence of a gene activity separate from the chemical ( chemical ) -dependent chemical dehydrogenase recently purified and cloned from rat liver .	T18	T29	1727721
NA	CHEMICAL	GENE-Y	17	6	These results demonstrate the presence of a gene activity separate from the chemical ( chemical ) -dependent chemical dehydrogenase recently purified and cloned from rat liver .	T18	T30	1727721
NA	CHEMICAL	GENE-Y	11	5	We have named this activity gene to distinguish it from the chemical-dependent gene .	T19	T31	1727721
NA	CHEMICAL	GENE-Y	11	12	We have named this activity gene to distinguish it from the chemical-dependent gene .	T19	T32	1727721
NA	CHEMICAL	GENE-Y	9	11	An investigation of the absolute configuration of the potent chemical H3 receptor antagonist chemical using vibrational circular dichroism .	T4	T7	17575572
CPR:6	CHEMICAL	GENE-Y	13	11	An investigation of the absolute configuration of the potent chemical H3 receptor antagonist chemical using vibrational circular dichroism .	T5	T7	17575572
NA	CHEMICAL	GENE-N	9	5	Analysis of coenzyme binding by gene and gene using chemical , an affinity labeling cofactor analog .	T18	T27	1911436
NA	CHEMICAL	GENE-N	9	7	Analysis of coenzyme binding by gene and gene using chemical , an affinity labeling cofactor analog .	T18	T28	1911436
NA	CHEMICAL	GENE-N	0	1	chemical dehydrogenase and gene copurify as a single , homogeneous protein from human placental microsomes .	T1	T20	1911436
NA	CHEMICAL	GENE-N	0	3	chemical dehydrogenase and gene copurify as a single , homogeneous protein from human placental microsomes .	T1	T24	1911436
NA	CHEMICAL	GENE-N	4	8	Affinity alkylation with 2 chemical suggests that the gene and isomerase substrate chemical bind at different sites on the same protein .	T7	T23	1911436
CPR:9	CHEMICAL	GENE-N	12	8	Affinity alkylation with 2 chemical suggests that the gene and isomerase substrate chemical bind at different sites on the same protein .	T8	T23	1911436
NA	CHEMICAL	GENE-N	2	3	Unlike bacterial chemical isomerase , the human isomerase reaction is stimulated by chemical ( chemical , chemical ) .	T11	T25	1911436
NA	CHEMICAL	GENE-N	12	3	Unlike bacterial chemical isomerase , the human isomerase reaction is stimulated by chemical ( chemical , chemical ) .	T12	T25	1911436
NA	CHEMICAL	GENE-N	14	3	Unlike bacterial chemical isomerase , the human isomerase reaction is stimulated by chemical ( chemical , chemical ) .	T13	T25	1911436
NA	CHEMICAL	GENE-N	16	3	Unlike bacterial chemical isomerase , the human isomerase reaction is stimulated by chemical ( chemical , chemical ) .	T14	T25	1911436
CPR:4	CHEMICAL	GENE-N	3	13	The affinity labeling chemical analog , chemical ( chemical ) , inactivates the gene and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration ( 0.2-0.6 mM ) .	T15	T26	1911436
CPR:4	CHEMICAL	GENE-N	6	13	The affinity labeling chemical analog , chemical ( chemical ) , inactivates the gene and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration ( 0.2-0.6 mM ) .	T16	T26	1911436
CPR:4	CHEMICAL	GENE-N	8	13	The affinity labeling chemical analog , chemical ( chemical ) , inactivates the gene and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration ( 0.2-0.6 mM ) .	T17	T26	1911436
NA	CHEMICAL	GENE-N	16	2	FSA is a cofactor site-directed reagent that binds with similar affinity as a competitive inhibitor of chemical reduction by gene ( Ki = 162 microM ) or as a stimulator of isomerase ( Km = 153 microM ) .	T2	T21	1911436
CPR:4	CHEMICAL	GENE-Y	4	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T3	T17	23396144
CPR:4	CHEMICAL	GENE-Y	4	37	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T3	T18	23396144
CPR:4	CHEMICAL	GENE-Y	4	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T3	T19	23396144
CPR:4	CHEMICAL	GENE-Y	4	56	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T3	T20	23396144
CPR:4	CHEMICAL	GENE-Y	4	17	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T3	T21	23396144
CPR:4	CHEMICAL	GENE-Y	4	62	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T3	T22	23396144
CPR:4	CHEMICAL	GENE-Y	6	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T4	T17	23396144
CPR:4	CHEMICAL	GENE-Y	6	37	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T4	T18	23396144
CPR:4	CHEMICAL	GENE-Y	6	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T4	T19	23396144
CPR:4	CHEMICAL	GENE-Y	6	56	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T4	T20	23396144
CPR:4	CHEMICAL	GENE-Y	6	17	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T4	T21	23396144
CPR:4	CHEMICAL	GENE-Y	6	62	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T4	T22	23396144
CPR:4	CHEMICAL	GENE-Y	11	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T5	T17	23396144
CPR:4	CHEMICAL	GENE-Y	11	37	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T5	T18	23396144
CPR:4	CHEMICAL	GENE-Y	11	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T5	T19	23396144
CPR:4	CHEMICAL	GENE-Y	11	56	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T5	T20	23396144
CPR:4	CHEMICAL	GENE-Y	11	17	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T5	T21	23396144
CPR:4	CHEMICAL	GENE-Y	11	62	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T5	T22	23396144
CPR:4	CHEMICAL	GENE-Y	25	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T6	T17	23396144
CPR:4	CHEMICAL	GENE-Y	25	37	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T6	T18	23396144
CPR:4	CHEMICAL	GENE-Y	25	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T6	T19	23396144
CPR:4	CHEMICAL	GENE-Y	25	56	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T6	T20	23396144
CPR:4	CHEMICAL	GENE-Y	25	17	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T6	T21	23396144
CPR:4	CHEMICAL	GENE-Y	25	62	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T6	T22	23396144
CPR:4	CHEMICAL	GENE-Y	27	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T7	T17	23396144
CPR:4	CHEMICAL	GENE-Y	27	37	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T7	T18	23396144
CPR:4	CHEMICAL	GENE-Y	27	21	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T7	T19	23396144
CPR:4	CHEMICAL	GENE-Y	27	56	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T7	T20	23396144
CPR:4	CHEMICAL	GENE-Y	27	17	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T7	T21	23396144
CPR:4	CHEMICAL	GENE-Y	27	62	In HaCaT cells , chemical and chemical fractions of 80 % chemical C. fragile extract ( CFB or CFE ) and a single compound , chemical ( chemical ) isolated from CFE attenuated UVB ( 60mJ/cm ( 2 ) ) -induced cytotoxicity and reduced expression of pro-inflammatory proteins including gene ( gene ) , gene ( gene ) , and gene ( gene ) .	T7	T22	23396144
CPR:4	CHEMICAL	GENE-Y	11	19	In another experiment , topical application of CFB , CFE or chemical prior to UVB irradiation ( 200mJ/cm ( 2 ) ) on BALB/c mice , inhibited the UVB-elevated protein levels of gene , gene , and gene .	T1	T14	23396144
CPR:4	CHEMICAL	GENE-Y	11	34	In another experiment , topical application of CFB , CFE or chemical prior to UVB irradiation ( 200mJ/cm ( 2 ) ) on BALB/c mice , inhibited the UVB-elevated protein levels of gene , gene , and gene .	T1	T15	23396144
CPR:4	CHEMICAL	GENE-Y	11	37	In another experiment , topical application of CFB , CFE or chemical prior to UVB irradiation ( 200mJ/cm ( 2 ) ) on BALB/c mice , inhibited the UVB-elevated protein levels of gene , gene , and gene .	T1	T16	23396144
NA	CHEMICAL	GENE-Y	5	31	When using double staining with chemical for mineralized matrix and chemical for cartilaginous matrix , we observed previously that mineralization was totally absent at embryonic day 15.5 throughout the body in gene ( -/- ) mice , but was found in areas undergoing intramembranous ossification such as skull and clavicles in gene-Cre ; gene ( flox/flox ) mice .	T1	T26	23553905
NA	CHEMICAL	GENE-Y	5	32	When using double staining with chemical for mineralized matrix and chemical for cartilaginous matrix , we observed previously that mineralization was totally absent at embryonic day 15.5 throughout the body in gene ( -/- ) mice , but was found in areas undergoing intramembranous ossification such as skull and clavicles in gene-Cre ; gene ( flox/flox ) mice .	T1	T3	23553905
NA	CHEMICAL	GENE-Y	10	31	When using double staining with chemical for mineralized matrix and chemical for cartilaginous matrix , we observed previously that mineralization was totally absent at embryonic day 15.5 throughout the body in gene ( -/- ) mice , but was found in areas undergoing intramembranous ossification such as skull and clavicles in gene-Cre ; gene ( flox/flox ) mice .	T2	T26	23553905
NA	CHEMICAL	GENE-Y	10	32	When using double staining with chemical for mineralized matrix and chemical for cartilaginous matrix , we observed previously that mineralization was totally absent at embryonic day 15.5 throughout the body in gene ( -/- ) mice , but was found in areas undergoing intramembranous ossification such as skull and clavicles in gene-Cre ; gene ( flox/flox ) mice .	T2	T3	23553905
NA	CHEMICAL	GENE-Y	7	44	In the current study dietary relevant mixtures of chemical and their metabolites , chemical and their metabolites , chemical , and a mixture containing all of them , were examined for effects on adipogenesis in 3T3-L1 adipocytes , as well as tested for their gene activating abilities .	T2	T11	23348407
NA	CHEMICAL	GENE-Y	13	44	In the current study dietary relevant mixtures of chemical and their metabolites , chemical and their metabolites , chemical , and a mixture containing all of them , were examined for effects on adipogenesis in 3T3-L1 adipocytes , as well as tested for their gene activating abilities .	T3	T11	23348407
NA	CHEMICAL	GENE-Y	18	44	In the current study dietary relevant mixtures of chemical and their metabolites , chemical and their metabolites , chemical , and a mixture containing all of them , were examined for effects on adipogenesis in 3T3-L1 adipocytes , as well as tested for their gene activating abilities .	T4	T11	23348407
CPR:3	CHEMICAL	GENE-Y	2	19	Furthermore , a mixture of chemical parent compounds , and a mixture of chemical metabolites were found to have gene activating abilities .	T8	T12	23348407
CPR:3	CHEMICAL	GENE-Y	2	19	Furthermore , a mixture of chemical parent compounds , and a mixture of chemical metabolites were found to have gene activating abilities .	T9	T12	23348407
NA	CHEMICAL	GENE-N	0	1	chemical receptors of type 6 ( gene ) : from neuroscience to clinical pharmacology .	T6	T14	23157629
NA	CHEMICAL	GENE-Y	0	4	chemical receptors of type 6 ( gene ) : from neuroscience to clinical pharmacology .	T6	T15	23157629
NA	CHEMICAL	GENE-N	1	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T4	T9	23157629
NA	CHEMICAL	GENE-Y	1	8	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T4	T8	23157629
NA	CHEMICAL	GENE-N	1	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T4	T13	23157629
NA	CHEMICAL	GENE-N	3	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T1	T9	23157629
NA	CHEMICAL	GENE-Y	3	8	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T1	T8	23157629
NA	CHEMICAL	GENE-N	3	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T1	T13	23157629
NA	CHEMICAL	GENE-N	18	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T5	T9	23157629
NA	CHEMICAL	GENE-Y	18	8	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T5	T8	23157629
NA	CHEMICAL	GENE-N	18	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T5	T13	23157629
NA	CHEMICAL	GENE-N	32	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T2	T9	23157629
NA	CHEMICAL	GENE-Y	32	8	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T2	T8	23157629
NA	CHEMICAL	GENE-N	32	5	The chemical ( chemical ) receptors of type 6 ( gene ) are quite different from all other chemical receptors , as they include a short third cytoplasmatic loop and a long chemical-terminal tail , and one intron located in the middle of the third cytoplasmatic loop .	T2	T13	23157629
NA	CHEMICAL	GENE-Y	17	13	A lot of controversies still exist regarding their binding affinity , effects of gene ligands on brain chemical , behavioral syndromes regulated by them , and brain distribution .	T3	T7	23157629
NA	CHEMICAL	GENE-N	2	6	Binding and chemical autoradiographic analysis of gene products at the gene and gene .	T9	T38	12842269
NA	CHEMICAL	GENE-Y	2	10	Binding and chemical autoradiographic analysis of gene products at the gene and gene .	T9	T36	12842269
NA	CHEMICAL	GENE-N	2	12	Binding and chemical autoradiographic analysis of gene products at the gene and gene .	T9	T37	12842269
NA	CHEMICAL	GENE-N	2	10	Utilizing agonist-stimulated chemical autoradiography , we analyzed the ability of gene to stimulate chemical binding in adult rat brain .	T5	T30	12842269
NA	CHEMICAL	GENE-N	13	10	Utilizing agonist-stimulated chemical autoradiography , we analyzed the ability of gene to stimulate chemical binding in adult rat brain .	T1	T30	12842269
NA	CHEMICAL	GENE-Y	5	0	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T3	T17	12842269
NA	CHEMICAL	GENE-Y	5	2	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T3	T18	12842269
NA	CHEMICAL	GENE-Y	5	18	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T3	T19	12842269
NA	CHEMICAL	GENE-Y	5	11	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T3	T20	12842269
NA	CHEMICAL	GENE-Y	16	0	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T4	T17	12842269
NA	CHEMICAL	GENE-Y	16	2	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T4	T18	12842269
NA	CHEMICAL	GENE-Y	16	18	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T4	T19	12842269
NA	CHEMICAL	GENE-Y	16	11	gene ( gene ) stimulated chemical binding in a pattern similar to that described for [ chemical ] -gene at the endogenous gene .	T4	T20	12842269
NA	CHEMICAL	GENE-Y	7	1	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T6	T26	12842269
NA	CHEMICAL	GENE-Y	7	10	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T6	T27	12842269
NA	CHEMICAL	GENE-Y	7	17	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T6	T28	12842269
NA	CHEMICAL	GENE-Y	13	1	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T7	T26	12842269
NA	CHEMICAL	GENE-Y	13	10	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T7	T27	12842269
NA	CHEMICAL	GENE-Y	13	17	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T7	T28	12842269
NA	CHEMICAL	GENE-Y	16	1	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T8	T26	12842269
NA	CHEMICAL	GENE-Y	16	10	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T8	T27	12842269
NA	CHEMICAL	GENE-Y	16	17	Unlike gene , high concentrations of its chemical-terminal extension , gene , stimulated chemical binding in a gene-like distribution and the effect was blocked by chemical .	T8	T28	12842269
NA	CHEMICAL	GENE-Y	0	4	chemical , chemical and gene inhibitors in renal cancer .	T11	T27	17935273
NA	CHEMICAL	GENE-Y	2	4	chemical , chemical and gene inhibitors in renal cancer .	T12	T27	17935273
NA	CHEMICAL	GENE-N	16	2	Overexpression of gene ( gene ) is also caused by the gene ( gene ) , a key component of signaling pathways inside the cell , involved in cell proliferation .	T10	T22	17935273
NA	CHEMICAL	GENE-N	16	4	Overexpression of gene ( gene ) is also caused by the gene ( gene ) , a key component of signaling pathways inside the cell , involved in cell proliferation .	T10	T23	17935273
NA	CHEMICAL	GENE-Y	16	11	Overexpression of gene ( gene ) is also caused by the gene ( gene ) , a key component of signaling pathways inside the cell , involved in cell proliferation .	T10	T24	17935273
NA	CHEMICAL	GENE-Y	16	13	Overexpression of gene ( gene ) is also caused by the gene ( gene ) , a key component of signaling pathways inside the cell , involved in cell proliferation .	T10	T25	17935273
NA	CHEMICAL	GENE-N	0	13	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T4	T13	17935273
CPR:4	CHEMICAL	GENE-Y	0	15	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T4	T14	17935273
CPR:4	CHEMICAL	GENE-Y	0	17	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T4	T15	17935273
CPR:4	CHEMICAL	GENE-Y	0	20	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T4	T16	17935273
CPR:4	CHEMICAL	GENE-Y	0	22	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T4	T17	17935273
NA	CHEMICAL	GENE-Y	0	29	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T4	T18	17935273
NA	CHEMICAL	GENE-N	2	13	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T5	T13	17935273
CPR:4	CHEMICAL	GENE-Y	2	15	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T5	T14	17935273
CPR:4	CHEMICAL	GENE-Y	2	17	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T5	T15	17935273
CPR:4	CHEMICAL	GENE-Y	2	20	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T5	T16	17935273
CPR:4	CHEMICAL	GENE-Y	2	22	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T5	T17	17935273
NA	CHEMICAL	GENE-Y	2	29	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T5	T18	17935273
NA	CHEMICAL	GENE-N	26	13	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T6	T13	17935273
NA	CHEMICAL	GENE-Y	26	15	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T6	T14	17935273
NA	CHEMICAL	GENE-Y	26	17	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T6	T15	17935273
NA	CHEMICAL	GENE-Y	26	20	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T6	T16	17935273
NA	CHEMICAL	GENE-Y	26	22	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T6	T17	17935273
CPR:4	CHEMICAL	GENE-Y	26	29	chemical and chemical are synthetic , orally active agents shown to directly inhibit gene ( gene , gene ) and gene ( gene ) , while chemical is an gene inhibitor .	T6	T18	17935273
CPR:3	CHEMICAL	GENE-Y	0	6	chemical alleviates hepatocyte steatosis through activating gene signaling pathway .	T7	T22	23395669
NA	CHEMICAL	GENE-N	0	25	chemical , an effective compound derived from foxtail-like sophora herb and seed , has been reported that it can alleviate non-alcoholic steatohepatitis ( NASH ) in rats and affect gene synthesis .	T1	T15	23395669
CPR:4	CHEMICAL	GENE-Y	1	4	While chemical treatment resulted in : significant improvement of steatosis ( > 50 % decrease ) , decrease of gene expression ( < 0.57-fold ) and increase of gene expression ( > 1.48-fold ) .	T6	T20	23395669
CPR:3	CHEMICAL	GENE-Y	1	4	While chemical treatment resulted in : significant improvement of steatosis ( > 50 % decrease ) , decrease of gene expression ( < 0.57-fold ) and increase of gene expression ( > 1.48-fold ) .	T6	T21	23395669
CPR:3	CHEMICAL	GENE-N	8	12	Moreover , compared with the model group , chemical could significantly increase gene ( > 5.82-fold ) , gene ( > 1.29-fold ) and gene ( > 3.27-fold ) protein expressions , and reduce gene ( < 0.30-fold ) and gene ( < 0.20-fold ) protein expression .	T2	T8	23395669
CPR:3	CHEMICAL	GENE-N	8	18	Moreover , compared with the model group , chemical could significantly increase gene ( > 5.82-fold ) , gene ( > 1.29-fold ) and gene ( > 3.27-fold ) protein expressions , and reduce gene ( < 0.30-fold ) and gene ( < 0.20-fold ) protein expression .	T2	T9	23395669
CPR:3	CHEMICAL	GENE-N	8	24	Moreover , compared with the model group , chemical could significantly increase gene ( > 5.82-fold ) , gene ( > 1.29-fold ) and gene ( > 3.27-fold ) protein expressions , and reduce gene ( < 0.30-fold ) and gene ( < 0.20-fold ) protein expression .	T2	T10	23395669
CPR:4	CHEMICAL	GENE-N	8	34	Moreover , compared with the model group , chemical could significantly increase gene ( > 5.82-fold ) , gene ( > 1.29-fold ) and gene ( > 3.27-fold ) protein expressions , and reduce gene ( < 0.30-fold ) and gene ( < 0.20-fold ) protein expression .	T2	T11	23395669
CPR:4	CHEMICAL	GENE-Y	8	40	Moreover , compared with the model group , chemical could significantly increase gene ( > 5.82-fold ) , gene ( > 1.29-fold ) and gene ( > 3.27-fold ) protein expressions , and reduce gene ( < 0.30-fold ) and gene ( < 0.20-fold ) protein expression .	T2	T12	23395669
CPR:3	CHEMICAL	GENE-N	0	4	chemical increases chemical-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes .	T18	T30	12086935
NA	CHEMICAL	GENE-N	2	4	chemical increases chemical-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes .	T19	T30	12086935
NA	CHEMICAL	GENE-N	0	2	chemical-activated protein kinase ( gene ) activity increases in response to depletion of cellular energy stores , and this enzyme has been implicated in the stimulation of chemical uptake into skeletal muscle and the inhibition of liver gluconeogenesis .	T10	T23	12086935
NA	CHEMICAL	GENE-N	0	4	chemical-activated protein kinase ( gene ) activity increases in response to depletion of cellular energy stores , and this enzyme has been implicated in the stimulation of chemical uptake into skeletal muscle and the inhibition of liver gluconeogenesis .	T10	T24	12086935
CPR:9	CHEMICAL	GENE-N	27	2	chemical-activated protein kinase ( gene ) activity increases in response to depletion of cellular energy stores , and this enzyme has been implicated in the stimulation of chemical uptake into skeletal muscle and the inhibition of liver gluconeogenesis .	T11	T23	12086935
CPR:9	CHEMICAL	GENE-N	27	4	chemical-activated protein kinase ( gene ) activity increases in response to depletion of cellular energy stores , and this enzyme has been implicated in the stimulation of chemical uptake into skeletal muscle and the inhibition of liver gluconeogenesis .	T11	T24	12086935
CPR:3	CHEMICAL	GENE-N	8	4	We recently reported that gene is activated by chemical in cultured rat hepatocytes , mediating the inhibitory effects of the drug on hepatic chemical production .	T12	T25	12086935
NA	CHEMICAL	GENE-N	23	4	We recently reported that gene is activated by chemical in cultured rat hepatocytes , mediating the inhibitory effects of the drug on hepatic chemical production .	T14	T25	12086935
CPR:3	CHEMICAL	GENE-N	11	13	In the present study , we evaluated whether therapeutic doses of chemical increase gene activity in vivo in subjects with type 2 diabetes .	T15	T26	12086935
CPR:3	CHEMICAL	GENE-Y	0	7	chemical treatment for 10 weeks significantly increased gene activity in the skeletal muscle , and this was associated with increased phosphorylation of gene on Thr172 and decreased chemical carboxylase-2 activity .	T16	T27	12086935
CPR:3	CHEMICAL	GENE-N	0	22	chemical treatment for 10 weeks significantly increased gene activity in the skeletal muscle , and this was associated with increased phosphorylation of gene on Thr172 and decreased chemical carboxylase-2 activity .	T16	T28	12086935
CPR:4	CHEMICAL	GENE-Y	0	28	chemical treatment for 10 weeks significantly increased gene activity in the skeletal muscle , and this was associated with increased phosphorylation of gene on Thr172 and decreased chemical carboxylase-2 activity .	T16	T29	12086935
NA	CHEMICAL	GENE-Y	27	7	chemical treatment for 10 weeks significantly increased gene activity in the skeletal muscle , and this was associated with increased phosphorylation of gene on Thr172 and decreased chemical carboxylase-2 activity .	T17	T27	12086935
NA	CHEMICAL	GENE-N	27	22	chemical treatment for 10 weeks significantly increased gene activity in the skeletal muscle , and this was associated with increased phosphorylation of gene on Thr172 and decreased chemical carboxylase-2 activity .	T17	T28	12086935
NA	CHEMICAL	GENE-Y	27	28	chemical treatment for 10 weeks significantly increased gene activity in the skeletal muscle , and this was associated with increased phosphorylation of gene on Thr172 and decreased chemical carboxylase-2 activity .	T17	T29	12086935
NA	CHEMICAL	GENE-Y	16	3	The increase in gene activity was likely due to a change in muscle energy status because chemical and chemical concentrations were lower after chemical treatment .	T3	T20	12086935
NA	CHEMICAL	GENE-Y	2	3	The increase in gene activity was likely due to a change in muscle energy status because chemical and chemical concentrations were lower after chemical treatment .	T4	T20	12086935
CPR:3	CHEMICAL	GENE-Y	2	3	The increase in gene activity was likely due to a change in muscle energy status because chemical and chemical concentrations were lower after chemical treatment .	T5	T20	12086935
CPR:3	CHEMICAL	GENE-N	0	3	chemical-induced increases in gene activity were associated with higher rates of chemical disposal and muscle glycogen concentrations .	T6	T21	12086935
NA	CHEMICAL	GENE-N	11	3	chemical-induced increases in gene activity were associated with higher rates of chemical disposal and muscle glycogen concentrations .	T7	T21	12086935
CPR:4	CHEMICAL	GENE-N	4	9	In utero exposure to chemical ( chemical ) , a gene ( gene ) inhibitor , causes neural tube , heart , and limb defects .	T6	T19	23042728
CPR:4	CHEMICAL	GENE-N	4	12	In utero exposure to chemical ( chemical ) , a gene ( gene ) inhibitor , causes neural tube , heart , and limb defects .	T6	T20	23042728
CPR:4	CHEMICAL	GENE-N	6	9	In utero exposure to chemical ( chemical ) , a gene ( gene ) inhibitor , causes neural tube , heart , and limb defects .	T9	T19	23042728
CPR:4	CHEMICAL	GENE-N	6	12	In utero exposure to chemical ( chemical ) , a gene ( gene ) inhibitor , causes neural tube , heart , and limb defects .	T9	T20	23042728
NA	CHEMICAL	GENE-N	0	14	chemical ( chemical ) , the chemical derivative of chemical , does not inhibit gene activity and is a weak teratogen in vivo .	T2	T18	23042728
NA	CHEMICAL	GENE-N	2	14	chemical ( chemical ) , the chemical derivative of chemical , does not inhibit gene activity and is a weak teratogen in vivo .	T3	T18	23042728
NA	CHEMICAL	GENE-N	6	14	chemical ( chemical ) , the chemical derivative of chemical , does not inhibit gene activity and is a weak teratogen in vivo .	T4	T18	23042728
NA	CHEMICAL	GENE-N	9	14	chemical ( chemical ) , the chemical derivative of chemical , does not inhibit gene activity and is a weak teratogen in vivo .	T5	T18	23042728
CPR:4	CHEMICAL	GENE-N	0	16	chemical caused a significant concentration- dependent increase in limb abnormalities , which was correlated with its gene inhibitory effect .	T12	T21	23042728
CPR:4	CHEMICAL	GENE-Y	16	4	The signaling of both gene and gene , key regulators of chondrogenesis , was downregulated by chemical .	T13	T22	23042728
CPR:4	CHEMICAL	GENE-Y	16	6	The signaling of both gene and gene , key regulators of chondrogenesis , was downregulated by chemical .	T13	T23	23042728
NA	CHEMICAL	GENE-N	3	15	In contrast , chemical had little effect on limb morphology and no significant effect on gene activity or the expression of marker genes .	T14	T24	23042728
NA	CHEMICAL	GENE-N	2	3	Analysis of chemical receptors in the human spinal cord .	T11	T27	9417820
NA	CHEMICAL	GENE-N	0	1	chemical receptors in postmortem human spinal cord were analyzed using chemical ligand binding and immunoblotting with chemical receptor subunit-specific antibodies .	T1	T12	9417820
NA	CHEMICAL	GENE-N	0	17	chemical receptors in postmortem human spinal cord were analyzed using chemical ligand binding and immunoblotting with chemical receptor subunit-specific antibodies .	T1	T13	9417820
NA	CHEMICAL	GENE-N	10	1	chemical receptors in postmortem human spinal cord were analyzed using chemical ligand binding and immunoblotting with chemical receptor subunit-specific antibodies .	T7	T12	9417820
NA	CHEMICAL	GENE-N	10	17	chemical receptors in postmortem human spinal cord were analyzed using chemical ligand binding and immunoblotting with chemical receptor subunit-specific antibodies .	T7	T13	9417820
NA	CHEMICAL	GENE-N	16	1	chemical receptors in postmortem human spinal cord were analyzed using chemical ligand binding and immunoblotting with chemical receptor subunit-specific antibodies .	T2	T12	9417820
NA	CHEMICAL	GENE-N	16	17	chemical receptors in postmortem human spinal cord were analyzed using chemical ligand binding and immunoblotting with chemical receptor subunit-specific antibodies .	T2	T13	9417820
NA	CHEMICAL	GENE-N	16	10	None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native chemical receptors showed that gene , gene , gene , and gene subunits could all be found in the human spinal cord of which gene was preferentially located to the dorsal half .	T6	T14	9417820
NA	CHEMICAL	GENE-Y	16	20	None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native chemical receptors showed that gene , gene , gene , and gene subunits could all be found in the human spinal cord of which gene was preferentially located to the dorsal half .	T6	T15	9417820
NA	CHEMICAL	GENE-Y	16	22	None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native chemical receptors showed that gene , gene , gene , and gene subunits could all be found in the human spinal cord of which gene was preferentially located to the dorsal half .	T6	T16	9417820
NA	CHEMICAL	GENE-N	16	24	None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native chemical receptors showed that gene , gene , gene , and gene subunits could all be found in the human spinal cord of which gene was preferentially located to the dorsal half .	T6	T17	9417820
NA	CHEMICAL	GENE-Y	16	27	None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native chemical receptors showed that gene , gene , gene , and gene subunits could all be found in the human spinal cord of which gene was preferentially located to the dorsal half .	T6	T18	9417820
NA	CHEMICAL	GENE-Y	16	40	None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native chemical receptors showed that gene , gene , gene , and gene subunits could all be found in the human spinal cord of which gene was preferentially located to the dorsal half .	T6	T19	9417820
NA	CHEMICAL	GENE-Y	25	6	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T8	T20	9417820
NA	CHEMICAL	GENE-N	25	8	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T8	T21	9417820
NA	CHEMICAL	GENE-Y	25	11	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T8	T22	9417820
NA	CHEMICAL	GENE-Y	25	16	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T8	T23	9417820
NA	CHEMICAL	GENE-N	25	3	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T8	T24	9417820
NA	CHEMICAL	GENE-N	25	3	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T8	T25	9417820
NA	CHEMICAL	GENE-Y	28	6	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T9	T20	9417820
NA	CHEMICAL	GENE-N	28	8	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T9	T21	9417820
NA	CHEMICAL	GENE-Y	28	11	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T9	T22	9417820
NA	CHEMICAL	GENE-Y	28	16	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T9	T23	9417820
NA	CHEMICAL	GENE-N	28	3	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T9	T24	9417820
NA	CHEMICAL	GENE-N	28	3	Immunoprecipitation of solubilized receptors revealed that gene , gene , and gene subunits coprecipitated with the gene subunit , indicating that native human spinal cord chemical receptors are chemical receptors assembled by at least three different receptor subunits .	T9	T25	9417820
NA	CHEMICAL	GENE-N	0	9	chemical , a novel anti-convulsant , enhances activation of gene chemical channels .	T17	T28	10953053
CPR:3	CHEMICAL	GENE-N	0	2	chemical , a novel anti-convulsant , enhances activation of gene chemical channels .	T17	T29	10953053
NA	CHEMICAL	GENE-N	2	9	chemical , a novel anti-convulsant , enhances activation of gene chemical channels .	T18	T28	10953053
NA	CHEMICAL	GENE-N	2	2	chemical , a novel anti-convulsant , enhances activation of gene chemical channels .	T18	T29	10953053
NA	CHEMICAL	GENE-N	22	21	In the present study , we sought to determine whether retigabine could enhance current through M-like currents in PC12 cells and gene chemical channels expressed in Chinese hamster ovary cells ( CHO-gene ) .	T7	T21	10953053
NA	CHEMICAL	GENE-N	22	23	In the present study , we sought to determine whether retigabine could enhance current through M-like currents in PC12 cells and gene chemical channels expressed in Chinese hamster ovary cells ( CHO-gene ) .	T7	T22	10953053
NA	CHEMICAL	GENE-N	22	31	In the present study , we sought to determine whether retigabine could enhance current through M-like currents in PC12 cells and gene chemical channels expressed in Chinese hamster ovary cells ( CHO-gene ) .	T7	T23	10953053
NA	CHEMICAL	GENE-N	0	16	chemical ( 0.1 to 10 microM ) induced a chemical current and hyperpolarized CHO cells expressing gene cells but not in wild-type cells .	T10	T24	10953053
NA	CHEMICAL	GENE-N	8	16	chemical ( 0.1 to 10 microM ) induced a chemical current and hyperpolarized CHO cells expressing gene cells but not in wild-type cells .	T11	T24	10953053
NA	CHEMICAL	GENE-N	0	3	chemical-induced currents in CHO-gene cells were inhibited by 60.6 +/- 11 % ( n = 4 ) by the gene blocker , chemical ( 10 microM ) , and 82.7 +/- 5.4 % ( n = 4 ) by chemical ( 10 mM ) .	T13	T25	10953053
NA	CHEMICAL	GENE-N	0	19	chemical-induced currents in CHO-gene cells were inhibited by 60.6 +/- 11 % ( n = 4 ) by the gene blocker , chemical ( 10 microM ) , and 82.7 +/- 5.4 % ( n = 4 ) by chemical ( 10 mM ) .	T13	T26	10953053
NA	CHEMICAL	GENE-N	2	3	chemical-induced currents in CHO-gene cells were inhibited by 60.6 +/- 11 % ( n = 4 ) by the gene blocker , chemical ( 10 microM ) , and 82.7 +/- 5.4 % ( n = 4 ) by chemical ( 10 mM ) .	T14	T25	10953053
NA	CHEMICAL	GENE-N	2	19	chemical-induced currents in CHO-gene cells were inhibited by 60.6 +/- 11 % ( n = 4 ) by the gene blocker , chemical ( 10 microM ) , and 82.7 +/- 5.4 % ( n = 4 ) by chemical ( 10 mM ) .	T14	T26	10953053
NA	CHEMICAL	GENE-N	12	3	chemical-induced currents in CHO-gene cells were inhibited by 60.6 +/- 11 % ( n = 4 ) by the gene blocker , chemical ( 10 microM ) , and 82.7 +/- 5.4 % ( n = 4 ) by chemical ( 10 mM ) .	T15	T25	10953053
NA	CHEMICAL	GENE-N	12	19	chemical-induced currents in CHO-gene cells were inhibited by 60.6 +/- 11 % ( n = 4 ) by the gene blocker , chemical ( 10 microM ) , and 82.7 +/- 5.4 % ( n = 4 ) by chemical ( 10 mM ) .	T15	T26	10953053
NA	CHEMICAL	GENE-N	4	6	The mechanism by which chemical enhanced gene currents involved large , drug-induced , leftward shifts in the voltage dependence of channel activation ( -33.1 +/- 2.6 mV , n = 4 , by 10 microM chemical ) .	T16	T27	10953053
NA	CHEMICAL	GENE-N	6	6	The mechanism by which chemical enhanced gene currents involved large , drug-induced , leftward shifts in the voltage dependence of channel activation ( -33.1 +/- 2.6 mV , n = 4 , by 10 microM chemical ) .	T2	T27	10953053
NA	CHEMICAL	GENE-N	0	1	chemical receptors : development of selective agonists and antagonists .	T37	T54	3588607
NA	CHEMICAL	GENE-N	0	10	chemical modulates a variety of physiological functions through interaction with gene , where agonists mediate inhibition and stimulation , respectively , of chemical cyclase .	T1	T53	3588607
NA	CHEMICAL	GENE-N	0	2	chemical modulates a variety of physiological functions through interaction with gene , where agonists mediate inhibition and stimulation , respectively , of chemical cyclase .	T1	T43	3588607
NA	CHEMICAL	GENE-N	2	10	chemical modulates a variety of physiological functions through interaction with gene , where agonists mediate inhibition and stimulation , respectively , of chemical cyclase .	T36	T53	3588607
NA	CHEMICAL	GENE-N	2	2	chemical modulates a variety of physiological functions through interaction with gene , where agonists mediate inhibition and stimulation , respectively , of chemical cyclase .	T36	T43	3588607
NA	CHEMICAL	GENE-N	2	10	chemical modulates a variety of physiological functions through interaction with gene , where agonists mediate inhibition and stimulation , respectively , of chemical cyclase .	T18	T53	3588607
NA	CHEMICAL	GENE-N	2	2	chemical modulates a variety of physiological functions through interaction with gene , where agonists mediate inhibition and stimulation , respectively , of chemical cyclase .	T18	T43	3588607
NA	CHEMICAL	GENE-N	3	4	The involvement of chemical cyclase in these responses remains unresolved .	T27	T48	3588607
NA	CHEMICAL	GENE-Y	0	11	chemical analogs in particular the chemical-substituted compounds are more potent at gene than at gene .	T28	T49	3588607
NA	CHEMICAL	GENE-N	0	14	chemical analogs in particular the chemical-substituted compounds are more potent at gene than at gene .	T28	T50	3588607
NA	CHEMICAL	GENE-Y	5	11	chemical analogs in particular the chemical-substituted compounds are more potent at gene than at gene .	T29	T49	3588607
NA	CHEMICAL	GENE-N	5	14	chemical analogs in particular the chemical-substituted compounds are more potent at gene than at gene .	T29	T50	3588607
NA	CHEMICAL	GENE-N	4	5	The subregion of the chemical receptor that interacts with the chemical-substituent is different for gene , particularly with respect to chemical interactions , bulk tolerance and stereoselectivity .	T30	T51	3588607
NA	CHEMICAL	GENE-N	4	5	The subregion of the chemical receptor that interacts with the chemical-substituent is different for gene , particularly with respect to chemical interactions , bulk tolerance and stereoselectivity .	T30	T52	3588607
NA	CHEMICAL	GENE-N	10	5	The subregion of the chemical receptor that interacts with the chemical-substituent is different for gene , particularly with respect to chemical interactions , bulk tolerance and stereoselectivity .	T31	T51	3588607
NA	CHEMICAL	GENE-N	10	5	The subregion of the chemical receptor that interacts with the chemical-substituent is different for gene , particularly with respect to chemical interactions , bulk tolerance and stereoselectivity .	T31	T52	3588607
NA	CHEMICAL	GENE-N	20	5	The subregion of the chemical receptor that interacts with the chemical-substituent is different for gene , particularly with respect to chemical interactions , bulk tolerance and stereoselectivity .	T32	T51	3588607
NA	CHEMICAL	GENE-N	20	5	The subregion of the chemical receptor that interacts with the chemical-substituent is different for gene , particularly with respect to chemical interactions , bulk tolerance and stereoselectivity .	T32	T52	3588607
NA	CHEMICAL	GENE-Y	3	9	Certain of the chemical conjugates are highly selective for gene .	T2	T38	3588607
CPR:6	CHEMICAL	GENE-N	0	6	chemical are classical antagonists for chemical receptors for many of their pharmacological actions may be due to blockade of gene .	T3	T39	3588607
CPR:4	CHEMICAL	GENE-N	0	6	chemical are classical antagonists for chemical receptors for many of their pharmacological actions may be due to blockade of gene .	T3	T40	3588607
NA	CHEMICAL	GENE-N	5	6	chemical are classical antagonists for chemical receptors for many of their pharmacological actions may be due to blockade of gene .	T4	T39	3588607
NA	CHEMICAL	GENE-N	5	6	chemical are classical antagonists for chemical receptors for many of their pharmacological actions may be due to blockade of gene .	T4	T40	3588607
NA	CHEMICAL	GENE-N	0	7	chemical and chemical are virtually non-selective for gene .	T6	T41	3588607
NA	CHEMICAL	GENE-N	2	7	chemical and chemical are virtually non-selective for gene .	T7	T41	3588607
NA	CHEMICAL	GENE-Y	3	9	Replacement of the chemical groups of chemical with chemical or larger chemical groups yields chemical with selectivity for gene , particularly when combined with an chemical moiety .	T8	T42	3588607
NA	CHEMICAL	GENE-Y	2	9	Replacement of the chemical groups of chemical with chemical or larger chemical groups yields chemical with selectivity for gene , particularly when combined with an chemical moiety .	T9	T42	3588607
NA	CHEMICAL	GENE-Y	8	9	Replacement of the chemical groups of chemical with chemical or larger chemical groups yields chemical with selectivity for gene , particularly when combined with an chemical moiety .	T10	T42	3588607
NA	CHEMICAL	GENE-Y	11	9	Replacement of the chemical groups of chemical with chemical or larger chemical groups yields chemical with selectivity for gene , particularly when combined with an chemical moiety .	T11	T42	3588607
NA	CHEMICAL	GENE-Y	14	9	Replacement of the chemical groups of chemical with chemical or larger chemical groups yields chemical with selectivity for gene , particularly when combined with an chemical moiety .	T12	T42	3588607
NA	CHEMICAL	GENE-Y	25	9	Replacement of the chemical groups of chemical with chemical or larger chemical groups yields chemical with selectivity for gene , particularly when combined with an chemical moiety .	T13	T42	3588607
NA	CHEMICAL	GENE-N	3	12	Certain analogs of chemical in which the chemical group at the 1- or 7-position is replaced with a propargyl or chemical group display selectivity for gene .	T21	T44	3588607
NA	CHEMICAL	GENE-N	7	12	Certain analogs of chemical in which the chemical group at the 1- or 7-position is replaced with a propargyl or chemical group display selectivity for gene .	T22	T44	3588607
NA	CHEMICAL	GENE-N	20	12	Certain analogs of chemical in which the chemical group at the 1- or 7-position is replaced with a propargyl or chemical group display selectivity for gene .	T23	T44	3588607
NA	CHEMICAL	GENE-Y	18	6	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T3	T11	23601203
NA	CHEMICAL	GENE-Y	18	8	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T3	T12	23601203
NA	CHEMICAL	GENE-Y	18	28	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T3	T13	23601203
NA	CHEMICAL	GENE-Y	20	6	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T4	T11	23601203
NA	CHEMICAL	GENE-Y	20	8	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T4	T12	23601203
NA	CHEMICAL	GENE-Y	20	28	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T4	T13	23601203
NA	CHEMICAL	GENE-Y	22	6	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T5	T11	23601203
NA	CHEMICAL	GENE-Y	22	8	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T5	T12	23601203
NA	CHEMICAL	GENE-Y	22	28	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T5	T13	23601203
NA	CHEMICAL	GENE-Y	24	6	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T6	T11	23601203
NA	CHEMICAL	GENE-Y	24	8	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T6	T12	23601203
NA	CHEMICAL	GENE-Y	24	28	Molecular docking studies were performed with gene ( gene : PDB 1E78 ) , showing binding pattern with chemical residues chemical218 , chemical222 and chemical444 , identifies the ligand-gene interaction for the transportation affinity of the ligand at the specific site of the target .	T6	T13	23601203
NA	CHEMICAL	GENE-N	0	9	chemical , but not leptin , regulates chemical-activated protein kinase in pancreatic islets : impact on chemical-stimulated gene secretion .	T11	T28	14871885
NA	CHEMICAL	GENE-N	0	10	chemical , but not leptin , regulates chemical-activated protein kinase in pancreatic islets : impact on chemical-stimulated gene secretion .	T11	T27	14871885
NA	CHEMICAL	GENE-N	7	9	chemical , but not leptin , regulates chemical-activated protein kinase in pancreatic islets : impact on chemical-stimulated gene secretion .	T12	T28	14871885
NA	CHEMICAL	GENE-N	7	10	chemical , but not leptin , regulates chemical-activated protein kinase in pancreatic islets : impact on chemical-stimulated gene secretion .	T12	T27	14871885
NA	CHEMICAL	GENE-N	16	9	chemical , but not leptin , regulates chemical-activated protein kinase in pancreatic islets : impact on chemical-stimulated gene secretion .	T13	T28	14871885
CPR:3	CHEMICAL	GENE-N	16	10	chemical , but not leptin , regulates chemical-activated protein kinase in pancreatic islets : impact on chemical-stimulated gene secretion .	T13	T27	14871885
CPR:3	CHEMICAL	GENE-N	0	2	chemical , a drug widely used in the treatment of type 2 diabetes , has recently been shown to act on skeletal muscle and liver in part through the activation of chemical-activated protein kinase ( gene ) .	T1	T17	14871885
CPR:3	CHEMICAL	GENE-N	0	35	chemical , a drug widely used in the treatment of type 2 diabetes , has recently been shown to act on skeletal muscle and liver in part through the activation of chemical-activated protein kinase ( gene ) .	T1	T18	14871885
NA	CHEMICAL	GENE-N	31	2	chemical , a drug widely used in the treatment of type 2 diabetes , has recently been shown to act on skeletal muscle and liver in part through the activation of chemical-activated protein kinase ( gene ) .	T5	T17	14871885
NA	CHEMICAL	GENE-N	31	35	chemical , a drug widely used in the treatment of type 2 diabetes , has recently been shown to act on skeletal muscle and liver in part through the activation of chemical-activated protein kinase ( gene ) .	T5	T18	14871885
CPR:3	CHEMICAL	GENE-N	1	11	Whether chemical or the satiety factor leptin , which also stimulates gene in muscle , regulates this enzyme in pancreatic islets is unknown .	T6	T19	14871885
NA	CHEMICAL	GENE-N	7	14	Here , we explore whether 1 ) chemical , chemical , or leptin regulates gene activity in isolated islets from rodent and human and 2 ) whether changes in gene activity modulate gene secretion from human islets .	T7	T22	14871885
NA	CHEMICAL	GENE-N	7	29	Here , we explore whether 1 ) chemical , chemical , or leptin regulates gene activity in isolated islets from rodent and human and 2 ) whether changes in gene activity modulate gene secretion from human islets .	T7	T23	14871885
NA	CHEMICAL	GENE-Y	7	16	Here , we explore whether 1 ) chemical , chemical , or leptin regulates gene activity in isolated islets from rodent and human and 2 ) whether changes in gene activity modulate gene secretion from human islets .	T7	T24	14871885
NA	CHEMICAL	GENE-N	9	14	Here , we explore whether 1 ) chemical , chemical , or leptin regulates gene activity in isolated islets from rodent and human and 2 ) whether changes in gene activity modulate gene secretion from human islets .	T8	T22	14871885
NA	CHEMICAL	GENE-N	9	29	Here , we explore whether 1 ) chemical , chemical , or leptin regulates gene activity in isolated islets from rodent and human and 2 ) whether changes in gene activity modulate gene secretion from human islets .	T8	T23	14871885
NA	CHEMICAL	GENE-Y	9	16	Here , we explore whether 1 ) chemical , chemical , or leptin regulates gene activity in isolated islets from rodent and human and 2 ) whether changes in gene activity modulate gene secretion from human islets .	T8	T24	14871885
CPR:4	CHEMICAL	GENE-N	2	15	Increases in chemical concentration from 0 to 3 and from 3 to 17 mM inhibited gene activity in primary islets from mouse , rat , and human , confirming previous findings in insulinoma cells .	T9	T25	14871885
CPR:3	CHEMICAL	GENE-N	2	8	Incubation with chemical ( 0.2-1 mM ) activated gene in both human islets and MIN6 beta-cells in parallel with an inhibition of gene secretion , whereas leptin ( 10-100 nM ) was without effect in MIN6 cells .	T10	T26	14871885
CPR:4	CHEMICAL	GENE-N	2	9	Incubation with chemical ( 0.2-1 mM ) activated gene in both human islets and MIN6 beta-cells in parallel with an inhibition of gene secretion , whereas leptin ( 10-100 nM ) was without effect in MIN6 cells .	T10	T14	14871885
NA	CHEMICAL	GENE-N	12	4	These studies demonstrate that gene activity is subject to regulation by both chemical and chemical in pancreatic islets and clonal beta-cells .	T2	T15	14871885
NA	CHEMICAL	GENE-N	14	4	These studies demonstrate that gene activity is subject to regulation by both chemical and chemical in pancreatic islets and clonal beta-cells .	T3	T15	14871885
NA	CHEMICAL	GENE-N	4	2	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T51	T88	12487427
NA	CHEMICAL	GENE-N	4	15	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T51	T89	12487427
NA	CHEMICAL	GENE-N	4	15	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T51	T90	12487427
NA	CHEMICAL	GENE-N	17	2	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T49	T88	12487427
CPR:4	CHEMICAL	GENE-N	17	15	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T49	T89	12487427
CPR:4	CHEMICAL	GENE-N	17	15	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T49	T90	12487427
NA	CHEMICAL	GENE-N	19	2	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T50	T88	12487427
CPR:4	CHEMICAL	GENE-N	19	15	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T50	T89	12487427
CPR:4	CHEMICAL	GENE-N	19	15	Investigation of gene metabolism in human and rat plasma in the presence of the dual gene/gene inhibitors chemical and chemical .	T50	T90	12487427
NA	CHEMICAL	GENE-Y	20	8	Several studies have suggested that the accumulation of gene , or that of one its metabolites BK1-8 , is involved in the occurrence of side effects such as AE associated with the use of various genei .	T36	T78	12487427
NA	CHEMICAL	GENE-Y	20	35	Several studies have suggested that the accumulation of gene , or that of one its metabolites BK1-8 , is involved in the occurrence of side effects such as AE associated with the use of various genei .	T36	T69	12487427
NA	CHEMICAL	GENE-N	30	26	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T30	T72	12487427
NA	CHEMICAL	GENE-N	30	28	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T30	T73	12487427
NA	CHEMICAL	GENE-N	30	38	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T30	T75	12487427
NA	CHEMICAL	GENE-N	30	38	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T30	T76	12487427
NA	CHEMICAL	GENE-N	41	26	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T33	T72	12487427
NA	CHEMICAL	GENE-N	41	28	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T33	T73	12487427
CPR:4	CHEMICAL	GENE-N	41	38	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T33	T75	12487427
CPR:4	CHEMICAL	GENE-N	41	38	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T33	T76	12487427
NA	CHEMICAL	GENE-N	3	26	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T34	T72	12487427
NA	CHEMICAL	GENE-N	3	28	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T34	T73	12487427
CPR:4	CHEMICAL	GENE-N	3	38	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T34	T75	12487427
CPR:4	CHEMICAL	GENE-N	3	38	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled gene ( gene ) Brchemical in the presence of two new dual gene/gene inhibitors ( chemical and chemical ) currently under clinical trial .	T34	T76	12487427
NA	CHEMICAL	GENE-Y	4	42	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T35	T77	12487427
NA	CHEMICAL	GENE-Y	15	42	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T37	T77	12487427
NA	CHEMICAL	GENE-Y	15	48	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T37	T79	12487427
NA	CHEMICAL	GENE-Y	15	50	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T37	T82	12487427
NA	CHEMICAL	GENE-Y	15	52	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T37	T83	12487427
NA	CHEMICAL	GENE-Y	21	42	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T38	T77	12487427
NA	CHEMICAL	GENE-Y	21	48	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T38	T79	12487427
NA	CHEMICAL	GENE-Y	21	50	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T38	T82	12487427
NA	CHEMICAL	GENE-Y	21	52	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T38	T83	12487427
NA	CHEMICAL	GENE-Y	46	42	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T39	T77	12487427
NA	CHEMICAL	GENE-Y	46	48	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T39	T79	12487427
NA	CHEMICAL	GENE-Y	46	50	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T39	T82	12487427
NA	CHEMICAL	GENE-Y	46	52	In human plasma the chemical half-life values in the absence or in the presence of chemical ( 3.8 microM ) or chemical ( 32 nM ) were 38.7 +/- 2.4 , 51.2 +/- 4.7 and 114.7 +/- 9.3 min , respectively and gene was degraded into chemical1-8 , gene1-7 , gene and gene .	T39	T83	12487427
NA	CHEMICAL	GENE-Y	1	8	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T44	T84	12487427
NA	CHEMICAL	GENE-Y	1	15	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T44	T86	12487427
NA	CHEMICAL	GENE-Y	1	22	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T44	T87	12487427
CPR:4	CHEMICAL	GENE-Y	3	8	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T45	T84	12487427
CPR:4	CHEMICAL	GENE-Y	3	15	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T45	T86	12487427
NA	CHEMICAL	GENE-Y	3	22	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T45	T87	12487427
NA	CHEMICAL	GENE-Y	10	8	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T47	T84	12487427
NA	CHEMICAL	GENE-Y	10	15	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T47	T86	12487427
NA	CHEMICAL	GENE-Y	10	22	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T47	T87	12487427
NA	CHEMICAL	GENE-Y	19	8	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T48	T84	12487427
CPR:4	CHEMICAL	GENE-Y	19	15	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T48	T86	12487427
NA	CHEMICAL	GENE-Y	19	22	Unlike chemical , chemical abolished the production of gene and chemical , suggesting a better gene inhibition effect over chemical as no gene activity was found .	T48	T87	12487427
NA	CHEMICAL	GENE-Y	18	3	The production of gene was reduced with chemical while no significant change was observed with chemical after 4 h of incubation .	T3	T53	12487427
CPR:4	CHEMICAL	GENE-Y	7	3	The production of gene was reduced with chemical while no significant change was observed with chemical after 4 h of incubation .	T4	T53	12487427
NA	CHEMICAL	GENE-Y	3	3	The production of gene was reduced with chemical while no significant change was observed with chemical after 4 h of incubation .	T5	T53	12487427
NA	CHEMICAL	GENE-Y	42	4	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T6	T54	12487427
NA	CHEMICAL	GENE-Y	42	46	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T6	T55	12487427
NA	CHEMICAL	GENE-Y	42	50	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T6	T58	12487427
NA	CHEMICAL	GENE-Y	42	52	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T6	T59	12487427
NA	CHEMICAL	GENE-Y	42	54	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T6	T60	12487427
NA	CHEMICAL	GENE-Y	15	4	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T7	T54	12487427
NA	CHEMICAL	GENE-Y	15	46	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T7	T55	12487427
NA	CHEMICAL	GENE-Y	15	50	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T7	T58	12487427
NA	CHEMICAL	GENE-Y	15	52	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T7	T59	12487427
NA	CHEMICAL	GENE-Y	15	54	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T7	T60	12487427
NA	CHEMICAL	GENE-Y	21	4	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T8	T54	12487427
NA	CHEMICAL	GENE-Y	21	46	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T8	T55	12487427
NA	CHEMICAL	GENE-Y	21	50	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T8	T58	12487427
NA	CHEMICAL	GENE-Y	21	52	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T8	T59	12487427
NA	CHEMICAL	GENE-Y	21	54	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T8	T60	12487427
NA	CHEMICAL	GENE-Y	48	46	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T9	T55	12487427
NA	CHEMICAL	GENE-Y	48	50	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T9	T58	12487427
NA	CHEMICAL	GENE-Y	48	52	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T9	T59	12487427
NA	CHEMICAL	GENE-Y	48	54	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T9	T60	12487427
NA	CHEMICAL	GENE-Y	56	46	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T15	T55	12487427
NA	CHEMICAL	GENE-Y	56	50	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T15	T58	12487427
NA	CHEMICAL	GENE-Y	56	52	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T15	T59	12487427
NA	CHEMICAL	GENE-Y	56	54	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T15	T60	12487427
NA	CHEMICAL	GENE-Y	58	46	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T16	T55	12487427
NA	CHEMICAL	GENE-Y	58	50	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T16	T58	12487427
NA	CHEMICAL	GENE-Y	58	52	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T16	T59	12487427
NA	CHEMICAL	GENE-Y	58	54	In rat plasma the gene half-life values in the absence or in the presence of chemical ( 530 nM ) or chemical ( 50 nM ) were 9.31 +/- 1.7 , 22.06 +/- 3.1 and 25.3 +/- 1.7 min , respectively and chemical was degraded into gene1-8 , chemical1-7 , gene and gene plus gene , chemical and chemical metabolites not found in human plasma .	T16	T60	12487427
CPR:4	CHEMICAL	GENE-Y	0	7	chemical and chemical reduced the production of gene and gene with more effect being observed with chemical .	T17	T63	12487427
CPR:4	CHEMICAL	GENE-Y	0	9	chemical and chemical reduced the production of gene and gene with more effect being observed with chemical .	T17	T64	12487427
CPR:4	CHEMICAL	GENE-Y	2	7	chemical and chemical reduced the production of gene and gene with more effect being observed with chemical .	T18	T63	12487427
CPR:4	CHEMICAL	GENE-Y	2	9	chemical and chemical reduced the production of gene and gene with more effect being observed with chemical .	T18	T64	12487427
CPR:4	CHEMICAL	GENE-Y	16	7	chemical and chemical reduced the production of gene and gene with more effect being observed with chemical .	T21	T63	12487427
CPR:4	CHEMICAL	GENE-Y	16	9	chemical and chemical reduced the production of gene and gene with more effect being observed with chemical .	T21	T64	12487427
NA	CHEMICAL	GENE-N	0	17	chemical and chemical increased the production of both chemical and chemical but not that of chemical and gene .	T22	T68	12487427
NA	CHEMICAL	GENE-N	2	17	chemical and chemical increased the production of both chemical and chemical but not that of chemical and gene .	T23	T68	12487427
NA	CHEMICAL	GENE-N	8	17	chemical and chemical increased the production of both chemical and chemical but not that of chemical and gene .	T24	T68	12487427
NA	CHEMICAL	GENE-N	10	17	chemical and chemical increased the production of both chemical and chemical but not that of chemical and gene .	T25	T68	12487427
NA	CHEMICAL	GENE-N	15	17	chemical and chemical increased the production of both chemical and chemical but not that of chemical and gene .	T26	T68	12487427
NA	CHEMICAL	GENE-N	13	18	Although not all of the signaling pathways for radioresistance are well defined , it is now clear that gene-dependent signaling pathways involved in radioresistance include those mediated by chemical 3'-kinase ( gene ) and gene .	T5	T22	14633707
NA	CHEMICAL	GENE-N	13	22	Although not all of the signaling pathways for radioresistance are well defined , it is now clear that gene-dependent signaling pathways involved in radioresistance include those mediated by chemical 3'-kinase ( gene ) and gene .	T5	T24	14633707
NA	CHEMICAL	GENE-N	13	31	Although not all of the signaling pathways for radioresistance are well defined , it is now clear that gene-dependent signaling pathways involved in radioresistance include those mediated by chemical 3'-kinase ( gene ) and gene .	T5	T25	14633707
NA	CHEMICAL	GENE-N	13	34	Although not all of the signaling pathways for radioresistance are well defined , it is now clear that gene-dependent signaling pathways involved in radioresistance include those mediated by chemical 3'-kinase ( gene ) and gene .	T5	T26	14633707
CPR:4	CHEMICAL	GENE-Y	11	1	Blocking gene signaling with the gene/gene kinase inhibitor ( KI ) chemical decreased the postradiation survival of irradiated gene-transformed cells and normal cells but had no effect on the survival of unirradiated cells .	T1	T7	14633707
CPR:4	CHEMICAL	GENE-Y	11	5	Blocking gene signaling with the gene/gene kinase inhibitor ( KI ) chemical decreased the postradiation survival of irradiated gene-transformed cells and normal cells but had no effect on the survival of unirradiated cells .	T1	T8	14633707
CPR:4	CHEMICAL	GENE-Y	11	5	Blocking gene signaling with the gene/gene kinase inhibitor ( KI ) chemical decreased the postradiation survival of irradiated gene-transformed cells and normal cells but had no effect on the survival of unirradiated cells .	T1	T9	14633707
CPR:4	CHEMICAL	GENE-N	11	18	Blocking gene signaling with the gene/gene kinase inhibitor ( KI ) chemical decreased the postradiation survival of irradiated gene-transformed cells and normal cells but had no effect on the survival of unirradiated cells .	T1	T10	14633707
NA	CHEMICAL	GENE-N	22	0	gene-CM and gene also increase gene activity downstream of the gene and increase postradiation survival , both of which are abrogated by chemical .	T2	T11	14633707
NA	CHEMICAL	GENE-Y	22	2	gene-CM and gene also increase gene activity downstream of the gene and increase postradiation survival , both of which are abrogated by chemical .	T2	T12	14633707
CPR:4	CHEMICAL	GENE-N	22	5	gene-CM and gene also increase gene activity downstream of the gene and increase postradiation survival , both of which are abrogated by chemical .	T2	T13	14633707
CPR:4	CHEMICAL	GENE-Y	22	10	gene-CM and gene also increase gene activity downstream of the gene and increase postradiation survival , both of which are abrogated by chemical .	T2	T14	14633707
CPR:4	CHEMICAL	GENE-N	16	2	Thus , gene utilizes autocrine signaling through gene to increase radioresistance , and the gene KI chemical acts as a radiosensitizer .	T3	T15	14633707
NA	CHEMICAL	GENE-Y	16	7	Thus , gene utilizes autocrine signaling through gene to increase radioresistance , and the gene KI chemical acts as a radiosensitizer .	T3	T16	14633707
CPR:4	CHEMICAL	GENE-Y	16	14	Thus , gene utilizes autocrine signaling through gene to increase radioresistance , and the gene KI chemical acts as a radiosensitizer .	T3	T17	14633707
CPR:6	CHEMICAL	GENE-Y	3	0	gene antagonism with chemical reduced responses to chemical in controls but not during inflammation .	T10	T15	17138606
NA	CHEMICAL	GENE-Y	7	0	gene antagonism with chemical reduced responses to chemical in controls but not during inflammation .	T11	T15	17138606
NA	CHEMICAL	GENE-N	10	28	Responses to the mast cell degranulator 48/80 mimicked those to chemical in inflamed tissue but not in controls , and more chemical-containing mast cells were seen close to gene-containing fibres in inflamed serosa .	T2	T13	17138606
NA	CHEMICAL	GENE-N	21	28	Responses to the mast cell degranulator 48/80 mimicked those to chemical in inflamed tissue but not in controls , and more chemical-containing mast cells were seen close to gene-containing fibres in inflamed serosa .	T3	T13	17138606
NA	CHEMICAL	GENE-N	3	5	Relative expression of chemical transport-related proteins and inflammation markers through the induction of chemical-mediated stress in Caco-2 cells .	T23	T40	23454145
NA	CHEMICAL	GENE-N	13	5	Relative expression of chemical transport-related proteins and inflammation markers through the induction of chemical-mediated stress in Caco-2 cells .	T22	T40	23454145
NA	CHEMICAL	GENE-Y	28	9	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T27	23454145
NA	CHEMICAL	GENE-Y	28	11	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T28	23454145
NA	CHEMICAL	GENE-Y	28	13	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T29	23454145
NA	CHEMICAL	GENE-Y	28	15	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T30	23454145
NA	CHEMICAL	GENE-Y	28	33	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T31	23454145
NA	CHEMICAL	GENE-N	28	35	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T32	23454145
NA	CHEMICAL	GENE-Y	28	37	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T33	23454145
NA	CHEMICAL	GENE-Y	28	39	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T11	T34	23454145
NA	CHEMICAL	GENE-Y	27	9	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T27	23454145
NA	CHEMICAL	GENE-Y	27	11	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T28	23454145
NA	CHEMICAL	GENE-Y	27	13	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T29	23454145
NA	CHEMICAL	GENE-Y	27	15	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T30	23454145
NA	CHEMICAL	GENE-Y	27	33	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T31	23454145
NA	CHEMICAL	GENE-N	27	35	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T32	23454145
NA	CHEMICAL	GENE-Y	27	37	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T33	23454145
NA	CHEMICAL	GENE-Y	27	39	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T13	T34	23454145
NA	CHEMICAL	GENE-Y	45	9	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T27	23454145
NA	CHEMICAL	GENE-Y	45	11	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T28	23454145
NA	CHEMICAL	GENE-Y	45	13	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T29	23454145
NA	CHEMICAL	GENE-Y	45	15	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T30	23454145
NA	CHEMICAL	GENE-Y	45	33	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T31	23454145
NA	CHEMICAL	GENE-N	45	35	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T32	23454145
NA	CHEMICAL	GENE-Y	45	37	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T33	23454145
NA	CHEMICAL	GENE-Y	45	39	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T14	T34	23454145
NA	CHEMICAL	GENE-Y	45	9	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T27	23454145
NA	CHEMICAL	GENE-Y	45	11	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T28	23454145
NA	CHEMICAL	GENE-Y	45	13	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T29	23454145
NA	CHEMICAL	GENE-Y	45	15	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T30	23454145
NA	CHEMICAL	GENE-Y	45	33	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T31	23454145
NA	CHEMICAL	GENE-N	45	35	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T32	23454145
NA	CHEMICAL	GENE-Y	45	37	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T33	23454145
NA	CHEMICAL	GENE-Y	45	39	This study evaluates the production of inflammatory biomarkers ( gene , gene , gene , gene ) and the influence of gene expression transporters and enzymes related to chemical absorption and metabolism ( gene , gene , gene , gene ) produced by chemical ( chemical/chemical ) in Caco-2 cells .	T15	T34	23454145
CPR:4	CHEMICAL	GENE-N	9	5	In non-pre-treated cells , only gene were down-regulated by chemical , showing a greater influence upon gene expression .	T18	T35	23454145
NA	CHEMICAL	GENE-Y	9	16	In non-pre-treated cells , only gene were down-regulated by chemical , showing a greater influence upon gene expression .	T18	T36	23454145
NA	CHEMICAL	GENE-Y	5	2	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T19	T37	23454145
NA	CHEMICAL	GENE-N	5	6	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T19	T38	23454145
NA	CHEMICAL	GENE-Y	5	19	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T19	T39	23454145
NA	CHEMICAL	GENE-Y	10	2	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T20	T37	23454145
NA	CHEMICAL	GENE-N	10	6	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T20	T38	23454145
NA	CHEMICAL	GENE-Y	10	19	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T20	T39	23454145
NA	CHEMICAL	GENE-Y	23	2	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T1	T37	23454145
NA	CHEMICAL	GENE-N	23	6	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T1	T38	23454145
CPR:4	CHEMICAL	GENE-Y	23	19	Cell-pre-incubation with gene induced changes in gene expression levels after chemical-incubation ; however , the energetic metabolism inhibition reduced gene expression only in chemical-incubated cells .	T1	T39	23454145
NA	CHEMICAL	GENE-Y	4	4	In non-pre-treated cells , gene was up-regulated by both chemical .	T2	T24	23454145
CPR:3	CHEMICAL	GENE-Y	9	4	In non-pre-treated cells , gene was up-regulated by both chemical .	T3	T24	23454145
NA	CHEMICAL	GENE-Y	0	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T17	T37	23395825
NA	CHEMICAL	GENE-Y	0	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T17	T38	23395825
NA	CHEMICAL	GENE-N	0	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T17	T39	23395825
NA	CHEMICAL	GENE-Y	2	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T18	T37	23395825
NA	CHEMICAL	GENE-Y	2	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T18	T38	23395825
NA	CHEMICAL	GENE-N	2	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T18	T39	23395825
NA	CHEMICAL	GENE-Y	5	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T19	T37	23395825
NA	CHEMICAL	GENE-Y	5	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T19	T38	23395825
NA	CHEMICAL	GENE-N	5	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T19	T39	23395825
NA	CHEMICAL	GENE-Y	7	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T20	T37	23395825
NA	CHEMICAL	GENE-Y	7	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T20	T38	23395825
NA	CHEMICAL	GENE-N	7	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T20	T39	23395825
NA	CHEMICAL	GENE-Y	11	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T21	T37	23395825
NA	CHEMICAL	GENE-Y	11	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T21	T38	23395825
NA	CHEMICAL	GENE-N	11	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T21	T39	23395825
NA	CHEMICAL	GENE-Y	13	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T22	T37	23395825
NA	CHEMICAL	GENE-Y	13	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T22	T38	23395825
NA	CHEMICAL	GENE-N	13	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T22	T39	23395825
NA	CHEMICAL	GENE-Y	17	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T23	T37	23395825
NA	CHEMICAL	GENE-Y	17	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T23	T38	23395825
NA	CHEMICAL	GENE-N	17	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T23	T39	23395825
NA	CHEMICAL	GENE-Y	23	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T24	T37	23395825
NA	CHEMICAL	GENE-Y	23	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T24	T38	23395825
NA	CHEMICAL	GENE-N	23	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T24	T39	23395825
NA	CHEMICAL	GENE-Y	26	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T25	T37	23395825
NA	CHEMICAL	GENE-Y	26	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T25	T38	23395825
NA	CHEMICAL	GENE-N	26	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T25	T39	23395825
NA	CHEMICAL	GENE-Y	30	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T26	T37	23395825
NA	CHEMICAL	GENE-Y	30	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T26	T38	23395825
NA	CHEMICAL	GENE-N	30	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T26	T39	23395825
NA	CHEMICAL	GENE-Y	32	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T27	T37	23395825
NA	CHEMICAL	GENE-Y	32	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T27	T38	23395825
NA	CHEMICAL	GENE-N	32	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T27	T39	23395825
NA	CHEMICAL	GENE-Y	39	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T28	T37	23395825
NA	CHEMICAL	GENE-Y	39	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T28	T38	23395825
NA	CHEMICAL	GENE-N	39	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T28	T39	23395825
NA	CHEMICAL	GENE-Y	41	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T29	T37	23395825
NA	CHEMICAL	GENE-Y	41	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T29	T38	23395825
NA	CHEMICAL	GENE-N	41	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T29	T39	23395825
NA	CHEMICAL	GENE-Y	44	18	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T30	T37	23395825
NA	CHEMICAL	GENE-Y	44	20	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T30	T38	23395825
NA	CHEMICAL	GENE-N	44	24	chemical ( chemical ) , chemical ( chemical ) and total chemical ( total-chemical ) content , chemical reductase ( gene ) and chemical peroxidase ( chemical-Px ) activities , chemical ( chemical ) level , as well as chemical ( chemical ) and chemical modified proteins in homogenates of cerebral cortex were measured .	T30	T39	23395825
NA	CHEMICAL	GENE-Y	0	8	chemical and total-chemical content , chemical/chemical ratio , gene activity significantly decreased in cerebral cortex of rats , coupling with the increase of chemical level .	T2	T35	23395825
NA	CHEMICAL	GENE-Y	2	8	chemical and total-chemical content , chemical/chemical ratio , gene activity significantly decreased in cerebral cortex of rats , coupling with the increase of chemical level .	T3	T35	23395825
NA	CHEMICAL	GENE-Y	5	8	chemical and total-chemical content , chemical/chemical ratio , gene activity significantly decreased in cerebral cortex of rats , coupling with the increase of chemical level .	T4	T35	23395825
NA	CHEMICAL	GENE-Y	5	8	chemical and total-chemical content , chemical/chemical ratio , gene activity significantly decreased in cerebral cortex of rats , coupling with the increase of chemical level .	T5	T35	23395825
NA	CHEMICAL	GENE-Y	23	8	chemical and total-chemical content , chemical/chemical ratio , gene activity significantly decreased in cerebral cortex of rats , coupling with the increase of chemical level .	T6	T35	23395825
CPR:3	CHEMICAL	GENE-N	7	0	gene upsurge precedes standard biomarkers of hepatotoxicity in chemical-injected mice .	T20	T34	23370008
NA	CHEMICAL	GENE-Y	3	7	The tocolytic agent chemical acts on the gene and is an effective treatment option for preterm labor .	T12	T30	23370008
CPR:3	CHEMICAL	GENE-N	14	7	Importantly , expression of the acute-phase reactant gene ( gene ) significantly increased after chemical injection , with values indicating the largest fold-change .	T19	T31	23370008
CPR:3	CHEMICAL	GENE-N	14	9	Importantly , expression of the acute-phase reactant gene ( gene ) significantly increased after chemical injection , with values indicating the largest fold-change .	T19	T32	23370008
NA	CHEMICAL	GENE-N	8	5	This large increase in blood gene levels serves as a more sensitive biomarker than conventional liver enzymes , such as chemical aminotransferase and chemical aminotransferase .	T1	T33	23370008
NA	CHEMICAL	GENE-Y	8	3	This large increase in blood gene levels serves as a more sensitive biomarker than conventional liver enzymes , such as chemical aminotransferase and chemical aminotransferase .	T1	T21	23370008
NA	CHEMICAL	GENE-N	8	3	This large increase in blood gene levels serves as a more sensitive biomarker than conventional liver enzymes , such as chemical aminotransferase and chemical aminotransferase .	T1	T22	23370008
NA	CHEMICAL	GENE-N	3	5	This large increase in blood gene levels serves as a more sensitive biomarker than conventional liver enzymes , such as chemical aminotransferase and chemical aminotransferase .	T2	T33	23370008
NA	CHEMICAL	GENE-Y	3	3	This large increase in blood gene levels serves as a more sensitive biomarker than conventional liver enzymes , such as chemical aminotransferase and chemical aminotransferase .	T2	T21	23370008
NA	CHEMICAL	GENE-N	3	3	This large increase in blood gene levels serves as a more sensitive biomarker than conventional liver enzymes , such as chemical aminotransferase and chemical aminotransferase .	T2	T22	23370008
CPR:3	CHEMICAL	GENE-N	2	3	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T3	T23	23370008
NA	CHEMICAL	GENE-N	2	13	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T3	T24	23370008
NA	CHEMICAL	GENE-N	2	3	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T4	T23	23370008
NA	CHEMICAL	GENE-N	2	13	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T4	T24	23370008
NA	CHEMICAL	GENE-N	26	3	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T5	T23	23370008
NA	CHEMICAL	GENE-N	26	13	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T5	T24	23370008
NA	CHEMICAL	GENE-N	2	3	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T6	T23	23370008
NA	CHEMICAL	GENE-N	2	13	The increase in gene expression is specific to chemical-induced liver damage , because gene expression was not induced by other hepatotoxic drugs such as chemical , chemical , or chemical .	T6	T24	23370008
NA	CHEMICAL	GENE-N	6	19	Our in vitro studies showed that chemical ( chemical ) accumulation was not a primary cause of the chemical-induced gene increase .	T7	T25	23370008
NA	CHEMICAL	GENE-N	8	19	Our in vitro studies showed that chemical ( chemical ) accumulation was not a primary cause of the chemical-induced gene increase .	T8	T25	23370008
CPR:3	CHEMICAL	GENE-N	1	19	Our in vitro studies showed that chemical ( chemical ) accumulation was not a primary cause of the chemical-induced gene increase .	T9	T25	23370008
NA	CHEMICAL	GENE-N	20	0	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T39	9730867
NA	CHEMICAL	GENE-N	20	2	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T40	9730867
CPR:4	CHEMICAL	GENE-Y	20	5	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T41	9730867
CPR:4	CHEMICAL	GENE-Y	20	7	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T42	9730867
CPR:4	CHEMICAL	GENE-Y	20	10	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T43	9730867
CPR:5	CHEMICAL	GENE-N	20	18	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T44	9730867
NA	CHEMICAL	GENE-Y	20	25	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T8	T45	9730867
NA	CHEMICAL	GENE-N	27	0	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T39	9730867
NA	CHEMICAL	GENE-N	27	2	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T40	9730867
CPR:4	CHEMICAL	GENE-Y	27	5	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T41	9730867
CPR:4	CHEMICAL	GENE-Y	27	7	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T42	9730867
CPR:4	CHEMICAL	GENE-Y	27	10	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T43	9730867
NA	CHEMICAL	GENE-N	27	18	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T44	9730867
CPR:5	CHEMICAL	GENE-Y	27	25	gene ( gene ) -induced gene , gene , and gene mRNAs are dose-dependently inhibited by the nonselective gene agonist chemical and by the selective gene agonist chemical .	T9	T45	9730867
CPR:3	CHEMICAL	GENE-Y	5	4	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T10	T48	9730867
CPR:3	CHEMICAL	GENE-Y	5	6	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T10	T49	9730867
CPR:3	CHEMICAL	GENE-Y	5	9	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T10	T50	9730867
CPR:6	CHEMICAL	GENE-Y	5	16	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T10	T51	9730867
CPR:3	CHEMICAL	GENE-Y	18	4	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T1	T48	9730867
CPR:3	CHEMICAL	GENE-Y	18	6	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T1	T49	9730867
CPR:3	CHEMICAL	GENE-Y	18	9	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T1	T50	9730867
CPR:6	CHEMICAL	GENE-Y	18	16	The observed inhibition on gene , gene , and gene mRNA was blocked by the selective gene antagonist chemical ( 10 ( -6 ) M ) and by chemical ( 10 ( -6 ) M ) , a nonselective antagonist .	T1	T51	9730867
CPR:6	CHEMICAL	GENE-Y	4	2	The selective gene antagonist chemical ( 0.3 x 10 ( -6 ) M ) did not have any effect .	T2	T12	9730867
CPR:3	CHEMICAL	GENE-Y	11	2	Secretion of gene protein in the presence of increasing concentrations of chemical followed a similar pattern as observed for gene mRNA .	T3	T13	9730867
CPR:3	CHEMICAL	GENE-Y	11	19	Secretion of gene protein in the presence of increasing concentrations of chemical followed a similar pattern as observed for gene mRNA .	T3	T15	9730867
NA	CHEMICAL	GENE-N	26	4	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T4	T16	9730867
NA	CHEMICAL	GENE-Y	26	7	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T4	T17	9730867
NA	CHEMICAL	GENE-Y	26	9	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T4	T18	9730867
NA	CHEMICAL	GENE-Y	26	12	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T4	T19	9730867
NA	CHEMICAL	GENE-Y	26	16	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T4	T20	9730867
NA	CHEMICAL	GENE-N	28	4	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T5	T16	9730867
NA	CHEMICAL	GENE-Y	28	7	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T5	T17	9730867
NA	CHEMICAL	GENE-Y	28	9	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T5	T18	9730867
NA	CHEMICAL	GENE-Y	28	12	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T5	T19	9730867
NA	CHEMICAL	GENE-Y	28	16	In addition , the gene-mediated inhibition of gene , gene , and gene mRNA accumulation and gene protein secretion were related to the accumulation of intracellular chemical ( chemical ) levels .	T5	T20	9730867
NA	CHEMICAL	GENE-Y	27	1	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T6	T22	9730867
NA	CHEMICAL	GENE-N	27	6	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T6	T23	9730867
NA	CHEMICAL	GENE-N	27	5	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T6	T24	9730867
CPR:5	CHEMICAL	GENE-Y	27	14	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T6	T25	9730867
NA	CHEMICAL	GENE-N	27	5	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T6	T26	9730867
NA	CHEMICAL	GENE-N	46	6	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T7	T23	9730867
NA	CHEMICAL	GENE-Y	46	14	Although gene mRNA was detectable in gene-activated T lymphocytes , we could not demonstrate a functional activity in the regulation of gene expression : the gene agonist chemical had no effect on the accumulation of the studied gene mRNAs , and did not significantly affect cellular chemical levels .	T7	T25	9730867
NA	CHEMICAL	GENE-N	2	4	A selective chemical X receptor agonist chemical ( chemical , chemical ) inhibits angiogenesis and metastasis in solid tumours .	T11	T22	16495926
CPR:5	CHEMICAL	GENE-N	6	4	A selective chemical X receptor agonist chemical ( chemical , chemical ) inhibits angiogenesis and metastasis in solid tumours .	T12	T22	16495926
CPR:5	CHEMICAL	GENE-N	8	4	A selective chemical X receptor agonist chemical ( chemical , chemical ) inhibits angiogenesis and metastasis in solid tumours .	T13	T22	16495926
CPR:5	CHEMICAL	GENE-N	10	4	A selective chemical X receptor agonist chemical ( chemical , chemical ) inhibits angiogenesis and metastasis in solid tumours .	T14	T22	16495926
NA	CHEMICAL	GENE-N	8	10	The present study determined the influence of a chemical X receptor agonist chemical on angiogenesis and metastasis in solid tumours .	T6	T21	16495926
CPR:5	CHEMICAL	GENE-N	7	10	The present study determined the influence of a chemical X receptor agonist chemical on angiogenesis and metastasis in solid tumours .	T9	T21	16495926
NA	CHEMICAL	GENE-Y	8	14	In vivo angiogenesis assay utilising gelfoam sponges , chemical reduced angiogenesis in sponges containing gene , gene and basic gene to various extent .	T5	T18	16495926
NA	CHEMICAL	GENE-Y	8	16	In vivo angiogenesis assay utilising gelfoam sponges , chemical reduced angiogenesis in sponges containing gene , gene and basic gene to various extent .	T5	T19	16495926
NA	CHEMICAL	GENE-N	8	19	In vivo angiogenesis assay utilising gelfoam sponges , chemical reduced angiogenesis in sponges containing gene , gene and basic gene to various extent .	T5	T20	16495926
CPR:4	CHEMICAL	GENE-N	6	14	Analysis of tumour-conditioned medium indicated that chemical decreased the secretion of angiogenic factors and gene and increased the tissue inhibitor of gene .	T1	T15	16495926
CPR:3	CHEMICAL	GENE-N	6	21	Analysis of tumour-conditioned medium indicated that chemical decreased the secretion of angiogenic factors and gene and increased the tissue inhibitor of gene .	T1	T16	16495926
CPR:3	CHEMICAL	GENE-Y	3	17	The ability of chemical to inhibit angiogenesis and metastasis was dependent on activation of its heterodimerisation partner gene .	T2	T17	16495926
CPR:4	CHEMICAL	GENE-N	0	5	chemical attenuates metastasis via both gene and gene/gene pathways in gene-treated liver cancer HepG2 cells .	T12	T35	23537747
CPR:4	CHEMICAL	GENE-N	0	7	chemical attenuates metastasis via both gene and gene/gene pathways in gene-treated liver cancer HepG2 cells .	T12	T36	23537747
CPR:4	CHEMICAL	GENE-N	0	7	chemical attenuates metastasis via both gene and gene/gene pathways in gene-treated liver cancer HepG2 cells .	T12	T37	23537747
NA	CHEMICAL	GENE-Y	0	10	chemical attenuates metastasis via both gene and gene/gene pathways in gene-treated liver cancer HepG2 cells .	T12	T38	23537747
NA	CHEMICAL	GENE-Y	19	2	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T2	T18	23537747
NA	CHEMICAL	GENE-Y	19	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T2	T20	23537747
NA	CHEMICAL	GENE-Y	19	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T2	T21	23537747
NA	CHEMICAL	GENE-Y	21	2	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T3	T18	23537747
NA	CHEMICAL	GENE-Y	21	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T3	T20	23537747
NA	CHEMICAL	GENE-Y	21	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T3	T21	23537747
NA	CHEMICAL	GENE-Y	4	2	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T4	T18	23537747
NA	CHEMICAL	GENE-Y	4	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T4	T20	23537747
NA	CHEMICAL	GENE-Y	4	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T4	T21	23537747
NA	CHEMICAL	GENE-Y	26	2	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T5	T18	23537747
NA	CHEMICAL	GENE-Y	26	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T5	T20	23537747
NA	CHEMICAL	GENE-Y	26	28	We use gene as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including chemical , chemical , chemical , and chemical on gene/gene-mediated tumor invasion and metastasis .	T5	T21	23537747
CPR:4	CHEMICAL	GENE-Y	3	6	Among them , chemical markedly inhibited gene-induced the abilities of the adhesion , invasion , and migration by cell-matrix adhesion assay and transwell-chamber invasion/migration assay under non-cytotoxic concentrations .	T6	T22	23537747
CPR:4	CHEMICAL	GENE-Y	3	5	Data also showed chemical inhibited gene-induced cell scattering and cytoskeleton changed such as filopodia and lamellipodia .	T7	T24	23537747
CPR:4	CHEMICAL	GENE-Y	2	5	Furthermore , chemical could inhibit gene-induced the membrane localization of phosphorylated gene , gene , and gene , but not gene and gene .	T8	T25	23537747
CPR:4	CHEMICAL	GENE-Y	2	11	Furthermore , chemical could inhibit gene-induced the membrane localization of phosphorylated gene , gene , and gene , but not gene and gene .	T8	T26	23537747
CPR:4	CHEMICAL	GENE-Y	2	13	Furthermore , chemical could inhibit gene-induced the membrane localization of phosphorylated gene , gene , and gene , but not gene and gene .	T8	T27	23537747
CPR:4	CHEMICAL	GENE-N	2	16	Furthermore , chemical could inhibit gene-induced the membrane localization of phosphorylated gene , gene , and gene , but not gene and gene .	T8	T28	23537747
NA	CHEMICAL	GENE-N	2	20	Furthermore , chemical could inhibit gene-induced the membrane localization of phosphorylated gene , gene , and gene , but not gene and gene .	T8	T29	23537747
NA	CHEMICAL	GENE-N	2	22	Furthermore , chemical could inhibit gene-induced the membrane localization of phosphorylated gene , gene , and gene , but not gene and gene .	T8	T30	23537747
CPR:4	CHEMICAL	GENE-Y	2	12	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T9	T31	23537747
CPR:4	CHEMICAL	GENE-N	2	14	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T9	T32	23537747
CPR:4	CHEMICAL	GENE-Y	2	8	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T9	T33	23537747
CPR:4	CHEMICAL	GENE-N	2	10	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T9	T34	23537747
NA	CHEMICAL	GENE-Y	8	12	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T10	T31	23537747
NA	CHEMICAL	GENE-N	8	14	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T10	T32	23537747
NA	CHEMICAL	GENE-Y	8	8	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T10	T33	23537747
NA	CHEMICAL	GENE-N	8	10	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T10	T34	23537747
NA	CHEMICAL	GENE-Y	10	12	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T11	T31	23537747
NA	CHEMICAL	GENE-N	10	14	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T11	T32	23537747
NA	CHEMICAL	GENE-Y	10	8	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T11	T33	23537747
NA	CHEMICAL	GENE-N	10	10	Next , chemical significantly decreased the levels of chemical-gene and chemical-gene in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration .	T11	T34	23537747
CPR:6	CHEMICAL	GENE-Y	0	15	chemical ( chemical , chemical , chemical , chemical ) , an chemical receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .	T1	T12	18627212
CPR:6	CHEMICAL	GENE-Y	2	15	chemical ( chemical , chemical , chemical , chemical ) , an chemical receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .	T2	T12	18627212
CPR:6	CHEMICAL	GENE-Y	4	15	chemical ( chemical , chemical , chemical , chemical ) , an chemical receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .	T3	T12	18627212
CPR:6	CHEMICAL	GENE-Y	6	15	chemical ( chemical , chemical , chemical , chemical ) , an chemical receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .	T4	T12	18627212
CPR:6	CHEMICAL	GENE-Y	8	15	chemical ( chemical , chemical , chemical , chemical ) , an chemical receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .	T6	T12	18627212
NA	CHEMICAL	GENE-Y	12	15	chemical ( chemical , chemical , chemical , chemical ) , an chemical receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .	T8	T12	18627212
CPR:4	CHEMICAL	GENE-N	6	2	Inhibition of gene-primed eosinophil chemotaxis by chemical .	T10	T33	8384226
NA	CHEMICAL	GENE-N	15	1	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T5	T20	8384226
NA	CHEMICAL	GENE-Y	15	5	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T5	T21	8384226
NA	CHEMICAL	GENE-Y	15	23	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T5	T22	8384226
NA	CHEMICAL	GENE-Y	15	25	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T5	T23	8384226
NA	CHEMICAL	GENE-Y	15	30	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T5	T24	8384226
NA	CHEMICAL	GENE-Y	15	32	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T5	T25	8384226
NA	CHEMICAL	GENE-N	18	1	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T6	T20	8384226
NA	CHEMICAL	GENE-Y	18	5	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T6	T21	8384226
NA	CHEMICAL	GENE-Y	18	23	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T6	T22	8384226
NA	CHEMICAL	GENE-Y	18	25	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T6	T23	8384226
NA	CHEMICAL	GENE-Y	18	30	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T6	T24	8384226
NA	CHEMICAL	GENE-Y	18	32	These gene have the capacity to modulate chemotactic responses of eosinophils toward platelet-activating factor , chemical , ( chemical ) and gene ( gene ) /gene , but not toward gene ( gene ) .	T6	T25	8384226
NA	CHEMICAL	GENE-Y	4	21	Here the effect of chemical on the chemotactic response of eosinophils from allergic asthmatic individuals and from normal donors preincubated with gene or gene toward FMLP , gene/gene was evaluated .	T7	T26	8384226
NA	CHEMICAL	GENE-N	4	23	Here the effect of chemical on the chemotactic response of eosinophils from allergic asthmatic individuals and from normal donors preincubated with gene or gene toward FMLP , gene/gene was evaluated .	T7	T27	8384226
NA	CHEMICAL	GENE-Y	4	27	Here the effect of chemical on the chemotactic response of eosinophils from allergic asthmatic individuals and from normal donors preincubated with gene or gene toward FMLP , gene/gene was evaluated .	T7	T28	8384226
NA	CHEMICAL	GENE-Y	4	27	Here the effect of chemical on the chemotactic response of eosinophils from allergic asthmatic individuals and from normal donors preincubated with gene or gene toward FMLP , gene/gene was evaluated .	T7	T29	8384226
CPR:4	CHEMICAL	GENE-Y	2	10	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T8	T30	8384226
CPR:4	CHEMICAL	GENE-Y	2	10	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T8	T31	8384226
CPR:4	CHEMICAL	GENE-Y	2	12	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T8	T32	8384226
CPR:4	CHEMICAL	GENE-Y	2	38	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T8	T11	8384226
NA	CHEMICAL	GENE-Y	8	10	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T9	T30	8384226
NA	CHEMICAL	GENE-Y	8	10	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T9	T31	8384226
NA	CHEMICAL	GENE-Y	8	12	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T9	T32	8384226
NA	CHEMICAL	GENE-Y	8	38	RESULTS : chemical inhibited the chemotactic response toward chemical and gene/gene of gene primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol/L ) , whereas these responses of gene primed eosinophils was completely inhibited ( IC50 approximately 1 nmol/L ) .	T9	T11	8384226
CPR:4	CHEMICAL	GENE-Y	6	6	CONCLUSIONS : The chemotactic responses toward gene were inhibited by chemical at higher concentrations than were required in the priming studies ( IC50 approximately 10 to 100 nmol/L ) .	T1	T12	8384226
NA	CHEMICAL	GENE-Y	5	3	Circulating levels of gene and gene reflect the nutritional state of animals and elicit regulatory responses in the liver that maintain chemical and lipid homeostasis .	T1	T6	23416070
NA	CHEMICAL	GENE-Y	5	5	Circulating levels of gene and gene reflect the nutritional state of animals and elicit regulatory responses in the liver that maintain chemical and lipid homeostasis .	T1	T10	23416070
NA	CHEMICAL	GENE-N	16	5	Introduction of the acetylation-mimicking ( gene ) or -deficient ( gene ) mutations promotes or inhibits gene activity , respectively , and adenoviral expression of gene-gene augments expression of genes involved in chemical oxidation and ketogenesis .	T2	T18	23416070
NA	CHEMICAL	GENE-N	16	10	Introduction of the acetylation-mimicking ( gene ) or -deficient ( gene ) mutations promotes or inhibits gene activity , respectively , and adenoviral expression of gene-gene augments expression of genes involved in chemical oxidation and ketogenesis .	T2	T19	23416070
NA	CHEMICAL	GENE-Y	16	16	Introduction of the acetylation-mimicking ( gene ) or -deficient ( gene ) mutations promotes or inhibits gene activity , respectively , and adenoviral expression of gene-gene augments expression of genes involved in chemical oxidation and ketogenesis .	T2	T20	23416070
NA	CHEMICAL	GENE-Y	16	25	Introduction of the acetylation-mimicking ( gene ) or -deficient ( gene ) mutations promotes or inhibits gene activity , respectively , and adenoviral expression of gene-gene augments expression of genes involved in chemical oxidation and ketogenesis .	T2	T21	23416070
NA	CHEMICAL	GENE-N	16	25	Introduction of the acetylation-mimicking ( gene ) or -deficient ( gene ) mutations promotes or inhibits gene activity , respectively , and adenoviral expression of gene-gene augments expression of genes involved in chemical oxidation and ketogenesis .	T2	T22	23416070
CPR:5	CHEMICAL	GENE-Y	16	17	OBJECTIVE : The aim of this study was to assess the efficacy and tolerability of nebulized chemical ( a selective , long-acting gene agonist that is the chemical ) and chemical versus placebo in patients with chronic obstructive pulmonary disease ( COPD ) .	T8	T10	17472819
CPR:5	CHEMICAL	GENE-Y	27	17	OBJECTIVE : The aim of this study was to assess the efficacy and tolerability of nebulized chemical ( a selective , long-acting gene agonist that is the chemical ) and chemical versus placebo in patients with chronic obstructive pulmonary disease ( COPD ) .	T3	T10	17472819
NA	CHEMICAL	GENE-Y	18	17	OBJECTIVE : The aim of this study was to assess the efficacy and tolerability of nebulized chemical ( a selective , long-acting gene agonist that is the chemical ) and chemical versus placebo in patients with chronic obstructive pulmonary disease ( COPD ) .	T5	T10	17472819
NA	CHEMICAL	GENE-Y	0	4	chemical and chemical exhibit gene activity : a combined virtual screening and biological assay approach .	T20	T38	17082235
NA	CHEMICAL	GENE-Y	2	4	chemical and chemical exhibit gene activity : a combined virtual screening and biological assay approach .	T21	T38	17082235
NA	CHEMICAL	GENE-N	14	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T15	T36	17082235
NA	CHEMICAL	GENE-Y	14	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T15	T23	17082235
NA	CHEMICAL	GENE-N	14	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T15	T29	17082235
NA	CHEMICAL	GENE-Y	14	30	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T15	T30	17082235
NA	CHEMICAL	GENE-Y	14	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T15	T31	17082235
NA	CHEMICAL	GENE-N	20	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T5	T36	17082235
CPR:3	CHEMICAL	GENE-Y	20	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T5	T23	17082235
NA	CHEMICAL	GENE-N	20	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T5	T29	17082235
NA	CHEMICAL	GENE-Y	20	30	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T5	T30	17082235
NA	CHEMICAL	GENE-Y	20	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T5	T31	17082235
NA	CHEMICAL	GENE-N	4	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T6	T36	17082235
CPR:3	CHEMICAL	GENE-Y	4	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T6	T23	17082235
NA	CHEMICAL	GENE-N	4	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T6	T29	17082235
NA	CHEMICAL	GENE-Y	4	30	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T6	T30	17082235
NA	CHEMICAL	GENE-Y	4	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T6	T31	17082235
NA	CHEMICAL	GENE-N	4	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T7	T36	17082235
NA	CHEMICAL	GENE-Y	4	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T7	T23	17082235
NA	CHEMICAL	GENE-N	4	15	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T7	T29	17082235
NA	CHEMICAL	GENE-Y	4	30	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T7	T30	17082235
NA	CHEMICAL	GENE-Y	4	4	Most drugs currently employed in the treatment of type 2 diabetes either target the chemical receptor stimulating gene release ( chemical , chemical ) , or target the gene ( gene ) improving gene resistance ( chemical ) .	T7	T31	17082235
NA	CHEMICAL	GENE-Y	4	10	Our work shows that chemical and chemical additionally bind to gene and exhibit gene agonistic activity .	T8	T32	17082235
CPR:5	CHEMICAL	GENE-Y	4	13	Our work shows that chemical and chemical additionally bind to gene and exhibit gene agonistic activity .	T8	T33	17082235
NA	CHEMICAL	GENE-Y	6	10	Our work shows that chemical and chemical additionally bind to gene and exhibit gene agonistic activity .	T9	T32	17082235
CPR:5	CHEMICAL	GENE-Y	6	13	Our work shows that chemical and chemical additionally bind to gene and exhibit gene agonistic activity .	T9	T33	17082235
CPR:5	CHEMICAL	GENE-Y	5	18	Among the measured compounds , chemical and chemical ( two chemical ) , as well as chemical ( a chemical ) , exhibit gene agonistic activity at concentrations comparable with those reached under pharmacological treatment .	T10	T35	17082235
CPR:5	CHEMICAL	GENE-Y	7	18	Among the measured compounds , chemical and chemical ( two chemical ) , as well as chemical ( a chemical ) , exhibit gene agonistic activity at concentrations comparable with those reached under pharmacological treatment .	T11	T35	17082235
CPR:5	CHEMICAL	GENE-Y	10	18	Among the measured compounds , chemical and chemical ( two chemical ) , as well as chemical ( a chemical ) , exhibit gene agonistic activity at concentrations comparable with those reached under pharmacological treatment .	T12	T35	17082235
CPR:5	CHEMICAL	GENE-Y	16	18	Among the measured compounds , chemical and chemical ( two chemical ) , as well as chemical ( a chemical ) , exhibit gene agonistic activity at concentrations comparable with those reached under pharmacological treatment .	T13	T35	17082235
CPR:5	CHEMICAL	GENE-Y	19	18	Among the measured compounds , chemical and chemical ( two chemical ) , as well as chemical ( a chemical ) , exhibit gene agonistic activity at concentrations comparable with those reached under pharmacological treatment .	T14	T35	17082235
CPR:3	CHEMICAL	GENE-Y	7	19	The most active of these compounds , chemical , is shown to be as potent as chemical at inducing gene target gene expression .	T16	T37	17082235
CPR:3	CHEMICAL	GENE-Y	16	19	The most active of these compounds , chemical , is shown to be as potent as chemical at inducing gene target gene expression .	T17	T37	17082235
NA	CHEMICAL	GENE-N	6	35	This dual mode of action of chemical and chemical may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the chemical receptor and gene .	T18	T22	17082235
NA	CHEMICAL	GENE-Y	6	37	This dual mode of action of chemical and chemical may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the chemical receptor and gene .	T18	T24	17082235
NA	CHEMICAL	GENE-N	8	35	This dual mode of action of chemical and chemical may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the chemical receptor and gene .	T19	T22	17082235
NA	CHEMICAL	GENE-Y	8	37	This dual mode of action of chemical and chemical may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the chemical receptor and gene .	T19	T24	17082235
NA	CHEMICAL	GENE-N	6	35	This dual mode of action of chemical and chemical may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the chemical receptor and gene .	T1	T22	17082235
NA	CHEMICAL	GENE-Y	6	37	This dual mode of action of chemical and chemical may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the chemical receptor and gene .	T1	T24	17082235
CPR:5	CHEMICAL	GENE-Y	0	16	chemical , chemical , and other chemical may be promising leads in the development of new gene agonists .	T2	T27	17082235
CPR:5	CHEMICAL	GENE-Y	2	16	chemical , chemical , and other chemical may be promising leads in the development of new gene agonists .	T3	T27	17082235
CPR:5	CHEMICAL	GENE-Y	6	16	chemical , chemical , and other chemical may be promising leads in the development of new gene agonists .	T4	T27	17082235
NA	CHEMICAL	GENE-Y	11	21	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T3	T19	12213119
NA	CHEMICAL	GENE-Y	11	3	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T3	T20	12213119
NA	CHEMICAL	GENE-Y	13	21	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T4	T19	12213119
NA	CHEMICAL	GENE-Y	13	3	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T4	T20	12213119
NA	CHEMICAL	GENE-Y	16	21	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T5	T19	12213119
NA	CHEMICAL	GENE-Y	16	3	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T5	T20	12213119
NA	CHEMICAL	GENE-Y	18	21	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T6	T19	12213119
NA	CHEMICAL	GENE-Y	18	3	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T6	T20	12213119
NA	CHEMICAL	GENE-Y	29	21	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T8	T19	12213119
NA	CHEMICAL	GENE-Y	29	3	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T8	T20	12213119
NA	CHEMICAL	GENE-Y	31	21	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T9	T19	12213119
NA	CHEMICAL	GENE-Y	31	3	The higher concentrations in calves were insufficient to inhibit significantly exudate chemical ( chemical ) , chemical ( chemical ) and gene concentrations and exudate leucocyte numbers , serum chemical ( chemical ) , and gene-induced skin swelling .	T9	T20	12213119
NA	CHEMICAL	GENE-N	29	12	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T10	T21	12213119
NA	CHEMICAL	GENE-N	29	64	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T10	T22	12213119
NA	CHEMICAL	GENE-Y	29	68	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T10	T23	12213119
NA	CHEMICAL	GENE-N	32	12	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T11	T21	12213119
NA	CHEMICAL	GENE-N	32	64	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T11	T22	12213119
NA	CHEMICAL	GENE-Y	32	68	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T11	T23	12213119
NA	CHEMICAL	GENE-Y	32	70	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T11	T24	12213119
NA	CHEMICAL	GENE-N	43	12	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T12	T21	12213119
NA	CHEMICAL	GENE-N	43	64	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T12	T22	12213119
NA	CHEMICAL	GENE-Y	43	68	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T12	T23	12213119
NA	CHEMICAL	GENE-Y	43	70	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T12	T24	12213119
NA	CHEMICAL	GENE-N	59	64	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T13	T22	12213119
NA	CHEMICAL	GENE-Y	59	68	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T13	T23	12213119
NA	CHEMICAL	GENE-Y	59	70	These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active chemical metabolite , chemical ; ( b ) a greater degree of binding of chemical to plasma protein in calves ; ( c ) species differences in the sensitivity to chemical of the gene ( gene ) isoenzymes , gene and gene or ; ( d ) a combination of these factors .	T13	T24	12213119
NA	CHEMICAL	GENE-N	18	15	Consistent with an adult-onset isolated GHD model , mutant animals are hypoglycemic and display increased gene sensitivity and chemical clearance .	T1	T5	23150495
CPR:9	CHEMICAL	GENE-Y	5	2	Inhibition of gene pathway of chemical metabolism in human neutrophils by chemical and chemical .	T20	T23	2882965
CPR:4	CHEMICAL	GENE-Y	7	2	Inhibition of gene pathway of chemical metabolism in human neutrophils by chemical and chemical .	T21	T23	2882965
CPR:4	CHEMICAL	GENE-Y	13	2	Inhibition of gene pathway of chemical metabolism in human neutrophils by chemical and chemical .	T19	T23	2882965
NA	CHEMICAL	GENE-Y	2	3	Inhibition of the gene by chemical : affinity for open and inactivated states .	T10	T17	10510456
CPR:4	CHEMICAL	GENE-Y	5	3	Inhibition of the gene by chemical : affinity for open and inactivated states .	T12	T17	10510456
CPR:4	CHEMICAL	GENE-Y	2	12	2 In a chronic transfection model using CHO-K1 cells , chemical inhibited gene tail currents after a step to +25 mV with similar potency at room and physiological temperatures ( IC50 16 .	T6	T16	10510456
CPR:4	CHEMICAL	GENE-Y	8	4	6 In conclusion , gene channel inhibition by chemical exhibits features consistent with open and inactivated state binding and is sensitive to external chemical concentration .	T2	T13	10510456
NA	CHEMICAL	GENE-Y	23	4	6 In conclusion , gene channel inhibition by chemical exhibits features consistent with open and inactivated state binding and is sensitive to external chemical concentration .	T3	T13	10510456
CPR:3	CHEMICAL	GENE-N	7	2	Induction of gene ( gene ) by chemical in cultured astrocytes and reduction of chemical-induced cell death .	T16	T38	12472888
CPR:3	CHEMICAL	GENE-N	7	4	Induction of gene ( gene ) by chemical in cultured astrocytes and reduction of chemical-induced cell death .	T16	T39	12472888
NA	CHEMICAL	GENE-N	14	2	Induction of gene ( gene ) by chemical in cultured astrocytes and reduction of chemical-induced cell death .	T17	T38	12472888
NA	CHEMICAL	GENE-N	14	4	Induction of gene ( gene ) by chemical in cultured astrocytes and reduction of chemical-induced cell death .	T17	T39	12472888
CPR:3	CHEMICAL	GENE-N	0	5	chemical triggered strong induction of gene , which was prevented by 1 micro g/mL chemical ( chemical ) .	T9	T31	12472888
CPR:4	CHEMICAL	GENE-N	14	5	chemical triggered strong induction of gene , which was prevented by 1 micro g/mL chemical ( chemical ) .	T10	T31	12472888
CPR:4	CHEMICAL	GENE-N	16	5	chemical triggered strong induction of gene , which was prevented by 1 micro g/mL chemical ( chemical ) .	T11	T31	12472888
CPR:3	CHEMICAL	GENE-N	11	4	Pre-treatment with arsenite increased gene ( gene ) and gene ( gene ) phosphorylation after chemical .	T1	T35	12472888
CPR:3	CHEMICAL	GENE-N	11	6	Pre-treatment with arsenite increased gene ( gene ) and gene ( gene ) phosphorylation after chemical .	T1	T36	12472888
NA	CHEMICAL	GENE-N	11	9	Pre-treatment with arsenite increased gene ( gene ) and gene ( gene ) phosphorylation after chemical .	T1	T37	12472888
NA	CHEMICAL	GENE-N	11	11	Pre-treatment with arsenite increased gene ( gene ) and gene ( gene ) phosphorylation after chemical .	T1	T19	12472888
CPR:4	CHEMICAL	GENE-N	3	3	However , while gene phosphorylation was prevented by chemical , gene phosphorylation was further enhanced by CHX .	T2	T20	12472888
NA	CHEMICAL	GENE-N	3	10	However , while gene phosphorylation was prevented by chemical , gene phosphorylation was further enhanced by CHX .	T2	T21	12472888
CPR:3	CHEMICAL	GENE-Y	5	8	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T3	T23	12472888
CPR:3	CHEMICAL	GENE-Y	5	10	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T3	T24	12472888
CPR:3	CHEMICAL	GENE-Y	5	18	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T3	T25	12472888
CPR:3	CHEMICAL	GENE-N	5	32	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T3	T27	12472888
NA	CHEMICAL	GENE-Y	22	8	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T4	T23	12472888
NA	CHEMICAL	GENE-Y	22	10	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T4	T24	12472888
NA	CHEMICAL	GENE-Y	22	18	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T4	T25	12472888
NA	CHEMICAL	GENE-N	22	32	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T4	T27	12472888
NA	CHEMICAL	GENE-Y	34	8	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T5	T23	12472888
NA	CHEMICAL	GENE-Y	34	10	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T5	T24	12472888
NA	CHEMICAL	GENE-Y	34	18	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T5	T25	12472888
CPR:3	CHEMICAL	GENE-N	34	32	The results show that transient chemical pre-treatment induces gene , gene and , to a lesser extent , gene ; it reduces chemical-induced astrocyte death ; and it causes selective activation of gene following chemical .	T5	T27	12472888
NA	CHEMICAL	GENE-Y	0	4	chemical : recent update on activity as a single agent and in combination with gene in patients with advanced-stage renal cell carcinoma .	T7	T18	16729906
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a small-molecule inhibitor that has been shown to target members of multiple classes of chemical kinases that are known to be involved in tumor cell proliferation and tumor angiogenesis .	T2	T8	16729906
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a small-molecule inhibitor that has been shown to target members of multiple classes of chemical kinases that are known to be involved in tumor cell proliferation and tumor angiogenesis .	T3	T8	16729906
NA	CHEMICAL	GENE-N	19	5	chemical ( chemical ) is a small-molecule inhibitor that has been shown to target members of multiple classes of chemical kinases that are known to be involved in tumor cell proliferation and tumor angiogenesis .	T4	T8	16729906
CPR:4	CHEMICAL	GENE-N	6	8	Synthesis and in-silico studies of some chemical derivatives as potential gene inhibitors .	T5	T10	23479193
CPR:5	CHEMICAL	GENE-Y	6	6	for 15 days or along with a gene agonist chemical ( chemical ; 30 μg/100 g BW , oral ) and were found to improve in the chemical co-treated condition .	T3	T10	23428368
CPR:5	CHEMICAL	GENE-Y	11	6	for 15 days or along with a gene agonist chemical ( chemical ; 30 μg/100 g BW , oral ) and were found to improve in the chemical co-treated condition .	T4	T10	23428368
NA	CHEMICAL	GENE-Y	27	6	for 15 days or along with a gene agonist chemical ( chemical ; 30 μg/100 g BW , oral ) and were found to improve in the chemical co-treated condition .	T5	T10	23428368
NA	CHEMICAL	GENE-N	11	6	Hyperthyroidism-induced oxidative stress , reduction in gene activity , and myocardial chemical concentration were also significantly checked by chemical .	T7	T11	23428368
NA	CHEMICAL	GENE-N	18	6	Hyperthyroidism-induced oxidative stress , reduction in gene activity , and myocardial chemical concentration were also significantly checked by chemical .	T8	T11	23428368
NA	CHEMICAL	GENE-Y	3	11	In addition , chemical levels in splenic tissue or serum and gene mRNA expression ( mRNA encoding chemical side-chain cleavage p450 enzyme ) in CD4+ T cells were increased in these mice .	T2	T9	11161433
NA	CHEMICAL	GENE-Y	3	21	In addition , chemical levels in splenic tissue or serum and gene mRNA expression ( mRNA encoding chemical side-chain cleavage p450 enzyme ) in CD4+ T cells were increased in these mice .	T2	T10	11161433
NA	CHEMICAL	GENE-Y	17	11	In addition , chemical levels in splenic tissue or serum and gene mRNA expression ( mRNA encoding chemical side-chain cleavage p450 enzyme ) in CD4+ T cells were increased in these mice .	T3	T9	11161433
NA	CHEMICAL	GENE-Y	17	21	In addition , chemical levels in splenic tissue or serum and gene mRNA expression ( mRNA encoding chemical side-chain cleavage p450 enzyme ) in CD4+ T cells were increased in these mice .	T3	T10	11161433
CPR:4	CHEMICAL	GENE-Y	4	6	When the anti-chemical drug chemical ( gene inhibitor ) was administered to B16F10 mice , corticosterone levels in splenic tissue or serum and gene mRNA expression were decreased at 14 days after tumor inoculation .	T4	T11	11161433
CPR:4	CHEMICAL	GENE-Y	4	23	When the anti-chemical drug chemical ( gene inhibitor ) was administered to B16F10 mice , corticosterone levels in splenic tissue or serum and gene mRNA expression were decreased at 14 days after tumor inoculation .	T4	T13	11161433
NA	CHEMICAL	GENE-Y	2	6	When the anti-chemical drug chemical ( gene inhibitor ) was administered to B16F10 mice , corticosterone levels in splenic tissue or serum and gene mRNA expression were decreased at 14 days after tumor inoculation .	T5	T11	11161433
NA	CHEMICAL	GENE-Y	2	23	When the anti-chemical drug chemical ( gene inhibitor ) was administered to B16F10 mice , corticosterone levels in splenic tissue or serum and gene mRNA expression were decreased at 14 days after tumor inoculation .	T5	T13	11161433
NA	CHEMICAL	GENE-Y	6	5	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T1	T21	23455323
NA	CHEMICAL	GENE-Y	6	13	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T1	T22	23455323
NA	CHEMICAL	GENE-N	6	15	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T1	T23	23455323
NA	CHEMICAL	GENE-N	6	21	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T1	T24	23455323
NA	CHEMICAL	GENE-N	6	26	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T1	T25	23455323
NA	CHEMICAL	GENE-Y	6	29	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T1	T26	23455323
NA	CHEMICAL	GENE-Y	5	5	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T2	T21	23455323
NA	CHEMICAL	GENE-Y	5	13	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T2	T22	23455323
NA	CHEMICAL	GENE-N	5	15	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T2	T23	23455323
NA	CHEMICAL	GENE-N	5	21	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T2	T24	23455323
NA	CHEMICAL	GENE-N	5	26	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T2	T25	23455323
NA	CHEMICAL	GENE-Y	5	29	We demonstrate that activation of gene chemical-727 and chemical-705 phosphorylations is promoted by gene ( gene ) activity and that the gene is dependent on a gene consensus-site for gene-mediated activation .	T2	T26	23455323
NA	CHEMICAL	GENE-Y	11	23	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T12	T24	7560228
NA	CHEMICAL	GENE-Y	11	25	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T12	T25	7560228
NA	CHEMICAL	GENE-Y	11	27	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T12	T26	7560228
NA	CHEMICAL	GENE-Y	11	29	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T12	T27	7560228
NA	CHEMICAL	GENE-Y	20	23	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T13	T24	7560228
NA	CHEMICAL	GENE-Y	20	25	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T13	T25	7560228
NA	CHEMICAL	GENE-Y	20	27	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T13	T26	7560228
NA	CHEMICAL	GENE-Y	20	29	Several in vitro studies were conducted to evaluate the effect of chemical on 4 primary enzymes of the pathways of chemical metabolism , gene , gene , gene and gene .	T13	T27	7560228
CPR:4	CHEMICAL	GENE-Y	0	3	chemical inhibited both gene and gene with IC-50 values of 43 microM and 227 microM , respectively .	T17	T28	7560228
CPR:4	CHEMICAL	GENE-Y	0	5	chemical inhibited both gene and gene with IC-50 values of 43 microM and 227 microM , respectively .	T17	T29	7560228
CPR:4	CHEMICAL	GENE-Y	0	3	chemical also inhibited gene with an IC-50 of 43 microM .	T2	T19	7560228
CPR:4	CHEMICAL	GENE-Y	6	1	The gene was similarly inhibited by chemical with an IC-50 of 61 microM .	T4	T20	7560228
CPR:4	CHEMICAL	GENE-N	2	10	Hence , chemical has the ability to inhibit both the gene and gene pathways of chemical metabolism with similar efficacy .	T5	T21	7560228
CPR:4	CHEMICAL	GENE-N	2	12	Hence , chemical has the ability to inhibit both the gene and gene pathways of chemical metabolism with similar efficacy .	T5	T22	7560228
CPR:9	CHEMICAL	GENE-N	15	10	Hence , chemical has the ability to inhibit both the gene and gene pathways of chemical metabolism with similar efficacy .	T6	T21	7560228
CPR:9	CHEMICAL	GENE-N	15	12	Hence , chemical has the ability to inhibit both the gene and gene pathways of chemical metabolism with similar efficacy .	T6	T22	7560228
CPR:4	CHEMICAL	GENE-Y	9	11	In cell culture experiments , it was found that chemical inhibited gene induced chemical production by human gingival fibroblasts in a concentration dependent manner , and at relatively low concentrations .	T7	T23	7560228
CPR:9	CHEMICAL	GENE-Y	13	11	In cell culture experiments , it was found that chemical inhibited gene induced chemical production by human gingival fibroblasts in a concentration dependent manner , and at relatively low concentrations .	T8	T23	7560228
CPR:4	CHEMICAL	GENE-Y	10	26	BACKGROUND : Recent epidemiologic and laboratory studies have suggested that non-chemical anti-inflammatory drugs ( NSAIDs ) may reduce the risk of breast cancer through inhibition of gene ( gene ) .	T7	T12	20724158
CPR:4	CHEMICAL	GENE-Y	10	28	BACKGROUND : Recent epidemiologic and laboratory studies have suggested that non-chemical anti-inflammatory drugs ( NSAIDs ) may reduce the risk of breast cancer through inhibition of gene ( gene ) .	T7	T13	20724158
CPR:4	CHEMICAL	GENE-Y	17	13	METHODS : We conducted a case-control study to measure the association between selective gene inhibitors , particularly chemical , chemical , chemical and non-specific NSAID subgroups , and breast cancer risk .	T4	T14	20724158
CPR:4	CHEMICAL	GENE-Y	19	13	METHODS : We conducted a case-control study to measure the association between selective gene inhibitors , particularly chemical , chemical , chemical and non-specific NSAID subgroups , and breast cancer risk .	T5	T14	20724158
CPR:4	CHEMICAL	GENE-Y	4	13	METHODS : We conducted a case-control study to measure the association between selective gene inhibitors , particularly chemical , chemical , chemical and non-specific NSAID subgroups , and breast cancer risk .	T6	T14	20724158
CPR:4	CHEMICAL	GENE-N	7	5	Global target profile of the gene inhibitor chemical in primary chronic myeloid leukemia cells .	T12	T33	19039322
CPR:4	CHEMICAL	GENE-Y	12	10	Here , we characterized the target profile of the dual gene/gene inhibitor chemical employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro gene assays against a large recombinant gene panel .	T3	T20	19039322
CPR:4	CHEMICAL	GENE-Y	12	10	Here , we characterized the target profile of the dual gene/gene inhibitor chemical employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro gene assays against a large recombinant gene panel .	T3	T21	19039322
NA	CHEMICAL	GENE-N	12	14	Here , we characterized the target profile of the dual gene/gene inhibitor chemical employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro gene assays against a large recombinant gene panel .	T3	T22	19039322
NA	CHEMICAL	GENE-N	12	14	Here , we characterized the target profile of the dual gene/gene inhibitor chemical employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro gene assays against a large recombinant gene panel .	T3	T23	19039322
NA	CHEMICAL	GENE-N	4	4	The combined strategy resulted in a global survey of chemical targets comprised of over 45 novel chemical and chemical/chemical kinases .	T4	T25	19039322
NA	CHEMICAL	GENE-N	4	4	The combined strategy resulted in a global survey of chemical targets comprised of over 45 novel chemical and chemical/chemical kinases .	T5	T25	19039322
NA	CHEMICAL	GENE-N	4	4	The combined strategy resulted in a global survey of chemical targets comprised of over 45 novel chemical and chemical/chemical kinases .	T6	T25	19039322
NA	CHEMICAL	GENE-N	4	4	The combined strategy resulted in a global survey of chemical targets comprised of over 45 novel chemical and chemical/chemical kinases .	T7	T25	19039322
CPR:4	CHEMICAL	GENE-N	3	9	A comparison of chemical with chemical across the whole gene panel revealed overlapping , but distinct , inhibition profiles .	T9	T28	19039322
CPR:4	CHEMICAL	GENE-N	5	9	A comparison of chemical with chemical across the whole gene panel revealed overlapping , but distinct , inhibition profiles .	T10	T28	19039322
NA	CHEMICAL	GENE-Y	0	4	chemical did not inhibit gene or gene , but prominently targeted the apoptosis-linked gene .	T11	T13	19039322
NA	CHEMICAL	GENE-N	0	5	chemical did not inhibit gene or gene , but prominently targeted the apoptosis-linked gene .	T11	T14	19039322
NA	CHEMICAL	GENE-N	0	13	chemical did not inhibit gene or gene , but prominently targeted the apoptosis-linked gene .	T11	T15	19039322
NA	CHEMICAL	GENE-Y	1	7	Although in vivo chemical is inactive against gene gene , we found this clinically important mutant to be enzymatically inhibited in the mid-nanomolar range .	T1	T16	19039322
NA	CHEMICAL	GENE-N	1	8	Although in vivo chemical is inactive against gene gene , we found this clinically important mutant to be enzymatically inhibited in the mid-nanomolar range .	T1	T17	19039322
NA	CHEMICAL	GENE-N	3	7	The role of chemical transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population .	T2	T13	17381051
NA	CHEMICAL	GENE-N	11	15	AIM : This study seeks to determine the role of the chemical transferases M1 and T1 null genotypes ( gene*0 and gene*0 ) in individual susceptibility to bladder cancer in a Tunisian population .	T1	T4	17381051
NA	CHEMICAL	GENE-Y	11	13	AIM : This study seeks to determine the role of the chemical transferases M1 and T1 null genotypes ( gene*0 and gene*0 ) in individual susceptibility to bladder cancer in a Tunisian population .	T1	T5	17381051
NA	CHEMICAL	GENE-Y	11	15	AIM : This study seeks to determine the role of the chemical transferases M1 and T1 null genotypes ( gene*0 and gene*0 ) in individual susceptibility to bladder cancer in a Tunisian population .	T1	T6	17381051
CPR:6	CHEMICAL	GENE-Y	2	6	Effect of chemical , a new gene antagonist , on gastric emptying of a solid-liquid meal in humans .	T8	T20	9712175
NA	CHEMICAL	GENE-Y	7	6	We studied the role of endogenous gene in the emptying of a solid/liquid meal administering the new , highly specific and potent gene antagonist chemical .	T3	T14	9712175
CPR:6	CHEMICAL	GENE-Y	7	22	We studied the role of endogenous gene in the emptying of a solid/liquid meal administering the new , highly specific and potent gene antagonist chemical .	T3	T15	9712175
CPR:3	CHEMICAL	GENE-Y	0	5	chemical markedly increased postprandial plasma gene release ( P < 0.001 ) while distinctly reducing postprandial gene levels ( P < 0.01 ) as compared to placebo .	T1	T9	9712175
CPR:4	CHEMICAL	GENE-Y	0	8	chemical markedly increased postprandial plasma gene release ( P < 0.001 ) while distinctly reducing postprandial gene levels ( P < 0.01 ) as compared to placebo .	T1	T10	9712175
CPR:4	CHEMICAL	GENE-N	5	6	Manipulation of kinetic profiles in chemical gene inhibitors .	T8	T10	14741265
NA	CHEMICAL	GENE-Y	4	20	The nonsteroidal anti-inflammatory drugs chemical and chemical were modified in an attempt to alter the kinetics of inhibitor binding by gene .	T6	T9	14741265
NA	CHEMICAL	GENE-Y	6	20	The nonsteroidal anti-inflammatory drugs chemical and chemical were modified in an attempt to alter the kinetics of inhibitor binding by gene .	T7	T9	14741265
NA	CHEMICAL	GENE-N	0	2	chemical-chemical-transferase , a phase II enzyme , was inhibited by both chemical and chemical but no such inhibition was noted in chemical-treated animals pre-exposed to chemical .	T19	T30	23475432
NA	CHEMICAL	GENE-N	0	2	chemical-chemical-transferase , a phase II enzyme , was inhibited by both chemical and chemical but no such inhibition was noted in chemical-treated animals pre-exposed to chemical .	T20	T30	23475432
CPR:4	CHEMICAL	GENE-N	2	2	chemical-chemical-transferase , a phase II enzyme , was inhibited by both chemical and chemical but no such inhibition was noted in chemical-treated animals pre-exposed to chemical .	T21	T30	23475432
CPR:4	CHEMICAL	GENE-N	13	2	chemical-chemical-transferase , a phase II enzyme , was inhibited by both chemical and chemical but no such inhibition was noted in chemical-treated animals pre-exposed to chemical .	T22	T30	23475432
NA	CHEMICAL	GENE-N	2	2	chemical-chemical-transferase , a phase II enzyme , was inhibited by both chemical and chemical but no such inhibition was noted in chemical-treated animals pre-exposed to chemical .	T23	T30	23475432
NA	CHEMICAL	GENE-N	0	2	chemical-chemical-transferase , a phase II enzyme , was inhibited by both chemical and chemical but no such inhibition was noted in chemical-treated animals pre-exposed to chemical .	T1	T30	23475432
CPR:3	CHEMICAL	GENE-Y	1	5	Upon chemical pre-exposure , brain gene increased , while gene ( gene ) decreased .	T2	T26	23475432
CPR:4	CHEMICAL	GENE-N	1	9	Upon chemical pre-exposure , brain gene increased , while gene ( gene ) decreased .	T2	T27	23475432
CPR:4	CHEMICAL	GENE-N	1	11	Upon chemical pre-exposure , brain gene increased , while gene ( gene ) decreased .	T2	T28	23475432
CPR:4	CHEMICAL	GENE-N	8	4	The toxic effects of gene significantly attenuated with chemical pre-exposure .	T3	T29	23475432
NA	CHEMICAL	GENE-Y	16	3	The octanoylation of gene is critical for its orexigenic functions and is dependent upon gene ( GchemicalAT ) catalyzation .	T1	T8	23399323
NA	CHEMICAL	GENE-Y	16	14	The octanoylation of gene is critical for its orexigenic functions and is dependent upon gene ( GchemicalAT ) catalyzation .	T1	T9	23399323
NA	CHEMICAL	GENE-Y	4	6	Phosphorylation and up-regulation of chemical kinase gamma via its interaction with gene .	T12	T38	16905533
NA	CHEMICAL	GENE-Y	4	6	Phosphorylation and up-regulation of chemical kinase gamma via its interaction with gene .	T12	T39	16905533
NA	CHEMICAL	GENE-N	0	10	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T1	T28	16905533
NA	CHEMICAL	GENE-N	0	12	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T1	T32	16905533
CPR:9	CHEMICAL	GENE-N	0	5	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T1	T18	16905533
CPR:9	CHEMICAL	GENE-N	0	22	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T1	T20	16905533
NA	CHEMICAL	GENE-N	2	10	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T2	T28	16905533
NA	CHEMICAL	GENE-N	2	12	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T2	T32	16905533
CPR:9	CHEMICAL	GENE-N	2	5	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T2	T18	16905533
CPR:9	CHEMICAL	GENE-N	2	22	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T2	T20	16905533
NA	CHEMICAL	GENE-N	18	10	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T11	T28	16905533
NA	CHEMICAL	GENE-N	18	12	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T11	T32	16905533
CPR:9	CHEMICAL	GENE-N	18	5	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T11	T18	16905533
CPR:9	CHEMICAL	GENE-N	18	22	chemical ( chemical ) acts as an allosteric activator of gene ( gene ) and is converted to chemical by gene ( gene ) .	T11	T20	16905533
NA	CHEMICAL	GENE-Y	15	0	gene directly associated with gene through its accessory domain ( AD ) , depending on chemical as well as chemical/chemical in vitro .	T3	T24	16905533
NA	CHEMICAL	GENE-Y	15	4	gene directly associated with gene through its accessory domain ( AD ) , depending on chemical as well as chemical/chemical in vitro .	T3	T25	16905533
NA	CHEMICAL	GENE-Y	19	0	gene directly associated with gene through its accessory domain ( AD ) , depending on chemical as well as chemical/chemical in vitro .	T4	T24	16905533
NA	CHEMICAL	GENE-Y	19	4	gene directly associated with gene through its accessory domain ( AD ) , depending on chemical as well as chemical/chemical in vitro .	T4	T25	16905533
NA	CHEMICAL	GENE-Y	19	0	gene directly associated with gene through its accessory domain ( AD ) , depending on chemical as well as chemical/chemical in vitro .	T5	T24	16905533
NA	CHEMICAL	GENE-Y	19	4	gene directly associated with gene through its accessory domain ( AD ) , depending on chemical as well as chemical/chemical in vitro .	T5	T25	16905533
NA	CHEMICAL	GENE-Y	9	8	Mass spectrometric analysis and mutation studies revealed that gene chemical-776 and chemical-779 in the AD of gene .	T6	T26	16905533
NA	CHEMICAL	GENE-Y	9	16	Mass spectrometric analysis and mutation studies revealed that gene chemical-776 and chemical-779 in the AD of gene .	T6	T27	16905533
NA	CHEMICAL	GENE-Y	11	8	Mass spectrometric analysis and mutation studies revealed that gene chemical-776 and chemical-779 in the AD of gene .	T7	T26	16905533
NA	CHEMICAL	GENE-Y	11	16	Mass spectrometric analysis and mutation studies revealed that gene chemical-776 and chemical-779 in the AD of gene .	T7	T27	16905533
NA	CHEMICAL	GENE-Y	15	3	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T8	T29	16905533
NA	CHEMICAL	GENE-Y	15	8	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T8	T30	16905533
NA	CHEMICAL	GENE-Y	15	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T8	T31	16905533
NA	CHEMICAL	GENE-Y	15	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T8	T33	16905533
NA	CHEMICAL	GENE-Y	15	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T8	T34	16905533
NA	CHEMICAL	GENE-Y	17	3	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T9	T29	16905533
NA	CHEMICAL	GENE-Y	17	8	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T9	T30	16905533
NA	CHEMICAL	GENE-Y	17	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T9	T31	16905533
NA	CHEMICAL	GENE-Y	17	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T9	T33	16905533
NA	CHEMICAL	GENE-Y	17	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T9	T34	16905533
NA	CHEMICAL	GENE-Y	10	3	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T10	T29	16905533
NA	CHEMICAL	GENE-Y	10	8	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T10	T30	16905533
NA	CHEMICAL	GENE-Y	10	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T10	T31	16905533
NA	CHEMICAL	GENE-Y	10	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T10	T33	16905533
NA	CHEMICAL	GENE-Y	10	10	The phosphorylation by gene resulted in activation of gene because a gene mutant in which chemical-776 and chemical-779 were substituted with chemical to mimic phosphorylation exhibited significantly higher activity compared with wild type gene and an unphosphorylatable gene mutant .	T10	T34	16905533
CPR:6	CHEMICAL	GENE-Y	0	5	chemical , the first prostate-selective gene antagonist .	T10	T13	8647141
NA	CHEMICAL	GENE-Y	0	1	chemical receptor agonists ( VDRAs ) directly suppress gene ( gene ) mRNA expression .	T1	T21	20204178
NA	CHEMICAL	GENE-Y	0	8	chemical receptor agonists ( VDRAs ) directly suppress gene ( gene ) mRNA expression .	T1	T33	20204178
NA	CHEMICAL	GENE-Y	0	10	chemical receptor agonists ( VDRAs ) directly suppress gene ( gene ) mRNA expression .	T1	T36	20204178
NA	CHEMICAL	GENE-Y	10	20	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T5	T25	20204178
NA	CHEMICAL	GENE-Y	10	26	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T5	T26	20204178
NA	CHEMICAL	GENE-Y	10	4	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T5	T27	20204178
NA	CHEMICAL	GENE-Y	10	34	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T5	T28	20204178
NA	CHEMICAL	GENE-Y	12	20	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T6	T25	20204178
NA	CHEMICAL	GENE-Y	12	26	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T6	T26	20204178
NA	CHEMICAL	GENE-Y	12	4	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T6	T27	20204178
NA	CHEMICAL	GENE-Y	12	34	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T6	T28	20204178
NA	CHEMICAL	GENE-Y	24	20	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T7	T25	20204178
CPR:3	CHEMICAL	GENE-Y	24	26	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T7	T26	20204178
NA	CHEMICAL	GENE-Y	24	4	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T7	T27	20204178
NA	CHEMICAL	GENE-Y	24	34	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T7	T28	20204178
NA	CHEMICAL	GENE-Y	31	20	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T8	T25	20204178
NA	CHEMICAL	GENE-Y	31	26	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T8	T26	20204178
NA	CHEMICAL	GENE-Y	31	4	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T8	T27	20204178
NA	CHEMICAL	GENE-Y	31	34	Different VDRAs are known to have differential effects on serum chemical ( chemical ) , which may also affect serum gene levels since serum chemical regulates gene secretion mediated by the chemical-sensing receptor ( gene ) .	T8	T28	20204178
NA	CHEMICAL	GENE-Y	9	17	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T9	T29	20204178
NA	CHEMICAL	GENE-Y	9	24	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T9	T30	20204178
NA	CHEMICAL	GENE-Y	9	26	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T9	T31	20204178
NA	CHEMICAL	GENE-Y	9	29	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T9	T32	20204178
NA	CHEMICAL	GENE-Y	11	17	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T10	T29	20204178
NA	CHEMICAL	GENE-Y	11	24	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T10	T30	20204178
NA	CHEMICAL	GENE-Y	11	26	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T10	T31	20204178
NA	CHEMICAL	GENE-Y	11	29	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T10	T32	20204178
NA	CHEMICAL	GENE-Y	15	17	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T11	T29	20204178
NA	CHEMICAL	GENE-Y	15	24	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T11	T30	20204178
NA	CHEMICAL	GENE-Y	15	26	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T11	T31	20204178
NA	CHEMICAL	GENE-Y	15	29	In this study , we compared the effects of chemical and chemical on regulating serum chemical and gene , and also the expression of gene , gene , and gene mRNA .	T11	T32	20204178
CPR:4	CHEMICAL	GENE-Y	25	11	Both drugs at the tested doses ( 0.042-0.33 mug/kg ) suppressed gene mRNA expression and serum gene effectively in the 5/6 NX rats , but chemical was less potent in raising serum chemical than chemical .	T14	T34	20204178
CPR:4	CHEMICAL	GENE-Y	25	16	Both drugs at the tested doses ( 0.042-0.33 mug/kg ) suppressed gene mRNA expression and serum gene effectively in the 5/6 NX rats , but chemical was less potent in raising serum chemical than chemical .	T14	T35	20204178
NA	CHEMICAL	GENE-Y	32	11	Both drugs at the tested doses ( 0.042-0.33 mug/kg ) suppressed gene mRNA expression and serum gene effectively in the 5/6 NX rats , but chemical was less potent in raising serum chemical than chemical .	T15	T34	20204178
NA	CHEMICAL	GENE-Y	32	16	Both drugs at the tested doses ( 0.042-0.33 mug/kg ) suppressed gene mRNA expression and serum gene effectively in the 5/6 NX rats , but chemical was less potent in raising serum chemical than chemical .	T15	T35	20204178
CPR:4	CHEMICAL	GENE-Y	34	11	Both drugs at the tested doses ( 0.042-0.33 mug/kg ) suppressed gene mRNA expression and serum gene effectively in the 5/6 NX rats , but chemical was less potent in raising serum chemical than chemical .	T16	T34	20204178
CPR:4	CHEMICAL	GENE-Y	34	16	Both drugs at the tested doses ( 0.042-0.33 mug/kg ) suppressed gene mRNA expression and serum gene effectively in the 5/6 NX rats , but chemical was less potent in raising serum chemical than chemical .	T16	T35	20204178
NA	CHEMICAL	GENE-Y	5	13	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T17	T37	20204178
CPR:4	CHEMICAL	GENE-Y	5	23	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T17	T38	20204178
NA	CHEMICAL	GENE-Y	5	31	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T17	T22	20204178
NA	CHEMICAL	GENE-Y	11	13	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T18	T37	20204178
CPR:4	CHEMICAL	GENE-Y	11	23	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T18	T38	20204178
NA	CHEMICAL	GENE-Y	11	31	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T18	T22	20204178
NA	CHEMICAL	GENE-Y	31	13	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T2	T37	20204178
NA	CHEMICAL	GENE-Y	31	23	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T2	T38	20204178
CPR:3	CHEMICAL	GENE-Y	31	31	In pig parathyroid cells , chemical and the active form of chemical induced gene translocation from the cytoplasm into the nucleus , suppressed gene mRNA expression and inhibited cell proliferation in a similar manner , although chemical induced the expression of gene mRNA more effectively .	T2	T22	20204178
NA	CHEMICAL	GENE-Y	0	5	chemical suppresses cell survival via gene-mediated proteasomal degradation of gene protein .	T8	T34	23271742
NA	CHEMICAL	GENE-Y	0	9	chemical suppresses cell survival via gene-mediated proteasomal degradation of gene protein .	T8	T35	23271742
CPR:4	CHEMICAL	GENE-Y	4	15	Here we found that chemical , a frontline agent for acute promyelocytic leukemia , inhibits gene but not gene expression in time- and dose-dependent manners .	T5	T25	23271742
NA	CHEMICAL	GENE-Y	4	18	Here we found that chemical , a frontline agent for acute promyelocytic leukemia , inhibits gene but not gene expression in time- and dose-dependent manners .	T5	T26	23271742
CPR:4	CHEMICAL	GENE-Y	6	11	In addition , we found that chemical decreases the stability of gene protein via a gene-dependent pathway but has little effect on the level of gene transcript .	T6	T27	23271742
NA	CHEMICAL	GENE-N	6	14	In addition , we found that chemical decreases the stability of gene protein via a gene-dependent pathway but has little effect on the level of gene transcript .	T6	T28	23271742
NA	CHEMICAL	GENE-Y	6	25	In addition , we found that chemical decreases the stability of gene protein via a gene-dependent pathway but has little effect on the level of gene transcript .	T6	T29	23271742
CPR:3	CHEMICAL	GENE-N	5	8	Furthermore , we found that chemical activates the gene and consequently induces gene expression .	T7	T30	23271742
CPR:3	CHEMICAL	GENE-Y	5	12	Furthermore , we found that chemical activates the gene and consequently induces gene expression .	T7	T31	23271742
NA	CHEMICAL	GENE-Y	19	9	Consistent with this , we found that knockdown of gene inhibits , whereas ectopic expression of gene enhances , chemical-induced degradation of gene protein .	T1	T32	23271742
NA	CHEMICAL	GENE-Y	19	16	Consistent with this , we found that knockdown of gene inhibits , whereas ectopic expression of gene enhances , chemical-induced degradation of gene protein .	T1	T33	23271742
CPR:4	CHEMICAL	GENE-Y	19	22	Consistent with this , we found that knockdown of gene inhibits , whereas ectopic expression of gene enhances , chemical-induced degradation of gene protein .	T1	T11	23271742
NA	CHEMICAL	GENE-Y	21	7	Importantly , we found that knockdown of gene sensitizes , whereas ectopic expression of gene inhibits , growth suppression induced by chemical .	T2	T12	23271742
NA	CHEMICAL	GENE-Y	21	14	Importantly , we found that knockdown of gene sensitizes , whereas ectopic expression of gene inhibits , growth suppression induced by chemical .	T2	T13	23271742
CPR:4	CHEMICAL	GENE-Y	6	4	The effects of the gene inhibitor chemical on cognitive performance in healthy adults : a behavioral- electroencephalography study .	T9	T14	23427190
CPR:4	CHEMICAL	GENE-Y	7	6	Therefore , we examined whether the gene-I chemical improves memory and executive functioning and affect electroencephalography ( EEG ) in healthy young adults .	T4	T12	23427190
NA	CHEMICAL	GENE-Y	5	0	gene potentiates the cytotoxicity of chemical in Hepa1c1c7 cells : roles of gene activation and oxidative stress .	T23	T40	23042730
NA	CHEMICAL	GENE-N	5	12	gene potentiates the cytotoxicity of chemical in Hepa1c1c7 cells : roles of gene activation and oxidative stress .	T23	T41	23042730
NA	CHEMICAL	GENE-Y	17	4	We demonstrated previously that gene ( gene ) plays an important role in a rat model of chemical-induced hepatotoxicity under inflammatory stress .	T11	T29	23042730
NA	CHEMICAL	GENE-Y	17	6	We demonstrated previously that gene ( gene ) plays an important role in a rat model of chemical-induced hepatotoxicity under inflammatory stress .	T11	T32	23042730
NA	CHEMICAL	GENE-N	24	6	In this study , we developed a model in vitro to study the roles of gene activation and oxidative stress in gene potentiation of chemical cytotoxicity .	T12	T33	23042730
NA	CHEMICAL	GENE-Y	24	21	In this study , we developed a model in vitro to study the roles of gene activation and oxidative stress in gene potentiation of chemical cytotoxicity .	T12	T34	23042730
NA	CHEMICAL	GENE-Y	0	9	chemical caused cell death in Hepa1c1c7 cells , and gene cotreatment potentiated its toxicity .	T13	T35	23042730
NA	CHEMICAL	GENE-N	6	2	Activation of gene was observed in chemical/gene-cotreated cells , and caspase inhibitors provided minor protection from cytotoxicity .	T14	T36	23042730
NA	CHEMICAL	GENE-Y	6	6	Activation of gene was observed in chemical/gene-cotreated cells , and caspase inhibitors provided minor protection from cytotoxicity .	T14	T37	23042730
NA	CHEMICAL	GENE-Y	2	22	Intracellular reactive chemical species ( ROS ) generation and lipid peroxidation were observed after treatment with chemical and were further elevated by gene cotreatment .	T15	T38	23042730
NA	CHEMICAL	GENE-Y	16	22	Intracellular reactive chemical species ( ROS ) generation and lipid peroxidation were observed after treatment with chemical and were further elevated by gene cotreatment .	T16	T38	23042730
NA	CHEMICAL	GENE-Y	4	18	Adding water-soluble antioxidants ( chemical , chemical , chemical , or chemical ) produced only minor attenuation of chemical/gene-induced cytotoxicity and did not influence the effect of chemical alone .	T17	T39	23042730
NA	CHEMICAL	GENE-Y	6	18	Adding water-soluble antioxidants ( chemical , chemical , chemical , or chemical ) produced only minor attenuation of chemical/gene-induced cytotoxicity and did not influence the effect of chemical alone .	T18	T39	23042730
NA	CHEMICAL	GENE-Y	8	18	Adding water-soluble antioxidants ( chemical , chemical , chemical , or chemical ) produced only minor attenuation of chemical/gene-induced cytotoxicity and did not influence the effect of chemical alone .	T19	T39	23042730
NA	CHEMICAL	GENE-Y	10	18	Adding water-soluble antioxidants ( chemical , chemical , chemical , or chemical ) produced only minor attenuation of chemical/gene-induced cytotoxicity and did not influence the effect of chemical alone .	T20	T39	23042730
NA	CHEMICAL	GENE-Y	18	18	Adding water-soluble antioxidants ( chemical , chemical , chemical , or chemical ) produced only minor attenuation of chemical/gene-induced cytotoxicity and did not influence the effect of chemical alone .	T21	T39	23042730
NA	CHEMICAL	GENE-Y	27	18	Adding water-soluble antioxidants ( chemical , chemical , chemical , or chemical ) produced only minor attenuation of chemical/gene-induced cytotoxicity and did not influence the effect of chemical alone .	T22	T39	23042730
NA	CHEMICAL	GENE-Y	5	28	On the other hand , chemical ( chemical ) , which reduced lipid peroxidation and ROS generation , prevented chemical toxicity and caused pronounced reduction in cytotoxicity from chemical/gene cotreatment .	T2	T24	23042730
NA	CHEMICAL	GENE-Y	7	28	On the other hand , chemical ( chemical ) , which reduced lipid peroxidation and ROS generation , prevented chemical toxicity and caused pronounced reduction in cytotoxicity from chemical/gene cotreatment .	T3	T24	23042730
NA	CHEMICAL	GENE-Y	19	28	On the other hand , chemical ( chemical ) , which reduced lipid peroxidation and ROS generation , prevented chemical toxicity and caused pronounced reduction in cytotoxicity from chemical/gene cotreatment .	T4	T24	23042730
NA	CHEMICAL	GENE-Y	28	28	On the other hand , chemical ( chemical ) , which reduced lipid peroxidation and ROS generation , prevented chemical toxicity and caused pronounced reduction in cytotoxicity from chemical/gene cotreatment .	T5	T24	23042730
CPR:4	CHEMICAL	GENE-N	0	2	chemical plus a gene inhibitor completely abolished chemical/gene-induced cytotoxicity .	T6	T25	23042730
NA	CHEMICAL	GENE-Y	0	7	chemical plus a gene inhibitor completely abolished chemical/gene-induced cytotoxicity .	T6	T26	23042730
NA	CHEMICAL	GENE-N	7	2	chemical plus a gene inhibitor completely abolished chemical/gene-induced cytotoxicity .	T8	T25	23042730
NA	CHEMICAL	GENE-Y	7	7	chemical plus a gene inhibitor completely abolished chemical/gene-induced cytotoxicity .	T8	T26	23042730
NA	CHEMICAL	GENE-Y	3	12	Cholestatic effect of chemical in rats is mediated via decreased expression of gene .	T25	T38	23146761
NA	CHEMICAL	GENE-N	4	5	Accordingly , the main chemical transporter on the hepatocyte canalicular membrane , gene ( gene ) , was significantly decreased at the protein level .	T19	T33	23146761
NA	CHEMICAL	GENE-Y	4	12	Accordingly , the main chemical transporter on the hepatocyte canalicular membrane , gene ( gene ) , was significantly decreased at the protein level .	T19	T34	23146761
NA	CHEMICAL	GENE-Y	4	14	Accordingly , the main chemical transporter on the hepatocyte canalicular membrane , gene ( gene ) , was significantly decreased at the protein level .	T19	T35	23146761
NA	CHEMICAL	GENE-Y	15	6	While protein levels of the main gene were unchanged , the rate-limiting enzyme in the chemical synthesis , gene , was significantly increased by chemical .	T22	T36	23146761
NA	CHEMICAL	GENE-Y	15	18	While protein levels of the main gene were unchanged , the rate-limiting enzyme in the chemical synthesis , gene , was significantly increased by chemical .	T22	T37	23146761
NA	CHEMICAL	GENE-Y	24	6	While protein levels of the main gene were unchanged , the rate-limiting enzyme in the chemical synthesis , gene , was significantly increased by chemical .	T24	T36	23146761
NA	CHEMICAL	GENE-Y	24	18	While protein levels of the main gene were unchanged , the rate-limiting enzyme in the chemical synthesis , gene , was significantly increased by chemical .	T24	T37	23146761
CPR:4	CHEMICAL	GENE-N	3	8	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T4	T26	23146761
CPR:4	CHEMICAL	GENE-Y	3	10	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T4	T27	23146761
CPR:4	CHEMICAL	GENE-Y	3	12	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T4	T28	23146761
CPR:4	CHEMICAL	GENE-Y	3	18	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T4	T29	23146761
CPR:4	CHEMICAL	GENE-Y	3	20	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T4	T30	23146761
NA	CHEMICAL	GENE-N	7	8	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T5	T26	23146761
NA	CHEMICAL	GENE-Y	7	10	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T5	T27	23146761
NA	CHEMICAL	GENE-Y	7	12	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T5	T28	23146761
NA	CHEMICAL	GENE-Y	7	18	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T5	T29	23146761
NA	CHEMICAL	GENE-Y	7	20	In contrast , chemical markedly downregulated major chemical transporters ( gene and gene ) and regulatory molecules ( gene and gene ) in the ileum .	T5	T30	23146761
CPR:3	CHEMICAL	GENE-Y	5	14	This study shows ability of chemical to raise plasma chemical concentrations , mainly through gene upregulation , and to decrease bile production through reduction in gene-mediated chemical-independent bile flow .	T8	T31	23146761
NA	CHEMICAL	GENE-Y	5	25	This study shows ability of chemical to raise plasma chemical concentrations , mainly through gene upregulation , and to decrease bile production through reduction in gene-mediated chemical-independent bile flow .	T8	T32	23146761
NA	CHEMICAL	GENE-Y	9	14	This study shows ability of chemical to raise plasma chemical concentrations , mainly through gene upregulation , and to decrease bile production through reduction in gene-mediated chemical-independent bile flow .	T9	T31	23146761
NA	CHEMICAL	GENE-Y	9	25	This study shows ability of chemical to raise plasma chemical concentrations , mainly through gene upregulation , and to decrease bile production through reduction in gene-mediated chemical-independent bile flow .	T9	T32	23146761
NA	CHEMICAL	GENE-Y	26	14	This study shows ability of chemical to raise plasma chemical concentrations , mainly through gene upregulation , and to decrease bile production through reduction in gene-mediated chemical-independent bile flow .	T10	T31	23146761
NA	CHEMICAL	GENE-Y	26	25	This study shows ability of chemical to raise plasma chemical concentrations , mainly through gene upregulation , and to decrease bile production through reduction in gene-mediated chemical-independent bile flow .	T10	T32	23146761
NA	CHEMICAL	GENE-Y	6	11	Allosteric interaction of the neuromuscular blockers chemical and chemical with recombinant gene .	T16	T21	17588565
NA	CHEMICAL	GENE-Y	8	11	Allosteric interaction of the neuromuscular blockers chemical and chemical with recombinant gene .	T17	T21	17588565
CPR:4	CHEMICAL	GENE-Y	7	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T1	T18	17588565
CPR:4	CHEMICAL	GENE-Y	11	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T2	T18	17588565
CPR:4	CHEMICAL	GENE-Y	13	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T3	T18	17588565
NA	CHEMICAL	GENE-Y	18	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T4	T18	17588565
NA	CHEMICAL	GENE-Y	20	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T5	T18	17588565
NA	CHEMICAL	GENE-Y	40	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T6	T18	17588565
NA	CHEMICAL	GENE-Y	46	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T7	T18	17588565
NA	CHEMICAL	GENE-Y	35	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T8	T18	17588565
NA	CHEMICAL	GENE-Y	56	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T9	T18	17588565
NA	CHEMICAL	GENE-Y	60	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T10	T18	17588565
NA	CHEMICAL	GENE-Y	66	29	In this study the neuromuscular blocking drug chemical and the controls chemical and chemical slowed the rate of chemical induced chemical dissociation from Chinese hamster ovary cells expressing recombinant gene K ( off ) values min ( -1 ) ; chemical ( 125 nM ) , chemical 0.45+/-0.07+blocker 0.04+/-0.02 ; chemical ( 21 nM ) , chemical 0.42+/-0.05+blocker 0.15+/-0.04 ; chemical ( 21 nM ) , chemical 0.36+/-0.03+blocker 0.03+/-0.01 ) .	T11	T18	17588565
CPR:3	CHEMICAL	GENE-Y	2	8	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T14	23296102
NA	CHEMICAL	GENE-Y	2	10	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T15	23296102
CPR:3	CHEMICAL	GENE-N	2	13	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T16	23296102
CPR:3	CHEMICAL	GENE-Y	2	15	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T17	23296102
CPR:3	CHEMICAL	GENE-Y	2	19	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T18	23296102
CPR:3	CHEMICAL	GENE-Y	2	20	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T19	23296102
CPR:4	CHEMICAL	GENE-Y	2	24	Interestingly , chemical increased proteins ' levels of gene ( gene ) , gene ( gene ) and the gene gene , and decreased gene levels .	T5	T20	23296102
NA	CHEMICAL	GENE-N	3	4	The activity of chemical dismutase was down-regulated while the level of chemical was up-regulated in rat brain .	T8	T21	23296102
NA	CHEMICAL	GENE-N	11	4	The activity of chemical dismutase was down-regulated while the level of chemical was up-regulated in rat brain .	T9	T21	23296102
CPR:3	CHEMICAL	GENE-Y	2	11	Moreover , chemical resulted in activation of astrocytes , up-regulation of gene in cortex and down-regulation of gene in hippocampus and cortex .	T10	T12	23296102
CPR:4	CHEMICAL	GENE-Y	2	17	Moreover , chemical resulted in activation of astrocytes , up-regulation of gene in cortex and down-regulation of gene in hippocampus and cortex .	T10	T13	23296102
NA	CHEMICAL	GENE-N	5	0	gene play an important role in recognizing chromatin modifications and recruiting regulatory proteins to specific genes .	T1	T5	23263989
NA	CHEMICAL	GENE-Y	0	11	gene has mostly been studied in the context of the leukemic gene-gene fusion protein , which lacks the chemical-terminal PHD fingers of gene .	T2	T14	23263989
NA	CHEMICAL	GENE-Y	0	11	gene has mostly been studied in the context of the leukemic gene-gene fusion protein , which lacks the chemical-terminal PHD fingers of gene .	T2	T15	23263989
NA	CHEMICAL	GENE-N	0	5	gene has mostly been studied in the context of the leukemic gene-gene fusion protein , which lacks the chemical-terminal PHD fingers of gene .	T2	T16	23263989
NA	CHEMICAL	GENE-Y	0	20	gene has mostly been studied in the context of the leukemic gene-gene fusion protein , which lacks the chemical-terminal PHD fingers of gene .	T2	T17	23263989
NA	CHEMICAL	GENE-N	23	13	In this study , we used genetic and biochemical approaches to examine the gene region of the Caenorhabditis elegans ortholog of gene , chemical finger protein 1 ( gene ) .	T3	T19	23263989
NA	CHEMICAL	GENE-Y	23	21	In this study , we used genetic and biochemical approaches to examine the gene region of the Caenorhabditis elegans ortholog of gene , chemical finger protein 1 ( gene ) .	T3	T20	23263989
NA	CHEMICAL	GENE-Y	23	26	In this study , we used genetic and biochemical approaches to examine the gene region of the Caenorhabditis elegans ortholog of gene , chemical finger protein 1 ( gene ) .	T3	T21	23263989
NA	CHEMICAL	GENE-Y	23	26	In this study , we used genetic and biochemical approaches to examine the gene region of the Caenorhabditis elegans ortholog of gene , chemical finger protein 1 ( gene ) .	T3	T22	23263989
NA	CHEMICAL	GENE-N	23	4	We demonstrate that the gene region is essential for viability and that the first gene contributes to the preferred binding of gene to chemical 4-methylated histone H3 tails .	T4	T23	23263989
NA	CHEMICAL	GENE-N	23	14	We demonstrate that the gene region is essential for viability and that the first gene contributes to the preferred binding of gene to chemical 4-methylated histone H3 tails .	T4	T24	23263989
NA	CHEMICAL	GENE-N	23	21	We demonstrate that the gene region is essential for viability and that the first gene contributes to the preferred binding of gene to chemical 4-methylated histone H3 tails .	T4	T25	23263989
NA	CHEMICAL	GENE-Y	3	1	Presynaptic gene modulates chemical D3 receptor activation in striatonigral terminals of the rat brain in a chemical dependent manner .	T31	T51	23602989
NA	CHEMICAL	GENE-Y	3	5	Presynaptic gene modulates chemical D3 receptor activation in striatonigral terminals of the rat brain in a chemical dependent manner .	T31	T52	23602989
NA	CHEMICAL	GENE-Y	15	1	Presynaptic gene modulates chemical D3 receptor activation in striatonigral terminals of the rat brain in a chemical dependent manner .	T30	T51	23602989
NA	CHEMICAL	GENE-Y	15	5	Presynaptic gene modulates chemical D3 receptor activation in striatonigral terminals of the rat brain in a chemical dependent manner .	T30	T52	23602989
NA	CHEMICAL	GENE-Y	17	10	In this study we examined whether the presynaptic effects of gene stimulation in the substantia nigra reticulata ( SNr ) are modulated by chemical activation of gene .	T16	T45	23602989
NA	CHEMICAL	GENE-Y	17	26	In this study we examined whether the presynaptic effects of gene stimulation in the substantia nigra reticulata ( SNr ) are modulated by chemical activation of gene .	T16	T46	23602989
NA	CHEMICAL	GENE-N	8	24	In SNr synaptosomes two procedures that increase cytoplasmic chemical , chemical and chemical-depolarization , blocked the additional stimulation of chemical accumulation produced by coactivating gene .	T17	T47	23602989
NA	CHEMICAL	GENE-N	10	24	In SNr synaptosomes two procedures that increase cytoplasmic chemical , chemical and chemical-depolarization , blocked the additional stimulation of chemical accumulation produced by coactivating gene .	T18	T47	23602989
NA	CHEMICAL	GENE-N	12	24	In SNr synaptosomes two procedures that increase cytoplasmic chemical , chemical and chemical-depolarization , blocked the additional stimulation of chemical accumulation produced by coactivating gene .	T19	T47	23602989
NA	CHEMICAL	GENE-N	19	24	In SNr synaptosomes two procedures that increase cytoplasmic chemical , chemical and chemical-depolarization , blocked the additional stimulation of chemical accumulation produced by coactivating gene .	T20	T47	23602989
CPR:4	CHEMICAL	GENE-Y	4	2	The selective gene inhibitor chemical reversed the blockade produced by chemical and chemical-depolarization .	T22	T48	23602989
CPR:4	CHEMICAL	GENE-Y	10	2	The selective gene inhibitor chemical reversed the blockade produced by chemical and chemical-depolarization .	T23	T48	23602989
NA	CHEMICAL	GENE-Y	12	2	The selective gene inhibitor chemical reversed the blockade produced by chemical and chemical-depolarization .	T24	T48	23602989
NA	CHEMICAL	GENE-Y	4	6	Immunoblot studies showed that chemical-depolarization increased gene phosphorylation in a chemical sensitive manner and promoted gene binding to gene .	T29	T50	23602989
NA	CHEMICAL	GENE-Y	4	9	Immunoblot studies showed that chemical-depolarization increased gene phosphorylation in a chemical sensitive manner and promoted gene binding to gene .	T29	T33	23602989
NA	CHEMICAL	GENE-Y	4	17	Immunoblot studies showed that chemical-depolarization increased gene phosphorylation in a chemical sensitive manner and promoted gene binding to gene .	T29	T34	23602989
NA	CHEMICAL	GENE-Y	10	6	Immunoblot studies showed that chemical-depolarization increased gene phosphorylation in a chemical sensitive manner and promoted gene binding to gene .	T1	T50	23602989
NA	CHEMICAL	GENE-Y	10	9	Immunoblot studies showed that chemical-depolarization increased gene phosphorylation in a chemical sensitive manner and promoted gene binding to gene .	T1	T33	23602989
NA	CHEMICAL	GENE-Y	10	17	Immunoblot studies showed that chemical-depolarization increased gene phosphorylation in a chemical sensitive manner and promoted gene binding to gene .	T1	T34	23602989
NA	CHEMICAL	GENE-Y	1	4	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T2	T35	23602989
NA	CHEMICAL	GENE-N	1	6	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T2	T36	23602989
NA	CHEMICAL	GENE-Y	1	13	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T2	T37	23602989
NA	CHEMICAL	GENE-Y	4	4	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T3	T35	23602989
NA	CHEMICAL	GENE-N	4	6	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T3	T36	23602989
NA	CHEMICAL	GENE-Y	4	13	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T3	T37	23602989
NA	CHEMICAL	GENE-Y	17	4	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T4	T35	23602989
NA	CHEMICAL	GENE-N	17	6	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T4	T36	23602989
CPR:4	CHEMICAL	GENE-Y	17	13	In chemical-depolarized tissues , gene potentiated gene-induced stimulation of chemical release only when gene was blocked with chemical .	T4	T37	23602989
CPR:5	CHEMICAL	GENE-Y	6	9	In the presence of this inhibitor , the selective gene agonist chemical reduced the ED50 for the gene agonist chemical from 56 to 4 nM .	T5	T38	23602989
NA	CHEMICAL	GENE-Y	6	17	In the presence of this inhibitor , the selective gene agonist chemical reduced the ED50 for the gene agonist chemical from 56 to 4 nM .	T5	T39	23602989
NA	CHEMICAL	GENE-Y	19	9	In the presence of this inhibitor , the selective gene agonist chemical reduced the ED50 for the gene agonist chemical from 56 to 4 nM .	T6	T38	23602989
CPR:5	CHEMICAL	GENE-Y	19	17	In the presence of this inhibitor , the selective gene agonist chemical reduced the ED50 for the gene agonist chemical from 56 to 4 nM .	T6	T39	23602989
NA	CHEMICAL	GENE-N	0	4	chemical did not affect gene responses .	T12	T40	23602989
NA	CHEMICAL	GENE-Y	15	8	These experiments show that in striatonigral projections , gene inhibits the action of gene in a chemical dependent manner blocking their modulatory effects on chemical release .	T13	T41	23602989
NA	CHEMICAL	GENE-Y	15	13	These experiments show that in striatonigral projections , gene inhibits the action of gene in a chemical dependent manner blocking their modulatory effects on chemical release .	T13	T42	23602989
NA	CHEMICAL	GENE-Y	24	8	These experiments show that in striatonigral projections , gene inhibits the action of gene in a chemical dependent manner blocking their modulatory effects on chemical release .	T14	T41	23602989
NA	CHEMICAL	GENE-Y	24	13	These experiments show that in striatonigral projections , gene inhibits the action of gene in a chemical dependent manner blocking their modulatory effects on chemical release .	T14	T42	23602989
NA	CHEMICAL	GENE-Y	4	5	Novel inhibitors complexed with chemical dehydrogenase : allosteric regulation by control of protein dynamics .	T14	T26	19531491
NA	CHEMICAL	GENE-N	0	0	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T1	T15	19531491
NA	CHEMICAL	GENE-N	0	2	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T1	T19	19531491
CPR:9	CHEMICAL	GENE-N	5	0	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T4	T15	19531491
CPR:9	CHEMICAL	GENE-N	5	2	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T4	T19	19531491
CPR:9	CHEMICAL	GENE-N	5	0	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T5	T15	19531491
CPR:9	CHEMICAL	GENE-N	5	2	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T5	T19	19531491
NA	CHEMICAL	GENE-N	1	0	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T6	T15	19531491
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l-chemical to chemical using chemical as coenzyme .	T6	T19	19531491
NA	CHEMICAL	GENE-Y	15	13	The recently discovered hypergeneism/hyperammonemia disorder showed that the loss of allosteric inhibition of gene by chemical causes excessive secretion of insulin .	T7	T20	19531491
CPR:3	CHEMICAL	GENE-Y	15	3	The recently discovered hypergeneism/hyperammonemia disorder showed that the loss of allosteric inhibition of gene by chemical causes excessive secretion of insulin .	T7	T21	19531491
CPR:4	CHEMICAL	GENE-Y	18	9	Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of gene are inhibited by the green tea polyphenols , chemical and chemical .	T8	T22	19531491
CPR:4	CHEMICAL	GENE-Y	20	9	Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of gene are inhibited by the green tea polyphenols , chemical and chemical .	T9	T22	19531491
NA	CHEMICAL	GENE-Y	0	9	chemical forms a ring around the internal cavity in gene through aromatic stacking interactions between the drug and gene as well as between the drug molecules themselves .	T13	T24	19531491
NA	CHEMICAL	GENE-Y	0	18	chemical forms a ring around the internal cavity in gene through aromatic stacking interactions between the drug and gene as well as between the drug molecules themselves .	T13	T25	19531491
NA	CHEMICAL	GENE-Y	2	9	Mediation of chemical-induced contractions of rat aorta by the gene subtype .	T23	T32	7773533
NA	CHEMICAL	GENE-N	8	3	The subtypes of gene mediating contractions to exogenous chemical ( chemical ) in rat aorta have been examined in both biochemical and functional studies .	T14	T30	7773533
NA	CHEMICAL	GENE-N	10	3	The subtypes of gene mediating contractions to exogenous chemical ( chemical ) in rat aorta have been examined in both biochemical and functional studies .	T22	T30	7773533
CPR:6	CHEMICAL	GENE-Y	11	8	Incubation of rat aortic membranes with the irreversible gene antagonist , chemical ( chemical : 10 microM ) did not change the KD of chemical binding in comparison to untreated membranes , but reduced by 88 % the total number of binding sites ( Bmax ) .	T5	T31	7773533
CPR:6	CHEMICAL	GENE-Y	13	8	Incubation of rat aortic membranes with the irreversible gene antagonist , chemical ( chemical : 10 microM ) did not change the KD of chemical binding in comparison to untreated membranes , but reduced by 88 % the total number of binding sites ( Bmax ) .	T6	T31	7773533
NA	CHEMICAL	GENE-Y	24	8	Incubation of rat aortic membranes with the irreversible gene antagonist , chemical ( chemical : 10 microM ) did not change the KD of chemical binding in comparison to untreated membranes , but reduced by 88 % the total number of binding sites ( Bmax ) .	T7	T31	7773533
NA	CHEMICAL	GENE-N	19	8	The affinity of the same antagonists for the gene was evaluated by utilizing membranes from rat hippocampus pretreated with chemical , and rat liver , respectively .	T1	T24	7773533
NA	CHEMICAL	GENE-Y	0	9	chemical and chemical were confirmed as selective for the gene , whereas chemical was alpha 1B-selective .	T2	T25	7773533
NA	CHEMICAL	GENE-Y	2	9	chemical and chemical were confirmed as selective for the gene , whereas chemical was alpha 1B-selective .	T3	T25	7773533
NA	CHEMICAL	GENE-Y	12	9	chemical and chemical were confirmed as selective for the gene , whereas chemical was alpha 1B-selective .	T4	T25	7773533
NA	CHEMICAL	GENE-Y	11	6	In vivo activity of the potent gene antagonist on uterine activity in the rat .	T31	T45	15646817
NA	CHEMICAL	GENE-Y	0	15	chemical antagonist ( OTA ) , chemical , was developed by our group and shown to inhibit either spontaneous or gene-induced uterine contractions in primates .	T1	T32	15646817
NA	CHEMICAL	GENE-Y	0	15	chemical antagonist ( OTA ) , chemical , was developed by our group and shown to inhibit either spontaneous or gene-induced uterine contractions in primates .	T1	T34	15646817
CPR:6	CHEMICAL	GENE-Y	6	15	chemical antagonist ( OTA ) , chemical , was developed by our group and shown to inhibit either spontaneous or gene-induced uterine contractions in primates .	T25	T32	15646817
CPR:4	CHEMICAL	GENE-Y	6	15	chemical antagonist ( OTA ) , chemical , was developed by our group and shown to inhibit either spontaneous or gene-induced uterine contractions in primates .	T25	T34	15646817
NA	CHEMICAL	GENE-Y	15	15	chemical antagonist ( OTA ) , chemical , was developed by our group and shown to inhibit either spontaneous or gene-induced uterine contractions in primates .	T3	T32	15646817
NA	CHEMICAL	GENE-Y	15	15	chemical antagonist ( OTA ) , chemical , was developed by our group and shown to inhibit either spontaneous or gene-induced uterine contractions in primates .	T3	T34	15646817
CPR:4	CHEMICAL	GENE-Y	12	7	The purpose of the present study was to confirm the duration of chemical to block chemical-induced uterine contractions in estrous rats .	T22	T42	15646817
NA	CHEMICAL	GENE-Y	7	7	The purpose of the present study was to confirm the duration of chemical to block chemical-induced uterine contractions in estrous rats .	T24	T42	15646817
NA	CHEMICAL	GENE-Y	11	12	Experiment 2 determined the effect of the three OTAs on uterine chemical receptor number ( Rn ) and binding affinity ( Kd ) .	T2	T33	15646817
CPR:4	CHEMICAL	GENE-Y	4	14	In Experiment 1 , chemical , chemical and chemical inhibited the integrated uterine response to chemical at 5 minutes by 76 % , 77 % and 80 % , respectively , compared to controls ( p < 0.05 ) .	T4	T35	15646817
CPR:4	CHEMICAL	GENE-Y	6	14	In Experiment 1 , chemical , chemical and chemical inhibited the integrated uterine response to chemical at 5 minutes by 76 % , 77 % and 80 % , respectively , compared to controls ( p < 0.05 ) .	T5	T35	15646817
CPR:4	CHEMICAL	GENE-Y	8	14	In Experiment 1 , chemical , chemical and chemical inhibited the integrated uterine response to chemical at 5 minutes by 76 % , 77 % and 80 % , respectively , compared to controls ( p < 0.05 ) .	T6	T35	15646817
NA	CHEMICAL	GENE-Y	14	14	In Experiment 1 , chemical , chemical and chemical inhibited the integrated uterine response to chemical at 5 minutes by 76 % , 77 % and 80 % , respectively , compared to controls ( p < 0.05 ) .	T7	T35	15646817
CPR:4	CHEMICAL	GENE-Y	2	10	In Experiment 2 , chemical induced a significant decrease ( p < 0.05 ) in chemical receptor number and binding affinity at both 0.5 and 4 hours compared with controls .	T12	T36	15646817
NA	CHEMICAL	GENE-Y	14	10	In Experiment 2 , chemical induced a significant decrease ( p < 0.05 ) in chemical receptor number and binding affinity at both 0.5 and 4 hours compared with controls .	T13	T36	15646817
NA	CHEMICAL	GENE-Y	0	7	chemical and chemical did not alter chemical receptor number or binding affinity significantly at each time point studied compared with controls .	T14	T37	15646817
NA	CHEMICAL	GENE-Y	2	7	chemical and chemical did not alter chemical receptor number or binding affinity significantly at each time point studied compared with controls .	T15	T37	15646817
NA	CHEMICAL	GENE-Y	6	7	chemical and chemical did not alter chemical receptor number or binding affinity significantly at each time point studied compared with controls .	T16	T37	15646817
NA	CHEMICAL	GENE-Y	15	4	PB induction of the gene-gene cluster noncoding RNA ( ncRNA ) Meg3 was localized to chemical synthetase-positive hypertrophic perivenous hepatocytes , suggesting a role for gene signaling in the dysregulation of gene-gene ncRNAs .	T3	T10	23091169
NA	CHEMICAL	GENE-Y	15	4	PB induction of the gene-gene cluster noncoding RNA ( ncRNA ) Meg3 was localized to chemical synthetase-positive hypertrophic perivenous hepatocytes , suggesting a role for gene signaling in the dysregulation of gene-gene ncRNAs .	T3	T11	23091169
NA	CHEMICAL	GENE-N	15	3	PB induction of the gene-gene cluster noncoding RNA ( ncRNA ) Meg3 was localized to chemical synthetase-positive hypertrophic perivenous hepatocytes , suggesting a role for gene signaling in the dysregulation of gene-gene ncRNAs .	T3	T12	23091169
NA	CHEMICAL	GENE-N	15	22	PB induction of the gene-gene cluster noncoding RNA ( ncRNA ) Meg3 was localized to chemical synthetase-positive hypertrophic perivenous hepatocytes , suggesting a role for gene signaling in the dysregulation of gene-gene ncRNAs .	T3	T13	23091169
NA	CHEMICAL	GENE-Y	15	31	PB induction of the gene-gene cluster noncoding RNA ( ncRNA ) Meg3 was localized to chemical synthetase-positive hypertrophic perivenous hepatocytes , suggesting a role for gene signaling in the dysregulation of gene-gene ncRNAs .	T3	T14	23091169
NA	CHEMICAL	GENE-Y	15	31	PB induction of the gene-gene cluster noncoding RNA ( ncRNA ) Meg3 was localized to chemical synthetase-positive hypertrophic perivenous hepatocytes , suggesting a role for gene signaling in the dysregulation of gene-gene ncRNAs .	T3	T15	23091169
NA	CHEMICAL	GENE-Y	4	4	The carcinogenic relevance of gene-gene locus ncRNA induction was further supported by in vivo genetic dependence on gene and gene pathways .	T1	T16	23091169
NA	CHEMICAL	GENE-Y	4	4	The carcinogenic relevance of gene-gene locus ncRNA induction was further supported by in vivo genetic dependence on gene and gene pathways .	T1	T17	23091169
NA	CHEMICAL	GENE-N	4	17	The carcinogenic relevance of gene-gene locus ncRNA induction was further supported by in vivo genetic dependence on gene and gene pathways .	T1	T4	23091169
NA	CHEMICAL	GENE-N	4	12	The carcinogenic relevance of gene-gene locus ncRNA induction was further supported by in vivo genetic dependence on gene and gene pathways .	T1	T5	23091169
NA	CHEMICAL	GENE-Y	22	31	The radioactivity was rapidly and widely distributed throughout the body , and remained detectable in all tissues investigated at later time points ( 24 and 48 hours for [ chemical ] -gene and [ chemical ] -SSB siRNA , respectively ) .	T1	T12	23524663
NA	CHEMICAL	GENE-Y	22	31	The radioactivity was rapidly and widely distributed throughout the body , and remained detectable in all tissues investigated at later time points ( 24 and 48 hours for [ chemical ] -gene and [ chemical ] -SSB siRNA , respectively ) .	T2	T12	23524663
CPR:9	CHEMICAL	GENE-N	3	6	Instead , radiolabeled chemical resulting from gene hydrolysis were observed .	T5	T13	23524663
NA	CHEMICAL	GENE-Y	0	10	chemical and nonsteroidal anti-inflammatory drugs induce conformational changes in the gene ( gene ) .	T9	T24	11006278
NA	CHEMICAL	GENE-Y	0	12	chemical and nonsteroidal anti-inflammatory drugs induce conformational changes in the gene ( gene ) .	T9	T23	11006278
NA	CHEMICAL	GENE-N	19	29	By using the technique of site-directed spin labeling combined with EPR spectroscopy , we have observed that binding of chemical and nonsteroidal anti-inflammatory drugs induces conformational changes in the gene ( gene ) .	T1	T16	11006278
NA	CHEMICAL	GENE-Y	19	31	By using the technique of site-directed spin labeling combined with EPR spectroscopy , we have observed that binding of chemical and nonsteroidal anti-inflammatory drugs induces conformational changes in the gene ( gene ) .	T1	T17	11006278
NA	CHEMICAL	GENE-N	30	29	By using the technique of site-directed spin labeling combined with EPR spectroscopy , we have observed that binding of chemical and nonsteroidal anti-inflammatory drugs induces conformational changes in the gene ( gene ) .	T4	T16	11006278
NA	CHEMICAL	GENE-Y	30	31	By using the technique of site-directed spin labeling combined with EPR spectroscopy , we have observed that binding of chemical and nonsteroidal anti-inflammatory drugs induces conformational changes in the gene ( gene ) .	T4	T17	11006278
NA	CHEMICAL	GENE-Y	8	16	Line shape broadening resulting from spin-spin coupling of chemical pairs introduced into the membrane-binding helices of gene was used to calculate the inter-helical distances and changes in these distances that occur in response to binding various ligands .	T5	T18	11006278
NA	CHEMICAL	GENE-Y	13	10	However , inter-helical distances calculated and determined by EPR for gene complexed with chemical , chemical , and chemical were in close agreement with those obtained from the cognate crystal structures .	T6	T21	11006278
NA	CHEMICAL	GENE-Y	15	10	However , inter-helical distances calculated and determined by EPR for gene complexed with chemical , chemical , and chemical were in close agreement with those obtained from the cognate crystal structures .	T7	T21	11006278
NA	CHEMICAL	GENE-Y	18	10	However , inter-helical distances calculated and determined by EPR for gene complexed with chemical , chemical , and chemical were in close agreement with those obtained from the cognate crystal structures .	T8	T21	11006278
NA	CHEMICAL	GENE-N	13	20	Proteolysis protection assays had previously provided circumstantial evidence that binding of heme and non-chemical anti-inflammatory drugs alters the conformation of gene , but the present experiments are the first to directly measure such changes .	T2	T13	11006278
NA	CHEMICAL	GENE-Y	20	10	Indirect systemic and direct oral factor Xa and direct oral gene inhibitors with improved pharmacologic profiles compared with heparins and chemical antagonists are currently in clinical development .	T1	T8	18393142
NA	CHEMICAL	GENE-Y	9	2	Loss of gene and gene surface binding induced by chemical and chemical .	T20	T44	6319437
NA	CHEMICAL	GENE-Y	9	4	Loss of gene and gene surface binding induced by chemical and chemical .	T20	T43	6319437
NA	CHEMICAL	GENE-Y	11	2	Loss of gene and gene surface binding induced by chemical and chemical .	T19	T44	6319437
NA	CHEMICAL	GENE-Y	11	4	Loss of gene and gene surface binding induced by chemical and chemical .	T19	T43	6319437
NA	CHEMICAL	GENE-Y	5	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T14	T30	6319437
NA	CHEMICAL	GENE-Y	5	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T14	T33	6319437
NA	CHEMICAL	GENE-Y	5	36	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T14	T37	6319437
NA	CHEMICAL	GENE-Y	9	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T16	T30	6319437
NA	CHEMICAL	GENE-Y	9	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T16	T33	6319437
NA	CHEMICAL	GENE-Y	9	36	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T16	T37	6319437
NA	CHEMICAL	GENE-Y	5	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T1	T30	6319437
NA	CHEMICAL	GENE-Y	5	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T1	T33	6319437
NA	CHEMICAL	GENE-Y	5	36	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T1	T37	6319437
NA	CHEMICAL	GENE-Y	15	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T2	T30	6319437
NA	CHEMICAL	GENE-Y	15	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T2	T33	6319437
NA	CHEMICAL	GENE-Y	15	36	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T2	T37	6319437
NA	CHEMICAL	GENE-Y	19	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T5	T30	6319437
NA	CHEMICAL	GENE-Y	19	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T5	T33	6319437
NA	CHEMICAL	GENE-Y	19	36	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T5	T37	6319437
NA	CHEMICAL	GENE-Y	21	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T6	T30	6319437
NA	CHEMICAL	GENE-Y	21	25	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T6	T33	6319437
NA	CHEMICAL	GENE-Y	21	36	We have found that certain chemical [ e.g. , chemical ( chemical ) ] and chemical [ e.g. , chemical ( chemical ) ] induce a loss of cell-surface receptors for gene , and gene ( gene ) in fibroblasts .	T6	T37	6319437
NA	CHEMICAL	GENE-Y	21	3	The extent of gene loss is less than for gene , and the gene do not reappear at the surface when chemical is removed .	T15	T39	6319437
NA	CHEMICAL	GENE-Y	21	9	The extent of gene loss is less than for gene , and the gene do not reappear at the surface when chemical is removed .	T15	T40	6319437
NA	CHEMICAL	GENE-Y	21	13	The extent of gene loss is less than for gene , and the gene do not reappear at the surface when chemical is removed .	T15	T41	6319437
NA	CHEMICAL	GENE-Y	0	9	chemical did not induce a loss of cell surface gene , a membrane protein which is excluded from coated pits and which is not internalized , indicating that the effect of chemical was specific for membrane receptors and not a result of bulk depletion of plasma membrane .	T17	T42	6319437
NA	CHEMICAL	GENE-Y	31	9	chemical did not induce a loss of cell surface gene , a membrane protein which is excluded from coated pits and which is not internalized , indicating that the effect of chemical was specific for membrane receptors and not a result of bulk depletion of plasma membrane .	T18	T42	6319437
CPR:4	CHEMICAL	GENE-N	2	9	Since both chemical and chemical are potent inhibitors of gene , we investigated the possibility that inhibition of gene was responsible for the loss of receptors .	T3	T23	6319437
NA	CHEMICAL	GENE-N	2	18	Since both chemical and chemical are potent inhibitors of gene , we investigated the possibility that inhibition of gene was responsible for the loss of receptors .	T3	T24	6319437
CPR:4	CHEMICAL	GENE-N	4	9	Since both chemical and chemical are potent inhibitors of gene , we investigated the possibility that inhibition of gene was responsible for the loss of receptors .	T4	T23	6319437
NA	CHEMICAL	GENE-N	4	18	Since both chemical and chemical are potent inhibitors of gene , we investigated the possibility that inhibition of gene was responsible for the loss of receptors .	T4	T24	6319437
NA	CHEMICAL	GENE-N	21	6	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T25	6319437
CPR:4	CHEMICAL	GENE-N	21	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T26	6319437
NA	CHEMICAL	GENE-N	21	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T27	6319437
NA	CHEMICAL	GENE-N	21	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T28	6319437
NA	CHEMICAL	GENE-Y	21	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T29	6319437
NA	CHEMICAL	GENE-N	21	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T31	6319437
NA	CHEMICAL	GENE-Y	21	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T7	T34	6319437
NA	CHEMICAL	GENE-N	9	6	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T25	6319437
CPR:4	CHEMICAL	GENE-N	9	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T26	6319437
NA	CHEMICAL	GENE-N	9	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T27	6319437
NA	CHEMICAL	GENE-N	9	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T28	6319437
NA	CHEMICAL	GENE-Y	9	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T29	6319437
NA	CHEMICAL	GENE-N	9	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T31	6319437
NA	CHEMICAL	GENE-Y	9	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T8	T34	6319437
NA	CHEMICAL	GENE-N	38	6	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T25	6319437
CPR:4	CHEMICAL	GENE-N	38	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T26	6319437
NA	CHEMICAL	GENE-N	38	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T27	6319437
NA	CHEMICAL	GENE-N	38	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T28	6319437
NA	CHEMICAL	GENE-Y	38	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T29	6319437
NA	CHEMICAL	GENE-N	38	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T31	6319437
NA	CHEMICAL	GENE-Y	38	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T9	T34	6319437
NA	CHEMICAL	GENE-N	23	6	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T25	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T26	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T27	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T28	6319437
NA	CHEMICAL	GENE-Y	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T29	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T31	6319437
NA	CHEMICAL	GENE-Y	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T11	T34	6319437
NA	CHEMICAL	GENE-N	107	116	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T12	T32	6319437
NA	CHEMICAL	GENE-N	23	6	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T25	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T26	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T27	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T28	6319437
NA	CHEMICAL	GENE-Y	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T29	6319437
NA	CHEMICAL	GENE-N	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T31	6319437
NA	CHEMICAL	GENE-Y	23	23	Three lines of evidence suggest that gene inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) chemical , a chemical that is a poor inhibitor of gene , is nearly as effective as chemical at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several gene functions , did not cause a loss of binding ; 2 ) the microinjection of gene into cells did not reverse the effects of chemical ; using pressure microinjection , we introduced up to a 100-fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using chemical-labeled gene , we saw that the chemical induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected gene , a gene , into cells ( 1-3 pg/cell ) and observed no effect on the receptor-mediated endocytosis of chemical-labeled gene .	T13	T34	6319437
NA	CHEMICAL	GENE-Y	5	6	Discovery of liver-targeted inhibitors of chemical desaturase ( gene ) .	T14	T17	23265904
NA	CHEMICAL	GENE-Y	5	8	Discovery of liver-targeted inhibitors of chemical desaturase ( gene ) .	T14	T18	23265904
CPR:4	CHEMICAL	GENE-Y	3	14	Inhibitors based on a chemical scaffold were discovered for chemical ( chemical ) desaturase 1 ( gene ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .	T3	T16	23265904
CPR:4	CHEMICAL	GENE-Y	3	14	Inhibitors based on a chemical scaffold were discovered for chemical ( chemical ) desaturase 1 ( gene ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .	T3	T15	23265904
NA	CHEMICAL	GENE-Y	9	14	Inhibitors based on a chemical scaffold were discovered for chemical ( chemical ) desaturase 1 ( gene ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .	T12	T16	23265904
NA	CHEMICAL	GENE-Y	9	14	Inhibitors based on a chemical scaffold were discovered for chemical ( chemical ) desaturase 1 ( gene ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .	T12	T15	23265904
NA	CHEMICAL	GENE-Y	11	14	Inhibitors based on a chemical scaffold were discovered for chemical ( chemical ) desaturase 1 ( gene ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .	T2	T16	23265904
NA	CHEMICAL	GENE-Y	11	14	Inhibitors based on a chemical scaffold were discovered for chemical ( chemical ) desaturase 1 ( gene ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .	T2	T15	23265904
NA	CHEMICAL	GENE-Y	3	6	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T23	T50	23274898
NA	CHEMICAL	GENE-Y	3	12	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T23	T51	23274898
NA	CHEMICAL	GENE-N	3	12	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T23	T52	23274898
NA	CHEMICAL	GENE-Y	3	12	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T23	T53	23274898
CPR:9	CHEMICAL	GENE-Y	9	6	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T24	T50	23274898
NA	CHEMICAL	GENE-Y	9	12	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T24	T51	23274898
NA	CHEMICAL	GENE-N	9	12	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T24	T52	23274898
NA	CHEMICAL	GENE-Y	9	12	Electrical Stimuli Release chemical to Increase gene Translocation and chemical Uptake via gene-gene-gene in Skeletal Muscle Cells .	T24	T53	23274898
NA	CHEMICAL	GENE-Y	2	4	Skeletal muscle chemical uptake in response to exercise is preserved in gene-resistant conditions , but the signals involved are debated .	T7	T42	23274898
NA	CHEMICAL	GENE-N	0	14	chemical is released from skeletal muscle by contractile activity and can autocrinely signal through gene , and we hypothesized it may influence chemical uptake .	T5	T36	23274898
NA	CHEMICAL	GENE-N	22	14	chemical is released from skeletal muscle by contractile activity and can autocrinely signal through gene , and we hypothesized it may influence chemical uptake .	T8	T36	23274898
NA	CHEMICAL	GENE-Y	3	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T9	T37	23274898
NA	CHEMICAL	GENE-N	3	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T9	T38	23274898
NA	CHEMICAL	GENE-N	3	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T9	T39	23274898
NA	CHEMICAL	GENE-Y	10	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T10	T37	23274898
NA	CHEMICAL	GENE-N	10	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T10	T38	23274898
NA	CHEMICAL	GENE-N	10	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T10	T39	23274898
NA	CHEMICAL	GENE-Y	12	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T11	T37	23274898
NA	CHEMICAL	GENE-N	12	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T11	T38	23274898
NA	CHEMICAL	GENE-N	12	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T11	T39	23274898
NA	CHEMICAL	GENE-Y	24	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T12	T37	23274898
NA	CHEMICAL	GENE-N	24	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T12	T38	23274898
NA	CHEMICAL	GENE-N	24	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T12	T39	23274898
NA	CHEMICAL	GENE-Y	25	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T13	T37	23274898
NA	CHEMICAL	GENE-N	25	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T13	T38	23274898
NA	CHEMICAL	GENE-N	25	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T13	T39	23274898
NA	CHEMICAL	GENE-Y	15	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T14	T37	23274898
NA	CHEMICAL	GENE-N	15	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T14	T38	23274898
NA	CHEMICAL	GENE-N	15	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T14	T39	23274898
NA	CHEMICAL	GENE-Y	15	6	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T15	T37	23274898
CPR:4	CHEMICAL	GENE-N	15	31	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T15	T38	23274898
CPR:4	CHEMICAL	GENE-N	15	34	Electrical stimulation , chemical , and gene each increased fluorescent chemical ( chemical ) uptake in primary myotubes , but only electrical stimulation and chemical-dependent chemical uptake were inhibited by chemical phosphatase and by gene blockade ( chemical ) .	T15	T39	23274898
NA	CHEMICAL	GENE-N	5	8	Electrical stimulation transiently elevated extracellular chemical and caused gene phosphorylation that was additive to gene and inhibited by chemical .	T16	T40	23274898
NA	CHEMICAL	GENE-Y	5	14	Electrical stimulation transiently elevated extracellular chemical and caused gene phosphorylation that was additive to gene and inhibited by chemical .	T16	T41	23274898
CPR:4	CHEMICAL	GENE-N	18	8	Electrical stimulation transiently elevated extracellular chemical and caused gene phosphorylation that was additive to gene and inhibited by chemical .	T17	T40	23274898
NA	CHEMICAL	GENE-Y	18	14	Electrical stimulation transiently elevated extracellular chemical and caused gene phosphorylation that was additive to gene and inhibited by chemical .	T17	T41	23274898
CPR:3	CHEMICAL	GENE-N	1	4	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T18	T43	23274898
NA	CHEMICAL	GENE-N	1	8	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T18	T44	23274898
NA	CHEMICAL	GENE-N	1	10	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T18	T45	23274898
NA	CHEMICAL	GENE-N	1	13	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T18	T46	23274898
NA	CHEMICAL	GENE-N	1	18	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T18	T47	23274898
NA	CHEMICAL	GENE-N	1	26	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T18	T48	23274898
NA	CHEMICAL	GENE-N	22	4	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T19	T43	23274898
NA	CHEMICAL	GENE-N	22	8	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T19	T44	23274898
NA	CHEMICAL	GENE-N	22	10	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T19	T45	23274898
NA	CHEMICAL	GENE-N	22	13	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T19	T46	23274898
NA	CHEMICAL	GENE-N	22	18	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T19	T47	23274898
NA	CHEMICAL	GENE-N	22	26	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T19	T48	23274898
NA	CHEMICAL	GENE-N	23	4	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T20	T43	23274898
NA	CHEMICAL	GENE-N	23	8	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T20	T44	23274898
NA	CHEMICAL	GENE-N	23	10	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T20	T45	23274898
NA	CHEMICAL	GENE-N	23	13	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T20	T46	23274898
NA	CHEMICAL	GENE-N	23	18	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T20	T47	23274898
NA	CHEMICAL	GENE-N	23	26	Exogenous chemical transiently activated gene and , inhibiting gene ( gene ) or gene as well as dominant-negative gene mutant , reduced chemical-dependent chemical uptake and gene phosphorylation .	T20	T48	23274898
NA	CHEMICAL	GENE-N	0	8	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T21	T49	23274898
NA	CHEMICAL	GENE-Y	0	15	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T21	T25	23274898
NA	CHEMICAL	GENE-Y	0	17	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T21	T26	23274898
NA	CHEMICAL	GENE-N	1	8	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T22	T49	23274898
NA	CHEMICAL	GENE-Y	1	15	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T22	T25	23274898
NA	CHEMICAL	GENE-Y	1	17	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T22	T26	23274898
NA	CHEMICAL	GENE-N	20	8	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T1	T49	23274898
CPR:4	CHEMICAL	GENE-Y	20	15	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T1	T25	23274898
CPR:4	CHEMICAL	GENE-Y	20	17	chemical-dependent chemical uptake was also inhibited by the gene subunit-interacting peptide βark-ct and by the gene ( gene ) inhibitor chemical .	T1	T26	23274898
NA	CHEMICAL	GENE-Y	0	4	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T27	23274898
NA	CHEMICAL	GENE-Y	0	16	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T28	23274898
NA	CHEMICAL	GENE-Y	0	16	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T29	23274898
NA	CHEMICAL	GENE-N	0	20	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T30	23274898
NA	CHEMICAL	GENE-Y	0	22	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T31	23274898
NA	CHEMICAL	GENE-N	0	23	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T32	23274898
NA	CHEMICAL	GENE-Y	0	29	chemical caused translocation of genemyc-eGFP to the cell surface , mechanistically mediated by increased exocytosis involving gene/gene reduced by dominant-negative gene or gene gene-dead mutants , and potentiated by gene .	T2	T33	23274898
NA	CHEMICAL	GENE-Y	0	4	chemical stimulated chemical uptake in normal and gene-resistant adult muscle fibers , resembling the reported effect of exercise .	T3	T34	23274898
NA	CHEMICAL	GENE-Y	2	4	chemical stimulated chemical uptake in normal and gene-resistant adult muscle fibers , resembling the reported effect of exercise .	T4	T34	23274898
CPR:4	CHEMICAL	GENE-N	0	5	chemical decreased expression of pro-inflammatory gene , such as gene , gene gene , gene , and gene .	T12	T19	23535185
CPR:4	CHEMICAL	GENE-Y	0	9	chemical decreased expression of pro-inflammatory gene , such as gene , gene gene , gene , and gene .	T12	T20	23535185
CPR:4	CHEMICAL	GENE-Y	0	11	chemical decreased expression of pro-inflammatory gene , such as gene , gene gene , gene , and gene .	T12	T21	23535185
CPR:4	CHEMICAL	GENE-Y	0	12	chemical decreased expression of pro-inflammatory gene , such as gene , gene gene , gene , and gene .	T12	T22	23535185
CPR:4	CHEMICAL	GENE-Y	0	14	chemical decreased expression of pro-inflammatory gene , such as gene , gene gene , gene , and gene .	T12	T23	23535185
CPR:4	CHEMICAL	GENE-Y	0	17	chemical decreased expression of pro-inflammatory gene , such as gene , gene gene , gene , and gene .	T12	T24	23535185
NA	CHEMICAL	GENE-N	4	8	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T25	23535185
NA	CHEMICAL	GENE-Y	4	12	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T26	23535185
NA	CHEMICAL	GENE-N	4	13	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T27	23535185
NA	CHEMICAL	GENE-N	4	16	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T28	23535185
NA	CHEMICAL	GENE-N	4	17	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T29	23535185
NA	CHEMICAL	GENE-N	4	19	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T30	23535185
NA	CHEMICAL	GENE-Y	4	22	The inhibitory effect of chemical on theses pro-inflammatory gene was related with gene chemical-terminal kinases , and gene gene , gene , and gene .	T14	T31	23535185
CPR:4	CHEMICAL	GENE-N	2	4	Furthermore , chemical attenuated gene-mediated passive cutaneous anaphylaxis and the expression of chemical receptor 1 at the inflamed tissue .	T15	T32	23535185
CPR:4	CHEMICAL	GENE-Y	2	14	Furthermore , chemical attenuated gene-mediated passive cutaneous anaphylaxis and the expression of chemical receptor 1 at the inflamed tissue .	T15	T33	23535185
NA	CHEMICAL	GENE-N	12	4	Furthermore , chemical attenuated gene-mediated passive cutaneous anaphylaxis and the expression of chemical receptor 1 at the inflamed tissue .	T16	T32	23535185
NA	CHEMICAL	GENE-Y	12	14	Furthermore , chemical attenuated gene-mediated passive cutaneous anaphylaxis and the expression of chemical receptor 1 at the inflamed tissue .	T16	T33	23535185
CPR:4	CHEMICAL	GENE-N	4	19	Our results showed that chemical down-regulates mast cell-derived allergic inflammatory reactions by blocking chemical release and expression of pro-inflammatory gene .	T3	T18	23535185
NA	CHEMICAL	GENE-N	13	19	Our results showed that chemical down-regulates mast cell-derived allergic inflammatory reactions by blocking chemical release and expression of pro-inflammatory gene .	T4	T18	23535185
NA	CHEMICAL	GENE-Y	7	0	gene controls gene expression by turning on chemical synthesis in developing human dendritic cells .	T14	T32	16982809
NA	CHEMICAL	GENE-Y	7	2	gene controls gene expression by turning on chemical synthesis in developing human dendritic cells .	T14	T33	16982809
NA	CHEMICAL	GENE-Y	8	4	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T3	T24	16982809
CPR:9	CHEMICAL	GENE-Y	8	24	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T3	T25	16982809
CPR:9	CHEMICAL	GENE-Y	8	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T3	T26	16982809
CPR:9	CHEMICAL	GENE-Y	8	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T3	T27	16982809
NA	CHEMICAL	GENE-Y	15	4	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T4	T24	16982809
CPR:9	CHEMICAL	GENE-Y	15	24	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T4	T25	16982809
CPR:9	CHEMICAL	GENE-Y	15	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T4	T26	16982809
CPR:9	CHEMICAL	GENE-Y	15	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T4	T27	16982809
NA	CHEMICAL	GENE-Y	17	4	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T5	T24	16982809
CPR:9	CHEMICAL	GENE-Y	17	24	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T5	T25	16982809
CPR:9	CHEMICAL	GENE-Y	17	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T5	T26	16982809
CPR:9	CHEMICAL	GENE-Y	17	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T5	T27	16982809
NA	CHEMICAL	GENE-Y	22	4	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T6	T24	16982809
NA	CHEMICAL	GENE-Y	22	24	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T6	T25	16982809
NA	CHEMICAL	GENE-Y	22	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T6	T26	16982809
NA	CHEMICAL	GENE-Y	22	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T6	T27	16982809
NA	CHEMICAL	GENE-Y	26	4	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T7	T24	16982809
NA	CHEMICAL	GENE-Y	26	24	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T7	T25	16982809
NA	CHEMICAL	GENE-Y	26	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T7	T26	16982809
NA	CHEMICAL	GENE-Y	26	29	Here we demonstrate that gene , turns on chemical synthesis by inducing the expression of chemical and chemical metabolizing enzymes such as chemical dehydrogenase 10 and chemical dehydrogenase type 2 ( gene ) .	T7	T27	16982809
NA	CHEMICAL	GENE-Y	14	0	gene-regulated expression of these enzymes leads to an increase in the intracellular generation of chemical ( chemical ) from chemical .	T8	T28	16982809
NA	CHEMICAL	GENE-Y	16	0	gene-regulated expression of these enzymes leads to an increase in the intracellular generation of chemical ( chemical ) from chemical .	T9	T28	16982809
NA	CHEMICAL	GENE-Y	9	0	gene-regulated expression of these enzymes leads to an increase in the intracellular generation of chemical ( chemical ) from chemical .	T10	T28	16982809
CPR:3	CHEMICAL	GENE-Y	0	11	chemical regulates gene expression via the activation of the chemical receptor ( RAR ) alpha in human DCs , and gene acutely regulates gene expression .	T11	T29	16982809
CPR:3	CHEMICAL	GENE-Y	0	12	chemical regulates gene expression via the activation of the chemical receptor ( RAR ) alpha in human DCs , and gene acutely regulates gene expression .	T11	T30	16982809
CPR:3	CHEMICAL	GENE-Y	0	23	chemical regulates gene expression via the activation of the chemical receptor ( RAR ) alpha in human DCs , and gene acutely regulates gene expression .	T11	T31	16982809
NA	CHEMICAL	GENE-Y	9	11	chemical regulates gene expression via the activation of the chemical receptor ( RAR ) alpha in human DCs , and gene acutely regulates gene expression .	T12	T29	16982809
NA	CHEMICAL	GENE-Y	9	12	chemical regulates gene expression via the activation of the chemical receptor ( RAR ) alpha in human DCs , and gene acutely regulates gene expression .	T12	T30	16982809
NA	CHEMICAL	GENE-Y	9	23	chemical regulates gene expression via the activation of the chemical receptor ( RAR ) alpha in human DCs , and gene acutely regulates gene expression .	T12	T31	16982809
CPR:3	CHEMICAL	GENE-Y	1	5	The chemical-induced elevated expression of gene is coupled to enhanced iNKT cell activation .	T13	T15	16982809
CPR:3	CHEMICAL	GENE-Y	2	18	Furthermore , in vivo relevant lipids such as oxidized low-density lipoprotein can also elicit chemical signaling leading to gene up-regulation .	T1	T16	16982809
NA	CHEMICAL	GENE-Y	6	14	These data show that regulation of chemical metabolism and signaling is part of the gene-controlled transcriptional events in DCs .	T2	T17	16982809
NA	CHEMICAL	GENE-Y	34	0	gene expression was suppressed by means of RNA interference technology , and the overall outcome of this treatment on the hepatocellular proteome and metabolome was investigated using tandem mass tag-based differential protein profiling and chemical NMR spectroscopy , respectively .	T5	T18	23224291
NA	CHEMICAL	GENE-Y	20	10	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T19	23224291
NA	CHEMICAL	GENE-Y	20	18	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T20	23224291
NA	CHEMICAL	GENE-Y	20	22	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T21	23224291
NA	CHEMICAL	GENE-Y	20	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T22	23224291
NA	CHEMICAL	GENE-N	20	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T8	23224291
NA	CHEMICAL	GENE-Y	20	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T9	23224291
NA	CHEMICAL	GENE-N	20	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T6	T10	23224291
NA	CHEMICAL	GENE-Y	4	10	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T19	23224291
NA	CHEMICAL	GENE-Y	4	18	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T20	23224291
NA	CHEMICAL	GENE-Y	4	22	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T21	23224291
NA	CHEMICAL	GENE-Y	4	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T22	23224291
NA	CHEMICAL	GENE-N	4	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T8	23224291
NA	CHEMICAL	GENE-Y	4	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T9	23224291
NA	CHEMICAL	GENE-N	4	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T7	T10	23224291
NA	CHEMICAL	GENE-Y	4	10	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T19	23224291
NA	CHEMICAL	GENE-Y	4	18	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T20	23224291
NA	CHEMICAL	GENE-Y	4	22	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T21	23224291
NA	CHEMICAL	GENE-Y	4	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T22	23224291
NA	CHEMICAL	GENE-N	4	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T8	23224291
NA	CHEMICAL	GENE-Y	4	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T9	23224291
NA	CHEMICAL	GENE-N	4	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T1	T10	23224291
NA	CHEMICAL	GENE-Y	4	10	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T19	23224291
NA	CHEMICAL	GENE-Y	4	18	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T20	23224291
NA	CHEMICAL	GENE-Y	4	22	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T21	23224291
NA	CHEMICAL	GENE-Y	4	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T22	23224291
NA	CHEMICAL	GENE-N	4	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T8	23224291
NA	CHEMICAL	GENE-Y	4	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T9	23224291
NA	CHEMICAL	GENE-N	4	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T2	T10	23224291
NA	CHEMICAL	GENE-Y	35	10	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T19	23224291
NA	CHEMICAL	GENE-Y	35	18	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T20	23224291
NA	CHEMICAL	GENE-Y	35	22	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T21	23224291
NA	CHEMICAL	GENE-Y	35	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T22	23224291
NA	CHEMICAL	GENE-N	35	4	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T8	23224291
NA	CHEMICAL	GENE-Y	35	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T9	23224291
NA	CHEMICAL	GENE-N	35	37	Global protein profiling revealed a number of targets of the gene knock-down procedure , including mitochondrial proteins ( gene , chemical-regulated protein 75 , chemical sulphurtransferase and chemical synthase ) and detoxifying enzymes ( chemical chemical-transferase μ 2 and gene ) .	T3	T10	23224291
NA	CHEMICAL	GENE-Y	21	5	At the metabolomic level , gene silencing caused no overt changes , though there was some evidence for a subtle increase in intracellular chemical quantities .	T4	T11	23224291
CPR:5	CHEMICAL	GENE-Y	1	12	Oral chemical ( chemical ( ® ) ) , a selective chemical gene receptor agonist , is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults , or overweight adults with at least one weight-related comorbidity ( e.g .	T10	T14	23529825
CPR:5	CHEMICAL	GENE-Y	3	12	Oral chemical ( chemical ( ® ) ) , a selective chemical gene receptor agonist , is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults , or overweight adults with at least one weight-related comorbidity ( e.g .	T6	T14	23529825
NA	CHEMICAL	GENE-Y	11	12	Oral chemical ( chemical ( ® ) ) , a selective chemical gene receptor agonist , is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults , or overweight adults with at least one weight-related comorbidity ( e.g .	T8	T14	23529825
NA	CHEMICAL	GENE-N	7	14	Comparative study on transcriptional activity of 17 chemical mediated by chemical receptor α and β and chemical receptor .	T15	T35	23567241
NA	CHEMICAL	GENE-Y	7	11	Comparative study on transcriptional activity of 17 chemical mediated by chemical receptor α and β and chemical receptor .	T15	T34	23567241
NA	CHEMICAL	GENE-N	10	14	Comparative study on transcriptional activity of 17 chemical mediated by chemical receptor α and β and chemical receptor .	T16	T35	23567241
NA	CHEMICAL	GENE-Y	10	11	Comparative study on transcriptional activity of 17 chemical mediated by chemical receptor α and β and chemical receptor .	T16	T34	23567241
NA	CHEMICAL	GENE-N	13	14	Comparative study on transcriptional activity of 17 chemical mediated by chemical receptor α and β and chemical receptor .	T14	T35	23567241
NA	CHEMICAL	GENE-Y	13	11	Comparative study on transcriptional activity of 17 chemical mediated by chemical receptor α and β and chemical receptor .	T14	T34	23567241
NA	CHEMICAL	GENE-Y	4	16	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T7	T22	23567241
NA	CHEMICAL	GENE-Y	4	18	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T7	T23	23567241
NA	CHEMICAL	GENE-Y	4	21	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T7	T24	23567241
NA	CHEMICAL	GENE-Y	4	24	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T7	T25	23567241
NA	CHEMICAL	GENE-Y	4	26	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T7	T26	23567241
NA	CHEMICAL	GENE-Y	22	16	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T4	T22	23567241
NA	CHEMICAL	GENE-Y	22	18	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T4	T23	23567241
NA	CHEMICAL	GENE-Y	22	21	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T4	T24	23567241
NA	CHEMICAL	GENE-Y	22	24	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T4	T25	23567241
NA	CHEMICAL	GENE-Y	22	26	The structure-activity relationships of chemical which are widely used as preservatives for transcriptional activities mediated by gene ( gene ) , gene and chemical receptor ( gene ) were investigated .	T4	T26	23567241
CPR:5	CHEMICAL	GENE-Y	3	5	Fourteen of 17 chemical exhibited gene and/or gene agonistic activity at concentrations of ⩽1×10 ( -5 ) M , whereas none of the 17 chemical showed gene agonistic or antagonistic activity .	T5	T27	23567241
CPR:5	CHEMICAL	GENE-Y	3	7	Fourteen of 17 chemical exhibited gene and/or gene agonistic activity at concentrations of ⩽1×10 ( -5 ) M , whereas none of the 17 chemical showed gene agonistic or antagonistic activity .	T5	T28	23567241
NA	CHEMICAL	GENE-Y	3	26	Fourteen of 17 chemical exhibited gene and/or gene agonistic activity at concentrations of ⩽1×10 ( -5 ) M , whereas none of the 17 chemical showed gene agonistic or antagonistic activity .	T5	T29	23567241
NA	CHEMICAL	GENE-Y	24	5	Fourteen of 17 chemical exhibited gene and/or gene agonistic activity at concentrations of ⩽1×10 ( -5 ) M , whereas none of the 17 chemical showed gene agonistic or antagonistic activity .	T6	T27	23567241
NA	CHEMICAL	GENE-Y	24	7	Fourteen of 17 chemical exhibited gene and/or gene agonistic activity at concentrations of ⩽1×10 ( -5 ) M , whereas none of the 17 chemical showed gene agonistic or antagonistic activity .	T6	T28	23567241
NA	CHEMICAL	GENE-Y	24	26	Fourteen of 17 chemical exhibited gene and/or gene agonistic activity at concentrations of ⩽1×10 ( -5 ) M , whereas none of the 17 chemical showed gene agonistic or antagonistic activity .	T6	T29	23567241
CPR:5	CHEMICAL	GENE-Y	2	28	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T8	T30	23567241
CPR:5	CHEMICAL	GENE-Y	2	30	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T8	T31	23567241
CPR:5	CHEMICAL	GENE-Y	5	28	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T9	T30	23567241
CPR:5	CHEMICAL	GENE-Y	5	30	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T9	T31	23567241
CPR:5	CHEMICAL	GENE-Y	15	28	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T10	T30	23567241
CPR:5	CHEMICAL	GENE-Y	15	30	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T10	T31	23567241
CPR:5	CHEMICAL	GENE-Y	20	28	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T11	T30	23567241
CPR:5	CHEMICAL	GENE-Y	20	30	Among 12 chemical with linear chemical chains ranging in length from C1 to C12 , chemical ( C7 ) and chemical ( C5 ) showed the most potent gene and gene agonistic activity in the order of 10 ( -7 ) M and 10 ( -8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .	T11	T31	23567241
CPR:5	CHEMICAL	GENE-Y	1	6	Most chemical showing estrogenic activity exhibited gene-agonistic activity at lower concentrations than those inducing gene-agonistic activity .	T12	T32	23567241
CPR:5	CHEMICAL	GENE-Y	1	14	Most chemical showing estrogenic activity exhibited gene-agonistic activity at lower concentrations than those inducing gene-agonistic activity .	T12	T33	23567241
NA	CHEMICAL	GENE-N	4	23	The estrogenic activity of chemical was markedly decreased by incubation with rat liver microsomes , and the decrease of activity was blocked by a gene inhibitor .	T13	T17	23567241
CPR:9	CHEMICAL	GENE-Y	2	8	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T23	T41	23024204
CPR:9	CHEMICAL	GENE-N	2	14	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T23	T40	23024204
CPR:9	CHEMICAL	GENE-Y	4	8	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T24	T41	23024204
CPR:9	CHEMICAL	GENE-N	4	14	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T24	T40	23024204
NA	CHEMICAL	GENE-Y	7	8	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T25	T41	23024204
NA	CHEMICAL	GENE-N	7	14	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T25	T40	23024204
NA	CHEMICAL	GENE-Y	7	8	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T26	T41	23024204
NA	CHEMICAL	GENE-N	7	14	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T26	T40	23024204
NA	CHEMICAL	GENE-Y	13	8	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T22	T41	23024204
NA	CHEMICAL	GENE-N	13	14	Metabolism of chemical and chemical by the chemical/chemical-N ( 1 ) -acetyltransferase and chemical acetyltransferase .	T22	T40	23024204
CPR:9	CHEMICAL	GENE-Y	4	7	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T8	T30	23024204
CPR:9	CHEMICAL	GENE-Y	4	15	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T8	T31	23024204
CPR:9	CHEMICAL	GENE-Y	4	24	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T8	T32	23024204
CPR:9	CHEMICAL	GENE-Y	4	26	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T8	T33	23024204
CPR:9	CHEMICAL	GENE-Y	7	7	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T9	T30	23024204
CPR:9	CHEMICAL	GENE-Y	7	15	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T9	T31	23024204
NA	CHEMICAL	GENE-Y	7	24	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T9	T32	23024204
NA	CHEMICAL	GENE-Y	7	26	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T9	T33	23024204
NA	CHEMICAL	GENE-Y	7	7	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T11	T30	23024204
NA	CHEMICAL	GENE-Y	7	15	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T11	T31	23024204
NA	CHEMICAL	GENE-Y	7	24	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T11	T32	23024204
NA	CHEMICAL	GENE-Y	7	26	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T11	T33	23024204
NA	CHEMICAL	GENE-Y	7	7	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T12	T30	23024204
NA	CHEMICAL	GENE-Y	7	15	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T12	T31	23024204
NA	CHEMICAL	GENE-Y	7	24	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T12	T32	23024204
NA	CHEMICAL	GENE-Y	7	26	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T12	T33	23024204
NA	CHEMICAL	GENE-Y	7	7	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T14	T30	23024204
NA	CHEMICAL	GENE-Y	7	15	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T14	T31	23024204
NA	CHEMICAL	GENE-Y	7	24	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T14	T32	23024204
NA	CHEMICAL	GENE-Y	7	26	We recently showed that chemical is metabolized in vitro by chemical catabolic enzyme chemical/chemical-N ( 1 ) -acetyltransferase ( gene ) and by chemical acetyltransferase ( gene ) to its monoacetylated derivative ( MAT ) .	T14	T33	23024204
CPR:9	CHEMICAL	GENE-Y	3	7	The acetylation of chemical is increased in gene-overexpressing mice compared with wild-type mice .	T15	T34	23024204
NA	CHEMICAL	GENE-Y	5	2	However , gene-deficient mice metabolize chemical at the same rate as the wild-type mice , indicating the existence of another gene respons 2ible for its metabolism in mice .	T16	T35	23024204
CPR:9	CHEMICAL	GENE-N	5	10	However , gene-deficient mice metabolize chemical at the same rate as the wild-type mice , indicating the existence of another gene respons 2ible for its metabolism in mice .	T16	T36	23024204
CPR:9	CHEMICAL	GENE-Y	26	8	Here , we show that siRNA-mediated knockdown of gene in HEPG2 cells and in primary hepatocytes from the gene-deficient or wild-type mice reduced the metabolism of chemical to MAT .	T17	T37	23024204
NA	CHEMICAL	GENE-Y	26	18	Here , we show that siRNA-mediated knockdown of gene in HEPG2 cells and in primary hepatocytes from the gene-deficient or wild-type mice reduced the metabolism of chemical to MAT .	T17	T38	23024204
CPR:9	CHEMICAL	GENE-Y	2	19	By contrast , chemical ( chemical ) , a charge-deficient chemical analog , was an extremely poor substrate of gene and was metabolized by gene in HEPG2 cells and in wild-type primary hepatocytes .	T18	T39	23024204
CPR:9	CHEMICAL	GENE-Y	2	24	By contrast , chemical ( chemical ) , a charge-deficient chemical analog , was an extremely poor substrate of gene and was metabolized by gene in HEPG2 cells and in wild-type primary hepatocytes .	T18	T27	23024204
CPR:9	CHEMICAL	GENE-Y	5	19	By contrast , chemical ( chemical ) , a charge-deficient chemical analog , was an extremely poor substrate of gene and was metabolized by gene in HEPG2 cells and in wild-type primary hepatocytes .	T19	T39	23024204
CPR:9	CHEMICAL	GENE-Y	5	24	By contrast , chemical ( chemical ) , a charge-deficient chemical analog , was an extremely poor substrate of gene and was metabolized by gene in HEPG2 cells and in wild-type primary hepatocytes .	T19	T27	23024204
CPR:9	CHEMICAL	GENE-Y	10	19	By contrast , chemical ( chemical ) , a charge-deficient chemical analog , was an extremely poor substrate of gene and was metabolized by gene in HEPG2 cells and in wild-type primary hepatocytes .	T20	T39	23024204
CPR:9	CHEMICAL	GENE-Y	10	24	By contrast , chemical ( chemical ) , a charge-deficient chemical analog , was an extremely poor substrate of gene and was metabolized by gene in HEPG2 cells and in wild-type primary hepatocytes .	T20	T27	23024204
NA	CHEMICAL	GENE-Y	2	4	Discovery of chemical carboxylase 2 inhibitors : comparison of a fluorescence intensity-based chemical assay and a fluorescence polarization-based chemical Assay for high-throughput screening .	T17	T27	17477831
NA	CHEMICAL	GENE-Y	9	4	Discovery of chemical carboxylase 2 inhibitors : comparison of a fluorescence intensity-based chemical assay and a fluorescence polarization-based chemical Assay for high-throughput screening .	T16	T27	17477831
NA	CHEMICAL	GENE-Y	18	4	Discovery of chemical carboxylase 2 inhibitors : comparison of a fluorescence intensity-based chemical assay and a fluorescence polarization-based chemical Assay for high-throughput screening .	T18	T27	17477831
NA	CHEMICAL	GENE-N	0	1	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T1	T19	17477831
NA	CHEMICAL	GENE-N	0	3	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T1	T21	17477831
NA	CHEMICAL	GENE-Y	0	11	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T1	T24	17477831
NA	CHEMICAL	GENE-Y	0	13	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T1	T26	17477831
CPR:9	CHEMICAL	GENE-N	20	1	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T4	T19	17477831
CPR:9	CHEMICAL	GENE-N	20	3	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T4	T21	17477831
CPR:9	CHEMICAL	GENE-Y	20	11	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T4	T24	17477831
CPR:9	CHEMICAL	GENE-Y	20	13	chemical carboxylase ( gene ) enzymes exist as two isoforms , gene and gene , which play critical roles in chemical biosynthesis and oxidation .	T4	T26	17477831
NA	CHEMICAL	GENE-Y	14	2	The cytosolic gene is expressed primarily in liver and adipose tissue , and uses chemical as a key building block in chemical biosynthesis .	T11	T22	17477831
CPR:9	CHEMICAL	GENE-Y	16	2	The cytosolic gene is expressed primarily in liver and adipose tissue , and uses chemical as a key building block in chemical biosynthesis .	T12	T22	17477831
CPR:9	CHEMICAL	GENE-Y	20	2	The mitochondrial gene is primarily expressed in heart and skeletal muscle , where it is involved in the regulation of chemical oxidation .	T13	T23	17477831
CPR:4	CHEMICAL	GENE-N	3	1	The gene-specific inhibitor chemical selectively disrupts gene-mediated signaling events of T-lymphocyte activation .	T8	T30	10701840
CPR:4	CHEMICAL	GENE-N	3	6	The gene-specific inhibitor chemical selectively disrupts gene-mediated signaling events of T-lymphocyte activation .	T8	T31	10701840
CPR:4	CHEMICAL	GENE-N	18	15	Improper function of these proteins can be induced by selective disruption of their complexes with gene using the chemical chemical .	T2	T18	10701840
CPR:4	CHEMICAL	GENE-N	19	15	Improper function of these proteins can be induced by selective disruption of their complexes with gene using the chemical chemical .	T3	T18	10701840
CPR:4	CHEMICAL	GENE-Y	7	10	In this study , we demonstrate that chemical treatment blocks gene secretion , gene expression , and proliferation of stimulated T-lymphocytes .	T4	T19	10701840
CPR:4	CHEMICAL	GENE-N	7	13	In this study , we demonstrate that chemical treatment blocks gene secretion , gene expression , and proliferation of stimulated T-lymphocytes .	T4	T20	10701840
CPR:4	CHEMICAL	GENE-Y	2	9	Moreover , chemical decreases the amount and phosphorylation of gene and gene gene and prevents activation of the gene gene .	T5	T22	10701840
CPR:4	CHEMICAL	GENE-Y	2	11	Moreover , chemical decreases the amount and phosphorylation of gene and gene gene and prevents activation of the gene gene .	T5	T23	10701840
CPR:4	CHEMICAL	GENE-N	2	12	Moreover , chemical decreases the amount and phosphorylation of gene and gene gene and prevents activation of the gene gene .	T5	T24	10701840
CPR:4	CHEMICAL	GENE-Y	2	18	Moreover , chemical decreases the amount and phosphorylation of gene and gene gene and prevents activation of the gene gene .	T5	T25	10701840
CPR:4	CHEMICAL	GENE-N	2	19	Moreover , chemical decreases the amount and phosphorylation of gene and gene gene and prevents activation of the gene gene .	T5	T26	10701840
CPR:4	CHEMICAL	GENE-N	0	4	chemical also disrupts the gene-mediated activation of gene ( gene ) .	T6	T27	10701840
CPR:4	CHEMICAL	GENE-N	0	7	chemical also disrupts the gene-mediated activation of gene ( gene ) .	T6	T28	10701840
CPR:4	CHEMICAL	GENE-N	0	9	chemical also disrupts the gene-mediated activation of gene ( gene ) .	T6	T29	10701840
NA	CHEMICAL	GENE-N	2	12	Treatment with chemical , however , does not affect the activation of gene , which is a plasma membrane enzyme coupled to the gene after T-cell stimulation .	T7	T9	10701840
NA	CHEMICAL	GENE-N	2	21	Treatment with chemical , however , does not affect the activation of gene , which is a plasma membrane enzyme coupled to the gene after T-cell stimulation .	T7	T10	10701840
NA	CHEMICAL	GENE-N	3	5	Localization of the chemical transporter proteins gene and gene in mouse kidney .	T6	T34	12388412
NA	CHEMICAL	GENE-Y	3	6	Localization of the chemical transporter proteins gene and gene in mouse kidney .	T6	T35	12388412
NA	CHEMICAL	GENE-Y	3	8	Localization of the chemical transporter proteins gene and gene in mouse kidney .	T6	T36	12388412
NA	CHEMICAL	GENE-N	4	4	Recent studies have identified a family of putative chemical transporters ; mRNA for two members of this family , gene ( gene ) and gene ( gene ) , is expressed in the kidney .	T3	T18	12388412
NA	CHEMICAL	GENE-Y	4	19	Recent studies have identified a family of putative chemical transporters ; mRNA for two members of this family , gene ( gene ) and gene ( gene ) , is expressed in the kidney .	T3	T23	12388412
NA	CHEMICAL	GENE-Y	4	21	Recent studies have identified a family of putative chemical transporters ; mRNA for two members of this family , gene ( gene ) and gene ( gene ) , is expressed in the kidney .	T3	T24	12388412
NA	CHEMICAL	GENE-Y	4	24	Recent studies have identified a family of putative chemical transporters ; mRNA for two members of this family , gene ( gene ) and gene ( gene ) , is expressed in the kidney .	T3	T25	12388412
NA	CHEMICAL	GENE-Y	4	26	Recent studies have identified a family of putative chemical transporters ; mRNA for two members of this family , gene ( gene ) and gene ( gene ) , is expressed in the kidney .	T3	T26	12388412
NA	CHEMICAL	GENE-Y	7	2	Colocalization of gene with gene , the chemical-sensitive transporter , and the gene gene and gene demonstrated gene immunoreactivity in all CNT cells and all CCD and ICT principal cells .	T5	T32	12388412
NA	CHEMICAL	GENE-Y	7	4	Colocalization of gene with gene , the chemical-sensitive transporter , and the gene gene and gene demonstrated gene immunoreactivity in all CNT cells and all CCD and ICT principal cells .	T5	T33	12388412
NA	CHEMICAL	GENE-N	7	12	Colocalization of gene with gene , the chemical-sensitive transporter , and the gene gene and gene demonstrated gene immunoreactivity in all CNT cells and all CCD and ICT principal cells .	T5	T7	12388412
NA	CHEMICAL	GENE-Y	7	13	Colocalization of gene with gene , the chemical-sensitive transporter , and the gene gene and gene demonstrated gene immunoreactivity in all CNT cells and all CCD and ICT principal cells .	T5	T8	12388412
NA	CHEMICAL	GENE-Y	7	15	Colocalization of gene with gene , the chemical-sensitive transporter , and the gene gene and gene demonstrated gene immunoreactivity in all CNT cells and all CCD and ICT principal cells .	T5	T9	12388412
NA	CHEMICAL	GENE-Y	7	17	Colocalization of gene with gene , the chemical-sensitive transporter , and the gene gene and gene demonstrated gene immunoreactivity in all CNT cells and all CCD and ICT principal cells .	T5	T10	12388412
NA	CHEMICAL	GENE-N	2	2	Immunoreactivity for a second putative chemical transporter , gene , was present in the apical region of cells with almost the same distribution as gene .	T2	T14	12388412
NA	CHEMICAL	GENE-Y	2	8	Immunoreactivity for a second putative chemical transporter , gene , was present in the apical region of cells with almost the same distribution as gene .	T2	T15	12388412
NA	CHEMICAL	GENE-Y	2	24	Immunoreactivity for a second putative chemical transporter , gene , was present in the apical region of cells with almost the same distribution as gene .	T2	T16	12388412
NA	CHEMICAL	GENE-Y	2	6	Effect of chemical and chemical on gene expression in Jurkat T cells .	T9	T25	15795105
NA	CHEMICAL	GENE-Y	4	6	Effect of chemical and chemical on gene expression in Jurkat T cells .	T10	T25	15795105
CPR:4	CHEMICAL	GENE-Y	2	15	The compounds chemical ( chemical ) and chemical ( chemical ) belong to inhibitors of gene , whose low activity correlates with increase in transcription of various genes .	T1	T20	15795105
CPR:4	CHEMICAL	GENE-Y	4	15	The compounds chemical ( chemical ) and chemical ( chemical ) belong to inhibitors of gene , whose low activity correlates with increase in transcription of various genes .	T2	T20	15795105
CPR:4	CHEMICAL	GENE-Y	7	15	The compounds chemical ( chemical ) and chemical ( chemical ) belong to inhibitors of gene , whose low activity correlates with increase in transcription of various genes .	T3	T20	15795105
CPR:4	CHEMICAL	GENE-Y	9	15	The compounds chemical ( chemical ) and chemical ( chemical ) belong to inhibitors of gene , whose low activity correlates with increase in transcription of various genes .	T4	T20	15795105
NA	CHEMICAL	GENE-Y	15	23	Using the reverse-transcription and real-time quantitative PCR ( RQ-PCR ) analysis , we indicated that chemical and chemical did not profoundly affect on gene transcription in Jurkat T leukemia cells clone E6-1 .	T5	T22	15795105
NA	CHEMICAL	GENE-Y	17	23	Using the reverse-transcription and real-time quantitative PCR ( RQ-PCR ) analysis , we indicated that chemical and chemical did not profoundly affect on gene transcription in Jurkat T leukemia cells clone E6-1 .	T6	T22	15795105
CPR:4	CHEMICAL	GENE-Y	7	14	However , the flowcytometric analysis revealed that chemical and chemical decreased intracellular contents of gene in these cells in dose dependent manner .	T7	T23	15795105
CPR:4	CHEMICAL	GENE-Y	9	14	However , the flowcytometric analysis revealed that chemical and chemical decreased intracellular contents of gene in these cells in dose dependent manner .	T8	T23	15795105
NA	CHEMICAL	GENE-N	3	9	Reduction of oral chemical self-administration in rats by chemical oxidase inhibitors .	T26	T36	10548268
NA	CHEMICAL	GENE-N	5	9	Reduction of oral chemical self-administration in rats by chemical oxidase inhibitors .	T27	T36	10548268
NA	CHEMICAL	GENE-N	2	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T12	T28	10548268
NA	CHEMICAL	GENE-N	2	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T12	T29	10548268
NA	CHEMICAL	GENE-N	7	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T14	T28	10548268
NA	CHEMICAL	GENE-N	7	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T14	T29	10548268
NA	CHEMICAL	GENE-N	2	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T20	T28	10548268
NA	CHEMICAL	GENE-N	2	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T20	T29	10548268
NA	CHEMICAL	GENE-N	2	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T3	T28	10548268
NA	CHEMICAL	GENE-N	2	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T3	T29	10548268
NA	CHEMICAL	GENE-N	8	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T10	T28	10548268
NA	CHEMICAL	GENE-N	8	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T10	T29	10548268
NA	CHEMICAL	GENE-N	2	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T11	T28	10548268
NA	CHEMICAL	GENE-N	2	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T11	T29	10548268
NA	CHEMICAL	GENE-N	2	2	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T13	T28	10548268
NA	CHEMICAL	GENE-N	2	21	Evidence for a role of chemical and chemical in the control of chemical intake in animals suggests that chemical oxidase ( gene ) inhibitors , which increase the synaptic availability of chemical and chemical by blocking their metabolism , might have efficacy in the treatment of chemical dependence .	T13	T29	10548268
NA	CHEMICAL	GENE-N	20	13	The aim of the present study was , therefore , to evaluate several gene inhibitors for their capacity to affect chemical self-administration in rats trained to self-administer chemical ( 10 % v/v ) orally in a free-choice two-lever operant task .	T15	T31	10548268
NA	CHEMICAL	GENE-N	27	13	The aim of the present study was , therefore , to evaluate several gene inhibitors for their capacity to affect chemical self-administration in rats trained to self-administer chemical ( 10 % v/v ) orally in a free-choice two-lever operant task .	T16	T31	10548268
CPR:4	CHEMICAL	GENE-N	7	4	The nonselective and irreversible gene inhibitors , chemical ( 3-10 mg/kg ) , chemical ( 1-3 mg/kg ) , and chemical ( 30 mg/kg ) , decreased rates of responding maintained by chemical reinforcement .	T17	T32	10548268
CPR:4	CHEMICAL	GENE-N	13	4	The nonselective and irreversible gene inhibitors , chemical ( 3-10 mg/kg ) , chemical ( 1-3 mg/kg ) , and chemical ( 30 mg/kg ) , decreased rates of responding maintained by chemical reinforcement .	T18	T32	10548268
CPR:4	CHEMICAL	GENE-N	20	4	The nonselective and irreversible gene inhibitors , chemical ( 3-10 mg/kg ) , chemical ( 1-3 mg/kg ) , and chemical ( 30 mg/kg ) , decreased rates of responding maintained by chemical reinforcement .	T19	T32	10548268
NA	CHEMICAL	GENE-N	32	4	The nonselective and irreversible gene inhibitors , chemical ( 3-10 mg/kg ) , chemical ( 1-3 mg/kg ) , and chemical ( 30 mg/kg ) , decreased rates of responding maintained by chemical reinforcement .	T21	T32	10548268
CPR:4	CHEMICAL	GENE-Y	5	2	The reversible gene inhibitor , chemical ( 0.3-3 mg/kg ) , and the irreversible gene inhibitor , chemical ( 10-30 mg/kg ) , also reduced chemical self-administration .	T22	T33	10548268
NA	CHEMICAL	GENE-Y	5	14	The reversible gene inhibitor , chemical ( 0.3-3 mg/kg ) , and the irreversible gene inhibitor , chemical ( 10-30 mg/kg ) , also reduced chemical self-administration .	T22	T34	10548268
NA	CHEMICAL	GENE-Y	17	2	The reversible gene inhibitor , chemical ( 0.3-3 mg/kg ) , and the irreversible gene inhibitor , chemical ( 10-30 mg/kg ) , also reduced chemical self-administration .	T23	T33	10548268
CPR:4	CHEMICAL	GENE-Y	17	14	The reversible gene inhibitor , chemical ( 0.3-3 mg/kg ) , and the irreversible gene inhibitor , chemical ( 10-30 mg/kg ) , also reduced chemical self-administration .	T23	T34	10548268
NA	CHEMICAL	GENE-Y	25	2	The reversible gene inhibitor , chemical ( 0.3-3 mg/kg ) , and the irreversible gene inhibitor , chemical ( 10-30 mg/kg ) , also reduced chemical self-administration .	T24	T33	10548268
NA	CHEMICAL	GENE-Y	25	14	The reversible gene inhibitor , chemical ( 0.3-3 mg/kg ) , and the irreversible gene inhibitor , chemical ( 10-30 mg/kg ) , also reduced chemical self-administration .	T24	T34	10548268
CPR:4	CHEMICAL	GENE-Y	5	2	The irreversible gene inhibitors , chemical ( 30 mg/kg ) and chemical ( 3-10 mg/kg ) also decreased responding maintained by chemical reinforcement ; these results are consistent with previous findings that both drugs decreased chemical intake in mice .	T1	T35	10548268
CPR:4	CHEMICAL	GENE-Y	11	2	The irreversible gene inhibitors , chemical ( 30 mg/kg ) and chemical ( 3-10 mg/kg ) also decreased responding maintained by chemical reinforcement ; these results are consistent with previous findings that both drugs decreased chemical intake in mice .	T2	T35	10548268
NA	CHEMICAL	GENE-Y	21	2	The irreversible gene inhibitors , chemical ( 30 mg/kg ) and chemical ( 3-10 mg/kg ) also decreased responding maintained by chemical reinforcement ; these results are consistent with previous findings that both drugs decreased chemical intake in mice .	T4	T35	10548268
NA	CHEMICAL	GENE-Y	35	2	The irreversible gene inhibitors , chemical ( 30 mg/kg ) and chemical ( 3-10 mg/kg ) also decreased responding maintained by chemical reinforcement ; these results are consistent with previous findings that both drugs decreased chemical intake in mice .	T5	T35	10548268
NA	CHEMICAL	GENE-Y	10	4	Mutation of Gly721 alters gene active site architecture and sensitivity to chemical .	T28	T40	18056711
NA	CHEMICAL	GENE-Y	2	0	gene is the cellular target of the anti-cancer drug chemical ( chemical ) , which reversibly stabilizes a covalent enzyme-DNA intermediate .	T17	T31	18056711
NA	CHEMICAL	GENE-Y	11	0	gene is the cellular target of the anti-cancer drug chemical ( chemical ) , which reversibly stabilizes a covalent enzyme-DNA intermediate .	T18	T31	18056711
NA	CHEMICAL	GENE-Y	10	0	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T19	T34	18056711
NA	CHEMICAL	GENE-N	10	16	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T19	T35	18056711
NA	CHEMICAL	GENE-N	10	18	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T19	T36	18056711
NA	CHEMICAL	GENE-Y	26	0	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T20	T34	18056711
NA	CHEMICAL	GENE-N	26	16	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T20	T35	18056711
NA	CHEMICAL	GENE-N	26	18	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T20	T36	18056711
NA	CHEMICAL	GENE-Y	29	0	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T21	T34	18056711
NA	CHEMICAL	GENE-N	29	16	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T21	T35	18056711
NA	CHEMICAL	GENE-N	29	18	gene clamps around duplex DNA , wherein the core and chemical-terminal domains are connected by extended gene ( gene ) , which position the active site chemical of the chemical-terminal domain within the catalytic pocket .	T21	T36	18056711
NA	CHEMICAL	GENE-Y	19	8	The physical connection of the linker with the gene clamp as well as linker flexibility affect enzyme sensitivity to chemical .	T22	T37	18056711
NA	CHEMICAL	GENE-N	6	4	chemicalrystallographic data reveal that a conserved chemical residue ( located at the juncture between the linker and C-terminal domains ) is at one end of a short gene , which extends to the active site chemical covalently linked to the DNA .	T23	T38	18056711
NA	CHEMICAL	GENE-N	0	4	chemicalrystallographic data reveal that a conserved chemical residue ( located at the juncture between the linker and C-terminal domains ) is at one end of a short gene , which extends to the active site chemical covalently linked to the DNA .	T24	T38	18056711
NA	CHEMICAL	GENE-N	35	4	chemicalrystallographic data reveal that a conserved chemical residue ( located at the juncture between the linker and C-terminal domains ) is at one end of a short gene , which extends to the active site chemical covalently linked to the DNA .	T25	T38	18056711
NA	CHEMICAL	GENE-N	16	12	In the presence of drug , the linker is rigid and this gene extends to include chemical and the preceding chemical .	T26	T39	18056711
NA	CHEMICAL	GENE-N	20	12	In the presence of drug , the linker is rigid and this gene extends to include chemical and the preceding chemical .	T27	T39	18056711
NA	CHEMICAL	GENE-Y	7	9	We report that mutation of this conserved chemical in gene alters enzyme sensitivity to chemical .	T1	T30	18056711
NA	CHEMICAL	GENE-Y	14	9	We report that mutation of this conserved chemical in gene alters enzyme sensitivity to chemical .	T2	T30	18056711
CPR:4	CHEMICAL	GENE-N	0	11	chemical and chemical , are potent , oral direct inhibitors of gene-bound , clot-associated or free gene .	T1	T24	23292752
CPR:4	CHEMICAL	GENE-Y	0	16	chemical and chemical , are potent , oral direct inhibitors of gene-bound , clot-associated or free gene .	T1	T25	23292752
CPR:4	CHEMICAL	GENE-N	2	11	chemical and chemical , are potent , oral direct inhibitors of gene-bound , clot-associated or free gene .	T2	T24	23292752
CPR:4	CHEMICAL	GENE-Y	2	16	chemical and chemical , are potent , oral direct inhibitors of gene-bound , clot-associated or free gene .	T2	T25	23292752
NA	CHEMICAL	GENE-Y	7	12	Since both are substrates , co-administration of chemical and chemical with strong gene and gene ( gene ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong gene and gene inducers .	T3	T26	23292752
NA	CHEMICAL	GENE-Y	7	14	Since both are substrates , co-administration of chemical and chemical with strong gene and gene ( gene ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong gene and gene inducers .	T3	T27	23292752
NA	CHEMICAL	GENE-Y	7	16	Since both are substrates , co-administration of chemical and chemical with strong gene and gene ( gene ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong gene and gene inducers .	T3	T28	23292752
NA	CHEMICAL	GENE-Y	9	12	Since both are substrates , co-administration of chemical and chemical with strong gene and gene ( gene ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong gene and gene inducers .	T4	T26	23292752
NA	CHEMICAL	GENE-Y	9	14	Since both are substrates , co-administration of chemical and chemical with strong gene and gene ( gene ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong gene and gene inducers .	T4	T27	23292752
NA	CHEMICAL	GENE-Y	9	16	Since both are substrates , co-administration of chemical and chemical with strong gene and gene ( gene ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong gene and gene inducers .	T4	T28	23292752
CPR:4	CHEMICAL	GENE-Y	12	4	Although parenteral oral direct gene inhibitors ( DTIs ) , such as chemical and bivalirudin , have been on the market for years , DTIs such as chemical are novel synthetic gene antagonists .	T5	T31	23292752
NA	CHEMICAL	GENE-Y	12	31	Although parenteral oral direct gene inhibitors ( DTIs ) , such as chemical and bivalirudin , have been on the market for years , DTIs such as chemical are novel synthetic gene antagonists .	T5	T32	23292752
NA	CHEMICAL	GENE-Y	27	4	Although parenteral oral direct gene inhibitors ( DTIs ) , such as chemical and bivalirudin , have been on the market for years , DTIs such as chemical are novel synthetic gene antagonists .	T6	T31	23292752
CPR:6	CHEMICAL	GENE-Y	27	31	Although parenteral oral direct gene inhibitors ( DTIs ) , such as chemical and bivalirudin , have been on the market for years , DTIs such as chemical are novel synthetic gene antagonists .	T6	T32	23292752
CPR:4	CHEMICAL	GENE-Y	0	7	chemical has an advantage over the indirect gene inhibitors , unfractionated heparin and low-molecular-weight heparin , in that it inhibits free and gene-bound gene .	T10	T33	23292752
CPR:4	CHEMICAL	GENE-N	0	16	chemical has an advantage over the indirect gene inhibitors , unfractionated heparin and low-molecular-weight heparin , in that it inhibits free and gene-bound gene .	T10	T34	23292752
CPR:4	CHEMICAL	GENE-Y	0	16	chemical has an advantage over the indirect gene inhibitors , unfractionated heparin and low-molecular-weight heparin , in that it inhibits free and gene-bound gene .	T10	T35	23292752
CPR:4	CHEMICAL	GENE-Y	4	19	The reversible binding of chemical may provide safer and more predictable anticoagulant treatment than seen with irreversible , non-covalent gene inhibitors , e.g .	T11	T36	23292752
CPR:4	CHEMICAL	GENE-Y	0	7	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T1	T24	15465654
CPR:4	CHEMICAL	GENE-Y	0	9	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T1	T26	15465654
CPR:4	CHEMICAL	GENE-Y	2	7	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T7	T24	15465654
CPR:4	CHEMICAL	GENE-Y	2	9	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T7	T26	15465654
CPR:4	CHEMICAL	GENE-Y	4	7	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T9	T24	15465654
CPR:4	CHEMICAL	GENE-Y	4	9	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T9	T26	15465654
CPR:9	CHEMICAL	GENE-Y	13	7	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T17	T24	15465654
CPR:9	CHEMICAL	GENE-Y	13	9	chemical , chemical and chemical inhibit the gene ( gene ) which transports chemical into bile .	T17	T26	15465654
NA	CHEMICAL	GENE-Y	5	7	Sandwich-cultured rat hepatocytes maintain functional chemical co-transporting polypeptide and gene transport proteins , and may be useful to study inhibition of transport by xenobiotics at concentrations below the lowest observable adverse effect level ( LOAEL ) .	T8	T20	15465654
NA	CHEMICAL	GENE-Y	5	9	Sandwich-cultured rat hepatocytes maintain functional chemical co-transporting polypeptide and gene transport proteins , and may be useful to study inhibition of transport by xenobiotics at concentrations below the lowest observable adverse effect level ( LOAEL ) .	T8	T21	15465654
NA	CHEMICAL	GENE-N	16	17	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T10	T22	15465654
NA	CHEMICAL	GENE-N	16	19	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T10	T23	15465654
NA	CHEMICAL	GENE-Y	16	42	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T10	T25	15465654
NA	CHEMICAL	GENE-N	22	17	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T11	T22	15465654
NA	CHEMICAL	GENE-N	22	19	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T11	T23	15465654
NA	CHEMICAL	GENE-Y	22	42	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T11	T25	15465654
NA	CHEMICAL	GENE-N	24	17	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T12	T22	15465654
NA	CHEMICAL	GENE-N	24	19	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T12	T23	15465654
NA	CHEMICAL	GENE-Y	24	42	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T12	T25	15465654
NA	CHEMICAL	GENE-N	26	17	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T13	T22	15465654
NA	CHEMICAL	GENE-N	26	19	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T13	T23	15465654
NA	CHEMICAL	GENE-Y	26	42	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T13	T25	15465654
NA	CHEMICAL	GENE-N	29	17	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T14	T22	15465654
NA	CHEMICAL	GENE-N	29	19	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T14	T23	15465654
NA	CHEMICAL	GENE-Y	29	42	The purpose of this study was to compare viability assessments determined with the neutral red , chemical dehydrogenase ( gene ) , chemical , chemical ( chemical ) and chemical assays in sandwich-cultured rat hepatocytes following exposure to xenobiotics known to inhibit gene , and to define the LOAEL for these xenobiotics in this system .	T14	T25	15465654
NA	CHEMICAL	GENE-N	0	8	chemical also decreased viability as measured by the gene , chemical and chemical assays , with a LOAEL approximately 200 microM ; however , a significant decrease in viability was not observed with the chemical assay .	T16	T18	15465654
NA	CHEMICAL	GENE-N	10	8	chemical also decreased viability as measured by the gene , chemical and chemical assays , with a LOAEL approximately 200 microM ; however , a significant decrease in viability was not observed with the chemical assay .	T2	T18	15465654
NA	CHEMICAL	GENE-N	12	8	chemical also decreased viability as measured by the gene , chemical and chemical assays , with a LOAEL approximately 200 microM ; however , a significant decrease in viability was not observed with the chemical assay .	T3	T18	15465654
NA	CHEMICAL	GENE-N	34	8	chemical also decreased viability as measured by the gene , chemical and chemical assays , with a LOAEL approximately 200 microM ; however , a significant decrease in viability was not observed with the chemical assay .	T4	T18	15465654
NA	CHEMICAL	GENE-N	7	17	To clarify if the behavioral interaction between chemical and chemical reported previously occur centrally or due to a peripheral hemodynamic change , the effect of i.c.v .	T22	T40	2262902
NA	CHEMICAL	GENE-N	9	17	To clarify if the behavioral interaction between chemical and chemical reported previously occur centrally or due to a peripheral hemodynamic change , the effect of i.c.v .	T24	T40	2262902
NA	CHEMICAL	GENE-N	7	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T10	T37	2262902
CPR:5	CHEMICAL	GENE-N	3	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T13	T37	2262902
CPR:5	CHEMICAL	GENE-N	9	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T14	T37	2262902
CPR:5	CHEMICAL	GENE-N	3	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T15	T37	2262902
CPR:5	CHEMICAL	GENE-N	4	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T16	T37	2262902
CPR:6	CHEMICAL	GENE-N	18	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T17	T37	2262902
CPR:6	CHEMICAL	GENE-N	4	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T18	T37	2262902
CPR:6	CHEMICAL	GENE-N	24	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T19	T37	2262902
NA	CHEMICAL	GENE-N	26	0	gene agonists , N6- ( R-phenylisopropyl ) chemical ( chemical ) , chemical , chemical , antagonists , chemical and chemical as well as chemical on chemical- ( i.p .	T20	T37	2262902
NA	CHEMICAL	GENE-N	34	0	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T21	T39	2262902
NA	CHEMICAL	GENE-N	34	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T21	T41	2262902
NA	CHEMICAL	GENE-N	34	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T21	T42	2262902
NA	CHEMICAL	GENE-N	12	0	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T23	T39	2262902
NA	CHEMICAL	GENE-N	12	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T23	T41	2262902
NA	CHEMICAL	GENE-N	12	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T23	T42	2262902
NA	CHEMICAL	GENE-N	18	0	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T25	T39	2262902
NA	CHEMICAL	GENE-N	18	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T25	T41	2262902
NA	CHEMICAL	GENE-N	18	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T25	T42	2262902
NA	CHEMICAL	GENE-N	18	0	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T26	T39	2262902
NA	CHEMICAL	GENE-N	18	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T26	T41	2262902
NA	CHEMICAL	GENE-N	18	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T26	T42	2262902
NA	CHEMICAL	GENE-N	18	0	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T27	T39	2262902
NA	CHEMICAL	GENE-N	18	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T27	T41	2262902
NA	CHEMICAL	GENE-N	18	18	gene agonists and antagonists dose dependently accentuated and attenuated , respectively , chemical-induced motor incoordination , thereby suggesting a central mechanism of gene modulation of this effect of chemical and confirmed our previous reports in which chemical agonists and antagonists were given i.p .	T27	T42	2262902
CPR:6	CHEMICAL	GENE-N	0	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T28	T43	2262902
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T28	T44	2262902
NA	CHEMICAL	GENE-N	0	27	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T28	T45	2262902
NA	CHEMICAL	GENE-N	0	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T28	T33	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T29	T43	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T29	T44	2262902
NA	CHEMICAL	GENE-N	2	27	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T29	T45	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T29	T33	2262902
NA	CHEMICAL	GENE-N	10	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T30	T43	2262902
NA	CHEMICAL	GENE-N	10	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T30	T44	2262902
NA	CHEMICAL	GENE-N	10	27	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T30	T45	2262902
NA	CHEMICAL	GENE-N	10	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T30	T33	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T31	T43	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T31	T44	2262902
NA	CHEMICAL	GENE-N	2	27	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T31	T45	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T31	T33	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T1	T43	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T1	T44	2262902
NA	CHEMICAL	GENE-N	2	27	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T1	T45	2262902
NA	CHEMICAL	GENE-N	2	2	chemical , a weak gene antagonist but potent inhibitor of chemical phosphodiesterase , did not alter chemical 's motor incoordination , further supporting involvement of brain chemical receptor mechanism ( s ) in ethanol-chemical interactions .	T1	T33	2262902
NA	CHEMICAL	GENE-Y	5	6	S-diastereoisomer , suggesting predominance of chemical A1 subtype .	T3	T34	2262902
NA	CHEMICAL	GENE-N	2	25	However , chemical data indicate complexity of the mechanism ( s ) and point toward an additional involvement of a yet unknown subtype of chemical A2 .	T4	T35	2262902
NA	CHEMICAL	GENE-N	10	25	However , chemical data indicate complexity of the mechanism ( s ) and point toward an additional involvement of a yet unknown subtype of chemical A2 .	T5	T35	2262902
NA	CHEMICAL	GENE-N	10	6	No effect of chemical on blood or brain levels of chemical was noted and sufficient amount of the latter entered the brain to suggest chemical receptor activation adequate to produce behavioral interaction with ethanol .	T6	T36	2262902
NA	CHEMICAL	GENE-N	24	6	No effect of chemical on blood or brain levels of chemical was noted and sufficient amount of the latter entered the brain to suggest chemical receptor activation adequate to produce behavioral interaction with ethanol .	T7	T36	2262902
NA	CHEMICAL	GENE-N	3	6	No effect of chemical on blood or brain levels of chemical was noted and sufficient amount of the latter entered the brain to suggest chemical receptor activation adequate to produce behavioral interaction with ethanol .	T8	T36	2262902
NA	CHEMICAL	GENE-Y	1	3	Decreased chemical H1 receptor binding in the brain of depressed patients .	T8	T12	15255990
NA	CHEMICAL	GENE-Y	1	3	Cerebral chemical H1 receptor ( gene ) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and chemical .	T4	T10	15255990
NA	CHEMICAL	GENE-Y	1	4	Cerebral chemical H1 receptor ( gene ) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and chemical .	T4	T11	15255990
NA	CHEMICAL	GENE-Y	4	3	Cerebral chemical H1 receptor ( gene ) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and chemical .	T5	T10	15255990
NA	CHEMICAL	GENE-Y	4	4	Cerebral chemical H1 receptor ( gene ) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and chemical .	T5	T11	15255990
NA	CHEMICAL	GENE-N	0	1	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T1	T4	16336752
NA	CHEMICAL	GENE-N	0	18	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T1	T5	16336752
NA	CHEMICAL	GENE-Y	0	24	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T1	T6	16336752
NA	CHEMICAL	GENE-Y	0	26	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T1	T7	16336752
NA	CHEMICAL	GENE-N	0	29	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T1	T8	16336752
CPR:4	CHEMICAL	GENE-N	4	1	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T2	T4	16336752
CPR:4	CHEMICAL	GENE-N	4	18	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T2	T5	16336752
CPR:4	CHEMICAL	GENE-Y	4	24	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T2	T6	16336752
CPR:4	CHEMICAL	GENE-Y	4	26	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T2	T7	16336752
CPR:4	CHEMICAL	GENE-N	4	29	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T2	T8	16336752
CPR:4	CHEMICAL	GENE-Y	4	43	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T2	T9	16336752
NA	CHEMICAL	GENE-N	16	1	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T3	T4	16336752
NA	CHEMICAL	GENE-N	16	18	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T3	T5	16336752
NA	CHEMICAL	GENE-Y	16	24	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T3	T6	16336752
NA	CHEMICAL	GENE-Y	16	26	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T3	T7	16336752
NA	CHEMICAL	GENE-N	16	29	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T3	T8	16336752
NA	CHEMICAL	GENE-Y	16	43	chemical kinase inhibitors are chemical-derived , low molecular weight synthetic molecules that can block the intracellular chemical kinase domain of several receptors , including gene , gene , and gene , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of gene signaling .	T3	T9	16336752
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene signaling , activates chemical-activated protein kinase , and induces autophagy in colorectal cancer cells .	T28	T66	22406476
CPR:3	CHEMICAL	GENE-N	0	8	chemical inhibits gene signaling , activates chemical-activated protein kinase , and induces autophagy in colorectal cancer cells .	T28	T67	22406476
NA	CHEMICAL	GENE-Y	6	2	chemical inhibits gene signaling , activates chemical-activated protein kinase , and induces autophagy in colorectal cancer cells .	T30	T66	22406476
NA	CHEMICAL	GENE-N	6	8	chemical inhibits gene signaling , activates chemical-activated protein kinase , and induces autophagy in colorectal cancer cells .	T30	T67	22406476
NA	CHEMICAL	GENE-Y	4	4	Cancer cells have defects in signaling via the gene ( chemical ) , which regulates proliferation .	T15	T48	22406476
NA	CHEMICAL	GENE-Y	10	4	Cancer cells have defects in signaling via the gene ( chemical ) , which regulates proliferation .	T17	T48	22406476
NA	CHEMICAL	GENE-N	3	7	We investigated whether chemical affects chemical-activated protein kinase ( gene ) and gene signaling in CRC cells .	T18	T50	22406476
NA	CHEMICAL	GENE-N	3	9	We investigated whether chemical affects chemical-activated protein kinase ( gene ) and gene signaling in CRC cells .	T18	T51	22406476
NA	CHEMICAL	GENE-Y	3	12	We investigated whether chemical affects chemical-activated protein kinase ( gene ) and gene signaling in CRC cells .	T18	T52	22406476
NA	CHEMICAL	GENE-N	5	7	We investigated whether chemical affects chemical-activated protein kinase ( gene ) and gene signaling in CRC cells .	T19	T50	22406476
NA	CHEMICAL	GENE-N	5	9	We investigated whether chemical affects chemical-activated protein kinase ( gene ) and gene signaling in CRC cells .	T19	T51	22406476
NA	CHEMICAL	GENE-Y	5	12	We investigated whether chemical affects chemical-activated protein kinase ( gene ) and gene signaling in CRC cells .	T19	T52	22406476
NA	CHEMICAL	GENE-Y	5	11	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T21	T54	22406476
NA	CHEMICAL	GENE-Y	5	13	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T21	T55	22406476
NA	CHEMICAL	GENE-Y	5	15	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T21	T56	22406476
NA	CHEMICAL	GENE-Y	5	19	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T21	T57	22406476
NA	CHEMICAL	GENE-Y	5	21	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T21	T58	22406476
NA	CHEMICAL	GENE-Y	7	11	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T22	T54	22406476
NA	CHEMICAL	GENE-Y	7	13	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T22	T55	22406476
NA	CHEMICAL	GENE-Y	7	15	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T22	T56	22406476
NA	CHEMICAL	GENE-Y	7	19	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T22	T57	22406476
NA	CHEMICAL	GENE-Y	7	21	METHODS : The effects of chemical on chemical signaling , the gene , gene ( gene ) , and gene ( gene ) were examined in CRC cells by immunoblotting .	T22	T58	22406476
NA	CHEMICAL	GENE-N	14	2	Phosphorylation of gene was measured ; the effects of loss of gene on the chemical-induced effects of chemical were determined using small interfering RNA ( siRNA ) in CRC cells and in gene-/- ) mouse embryonic fibroblasts .	T23	T59	22406476
NA	CHEMICAL	GENE-N	14	11	Phosphorylation of gene was measured ; the effects of loss of gene on the chemical-induced effects of chemical were determined using small interfering RNA ( siRNA ) in CRC cells and in gene-/- ) mouse embryonic fibroblasts .	T23	T60	22406476
NA	CHEMICAL	GENE-N	14	24	Phosphorylation of gene was measured ; the effects of loss of gene on the chemical-induced effects of chemical were determined using small interfering RNA ( siRNA ) in CRC cells and in gene-/- ) mouse embryonic fibroblasts .	T23	T62	22406476
NA	CHEMICAL	GENE-N	17	2	Phosphorylation of gene was measured ; the effects of loss of gene on the chemical-induced effects of chemical were determined using small interfering RNA ( siRNA ) in CRC cells and in gene-/- ) mouse embryonic fibroblasts .	T24	T59	22406476
NA	CHEMICAL	GENE-N	17	11	Phosphorylation of gene was measured ; the effects of loss of gene on the chemical-induced effects of chemical were determined using small interfering RNA ( siRNA ) in CRC cells and in gene-/- ) mouse embryonic fibroblasts .	T24	T60	22406476
NA	CHEMICAL	GENE-N	17	24	Phosphorylation of gene was measured ; the effects of loss of gene on the chemical-induced effects of chemical were determined using small interfering RNA ( siRNA ) in CRC cells and in gene-/- ) mouse embryonic fibroblasts .	T24	T62	22406476
CPR:4	CHEMICAL	GENE-Y	2	12	RESULTS : chemical reduced chemical signaling in CRC cells by inhibiting the gene effectors gene and gene .	T26	T65	22406476
CPR:4	CHEMICAL	GENE-Y	2	14	RESULTS : chemical reduced chemical signaling in CRC cells by inhibiting the gene effectors gene and gene .	T26	T32	22406476
CPR:4	CHEMICAL	GENE-Y	2	16	RESULTS : chemical reduced chemical signaling in CRC cells by inhibiting the gene effectors gene and gene .	T26	T33	22406476
NA	CHEMICAL	GENE-Y	4	12	RESULTS : chemical reduced chemical signaling in CRC cells by inhibiting the gene effectors gene and gene .	T27	T65	22406476
NA	CHEMICAL	GENE-Y	4	14	RESULTS : chemical reduced chemical signaling in CRC cells by inhibiting the gene effectors gene and gene .	T27	T32	22406476
NA	CHEMICAL	GENE-Y	4	16	RESULTS : chemical reduced chemical signaling in CRC cells by inhibiting the gene effectors gene and gene .	T27	T33	22406476
CPR:3	CHEMICAL	GENE-N	0	6	chemical changed nucleotide ratios and activated gene in CRC cells .	T2	T34	22406476
NA	CHEMICAL	GENE-Y	0	0	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T3	T35	22406476
NA	CHEMICAL	GENE-N	0	13	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T3	T36	22406476
NA	CHEMICAL	GENE-N	0	16	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T3	T37	22406476
NA	CHEMICAL	GENE-N	0	18	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T3	T38	22406476
CPR:4	CHEMICAL	GENE-Y	5	0	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T4	T35	22406476
NA	CHEMICAL	GENE-N	5	13	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T4	T36	22406476
NA	CHEMICAL	GENE-N	5	16	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T4	T37	22406476
NA	CHEMICAL	GENE-N	5	18	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T4	T38	22406476
NA	CHEMICAL	GENE-Y	6	0	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T5	T35	22406476
NA	CHEMICAL	GENE-N	6	13	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T5	T36	22406476
NA	CHEMICAL	GENE-N	6	16	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T5	T37	22406476
NA	CHEMICAL	GENE-N	6	18	gene was still inhibited by chemical in CRC cells after siRNA knockdown of gene , indicating gene-dependent and gene-independent mechanisms of chemical-induced inhibition of chemical .	T5	T38	22406476
CPR:4	CHEMICAL	GENE-Y	0	7	chemical induced autophagy , a feature of gene inhibition .	T7	T40	22406476
CPR:3	CHEMICAL	GENE-N	0	7	chemical and chemical ( an activator of gene ) increased inhibition of gene and gene , as well as autophagy in CRC cells .	T9	T41	22406476
CPR:4	CHEMICAL	GENE-Y	0	12	chemical and chemical ( an activator of gene ) increased inhibition of gene and gene , as well as autophagy in CRC cells .	T9	T42	22406476
CPR:4	CHEMICAL	GENE-N	0	14	chemical and chemical ( an activator of gene ) increased inhibition of gene and gene , as well as autophagy in CRC cells .	T9	T43	22406476
CPR:3	CHEMICAL	GENE-N	2	7	chemical and chemical ( an activator of gene ) increased inhibition of gene and gene , as well as autophagy in CRC cells .	T10	T41	22406476
CPR:4	CHEMICAL	GENE-Y	2	12	chemical and chemical ( an activator of gene ) increased inhibition of gene and gene , as well as autophagy in CRC cells .	T10	T42	22406476
CPR:4	CHEMICAL	GENE-N	2	14	chemical and chemical ( an activator of gene ) increased inhibition of gene and gene , as well as autophagy in CRC cells .	T10	T43	22406476
CPR:4	CHEMICAL	GENE-Y	6	11	Rectal mucosal samples from patients given chemical had reduced phosphorylation of gene and gene .	T12	T44	22406476
CPR:4	CHEMICAL	GENE-Y	6	13	Rectal mucosal samples from patients given chemical had reduced phosphorylation of gene and gene .	T12	T45	22406476
CPR:4	CHEMICAL	GENE-Y	0	4	chemical inhibits LPS plus gene-induced inflammatory response in astrocytes primary cultures .	T11	T20	23164921
NA	CHEMICAL	GENE-Y	10	33	To further investigate the protective effect and underlying mechanism of chemical , astrocytes were pretreated with low ( 0.1mM ) and high dose ( 0.5mM ) chemical for 1h prior to LPS plus gene stimulation .	T5	T14	23164921
NA	CHEMICAL	GENE-Y	26	33	To further investigate the protective effect and underlying mechanism of chemical , astrocytes were pretreated with low ( 0.1mM ) and high dose ( 0.5mM ) chemical for 1h prior to LPS plus gene stimulation .	T6	T14	23164921
NA	CHEMICAL	GENE-Y	4	9	Biochemical analyses showed that chemical and ROS production and gene activity were significantly reduced by chemical .	T7	T15	23164921
CPR:4	CHEMICAL	GENE-Y	15	9	Biochemical analyses showed that chemical and ROS production and gene activity were significantly reduced by chemical .	T8	T15	23164921
CPR:4	CHEMICAL	GENE-Y	1	18	Data at transcriptional level also demonstrated that chemical potently attenuated gene expressions involved in inflammation , such as gene , gene and gene .	T9	T16	23164921
CPR:4	CHEMICAL	GENE-Y	1	20	Data at transcriptional level also demonstrated that chemical potently attenuated gene expressions involved in inflammation , such as gene , gene and gene .	T9	T17	23164921
CPR:4	CHEMICAL	GENE-Y	1	22	Data at transcriptional level also demonstrated that chemical potently attenuated gene expressions involved in inflammation , such as gene , gene and gene .	T9	T18	23164921
CPR:4	CHEMICAL	GENE-N	12	19	In addition , our exploration further revealed that the suppressive action of chemical on inflammation was mediated via inhibiting gene ( gene ) activation .	T10	T19	23164921
CPR:4	CHEMICAL	GENE-N	12	21	In addition , our exploration further revealed that the suppressive action of chemical on inflammation was mediated via inhibiting gene ( gene ) activation .	T10	T12	23164921
CPR:4	CHEMICAL	GENE-N	6	21	Collectively , these results suggest that chemical can exert inhibitory effects on the inflammatory reaction in astrocytes and that inactivation of gene could be the major determinant for its anti-inflammatory mechanism .	T1	T13	23164921
CPR:4	CHEMICAL	GENE-Y	0	7	chemical ( chemical ) , a novel gene and gene inhibitor , simultaneously suppresses metastasis , angiogenesis , and tumor growth .	T8	T31	21926191
CPR:4	CHEMICAL	GENE-Y	0	9	chemical ( chemical ) , a novel gene and gene inhibitor , simultaneously suppresses metastasis , angiogenesis , and tumor growth .	T8	T32	21926191
CPR:4	CHEMICAL	GENE-Y	2	7	chemical ( chemical ) , a novel gene and gene inhibitor , simultaneously suppresses metastasis , angiogenesis , and tumor growth .	T9	T31	21926191
CPR:4	CHEMICAL	GENE-Y	2	9	chemical ( chemical ) , a novel gene and gene inhibitor , simultaneously suppresses metastasis , angiogenesis , and tumor growth .	T9	T32	21926191
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T18	21926191
CPR:4	CHEMICAL	GENE-Y	0	13	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T19	21926191
CPR:4	CHEMICAL	GENE-Y	0	15	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T20	21926191
CPR:4	CHEMICAL	GENE-Y	0	17	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T21	21926191
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T22	21926191
CPR:4	CHEMICAL	GENE-Y	0	38	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T23	21926191
CPR:4	CHEMICAL	GENE-Y	0	40	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T24	21926191
CPR:4	CHEMICAL	GENE-Y	0	42	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T25	21926191
CPR:4	CHEMICAL	GENE-Y	0	45	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T3	T26	21926191
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T18	21926191
CPR:4	CHEMICAL	GENE-Y	2	13	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T19	21926191
CPR:4	CHEMICAL	GENE-Y	2	15	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T20	21926191
CPR:4	CHEMICAL	GENE-Y	2	17	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T21	21926191
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T22	21926191
CPR:4	CHEMICAL	GENE-Y	2	38	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T23	21926191
CPR:4	CHEMICAL	GENE-Y	2	40	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T24	21926191
CPR:4	CHEMICAL	GENE-Y	2	42	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T25	21926191
CPR:4	CHEMICAL	GENE-Y	2	45	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T4	T26	21926191
NA	CHEMICAL	GENE-N	33	5	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T18	21926191
NA	CHEMICAL	GENE-Y	33	13	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T19	21926191
NA	CHEMICAL	GENE-Y	33	15	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T20	21926191
NA	CHEMICAL	GENE-Y	33	17	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T21	21926191
NA	CHEMICAL	GENE-N	33	5	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T22	21926191
NA	CHEMICAL	GENE-Y	33	38	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T23	21926191
NA	CHEMICAL	GENE-Y	33	40	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T24	21926191
NA	CHEMICAL	GENE-Y	33	42	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T25	21926191
NA	CHEMICAL	GENE-Y	33	45	chemical ( chemical ) is a small-molecule gene inhibitor with potent activity toward gene and gene ( gene ) , as well as a number of other gene that have also been implicated in tumor pathobiology , including gene , gene , gene , and gene .	T5	T26	21926191
CPR:4	CHEMICAL	GENE-Y	2	4	Treatment with chemical inhibited gene and gene phosphorylation in vitro and in tumor models in vivo and led to significant reductions in cell invasion in vitro .	T6	T27	21926191
CPR:4	CHEMICAL	GENE-Y	2	6	Treatment with chemical inhibited gene and gene phosphorylation in vitro and in tumor models in vivo and led to significant reductions in cell invasion in vitro .	T6	T28	21926191
CPR:4	CHEMICAL	GENE-Y	4	25	Importantly , treatment with chemical did not increase lung tumor burden in an experimental model of metastasis , which has been observed with inhibitors of gene signaling that do not target gene .	T1	T10	21926191
NA	CHEMICAL	GENE-Y	4	31	Importantly , treatment with chemical did not increase lung tumor burden in an experimental model of metastasis , which has been observed with inhibitors of gene signaling that do not target gene .	T1	T11	21926191
NA	CHEMICAL	GENE-Y	3	4	Crystal structure of chemical dehydratase from rat liver .	T36	T52	14596599
NA	CHEMICAL	GENE-Y	14	0	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T27	T37	14596599
NA	CHEMICAL	GENE-Y	14	1	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T27	T46	14596599
NA	CHEMICAL	GENE-Y	14	3	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T27	T45	14596599
NA	CHEMICAL	GENE-Y	7	0	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T28	T37	14596599
NA	CHEMICAL	GENE-Y	7	1	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T28	T46	14596599
NA	CHEMICAL	GENE-Y	7	3	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T28	T45	14596599
NA	CHEMICAL	GENE-Y	9	0	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T31	T37	14596599
NA	CHEMICAL	GENE-Y	9	1	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T31	T46	14596599
NA	CHEMICAL	GENE-Y	9	3	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T31	T45	14596599
CPR:9	CHEMICAL	GENE-Y	7	0	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T2	T37	14596599
CPR:9	CHEMICAL	GENE-Y	7	1	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T2	T46	14596599
CPR:9	CHEMICAL	GENE-Y	7	3	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T2	T45	14596599
CPR:9	CHEMICAL	GENE-Y	19	0	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T8	T37	14596599
CPR:9	CHEMICAL	GENE-Y	19	1	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T8	T46	14596599
CPR:9	CHEMICAL	GENE-Y	19	3	gene gene , gene ) catalyzes the chemical ( chemical ) -dependent dehydration of chemical to yield chemical and chemical .	T8	T45	14596599
CPR:9	CHEMICAL	GENE-Y	2	4	Formation of chemical by gene is a two-step reaction in which the chemical group of chemical is cleaved to produce chemical , and then the chemical is deaminated by nonenzymatic hydrolysis to produce chemical .	T21	T44	14596599
NA	CHEMICAL	GENE-Y	12	4	Formation of chemical by gene is a two-step reaction in which the chemical group of chemical is cleaved to produce chemical , and then the chemical is deaminated by nonenzymatic hydrolysis to produce chemical .	T22	T44	14596599
NA	CHEMICAL	GENE-Y	9	4	Formation of chemical by gene is a two-step reaction in which the chemical group of chemical is cleaved to produce chemical , and then the chemical is deaminated by nonenzymatic hydrolysis to produce chemical .	T23	T44	14596599
CPR:9	CHEMICAL	GENE-Y	6	4	Formation of chemical by gene is a two-step reaction in which the chemical group of chemical is cleaved to produce chemical , and then the chemical is deaminated by nonenzymatic hydrolysis to produce chemical .	T24	T44	14596599
NA	CHEMICAL	GENE-Y	6	4	Formation of chemical by gene is a two-step reaction in which the chemical group of chemical is cleaved to produce chemical , and then the chemical is deaminated by nonenzymatic hydrolysis to produce chemical .	T25	T44	14596599
CPR:9	CHEMICAL	GENE-Y	6	4	Formation of chemical by gene is a two-step reaction in which the chemical group of chemical is cleaved to produce chemical , and then the chemical is deaminated by nonenzymatic hydrolysis to produce chemical .	T26	T44	14596599
NA	CHEMICAL	GENE-Y	4	1	The gene crystallized with chemical ( chemical ) was also determined at 2.6 A resolution by molecular replacement .	T29	T48	14596599
NA	CHEMICAL	GENE-Y	6	1	The gene crystallized with chemical ( chemical ) was also determined at 2.6 A resolution by molecular replacement .	T30	T48	14596599
NA	CHEMICAL	GENE-Y	4	1	The gene contained chemical-chemical chemical in the active site , indicating that OMS can form the chemical linkage with PLP , but the subsequent dehydration did not occur .	T32	T50	14596599
NA	CHEMICAL	GENE-Y	3	1	The gene contained chemical-chemical chemical in the active site , indicating that OMS can form the chemical linkage with PLP , but the subsequent dehydration did not occur .	T33	T50	14596599
NA	CHEMICAL	GENE-Y	16	1	The gene contained chemical-chemical chemical in the active site , indicating that OMS can form the chemical linkage with PLP , but the subsequent dehydration did not occur .	T34	T50	14596599
NA	CHEMICAL	GENE-Y	3	1	The gene contained chemical-chemical chemical in the active site , indicating that OMS can form the chemical linkage with PLP , but the subsequent dehydration did not occur .	T35	T50	14596599
NA	CHEMICAL	GENE-N	4	10	The chemical group of chemical is surrounded by a characteristic gene ( ( 168 ) chemical ( 172 ) ) and forms chemical bonds with the chemical groups of those chemical residues , suggesting that the phosphate group can be protonated .	T3	T39	14596599
NA	CHEMICAL	GENE-N	15	10	The chemical group of chemical is surrounded by a characteristic gene ( ( 168 ) chemical ( 172 ) ) and forms chemical bonds with the chemical groups of those chemical residues , suggesting that the phosphate group can be protonated .	T4	T39	14596599
NA	CHEMICAL	GENE-N	22	10	The chemical group of chemical is surrounded by a characteristic gene ( ( 168 ) chemical ( 172 ) ) and forms chemical bonds with the chemical groups of those chemical residues , suggesting that the phosphate group can be protonated .	T5	T39	14596599
NA	CHEMICAL	GENE-N	8	10	The chemical group of chemical is surrounded by a characteristic gene ( ( 168 ) chemical ( 172 ) ) and forms chemical bonds with the chemical groups of those chemical residues , suggesting that the phosphate group can be protonated .	T6	T39	14596599
NA	CHEMICAL	GENE-N	8	10	The chemical group of chemical is surrounded by a characteristic gene ( ( 168 ) chemical ( 172 ) ) and forms chemical bonds with the chemical groups of those chemical residues , suggesting that the phosphate group can be protonated .	T7	T39	14596599
NA	CHEMICAL	GENE-N	1	10	The chemical group of chemical is surrounded by a characteristic gene ( ( 168 ) chemical ( 172 ) ) and forms chemical bonds with the chemical groups of those chemical residues , suggesting that the phosphate group can be protonated .	T9	T39	14596599
NA	CHEMICAL	GENE-Y	5	8	These characteristics of the bound chemical suggest that gene catalysis is not facilitated by forming the resonance-stabilized structure of the chemical as seen in gene .	T16	T42	14596599
NA	CHEMICAL	GENE-N	5	11	These characteristics of the bound chemical suggest that gene catalysis is not facilitated by forming the resonance-stabilized structure of the chemical as seen in gene .	T16	T43	14596599
NA	CHEMICAL	GENE-Y	20	8	These characteristics of the bound chemical suggest that gene catalysis is not facilitated by forming the resonance-stabilized structure of the chemical as seen in gene .	T17	T42	14596599
NA	CHEMICAL	GENE-N	20	11	These characteristics of the bound chemical suggest that gene catalysis is not facilitated by forming the resonance-stabilized structure of the chemical as seen in gene .	T17	T43	14596599
NA	CHEMICAL	GENE-Y	8	3	We observed that gene drives the evasion of reactive-chemical stress-induced melanocyte senescence , caused by activated gene signaling .	T3	T20	23353821
NA	CHEMICAL	GENE-N	8	16	We observed that gene drives the evasion of reactive-chemical stress-induced melanocyte senescence , caused by activated gene signaling .	T3	T21	23353821
NA	CHEMICAL	GENE-Y	14	2	Both , gene overexpression and gene knockdown led to a strong reduction of endogenous reactive-chemical species ( ROS ) , DNA damage and senescence .	T1	T24	23353821
NA	CHEMICAL	GENE-Y	14	5	Both , gene overexpression and gene knockdown led to a strong reduction of endogenous reactive-chemical species ( ROS ) , DNA damage and senescence .	T1	T25	23353821
NA	CHEMICAL	GENE-Y	30	5	Importantly , pharmacological inhibition of gene in human melanoma cells also reconstituted senescence in the majority of cell lines , and gene knockdown reduced tumorigenic effects such as proliferation , chemical resistance and soft agar growth .	T2	T12	23353821
NA	CHEMICAL	GENE-Y	30	21	Importantly , pharmacological inhibition of gene in human melanoma cells also reconstituted senescence in the majority of cell lines , and gene knockdown reduced tumorigenic effects such as proliferation , chemical resistance and soft agar growth .	T2	T13	23353821
CPR:4	CHEMICAL	GENE-N	9	7	Reduction of cerebral infarct size by the gene-receptor blocker chemical , the chemical reductase inhibitor chemical and their combination .	T23	T30	16901636
NA	CHEMICAL	GENE-Y	9	13	Reduction of cerebral infarct size by the gene-receptor blocker chemical , the chemical reductase inhibitor chemical and their combination .	T23	T31	16901636
NA	CHEMICAL	GENE-N	12	7	Reduction of cerebral infarct size by the gene-receptor blocker chemical , the chemical reductase inhibitor chemical and their combination .	T24	T30	16901636
NA	CHEMICAL	GENE-Y	12	13	Reduction of cerebral infarct size by the gene-receptor blocker chemical , the chemical reductase inhibitor chemical and their combination .	T24	T31	16901636
NA	CHEMICAL	GENE-N	15	7	Reduction of cerebral infarct size by the gene-receptor blocker chemical , the chemical reductase inhibitor chemical and their combination .	T22	T30	16901636
CPR:4	CHEMICAL	GENE-Y	15	13	Reduction of cerebral infarct size by the gene-receptor blocker chemical , the chemical reductase inhibitor chemical and their combination .	T22	T31	16901636
CPR:4	CHEMICAL	GENE-N	16	14	Our purpose was to test the impact of single and/or combined treatment with the gene-receptor blocker chemical and the chemical reductase inhibitor chemical on infarct size and neuroscore in transient cerebral ischemia in rats .	T1	T29	16901636
NA	CHEMICAL	GENE-Y	16	20	Our purpose was to test the impact of single and/or combined treatment with the gene-receptor blocker chemical and the chemical reductase inhibitor chemical on infarct size and neuroscore in transient cerebral ischemia in rats .	T1	T25	16901636
NA	CHEMICAL	GENE-N	19	14	Our purpose was to test the impact of single and/or combined treatment with the gene-receptor blocker chemical and the chemical reductase inhibitor chemical on infarct size and neuroscore in transient cerebral ischemia in rats .	T3	T29	16901636
NA	CHEMICAL	GENE-Y	19	20	Our purpose was to test the impact of single and/or combined treatment with the gene-receptor blocker chemical and the chemical reductase inhibitor chemical on infarct size and neuroscore in transient cerebral ischemia in rats .	T3	T25	16901636
NA	CHEMICAL	GENE-N	22	14	Our purpose was to test the impact of single and/or combined treatment with the gene-receptor blocker chemical and the chemical reductase inhibitor chemical on infarct size and neuroscore in transient cerebral ischemia in rats .	T8	T29	16901636
CPR:4	CHEMICAL	GENE-Y	22	20	Our purpose was to test the impact of single and/or combined treatment with the gene-receptor blocker chemical and the chemical reductase inhibitor chemical on infarct size and neuroscore in transient cerebral ischemia in rats .	T8	T25	16901636
NA	CHEMICAL	GENE-Y	0	14	chemical was used to test whether any potential effect was due to activation of gene ( gene ) .	T12	T27	16901636
NA	CHEMICAL	GENE-Y	0	16	chemical was used to test whether any potential effect was due to activation of gene ( gene ) .	T12	T28	16901636
NA	CHEMICAL	GENE-Y	13	11	The present study investigates enzyme activities of the urea cycle , gene and chemical-chemical inter-conversion in the hypertrophied kidney after unilateral nephrectomy in mice .	T4	T10	11691635
NA	CHEMICAL	GENE-Y	13	11	The present study investigates enzyme activities of the urea cycle , gene and chemical-chemical inter-conversion in the hypertrophied kidney after unilateral nephrectomy in mice .	T5	T10	11691635
NA	CHEMICAL	GENE-Y	5	6	The specific activity of only chemical aminotransferase ( gene ) , the rate-limiting enzyme in the conversion of chemical to chemical , increased in 2 weeks of hypertrophy .	T1	T8	11691635
NA	CHEMICAL	GENE-Y	5	8	The specific activity of only chemical aminotransferase ( gene ) , the rate-limiting enzyme in the conversion of chemical to chemical , increased in 2 weeks of hypertrophy .	T1	T9	11691635
CPR:9	CHEMICAL	GENE-Y	14	6	The specific activity of only chemical aminotransferase ( gene ) , the rate-limiting enzyme in the conversion of chemical to chemical , increased in 2 weeks of hypertrophy .	T2	T8	11691635
CPR:9	CHEMICAL	GENE-Y	14	8	The specific activity of only chemical aminotransferase ( gene ) , the rate-limiting enzyme in the conversion of chemical to chemical , increased in 2 weeks of hypertrophy .	T2	T9	11691635
CPR:9	CHEMICAL	GENE-Y	14	6	The specific activity of only chemical aminotransferase ( gene ) , the rate-limiting enzyme in the conversion of chemical to chemical , increased in 2 weeks of hypertrophy .	T3	T8	11691635
CPR:9	CHEMICAL	GENE-Y	14	8	The specific activity of only chemical aminotransferase ( gene ) , the rate-limiting enzyme in the conversion of chemical to chemical , increased in 2 weeks of hypertrophy .	T3	T9	11691635
CPR:4	CHEMICAL	GENE-N	5	7	Investigating the enteroenteric recirculation of chemical , a gene inhibitor : administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats .	T15	T26	23386703
NA	CHEMICAL	GENE-Y	19	5	Additionally , the role of gene ( gene ; gene ) and gene ( gene ; gene ) in chemical disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .	T12	T20	23386703
NA	CHEMICAL	GENE-Y	19	7	Additionally , the role of gene ( gene ; gene ) and gene ( gene ; gene ) in chemical disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .	T12	T21	23386703
NA	CHEMICAL	GENE-Y	19	9	Additionally , the role of gene ( gene ; gene ) and gene ( gene ; gene ) in chemical disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .	T12	T22	23386703
NA	CHEMICAL	GENE-Y	19	12	Additionally , the role of gene ( gene ; gene ) and gene ( gene ; gene ) in chemical disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .	T12	T23	23386703
NA	CHEMICAL	GENE-Y	19	14	Additionally , the role of gene ( gene ; gene ) and gene ( gene ; gene ) in chemical disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .	T12	T24	23386703
NA	CHEMICAL	GENE-Y	19	16	Additionally , the role of gene ( gene ; gene ) and gene ( gene ; gene ) in chemical disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .	T12	T25	23386703
NA	CHEMICAL	GENE-Y	10	34	The fecal elimination , IC , and systemic clearance of chemical were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with chemical , a dual gene and gene inhibitor ) .	T14	T16	23386703
NA	CHEMICAL	GENE-N	10	36	The fecal elimination , IC , and systemic clearance of chemical were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with chemical , a dual gene and gene inhibitor ) .	T14	T17	23386703
CPR:4	CHEMICAL	GENE-Y	10	34	The fecal elimination , IC , and systemic clearance of chemical were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with chemical , a dual gene and gene inhibitor ) .	T1	T16	23386703
CPR:4	CHEMICAL	GENE-N	10	36	The fecal elimination , IC , and systemic clearance of chemical were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with chemical , a dual gene and gene inhibitor ) .	T1	T17	23386703
CPR:9	CHEMICAL	GENE-Y	4	0	gene appeared to play a more important role for absorption and intestinal and renal elimination of chemical than gene in transporter-KO rats after oral and i.v .	T2	T18	23386703
CPR:9	CHEMICAL	GENE-N	4	18	gene appeared to play a more important role for absorption and intestinal and renal elimination of chemical than gene in transporter-KO rats after oral and i.v .	T2	T19	23386703
NA	CHEMICAL	GENE-N	3	11	Immunoregulatory effects of chemical exerts anti-asthmatic effects via modulation of Th1/Th2 gene and enhancement of CD4 ( + ) CD25 ( + ) Foxp3 ( + ) regulatory T cells in gene-sensitized mice .	T6	T17	23632310
NA	CHEMICAL	GENE-Y	3	30	Immunoregulatory effects of chemical exerts anti-asthmatic effects via modulation of Th1/Th2 gene and enhancement of CD4 ( + ) CD25 ( + ) Foxp3 ( + ) regulatory T cells in gene-sensitized mice .	T6	T18	23632310
NA	CHEMICAL	GENE-N	19	30	Airway resistance ( Raw ) were measured by the forced oscillation technique , histological studies were evaluated by The chemical and chemical ( HE ) staining , Th1/Th2 and Th17 gene were evaluated by enzyme-linked immunosorbent assay ( ELISA ) , and CD4 ( + ) CD25 ( + ) gene ( + ) regulatory T cells ( Tregs ) was evaluated by Flow Cytometry ( FCM ) , the gene ( Foxp3 ) was evaluated by western blotting .	T4	T14	23632310
NA	CHEMICAL	GENE-Y	19	50	Airway resistance ( Raw ) were measured by the forced oscillation technique , histological studies were evaluated by The chemical and chemical ( HE ) staining , Th1/Th2 and Th17 gene were evaluated by enzyme-linked immunosorbent assay ( ELISA ) , and CD4 ( + ) CD25 ( + ) gene ( + ) regulatory T cells ( Tregs ) was evaluated by Flow Cytometry ( FCM ) , the gene ( Foxp3 ) was evaluated by western blotting .	T4	T16	23632310
NA	CHEMICAL	GENE-N	21	30	Airway resistance ( Raw ) were measured by the forced oscillation technique , histological studies were evaluated by The chemical and chemical ( HE ) staining , Th1/Th2 and Th17 gene were evaluated by enzyme-linked immunosorbent assay ( ELISA ) , and CD4 ( + ) CD25 ( + ) gene ( + ) regulatory T cells ( Tregs ) was evaluated by Flow Cytometry ( FCM ) , the gene ( Foxp3 ) was evaluated by western blotting .	T5	T14	23632310
NA	CHEMICAL	GENE-Y	21	50	Airway resistance ( Raw ) were measured by the forced oscillation technique , histological studies were evaluated by The chemical and chemical ( HE ) staining , Th1/Th2 and Th17 gene were evaluated by enzyme-linked immunosorbent assay ( ELISA ) , and CD4 ( + ) CD25 ( + ) gene ( + ) regulatory T cells ( Tregs ) was evaluated by Flow Cytometry ( FCM ) , the gene ( Foxp3 ) was evaluated by western blotting .	T5	T16	23632310
NA	CHEMICAL	GENE-Y	3	13	Metabolic derangement of chemical and chemical metabolism in mice deficient in chemical synthase reductase .	T26	T38	17369066
NA	CHEMICAL	GENE-Y	5	13	Metabolic derangement of chemical and chemical metabolism in mice deficient in chemical synthase reductase .	T27	T38	17369066
NA	CHEMICAL	GENE-Y	7	13	Metabolic derangement of chemical and chemical metabolism in mice deficient in chemical synthase reductase .	T28	T38	17369066
NA	CHEMICAL	GENE-Y	3	4	In humans , chemical synthase deficiency results in the accumulation of chemical at the expense of chemical derivatives required for chemical and chemical biosynthesis .	T13	T32	17369066
CPR:9	CHEMICAL	GENE-Y	10	4	In humans , chemical synthase deficiency results in the accumulation of chemical at the expense of chemical derivatives required for chemical and chemical biosynthesis .	T14	T32	17369066
NA	CHEMICAL	GENE-Y	12	4	In humans , chemical synthase deficiency results in the accumulation of chemical at the expense of chemical derivatives required for chemical and chemical biosynthesis .	T15	T32	17369066
NA	CHEMICAL	GENE-Y	7	4	In humans , chemical synthase deficiency results in the accumulation of chemical at the expense of chemical derivatives required for chemical and chemical biosynthesis .	T16	T32	17369066
NA	CHEMICAL	GENE-Y	12	4	In humans , chemical synthase deficiency results in the accumulation of chemical at the expense of chemical derivatives required for chemical and chemical biosynthesis .	T17	T32	17369066
NA	CHEMICAL	GENE-Y	3	4	Complete ablation of chemical synthase activity in mice results in embryonic lethality .	T18	T33	17369066
NA	CHEMICAL	GENE-Y	11	13	We have constructed a mouse model with a gene trap insertion in the gene gene specifying chemical synthase reductase , an enzyme essential for the activity of chemical synthase .	T22	T34	17369066
NA	CHEMICAL	GENE-Y	11	3	We have constructed a mouse model with a gene trap insertion in the gene gene specifying chemical synthase reductase , an enzyme essential for the activity of chemical synthase .	T22	T35	17369066
NA	CHEMICAL	GENE-Y	11	3	We have constructed a mouse model with a gene trap insertion in the gene gene specifying chemical synthase reductase , an enzyme essential for the activity of chemical synthase .	T22	T36	17369066
NA	CHEMICAL	GENE-Y	11	13	We have constructed a mouse model with a gene trap insertion in the gene gene specifying chemical synthase reductase , an enzyme essential for the activity of chemical synthase .	T23	T34	17369066
NA	CHEMICAL	GENE-Y	11	3	We have constructed a mouse model with a gene trap insertion in the gene gene specifying chemical synthase reductase , an enzyme essential for the activity of chemical synthase .	T23	T35	17369066
NA	CHEMICAL	GENE-Y	11	3	We have constructed a mouse model with a gene trap insertion in the gene gene specifying chemical synthase reductase , an enzyme essential for the activity of chemical synthase .	T23	T36	17369066
NA	CHEMICAL	GENE-Y	8	3	This model is a hypomorph , with reduced chemical synthase reductase activity , thus avoiding the lethality associated with the absence of chemical synthase activity .	T25	T37	17369066
NA	CHEMICAL	GENE-Y	8	3	This model is a hypomorph , with reduced chemical synthase reductase activity , thus avoiding the lethality associated with the absence of chemical synthase activity .	T25	T29	17369066
NA	CHEMICAL	GENE-Y	22	3	This model is a hypomorph , with reduced chemical synthase reductase activity , thus avoiding the lethality associated with the absence of chemical synthase activity .	T1	T37	17369066
NA	CHEMICAL	GENE-Y	22	3	This model is a hypomorph , with reduced chemical synthase reductase activity , thus avoiding the lethality associated with the absence of chemical synthase activity .	T1	T29	17369066
NA	CHEMICAL	GENE-Y	1	0	gene ( gt/gt ) mice have increased plasma chemical , decreased plasma chemical , and increased tissue chemical .	T2	T30	17369066
NA	CHEMICAL	GENE-Y	0	0	gene ( gt/gt ) mice have increased plasma chemical , decreased plasma chemical , and increased tissue chemical .	T3	T30	17369066
NA	CHEMICAL	GENE-Y	17	0	gene ( gt/gt ) mice have increased plasma chemical , decreased plasma chemical , and increased tissue chemical .	T4	T30	17369066
NA	CHEMICAL	GENE-Y	7	2	Unexpectedly , gene ( gt/gt ) mice do not show decreases in the chemical/chemical ratio in most tissues .	T6	T31	17369066
NA	CHEMICAL	GENE-Y	7	2	Unexpectedly , gene ( gt/gt ) mice do not show decreases in the chemical/chemical ratio in most tissues .	T7	T31	17369066
NA	CHEMICAL	GENE-Y	2	5	Effects of chemical deficiency and gene gene polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes .	T19	T28	16950805
NA	CHEMICAL	GENE-N	2	6	Effects of chemical deficiency and gene gene polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes .	T19	T29	16950805
NA	CHEMICAL	GENE-N	3	1	The gene polymorphism of the chemical reductase ( gene ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on chemical status .	T14	T24	16950805
NA	CHEMICAL	GENE-Y	3	6	The gene polymorphism of the chemical reductase ( gene ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on chemical status .	T14	T25	16950805
NA	CHEMICAL	GENE-Y	3	8	The gene polymorphism of the chemical reductase ( gene ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on chemical status .	T14	T26	16950805
NA	CHEMICAL	GENE-N	14	1	The gene polymorphism of the chemical reductase ( gene ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on chemical status .	T15	T24	16950805
NA	CHEMICAL	GENE-Y	14	6	The gene polymorphism of the chemical reductase ( gene ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on chemical status .	T15	T25	16950805
NA	CHEMICAL	GENE-Y	14	8	The gene polymorphism of the chemical reductase ( gene ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on chemical status .	T15	T26	16950805
NA	CHEMICAL	GENE-Y	6	24	In this work the effect of chemical deficiency on genome stability and radiosensitivity has been investigated in cultured lymphocytes of 12 subjects with different gene genotype ( four for each genotype ) .	T16	T27	16950805
NA	CHEMICAL	GENE-Y	5	20	The results obtained indicate that chemical deficiency induces to a comparable extent chromosome loss and breakage , irrespective of the gene genotype .	T2	T20	16950805
NA	CHEMICAL	GENE-Y	10	30	Also nucleoplasmic bridges and buds were significantly increased under low chemical supply ; the increase in bridges was mainly observed in TT cells , highlighting a significant effect of the gene genotype ( P = 0.006 ) on this biomarker .	T6	T21	16950805
NA	CHEMICAL	GENE-Y	0	30	chemical concentration significantly affected radiation-induced micronuclei ( P < 0.001 ) : the increased incidence of radiation-induced micronuclei with low chemical was mainly accounted for by carriers of the variant gene allele ( both homozygotes and heterozygotes ) , but the overall effect of genotype did not attain statistical significance .	T7	T22	16950805
NA	CHEMICAL	GENE-Y	20	30	chemical concentration significantly affected radiation-induced micronuclei ( P < 0.001 ) : the increased incidence of radiation-induced micronuclei with low chemical was mainly accounted for by carriers of the variant gene allele ( both homozygotes and heterozygotes ) , but the overall effect of genotype did not attain statistical significance .	T8	T22	16950805
NA	CHEMICAL	GENE-Y	3	12	The effect of chemical level on this end-point was modulated by the gene genotype ( P for interaction = 0.02 ) , with TT cells grown at low chemical concentration apparently resistant to the induction of radiation-induced bridges .	T10	T23	16950805
NA	CHEMICAL	GENE-Y	28	12	The effect of chemical level on this end-point was modulated by the gene genotype ( P for interaction = 0.02 ) , with TT cells grown at low chemical concentration apparently resistant to the induction of radiation-induced bridges .	T11	T23	16950805
NA	CHEMICAL	GENE-N	11	6	Antidepressants suppress production of the Th1 gene gene , independent of chemical transporter blockade .	T17	T39	16388933
NA	CHEMICAL	GENE-Y	11	7	Antidepressants suppress production of the Th1 gene gene , independent of chemical transporter blockade .	T17	T40	16388933
NA	CHEMICAL	GENE-N	11	12	Antidepressants suppress production of the Th1 gene gene , independent of chemical transporter blockade .	T17	T41	16388933
NA	CHEMICAL	GENE-Y	9	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T12	T30	16388933
NA	CHEMICAL	GENE-Y	9	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T12	T20	16388933
NA	CHEMICAL	GENE-N	9	28	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T12	T25	16388933
NA	CHEMICAL	GENE-Y	12	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T14	T30	16388933
NA	CHEMICAL	GENE-Y	12	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T14	T20	16388933
NA	CHEMICAL	GENE-N	12	28	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T14	T25	16388933
NA	CHEMICAL	GENE-Y	14	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T16	T30	16388933
NA	CHEMICAL	GENE-Y	14	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T16	T20	16388933
NA	CHEMICAL	GENE-N	14	28	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T16	T25	16388933
NA	CHEMICAL	GENE-Y	19	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T2	T30	16388933
NA	CHEMICAL	GENE-Y	19	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T2	T20	16388933
NA	CHEMICAL	GENE-N	19	28	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T2	T25	16388933
NA	CHEMICAL	GENE-Y	22	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T4	T30	16388933
NA	CHEMICAL	GENE-Y	22	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T4	T20	16388933
NA	CHEMICAL	GENE-N	22	28	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T4	T25	16388933
NA	CHEMICAL	GENE-Y	24	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T8	T30	16388933
NA	CHEMICAL	GENE-Y	24	10	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T8	T20	16388933
NA	CHEMICAL	GENE-N	24	28	In this study , antidepressants with selectivity for the chemical transporter ( chemical and chemical ) , or the chemical transporter ( chemical and chemical ) were examined in terms of their ability to promote an anti-inflammatory gene phenotype in human blood .	T8	T25	16388933
NA	CHEMICAL	GENE-N	8	22	In addition , we examined the ability of chemical ; a chemical antidepressant that is devoid of chemical reuptake inhibitory properties on gene production .	T9	T26	16388933
NA	CHEMICAL	GENE-N	11	22	In addition , we examined the ability of chemical ; a chemical antidepressant that is devoid of chemical reuptake inhibitory properties on gene production .	T10	T26	16388933
NA	CHEMICAL	GENE-N	10	22	In addition , we examined the ability of chemical ; a chemical antidepressant that is devoid of chemical reuptake inhibitory properties on gene production .	T11	T26	16388933
NA	CHEMICAL	GENE-Y	7	5	All of the antidepressants suppressed gene production in the 10-50 microM concentration range , irrespective of their preference for chemical or chemical transporters .	T13	T36	16388933
NA	CHEMICAL	GENE-N	7	20	All of the antidepressants suppressed gene production in the 10-50 microM concentration range , irrespective of their preference for chemical or chemical transporters .	T13	T37	16388933
NA	CHEMICAL	GENE-Y	7	5	All of the antidepressants suppressed gene production in the 10-50 microM concentration range , irrespective of their preference for chemical or chemical transporters .	T15	T36	16388933
NA	CHEMICAL	GENE-N	7	20	All of the antidepressants suppressed gene production in the 10-50 microM concentration range , irrespective of their preference for chemical or chemical transporters .	T15	T37	16388933
CPR:4	CHEMICAL	GENE-Y	3	6	The fact that chemical also suppressed gene production and T-cell proliferation indicates that these immunomodulatory actions of antidepressants are most likely unrelated to inhibition of chemical reuptake .	T1	T19	16388933
NA	CHEMICAL	GENE-Y	25	6	The fact that chemical also suppressed gene production and T-cell proliferation indicates that these immunomodulatory actions of antidepressants are most likely unrelated to inhibition of chemical reuptake .	T3	T19	16388933
NA	CHEMICAL	GENE-Y	4	8	Interestingly , exposure to a lower concentration ( 1 microM ) of the antidepressants tended to increase T-cell-derived gene production , with significant effects elicited by the chemical reuptake inhibitors chemical and chemical .	T5	T21	16388933
NA	CHEMICAL	GENE-Y	30	8	Interestingly , exposure to a lower concentration ( 1 microM ) of the antidepressants tended to increase T-cell-derived gene production , with significant effects elicited by the chemical reuptake inhibitors chemical and chemical .	T6	T21	16388933
NA	CHEMICAL	GENE-Y	4	8	Interestingly , exposure to a lower concentration ( 1 microM ) of the antidepressants tended to increase T-cell-derived gene production , with significant effects elicited by the chemical reuptake inhibitors chemical and chemical .	T7	T21	16388933
NA	CHEMICAL	GENE-N	8	2	Loss of gene response in myocytes overexpressing the chemical/chemical-exchanger .	T7	T30	14734046
NA	CHEMICAL	GENE-N	8	2	Loss of gene response in myocytes overexpressing the chemical/chemical-exchanger .	T8	T30	14734046
NA	CHEMICAL	GENE-N	1	2	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T1	T9	14734046
NA	CHEMICAL	GENE-N	1	3	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T1	T13	14734046
NA	CHEMICAL	GENE-N	1	7	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T1	T16	14734046
NA	CHEMICAL	GENE-N	1	9	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T1	T20	14734046
NA	CHEMICAL	GENE-N	1	2	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T2	T9	14734046
NA	CHEMICAL	GENE-N	1	3	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T2	T13	14734046
NA	CHEMICAL	GENE-N	1	7	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T2	T16	14734046
NA	CHEMICAL	GENE-N	1	9	Increased chemical/chemical-exchanger ( gene ) and altered gene ( gene ) responses are observed in failing human heart .	T2	T20	14734046
NA	CHEMICAL	GENE-Y	2	8	Responses to chemical were largely mediated through the gene in control myocytes .	T3	T14	14734046
NA	CHEMICAL	GENE-N	20	3	Adenovirally-mediated overexpression of gene , at levels , which did not alter basal contraction of myocytes , markedly depressed the chemical concentration-response curve .	T4	T15	14734046
NA	CHEMICAL	GENE-Y	2	4	Responses to chemical could be restored to normal by gene blockade , suggesting a gene-mediated inhibition of gene signalling .	T5	T17	14734046
NA	CHEMICAL	GENE-Y	2	4	Responses to chemical could be restored to normal by gene blockade , suggesting a gene-mediated inhibition of gene signalling .	T5	T18	14734046
NA	CHEMICAL	GENE-Y	2	4	Responses to chemical could be restored to normal by gene blockade , suggesting a gene-mediated inhibition of gene signalling .	T5	T19	14734046
NA	CHEMICAL	GENE-N	2	0	gene normalised chemical responses in gene cells , indicating that gene effects were mediated by gene .	T6	T21	14734046
NA	CHEMICAL	GENE-N	2	5	gene normalised chemical responses in gene cells , indicating that gene effects were mediated by gene .	T6	T22	14734046
NA	CHEMICAL	GENE-Y	2	10	gene normalised chemical responses in gene cells , indicating that gene effects were mediated by gene .	T6	T23	14734046
NA	CHEMICAL	GENE-N	2	15	gene normalised chemical responses in gene cells , indicating that gene effects were mediated by gene .	T6	T24	14734046
NA	CHEMICAL	GENE-Y	0	1	chemical transporter gene regulatory region polymorphism ( gene ) , chemical binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity .	T24	T35	10980326
NA	CHEMICAL	GENE-Y	0	7	chemical transporter gene regulatory region polymorphism ( gene ) , chemical binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity .	T24	T36	10980326
NA	CHEMICAL	GENE-Y	10	1	chemical transporter gene regulatory region polymorphism ( gene ) , chemical binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity .	T25	T35	10980326
NA	CHEMICAL	GENE-Y	10	7	chemical transporter gene regulatory region polymorphism ( gene ) , chemical binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity .	T25	T36	10980326
NA	CHEMICAL	GENE-Y	8	21	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T17	T27	10980326
NA	CHEMICAL	GENE-Y	8	27	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T17	T28	10980326
NA	CHEMICAL	GENE-Y	8	31	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T17	T30	10980326
NA	CHEMICAL	GENE-Y	13	21	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T22	T27	10980326
NA	CHEMICAL	GENE-Y	13	27	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T22	T28	10980326
NA	CHEMICAL	GENE-Y	13	31	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T22	T30	10980326
NA	CHEMICAL	GENE-Y	6	21	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T6	T27	10980326
NA	CHEMICAL	GENE-Y	6	27	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T6	T28	10980326
NA	CHEMICAL	GENE-Y	6	31	The aim of this study was to investigate chemical binding and impulsivity in chemical-dependent and age-matched control subjects in relation to a 5'-promoter region chemical transporter ( gene ) polymorphism ( gene ) .	T6	T30	10980326
NA	CHEMICAL	GENE-Y	5	0	gene S-genotype carriers in both chemical-dependent and control subjects were expected to show significantly fewer binding sites and a lower dissociation constant .	T16	T34	10980326
NA	CHEMICAL	GENE-Y	6	12	Blood samples were taken from both chemical-dependent and control subjects to determine gene genotypes using PCR of lymphocyte DNA , and to perform platelet chemical binding ( binding capacity : B ( max ) ; and dissociation constant : K ( D ) ) .	T23	T26	10980326
NA	CHEMICAL	GENE-Y	24	12	Blood samples were taken from both chemical-dependent and control subjects to determine gene genotypes using PCR of lymphocyte DNA , and to perform platelet chemical binding ( binding capacity : B ( max ) ; and dissociation constant : K ( D ) ) .	T1	T26	10980326
NA	CHEMICAL	GENE-Y	8	20	This was the first study to investigate platelet chemical binding in chemical-dependent and age-matched control subjects in relation to the gene genotype .	T10	T31	10980326
NA	CHEMICAL	GENE-Y	11	20	This was the first study to investigate platelet chemical binding in chemical-dependent and age-matched control subjects in relation to the gene genotype .	T11	T31	10980326
NA	CHEMICAL	GENE-Y	22	3	No differences concerning gene-alleles were found in these groups Furthermore , no significant interaction between these parameters and impulsivity was shown in chemical-dependent subjects .	T12	T32	10980326
NA	CHEMICAL	GENE-Y	9	16	These results do not support previous results of altered chemical binding sites in alcohol-dependent subjects or gene S-allele carriers .	T13	T33	10980326
NA	CHEMICAL	GENE-Y	46	9	In early pregnancy , there were no significant differences in gene sensitivity ( gene sensitivity index derived from OGTT [ ISOGTT ] and homeostasis model assessment for gene resistance [ HOMA-IR ] ) and gene secretion ( a ratio of the total area-under-the-gene-curve to the total area-under-the-chemical-curve [ AUCins/glu ] and insulinogenic index [ IGI ] ) between the NGT and late-onset GDM groups .	T4	T10	23292170
NA	CHEMICAL	GENE-Y	46	9	In early pregnancy , there were no significant differences in gene sensitivity ( gene sensitivity index derived from OGTT [ ISOGTT ] and homeostasis model assessment for gene resistance [ HOMA-IR ] ) and gene secretion ( a ratio of the total area-under-the-gene-curve to the total area-under-the-chemical-curve [ AUCins/glu ] and insulinogenic index [ IGI ] ) between the NGT and late-onset GDM groups .	T4	T11	23292170
NA	CHEMICAL	GENE-Y	46	9	In early pregnancy , there were no significant differences in gene sensitivity ( gene sensitivity index derived from OGTT [ ISOGTT ] and homeostasis model assessment for gene resistance [ HOMA-IR ] ) and gene secretion ( a ratio of the total area-under-the-gene-curve to the total area-under-the-chemical-curve [ AUCins/glu ] and insulinogenic index [ IGI ] ) between the NGT and late-onset GDM groups .	T4	T12	23292170
NA	CHEMICAL	GENE-Y	46	9	In early pregnancy , there were no significant differences in gene sensitivity ( gene sensitivity index derived from OGTT [ ISOGTT ] and homeostasis model assessment for gene resistance [ HOMA-IR ] ) and gene secretion ( a ratio of the total area-under-the-gene-curve to the total area-under-the-chemical-curve [ AUCins/glu ] and insulinogenic index [ IGI ] ) between the NGT and late-onset GDM groups .	T4	T13	23292170
NA	CHEMICAL	GENE-Y	46	9	In early pregnancy , there were no significant differences in gene sensitivity ( gene sensitivity index derived from OGTT [ ISOGTT ] and homeostasis model assessment for gene resistance [ HOMA-IR ] ) and gene secretion ( a ratio of the total area-under-the-gene-curve to the total area-under-the-chemical-curve [ AUCins/glu ] and insulinogenic index [ IGI ] ) between the NGT and late-onset GDM groups .	T4	T14	23292170
CPR:3	CHEMICAL	GENE-Y	0	2	chemical induces gene production in human peripheral blood mononuclear cells .	T14	T35	15936988
NA	CHEMICAL	GENE-Y	12	16	The effects of statins on immune response depend on the inhibition of chemical ( chemical ) reductase and gene , which is a ligand of gene .	T9	T27	15936988
NA	CHEMICAL	GENE-Y	12	13	The effects of statins on immune response depend on the inhibition of chemical ( chemical ) reductase and gene , which is a ligand of gene .	T9	T16	15936988
NA	CHEMICAL	GENE-Y	12	13	The effects of statins on immune response depend on the inhibition of chemical ( chemical ) reductase and gene , which is a ligand of gene .	T9	T17	15936988
NA	CHEMICAL	GENE-Y	14	16	The effects of statins on immune response depend on the inhibition of chemical ( chemical ) reductase and gene , which is a ligand of gene .	T4	T27	15936988
NA	CHEMICAL	GENE-Y	14	13	The effects of statins on immune response depend on the inhibition of chemical ( chemical ) reductase and gene , which is a ligand of gene .	T4	T16	15936988
NA	CHEMICAL	GENE-Y	14	13	The effects of statins on immune response depend on the inhibition of chemical ( chemical ) reductase and gene , which is a ligand of gene .	T4	T17	15936988
CPR:4	CHEMICAL	GENE-Y	0	4	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T5	T18	15936988
CPR:4	CHEMICAL	GENE-Y	0	10	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T5	T19	15936988
CPR:3	CHEMICAL	GENE-Y	0	16	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T5	T20	15936988
CPR:3	CHEMICAL	GENE-Y	0	18	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T5	T21	15936988
CPR:3	CHEMICAL	GENE-Y	0	20	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T5	T22	15936988
NA	CHEMICAL	GENE-Y	3	4	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T6	T18	15936988
NA	CHEMICAL	GENE-Y	3	10	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T6	T19	15936988
NA	CHEMICAL	GENE-Y	3	16	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T6	T20	15936988
NA	CHEMICAL	GENE-Y	3	18	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T6	T21	15936988
NA	CHEMICAL	GENE-Y	3	20	chemical , an chemical reductase inhibitor with mild inhibition of gene , induced the production of gene , gene and gene in human peripheral blood mononuclear cells ( PBMC ) .	T6	T22	15936988
CPR:3	CHEMICAL	GENE-Y	12	1	The gene production is located upstream of the gene cascade activated by chemical .	T7	T23	15936988
CPR:3	CHEMICAL	GENE-N	12	8	The gene production is located upstream of the gene cascade activated by chemical .	T7	T24	15936988
CPR:4	CHEMICAL	GENE-Y	2	8	Moreover , chemical concentration-dependently inhibited the expression of gene and induced the expression of gene on monocytes .	T8	T25	15936988
CPR:3	CHEMICAL	GENE-Y	2	14	Moreover , chemical concentration-dependently inhibited the expression of gene and induced the expression of gene on monocytes .	T8	T26	15936988
NA	CHEMICAL	GENE-Y	6	4	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T10	T28	15936988
CPR:4	CHEMICAL	GENE-Y	6	11	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T10	T29	15936988
CPR:4	CHEMICAL	GENE-Y	6	13	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T10	T30	15936988
CPR:3	CHEMICAL	GENE-N	6	20	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T10	T31	15936988
CPR:3	CHEMICAL	GENE-Y	6	22	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T10	T32	15936988
CPR:3	CHEMICAL	GENE-Y	6	24	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T10	T33	15936988
NA	CHEMICAL	GENE-Y	14	4	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T11	T28	15936988
NA	CHEMICAL	GENE-Y	14	11	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T11	T29	15936988
NA	CHEMICAL	GENE-Y	14	13	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T11	T30	15936988
NA	CHEMICAL	GENE-N	14	20	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T11	T31	15936988
NA	CHEMICAL	GENE-Y	14	22	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T11	T32	15936988
NA	CHEMICAL	GENE-Y	14	24	In the presence of gene , chemical suppressed the expression of gene and gene as well as the production of gene , gene and gene in PBMC , contributing to the anti-inflammatory effect of chemical .	T11	T33	15936988
NA	CHEMICAL	GENE-Y	27	4	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T5	T17	17660958
NA	CHEMICAL	GENE-Y	27	4	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T5	T18	17660958
NA	CHEMICAL	GENE-Y	27	19	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T5	T19	17660958
NA	CHEMICAL	GENE-Y	27	19	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T5	T20	17660958
NA	CHEMICAL	GENE-Y	29	4	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T6	T17	17660958
NA	CHEMICAL	GENE-Y	29	4	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T6	T18	17660958
NA	CHEMICAL	GENE-Y	29	19	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T6	T19	17660958
NA	CHEMICAL	GENE-Y	29	19	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T6	T20	17660958
NA	CHEMICAL	GENE-Y	32	4	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T7	T17	17660958
NA	CHEMICAL	GENE-Y	32	4	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T7	T18	17660958
NA	CHEMICAL	GENE-Y	32	19	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T7	T19	17660958
NA	CHEMICAL	GENE-Y	32	19	A humanized antibody to gene/gene , trastuzumab , is now FDA approved for the treatment of early stage , gene/gene overexpressing breast cancer sequenced with chemotherapy including chemical , chemical , and chemical .	T7	T20	17660958
NA	CHEMICAL	GENE-Y	28	32	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T2	T10	17660958
NA	CHEMICAL	GENE-Y	28	32	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T2	T11	17660958
NA	CHEMICAL	GENE-Y	28	18	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T2	T12	17660958
NA	CHEMICAL	GENE-Y	28	39	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T2	T13	17660958
CPR:4	CHEMICAL	GENE-Y	42	32	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T3	T10	17660958
CPR:4	CHEMICAL	GENE-Y	42	32	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T3	T11	17660958
CPR:4	CHEMICAL	GENE-Y	42	18	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T3	T12	17660958
CPR:4	CHEMICAL	GENE-Y	42	39	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral chemical kinase inhibitor targeting gene/gene as well as the gene ( gene ) , chemical .	T3	T13	17660958
NA	CHEMICAL	GENE-Y	2	0	gene inhibits chemical-induced pulmonary fibrosis in rats .	T14	T42	23639248
NA	CHEMICAL	GENE-Y	17	6	There is no study to investigate gene 's role in the development of pulmonary fibrosis induced by chemical .	T5	T25	23639248
NA	CHEMICAL	GENE-Y	23	17	In the current study , we used the rat model to explore the potential antifibrotic role of gene and its underlying mechanism in chemical-induced pulmonary fibrosis .	T6	T33	23639248
NA	CHEMICAL	GENE-Y	5	10	Control group received saline , chemical group received chemical and gene treated group received chemical and gene .	T7	T34	23639248
NA	CHEMICAL	GENE-Y	5	16	Control group received saline , chemical group received chemical and gene treated group received chemical and gene .	T7	T35	23639248
NA	CHEMICAL	GENE-Y	8	10	Control group received saline , chemical group received chemical and gene treated group received chemical and gene .	T8	T34	23639248
NA	CHEMICAL	GENE-Y	8	16	Control group received saline , chemical group received chemical and gene treated group received chemical and gene .	T8	T35	23639248
NA	CHEMICAL	GENE-Y	14	10	Control group received saline , chemical group received chemical and gene treated group received chemical and gene .	T9	T34	23639248
NA	CHEMICAL	GENE-Y	14	16	Control group received saline , chemical group received chemical and gene treated group received chemical and gene .	T9	T35	23639248
NA	CHEMICAL	GENE-Y	4	0	gene was administered to chemical-treated rats intraperitoneally at a dose of 300μg/kg/injection from day 8 to day 30 every other day .	T10	T36	23639248
NA	CHEMICAL	GENE-N	11	18	After the animals were sacrificed on day 15 and 30 , chemical levels , the protein expressions of gene/gene and gene/gene signaling , and histopathology in lung tissues were analyzed .	T11	T37	23639248
NA	CHEMICAL	GENE-N	11	18	After the animals were sacrificed on day 15 and 30 , chemical levels , the protein expressions of gene/gene and gene/gene signaling , and histopathology in lung tissues were analyzed .	T11	T38	23639248
NA	CHEMICAL	GENE-Y	11	20	After the animals were sacrificed on day 15 and 30 , chemical levels , the protein expressions of gene/gene and gene/gene signaling , and histopathology in lung tissues were analyzed .	T11	T39	23639248
NA	CHEMICAL	GENE-N	11	20	After the animals were sacrificed on day 15 and 30 , chemical levels , the protein expressions of gene/gene and gene/gene signaling , and histopathology in lung tissues were analyzed .	T11	T40	23639248
NA	CHEMICAL	GENE-Y	1	4	The chemical contents in gene treated groups were significantly lower than the chemical groups ( P < 0.05 ) .	T12	T41	23639248
NA	CHEMICAL	GENE-Y	12	4	The chemical contents in gene treated groups were significantly lower than the chemical groups ( P < 0.05 ) .	T13	T41	23639248
NA	CHEMICAL	GENE-Y	3	3	Histopathological results showed gene could reduce the progression of chemical induced fibrosis .	T1	T16	23639248
NA	CHEMICAL	GENE-N	7	5	Furthermore , the expression of gene , a marker of gene/gene signaling , was significantly up-regulated in gene treated groups ( P < 0.05 ) compared with the chemical groups .	T2	T17	23639248
NA	CHEMICAL	GENE-N	7	10	Furthermore , the expression of gene , a marker of gene/gene signaling , was significantly up-regulated in gene treated groups ( P < 0.05 ) compared with the chemical groups .	T2	T18	23639248
NA	CHEMICAL	GENE-N	7	7	Furthermore , the expression of gene , a marker of gene/gene signaling , was significantly up-regulated in gene treated groups ( P < 0.05 ) compared with the chemical groups .	T2	T19	23639248
NA	CHEMICAL	GENE-Y	7	17	Furthermore , the expression of gene , a marker of gene/gene signaling , was significantly up-regulated in gene treated groups ( P < 0.05 ) compared with the chemical groups .	T2	T20	23639248
NA	CHEMICAL	GENE-N	9	7	On the contrary , the expression of gene , a marker for gene/gene signaling , reduced significantly in gene-treated groups compared with chemical groups ( P < 0.05 ) .	T3	T21	23639248
NA	CHEMICAL	GENE-Y	9	12	On the contrary , the expression of gene , a marker for gene/gene signaling , reduced significantly in gene-treated groups compared with chemical groups ( P < 0.05 ) .	T3	T22	23639248
NA	CHEMICAL	GENE-N	9	9	On the contrary , the expression of gene , a marker for gene/gene signaling , reduced significantly in gene-treated groups compared with chemical groups ( P < 0.05 ) .	T3	T23	23639248
NA	CHEMICAL	GENE-Y	9	18	On the contrary , the expression of gene , a marker for gene/gene signaling , reduced significantly in gene-treated groups compared with chemical groups ( P < 0.05 ) .	T3	T24	23639248
NA	CHEMICAL	GENE-Y	8	19	In conclusion , the pulmonary fibrosis induced by chemical in rats was significantly reduced with the therapeutic treatment of gene .	T4	T26	23639248
CPR:9	CHEMICAL	GENE-Y	26	18	All the compounds were evaluated for their anti-tumor activity against MCF-7 , A549 and B16-F10 tumor cell lines as well as gene ( gene ) -derived chemical ( chemical ) inhibitory activity of murine macrophage RAW 264.7 cell line .	T4	T7	23353741
CPR:9	CHEMICAL	GENE-Y	26	23	All the compounds were evaluated for their anti-tumor activity against MCF-7 , A549 and B16-F10 tumor cell lines as well as gene ( gene ) -derived chemical ( chemical ) inhibitory activity of murine macrophage RAW 264.7 cell line .	T4	T8	23353741
CPR:9	CHEMICAL	GENE-Y	28	18	All the compounds were evaluated for their anti-tumor activity against MCF-7 , A549 and B16-F10 tumor cell lines as well as gene ( gene ) -derived chemical ( chemical ) inhibitory activity of murine macrophage RAW 264.7 cell line .	T5	T7	23353741
CPR:9	CHEMICAL	GENE-Y	28	23	All the compounds were evaluated for their anti-tumor activity against MCF-7 , A549 and B16-F10 tumor cell lines as well as gene ( gene ) -derived chemical ( chemical ) inhibitory activity of murine macrophage RAW 264.7 cell line .	T5	T8	23353741
NA	CHEMICAL	GENE-Y	3	0	gene suppresses postischemic chemical intolerance and neuronal damage through hypothalamic gene .	T9	T28	23117790
NA	CHEMICAL	GENE-Y	3	10	gene suppresses postischemic chemical intolerance and neuronal damage through hypothalamic gene .	T9	T29	23117790
NA	CHEMICAL	GENE-Y	3	0	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T2	T10	23117790
NA	CHEMICAL	GENE-Y	3	2	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T2	T23	23117790
NA	CHEMICAL	GENE-Y	3	12	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T2	T11	23117790
NA	CHEMICAL	GENE-N	3	5	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T2	T13	23117790
NA	CHEMICAL	GENE-Y	31	0	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T5	T10	23117790
NA	CHEMICAL	GENE-Y	31	2	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T5	T23	23117790
NA	CHEMICAL	GENE-Y	31	12	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T5	T11	23117790
NA	CHEMICAL	GENE-N	31	5	gene ( a chemical-sensing neuropeptide in the hypothalamus ) and gene ( gene ; a member of the gene family ) play roles in many physiologic functions , including regulation of chemical metabolism .	T5	T13	23117790
NA	CHEMICAL	GENE-Y	9	4	Small interfering RNA directed gene , gene , and chemical [ chemical ; a specific gene antagonist ] were administered directly into the hypothalamus .	T7	T24	23117790
NA	CHEMICAL	GENE-Y	9	6	Small interfering RNA directed gene , gene , and chemical [ chemical ; a specific gene antagonist ] were administered directly into the hypothalamus .	T7	T25	23117790
CPR:6	CHEMICAL	GENE-Y	9	15	Small interfering RNA directed gene , gene , and chemical [ chemical ; a specific gene antagonist ] were administered directly into the hypothalamus .	T7	T26	23117790
NA	CHEMICAL	GENE-Y	11	4	Small interfering RNA directed gene , gene , and chemical [ chemical ; a specific gene antagonist ] were administered directly into the hypothalamus .	T8	T24	23117790
NA	CHEMICAL	GENE-Y	11	6	Small interfering RNA directed gene , gene , and chemical [ chemical ; a specific gene antagonist ] were administered directly into the hypothalamus .	T8	T25	23117790
CPR:6	CHEMICAL	GENE-Y	11	15	Small interfering RNA directed gene , gene , and chemical [ chemical ; a specific gene antagonist ] were administered directly into the hypothalamus .	T8	T26	23117790
NA	CHEMICAL	GENE-Y	3	3	Intrahypothalamic administration of gene ( 1 or 5 pmol/mouse ) significantly and dose-dependently suppressed the development of postischemic chemical intolerance on day 1 and development of neuronal damage on day 3 .	T1	T12	23117790
CPR:4	CHEMICAL	GENE-Y	34	4	The MCAO-induced decrease in gene levels in the liver and skeletal muscle on day 1 was recovered to control levels by gene , and this effect of gene was reversed by the administration of chemical as well as by hypothalamic gene knockdown .	T3	T14	23117790
NA	CHEMICAL	GENE-Y	34	3	The MCAO-induced decrease in gene levels in the liver and skeletal muscle on day 1 was recovered to control levels by gene , and this effect of gene was reversed by the administration of chemical as well as by hypothalamic gene knockdown .	T3	T15	23117790
CPR:4	CHEMICAL	GENE-Y	34	3	The MCAO-induced decrease in gene levels in the liver and skeletal muscle on day 1 was recovered to control levels by gene , and this effect of gene was reversed by the administration of chemical as well as by hypothalamic gene knockdown .	T3	T16	23117790
NA	CHEMICAL	GENE-Y	34	40	The MCAO-induced decrease in gene levels in the liver and skeletal muscle on day 1 was recovered to control levels by gene , and this effect of gene was reversed by the administration of chemical as well as by hypothalamic gene knockdown .	T3	T17	23117790
NA	CHEMICAL	GENE-Y	7	10	These results suggest that suppression of postischemic chemical intolerance by gene assists in the prevention of cerebral ischemic neuronal damage .	T4	T18	23117790
NA	CHEMICAL	GENE-Y	3	2	Adipose tissue as a source of chemical chemical-methyltransferase and chemical .	T14	T25	18996527
NA	CHEMICAL	GENE-Y	6	2	Adipose tissue as a source of chemical chemical-methyltransferase and chemical .	T15	T25	18996527
NA	CHEMICAL	GENE-Y	9	2	Adipose tissue as a source of chemical chemical-methyltransferase and chemical .	T16	T25	18996527
NA	CHEMICAL	GENE-Y	11	1	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T1	T17	18996527
NA	CHEMICAL	GENE-Y	11	3	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T1	T21	18996527
NA	CHEMICAL	GENE-Y	0	1	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T4	T17	18996527
NA	CHEMICAL	GENE-Y	0	3	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T4	T21	18996527
CPR:9	CHEMICAL	GENE-Y	9	1	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T7	T17	18996527
CPR:9	CHEMICAL	GENE-Y	9	3	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T7	T21	18996527
CPR:9	CHEMICAL	GENE-Y	11	1	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T11	T17	18996527
CPR:9	CHEMICAL	GENE-Y	11	3	chemical chemical-methyltransferase ( gene ) catalyses the conversion of chemical to chemical and plays an important role in hepatic detoxification reactions .	T11	T21	18996527
CPR:9	CHEMICAL	GENE-Y	0	7	chemical , the atherogenic product of the gene-catalyzed reaction , was secreted from 3T3-L1 cells or adipose tissue cultures .	T5	T22	18996527
NA	CHEMICAL	GENE-Y	0	16	chemical release increased during 3T3-L1 differentiation and was reduced when adipose tissue was treated with the gene inhibitor chemical .	T6	T23	18996527
CPR:4	CHEMICAL	GENE-Y	18	16	chemical release increased during 3T3-L1 differentiation and was reduced when adipose tissue was treated with the gene inhibitor chemical .	T8	T23	18996527
CPR:3	CHEMICAL	GENE-Y	0	17	chemical ( chemical ) , a widely used drug to lower elevated plasma lipid levels , induced gene enzyme activity in white adipose tissue of mice .	T9	T24	18996527
CPR:3	CHEMICAL	GENE-Y	2	17	chemical ( chemical ) , a widely used drug to lower elevated plasma lipid levels , induced gene enzyme activity in white adipose tissue of mice .	T10	T24	18996527
NA	CHEMICAL	GENE-N	0	10	chemical-evoked currents were completely and reversibly blocked by the competitive gene antagonist chemical ( IC50 = 1.7 microM ) , indicating expression of gene but not gene .	T11	T21	15240758
NA	CHEMICAL	GENE-N	0	23	chemical-evoked currents were completely and reversibly blocked by the competitive gene antagonist chemical ( IC50 = 1.7 microM ) , indicating expression of gene but not gene .	T11	T22	15240758
NA	CHEMICAL	GENE-N	0	26	chemical-evoked currents were completely and reversibly blocked by the competitive gene antagonist chemical ( IC50 = 1.7 microM ) , indicating expression of gene but not gene .	T11	T23	15240758
CPR:6	CHEMICAL	GENE-N	12	10	chemical-evoked currents were completely and reversibly blocked by the competitive gene antagonist chemical ( IC50 = 1.7 microM ) , indicating expression of gene but not gene .	T12	T21	15240758
NA	CHEMICAL	GENE-N	12	23	chemical-evoked currents were completely and reversibly blocked by the competitive gene antagonist chemical ( IC50 = 1.7 microM ) , indicating expression of gene but not gene .	T12	T22	15240758
NA	CHEMICAL	GENE-N	12	26	chemical-evoked currents were completely and reversibly blocked by the competitive gene antagonist chemical ( IC50 = 1.7 microM ) , indicating expression of gene but not gene .	T12	T23	15240758
NA	CHEMICAL	GENE-N	3	25	Their affinity for chemical was moderate ( EC50 = 30 microM ) , and the Hill coefficient was 1.3 , corresponding to two chemical binding sites .	T13	T24	15240758
NA	CHEMICAL	GENE-N	23	25	Their affinity for chemical was moderate ( EC50 = 30 microM ) , and the Hill coefficient was 1.3 , corresponding to two chemical binding sites .	T14	T24	15240758
NA	CHEMICAL	GENE-N	2	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T2	T19	15240758
NA	CHEMICAL	GENE-N	2	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T2	T20	15240758
NA	CHEMICAL	GENE-N	13	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T3	T19	15240758
NA	CHEMICAL	GENE-N	13	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T3	T20	15240758
NA	CHEMICAL	GENE-N	15	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T4	T19	15240758
NA	CHEMICAL	GENE-N	15	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T4	T20	15240758
NA	CHEMICAL	GENE-N	1	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T5	T19	15240758
NA	CHEMICAL	GENE-N	1	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T5	T20	15240758
NA	CHEMICAL	GENE-N	19	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T6	T19	15240758
NA	CHEMICAL	GENE-N	19	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T6	T20	15240758
NA	CHEMICAL	GENE-N	22	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T7	T19	15240758
NA	CHEMICAL	GENE-N	22	3	Furthermore , chemical receptors of horizontal cells were modulated by extracellular application of chemical , chemical , chemical , chemical , and chemical , thus showing typical pharmacological properties of CNS gene .	T7	T20	15240758
NA	CHEMICAL	GENE-Y	6	11	Various biochemical processes including oligomerization , chemical chemical/dATP binding , and gene interaction play a role in regulating the ternary death complex .	T1	T17	10935465
NA	CHEMICAL	GENE-Y	7	11	Various biochemical processes including oligomerization , chemical chemical/dATP binding , and gene interaction play a role in regulating the ternary death complex .	T2	T17	10935465
NA	CHEMICAL	GENE-Y	7	12	OBJECTIVE : All antipsychotics act on the chemical D ( 2 ) receptor .	T1	T8	16513877
NA	CHEMICAL	GENE-N	37	16	METHOD : Patients experiencing their first episode of schizophrenia ( N=61 ) were genotyped for two gene region polymorphisms ( gene and -141C Ins/Del ) and were randomly assigned to receive 16 weeks of treatment with either chemical or chemical .	T2	T7	16513877
NA	CHEMICAL	GENE-N	37	20	METHOD : Patients experiencing their first episode of schizophrenia ( N=61 ) were genotyped for two gene region polymorphisms ( gene and -141C Ins/Del ) and were randomly assigned to receive 16 weeks of treatment with either chemical or chemical .	T2	T9	16513877
NA	CHEMICAL	GENE-N	39	16	METHOD : Patients experiencing their first episode of schizophrenia ( N=61 ) were genotyped for two gene region polymorphisms ( gene and -141C Ins/Del ) and were randomly assigned to receive 16 weeks of treatment with either chemical or chemical .	T3	T7	16513877
NA	CHEMICAL	GENE-N	39	20	METHOD : Patients experiencing their first episode of schizophrenia ( N=61 ) were genotyped for two gene region polymorphisms ( gene and -141C Ins/Del ) and were randomly assigned to receive 16 weeks of treatment with either chemical or chemical .	T3	T9	16513877
NA	CHEMICAL	GENE-N	3	5	Interaction of silymarin chemical with gene .	T14	T30	23401473
NA	CHEMICAL	GENE-Y	8	10	The present study examined the effect of silymarin chemical on gene- , gene- , and gene-mediated transport in cell lines stably expressing these transporters and in human hepatocytes .	T9	T20	23401473
NA	CHEMICAL	GENE-Y	8	12	The present study examined the effect of silymarin chemical on gene- , gene- , and gene-mediated transport in cell lines stably expressing these transporters and in human hepatocytes .	T9	T21	23401473
NA	CHEMICAL	GENE-Y	8	15	The present study examined the effect of silymarin chemical on gene- , gene- , and gene-mediated transport in cell lines stably expressing these transporters and in human hepatocytes .	T9	T23	23401473
CPR:9	CHEMICAL	GENE-Y	8	5	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T10	T24	23401473
CPR:9	CHEMICAL	GENE-Y	8	7	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T10	T25	23401473
NA	CHEMICAL	GENE-Y	8	11	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T10	T26	23401473
NA	CHEMICAL	GENE-Y	12	5	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T11	T24	23401473
NA	CHEMICAL	GENE-Y	12	7	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T11	T25	23401473
CPR:9	CHEMICAL	GENE-Y	12	11	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T11	T26	23401473
CPR:4	CHEMICAL	GENE-Y	21	5	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T12	T24	23401473
CPR:4	CHEMICAL	GENE-Y	21	7	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T12	T25	23401473
CPR:4	CHEMICAL	GENE-Y	21	11	In overexpressing cell lines , gene- and gene-mediated chemical uptake and gene-mediated chemical uptake were inhibited by most of the silymarin chemical investigated .	T12	T26	23401473
CPR:4	CHEMICAL	GENE-Y	27	0	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T13	T27	23401473
CPR:4	CHEMICAL	GENE-Y	27	2	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T13	T28	23401473
CPR:4	CHEMICAL	GENE-Y	27	5	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T13	T29	23401473
CPR:4	CHEMICAL	GENE-Y	27	0	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T1	T27	23401473
CPR:4	CHEMICAL	GENE-Y	27	2	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T1	T28	23401473
CPR:4	CHEMICAL	GENE-Y	27	5	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T1	T29	23401473
CPR:4	CHEMICAL	GENE-Y	0	0	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T2	T27	23401473
CPR:4	CHEMICAL	GENE-Y	0	2	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T2	T28	23401473
CPR:4	CHEMICAL	GENE-Y	0	5	gene- , gene- , and gene-mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , chemical ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , chemical ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and chemical ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .	T2	T29	23401473
CPR:4	CHEMICAL	GENE-N	4	14	Furthermore , silymarin , chemical , and chemical ( 100 µM ) significantly inhibited gene-mediated chemical and chemical uptake into human hepatocytes .	T3	T16	23401473
CPR:4	CHEMICAL	GENE-N	7	14	Furthermore , silymarin , chemical , and chemical ( 100 µM ) significantly inhibited gene-mediated chemical and chemical uptake into human hepatocytes .	T4	T16	23401473
CPR:9	CHEMICAL	GENE-N	15	14	Furthermore , silymarin , chemical , and chemical ( 100 µM ) significantly inhibited gene-mediated chemical and chemical uptake into human hepatocytes .	T5	T16	23401473
CPR:9	CHEMICAL	GENE-N	17	14	Furthermore , silymarin , chemical , and chemical ( 100 µM ) significantly inhibited gene-mediated chemical and chemical uptake into human hepatocytes .	T6	T16	23401473
NA	CHEMICAL	GENE-N	6	7	The extent of silymarin-drug interactions depends on gene isoform specificity and concentrations of chemical at the site of drug transport .	T7	T17	23401473
NA	CHEMICAL	GENE-Y	10	10	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that chemical behaves as an chemical analogue in every respect , it strongly interferes with cellular acquisition of iron from blood by competitive interaction with gene and gene-mediated endocytosis .	T24	T37	15206110
NA	CHEMICAL	GENE-N	10	4	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that chemical behaves as an chemical analogue in every respect , it strongly interferes with cellular acquisition of iron from blood by competitive interaction with gene and gene-mediated endocytosis .	T24	T38	15206110
NA	CHEMICAL	GENE-Y	20	10	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that chemical behaves as an chemical analogue in every respect , it strongly interferes with cellular acquisition of iron from blood by competitive interaction with gene and gene-mediated endocytosis .	T25	T37	15206110
NA	CHEMICAL	GENE-N	20	4	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that chemical behaves as an chemical analogue in every respect , it strongly interferes with cellular acquisition of iron from blood by competitive interaction with gene and gene-mediated endocytosis .	T25	T38	15206110
CPR:4	CHEMICAL	GENE-N	2	25	Furthermore , chemical also seems to affect intracellular availability of chemical already taken up via this pathway , probably due to its inhibitory activity on gene .	T26	T39	15206110
NA	CHEMICAL	GENE-N	10	25	Furthermore , chemical also seems to affect intracellular availability of chemical already taken up via this pathway , probably due to its inhibitory activity on gene .	T27	T39	15206110
NA	CHEMICAL	GENE-N	5	20	Apart from the consequences of chemical deprivation , chemical exerts cytotoxic effects by direct interaction with the chemical-dependent enzyme chemical reductase , resulting in reduced dNTP pools and inhibition of DNA synthesis .	T29	T40	15206110
NA	CHEMICAL	GENE-N	8	20	Apart from the consequences of chemical deprivation , chemical exerts cytotoxic effects by direct interaction with the chemical-dependent enzyme chemical reductase , resulting in reduced dNTP pools and inhibition of DNA synthesis .	T30	T40	15206110
NA	CHEMICAL	GENE-N	17	20	Apart from the consequences of chemical deprivation , chemical exerts cytotoxic effects by direct interaction with the chemical-dependent enzyme chemical reductase , resulting in reduced dNTP pools and inhibition of DNA synthesis .	T31	T40	15206110
NA	CHEMICAL	GENE-N	19	20	Apart from the consequences of chemical deprivation , chemical exerts cytotoxic effects by direct interaction with the chemical-dependent enzyme chemical reductase , resulting in reduced dNTP pools and inhibition of DNA synthesis .	T32	T40	15206110
NA	CHEMICAL	GENE-N	8	4	Both the abundance of gene and upregulation of chemical reductase render tumors susceptible to chemical-induced cytotoxicity .	T2	T34	15206110
NA	CHEMICAL	GENE-N	8	9	Both the abundance of gene and upregulation of chemical reductase render tumors susceptible to chemical-induced cytotoxicity .	T2	T35	15206110
NA	CHEMICAL	GENE-N	4	4	Both the abundance of gene and upregulation of chemical reductase render tumors susceptible to chemical-induced cytotoxicity .	T3	T34	15206110
NA	CHEMICAL	GENE-N	4	9	Both the abundance of gene and upregulation of chemical reductase render tumors susceptible to chemical-induced cytotoxicity .	T3	T35	15206110
CPR:4	CHEMICAL	GENE-N	14	43	However , some experimental findings raise the question whether these effects resulting from the chemical-mimicking properties of chemical are solely responsible for its antineoplastic activity or whether additional mechanisms are involved , such as antimitotic effects which result from its capability of inhibiting gene polymerization .	T5	T36	15206110
CPR:4	CHEMICAL	GENE-N	17	43	However , some experimental findings raise the question whether these effects resulting from the chemical-mimicking properties of chemical are solely responsible for its antineoplastic activity or whether additional mechanisms are involved , such as antimitotic effects which result from its capability of inhibiting gene polymerization .	T6	T36	15206110
NA	CHEMICAL	GENE-Y	9	16	Here we tested the effect of chronic supplementation with a mineral extract from red marine algae - rich in chemical ( 34 % ) , chemical , chemical , chemical and other trace minerals - in a clinically relevant model of spontaneous enterocolitis , gene ( -/- ) mice .	T1	T7	23554071
NA	CHEMICAL	GENE-Y	9	16	Here we tested the effect of chronic supplementation with a mineral extract from red marine algae - rich in chemical ( 34 % ) , chemical , chemical , chemical and other trace minerals - in a clinically relevant model of spontaneous enterocolitis , gene ( -/- ) mice .	T2	T7	23554071
NA	CHEMICAL	GENE-Y	27	16	Here we tested the effect of chronic supplementation with a mineral extract from red marine algae - rich in chemical ( 34 % ) , chemical , chemical , chemical and other trace minerals - in a clinically relevant model of spontaneous enterocolitis , gene ( -/- ) mice .	T3	T7	23554071
NA	CHEMICAL	GENE-Y	29	16	Here we tested the effect of chronic supplementation with a mineral extract from red marine algae - rich in chemical ( 34 % ) , chemical , chemical , chemical and other trace minerals - in a clinically relevant model of spontaneous enterocolitis , gene ( -/- ) mice .	T4	T7	23554071
CPR:3	CHEMICAL	GENE-Y	9	2	Induction of gene through gene gene/gene signaling pathway by chemical extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice .	T8	T38	23298677
CPR:3	CHEMICAL	GENE-N	9	4	Induction of gene through gene gene/gene signaling pathway by chemical extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice .	T8	T39	23298677
CPR:3	CHEMICAL	GENE-N	9	5	Induction of gene through gene gene/gene signaling pathway by chemical extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice .	T8	T40	23298677
NA	CHEMICAL	GENE-Y	9	5	Induction of gene through gene gene/gene signaling pathway by chemical extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice .	T8	T41	23298677
NA	CHEMICAL	GENE-Y	4	5	We recently proposed that chemical oxygenase-1 ( gene ) negatively regulates gene in inflammatory conditions .	T6	T14	23298677
NA	CHEMICAL	GENE-Y	4	7	We recently proposed that chemical oxygenase-1 ( gene ) negatively regulates gene in inflammatory conditions .	T6	T18	23298677
NA	CHEMICAL	GENE-Y	4	11	We recently proposed that chemical oxygenase-1 ( gene ) negatively regulates gene in inflammatory conditions .	T6	T19	23298677
CPR:4	CHEMICAL	GENE-Y	9	3	The induction of gene by EIH was inhibited by chemical but not by chemical , chemical , nor chemical .	T1	T37	23298677
NA	CHEMICAL	GENE-Y	13	3	The induction of gene by EIH was inhibited by chemical but not by chemical , chemical , nor chemical .	T2	T37	23298677
NA	CHEMICAL	GENE-Y	3	3	The induction of gene by EIH was inhibited by chemical but not by chemical , chemical , nor chemical .	T3	T37	23298677
NA	CHEMICAL	GENE-Y	18	3	The induction of gene by EIH was inhibited by chemical but not by chemical , chemical , nor chemical .	T4	T37	23298677
NA	CHEMICAL	GENE-Y	11	13	Most importantly , administration of EIH significantly reduced not only increase in blood gene , gene gene , BUN , chemical levels but also decrease macrophage infiltrate in the liver of septic mice , which were reversed by ZnPPIX , a gene inhibitor .	T5	T10	23298677
NA	CHEMICAL	GENE-N	11	2	Most importantly , administration of EIH significantly reduced not only increase in blood gene , gene gene , BUN , chemical levels but also decrease macrophage infiltrate in the liver of septic mice , which were reversed by ZnPPIX , a gene inhibitor .	T5	T11	23298677
NA	CHEMICAL	GENE-N	11	16	Most importantly , administration of EIH significantly reduced not only increase in blood gene , gene gene , BUN , chemical levels but also decrease macrophage infiltrate in the liver of septic mice , which were reversed by ZnPPIX , a gene inhibitor .	T5	T12	23298677
NA	CHEMICAL	GENE-Y	11	41	Most importantly , administration of EIH significantly reduced not only increase in blood gene , gene gene , BUN , chemical levels but also decrease macrophage infiltrate in the liver of septic mice , which were reversed by ZnPPIX , a gene inhibitor .	T5	T13	23298677
NA	CHEMICAL	GENE-Y	7	21	After 18 h incubation with 0.5 μM chemical and subsequent red light irradiation ( 3.6 J/cm ( 2 ) ) , a high number of cells die by apoptosis , as evaluated by morphological alterations , immunofluorescent relocalization of gene from cytosol to mitochondria , and TUNEL assay .	T1	T16	23517729
NA	CHEMICAL	GENE-Y	1	6	Synthesis , structure-activity relationships , and in vivo efficacy of the novel potent and selective gene ( gene ) inhibitor chemical ( chemical ) currently in phase 1 and phase 2 clinical trials .	T3	T8	23742252
NA	CHEMICAL	GENE-Y	1	17	Synthesis , structure-activity relationships , and in vivo efficacy of the novel potent and selective gene ( gene ) inhibitor chemical ( chemical ) currently in phase 1 and phase 2 clinical trials .	T3	T9	23742252
NA	CHEMICAL	GENE-Y	22	6	Synthesis , structure-activity relationships , and in vivo efficacy of the novel potent and selective gene ( gene ) inhibitor chemical ( chemical ) currently in phase 1 and phase 2 clinical trials .	T4	T8	23742252
NA	CHEMICAL	GENE-Y	22	17	Synthesis , structure-activity relationships , and in vivo efficacy of the novel potent and selective gene ( gene ) inhibitor chemical ( chemical ) currently in phase 1 and phase 2 clinical trials .	T4	T9	23742252
CPR:4	CHEMICAL	GENE-Y	23	7	The synthesis , preclinical profile , and in vivo efficacy in rat xenograft models of the novel and selective gene inhibitor 15b ( chemical ) are described .	T1	T5	23742252
CPR:4	CHEMICAL	GENE-Y	32	30	In this initial report , preliminary structure-activity relationships ( SARs ) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation gene inhibitor 4 ( chemical ) .	T2	T6	23742252
NA	CHEMICAL	GENE-N	22	20	This review focuses on the mechanisms regulating the synthesis , secretion , biological actions , and therapeutic relevance of the gene peptides chemical-dependent insulinotropic polypeptide ( gene ) and gene ( gene ) .	T2	T10	17498508
NA	CHEMICAL	GENE-Y	22	24	This review focuses on the mechanisms regulating the synthesis , secretion , biological actions , and therapeutic relevance of the gene peptides chemical-dependent insulinotropic polypeptide ( gene ) and gene ( gene ) .	T2	T14	17498508
NA	CHEMICAL	GENE-Y	22	26	This review focuses on the mechanisms regulating the synthesis , secretion , biological actions , and therapeutic relevance of the gene peptides chemical-dependent insulinotropic polypeptide ( gene ) and gene ( gene ) .	T2	T19	17498508
NA	CHEMICAL	GENE-Y	22	29	This review focuses on the mechanisms regulating the synthesis , secretion , biological actions , and therapeutic relevance of the gene peptides chemical-dependent insulinotropic polypeptide ( gene ) and gene ( gene ) .	T2	T20	17498508
NA	CHEMICAL	GENE-Y	22	31	This review focuses on the mechanisms regulating the synthesis , secretion , biological actions , and therapeutic relevance of the gene peptides chemical-dependent insulinotropic polypeptide ( gene ) and gene ( gene ) .	T2	T21	17498508
NA	CHEMICAL	GENE-N	4	0	gene activation leads to chemical-dependent gene secretion , induction of beta-cell proliferation , and enhanced resistance to apoptosis .	T3	T26	17498508
CPR:3	CHEMICAL	GENE-Y	4	5	gene activation leads to chemical-dependent gene secretion , induction of beta-cell proliferation , and enhanced resistance to apoptosis .	T3	T27	17498508
NA	CHEMICAL	GENE-Y	13	3	In contrast , gene exerts glucoregulatory actions via slowing of gastric emptying and chemical-dependent inhibition of gene secretion .	T1	T29	17498508
NA	CHEMICAL	GENE-Y	13	16	In contrast , gene exerts glucoregulatory actions via slowing of gastric emptying and chemical-dependent inhibition of gene secretion .	T1	T4	17498508
CPR:4	CHEMICAL	GENE-Y	0	6	chemical , which belongs chemically to a class that can be described as chemical , was selected for further pharmacologic characterization based on potent inhibition of gene and its favorable gene selectivity profile .	T8	T23	16474853
CPR:4	CHEMICAL	GENE-N	0	6	chemical , which belongs chemically to a class that can be described as chemical , was selected for further pharmacologic characterization based on potent inhibition of gene and its favorable gene selectivity profile .	T8	T24	16474853
CPR:4	CHEMICAL	GENE-Y	6	6	chemical , which belongs chemically to a class that can be described as chemical , was selected for further pharmacologic characterization based on potent inhibition of gene and its favorable gene selectivity profile .	T9	T23	16474853
CPR:4	CHEMICAL	GENE-N	6	6	chemical , which belongs chemically to a class that can be described as chemical , was selected for further pharmacologic characterization based on potent inhibition of gene and its favorable gene selectivity profile .	T9	T24	16474853
CPR:4	CHEMICAL	GENE-N	4	9	Further characterization showed that chemical suppresses both wild-type and gene mutant gene activity in vitro .	T10	T25	16474853
CPR:4	CHEMICAL	GENE-Y	4	11	Further characterization showed that chemical suppresses both wild-type and gene mutant gene activity in vitro .	T10	T26	16474853
CPR:3	CHEMICAL	GENE-N	3	9	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T11	T27	16474853
CPR:3	CHEMICAL	GENE-Y	3	18	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T11	T28	16474853
CPR:3	CHEMICAL	GENE-Y	3	20	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T11	T14	16474853
CPR:3	CHEMICAL	GENE-Y	3	22	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T11	T15	16474853
CPR:3	CHEMICAL	GENE-Y	3	23	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T11	T16	16474853
CPR:3	CHEMICAL	GENE-Y	3	26	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T11	T17	16474853
NA	CHEMICAL	GENE-N	11	9	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T12	T27	16474853
NA	CHEMICAL	GENE-Y	11	18	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T12	T28	16474853
NA	CHEMICAL	GENE-Y	11	20	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T12	T14	16474853
NA	CHEMICAL	GENE-Y	11	22	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T12	T15	16474853
NA	CHEMICAL	GENE-Y	11	23	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T12	T16	16474853
NA	CHEMICAL	GENE-Y	11	26	In addition , chemical demonstrated significant activity against several gene involved in neovascularization and tumor progression , including gene , gene , gene gene , and gene .	T12	T17	16474853
CPR:9	CHEMICAL	GENE-N	2	9	Blockade of chemical synthesis caused by additive inhibition of gene phosphorylation : Effect of chemical and gene inhibition in human eosinophils .	T34	T53	12897749
NA	CHEMICAL	GENE-N	2	16	Blockade of chemical synthesis caused by additive inhibition of gene phosphorylation : Effect of chemical and gene inhibition in human eosinophils .	T34	T52	12897749
NA	CHEMICAL	GENE-N	14	9	Blockade of chemical synthesis caused by additive inhibition of gene phosphorylation : Effect of chemical and gene inhibition in human eosinophils .	T35	T53	12897749
NA	CHEMICAL	GENE-N	14	16	Blockade of chemical synthesis caused by additive inhibition of gene phosphorylation : Effect of chemical and gene inhibition in human eosinophils .	T35	T52	12897749
NA	CHEMICAL	GENE-N	44	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T24	T49	12897749
NA	CHEMICAL	GENE-Y	44	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T24	T51	12897749
CPR:4	CHEMICAL	GENE-N	5	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T25	T49	12897749
NA	CHEMICAL	GENE-Y	5	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T25	T51	12897749
NA	CHEMICAL	GENE-N	5	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T26	T49	12897749
NA	CHEMICAL	GENE-Y	5	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T26	T51	12897749
NA	CHEMICAL	GENE-N	18	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T27	T49	12897749
NA	CHEMICAL	GENE-Y	18	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T27	T51	12897749
NA	CHEMICAL	GENE-N	4	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T28	T49	12897749
NA	CHEMICAL	GENE-Y	4	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T28	T51	12897749
NA	CHEMICAL	GENE-N	4	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T29	T49	12897749
NA	CHEMICAL	GENE-Y	4	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T29	T51	12897749
NA	CHEMICAL	GENE-N	31	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T30	T49	12897749
NA	CHEMICAL	GENE-Y	31	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T30	T51	12897749
NA	CHEMICAL	GENE-N	33	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T31	T49	12897749
NA	CHEMICAL	GENE-Y	33	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T31	T51	12897749
NA	CHEMICAL	GENE-N	12	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T2	T49	12897749
NA	CHEMICAL	GENE-Y	12	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T2	T51	12897749
NA	CHEMICAL	GENE-N	4	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T3	T49	12897749
NA	CHEMICAL	GENE-Y	4	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T3	T51	12897749
NA	CHEMICAL	GENE-N	8	8	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T4	T49	12897749
NA	CHEMICAL	GENE-Y	8	4	OBJECTIVE : To determine ( a ) whether gene inhibition alone with chemical blocked secretions of chemical ( chemical ) and chemical ( chemical ) caused by activation of eosinophils with chemical plus chemical ( FMLP/B ) , ( b ) to determine if chemical inhibition plus gene agonist act additively to augment endogenous chemical concentration , and ( c ) to determine the mechanism by which additive inhibition of chemical and chemical synthesis is regulated by chemical .	T4	T51	12897749
NA	CHEMICAL	GENE-N	2	15	Release of chemical and chemical , intracellular chemical concentration , and phosphorylation and activation of gene were determined .	T7	T36	12897749
NA	CHEMICAL	GENE-N	4	15	Release of chemical and chemical , intracellular chemical concentration , and phosphorylation and activation of gene were determined .	T8	T36	12897749
NA	CHEMICAL	GENE-N	7	15	Release of chemical and chemical , intracellular chemical concentration , and phosphorylation and activation of gene were determined .	T9	T36	12897749
NA	CHEMICAL	GENE-N	2	8	RESULTS : chemical unmasked the inhibitory effect of gene stimulation with chemical and significantly attenuated the stimulated release of chemical and subsequent chemical .	T10	T37	12897749
CPR:3	CHEMICAL	GENE-N	11	8	RESULTS : chemical unmasked the inhibitory effect of gene stimulation with chemical and significantly attenuated the stimulated release of chemical and subsequent chemical .	T11	T37	12897749
NA	CHEMICAL	GENE-N	19	8	RESULTS : chemical unmasked the inhibitory effect of gene stimulation with chemical and significantly attenuated the stimulated release of chemical and subsequent chemical .	T12	T37	12897749
NA	CHEMICAL	GENE-N	22	8	RESULTS : chemical unmasked the inhibitory effect of gene stimulation with chemical and significantly attenuated the stimulated release of chemical and subsequent chemical .	T13	T37	12897749
NA	CHEMICAL	GENE-N	4	22	Inhibition corresponded to increased chemical production caused by chemical alone or chemical plus chemical and blocked proportionately the phosphorylation and activation of gene in FMLP/B-activated eosinophils .	T14	T38	12897749
NA	CHEMICAL	GENE-N	8	22	Inhibition corresponded to increased chemical production caused by chemical alone or chemical plus chemical and blocked proportionately the phosphorylation and activation of gene in FMLP/B-activated eosinophils .	T15	T38	12897749
CPR:4	CHEMICAL	GENE-N	11	22	Inhibition corresponded to increased chemical production caused by chemical alone or chemical plus chemical and blocked proportionately the phosphorylation and activation of gene in FMLP/B-activated eosinophils .	T16	T38	12897749
CPR:4	CHEMICAL	GENE-N	13	22	Inhibition corresponded to increased chemical production caused by chemical alone or chemical plus chemical and blocked proportionately the phosphorylation and activation of gene in FMLP/B-activated eosinophils .	T17	T38	12897749
NA	CHEMICAL	GENE-N	3	16	We found that chemical NPs were highly cytotoxic to hepatocytes ( LC ( 50 ) chemical dehydrogenase : 2.5 μg/cm ( 2 ) ) and affected hepatocyte homeostasis by reducing gene release .	T1	T10	23086748
CPR:4	CHEMICAL	GENE-Y	3	30	We found that chemical NPs were highly cytotoxic to hepatocytes ( LC ( 50 ) chemical dehydrogenase : 2.5 μg/cm ( 2 ) ) and affected hepatocyte homeostasis by reducing gene release .	T1	T11	23086748
NA	CHEMICAL	GENE-N	15	16	We found that chemical NPs were highly cytotoxic to hepatocytes ( LC ( 50 ) chemical dehydrogenase : 2.5 μg/cm ( 2 ) ) and affected hepatocyte homeostasis by reducing gene release .	T2	T10	23086748
NA	CHEMICAL	GENE-Y	15	30	We found that chemical NPs were highly cytotoxic to hepatocytes ( LC ( 50 ) chemical dehydrogenase : 2.5 μg/cm ( 2 ) ) and affected hepatocyte homeostasis by reducing gene release .	T2	T11	23086748
CPR:3	CHEMICAL	GENE-Y	5	11	We observed similar effects of chemical NPs on inflammatory mediator expression in vitro and in vivo with increase of gene ( gene ) /gene , gene , and gene expression in both models and increased gene protein release in vitro .	T4	T12	23086748
CPR:3	CHEMICAL	GENE-Y	5	21	We observed similar effects of chemical NPs on inflammatory mediator expression in vitro and in vivo with increase of gene ( gene ) /gene , gene , and gene expression in both models and increased gene protein release in vitro .	T4	T13	23086748
CPR:3	CHEMICAL	GENE-N	5	23	We observed similar effects of chemical NPs on inflammatory mediator expression in vitro and in vivo with increase of gene ( gene ) /gene , gene , and gene expression in both models and increased gene protein release in vitro .	T4	T14	23086748
CPR:3	CHEMICAL	GENE-Y	5	25	We observed similar effects of chemical NPs on inflammatory mediator expression in vitro and in vivo with increase of gene ( gene ) /gene , gene , and gene expression in both models and increased gene protein release in vitro .	T4	T15	23086748
CPR:3	CHEMICAL	GENE-Y	5	28	We observed similar effects of chemical NPs on inflammatory mediator expression in vitro and in vivo with increase of gene ( gene ) /gene , gene , and gene expression in both models and increased gene protein release in vitro .	T4	T16	23086748
CPR:3	CHEMICAL	GENE-Y	5	35	We observed similar effects of chemical NPs on inflammatory mediator expression in vitro and in vivo with increase of gene ( gene ) /gene , gene , and gene expression in both models and increased gene protein release in vitro .	T4	T17	23086748
NA	CHEMICAL	GENE-Y	4	2	Characterization of gene receptors in rat spinal cord via chemical binding and inhibition of chemical release .	T47	T64	1738111
NA	CHEMICAL	GENE-Y	4	2	Characterization of gene receptors in rat spinal cord via chemical binding and inhibition of chemical release .	T46	T64	1738111
NA	CHEMICAL	GENE-Y	6	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T2	T53	1738111
NA	CHEMICAL	GENE-Y	6	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T2	T61	1738111
NA	CHEMICAL	GENE-Y	6	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T12	T53	1738111
NA	CHEMICAL	GENE-Y	6	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T12	T61	1738111
NA	CHEMICAL	GENE-Y	22	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T17	T53	1738111
NA	CHEMICAL	GENE-Y	22	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T17	T61	1738111
NA	CHEMICAL	GENE-Y	21	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T28	T53	1738111
NA	CHEMICAL	GENE-Y	21	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T28	T61	1738111
NA	CHEMICAL	GENE-Y	37	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T32	T53	1738111
NA	CHEMICAL	GENE-Y	37	12	The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the chemical ( chemical ) 1B receptor defined by chemical chemical binding and the gene defined by inhibition of chemical release .	T32	T61	1738111
NA	CHEMICAL	GENE-Y	0	10	chemical binding was not altered by compounds with activity at gene , gene , gene , gene or alpha-2 receptor sites .	T45	T48	1738111
NA	CHEMICAL	GENE-Y	0	12	chemical binding was not altered by compounds with activity at gene , gene , gene , gene or alpha-2 receptor sites .	T45	T49	1738111
NA	CHEMICAL	GENE-Y	0	14	chemical binding was not altered by compounds with activity at gene , gene , gene , gene or alpha-2 receptor sites .	T45	T50	1738111
NA	CHEMICAL	GENE-Y	0	16	chemical binding was not altered by compounds with activity at gene , gene , gene , gene or alpha-2 receptor sites .	T45	T51	1738111
NA	CHEMICAL	GENE-Y	11	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T1	T52	1738111
NA	CHEMICAL	GENE-Y	20	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T3	T52	1738111
NA	CHEMICAL	GENE-Y	23	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T4	T52	1738111
NA	CHEMICAL	GENE-Y	7	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T5	T52	1738111
NA	CHEMICAL	GENE-Y	27	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T6	T52	1738111
NA	CHEMICAL	GENE-Y	28	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T7	T52	1738111
NA	CHEMICAL	GENE-Y	30	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T8	T52	1738111
NA	CHEMICAL	GENE-Y	33	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T9	T52	1738111
NA	CHEMICAL	GENE-Y	36	7	Similar to the pharmacological characteristics of the gene site defined by chemical , compounds most active at inhibiting 15 mM chemical-stimulated release of chemical were chemical = chemical chemical = chemical greater than chemical greater than chemical .	T10	T52	1738111
NA	CHEMICAL	GENE-Y	13	5	A correlation analysis of selective gene compounds comparing the pKD for displacement of chemical vs .	T11	T58	1738111
NA	CHEMICAL	GENE-Y	5	16	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T13	T59	1738111
NA	CHEMICAL	GENE-Y	5	20	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T13	T60	1738111
NA	CHEMICAL	GENE-Y	15	16	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T14	T59	1738111
NA	CHEMICAL	GENE-Y	15	20	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T14	T60	1738111
NA	CHEMICAL	GENE-Y	19	16	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T15	T59	1738111
NA	CHEMICAL	GENE-Y	19	20	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T15	T60	1738111
NA	CHEMICAL	GENE-Y	24	16	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T16	T59	1738111
NA	CHEMICAL	GENE-Y	24	20	the IC50 for inhibition of chemical release demonstrated the pharmacological similarity of the presynaptic inhibitory chemical autoreceptor and the chemical receptor site defined by chemical binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .	T16	T60	1738111
CPR:3	CHEMICAL	GENE-N	0	6	chemical and chemical activate chemical-activated protein kinase in the heart by increasing cytosolic chemical concentration .	T40	T59	17369473
CPR:3	CHEMICAL	GENE-N	2	6	chemical and chemical activate chemical-activated protein kinase in the heart by increasing cytosolic chemical concentration .	T42	T59	17369473
NA	CHEMICAL	GENE-N	4	6	chemical and chemical activate chemical-activated protein kinase in the heart by increasing cytosolic chemical concentration .	T43	T59	17369473
NA	CHEMICAL	GENE-N	13	6	chemical and chemical activate chemical-activated protein kinase in the heart by increasing cytosolic chemical concentration .	T41	T59	17369473
NA	CHEMICAL	GENE-N	0	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T1	T44	17369473
NA	CHEMICAL	GENE-N	0	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T1	T52	17369473
NA	CHEMICAL	GENE-N	19	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T2	T44	17369473
NA	CHEMICAL	GENE-N	19	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T2	T52	17369473
NA	CHEMICAL	GENE-N	23	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T7	T44	17369473
NA	CHEMICAL	GENE-N	23	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T7	T52	17369473
NA	CHEMICAL	GENE-N	28	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T13	T44	17369473
NA	CHEMICAL	GENE-N	28	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T13	T52	17369473
NA	CHEMICAL	GENE-N	28	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T14	T44	17369473
NA	CHEMICAL	GENE-N	28	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T14	T52	17369473
NA	CHEMICAL	GENE-N	31	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T17	T44	17369473
NA	CHEMICAL	GENE-N	31	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T17	T52	17369473
NA	CHEMICAL	GENE-N	31	2	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T20	T44	17369473
NA	CHEMICAL	GENE-N	31	4	chemical-activated protein kinase ( gene ) acts as a cellular energy sensor : it responds to an increase in chemical concentration ( [ chemical ] ) or the chemical-to-chemical ratio ( chemical/chemical ) .	T20	T52	17369473
CPR:3	CHEMICAL	GENE-N	0	13	chemical and chemical , which are chemical , have been reported to increase gene activity without increasing chemical/chemical .	T23	T51	17369473
CPR:3	CHEMICAL	GENE-N	2	13	chemical and chemical , which are chemical , have been reported to increase gene activity without increasing chemical/chemical .	T25	T51	17369473
CPR:3	CHEMICAL	GENE-N	6	13	chemical and chemical , which are chemical , have been reported to increase gene activity without increasing chemical/chemical .	T26	T51	17369473
NA	CHEMICAL	GENE-N	17	13	chemical and chemical , which are chemical , have been reported to increase gene activity without increasing chemical/chemical .	T27	T51	17369473
NA	CHEMICAL	GENE-N	17	13	chemical and chemical , which are chemical , have been reported to increase gene activity without increasing chemical/chemical .	T28	T51	17369473
NA	CHEMICAL	GENE-N	7	9	This study tests the hypothesis that these chemical increase gene activity in the heart by increasing cytosolic [ chemical ] .	T29	T53	17369473
NA	CHEMICAL	GENE-N	18	9	This study tests the hypothesis that these chemical increase gene activity in the heart by increasing cytosolic [ chemical ] .	T30	T53	17369473
NA	CHEMICAL	GENE-N	30	10	At various times , hearts were freeze-clamped and assayed for gene activity , phosphorylation of Thr ( 172 ) on gene , and phosphorylation of Ser ( 79 ) on chemical carboxylase , an gene target .	T37	T54	17369473
NA	CHEMICAL	GENE-N	30	20	At various times , hearts were freeze-clamped and assayed for gene activity , phosphorylation of Thr ( 172 ) on gene , and phosphorylation of Ser ( 79 ) on chemical carboxylase , an gene target .	T37	T55	17369473
NA	CHEMICAL	GENE-N	30	31	At various times , hearts were freeze-clamped and assayed for gene activity , phosphorylation of Thr ( 172 ) on gene , and phosphorylation of Ser ( 79 ) on chemical carboxylase , an gene target .	T37	T56	17369473
NA	CHEMICAL	GENE-N	30	34	At various times , hearts were freeze-clamped and assayed for gene activity , phosphorylation of Thr ( 172 ) on gene , and phosphorylation of Ser ( 79 ) on chemical carboxylase , an gene target .	T37	T57	17369473
CPR:3	CHEMICAL	GENE-N	4	28	In hearts treated with chemical for 18 min and then perfused for 20 min with Krebs-Henseleit buffer , [ chemical ] began to increase at 26 min and gene activity was elevated at 36 min .	T38	T58	17369473
NA	CHEMICAL	GENE-N	19	28	In hearts treated with chemical for 18 min and then perfused for 20 min with Krebs-Henseleit buffer , [ chemical ] began to increase at 26 min and gene activity was elevated at 36 min .	T39	T58	17369473
CPR:3	CHEMICAL	GENE-N	4	15	In hearts treated with chemical , [ chemical ] was increased at 50 min and gene activity , phosphorylated gene , and gene were elevated at 61 min .	T3	T45	17369473
CPR:3	CHEMICAL	GENE-N	4	19	In hearts treated with chemical , [ chemical ] was increased at 50 min and gene activity , phosphorylated gene , and gene were elevated at 61 min .	T3	T46	17369473
CPR:3	CHEMICAL	GENE-N	4	22	In hearts treated with chemical , [ chemical ] was increased at 50 min and gene activity , phosphorylated gene , and gene were elevated at 61 min .	T3	T47	17369473
NA	CHEMICAL	GENE-N	7	15	In hearts treated with chemical , [ chemical ] was increased at 50 min and gene activity , phosphorylated gene , and gene were elevated at 61 min .	T4	T45	17369473
NA	CHEMICAL	GENE-N	7	19	In hearts treated with chemical , [ chemical ] was increased at 50 min and gene activity , phosphorylated gene , and gene were elevated at 61 min .	T4	T46	17369473
NA	CHEMICAL	GENE-N	7	22	In hearts treated with chemical , [ chemical ] was increased at 50 min and gene activity , phosphorylated gene , and gene were elevated at 61 min .	T4	T47	17369473
CPR:3	CHEMICAL	GENE-N	3	7	In summary , chemical and chemical increase gene activity and phosphorylation in the isolated heart .	T11	T48	17369473
CPR:3	CHEMICAL	GENE-N	5	7	In summary , chemical and chemical increase gene activity and phosphorylation in the isolated heart .	T12	T48	17369473
NA	CHEMICAL	GENE-N	15	3	The increase in gene activity was always preceded by and correlated with increased cytosolic [ chemical ] .	T15	T49	17369473
NA	CHEMICAL	GENE-Y	3	4	The effect of chemical-H1 receptor antagonism with chemical on concentration-related chemical-induced bronchoconstriction in asthma .	T12	T17	2569356
CPR:6	CHEMICAL	GENE-Y	7	4	The effect of chemical-H1 receptor antagonism with chemical on concentration-related chemical-induced bronchoconstriction in asthma .	T13	T17	2569356
NA	CHEMICAL	GENE-Y	10	4	The effect of chemical-H1 receptor antagonism with chemical on concentration-related chemical-induced bronchoconstriction in asthma .	T14	T17	2569356
NA	CHEMICAL	GENE-Y	1	2	Selective chemical-H1 receptor antagonists inhibit chemical ( chemical ) -induced bronchoconstriction by greater than 80 % when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of chemical required to produce a 20 % decrease in FEV1 from baseline ( PC20 ) .	T1	T15	2569356
NA	CHEMICAL	GENE-Y	5	2	Selective chemical-H1 receptor antagonists inhibit chemical ( chemical ) -induced bronchoconstriction by greater than 80 % when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of chemical required to produce a 20 % decrease in FEV1 from baseline ( PC20 ) .	T5	T15	2569356
NA	CHEMICAL	GENE-Y	7	2	Selective chemical-H1 receptor antagonists inhibit chemical ( chemical ) -induced bronchoconstriction by greater than 80 % when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of chemical required to produce a 20 % decrease in FEV1 from baseline ( PC20 ) .	T8	T15	2569356
NA	CHEMICAL	GENE-Y	34	2	Selective chemical-H1 receptor antagonists inhibit chemical ( chemical ) -induced bronchoconstriction by greater than 80 % when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of chemical required to produce a 20 % decrease in FEV1 from baseline ( PC20 ) .	T2	T15	2569356
NA	CHEMICAL	GENE-Y	0	2	chemical H1 receptor involvement in prepulse inhibition and memory function : relevance for the antipsychotic actions of chemical .	T24	T32	17382376
NA	CHEMICAL	GENE-Y	4	2	chemical H1 receptor involvement in prepulse inhibition and memory function : relevance for the antipsychotic actions of chemical .	T25	T32	17382376
NA	CHEMICAL	GENE-Y	0	1	chemical H ( 1 ) blockade is one of the more prominent actions of the multi-receptor acting antipsychotic chemical .	T1	T26	17382376
CPR:4	CHEMICAL	GENE-Y	18	1	chemical H ( 1 ) blockade is one of the more prominent actions of the multi-receptor acting antipsychotic chemical .	T2	T26	17382376
CPR:6	CHEMICAL	GENE-Y	11	8	It is currently not known how much this gene antagonism of chemical contributes to the therapeutic or adverse side effects of chemical .	T12	T29	17382376
NA	CHEMICAL	GENE-Y	21	8	It is currently not known how much this gene antagonism of chemical contributes to the therapeutic or adverse side effects of chemical .	T13	T29	17382376
NA	CHEMICAL	GENE-Y	15	8	The current studies with Sprague-Dawley rats were conducted to determine the participation of gene subtype in sensorimotor plasticity and memory function affected by chemical using tests of prepulse inhibition ( PPI ) and radial-arm maze choice accuracy .	T14	T30	17382376
CPR:6	CHEMICAL	GENE-Y	12	10	In the current project , we found that the selective gene antagonist chemical also reversed the chemical-induced impairment in PPI of tactile startle with an auditory prepulse .	T19	T31	17382376
CPR:3	CHEMICAL	GENE-Y	16	10	In the current project , we found that the selective gene antagonist chemical also reversed the chemical-induced impairment in PPI of tactile startle with an auditory prepulse .	T20	T31	17382376
CPR:4	CHEMICAL	GENE-Y	7	16	In summary , the therapeutic effect of chemical in reversing PPI impairment was mimicked by the gene antagonist chemical , while chemical had a mixed effect on cognition .	T7	T27	17382376
CPR:6	CHEMICAL	GENE-Y	8	16	In summary , the therapeutic effect of chemical in reversing PPI impairment was mimicked by the gene antagonist chemical , while chemical had a mixed effect on cognition .	T8	T27	17382376
CPR:6	CHEMICAL	GENE-Y	8	16	In summary , the therapeutic effect of chemical in reversing PPI impairment was mimicked by the gene antagonist chemical , while chemical had a mixed effect on cognition .	T9	T27	17382376
NA	CHEMICAL	GENE-Y	0	1	chemical receptor signaling as a target for novel breast cancer therapeutics .	T9	T43	23103568
NA	CHEMICAL	GENE-Y	13	22	In breast cancer ( BC ) epithelial cells , the mitogenic action of chemical is transduced through binding to two receptors , gene and gene , which act as transcription factors .	T7	T17	23103568
NA	CHEMICAL	GENE-Y	13	24	In breast cancer ( BC ) epithelial cells , the mitogenic action of chemical is transduced through binding to two receptors , gene and gene , which act as transcription factors .	T7	T21	23103568
NA	CHEMICAL	GENE-Y	0	5	Anti-chemical ( AEs ) and gene inhibitors ( AIs ) are used clinically to arrest the chemical-dependent growth of BC .	T2	T23	23103568
NA	CHEMICAL	GENE-Y	16	5	Anti-chemical ( AEs ) and gene inhibitors ( AIs ) are used clinically to arrest the chemical-dependent growth of BC .	T3	T23	23103568
NA	CHEMICAL	GENE-Y	0	8	chemical effects are mediated not only through nuclear gene but also through cytoplasmic/membrane gene and gene-coupled gene .	T5	T24	23103568
NA	CHEMICAL	GENE-Y	0	13	chemical effects are mediated not only through nuclear gene but also through cytoplasmic/membrane gene and gene-coupled gene .	T5	T25	23103568
NA	CHEMICAL	GENE-N	0	15	chemical effects are mediated not only through nuclear gene but also through cytoplasmic/membrane gene and gene-coupled gene .	T5	T26	23103568
NA	CHEMICAL	GENE-Y	0	16	chemical effects are mediated not only through nuclear gene but also through cytoplasmic/membrane gene and gene-coupled gene .	T5	T27	23103568
NA	CHEMICAL	GENE-Y	9	4	The partners of extra-nuclear gene include gene and the chemical kinase gene .	T8	T37	23103568
NA	CHEMICAL	GENE-N	9	6	The partners of extra-nuclear gene include gene and the chemical kinase gene .	T8	T38	23103568
NA	CHEMICAL	GENE-N	9	10	The partners of extra-nuclear gene include gene and the chemical kinase gene .	T8	T39	23103568
NA	CHEMICAL	GENE-Y	9	11	The partners of extra-nuclear gene include gene and the chemical kinase gene .	T8	T40	23103568
NA	CHEMICAL	GENE-N	5	0	gene-mediated signaling also modulates the chemical response .	T1	T20	23103568
NA	CHEMICAL	GENE-Y	0	2	chemical dehydrogenase 5 ( gene ) is a member of the gene family of yet undefined functions .	T1	T7	23159888
NA	CHEMICAL	GENE-Y	0	2	chemical dehydrogenase 5 ( gene ) is a member of the gene family of yet undefined functions .	T1	T15	23159888
NA	CHEMICAL	GENE-N	0	1	chemical dehydrogenase 5 ( gene ) is a member of the gene family of yet undefined functions .	T1	T19	23159888
NA	CHEMICAL	GENE-Y	7	2	chemical dehydrogenase 5 ( gene ) is a member of the gene family of yet undefined functions .	T3	T7	23159888
NA	CHEMICAL	GENE-Y	7	2	chemical dehydrogenase 5 ( gene ) is a member of the gene family of yet undefined functions .	T3	T15	23159888
NA	CHEMICAL	GENE-N	7	1	chemical dehydrogenase 5 ( gene ) is a member of the gene family of yet undefined functions .	T3	T19	23159888
NA	CHEMICAL	GENE-N	16	1	A gene structure of similar type has been isolated at the cDNA level using gene as a screening probe , where the rat cDNA structure displayed several atypical properties .	T2	T14	23159888
NA	CHEMICAL	GENE-Y	16	0	A gene structure of similar type has been isolated at the cDNA level using gene as a screening probe , where the rat cDNA structure displayed several atypical properties .	T2	T16	23159888
NA	CHEMICAL	GENE-Y	26	4	However , no soluble gene protein could be heterologously expressed in Escherichia coli cells with expression systems successfully used for other gene , including fused to chemical-chemical-transferase .	T4	T22	23159888
NA	CHEMICAL	GENE-N	26	21	However , no soluble gene protein could be heterologously expressed in Escherichia coli cells with expression systems successfully used for other gene , including fused to chemical-chemical-transferase .	T4	T23	23159888
NA	CHEMICAL	GENE-Y	26	4	However , no soluble gene protein could be heterologously expressed in Escherichia coli cells with expression systems successfully used for other gene , including fused to chemical-chemical-transferase .	T5	T22	23159888
NA	CHEMICAL	GENE-N	26	21	However , no soluble gene protein could be heterologously expressed in Escherichia coli cells with expression systems successfully used for other gene , including fused to chemical-chemical-transferase .	T5	T23	23159888
NA	CHEMICAL	GENE-Y	8	2	T-Cells from gene+ Human Subjects Are Activated with chemical through Two Independent Pathways and Induce Cell Death by Multiple Mechanisms .	T12	T22	23541086
NA	CHEMICAL	GENE-Y	26	17	The objectives of this study were to characterize the functionality of drug-responsive CD8+ T-cell clones generated from gene+ drug-naive subjects and to explore the relationship between chemical accumulation in antigen presenting cells and the T-cell response .	T8	T19	23541086
NA	CHEMICAL	GENE-N	20	5	Seventy-four CD8+ clones expressing different gene were shown to proliferate and kill target cells via different mechanisms when exposed to chemical .	T9	T20	23541086
NA	CHEMICAL	GENE-N	9	18	These data suggest that T-cells can be activated by chemical through a direct interaction with surface and intracellular gene ( gene ) molecules .	T4	T14	23541086
NA	CHEMICAL	GENE-N	9	20	These data suggest that T-cells can be activated by chemical through a direct interaction with surface and intracellular gene ( gene ) molecules .	T4	T15	23541086
NA	CHEMICAL	GENE-N	4	9	With the former , chemical seemingly participates in the gene gene binding interaction .	T5	T16	23541086
NA	CHEMICAL	GENE-N	4	10	With the former , chemical seemingly participates in the gene gene binding interaction .	T5	T17	23541086
NA	CHEMICAL	GENE-N	9	5	Genetic polymorphism and activities of gene : implications for chemical metabolism and cytotoxicity .	T11	T31	1590750
NA	CHEMICAL	GENE-N	0	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T1	T14	1590750
NA	CHEMICAL	GENE-N	0	3	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T1	T22	1590750
NA	CHEMICAL	GENE-N	0	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T1	T24	1590750
NA	CHEMICAL	GENE-N	0	9	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T1	T25	1590750
NA	CHEMICAL	GENE-N	6	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T5	T14	1590750
NA	CHEMICAL	GENE-N	6	3	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T5	T22	1590750
NA	CHEMICAL	GENE-N	6	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T5	T24	1590750
NA	CHEMICAL	GENE-N	6	9	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) exhibit genetic polymorphism and tissue specificity .	T5	T25	1590750
CPR:9	CHEMICAL	GENE-N	15	5	The identity of the lung gene was further demonstrated by their characteristic pH-activity profiles for chemical oxidation , Km values for NAD and chemical , and inhibition by chemical or chemical .	T6	T23	1590750
CPR:9	CHEMICAL	GENE-N	23	5	The identity of the lung gene was further demonstrated by their characteristic pH-activity profiles for chemical oxidation , Km values for NAD and chemical , and inhibition by chemical or chemical .	T7	T23	1590750
CPR:4	CHEMICAL	GENE-N	28	5	The identity of the lung gene was further demonstrated by their characteristic pH-activity profiles for chemical oxidation , Km values for NAD and chemical , and inhibition by chemical or chemical .	T8	T23	1590750
CPR:4	CHEMICAL	GENE-N	17	5	The identity of the lung gene was further demonstrated by their characteristic pH-activity profiles for chemical oxidation , Km values for NAD and chemical , and inhibition by chemical or chemical .	T9	T23	1590750
CPR:9	CHEMICAL	GENE-Y	6	18	These findings indicate that human pulmonary chemical-metabolizing activities differ significantly with respect to genetic polymorphism at both the gene and the gene loci .	T2	T18	1590750
CPR:9	CHEMICAL	GENE-Y	6	21	These findings indicate that human pulmonary chemical-metabolizing activities differ significantly with respect to genetic polymorphism at both the gene and the gene loci .	T2	T19	1590750
CPR:3	CHEMICAL	GENE-N	0	7	chemical exposure ( 20 mg/kg ) increased gene ( gene ) and gene phosphorylation , but decreased gene-Thr-34 phosphorylation .	T19	T33	23385959
CPR:3	CHEMICAL	GENE-N	0	9	chemical exposure ( 20 mg/kg ) increased gene ( gene ) and gene phosphorylation , but decreased gene-Thr-34 phosphorylation .	T19	T34	23385959
CPR:3	CHEMICAL	GENE-N	0	12	chemical exposure ( 20 mg/kg ) increased gene ( gene ) and gene phosphorylation , but decreased gene-Thr-34 phosphorylation .	T19	T35	23385959
CPR:4	CHEMICAL	GENE-Y	0	17	chemical exposure ( 20 mg/kg ) increased gene ( gene ) and gene phosphorylation , but decreased gene-Thr-34 phosphorylation .	T19	T36	23385959
CPR:3	CHEMICAL	GENE-N	0	8	chemical ( 10 and 20 mg/kg ) increased gene activity and chemical production ( a biological marker of lipid peroxidation ) .	T1	T23	23385959
NA	CHEMICAL	GENE-N	1	8	chemical ( 10 and 20 mg/kg ) increased gene activity and chemical production ( a biological marker of lipid peroxidation ) .	T2	T23	23385959
CPR:4	CHEMICAL	GENE-N	4	15	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T5	T24	23385959
CPR:4	CHEMICAL	GENE-N	4	17	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T5	T25	23385959
CPR:4	CHEMICAL	GENE-N	4	29	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T5	T26	23385959
CPR:3	CHEMICAL	GENE-N	7	15	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T6	T24	23385959
CPR:3	CHEMICAL	GENE-N	7	17	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T6	T25	23385959
NA	CHEMICAL	GENE-N	7	29	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T6	T26	23385959
NA	CHEMICAL	GENE-N	23	15	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T7	T24	23385959
NA	CHEMICAL	GENE-N	23	17	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T7	T25	23385959
CPR:3	CHEMICAL	GENE-N	23	29	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T7	T26	23385959
NA	CHEMICAL	GENE-N	8	15	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T8	T24	23385959
NA	CHEMICAL	GENE-N	8	17	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T8	T25	23385959
NA	CHEMICAL	GENE-N	8	29	Notably , the antioxidant chemical™ reversed the chemical ( 20 mg/kg ) -dependent augmentation in gene ( gene ) phosphorylation and reduced the chemical ( 20 mg/kg ) -induced gene activity and chemical production .	T8	T26	23385959
CPR:3	CHEMICAL	GENE-N	11	30	These findings are the first to show that long-term exposure to chemical during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers , gene ( gene ) phosphorylation and gene activity in the striatum .	T11	T27	23385959
CPR:3	CHEMICAL	GENE-N	11	32	These findings are the first to show that long-term exposure to chemical during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers , gene ( gene ) phosphorylation and gene activity in the striatum .	T11	T28	23385959
CPR:3	CHEMICAL	GENE-N	11	13	These findings are the first to show that long-term exposure to chemical during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers , gene ( gene ) phosphorylation and gene activity in the striatum .	T11	T29	23385959
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a potent inhibitor of chemical oxidoreductase , at high concentration ( 500 microm ) caused only a 72 % decrease in the utilization of chemical .	T3	T6	10561120
NA	CHEMICAL	GENE-N	6	2	chemical , a potent inhibitor of chemical oxidoreductase , at high concentration ( 500 microm ) caused only a 72 % decrease in the utilization of chemical .	T4	T6	10561120
NA	CHEMICAL	GENE-N	22	2	chemical , a potent inhibitor of chemical oxidoreductase , at high concentration ( 500 microm ) caused only a 72 % decrease in the utilization of chemical .	T5	T6	10561120
NA	CHEMICAL	GENE-N	7	0	gene potentiator drugs , huprine X and chemical , increase chemical release by blocking gene activity but not acting on gene .	T18	T28	16248990
CPR:4	CHEMICAL	GENE-Y	7	14	gene potentiator drugs , huprine X and chemical , increase chemical release by blocking gene activity but not acting on gene .	T18	T30	16248990
NA	CHEMICAL	GENE-N	7	20	gene potentiator drugs , huprine X and chemical , increase chemical release by blocking gene activity but not acting on gene .	T18	T29	16248990
NA	CHEMICAL	GENE-N	10	0	gene potentiator drugs , huprine X and chemical , increase chemical release by blocking gene activity but not acting on gene .	T19	T28	16248990
NA	CHEMICAL	GENE-Y	10	14	gene potentiator drugs , huprine X and chemical , increase chemical release by blocking gene activity but not acting on gene .	T19	T30	16248990
NA	CHEMICAL	GENE-N	10	20	gene potentiator drugs , huprine X and chemical , increase chemical release by blocking gene activity but not acting on gene .	T19	T29	16248990
NA	CHEMICAL	GENE-N	38	8	The main goal of the present study was to analyse the effects of ( +/- ) -huprine X ( ( +/- ) -HX ) and galantamine ( GAL ) , with potentiating action on gene , and huperzine A ( HPA ) , devoid of nicotinic activity , on chemical ( chemical ) release in striatal slices of rat brain .	T9	T21	16248990
CPR:4	CHEMICAL	GENE-Y	4	20	This effect was reverted in the presence of chemical ( chemical ; 0.1 microM ) , which blocks the pre-synaptic gene .	T11	T26	16248990
CPR:4	CHEMICAL	GENE-Y	10	20	This effect was reverted in the presence of chemical ( chemical ; 0.1 microM ) , which blocks the pre-synaptic gene .	T12	T26	16248990
NA	CHEMICAL	GENE-Y	13	35	After that , a wide range of concentrations of drugs , concomitantly with chemical ( 0.1 microM ) , was studied in the presence of chemical ( chemical ; 0.01 microM ) , a chemical D2 antagonist .	T13	T27	16248990
CPR:6	CHEMICAL	GENE-Y	3	35	After that , a wide range of concentrations of drugs , concomitantly with chemical ( 0.1 microM ) , was studied in the presence of chemical ( chemical ; 0.01 microM ) , a chemical D2 antagonist .	T14	T27	16248990
CPR:6	CHEMICAL	GENE-Y	27	35	After that , a wide range of concentrations of drugs , concomitantly with chemical ( 0.1 microM ) , was studied in the presence of chemical ( chemical ; 0.01 microM ) , a chemical D2 antagonist .	T15	T27	16248990
NA	CHEMICAL	GENE-Y	3	35	After that , a wide range of concentrations of drugs , concomitantly with chemical ( 0.1 microM ) , was studied in the presence of chemical ( chemical ; 0.01 microM ) , a chemical D2 antagonist .	T16	T27	16248990
NA	CHEMICAL	GENE-N	12	5	To test the role of gene in the drugs ' effects on chemical release , chemical ( chemical ) 100 microM was used to block such receptors .	T1	T20	16248990
CPR:4	CHEMICAL	GENE-N	5	5	To test the role of gene in the drugs ' effects on chemical release , chemical ( chemical ) 100 microM was used to block such receptors .	T2	T20	16248990
CPR:4	CHEMICAL	GENE-N	17	5	To test the role of gene in the drugs ' effects on chemical release , chemical ( chemical ) 100 microM was used to block such receptors .	T3	T20	16248990
NA	CHEMICAL	GENE-N	2	3	A novel chemical-responsive element regulates chemical-induced gene expression .	T21	T65	14993281
NA	CHEMICAL	GENE-N	2	6	A novel chemical-responsive element regulates chemical-induced gene expression .	T21	T64	14993281
NA	CHEMICAL	GENE-N	5	3	A novel chemical-responsive element regulates chemical-induced gene expression .	T20	T65	14993281
CPR:3	CHEMICAL	GENE-N	5	6	A novel chemical-responsive element regulates chemical-induced gene expression .	T20	T64	14993281
CPR:3	CHEMICAL	GENE-Y	0	8	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T2	T34	14993281
CPR:3	CHEMICAL	GENE-Y	0	10	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T2	T39	14993281
NA	CHEMICAL	GENE-Y	0	36	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T2	T50	14993281
NA	CHEMICAL	GENE-Y	15	8	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T9	T34	14993281
NA	CHEMICAL	GENE-Y	15	10	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T9	T39	14993281
NA	CHEMICAL	GENE-Y	15	36	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T9	T50	14993281
NA	CHEMICAL	GENE-Y	39	8	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T12	T34	14993281
NA	CHEMICAL	GENE-Y	39	10	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T12	T39	14993281
CPR:3	CHEMICAL	GENE-Y	39	36	chemical is known to induce expression of the gene ( gene ) gene which propels chemical-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of gene expression by chemical .	T12	T50	14993281
NA	CHEMICAL	GENE-N	1	9	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T13	T51	14993281
NA	CHEMICAL	GENE-N	1	11	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T13	T52	14993281
NA	CHEMICAL	GENE-N	1	9	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T13	T53	14993281
NA	CHEMICAL	GENE-N	1	15	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T13	T54	14993281
NA	CHEMICAL	GENE-Y	1	15	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T13	T55	14993281
NA	CHEMICAL	GENE-N	8	9	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T15	T51	14993281
NA	CHEMICAL	GENE-N	8	11	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T15	T52	14993281
NA	CHEMICAL	GENE-N	8	9	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T15	T53	14993281
NA	CHEMICAL	GENE-N	8	15	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T15	T54	14993281
NA	CHEMICAL	GENE-Y	8	15	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T15	T55	14993281
NA	CHEMICAL	GENE-N	14	9	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T16	T51	14993281
NA	CHEMICAL	GENE-N	14	11	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T16	T52	14993281
NA	CHEMICAL	GENE-N	14	9	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T16	T53	14993281
NA	CHEMICAL	GENE-N	14	15	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T16	T54	14993281
NA	CHEMICAL	GENE-Y	14	15	The chemical-treated HL-60 cells used here expressed all chemical receptor ( gene ) and chemical X receptor ( gene ) subtypes ( as detected by Northern analysis ) except gene .	T16	T55	14993281
CPR:3	CHEMICAL	GENE-Y	0	7	A 5'-flanking region capable of supporting chemical-induced gene activation in HL-60 cells was found to contain a 205-bp sequence in the distal portion that was necessary for transcriptional activation by chemical .	T17	T61	14993281
NA	CHEMICAL	GENE-Y	0	7	A 5'-flanking region capable of supporting chemical-induced gene activation in HL-60 cells was found to contain a 205-bp sequence in the distal portion that was necessary for transcriptional activation by chemical .	T18	T61	14993281
NA	CHEMICAL	GENE-Y	7	3	Within this sequence gene footprinting revealed that chemical induced binding of a gene to an element containing two gene .	T19	T62	14993281
NA	CHEMICAL	GENE-N	7	12	Within this sequence gene footprinting revealed that chemical induced binding of a gene to an element containing two gene .	T19	T63	14993281
NA	CHEMICAL	GENE-N	7	18	Within this sequence gene footprinting revealed that chemical induced binding of a gene to an element containing two gene .	T19	T22	14993281
NA	CHEMICAL	GENE-N	21	1	Both gene were needed for binding the complex , and mutation of either gene caused the loss of transcriptional activation by chemical .	T3	T25	14993281
NA	CHEMICAL	GENE-N	21	13	Both gene were needed for binding the complex , and mutation of either gene caused the loss of transcriptional activation by chemical .	T3	T26	14993281
NA	CHEMICAL	GENE-N	12	5	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T27	14993281
NA	CHEMICAL	GENE-Y	12	20	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T28	14993281
NA	CHEMICAL	GENE-Y	12	22	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T29	14993281
CPR:4	CHEMICAL	GENE-Y	12	27	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T30	14993281
NA	CHEMICAL	GENE-Y	12	29	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T31	14993281
NA	CHEMICAL	GENE-N	12	6	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T32	14993281
NA	CHEMICAL	GENE-N	12	50	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T4	T33	14993281
NA	CHEMICAL	GENE-N	44	5	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T27	14993281
NA	CHEMICAL	GENE-Y	44	20	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T28	14993281
NA	CHEMICAL	GENE-Y	44	22	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T29	14993281
NA	CHEMICAL	GENE-Y	44	27	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T30	14993281
NA	CHEMICAL	GENE-Y	44	29	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T31	14993281
NA	CHEMICAL	GENE-N	44	6	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T32	14993281
NA	CHEMICAL	GENE-N	44	50	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T33	14993281
NA	CHEMICAL	GENE-Y	44	62	The ability of this cis-acting gene to activate transcription in response to chemical also depended on downstream sequences where an gene ( gene ) site and a gene ( gene ) site between this element and the transcriptional start , as well as a chemical response element binding factor ( gene ) site between the transcriptional start and first exon of the gene gene , were necessary .	T5	T35	14993281
NA	CHEMICAL	GENE-Y	0	0	A transcription factor-transcription factor binding array analysis of nuclear lysate from chemical-treated cells indicated several prominent gene binding partners ; among these , gene , gene , and gene were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex .	T6	T36	14993281
NA	CHEMICAL	GENE-Y	0	23	A transcription factor-transcription factor binding array analysis of nuclear lysate from chemical-treated cells indicated several prominent gene binding partners ; among these , gene , gene , and gene were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex .	T6	T37	14993281
NA	CHEMICAL	GENE-Y	0	0	A transcription factor-transcription factor binding array analysis of nuclear lysate from chemical-treated cells indicated several prominent gene binding partners ; among these , gene , gene , and gene were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex .	T6	T38	14993281
NA	CHEMICAL	GENE-Y	0	28	A transcription factor-transcription factor binding array analysis of nuclear lysate from chemical-treated cells indicated several prominent gene binding partners ; among these , gene , gene , and gene were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex .	T6	T40	14993281
CPR:3	CHEMICAL	GENE-Y	10	13	In sum the results of the present study indicate that chemical-induced expression of gene expression depends on a novel chemical response element .	T8	T41	14993281
NA	CHEMICAL	GENE-N	10	21	In sum the results of the present study indicate that chemical-induced expression of gene expression depends on a novel chemical response element .	T8	T42	14993281
NA	CHEMICAL	GENE-Y	19	13	In sum the results of the present study indicate that chemical-induced expression of gene expression depends on a novel chemical response element .	T10	T41	14993281
NA	CHEMICAL	GENE-N	19	21	In sum the results of the present study indicate that chemical-induced expression of gene expression depends on a novel chemical response element .	T10	T42	14993281
NA	CHEMICAL	GENE-N	4	32	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T3	T12	23440512
NA	CHEMICAL	GENE-N	4	34	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T3	T13	23440512
NA	CHEMICAL	GENE-N	4	36	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T3	T14	23440512
NA	CHEMICAL	GENE-N	4	38	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T3	T15	23440512
NA	CHEMICAL	GENE-N	4	41	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T3	T16	23440512
CPR:3	CHEMICAL	GENE-N	13	32	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T4	T12	23440512
CPR:3	CHEMICAL	GENE-N	13	34	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T4	T13	23440512
CPR:3	CHEMICAL	GENE-N	13	36	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T4	T14	23440512
NA	CHEMICAL	GENE-N	13	38	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T4	T15	23440512
CPR:3	CHEMICAL	GENE-N	13	41	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T4	T16	23440512
CPR:3	CHEMICAL	GENE-N	15	32	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T5	T12	23440512
CPR:3	CHEMICAL	GENE-N	15	34	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T5	T13	23440512
CPR:3	CHEMICAL	GENE-N	15	36	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T5	T14	23440512
NA	CHEMICAL	GENE-N	15	38	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T5	T15	23440512
CPR:3	CHEMICAL	GENE-N	15	41	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T5	T16	23440512
NA	CHEMICAL	GENE-N	23	32	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T6	T12	23440512
NA	CHEMICAL	GENE-N	23	34	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T6	T13	23440512
NA	CHEMICAL	GENE-N	23	36	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T6	T14	23440512
NA	CHEMICAL	GENE-N	23	38	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T6	T15	23440512
NA	CHEMICAL	GENE-N	23	41	The pleiotropic effects of chemical are exerted mainly by one active metabolite , chemical ( chemical ) , which regulates the expression of a battery of target genes through several families of gene ( gene , gene and gene ) , gene and multiple coregulators .	T6	T16	23440512
NA	CHEMICAL	GENE-N	2	10	However , chemical itself proved recently to be active and gene to be present in the cytosol to regulate translation and cell plasticity .	T8	T18	23440512
CPR:4	CHEMICAL	GENE-Y	4	6	Synthesis and evaluation of chemical as gene inhibitory anticancer agents .	T6	T10	23474389
CPR:4	CHEMICAL	GENE-Y	4	15	A series of substituted chemical has been synthesised and tested in vitro as potential pro-apoptotic gene-inhibitory anticancer agents .	T1	T7	23474389
CPR:4	CHEMICAL	GENE-Y	6	18	Active compounds , such as the chemical analogue 6c , were found to exhibit sub-micromolar IC50 values in gene expressing human cancer cell lines .	T5	T8	23474389
NA	CHEMICAL	GENE-Y	10	6	Modification of the Catalytic Function of gene by Formation of chemical Bonds .	T20	T29	23444386
CPR:9	CHEMICAL	GENE-Y	16	1	The gene catalyzes the sulfation of a broad range of xenobiotics , as well as endogenous chemical and chemical .	T4	T25	23444386
CPR:9	CHEMICAL	GENE-Y	6	1	The gene catalyzes the sulfation of a broad range of xenobiotics , as well as endogenous chemical and chemical .	T8	T25	23444386
NA	CHEMICAL	GENE-Y	9	12	We have examined the hypothesis that the formation of chemical bonds in gene can reversibly regulate the catalytic function of the enzyme .	T13	T26	23444386
NA	CHEMICAL	GENE-Y	1	16	Three chemical oxidants were used as model compounds to investigate their effects on homogeneous preparations of gene : chemical , chemical , and chemical ) ( chemical ) .	T14	T27	23444386
NA	CHEMICAL	GENE-Y	18	16	Three chemical oxidants were used as model compounds to investigate their effects on homogeneous preparations of gene : chemical , chemical , and chemical ) ( chemical ) .	T15	T27	23444386
NA	CHEMICAL	GENE-Y	20	16	Three chemical oxidants were used as model compounds to investigate their effects on homogeneous preparations of gene : chemical , chemical , and chemical ) ( chemical ) .	T16	T27	23444386
NA	CHEMICAL	GENE-Y	19	16	Three chemical oxidants were used as model compounds to investigate their effects on homogeneous preparations of gene : chemical , chemical , and chemical ) ( chemical ) .	T17	T27	23444386
NA	CHEMICAL	GENE-Y	26	16	Three chemical oxidants were used as model compounds to investigate their effects on homogeneous preparations of gene : chemical , chemical , and chemical ) ( chemical ) .	T18	T27	23444386
CPR:9	CHEMICAL	GENE-Y	1	6	Studies on the kinetics of the gene-catalyzed sulfation of chemical ( chemical ) showed the effects of chemical bond formation on the substrate inhibition characteristics of the enzyme .	T1	T28	23444386
CPR:9	CHEMICAL	GENE-Y	6	6	Studies on the kinetics of the gene-catalyzed sulfation of chemical ( chemical ) showed the effects of chemical bond formation on the substrate inhibition characteristics of the enzyme .	T2	T28	23444386
NA	CHEMICAL	GENE-Y	17	6	Studies on the kinetics of the gene-catalyzed sulfation of chemical ( chemical ) showed the effects of chemical bond formation on the substrate inhibition characteristics of the enzyme .	T3	T28	23444386
CPR:4	CHEMICAL	GENE-N	13	5	Late INa induced by the gene long QT mutant gene was reduced by chemical and chemical .	T5	T21	17016511
CPR:4	CHEMICAL	GENE-N	13	9	Late INa induced by the gene long QT mutant gene was reduced by chemical and chemical .	T5	T22	17016511
CPR:4	CHEMICAL	GENE-N	15	5	Late INa induced by the gene long QT mutant gene was reduced by chemical and chemical .	T6	T21	17016511
CPR:4	CHEMICAL	GENE-N	15	9	Late INa induced by the gene long QT mutant gene was reduced by chemical and chemical .	T6	T22	17016511
NA	CHEMICAL	GENE-Y	5	5	A cDNA clone similar to gene ( gene ) is deposited in the GenBank/EMBL databases , but its structural and functional bases remain unknown .	T1	T10	16580895
NA	CHEMICAL	GENE-Y	5	7	A cDNA clone similar to gene ( gene ) is deposited in the GenBank/EMBL databases , but its structural and functional bases remain unknown .	T1	T13	16580895
NA	CHEMICAL	GENE-Y	4	7	The purified protein showed chemical and chemical dehydratase activity , demonstrating to be an isoform of gene .	T2	T12	16580895
NA	CHEMICAL	GENE-Y	4	16	The purified protein showed chemical and chemical dehydratase activity , demonstrating to be an isoform of gene .	T2	T14	16580895
NA	CHEMICAL	GENE-Y	6	7	The purified protein showed chemical and chemical dehydratase activity , demonstrating to be an isoform of gene .	T3	T12	16580895
NA	CHEMICAL	GENE-Y	6	16	The purified protein showed chemical and chemical dehydratase activity , demonstrating to be an isoform of gene .	T3	T14	16580895
NA	CHEMICAL	GENE-Y	36	6	Removal of Pro128 from the hepatic gene consisting of 328 residues , which is missing in the corresponding position of the isoform consisting of 329 residues , significantly changed the Michaelis constants and Kd value for chemical , whereas addition of a chemical residue to the isoform was without effect .	T4	T15	16580895
NA	CHEMICAL	GENE-Y	15	6	Removal of Pro128 from the hepatic gene consisting of 328 residues , which is missing in the corresponding position of the isoform consisting of 329 residues , significantly changed the Michaelis constants and Kd value for chemical , whereas addition of a chemical residue to the isoform was without effect .	T5	T15	16580895
NA	CHEMICAL	GENE-N	5	7	Study of the nematode putative chemical type-A receptor subunits : evidence for modulation by chemical .	T16	T37	12421359
NA	CHEMICAL	GENE-N	14	7	Study of the nematode putative chemical type-A receptor subunits : evidence for modulation by chemical .	T17	T37	12421359
NA	CHEMICAL	GENE-Y	11	4	Two alleles of the gene gene , which encodes a putative chemical receptor alpha/gamma subunit , were isolated from Haemonchus contortus .	T11	T25	12421359
NA	CHEMICAL	GENE-N	11	9	Two alleles of the gene gene , which encodes a putative chemical receptor alpha/gamma subunit , were isolated from Haemonchus contortus .	T11	T30	12421359
NA	CHEMICAL	GENE-Y	10	13	These two alleles were shown previously to be associated with chemical susceptibility ( gene ) and resistance ( gene ) , respectively .	T8	T26	12421359
NA	CHEMICAL	GENE-Y	10	18	These two alleles were shown previously to be associated with chemical susceptibility ( gene ) and resistance ( gene ) , respectively .	T8	T27	12421359
NA	CHEMICAL	GENE-N	24	25	To explore the functional properties of the two alleles , a full-length cDNA encoding the beta subunit , a key functional component of the chemical receptor , was isolated from Caenorhabditis elegans ( gene , corresponding to the gene ) and coexpressed in Xenopus oocytes with the gene alleles .	T10	T28	12421359
NA	CHEMICAL	GENE-Y	24	10	To explore the functional properties of the two alleles , a full-length cDNA encoding the beta subunit , a key functional component of the chemical receptor , was isolated from Caenorhabditis elegans ( gene , corresponding to the gene ) and coexpressed in Xenopus oocytes with the gene alleles .	T10	T29	12421359
NA	CHEMICAL	GENE-Y	24	38	To explore the functional properties of the two alleles , a full-length cDNA encoding the beta subunit , a key functional component of the chemical receptor , was isolated from Caenorhabditis elegans ( gene , corresponding to the gene ) and coexpressed in Xenopus oocytes with the gene alleles .	T10	T31	12421359
NA	CHEMICAL	GENE-Y	24	47	To explore the functional properties of the two alleles , a full-length cDNA encoding the beta subunit , a key functional component of the chemical receptor , was isolated from Caenorhabditis elegans ( gene , corresponding to the gene ) and coexpressed in Xenopus oocytes with the gene alleles .	T10	T32	12421359
NA	CHEMICAL	GENE-Y	17	1	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T12	T33	12421359
NA	CHEMICAL	GENE-Y	17	7	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T12	T34	12421359
NA	CHEMICAL	GENE-Y	17	11	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T12	T35	12421359
NA	CHEMICAL	GENE-N	17	22	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T12	T36	12421359
NA	CHEMICAL	GENE-Y	19	1	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T13	T33	12421359
NA	CHEMICAL	GENE-Y	19	7	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T13	T34	12421359
NA	CHEMICAL	GENE-Y	19	11	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T13	T35	12421359
NA	CHEMICAL	GENE-N	19	22	When gene was coexpressed with either the gene allele or the gene allele in Xenopus oocytes , chemical ( chemical ) -responsive channels with different sensitivity to the agonist were formed .	T13	T36	12421359
NA	CHEMICAL	GENE-Y	8	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T1	T18	12421359
NA	CHEMICAL	GENE-Y	8	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T1	T19	12421359
NA	CHEMICAL	GENE-Y	8	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T1	T20	12421359
NA	CHEMICAL	GENE-Y	8	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T1	T21	12421359
CPR:3	CHEMICAL	GENE-Y	7	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T2	T18	12421359
CPR:3	CHEMICAL	GENE-Y	7	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T2	T19	12421359
CPR:4	CHEMICAL	GENE-Y	7	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T2	T20	12421359
CPR:4	CHEMICAL	GENE-Y	7	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T2	T21	12421359
NA	CHEMICAL	GENE-Y	13	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T3	T18	12421359
NA	CHEMICAL	GENE-Y	13	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T3	T19	12421359
NA	CHEMICAL	GENE-Y	13	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T3	T20	12421359
NA	CHEMICAL	GENE-Y	13	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T3	T21	12421359
NA	CHEMICAL	GENE-Y	23	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T4	T18	12421359
NA	CHEMICAL	GENE-Y	23	17	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T4	T19	12421359
NA	CHEMICAL	GENE-Y	23	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T4	T20	12421359
NA	CHEMICAL	GENE-Y	23	27	However , when coapplied with 10 micro m chemical , chemical potentiated the chemical-evoked current of the gene/gene receptor , but attenuated the chemical response of the gene/gene receptor .	T4	T21	12421359
NA	CHEMICAL	GENE-Y	20	13	Efficacies and potencies of these ligands were determined relative to the endogenous ligand gene and the common mu agonist , chemical .	T16	T37	12513698
NA	CHEMICAL	GENE-Y	13	4	Anti-apoptotic cardioprotective effects of gene gene silencing against ischemia-reperfusion injury : Use of chemical-modified low molecular weight chemical as a cardiac siRNA-carrier .	T4	T17	23500061
NA	CHEMICAL	GENE-Y	17	4	Anti-apoptotic cardioprotective effects of gene gene silencing against ischemia-reperfusion injury : Use of chemical-modified low molecular weight chemical as a cardiac siRNA-carrier .	T5	T17	23500061
NA	CHEMICAL	GENE-Y	14	14	Herein , we report ischemic-reperfused myocardial infarction ( MI ) repair with siRNA against gene ( gene ) , which is known as a key factor involved in regulating the progress of apoptosis in many cell types .	T1	T12	23500061
NA	CHEMICAL	GENE-Y	14	16	Herein , we report ischemic-reperfused myocardial infarction ( MI ) repair with siRNA against gene ( gene ) , which is known as a key factor involved in regulating the progress of apoptosis in many cell types .	T1	T13	23500061
NA	CHEMICAL	GENE-Y	4	21	A low molecular weight chemical modified with chemical ( PEI1.8-DA ) -based delivery strategy was suggested for the cardiac application of gene siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles .	T2	T14	23500061
NA	CHEMICAL	GENE-Y	7	21	A low molecular weight chemical modified with chemical ( PEI1.8-DA ) -based delivery strategy was suggested for the cardiac application of gene siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles .	T3	T14	23500061
NA	CHEMICAL	GENE-Y	6	10	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T16	T44	23479738
NA	CHEMICAL	GENE-Y	6	15	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T16	T45	23479738
NA	CHEMICAL	GENE-N	6	22	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T16	T46	23479738
NA	CHEMICAL	GENE-Y	6	10	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T16	T47	23479738
NA	CHEMICAL	GENE-Y	6	29	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T16	T48	23479738
NA	CHEMICAL	GENE-N	6	18	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T16	T49	23479738
NA	CHEMICAL	GENE-Y	6	10	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T17	T44	23479738
NA	CHEMICAL	GENE-Y	6	15	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T17	T45	23479738
NA	CHEMICAL	GENE-N	6	22	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T17	T46	23479738
NA	CHEMICAL	GENE-Y	6	10	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T17	T47	23479738
NA	CHEMICAL	GENE-Y	6	29	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T17	T48	23479738
NA	CHEMICAL	GENE-N	6	18	In this study we investigated how chemical/chemical may affect the redox cycle of gene ( gene ) , a representative of the gene , a group of gene ( gene ) -dependent gene .	T17	T49	23479738
NA	CHEMICAL	GENE-Y	13	25	We found that , both in a cell-free system and in cells , chemical/chemical donors such as chemical and chemical readily induced the chemical-nitrosylation of gene , causing structural and functional alterations .	T21	T50	23479738
NA	CHEMICAL	GENE-Y	13	25	We found that , both in a cell-free system and in cells , chemical/chemical donors such as chemical and chemical readily induced the chemical-nitrosylation of gene , causing structural and functional alterations .	T22	T50	23479738
NA	CHEMICAL	GENE-Y	5	25	We found that , both in a cell-free system and in cells , chemical/chemical donors such as chemical and chemical readily induced the chemical-nitrosylation of gene , causing structural and functional alterations .	T23	T50	23479738
NA	CHEMICAL	GENE-Y	6	25	We found that , both in a cell-free system and in cells , chemical/chemical donors such as chemical and chemical readily induced the chemical-nitrosylation of gene , causing structural and functional alterations .	T24	T50	23479738
NA	CHEMICAL	GENE-Y	23	25	We found that , both in a cell-free system and in cells , chemical/chemical donors such as chemical and chemical readily induced the chemical-nitrosylation of gene , causing structural and functional alterations .	T25	T50	23479738
NA	CHEMICAL	GENE-Y	5	24	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T27	T32	23479738
NA	CHEMICAL	GENE-N	5	30	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T27	T33	23479738
NA	CHEMICAL	GENE-Y	12	24	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T28	T32	23479738
NA	CHEMICAL	GENE-N	12	30	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T28	T33	23479738
NA	CHEMICAL	GENE-Y	14	24	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T29	T32	23479738
NA	CHEMICAL	GENE-N	14	30	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T29	T33	23479738
NA	CHEMICAL	GENE-Y	16	24	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T30	T32	23479738
NA	CHEMICAL	GENE-N	16	30	In particular , nitrosylation promoted chemical formation involving the pair of catalytic chemical ( chemical-52 and chemical-173 ) and disrupted the oligomeric structure of gene , leading to loss of gene activity .	T30	T33	23479738
CPR:4	CHEMICAL	GENE-N	6	6	A highly potent inhibition of the gene catalytic reaction by chemical/chemical was seen in assays employing the coupled gene-gene system .	T3	T34	23479738
NA	CHEMICAL	GENE-N	6	18	A highly potent inhibition of the gene catalytic reaction by chemical/chemical was seen in assays employing the coupled gene-gene system .	T3	T35	23479738
NA	CHEMICAL	GENE-Y	6	18	A highly potent inhibition of the gene catalytic reaction by chemical/chemical was seen in assays employing the coupled gene-gene system .	T3	T36	23479738
CPR:4	CHEMICAL	GENE-N	10	6	A highly potent inhibition of the gene catalytic reaction by chemical/chemical was seen in assays employing the coupled gene-gene system .	T4	T34	23479738
NA	CHEMICAL	GENE-N	10	18	A highly potent inhibition of the gene catalytic reaction by chemical/chemical was seen in assays employing the coupled gene-gene system .	T4	T35	23479738
NA	CHEMICAL	GENE-Y	10	18	A highly potent inhibition of the gene catalytic reaction by chemical/chemical was seen in assays employing the coupled gene-gene system .	T4	T36	23479738
CPR:4	CHEMICAL	GENE-Y	4	12	In this setting , chemical ( 10 μm ) effectively blocked the gene-mediated regeneration of gene .	T5	T37	23479738
CPR:4	CHEMICAL	GENE-Y	4	15	In this setting , chemical ( 10 μm ) effectively blocked the gene-mediated regeneration of gene .	T5	T38	23479738
NA	CHEMICAL	GENE-Y	10	12	This effect appeared to be due to both competition between chemical and gene for the gene system and direct modulation by chemical of gene activity .	T7	T39	23479738
NA	CHEMICAL	GENE-Y	10	15	This effect appeared to be due to both competition between chemical and gene for the gene system and direct modulation by chemical of gene activity .	T7	T40	23479738
NA	CHEMICAL	GENE-N	10	23	This effect appeared to be due to both competition between chemical and gene for the gene system and direct modulation by chemical of gene activity .	T7	T41	23479738
NA	CHEMICAL	GENE-Y	21	12	This effect appeared to be due to both competition between chemical and gene for the gene system and direct modulation by chemical of gene activity .	T8	T39	23479738
NA	CHEMICAL	GENE-Y	21	15	This effect appeared to be due to both competition between chemical and gene for the gene system and direct modulation by chemical of gene activity .	T8	T40	23479738
NA	CHEMICAL	GENE-N	21	23	This effect appeared to be due to both competition between chemical and gene for the gene system and direct modulation by chemical of gene activity .	T8	T41	23479738
CPR:9	CHEMICAL	GENE-Y	5	21	The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a gene substrate , chemical , and its major metabolite , chemical , in rats .	T4	T17	23205514
CPR:9	CHEMICAL	GENE-Y	5	21	The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a gene substrate , chemical , and its major metabolite , chemical , in rats .	T5	T17	23205514
CPR:4	CHEMICAL	GENE-N	6	9	All GCs including the antagonistic compound chemical efficiently reduced gene-mediated transactivation to comparable extents , suggesting that ligand-induced nuclear localization of the gene is sufficient for transrepression .	T6	T12	9891987
NA	CHEMICAL	GENE-Y	6	22	All GCs including the antagonistic compound chemical efficiently reduced gene-mediated transactivation to comparable extents , suggesting that ligand-induced nuclear localization of the gene is sufficient for transrepression .	T6	T13	9891987
NA	CHEMICAL	GENE-Y	2	3	Association of chemical receptor-alpha and chemical receptor A expression with hormonal mammary carcinogenesis : role of the host microenvironment .	T20	T39	17341305
NA	CHEMICAL	GENE-Y	2	6	Association of chemical receptor-alpha and chemical receptor A expression with hormonal mammary carcinogenesis : role of the host microenvironment .	T20	T40	17341305
NA	CHEMICAL	GENE-Y	5	3	Association of chemical receptor-alpha and chemical receptor A expression with hormonal mammary carcinogenesis : role of the host microenvironment .	T21	T39	17341305
NA	CHEMICAL	GENE-Y	5	6	Association of chemical receptor-alpha and chemical receptor A expression with hormonal mammary carcinogenesis : role of the host microenvironment .	T21	T40	17341305
CPR:3	CHEMICAL	GENE-Y	2	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T2	T36	17341305
CPR:3	CHEMICAL	GENE-Y	2	10	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T2	T37	17341305
CPR:3	CHEMICAL	GENE-Y	2	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T2	T38	17341305
CPR:3	CHEMICAL	GENE-Y	2	17	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T2	T24	17341305
CPR:3	CHEMICAL	GENE-Y	4	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T10	T36	17341305
CPR:3	CHEMICAL	GENE-Y	4	10	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T10	T37	17341305
NA	CHEMICAL	GENE-Y	4	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T10	T38	17341305
CPR:3	CHEMICAL	GENE-Y	4	17	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T10	T24	17341305
NA	CHEMICAL	GENE-Y	7	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T15	T36	17341305
NA	CHEMICAL	GENE-Y	7	10	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T15	T37	17341305
NA	CHEMICAL	GENE-Y	7	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T15	T38	17341305
NA	CHEMICAL	GENE-Y	7	17	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T15	T24	17341305
NA	CHEMICAL	GENE-Y	14	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T19	T36	17341305
NA	CHEMICAL	GENE-Y	14	10	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T19	T37	17341305
NA	CHEMICAL	GENE-Y	14	8	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T19	T38	17341305
NA	CHEMICAL	GENE-Y	14	17	INTRODUCTION : chemical ( chemical ) induces chemical receptor ( gene ) -positive and chemical receptor ( gene ) -positive ductal invasive mammary carcinomas in BALB/c mice .	T19	T24	17341305
NA	CHEMICAL	GENE-Y	11	31	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T9	T34	17341305
NA	CHEMICAL	GENE-Y	11	33	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T9	T35	17341305
NA	CHEMICAL	GENE-Y	23	31	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T11	T34	17341305
NA	CHEMICAL	GENE-Y	23	33	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T11	T35	17341305
NA	CHEMICAL	GENE-Y	25	31	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T12	T34	17341305
NA	CHEMICAL	GENE-Y	25	33	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T12	T35	17341305
NA	CHEMICAL	GENE-Y	36	31	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T13	T34	17341305
NA	CHEMICAL	GENE-Y	36	33	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T13	T35	17341305
NA	CHEMICAL	GENE-Y	38	31	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T14	T34	17341305
NA	CHEMICAL	GENE-Y	38	33	Within this experimental setting , we studied the carcinogenic effects of chemical , the morphologic changes in mammary glands that are induced by chemical and chemical , and the levels of gene and gene expression in chemical-treated and chemical-treated mammary glands .	T14	T35	17341305
NA	CHEMICAL	GENE-Y	10	35	In addition , BALB/c and C57BL/6 females were treated with chemical or chemical for 1 or 2 months , and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of gene and gene .	T17	T22	17341305
NA	CHEMICAL	GENE-Y	10	37	In addition , BALB/c and C57BL/6 females were treated with chemical or chemical for 1 or 2 months , and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of gene and gene .	T17	T23	17341305
NA	CHEMICAL	GENE-Y	12	35	In addition , BALB/c and C57BL/6 females were treated with chemical or chemical for 1 or 2 months , and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of gene and gene .	T18	T22	17341305
NA	CHEMICAL	GENE-Y	12	37	In addition , BALB/c and C57BL/6 females were treated with chemical or chemical for 1 or 2 months , and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of gene and gene .	T18	T23	17341305
CPR:4	CHEMICAL	GENE-Y	6	3	The expression of gene and gene in virgin mice was surprisingly much higher in BALB/c than in C57BL/6 mammary glands , and both receptors were downregulated in chemical-treated BALB/c mice ( P < 0.05 ) .	T3	T25	17341305
CPR:4	CHEMICAL	GENE-Y	6	5	The expression of gene and gene in virgin mice was surprisingly much higher in BALB/c than in C57BL/6 mammary glands , and both receptors were downregulated in chemical-treated BALB/c mice ( P < 0.05 ) .	T3	T26	17341305
CPR:3	CHEMICAL	GENE-Y	4	0	gene levels were low in virgin control mice and increased after chemical treatment in both strains .	T4	T27	17341305
CPR:4	CHEMICAL	GENE-Y	9	3	Potency switch between gene and gene : Discovery of chemical- and chemical-based gene inhibitors .	T3	T9	23587425
CPR:4	CHEMICAL	GENE-Y	9	5	Potency switch between gene and gene : Discovery of chemical- and chemical-based gene inhibitors .	T3	T10	23587425
CPR:4	CHEMICAL	GENE-N	9	12	Potency switch between gene and gene : Discovery of chemical- and chemical-based gene inhibitors .	T3	T8	23587425
CPR:4	CHEMICAL	GENE-Y	11	3	Potency switch between gene and gene : Discovery of chemical- and chemical-based gene inhibitors .	T4	T9	23587425
CPR:4	CHEMICAL	GENE-Y	11	5	Potency switch between gene and gene : Discovery of chemical- and chemical-based gene inhibitors .	T4	T10	23587425
CPR:4	CHEMICAL	GENE-N	11	12	Potency switch between gene and gene : Discovery of chemical- and chemical-based gene inhibitors .	T4	T8	23587425
NA	CHEMICAL	GENE-N	1	9	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T2	T8	9557255
NA	CHEMICAL	GENE-N	1	11	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T2	T9	9557255
NA	CHEMICAL	GENE-Y	1	12	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T2	T10	9557255
NA	CHEMICAL	GENE-Y	1	14	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T2	T11	9557255
NA	CHEMICAL	GENE-N	4	9	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T4	T8	9557255
NA	CHEMICAL	GENE-N	4	11	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T4	T9	9557255
NA	CHEMICAL	GENE-Y	4	12	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T4	T10	9557255
NA	CHEMICAL	GENE-Y	4	14	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T4	T11	9557255
NA	CHEMICAL	GENE-N	10	9	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T5	T8	9557255
NA	CHEMICAL	GENE-N	10	11	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T5	T9	9557255
NA	CHEMICAL	GENE-Y	10	12	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T5	T10	9557255
NA	CHEMICAL	GENE-Y	10	14	The chemical action of chemical are mediated by the gene chemical receptors gene and gene .	T5	T11	9557255
CPR:4	CHEMICAL	GENE-Y	9	3	Blockage of the gene by the gastrointestinal prokinetic agent chemical .	T13	T22	9374794
NA	CHEMICAL	GENE-Y	13	1	The gene ( gene ) , which encodes the rapidly activating delayed rectifier chemical current and is important in cardiac repolarization , may serve as a target for the action of chemical .	T5	T15	9374794
NA	CHEMICAL	GENE-Y	13	3	The gene ( gene ) , which encodes the rapidly activating delayed rectifier chemical current and is important in cardiac repolarization , may serve as a target for the action of chemical .	T5	T16	9374794
NA	CHEMICAL	GENE-Y	16	1	The gene ( gene ) , which encodes the rapidly activating delayed rectifier chemical current and is important in cardiac repolarization , may serve as a target for the action of chemical .	T6	T15	9374794
NA	CHEMICAL	GENE-Y	16	3	The gene ( gene ) , which encodes the rapidly activating delayed rectifier chemical current and is important in cardiac repolarization , may serve as a target for the action of chemical .	T6	T16	9374794
CPR:4	CHEMICAL	GENE-Y	5	7	We tested the hypothesis that chemical blocks gene .	T7	T17	9374794
CPR:4	CHEMICAL	GENE-Y	4	7	Under voltage-clamp conditions , chemical block of gene is dose dependent with a half-maximal inhibitory concentration of 6.5 nM at 22 degrees C ( n = 25 cells ) .	T8	T19	9374794
CPR:4	CHEMICAL	GENE-Y	4	2	Block of gene with chemical after channel activation was voltage dependent .	T10	T20	9374794
CPR:4	CHEMICAL	GENE-Y	6	8	At -20 mV , 10 nM chemical reduced gene tail-current amplitude by 5 % , whereas , at + 20 mV , the tail-current amplitude was reduced by 45 % ( n = 4 cells ) .	T11	T21	9374794
CPR:4	CHEMICAL	GENE-Y	3	9	We conclude that chemical is a potent blocker of gene channels expressed in HEK293 cells .	T3	T14	9374794
CPR:6	CHEMICAL	GENE-Y	2	18	Pentosan polysulfate chemical ( PPS ) has been shown to exert antitumor activity by antagonizing the binding of gene to cell surface receptors .	T2	T8	12375053
NA	CHEMICAL	GENE-N	8	0	gene is one of four major classes of chemical/chemical phosphatases .	T6	T8	23381641
NA	CHEMICAL	GENE-N	8	9	gene is one of four major classes of chemical/chemical phosphatases .	T6	T21	23381641
NA	CHEMICAL	GENE-N	8	0	gene is one of four major classes of chemical/chemical phosphatases .	T7	T8	23381641
NA	CHEMICAL	GENE-N	8	9	gene is one of four major classes of chemical/chemical phosphatases .	T7	T21	23381641
NA	CHEMICAL	GENE-Y	10	4	We have reported that gene clones are sensitive to reactive chemical species ( ROS ) treatment by inducing autophagic cell death .	T5	T20	23381641
NA	CHEMICAL	GENE-N	3	5	Rice with high chemical content in seed endosperm has been developed by insertion of gene gene under the control of the endosperm specific gene into the genome of indica rice line IR68144 .	T3	T7	23411185
NA	CHEMICAL	GENE-N	3	23	Rice with high chemical content in seed endosperm has been developed by insertion of gene gene under the control of the endosperm specific gene into the genome of indica rice line IR68144 .	T3	T8	23411185
NA	CHEMICAL	GENE-N	0	7	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T1	T12	12942109
NA	CHEMICAL	GENE-Y	0	17	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T1	T13	12942109
NA	CHEMICAL	GENE-Y	0	19	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T1	T14	12942109
NA	CHEMICAL	GENE-N	3	7	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T6	T12	12942109
NA	CHEMICAL	GENE-Y	3	17	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T6	T13	12942109
NA	CHEMICAL	GENE-Y	3	19	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T6	T14	12942109
NA	CHEMICAL	GENE-N	8	7	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T10	T12	12942109
NA	CHEMICAL	GENE-Y	8	17	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T10	T13	12942109
NA	CHEMICAL	GENE-Y	8	19	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T10	T14	12942109
NA	CHEMICAL	GENE-N	15	7	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T3	T12	12942109
NA	CHEMICAL	GENE-Y	15	17	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T3	T13	12942109
NA	CHEMICAL	GENE-Y	15	19	chemical is an chemical which is metabolised to chemical and which binds selectively to the chemical receptors gene and gene .	T3	T14	12942109
NA	CHEMICAL	GENE-N	0	1	chemical receptor binding of chemical in vivo : increased receptor number with low-dose chemical .	T17	T21	2889803
NA	CHEMICAL	GENE-N	4	1	chemical receptor binding of chemical in vivo : increased receptor number with low-dose chemical .	T19	T21	2889803
NA	CHEMICAL	GENE-N	13	1	chemical receptor binding of chemical in vivo : increased receptor number with low-dose chemical .	T18	T21	2889803
CPR:3	CHEMICAL	GENE-N	67	34	When dual angiogenic growth factors ( GFs ) , such as gene ( gene ) and gene ( gene ) , are encapsulated separately in the core and shell domains , respectively , the gene release rate is much greater than that of gene , and the difference of the cumulative release percentage between the two GFs is about 30 % on day 7 with LMW core chemical and more than 45 % with HMW core chemical .	T2	T14	23585380
CPR:3	CHEMICAL	GENE-N	67	43	When dual angiogenic growth factors ( GFs ) , such as gene ( gene ) and gene ( gene ) , are encapsulated separately in the core and shell domains , respectively , the gene release rate is much greater than that of gene , and the difference of the cumulative release percentage between the two GFs is about 30 % on day 7 with LMW core chemical and more than 45 % with HMW core chemical .	T2	T8	23585380
CPR:3	CHEMICAL	GENE-N	76	34	When dual angiogenic growth factors ( GFs ) , such as gene ( gene ) and gene ( gene ) , are encapsulated separately in the core and shell domains , respectively , the gene release rate is much greater than that of gene , and the difference of the cumulative release percentage between the two GFs is about 30 % on day 7 with LMW core chemical and more than 45 % with HMW core chemical .	T3	T14	23585380
CPR:3	CHEMICAL	GENE-N	76	43	When dual angiogenic growth factors ( GFs ) , such as gene ( gene ) and gene ( gene ) , are encapsulated separately in the core and shell domains , respectively , the gene release rate is much greater than that of gene , and the difference of the cumulative release percentage between the two GFs is about 30 % on day 7 with LMW core chemical and more than 45 % with HMW core chemical .	T3	T8	23585380
NA	CHEMICAL	GENE-N	1	6	The gene subunit contains several functional domains : the chemical-terminal heptad repeat ( NHR ) domains fold a triple stranded coiled-coil forming a meta-stable prefusion intermediate .	T1	T9	23522564
NA	CHEMICAL	GENE-Y	0	7	chemical-mediated oxidative stress disrupts chemical binding on gene : more evidence for oxidative stress in vitiligo .	T16	T27	17592724
NA	CHEMICAL	GENE-Y	4	7	chemical-mediated oxidative stress disrupts chemical binding on gene : more evidence for oxidative stress in vitiligo .	T17	T27	17592724
CPR:9	CHEMICAL	GENE-Y	7	7	Patients with acute vitiligo have low epidermal gene expression/activities and accumulate 10 ( -3 ) M chemical .	T2	T21	17592724
NA	CHEMICAL	GENE-Y	2	12	Since 10 ( -3 ) M chemical oxidises chemical and chemical residues in proteins , we examined chemical binding to gene in the presence and absence of chemical utilising ( 45 ) chemical .	T7	T20	17592724
NA	CHEMICAL	GENE-Y	8	12	Since 10 ( -3 ) M chemical oxidises chemical and chemical residues in proteins , we examined chemical binding to gene in the presence and absence of chemical utilising ( 45 ) chemical .	T8	T20	17592724
NA	CHEMICAL	GENE-Y	10	12	Since 10 ( -3 ) M chemical oxidises chemical and chemical residues in proteins , we examined chemical binding to gene in the presence and absence of chemical utilising ( 45 ) chemical .	T9	T20	17592724
NA	CHEMICAL	GENE-Y	17	12	Since 10 ( -3 ) M chemical oxidises chemical and chemical residues in proteins , we examined chemical binding to gene in the presence and absence of chemical utilising ( 45 ) chemical .	T10	T20	17592724
NA	CHEMICAL	GENE-Y	2	12	Since 10 ( -3 ) M chemical oxidises chemical and chemical residues in proteins , we examined chemical binding to gene in the presence and absence of chemical utilising ( 45 ) chemical .	T11	T20	17592724
NA	CHEMICAL	GENE-Y	32	12	Since 10 ( -3 ) M chemical oxidises chemical and chemical residues in proteins , we examined chemical binding to gene in the presence and absence of chemical utilising ( 45 ) chemical .	T12	T20	17592724
NA	CHEMICAL	GENE-Y	6	12	The results showed that all four chemical atoms exchanged per molecule of gene .	T13	T22	17592724
NA	CHEMICAL	GENE-Y	8	2	Since oxidised gene looses its ability to activate chemical ATPase , enzyme activities were followed in full skin biopsies from lesional skin of patients with acute vitiligo ( n=6 ) and healthy controls ( n=6 ) .	T14	T23	17592724
NA	CHEMICAL	GENE-N	8	9	Since oxidised gene looses its ability to activate chemical ATPase , enzyme activities were followed in full skin biopsies from lesional skin of patients with acute vitiligo ( n=6 ) and healthy controls ( n=6 ) .	T14	T24	17592724
NA	CHEMICAL	GENE-Y	13	6	Computer simulation of native and oxidised gene confirmed the loss of all four chemical ions from their specific gene .	T15	T25	17592724
NA	CHEMICAL	GENE-N	13	18	Computer simulation of native and oxidised gene confirmed the loss of all four chemical ions from their specific gene .	T15	T26	17592724
CPR:4	CHEMICAL	GENE-N	5	9	Determinants of voltage-dependent inactivation affect chemical block of chemical channels .	T18	T27	10665814
NA	CHEMICAL	GENE-N	8	9	Determinants of voltage-dependent inactivation affect chemical block of chemical channels .	T19	T27	10665814
NA	CHEMICAL	GENE-N	4	1	The gene family is a major target for a range of therapeutic drugs .	T5	T24	10665814
CPR:4	CHEMICAL	GENE-N	0	6	chemical ( chemical ) belongs to a new chemical class of these molecules which differs from other chemical antagonists by its ability to potently block gene .	T16	T21	10665814
CPR:4	CHEMICAL	GENE-N	0	6	chemical ( chemical ) belongs to a new chemical class of these molecules which differs from other chemical antagonists by its ability to potently block gene .	T1	T21	10665814
NA	CHEMICAL	GENE-N	6	6	chemical ( chemical ) belongs to a new chemical class of these molecules which differs from other chemical antagonists by its ability to potently block gene .	T6	T21	10665814
NA	CHEMICAL	GENE-N	6	6	chemical ( chemical ) belongs to a new chemical class of these molecules which differs from other chemical antagonists by its ability to potently block gene .	T7	T21	10665814
NA	CHEMICAL	GENE-N	11	12	However , this molecule has also been shown to inhibit other chemical channel subtypes .	T8	T22	10665814
NA	CHEMICAL	GENE-N	7	20	To further analyze the mechanism governing the chemical channel-chemical interaction , we examined the effect of chemical on various recombinant genes expressed in mammalian cells from their cloned cDNAs , using chemical as the permeant ion at physiological concentration .	T9	T23	10665814
NA	CHEMICAL	GENE-N	8	20	To further analyze the mechanism governing the chemical channel-chemical interaction , we examined the effect of chemical on various recombinant genes expressed in mammalian cells from their cloned cDNAs , using chemical as the permeant ion at physiological concentration .	T10	T23	10665814
NA	CHEMICAL	GENE-N	16	20	To further analyze the mechanism governing the chemical channel-chemical interaction , we examined the effect of chemical on various recombinant genes expressed in mammalian cells from their cloned cDNAs , using chemical as the permeant ion at physiological concentration .	T11	T23	10665814
NA	CHEMICAL	GENE-N	31	20	To further analyze the mechanism governing the chemical channel-chemical interaction , we examined the effect of chemical on various recombinant genes expressed in mammalian cells from their cloned cDNAs , using chemical as the permeant ion at physiological concentration .	T12	T23	10665814
CPR:4	CHEMICAL	GENE-N	0	6	chemical blocked alpha1A and alpha1E with a Kd comparable to that reported for gene , but had a lower affinity ( approximately 30-fold ) for alpha1C .	T15	T26	10665814
CPR:6	CHEMICAL	GENE-Y	0	8	chemical identifies novel antagonist binding determinants in the gene .	T23	T33	17673606
NA	CHEMICAL	GENE-Y	6	8	chemical identifies novel antagonist binding determinants in the gene .	T24	T33	17673606
NA	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T1	T31	17673606
CPR:6	CHEMICAL	GENE-Y	0	13	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T1	T25	17673606
CPR:6	CHEMICAL	GENE-Y	0	15	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T1	T27	17673606
NA	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T3	T31	17673606
CPR:6	CHEMICAL	GENE-Y	2	13	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T3	T25	17673606
CPR:6	CHEMICAL	GENE-Y	2	15	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T3	T27	17673606
NA	CHEMICAL	GENE-N	21	5	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T14	T31	17673606
NA	CHEMICAL	GENE-Y	21	13	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T14	T25	17673606
NA	CHEMICAL	GENE-Y	21	15	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T14	T27	17673606
NA	CHEMICAL	GENE-N	21	5	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T21	T31	17673606
NA	CHEMICAL	GENE-Y	21	13	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T21	T25	17673606
NA	CHEMICAL	GENE-Y	21	15	chemical ( chemical ) is a recently introduced antagonist of the gene ( gene and gene , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .	T21	T27	17673606
NA	CHEMICAL	GENE-Y	7	23	Initial evaluation of the pharmacological properties of chemical ( J Pharmacol Exp Ther 318:657-665 , 2006 ) revealed significantly reduced potency for the gene expressed in membranes compared with whole cells when competing for chemical ( chemical ) binding .	T4	T29	17673606
NA	CHEMICAL	GENE-Y	8	23	Initial evaluation of the pharmacological properties of chemical ( J Pharmacol Exp Ther 318:657-665 , 2006 ) revealed significantly reduced potency for the gene expressed in membranes compared with whole cells when competing for chemical ( chemical ) binding .	T5	T29	17673606
NA	CHEMICAL	GENE-Y	36	23	Initial evaluation of the pharmacological properties of chemical ( J Pharmacol Exp Ther 318:657-665 , 2006 ) revealed significantly reduced potency for the gene expressed in membranes compared with whole cells when competing for chemical ( chemical ) binding .	T6	T29	17673606
NA	CHEMICAL	GENE-Y	14	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T7	T30	17673606
NA	CHEMICAL	GENE-Y	14	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T7	T32	17673606
NA	CHEMICAL	GENE-Y	19	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T8	T30	17673606
NA	CHEMICAL	GENE-Y	19	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T8	T32	17673606
CPR:6	CHEMICAL	GENE-Y	24	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T9	T30	17673606
NA	CHEMICAL	GENE-Y	24	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T9	T32	17673606
CPR:6	CHEMICAL	GENE-Y	27	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T10	T30	17673606
NA	CHEMICAL	GENE-Y	27	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T10	T32	17673606
CPR:6	CHEMICAL	GENE-Y	2	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T11	T30	17673606
CPR:6	CHEMICAL	GENE-Y	31	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T12	T30	17673606
NA	CHEMICAL	GENE-Y	31	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T12	T32	17673606
CPR:6	CHEMICAL	GENE-Y	15	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T13	T30	17673606
NA	CHEMICAL	GENE-Y	15	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T13	T32	17673606
CPR:6	CHEMICAL	GENE-Y	2	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T15	T30	17673606
CPR:6	CHEMICAL	GENE-Y	40	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T16	T30	17673606
NA	CHEMICAL	GENE-Y	40	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T16	T32	17673606
CPR:6	CHEMICAL	GENE-Y	42	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T17	T30	17673606
NA	CHEMICAL	GENE-Y	42	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T17	T32	17673606
CPR:6	CHEMICAL	GENE-Y	51	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T18	T32	17673606
NA	CHEMICAL	GENE-Y	2	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T19	T30	17673606
CPR:6	CHEMICAL	GENE-Y	2	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T19	T32	17673606
CPR:6	CHEMICAL	GENE-Y	55	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T20	T32	17673606
NA	CHEMICAL	GENE-Y	2	1	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T22	T30	17673606
CPR:6	CHEMICAL	GENE-Y	2	46	Using gene in transfected human embryonic kidney-293 cells , this difference in potency for chemical at sites labeled by chemical was found to distinguish chemical , the chemical analog chemical ( chemical ) , chemical , and the chemical analog chemical ( chemical ) from other gene antagonists , such as chemical , chemical , chemical antidepressants , and chemical .	T22	T32	17673606
CPR:4	CHEMICAL	GENE-N	5	3	Isoform-specific inhibition of gene by chemical is independent of isoform-specific gating properties .	T13	T21	9584217
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) block gene more potently at depolarized membrane potentials , consistent with high affinity binding to the inactivated state .	T1	T19	9584217
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) block gene more potently at depolarized membrane potentials , consistent with high affinity binding to the inactivated state .	T8	T19	9584217
CPR:4	CHEMICAL	GENE-N	0	2	chemical ( a chemical antagonist ) blocks the gene more potently than the cardiac one , a phenomenon observed not only in native channels but also in expressed channels .	T4	T18	9584217
CPR:4	CHEMICAL	GENE-N	3	2	chemical ( a chemical antagonist ) blocks the gene more potently than the cardiac one , a phenomenon observed not only in native channels but also in expressed channels .	T7	T18	9584217
NA	CHEMICAL	GENE-Y	21	4	We expressed cardiac or gene subunits in combination with beta2a and alpha2/delta subunits in human embryonic kidney cells , and used 2 mM chemical as the permeant ion .	T10	T20	9584217
CPR:4	CHEMICAL	GENE-N	7	13	We thus conclude that the more potent chemical inhibition of smooth muscle versus gene is not attributable to differences in channel inactivation or activation .	T2	T16	9584217
CPR:3	CHEMICAL	GENE-Y	0	5	chemical induces the expression of gene and gene .	T6	T19	22080037
CPR:3	CHEMICAL	GENE-Y	0	7	chemical induces the expression of gene and gene .	T6	T20	22080037
NA	CHEMICAL	GENE-N	8	0	gene activation induces numerous proinflammatory gene products including gene , gene ( gene ) , and gene ( gene ) .	T1	T9	22080037
NA	CHEMICAL	GENE-N	8	8	gene activation induces numerous proinflammatory gene products including gene , gene ( gene ) , and gene ( gene ) .	T1	T11	22080037
NA	CHEMICAL	GENE-Y	8	10	gene activation induces numerous proinflammatory gene products including gene , gene ( gene ) , and gene ( gene ) .	T1	T12	22080037
NA	CHEMICAL	GENE-Y	8	12	gene activation induces numerous proinflammatory gene products including gene , gene ( gene ) , and gene ( gene ) .	T1	T13	22080037
NA	CHEMICAL	GENE-Y	8	16	gene activation induces numerous proinflammatory gene products including gene , gene ( gene ) , and gene ( gene ) .	T1	T14	22080037
NA	CHEMICAL	GENE-Y	8	18	gene activation induces numerous proinflammatory gene products including gene , gene ( gene ) , and gene ( gene ) .	T1	T15	22080037
CPR:3	CHEMICAL	GENE-N	7	10	Here , we report biochemical evidence that chemical alone induces gene activation , resulting in the induced expression of gene and gene .	T4	T16	22080037
CPR:3	CHEMICAL	GENE-Y	7	19	Here , we report biochemical evidence that chemical alone induces gene activation , resulting in the induced expression of gene and gene .	T4	T17	22080037
CPR:3	CHEMICAL	GENE-Y	7	21	Here , we report biochemical evidence that chemical alone induces gene activation , resulting in the induced expression of gene and gene .	T4	T18	22080037
NA	CHEMICAL	GENE-N	2	5	Expression of chemical-responsive element binding proteins ( gene ) in fast- and slow-twitch muscles : A signaling pathway to account for the synaptic expression of gene ( gene ) of gene at the rat neuromuscular junction .	T4	T22	23159887
NA	CHEMICAL	GENE-N	2	7	Expression of chemical-responsive element binding proteins ( gene ) in fast- and slow-twitch muscles : A signaling pathway to account for the synaptic expression of gene ( gene ) of gene at the rat neuromuscular junction .	T4	T26	23159887
NA	CHEMICAL	GENE-Y	2	25	Expression of chemical-responsive element binding proteins ( gene ) in fast- and slow-twitch muscles : A signaling pathway to account for the synaptic expression of gene ( gene ) of gene at the rat neuromuscular junction .	T4	T23	23159887
NA	CHEMICAL	GENE-Y	2	27	Expression of chemical-responsive element binding proteins ( gene ) in fast- and slow-twitch muscles : A signaling pathway to account for the synaptic expression of gene ( gene ) of gene at the rat neuromuscular junction .	T4	T24	23159887
NA	CHEMICAL	GENE-Y	2	9	Expression of chemical-responsive element binding proteins ( gene ) in fast- and slow-twitch muscles : A signaling pathway to account for the synaptic expression of gene ( gene ) of gene at the rat neuromuscular junction .	T4	T25	23159887
NA	CHEMICAL	GENE-Y	28	0	gene is expressed at the neuromuscular junction ( NMJ ) in fast-twitch muscle , and this expression depends on trophic factors supplied by motor neurons signaling via a chemical-dependent pathway in muscle .	T2	T11	23159887
NA	CHEMICAL	GENE-Y	19	7	To further elucidate the molecular basis of gene synaptic expression , here we investigated the expression and localization of chemical-responsive element binding protein ( gene ) at the synaptic and extra-synaptic regions of fast- and slow-twitch muscles from adult rats .	T3	T13	23159887
NA	CHEMICAL	GENE-N	19	22	To further elucidate the molecular basis of gene synaptic expression , here we investigated the expression and localization of chemical-responsive element binding protein ( gene ) at the synaptic and extra-synaptic regions of fast- and slow-twitch muscles from adult rats .	T3	T14	23159887
NA	CHEMICAL	GENE-N	19	24	To further elucidate the molecular basis of gene synaptic expression , here we investigated the expression and localization of chemical-responsive element binding protein ( gene ) at the synaptic and extra-synaptic regions of fast- and slow-twitch muscles from adult rats .	T3	T16	23159887
NA	CHEMICAL	GENE-Y	6	11	The main outcome measures were serum chemical , lipids , and gene , and anthropometric measurements .	T2	T13	23256446
NA	CHEMICAL	GENE-N	19	3	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T3	T14	23256446
NA	CHEMICAL	GENE-Y	19	50	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T3	T15	23256446
NA	CHEMICAL	GENE-Y	19	52	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T3	T6	23256446
NA	CHEMICAL	GENE-Y	19	58	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T3	T7	23256446
NA	CHEMICAL	GENE-N	27	3	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T4	T14	23256446
NA	CHEMICAL	GENE-Y	27	50	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T4	T15	23256446
NA	CHEMICAL	GENE-Y	27	52	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T4	T6	23256446
NA	CHEMICAL	GENE-Y	27	58	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T4	T7	23256446
NA	CHEMICAL	GENE-Y	27	60	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T4	T8	23256446
NA	CHEMICAL	GENE-N	33	3	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T5	T14	23256446
NA	CHEMICAL	GENE-Y	33	50	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T5	T15	23256446
NA	CHEMICAL	GENE-Y	33	52	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T5	T6	23256446
NA	CHEMICAL	GENE-Y	33	58	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T5	T7	23256446
NA	CHEMICAL	GENE-Y	33	60	The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P=.002 ) , fasting serum chemical ( FSG ; P=.001 ) , total chemical ( P=.0001 ) , serum chemical ( TG ; P=.0001 ) , and gene ( P=.0009 ) , and significant increases in gene ( gene ; P=.0004 ) and 2-h gene ( gene ; P=.002 ) .	T5	T8	23256446
NA	CHEMICAL	GENE-Y	0	1	chemical receptor is a target of chemical and enhances its anticancer activity in lung adenocarcinoma cells .	T15	T42	23229511
NA	CHEMICAL	GENE-Y	3	1	chemical receptor is a target of chemical and enhances its anticancer activity in lung adenocarcinoma cells .	T16	T42	23229511
NA	CHEMICAL	GENE-Y	4	5	We have demonstrated that chemical receptor ( gene ) is overexpressed in lung adenocarcinoma ( AD ) .	T12	T37	23229511
NA	CHEMICAL	GENE-Y	4	7	We have demonstrated that chemical receptor ( gene ) is overexpressed in lung adenocarcinoma ( AD ) .	T12	T40	23229511
CPR:4	CHEMICAL	GENE-N	0	6	chemical ( chemical ) , an gene inhibitor , is currently under evaluation for its anticancer activity in clinical trials .	T10	T36	23229511
CPR:4	CHEMICAL	GENE-N	2	6	chemical ( chemical ) , an gene inhibitor , is currently under evaluation for its anticancer activity in clinical trials .	T11	T36	23229511
NA	CHEMICAL	GENE-Y	9	4	Here we investigated whether gene plays a role in chemical-mediated anticancer activity by functioning as a downstream target or by modulating its anticancer efficacy .	T13	T38	23229511
CPR:4	CHEMICAL	GENE-Y	3	5	Although treatment with chemical reduced gene levels and gene-regulated gene expression in lung AD cells , gene expression increased anticancer activity of chemical .	T1	T19	23229511
CPR:4	CHEMICAL	GENE-Y	3	8	Although treatment with chemical reduced gene levels and gene-regulated gene expression in lung AD cells , gene expression increased anticancer activity of chemical .	T1	T20	23229511
NA	CHEMICAL	GENE-Y	3	16	Although treatment with chemical reduced gene levels and gene-regulated gene expression in lung AD cells , gene expression increased anticancer activity of chemical .	T1	T21	23229511
NA	CHEMICAL	GENE-Y	8	5	Although treatment with chemical reduced gene levels and gene-regulated gene expression in lung AD cells , gene expression increased anticancer activity of chemical .	T2	T19	23229511
NA	CHEMICAL	GENE-Y	8	8	Although treatment with chemical reduced gene levels and gene-regulated gene expression in lung AD cells , gene expression increased anticancer activity of chemical .	T2	T20	23229511
NA	CHEMICAL	GENE-Y	8	16	Although treatment with chemical reduced gene levels and gene-regulated gene expression in lung AD cells , gene expression increased anticancer activity of chemical .	T2	T21	23229511
CPR:4	CHEMICAL	GENE-Y	3	9	In addition , chemical treatment reduced cell viability , gene , gene , gene , gene , and gene levels in gene-expressing lung AD cells .	T3	T22	23229511
CPR:4	CHEMICAL	GENE-Y	3	11	In addition , chemical treatment reduced cell viability , gene , gene , gene , gene , and gene levels in gene-expressing lung AD cells .	T3	T23	23229511
CPR:4	CHEMICAL	GENE-N	3	13	In addition , chemical treatment reduced cell viability , gene , gene , gene , gene , and gene levels in gene-expressing lung AD cells .	T3	T24	23229511
CPR:4	CHEMICAL	GENE-Y	3	15	In addition , chemical treatment reduced cell viability , gene , gene , gene , gene , and gene levels in gene-expressing lung AD cells .	T3	T25	23229511
CPR:4	CHEMICAL	GENE-Y	3	18	In addition , chemical treatment reduced cell viability , gene , gene , gene , gene , and gene levels in gene-expressing lung AD cells .	T3	T26	23229511
NA	CHEMICAL	GENE-Y	3	21	In addition , chemical treatment reduced cell viability , gene , gene , gene , gene , and gene levels in gene-expressing lung AD cells .	T3	T27	23229511
NA	CHEMICAL	GENE-Y	0	3	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T4	T29	23229511
NA	CHEMICAL	GENE-Y	0	5	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T4	T30	23229511
NA	CHEMICAL	GENE-Y	0	12	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T4	T31	23229511
NA	CHEMICAL	GENE-Y	2	3	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T5	T29	23229511
NA	CHEMICAL	GENE-Y	2	5	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T5	T30	23229511
NA	CHEMICAL	GENE-Y	2	12	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T5	T31	23229511
NA	CHEMICAL	GENE-Y	21	3	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T6	T29	23229511
NA	CHEMICAL	GENE-Y	21	5	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T6	T30	23229511
NA	CHEMICAL	GENE-Y	21	12	chemical : chemical oxidoreductase ( gene ) , which is regulated by gene , was shown to increase anticancer activity of chemical in cells .	T6	T31	23229511
NA	CHEMICAL	GENE-Y	12	2	Knockdown of gene expression attenuated the reduction of cell cycle regulators by chemical treatment in gene overexpressed cells .	T7	T32	23229511
NA	CHEMICAL	GENE-Y	12	15	Knockdown of gene expression attenuated the reduction of cell cycle regulators by chemical treatment in gene overexpressed cells .	T7	T34	23229511
NA	CHEMICAL	GENE-N	12	13	Recent developments include the identification of non-peptidic small-molecules that selectively inhibit certain chemical proteases within the coagulation cascade .	T9	T21	20135071
CPR:4	CHEMICAL	GENE-Y	6	4	Of these , the gene inhibitor chemical and gene inhibitor chemical have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe .	T10	T22	20135071
NA	CHEMICAL	GENE-Y	6	8	Of these , the gene inhibitor chemical and gene inhibitor chemical have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe .	T10	T23	20135071
NA	CHEMICAL	GENE-Y	10	4	Of these , the gene inhibitor chemical and gene inhibitor chemical have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe .	T11	T22	20135071
CPR:4	CHEMICAL	GENE-Y	10	8	Of these , the gene inhibitor chemical and gene inhibitor chemical have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe .	T11	T23	20135071
CPR:4	CHEMICAL	GENE-Y	6	4	In addition , the gene inhibitor chemical is in late-stage clinical development .	T12	T24	20135071
NA	CHEMICAL	GENE-Y	4	15	However , alterations of chemical and chemical pharmacokinetics upon interactions with inhibitors and inducers of gene or gene may complicate the use of these compounds in daily practice , whereas chemical elimination largely depends on renal function .	T3	T19	20135071
NA	CHEMICAL	GENE-N	4	17	However , alterations of chemical and chemical pharmacokinetics upon interactions with inhibitors and inducers of gene or gene may complicate the use of these compounds in daily practice , whereas chemical elimination largely depends on renal function .	T3	T20	20135071
NA	CHEMICAL	GENE-Y	6	15	However , alterations of chemical and chemical pharmacokinetics upon interactions with inhibitors and inducers of gene or gene may complicate the use of these compounds in daily practice , whereas chemical elimination largely depends on renal function .	T4	T19	20135071
NA	CHEMICAL	GENE-N	6	17	However , alterations of chemical and chemical pharmacokinetics upon interactions with inhibitors and inducers of gene or gene may complicate the use of these compounds in daily practice , whereas chemical elimination largely depends on renal function .	T4	T20	20135071
NA	CHEMICAL	GENE-Y	30	15	However , alterations of chemical and chemical pharmacokinetics upon interactions with inhibitors and inducers of gene or gene may complicate the use of these compounds in daily practice , whereas chemical elimination largely depends on renal function .	T5	T19	20135071
NA	CHEMICAL	GENE-N	30	17	However , alterations of chemical and chemical pharmacokinetics upon interactions with inhibitors and inducers of gene or gene may complicate the use of these compounds in daily practice , whereas chemical elimination largely depends on renal function .	T5	T20	20135071
CPR:9	CHEMICAL	GENE-Y	10	17	The juvenile visceral steatosis ( jvs ) mouse , having a mutation in the chemical transporter gene gene , is a model of primary systemic chemical deficiency in humans ( SCD , OMIM 212140 ) .	T16	T20	12175785
NA	CHEMICAL	GENE-Y	10	17	The juvenile visceral steatosis ( jvs ) mouse , having a mutation in the chemical transporter gene gene , is a model of primary systemic chemical deficiency in humans ( SCD , OMIM 212140 ) .	T5	T20	12175785
CPR:4	CHEMICAL	GENE-Y	2	15	Wattakaka volubilis chemical mixture ( WVSM ) and chemical ( 1-50μM ) significantly inhibited the gene and gene enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells .	T3	T15	23570999
CPR:4	CHEMICAL	GENE-Y	2	17	Wattakaka volubilis chemical mixture ( WVSM ) and chemical ( 1-50μM ) significantly inhibited the gene and gene enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells .	T3	T16	23570999
CPR:4	CHEMICAL	GENE-Y	8	15	Wattakaka volubilis chemical mixture ( WVSM ) and chemical ( 1-50μM ) significantly inhibited the gene and gene enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells .	T4	T15	23570999
CPR:4	CHEMICAL	GENE-Y	8	17	Wattakaka volubilis chemical mixture ( WVSM ) and chemical ( 1-50μM ) significantly inhibited the gene and gene enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells .	T4	T16	23570999
NA	CHEMICAL	GENE-N	4	2	The mutant gene ( gene ) contained a total of 5 chemical substitutions that conferred an activating to inhibitory ratio of 25 ( A/I ratio ; gene-R131 : gene ) .	T1	T9	23030766
NA	CHEMICAL	GENE-N	4	4	The mutant gene ( gene ) contained a total of 5 chemical substitutions that conferred an activating to inhibitory ratio of 25 ( A/I ratio ; gene-R131 : gene ) .	T1	T10	23030766
NA	CHEMICAL	GENE-Y	4	7	The mutant gene ( gene ) contained a total of 5 chemical substitutions that conferred an activating to inhibitory ratio of 25 ( A/I ratio ; gene-R131 : gene ) .	T1	T11	23030766
NA	CHEMICAL	GENE-Y	4	28	The mutant gene ( gene ) contained a total of 5 chemical substitutions that conferred an activating to inhibitory ratio of 25 ( A/I ratio ; gene-R131 : gene ) .	T1	T12	23030766
CPR:4	CHEMICAL	GENE-Y	4	0	gene inhibitory effect by chemical-type chemical from hydrolyzate of total Gynostemma pentaphyllum chemical .	T5	T13	23177789
CPR:4	CHEMICAL	GENE-Y	5	0	gene inhibitory effect by chemical-type chemical from hydrolyzate of total Gynostemma pentaphyllum chemical .	T6	T13	23177789
CPR:4	CHEMICAL	GENE-Y	12	0	gene inhibitory effect by chemical-type chemical from hydrolyzate of total Gynostemma pentaphyllum chemical .	T4	T13	23177789
NA	CHEMICAL	GENE-Y	8	0	gene ( gene ) is an important factor in non-gene-dependent diabetes mellitus ( type-2 diabetes ) , and a promising target for treatment of diabetes and obesity .	T3	T8	23177789
NA	CHEMICAL	GENE-Y	8	2	gene ( gene ) is an important factor in non-gene-dependent diabetes mellitus ( type-2 diabetes ) , and a promising target for treatment of diabetes and obesity .	T3	T9	23177789
NA	CHEMICAL	GENE-Y	8	8	gene ( gene ) is an important factor in non-gene-dependent diabetes mellitus ( type-2 diabetes ) , and a promising target for treatment of diabetes and obesity .	T3	T11	23177789
NA	CHEMICAL	GENE-Y	7	14	Recent evidence suggests that processes other than chemical binding , such as phosphorylation of gene ( gene ) also controls contraction of vertebrate striated muscle ( Cooke , R .	T2	T7	23319584
NA	CHEMICAL	GENE-Y	7	16	Recent evidence suggests that processes other than chemical binding , such as phosphorylation of gene ( gene ) also controls contraction of vertebrate striated muscle ( Cooke , R .	T2	T8	23319584
NA	CHEMICAL	GENE-N	8	15	Electron paramagnetic resonance ( EPR ) studies using chemical analog spin label probes showed that gene heads are highly ordered in the relaxed fibers and have very low gene activity .	T4	T9	23319584
NA	CHEMICAL	GENE-N	8	28	Electron paramagnetic resonance ( EPR ) studies using chemical analog spin label probes showed that gene heads are highly ordered in the relaxed fibers and have very low gene activity .	T4	T10	23319584
NA	CHEMICAL	GENE-Y	6	3	Blockade of the gene-gene system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by chemical II throughout the cardiovascular and renal continua .	T5	T18	20448797
NA	CHEMICAL	GENE-Y	6	3	Blockade of the gene-gene system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by chemical II throughout the cardiovascular and renal continua .	T5	T20	20448797
NA	CHEMICAL	GENE-Y	6	28	Blockade of the gene-gene system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by chemical II throughout the cardiovascular and renal continua .	T5	T19	20448797
NA	CHEMICAL	GENE-Y	28	3	Blockade of the gene-gene system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by chemical II throughout the cardiovascular and renal continua .	T4	T18	20448797
NA	CHEMICAL	GENE-Y	28	3	Blockade of the gene-gene system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by chemical II throughout the cardiovascular and renal continua .	T4	T20	20448797
NA	CHEMICAL	GENE-Y	28	28	Blockade of the gene-gene system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by chemical II throughout the cardiovascular and renal continua .	T4	T19	20448797
CPR:4	CHEMICAL	GENE-N	0	4	chemical is an chemical receptor blocker ( ARB ) displaying unique pharmacologic properties , including a longer half life than any other ARB , that result in large and sustained reductions of blood pressure .	T6	T21	20448797
NA	CHEMICAL	GENE-N	3	4	chemical is an chemical receptor blocker ( ARB ) displaying unique pharmacologic properties , including a longer half life than any other ARB , that result in large and sustained reductions of blood pressure .	T7	T21	20448797
NA	CHEMICAL	GENE-N	0	2	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T20	T46	23643747
CPR:3	CHEMICAL	GENE-Y	0	5	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T20	T47	23643747
NA	CHEMICAL	GENE-Y	0	13	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T20	T48	23643747
CPR:4	CHEMICAL	GENE-N	0	17	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T20	T45	23643747
NA	CHEMICAL	GENE-N	7	2	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T21	T46	23643747
NA	CHEMICAL	GENE-Y	7	5	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T21	T47	23643747
NA	CHEMICAL	GENE-Y	7	13	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T21	T48	23643747
NA	CHEMICAL	GENE-N	7	17	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T21	T45	23643747
NA	CHEMICAL	GENE-N	9	2	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T22	T46	23643747
NA	CHEMICAL	GENE-Y	9	5	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T22	T47	23643747
NA	CHEMICAL	GENE-Y	9	13	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T22	T48	23643747
NA	CHEMICAL	GENE-N	9	17	chemical promotes gene-dependent phosphorylation of gene via chemical- and chemical-regulated phosphoprotein of 32 kDa and inhibition of gene .	T22	T45	23643747
NA	CHEMICAL	GENE-Y	8	19	Here , we examined the effects produced by chemical , a typical antipsychotic drug , on the phosphorylation of gene at chemical240/244 in the striatum , a brain region involved in neurodegenerative and neuropsychiatric disorders .	T7	T31	23643747
NA	CHEMICAL	GENE-Y	21	19	Here , we examined the effects produced by chemical , a typical antipsychotic drug , on the phosphorylation of gene at chemical240/244 in the striatum , a brain region involved in neurodegenerative and neuropsychiatric disorders .	T8	T31	23643747
NA	CHEMICAL	GENE-Y	2	22	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T9	T34	23643747
NA	CHEMICAL	GENE-Y	2	21	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T9	T35	23643747
NA	CHEMICAL	GENE-Y	4	22	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T10	T34	23643747
NA	CHEMICAL	GENE-Y	4	21	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T10	T35	23643747
NA	CHEMICAL	GENE-Y	10	22	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T11	T34	23643747
NA	CHEMICAL	GENE-Y	10	21	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T11	T35	23643747
NA	CHEMICAL	GENE-Y	6	22	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T12	T34	23643747
NA	CHEMICAL	GENE-Y	6	21	Administration of chemical increased chemical240/244 phosphorylation in a subpopulation of chemical-ergic medium spiny neurons ( MSNs ) , which express chemical D2 receptors ( gene ) .	T12	T35	23643747
CPR:4	CHEMICAL	GENE-N	5	11	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T13	T36	23643747
CPR:4	CHEMICAL	GENE-N	5	13	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T13	T38	23643747
NA	CHEMICAL	GENE-Y	5	25	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T13	T39	23643747
NA	CHEMICAL	GENE-N	5	27	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T13	T40	23643747
NA	CHEMICAL	GENE-N	20	11	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T14	T36	23643747
NA	CHEMICAL	GENE-N	20	13	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T14	T38	23643747
NA	CHEMICAL	GENE-Y	20	25	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T14	T39	23643747
NA	CHEMICAL	GENE-N	20	27	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T14	T40	23643747
NA	CHEMICAL	GENE-N	18	11	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T15	T36	23643747
NA	CHEMICAL	GENE-N	18	13	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T15	T38	23643747
CPR:4	CHEMICAL	GENE-Y	18	25	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T15	T39	23643747
CPR:4	CHEMICAL	GENE-N	18	27	This effect was prevented by chemical , an inhibitor of the gene ( gene ) , or by chemical , a selective inhibitor of the gene ( gene ) .	T15	T40	23643747
NA	CHEMICAL	GENE-Y	7	23	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T16	T41	23643747
NA	CHEMICAL	GENE-Y	7	22	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T16	T42	23643747
NA	CHEMICAL	GENE-N	7	32	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T16	T43	23643747
NA	CHEMICAL	GENE-N	7	34	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T16	T44	23643747
NA	CHEMICAL	GENE-Y	9	23	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T17	T41	23643747
NA	CHEMICAL	GENE-Y	9	22	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T17	T42	23643747
NA	CHEMICAL	GENE-N	9	32	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T17	T43	23643747
NA	CHEMICAL	GENE-N	9	34	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T17	T44	23643747
NA	CHEMICAL	GENE-Y	17	23	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T18	T41	23643747
NA	CHEMICAL	GENE-Y	17	22	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T18	T42	23643747
NA	CHEMICAL	GENE-N	17	32	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T18	T43	23643747
NA	CHEMICAL	GENE-N	17	34	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T18	T44	23643747
NA	CHEMICAL	GENE-Y	19	23	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T19	T41	23643747
NA	CHEMICAL	GENE-Y	19	22	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T19	T42	23643747
NA	CHEMICAL	GENE-N	19	32	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T19	T43	23643747
NA	CHEMICAL	GENE-N	19	34	We also found that the effect of chemical on chemical240/244 phosphorylation was prevented by functional inactivation of chemical- and chemical-regulated phosphoprotein of 32 kDa ( gene ) , an endogenous inhibitor of gene ( gene ) .	T19	T44	23643747
CPR:4	CHEMICAL	GENE-N	11	18	In line with this observation , incubation of striatal slices with chemical and chemical , two inhibitors of gene , increased chemical240/244 phosphorylation .	T1	T23	23643747
CPR:4	CHEMICAL	GENE-N	13	18	In line with this observation , incubation of striatal slices with chemical and chemical , two inhibitors of gene , increased chemical240/244 phosphorylation .	T2	T23	23643747
NA	CHEMICAL	GENE-N	21	18	In line with this observation , incubation of striatal slices with chemical and chemical , two inhibitors of gene , increased chemical240/244 phosphorylation .	T3	T23	23643747
NA	CHEMICAL	GENE-N	4	6	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T4	T24	23643747
NA	CHEMICAL	GENE-N	4	8	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T4	T25	23643747
CPR:3	CHEMICAL	GENE-Y	4	11	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T4	T26	23643747
NA	CHEMICAL	GENE-Y	4	22	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T4	T27	23643747
NA	CHEMICAL	GENE-N	13	6	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T5	T24	23643747
NA	CHEMICAL	GENE-N	13	8	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T5	T25	23643747
NA	CHEMICAL	GENE-Y	13	11	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T5	T26	23643747
NA	CHEMICAL	GENE-Y	13	22	These results show that chemical promotes gene- and gene-dependent phosphorylation of gene at chemical240/244 , in a subpopulation of striatal MSNs expressing gene .	T5	T27	23643747
NA	CHEMICAL	GENE-Y	0	2	chemical receptor 1 is involved in chemical-mediated neuronal injury in mice .	T20	T32	17112405
NA	CHEMICAL	GENE-Y	6	2	chemical receptor 1 is involved in chemical-mediated neuronal injury in mice .	T21	T32	17112405
NA	CHEMICAL	GENE-Y	5	7	AIM : To determine whether chemical receptor 1 ( gene ) is involved in chemical ( chemical ) -induced excitotoxic injury in the mouse brain .	T4	T24	17112405
NA	CHEMICAL	GENE-Y	5	6	AIM : To determine whether chemical receptor 1 ( gene ) is involved in chemical ( chemical ) -induced excitotoxic injury in the mouse brain .	T4	T29	17112405
NA	CHEMICAL	GENE-Y	14	7	AIM : To determine whether chemical receptor 1 ( gene ) is involved in chemical ( chemical ) -induced excitotoxic injury in the mouse brain .	T17	T24	17112405
NA	CHEMICAL	GENE-Y	14	6	AIM : To determine whether chemical receptor 1 ( gene ) is involved in chemical ( chemical ) -induced excitotoxic injury in the mouse brain .	T17	T29	17112405
NA	CHEMICAL	GENE-Y	9	7	AIM : To determine whether chemical receptor 1 ( gene ) is involved in chemical ( chemical ) -induced excitotoxic injury in the mouse brain .	T2	T24	17112405
NA	CHEMICAL	GENE-Y	9	6	AIM : To determine whether chemical receptor 1 ( gene ) is involved in chemical ( chemical ) -induced excitotoxic injury in the mouse brain .	T2	T29	17112405
NA	CHEMICAL	GENE-Y	8	3	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T5	T25	17112405
NA	CHEMICAL	GENE-Y	8	15	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T5	T26	17112405
NA	CHEMICAL	GENE-N	8	28	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T5	T27	17112405
NA	CHEMICAL	GENE-Y	14	3	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T6	T25	17112405
CPR:6	CHEMICAL	GENE-Y	14	15	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T6	T26	17112405
NA	CHEMICAL	GENE-N	14	28	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T6	T27	17112405
NA	CHEMICAL	GENE-Y	27	3	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T7	T25	17112405
NA	CHEMICAL	GENE-Y	27	15	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T7	T26	17112405
NA	CHEMICAL	GENE-N	27	28	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T7	T27	17112405
NA	CHEMICAL	GENE-Y	2	3	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T8	T25	17112405
NA	CHEMICAL	GENE-Y	2	15	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T8	T26	17112405
CPR:6	CHEMICAL	GENE-N	2	28	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T8	T27	17112405
NA	CHEMICAL	GENE-Y	14	3	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T9	T25	17112405
NA	CHEMICAL	GENE-Y	14	15	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T9	T26	17112405
NA	CHEMICAL	GENE-N	14	28	The changes in gene expression 24 h after chemical injection and the effects of a gene antagonist , chemical ( 0.01 and 0.1 mg/kg ) , an chemical receptor antagonist , chemical ( 30 mg/kg ) , and an antioxidant , chemical ( 9 mg/kg ) were observed .	T9	T27	17112405
CPR:3	CHEMICAL	GENE-Y	4	8	RESULTS : In the chemical-injured brain , the gene mRNA , and protein expression were upregulated , and the receptor was mainly localized in the neurons and not in the astrocytes .	T10	T28	17112405
NA	CHEMICAL	GENE-Y	0	22	chemical , chemical and chemical decreased chemical-induced injury ; chemical ( 0.1 mg/kg ) and chemical inhibited the upregulated expression of the gene .	T11	T30	17112405
NA	CHEMICAL	GENE-Y	2	22	chemical , chemical and chemical decreased chemical-induced injury ; chemical ( 0.1 mg/kg ) and chemical inhibited the upregulated expression of the gene .	T12	T30	17112405
NA	CHEMICAL	GENE-Y	4	22	chemical , chemical and chemical decreased chemical-induced injury ; chemical ( 0.1 mg/kg ) and chemical inhibited the upregulated expression of the gene .	T13	T30	17112405
NA	CHEMICAL	GENE-Y	6	22	chemical , chemical and chemical decreased chemical-induced injury ; chemical ( 0.1 mg/kg ) and chemical inhibited the upregulated expression of the gene .	T14	T30	17112405
CPR:4	CHEMICAL	GENE-Y	9	22	chemical , chemical and chemical decreased chemical-induced injury ; chemical ( 0.1 mg/kg ) and chemical inhibited the upregulated expression of the gene .	T15	T30	17112405
CPR:4	CHEMICAL	GENE-Y	15	22	chemical , chemical and chemical decreased chemical-induced injury ; chemical ( 0.1 mg/kg ) and chemical inhibited the upregulated expression of the gene .	T16	T30	17112405
NA	CHEMICAL	GENE-N	3	2	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T32	T41	3004501
NA	CHEMICAL	GENE-Y	3	20	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T32	T40	3004501
CPR:4	CHEMICAL	GENE-N	11	2	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T33	T41	3004501
NA	CHEMICAL	GENE-Y	11	20	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T33	T40	3004501
NA	CHEMICAL	GENE-N	16	2	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T30	T41	3004501
CPR:4	CHEMICAL	GENE-Y	16	20	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T30	T40	3004501
NA	CHEMICAL	GENE-N	18	2	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T31	T41	3004501
CPR:4	CHEMICAL	GENE-Y	18	20	Inhibition of the chemical synthetase of rat basophil leukemia cells by chemical , and synergism between chemical and chemical , a gene inhibitor .	T31	T40	3004501
CPR:9	CHEMICAL	GENE-Y	7	4	Similar concentrations also inhibited the formation of chemical ( chemical ) by gene , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling chemical to chemical .	T12	T37	3004501
CPR:9	CHEMICAL	GENE-Y	9	4	Similar concentrations also inhibited the formation of chemical ( chemical ) by gene , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling chemical to chemical .	T13	T37	3004501
CPR:9	CHEMICAL	GENE-Y	28	4	Similar concentrations also inhibited the formation of chemical ( chemical ) by gene , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling chemical to chemical .	T14	T37	3004501
NA	CHEMICAL	GENE-Y	14	4	Similar concentrations also inhibited the formation of chemical ( chemical ) by gene , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling chemical to chemical .	T15	T37	3004501
NA	CHEMICAL	GENE-Y	6	5	The EC50 for inhibition of the chemical synthetase of RBL cells was directly proportional to the chemical concentration in the incubations , ranging from 1.5 mM at 10 microM chemical to over 40 mM at 500 microM chemical .	T19	T38	3004501
CPR:9	CHEMICAL	GENE-Y	16	5	The EC50 for inhibition of the chemical synthetase of RBL cells was directly proportional to the chemical concentration in the incubations , ranging from 1.5 mM at 10 microM chemical to over 40 mM at 500 microM chemical .	T20	T38	3004501
NA	CHEMICAL	GENE-Y	29	5	The EC50 for inhibition of the chemical synthetase of RBL cells was directly proportional to the chemical concentration in the incubations , ranging from 1.5 mM at 10 microM chemical to over 40 mM at 500 microM chemical .	T21	T38	3004501
NA	CHEMICAL	GENE-Y	37	5	The EC50 for inhibition of the chemical synthetase of RBL cells was directly proportional to the chemical concentration in the incubations , ranging from 1.5 mM at 10 microM chemical to over 40 mM at 500 microM chemical .	T22	T38	3004501
NA	CHEMICAL	GENE-Y	8	4	Kinetic analysis revealed that the inhibition of the chemical synthetase reaction by chemical was competitive with respect to chemical .	T23	T39	3004501
CPR:4	CHEMICAL	GENE-Y	12	4	Kinetic analysis revealed that the inhibition of the chemical synthetase reaction by chemical was competitive with respect to chemical .	T24	T39	3004501
NA	CHEMICAL	GENE-Y	18	4	Kinetic analysis revealed that the inhibition of the chemical synthetase reaction by chemical was competitive with respect to chemical .	T25	T39	3004501
CPR:4	CHEMICAL	GENE-Y	3	23	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T26	T34	3004501
CPR:4	CHEMICAL	GENE-N	3	14	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T26	T35	3004501
CPR:4	CHEMICAL	GENE-Y	5	23	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T27	T34	3004501
NA	CHEMICAL	GENE-N	5	14	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T27	T35	3004501
CPR:4	CHEMICAL	GENE-Y	4	23	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T28	T34	3004501
NA	CHEMICAL	GENE-N	4	14	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T28	T35	3004501
CPR:4	CHEMICAL	GENE-Y	9	23	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T29	T34	3004501
NA	CHEMICAL	GENE-N	9	14	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T29	T35	3004501
CPR:9	CHEMICAL	GENE-Y	3	23	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T2	T34	3004501
NA	CHEMICAL	GENE-N	3	14	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T2	T35	3004501
NA	CHEMICAL	GENE-Y	23	23	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T3	T34	3004501
NA	CHEMICAL	GENE-N	23	14	In contrast to chemical , chemical ( chemical ; chemical ) , which inhibits the formation of chemical in RBL cells at the gene step ( EC50 5 microM ) , did not inhibit the chemical synthetase of these cells .	T3	T35	3004501
CPR:4	CHEMICAL	GENE-Y	6	3	Preferential cerebrospinal fluid gene inhibition by chemical in humans .	T15	T32	10587286
NA	CHEMICAL	GENE-Y	16	11	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T5	T26	10587286
NA	CHEMICAL	GENE-Y	16	13	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T5	T31	10587286
NA	CHEMICAL	GENE-Y	16	47	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T5	T25	10587286
NA	CHEMICAL	GENE-Y	33	11	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T7	T26	10587286
NA	CHEMICAL	GENE-Y	33	13	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T7	T31	10587286
NA	CHEMICAL	GENE-Y	33	47	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T7	T25	10587286
NA	CHEMICAL	GENE-Y	35	11	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T8	T26	10587286
NA	CHEMICAL	GENE-Y	35	13	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T8	T31	10587286
NA	CHEMICAL	GENE-Y	35	47	This study sought to examine the feasibility of prolonged assessment of gene ( gene ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that chemical ( chemical ; chemical , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits gene in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .	T8	T25	10587286
NA	CHEMICAL	GENE-Y	15	25	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T11	T27	10587286
NA	CHEMICAL	GENE-Y	15	29	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T11	T28	10587286
NA	CHEMICAL	GENE-Y	15	36	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T11	T29	10587286
NA	CHEMICAL	GENE-Y	15	38	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T11	T30	10587286
NA	CHEMICAL	GENE-Y	19	25	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T12	T27	10587286
NA	CHEMICAL	GENE-Y	19	29	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T12	T28	10587286
NA	CHEMICAL	GENE-Y	19	36	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T12	T29	10587286
NA	CHEMICAL	GENE-Y	19	38	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T12	T30	10587286
NA	CHEMICAL	GENE-Y	20	25	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T13	T27	10587286
NA	CHEMICAL	GENE-Y	20	29	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T13	T28	10587286
NA	CHEMICAL	GENE-Y	20	36	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T13	T29	10587286
NA	CHEMICAL	GENE-Y	20	38	CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for chemical and its metabolite chemical ( chemical ) , erythrocyte gene activity , CSF gene activity , and plasma and CSF gene ( gene ) activity .	T13	T30	10587286
CPR:4	CHEMICAL	GENE-Y	3	2	Inhibition of gene in the CSF after chemical administration was significantly greater than after placebo for up to 8.4 hours after the dose and was maximal ( 40 % ) at 2.4 hours .	T3	T17	10587286
CPR:4	CHEMICAL	GENE-Y	7	1	Plasma gene activity was significantly lower after chemical than after placebo , but this was not clinically relevant .	T4	T18	10587286
CPR:4	CHEMICAL	GENE-Y	2	0	gene activity in CSF was significantly lower after chemical than after placebo for up to 3.6 hours after dosing , but this difference was not sustained .	T6	T19	10587286
CPR:6	CHEMICAL	GENE-Y	0	14	chemical antagonistic effect of chemical ( chemical ) metabolites on wild-type and mutated chemical receptor .	T44	T63	10076535
CPR:6	CHEMICAL	GENE-Y	4	14	chemical antagonistic effect of chemical ( chemical ) metabolites on wild-type and mutated chemical receptor .	T45	T63	10076535
CPR:6	CHEMICAL	GENE-Y	6	14	chemical antagonistic effect of chemical ( chemical ) metabolites on wild-type and mutated chemical receptor .	T46	T63	10076535
NA	CHEMICAL	GENE-Y	11	14	chemical antagonistic effect of chemical ( chemical ) metabolites on wild-type and mutated chemical receptor .	T47	T63	10076535
NA	CHEMICAL	GENE-Y	14	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T33	T59	10076535
NA	CHEMICAL	GENE-Y	14	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T33	T60	10076535
NA	CHEMICAL	GENE-Y	14	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T33	T61	10076535
NA	CHEMICAL	GENE-Y	19	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T34	T59	10076535
NA	CHEMICAL	GENE-Y	19	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T34	T60	10076535
NA	CHEMICAL	GENE-Y	19	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T34	T61	10076535
NA	CHEMICAL	GENE-Y	7	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T35	T59	10076535
NA	CHEMICAL	GENE-Y	7	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T35	T61	10076535
NA	CHEMICAL	GENE-Y	7	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T36	T59	10076535
NA	CHEMICAL	GENE-Y	7	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T36	T61	10076535
NA	CHEMICAL	GENE-Y	28	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T37	T59	10076535
NA	CHEMICAL	GENE-Y	28	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T37	T60	10076535
NA	CHEMICAL	GENE-Y	28	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T37	T61	10076535
NA	CHEMICAL	GENE-Y	28	65	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T37	T62	10076535
NA	CHEMICAL	GENE-Y	31	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T38	T59	10076535
NA	CHEMICAL	GENE-Y	31	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T38	T60	10076535
NA	CHEMICAL	GENE-Y	31	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T38	T61	10076535
NA	CHEMICAL	GENE-Y	31	65	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T38	T62	10076535
NA	CHEMICAL	GENE-Y	40	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T39	T59	10076535
NA	CHEMICAL	GENE-Y	40	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T39	T60	10076535
NA	CHEMICAL	GENE-Y	40	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T39	T61	10076535
NA	CHEMICAL	GENE-Y	40	65	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T39	T62	10076535
NA	CHEMICAL	GENE-Y	42	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T40	T59	10076535
NA	CHEMICAL	GENE-Y	42	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T40	T60	10076535
NA	CHEMICAL	GENE-Y	42	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T40	T61	10076535
NA	CHEMICAL	GENE-Y	42	65	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T40	T62	10076535
NA	CHEMICAL	GENE-Y	45	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T41	T59	10076535
NA	CHEMICAL	GENE-Y	45	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T41	T60	10076535
NA	CHEMICAL	GENE-Y	45	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T41	T61	10076535
NA	CHEMICAL	GENE-Y	45	65	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T41	T62	10076535
NA	CHEMICAL	GENE-Y	20	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T42	T59	10076535
NA	CHEMICAL	GENE-Y	20	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T42	T60	10076535
NA	CHEMICAL	GENE-Y	20	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T42	T61	10076535
NA	CHEMICAL	GENE-Y	20	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T43	T59	10076535
NA	CHEMICAL	GENE-Y	20	52	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T43	T60	10076535
NA	CHEMICAL	GENE-Y	20	47	We investigated , by displacement of chemical in the presence of 2.5 mM of chemical , the binding of chemical and its metabolites , chemical , chemical , chemical , and chemical , as well as other antichemical agents including chemical , chemical , and chemical , to the mutated gene ( m-gene ) in LNCaP cells and to the wild-type chemical receptor in wild-type gene cDNA expression plasmid ( w-pAR0 ) cDNA-transfected HeLa cells .	T43	T61	10076535
NA	CHEMICAL	GENE-Y	5	1	Analogous to the antichemicals , chemical and chemical , binding of chemical metabolites to the gene was observed .	T2	T48	10076535
NA	CHEMICAL	GENE-Y	7	1	Analogous to the antichemicals , chemical and chemical , binding of chemical metabolites to the gene was observed .	T3	T48	10076535
NA	CHEMICAL	GENE-Y	11	1	Analogous to the antichemicals , chemical and chemical , binding of chemical metabolites to the gene was observed .	T4	T48	10076535
NA	CHEMICAL	GENE-Y	3	1	Analogous to the antichemicals , chemical and chemical , binding of chemical metabolites to the gene was observed .	T5	T48	10076535
CPR:4	CHEMICAL	GENE-Y	13	2	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T18	T49	10076535
CPR:4	CHEMICAL	GENE-Y	13	4	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T18	T50	10076535
CPR:4	CHEMICAL	GENE-Y	13	9	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T18	T51	10076535
CPR:4	CHEMICAL	GENE-Y	13	25	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T18	T52	10076535
CPR:4	CHEMICAL	GENE-Y	15	2	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T19	T49	10076535
CPR:4	CHEMICAL	GENE-Y	15	4	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T19	T50	10076535
CPR:4	CHEMICAL	GENE-Y	15	9	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T19	T51	10076535
CPR:4	CHEMICAL	GENE-Y	15	25	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T19	T52	10076535
NA	CHEMICAL	GENE-Y	8	2	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T20	T49	10076535
NA	CHEMICAL	GENE-Y	8	4	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T20	T50	10076535
NA	CHEMICAL	GENE-Y	8	9	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T20	T51	10076535
NA	CHEMICAL	GENE-Y	8	25	Down-regulation of gene ( gene ) expression , an gene-target gene , by chemical and chemical was accompanied by the blockade of the mutated chemical receptor .	T20	T52	10076535
CPR:4	CHEMICAL	GENE-Y	5	13	Exposure of LNCaP cells to chemical for 24 hr caused transcriptional inhibition of gene in a concentration-dependent manner .	T21	T53	10076535
CPR:4	CHEMICAL	GENE-Y	21	3	The levels of gene mRNA decreased 56 and 90 % when LNCaP cells were treated with 5 and 10 microM of chemical , respectively ( IC50 = 10.97 +/- 1.68 microM ) .	T22	T54	10076535
NA	CHEMICAL	GENE-Y	2	4	Binding of chemical to m-gene in LNCaP cells resulted in a concentration-dependent stimulation of gene expression , suggesting that chemical acted as an agonist of the m-gene .	T23	T55	10076535
CPR:3	CHEMICAL	GENE-Y	2	14	Binding of chemical to m-gene in LNCaP cells resulted in a concentration-dependent stimulation of gene expression , suggesting that chemical acted as an agonist of the m-gene .	T23	T56	10076535
NA	CHEMICAL	GENE-Y	2	26	Binding of chemical to m-gene in LNCaP cells resulted in a concentration-dependent stimulation of gene expression , suggesting that chemical acted as an agonist of the m-gene .	T23	T57	10076535
NA	CHEMICAL	GENE-Y	10	4	Binding of chemical to m-gene in LNCaP cells resulted in a concentration-dependent stimulation of gene expression , suggesting that chemical acted as an agonist of the m-gene .	T24	T55	10076535
NA	CHEMICAL	GENE-Y	10	14	Binding of chemical to m-gene in LNCaP cells resulted in a concentration-dependent stimulation of gene expression , suggesting that chemical acted as an agonist of the m-gene .	T24	T56	10076535
CPR:5	CHEMICAL	GENE-Y	10	26	Binding of chemical to m-gene in LNCaP cells resulted in a concentration-dependent stimulation of gene expression , suggesting that chemical acted as an agonist of the m-gene .	T24	T57	10076535
NA	CHEMICAL	GENE-N	2	3	Inactivation of chemical synthase and chemical synthase by chemical .	T32	T47	3917545
NA	CHEMICAL	GENE-Y	2	3	Inactivation of chemical synthase and chemical synthase by chemical .	T32	T48	3917545
NA	CHEMICAL	GENE-N	5	3	Inactivation of chemical synthase and chemical synthase by chemical .	T33	T47	3917545
NA	CHEMICAL	GENE-Y	5	3	Inactivation of chemical synthase and chemical synthase by chemical .	T33	T48	3917545
CPR:4	CHEMICAL	GENE-N	8	3	Inactivation of chemical synthase and chemical synthase by chemical .	T34	T47	3917545
CPR:4	CHEMICAL	GENE-Y	8	3	Inactivation of chemical synthase and chemical synthase by chemical .	T34	T48	3917545
NA	CHEMICAL	GENE-N	0	5	chemical ( chemical ) , a nonsteroidal anti-inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of chemical synthase ( gene ) .	T1	T36	3917545
NA	CHEMICAL	GENE-N	0	23	chemical ( chemical ) , a nonsteroidal anti-inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of chemical synthase ( gene ) .	T1	T40	3917545
NA	CHEMICAL	GENE-N	2	5	chemical ( chemical ) , a nonsteroidal anti-inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of chemical synthase ( gene ) .	T17	T36	3917545
NA	CHEMICAL	GENE-N	2	23	chemical ( chemical ) , a nonsteroidal anti-inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of chemical synthase ( gene ) .	T17	T40	3917545
NA	CHEMICAL	GENE-N	20	5	chemical ( chemical ) , a nonsteroidal anti-inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of chemical synthase ( gene ) .	T8	T36	3917545
NA	CHEMICAL	GENE-N	20	23	chemical ( chemical ) , a nonsteroidal anti-inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of chemical synthase ( gene ) .	T8	T40	3917545
NA	CHEMICAL	GENE-N	9	7	Most reducing cofactors for the peroxidase protect gene and chemical synthase from inactivation by chemical .	T18	T41	3917545
NA	CHEMICAL	GENE-Y	9	10	Most reducing cofactors for the peroxidase protect gene and chemical synthase from inactivation by chemical .	T18	T42	3917545
CPR:4	CHEMICAL	GENE-N	14	7	Most reducing cofactors for the peroxidase protect gene and chemical synthase from inactivation by chemical .	T19	T41	3917545
CPR:4	CHEMICAL	GENE-Y	14	10	Most reducing cofactors for the peroxidase protect gene and chemical synthase from inactivation by chemical .	T19	T42	3917545
NA	CHEMICAL	GENE-N	6	9	Using ram seminal vesicle microsomes as a source of gene and chemical synthase , we have examined the interaction of chemical and exogenous chemical .	T22	T43	3917545
NA	CHEMICAL	GENE-Y	6	5	Using ram seminal vesicle microsomes as a source of gene and chemical synthase , we have examined the interaction of chemical and exogenous chemical .	T22	T44	3917545
NA	CHEMICAL	GENE-N	20	9	Using ram seminal vesicle microsomes as a source of gene and chemical synthase , we have examined the interaction of chemical and exogenous chemical .	T23	T43	3917545
NA	CHEMICAL	GENE-Y	20	5	Using ram seminal vesicle microsomes as a source of gene and chemical synthase , we have examined the interaction of chemical and exogenous chemical .	T23	T44	3917545
NA	CHEMICAL	GENE-N	23	9	Using ram seminal vesicle microsomes as a source of gene and chemical synthase , we have examined the interaction of chemical and exogenous chemical .	T24	T43	3917545
NA	CHEMICAL	GENE-Y	23	5	Using ram seminal vesicle microsomes as a source of gene and chemical synthase , we have examined the interaction of chemical and exogenous chemical .	T24	T44	3917545
CPR:9	CHEMICAL	GENE-N	6	15	Chromatographic analysis of the metabolism of chemical in this system revealed that chemical-dependent inactivation of gene is markedly increased in the presence of 100 microM chemical .	T25	T45	3917545
NA	CHEMICAL	GENE-N	12	15	Chromatographic analysis of the metabolism of chemical in this system revealed that chemical-dependent inactivation of gene is markedly increased in the presence of 100 microM chemical .	T26	T45	3917545
CPR:4	CHEMICAL	GENE-N	25	15	Chromatographic analysis of the metabolism of chemical in this system revealed that chemical-dependent inactivation of gene is markedly increased in the presence of 100 microM chemical .	T27	T45	3917545
NA	CHEMICAL	GENE-Y	0	1	chemical synthase is even more sensitive to inactivation by the combined chemical and chemical treatment , with a corresponding half-maximal effect at chemical concentrations near 25 microM .	T29	T46	3917545
NA	CHEMICAL	GENE-Y	11	1	chemical synthase is even more sensitive to inactivation by the combined chemical and chemical treatment , with a corresponding half-maximal effect at chemical concentrations near 25 microM .	T30	T46	3917545
NA	CHEMICAL	GENE-Y	13	1	chemical synthase is even more sensitive to inactivation by the combined chemical and chemical treatment , with a corresponding half-maximal effect at chemical concentrations near 25 microM .	T31	T46	3917545
NA	CHEMICAL	GENE-Y	0	1	chemical synthase is even more sensitive to inactivation by the combined chemical and chemical treatment , with a corresponding half-maximal effect at chemical concentrations near 25 microM .	T2	T46	3917545
NA	CHEMICAL	GENE-Y	1	21	This chemical- and chemical-dependent inactivation is demonstrable whether chemical is generated in situ from chemical or is added exogenously , supporting a direct effect of the treatment on chemical synthase .	T3	T35	3917545
NA	CHEMICAL	GENE-Y	3	21	This chemical- and chemical-dependent inactivation is demonstrable whether chemical is generated in situ from chemical or is added exogenously , supporting a direct effect of the treatment on chemical synthase .	T4	T35	3917545
NA	CHEMICAL	GENE-Y	8	21	This chemical- and chemical-dependent inactivation is demonstrable whether chemical is generated in situ from chemical or is added exogenously , supporting a direct effect of the treatment on chemical synthase .	T5	T35	3917545
NA	CHEMICAL	GENE-Y	14	21	This chemical- and chemical-dependent inactivation is demonstrable whether chemical is generated in situ from chemical or is added exogenously , supporting a direct effect of the treatment on chemical synthase .	T6	T35	3917545
NA	CHEMICAL	GENE-Y	11	21	This chemical- and chemical-dependent inactivation is demonstrable whether chemical is generated in situ from chemical or is added exogenously , supporting a direct effect of the treatment on chemical synthase .	T7	T35	3917545
NA	CHEMICAL	GENE-N	1	7	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T9	T37	3917545
NA	CHEMICAL	GENE-N	1	33	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T9	T38	3917545
NA	CHEMICAL	GENE-Y	1	36	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T9	T39	3917545
NA	CHEMICAL	GENE-N	3	7	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T10	T37	3917545
NA	CHEMICAL	GENE-N	3	33	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T10	T38	3917545
NA	CHEMICAL	GENE-Y	3	36	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T10	T39	3917545
NA	CHEMICAL	GENE-N	18	7	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T11	T37	3917545
NA	CHEMICAL	GENE-N	18	33	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T11	T38	3917545
NA	CHEMICAL	GENE-Y	18	36	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T11	T39	3917545
NA	CHEMICAL	GENE-N	35	7	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T12	T37	3917545
NA	CHEMICAL	GENE-N	35	33	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T12	T38	3917545
NA	CHEMICAL	GENE-Y	35	36	As chemical undergoes chemical-dependent co-oxygenation catalyzed by gene , we propose that it is an oxygenated derivative of chemical , rather than the parent compound , which is responsible for the inactivation of gene and chemical synthase .	T12	T39	3917545
NA	CHEMICAL	GENE-N	16	3	Two pharmacologically distinct gene subtypes in the contraction of rabbit aorta : each subtype couples with a different chemical signalling mechanism and plays a different physiological role .	T27	T37	1978244
CPR:6	CHEMICAL	GENE-N	5	2	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T20	T28	1978244
NA	CHEMICAL	GENE-N	5	23	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T20	T31	1978244
CPR:6	CHEMICAL	GENE-N	7	2	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T22	T28	1978244
NA	CHEMICAL	GENE-N	7	23	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T22	T31	1978244
CPR:6	CHEMICAL	GENE-N	10	2	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T24	T28	1978244
NA	CHEMICAL	GENE-N	10	23	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T24	T31	1978244
CPR:6	CHEMICAL	GENE-N	13	2	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T1	T28	1978244
NA	CHEMICAL	GENE-N	13	23	Using the gene subtype-selective antagonists chemical ( chemical ) , chemical , and chemical , we have examined the possible heterogeneity in the gene populations in rabbit aorta .	T1	T31	1978244
NA	CHEMICAL	GENE-N	12	1	The gene alkylating agent CEC selectively inhibited the phasic component of the chemical-induced contractile response , with little effect on the tonic component .	T18	T33	1978244
NA	CHEMICAL	GENE-N	7	1	The gene occupancy-response relationship defined by the chemical inactivation method was rectangular hyperbolic for the tonic response , whereas that for the phasic response was linear , indicating the different degree of receptor reserve for the two responses .	T19	T34	1978244
CPR:6	CHEMICAL	GENE-N	9	6	Radioligand binding studies with the nonselective gene antagonist radioligand chemical showed that 73-87 % of the binding sites in rabbit aorta are chemical sensitive and they are predominantly low affinity sites both for chemical ( pKd = 8.1 ) and for chemical ( pKd = 7.1 ) .	T21	T35	1978244
NA	CHEMICAL	GENE-N	22	6	Radioligand binding studies with the nonselective gene antagonist radioligand chemical showed that 73-87 % of the binding sites in rabbit aorta are chemical sensitive and they are predominantly low affinity sites both for chemical ( pKd = 8.1 ) and for chemical ( pKd = 7.1 ) .	T23	T35	1978244
NA	CHEMICAL	GENE-N	33	6	Radioligand binding studies with the nonselective gene antagonist radioligand chemical showed that 73-87 % of the binding sites in rabbit aorta are chemical sensitive and they are predominantly low affinity sites both for chemical ( pKd = 8.1 ) and for chemical ( pKd = 7.1 ) .	T25	T35	1978244
NA	CHEMICAL	GENE-N	41	6	Radioligand binding studies with the nonselective gene antagonist radioligand chemical showed that 73-87 % of the binding sites in rabbit aorta are chemical sensitive and they are predominantly low affinity sites both for chemical ( pKd = 8.1 ) and for chemical ( pKd = 7.1 ) .	T26	T35	1978244
NA	CHEMICAL	GENE-N	3	2	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T2	T36	1978244
NA	CHEMICAL	GENE-N	3	16	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T2	T29	1978244
NA	CHEMICAL	GENE-N	2	2	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T3	T36	1978244
NA	CHEMICAL	GENE-N	2	16	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T3	T29	1978244
NA	CHEMICAL	GENE-N	9	2	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T4	T36	1978244
NA	CHEMICAL	GENE-N	9	16	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T4	T29	1978244
NA	CHEMICAL	GENE-N	18	2	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T5	T36	1978244
NA	CHEMICAL	GENE-N	18	16	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T5	T29	1978244
NA	CHEMICAL	GENE-N	26	2	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T6	T36	1978244
NA	CHEMICAL	GENE-N	26	16	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T6	T29	1978244
NA	CHEMICAL	GENE-N	42	2	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T7	T36	1978244
NA	CHEMICAL	GENE-N	42	16	Moreover , gene-mediated chemical ( chemical ) hydrolysis was chemical sensitive , and fractional inactivation of gene with chemical showed equivalent increments in the reduction of chemical hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the chemical-sensitive receptor sites .	T7	T29	1978244
CPR:6	CHEMICAL	GENE-Y	7	11	The Schild plots for the competitive antagonists chemical and chemical against gene-selective agonist chemical-induced contraction were linear and had slopes not significantly different from unity , with a pA2 of 9.07 +/- 0.07 ( n = 5 ) for chemical and 9.09 +/- 0.05 ( n = 3 ) for chemical .	T8	T30	1978244
CPR:6	CHEMICAL	GENE-Y	9	11	The Schild plots for the competitive antagonists chemical and chemical against gene-selective agonist chemical-induced contraction were linear and had slopes not significantly different from unity , with a pA2 of 9.07 +/- 0.07 ( n = 5 ) for chemical and 9.09 +/- 0.05 ( n = 3 ) for chemical .	T9	T30	1978244
CPR:5	CHEMICAL	GENE-Y	13	11	The Schild plots for the competitive antagonists chemical and chemical against gene-selective agonist chemical-induced contraction were linear and had slopes not significantly different from unity , with a pA2 of 9.07 +/- 0.07 ( n = 5 ) for chemical and 9.09 +/- 0.05 ( n = 3 ) for chemical .	T10	T30	1978244
CPR:6	CHEMICAL	GENE-Y	39	11	The Schild plots for the competitive antagonists chemical and chemical against gene-selective agonist chemical-induced contraction were linear and had slopes not significantly different from unity , with a pA2 of 9.07 +/- 0.07 ( n = 5 ) for chemical and 9.09 +/- 0.05 ( n = 3 ) for chemical .	T11	T30	1978244
CPR:6	CHEMICAL	GENE-Y	27	11	The Schild plots for the competitive antagonists chemical and chemical against gene-selective agonist chemical-induced contraction were linear and had slopes not significantly different from unity , with a pA2 of 9.07 +/- 0.07 ( n = 5 ) for chemical and 9.09 +/- 0.05 ( n = 3 ) for chemical .	T12	T30	1978244
CPR:4	CHEMICAL	GENE-Y	2	18	Comparison of chemical and chemical to study the role of the chemical-group in improvement of endothelial dysfunction with gene inhibitors in high dieted chemical mice .	T45	T67	16424790
CPR:4	CHEMICAL	GENE-Y	4	18	Comparison of chemical and chemical to study the role of the chemical-group in improvement of endothelial dysfunction with gene inhibitors in high dieted chemical mice .	T47	T67	16424790
CPR:4	CHEMICAL	GENE-Y	11	18	Comparison of chemical and chemical to study the role of the chemical-group in improvement of endothelial dysfunction with gene inhibitors in high dieted chemical mice .	T48	T67	16424790
NA	CHEMICAL	GENE-Y	12	18	Comparison of chemical and chemical to study the role of the chemical-group in improvement of endothelial dysfunction with gene inhibitors in high dieted chemical mice .	T46	T67	16424790
NA	CHEMICAL	GENE-Y	5	17	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T24	T66	16424790
NA	CHEMICAL	GENE-Y	5	19	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T24	T54	16424790
NA	CHEMICAL	GENE-Y	7	17	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T31	T66	16424790
NA	CHEMICAL	GENE-Y	7	19	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T31	T54	16424790
NA	CHEMICAL	GENE-Y	10	17	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T43	T66	16424790
NA	CHEMICAL	GENE-Y	10	19	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T43	T54	16424790
NA	CHEMICAL	GENE-Y	10	17	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T11	T66	16424790
NA	CHEMICAL	GENE-Y	10	19	To examine the role of chemical ( -chemical ) group in improvement of endothelial dysfunction with chemical-converting enzyme ( gene ) inhibitors in experimental high dose of chemical dieted rats .	T11	T54	16424790
CPR:4	CHEMICAL	GENE-Y	5	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T22	T63	16424790
NA	CHEMICAL	GENE-Y	5	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T22	T64	16424790
NA	CHEMICAL	GENE-Y	5	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T22	T65	16424790
CPR:4	CHEMICAL	GENE-Y	11	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T26	T63	16424790
NA	CHEMICAL	GENE-Y	11	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T26	T64	16424790
NA	CHEMICAL	GENE-Y	11	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T26	T65	16424790
NA	CHEMICAL	GENE-Y	15	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T27	T63	16424790
CPR:4	CHEMICAL	GENE-Y	15	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T27	T64	16424790
NA	CHEMICAL	GENE-Y	15	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T27	T65	16424790
NA	CHEMICAL	GENE-Y	20	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T28	T63	16424790
NA	CHEMICAL	GENE-Y	20	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T28	T64	16424790
NA	CHEMICAL	GENE-Y	20	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T28	T65	16424790
NA	CHEMICAL	GENE-Y	24	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T29	T63	16424790
NA	CHEMICAL	GENE-Y	24	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T29	T64	16424790
NA	CHEMICAL	GENE-Y	24	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T29	T65	16424790
NA	CHEMICAL	GENE-Y	27	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T30	T63	16424790
NA	CHEMICAL	GENE-Y	27	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T30	T64	16424790
NA	CHEMICAL	GENE-Y	27	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T30	T65	16424790
NA	CHEMICAL	GENE-Y	33	8	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T32	T63	16424790
NA	CHEMICAL	GENE-Y	33	18	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T32	T64	16424790
NA	CHEMICAL	GENE-Y	33	30	We compared the effects of chemical ( an gene inhibitor with -chemical group ) , chemical ( an gene-inhibitor without -chemical group ) , chemical ( only -chemical group not gene inhibitor ) on endothelial dysfunction injured by chemical-induced hyperhomocysteinemia ( HHcy ) in rats .	T32	T65	16424790
NA	CHEMICAL	GENE-Y	8	0	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T1	T49	16424790
NA	CHEMICAL	GENE-Y	8	2	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T1	T50	16424790
NA	CHEMICAL	GENE-Y	8	5	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T1	T51	16424790
NA	CHEMICAL	GENE-N	8	19	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T1	T52	16424790
NA	CHEMICAL	GENE-N	8	21	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T1	T53	16424790
NA	CHEMICAL	GENE-Y	10	0	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T2	T49	16424790
NA	CHEMICAL	GENE-Y	10	2	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T2	T50	16424790
NA	CHEMICAL	GENE-Y	10	5	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T2	T51	16424790
NA	CHEMICAL	GENE-N	10	19	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T2	T52	16424790
NA	CHEMICAL	GENE-N	10	21	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T2	T53	16424790
NA	CHEMICAL	GENE-Y	13	0	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T3	T49	16424790
NA	CHEMICAL	GENE-Y	13	2	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T3	T50	16424790
NA	CHEMICAL	GENE-Y	13	5	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T3	T51	16424790
NA	CHEMICAL	GENE-N	13	19	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T3	T52	16424790
NA	CHEMICAL	GENE-N	13	21	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T3	T53	16424790
NA	CHEMICAL	GENE-Y	0	0	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T4	T49	16424790
NA	CHEMICAL	GENE-Y	0	2	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T4	T50	16424790
NA	CHEMICAL	GENE-Y	0	5	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T4	T51	16424790
NA	CHEMICAL	GENE-N	0	19	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T4	T52	16424790
NA	CHEMICAL	GENE-N	0	21	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T4	T53	16424790
NA	CHEMICAL	GENE-Y	2	0	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T5	T49	16424790
NA	CHEMICAL	GENE-Y	2	2	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T5	T50	16424790
NA	CHEMICAL	GENE-Y	2	5	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T5	T51	16424790
NA	CHEMICAL	GENE-N	2	19	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T5	T52	16424790
NA	CHEMICAL	GENE-N	2	21	gene ( gene ) and gene activity , chemical ( chemical ) , chemical ( chemical ) , chemical dismutase ( gene ) in serum were analyzed .	T5	T53	16424790
CPR:4	CHEMICAL	GENE-Y	9	29	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T6	T55	16424790
CPR:4	CHEMICAL	GENE-N	9	31	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T6	T56	16424790
NA	CHEMICAL	GENE-Y	4	29	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T7	T55	16424790
NA	CHEMICAL	GENE-N	4	31	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T7	T56	16424790
NA	CHEMICAL	GENE-Y	38	29	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T8	T55	16424790
NA	CHEMICAL	GENE-N	38	31	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T8	T56	16424790
NA	CHEMICAL	GENE-Y	38	52	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T8	T57	16424790
NA	CHEMICAL	GENE-Y	4	29	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T9	T55	16424790
NA	CHEMICAL	GENE-N	4	31	It was found that a single intragastric gavage by chemical resulted in inhibition of endothelium-dependent relaxation , markedly increased the serum level of chemical and decreased the activity of gene and gene , similarly decreased the level of chemical in the serum ; but had no effects on endothelium-independent relaxation and chemical-converting enzyme activity compared with the control group .	T9	T56	16424790
CPR:3	CHEMICAL	GENE-Y	7	39	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T10	T58	16424790
CPR:3	CHEMICAL	GENE-N	7	41	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T10	T59	16424790
NA	CHEMICAL	GENE-Y	21	39	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T12	T58	16424790
NA	CHEMICAL	GENE-N	21	41	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T12	T59	16424790
NA	CHEMICAL	GENE-Y	29	39	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T13	T58	16424790
NA	CHEMICAL	GENE-N	29	41	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T13	T59	16424790
NA	CHEMICAL	GENE-Y	35	39	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T14	T58	16424790
NA	CHEMICAL	GENE-N	35	41	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T14	T59	16424790
NA	CHEMICAL	GENE-Y	42	39	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T15	T58	16424790
NA	CHEMICAL	GENE-N	42	41	Given the treatment with three doses of chemical ( 15 approximately 45 mg/kg ) markedly attenuated inhibition of vasodilator responses to chemical , and eliminated the increased level of chemical , the decreased level of chemical , activity of gene and gene in serum by single intragastric gavaged chemical .	T15	T59	16424790
NA	CHEMICAL	GENE-Y	8	30	However , there were some significant differences among chemical ( 30 mg/kg or 45 mg/kg ) , chemical ( 20 mg/kg ) , and chemical particular in the activity of gene and gene .	T16	T60	16424790
NA	CHEMICAL	GENE-Y	8	32	However , there were some significant differences among chemical ( 30 mg/kg or 45 mg/kg ) , chemical ( 20 mg/kg ) , and chemical particular in the activity of gene and gene .	T16	T61	16424790
NA	CHEMICAL	GENE-Y	17	30	However , there were some significant differences among chemical ( 30 mg/kg or 45 mg/kg ) , chemical ( 20 mg/kg ) , and chemical particular in the activity of gene and gene .	T17	T60	16424790
NA	CHEMICAL	GENE-Y	17	32	However , there were some significant differences among chemical ( 30 mg/kg or 45 mg/kg ) , chemical ( 20 mg/kg ) , and chemical particular in the activity of gene and gene .	T17	T61	16424790
NA	CHEMICAL	GENE-Y	24	30	However , there were some significant differences among chemical ( 30 mg/kg or 45 mg/kg ) , chemical ( 20 mg/kg ) , and chemical particular in the activity of gene and gene .	T18	T60	16424790
NA	CHEMICAL	GENE-Y	24	32	However , there were some significant differences among chemical ( 30 mg/kg or 45 mg/kg ) , chemical ( 20 mg/kg ) , and chemical particular in the activity of gene and gene .	T18	T61	16424790
NA	CHEMICAL	GENE-Y	4	33	These results suggested that chemical can protect the vascular endothelium against the damages induced by chemical in rats , and the beneficial effects of chemical may be related to attenuating the decrease in gene activity and chemical levels .	T19	T62	16424790
CPR:4	CHEMICAL	GENE-Y	15	33	These results suggested that chemical can protect the vascular endothelium against the damages induced by chemical in rats , and the beneficial effects of chemical may be related to attenuating the decrease in gene activity and chemical levels .	T20	T62	16424790
CPR:3	CHEMICAL	GENE-Y	24	33	These results suggested that chemical can protect the vascular endothelium against the damages induced by chemical in rats , and the beneficial effects of chemical may be related to attenuating the decrease in gene activity and chemical levels .	T21	T62	16424790
NA	CHEMICAL	GENE-Y	36	33	These results suggested that chemical can protect the vascular endothelium against the damages induced by chemical in rats , and the beneficial effects of chemical may be related to attenuating the decrease in gene activity and chemical levels .	T23	T62	16424790
CPR:3	CHEMICAL	GENE-Y	0	16	chemical enhances the depolarizing afterpotential of immunohistochemically identified chemical neurons in the rat supraoptic nucleus via gene activation .	T20	T26	8098142
NA	CHEMICAL	GENE-Y	8	16	chemical enhances the depolarizing afterpotential of immunohistochemically identified chemical neurons in the rat supraoptic nucleus via gene activation .	T21	T26	8098142
NA	CHEMICAL	GENE-Y	7	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T2	T22	8098142
NA	CHEMICAL	GENE-Y	7	13	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T2	T23	8098142
NA	CHEMICAL	GENE-Y	7	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T2	T24	8098142
NA	CHEMICAL	GENE-Y	12	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T3	T22	8098142
NA	CHEMICAL	GENE-Y	12	13	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T3	T23	8098142
NA	CHEMICAL	GENE-Y	12	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T3	T24	8098142
CPR:5	CHEMICAL	GENE-Y	15	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T4	T22	8098142
NA	CHEMICAL	GENE-Y	15	13	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T4	T23	8098142
NA	CHEMICAL	GENE-Y	15	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T4	T24	8098142
NA	CHEMICAL	GENE-Y	25	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T5	T22	8098142
CPR:6	CHEMICAL	GENE-Y	25	13	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T5	T23	8098142
NA	CHEMICAL	GENE-Y	25	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T5	T24	8098142
NA	CHEMICAL	GENE-Y	33	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T6	T22	8098142
NA	CHEMICAL	GENE-Y	33	13	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T6	T23	8098142
NA	CHEMICAL	GENE-Y	33	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T6	T24	8098142
NA	CHEMICAL	GENE-Y	33	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T7	T22	8098142
NA	CHEMICAL	GENE-Y	33	13	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T7	T23	8098142
CPR:6	CHEMICAL	GENE-Y	33	19	The enhancement of the depolarizing afterpotential by chemical was mimicked by the chemical gene agonist chemical and was reduced or blocked by the H1-receptor antagonist chemical , but was not blocked or reduced in the presence of the chemical H2-receptor antagonist , chemical .	T7	T24	8098142
NA	CHEMICAL	GENE-N	8	3	The effect of a peripheral block on inflammation-induced chemical and gene expression in rats .	T11	T19	19690271
CPR:9	CHEMICAL	GENE-Y	24	13	BACKGROUND : Peripheral inflammatory pain is associated with an upregulation of spinal cord gene ( gene ) , with a subsequent increase in central chemical ( chemical ) levels associated with the development of hyperalgesia .	T3	T17	19690271
CPR:9	CHEMICAL	GENE-Y	24	15	BACKGROUND : Peripheral inflammatory pain is associated with an upregulation of spinal cord gene ( gene ) , with a subsequent increase in central chemical ( chemical ) levels associated with the development of hyperalgesia .	T3	T18	19690271
CPR:9	CHEMICAL	GENE-Y	26	13	BACKGROUND : Peripheral inflammatory pain is associated with an upregulation of spinal cord gene ( gene ) , with a subsequent increase in central chemical ( chemical ) levels associated with the development of hyperalgesia .	T4	T17	19690271
CPR:9	CHEMICAL	GENE-Y	26	15	BACKGROUND : Peripheral inflammatory pain is associated with an upregulation of spinal cord gene ( gene ) , with a subsequent increase in central chemical ( chemical ) levels associated with the development of hyperalgesia .	T4	T18	19690271
NA	CHEMICAL	GENE-N	9	27	In this study , we evaluated the effect of chemical administered via a nerve block or via a systemic route on the spinal expression of chemical and gene in a model of peripheral inflammation in rats .	T5	T14	19690271
NA	CHEMICAL	GENE-N	25	27	In this study , we evaluated the effect of chemical administered via a nerve block or via a systemic route on the spinal expression of chemical and gene in a model of peripheral inflammation in rats .	T6	T14	19690271
NA	CHEMICAL	GENE-Y	13	16	Local edema , thermal , and mechanical hyperalgesia as well as cerebrospinal fluid chemical concentration and gene and gene expression in the spinal cord in dorsal root ganglions were measured .	T9	T15	19690271
NA	CHEMICAL	GENE-Y	13	18	Local edema , thermal , and mechanical hyperalgesia as well as cerebrospinal fluid chemical concentration and gene and gene expression in the spinal cord in dorsal root ganglions were measured .	T9	T16	19690271
NA	CHEMICAL	GENE-Y	25	7	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T6	T31	23532932
NA	CHEMICAL	GENE-Y	25	11	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T6	T32	23532932
NA	CHEMICAL	GENE-Y	25	14	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T6	T33	23532932
NA	CHEMICAL	GENE-Y	25	32	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T6	T34	23532932
NA	CHEMICAL	GENE-Y	27	7	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T7	T31	23532932
NA	CHEMICAL	GENE-Y	27	11	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T7	T32	23532932
NA	CHEMICAL	GENE-Y	27	14	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T7	T33	23532932
NA	CHEMICAL	GENE-Y	27	32	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T7	T34	23532932
NA	CHEMICAL	GENE-Y	30	7	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T8	T31	23532932
NA	CHEMICAL	GENE-Y	30	11	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T8	T32	23532932
NA	CHEMICAL	GENE-Y	30	14	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T8	T33	23532932
NA	CHEMICAL	GENE-Y	30	32	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T8	T34	23532932
NA	CHEMICAL	GENE-Y	30	7	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T1	T31	23532932
NA	CHEMICAL	GENE-Y	30	11	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T1	T32	23532932
NA	CHEMICAL	GENE-Y	30	14	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T1	T33	23532932
NA	CHEMICAL	GENE-Y	30	32	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T1	T34	23532932
NA	CHEMICAL	GENE-Y	30	7	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T2	T31	23532932
NA	CHEMICAL	GENE-Y	30	11	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T2	T32	23532932
NA	CHEMICAL	GENE-Y	30	14	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T2	T33	23532932
NA	CHEMICAL	GENE-Y	30	32	In the current study , we crossed gene.fLUC mice into the gene knockout ( gene ( -/- ) ) genetic background and injected mice with chemical ( chemical ) , a strong gene ligand , and two therapeutically relevant chemical , chemical and chemical .	T2	T34	23532932
NA	CHEMICAL	GENE-Y	12	4	All three agents induced gene.fLUC expression ( bioluminescence ) , but only chemical and chemical appeared to act primarily via gene .	T3	T9	23532932
NA	CHEMICAL	GENE-Y	12	20	All three agents induced gene.fLUC expression ( bioluminescence ) , but only chemical and chemical appeared to act primarily via gene .	T3	T10	23532932
NA	CHEMICAL	GENE-Y	14	4	All three agents induced gene.fLUC expression ( bioluminescence ) , but only chemical and chemical appeared to act primarily via gene .	T4	T9	23532932
NA	CHEMICAL	GENE-Y	14	20	All three agents induced gene.fLUC expression ( bioluminescence ) , but only chemical and chemical appeared to act primarily via gene .	T4	T10	23532932
NA	CHEMICAL	GENE-Y	0	3	chemical , a gene ligand , modestly induced gene.fLUC in gene ( +/+ ) and gene ( -/- ) strains , consistent with gene 's minor role in gene regulation .	T5	T12	23532932
CPR:3	CHEMICAL	GENE-Y	0	2	chemical , a gene ligand , modestly induced gene.fLUC in gene ( +/+ ) and gene ( -/- ) strains , consistent with gene 's minor role in gene regulation .	T5	T13	23532932
NA	CHEMICAL	GENE-Y	0	10	chemical , a gene ligand , modestly induced gene.fLUC in gene ( +/+ ) and gene ( -/- ) strains , consistent with gene 's minor role in gene regulation .	T5	T14	23532932
NA	CHEMICAL	GENE-Y	0	15	chemical , a gene ligand , modestly induced gene.fLUC in gene ( +/+ ) and gene ( -/- ) strains , consistent with gene 's minor role in gene regulation .	T5	T15	23532932
NA	CHEMICAL	GENE-Y	0	23	chemical , a gene ligand , modestly induced gene.fLUC in gene ( +/+ ) and gene ( -/- ) strains , consistent with gene 's minor role in gene regulation .	T5	T16	23532932
NA	CHEMICAL	GENE-Y	0	2	chemical , a gene ligand , modestly induced gene.fLUC in gene ( +/+ ) and gene ( -/- ) strains , consistent with gene 's minor role in gene regulation .	T5	T17	23532932
CPR:4	CHEMICAL	GENE-Y	0	18	chemical , isolated from dietary mugwort ( Artemisia princeps ) , induces G2/M cell cycle arrest by inactivating gene-gene via gene-gene activation .	T17	T32	23274058
CPR:4	CHEMICAL	GENE-Y	0	18	chemical , isolated from dietary mugwort ( Artemisia princeps ) , induces G2/M cell cycle arrest by inactivating gene-gene via gene-gene activation .	T17	T33	23274058
CPR:3	CHEMICAL	GENE-Y	0	20	chemical , isolated from dietary mugwort ( Artemisia princeps ) , induces G2/M cell cycle arrest by inactivating gene-gene via gene-gene activation .	T17	T34	23274058
NA	CHEMICAL	GENE-N	0	20	chemical , isolated from dietary mugwort ( Artemisia princeps ) , induces G2/M cell cycle arrest by inactivating gene-gene via gene-gene activation .	T17	T35	23274058
NA	CHEMICAL	GENE-Y	0	12	chemical induced G2/M phase cell cycle arrest and modulated the levels of gene and gene in Hec1A cells .	T14	T25	23274058
NA	CHEMICAL	GENE-Y	0	14	chemical induced G2/M phase cell cycle arrest and modulated the levels of gene and gene in Hec1A cells .	T14	T26	23274058
NA	CHEMICAL	GENE-Y	8	2	Knockdown of gene using specific siRNAs partially abrogated chemical-induced cell growth inhibition .	T15	T27	23274058
CPR:3	CHEMICAL	GENE-Y	5	14	Additional mechanistic studies revealed that chemical treatment resulted in an increase in phosphorylation of gene and gene-gene .	T16	T28	23274058
CPR:3	CHEMICAL	GENE-Y	5	16	Additional mechanistic studies revealed that chemical treatment resulted in an increase in phosphorylation of gene and gene-gene .	T16	T29	23274058
NA	CHEMICAL	GENE-N	5	16	Additional mechanistic studies revealed that chemical treatment resulted in an increase in phosphorylation of gene and gene-gene .	T16	T30	23274058
NA	CHEMICAL	GENE-Y	7	3	Ku55933 , an gene inhibitor , reversed chemical-induced cell growth inhibition , in part .	T2	T31	23274058
NA	CHEMICAL	GENE-N	2	8	Moreover , chemical treatment resulted in phosphorylation of gene , and pretreatment with the gene inhibitor , chemical , attenuated cell growth inhibition by chemical .	T3	T18	23274058
NA	CHEMICAL	GENE-N	2	14	Moreover , chemical treatment resulted in phosphorylation of gene , and pretreatment with the gene inhibitor , chemical , attenuated cell growth inhibition by chemical .	T3	T19	23274058
NA	CHEMICAL	GENE-N	17	8	Moreover , chemical treatment resulted in phosphorylation of gene , and pretreatment with the gene inhibitor , chemical , attenuated cell growth inhibition by chemical .	T4	T18	23274058
CPR:4	CHEMICAL	GENE-N	17	14	Moreover , chemical treatment resulted in phosphorylation of gene , and pretreatment with the gene inhibitor , chemical , attenuated cell growth inhibition by chemical .	T4	T19	23274058
NA	CHEMICAL	GENE-N	5	8	Moreover , chemical treatment resulted in phosphorylation of gene , and pretreatment with the gene inhibitor , chemical , attenuated cell growth inhibition by chemical .	T5	T18	23274058
NA	CHEMICAL	GENE-N	5	14	Moreover , chemical treatment resulted in phosphorylation of gene , and pretreatment with the gene inhibitor , chemical , attenuated cell growth inhibition by chemical .	T5	T19	23274058
CPR:4	CHEMICAL	GENE-Y	18	15	The goal of the present study was to compare the effects of three potent reference gene inhibitors ( chemical , chemical , and chemical ) in chemical-depleted normotensive squirrel monkeys .	T1	T26	8319997
CPR:4	CHEMICAL	GENE-Y	15	15	The goal of the present study was to compare the effects of three potent reference gene inhibitors ( chemical , chemical , and chemical ) in chemical-depleted normotensive squirrel monkeys .	T2	T26	8319997
CPR:4	CHEMICAL	GENE-Y	23	15	The goal of the present study was to compare the effects of three potent reference gene inhibitors ( chemical , chemical , and chemical ) in chemical-depleted normotensive squirrel monkeys .	T3	T26	8319997
NA	CHEMICAL	GENE-Y	26	15	The goal of the present study was to compare the effects of three potent reference gene inhibitors ( chemical , chemical , and chemical ) in chemical-depleted normotensive squirrel monkeys .	T7	T26	8319997
CPR:4	CHEMICAL	GENE-Y	11	9	Finally , the three drugs were compared with the gene inhibitor chemical .	T10	T20	8319997
NA	CHEMICAL	GENE-Y	32	4	The residence time of a stoichiometric bioscavenger , gene ( gene ) , in the plasma more closely matches that of VX than do the residence times of conventional therapy drugs ( chemical , anti-muscarinic , anticonvulsant ) .	T4	T9	22981459
NA	CHEMICAL	GENE-Y	32	10	The residence time of a stoichiometric bioscavenger , gene ( gene ) , in the plasma more closely matches that of VX than do the residence times of conventional therapy drugs ( chemical , anti-muscarinic , anticonvulsant ) .	T4	T10	22981459
NA	CHEMICAL	GENE-Y	8	15	A combination of nerve agent therapy drugs ( chemical , anti-muscarinic , anticonvulsant ) with gene ( i.m . )	T5	T13	22981459
NA	CHEMICAL	GENE-Y	2	23	The transport chemical-sensitive mechanism , that decreased the acidic intracellular pH change occurring in this medium , would correspond to chemical-chemical exchange ( gene isoform ) .	T3	T20	11688549
CPR:9	CHEMICAL	GENE-Y	20	23	The transport chemical-sensitive mechanism , that decreased the acidic intracellular pH change occurring in this medium , would correspond to chemical-chemical exchange ( gene isoform ) .	T4	T20	11688549
CPR:9	CHEMICAL	GENE-Y	20	23	The transport chemical-sensitive mechanism , that decreased the acidic intracellular pH change occurring in this medium , would correspond to chemical-chemical exchange ( gene isoform ) .	T5	T20	11688549
NA	CHEMICAL	GENE-Y	6	8	MATERIALS AND METHODS : Methylation of chemical sulfotransferase pi ( gene ) and gene ( gene ) genes was studied using methylation sensitive PCR ( MS-PCR ) .	T5	T9	17465221
NA	CHEMICAL	GENE-Y	6	10	MATERIALS AND METHODS : Methylation of chemical sulfotransferase pi ( gene ) and gene ( gene ) genes was studied using methylation sensitive PCR ( MS-PCR ) .	T5	T10	17465221
NA	CHEMICAL	GENE-Y	6	13	MATERIALS AND METHODS : Methylation of chemical sulfotransferase pi ( gene ) and gene ( gene ) genes was studied using methylation sensitive PCR ( MS-PCR ) .	T5	T11	17465221
NA	CHEMICAL	GENE-Y	6	15	MATERIALS AND METHODS : Methylation of chemical sulfotransferase pi ( gene ) and gene ( gene ) genes was studied using methylation sensitive PCR ( MS-PCR ) .	T5	T12	17465221
NA	CHEMICAL	GENE-Y	5	2	PURPOSE : gene deficiency is a recently described inborn error of chemical pathway .	T1	T5	23315216
CPR:4	CHEMICAL	GENE-N	0	12	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T1	T15	15191400
CPR:4	CHEMICAL	GENE-Y	0	15	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T1	T17	15191400
CPR:4	CHEMICAL	GENE-N	0	15	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T1	T12	15191400
NA	CHEMICAL	GENE-N	11	12	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T6	T15	15191400
NA	CHEMICAL	GENE-Y	11	15	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T6	T17	15191400
NA	CHEMICAL	GENE-N	11	15	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T6	T12	15191400
NA	CHEMICAL	GENE-N	18	12	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T3	T15	15191400
NA	CHEMICAL	GENE-Y	18	15	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T3	T17	15191400
NA	CHEMICAL	GENE-N	18	15	chemical , an antirheumatic gold compound , is an inhibitor of chemical enzymes , such as gene and chemical peroxidase .	T3	T12	15191400
NA	CHEMICAL	GENE-Y	5	3	The activity of gene and chemical peroxidase was determined in liver and heart tissues in an attempt to correlate enzymatic activity with heart recovery after ischaemia-reperfusion .	T5	T13	15191400
NA	CHEMICAL	GENE-N	5	6	The activity of gene and chemical peroxidase was determined in liver and heart tissues in an attempt to correlate enzymatic activity with heart recovery after ischaemia-reperfusion .	T5	T14	15191400
NA	CHEMICAL	GENE-Y	15	4	There was significantly less gene activity in rat liver extracts , whereas the level of chemical activity remained unchanged , demonstrating that the dose of chemical used was able to selectively inhibit one of these enzyme systems .	T7	T16	15191400
CPR:4	CHEMICAL	GENE-Y	6	4	There was significantly less gene activity in rat liver extracts , whereas the level of chemical activity remained unchanged , demonstrating that the dose of chemical used was able to selectively inhibit one of these enzyme systems .	T8	T16	15191400
NA	CHEMICAL	GENE-N	22	25	There are 2 forms of PHA1 : the autosomal recessive form with symptoms persisting into adulthood , caused by mutations in the chemical-sensitive luminal chemical channel , and the autosomal dominant or sporadic form , which shows milder symptoms that remit with age .	T1	T4	11344206
NA	CHEMICAL	GENE-N	24	25	There are 2 forms of PHA1 : the autosomal recessive form with symptoms persisting into adulthood , caused by mutations in the chemical-sensitive luminal chemical channel , and the autosomal dominant or sporadic form , which shows milder symptoms that remit with age .	T2	T4	11344206
NA	CHEMICAL	GENE-N	14	6	This mutation is the first described in exon 9 and impairs the last 27 chemical of the gene .	T3	T9	11344206
NA	CHEMICAL	GENE-Y	13	4	Genetic variants at the gene ( gene ) may modify asthma severity and chemical responsiveness .	T2	T11	15557128
NA	CHEMICAL	GENE-Y	13	5	Genetic variants at the gene ( gene ) may modify asthma severity and chemical responsiveness .	T2	T12	15557128
NA	CHEMICAL	GENE-Y	14	5	We tested the association of gene genotypes with asthma severity and bronchodilator response to chemical in Puerto Ricans and Mexicans with asthma .	T3	T13	15557128
NA	CHEMICAL	GENE-Y	15	13	METHODS : We used both family-based and cross-sectional tests of association with 8 gene single chemical polymorphisms in 684 Puerto Rican and Mexican families .	T4	T14	15557128
NA	CHEMICAL	GENE-N	15	9	We found a strong interaction of baseline FEV ( 1 ) with the gene ( chemical ) polymorphism in predicting bronchodilator response .	T1	T8	15557128
NA	CHEMICAL	GENE-N	3	9	Cooperative binding of chemical and chemical in the chemical receptor is modulated by chemical .	T28	T56	9990013
NA	CHEMICAL	GENE-N	5	9	Cooperative binding of chemical and chemical in the chemical receptor is modulated by chemical .	T29	T56	9990013
NA	CHEMICAL	GENE-N	8	9	Cooperative binding of chemical and chemical in the chemical receptor is modulated by chemical .	T30	T56	9990013
NA	CHEMICAL	GENE-N	13	9	Cooperative binding of chemical and chemical in the chemical receptor is modulated by chemical .	T31	T56	9990013
NA	CHEMICAL	GENE-N	1	6	The chemical-sensitive chemical ( KATP ) channels in pancreatic beta cells are critical in the regulation of chemical-induced gene secretion .	T16	T42	9990013
NA	CHEMICAL	GENE-Y	1	7	The chemical-sensitive chemical ( KATP ) channels in pancreatic beta cells are critical in the regulation of chemical-induced gene secretion .	T16	T33	9990013
NA	CHEMICAL	GENE-N	2	6	The chemical-sensitive chemical ( KATP ) channels in pancreatic beta cells are critical in the regulation of chemical-induced gene secretion .	T11	T42	9990013
NA	CHEMICAL	GENE-Y	2	7	The chemical-sensitive chemical ( KATP ) channels in pancreatic beta cells are critical in the regulation of chemical-induced gene secretion .	T11	T33	9990013
NA	CHEMICAL	GENE-N	1	6	The chemical-sensitive chemical ( KATP ) channels in pancreatic beta cells are critical in the regulation of chemical-induced gene secretion .	T1	T42	9990013
CPR:3	CHEMICAL	GENE-Y	1	7	The chemical-sensitive chemical ( KATP ) channels in pancreatic beta cells are critical in the regulation of chemical-induced gene secretion .	T1	T33	9990013
NA	CHEMICAL	GENE-N	12	10	Although electrophysiological studies provide clues to the complex control of gene by chemical , chemical , and pharmacological agents , the molecular mechanism of gene regulation remains unclear .	T12	T38	9990013
NA	CHEMICAL	GENE-N	12	24	Although electrophysiological studies provide clues to the complex control of gene by chemical , chemical , and pharmacological agents , the molecular mechanism of gene regulation remains unclear .	T12	T39	9990013
NA	CHEMICAL	GENE-N	14	10	Although electrophysiological studies provide clues to the complex control of gene by chemical , chemical , and pharmacological agents , the molecular mechanism of gene regulation remains unclear .	T13	T38	9990013
NA	CHEMICAL	GENE-N	14	24	Although electrophysiological studies provide clues to the complex control of gene by chemical , chemical , and pharmacological agents , the molecular mechanism of gene regulation remains unclear .	T13	T39	9990013
NA	CHEMICAL	GENE-N	11	1	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T14	T40	9990013
NA	CHEMICAL	GENE-Y	11	7	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T14	T41	9990013
NA	CHEMICAL	GENE-N	11	16	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T14	T43	9990013
NA	CHEMICAL	GENE-N	11	18	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T14	T44	9990013
NA	CHEMICAL	GENE-N	11	20	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T14	T45	9990013
NA	CHEMICAL	GENE-Y	11	25	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T14	T46	9990013
NA	CHEMICAL	GENE-N	15	1	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T15	T40	9990013
NA	CHEMICAL	GENE-Y	15	7	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T15	T41	9990013
NA	CHEMICAL	GENE-N	15	16	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T15	T43	9990013
NA	CHEMICAL	GENE-N	15	18	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T15	T44	9990013
NA	CHEMICAL	GENE-N	15	20	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T15	T45	9990013
NA	CHEMICAL	GENE-Y	15	25	The gene is a heterooligomeric complex of gene subunits of the chemical-binding-cassette superfamily with two chemical-binding folds ( gene and gene ) and the pore-forming gene subunits .	T15	T46	9990013
NA	CHEMICAL	GENE-Y	5	24	Here , we report that chemical and chemical , but not the chemical salt of chemical , stabilize the binding of prebound chemical to gene .	T17	T47	9990013
NA	CHEMICAL	GENE-Y	7	24	Here , we report that chemical and chemical , but not the chemical salt of chemical , stabilize the binding of prebound chemical to gene .	T18	T47	9990013
NA	CHEMICAL	GENE-Y	12	24	Here , we report that chemical and chemical , but not the chemical salt of chemical , stabilize the binding of prebound chemical to gene .	T19	T47	9990013
NA	CHEMICAL	GENE-Y	15	24	Here , we report that chemical and chemical , but not the chemical salt of chemical , stabilize the binding of prebound chemical to gene .	T20	T47	9990013
NA	CHEMICAL	GENE-Y	22	24	Here , we report that chemical and chemical , but not the chemical salt of chemical , stabilize the binding of prebound chemical to gene .	T21	T47	9990013
NA	CHEMICAL	GENE-N	13	3	Mutation in the gene of gene of gene abolished this stabilizing effect of chemical .	T22	T48	9990013
NA	CHEMICAL	GENE-N	13	5	Mutation in the gene of gene of gene abolished this stabilizing effect of chemical .	T22	T49	9990013
NA	CHEMICAL	GENE-Y	13	7	Mutation in the gene of gene of gene abolished this stabilizing effect of chemical .	T22	T50	9990013
NA	CHEMICAL	GENE-Y	6	4	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T23	T51	9990013
NA	CHEMICAL	GENE-N	6	9	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T23	T52	9990013
NA	CHEMICAL	GENE-N	6	19	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T23	T53	9990013
NA	CHEMICAL	GENE-N	6	27	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T23	T54	9990013
NA	CHEMICAL	GENE-N	6	34	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T23	T55	9990013
NA	CHEMICAL	GENE-Y	12	4	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T24	T51	9990013
NA	CHEMICAL	GENE-N	12	9	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T24	T52	9990013
NA	CHEMICAL	GENE-N	12	19	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T24	T53	9990013
NA	CHEMICAL	GENE-N	12	27	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T24	T54	9990013
NA	CHEMICAL	GENE-N	12	34	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T24	T55	9990013
NA	CHEMICAL	GENE-Y	25	4	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T25	T51	9990013
NA	CHEMICAL	GENE-N	25	9	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T25	T52	9990013
NA	CHEMICAL	GENE-N	25	19	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T25	T53	9990013
CPR:9	CHEMICAL	GENE-N	25	27	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T25	T54	9990013
NA	CHEMICAL	GENE-N	25	34	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T25	T55	9990013
NA	CHEMICAL	GENE-Y	31	4	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T26	T51	9990013
NA	CHEMICAL	GENE-N	31	9	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T26	T52	9990013
NA	CHEMICAL	GENE-N	31	19	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T26	T53	9990013
NA	CHEMICAL	GENE-N	31	27	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T26	T54	9990013
NA	CHEMICAL	GENE-N	31	34	These results suggest that gene binds chemical strongly at gene and that chemical , either by direct binding to gene or by hydrolysis of bound chemical at gene , stabilizes prebound chemical binding at gene .	T26	T55	9990013
NA	CHEMICAL	GENE-Y	1	8	The chemical caused release of prebound chemical from gene in the presence of chemical or chemical in a concentration-dependent manner .	T27	T32	9990013
NA	CHEMICAL	GENE-Y	1	8	The chemical caused release of prebound chemical from gene in the presence of chemical or chemical in a concentration-dependent manner .	T2	T32	9990013
NA	CHEMICAL	GENE-Y	8	8	The chemical caused release of prebound chemical from gene in the presence of chemical or chemical in a concentration-dependent manner .	T3	T32	9990013
NA	CHEMICAL	GENE-Y	15	8	The chemical caused release of prebound chemical from gene in the presence of chemical or chemical in a concentration-dependent manner .	T4	T32	9990013
NA	CHEMICAL	GENE-Y	8	19	Synthesis , radiosynthesis , and biological evaluation of chemical : candidate radioligands for in vivo imaging of the chemical transporter with positron emission tomography .	T14	T25	17154506
NA	CHEMICAL	GENE-Y	13	19	Synthesis , radiosynthesis , and biological evaluation of chemical : candidate radioligands for in vivo imaging of the chemical transporter with positron emission tomography .	T13	T25	17154506
NA	CHEMICAL	GENE-N	0	21	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T1	T15	17154506
NA	CHEMICAL	GENE-Y	0	23	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T1	T16	17154506
NA	CHEMICAL	GENE-Y	0	25	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T1	T17	17154506
NA	CHEMICAL	GENE-Y	0	28	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T1	T18	17154506
NA	CHEMICAL	GENE-N	2	21	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T8	T15	17154506
NA	CHEMICAL	GENE-Y	2	23	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T8	T16	17154506
NA	CHEMICAL	GENE-Y	2	25	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T8	T17	17154506
NA	CHEMICAL	GENE-Y	2	28	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T8	T18	17154506
NA	CHEMICAL	GENE-N	1	21	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T10	T15	17154506
NA	CHEMICAL	GENE-Y	1	23	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T10	T16	17154506
NA	CHEMICAL	GENE-Y	1	25	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T10	T17	17154506
NA	CHEMICAL	GENE-Y	1	28	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T10	T18	17154506
NA	CHEMICAL	GENE-N	9	21	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T2	T15	17154506
NA	CHEMICAL	GENE-Y	9	23	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T2	T16	17154506
NA	CHEMICAL	GENE-Y	9	25	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T2	T17	17154506
NA	CHEMICAL	GENE-Y	9	28	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T2	T18	17154506
NA	CHEMICAL	GENE-N	19	21	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T3	T15	17154506
NA	CHEMICAL	GENE-Y	19	23	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T3	T16	17154506
NA	CHEMICAL	GENE-Y	19	25	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T3	T17	17154506
NA	CHEMICAL	GENE-Y	19	28	chemical ( chemical , 1 ) and chemical ( chemical , 2 ) were synthesized and evaluated for binding to the gene ( gene , gene , and gene , respectively ) using transfected cells .	T3	T18	17154506
NA	CHEMICAL	GENE-Y	3	9	Compound 2 has a significantly higher affinity for the gene than 1 , and this may be a result of the different size and electronegativity of the chemical atoms .	T6	T22	17154506
CPR:9	CHEMICAL	GENE-N	7	30	MicroPET imaging in nonhuman primates with [ chemical ] 1 and [ chemical ] 2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the gene-rich brain regions and peak uptake being achieved in about 55 min postinjection .	T7	T23	17154506
CPR:9	CHEMICAL	GENE-N	9	30	MicroPET imaging in nonhuman primates with [ chemical ] 1 and [ chemical ] 2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the gene-rich brain regions and peak uptake being achieved in about 55 min postinjection .	T9	T23	17154506
NA	CHEMICAL	GENE-Y	2	3	Sedation and chemical H1-receptor antagonism : studies in man with the enantiomers of chemical and chemical .	T14	T18	1686208
CPR:6	CHEMICAL	GENE-Y	7	3	Sedation and chemical H1-receptor antagonism : studies in man with the enantiomers of chemical and chemical .	T15	T18	1686208
CPR:6	CHEMICAL	GENE-Y	7	3	Sedation and chemical H1-receptor antagonism : studies in man with the enantiomers of chemical and chemical .	T13	T18	1686208
NA	CHEMICAL	GENE-Y	6	14	In the present study , changes in measures of drowsiness and performance were limited to the enantiomers with high affinity for the chemical H1-receptor .	T12	T16	1686208
CPR:3	CHEMICAL	GENE-N	2	17	Accumulated evidence in humans and animals shows that both chemical and H. pylori upregulate the expression of gene both at mRNA and protein levels at the ulcer margin , but failed to influence significantly that of gene .	T3	T7	17033106
NA	CHEMICAL	GENE-N	2	36	Accumulated evidence in humans and animals shows that both chemical and H. pylori upregulate the expression of gene both at mRNA and protein levels at the ulcer margin , but failed to influence significantly that of gene .	T3	T8	17033106
NA	CHEMICAL	GENE-Y	16	22	BACKGROUND : Hypertension treatment guidelines recommend combination therapy with diuretics and other antihypertensive agents , including chemical type 1 ( AT1 ) receptor antagonists .	T5	T22	17163232
CPR:6	CHEMICAL	GENE-Y	12	10	This trial investigated the possibility of pharmacokinetic interactions between the gene antagonist chemical and the chemical diuretic chemical in healthy subjects .	T13	T23	17163232
NA	CHEMICAL	GENE-Y	15	10	This trial investigated the possibility of pharmacokinetic interactions between the gene antagonist chemical and the chemical diuretic chemical in healthy subjects .	T14	T23	17163232
NA	CHEMICAL	GENE-Y	17	10	This trial investigated the possibility of pharmacokinetic interactions between the gene antagonist chemical and the chemical diuretic chemical in healthy subjects .	T15	T23	17163232
NA	CHEMICAL	GENE-Y	0	5	chemical suppresses osteoclastogenesis induced by gene and cancer cells through inhibition of inflammatory pathways : a new use for an old drug .	T8	T30	21955206
NA	CHEMICAL	GENE-Y	15	3	To search for an inhibitor of cancer-induced bone loss , we investigated the effect of chemical , a semi-synthetic chemical derived from the plant Gloriosa superba and clinically used as a muscle relaxant , on osteoclastogenesis induced by gene ( gene ) and tumour cells .	T4	T24	21955206
NA	CHEMICAL	GENE-Y	15	40	To search for an inhibitor of cancer-induced bone loss , we investigated the effect of chemical , a semi-synthetic chemical derived from the plant Gloriosa superba and clinically used as a muscle relaxant , on osteoclastogenesis induced by gene ( gene ) and tumour cells .	T4	T25	21955206
NA	CHEMICAL	GENE-Y	19	3	To search for an inhibitor of cancer-induced bone loss , we investigated the effect of chemical , a semi-synthetic chemical derived from the plant Gloriosa superba and clinically used as a muscle relaxant , on osteoclastogenesis induced by gene ( gene ) and tumour cells .	T5	T24	21955206
NA	CHEMICAL	GENE-Y	19	40	To search for an inhibitor of cancer-induced bone loss , we investigated the effect of chemical , a semi-synthetic chemical derived from the plant Gloriosa superba and clinically used as a muscle relaxant , on osteoclastogenesis induced by gene ( gene ) and tumour cells .	T5	T25	21955206
NA	CHEMICAL	GENE-Y	24	26	EXPERIMENTAL APPROACH : We used RAW 264.7 ( murine macrophage ) cells , a well-established system for osteoclastogenesis , and evaluated the effect of chemical on gene-induced gene signalling and osteoclastogenesis as well as on osteoclastogenesis induced by tumour cells .	T6	T26	21955206
NA	CHEMICAL	GENE-N	24	13	EXPERIMENTAL APPROACH : We used RAW 264.7 ( murine macrophage ) cells , a well-established system for osteoclastogenesis , and evaluated the effect of chemical on gene-induced gene signalling and osteoclastogenesis as well as on osteoclastogenesis induced by tumour cells .	T6	T27	21955206
NA	CHEMICAL	GENE-Y	3	8	KEY RESULTS : chemical suppressed osteoclastogenesis induced by gene , and by breast cancer and multiple myeloma cells .	T7	T28	21955206
NA	CHEMICAL	GENE-N	12	3	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T29	21955206
CPR:4	CHEMICAL	GENE-Y	12	14	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T9	21955206
CPR:4	CHEMICAL	GENE-N	12	15	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T10	21955206
CPR:4	CHEMICAL	GENE-N	12	20	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T11	21955206
CPR:4	CHEMICAL	GENE-N	12	22	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T12	21955206
CPR:4	CHEMICAL	GENE-Y	12	28	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T13	21955206
CPR:4	CHEMICAL	GENE-Y	12	30	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T14	21955206
CPR:4	CHEMICAL	GENE-N	12	39	Inhibition of the gene pathway was responsible for this effect since the chemical inhibited gene-induced gene activation , activation of gene ( gene ) and suppressed inhibitor of gene ( gene ) phosphorylation and degradation , an inhibitor of gene .	T1	T15	21955206
CPR:4	CHEMICAL	GENE-Y	10	16	CONCLUSIONS AND IMPLICATIONS : Together , these data suggest that chemical significantly suppressed osteoclastogenesis induced by gene and tumour cells via the gene signalling pathway .	T2	T22	21955206
CPR:4	CHEMICAL	GENE-N	10	22	CONCLUSIONS AND IMPLICATIONS : Together , these data suggest that chemical significantly suppressed osteoclastogenesis induced by gene and tumour cells via the gene signalling pathway .	T2	T23	21955206
NA	CHEMICAL	GENE-Y	4	5	Combination chemotherapy with a chemical receptor antagonist ( chemical ) and chemical in a mouse model of human African trypanosomiasis .	T10	T15	17643344
CPR:6	CHEMICAL	GENE-Y	3	5	Combination chemotherapy with a chemical receptor antagonist ( chemical ) and chemical in a mouse model of human African trypanosomiasis .	T11	T15	17643344
CPR:6	CHEMICAL	GENE-Y	3	5	Combination chemotherapy with a chemical receptor antagonist ( chemical ) and chemical in a mouse model of human African trypanosomiasis .	T12	T15	17643344
NA	CHEMICAL	GENE-Y	10	14	There is evidence in a mouse model of HAT that chemical ( chemical ) receptor antagonism reduces the neuroinflammatory reaction to CNS trypanosome infection .	T2	T13	17643344
NA	CHEMICAL	GENE-Y	12	14	There is evidence in a mouse model of HAT that chemical ( chemical ) receptor antagonism reduces the neuroinflammatory reaction to CNS trypanosome infection .	T3	T13	17643344
NA	CHEMICAL	GENE-Y	11	14	In this study we investigated the effects of combination chemotherapy with chemical and a gene antagonist chemical ( chemical ) in this mouse model .	T4	T14	17643344
CPR:6	CHEMICAL	GENE-Y	13	14	In this study we investigated the effects of combination chemotherapy with chemical and a gene antagonist chemical ( chemical ) in this mouse model .	T6	T14	17643344
CPR:6	CHEMICAL	GENE-Y	18	14	In this study we investigated the effects of combination chemotherapy with chemical and a gene antagonist chemical ( chemical ) in this mouse model .	T7	T14	17643344
NA	CHEMICAL	GENE-Y	0	5	chemical attenuates renal fibrosis via gene-mediated inhibition of gene/gene signaling .	T13	T54	23056222
CPR:4	CHEMICAL	GENE-Y	0	8	chemical attenuates renal fibrosis via gene-mediated inhibition of gene/gene signaling .	T13	T55	23056222
CPR:4	CHEMICAL	GENE-N	0	8	chemical attenuates renal fibrosis via gene-mediated inhibition of gene/gene signaling .	T13	T53	23056222
NA	CHEMICAL	GENE-Y	4	11	This study examines whether chemical ( chemical ) , which stimulates gene , prevents renal fibrosis via the gene-mediated suppression of gene signaling .	T8	T32	23056222
NA	CHEMICAL	GENE-Y	4	18	This study examines whether chemical ( chemical ) , which stimulates gene , prevents renal fibrosis via the gene-mediated suppression of gene signaling .	T8	T33	23056222
NA	CHEMICAL	GENE-Y	4	21	This study examines whether chemical ( chemical ) , which stimulates gene , prevents renal fibrosis via the gene-mediated suppression of gene signaling .	T8	T34	23056222
NA	CHEMICAL	GENE-Y	6	11	This study examines whether chemical ( chemical ) , which stimulates gene , prevents renal fibrosis via the gene-mediated suppression of gene signaling .	T9	T32	23056222
NA	CHEMICAL	GENE-Y	6	18	This study examines whether chemical ( chemical ) , which stimulates gene , prevents renal fibrosis via the gene-mediated suppression of gene signaling .	T9	T33	23056222
NA	CHEMICAL	GENE-Y	6	21	This study examines whether chemical ( chemical ) , which stimulates gene , prevents renal fibrosis via the gene-mediated suppression of gene signaling .	T9	T34	23056222
CPR:3	CHEMICAL	GENE-Y	3	8	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T35	23056222
NA	CHEMICAL	GENE-Y	3	17	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T36	23056222
NA	CHEMICAL	GENE-Y	3	19	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T37	23056222
NA	CHEMICAL	GENE-Y	3	22	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T38	23056222
NA	CHEMICAL	GENE-Y	3	24	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T39	23056222
NA	CHEMICAL	GENE-Y	3	26	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T40	23056222
NA	CHEMICAL	GENE-Y	3	29	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T41	23056222
NA	CHEMICAL	GENE-N	3	31	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T42	23056222
NA	CHEMICAL	GENE-Y	3	34	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T10	T43	23056222
NA	CHEMICAL	GENE-Y	12	8	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T35	23056222
CPR:3	CHEMICAL	GENE-Y	12	17	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T36	23056222
NA	CHEMICAL	GENE-Y	12	19	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T37	23056222
CPR:4	CHEMICAL	GENE-Y	12	22	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T38	23056222
CPR:4	CHEMICAL	GENE-Y	12	24	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T39	23056222
CPR:4	CHEMICAL	GENE-Y	12	26	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T40	23056222
CPR:4	CHEMICAL	GENE-Y	12	29	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T41	23056222
CPR:4	CHEMICAL	GENE-N	12	31	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T42	23056222
NA	CHEMICAL	GENE-Y	12	34	Results showed that chemical increased nuclear levels of gene , and both chemical and adenovirus-mediated overexpression of gene ( Ad-gene ) decreased gene , gene ( gene ) , gene and gene expression in gene-treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK-49F ) .	T11	T43	23056222
NA	CHEMICAL	GENE-Y	2	4	Additionally , chemical and Ad-gene repressed gene-stimulated gene activity by inhibiting gene phosphorylation , which was restored by siRNA-mediated knockdown of gene expression .	T12	T44	23056222
CPR:4	CHEMICAL	GENE-Y	2	6	Additionally , chemical and Ad-gene repressed gene-stimulated gene activity by inhibiting gene phosphorylation , which was restored by siRNA-mediated knockdown of gene expression .	T12	T45	23056222
CPR:4	CHEMICAL	GENE-Y	2	7	Additionally , chemical and Ad-gene repressed gene-stimulated gene activity by inhibiting gene phosphorylation , which was restored by siRNA-mediated knockdown of gene expression .	T12	T46	23056222
CPR:4	CHEMICAL	GENE-Y	2	11	Additionally , chemical and Ad-gene repressed gene-stimulated gene activity by inhibiting gene phosphorylation , which was restored by siRNA-mediated knockdown of gene expression .	T12	T48	23056222
NA	CHEMICAL	GENE-Y	2	21	Additionally , chemical and Ad-gene repressed gene-stimulated gene activity by inhibiting gene phosphorylation , which was restored by siRNA-mediated knockdown of gene expression .	T12	T49	23056222
NA	CHEMICAL	GENE-N	15	5	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T50	23056222
NA	CHEMICAL	GENE-N	15	7	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T51	23056222
NA	CHEMICAL	GENE-Y	15	10	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T52	23056222
NA	CHEMICAL	GENE-Y	15	15	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T15	23056222
NA	CHEMICAL	GENE-Y	15	17	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T16	23056222
NA	CHEMICAL	GENE-N	15	14	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T17	23056222
NA	CHEMICAL	GENE-N	15	22	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T18	23056222
NA	CHEMICAL	GENE-Y	15	33	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T19	23056222
NA	CHEMICAL	GENE-N	15	45	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T1	T20	23056222
NA	CHEMICAL	GENE-N	20	5	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T50	23056222
NA	CHEMICAL	GENE-N	20	7	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T51	23056222
NA	CHEMICAL	GENE-Y	20	10	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T52	23056222
NA	CHEMICAL	GENE-Y	20	15	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T15	23056222
NA	CHEMICAL	GENE-Y	20	17	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T16	23056222
NA	CHEMICAL	GENE-N	20	14	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T17	23056222
NA	CHEMICAL	GENE-N	20	22	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T18	23056222
NA	CHEMICAL	GENE-Y	20	33	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T19	23056222
NA	CHEMICAL	GENE-N	20	45	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T2	T20	23056222
NA	CHEMICAL	GENE-N	31	5	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T50	23056222
NA	CHEMICAL	GENE-N	31	7	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T51	23056222
NA	CHEMICAL	GENE-Y	31	10	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T52	23056222
NA	CHEMICAL	GENE-Y	31	15	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T15	23056222
NA	CHEMICAL	GENE-Y	31	17	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T16	23056222
NA	CHEMICAL	GENE-N	31	14	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T17	23056222
NA	CHEMICAL	GENE-N	31	22	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T18	23056222
CPR:4	CHEMICAL	GENE-Y	31	33	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T19	23056222
NA	CHEMICAL	GENE-N	31	45	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T3	T20	23056222
NA	CHEMICAL	GENE-Y	49	10	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T52	23056222
NA	CHEMICAL	GENE-Y	49	15	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T15	23056222
NA	CHEMICAL	GENE-Y	49	17	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T16	23056222
NA	CHEMICAL	GENE-N	49	14	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T17	23056222
NA	CHEMICAL	GENE-N	49	22	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T18	23056222
NA	CHEMICAL	GENE-Y	49	33	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T19	23056222
NA	CHEMICAL	GENE-N	49	45	However , downregulation of the gene ( gene ) -driven gene target genes such as gene , gene and chemical chemical-transferase ( gene ) did not reverse the inhibitory effect of chemical on gene-induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an gene-independent anti-fibrotic activity of chemical .	T4	T20	23056222
CPR:4	CHEMICAL	GENE-Y	2	14	Finally , chemical suppressed unilateral ureteral obstruction ( UUO ) -induced renal fibrosis and gene , gene and gene expression in the obstructed kidneys from UUO mice , along with increased and decreased expression of gene and gene , respectively .	T5	T21	23056222
CPR:4	CHEMICAL	GENE-Y	2	16	Finally , chemical suppressed unilateral ureteral obstruction ( UUO ) -induced renal fibrosis and gene , gene and gene expression in the obstructed kidneys from UUO mice , along with increased and decreased expression of gene and gene , respectively .	T5	T22	23056222
CPR:4	CHEMICAL	GENE-N	2	18	Finally , chemical suppressed unilateral ureteral obstruction ( UUO ) -induced renal fibrosis and gene , gene and gene expression in the obstructed kidneys from UUO mice , along with increased and decreased expression of gene and gene , respectively .	T5	T23	23056222
CPR:3	CHEMICAL	GENE-Y	2	35	Finally , chemical suppressed unilateral ureteral obstruction ( UUO ) -induced renal fibrosis and gene , gene and gene expression in the obstructed kidneys from UUO mice , along with increased and decreased expression of gene and gene , respectively .	T5	T24	23056222
CPR:4	CHEMICAL	GENE-Y	2	37	Finally , chemical suppressed unilateral ureteral obstruction ( UUO ) -induced renal fibrosis and gene , gene and gene expression in the obstructed kidneys from UUO mice , along with increased and decreased expression of gene and gene , respectively .	T5	T25	23056222
NA	CHEMICAL	GENE-Y	18	18	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T10	22862926
NA	CHEMICAL	GENE-Y	18	12	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T12	22862926
NA	CHEMICAL	GENE-Y	18	17	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T13	22862926
NA	CHEMICAL	GENE-Y	18	29	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T14	22862926
NA	CHEMICAL	GENE-Y	18	33	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T15	22862926
NA	CHEMICAL	GENE-Y	18	35	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T16	22862926
NA	CHEMICAL	GENE-Y	18	38	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T17	22862926
NA	CHEMICAL	GENE-Y	18	40	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T18	22862926
NA	CHEMICAL	GENE-Y	18	17	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T1	T19	22862926
NA	CHEMICAL	GENE-Y	49	18	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T10	22862926
NA	CHEMICAL	GENE-Y	49	12	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T12	22862926
NA	CHEMICAL	GENE-Y	49	17	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T13	22862926
NA	CHEMICAL	GENE-Y	49	29	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T14	22862926
NA	CHEMICAL	GENE-Y	49	33	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T15	22862926
NA	CHEMICAL	GENE-Y	49	35	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T16	22862926
NA	CHEMICAL	GENE-Y	49	38	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T17	22862926
NA	CHEMICAL	GENE-Y	49	40	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T18	22862926
NA	CHEMICAL	GENE-Y	49	17	We characterised 62 non-diabetic , middle-aged , Caucasians with and without the T risk allele of rs7903146 in gene ( gene ) with regard to secretion of gene , gene , chemical-dependent geneotropic polypeptide ( gene ) , gene ( gene ) as well as insulin sensitivity and endogenous chemical production .	T2	T19	22862926
NA	CHEMICAL	GENE-Y	7	5	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T5	T25	22862926
NA	CHEMICAL	GENE-Y	7	5	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T5	T26	22862926
NA	CHEMICAL	GENE-Y	7	21	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T5	T7	22862926
NA	CHEMICAL	GENE-Y	7	23	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T5	T8	22862926
NA	CHEMICAL	GENE-Y	17	5	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T6	T25	22862926
NA	CHEMICAL	GENE-Y	17	5	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T6	T26	22862926
NA	CHEMICAL	GENE-Y	17	21	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T6	T7	22862926
NA	CHEMICAL	GENE-Y	17	23	We found no significant differences in endogenous chemical production , hepatic gene sensitivity or fasting concentrations of chemical , gene , gene and gene between the groups .	T6	T8	22862926
NA	CHEMICAL	GENE-Y	3	12	Effects of High chemical and chemical Concentrations over the Relative Expression of gene , gene , and gene in MIN6 Cells .	T15	T34	23605050
NA	CHEMICAL	GENE-Y	3	14	Effects of High chemical and chemical Concentrations over the Relative Expression of gene , gene , and gene in MIN6 Cells .	T15	T35	23605050
NA	CHEMICAL	GENE-Y	3	17	Effects of High chemical and chemical Concentrations over the Relative Expression of gene , gene , and gene in MIN6 Cells .	T15	T36	23605050
NA	CHEMICAL	GENE-Y	5	12	Effects of High chemical and chemical Concentrations over the Relative Expression of gene , gene , and gene in MIN6 Cells .	T16	T34	23605050
NA	CHEMICAL	GENE-Y	5	14	Effects of High chemical and chemical Concentrations over the Relative Expression of gene , gene , and gene in MIN6 Cells .	T16	T35	23605050
NA	CHEMICAL	GENE-Y	5	17	Effects of High chemical and chemical Concentrations over the Relative Expression of gene , gene , and gene in MIN6 Cells .	T16	T36	23605050
NA	CHEMICAL	GENE-Y	12	17	The purpose of this study was to describe the effect of different chemical and/or chemical concentrations over gene , gene , and gene expressions in a β-pancreatic cell line ( MIN6 cells ) .	T3	T22	23605050
NA	CHEMICAL	GENE-Y	12	19	The purpose of this study was to describe the effect of different chemical and/or chemical concentrations over gene , gene , and gene expressions in a β-pancreatic cell line ( MIN6 cells ) .	T3	T23	23605050
NA	CHEMICAL	GENE-Y	12	22	The purpose of this study was to describe the effect of different chemical and/or chemical concentrations over gene , gene , and gene expressions in a β-pancreatic cell line ( MIN6 cells ) .	T3	T24	23605050
NA	CHEMICAL	GENE-Y	14	17	The purpose of this study was to describe the effect of different chemical and/or chemical concentrations over gene , gene , and gene expressions in a β-pancreatic cell line ( MIN6 cells ) .	T4	T22	23605050
NA	CHEMICAL	GENE-Y	14	19	The purpose of this study was to describe the effect of different chemical and/or chemical concentrations over gene , gene , and gene expressions in a β-pancreatic cell line ( MIN6 cells ) .	T4	T23	23605050
NA	CHEMICAL	GENE-Y	14	22	The purpose of this study was to describe the effect of different chemical and/or chemical concentrations over gene , gene , and gene expressions in a β-pancreatic cell line ( MIN6 cells ) .	T4	T24	23605050
NA	CHEMICAL	GENE-Y	6	18	MIN6 cells were pre-incubated with different chemical and/or chemical concentrations , and the relative mRNA abundance of the gene/gene ratio and of gene genes was measured by qRT-PCR .	T5	T25	23605050
NA	CHEMICAL	GENE-Y	6	18	MIN6 cells were pre-incubated with different chemical and/or chemical concentrations , and the relative mRNA abundance of the gene/gene ratio and of gene genes was measured by qRT-PCR .	T5	T26	23605050
NA	CHEMICAL	GENE-Y	6	22	MIN6 cells were pre-incubated with different chemical and/or chemical concentrations , and the relative mRNA abundance of the gene/gene ratio and of gene genes was measured by qRT-PCR .	T5	T27	23605050
NA	CHEMICAL	GENE-Y	8	18	MIN6 cells were pre-incubated with different chemical and/or chemical concentrations , and the relative mRNA abundance of the gene/gene ratio and of gene genes was measured by qRT-PCR .	T6	T25	23605050
NA	CHEMICAL	GENE-Y	8	18	MIN6 cells were pre-incubated with different chemical and/or chemical concentrations , and the relative mRNA abundance of the gene/gene ratio and of gene genes was measured by qRT-PCR .	T6	T26	23605050
NA	CHEMICAL	GENE-Y	8	22	MIN6 cells were pre-incubated with different chemical and/or chemical concentrations , and the relative mRNA abundance of the gene/gene ratio and of gene genes was measured by qRT-PCR .	T6	T27	23605050
NA	CHEMICAL	GENE-N	6	0	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T7	T28	23605050
NA	CHEMICAL	GENE-N	6	2	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T7	T29	23605050
NA	CHEMICAL	GENE-N	6	10	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T7	T30	23605050
NA	CHEMICAL	GENE-N	9	0	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T8	T28	23605050
NA	CHEMICAL	GENE-N	9	2	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T8	T29	23605050
NA	CHEMICAL	GENE-N	9	10	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T8	T30	23605050
NA	CHEMICAL	GENE-N	14	0	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T9	T28	23605050
NA	CHEMICAL	GENE-N	14	2	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T9	T29	23605050
NA	CHEMICAL	GENE-N	14	10	gene ( gene ) activity , chemical uptake , chemical dismutase activity , and chemical content were also determined .	T9	T30	23605050
CPR:3	CHEMICAL	GENE-Y	12	1	The gene/gene ratio increased and gene expression decreased in MIN6 cells after chemical stimulation .	T10	T31	23605050
CPR:3	CHEMICAL	GENE-Y	12	1	The gene/gene ratio increased and gene expression decreased in MIN6 cells after chemical stimulation .	T10	T32	23605050
CPR:4	CHEMICAL	GENE-Y	12	5	The gene/gene ratio increased and gene expression decreased in MIN6 cells after chemical stimulation .	T10	T33	23605050
CPR:3	CHEMICAL	GENE-N	4	8	Additionally , treatment with chemical/chemical showed a higher gene activity .	T13	T17	23605050
CPR:3	CHEMICAL	GENE-N	4	8	Additionally , treatment with chemical/chemical showed a higher gene activity .	T14	T17	23605050
NA	CHEMICAL	GENE-N	0	3	chemical generation and gene-dependent reverse chemical transport : not all roads lead to Rome .	T14	T23	22884520
NA	CHEMICAL	GENE-N	5	3	chemical generation and gene-dependent reverse chemical transport : not all roads lead to Rome .	T15	T23	22884520
NA	CHEMICAL	GENE-N	1	15	Cell chemical metabolism is a tightly regulated process , dependent in part on activation of gene ( gene ) to increase expression of genes mediating removal of excess chemical from cells in the reverse chemical transport pathway .	T7	T22	22884520
NA	CHEMICAL	GENE-N	1	17	Cell chemical metabolism is a tightly regulated process , dependent in part on activation of gene ( gene ) to increase expression of genes mediating removal of excess chemical from cells in the reverse chemical transport pathway .	T7	T17	22884520
NA	CHEMICAL	GENE-N	17	15	Cell chemical metabolism is a tightly regulated process , dependent in part on activation of gene ( gene ) to increase expression of genes mediating removal of excess chemical from cells in the reverse chemical transport pathway .	T1	T22	22884520
NA	CHEMICAL	GENE-N	17	17	Cell chemical metabolism is a tightly regulated process , dependent in part on activation of gene ( gene ) to increase expression of genes mediating removal of excess chemical from cells in the reverse chemical transport pathway .	T1	T17	22884520
NA	CHEMICAL	GENE-N	15	15	Cell chemical metabolism is a tightly regulated process , dependent in part on activation of gene ( gene ) to increase expression of genes mediating removal of excess chemical from cells in the reverse chemical transport pathway .	T2	T22	22884520
NA	CHEMICAL	GENE-N	15	17	Cell chemical metabolism is a tightly regulated process , dependent in part on activation of gene ( gene ) to increase expression of genes mediating removal of excess chemical from cells in the reverse chemical transport pathway .	T2	T17	22884520
CPR:3	CHEMICAL	GENE-N	8	0	gene are thought to be activated predominantly by chemical generated enzymatically from chemical in different cell organelles .	T3	T18	22884520
NA	CHEMICAL	GENE-N	12	0	gene are thought to be activated predominantly by chemical generated enzymatically from chemical in different cell organelles .	T4	T18	22884520
NA	CHEMICAL	GENE-N	6	26	Defects resulting in slowed release of chemical from late endosomes and lysosomes or reduction in chemical-27-hydroxylase activity lead to specific blocks in chemical production and impaired gene-dependent gene activation .	T5	T20	22884520
NA	CHEMICAL	GENE-N	15	26	Defects resulting in slowed release of chemical from late endosomes and lysosomes or reduction in chemical-27-hydroxylase activity lead to specific blocks in chemical production and impaired gene-dependent gene activation .	T6	T20	22884520
NA	CHEMICAL	GENE-N	22	26	Defects resulting in slowed release of chemical from late endosomes and lysosomes or reduction in chemical-27-hydroxylase activity lead to specific blocks in chemical production and impaired gene-dependent gene activation .	T8	T20	22884520
NA	CHEMICAL	GENE-Y	6	13	Fluorescence lifetime analysis and effect of chemical ions on binding of chemical to gene .	T35	T47	23295229
NA	CHEMICAL	GENE-Y	11	13	Fluorescence lifetime analysis and effect of chemical ions on binding of chemical to gene .	T36	T47	23295229
NA	CHEMICAL	GENE-Y	0	2	chemical dehydrogenase 1 ( gene ) catalyzes the oxidation of toxic chemical to chemical .	T1	T38	23295229
NA	CHEMICAL	GENE-Y	0	2	chemical dehydrogenase 1 ( gene ) catalyzes the oxidation of toxic chemical to chemical .	T1	T44	23295229
CPR:9	CHEMICAL	GENE-Y	11	2	chemical dehydrogenase 1 ( gene ) catalyzes the oxidation of toxic chemical to chemical .	T26	T38	23295229
CPR:9	CHEMICAL	GENE-Y	11	2	chemical dehydrogenase 1 ( gene ) catalyzes the oxidation of toxic chemical to chemical .	T26	T44	23295229
CPR:9	CHEMICAL	GENE-Y	13	2	chemical dehydrogenase 1 ( gene ) catalyzes the oxidation of toxic chemical to chemical .	T29	T38	23295229
CPR:9	CHEMICAL	GENE-Y	13	2	chemical dehydrogenase 1 ( gene ) catalyzes the oxidation of toxic chemical to chemical .	T29	T44	23295229
CPR:4	CHEMICAL	GENE-Y	3	6	Physiologic levels of chemical ions decrease gene activity in part by increasing chemical binding affinity to the enzyme .	T6	T39	23295229
NA	CHEMICAL	GENE-Y	12	6	Physiologic levels of chemical ions decrease gene activity in part by increasing chemical binding affinity to the enzyme .	T16	T39	23295229
NA	CHEMICAL	GENE-Y	9	13	We used this technique to investigate the effects of chemical ions on the gene-chemical binding characteristics and enzyme catalysis .	T22	T45	23295229
NA	CHEMICAL	GENE-Y	13	13	We used this technique to investigate the effects of chemical ions on the gene-chemical binding characteristics and enzyme catalysis .	T23	T45	23295229
NA	CHEMICAL	GENE-Y	6	18	From the resolved free and bound chemical fluorescence signatures , the KD values for both chemical conformations in gene ranged from about 24 μM to 1 μM for chemical ion concentrations of 0-6000 μM , respectively .	T24	T46	23295229
NA	CHEMICAL	GENE-Y	15	18	From the resolved free and bound chemical fluorescence signatures , the KD values for both chemical conformations in gene ranged from about 24 μM to 1 μM for chemical ion concentrations of 0-6000 μM , respectively .	T25	T46	23295229
NA	CHEMICAL	GENE-Y	28	18	From the resolved free and bound chemical fluorescence signatures , the KD values for both chemical conformations in gene ranged from about 24 μM to 1 μM for chemical ion concentrations of 0-6000 μM , respectively .	T27	T46	23295229
CPR:4	CHEMICAL	GENE-Y	2	53	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T8	T40	23295229
NA	CHEMICAL	GENE-Y	21	53	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T9	T40	23295229
NA	CHEMICAL	GENE-Y	21	53	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T10	T40	23295229
NA	CHEMICAL	GENE-Y	53	53	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T11	T40	23295229
NA	CHEMICAL	GENE-Y	53	76	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T11	T41	23295229
NA	CHEMICAL	GENE-Y	76	53	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T13	T40	23295229
NA	CHEMICAL	GENE-Y	76	76	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T13	T41	23295229
NA	CHEMICAL	GENE-Y	21	53	As the chemical ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( -1 ) ( 0 μM chemical ) to 0.050 s ( -1 ) ( 6000 μM chemical ) and a distinct shift in steady-state conformational population from one that favors the gene-chemical complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of chemical ion to one that favors the gene-chemical complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM chemical .	T14	T40	23295229
CPR:4	CHEMICAL	GENE-Y	7	27	This shift in conformational population at higher chemical ion concentrations and to lower enzyme activity may be due to longer residence time of the chemical in the gene pocket .	T15	T42	23295229
NA	CHEMICAL	GENE-Y	24	27	This shift in conformational population at higher chemical ion concentrations and to lower enzyme activity may be due to longer residence time of the chemical in the gene pocket .	T17	T42	23295229
NA	CHEMICAL	GENE-Y	5	2	Inhibition of gene translocation and chemical secretion by chemical in exogenously activated human eosinophils .	T24	T36	10351938
CPR:4	CHEMICAL	GENE-Y	8	2	Inhibition of gene translocation and chemical secretion by chemical in exogenously activated human eosinophils .	T25	T36	10351938
NA	CHEMICAL	GENE-Y	10	25	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T18	T29	10351938
NA	CHEMICAL	GENE-Y	10	27	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T18	T31	10351938
NA	CHEMICAL	GENE-Y	12	25	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T22	T29	10351938
NA	CHEMICAL	GENE-Y	12	27	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T22	T31	10351938
NA	CHEMICAL	GENE-Y	36	25	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T9	T29	10351938
NA	CHEMICAL	GENE-Y	36	27	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T9	T31	10351938
NA	CHEMICAL	GENE-Y	38	25	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T10	T29	10351938
NA	CHEMICAL	GENE-Y	38	27	We examined the effect of the highly lipophilic corticosteroid , chemical ( chemical ) , in causing ( 1 ) inhibition of nuclear translocation of gene ( gene ) , and ( 2 ) blockade of chemical ( chemical ) synthesis in isolated human eosinophils in vitro .	T10	T31	10351938
NA	CHEMICAL	GENE-Y	25	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T11	T32	10351938
NA	CHEMICAL	GENE-Y	25	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T11	T33	10351938
NA	CHEMICAL	GENE-Y	11	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T12	T32	10351938
NA	CHEMICAL	GENE-Y	11	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T12	T33	10351938
NA	CHEMICAL	GENE-Y	17	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T13	T32	10351938
NA	CHEMICAL	GENE-Y	17	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T13	T33	10351938
NA	CHEMICAL	GENE-Y	44	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T14	T32	10351938
NA	CHEMICAL	GENE-Y	44	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T14	T33	10351938
NA	CHEMICAL	GENE-Y	46	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T15	T32	10351938
NA	CHEMICAL	GENE-Y	46	14	Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M chemical in the presence of 10 pg/ml gene ( gene ) and activated with chemical ( chemical ) + chemical ( chemical ) .	T15	T33	10351938
NA	CHEMICAL	GENE-Y	0	3	chemical/chemical-stimulated translocation of gene to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by chemical .	T20	T34	10351938
NA	CHEMICAL	GENE-Y	0	3	chemical/chemical-stimulated translocation of gene to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by chemical .	T21	T34	10351938
CPR:4	CHEMICAL	GENE-Y	17	3	chemical/chemical-stimulated translocation of gene to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by chemical .	T23	T34	10351938
NA	CHEMICAL	GENE-Y	32	6	By contrast , membrane expression of gene , which was not minimal at 30 min , was substantial at 48 h for eosinophils treated with > 10 ( - ) 10 M chemical , and inhibition of chemical synthesis was reversed by exogenous chemical ( chemical ) .	T1	T35	10351938
NA	CHEMICAL	GENE-Y	37	6	By contrast , membrane expression of gene , which was not minimal at 30 min , was substantial at 48 h for eosinophils treated with > 10 ( - ) 10 M chemical , and inhibition of chemical synthesis was reversed by exogenous chemical ( chemical ) .	T2	T35	10351938
NA	CHEMICAL	GENE-Y	6	6	By contrast , membrane expression of gene , which was not minimal at 30 min , was substantial at 48 h for eosinophils treated with > 10 ( - ) 10 M chemical , and inhibition of chemical synthesis was reversed by exogenous chemical ( chemical ) .	T3	T35	10351938
NA	CHEMICAL	GENE-Y	45	6	By contrast , membrane expression of gene , which was not minimal at 30 min , was substantial at 48 h for eosinophils treated with > 10 ( - ) 10 M chemical , and inhibition of chemical synthesis was reversed by exogenous chemical ( chemical ) .	T4	T35	10351938
CPR:4	CHEMICAL	GENE-Y	3	17	We find that chemical causes a decrease in stimulated eosinophil secretion of chemical that is regulated by gene ( gene ) .	T5	T26	10351938
NA	CHEMICAL	GENE-Y	3	19	We find that chemical causes a decrease in stimulated eosinophil secretion of chemical that is regulated by gene ( gene ) .	T5	T27	10351938
CPR:9	CHEMICAL	GENE-Y	12	17	We find that chemical causes a decrease in stimulated eosinophil secretion of chemical that is regulated by gene ( gene ) .	T6	T26	10351938
CPR:9	CHEMICAL	GENE-Y	12	19	We find that chemical causes a decrease in stimulated eosinophil secretion of chemical that is regulated by gene ( gene ) .	T6	T27	10351938
NA	CHEMICAL	GENE-Y	2	18	Inhibition of chemical synthesis precedes the global cytotoxic effects of chemical as indicated by the simultaneous upregulation of gene expression .	T7	T28	10351938
CPR:3	CHEMICAL	GENE-Y	10	18	Inhibition of chemical synthesis precedes the global cytotoxic effects of chemical as indicated by the simultaneous upregulation of gene expression .	T8	T28	10351938
NA	CHEMICAL	GENE-Y	5	0	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T3	T7	23066090
NA	CHEMICAL	GENE-Y	5	2	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T3	T9	23066090
NA	CHEMICAL	GENE-N	5	7	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T3	T11	23066090
NA	CHEMICAL	GENE-N	5	9	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T3	T20	23066090
NA	CHEMICAL	GENE-Y	24	0	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T6	T7	23066090
NA	CHEMICAL	GENE-Y	24	2	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T6	T9	23066090
NA	CHEMICAL	GENE-N	24	7	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T6	T11	23066090
NA	CHEMICAL	GENE-N	24	9	gene ( gene ) and chemical-dependent protein kinase ( gene ) are two intracellular receptors that mediate the effects of the prototypic second messenger chemical .	T6	T20	23066090
CPR:6	CHEMICAL	GENE-Y	9	18	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T2	T10	23066090
CPR:4	CHEMICAL	GENE-Y	9	27	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T2	T12	23066090
CPR:4	CHEMICAL	GENE-Y	9	14	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T2	T13	23066090
CPR:4	CHEMICAL	GENE-N	9	31	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T2	T14	23066090
CPR:4	CHEMICAL	GENE-Y	9	37	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T2	T15	23066090
CPR:4	CHEMICAL	GENE-Y	9	38	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T2	T16	23066090
CPR:6	CHEMICAL	GENE-Y	11	18	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T4	T10	23066090
CPR:4	CHEMICAL	GENE-Y	11	27	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T4	T12	23066090
CPR:4	CHEMICAL	GENE-Y	11	14	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T4	T13	23066090
CPR:4	CHEMICAL	GENE-N	11	31	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T4	T14	23066090
CPR:4	CHEMICAL	GENE-Y	11	37	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T4	T15	23066090
CPR:4	CHEMICAL	GENE-Y	11	38	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T4	T16	23066090
CPR:6	CHEMICAL	GENE-Y	17	18	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T5	T10	23066090
CPR:4	CHEMICAL	GENE-Y	17	27	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T5	T12	23066090
CPR:4	CHEMICAL	GENE-Y	17	14	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T5	T13	23066090
CPR:4	CHEMICAL	GENE-N	17	31	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T5	T14	23066090
CPR:4	CHEMICAL	GENE-Y	17	37	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T5	T15	23066090
CPR:4	CHEMICAL	GENE-Y	17	38	Herein , we report the identification and characterization of chemical ( chemical ) , a novel noncyclic chemical gene antagonist that is capable of specifically blocking intracellular gene-mediated gene activation and gene phosphorylation , as well as gene-mediated gene secretion in pancreatic β cells .	T5	T16	23066090
NA	CHEMICAL	GENE-N	3	2	Evolution of the chemical-tRNA synthetase family and the organization of the Drosophila chemical-prolyl-tRNA synthetase gene .	T8	T13	9063462
NA	CHEMICAL	GENE-Y	3	2	Evolution of the chemical-tRNA synthetase family and the organization of the Drosophila chemical-prolyl-tRNA synthetase gene .	T8	T14	9063462
NA	CHEMICAL	GENE-N	12	2	Evolution of the chemical-tRNA synthetase family and the organization of the Drosophila chemical-prolyl-tRNA synthetase gene .	T9	T13	9063462
NA	CHEMICAL	GENE-Y	12	2	Evolution of the chemical-tRNA synthetase family and the organization of the Drosophila chemical-prolyl-tRNA synthetase gene .	T9	T14	9063462
NA	CHEMICAL	GENE-Y	3	4	In Drosophila , chemical-prolyl-tRNA synthetase is a multifunctional synthetase encoded by a unique gene and composed of three domains : the chemical- and chemical-terminal domains catalyze the aminoacylation of chemical and proline tRNA species , respectively , and the central domain is made of 75 chemical repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [ Cerini , C. , Kerjan , P. , Astier , M. , Gratecos , D. , Mirande , M .	T4	T11	9063462
NA	CHEMICAL	GENE-Y	6	4	In Drosophila , chemical-prolyl-tRNA synthetase is a multifunctional synthetase encoded by a unique gene and composed of three domains : the chemical- and chemical-terminal domains catalyze the aminoacylation of chemical and proline tRNA species , respectively , and the central domain is made of 75 chemical repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [ Cerini , C. , Kerjan , P. , Astier , M. , Gratecos , D. , Mirande , M .	T1	T11	9063462
NA	CHEMICAL	GENE-Y	6	4	In Drosophila , chemical-prolyl-tRNA synthetase is a multifunctional synthetase encoded by a unique gene and composed of three domains : the chemical- and chemical-terminal domains catalyze the aminoacylation of chemical and proline tRNA species , respectively , and the central domain is made of 75 chemical repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [ Cerini , C. , Kerjan , P. , Astier , M. , Gratecos , D. , Mirande , M .	T3	T11	9063462
NA	CHEMICAL	GENE-Y	6	4	In Drosophila , chemical-prolyl-tRNA synthetase is a multifunctional synthetase encoded by a unique gene and composed of three domains : the chemical- and chemical-terminal domains catalyze the aminoacylation of chemical and proline tRNA species , respectively , and the central domain is made of 75 chemical repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [ Cerini , C. , Kerjan , P. , Astier , M. , Gratecos , D. , Mirande , M .	T5	T11	9063462
NA	CHEMICAL	GENE-Y	6	4	In Drosophila , chemical-prolyl-tRNA synthetase is a multifunctional synthetase encoded by a unique gene and composed of three domains : the chemical- and chemical-terminal domains catalyze the aminoacylation of chemical and proline tRNA species , respectively , and the central domain is made of 75 chemical repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [ Cerini , C. , Kerjan , P. , Astier , M. , Gratecos , D. , Mirande , M .	T6	T11	9063462
NA	CHEMICAL	GENE-N	8	4	Environmental pesticide exposure modulates gene , gene and chemical decarboxylase expression in human placenta .	T3	T23	23557688
NA	CHEMICAL	GENE-N	8	6	Environmental pesticide exposure modulates gene , gene and chemical decarboxylase expression in human placenta .	T3	T24	23557688
NA	CHEMICAL	GENE-Y	8	9	Environmental pesticide exposure modulates gene , gene and chemical decarboxylase expression in human placenta .	T3	T25	23557688
NA	CHEMICAL	GENE-N	35	3	To evaluate the gene balance and enzymatic alterations induced by environmental pesticide exposure during pregnancy , this transversal study explored placentas derived from non-exposed women ( control group-CG ) , and from women living in a rural area ( rural group-RG ) , collected during intensive chemical ( OP ) pesticide spraying season ( RG-SS ) and during non-spraying season ( RG-NSS ) .	T1	T5	23557688
NA	CHEMICAL	GENE-N	2	0	gene and chemical decarboxylase ( gene ) enzymes were induced in syncytiotrophoblast and endothelial cells .	T2	T17	23557688
NA	CHEMICAL	GENE-Y	2	3	gene and chemical decarboxylase ( gene ) enzymes were induced in syncytiotrophoblast and endothelial cells .	T2	T18	23557688
NA	CHEMICAL	GENE-Y	2	5	gene and chemical decarboxylase ( gene ) enzymes were induced in syncytiotrophoblast and endothelial cells .	T2	T19	23557688
NA	CHEMICAL	GENE-N	2	5	Loss of chemical/Calmodulin-Dependent Protein Kinase II Activity in Cortical Astrocytes Decreases chemical Uptake and Induces Neurotoxic Release of chemical .	T21	T35	23543737
NA	CHEMICAL	GENE-N	11	5	Loss of chemical/Calmodulin-Dependent Protein Kinase II Activity in Cortical Astrocytes Decreases chemical Uptake and Induces Neurotoxic Release of chemical .	T22	T35	23543737
NA	CHEMICAL	GENE-N	18	5	Loss of chemical/Calmodulin-Dependent Protein Kinase II Activity in Cortical Astrocytes Decreases chemical Uptake and Induces Neurotoxic Release of chemical .	T20	T35	23543737
NA	CHEMICAL	GENE-N	3	6	The extent of chemical/calmodulin-dependent protein kinase II ( gene ) inactivation in the brain following ischemia correlates with the extent of damage .	T7	T25	23543737
NA	CHEMICAL	GENE-N	3	6	The extent of chemical/calmodulin-dependent protein kinase II ( gene ) inactivation in the brain following ischemia correlates with the extent of damage .	T7	T29	23543737
NA	CHEMICAL	GENE-N	5	5	We have previously shown that a loss of gene activity in neurons is detrimental to neuronal viability by inducing excitotoxic chemical release .	T8	T26	23543737
CPR:9	CHEMICAL	GENE-N	19	23	In the current study , we extend these findings to show that the ability of astrocytes to buffer extracellular chemical is reduced when gene is inhibited .	T9	T27	23543737
NA	CHEMICAL	GENE-N	14	2	Furthermore , gene inhibition in astrocytes is associated with the rapid onset of intracellular chemical oscillations .	T10	T28	23543737
NA	CHEMICAL	GENE-N	4	10	Surprisingly , this rapid chemical influx is blocked by the chemical-type chemical channel antagonist , gene .	T12	T30	23543737
NA	CHEMICAL	GENE-N	4	13	Surprisingly , this rapid chemical influx is blocked by the chemical-type chemical channel antagonist , gene .	T12	T31	23543737
NA	CHEMICAL	GENE-N	4	6	While the function of chemical-type chemical channels within astrocytes is controversial , these gene have been linked to chemical-dependent vesicular gliotransmitter release .	T14	T32	23543737
NA	CHEMICAL	GENE-N	4	6	While the function of chemical-type chemical channels within astrocytes is controversial , these gene have been linked to chemical-dependent vesicular gliotransmitter release .	T14	T33	23543737
NA	CHEMICAL	GENE-N	5	6	While the function of chemical-type chemical channels within astrocytes is controversial , these gene have been linked to chemical-dependent vesicular gliotransmitter release .	T15	T32	23543737
NA	CHEMICAL	GENE-N	5	6	While the function of chemical-type chemical channels within astrocytes is controversial , these gene have been linked to chemical-dependent vesicular gliotransmitter release .	T15	T33	23543737
NA	CHEMICAL	GENE-N	18	6	While the function of chemical-type chemical channels within astrocytes is controversial , these gene have been linked to chemical-dependent vesicular gliotransmitter release .	T16	T32	23543737
NA	CHEMICAL	GENE-N	18	6	While the function of chemical-type chemical channels within astrocytes is controversial , these gene have been linked to chemical-dependent vesicular gliotransmitter release .	T16	T33	23543737
NA	CHEMICAL	GENE-N	2	9	When extracellular chemical and chemical levels are measured following gene inhibition within our enriched astrocyte cultures , no alterations in chemical levels are observed , whereas chemical levels in the extracellular environment significantly increase .	T18	T34	23543737
NA	CHEMICAL	GENE-N	4	9	When extracellular chemical and chemical levels are measured following gene inhibition within our enriched astrocyte cultures , no alterations in chemical levels are observed , whereas chemical levels in the extracellular environment significantly increase .	T19	T34	23543737
NA	CHEMICAL	GENE-N	2	9	When extracellular chemical and chemical levels are measured following gene inhibition within our enriched astrocyte cultures , no alterations in chemical levels are observed , whereas chemical levels in the extracellular environment significantly increase .	T1	T34	23543737
NA	CHEMICAL	GENE-N	26	9	When extracellular chemical and chemical levels are measured following gene inhibition within our enriched astrocyte cultures , no alterations in chemical levels are observed , whereas chemical levels in the extracellular environment significantly increase .	T2	T34	23543737
NA	CHEMICAL	GENE-N	1	5	Extracellular chemical accumulation associated with gene inhibition contributes both to chemical oscillations within astrocytes and ultimately cortical neuron toxicity .	T3	T23	23543737
NA	CHEMICAL	GENE-N	10	5	Extracellular chemical accumulation associated with gene inhibition contributes both to chemical oscillations within astrocytes and ultimately cortical neuron toxicity .	T4	T23	23543737
NA	CHEMICAL	GENE-Y	14	2	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T3	T17	17652763
NA	CHEMICAL	GENE-Y	14	4	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T3	T12	17652763
NA	CHEMICAL	GENE-Y	14	10	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T3	T15	17652763
NA	CHEMICAL	GENE-N	14	15	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T3	T18	17652763
NA	CHEMICAL	GENE-Y	2	2	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T1	T17	17652763
NA	CHEMICAL	GENE-Y	2	4	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T1	T12	17652763
NA	CHEMICAL	GENE-Y	2	10	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T1	T15	17652763
NA	CHEMICAL	GENE-N	2	15	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T1	T18	17652763
NA	CHEMICAL	GENE-Y	14	2	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T2	T17	17652763
NA	CHEMICAL	GENE-Y	14	4	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T2	T12	17652763
NA	CHEMICAL	GENE-Y	14	10	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T2	T15	17652763
NA	CHEMICAL	GENE-N	14	15	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T2	T18	17652763
NA	CHEMICAL	GENE-Y	14	2	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T4	T17	17652763
NA	CHEMICAL	GENE-Y	14	4	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T4	T12	17652763
NA	CHEMICAL	GENE-Y	14	10	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T4	T15	17652763
NA	CHEMICAL	GENE-N	14	15	PURPOSE : gene ( gene ) , transcribed from the gene gene , is a gene with 316 chemical found in the chemical pigment epithelium ( RPE ) and in chemical Muller cells .	T4	T18	17652763
CPR:9	CHEMICAL	GENE-N	1	1	It is thought to play a critical role in the visual cycle by functioning as an acceptor of chemical from the gene reaction .	T5	T11	17652763
CPR:4	CHEMICAL	GENE-Y	12	8	We have examined the effectiveness of two novel gene selective inhibitors , chemical and chemical , in a panel of melanoma cell lines and normal cell types .	T1	T6	22391562
CPR:4	CHEMICAL	GENE-Y	14	8	We have examined the effectiveness of two novel gene selective inhibitors , chemical and chemical , in a panel of melanoma cell lines and normal cell types .	T2	T6	22391562
NA	CHEMICAL	GENE-Y	7	12	Its pathogenesis is complex , and involves a state of 'lipotoxicity ' in which gene resistance , with increased chemical release from adipose tissue to the liver , play a key role in the onset of a 'lipotoxic liver disease ' and its progression to NASH .	T3	T7	23329465
NA	CHEMICAL	GENE-N	0	11	chemical administration in the olfactory bulbectomized rat : changes in brain gene and gene binding sites and their relationship to behaviour .	T12	T25	8730743
NA	CHEMICAL	GENE-Y	0	13	chemical administration in the olfactory bulbectomized rat : changes in brain gene and gene binding sites and their relationship to behaviour .	T12	T24	8730743
NA	CHEMICAL	GENE-N	7	31	The effects of repeated administration of the chemical antidepressant drug , chemical ( chemical ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain gene and gene receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham-operated control rats .	T7	T19	8730743
NA	CHEMICAL	GENE-Y	7	33	The effects of repeated administration of the chemical antidepressant drug , chemical ( chemical ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain gene and gene receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham-operated control rats .	T7	T22	8730743
NA	CHEMICAL	GENE-N	11	31	The effects of repeated administration of the chemical antidepressant drug , chemical ( chemical ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain gene and gene receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham-operated control rats .	T9	T19	8730743
NA	CHEMICAL	GENE-Y	11	33	The effects of repeated administration of the chemical antidepressant drug , chemical ( chemical ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain gene and gene receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham-operated control rats .	T9	T22	8730743
NA	CHEMICAL	GENE-N	13	31	The effects of repeated administration of the chemical antidepressant drug , chemical ( chemical ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain gene and gene receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham-operated control rats .	T10	T19	8730743
NA	CHEMICAL	GENE-Y	13	33	The effects of repeated administration of the chemical antidepressant drug , chemical ( chemical ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain gene and gene receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham-operated control rats .	T10	T22	8730743
CPR:4	CHEMICAL	GENE-N	4	9	After 7 days of chemical administration the number of gene was lower in frontal and occipital cortex and hippocampus .	T11	T23	8730743
NA	CHEMICAL	GENE-N	2	5	Administration of chemical for 14 or 21 days did not further reduce the number of gene .	T1	T14	8730743
CPR:4	CHEMICAL	GENE-N	1	5	The chemical induced reduction in gene did not differ in OB and sham-operated control rats .	T2	T15	8730743
CPR:4	CHEMICAL	GENE-Y	0	15	chemical administration for up to 21 days produced a progressive reduction in the number of gene receptors in frontal cortex , without significant alterations in occipital cortex .	T3	T16	8730743
CPR:4	CHEMICAL	GENE-Y	18	10	The time course of the reduction in the number of gene receptors was similar to that of the chemical-induced behavioural changes whereas that for the reduction in gene was clearly different .	T4	T17	8730743
CPR:4	CHEMICAL	GENE-N	18	14	The time course of the reduction in the number of gene receptors was similar to that of the chemical-induced behavioural changes whereas that for the reduction in gene was clearly different .	T4	T18	8730743
NA	CHEMICAL	GENE-Y	11	6	Evaluation of the positive effects on gene-resistance and β-cell measurements of chemical in addition to chemical in type 2 diabetic patients .	T17	T33	23624419
NA	CHEMICAL	GENE-Y	12	6	Evaluation of the positive effects on gene-resistance and β-cell measurements of chemical in addition to chemical in type 2 diabetic patients .	T16	T33	23624419
NA	CHEMICAL	GENE-Y	0	18	chemical+chemical were more effective than placebo+chemical in reducing body weight and BMI , glycemic control , HOMA-IR , gene and gene resistance measurements .	T11	T31	23624419
NA	CHEMICAL	GENE-Y	0	6	chemical+chemical were more effective than placebo+chemical in reducing body weight and BMI , glycemic control , HOMA-IR , gene and gene resistance measurements .	T11	T32	23624419
NA	CHEMICAL	GENE-Y	0	18	chemical+chemical were more effective than placebo+chemical in reducing body weight and BMI , glycemic control , HOMA-IR , gene and gene resistance measurements .	T12	T31	23624419
NA	CHEMICAL	GENE-Y	0	6	chemical+chemical were more effective than placebo+chemical in reducing body weight and BMI , glycemic control , HOMA-IR , gene and gene resistance measurements .	T12	T32	23624419
NA	CHEMICAL	GENE-Y	5	18	chemical+chemical were more effective than placebo+chemical in reducing body weight and BMI , glycemic control , HOMA-IR , gene and gene resistance measurements .	T13	T31	23624419
NA	CHEMICAL	GENE-Y	5	6	chemical+chemical were more effective than placebo+chemical in reducing body weight and BMI , glycemic control , HOMA-IR , gene and gene resistance measurements .	T13	T32	23624419
NA	CHEMICAL	GENE-Y	3	3	We also recorded a significant correlation between M value increase and the decrease of gene , gene , and gene obtained with chemical+chemical .	T1	T18	23624419
NA	CHEMICAL	GENE-Y	3	3	We also recorded a significant correlation between M value increase and the decrease of gene , gene , and gene obtained with chemical+chemical .	T1	T19	23624419
NA	CHEMICAL	GENE-Y	3	19	We also recorded a significant correlation between M value increase and the decrease of gene , gene , and gene obtained with chemical+chemical .	T1	T20	23624419
NA	CHEMICAL	GENE-Y	19	3	We also recorded a significant correlation between M value increase and the decrease of gene , gene , and gene obtained with chemical+chemical .	T2	T18	23624419
NA	CHEMICAL	GENE-Y	19	3	We also recorded a significant correlation between M value increase and the decrease of gene , gene , and gene obtained with chemical+chemical .	T2	T19	23624419
NA	CHEMICAL	GENE-Y	19	19	We also recorded a significant correlation between M value increase and the decrease of gene , gene , and gene obtained with chemical+chemical .	T2	T20	23624419
NA	CHEMICAL	GENE-Y	2	3	Role of chemical receptors on the modulation of chemical-diaphorase-positive cell number in supraoptic and paraventricular nuclei of ovariectomised female rats .	T20	T36	22967140
NA	CHEMICAL	GENE-Y	8	3	Role of chemical receptors on the modulation of chemical-diaphorase-positive cell number in supraoptic and paraventricular nuclei of ovariectomised female rats .	T19	T36	22967140
NA	CHEMICAL	GENE-Y	10	4	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T4	T26	22967140
NA	CHEMICAL	GENE-Y	10	35	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T4	T27	22967140
NA	CHEMICAL	GENE-Y	10	37	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T4	T28	22967140
NA	CHEMICAL	GENE-Y	13	4	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T5	T26	22967140
NA	CHEMICAL	GENE-Y	13	35	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T5	T27	22967140
NA	CHEMICAL	GENE-Y	13	37	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T5	T28	22967140
NA	CHEMICAL	GENE-Y	32	4	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T6	T26	22967140
NA	CHEMICAL	GENE-Y	32	35	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T6	T27	22967140
NA	CHEMICAL	GENE-Y	32	37	The present study aimed to explore the possible regulation of chemical-diaphorase activity by chemical in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of chemical receptors ( gene and gene ) in this regulation .	T6	T28	22967140
NA	CHEMICAL	GENE-Y	14	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T7	T29	22967140
NA	CHEMICAL	GENE-Y	14	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T7	T30	22967140
NA	CHEMICAL	GENE-Y	14	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T7	T32	22967140
NA	CHEMICAL	GENE-Y	14	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T7	T33	22967140
CPR:5	CHEMICAL	GENE-Y	23	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T8	T29	22967140
NA	CHEMICAL	GENE-Y	23	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T8	T30	22967140
NA	CHEMICAL	GENE-Y	23	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T8	T32	22967140
NA	CHEMICAL	GENE-Y	23	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T8	T33	22967140
CPR:5	CHEMICAL	GENE-Y	14	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T9	T29	22967140
NA	CHEMICAL	GENE-Y	14	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T9	T30	22967140
NA	CHEMICAL	GENE-Y	14	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T9	T32	22967140
NA	CHEMICAL	GENE-Y	14	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T9	T33	22967140
NA	CHEMICAL	GENE-Y	31	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T10	T29	22967140
CPR:5	CHEMICAL	GENE-Y	31	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T10	T30	22967140
NA	CHEMICAL	GENE-Y	31	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T10	T32	22967140
NA	CHEMICAL	GENE-Y	31	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T10	T33	22967140
NA	CHEMICAL	GENE-Y	19	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T11	T29	22967140
CPR:5	CHEMICAL	GENE-Y	19	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T11	T30	22967140
NA	CHEMICAL	GENE-Y	19	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T11	T32	22967140
NA	CHEMICAL	GENE-Y	19	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T11	T33	22967140
NA	CHEMICAL	GENE-Y	39	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T13	T29	22967140
NA	CHEMICAL	GENE-Y	39	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T13	T30	22967140
CPR:6	CHEMICAL	GENE-Y	39	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T13	T32	22967140
NA	CHEMICAL	GENE-Y	39	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T13	T33	22967140
NA	CHEMICAL	GENE-Y	19	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T14	T29	22967140
NA	CHEMICAL	GENE-Y	19	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T14	T30	22967140
CPR:6	CHEMICAL	GENE-Y	19	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T14	T32	22967140
NA	CHEMICAL	GENE-Y	19	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T14	T33	22967140
NA	CHEMICAL	GENE-Y	13	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T15	T29	22967140
NA	CHEMICAL	GENE-Y	13	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T15	T30	22967140
CPR:6	CHEMICAL	GENE-Y	13	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T15	T32	22967140
NA	CHEMICAL	GENE-Y	13	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T15	T33	22967140
NA	CHEMICAL	GENE-Y	49	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T16	T29	22967140
NA	CHEMICAL	GENE-Y	49	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T16	T30	22967140
NA	CHEMICAL	GENE-Y	49	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T16	T32	22967140
CPR:6	CHEMICAL	GENE-Y	49	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T16	T33	22967140
NA	CHEMICAL	GENE-Y	13	22	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T17	T29	22967140
NA	CHEMICAL	GENE-Y	13	30	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T17	T30	22967140
NA	CHEMICAL	GENE-Y	13	38	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T17	T32	22967140
CPR:6	CHEMICAL	GENE-Y	13	48	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of chemical , a selective gene agonist-chemical [ chemical ] , a selective gene agonist-chemical [ chemical ] , a selective gene antagonist-chemical [ chemical ] -chemical ] or a selective gene antagonist-chemical ( chemical ) .	T17	T33	22967140
NA	CHEMICAL	GENE-Y	3	16	The number of chemical-diaphorase positive elements in the SON and the PVN was modulated by both gene but , depending on the nucleus , gene and gene ligands induced different effects .	T18	T21	22967140
NA	CHEMICAL	GENE-Y	3	24	The number of chemical-diaphorase positive elements in the SON and the PVN was modulated by both gene but , depending on the nucleus , gene and gene ligands induced different effects .	T18	T22	22967140
NA	CHEMICAL	GENE-Y	3	26	The number of chemical-diaphorase positive elements in the SON and the PVN was modulated by both gene but , depending on the nucleus , gene and gene ligands induced different effects .	T18	T23	22967140
NA	CHEMICAL	GENE-N	5	6	On the relationship between the chemical transporter and the reinforcing effects of local anesthetics in rhesus monkeys : practical and theoretical concerns .	T23	T28	11255924
NA	CHEMICAL	GENE-N	12	13	OBJECTIVES : The hypothesis of the present study was that differences among chemical transporter ( gene ) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as chemical uptake inhibitors .	T14	T25	11255924
NA	CHEMICAL	GENE-N	12	15	OBJECTIVES : The hypothesis of the present study was that differences among chemical transporter ( gene ) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as chemical uptake inhibitors .	T14	T26	11255924
CPR:9	CHEMICAL	GENE-N	33	13	OBJECTIVES : The hypothesis of the present study was that differences among chemical transporter ( gene ) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as chemical uptake inhibitors .	T15	T25	11255924
CPR:9	CHEMICAL	GENE-N	33	15	OBJECTIVES : The hypothesis of the present study was that differences among chemical transporter ( gene ) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as chemical uptake inhibitors .	T15	T26	11255924
CPR:9	CHEMICAL	GENE-N	19	11	Accordingly , self-administration of a group of local anesthetics that are gene ligands was compared to their effects as chemical uptake blockers in vitro in brain tissue .	T16	T27	11255924
CPR:6	CHEMICAL	GENE-N	15	13	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T5	T17	2859531
NA	CHEMICAL	GENE-Y	15	17	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T5	T21	2859531
NA	CHEMICAL	GENE-Y	15	52	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T5	T22	2859531
CPR:6	CHEMICAL	GENE-N	17	13	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T6	T17	2859531
NA	CHEMICAL	GENE-Y	17	17	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T6	T21	2859531
NA	CHEMICAL	GENE-Y	17	52	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T6	T22	2859531
CPR:6	CHEMICAL	GENE-N	32	13	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T7	T17	2859531
NA	CHEMICAL	GENE-Y	32	17	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T7	T21	2859531
NA	CHEMICAL	GENE-Y	32	52	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T7	T22	2859531
NA	CHEMICAL	GENE-N	16	13	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T8	T17	2859531
NA	CHEMICAL	GENE-Y	16	17	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T8	T21	2859531
NA	CHEMICAL	GENE-Y	16	52	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T8	T22	2859531
NA	CHEMICAL	GENE-N	46	13	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T9	T17	2859531
NA	CHEMICAL	GENE-Y	46	17	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T9	T21	2859531
NA	CHEMICAL	GENE-Y	46	52	To study the mechanism underlying this phenomenon , the effects of the nonselective gene antagonists chemical [ no intrinsic sympathomimetic activity ( ISA ) ] , chemical ( weak ISA ) and chemical ( strong ISA ) on lymphocyte gene density -- assessed by chemical ( chemical ) binding -- and plasma gene activity ( PRA ) were investigated in male healthy volunteers aged 23-35 years .	T9	T22	2859531
CPR:3	CHEMICAL	GENE-Y	0	12	chemical treatment ( 4 X 40 mg/day ) increased the density of gene by 25 % after 2 days ; concomitantly PRA and heart rate were reduced .	T10	T23	2859531
NA	CHEMICAL	GENE-Y	16	0	gene density , however , declined slowly being still significantly increased after 3 days , although chemical was not detectable in plasma after 24 h. The affinity of chemical to gene was not changed during or after treatment .	T12	T25	2859531
NA	CHEMICAL	GENE-Y	16	29	gene density , however , declined slowly being still significantly increased after 3 days , although chemical was not detectable in plasma after 24 h. The affinity of chemical to gene was not changed during or after treatment .	T12	T13	2859531
NA	CHEMICAL	GENE-Y	16	0	gene density , however , declined slowly being still significantly increased after 3 days , although chemical was not detectable in plasma after 24 h. The affinity of chemical to gene was not changed during or after treatment .	T1	T25	2859531
NA	CHEMICAL	GENE-Y	16	29	gene density , however , declined slowly being still significantly increased after 3 days , although chemical was not detectable in plasma after 24 h. The affinity of chemical to gene was not changed during or after treatment .	T1	T13	2859531
CPR:4	CHEMICAL	GENE-Y	0	3	chemical treatment ( 2 X 5 mg/day ) caused a 30 % decrease of gene density and PRA after 2 days ; both parameters remained reduced during treatment .	T2	T14	2859531
NA	CHEMICAL	GENE-Y	0	9	chemical treatment ( 4 X 100 mg/day ) led to a rapid fall in PRA , but did not significantly affect gene density .	T4	T16	2859531
NA	CHEMICAL	GENE-N	6	8	Structure and energetics of gas phase chemical-bonding in gene as studied by BIRD .	T27	T31	23591590
NA	CHEMICAL	GENE-N	8	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T23	T28	23591590
NA	CHEMICAL	GENE-N	8	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T24	T28	23591590
NA	CHEMICAL	GENE-N	8	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T26	T28	23591590
NA	CHEMICAL	GENE-N	8	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T1	T28	23591590
NA	CHEMICAL	GENE-N	2	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T2	T28	23591590
NA	CHEMICAL	GENE-N	8	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T4	T28	23591590
NA	CHEMICAL	GENE-N	4	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T7	T28	23591590
NA	CHEMICAL	GENE-N	8	2	Complexes of gene with a range of anions ( chemical , chemical , chemical , chemical , chemical , chemical , and chemical ( chemical ) ) have been studied in the gas phase by both experimental and theoretical methods .	T8	T28	23591590
NA	CHEMICAL	GENE-N	28	6	An increase in the energy required to remove the same anion from the gene when compared to the gene is explained as being due to the increase in chemical bonding interactions .	T9	T29	23591590
NA	CHEMICAL	GENE-N	28	6	An increase in the energy required to remove the same anion from the gene when compared to the gene is explained as being due to the increase in chemical bonding interactions .	T9	T30	23591590
NA	CHEMICAL	GENE-Y	52	22	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T23	23182946
NA	CHEMICAL	GENE-Y	52	24	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T24	23182946
NA	CHEMICAL	GENE-Y	52	27	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T25	23182946
NA	CHEMICAL	GENE-N	52	32	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T26	23182946
NA	CHEMICAL	GENE-Y	52	23	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T27	23182946
NA	CHEMICAL	GENE-Y	52	23	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T28	23182946
NA	CHEMICAL	GENE-Y	52	23	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T29	23182946
NA	CHEMICAL	GENE-N	52	42	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T30	23182946
NA	CHEMICAL	GENE-N	52	44	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T31	23182946
NA	CHEMICAL	GENE-N	52	47	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T32	23182946
NA	CHEMICAL	GENE-N	52	54	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T34	23182946
NA	CHEMICAL	GENE-N	52	56	The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( gene - gene - and gene ) and neuron ( gene : gene , gene and gene ) ; increased gene ( gene ) ( gene and gene ) and chemical-dependent protein kinase ( gene ) activities .	T8	T35	23182946
CPR:3	CHEMICAL	GENE-Y	14	19	Also , reactive astrogliosis takes part of the early responses to the insult with chemical , evidenced by upregulated gene in Western blot , PCR and immunofluorescence analysis .	T10	T36	23182946
NA	CHEMICAL	GENE-Y	3	18	Six days after chemical injection we found persistent astrogliosis , increased chemical ( PI ) positive cells in gene positive population evidenced by flow cytometry and reduced immunofluorescence for gene , suggesting that the in vivo exposure to chemical progressed to neuronal death .	T11	T37	23182946
NA	CHEMICAL	GENE-Y	3	29	Six days after chemical injection we found persistent astrogliosis , increased chemical ( PI ) positive cells in gene positive population evidenced by flow cytometry and reduced immunofluorescence for gene , suggesting that the in vivo exposure to chemical progressed to neuronal death .	T11	T15	23182946
NA	CHEMICAL	GENE-Y	11	18	Six days after chemical injection we found persistent astrogliosis , increased chemical ( PI ) positive cells in gene positive population evidenced by flow cytometry and reduced immunofluorescence for gene , suggesting that the in vivo exposure to chemical progressed to neuronal death .	T12	T37	23182946
NA	CHEMICAL	GENE-Y	11	29	Six days after chemical injection we found persistent astrogliosis , increased chemical ( PI ) positive cells in gene positive population evidenced by flow cytometry and reduced immunofluorescence for gene , suggesting that the in vivo exposure to chemical progressed to neuronal death .	T12	T15	23182946
NA	CHEMICAL	GENE-Y	3	18	Six days after chemical injection we found persistent astrogliosis , increased chemical ( PI ) positive cells in gene positive population evidenced by flow cytometry and reduced immunofluorescence for gene , suggesting that the in vivo exposure to chemical progressed to neuronal death .	T1	T37	23182946
CPR:4	CHEMICAL	GENE-Y	3	29	Six days after chemical injection we found persistent astrogliosis , increased chemical ( PI ) positive cells in gene positive population evidenced by flow cytometry and reduced immunofluorescence for gene , suggesting that the in vivo exposure to chemical progressed to neuronal death .	T1	T15	23182946
NA	CHEMICAL	GENE-N	5	9	Neurodegeneration was related with decreased chemical uptake and decreased gene immunoreactivity , however gene ( chemical9 ) was not altered in chemical injected rat .	T2	T17	23182946
NA	CHEMICAL	GENE-Y	5	13	Neurodegeneration was related with decreased chemical uptake and decreased gene immunoreactivity , however gene ( chemical9 ) was not altered in chemical injected rat .	T2	T18	23182946
NA	CHEMICAL	GENE-N	15	9	Neurodegeneration was related with decreased chemical uptake and decreased gene immunoreactivity , however gene ( chemical9 ) was not altered in chemical injected rat .	T3	T17	23182946
NA	CHEMICAL	GENE-Y	15	13	Neurodegeneration was related with decreased chemical uptake and decreased gene immunoreactivity , however gene ( chemical9 ) was not altered in chemical injected rat .	T3	T18	23182946
CPR:4	CHEMICAL	GENE-N	14	9	Neurodegeneration was related with decreased chemical uptake and decreased gene immunoreactivity , however gene ( chemical9 ) was not altered in chemical injected rat .	T4	T17	23182946
NA	CHEMICAL	GENE-Y	14	13	Neurodegeneration was related with decreased chemical uptake and decreased gene immunoreactivity , however gene ( chemical9 ) was not altered in chemical injected rat .	T4	T18	23182946
CPR:3	CHEMICAL	GENE-N	12	23	Therefore , the present results show that the earlier cerebellar responses to chemical include disruption of cytoskeletal homeostasis that could be related with gene and gene activation and reactive astrogliosis .	T5	T19	23182946
CPR:3	CHEMICAL	GENE-N	12	25	Therefore , the present results show that the earlier cerebellar responses to chemical include disruption of cytoskeletal homeostasis that could be related with gene and gene activation and reactive astrogliosis .	T5	T20	23182946
NA	CHEMICAL	GENE-Y	28	19	The later events of the neurodegenerative process are characterized by persistent astrogliosis and activation of apoptotic neuronal death through gene mediated mechanisms , which could be related with chemical excitotoxicity .	T6	T22	23182946
NA	CHEMICAL	GENE-Y	10	0	gene-receptor antagonism in hypertension : what has been learned with chemical ?	T10	T15	15030294
NA	CHEMICAL	GENE-Y	0	17	chemical is a long-acting chemical antagonist acting specifically at the level of the Type 1-receptor subtype ( gene-receptor ) .	T1	T11	15030294
NA	CHEMICAL	GENE-Y	4	17	chemical is a long-acting chemical antagonist acting specifically at the level of the Type 1-receptor subtype ( gene-receptor ) .	T3	T11	15030294
CPR:4	CHEMICAL	GENE-N	3	22	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T20	T25	23645211
CPR:4	CHEMICAL	GENE-N	3	25	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T20	T26	23645211
CPR:4	CHEMICAL	GENE-Y	3	27	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T20	T27	23645211
NA	CHEMICAL	GENE-N	11	22	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T21	T25	23645211
NA	CHEMICAL	GENE-N	11	25	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T21	T26	23645211
NA	CHEMICAL	GENE-Y	11	27	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T21	T27	23645211
NA	CHEMICAL	GENE-N	13	22	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T22	T25	23645211
NA	CHEMICAL	GENE-N	13	25	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T22	T26	23645211
NA	CHEMICAL	GENE-Y	13	27	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T22	T27	23645211
NA	CHEMICAL	GENE-N	21	22	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T1	T25	23645211
NA	CHEMICAL	GENE-N	21	25	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T1	T26	23645211
NA	CHEMICAL	GENE-Y	21	27	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T1	T27	23645211
NA	CHEMICAL	GENE-N	3	22	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T2	T25	23645211
NA	CHEMICAL	GENE-N	3	25	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T2	T26	23645211
NA	CHEMICAL	GENE-Y	3	27	Rats intoxicated with chemical for 30 days , significantly increased tissue chemical ( chemical ) levels and significantly decreased enzymatic antioxidants chemical dismutase , chemical peroxidase and gene in the frontal cortex tissue .	T2	T27	23645211
CPR:3	CHEMICAL	GENE-Y	10	1	The gene immunopositivity was increased in degenerating neurons of the chemical group .	T8	T28	23645211
NA	CHEMICAL	GENE-Y	2	8	Binding of chemical at two sites in recombinant gene and interaction with beta-blockers .	T32	T37	15060759
CPR:5	CHEMICAL	GENE-Y	9	13	To verify the hypothesis that the non-conventional partial agonist chemical binds at two gene sites , gene , expressed in CHO cells , were labelled with chemical .	T25	T36	15060759
CPR:5	CHEMICAL	GENE-Y	9	16	To verify the hypothesis that the non-conventional partial agonist chemical binds at two gene sites , gene , expressed in CHO cells , were labelled with chemical .	T25	T33	15060759
NA	CHEMICAL	GENE-Y	26	13	To verify the hypothesis that the non-conventional partial agonist chemical binds at two gene sites , gene , expressed in CHO cells , were labelled with chemical .	T19	T36	15060759
NA	CHEMICAL	GENE-Y	26	16	To verify the hypothesis that the non-conventional partial agonist chemical binds at two gene sites , gene , expressed in CHO cells , were labelled with chemical .	T19	T33	15060759
NA	CHEMICAL	GENE-Y	0	4	chemical dissociated from the gene with a fast component ( k ( off ) =0.45 min ( -1 ) ) , consistent with the L-site , and a slow component ( k ( off ) =0.017-0.033 min ( -1 ) ) , consistent with the H-site .	T24	T35	15060759
NA	CHEMICAL	GENE-Y	3	11	We conclude that chemical binds at two sites in the recombinant gene .	T16	T34	15060759
NA	CHEMICAL	GENE-N	14	4	Plasmacytoid dendritic cells produce gene and mature in response to the gene agonists , chemical and chemical .	T13	T31	12470615
CPR:5	CHEMICAL	GENE-Y	14	11	Plasmacytoid dendritic cells produce gene and mature in response to the gene agonists , chemical and chemical .	T13	T32	12470615
NA	CHEMICAL	GENE-N	16	4	Plasmacytoid dendritic cells produce gene and mature in response to the gene agonists , chemical and chemical .	T12	T31	12470615
CPR:5	CHEMICAL	GENE-Y	16	11	Plasmacytoid dendritic cells produce gene and mature in response to the gene agonists , chemical and chemical .	T12	T32	12470615
CPR:5	CHEMICAL	GENE-Y	5	10	The immune response modifiers , chemical and chemical , are gene agonists that induce gene in numerous species , including humans .	T1	T22	12470615
CPR:3	CHEMICAL	GENE-N	5	14	The immune response modifiers , chemical and chemical , are gene agonists that induce gene in numerous species , including humans .	T1	T28	12470615
CPR:5	CHEMICAL	GENE-Y	7	10	The immune response modifiers , chemical and chemical , are gene agonists that induce gene in numerous species , including humans .	T6	T22	12470615
CPR:3	CHEMICAL	GENE-N	7	14	The immune response modifiers , chemical and chemical , are gene agonists that induce gene in numerous species , including humans .	T6	T28	12470615
CPR:5	CHEMICAL	GENE-Y	13	11	Here , we characterize the activation of human pDC with the gene agonists chemical and chemical .	T2	T17	12470615
CPR:5	CHEMICAL	GENE-Y	15	11	Here , we characterize the activation of human pDC with the gene agonists chemical and chemical .	T3	T17	12470615
CPR:3	CHEMICAL	GENE-N	3	7	Results indicate that chemical and chemical induce gene and gene from purified pDC , and pDC are the principle gene-producing cells in the blood .	T4	T18	12470615
CPR:3	CHEMICAL	GENE-N	3	9	Results indicate that chemical and chemical induce gene and gene from purified pDC , and pDC are the principle gene-producing cells in the blood .	T4	T19	12470615
NA	CHEMICAL	GENE-N	3	19	Results indicate that chemical and chemical induce gene and gene from purified pDC , and pDC are the principle gene-producing cells in the blood .	T4	T20	12470615
NA	CHEMICAL	GENE-N	5	7	Results indicate that chemical and chemical induce gene and gene from purified pDC , and pDC are the principle gene-producing cells in the blood .	T5	T18	12470615
NA	CHEMICAL	GENE-N	5	9	Results indicate that chemical and chemical induce gene and gene from purified pDC , and pDC are the principle gene-producing cells in the blood .	T5	T19	12470615
NA	CHEMICAL	GENE-N	5	19	Results indicate that chemical and chemical induce gene and gene from purified pDC , and pDC are the principle gene-producing cells in the blood .	T5	T20	12470615
CPR:3	CHEMICAL	GENE-N	0	8	chemical-stimulated pDC also produce a number of other gene including gene and gene .	T7	T21	12470615
CPR:3	CHEMICAL	GENE-Y	0	4	chemical-stimulated pDC also produce a number of other gene including gene and gene .	T7	T23	12470615
CPR:3	CHEMICAL	GENE-Y	0	12	chemical-stimulated pDC also produce a number of other gene including gene and gene .	T7	T24	12470615
CPR:3	CHEMICAL	GENE-Y	0	6	chemical enhances co-stimulatory marker expression , gene expression , and pDC viability .	T8	T25	12470615
NA	CHEMICAL	GENE-Y	0	12	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T9	T26	12470615
NA	CHEMICAL	GENE-N	0	14	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T9	T27	12470615
NA	CHEMICAL	GENE-Y	0	23	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T9	T29	12470615
NA	CHEMICAL	GENE-N	0	25	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T9	T30	12470615
NA	CHEMICAL	GENE-Y	16	12	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T10	T26	12470615
NA	CHEMICAL	GENE-N	16	14	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T10	T27	12470615
NA	CHEMICAL	GENE-Y	16	23	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T10	T29	12470615
NA	CHEMICAL	GENE-N	16	25	chemical was compared throughout the study to the pDC survival factors , gene and gene ; chemical more effectively matures pDC than either gene or gene alone .	T10	T30	12470615
NA	CHEMICAL	GENE-Y	3	18	Selective oxidation of chemical self-assembled chemical monolayers to chemical is shown to transform the adhesion of model proteins gene and gene upon them .	T3	T18	23402628
NA	CHEMICAL	GENE-N	3	20	Selective oxidation of chemical self-assembled chemical monolayers to chemical is shown to transform the adhesion of model proteins gene and gene upon them .	T3	T19	23402628
NA	CHEMICAL	GENE-Y	5	18	Selective oxidation of chemical self-assembled chemical monolayers to chemical is shown to transform the adhesion of model proteins gene and gene upon them .	T8	T18	23402628
NA	CHEMICAL	GENE-N	5	20	Selective oxidation of chemical self-assembled chemical monolayers to chemical is shown to transform the adhesion of model proteins gene and gene upon them .	T8	T19	23402628
NA	CHEMICAL	GENE-Y	8	18	Selective oxidation of chemical self-assembled chemical monolayers to chemical is shown to transform the adhesion of model proteins gene and gene upon them .	T12	T18	23402628
NA	CHEMICAL	GENE-N	8	20	Selective oxidation of chemical self-assembled chemical monolayers to chemical is shown to transform the adhesion of model proteins gene and gene upon them .	T12	T19	23402628
NA	CHEMICAL	GENE-Y	2	10	Oxidation with chemical was similarly assessed , and adhesion of gene and gene from chemical buffered saline was then assayed by QCM and imaged by AFM .	T9	T20	23402628
NA	CHEMICAL	GENE-N	2	12	Oxidation with chemical was similarly assessed , and adhesion of gene and gene from chemical buffered saline was then assayed by QCM and imaged by AFM .	T9	T21	23402628
NA	CHEMICAL	GENE-Y	14	10	Oxidation with chemical was similarly assessed , and adhesion of gene and gene from chemical buffered saline was then assayed by QCM and imaged by AFM .	T10	T20	23402628
NA	CHEMICAL	GENE-N	14	12	Oxidation with chemical was similarly assessed , and adhesion of gene and gene from chemical buffered saline was then assayed by QCM and imaged by AFM .	T10	T21	23402628
NA	CHEMICAL	GENE-Y	0	6	chemical-functionalized sensors adsorbed multilayers of aggregated gene , whereas chemical and chemical-terminated monolayers are consistent with small protein aggregates .	T11	T22	23402628
NA	CHEMICAL	GENE-Y	9	6	chemical-functionalized sensors adsorbed multilayers of aggregated gene , whereas chemical and chemical-terminated monolayers are consistent with small protein aggregates .	T13	T22	23402628
NA	CHEMICAL	GENE-Y	11	6	chemical-functionalized sensors adsorbed multilayers of aggregated gene , whereas chemical and chemical-terminated monolayers are consistent with small protein aggregates .	T14	T22	23402628
NA	CHEMICAL	GENE-Y	5	16	It had higher levels of chemical ( chemical ) , a nutraceutical compound exerting actions against gene and gene ( gene ) .	T10	T14	23356880
NA	CHEMICAL	GENE-Y	5	18	It had higher levels of chemical ( chemical ) , a nutraceutical compound exerting actions against gene and gene ( gene ) .	T10	T15	23356880
NA	CHEMICAL	GENE-N	5	10	It had higher levels of chemical ( chemical ) , a nutraceutical compound exerting actions against gene and gene ( gene ) .	T10	T16	23356880
NA	CHEMICAL	GENE-Y	7	16	It had higher levels of chemical ( chemical ) , a nutraceutical compound exerting actions against gene and gene ( gene ) .	T11	T14	23356880
NA	CHEMICAL	GENE-Y	7	18	It had higher levels of chemical ( chemical ) , a nutraceutical compound exerting actions against gene and gene ( gene ) .	T11	T15	23356880
NA	CHEMICAL	GENE-N	7	10	It had higher levels of chemical ( chemical ) , a nutraceutical compound exerting actions against gene and gene ( gene ) .	T11	T16	23356880
CPR:9	CHEMICAL	GENE-N	17	17	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the gene ( gene ) -pathway ( one having as precursors the chemical containing a chemical system ) .	T1	T12	23356880
CPR:9	CHEMICAL	GENE-N	17	19	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the gene ( gene ) -pathway ( one having as precursors the chemical containing a chemical system ) .	T1	T13	23356880
CPR:9	CHEMICAL	GENE-N	30	17	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the gene ( gene ) -pathway ( one having as precursors the chemical containing a chemical system ) .	T2	T12	23356880
CPR:9	CHEMICAL	GENE-N	30	19	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the gene ( gene ) -pathway ( one having as precursors the chemical containing a chemical system ) .	T2	T13	23356880
NA	CHEMICAL	GENE-Y	10	3	Mechanistic Aspects of gene Maturation from the Solution Structure of chemical -Loaded gene and Analysis of chemical-Free gene Mutants .	T8	T32	23625804
NA	CHEMICAL	GENE-N	10	12	Mechanistic Aspects of gene Maturation from the Solution Structure of chemical -Loaded gene and Analysis of chemical-Free gene Mutants .	T8	T33	23625804
NA	CHEMICAL	GENE-Y	10	17	Mechanistic Aspects of gene Maturation from the Solution Structure of chemical -Loaded gene and Analysis of chemical-Free gene Mutants .	T8	T31	23625804
NA	CHEMICAL	GENE-Y	16	3	Mechanistic Aspects of gene Maturation from the Solution Structure of chemical -Loaded gene and Analysis of chemical-Free gene Mutants .	T7	T32	23625804
NA	CHEMICAL	GENE-N	16	12	Mechanistic Aspects of gene Maturation from the Solution Structure of chemical -Loaded gene and Analysis of chemical-Free gene Mutants .	T7	T33	23625804
NA	CHEMICAL	GENE-Y	16	17	Mechanistic Aspects of gene Maturation from the Solution Structure of chemical -Loaded gene and Analysis of chemical-Free gene Mutants .	T7	T31	23625804
NA	CHEMICAL	GENE-Y	0	2	chemical dismutase 1 ( gene ) maturation within the cell is mainly accomplished with the gene , gene , a dimeric protein with three distinct domains in each monomer .	T1	T9	23625804
NA	CHEMICAL	GENE-Y	0	2	chemical dismutase 1 ( gene ) maturation within the cell is mainly accomplished with the gene , gene , a dimeric protein with three distinct domains in each monomer .	T1	T13	23625804
NA	CHEMICAL	GENE-Y	0	15	chemical dismutase 1 ( gene ) maturation within the cell is mainly accomplished with the gene , gene , a dimeric protein with three distinct domains in each monomer .	T1	T28	23625804
NA	CHEMICAL	GENE-Y	0	17	chemical dismutase 1 ( gene ) maturation within the cell is mainly accomplished with the gene , gene , a dimeric protein with three distinct domains in each monomer .	T1	T10	23625804
NA	CHEMICAL	GENE-Y	15	8	We recently showed that the first domain of gene ( gene ) is responsible for chemical transfer to its protein partner , gene ( gene ) .	T2	T11	23625804
NA	CHEMICAL	GENE-N	15	10	We recently showed that the first domain of gene ( gene ) is responsible for chemical transfer to its protein partner , gene ( gene ) .	T2	T12	23625804
NA	CHEMICAL	GENE-Y	15	22	We recently showed that the first domain of gene ( gene ) is responsible for chemical transfer to its protein partner , gene ( gene ) .	T2	T14	23625804
NA	CHEMICAL	GENE-Y	15	24	We recently showed that the first domain of gene ( gene ) is responsible for chemical transfer to its protein partner , gene ( gene ) .	T2	T15	23625804
NA	CHEMICAL	GENE-N	6	9	The NMR solution structure of the chemical-loaded form of gene reported here contributes further to characterization of the copper-transfer mechanism to gene .	T3	T16	23625804
NA	CHEMICAL	GENE-Y	6	21	The NMR solution structure of the chemical-loaded form of gene reported here contributes further to characterization of the copper-transfer mechanism to gene .	T3	T17	23625804
NA	CHEMICAL	GENE-Y	25	8	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T18	23625804
NA	CHEMICAL	GENE-N	25	10	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T19	23625804
NA	CHEMICAL	GENE-N	25	12	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T20	23625804
NA	CHEMICAL	GENE-N	25	15	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T21	23625804
NA	CHEMICAL	GENE-N	25	15	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T22	23625804
NA	CHEMICAL	GENE-Y	25	28	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T23	23625804
NA	CHEMICAL	GENE-Y	25	40	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T4	T24	23625804
NA	CHEMICAL	GENE-Y	27	8	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T18	23625804
NA	CHEMICAL	GENE-N	27	10	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T19	23625804
NA	CHEMICAL	GENE-N	27	12	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T20	23625804
NA	CHEMICAL	GENE-N	27	15	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T21	23625804
NA	CHEMICAL	GENE-N	27	15	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T22	23625804
NA	CHEMICAL	GENE-Y	27	28	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T23	23625804
NA	CHEMICAL	GENE-Y	27	40	NMR spectroscopy was also used to examine the gene mutants gene , gene , and gene/gene , which are unable to form the structurally conserved chemical bond in gene , in order to investigate the role of these chemical during gene copper acquisition .	T5	T24	23625804
CPR:4	CHEMICAL	GENE-N	0	10	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T5	T17	11885959
CPR:4	CHEMICAL	GENE-N	0	12	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T5	T19	11885959
CPR:9	CHEMICAL	GENE-N	21	10	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T2	T17	11885959
CPR:9	CHEMICAL	GENE-N	21	12	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T2	T19	11885959
CPR:9	CHEMICAL	GENE-N	23	10	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T3	T17	11885959
CPR:9	CHEMICAL	GENE-N	23	12	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T3	T19	11885959
CPR:9	CHEMICAL	GENE-N	25	10	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T4	T17	11885959
CPR:9	CHEMICAL	GENE-N	25	12	Non-chemical anti-inflammatory drugs ( NSAIDs ) are competitive inhibitors of gene ( gene ) , the enzyme that mediates biosynthesis of chemical and chemical from chemical .	T4	T19	11885959
CPR:4	CHEMICAL	GENE-N	3	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T6	T18	11885959
CPR:4	CHEMICAL	GENE-N	3	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T7	T18	11885959
CPR:4	CHEMICAL	GENE-N	3	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T8	T18	11885959
CPR:4	CHEMICAL	GENE-N	3	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T9	T18	11885959
CPR:4	CHEMICAL	GENE-N	22	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T10	T18	11885959
CPR:4	CHEMICAL	GENE-N	24	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T11	T18	11885959
CPR:4	CHEMICAL	GENE-N	3	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T12	T18	11885959
CPR:4	CHEMICAL	GENE-N	5	5	Accordingly , docking of different gene inhibitors , including selective and non-selective ligands : chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical were undertaken using the AMBER program .	T1	T18	11885959
NA	CHEMICAL	GENE-Y	0	2	chemical sensitizes gene-induced apoptosis via the upregulation of gene in an gene/gene-dependent manner .	T4	T35	22982206
CPR:3	CHEMICAL	GENE-Y	0	8	chemical sensitizes gene-induced apoptosis via the upregulation of gene in an gene/gene-dependent manner .	T4	T36	22982206
CPR:3	CHEMICAL	GENE-Y	0	11	chemical sensitizes gene-induced apoptosis via the upregulation of gene in an gene/gene-dependent manner .	T4	T37	22982206
CPR:3	CHEMICAL	GENE-Y	0	11	chemical sensitizes gene-induced apoptosis via the upregulation of gene in an gene/gene-dependent manner .	T4	T38	22982206
NA	CHEMICAL	GENE-Y	5	10	Therefore , we examined whether chemical ( VA ) sensitize gene-induced apoptosis in cancer cells by induction of ER stress .	T3	T21	22982206
CPR:3	CHEMICAL	GENE-Y	2	6	Furthermore , chemical , a specific gene phosphorylation-inducing agent , increased gene and gene expression in the presence of VA .	T1	T6	22982206
CPR:3	CHEMICAL	GENE-Y	2	11	Furthermore , chemical , a specific gene phosphorylation-inducing agent , increased gene and gene expression in the presence of VA .	T1	T7	22982206
CPR:3	CHEMICAL	GENE-Y	2	13	Furthermore , chemical , a specific gene phosphorylation-inducing agent , increased gene and gene expression in the presence of VA .	T1	T8	22982206
NA	CHEMICAL	GENE-Y	5	2	Association of gene polymorphisms and chemical-induced extrapyramidal syndrome in Chinese schizophrenic patients .	T5	T14	16867246
NA	CHEMICAL	GENE-Y	10	8	In this study , we evaluate the role gene plays in chemical-induced EPS in schizophrenic patients .	T2	T10	16867246
NA	CHEMICAL	GENE-N	8	20	METHODS : We identified seven SNP ( single chemical polymorphism ) ( -141Cins > del , TaqIB , TaqID , gene , rs6275 , rs6277 and TaqIA ) in the gene gene in 146 schizophrenic inpatients ( 59 with EPS and 87 without EPS according to the Simpson-Angus Scale ) treated with chemical after 8 weeks .	T3	T11	16867246
NA	CHEMICAL	GENE-Y	8	30	METHODS : We identified seven SNP ( single chemical polymorphism ) ( -141Cins > del , TaqIB , TaqID , gene , rs6275 , rs6277 and TaqIA ) in the gene gene in 146 schizophrenic inpatients ( 59 with EPS and 87 without EPS according to the Simpson-Angus Scale ) treated with chemical after 8 weeks .	T3	T12	16867246
NA	CHEMICAL	GENE-N	28	20	METHODS : We identified seven SNP ( single chemical polymorphism ) ( -141Cins > del , TaqIB , TaqID , gene , rs6275 , rs6277 and TaqIA ) in the gene gene in 146 schizophrenic inpatients ( 59 with EPS and 87 without EPS according to the Simpson-Angus Scale ) treated with chemical after 8 weeks .	T4	T11	16867246
NA	CHEMICAL	GENE-Y	28	30	METHODS : We identified seven SNP ( single chemical polymorphism ) ( -141Cins > del , TaqIB , TaqID , gene , rs6275 , rs6277 and TaqIA ) in the gene gene in 146 schizophrenic inpatients ( 59 with EPS and 87 without EPS according to the Simpson-Angus Scale ) treated with chemical after 8 weeks .	T4	T12	16867246
NA	CHEMICAL	GENE-Y	21	18	CONCLUSION : Our results did not lend strong support to the view that the genetic variation of the gene gene plays a major role in the individually variable adverse effect induced by chemical , at least in Chinese patients with schizophrenia .	T1	T7	16867246
NA	CHEMICAL	GENE-Y	5	1	Urinary gene , fasting plasma chemical ( FPG ) , fasting serum gene ( gene ) , gene ( gene ) , gene , and other chemistry laboratory parameters of T2DM participants and controls were measured .	T1	T6	22798249
NA	CHEMICAL	GENE-Y	5	12	Urinary gene , fasting plasma chemical ( FPG ) , fasting serum gene ( gene ) , gene ( gene ) , gene , and other chemistry laboratory parameters of T2DM participants and controls were measured .	T1	T7	22798249
NA	CHEMICAL	GENE-Y	5	14	Urinary gene , fasting plasma chemical ( FPG ) , fasting serum gene ( gene ) , gene ( gene ) , gene , and other chemistry laboratory parameters of T2DM participants and controls were measured .	T1	T8	22798249
NA	CHEMICAL	GENE-Y	5	17	Urinary gene , fasting plasma chemical ( FPG ) , fasting serum gene ( gene ) , gene ( gene ) , gene , and other chemistry laboratory parameters of T2DM participants and controls were measured .	T1	T9	22798249
NA	CHEMICAL	GENE-Y	5	19	Urinary gene , fasting plasma chemical ( FPG ) , fasting serum gene ( gene ) , gene ( gene ) , gene , and other chemistry laboratory parameters of T2DM participants and controls were measured .	T1	T10	22798249
NA	CHEMICAL	GENE-Y	5	22	Urinary gene , fasting plasma chemical ( FPG ) , fasting serum gene ( gene ) , gene ( gene ) , gene , and other chemistry laboratory parameters of T2DM participants and controls were measured .	T1	T11	22798249
CPR:4	CHEMICAL	GENE-Y	4	3	An inhibitor of gene ( gene ) , chemical ( chemical ) , was reported to have neuroprotective activity , but clinical trials failed to confirm it .	T10	T29	12200198
CPR:4	CHEMICAL	GENE-Y	4	5	An inhibitor of gene ( gene ) , chemical ( chemical ) , was reported to have neuroprotective activity , but clinical trials failed to confirm it .	T10	T30	12200198
CPR:4	CHEMICAL	GENE-Y	10	3	An inhibitor of gene ( gene ) , chemical ( chemical ) , was reported to have neuroprotective activity , but clinical trials failed to confirm it .	T11	T29	12200198
CPR:4	CHEMICAL	GENE-Y	10	5	An inhibitor of gene ( gene ) , chemical ( chemical ) , was reported to have neuroprotective activity , but clinical trials failed to confirm it .	T11	T30	12200198
CPR:3	CHEMICAL	GENE-Y	0	14	chemical prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic gene and a gene , gene ( gene ) .	T1	T22	12200198
CPR:3	CHEMICAL	GENE-N	0	16	chemical prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic gene and a gene , gene ( gene ) .	T1	T23	12200198
CPR:3	CHEMICAL	GENE-Y	0	16	chemical prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic gene and a gene , gene ( gene ) .	T1	T24	12200198
CPR:3	CHEMICAL	GENE-Y	0	21	chemical prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic gene and a gene , gene ( gene ) .	T1	T25	12200198
CPR:3	CHEMICAL	GENE-N	3	13	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T3	T26	12200198
CPR:3	CHEMICAL	GENE-N	3	15	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T3	T27	12200198
CPR:3	CHEMICAL	GENE-Y	3	18	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T3	T28	12200198
NA	CHEMICAL	GENE-N	12	13	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T4	T26	12200198
NA	CHEMICAL	GENE-N	12	15	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T4	T27	12200198
NA	CHEMICAL	GENE-Y	12	18	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T4	T28	12200198
NA	CHEMICAL	GENE-N	19	13	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T5	T26	12200198
NA	CHEMICAL	GENE-N	19	15	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T5	T27	12200198
NA	CHEMICAL	GENE-Y	19	18	Long-term administration of chemical to rats increased the activities of antioxidative enzymes chemical dismutase ( gene ) and gene in the brain regions containing chemical neurons .	T5	T28	12200198
NA	CHEMICAL	GENE-N	12	3	Expression of pituitary gene and gene , under the control of pulsatile chemical , is essential for fertility .	T10	T32	23393127
NA	CHEMICAL	GENE-N	12	5	Expression of pituitary gene and gene , under the control of pulsatile chemical , is essential for fertility .	T10	T35	23393127
NA	CHEMICAL	GENE-N	0	3	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T1	T15	23393127
NA	CHEMICAL	GENE-N	0	5	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T1	T25	23393127
NA	CHEMICAL	GENE-Y	0	14	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T1	T31	23393127
NA	CHEMICAL	GENE-N	0	27	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T1	T34	23393127
NA	CHEMICAL	GENE-N	25	3	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T6	T15	23393127
NA	CHEMICAL	GENE-N	25	5	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T6	T25	23393127
NA	CHEMICAL	GENE-Y	25	14	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T6	T31	23393127
CPR:3	CHEMICAL	GENE-N	25	27	chemical response element-binding protein ( gene ) has been implicated in the regulation of gene gene expression , but the molecular mechanisms by which pulsatile chemical regulates gene activation remain poorly understood .	T6	T34	23393127
CPR:3	CHEMICAL	GENE-N	15	3	We hypothesized that gene is activated by a distinct signaling pathway in response to pulsatile chemical in a frequency-dependent manner to dictate the gene transcriptional response .	T7	T36	23393127
NA	CHEMICAL	GENE-Y	15	23	We hypothesized that gene is activated by a distinct signaling pathway in response to pulsatile chemical in a frequency-dependent manner to dictate the gene transcriptional response .	T7	T38	23393127
NA	CHEMICAL	GENE-N	24	0	gene stimulation of gene phosphorylation ( gene ) in the gonadotrope-derived LβT2 cell line was attenuated by a gene ( gene ) inhibitor , chemical .	T9	T39	23393127
CPR:4	CHEMICAL	GENE-N	24	3	gene stimulation of gene phosphorylation ( gene ) in the gonadotrope-derived LβT2 cell line was attenuated by a gene ( gene ) inhibitor , chemical .	T9	T40	23393127
CPR:4	CHEMICAL	GENE-N	24	6	gene stimulation of gene phosphorylation ( gene ) in the gonadotrope-derived LβT2 cell line was attenuated by a gene ( gene ) inhibitor , chemical .	T9	T41	23393127
CPR:4	CHEMICAL	GENE-N	24	18	gene stimulation of gene phosphorylation ( gene ) in the gonadotrope-derived LβT2 cell line was attenuated by a gene ( gene ) inhibitor , chemical .	T9	T42	23393127
CPR:4	CHEMICAL	GENE-N	24	20	gene stimulation of gene phosphorylation ( gene ) in the gonadotrope-derived LβT2 cell line was attenuated by a gene ( gene ) inhibitor , chemical .	T9	T43	23393127
NA	CHEMICAL	GENE-N	11	0	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T44	23393127
NA	CHEMICAL	GENE-N	11	0	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T45	23393127
NA	CHEMICAL	GENE-N	11	6	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T47	23393127
CPR:3	CHEMICAL	GENE-N	11	7	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T48	23393127
NA	CHEMICAL	GENE-Y	11	14	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T50	23393127
NA	CHEMICAL	GENE-Y	11	17	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T51	23393127
NA	CHEMICAL	GENE-Y	11	25	A gene ( gene ) reduced gene-stimulated gene and markedly decreased chemical stimulation of gene mRNA and geneLUC activity , but had little effect on geneLUC activity , indicating relative specificity of this pathway .	T11	T52	23393127
CPR:4	CHEMICAL	GENE-Y	2	34	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T2	T23	15866500
CPR:4	CHEMICAL	GENE-Y	2	36	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T2	T24	15866500
CPR:4	CHEMICAL	GENE-Y	2	34	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T3	T23	15866500
CPR:4	CHEMICAL	GENE-Y	2	36	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T3	T24	15866500
CPR:4	CHEMICAL	GENE-Y	2	34	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T4	T23	15866500
CPR:4	CHEMICAL	GENE-Y	2	36	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T4	T24	15866500
CPR:4	CHEMICAL	GENE-Y	2	34	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T5	T23	15866500
CPR:4	CHEMICAL	GENE-Y	2	36	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T5	T24	15866500
NA	CHEMICAL	GENE-Y	33	34	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T6	T23	15866500
NA	CHEMICAL	GENE-Y	33	36	Clinical studies in cancer patients treated with the new chemical analogue chemical ( chemical ) have shown that plasma chemical was significantly elevated after 1 week of treatment , consistent with inhibition of chemical synthase ( gene ) .	T6	T24	15866500
CPR:4	CHEMICAL	GENE-Y	10	17	These findings suggest that the mechanism of antiproliferative toxicity of chemical is at least partly due to gene inhibitory activity of its active metabolite chemical ( chemical ) .	T8	T25	15866500
CPR:4	CHEMICAL	GENE-Y	12	17	These findings suggest that the mechanism of antiproliferative toxicity of chemical is at least partly due to gene inhibitory activity of its active metabolite chemical ( chemical ) .	T9	T25	15866500
CPR:4	CHEMICAL	GENE-Y	26	17	These findings suggest that the mechanism of antiproliferative toxicity of chemical is at least partly due to gene inhibitory activity of its active metabolite chemical ( chemical ) .	T10	T25	15866500
NA	CHEMICAL	GENE-Y	3	18	Monitoring of plasma chemical concentrations have the potential to help clinicians to guide scheduling of chemical or other gene inhibitors in clinical trials .	T12	T26	15866500
NA	CHEMICAL	GENE-Y	15	18	Monitoring of plasma chemical concentrations have the potential to help clinicians to guide scheduling of chemical or other gene inhibitors in clinical trials .	T13	T26	15866500
NA	CHEMICAL	GENE-Y	0	4	chemical bind to the gene , and chemical are ligands of gene .	T4	T27	11474486
NA	CHEMICAL	GENE-Y	0	11	chemical bind to the gene , and chemical are ligands of gene .	T4	T31	11474486
NA	CHEMICAL	GENE-Y	7	4	chemical bind to the gene , and chemical are ligands of gene .	T8	T27	11474486
NA	CHEMICAL	GENE-Y	7	11	chemical bind to the gene , and chemical are ligands of gene .	T8	T31	11474486
NA	CHEMICAL	GENE-N	6	8	These intracellular receptors form heterodimers with chemical X receptor to modulate gene transcription .	T9	T32	11474486
NA	CHEMICAL	GENE-Y	23	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T10	T33	11474486
NA	CHEMICAL	GENE-Y	23	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T10	T34	11474486
NA	CHEMICAL	GENE-N	23	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T10	T35	11474486
NA	CHEMICAL	GENE-Y	23	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T11	T33	11474486
NA	CHEMICAL	GENE-Y	23	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T11	T34	11474486
NA	CHEMICAL	GENE-N	23	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T11	T35	11474486
NA	CHEMICAL	GENE-Y	40	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T12	T33	11474486
NA	CHEMICAL	GENE-Y	40	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T12	T34	11474486
NA	CHEMICAL	GENE-N	40	23	To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a gene-specific compound , chemical , a gene-specific ligand , chemical , and a gene coagonist , chemical , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real-time polymerase chain reaction .	T12	T35	11474486
CPR:3	CHEMICAL	GENE-N	0	10	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T15	T36	11474486
CPR:3	CHEMICAL	GENE-Y	0	13	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T15	T37	11474486
CPR:4	CHEMICAL	GENE-Y	0	16	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T15	T38	11474486
CPR:4	CHEMICAL	GENE-N	0	19	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T15	T39	11474486
CPR:3	CHEMICAL	GENE-N	2	10	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T16	T36	11474486
CPR:3	CHEMICAL	GENE-Y	2	13	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T16	T37	11474486
CPR:4	CHEMICAL	GENE-Y	2	16	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T16	T38	11474486
CPR:4	CHEMICAL	GENE-N	2	19	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T16	T39	11474486
NA	CHEMICAL	GENE-N	6	10	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T17	T36	11474486
NA	CHEMICAL	GENE-Y	6	13	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T17	T37	11474486
NA	CHEMICAL	GENE-Y	6	16	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T17	T38	11474486
NA	CHEMICAL	GENE-N	6	19	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T17	T39	11474486
NA	CHEMICAL	GENE-N	8	10	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T18	T36	11474486
NA	CHEMICAL	GENE-Y	8	13	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T18	T37	11474486
NA	CHEMICAL	GENE-Y	8	16	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T18	T38	11474486
NA	CHEMICAL	GENE-N	8	19	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T18	T39	11474486
NA	CHEMICAL	GENE-N	12	10	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T19	T36	11474486
NA	CHEMICAL	GENE-Y	12	13	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T19	T37	11474486
NA	CHEMICAL	GENE-Y	12	16	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T19	T38	11474486
NA	CHEMICAL	GENE-N	12	19	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T19	T39	11474486
NA	CHEMICAL	GENE-N	18	10	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T20	T36	11474486
NA	CHEMICAL	GENE-Y	18	13	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T20	T37	11474486
NA	CHEMICAL	GENE-Y	18	16	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T20	T38	11474486
NA	CHEMICAL	GENE-N	18	19	chemical and chemical induced expression of chemical ( chemical ) oxidase and chemical hydratase and reduced gene and chemical carboxykinase mRNAs .	T20	T39	11474486
CPR:3	CHEMICAL	GENE-Y	0	3	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T21	T40	11474486
CPR:3	CHEMICAL	GENE-Y	0	26	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T21	T22	11474486
CPR:3	CHEMICAL	GENE-N	0	16	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T21	T23	11474486
NA	CHEMICAL	GENE-Y	0	3	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T2	T40	11474486
NA	CHEMICAL	GENE-Y	0	26	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T2	T22	11474486
NA	CHEMICAL	GENE-N	0	16	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T2	T23	11474486
NA	CHEMICAL	GENE-Y	7	3	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T3	T40	11474486
NA	CHEMICAL	GENE-Y	7	26	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T3	T22	11474486
NA	CHEMICAL	GENE-N	7	16	chemical modestly increased gene mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of chemical transporter 4 and chemical carboxykinase in adipose tissue .	T3	T23	11474486
NA	CHEMICAL	GENE-N	5	19	A double-labeling fluorescent technique ( chemical and chemical ) was used to validate the findings revealed by the FRET-based gene sensor .	T4	T11	23620256
NA	CHEMICAL	GENE-N	7	19	A double-labeling fluorescent technique ( chemical and chemical ) was used to validate the findings revealed by the FRET-based gene sensor .	T5	T11	23620256
NA	CHEMICAL	GENE-Y	23	27	Furthermore , the activation of the FRET biosensor also confirms the endothelial cell apoptosis induced by the abnormal pulsatile shear stress and high chemical concentration is through gene pathway .	T1	T7	23620256
NA	CHEMICAL	GENE-Y	3	0	gene , a chemical dehydrogenase causing Leber 's congenital amaurosis , is also involved in steroid metabolism .	T3	T12	17512723
NA	CHEMICAL	GENE-N	3	2	gene , a chemical dehydrogenase causing Leber 's congenital amaurosis , is also involved in steroid metabolism .	T3	T13	17512723
NA	CHEMICAL	GENE-N	1	2	Three chemical dehydrogenases ( gene ) were tested for steroid converting abilities : gene and gene .	T2	T10	17512723
NA	CHEMICAL	GENE-N	1	4	Three chemical dehydrogenases ( gene ) were tested for steroid converting abilities : gene and gene .	T2	T8	17512723
NA	CHEMICAL	GENE-N	1	13	Three chemical dehydrogenases ( gene ) were tested for steroid converting abilities : gene and gene .	T2	T11	17512723
NA	CHEMICAL	GENE-Y	1	15	Three chemical dehydrogenases ( gene ) were tested for steroid converting abilities : gene and gene .	T2	T4	17512723
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene production in endotoxic shock .	T12	T20	1611705
CPR:4	CHEMICAL	GENE-Y	4	17	We now demonstrate that chemical , a noncatechol inotrope , strongly inhibits lipopolysaccharide ( LPS ) -induced gene production at concentrations readily achieved in vivo .	T4	T17	1611705
CPR:4	CHEMICAL	GENE-Y	3	10	Combined application of chemical and chemical caused additive inhibition of gene biosynthesis in vitro .	T8	T19	1611705
CPR:4	CHEMICAL	GENE-Y	5	10	Combined application of chemical and chemical caused additive inhibition of gene biosynthesis in vitro .	T9	T19	1611705
CPR:3	CHEMICAL	GENE-Y	3	20	Abrupt removal of chemical or chemical from the culture medium prior to LPS stimulation , however , caused significantly augmented gene production .	T1	T14	1611705
CPR:3	CHEMICAL	GENE-Y	5	20	Abrupt removal of chemical or chemical from the culture medium prior to LPS stimulation , however , caused significantly augmented gene production .	T2	T14	1611705
CPR:4	CHEMICAL	GENE-Y	11	19	Design , Synthesis , Biological Evaluation , and Docking Studies of chemical Derivatives with a chemical Moiety as Potent gene Inhibitors .	T5	T10	23530834
CPR:4	CHEMICAL	GENE-Y	14	19	Design , Synthesis , Biological Evaluation , and Docking Studies of chemical Derivatives with a chemical Moiety as Potent gene Inhibitors .	T4	T10	23530834
NA	CHEMICAL	GENE-Y	19	9	Biological evaluation revealed that most tested compounds were potent gene ( gene ) inhibitors , among them , the chemical derivative 11h displayed the most potent gene inhibitory activity with an IC50 value of 0.247 μM .	T2	T6	23530834
NA	CHEMICAL	GENE-Y	19	11	Biological evaluation revealed that most tested compounds were potent gene ( gene ) inhibitors , among them , the chemical derivative 11h displayed the most potent gene inhibitory activity with an IC50 value of 0.247 μM .	T2	T7	23530834
CPR:4	CHEMICAL	GENE-Y	19	26	Biological evaluation revealed that most tested compounds were potent gene ( gene ) inhibitors , among them , the chemical derivative 11h displayed the most potent gene inhibitory activity with an IC50 value of 0.247 μM .	T2	T8	23530834
NA	CHEMICAL	GENE-Y	4	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T37	T61	15740719
NA	CHEMICAL	GENE-Y	4	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T37	T62	15740719
NA	CHEMICAL	GENE-Y	4	12	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T37	T60	15740719
NA	CHEMICAL	GENE-Y	12	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T38	T61	15740719
NA	CHEMICAL	GENE-Y	12	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T38	T62	15740719
NA	CHEMICAL	GENE-Y	12	12	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T38	T60	15740719
NA	CHEMICAL	GENE-Y	11	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T39	T61	15740719
CPR:6	CHEMICAL	GENE-Y	11	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T39	T62	15740719
NA	CHEMICAL	GENE-Y	11	12	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T39	T60	15740719
NA	CHEMICAL	GENE-Y	12	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T35	T61	15740719
CPR:5	CHEMICAL	GENE-Y	12	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T35	T62	15740719
NA	CHEMICAL	GENE-Y	12	12	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T35	T60	15740719
NA	CHEMICAL	GENE-Y	12	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T36	T61	15740719
CPR:5	CHEMICAL	GENE-Y	12	5	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T36	T62	15740719
NA	CHEMICAL	GENE-Y	12	12	Binding domains of the chemical receptor for the selective gene antagonist chemical in comparison to the agonists chemical and chemical .	T36	T60	15740719
NA	CHEMICAL	GENE-Y	7	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T24	T52	15740719
NA	CHEMICAL	GENE-Y	7	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T24	T58	15740719
NA	CHEMICAL	GENE-N	7	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T24	T45	15740719
NA	CHEMICAL	GENE-Y	7	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T24	T50	15740719
NA	CHEMICAL	GENE-Y	10	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T28	T52	15740719
CPR:6	CHEMICAL	GENE-Y	10	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T28	T58	15740719
NA	CHEMICAL	GENE-N	10	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T28	T45	15740719
NA	CHEMICAL	GENE-Y	10	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T28	T50	15740719
NA	CHEMICAL	GENE-Y	18	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T32	T52	15740719
NA	CHEMICAL	GENE-Y	18	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T32	T58	15740719
NA	CHEMICAL	GENE-N	18	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T32	T45	15740719
NA	CHEMICAL	GENE-Y	18	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T32	T50	15740719
NA	CHEMICAL	GENE-Y	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T12	T52	15740719
NA	CHEMICAL	GENE-Y	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T12	T58	15740719
NA	CHEMICAL	GENE-N	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T12	T45	15740719
NA	CHEMICAL	GENE-Y	12	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T12	T50	15740719
NA	CHEMICAL	GENE-Y	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T19	T52	15740719
NA	CHEMICAL	GENE-Y	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T19	T58	15740719
CPR:6	CHEMICAL	GENE-N	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T19	T45	15740719
NA	CHEMICAL	GENE-Y	12	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T19	T50	15740719
NA	CHEMICAL	GENE-Y	18	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T20	T52	15740719
NA	CHEMICAL	GENE-Y	18	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T20	T58	15740719
CPR:5	CHEMICAL	GENE-N	18	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T20	T45	15740719
NA	CHEMICAL	GENE-Y	18	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T20	T50	15740719
NA	CHEMICAL	GENE-Y	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T21	T52	15740719
NA	CHEMICAL	GENE-Y	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T21	T58	15740719
CPR:5	CHEMICAL	GENE-N	12	8	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T21	T45	15740719
NA	CHEMICAL	GENE-Y	12	18	We have analyzed binding domains of the chemical receptor for chemical , a highly selective gene antagonist , in comparison to the combined chemical V1A/chemical receptor antagonist chemical and the agonists gene and chemical .	T21	T50	15740719
NA	CHEMICAL	GENE-N	8	10	For this purpose , chimeric 'gain-in function ' chemical/chemical V2 receptors were expressed in COS-7 cells .	T22	T51	15740719
NA	CHEMICAL	GENE-N	8	10	For this purpose , chimeric 'gain-in function ' chemical/chemical V2 receptors were expressed in COS-7 cells .	T23	T51	15740719
NA	CHEMICAL	GENE-Y	12	13	These recombinant receptors have been produced by transfer of domains from the chemical receptor into the related chemical V2 receptor and have already been successfully employed for the identification of ligand binding domains at the gene ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .	T25	T53	15740719
NA	CHEMICAL	GENE-Y	12	13	These recombinant receptors have been produced by transfer of domains from the chemical receptor into the related chemical V2 receptor and have already been successfully employed for the identification of ligand binding domains at the gene ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .	T25	T54	15740719
NA	CHEMICAL	GENE-Y	12	13	These recombinant receptors have been produced by transfer of domains from the chemical receptor into the related chemical V2 receptor and have already been successfully employed for the identification of ligand binding domains at the gene ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .	T25	T55	15740719
NA	CHEMICAL	GENE-Y	17	13	These recombinant receptors have been produced by transfer of domains from the chemical receptor into the related chemical V2 receptor and have already been successfully employed for the identification of ligand binding domains at the gene ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .	T26	T53	15740719
NA	CHEMICAL	GENE-Y	17	13	These recombinant receptors have been produced by transfer of domains from the chemical receptor into the related chemical V2 receptor and have already been successfully employed for the identification of ligand binding domains at the gene ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .	T26	T54	15740719
NA	CHEMICAL	GENE-Y	17	13	These recombinant receptors have been produced by transfer of domains from the chemical receptor into the related chemical V2 receptor and have already been successfully employed for the identification of ligand binding domains at the gene ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .	T26	T55	15740719
NA	CHEMICAL	GENE-Y	9	10	Separate agonist and peptide antagonist binding sites of the chemical receptor defined by their transfer into the gene .	T29	T56	15740719
NA	CHEMICAL	GENE-Y	9	10	Separate agonist and peptide antagonist binding sites of the chemical receptor defined by their transfer into the gene .	T29	T57	15740719
NA	CHEMICAL	GENE-Y	11	6	The binding profiles for the agonists gene and chemical were found to be similar .	T3	T41	15740719
NA	CHEMICAL	GENE-Y	6	6	The binding profiles for the agonists gene and chemical were found to be similar .	T4	T41	15740719
NA	CHEMICAL	GENE-Y	10	24	For both agonists , important binding domains were the extracellular chemical-terminus ( =E1 ) and the extracellular loops E2 and E3 from the chemical receptor .	T5	T42	15740719
NA	CHEMICAL	GENE-Y	23	24	For both agonists , important binding domains were the extracellular chemical-terminus ( =E1 ) and the extracellular loops E2 and E3 from the chemical receptor .	T6	T42	15740719
NA	CHEMICAL	GENE-N	2	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T7	T43	15740719
NA	CHEMICAL	GENE-Y	2	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T7	T44	15740719
NA	CHEMICAL	GENE-N	3	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T8	T43	15740719
NA	CHEMICAL	GENE-Y	3	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T8	T44	15740719
CPR:6	CHEMICAL	GENE-N	6	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T9	T43	15740719
NA	CHEMICAL	GENE-Y	6	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T9	T44	15740719
NA	CHEMICAL	GENE-N	17	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T10	T43	15740719
NA	CHEMICAL	GENE-Y	17	4	For the chemical V1A/chemical receptor antagonist chemical , none of the receptor constructs were able to provide a binding with higher affinity than the starting chemical V2 receptor .	T10	T44	15740719
NA	CHEMICAL	GENE-Y	6	22	In contrast , the binding of chemical was significantly improved when the transmembrane domains 1 and 2 were transferred from the chemical receptor to the chemical V2 receptor .	T11	T46	15740719
NA	CHEMICAL	GENE-Y	21	22	In contrast , the binding of chemical was significantly improved when the transmembrane domains 1 and 2 were transferred from the chemical receptor to the chemical V2 receptor .	T13	T46	15740719
NA	CHEMICAL	GENE-Y	25	22	In contrast , the binding of chemical was significantly improved when the transmembrane domains 1 and 2 were transferred from the chemical receptor to the chemical V2 receptor .	T14	T46	15740719
NA	CHEMICAL	GENE-Y	4	17	The binding domain of chemical differs from the binding domain of the agonists and the nonselective chemical receptor antagonist chemical that has been used in previous studies .	T15	T47	15740719
NA	CHEMICAL	GENE-N	4	24	The binding domain of chemical differs from the binding domain of the agonists and the nonselective chemical receptor antagonist chemical that has been used in previous studies .	T15	T48	15740719
NA	CHEMICAL	GENE-Y	16	17	The binding domain of chemical differs from the binding domain of the agonists and the nonselective chemical receptor antagonist chemical that has been used in previous studies .	T16	T47	15740719
NA	CHEMICAL	GENE-N	16	24	The binding domain of chemical differs from the binding domain of the agonists and the nonselective chemical receptor antagonist chemical that has been used in previous studies .	T16	T48	15740719
CPR:6	CHEMICAL	GENE-Y	19	17	The binding domain of chemical differs from the binding domain of the agonists and the nonselective chemical receptor antagonist chemical that has been used in previous studies .	T17	T47	15740719
NA	CHEMICAL	GENE-N	19	24	The binding domain of chemical differs from the binding domain of the agonists and the nonselective chemical receptor antagonist chemical that has been used in previous studies .	T17	T48	15740719
NA	CHEMICAL	GENE-N	20	13	EXPERIMENTAL APPROACH : Stable clonal CHO-K1 cell lines , transfected with either the gene , were used , and whole-cell chemical radioligand binding and chemical accumulation were measured .	T11	T21	20590599
NA	CHEMICAL	GENE-N	24	13	EXPERIMENTAL APPROACH : Stable clonal CHO-K1 cell lines , transfected with either the gene , were used , and whole-cell chemical radioligand binding and chemical accumulation were measured .	T12	T21	20590599
CPR:5	CHEMICAL	GENE-Y	0	6	chemical and chemical , for the gene over the gene or gene ) , while others ( e.g .	T1	T13	20590599
CPR:5	CHEMICAL	GENE-Y	0	9	chemical and chemical , for the gene over the gene or gene ) , while others ( e.g .	T1	T14	20590599
NA	CHEMICAL	GENE-Y	0	11	chemical and chemical , for the gene over the gene or gene ) , while others ( e.g .	T1	T15	20590599
CPR:5	CHEMICAL	GENE-Y	2	6	chemical and chemical , for the gene over the gene or gene ) , while others ( e.g .	T2	T13	20590599
NA	CHEMICAL	GENE-Y	2	9	chemical and chemical , for the gene over the gene or gene ) , while others ( e.g .	T2	T14	20590599
CPR:5	CHEMICAL	GENE-Y	2	11	chemical and chemical , for the gene over the gene or gene ) , while others ( e.g .	T2	T15	20590599
NA	CHEMICAL	GENE-Y	0	2	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T7	T16	20590599
NA	CHEMICAL	GENE-Y	0	10	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T7	T17	20590599
NA	CHEMICAL	GENE-Y	4	2	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T8	T16	20590599
NA	CHEMICAL	GENE-Y	4	10	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T8	T17	20590599
NA	CHEMICAL	GENE-Y	6	2	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T9	T16	20590599
NA	CHEMICAL	GENE-Y	6	10	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T9	T17	20590599
NA	CHEMICAL	GENE-Y	8	2	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T10	T16	20590599
NA	CHEMICAL	GENE-Y	8	10	chemical for gene ; chemical , chemical , chemical for gene ) were found to have subtype-selective intrinsic efficacy .	T10	T17	20590599
CPR:4	CHEMICAL	GENE-Y	0	6	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T25	T55	17207582
NA	CHEMICAL	GENE-N	0	9	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T25	T56	17207582
NA	CHEMICAL	GENE-N	0	9	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T25	T57	17207582
NA	CHEMICAL	GENE-Y	0	16	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T25	T54	17207582
NA	CHEMICAL	GENE-Y	2	6	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T26	T55	17207582
NA	CHEMICAL	GENE-N	2	9	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T26	T56	17207582
NA	CHEMICAL	GENE-N	2	9	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T26	T57	17207582
NA	CHEMICAL	GENE-Y	2	16	chemical stimulates chemical receptor interacting protein 1 degradation by gene-gene system to regulate surface expression of gene .	T26	T54	17207582
NA	CHEMICAL	GENE-Y	1	5	The chemical receptor interacting protein 1 ( gene ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering chemical receptors to other signaling proteins .	T7	T43	17207582
NA	CHEMICAL	GENE-Y	1	5	The chemical receptor interacting protein 1 ( gene ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering chemical receptors to other signaling proteins .	T7	T44	17207582
NA	CHEMICAL	GENE-N	1	2	The chemical receptor interacting protein 1 ( gene ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering chemical receptors to other signaling proteins .	T7	T32	17207582
NA	CHEMICAL	GENE-Y	21	5	The chemical receptor interacting protein 1 ( gene ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering chemical receptors to other signaling proteins .	T2	T43	17207582
NA	CHEMICAL	GENE-Y	21	5	The chemical receptor interacting protein 1 ( gene ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering chemical receptors to other signaling proteins .	T2	T44	17207582
NA	CHEMICAL	GENE-N	21	2	The chemical receptor interacting protein 1 ( gene ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering chemical receptors to other signaling proteins .	T2	T32	17207582
CPR:4	CHEMICAL	GENE-Y	4	14	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T5	T37	17207582
NA	CHEMICAL	GENE-Y	4	22	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T5	T38	17207582
NA	CHEMICAL	GENE-Y	4	24	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T5	T39	17207582
NA	CHEMICAL	GENE-Y	4	26	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T5	T40	17207582
NA	CHEMICAL	GENE-Y	4	28	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T5	T41	17207582
NA	CHEMICAL	GENE-Y	7	14	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T6	T37	17207582
NA	CHEMICAL	GENE-Y	7	22	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T6	T38	17207582
NA	CHEMICAL	GENE-Y	7	24	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T6	T39	17207582
NA	CHEMICAL	GENE-Y	7	26	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T6	T40	17207582
NA	CHEMICAL	GENE-Y	7	28	Here we report that chemical stimulation caused a rapid reduction in protein levels of gene , but not that of chemical receptor gene , gene and gene ( gene ) in rat primary cortical neuron cultures .	T6	T41	17207582
CPR:4	CHEMICAL	GENE-Y	4	2	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T8	T42	17207582
NA	CHEMICAL	GENE-N	4	13	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T8	T45	17207582
NA	CHEMICAL	GENE-N	4	20	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T8	T46	17207582
NA	CHEMICAL	GENE-N	4	20	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T8	T47	17207582
NA	CHEMICAL	GENE-N	4	27	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T8	T48	17207582
NA	CHEMICAL	GENE-Y	8	2	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T9	T42	17207582
CPR:4	CHEMICAL	GENE-N	8	13	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T9	T45	17207582
NA	CHEMICAL	GENE-N	8	20	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T9	T46	17207582
NA	CHEMICAL	GENE-N	8	20	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T9	T47	17207582
NA	CHEMICAL	GENE-N	8	27	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T9	T48	17207582
NA	CHEMICAL	GENE-Y	10	2	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T10	T42	17207582
CPR:4	CHEMICAL	GENE-N	10	13	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T10	T45	17207582
NA	CHEMICAL	GENE-N	10	20	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T10	T46	17207582
NA	CHEMICAL	GENE-N	10	20	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T10	T47	17207582
NA	CHEMICAL	GENE-N	10	27	Down-regulation of gene by chemical was blocked by chemical ( chemical ) , a gene inhibitor and by expression of gene-gene , a dominant negative form of gene .	T10	T48	17207582
CPR:3	CHEMICAL	GENE-Y	6	1	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T11	T49	17207582
CPR:6	CHEMICAL	GENE-N	6	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T11	T50	17207582
NA	CHEMICAL	GENE-N	6	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T11	T51	17207582
NA	CHEMICAL	GENE-Y	9	1	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T12	T49	17207582
NA	CHEMICAL	GENE-N	9	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T12	T50	17207582
NA	CHEMICAL	GENE-N	9	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T12	T51	17207582
NA	CHEMICAL	GENE-Y	11	1	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T13	T49	17207582
NA	CHEMICAL	GENE-N	11	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T13	T50	17207582
NA	CHEMICAL	GENE-N	11	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T13	T51	17207582
NA	CHEMICAL	GENE-Y	7	1	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T14	T49	17207582
NA	CHEMICAL	GENE-N	7	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T14	T50	17207582
CPR:6	CHEMICAL	GENE-N	7	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T14	T51	17207582
NA	CHEMICAL	GENE-Y	21	1	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T15	T49	17207582
NA	CHEMICAL	GENE-N	21	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T15	T50	17207582
CPR:6	CHEMICAL	GENE-N	21	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T15	T51	17207582
NA	CHEMICAL	GENE-Y	25	1	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T16	T49	17207582
NA	CHEMICAL	GENE-N	25	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T16	T50	17207582
NA	CHEMICAL	GENE-N	25	13	The gene reduction was inhibited by chemical , an chemical ( chemical ) receptor antagonist , but not by chemical ( chemical ) , an chemical receptor antagonist .	T16	T51	17207582
NA	CHEMICAL	GENE-N	0	15	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T17	T52	17207582
CPR:3	CHEMICAL	GENE-Y	0	20	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T17	T53	17207582
NA	CHEMICAL	GENE-N	2	15	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T18	T52	17207582
CPR:3	CHEMICAL	GENE-Y	2	20	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T18	T53	17207582
NA	CHEMICAL	GENE-N	4	15	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T19	T52	17207582
CPR:3	CHEMICAL	GENE-Y	4	20	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T19	T53	17207582
NA	CHEMICAL	GENE-N	8	15	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T20	T52	17207582
NA	CHEMICAL	GENE-Y	8	20	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T20	T53	17207582
CPR:4	CHEMICAL	GENE-N	13	15	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T21	T52	17207582
NA	CHEMICAL	GENE-Y	13	20	chemical and chemical ( chemical ) , two chemical chelators , but not chemical , an gene blocker , prevented gene degradation .	T21	T53	17207582
NA	CHEMICAL	GENE-Y	2	10	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T23	T27	17207582
NA	CHEMICAL	GENE-Y	2	15	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T23	T28	17207582
NA	CHEMICAL	GENE-Y	2	19	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T23	T29	17207582
NA	CHEMICAL	GENE-Y	2	22	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T23	T30	17207582
CPR:4	CHEMICAL	GENE-Y	4	10	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T24	T27	17207582
NA	CHEMICAL	GENE-Y	4	15	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T24	T28	17207582
NA	CHEMICAL	GENE-Y	4	19	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T24	T29	17207582
NA	CHEMICAL	GENE-Y	4	22	Furthermore , chemical prevented chemical-stimulated reduction in surface amount of gene , and knockdown of gene by RNAi against gene reduced surface gene in neurons .	T24	T30	17207582
CPR:3	CHEMICAL	GENE-Y	3	10	Anabolic effects of chemical on skeletal muscle are mediated by gene activation .	T12	T17	1322047
CPR:5	CHEMICAL	GENE-Y	8	6	The potent anabolic effects of the gene agonist chemical on skeletal muscle have been reported to be independent of actions on gene .	T6	T15	1322047
NA	CHEMICAL	GENE-N	8	15	The potent anabolic effects of the gene agonist chemical on skeletal muscle have been reported to be independent of actions on gene .	T6	T14	1322047
CPR:5	CHEMICAL	GENE-Y	12	10	These effects were not mimicked by oral administration of the gene agonist chemical even at high dose ( 52 mg/kg diet ) , and the effects of chemical were not inhibited by addition of chemical ( 200 mg/kg diet ) .	T3	T16	1322047
CPR:5	CHEMICAL	GENE-Y	27	10	These effects were not mimicked by oral administration of the gene agonist chemical even at high dose ( 52 mg/kg diet ) , and the effects of chemical were not inhibited by addition of chemical ( 200 mg/kg diet ) .	T4	T16	1322047
NA	CHEMICAL	GENE-Y	34	10	These effects were not mimicked by oral administration of the gene agonist chemical even at high dose ( 52 mg/kg diet ) , and the effects of chemical were not inhibited by addition of chemical ( 200 mg/kg diet ) .	T5	T16	1322047
NA	CHEMICAL	GENE-Y	3	10	Platycodi Radix attenuates chemical-induced liver fibrosis in rats by inducing gene-mediated antioxidant enzymes .	T18	T48	23485615
NA	CHEMICAL	GENE-N	0	23	chemical treatment for 4weeks led to marked liver fibrosis as assessed by serum biochemistry , histopathological examination , and hepatic lipid peroxidation and gene content .	T10	T32	23485615
CPR:3	CHEMICAL	GENE-N	3	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T11	T33	23485615
CPR:3	CHEMICAL	GENE-N	3	10	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T11	T34	23485615
CPR:3	CHEMICAL	GENE-N	3	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T11	T35	23485615
CPR:3	CHEMICAL	GENE-N	3	16	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T11	T36	23485615
CPR:3	CHEMICAL	GENE-N	3	27	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T11	T37	23485615
NA	CHEMICAL	GENE-N	5	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T12	T33	23485615
NA	CHEMICAL	GENE-N	5	10	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T12	T34	23485615
NA	CHEMICAL	GENE-N	5	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T12	T35	23485615
NA	CHEMICAL	GENE-N	5	16	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T12	T36	23485615
NA	CHEMICAL	GENE-N	5	27	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T12	T37	23485615
NA	CHEMICAL	GENE-N	13	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T13	T33	23485615
NA	CHEMICAL	GENE-N	13	10	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T13	T34	23485615
NA	CHEMICAL	GENE-N	13	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T13	T35	23485615
NA	CHEMICAL	GENE-N	13	16	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T13	T36	23485615
NA	CHEMICAL	GENE-N	13	27	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T13	T37	23485615
NA	CHEMICAL	GENE-N	25	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T14	T33	23485615
NA	CHEMICAL	GENE-N	25	10	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T14	T34	23485615
NA	CHEMICAL	GENE-N	25	5	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T14	T35	23485615
NA	CHEMICAL	GENE-N	25	16	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T14	T36	23485615
NA	CHEMICAL	GENE-N	25	27	CK significantly inhibited chemical-induced increases in serum chemical aminotransferase ( gene ) and chemical aminotransferase ( gene ) activities , fibrosis score , and hepatic chemical and gene content .	T14	T37	23485615
CPR:3	CHEMICAL	GENE-Y	16	18	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T38	23485615
CPR:3	CHEMICAL	GENE-Y	16	21	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T39	23485615
CPR:3	CHEMICAL	GENE-Y	16	18	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T40	23485615
CPR:3	CHEMICAL	GENE-Y	16	26	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T41	23485615
CPR:3	CHEMICAL	GENE-Y	16	30	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T42	23485615
CPR:3	CHEMICAL	GENE-Y	16	32	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T43	23485615
CPR:3	CHEMICAL	GENE-N	16	37	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T44	23485615
CPR:3	CHEMICAL	GENE-Y	16	18	Reverse transcription polymerase chain reaction ( RT-PCR ) and western blot analyses revealed that CK inhibited chemical-induced increases in gene ( gene ) , gene ( gene ) , and gene ( gene ) mRNA , and gene and gene protein .	T16	T45	23485615
CPR:3	CHEMICAL	GENE-Y	0	1	chemical-induced gene ( gene ) expression and gene ( gene ) activation was reduced by CK treatment .	T17	T46	23485615
CPR:3	CHEMICAL	GENE-Y	0	3	chemical-induced gene ( gene ) expression and gene ( gene ) activation was reduced by CK treatment .	T17	T47	23485615
CPR:3	CHEMICAL	GENE-N	0	7	chemical-induced gene ( gene ) expression and gene ( gene ) activation was reduced by CK treatment .	T17	T19	23485615
CPR:3	CHEMICAL	GENE-N	0	9	chemical-induced gene ( gene ) expression and gene ( gene ) activation was reduced by CK treatment .	T17	T20	23485615
NA	CHEMICAL	GENE-Y	15	6	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T21	23485615
NA	CHEMICAL	GENE-Y	15	8	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T22	23485615
NA	CHEMICAL	GENE-Y	15	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T23	23485615
NA	CHEMICAL	GENE-Y	15	18	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T24	23485615
NA	CHEMICAL	GENE-Y	15	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T25	23485615
NA	CHEMICAL	GENE-Y	15	24	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T26	23485615
NA	CHEMICAL	GENE-Y	15	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T27	23485615
NA	CHEMICAL	GENE-Y	15	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T28	23485615
NA	CHEMICAL	GENE-N	15	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T29	23485615
NA	CHEMICAL	GENE-N	15	38	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T1	T30	23485615
NA	CHEMICAL	GENE-Y	6	6	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T21	23485615
NA	CHEMICAL	GENE-Y	6	8	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T22	23485615
NA	CHEMICAL	GENE-Y	6	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T23	23485615
NA	CHEMICAL	GENE-Y	6	18	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T24	23485615
NA	CHEMICAL	GENE-Y	6	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T25	23485615
NA	CHEMICAL	GENE-Y	6	24	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T26	23485615
NA	CHEMICAL	GENE-Y	6	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T27	23485615
NA	CHEMICAL	GENE-Y	6	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T28	23485615
NA	CHEMICAL	GENE-N	6	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T29	23485615
NA	CHEMICAL	GENE-N	6	38	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T2	T30	23485615
NA	CHEMICAL	GENE-Y	7	6	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T21	23485615
NA	CHEMICAL	GENE-Y	7	8	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T22	23485615
NA	CHEMICAL	GENE-Y	7	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T23	23485615
NA	CHEMICAL	GENE-Y	7	18	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T24	23485615
NA	CHEMICAL	GENE-Y	7	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T25	23485615
NA	CHEMICAL	GENE-Y	7	24	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T26	23485615
NA	CHEMICAL	GENE-Y	7	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T27	23485615
NA	CHEMICAL	GENE-Y	7	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T28	23485615
NA	CHEMICAL	GENE-N	7	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T29	23485615
NA	CHEMICAL	GENE-N	7	38	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T3	T30	23485615
NA	CHEMICAL	GENE-Y	28	6	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T21	23485615
NA	CHEMICAL	GENE-Y	28	8	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T22	23485615
NA	CHEMICAL	GENE-Y	28	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T23	23485615
NA	CHEMICAL	GENE-Y	28	18	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T24	23485615
NA	CHEMICAL	GENE-Y	28	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T25	23485615
NA	CHEMICAL	GENE-Y	28	24	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T26	23485615
NA	CHEMICAL	GENE-Y	28	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T27	23485615
NA	CHEMICAL	GENE-Y	28	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T28	23485615
NA	CHEMICAL	GENE-N	28	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T29	23485615
NA	CHEMICAL	GENE-N	28	38	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T4	T30	23485615
NA	CHEMICAL	GENE-Y	36	6	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T21	23485615
NA	CHEMICAL	GENE-Y	36	8	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T22	23485615
NA	CHEMICAL	GENE-Y	36	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T23	23485615
NA	CHEMICAL	GENE-Y	36	18	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T24	23485615
NA	CHEMICAL	GENE-Y	36	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T25	23485615
NA	CHEMICAL	GENE-Y	36	24	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T26	23485615
NA	CHEMICAL	GENE-Y	36	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T27	23485615
NA	CHEMICAL	GENE-Y	36	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T28	23485615
NA	CHEMICAL	GENE-N	36	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T29	23485615
NA	CHEMICAL	GENE-N	36	38	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T5	T30	23485615
NA	CHEMICAL	GENE-Y	36	6	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T21	23485615
NA	CHEMICAL	GENE-Y	36	8	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T22	23485615
NA	CHEMICAL	GENE-Y	36	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T23	23485615
NA	CHEMICAL	GENE-Y	36	18	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T24	23485615
NA	CHEMICAL	GENE-Y	36	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T25	23485615
NA	CHEMICAL	GENE-Y	36	24	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T26	23485615
NA	CHEMICAL	GENE-Y	36	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T27	23485615
NA	CHEMICAL	GENE-Y	36	30	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T28	23485615
NA	CHEMICAL	GENE-N	36	14	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T29	23485615
NA	CHEMICAL	GENE-N	36	38	Furthermore , CK induced activation of gene ( gene ) -mediated antioxidant enzymes such as chemical synthetase ( gene ) , chemical oxygenase-1 ( gene ) , chemical chemical oxidoreductase 1 ( gene ) , and chemical-chemical-transferase ( gene ) in HepG2 cells .	T6	T30	23485615
NA	CHEMICAL	GENE-Y	3	4	Effects of the chemical H1 antagonist chemical on rat fetal palate development .	T7	T17	21058326
CPR:6	CHEMICAL	GENE-Y	6	4	Effects of the chemical H1 antagonist chemical on rat fetal palate development .	T8	T17	21058326
NA	CHEMICAL	GENE-Y	5	6	BACKGROUND : The effects of chemical H1 antagonist chemical on rat palate development were characterized following in utero exposure .	T4	T16	21058326
CPR:6	CHEMICAL	GENE-Y	8	6	BACKGROUND : The effects of chemical H1 antagonist chemical on rat palate development were characterized following in utero exposure .	T6	T16	21058326
NA	CHEMICAL	GENE-Y	5	9	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T9	21058326
NA	CHEMICAL	GENE-Y	5	11	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T10	21058326
NA	CHEMICAL	GENE-Y	5	13	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T11	21058326
NA	CHEMICAL	GENE-Y	5	15	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T12	21058326
NA	CHEMICAL	GENE-Y	5	17	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T13	21058326
NA	CHEMICAL	GENE-Y	5	19	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T14	21058326
NA	CHEMICAL	GENE-Y	5	22	The altered genes associated with chemical-induced cleft palate included gene , gene , gene , gene , gene , gene , and gene but the magnitude of the change was relatively small ( 1.5- to 2-fold ) .	T1	T15	21058326
NA	CHEMICAL	GENE-N	5	7	Phosphorylation of this subunit by chemical-dependent protein kinase has previously been found to activate the complex .	T1	T9	11181577
NA	CHEMICAL	GENE-N	11	15	Fibroblast cultures from the patient exhibited severe reduction of the rotenone-sensitive chemical -- > UQ oxidoreductase activity of gene , which was insensitive to chemical stimulation .	T4	T11	11181577
NA	CHEMICAL	GENE-N	11	18	Fibroblast cultures from the patient exhibited severe reduction of the rotenone-sensitive chemical -- > UQ oxidoreductase activity of gene , which was insensitive to chemical stimulation .	T4	T12	11181577
NA	CHEMICAL	GENE-N	24	15	Fibroblast cultures from the patient exhibited severe reduction of the rotenone-sensitive chemical -- > UQ oxidoreductase activity of gene , which was insensitive to chemical stimulation .	T5	T11	11181577
NA	CHEMICAL	GENE-N	24	18	Fibroblast cultures from the patient exhibited severe reduction of the rotenone-sensitive chemical -- > UQ oxidoreductase activity of gene , which was insensitive to chemical stimulation .	T5	T12	11181577
CPR:9	CHEMICAL	GENE-N	4	7	In contrast , the chemical catabolising enzymes gene and gene which are known to be chemical-responsive were not expressed at all in the developing eye .	T6	T20	17486539
CPR:9	CHEMICAL	GENE-N	4	9	In contrast , the chemical catabolising enzymes gene and gene which are known to be chemical-responsive were not expressed at all in the developing eye .	T6	T21	17486539
NA	CHEMICAL	GENE-N	15	7	In contrast , the chemical catabolising enzymes gene and gene which are known to be chemical-responsive were not expressed at all in the developing eye .	T7	T20	17486539
NA	CHEMICAL	GENE-N	15	9	In contrast , the chemical catabolising enzymes gene and gene which are known to be chemical-responsive were not expressed at all in the developing eye .	T7	T21	17486539
CPR:4	CHEMICAL	GENE-Y	0	4	chemical derived from chemical as a novel chemotype of gene inhibitors .	T8	T14	23583910
CPR:4	CHEMICAL	GENE-Y	3	4	chemical derived from chemical as a novel chemotype of gene inhibitors .	T9	T14	23583910
NA	CHEMICAL	GENE-Y	3	6	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T1	T13	23583910
NA	CHEMICAL	GENE-Y	3	22	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T1	T10	23583910
NA	CHEMICAL	GENE-Y	9	6	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T7	T13	23583910
NA	CHEMICAL	GENE-Y	9	22	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T7	T10	23583910
CPR:9	CHEMICAL	GENE-Y	4	6	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T2	T13	23583910
CPR:9	CHEMICAL	GENE-Y	4	22	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T2	T10	23583910
CPR:9	CHEMICAL	GENE-Y	9	6	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T3	T13	23583910
CPR:9	CHEMICAL	GENE-Y	9	22	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T3	T10	23583910
NA	CHEMICAL	GENE-Y	28	6	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T4	T13	23583910
NA	CHEMICAL	GENE-Y	28	22	A series of chemical , designed as mimics of a cationic high energy intermediate in the chemical cyclase ( 1 ) ( gene ) -mediated cyclization of chemical to chemical was prepared from chemical .	T4	T10	23583910
CPR:4	CHEMICAL	GENE-N	0	8	chemical-based inhibitors of chemical protein thioesterases 1 and 2 .	T4	T13	23239555
NA	CHEMICAL	GENE-N	3	8	chemical-based inhibitors of chemical protein thioesterases 1 and 2 .	T5	T13	23239555
NA	CHEMICAL	GENE-N	5	3	Inhibition of the gene-depalmitoylating enzyme chemical protein thioesterases APT1 and -2 is a new approach to modulating the gene cycle .	T1	T7	23239555
NA	CHEMICAL	GENE-N	5	10	Inhibition of the gene-depalmitoylating enzyme chemical protein thioesterases APT1 and -2 is a new approach to modulating the gene cycle .	T1	T8	23239555
NA	CHEMICAL	GENE-N	5	12	Inhibition of the gene-depalmitoylating enzyme chemical protein thioesterases APT1 and -2 is a new approach to modulating the gene cycle .	T1	T9	23239555
CPR:4	CHEMICAL	GENE-N	3	15	Here we present chemical and chemical derivatives as a new class of potent and nontoxic gene inhibitors .	T2	T10	23239555
CPR:4	CHEMICAL	GENE-N	5	15	Here we present chemical and chemical derivatives as a new class of potent and nontoxic gene inhibitors .	T3	T10	23239555
CPR:4	CHEMICAL	GENE-Y	14	3	Protein expression of gene also decreased and corresponded with reduced in vitro glucuronidation of chemical in S9 fractions from livers of pregnant mice .	T2	T17	23055538
NA	CHEMICAL	GENE-N	13	2	Conversely , gene mRNAs increased 100 to 500 % at various time points in pregnant and lactating mice and corresponded with enhanced in vitro sulfation of chemical in liver S9 fractions .	T1	T20	23055538
NA	CHEMICAL	GENE-Y	2	0	gene is a direct protein target for immunomodulatory and antiproliferative activities of chemical and chemical .	T22	T43	22552008
NA	CHEMICAL	GENE-Y	2	0	gene is a direct protein target for immunomodulatory and antiproliferative activities of chemical and chemical .	T21	T43	22552008
NA	CHEMICAL	GENE-Y	19	6	The ubiquitously expressed E3 ligase protein gene ( gene ) has been identified as the primary teratogenic target of chemical .	T7	T27	22552008
NA	CHEMICAL	GENE-Y	19	8	The ubiquitously expressed E3 ligase protein gene ( gene ) has been identified as the primary teratogenic target of chemical .	T7	T28	22552008
NA	CHEMICAL	GENE-Y	4	16	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T8	T29	22552008
NA	CHEMICAL	GENE-Y	4	19	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T8	T30	22552008
NA	CHEMICAL	GENE-Y	4	19	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T8	T31	22552008
NA	CHEMICAL	GENE-Y	4	21	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T8	T32	22552008
NA	CHEMICAL	GENE-Y	6	16	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T9	T29	22552008
NA	CHEMICAL	GENE-Y	6	19	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T9	T30	22552008
NA	CHEMICAL	GENE-Y	6	19	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T9	T31	22552008
NA	CHEMICAL	GENE-Y	6	21	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T9	T32	22552008
NA	CHEMICAL	GENE-Y	12	16	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T10	T29	22552008
NA	CHEMICAL	GENE-Y	12	19	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T10	T30	22552008
NA	CHEMICAL	GENE-Y	12	19	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T10	T31	22552008
NA	CHEMICAL	GENE-Y	12	21	Our studies demonstrate that chemical , chemical and another immunomodulatory drug , chemical , bound endogenous gene and recombinant gene-gene ( gene ) complexes .	T10	T32	22552008
NA	CHEMICAL	GENE-Y	5	0	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T12	T33	22552008
NA	CHEMICAL	GENE-N	5	8	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T12	T34	22552008
NA	CHEMICAL	GENE-Y	7	0	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T13	T33	22552008
NA	CHEMICAL	GENE-N	7	8	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T13	T34	22552008
NA	CHEMICAL	GENE-Y	15	0	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T14	T33	22552008
CPR:3	CHEMICAL	GENE-N	15	8	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T14	T34	22552008
NA	CHEMICAL	GENE-Y	17	0	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T15	T33	22552008
CPR:3	CHEMICAL	GENE-N	17	8	gene mediated antiproliferative activities of chemical and chemical in myeloma cells , as well as chemical- and chemical-induced gene production in T cells .	T15	T34	22552008
CPR:4	CHEMICAL	GENE-Y	0	6	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T16	T35	22552008
CPR:4	CHEMICAL	GENE-Y	0	14	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T16	T36	22552008
NA	CHEMICAL	GENE-Y	0	20	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T16	T37	22552008
CPR:4	CHEMICAL	GENE-Y	2	6	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T17	T35	22552008
CPR:4	CHEMICAL	GENE-Y	2	14	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T17	T36	22552008
NA	CHEMICAL	GENE-Y	2	20	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T17	T37	22552008
NA	CHEMICAL	GENE-Y	11	6	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T18	T35	22552008
NA	CHEMICAL	GENE-Y	11	14	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T18	T36	22552008
NA	CHEMICAL	GENE-Y	11	20	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T18	T37	22552008
NA	CHEMICAL	GENE-Y	18	6	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T19	T35	22552008
NA	CHEMICAL	GENE-Y	18	14	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T19	T36	22552008
NA	CHEMICAL	GENE-Y	18	20	chemical and chemical inhibited autoubiquitination of gene in HEK293T cells expressing chemical-binding competent wild-type gene , but not chemical-binding defective gene ( YW/AA ) .	T19	T37	22552008
NA	CHEMICAL	GENE-Y	21	2	Overexpression of gene wild-type protein , but not gene ( YW/AA ) mutant protein , in KMS12 myeloma cells , amplified chemical-mediated reductions in gene and gene expression and increases in gene ( gene ) expression .	T20	T38	22552008
NA	CHEMICAL	GENE-Y	21	8	Overexpression of gene wild-type protein , but not gene ( YW/AA ) mutant protein , in KMS12 myeloma cells , amplified chemical-mediated reductions in gene and gene expression and increases in gene ( gene ) expression .	T20	T39	22552008
CPR:4	CHEMICAL	GENE-Y	21	24	Overexpression of gene wild-type protein , but not gene ( YW/AA ) mutant protein , in KMS12 myeloma cells , amplified chemical-mediated reductions in gene and gene expression and increases in gene ( gene ) expression .	T20	T40	22552008
CPR:4	CHEMICAL	GENE-Y	21	26	Overexpression of gene wild-type protein , but not gene ( YW/AA ) mutant protein , in KMS12 myeloma cells , amplified chemical-mediated reductions in gene and gene expression and increases in gene ( gene ) expression .	T20	T41	22552008
CPR:3	CHEMICAL	GENE-Y	21	31	Overexpression of gene wild-type protein , but not gene ( YW/AA ) mutant protein , in KMS12 myeloma cells , amplified chemical-mediated reductions in gene and gene expression and increases in gene ( gene ) expression .	T20	T42	22552008
CPR:3	CHEMICAL	GENE-Y	21	33	Overexpression of gene wild-type protein , but not gene ( YW/AA ) mutant protein , in KMS12 myeloma cells , amplified chemical-mediated reductions in gene and gene expression and increases in gene ( gene ) expression .	T20	T23	22552008
CPR:4	CHEMICAL	GENE-Y	3	16	Long-term selection for chemical resistance in H929 myeloma cell lines was accompanied by a reduction in gene , while in DF15R myeloma cells resistant to both chemical and chemical , gene protein was undetectable .	T2	T24	22552008
NA	CHEMICAL	GENE-Y	3	30	Long-term selection for chemical resistance in H929 myeloma cell lines was accompanied by a reduction in gene , while in DF15R myeloma cells resistant to both chemical and chemical , gene protein was undetectable .	T2	T25	22552008
NA	CHEMICAL	GENE-Y	13	16	Long-term selection for chemical resistance in H929 myeloma cell lines was accompanied by a reduction in gene , while in DF15R myeloma cells resistant to both chemical and chemical , gene protein was undetectable .	T3	T24	22552008
NA	CHEMICAL	GENE-Y	13	30	Long-term selection for chemical resistance in H929 myeloma cell lines was accompanied by a reduction in gene , while in DF15R myeloma cells resistant to both chemical and chemical , gene protein was undetectable .	T3	T25	22552008
NA	CHEMICAL	GENE-Y	13	16	Long-term selection for chemical resistance in H929 myeloma cell lines was accompanied by a reduction in gene , while in DF15R myeloma cells resistant to both chemical and chemical , gene protein was undetectable .	T4	T24	22552008
NA	CHEMICAL	GENE-Y	13	30	Long-term selection for chemical resistance in H929 myeloma cell lines was accompanied by a reduction in gene , while in DF15R myeloma cells resistant to both chemical and chemical , gene protein was undetectable .	T4	T25	22552008
NA	CHEMICAL	GENE-Y	12	15	Intrauterine pressure , ischemia markers , and experienced pain during administration of a chemical V1a receptor antagonist in spontaneous and chemical-induced dysmenorrhea .	T18	T29	16532916
NA	CHEMICAL	GENE-Y	12	12	Intrauterine pressure , ischemia markers , and experienced pain during administration of a chemical V1a receptor antagonist in spontaneous and chemical-induced dysmenorrhea .	T18	T28	16532916
NA	CHEMICAL	GENE-Y	12	15	Intrauterine pressure , ischemia markers , and experienced pain during administration of a chemical V1a receptor antagonist in spontaneous and chemical-induced dysmenorrhea .	T17	T29	16532916
NA	CHEMICAL	GENE-Y	12	12	Intrauterine pressure , ischemia markers , and experienced pain during administration of a chemical V1a receptor antagonist in spontaneous and chemical-induced dysmenorrhea .	T17	T28	16532916
NA	CHEMICAL	GENE-Y	9	10	BACKGROUND : A model to study the effect of chemical V1a antagonist in dysmenorrhea .	T10	T25	16532916
NA	CHEMICAL	GENE-Y	3	3	At each menstruation a bolus injection of 10 pmol/kg of gene was administered before and during infusion of either 300 microg/min of chemical or placebo .	T9	T24	16532916
NA	CHEMICAL	GENE-Y	3	3	At each menstruation a bolus injection of 10 pmol/kg of gene was administered before and during infusion of either 300 microg/min of chemical or placebo .	T11	T24	16532916
NA	CHEMICAL	GENE-Y	2	2	Ischemia markers in plasma and pain recorded by a visual analog scale were measured before and after each gene injection as well as before and after the start of either chemical or placebo infusion .	T12	T26	16532916
NA	CHEMICAL	GENE-Y	8	2	Ischemia markers in plasma and pain recorded by a visual analog scale were measured before and after each gene injection as well as before and after the start of either chemical or placebo infusion .	T13	T26	16532916
NA	CHEMICAL	GENE-Y	9	2	RESULTS : gene injections elevated area under the curve in both healthy volunteers and dysmenorrhea subjects .	T14	T27	16532916
NA	CHEMICAL	GENE-Y	6	6	In subjects with dysmenorrhea the increase in pain following the administration of gene was significantly lower during chemical than during placebo infusion .	T3	T19	16532916
CPR:4	CHEMICAL	GENE-Y	17	6	In subjects with dysmenorrhea the increase in pain following the administration of gene was significantly lower during chemical than during placebo infusion .	T4	T19	16532916
CPR:4	CHEMICAL	GENE-Y	2	7	CONCLUSIONS : chemical reduces chemical-induced intrauterine pressure in both healthy volunteers and dysmenorrheics , and reported pain in subjects with dysmenorrhea .	T6	T21	16532916
NA	CHEMICAL	GENE-Y	4	7	CONCLUSIONS : chemical reduces chemical-induced intrauterine pressure in both healthy volunteers and dysmenorrheics , and reported pain in subjects with dysmenorrhea .	T7	T21	16532916
NA	CHEMICAL	GENE-Y	3	4	Neuronal expression of chemical synthase in central nervous system regulates body weight and energy homeostasis .	T8	T20	23554574
NA	CHEMICAL	GENE-Y	14	15	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T1	T9	23554574
NA	CHEMICAL	GENE-Y	14	17	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T1	T10	23554574
NA	CHEMICAL	GENE-Y	14	22	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T1	T11	23554574
NA	CHEMICAL	GENE-Y	19	15	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T2	T9	23554574
NA	CHEMICAL	GENE-Y	19	17	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T2	T10	23554574
NA	CHEMICAL	GENE-Y	19	22	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T2	T11	23554574
NA	CHEMICAL	GENE-Y	19	15	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T3	T9	23554574
NA	CHEMICAL	GENE-Y	19	17	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T3	T10	23554574
NA	CHEMICAL	GENE-Y	19	22	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T3	T11	23554574
NA	CHEMICAL	GENE-Y	21	15	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T4	T9	23554574
NA	CHEMICAL	GENE-Y	21	17	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T4	T10	23554574
NA	CHEMICAL	GENE-Y	21	22	The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of chemical synthase ( gene ; chemical-chemical : chemical glucosyltransferase ) .	T4	T11	23554574
NA	CHEMICAL	GENE-Y	10	13	Consequently , mice with inducible forebrain neuron-specific deletion of the chemical-chemical : chemical glucosyltransferase gene ( gene ) display obesity , hypothermia , and lower sympathetic activity .	T5	T17	23554574
NA	CHEMICAL	GENE-Y	10	16	Consequently , mice with inducible forebrain neuron-specific deletion of the chemical-chemical : chemical glucosyltransferase gene ( gene ) display obesity , hypothermia , and lower sympathetic activity .	T5	T18	23554574
NA	CHEMICAL	GENE-Y	10	13	Consequently , mice with inducible forebrain neuron-specific deletion of the chemical-chemical : chemical glucosyltransferase gene ( gene ) display obesity , hypothermia , and lower sympathetic activity .	T6	T17	23554574
NA	CHEMICAL	GENE-Y	10	16	Consequently , mice with inducible forebrain neuron-specific deletion of the chemical-chemical : chemical glucosyltransferase gene ( gene ) display obesity , hypothermia , and lower sympathetic activity .	T6	T18	23554574
NA	CHEMICAL	GENE-Y	12	13	Consequently , mice with inducible forebrain neuron-specific deletion of the chemical-chemical : chemical glucosyltransferase gene ( gene ) display obesity , hypothermia , and lower sympathetic activity .	T7	T17	23554574
NA	CHEMICAL	GENE-Y	12	16	Consequently , mice with inducible forebrain neuron-specific deletion of the chemical-chemical : chemical glucosyltransferase gene ( gene ) display obesity , hypothermia , and lower sympathetic activity .	T7	T18	23554574
NA	CHEMICAL	GENE-Y	12	0	gene-gene interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local chemical/chemical balance during hypoglycemia .	T11	T27	23274893
NA	CHEMICAL	GENE-Y	12	0	gene-gene interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local chemical/chemical balance during hypoglycemia .	T11	T28	23274893
NA	CHEMICAL	GENE-Y	12	0	gene-gene interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local chemical/chemical balance during hypoglycemia .	T12	T27	23274893
NA	CHEMICAL	GENE-Y	12	0	gene-gene interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local chemical/chemical balance during hypoglycemia .	T12	T28	23274893
NA	CHEMICAL	GENE-Y	11	20	Given the similarities between islet and ventromedial hypothalamus ( VMH ) chemical sensing , we tested the hypothesis that the gene/gene system might function within the VMH during hypoglycemia to stimulate counterregulatory hormone release as well .	T7	T17	23274893
NA	CHEMICAL	GENE-Y	11	20	Given the similarities between islet and ventromedial hypothalamus ( VMH ) chemical sensing , we tested the hypothesis that the gene/gene system might function within the VMH during hypoglycemia to stimulate counterregulatory hormone release as well .	T7	T18	23274893
NA	CHEMICAL	GENE-Y	3	5	Counterregulatory responses and chemical/chemical concentrations in the VMH were assessed during a hyperinsulinemic-hypoglycemic chemical clamp study in chronically catheterized awake male Sprague-Dawley rats that received an acute VMH microinjection of gene-Fc , chronic VMH knockdown , or overexpression of gene using an adenoassociated viral construct .	T8	T20	23274893
NA	CHEMICAL	GENE-Y	3	5	Counterregulatory responses and chemical/chemical concentrations in the VMH were assessed during a hyperinsulinemic-hypoglycemic chemical clamp study in chronically catheterized awake male Sprague-Dawley rats that received an acute VMH microinjection of gene-Fc , chronic VMH knockdown , or overexpression of gene using an adenoassociated viral construct .	T8	T21	23274893
NA	CHEMICAL	GENE-Y	3	5	Counterregulatory responses and chemical/chemical concentrations in the VMH were assessed during a hyperinsulinemic-hypoglycemic chemical clamp study in chronically catheterized awake male Sprague-Dawley rats that received an acute VMH microinjection of gene-Fc , chronic VMH knockdown , or overexpression of gene using an adenoassociated viral construct .	T9	T20	23274893
NA	CHEMICAL	GENE-Y	3	5	Counterregulatory responses and chemical/chemical concentrations in the VMH were assessed during a hyperinsulinemic-hypoglycemic chemical clamp study in chronically catheterized awake male Sprague-Dawley rats that received an acute VMH microinjection of gene-Fc , chronic VMH knockdown , or overexpression of gene using an adenoassociated viral construct .	T9	T21	23274893
NA	CHEMICAL	GENE-Y	13	5	Counterregulatory responses and chemical/chemical concentrations in the VMH were assessed during a hyperinsulinemic-hypoglycemic chemical clamp study in chronically catheterized awake male Sprague-Dawley rats that received an acute VMH microinjection of gene-Fc , chronic VMH knockdown , or overexpression of gene using an adenoassociated viral construct .	T10	T20	23274893
NA	CHEMICAL	GENE-Y	13	5	Counterregulatory responses and chemical/chemical concentrations in the VMH were assessed during a hyperinsulinemic-hypoglycemic chemical clamp study in chronically catheterized awake male Sprague-Dawley rats that received an acute VMH microinjection of gene-Fc , chronic VMH knockdown , or overexpression of gene using an adenoassociated viral construct .	T10	T21	23274893
NA	CHEMICAL	GENE-Y	7	3	Overexpression of VMH gene transiently increased local chemical concentrations , whereas gene knockdown produced profound suppression of VMH interstitial fluid chemical concentrations in the basal state and during hypoglycemia .	T1	T26	23274893
NA	CHEMICAL	GENE-Y	7	11	Overexpression of VMH gene transiently increased local chemical concentrations , whereas gene knockdown produced profound suppression of VMH interstitial fluid chemical concentrations in the basal state and during hypoglycemia .	T1	T13	23274893
NA	CHEMICAL	GENE-Y	3	3	Overexpression of VMH gene transiently increased local chemical concentrations , whereas gene knockdown produced profound suppression of VMH interstitial fluid chemical concentrations in the basal state and during hypoglycemia .	T2	T26	23274893
NA	CHEMICAL	GENE-Y	3	11	Overexpression of VMH gene transiently increased local chemical concentrations , whereas gene knockdown produced profound suppression of VMH interstitial fluid chemical concentrations in the basal state and during hypoglycemia .	T2	T13	23274893
NA	CHEMICAL	GENE-Y	14	7	We report for the first time that gene binds heparin , and that the chemical-terminal propeptide significantly enhances this interaction ( removal of this propeptide from full-length gene completely prevents heparin binding ) .	T4	T19	23404505
NA	CHEMICAL	GENE-Y	14	27	We report for the first time that gene binds heparin , and that the chemical-terminal propeptide significantly enhances this interaction ( removal of this propeptide from full-length gene completely prevents heparin binding ) .	T4	T20	23404505
NA	CHEMICAL	GENE-Y	8	15	We also show that removal of either the chemical- or chemical-terminal propeptide is required for gene to drive formation of gene/gene heterodimers which have recently been shown to positively regulate angiogenic sprouting .	T5	T21	23404505
NA	CHEMICAL	GENE-Y	8	20	We also show that removal of either the chemical- or chemical-terminal propeptide is required for gene to drive formation of gene/gene heterodimers which have recently been shown to positively regulate angiogenic sprouting .	T5	T8	23404505
NA	CHEMICAL	GENE-Y	8	20	We also show that removal of either the chemical- or chemical-terminal propeptide is required for gene to drive formation of gene/gene heterodimers which have recently been shown to positively regulate angiogenic sprouting .	T5	T9	23404505
NA	CHEMICAL	GENE-Y	10	15	We also show that removal of either the chemical- or chemical-terminal propeptide is required for gene to drive formation of gene/gene heterodimers which have recently been shown to positively regulate angiogenic sprouting .	T6	T21	23404505
NA	CHEMICAL	GENE-Y	10	20	We also show that removal of either the chemical- or chemical-terminal propeptide is required for gene to drive formation of gene/gene heterodimers which have recently been shown to positively regulate angiogenic sprouting .	T6	T8	23404505
NA	CHEMICAL	GENE-Y	10	20	We also show that removal of either the chemical- or chemical-terminal propeptide is required for gene to drive formation of gene/gene heterodimers which have recently been shown to positively regulate angiogenic sprouting .	T6	T9	23404505
NA	CHEMICAL	GENE-Y	10	14	In a mouse tumor model , removal of only the chemical-terminal propeptide from full-length gene was sufficient to enhance angiogenesis and tumor growth .	T1	T11	23404505
NA	CHEMICAL	GENE-Y	7	8	Use of ( Gyro ) Gy and chemical synthase transgenic mice to study functions of chemical .	T12	T19	21318872
NA	CHEMICAL	GENE-Y	15	8	Use of ( Gyro ) Gy and chemical synthase transgenic mice to study functions of chemical .	T13	T19	21318872
NA	CHEMICAL	GENE-Y	10	30	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T5	T16	21318872
NA	CHEMICAL	GENE-Y	10	32	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T5	T17	21318872
NA	CHEMICAL	GENE-Y	12	30	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T6	T16	21318872
NA	CHEMICAL	GENE-Y	12	32	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T6	T17	21318872
NA	CHEMICAL	GENE-Y	20	30	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T8	T16	21318872
NA	CHEMICAL	GENE-Y	20	32	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T8	T17	21318872
NA	CHEMICAL	GENE-Y	29	30	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T10	T16	21318872
NA	CHEMICAL	GENE-Y	29	32	Loss of any of the enzymes needed to make either chemical or chemical ( which also -prevent the production of chemical ) is lethal , but male mice lacking chemical synthase ( gene ) due to a deletion of part of the X chromosome are viable on the B6C3H background .	T10	T17	21318872
CPR:5	CHEMICAL	GENE-N	6	12	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T11	T18	1356794
NA	CHEMICAL	GENE-N	6	21	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T11	T12	1356794
NA	CHEMICAL	GENE-Y	6	28	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T11	T13	1356794
NA	CHEMICAL	GENE-Y	6	35	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T11	T14	1356794
NA	CHEMICAL	GENE-N	12	12	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T1	T18	1356794
CPR:6	CHEMICAL	GENE-N	12	21	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T1	T12	1356794
NA	CHEMICAL	GENE-Y	12	28	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T1	T13	1356794
NA	CHEMICAL	GENE-Y	12	35	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T1	T14	1356794
NA	CHEMICAL	GENE-N	31	12	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T2	T18	1356794
NA	CHEMICAL	GENE-N	31	21	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T2	T12	1356794
CPR:6	CHEMICAL	GENE-Y	31	28	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T2	T13	1356794
NA	CHEMICAL	GENE-Y	31	35	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T2	T14	1356794
NA	CHEMICAL	GENE-N	38	12	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T3	T18	1356794
NA	CHEMICAL	GENE-N	38	21	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T3	T12	1356794
NA	CHEMICAL	GENE-Y	38	28	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T3	T13	1356794
CPR:6	CHEMICAL	GENE-Y	38	35	In the hot-plate test in mice , the antinociceptive action of the gene agonist , chemical , was abolished by the gene antagonist , chemical , the potent gene antagonist , chemical and the preferential gene antagonist , chemical .	T3	T14	1356794
NA	CHEMICAL	GENE-N	12	5	In contrast , the preferential gene ligands ( 'antagonists ' ) , chemical , chemical and chemical were inactive .	T4	T15	1356794
NA	CHEMICAL	GENE-N	14	5	In contrast , the preferential gene ligands ( 'antagonists ' ) , chemical , chemical and chemical were inactive .	T5	T15	1356794
NA	CHEMICAL	GENE-N	16	5	In contrast , the preferential gene ligands ( 'antagonists ' ) , chemical , chemical and chemical were inactive .	T6	T15	1356794
CPR:5	CHEMICAL	GENE-Y	6	2	The preferential gene partial agonist , chemical , partially inhibited chemical-induced antinociception .	T7	T16	1356794
CPR:5	CHEMICAL	GENE-Y	5	2	The preferential gene partial agonist , chemical , partially inhibited chemical-induced antinociception .	T8	T16	1356794
CPR:6	CHEMICAL	GENE-N	5	6	We examined the effect of chemical ( 3- inverted question markchemical chemical inverted question mark-chemical ) , a new gene antagonist , on prostatic function in isolated canine prostate and in anesthetized dogs .	T7	T23	10771044
CPR:6	CHEMICAL	GENE-N	6	6	We examined the effect of chemical ( 3- inverted question markchemical chemical inverted question mark-chemical ) , a new gene antagonist , on prostatic function in isolated canine prostate and in anesthetized dogs .	T13	T23	10771044
CPR:6	CHEMICAL	GENE-N	11	6	We examined the effect of chemical ( 3- inverted question markchemical chemical inverted question mark-chemical ) , a new gene antagonist , on prostatic function in isolated canine prostate and in anesthetized dogs .	T3	T23	10771044
CPR:6	CHEMICAL	GENE-N	14	6	We examined the effect of chemical ( 3- inverted question markchemical chemical inverted question mark-chemical ) , a new gene antagonist , on prostatic function in isolated canine prostate and in anesthetized dogs .	T6	T23	10771044
CPR:6	CHEMICAL	GENE-N	4	7	In these tissues , chemical , chemical ( a non-selective gene antagonist ) , and chemical ( an gene antagonist ) competitively antagonized contraction in a concentration-dependent manner .	T10	T24	10771044
NA	CHEMICAL	GENE-Y	4	7	In these tissues , chemical , chemical ( a non-selective gene antagonist ) , and chemical ( an gene antagonist ) competitively antagonized contraction in a concentration-dependent manner .	T10	T25	10771044
CPR:6	CHEMICAL	GENE-N	6	7	In these tissues , chemical , chemical ( a non-selective gene antagonist ) , and chemical ( an gene antagonist ) competitively antagonized contraction in a concentration-dependent manner .	T11	T24	10771044
NA	CHEMICAL	GENE-Y	6	7	In these tissues , chemical , chemical ( a non-selective gene antagonist ) , and chemical ( an gene antagonist ) competitively antagonized contraction in a concentration-dependent manner .	T11	T25	10771044
NA	CHEMICAL	GENE-N	8	7	In these tissues , chemical , chemical ( a non-selective gene antagonist ) , and chemical ( an gene antagonist ) competitively antagonized contraction in a concentration-dependent manner .	T12	T24	10771044
CPR:6	CHEMICAL	GENE-Y	8	7	In these tissues , chemical , chemical ( a non-selective gene antagonist ) , and chemical ( an gene antagonist ) competitively antagonized contraction in a concentration-dependent manner .	T12	T25	10771044
NA	CHEMICAL	GENE-Y	3	4	Use of the chemical transporter as a reporter gene for non-invasive imaging of genetically modified cells .	T13	T25	14716684
NA	CHEMICAL	GENE-Y	3	4	BACKGROUND : The chemical transporter ( gene ) is a high-affinity transporter for chemical .	T3	T18	14716684
NA	CHEMICAL	GENE-Y	3	6	BACKGROUND : The chemical transporter ( gene ) is a high-affinity transporter for chemical .	T3	T22	14716684
NA	CHEMICAL	GENE-Y	9	4	BACKGROUND : The chemical transporter ( gene ) is a high-affinity transporter for chemical .	T9	T18	14716684
NA	CHEMICAL	GENE-Y	9	6	BACKGROUND : The chemical transporter ( gene ) is a high-affinity transporter for chemical .	T9	T22	14716684
CPR:4	CHEMICAL	GENE-Y	12	10	The specificity of tracer uptake was determined by adding the gene inhibitor chemical .	T7	T23	14716684
NA	CHEMICAL	GENE-Y	13	2	Parental and A431gene cells were xenotransplanted into nude mice and tumor uptake of chemical in vivo was determined after tracer administration .	T8	T24	14716684
CPR:9	CHEMICAL	GENE-Y	0	9	chemical uptake in PC12 cells , which express the gene endogenously , was 20- to 28-fold lower than in transduced cells .	T1	T14	14716684
CPR:9	CHEMICAL	GENE-Y	9	3	In vivo , A431gene tumors demonstrated a 33-fold higher chemical uptake than parental tumors .	T2	T15	14716684
NA	CHEMICAL	GENE-Y	17	7	CONCLUSIONS : Transduction of tumor cells with gene cDNA causes highly specific uptake and significant retention of chemical analogs in vitro and in vivo .	T4	T17	14716684
NA	CHEMICAL	GENE-N	13	13	The Expressed Sequence Tag database has been searched for examples of previously undescribed gene .	T1	T12	9480897
NA	CHEMICAL	GENE-Y	6	7	Crystal structures of E2 in the chemical receptor ( gene ) confirm the importance of the A ring in stabilizing E2 in the gene .	T9	T24	23313336
NA	CHEMICAL	GENE-Y	6	9	Crystal structures of E2 in the chemical receptor ( gene ) confirm the importance of the A ring in stabilizing E2 in the gene .	T9	T25	23313336
NA	CHEMICAL	GENE-Y	6	23	Crystal structures of E2 in the chemical receptor ( gene ) confirm the importance of the A ring in stabilizing E2 in the gene .	T9	T26	23313336
NA	CHEMICAL	GENE-Y	3	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T10	T27	23313336
NA	CHEMICAL	GENE-Y	3	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T10	T28	23313336
NA	CHEMICAL	GENE-Y	3	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T10	T29	23313336
NA	CHEMICAL	GENE-Y	6	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T11	T27	23313336
NA	CHEMICAL	GENE-Y	6	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T11	T28	23313336
NA	CHEMICAL	GENE-Y	6	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T11	T29	23313336
NA	CHEMICAL	GENE-Y	8	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T12	T27	23313336
NA	CHEMICAL	GENE-Y	8	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T12	T28	23313336
NA	CHEMICAL	GENE-Y	8	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T12	T29	23313336
NA	CHEMICAL	GENE-Y	10	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T13	T27	23313336
NA	CHEMICAL	GENE-Y	10	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T13	T28	23313336
NA	CHEMICAL	GENE-Y	10	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T13	T29	23313336
NA	CHEMICAL	GENE-Y	20	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T14	T27	23313336
NA	CHEMICAL	GENE-Y	20	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T14	T28	23313336
NA	CHEMICAL	GENE-Y	20	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T14	T29	23313336
NA	CHEMICAL	GENE-Y	24	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T15	T27	23313336
NA	CHEMICAL	GENE-Y	24	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T15	T28	23313336
NA	CHEMICAL	GENE-Y	24	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T15	T29	23313336
NA	CHEMICAL	GENE-Y	34	33	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T16	T27	23313336
NA	CHEMICAL	GENE-Y	34	37	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T16	T28	23313336
NA	CHEMICAL	GENE-Y	34	40	However , other chemical , including chemical , chemical and chemical , which have a saturated A ring containing a chemical and a C19 chemical group , also mediate physiological responses through binding to chemical receptor-α ( gene ) and gene .	T16	T29	23313336
NA	CHEMICAL	GENE-Y	3	16	Moreover , selective chemical response modulators ( SERMs ) with diverse structures also regulate transcription of gene and gene .	T17	T30	23313336
NA	CHEMICAL	GENE-Y	3	18	Moreover , selective chemical response modulators ( SERMs ) with diverse structures also regulate transcription of gene and gene .	T17	T31	23313336
NA	CHEMICAL	GENE-N	6	0	gene and female reproduction : when chemical meets fertility !	T11	T17	23211426
CPR:3	CHEMICAL	GENE-Y	8	0	gene and gene are nuclear receptors activated by chemical , oxidized derivatives of chemical .	T7	T13	23211426
CPR:3	CHEMICAL	GENE-Y	8	2	gene and gene are nuclear receptors activated by chemical , oxidized derivatives of chemical .	T7	T14	23211426
NA	CHEMICAL	GENE-Y	13	0	gene and gene are nuclear receptors activated by chemical , oxidized derivatives of chemical .	T8	T13	23211426
NA	CHEMICAL	GENE-Y	13	2	gene and gene are nuclear receptors activated by chemical , oxidized derivatives of chemical .	T8	T14	23211426
NA	CHEMICAL	GENE-N	12	7	Since their discovery , the role of gene in the control of chemical homeostasis has been widely described .	T9	T15	23211426
NA	CHEMICAL	GENE-N	8	8	This review will try to enlighten on the gene as a molecular link between dietary chemical and reproductive diseases in women .	T1	T16	23211426
NA	CHEMICAL	GENE-N	6	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T6	T25	23454297
NA	CHEMICAL	GENE-N	6	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T6	T26	23454297
NA	CHEMICAL	GENE-N	6	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T6	T19	23454297
NA	CHEMICAL	GENE-Y	6	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T6	T20	23454297
NA	CHEMICAL	GENE-Y	6	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T6	T21	23454297
NA	CHEMICAL	GENE-Y	6	25	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T6	T22	23454297
NA	CHEMICAL	GENE-N	14	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T15	T25	23454297
NA	CHEMICAL	GENE-N	14	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T15	T26	23454297
NA	CHEMICAL	GENE-N	14	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T15	T19	23454297
NA	CHEMICAL	GENE-Y	14	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T15	T20	23454297
NA	CHEMICAL	GENE-Y	14	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T15	T21	23454297
NA	CHEMICAL	GENE-Y	14	25	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T15	T22	23454297
NA	CHEMICAL	GENE-N	22	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T5	T25	23454297
NA	CHEMICAL	GENE-N	22	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T5	T26	23454297
NA	CHEMICAL	GENE-N	22	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T5	T19	23454297
NA	CHEMICAL	GENE-Y	22	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T5	T20	23454297
NA	CHEMICAL	GENE-Y	22	11	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T5	T21	23454297
NA	CHEMICAL	GENE-Y	22	25	This study evaluated the effects of chemical on ectonucleotidase activities such as gene ( chemical diphosphohydrolase ) , gene , gene and chemical deaminase ( gene ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .	T5	T22	23454297
CPR:3	CHEMICAL	GENE-N	6	4	In lymphocytes , the gene and gene activities were increased in all groups treated with chemical when compared to control ( P < 0.05 ) .	T1	T27	23454297
CPR:3	CHEMICAL	GENE-Y	6	6	In lymphocytes , the gene and gene activities were increased in all groups treated with chemical when compared to control ( P < 0.05 ) .	T1	T18	23454297
NA	CHEMICAL	GENE-N	0	12	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T20	T57	17427197
CPR:3	CHEMICAL	GENE-Y	0	14	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T20	T58	17427197
NA	CHEMICAL	GENE-Y	0	17	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T20	T59	17427197
NA	CHEMICAL	GENE-N	3	12	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T21	T57	17427197
NA	CHEMICAL	GENE-Y	3	14	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T21	T58	17427197
NA	CHEMICAL	GENE-Y	3	17	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T21	T59	17427197
NA	CHEMICAL	GENE-N	6	12	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T22	T57	17427197
NA	CHEMICAL	GENE-Y	6	14	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T22	T58	17427197
NA	CHEMICAL	GENE-Y	6	17	chemical stimulation of chemical transport and chemical synthesis results from activation of gene and gene requiring functional gene in human umbilical vein endothelium .	T22	T59	17427197
CPR:3	CHEMICAL	GENE-Y	2	4	Elevated extracellular chemical increases gene ( gene ) release from human umbilical vein endothelium ( HUVEC ) .	T6	T49	17427197
CPR:3	CHEMICAL	GENE-Y	2	6	Elevated extracellular chemical increases gene ( gene ) release from human umbilical vein endothelium ( HUVEC ) .	T6	T53	17427197
NA	CHEMICAL	GENE-Y	3	11	We studied whether chemical-stimulation of chemical transport and chemical synthesis involves gene in primary cultures of HUVEC .	T7	T47	17427197
NA	CHEMICAL	GENE-Y	5	11	We studied whether chemical-stimulation of chemical transport and chemical synthesis involves gene in primary cultures of HUVEC .	T8	T47	17427197
NA	CHEMICAL	GENE-Y	8	11	We studied whether chemical-stimulation of chemical transport and chemical synthesis involves gene in primary cultures of HUVEC .	T9	T47	17427197
CPR:3	CHEMICAL	GENE-Y	21	0	gene release was higher ( approximately 1.6-fold ) in 25 mM ( high ) compared with 5 mM ( normal ) chemical .	T10	T48	17427197
NA	CHEMICAL	GENE-Y	2	0	gene increases chemical transport ( half maximal effect approximately 1.6 ng/ml ) in normal chemical , but did not alter high chemical-increased chemical transport .	T11	T50	17427197
NA	CHEMICAL	GENE-Y	14	0	gene increases chemical transport ( half maximal effect approximately 1.6 ng/ml ) in normal chemical , but did not alter high chemical-increased chemical transport .	T12	T50	17427197
NA	CHEMICAL	GENE-Y	21	0	gene increases chemical transport ( half maximal effect approximately 1.6 ng/ml ) in normal chemical , but did not alter high chemical-increased chemical transport .	T13	T50	17427197
NA	CHEMICAL	GENE-Y	12	0	gene increases chemical transport ( half maximal effect approximately 1.6 ng/ml ) in normal chemical , but did not alter high chemical-increased chemical transport .	T14	T50	17427197
NA	CHEMICAL	GENE-Y	3	0	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T15	T51	17427197
CPR:3	CHEMICAL	GENE-Y	3	5	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T15	T52	17427197
NA	CHEMICAL	GENE-Y	3	34	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T15	T54	17427197
NA	CHEMICAL	GENE-Y	8	0	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T16	T51	17427197
NA	CHEMICAL	GENE-Y	8	5	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T16	T52	17427197
NA	CHEMICAL	GENE-Y	8	34	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T16	T54	17427197
NA	CHEMICAL	GENE-Y	8	45	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T16	T55	17427197
NA	CHEMICAL	GENE-Y	8	0	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T17	T51	17427197
NA	CHEMICAL	GENE-Y	8	5	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T17	T52	17427197
NA	CHEMICAL	GENE-Y	8	34	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T17	T54	17427197
NA	CHEMICAL	GENE-Y	8	45	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T17	T55	17427197
NA	CHEMICAL	GENE-Y	30	0	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T18	T51	17427197
NA	CHEMICAL	GENE-Y	30	5	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T18	T52	17427197
CPR:9	CHEMICAL	GENE-Y	30	34	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T18	T54	17427197
CPR:9	CHEMICAL	GENE-Y	30	45	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T18	T55	17427197
NA	CHEMICAL	GENE-Y	36	0	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T19	T51	17427197
NA	CHEMICAL	GENE-Y	36	5	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T19	T52	17427197
NA	CHEMICAL	GENE-Y	36	34	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T19	T54	17427197
NA	CHEMICAL	GENE-Y	36	45	gene and high chemical increased gene mRNA expression ( approximately 8-fold ) and maximal transport velocity ( V ( max ) ) , chemical formation from chemical ( index of chemical synthesis ) and gene ( echemicalS ) protein abundance , but did not alter gene phosphorylation .	T19	T55	17427197
NA	CHEMICAL	GENE-Y	3	0	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T1	T23	17427197
NA	CHEMICAL	GENE-N	3	5	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T1	T24	17427197
NA	CHEMICAL	GENE-N	3	7	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T1	T25	17427197
CPR:3	CHEMICAL	GENE-Y	3	10	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T1	T26	17427197
NA	CHEMICAL	GENE-N	3	19	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T1	T27	17427197
NA	CHEMICAL	GENE-Y	0	0	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T2	T23	17427197
NA	CHEMICAL	GENE-N	0	5	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T2	T24	17427197
NA	CHEMICAL	GENE-N	0	7	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T2	T25	17427197
CPR:4	CHEMICAL	GENE-Y	0	10	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T2	T26	17427197
NA	CHEMICAL	GENE-N	0	19	gene and high chemical increased gene ( gene ) and gene phosphorylation , an effect blocked by chemical ( gene inhibitor ) .	T2	T27	17427197
NA	CHEMICAL	GENE-Y	5	2	However , gene and high chemical were ineffective in cells expressing a truncated , negative dominant gene .	T3	T28	17427197
NA	CHEMICAL	GENE-Y	5	11	However , gene and high chemical were ineffective in cells expressing a truncated , negative dominant gene .	T3	T29	17427197
CPR:3	CHEMICAL	GENE-Y	1	6	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T4	T30	17427197
CPR:3	CHEMICAL	GENE-Y	1	9	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T4	T31	17427197
NA	CHEMICAL	GENE-Y	1	12	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T4	T32	17427197
NA	CHEMICAL	GENE-N	1	14	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T4	T33	17427197
NA	CHEMICAL	GENE-N	1	16	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T4	T34	17427197
CPR:3	CHEMICAL	GENE-Y	1	19	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T4	T35	17427197
NA	CHEMICAL	GENE-Y	3	6	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T5	T30	17427197
NA	CHEMICAL	GENE-Y	3	9	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T5	T31	17427197
NA	CHEMICAL	GENE-Y	3	12	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T5	T32	17427197
NA	CHEMICAL	GENE-N	3	14	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T5	T33	17427197
NA	CHEMICAL	GENE-N	3	16	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T5	T34	17427197
NA	CHEMICAL	GENE-Y	3	19	High chemical increases chemical transport and gene expression following gene activation by gene involving gene ( gene ) and gene in HUVEC .	T5	T35	17427197
NA	CHEMICAL	GENE-N	23	6	Purification and characterization of a novel gene ( gene ) from human plasma : it has three EGF , a kringle and a chemical protease domain , similar to hepatocyte growth factor activator .	T9	T36	8827452
NA	CHEMICAL	GENE-Y	23	8	Purification and characterization of a novel gene ( gene ) from human plasma : it has three EGF , a kringle and a chemical protease domain , similar to hepatocyte growth factor activator .	T9	T37	8827452
NA	CHEMICAL	GENE-N	23	4	Purification and characterization of a novel gene ( gene ) from human plasma : it has three EGF , a kringle and a chemical protease domain , similar to hepatocyte growth factor activator .	T9	T35	8827452
NA	CHEMICAL	GENE-Y	16	2	Thus , gene was a heterodimer composed of 50-kDa and 17-kDa subunits , bridged by a chemical linkage .	T5	T29	8827452
NA	CHEMICAL	GENE-Y	4	9	Both subunits had novel chemical sequences , indicating that gene was a novel hyaluronan-binding protein in human plasma .	T6	T30	8827452
NA	CHEMICAL	GENE-Y	1	11	The chemical sequence deduced from the chemical sequence of the cloned gene cDNA exhibited significant homology to that of gene ( gene ) .	T7	T32	8827452
NA	CHEMICAL	GENE-Y	1	16	The chemical sequence deduced from the chemical sequence of the cloned gene cDNA exhibited significant homology to that of gene ( gene ) .	T7	T33	8827452
NA	CHEMICAL	GENE-Y	1	21	The chemical sequence deduced from the chemical sequence of the cloned gene cDNA exhibited significant homology to that of gene ( gene ) .	T7	T34	8827452
NA	CHEMICAL	GENE-Y	6	11	The chemical sequence deduced from the chemical sequence of the cloned gene cDNA exhibited significant homology to that of gene ( gene ) .	T8	T32	8827452
NA	CHEMICAL	GENE-Y	6	16	The chemical sequence deduced from the chemical sequence of the cloned gene cDNA exhibited significant homology to that of gene ( gene ) .	T8	T33	8827452
NA	CHEMICAL	GENE-Y	6	21	The chemical sequence deduced from the chemical sequence of the cloned gene cDNA exhibited significant homology to that of gene ( gene ) .	T8	T34	8827452
NA	CHEMICAL	GENE-Y	7	7	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T11	17119350
NA	CHEMICAL	GENE-Y	7	9	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T12	17119350
NA	CHEMICAL	GENE-N	7	15	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T13	17119350
NA	CHEMICAL	GENE-N	7	17	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T14	17119350
NA	CHEMICAL	GENE-Y	7	36	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T16	17119350
NA	CHEMICAL	GENE-N	7	40	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T17	17119350
NA	CHEMICAL	GENE-Y	7	40	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T1	T18	17119350
CPR:3	CHEMICAL	GENE-Y	50	7	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T11	17119350
CPR:3	CHEMICAL	GENE-Y	50	9	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T12	17119350
CPR:3	CHEMICAL	GENE-N	50	15	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T13	17119350
CPR:3	CHEMICAL	GENE-N	50	17	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T14	17119350
NA	CHEMICAL	GENE-Y	50	36	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T16	17119350
CPR:3	CHEMICAL	GENE-N	50	40	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T17	17119350
CPR:3	CHEMICAL	GENE-Y	50	40	We have previously demonstrated that phosphorylation of gene ( gene ) at 194 chemical through gene ( gene ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M , and that gene phosphorylation downstream of gene/gene plays an important role in cell growth suppression by chemical .	T3	T18	17119350
NA	CHEMICAL	GENE-Y	13	8	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T19	17119350
NA	CHEMICAL	GENE-Y	13	10	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T20	17119350
NA	CHEMICAL	GENE-N	13	18	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T21	17119350
NA	CHEMICAL	GENE-Y	13	20	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T22	17119350
NA	CHEMICAL	GENE-Y	13	23	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T23	17119350
NA	CHEMICAL	GENE-N	13	23	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T24	17119350
NA	CHEMICAL	GENE-Y	13	25	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T25	17119350
NA	CHEMICAL	GENE-N	13	25	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T4	T26	17119350
NA	CHEMICAL	GENE-Y	15	8	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T19	17119350
NA	CHEMICAL	GENE-Y	15	10	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T20	17119350
NA	CHEMICAL	GENE-N	15	18	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T21	17119350
NA	CHEMICAL	GENE-Y	15	20	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T22	17119350
NA	CHEMICAL	GENE-Y	15	23	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T23	17119350
NA	CHEMICAL	GENE-N	15	23	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T24	17119350
NA	CHEMICAL	GENE-Y	15	25	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T25	17119350
NA	CHEMICAL	GENE-N	15	25	In this study , the clinicopathological association of gene ( gene ) with chemical , chemical , c-erbB-2 receptors , gene expressions and gene/gene ( gene/gene ) was analyzed immunohistochemically using 107 human breast cancer specimens .	T5	T26	17119350
NA	CHEMICAL	GENE-Y	0	2	chemical and a nonconventional gene agonist , chemical ( chemical ) , induced concentration-dependent relaxation of chemical ( 0.3 microM ) preconstricted spiral preparations .	T6	T20	14660028
CPR:5	CHEMICAL	GENE-Y	7	2	chemical and a nonconventional gene agonist , chemical ( chemical ) , induced concentration-dependent relaxation of chemical ( 0.3 microM ) preconstricted spiral preparations .	T7	T20	14660028
CPR:5	CHEMICAL	GENE-Y	8	2	chemical and a nonconventional gene agonist , chemical ( chemical ) , induced concentration-dependent relaxation of chemical ( 0.3 microM ) preconstricted spiral preparations .	T8	T20	14660028
NA	CHEMICAL	GENE-Y	8	2	chemical and a nonconventional gene agonist , chemical ( chemical ) , induced concentration-dependent relaxation of chemical ( 0.3 microM ) preconstricted spiral preparations .	T9	T20	14660028
CPR:6	CHEMICAL	GENE-Y	2	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T10	T22	14660028
NA	CHEMICAL	GENE-Y	2	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T10	T23	14660028
NA	CHEMICAL	GENE-N	2	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T10	T16	14660028
CPR:6	CHEMICAL	GENE-Y	7	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T11	T22	14660028
NA	CHEMICAL	GENE-Y	7	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T11	T23	14660028
NA	CHEMICAL	GENE-N	7	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T11	T16	14660028
NA	CHEMICAL	GENE-Y	15	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T12	T22	14660028
CPR:6	CHEMICAL	GENE-Y	15	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T12	T23	14660028
NA	CHEMICAL	GENE-N	15	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T12	T16	14660028
NA	CHEMICAL	GENE-Y	8	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T13	T22	14660028
CPR:6	CHEMICAL	GENE-Y	8	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T13	T23	14660028
NA	CHEMICAL	GENE-N	8	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T13	T16	14660028
NA	CHEMICAL	GENE-Y	2	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T14	T22	14660028
NA	CHEMICAL	GENE-Y	2	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T14	T23	14660028
NA	CHEMICAL	GENE-N	2	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T14	T16	14660028
NA	CHEMICAL	GENE-Y	6	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T15	T22	14660028
NA	CHEMICAL	GENE-Y	6	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T15	T23	14660028
NA	CHEMICAL	GENE-N	6	2	Pretreatment with a combination of chemical ( chemical , a selective gene antagonist ) and chemical ( chemical , a selective gene antagonist ) ( 0.1 microM for each ) produced a 14-fold rightward shift of the concentration-response curve for chemical ; however , the relaxation in response to chemical was unaffected by the blockade of gene .	T15	T16	14660028
NA	CHEMICAL	GENE-N	4	7	In the presence of chemical and chemical ( 0.1 microM for each ) , the concentration-response curves for chemical and chemical were shifted to the right by a nonselective gene antagonist , chemical ( 3 and 10 microM ) .	T1	T17	14660028
NA	CHEMICAL	GENE-N	6	7	In the presence of chemical and chemical ( 0.1 microM for each ) , the concentration-response curves for chemical and chemical were shifted to the right by a nonselective gene antagonist , chemical ( 3 and 10 microM ) .	T2	T17	14660028
NA	CHEMICAL	GENE-N	7	7	In the presence of chemical and chemical ( 0.1 microM for each ) , the concentration-response curves for chemical and chemical were shifted to the right by a nonselective gene antagonist , chemical ( 3 and 10 microM ) .	T3	T17	14660028
NA	CHEMICAL	GENE-N	7	7	In the presence of chemical and chemical ( 0.1 microM for each ) , the concentration-response curves for chemical and chemical were shifted to the right by a nonselective gene antagonist , chemical ( 3 and 10 microM ) .	T4	T17	14660028
NA	CHEMICAL	GENE-N	7	7	In the presence of chemical and chemical ( 0.1 microM for each ) , the concentration-response curves for chemical and chemical were shifted to the right by a nonselective gene antagonist , chemical ( 3 and 10 microM ) .	T5	T17	14660028
NA	CHEMICAL	GENE-N	5	8	Activation of the anti-cancer agent chemical by the gene enzyme system .	T17	T27	23379481
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical® ) is a new small molecule chemical protease inhibitor .	T2	T20	23379481
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical® ) is a new small molecule chemical protease inhibitor .	T3	T20	23379481
NA	CHEMICAL	GENE-N	9	5	chemical ( chemical® ) is a new small molecule chemical protease inhibitor .	T10	T20	23379481
NA	CHEMICAL	GENE-N	20	6	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T12	T21	23379481
NA	CHEMICAL	GENE-N	20	9	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T12	T22	23379481
NA	CHEMICAL	GENE-N	20	15	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T12	T23	23379481
NA	CHEMICAL	GENE-Y	20	8	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T12	T24	23379481
NA	CHEMICAL	GENE-N	20	24	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T12	T25	23379481
NA	CHEMICAL	GENE-N	18	6	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T14	T21	23379481
NA	CHEMICAL	GENE-N	18	9	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T14	T22	23379481
NA	CHEMICAL	GENE-N	18	15	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T14	T23	23379481
NA	CHEMICAL	GENE-Y	18	8	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T14	T24	23379481
NA	CHEMICAL	GENE-N	18	24	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T14	T25	23379481
NA	CHEMICAL	GENE-N	3	6	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T15	T21	23379481
NA	CHEMICAL	GENE-N	3	9	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T15	T22	23379481
NA	CHEMICAL	GENE-N	3	15	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T15	T23	23379481
NA	CHEMICAL	GENE-Y	3	8	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T15	T24	23379481
NA	CHEMICAL	GENE-N	3	24	The recently discovered chemical enzyme `` gene '' ( gene ) catalyses together with its gene gene and chemical cytochrome b ( 5 ) reductase the reduction of chemical-hydroxylated prodrugs .	T15	T25	23379481
NA	CHEMICAL	GENE-N	11	1	Proteins gene and gene were not found to be involved in chemical import .	T3	T22	23257178
NA	CHEMICAL	GENE-N	11	3	Proteins gene and gene were not found to be involved in chemical import .	T3	T23	23257178
CPR:6	CHEMICAL	GENE-Y	3	1	The gene antagonist chemical prevents stress-induced cognitive deficit associated with hippocampal dysfunction : Comparison with chemical and chemical .	T15	T19	23407783
NA	CHEMICAL	GENE-Y	15	1	The gene antagonist chemical prevents stress-induced cognitive deficit associated with hippocampal dysfunction : Comparison with chemical and chemical .	T13	T19	23407783
NA	CHEMICAL	GENE-Y	17	1	The gene antagonist chemical prevents stress-induced cognitive deficit associated with hippocampal dysfunction : Comparison with chemical and chemical .	T14	T19	23407783
CPR:6	CHEMICAL	GENE-Y	6	4	RATIONALE : The selective gene antagonist chemical has been previously shown to attenuate the long-term cognitive deficit produced by traumatic stress exposure .	T12	T17	23407783
NA	CHEMICAL	GENE-N	2	5	Effects of chemical were compared to those of the chemical reuptake inhibitor , chemical ( 10 mg/kg/day ) , and the partial chemical ( chemical ) receptor agonist , chemical ( 10 mg/kg/day ) , two compounds which have demonstrated clinical efficacy against PTSD .	T6	T18	23407783
NA	CHEMICAL	GENE-N	9	5	Effects of chemical were compared to those of the chemical reuptake inhibitor , chemical ( 10 mg/kg/day ) , and the partial chemical ( chemical ) receptor agonist , chemical ( 10 mg/kg/day ) , two compounds which have demonstrated clinical efficacy against PTSD .	T7	T18	23407783
NA	CHEMICAL	GENE-N	13	5	Effects of chemical were compared to those of the chemical reuptake inhibitor , chemical ( 10 mg/kg/day ) , and the partial chemical ( chemical ) receptor agonist , chemical ( 10 mg/kg/day ) , two compounds which have demonstrated clinical efficacy against PTSD .	T8	T18	23407783
NA	CHEMICAL	GENE-N	22	5	Effects of chemical were compared to those of the chemical reuptake inhibitor , chemical ( 10 mg/kg/day ) , and the partial chemical ( chemical ) receptor agonist , chemical ( 10 mg/kg/day ) , two compounds which have demonstrated clinical efficacy against PTSD .	T9	T18	23407783
NA	CHEMICAL	GENE-N	24	5	Effects of chemical were compared to those of the chemical reuptake inhibitor , chemical ( 10 mg/kg/day ) , and the partial chemical ( chemical ) receptor agonist , chemical ( 10 mg/kg/day ) , two compounds which have demonstrated clinical efficacy against PTSD .	T10	T18	23407783
CPR:5	CHEMICAL	GENE-N	29	5	Effects of chemical were compared to those of the chemical reuptake inhibitor , chemical ( 10 mg/kg/day ) , and the partial chemical ( chemical ) receptor agonist , chemical ( 10 mg/kg/day ) , two compounds which have demonstrated clinical efficacy against PTSD .	T11	T18	23407783
CPR:4	CHEMICAL	GENE-Y	2	11	Moreover , chemical could also down-regulate the expression and activity of gene ( gene ) .	T5	T8	23561205
CPR:4	CHEMICAL	GENE-Y	2	13	Moreover , chemical could also down-regulate the expression and activity of gene ( gene ) .	T5	T9	23561205
NA	CHEMICAL	GENE-N	7	6	We hypothesized that corticosteroid exposure modulates gene ( gene ) expression and/or activity in bovine mammary epithelial cells .	T7	T24	17251323
NA	CHEMICAL	GENE-N	7	8	We hypothesized that corticosteroid exposure modulates gene ( gene ) expression and/or activity in bovine mammary epithelial cells .	T7	T25	17251323
CPR:6	CHEMICAL	GENE-Y	1	1	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T1	T18	17251323
NA	CHEMICAL	GENE-N	1	1	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T1	T19	17251323
NA	CHEMICAL	GENE-N	1	4	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T1	T20	17251323
NA	CHEMICAL	GENE-Y	1	1	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T2	T18	17251323
CPR:6	CHEMICAL	GENE-N	1	1	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T2	T19	17251323
NA	CHEMICAL	GENE-N	1	4	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T2	T20	17251323
NA	CHEMICAL	GENE-Y	4	1	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T3	T18	17251323
NA	CHEMICAL	GENE-N	4	1	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T3	T19	17251323
NA	CHEMICAL	GENE-N	4	4	Exposure to chemical ( a gene antagonist ) , but not chemical ( a gene antagonist ) , precluded both the corticosteroid-induced elevation in chemical-sensitive I ( sc ) and the induced changes in gene mRNA .	T3	T20	17251323
NA	CHEMICAL	GENE-Y	3	14	We conclude that chemical movement across mammary epithelia is modulated by corticosteroids via a gene-mediated mechanism that regulates the expression of the gene .	T4	T21	17251323
NA	CHEMICAL	GENE-N	3	13	We conclude that chemical movement across mammary epithelia is modulated by corticosteroids via a gene-mediated mechanism that regulates the expression of the gene .	T4	T22	17251323
NA	CHEMICAL	GENE-Y	4	7	All tested compounds proved to be potent gene receptor and chemical transporter protein ( gene ) ligands .	T4	T6	23524160
NA	CHEMICAL	GENE-Y	4	12	All tested compounds proved to be potent gene receptor and chemical transporter protein ( gene ) ligands .	T4	T7	23524160
NA	CHEMICAL	GENE-Y	4	14	All tested compounds proved to be potent gene receptor and chemical transporter protein ( gene ) ligands .	T4	T8	23524160
NA	CHEMICAL	GENE-Y	4	6	Activity-dependent cleavage of brain chemical decarboxylase 65 by gene .	T10	T27	16879709
NA	CHEMICAL	GENE-N	4	8	Activity-dependent cleavage of brain chemical decarboxylase 65 by gene .	T10	T28	16879709
NA	CHEMICAL	GENE-Y	19	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T3	T19	16879709
NA	CHEMICAL	GENE-Y	19	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T3	T22	16879709
NA	CHEMICAL	GENE-Y	19	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T3	T18	16879709
NA	CHEMICAL	GENE-Y	19	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T1	T19	16879709
NA	CHEMICAL	GENE-Y	19	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T1	T22	16879709
NA	CHEMICAL	GENE-Y	19	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T1	T18	16879709
NA	CHEMICAL	GENE-Y	5	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T2	T19	16879709
NA	CHEMICAL	GENE-Y	5	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T2	T22	16879709
NA	CHEMICAL	GENE-Y	5	8	Previously , we reported that chemical decarboxylase isoform 65 ( gene ) could be cleaved in vitro to release a stable truncated form which lacks chemical 1-69 from the chemical-terminus , gene .	T2	T18	16879709
NA	CHEMICAL	GENE-Y	0	11	chemical-chelating reagents such as chemical and chemical prevented the cleavage of gene .	T5	T23	16879709
NA	CHEMICAL	GENE-Y	4	11	chemical-chelating reagents such as chemical and chemical prevented the cleavage of gene .	T6	T23	16879709
NA	CHEMICAL	GENE-Y	6	11	chemical-chelating reagents such as chemical and chemical prevented the cleavage of gene .	T7	T23	16879709
NA	CHEMICAL	GENE-N	9	7	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T8	T24	16879709
NA	CHEMICAL	GENE-N	9	9	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T8	T25	16879709
NA	CHEMICAL	GENE-Y	9	28	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T8	T26	16879709
NA	CHEMICAL	GENE-Y	9	31	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T8	T11	16879709
NA	CHEMICAL	GENE-N	11	7	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T9	T24	16879709
NA	CHEMICAL	GENE-N	11	9	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T9	T25	16879709
NA	CHEMICAL	GENE-Y	11	28	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T9	T26	16879709
NA	CHEMICAL	GENE-Y	11	31	In addition , our data suggested that gene , a chemical-dependent chemical protease , is activated upon neuronal stimulation and could be responsible for the conversion of full-length gene to truncated gene in the brain .	T9	T11	16879709
CPR:4	CHEMICAL	GENE-N	6	4	Kinetics of inhibition of gene by chemical , chemical derivatives , chemical and chemical .	T40	T52	10658902
CPR:4	CHEMICAL	GENE-N	8	4	Kinetics of inhibition of gene by chemical , chemical derivatives , chemical and chemical .	T41	T52	10658902
CPR:4	CHEMICAL	GENE-N	11	4	Kinetics of inhibition of gene by chemical , chemical derivatives , chemical and chemical .	T37	T52	10658902
CPR:4	CHEMICAL	GENE-N	13	4	Kinetics of inhibition of gene by chemical , chemical derivatives , chemical and chemical .	T38	T52	10658902
NA	CHEMICAL	GENE-Y	1	2	Mitochondrially-bound chemical dehydrogenase ( gene ) catalyzes the fourth sequential step in the de novo synthesis of chemical .	T18	T47	10658902
NA	CHEMICAL	GENE-Y	1	4	Mitochondrially-bound chemical dehydrogenase ( gene ) catalyzes the fourth sequential step in the de novo synthesis of chemical .	T18	T50	10658902
CPR:9	CHEMICAL	GENE-Y	17	2	Mitochondrially-bound chemical dehydrogenase ( gene ) catalyzes the fourth sequential step in the de novo synthesis of chemical .	T8	T47	10658902
CPR:9	CHEMICAL	GENE-Y	17	4	Mitochondrially-bound chemical dehydrogenase ( gene ) catalyzes the fourth sequential step in the de novo synthesis of chemical .	T8	T50	10658902
NA	CHEMICAL	GENE-Y	17	18	Despite this broad spectrum of biological and clinical relevance , there have been no comparative studies on drug-chemical dehydrogenase interactions .	T28	T49	10658902
NA	CHEMICAL	GENE-N	4	4	Here , we describe a study of the inhibition of the purified recombinant gene by ten compounds .	T29	T51	10658902
CPR:9	CHEMICAL	GENE-Y	4	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T4	T42	10658902
NA	CHEMICAL	GENE-Y	4	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T4	T43	10658902
NA	CHEMICAL	GENE-Y	8	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T5	T42	10658902
NA	CHEMICAL	GENE-Y	8	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T5	T43	10658902
NA	CHEMICAL	GENE-Y	2	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T6	T42	10658902
CPR:4	CHEMICAL	GENE-Y	2	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T6	T43	10658902
NA	CHEMICAL	GENE-Y	19	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T7	T42	10658902
CPR:4	CHEMICAL	GENE-Y	19	9	With respect to the chemical co-substrate of the chemical dehydrogenase , chemical ( Kic = 2.7 microM ) and chemical ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human gene .	T7	T43	10658902
CPR:4	CHEMICAL	GENE-N	0	5	chemical was found to be a time-dependent inhibitor of the rat enzyme , with the lowest inhibition constant ( Ki* = 0.77 nM ) determined so far for gene .	T11	T44	10658902
NA	CHEMICAL	GENE-N	5	5	chemical was found to be a time-dependent inhibitor of the rat enzyme , with the lowest inhibition constant ( Ki* = 0.77 nM ) determined so far for gene .	T12	T44	10658902
CPR:4	CHEMICAL	GENE-Y	3	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T13	T45	10658902
NA	CHEMICAL	GENE-N	3	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T13	T46	10658902
NA	CHEMICAL	GENE-Y	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T14	T45	10658902
NA	CHEMICAL	GENE-N	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T14	T46	10658902
NA	CHEMICAL	GENE-Y	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T15	T45	10658902
NA	CHEMICAL	GENE-N	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T15	T46	10658902
NA	CHEMICAL	GENE-Y	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T16	T45	10658902
CPR:4	CHEMICAL	GENE-N	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T16	T46	10658902
NA	CHEMICAL	GENE-Y	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T17	T45	10658902
CPR:4	CHEMICAL	GENE-N	9	9	Another inhibitor , chemical was previously reported to be a slow-binding inhibitor of the gene [ W. Knecht , M. Loffler , Species-related inhibition of gene by immunosuppressive chemical and chemical derivatives , Biochem .	T17	T46	10658902
CPR:4	CHEMICAL	GENE-Y	5	13	With respect to the substrate chemical , chemical was an uncompetitive inhibitor of gene ( Kiu = 11.6 microM ) and a non-competitive inhibitor of the rat enzyme ( Kiu = 905/ Kic = 1,012 nM ) .	T19	T48	10658902
CPR:4	CHEMICAL	GENE-Y	2	13	With respect to the substrate chemical , chemical was an uncompetitive inhibitor of gene ( Kiu = 11.6 microM ) and a non-competitive inhibitor of the rat enzyme ( Kiu = 905/ Kic = 1,012 nM ) .	T20	T48	10658902
NA	CHEMICAL	GENE-Y	21	13	With respect to the substrate chemical , chemical was an uncompetitive inhibitor of gene ( Kiu = 11.6 microM ) and a non-competitive inhibitor of the rat enzyme ( Kiu = 905/ Kic = 1,012 nM ) .	T21	T48	10658902
NA	CHEMICAL	GENE-N	1	3	Compared to control gene , ABLP gene showed a 40 % decrease of chemical and an 11-fold increased chemical concentration .	T1	T4	23507868
NA	CHEMICAL	GENE-N	1	6	Compared to control gene , ABLP gene showed a 40 % decrease of chemical and an 11-fold increased chemical concentration .	T1	T5	23507868
NA	CHEMICAL	GENE-N	8	3	Compared to control gene , ABLP gene showed a 40 % decrease of chemical and an 11-fold increased chemical concentration .	T2	T4	23507868
NA	CHEMICAL	GENE-N	8	6	Compared to control gene , ABLP gene showed a 40 % decrease of chemical and an 11-fold increased chemical concentration .	T2	T5	23507868
NA	CHEMICAL	GENE-N	3	8	We have isolated a new member of the gene family from a fetal brain cDNA library .	T15	T37	8589992
NA	CHEMICAL	GENE-Y	11	5	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T12	T32	8589992
NA	CHEMICAL	GENE-Y	11	17	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T12	T33	8589992
NA	CHEMICAL	GENE-Y	11	24	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T12	T34	8589992
NA	CHEMICAL	GENE-Y	8	5	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T13	T32	8589992
NA	CHEMICAL	GENE-Y	8	17	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T13	T33	8589992
NA	CHEMICAL	GENE-Y	8	24	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T13	T34	8589992
NA	CHEMICAL	GENE-Y	8	5	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T14	T32	8589992
NA	CHEMICAL	GENE-Y	8	17	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T14	T33	8589992
NA	CHEMICAL	GENE-Y	8	24	This cDNA clone , designated gene , shares a 90 % chemical identity with the previously reported gene cDNA splice variant and differed from gene in the chemical and chemical terminal regions .	T14	T34	8589992
NA	CHEMICAL	GENE-Y	11	4	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T16	T35	8589992
NA	CHEMICAL	GENE-N	11	8	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T16	T36	8589992
NA	CHEMICAL	GENE-Y	21	4	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T17	T35	8589992
NA	CHEMICAL	GENE-N	21	8	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T17	T36	8589992
NA	CHEMICAL	GENE-Y	23	4	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T18	T35	8589992
NA	CHEMICAL	GENE-N	23	8	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T18	T36	8589992
NA	CHEMICAL	GENE-Y	25	4	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T19	T35	8589992
NA	CHEMICAL	GENE-N	25	8	Cell lines stably expressing gene protein formed homomeric gene responsive , in order of decreasing affinity to domoate , chemical , chemical and chemical ( chemical ) .	T19	T36	8589992
NA	CHEMICAL	GENE-N	0	11	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T20	T38	8589992
NA	CHEMICAL	GENE-N	0	8	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T20	T39	8589992
NA	CHEMICAL	GENE-N	0	27	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T20	T40	8589992
NA	CHEMICAL	GENE-N	17	11	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T21	T38	8589992
NA	CHEMICAL	GENE-N	17	8	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T21	T39	8589992
NA	CHEMICAL	GENE-N	17	27	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T21	T40	8589992
NA	CHEMICAL	GENE-N	8	11	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T22	T38	8589992
NA	CHEMICAL	GENE-N	8	8	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T22	T39	8589992
NA	CHEMICAL	GENE-N	8	27	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T22	T40	8589992
NA	CHEMICAL	GENE-N	25	11	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T23	T38	8589992
NA	CHEMICAL	GENE-N	25	8	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T23	T39	8589992
NA	CHEMICAL	GENE-N	25	27	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T23	T40	8589992
NA	CHEMICAL	GENE-N	29	11	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T24	T38	8589992
NA	CHEMICAL	GENE-N	29	8	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T24	T39	8589992
CPR:6	CHEMICAL	GENE-N	29	27	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T24	T40	8589992
NA	CHEMICAL	GENE-N	8	11	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T25	T38	8589992
NA	CHEMICAL	GENE-N	8	8	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T25	T39	8589992
CPR:6	CHEMICAL	GENE-N	8	27	chemical-evoked currents showed partial desensitization that was reduced on incubation with gene ( gene ) but not chemical and were attenuated by the chemical ( chemical ) receptor antagonist chemical ( chemical ) .	T25	T40	8589992
NA	CHEMICAL	GENE-Y	0	14	chemical and chemical activated the heteromeric channel with significantly higher affinities than observed for gene alone .	T26	T29	8589992
NA	CHEMICAL	GENE-Y	2	14	chemical and chemical activated the heteromeric channel with significantly higher affinities than observed for gene alone .	T27	T29	8589992
NA	CHEMICAL	GENE-Y	9	6	Ligand binding studies with the recombinant gene receptor expressed in mammalian cells indicated a high affinity chemical binding site ( Kd = 120 +/- 15.0 nM ) .	T1	T30	8589992
NA	CHEMICAL	GENE-Y	0	5	High-chemical-type glycan modifications of chemical reductase using glycan-chemical conjugates .	T8	T17	16647263
NA	CHEMICAL	GENE-Y	3	5	High-chemical-type glycan modifications of chemical reductase using glycan-chemical conjugates .	T7	T17	16647263
NA	CHEMICAL	GENE-Y	7	5	High-chemical-type glycan modifications of chemical reductase using glycan-chemical conjugates .	T9	T17	16647263
NA	CHEMICAL	GENE-Y	1	6	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T1	T15	16647263
NA	CHEMICAL	GENE-Y	1	8	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T1	T16	16647263
NA	CHEMICAL	GENE-Y	1	28	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T1	T10	16647263
NA	CHEMICAL	GENE-Y	4	6	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T5	T15	16647263
NA	CHEMICAL	GENE-Y	4	8	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T5	T16	16647263
NA	CHEMICAL	GENE-Y	4	28	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T5	T10	16647263
NA	CHEMICAL	GENE-Y	16	6	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T2	T15	16647263
NA	CHEMICAL	GENE-Y	16	8	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T2	T16	16647263
NA	CHEMICAL	GENE-Y	16	28	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T2	T10	16647263
NA	CHEMICAL	GENE-Y	18	6	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T3	T15	16647263
NA	CHEMICAL	GENE-Y	18	8	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T3	T16	16647263
NA	CHEMICAL	GENE-Y	18	28	Various high-chemical-type glycan modifications of chemical reductase ( gene ) were achieved by ligand-based approach using glycan-chemical ( chemical ) conjugates as tight binding glycan bearing ligands for gene .	T3	T10	16647263
NA	CHEMICAL	GENE-N	2	21	The resulting glycan-chemical conjugates and the corresponding artificial glycoproteins could be useful as oligosaccharide- and glycoprotein-probes to perform quantitative analysis of gene such as gene , gene or gene .	T4	T11	16647263
NA	CHEMICAL	GENE-N	2	24	The resulting glycan-chemical conjugates and the corresponding artificial glycoproteins could be useful as oligosaccharide- and glycoprotein-probes to perform quantitative analysis of gene such as gene , gene or gene .	T4	T12	16647263
NA	CHEMICAL	GENE-N	2	12	The resulting glycan-chemical conjugates and the corresponding artificial glycoproteins could be useful as oligosaccharide- and glycoprotein-probes to perform quantitative analysis of gene such as gene , gene or gene .	T4	T13	16647263
NA	CHEMICAL	GENE-N	2	12	The resulting glycan-chemical conjugates and the corresponding artificial glycoproteins could be useful as oligosaccharide- and glycoprotein-probes to perform quantitative analysis of gene such as gene , gene or gene .	T4	T14	16647263
NA	CHEMICAL	GENE-Y	6	7	Statins are inhibitors of the enzyme chemical reductase , the rate-limiting step in chemical biosynthesis .	T23	T35	23428346
CPR:9	CHEMICAL	GENE-Y	13	7	Statins are inhibitors of the enzyme chemical reductase , the rate-limiting step in chemical biosynthesis .	T4	T35	23428346
NA	CHEMICAL	GENE-Y	3	10	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T5	T26	23428346
NA	CHEMICAL	GENE-N	3	16	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T5	T27	23428346
NA	CHEMICAL	GENE-Y	8	10	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T6	T26	23428346
NA	CHEMICAL	GENE-N	8	16	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T6	T27	23428346
NA	CHEMICAL	GENE-Y	15	10	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T8	T26	23428346
NA	CHEMICAL	GENE-N	15	16	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T8	T27	23428346
NA	CHEMICAL	GENE-Y	25	10	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T9	T26	23428346
CPR:3	CHEMICAL	GENE-N	25	16	We found that chemical withdrawal decreased levels of chemical and gene activity , whereas increased chemical oxidase activity and immunoreactivity for the protein nitration marker chemical in the cerebral cortex .	T9	T27	23428346
NA	CHEMICAL	GENE-Y	2	0	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T10	T28	23428346
NA	CHEMICAL	GENE-N	2	16	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T10	T29	23428346
NA	CHEMICAL	GENE-Y	2	5	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T10	T30	23428346
NA	CHEMICAL	GENE-Y	2	0	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T11	T28	23428346
NA	CHEMICAL	GENE-N	2	16	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T11	T29	23428346
NA	CHEMICAL	GENE-Y	2	5	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T11	T30	23428346
NA	CHEMICAL	GENE-Y	4	0	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T12	T28	23428346
NA	CHEMICAL	GENE-N	4	16	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T12	T29	23428346
NA	CHEMICAL	GENE-Y	4	5	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T12	T30	23428346
NA	CHEMICAL	GENE-Y	11	0	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T13	T28	23428346
NA	CHEMICAL	GENE-N	11	16	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T13	T29	23428346
NA	CHEMICAL	GENE-Y	11	5	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T13	T30	23428346
NA	CHEMICAL	GENE-Y	20	0	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T14	T28	23428346
NA	CHEMICAL	GENE-N	20	16	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T14	T29	23428346
NA	CHEMICAL	GENE-Y	20	5	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T14	T30	23428346
NA	CHEMICAL	GENE-Y	22	0	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T15	T28	23428346
NA	CHEMICAL	GENE-N	22	16	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T15	T29	23428346
NA	CHEMICAL	GENE-Y	22	5	gene , chemical-chemical-transferase and chemical oxidase activities were not altered by chemical treatment or withdrawal , as well as protein chemical and chemical immunoreactivity .	T15	T30	23428346
NA	CHEMICAL	GENE-Y	7	2	Immunoprecipitation of gene followed by analysis of chemical revealed increased levels of nitrated gene , suggesting the mechanism underlying the chemical withdrawal-induced decrease in enzyme activity .	T16	T31	23428346
NA	CHEMICAL	GENE-Y	7	13	Immunoprecipitation of gene followed by analysis of chemical revealed increased levels of nitrated gene , suggesting the mechanism underlying the chemical withdrawal-induced decrease in enzyme activity .	T16	T32	23428346
NA	CHEMICAL	GENE-Y	20	2	Immunoprecipitation of gene followed by analysis of chemical revealed increased levels of nitrated gene , suggesting the mechanism underlying the chemical withdrawal-induced decrease in enzyme activity .	T17	T31	23428346
NA	CHEMICAL	GENE-Y	20	13	Immunoprecipitation of gene followed by analysis of chemical revealed increased levels of nitrated gene , suggesting the mechanism underlying the chemical withdrawal-induced decrease in enzyme activity .	T17	T32	23428346
CPR:3	CHEMICAL	GENE-Y	79	17	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T3	T19	23404443
NA	CHEMICAL	GENE-Y	79	86	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T3	T21	23404443
NA	CHEMICAL	GENE-Y	79	91	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T3	T22	23404443
CPR:3	CHEMICAL	GENE-Y	81	17	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T4	T19	23404443
NA	CHEMICAL	GENE-Y	81	86	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T4	T21	23404443
NA	CHEMICAL	GENE-Y	81	91	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T4	T22	23404443
CPR:3	CHEMICAL	GENE-Y	84	17	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T5	T19	23404443
NA	CHEMICAL	GENE-Y	84	86	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T5	T21	23404443
NA	CHEMICAL	GENE-Y	84	91	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T5	T22	23404443
CPR:3	CHEMICAL	GENE-Y	89	17	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T6	T19	23404443
NA	CHEMICAL	GENE-Y	89	86	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T6	T21	23404443
NA	CHEMICAL	GENE-Y	89	91	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T6	T22	23404443
CPR:3	CHEMICAL	GENE-Y	17	17	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T7	T19	23404443
NA	CHEMICAL	GENE-Y	17	17	Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart-rate variability [ HRV ] caused by peak-valley respiratory sinus arrhythmia [ pvRSA ] , and high-frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of gene ( achieved by administering gene plus chemical , chemical only , chemical and gene , and chemical and gene combined with chemical ) .	T7	T20	23404443
NA	CHEMICAL	GENE-Y	48	41	gene levels were negatively correlated with variables of vagal control , reaching significance for rMSSD and log ( 10 ) HF , but not for pvRSA , during the last four phases of the hyperglycaemic clamp ( hyperglycaemic second phase , gene first and second phases , and chemical ) .	T1	T9	23404443
NA	CHEMICAL	GENE-Y	8	6	Administration of the beta cell secretagogues gene and chemical led to a significant increase in HR , but this was not paired with a significant reduction in HRV measures .	T2	T12	23404443
NA	CHEMICAL	GENE-Y	13	13	AIM : To investigate the remodeling of mesenteric artery and the expression of gene , gene in mesenteric artery and effects of chemical and chemical on the remodeling in spontaneously hypertensive rats ( SHR ) .	T4	T40	15133856
NA	CHEMICAL	GENE-Y	13	15	AIM : To investigate the remodeling of mesenteric artery and the expression of gene , gene in mesenteric artery and effects of chemical and chemical on the remodeling in spontaneously hypertensive rats ( SHR ) .	T4	T43	15133856
NA	CHEMICAL	GENE-Y	24	13	AIM : To investigate the remodeling of mesenteric artery and the expression of gene , gene in mesenteric artery and effects of chemical and chemical on the remodeling in spontaneously hypertensive rats ( SHR ) .	T7	T40	15133856
NA	CHEMICAL	GENE-Y	24	15	AIM : To investigate the remodeling of mesenteric artery and the expression of gene , gene in mesenteric artery and effects of chemical and chemical on the remodeling in spontaneously hypertensive rats ( SHR ) .	T7	T43	15133856
NA	CHEMICAL	GENE-Y	2	0	gene ( chemical ) level in plasma and mesenteric arteries was measured by radioimmunoassay .	T26	T41	15133856
CPR:3	CHEMICAL	GENE-Y	29	3	The ratio of gene absorbed light value to gene absorbed light value in the SHR group was 0.887+/-0.019 , which was significantly higher than that in WKY group , chemical group , and chemical group with the ratios of 0.780+/-0.018 , 0.803+/-0.005 , and 0.847+/-0.017 , respectively ( P < 0.01 ) .	T8	T33	15133856
CPR:3	CHEMICAL	GENE-Y	29	8	The ratio of gene absorbed light value to gene absorbed light value in the SHR group was 0.887+/-0.019 , which was significantly higher than that in WKY group , chemical group , and chemical group with the ratios of 0.780+/-0.018 , 0.803+/-0.005 , and 0.847+/-0.017 , respectively ( P < 0.01 ) .	T8	T34	15133856
CPR:3	CHEMICAL	GENE-Y	33	3	The ratio of gene absorbed light value to gene absorbed light value in the SHR group was 0.887+/-0.019 , which was significantly higher than that in WKY group , chemical group , and chemical group with the ratios of 0.780+/-0.018 , 0.803+/-0.005 , and 0.847+/-0.017 , respectively ( P < 0.01 ) .	T9	T33	15133856
CPR:3	CHEMICAL	GENE-Y	33	8	The ratio of gene absorbed light value to gene absorbed light value in the SHR group was 0.887+/-0.019 , which was significantly higher than that in WKY group , chemical group , and chemical group with the ratios of 0.780+/-0.018 , 0.803+/-0.005 , and 0.847+/-0.017 , respectively ( P < 0.01 ) .	T9	T34	15133856
CPR:3	CHEMICAL	GENE-Y	28	1	The gene absorbed light value/gene absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015 , which was significantly higher than that in the WKY , chemical , and chemical groups ( 0.582+/-0.013 , 0.743+/-0.012 , and 0.789+/-0.013 , respectively , P < 0.01 ) , and was significantly lower in chemical group than in chemical group ( P < 0.05 ) .	T13	T36	15133856
CPR:3	CHEMICAL	GENE-Y	28	4	The gene absorbed light value/gene absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015 , which was significantly higher than that in the WKY , chemical , and chemical groups ( 0.582+/-0.013 , 0.743+/-0.012 , and 0.789+/-0.013 , respectively , P < 0.01 ) , and was significantly lower in chemical group than in chemical group ( P < 0.05 ) .	T13	T37	15133856
CPR:3	CHEMICAL	GENE-Y	31	1	The gene absorbed light value/gene absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015 , which was significantly higher than that in the WKY , chemical , and chemical groups ( 0.582+/-0.013 , 0.743+/-0.012 , and 0.789+/-0.013 , respectively , P < 0.01 ) , and was significantly lower in chemical group than in chemical group ( P < 0.05 ) .	T14	T36	15133856
CPR:3	CHEMICAL	GENE-Y	31	4	The gene absorbed light value/gene absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015 , which was significantly higher than that in the WKY , chemical , and chemical groups ( 0.582+/-0.013 , 0.743+/-0.012 , and 0.789+/-0.013 , respectively , P < 0.01 ) , and was significantly lower in chemical group than in chemical group ( P < 0.05 ) .	T14	T37	15133856
CPR:4	CHEMICAL	GENE-Y	2	21	CONCLUSION : chemical and chemical can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of gene , gene in SHR .	T17	T38	15133856
CPR:4	CHEMICAL	GENE-Y	2	23	CONCLUSION : chemical and chemical can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of gene , gene in SHR .	T17	T39	15133856
CPR:4	CHEMICAL	GENE-Y	4	21	CONCLUSION : chemical and chemical can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of gene , gene in SHR .	T18	T38	15133856
CPR:4	CHEMICAL	GENE-Y	4	23	CONCLUSION : chemical and chemical can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of gene , gene in SHR .	T18	T39	15133856
NA	CHEMICAL	GENE-Y	8	3	Targeted disruption of gene protects against aging , chemical-nitrosation , and gene resistance in muscle of male mice .	T9	T24	22991447
NA	CHEMICAL	GENE-N	8	11	Targeted disruption of gene protects against aging , chemical-nitrosation , and gene resistance in muscle of male mice .	T9	T25	22991447
NA	CHEMICAL	GENE-Y	7	7	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T1	T10	22991447
NA	CHEMICAL	GENE-Y	7	9	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T1	T11	22991447
NA	CHEMICAL	GENE-N	7	11	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T1	T12	22991447
NA	CHEMICAL	GENE-N	7	11	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T1	T13	22991447
NA	CHEMICAL	GENE-Y	13	7	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T2	T10	22991447
NA	CHEMICAL	GENE-Y	13	9	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T2	T11	22991447
NA	CHEMICAL	GENE-N	13	11	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T2	T12	22991447
NA	CHEMICAL	GENE-N	13	11	Here , we explored the role of gene ( gene ) in the chemical-nitrosation of proteins involved in the early steps of the gene-signaling pathway and gene resistance in the skeletal muscle of aged mice .	T2	T13	22991447
NA	CHEMICAL	GENE-Y	5	2	Aging increased gene expression and chemical-nitrosation of major proteins involved in gene signaling , thereby reducing gene sensitivity in skeletal muscle .	T3	T14	22991447
NA	CHEMICAL	GENE-N	5	10	Aging increased gene expression and chemical-nitrosation of major proteins involved in gene signaling , thereby reducing gene sensitivity in skeletal muscle .	T3	T15	22991447
NA	CHEMICAL	GENE-N	5	10	Aging increased gene expression and chemical-nitrosation of major proteins involved in gene signaling , thereby reducing gene sensitivity in skeletal muscle .	T3	T16	22991447
NA	CHEMICAL	GENE-Y	8	3	Conversely , aged gene-null mice were protected from chemical-nitrosation-induced gene resistance .	T5	T17	22991447
NA	CHEMICAL	GENE-N	8	9	Conversely , aged gene-null mice were protected from chemical-nitrosation-induced gene resistance .	T5	T18	22991447
NA	CHEMICAL	GENE-Y	13	6	Moreover , pharmacological treatment with an gene inhibitor and acute exercise reduced gene-induced chemical-nitrosation and increased gene sensitivity in the muscle of aged animals .	T6	T19	22991447
NA	CHEMICAL	GENE-Y	13	12	Moreover , pharmacological treatment with an gene inhibitor and acute exercise reduced gene-induced chemical-nitrosation and increased gene sensitivity in the muscle of aged animals .	T6	T20	22991447
NA	CHEMICAL	GENE-N	13	16	Moreover , pharmacological treatment with an gene inhibitor and acute exercise reduced gene-induced chemical-nitrosation and increased gene sensitivity in the muscle of aged animals .	T6	T21	22991447
NA	CHEMICAL	GENE-Y	13	8	Design , synthesis and structure-activity relationship of new gene analogues containing chemical derivatives in position 2 .	T15	T20	23205571
NA	CHEMICAL	GENE-Y	11	8	Design , synthesis and structure-activity relationship of new gene analogues containing chemical derivatives in position 2 .	T14	T20	23205571
NA	CHEMICAL	GENE-Y	17	17	In this study , we present the synthesis and pharmacological properties of new analogues of gene modified in the chemical-terminal part of the molecule with chemical derivatives : chemical ( chemical ) and chemical .	T12	T18	23205571
NA	CHEMICAL	GENE-Y	15	17	In this study , we present the synthesis and pharmacological properties of new analogues of gene modified in the chemical-terminal part of the molecule with chemical derivatives : chemical ( chemical ) and chemical .	T1	T18	23205571
NA	CHEMICAL	GENE-Y	17	17	In this study , we present the synthesis and pharmacological properties of new analogues of gene modified in the chemical-terminal part of the molecule with chemical derivatives : chemical ( chemical ) and chemical .	T2	T18	23205571
NA	CHEMICAL	GENE-Y	28	17	In this study , we present the synthesis and pharmacological properties of new analogues of gene modified in the chemical-terminal part of the molecule with chemical derivatives : chemical ( chemical ) and chemical .	T3	T18	23205571
NA	CHEMICAL	GENE-Y	30	17	In this study , we present the synthesis and pharmacological properties of new analogues of gene modified in the chemical-terminal part of the molecule with chemical derivatives : chemical ( chemical ) and chemical .	T4	T18	23205571
NA	CHEMICAL	GENE-Y	33	17	In this study , we present the synthesis and pharmacological properties of new analogues of gene modified in the chemical-terminal part of the molecule with chemical derivatives : chemical ( chemical ) and chemical .	T5	T18	23205571
NA	CHEMICAL	GENE-Y	6	6	We also determined their binding affinity to the gene .	T6	T16	23205571
CPR:6	CHEMICAL	GENE-Y	8	28	On the other hand , peptides modified with chemical , apart from their moderate antioxytocic activity , turned out to be weak antagonists of the pressor response to gene .	T10	T17	23205571
CPR:4	CHEMICAL	GENE-Y	0	2	chemical Derivatives as Novel chemical Oxidase Inhibitors .	T13	T20	23566269
NA	CHEMICAL	GENE-Y	4	2	chemical Derivatives as Novel chemical Oxidase Inhibitors .	T14	T20	23566269
NA	CHEMICAL	GENE-Y	0	1	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T1	T15	23566269
NA	CHEMICAL	GENE-Y	0	3	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T1	T18	23566269
NA	CHEMICAL	GENE-N	0	18	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T1	T16	23566269
CPR:9	CHEMICAL	GENE-Y	9	1	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T8	T15	23566269
CPR:9	CHEMICAL	GENE-Y	9	3	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T8	T18	23566269
NA	CHEMICAL	GENE-N	9	18	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T8	T16	23566269
CPR:9	CHEMICAL	GENE-Y	11	1	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T11	T15	23566269
CPR:9	CHEMICAL	GENE-Y	11	3	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T11	T18	23566269
CPR:5	CHEMICAL	GENE-N	11	18	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T11	T16	23566269
NA	CHEMICAL	GENE-Y	13	1	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T4	T15	23566269
NA	CHEMICAL	GENE-Y	13	3	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T4	T18	23566269
NA	CHEMICAL	GENE-N	13	18	chemical oxidase ( gene ) catalyzes the oxidation of chemical including chemical , a coagonist of the chemical receptor .	T4	T16	23566269
CPR:4	CHEMICAL	GENE-Y	2	9	We identified a series of chemical derivatives as novel gene inhibitors with high potency and substantial cell permeability using fragment-based drug design .	T6	T17	23566269
CPR:4	CHEMICAL	GENE-Y	0	12	chemical exhibited the predicted binding mode and demonstrated high inhibitory activity for gene in enzyme- and cell-based assays .	T10	T19	23566269
NA	CHEMICAL	GENE-Y	0	7	chemical Reveals a chemical-Dependent Desensitization Mechanism of gene .	T19	T38	23478802
NA	CHEMICAL	GENE-Y	3	7	chemical Reveals a chemical-Dependent Desensitization Mechanism of gene .	T20	T38	23478802
NA	CHEMICAL	GENE-Y	12	7	Electrophilic chemicals activate both insect and vertebrate gene via covalent modification of chemical residues in the chemical-terminal region .	T11	T25	23478802
NA	CHEMICAL	GENE-Y	14	7	Electrophilic chemicals activate both insect and vertebrate gene via covalent modification of chemical residues in the chemical-terminal region .	T12	T25	23478802
CPR:5	CHEMICAL	GENE-Y	12	15	Although naturally occurring electrophilic plant compounds , such as mustard oil and chemical , are gene agonists , it is unknown whether arthropod-produced electrophiles activate gene .	T13	T26	23478802
NA	CHEMICAL	GENE-Y	12	25	Although naturally occurring electrophilic plant compounds , such as mustard oil and chemical , are gene agonists , it is unknown whether arthropod-produced electrophiles activate gene .	T13	T29	23478802
NA	CHEMICAL	GENE-Y	10	16	We characterized the effects of the electrophilic arthropod defensive compound chemical ( chemical ) on the gene channel .	T14	T30	23478802
NA	CHEMICAL	GENE-Y	12	16	We characterized the effects of the electrophilic arthropod defensive compound chemical ( chemical ) on the gene channel .	T15	T30	23478802
NA	CHEMICAL	GENE-Y	18	13	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T16	T32	23478802
NA	CHEMICAL	GENE-Y	18	15	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T16	T33	23478802
NA	CHEMICAL	GENE-N	18	25	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T16	T34	23478802
NA	CHEMICAL	GENE-N	18	27	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T16	T35	23478802
NA	CHEMICAL	GENE-N	18	29	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T16	T36	23478802
NA	CHEMICAL	GENE-Y	19	13	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T17	T32	23478802
NA	CHEMICAL	GENE-Y	19	15	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T17	T33	23478802
NA	CHEMICAL	GENE-N	19	25	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T17	T34	23478802
NA	CHEMICAL	GENE-N	19	27	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T17	T35	23478802
NA	CHEMICAL	GENE-N	19	29	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type gene or gene with three chemical-substituted chemical crucial for electrophile activation ( gene , gene , gene ) .	T17	T36	23478802
CPR:3	CHEMICAL	GENE-Y	3	5	We found that chemical activates gene starting at 10 nM and peaking at 300 nM ; higher concentrations caused rapid activation followed by a fast decline .	T18	T37	23478802
NA	CHEMICAL	GENE-Y	7	14	The current reduction we found at higher chemical concentrations was a cysteine-dependent desensitization of gene , and did not require prior activation .	T3	T21	23478802
NA	CHEMICAL	GENE-Y	3	7	Interestingly , following chemical desensitization , wild-type gene had dramatically reduced response to the nonelectrophile agonist chemical , whereas the triple chemical mutant gene retained its full response .	T7	T22	23478802
NA	CHEMICAL	GENE-Y	3	23	Interestingly , following chemical desensitization , wild-type gene had dramatically reduced response to the nonelectrophile agonist chemical , whereas the triple chemical mutant gene retained its full response .	T7	T23	23478802
CPR:5	CHEMICAL	GENE-Y	16	7	Interestingly , following chemical desensitization , wild-type gene had dramatically reduced response to the nonelectrophile agonist chemical , whereas the triple chemical mutant gene retained its full response .	T8	T22	23478802
CPR:5	CHEMICAL	GENE-Y	16	23	Interestingly , following chemical desensitization , wild-type gene had dramatically reduced response to the nonelectrophile agonist chemical , whereas the triple chemical mutant gene retained its full response .	T8	T23	23478802
NA	CHEMICAL	GENE-Y	21	7	Interestingly , following chemical desensitization , wild-type gene had dramatically reduced response to the nonelectrophile agonist chemical , whereas the triple chemical mutant gene retained its full response .	T9	T22	23478802
NA	CHEMICAL	GENE-Y	21	23	Interestingly , following chemical desensitization , wild-type gene had dramatically reduced response to the nonelectrophile agonist chemical , whereas the triple chemical mutant gene retained its full response .	T9	T23	23478802
NA	CHEMICAL	GENE-N	2	3	Identification of chemical in the gene required for activation of gene .	T7	T33	10593931
NA	CHEMICAL	GENE-Y	2	10	Identification of chemical in the gene required for activation of gene .	T7	T34	10593931
NA	CHEMICAL	GENE-Y	3	6	To identify key chemical involved in gene activation , recombinant gene proteins containing chemical substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay .	T3	T13	10593931
NA	CHEMICAL	GENE-Y	3	10	To identify key chemical involved in gene activation , recombinant gene proteins containing chemical substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay .	T3	T14	10593931
NA	CHEMICAL	GENE-Y	5	6	To identify key chemical involved in gene activation , recombinant gene proteins containing chemical substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay .	T4	T13	10593931
NA	CHEMICAL	GENE-Y	5	10	To identify key chemical involved in gene activation , recombinant gene proteins containing chemical substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay .	T4	T14	10593931
NA	CHEMICAL	GENE-N	21	39	Substitutions for Ile ( 183 ) -Val ( 191 ) and Ser ( 195 ) -Ile ( 197 ) at the chemical terminus and for Ser ( 258 ) -Ser ( 264 ) at the chemical terminus of the gene markedly decreased gene coagulant activity .	T5	T16	10593931
NA	CHEMICAL	GENE-Y	21	42	Substitutions for Ile ( 183 ) -Val ( 191 ) and Ser ( 195 ) -Ile ( 197 ) at the chemical terminus and for Ser ( 258 ) -Ser ( 264 ) at the chemical terminus of the gene markedly decreased gene coagulant activity .	T5	T17	10593931
NA	CHEMICAL	GENE-N	35	39	Substitutions for Ile ( 183 ) -Val ( 191 ) and Ser ( 195 ) -Ile ( 197 ) at the chemical terminus and for Ser ( 258 ) -Ser ( 264 ) at the chemical terminus of the gene markedly decreased gene coagulant activity .	T6	T16	10593931
NA	CHEMICAL	GENE-Y	35	42	Substitutions for Ile ( 183 ) -Val ( 191 ) and Ser ( 195 ) -Ile ( 197 ) at the chemical terminus and for Ser ( 258 ) -Ser ( 264 ) at the chemical terminus of the gene markedly decreased gene coagulant activity .	T6	T17	10593931
CPR:9	CHEMICAL	GENE-Y	1	5	The chemical hydroxylation index reflects gene activity in healthy Japanese volunteers .	T14	T21	23435615
CPR:9	CHEMICAL	GENE-Y	2	24	PURPOSE : chemical has ( R ) - and ( S ) -enantiomers , which exhibit different pharmacokinetics ( PK ) among patients with gene genotype groups .	T13	T16	23435615
NA	CHEMICAL	GENE-Y	14	25	The aim of this study was to investigate whether the 1-point , 4-h postdose chemical hydroxylation index ( HI ) of chemical reflects the three gene genotype groups in Japanese individuals .	T8	T19	23435615
NA	CHEMICAL	GENE-Y	21	25	The aim of this study was to investigate whether the 1-point , 4-h postdose chemical hydroxylation index ( HI ) of chemical reflects the three gene genotype groups in Japanese individuals .	T9	T19	23435615
CPR:9	CHEMICAL	GENE-Y	4	13	Additionally , there was a significant difference in plasma concentrations of chemical among gene genotype groups , whereas no significant differences were observed in that of chemical .	T2	T15	23435615
CPR:9	CHEMICAL	GENE-Y	4	13	Additionally , there was a significant difference in plasma concentrations of chemical among gene genotype groups , whereas no significant differences were observed in that of chemical .	T3	T15	23435615
CPR:4	CHEMICAL	GENE-Y	14	8	One group of experimental animals was treated with gene ( gene ) inhibitor , chemical ( chemical , Sigma , St .	T4	T10	8606397
CPR:4	CHEMICAL	GENE-Y	14	10	One group of experimental animals was treated with gene ( gene ) inhibitor , chemical ( chemical , Sigma , St .	T4	T11	8606397
CPR:4	CHEMICAL	GENE-Y	16	8	One group of experimental animals was treated with gene ( gene ) inhibitor , chemical ( chemical , Sigma , St .	T5	T10	8606397
CPR:4	CHEMICAL	GENE-Y	16	10	One group of experimental animals was treated with gene ( gene ) inhibitor , chemical ( chemical , Sigma , St .	T5	T11	8606397
CPR:9	CHEMICAL	GENE-Y	6	6	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T8	T13	17289088
CPR:9	CHEMICAL	GENE-Y	6	18	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T8	T17	17289088
NA	CHEMICAL	GENE-N	6	27	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T8	T20	17289088
NA	CHEMICAL	GENE-N	6	31	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T8	T22	17289088
CPR:9	CHEMICAL	GENE-Y	13	6	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T11	T13	17289088
CPR:9	CHEMICAL	GENE-Y	13	18	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T11	T17	17289088
NA	CHEMICAL	GENE-N	13	27	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T11	T20	17289088
NA	CHEMICAL	GENE-N	13	31	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T11	T22	17289088
NA	CHEMICAL	GENE-Y	7	6	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T1	T13	17289088
NA	CHEMICAL	GENE-Y	7	18	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T1	T17	17289088
NA	CHEMICAL	GENE-N	7	27	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T1	T20	17289088
NA	CHEMICAL	GENE-N	7	31	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T1	T22	17289088
NA	CHEMICAL	GENE-Y	29	6	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T5	T13	17289088
NA	CHEMICAL	GENE-Y	29	18	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T5	T17	17289088
NA	CHEMICAL	GENE-N	29	27	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T5	T20	17289088
NA	CHEMICAL	GENE-N	29	31	Lymphocytes possess the essential components of a chemicalrgic system , including chemical ( chemical ) ; gene ( gene ) , its synthesizing enzyme ; and both gene ( mchemicalRs and gene , respectively ) .	T5	T22	17289088
NA	CHEMICAL	GENE-N	21	4	Stimulation of lymphocytes with gene , which activates T cells via the gene/gene complex , enhances the synthesis and release of chemical and up-regulates expression of gene and gene mRNAs .	T6	T23	17289088
NA	CHEMICAL	GENE-N	21	12	Stimulation of lymphocytes with gene , which activates T cells via the gene/gene complex , enhances the synthesis and release of chemical and up-regulates expression of gene and gene mRNAs .	T6	T24	17289088
NA	CHEMICAL	GENE-N	21	12	Stimulation of lymphocytes with gene , which activates T cells via the gene/gene complex , enhances the synthesis and release of chemical and up-regulates expression of gene and gene mRNAs .	T6	T25	17289088
NA	CHEMICAL	GENE-Y	21	8	Stimulation of lymphocytes with gene , which activates T cells via the gene/gene complex , enhances the synthesis and release of chemical and up-regulates expression of gene and gene mRNAs .	T6	T26	17289088
NA	CHEMICAL	GENE-Y	21	28	Stimulation of lymphocytes with gene , which activates T cells via the gene/gene complex , enhances the synthesis and release of chemical and up-regulates expression of gene and gene mRNAs .	T6	T27	17289088
NA	CHEMICAL	GENE-N	10	5	In addition , activation of gene and increases in intracellular chemical also enhance cholinergic activity in T cells , and gene ( gene ; gene/gene ) is an important mediator of leukocyte migration and T cell activation .	T7	T28	17289088
CPR:3	CHEMICAL	GENE-Y	10	20	In addition , activation of gene and increases in intracellular chemical also enhance cholinergic activity in T cells , and gene ( gene ; gene/gene ) is an important mediator of leukocyte migration and T cell activation .	T7	T29	17289088
CPR:3	CHEMICAL	GENE-Y	10	22	In addition , activation of gene and increases in intracellular chemical also enhance cholinergic activity in T cells , and gene ( gene ; gene/gene ) is an important mediator of leukocyte migration and T cell activation .	T7	T30	17289088
CPR:3	CHEMICAL	GENE-Y	10	24	In addition , activation of gene and increases in intracellular chemical also enhance cholinergic activity in T cells , and gene ( gene ; gene/gene ) is an important mediator of leukocyte migration and T cell activation .	T7	T31	17289088
CPR:3	CHEMICAL	GENE-Y	10	24	In addition , activation of gene and increases in intracellular chemical also enhance cholinergic activity in T cells , and gene ( gene ; gene/gene ) is an important mediator of leukocyte migration and T cell activation .	T7	T32	17289088
NA	CHEMICAL	GENE-Y	24	0	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T33	17289088
NA	CHEMICAL	GENE-N	24	10	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T34	17289088
NA	CHEMICAL	GENE-Y	24	14	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T35	17289088
NA	CHEMICAL	GENE-Y	24	16	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T36	17289088
NA	CHEMICAL	GENE-Y	24	18	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T37	17289088
NA	CHEMICAL	GENE-Y	24	21	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T38	17289088
NA	CHEMICAL	GENE-Y	24	32	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T39	17289088
NA	CHEMICAL	GENE-Y	24	34	Anti-gene monoclonal antibody ( mAb ) as well as antithymocyte gene containing antibodies against gene , gene and gene all increase gene activity , chemical synthesis and release , and expression of gene and gene mRNAs in T cells .	T9	T40	17289088
NA	CHEMICAL	GENE-Y	1	5	The chemical-lowering drug simvastatin inhibits gene signaling by binding to an allosteric site on gene ( gene chain ) , which leads to immunomodulation .	T10	T12	17289088
NA	CHEMICAL	GENE-Y	1	14	The chemical-lowering drug simvastatin inhibits gene signaling by binding to an allosteric site on gene ( gene chain ) , which leads to immunomodulation .	T10	T14	17289088
NA	CHEMICAL	GENE-Y	1	16	The chemical-lowering drug simvastatin inhibits gene signaling by binding to an allosteric site on gene ( gene chain ) , which leads to immunomodulation .	T10	T15	17289088
CPR:4	CHEMICAL	GENE-Y	3	5	We found that chemical abolishes anti-gene mAb-induced increases in lymphocytic cholinergic activity in a manner independent of its chemical-lowering activity .	T2	T16	17289088
NA	CHEMICAL	GENE-Y	18	5	We found that chemical abolishes anti-gene mAb-induced increases in lymphocytic cholinergic activity in a manner independent of its chemical-lowering activity .	T3	T16	17289088
NA	CHEMICAL	GENE-Y	8	27	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T10	T39	23485651
NA	CHEMICAL	GENE-Y	8	29	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T10	T40	23485651
NA	CHEMICAL	GENE-Y	10	27	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T11	T39	23485651
NA	CHEMICAL	GENE-Y	10	29	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T11	T40	23485651
NA	CHEMICAL	GENE-Y	13	27	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T12	T39	23485651
NA	CHEMICAL	GENE-Y	13	29	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T12	T40	23485651
NA	CHEMICAL	GENE-Y	13	27	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T13	T39	23485651
NA	CHEMICAL	GENE-Y	13	29	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T13	T40	23485651
NA	CHEMICAL	GENE-Y	22	27	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T14	T39	23485651
NA	CHEMICAL	GENE-Y	22	29	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T14	T40	23485651
NA	CHEMICAL	GENE-Y	22	27	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T15	T39	23485651
NA	CHEMICAL	GENE-Y	22	29	Altered antioxidant levels were demonstrated by depletion of chemical ( chemical ) , a decreased ratio of reduced chemical to chemical ( chemical/chemical ) and an increased gene ( gene ) activation .	T15	T40	23485651
NA	CHEMICAL	GENE-N	4	5	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T16	T41	23485651
NA	CHEMICAL	GENE-N	4	7	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T16	T42	23485651
NA	CHEMICAL	GENE-Y	4	13	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T16	T43	23485651
NA	CHEMICAL	GENE-Y	4	15	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T16	T44	23485651
NA	CHEMICAL	GENE-N	4	20	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T16	T46	23485651
NA	CHEMICAL	GENE-N	18	5	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T17	T41	23485651
NA	CHEMICAL	GENE-N	18	7	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T17	T42	23485651
NA	CHEMICAL	GENE-Y	18	13	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T17	T43	23485651
NA	CHEMICAL	GENE-Y	18	15	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T17	T44	23485651
NA	CHEMICAL	GENE-N	18	20	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T17	T46	23485651
NA	CHEMICAL	GENE-N	18	5	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T18	T41	23485651
NA	CHEMICAL	GENE-N	18	7	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T18	T42	23485651
NA	CHEMICAL	GENE-Y	18	13	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T18	T43	23485651
NA	CHEMICAL	GENE-Y	18	15	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T18	T44	23485651
NA	CHEMICAL	GENE-N	18	20	Enzyme assays showed that chemical dismutase ( gene ) activity was elevated whereas gene ( gene ) and chemical-chemical-transferase ( gene ) activities were depressed .	T18	T46	23485651
NA	CHEMICAL	GENE-Y	4	16	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T19	T47	23485651
NA	CHEMICAL	GENE-N	4	20	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T19	T48	23485651
NA	CHEMICAL	GENE-N	4	22	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T19	T49	23485651
NA	CHEMICAL	GENE-Y	19	16	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T20	T47	23485651
NA	CHEMICAL	GENE-N	19	20	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T20	T48	23485651
NA	CHEMICAL	GENE-N	19	22	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T20	T49	23485651
NA	CHEMICAL	GENE-Y	7	16	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T21	T47	23485651
NA	CHEMICAL	GENE-N	7	20	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T21	T48	23485651
NA	CHEMICAL	GENE-N	7	22	Further analyses revealed that chemical-QD exposure resulted in apoptosis , indicated by changes in levels of gene activity , chemical polymerase ( gene ) cleavage and chemical externalization .	T21	T49	23485651
CPR:3	CHEMICAL	GENE-Y	16	5	Extrinsic apoptotic pathway markers such as gene levels and gene activity increased as a result of chemical-QD exposure .	T23	T50	23485651
CPR:3	CHEMICAL	GENE-Y	16	5	Extrinsic apoptotic pathway markers such as gene levels and gene activity increased as a result of chemical-QD exposure .	T23	T51	23485651
NA	CHEMICAL	GENE-Y	12	14	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T26	23485651
NA	CHEMICAL	GENE-Y	12	19	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T27	23485651
NA	CHEMICAL	GENE-Y	12	16	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T28	23485651
NA	CHEMICAL	GENE-Y	12	29	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T29	23485651
NA	CHEMICAL	GENE-Y	12	33	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T30	23485651
NA	CHEMICAL	GENE-N	12	37	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T31	23485651
NA	CHEMICAL	GENE-N	12	39	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T32	23485651
NA	CHEMICAL	GENE-N	12	42	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T33	23485651
NA	CHEMICAL	GENE-N	12	45	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T34	23485651
NA	CHEMICAL	GENE-N	12	42	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T35	23485651
NA	CHEMICAL	GENE-N	12	50	Involvement of the intrinsic/mitochondrial apoptotic pathway was indicated by decreased levels of gene ( gene ) protein and mitochondrial gene , and by increased levels of mitochondrial gene ( gene ) and cytosolic gene . Further , gene ( gene ) such as gene ( JchemicalK ) , gene ( gene ) , and gene were all activated .	T2	T36	23485651
CPR:3	CHEMICAL	GENE-N	4	16	Our findings reveal that chemical-QDs cause oxidative stress , interfere with antioxidant defenses and activate protein gene , leading to apoptosis via both extrinsic and intrinsic pathways .	T3	T38	23485651
NA	CHEMICAL	GENE-N	25	26	Of the antihypertensive agents , methyldopa is now rarely prescribed and adverse effects are reported infrequently , whereas cases of liver injury associated with the chemical receptor and gene inhibitors are increasingly reported .	T10	T17	12016548
NA	CHEMICAL	GENE-Y	25	28	Of the antihypertensive agents , methyldopa is now rarely prescribed and adverse effects are reported infrequently , whereas cases of liver injury associated with the chemical receptor and gene inhibitors are increasingly reported .	T10	T18	12016548
NA	CHEMICAL	GENE-Y	5	12	Of the antidiabetic agents , chemical , chemical , chemical , and gene have been implicated in causing liver injury .	T11	T19	12016548
NA	CHEMICAL	GENE-Y	7	12	Of the antidiabetic agents , chemical , chemical , chemical , and gene have been implicated in causing liver injury .	T12	T19	12016548
NA	CHEMICAL	GENE-Y	9	12	Of the antidiabetic agents , chemical , chemical , chemical , and gene have been implicated in causing liver injury .	T13	T19	12016548
CPR:4	CHEMICAL	GENE-Y	2	11	Synthesis of chemical derivatives : discovery of a potent and selective gene inhibitor for the treatment of Alzheimer 's disease .	T7	T14	23313637
CPR:9	CHEMICAL	GENE-Y	8	0	gene ( gene ) mediates the degradation of chemical in a variety of tissues including brain .	T5	T8	23313637
CPR:9	CHEMICAL	GENE-Y	8	2	gene ( gene ) mediates the degradation of chemical in a variety of tissues including brain .	T5	T11	23313637
NA	CHEMICAL	GENE-N	8	10	Recent studies have demonstrated the importance of the chemical/chemical/chemical-responsive element-binding protein ( gene ) pathway to the process of learning and memory .	T1	T9	23313637
NA	CHEMICAL	GENE-N	8	12	Recent studies have demonstrated the importance of the chemical/chemical/chemical-responsive element-binding protein ( gene ) pathway to the process of learning and memory .	T1	T10	23313637
NA	CHEMICAL	GENE-N	8	10	Recent studies have demonstrated the importance of the chemical/chemical/chemical-responsive element-binding protein ( gene ) pathway to the process of learning and memory .	T2	T9	23313637
NA	CHEMICAL	GENE-N	8	12	Recent studies have demonstrated the importance of the chemical/chemical/chemical-responsive element-binding protein ( gene ) pathway to the process of learning and memory .	T2	T10	23313637
NA	CHEMICAL	GENE-N	8	10	Recent studies have demonstrated the importance of the chemical/chemical/chemical-responsive element-binding protein ( gene ) pathway to the process of learning and memory .	T3	T9	23313637
NA	CHEMICAL	GENE-N	8	12	Recent studies have demonstrated the importance of the chemical/chemical/chemical-responsive element-binding protein ( gene ) pathway to the process of learning and memory .	T3	T10	23313637
CPR:6	CHEMICAL	GENE-Y	2	11	Discovery of chemical and chemical as potent and selective chemical H3 receptor antagonists for the treatment of obesity ( Part I ) .	T3	T10	23591110
CPR:6	CHEMICAL	GENE-Y	4	11	Discovery of chemical and chemical as potent and selective chemical H3 receptor antagonists for the treatment of obesity ( Part I ) .	T4	T10	23591110
NA	CHEMICAL	GENE-Y	9	11	Discovery of chemical and chemical as potent and selective chemical H3 receptor antagonists for the treatment of obesity ( Part I ) .	T5	T10	23591110
CPR:6	CHEMICAL	GENE-Y	5	18	A series of structurally novel chemical was derived from optimization of the HTS lead as selective chemical H3 receptor ( gene ) antagonists .	T2	T6	23591110
CPR:6	CHEMICAL	GENE-Y	5	17	A series of structurally novel chemical was derived from optimization of the HTS lead as selective chemical H3 receptor ( gene ) antagonists .	T2	T7	23591110
NA	CHEMICAL	GENE-Y	16	18	A series of structurally novel chemical was derived from optimization of the HTS lead as selective chemical H3 receptor ( gene ) antagonists .	T1	T6	23591110
NA	CHEMICAL	GENE-Y	16	17	A series of structurally novel chemical was derived from optimization of the HTS lead as selective chemical H3 receptor ( gene ) antagonists .	T1	T7	23591110
NA	CHEMICAL	GENE-Y	3	3	However , plasma pro-gene and chemical concentrations were closely correlated ( P < .0001 ; r = 0.73 ) .	T1	T17	23539511
NA	CHEMICAL	GENE-N	5	10	Effects of the antidepressant/antipanic drug chemical on chemical and chemical transaminase in rat brain .	T29	T39	11775064
NA	CHEMICAL	GENE-N	7	10	Effects of the antidepressant/antipanic drug chemical on chemical and chemical transaminase in rat brain .	T30	T39	11775064
NA	CHEMICAL	GENE-N	9	10	Effects of the antidepressant/antipanic drug chemical on chemical and chemical transaminase in rat brain .	T31	T39	11775064
CPR:4	CHEMICAL	GENE-Y	3	10	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T24	T33	11775064
CPR:4	CHEMICAL	GENE-Y	3	34	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T24	T34	11775064
NA	CHEMICAL	GENE-Y	7	10	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T3	T33	11775064
NA	CHEMICAL	GENE-Y	7	34	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T3	T34	11775064
CPR:9	CHEMICAL	GENE-Y	27	10	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T9	T33	11775064
CPR:9	CHEMICAL	GENE-Y	27	34	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T9	T34	11775064
NA	CHEMICAL	GENE-Y	31	10	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T10	T33	11775064
NA	CHEMICAL	GENE-Y	31	34	Acute and chronic chemical administration increase brain chemical levels , an effect due , at least in part , to an inhibition of the activity of the chemical metabolizing enzyme , chemical transaminase ( gene ) .	T10	T34	11775064
NA	CHEMICAL	GENE-N	2	9	As with chemical , the metabolism of chemical involves a chemical-dependent transaminase .	T14	T35	11775064
CPR:9	CHEMICAL	GENE-N	7	9	As with chemical , the metabolism of chemical involves a chemical-dependent transaminase .	T15	T35	11775064
NA	CHEMICAL	GENE-N	9	9	As with chemical , the metabolism of chemical involves a chemical-dependent transaminase .	T16	T35	11775064
NA	CHEMICAL	GENE-N	10	27	In the study reported here , the effects of acute chemical treatment on the levels of various chemical , some of which are also metabolized by chemical-dependent transaminases were compared in rat whole brain .	T17	T36	11775064
CPR:9	CHEMICAL	GENE-N	17	27	In the study reported here , the effects of acute chemical treatment on the levels of various chemical , some of which are also metabolized by chemical-dependent transaminases were compared in rat whole brain .	T18	T36	11775064
NA	CHEMICAL	GENE-N	26	27	In the study reported here , the effects of acute chemical treatment on the levels of various chemical , some of which are also metabolized by chemical-dependent transaminases were compared in rat whole brain .	T19	T36	11775064
CPR:9	CHEMICAL	GENE-N	2	2	The elevation in brain chemical levels could be explained , at least in part , by a time- and dose-dependent inhibitory effect of chemical on chemical transaminase ( chemical-T ) , although as with chemical the increases are higher than expected from the degree of enzyme inhibition produced .	T23	T37	11775064
CPR:4	CHEMICAL	GENE-N	23	2	The elevation in brain chemical levels could be explained , at least in part , by a time- and dose-dependent inhibitory effect of chemical on chemical transaminase ( chemical-T ) , although as with chemical the increases are higher than expected from the degree of enzyme inhibition produced .	T25	T37	11775064
NA	CHEMICAL	GENE-N	2	2	The elevation in brain chemical levels could be explained , at least in part , by a time- and dose-dependent inhibitory effect of chemical on chemical transaminase ( chemical-T ) , although as with chemical the increases are higher than expected from the degree of enzyme inhibition produced .	T26	T37	11775064
NA	CHEMICAL	GENE-N	28	2	The elevation in brain chemical levels could be explained , at least in part , by a time- and dose-dependent inhibitory effect of chemical on chemical transaminase ( chemical-T ) , although as with chemical the increases are higher than expected from the degree of enzyme inhibition produced .	T27	T37	11775064
NA	CHEMICAL	GENE-N	34	2	The elevation in brain chemical levels could be explained , at least in part , by a time- and dose-dependent inhibitory effect of chemical on chemical transaminase ( chemical-T ) , although as with chemical the increases are higher than expected from the degree of enzyme inhibition produced .	T28	T37	11775064
CPR:9	CHEMICAL	GENE-N	9	9	In addition , we also showed that the elevation in chemical levels and the inhibition of chemical transaminase in the brain are retained after 14 days of chemical treatment , and that chemical produces a marked increase in extracellular levels of chemical .	T1	T32	11775064
NA	CHEMICAL	GENE-N	9	9	In addition , we also showed that the elevation in chemical levels and the inhibition of chemical transaminase in the brain are retained after 14 days of chemical treatment , and that chemical produces a marked increase in extracellular levels of chemical .	T2	T32	11775064
CPR:4	CHEMICAL	GENE-N	27	9	In addition , we also showed that the elevation in chemical levels and the inhibition of chemical transaminase in the brain are retained after 14 days of chemical treatment , and that chemical produces a marked increase in extracellular levels of chemical .	T4	T32	11775064
NA	CHEMICAL	GENE-N	32	9	In addition , we also showed that the elevation in chemical levels and the inhibition of chemical transaminase in the brain are retained after 14 days of chemical treatment , and that chemical produces a marked increase in extracellular levels of chemical .	T5	T32	11775064
NA	CHEMICAL	GENE-N	9	9	In addition , we also showed that the elevation in chemical levels and the inhibition of chemical transaminase in the brain are retained after 14 days of chemical treatment , and that chemical produces a marked increase in extracellular levels of chemical .	T6	T32	11775064
NA	CHEMICAL	GENE-Y	0	4	chemical : assessment of gene potency and selectivity .	T21	T42	15494548
NA	CHEMICAL	GENE-Y	3	3	The discovery of a gene ( gene ) led to the search for compounds that could selectively inhibit gene in humans while sparing chemical formation from gene .	T10	T31	15494548
NA	CHEMICAL	GENE-N	3	6	The discovery of a gene ( gene ) led to the search for compounds that could selectively inhibit gene in humans while sparing chemical formation from gene .	T10	T36	15494548
NA	CHEMICAL	GENE-Y	3	18	The discovery of a gene ( gene ) led to the search for compounds that could selectively inhibit gene in humans while sparing chemical formation from gene .	T10	T23	15494548
CPR:9	CHEMICAL	GENE-Y	3	26	The discovery of a gene ( gene ) led to the search for compounds that could selectively inhibit gene in humans while sparing chemical formation from gene .	T10	T29	15494548
CPR:4	CHEMICAL	GENE-Y	7	10	We report here the pharmacological properties of a third selective gene inhibitor , chemical , which is the most potent and in vitro selective of the marketed gene inhibitors that we have studied .	T15	T32	15494548
CPR:4	CHEMICAL	GENE-Y	7	27	We report here the pharmacological properties of a third selective gene inhibitor , chemical , which is the most potent and in vitro selective of the marketed gene inhibitors that we have studied .	T15	T33	15494548
CPR:4	CHEMICAL	GENE-Y	0	4	chemical potently inhibits recombinant gene , with an IC ( 50 ) of 0.005 microM ; this compares with IC values of 0.05 microM for chemical , 0.5 microM for chemical , and 5 microM for chemical .	T16	T39	15494548
CPR:4	CHEMICAL	GENE-Y	25	4	chemical potently inhibits recombinant gene , with an IC ( 50 ) of 0.005 microM ; this compares with IC values of 0.05 microM for chemical , 0.5 microM for chemical , and 5 microM for chemical .	T17	T39	15494548
CPR:4	CHEMICAL	GENE-Y	12	4	chemical potently inhibits recombinant gene , with an IC ( 50 ) of 0.005 microM ; this compares with IC values of 0.05 microM for chemical , 0.5 microM for chemical , and 5 microM for chemical .	T18	T39	15494548
CPR:4	CHEMICAL	GENE-Y	36	4	chemical potently inhibits recombinant gene , with an IC ( 50 ) of 0.005 microM ; this compares with IC values of 0.05 microM for chemical , 0.5 microM for chemical , and 5 microM for chemical .	T19	T39	15494548
NA	CHEMICAL	GENE-Y	4	6	Unique binding interactions of chemical with gene translate into a fast rate of inactivation of gene ( 110,000 M/s compared with 7000 M/s for chemical and 80 M/s for chemical ) .	T20	T40	15494548
CPR:4	CHEMICAL	GENE-Y	4	15	Unique binding interactions of chemical with gene translate into a fast rate of inactivation of gene ( 110,000 M/s compared with 7000 M/s for chemical and 80 M/s for chemical ) .	T20	T41	15494548
NA	CHEMICAL	GENE-Y	3	6	Unique binding interactions of chemical with gene translate into a fast rate of inactivation of gene ( 110,000 M/s compared with 7000 M/s for chemical and 80 M/s for chemical ) .	T1	T40	15494548
NA	CHEMICAL	GENE-Y	3	15	Unique binding interactions of chemical with gene translate into a fast rate of inactivation of gene ( 110,000 M/s compared with 7000 M/s for chemical and 80 M/s for chemical ) .	T1	T41	15494548
NA	CHEMICAL	GENE-Y	4	6	Unique binding interactions of chemical with gene translate into a fast rate of inactivation of gene ( 110,000 M/s compared with 7000 M/s for chemical and 80 M/s for chemical ) .	T2	T40	15494548
NA	CHEMICAL	GENE-Y	4	15	Unique binding interactions of chemical with gene translate into a fast rate of inactivation of gene ( 110,000 M/s compared with 7000 M/s for chemical and 80 M/s for chemical ) .	T2	T41	15494548
NA	CHEMICAL	GENE-Y	8	6	The overall saturation binding affinity for gene of chemical is 2.6 nM ( compared with 1.6 nM for chemical , 51 nM for chemical , and 260 nM for chemical ) , with a slow off-rate ( t ( 1/2 ) approximately 98 min ) .	T3	T22	15494548
NA	CHEMICAL	GENE-Y	18	6	The overall saturation binding affinity for gene of chemical is 2.6 nM ( compared with 1.6 nM for chemical , 51 nM for chemical , and 260 nM for chemical ) , with a slow off-rate ( t ( 1/2 ) approximately 98 min ) .	T4	T22	15494548
NA	CHEMICAL	GENE-Y	7	6	The overall saturation binding affinity for gene of chemical is 2.6 nM ( compared with 1.6 nM for chemical , 51 nM for chemical , and 260 nM for chemical ) , with a slow off-rate ( t ( 1/2 ) approximately 98 min ) .	T5	T22	15494548
NA	CHEMICAL	GENE-Y	29	6	The overall saturation binding affinity for gene of chemical is 2.6 nM ( compared with 1.6 nM for chemical , 51 nM for chemical , and 260 nM for chemical ) , with a slow off-rate ( t ( 1/2 ) approximately 98 min ) .	T6	T22	15494548
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene in a competitive fashion only at very high concentrations ( IC ( 50 ) = 150 microM ) .	T7	T24	15494548
NA	CHEMICAL	GENE-Y	5	18	Collectively , these data provide a mechanistic basis for the potency and in vitro selectivity of chemical for gene .	T8	T25	15494548
CPR:4	CHEMICAL	GENE-N	0	6	chemical showed similar activity in the gene assay ( gene IC ( 50 ) = 0.24 microM ; gene IC ( 50 ) = 21.9 microM ) .	T9	T26	15494548
CPR:4	CHEMICAL	GENE-Y	0	9	chemical showed similar activity in the gene assay ( gene IC ( 50 ) = 0.24 microM ; gene IC ( 50 ) = 21.9 microM ) .	T9	T27	15494548
CPR:4	CHEMICAL	GENE-Y	0	18	chemical showed similar activity in the gene assay ( gene IC ( 50 ) = 0.24 microM ; gene IC ( 50 ) = 21.9 microM ) .	T9	T28	15494548
NA	CHEMICAL	GENE-Y	17	4	The mRNA expression of gene ( gene ) and gene ( gene ) was not reduced by chemical .	T3	T18	17387686
NA	CHEMICAL	GENE-Y	17	6	The mRNA expression of gene ( gene ) and gene ( gene ) was not reduced by chemical .	T3	T19	17387686
NA	CHEMICAL	GENE-Y	17	9	The mRNA expression of gene ( gene ) and gene ( gene ) was not reduced by chemical .	T3	T20	17387686
NA	CHEMICAL	GENE-Y	17	11	The mRNA expression of gene ( gene ) and gene ( gene ) was not reduced by chemical .	T3	T21	17387686
NA	CHEMICAL	GENE-Y	10	3	Similarly , the gene enzyme level did not change after chemical exposure but gene could not be probed with the antibody available currently .	T4	T22	17387686
NA	CHEMICAL	GENE-Y	10	13	Similarly , the gene enzyme level did not change after chemical exposure but gene could not be probed with the antibody available currently .	T4	T23	17387686
NA	CHEMICAL	GENE-N	0	0	gene treatment of complex IV prevented trimer formation in the absence of chemical .	T1	T15	23172229
CPR:4	CHEMICAL	GENE-Y	9	13	Synthesis , biological evaluation , and molecular modeling of chemical derivatives as potent gene inhibitors with anti-heart-failure activity in vivo .	T5	T12	23199028
NA	CHEMICAL	GENE-Y	1	3	An chemical AT1 receptor antagonist , chemical augments chemical uptake and gene protein expression in 3T3-L1 adipocytes .	T9	T22	15498586
NA	CHEMICAL	GENE-Y	1	11	An chemical AT1 receptor antagonist , chemical augments chemical uptake and gene protein expression in 3T3-L1 adipocytes .	T9	T23	15498586
CPR:6	CHEMICAL	GENE-Y	6	3	An chemical AT1 receptor antagonist , chemical augments chemical uptake and gene protein expression in 3T3-L1 adipocytes .	T10	T22	15498586
CPR:3	CHEMICAL	GENE-Y	6	11	An chemical AT1 receptor antagonist , chemical augments chemical uptake and gene protein expression in 3T3-L1 adipocytes .	T10	T23	15498586
NA	CHEMICAL	GENE-Y	8	3	An chemical AT1 receptor antagonist , chemical augments chemical uptake and gene protein expression in 3T3-L1 adipocytes .	T11	T22	15498586
CPR:9	CHEMICAL	GENE-Y	8	11	An chemical AT1 receptor antagonist , chemical augments chemical uptake and gene protein expression in 3T3-L1 adipocytes .	T11	T23	15498586
NA	CHEMICAL	GENE-Y	7	9	Evidence has accumulated that some of the chemical AT1 receptor antagonists have gene-sensitizing property .	T4	T13	15498586
NA	CHEMICAL	GENE-N	7	12	Evidence has accumulated that some of the chemical AT1 receptor antagonists have gene-sensitizing property .	T4	T20	15498586
NA	CHEMICAL	GENE-N	6	8	We thus examined the effect of chemical on gene action using 3T3-L1 adipocytes .	T1	T12	15498586
CPR:3	CHEMICAL	GENE-Y	10	12	Treatment of both differentiating adipocytes and fully differentiated adipocytes with chemical caused a dose-dependent increase in mRNA levels for gene target genes such as gene and gene .	T3	T14	15498586
CPR:3	CHEMICAL	GENE-Y	10	12	Treatment of both differentiating adipocytes and fully differentiated adipocytes with chemical caused a dose-dependent increase in mRNA levels for gene target genes such as gene and gene .	T3	T15	15498586
CPR:3	CHEMICAL	GENE-Y	10	12	Treatment of both differentiating adipocytes and fully differentiated adipocytes with chemical caused a dose-dependent increase in mRNA levels for gene target genes such as gene and gene .	T3	T16	15498586
CPR:3	CHEMICAL	GENE-Y	3	8	By contrast , chemical attenuated chemical dehydrogenase type 1 mRNA level in differentiated adipocytes .	T5	T17	15498586
NA	CHEMICAL	GENE-Y	5	8	By contrast , chemical attenuated chemical dehydrogenase type 1 mRNA level in differentiated adipocytes .	T6	T17	15498586
